PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chen, ZM; Janes, K; Chen, C; Doyle, T; Bryant, L; Tosh, DK; Jacobson, KA; Salvemini, D				Chen, Zhoumou; Janes, Kali; Chen, Collin; Doyle, Tim; Bryant, Leesa; Tosh, Dilip K.; Jacobson, Kenneth A.; Salvemini, Daniela			Controlling murine and rat chronic pain through A(3) adenosine receptor activation	FASEB JOURNAL			English	Article						IB-MECA; MRS1898; paclitaxel; oxaliplatin; bortezomib	ISCHEMIC BRAIN-INJURY; SYNAPTIC-TRANSMISSION; RHEUMATOID-ARTHRITIS; INTERNATIONAL UNION; TARGET; CLASSIFICATION; A(3)-RECEPTORS; PHARMACOLOGY; NOMENCLATURE; OXALIPLATIN	Clinical management of chronic neuropathic pain is limited by marginal effectiveness and unacceptable side effects of current drugs. We demonstrate A(3) adenosine receptor (A(3)AR) agonism as a new target-based therapeutic strategy. The development of mechanoallodynia in a well-characterized mouse model of neuropathic pain following chronic constriction injury of the sciatic nerve was rapidly and dose-dependently reversed by the A(3)AR agonists: IB-MECA, its 2-chlorinated analog (Cl-IB-MECA), and the structurally distinct MRS1898. These effects were naloxone insensitive and thus are not opioid receptor mediated. IB-MECA was >= 1.6-fold more efficacious than morphine and >5-fold more potent. In addition, IB-MECA was equally efficacious as gabapentin (Neurontin) or amitriptyline, but respectively >350- and >75-fold more potent. Besides its potent standalone ability to reverse established mechanoallodynia, IB-MECA significantly increased the antiallodynic effects of all 3 analgesics. Moreover, neuropathic pain development in rats caused by widely used chemotherapeutics in the taxane (paclitaxel), platinum-complex (oxaliplatin), and proteasome-inhibitor (bortezomib) classes was blocked by IB-MECA without antagonizing their antitumor effect. A(3)AR agonist effects were blocked with A(3)AR antagonist MRS1523, but not with A(1)AR (DPCPX) or A(2)AAR (SCH-442416) antagonists. Our findings provide the scientific rationale and pharmacological basis for therapeutic development of A(3)AR agonists for chronic pain.-Chen, Z., Janes, K., Chen, C., Doyle, T., Bryant, L., Tosh, D. K., Jacobson, K. A., Salvemini, D. Controlling murine and rat chronic pain through A(3) adenosine receptor activation. FASEB J. 26, 1855-1865 (2012). www.fasebj.org	[Chen, Zhoumou; Janes, Kali; Chen, Collin; Doyle, Tim; Bryant, Leesa; Salvemini, Daniela] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA; [Tosh, Dilip K.; Jacobson, Kenneth A.] NIDDK, NIH, Bethesda, MD USA	Saint Louis University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Salvemini, D (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, 1402 S Grand Blvd, St Louis, MO 63104 USA.	salvemd@slu.edu	Jacobson, Kenneth Alan/A-1530-2009	Jacobson, Kenneth Alan/0000-0001-8104-1493	U.S. National Institutes of Health (NIH) [R01 DA024074]; St. Louis University; NIH National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK031117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024074] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Louis University; NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors are grateful to Dr. Gary Bennett, (McGill University, Montreal, QC, Canada) for critically reviewing our work. This work was supported by U.S. National Institutes of Health (NIH) grant R01 DA024074 (D. S.), St. Louis University President Research Funds (D. S.), and the NIH National Institute of Diabetes and Digestive and Kidney Diseases Intramural Program (K.A.J.). The authors report no conflicts of interest.	Abbracchio MP, 1997, BIOCHEM BIOPH RES CO, V241, P297, DOI 10.1006/bbrc.1997.7705; Bennett GJ, 2010, ONCOLOGIST, V15, P9, DOI 10.1634/theoncologist.2009-S503; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Cata JP, 2006, MINERVA ANESTESIOL, V72, P151; Chen GJ, 2006, J NEUROSCI RES, V84, P1848, DOI 10.1002/jnr.21071; Cohen S, 2011, J CELL PHYSIOL, V226, P2438, DOI 10.1002/jcp.22593; D'amour FE, 1941, J PHARMACOL EXP THER, V72, P74; Dahan L, 2009, BRIT J PHARMACOL, V158, P610, DOI 10.1111/j.1476-5381.2009.00341.x; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Farquhar-Smith Paul, 2011, Curr Opin Support Palliat Care, V5, P1, DOI 10.1097/SPC.0b013e328342f9cc; Fedorova IM, 2003, CELL MOL NEUROBIOL, V23, P431, DOI 10.1023/A:1023601007518; Finnerup NB, 2010, PAIN, V150, P573, DOI 10.1016/j.pain.2010.06.019; Fishman P, 2003, CURR TOP MED CHEM, V3, P463, DOI 10.2174/1568026033392147; Fishman P, 2002, ANTI-CANCER DRUG, V13, P437, DOI 10.1097/00001813-200206000-00001; Fishman P, 2012, DRUG DISCOV TODAY, V17, P359, DOI 10.1016/j.drudis.2011.10.007; FOLEY KM, 1995, ANTI-CANCER DRUG, V6, P4, DOI 10.1097/00001813-199504003-00002; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Gao ZG, 2009, PURINERG SIGNAL, V5, P31, DOI 10.1007/s11302-008-9107-1; Ge ZD, 2006, J PHARMACOL EXP THER, V319, P1200, DOI 10.1124/jpet.106.111351; Giannaccini G, 2008, NEUROCHEM RES, V33, P852, DOI 10.1007/s11064-007-9525-4; Hentschel S, 2003, RESTOR NEUROL NEUROS, V21, P55; JACOBSON KA, 1993, FEBS LETT, V336, P57, DOI 10.1016/0014-5793(93)81608-3; Jacobson KA, 1998, TRENDS PHARMACOL SCI, V19, P184, DOI 10.1016/S0165-6147(98)01203-6; Jacobson KA, 2011, ADV PHARMACOL, V61, P187, DOI 10.1016/B978-0-12-385526-8.00007-2; Joseph EK, 2004, EUR J NEUROSCI, V20, P2896, DOI 10.1111/j.1460-9568.2004.03750.x; Kiesman William F, 2009, Handb Exp Pharmacol, P25, DOI 10.1007/978-3-540-89615-9_2; KIM HO, 1994, J MED CHEM, V37, P3614, DOI 10.1021/jm00047a018; Kreckler LM, 2006, J PHARMACOL EXP THER, V317, P172, DOI 10.1124/jpet.105.096016; Kriedt Christopher L, 2010, J Exp Ther Oncol, V8, P287; Kumar V, 2009, EUR J PHARMACOL, V616, P7, DOI 10.1016/j.ejphar.2009.05.005; Li AH, 1998, J MED CHEM, V41, P3186, DOI 10.1021/jm980093j; Lopes LV, 2003, NEUROREPORT, V14, P1645, DOI 10.1097/00001756-200308260-00021; Loram LC, 2009, J NEUROSCI, V29, P14015, DOI 10.1523/JNEUROSCI.3447-09.2009; Ndengele MM, 2009, J PHARMACOL EXP THER, V329, P64, DOI 10.1124/jpet.108.146290; Ochaion A, 2009, CELL IMMUNOL, V258, P115, DOI 10.1016/j.cellimm.2009.03.020; PELLATDECEUNYNK C, 1995, BLOOD, V86, P4001, DOI 10.1182/blood.V86.10.4001.bloodjournal86104001; Polomano RC, 2001, PAIN, V94, P293, DOI 10.1016/S0304-3959(01)00363-3; Poulsen SA, 1998, BIOORGAN MED CHEM, V6, P619, DOI 10.1016/S0968-0896(98)00038-8; RANDALL LO, 1957, ARCH INT PHARMACOD T, V111, P409; Ru F, 2011, AM J PHYSIOL-GASTR L, V300, pG485, DOI 10.1152/ajpgi.00361.2010; Rubaj A, 2003, BEHAV BRAIN RES, V141, P11, DOI 10.1016/S0166-4328(02)00314-5; Shah MR, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-84; Shen H, 2005, STROKE, V36, P654, DOI 10.1161/01.STR.0000155747.15679.04; Silverman MH, 2008, J RHEUMATOL, V35, P41; Taliani S, 2010, CURR TOP MED CHEM, V10, P942, DOI 10.2174/156802610791293109; Tchilibon S, 2005, J MED CHEM, V48, P1745, DOI 10.1021/jm049580r; Torrance N, 2006, J PAIN, V7, P281, DOI 10.1016/j.jpain.2005.11.008; Von Lubitz DKJE, 1999, EUR J PHARMACOL, V367, P157, DOI 10.1016/S0014-2999(98)00977-7; Wang ZQ, 2004, J PHARMACOL EXP THER, V309, P869, DOI 10.1124/jpet.103.064154; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; Wunderlich JE, 2008, AM J PHYSIOL-GASTR L, V294, pG554, DOI 10.1152/ajpgi.00500.2007; Yi DH, 1997, ARCH BIOCHEM BIOPHYS, V344, P253, DOI 10.1006/abbi.1997.0218; Yoon MH, 2005, ANESTH ANALG, V101, P1417, DOI 10.1213/01.ANE.0000180994.10087.6F; Zhang M, 2010, NEUROCHEM INT, V56, P35, DOI 10.1016/j.neuint.2009.08.011; Zheng HE, 2011, EXP NEUROL, V232, P154, DOI 10.1016/j.expneurol.2011.08.016; Zheng J, 2007, AM J PHYSIOL-HEART C, V293, pH3685, DOI 10.1152/ajpheart.00819.2007; Zylka MJ, 2011, TRENDS MOL MED, V17, P188, DOI 10.1016/j.molmed.2010.12.006	58	83	83	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2012	26	5					1855	1865		10.1096/fj.11-201541	http://dx.doi.org/10.1096/fj.11-201541			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22345405	Green Published			2022-12-25	WOS:000303680800014
J	Malik, P; Tabarraei, A; Kehlenbach, RH; Korfali, N; Iwasawa, R; Graham, SV; Schirmer, EC				Malik, Poonam; Tabarraei, Alijan; Kehlenbach, Ralph H.; Korfali, Nadia; Iwasawa, Ryota; Graham, Sheila V.; Schirmer, Eric C.			Herpes Simplex Virus ICP27 Protein Directly Interacts with the Nuclear Pore Complex through Nup62, Inhibiting Host Nucleocytoplasmic Transport Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPORT; REGULATORY PROTEIN; BINDING-PROTEIN; GENE-REGULATION; CAPSID PROTEIN; HNRNP A1; ALPHA PROTEIN-ICP27; KARYOPHERIN-BETA; IMPORT RECEPTORS; ELEMENT CTE	The herpes simplex virus ICP27 protein is important for the expression and nuclear export of viral mRNAs. Although several binding sites have been mapped along the ICP27 sequence for various RNA and protein partners, including the transport receptor TAP of the host cell nuclear transport machinery, several aspects of ICP27 trafficking through the nuclear pore complex remain unclear. We investigated if ICP27 could interact directly with the nuclear pore complex itself, finding that ICP27 directly binds the core nucleoporin Nup62. This is confirmed through co-immunoprecipitation and in vitro binding assays with purified components. Mapping with ICP27 deletion and point mutants further shows that the interaction requires sequences in both the N and C termini of ICP27. Expression of wild type ICP27 protein inhibited both classical, importin alpha/beta-dependent and transportin-dependent nuclear import. In contrast, an ICP27 point mutant that does not interact with Nup62 had no such inhibitory effect. We suggest that ICP27 association with Nup62 provides additional binding sites at the nuclear pore for ICP27 shuttling, thus supporting ICP27-mediated transport. We propose that ICP27 competes with some host cell transport receptors for binding, resulting in inhibition of those host transport pathways.	[Malik, Poonam] Univ Edinburgh, Inst Cell Biol, Sch Biol Sci, Ctr Translat & Chem Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Malik, Poonam; Korfali, Nadia; Iwasawa, Ryota; Schirmer, Eric C.] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Malik, Poonam; Tabarraei, Alijan; Graham, Sheila V.] Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow G61 1QH, Lanark, Scotland; [Kehlenbach, Ralph H.] Univ Gottingen, Zentrum Biochem & Mol Zellbiol, D-37073 Gottingen, Germany	University of Edinburgh; University of Edinburgh; University of Glasgow; University of Gottingen	Malik, P (corresponding author), Univ Edinburgh, Inst Cell Biol, Sch Biol Sci, Ctr Translat & Chem Biol, Michael Swann Bldg,Kings Bldg,Mayfield Rd, Edinburgh EH9 3JR, Midlothian, Scotland.	p.malik@ed.ac.uk; sheila.graham@gla.ac.uk	Tabarraei, Alijan/D-4954-2016; Malik, Poonam/A-1756-2008	Tabarraei, Alijan/0000-0002-8167-5469; Malik, Poonam/0000-0002-1733-722X; Graham, Sheila/0000-0002-7140-8279; Schirmer, Eric/0000-0003-2635-1338; Kehlenbach, Ralph/0000-0003-4920-9916	Royal Society UK [RG090330]; Medical Research Council [G9826324]; Wellcome Trust [076616]; Wellcome Trust Centre for Cell Biology [077707]; Royal Society [DH051766, SS072172]; Education Section of the Ministry of Health and Medical Sciences, Iran; MRC [G9826324] Funding Source: UKRI	Royal Society UK(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Wellcome Trust Centre for Cell Biology(Wellcome Trust); Royal Society(Royal Society of London); Education Section of the Ministry of Health and Medical Sciences, Iran; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Royal Society UK Research Grant RG090330 (to P. M.) and Medical Research Council Program Grant G9826324 (to J. Barklie Clements/S. V. G.). This work was also supported by the Wellcome Trust through Senior Research Fellowship 076616 (to E. C. S.) and Wellcome Trust Centre for Cell Biology core funding 077707.; Recipient of Royal Society Research Fellowship Award DH051766.; Supported by a Ph.D. studentship from the Education Section of the Ministry of Health and Medical Sciences, Iran.; Supported by Royal Society Undergraduate Summer Studentship SS072172 (to P. M.).	Arnold M, 2006, J BIOL CHEM, V281, P20883, DOI 10.1074/jbc.M602189200; Aubert M, 2001, J VIROL, V75, P1013, DOI 10.1128/JVI.75.2.1013-1030.2001; Bachi A, 2000, RNA, V6, P136, DOI 10.1017/S1355838200991994; Bonifaci N, 1997, P NATL ACAD SCI USA, V94, P5055, DOI 10.1073/pnas.94.10.5055; Braun IC, 1999, EMBO J, V18, P1953, DOI 10.1093/emboj/18.7.1953; Bryant HE, 2000, J VIROL, V74, P11322, DOI 10.1128/JVI.74.23.11322-11328.2000; Chen IHB, 2005, J VIROL, V79, P3949, DOI 10.1128/JVI.79.7.3949-3961.2005; Chen IHB, 2002, J VIROL, V76, P12877, DOI 10.1128/JVI.76.24.12877-12889.2002; Copeland AM, 2009, J VIROL, V83, P1660, DOI 10.1128/JVI.01139-08; CULLEN BR, 1994, INFECT AGENT DIS, V3, P68; Darshan MS, 2004, J VIROL, V78, P12179, DOI 10.1128/JVI.78.22.12179-12188.2004; Ellison KS, 2000, J VIROL, V74, P7307, DOI 10.1128/JVI.74.16.7307-7319.2000; Ellison KS, 2005, J VIROL, V79, P4120, DOI 10.1128/JVI.79.7.4120-4131.2005; Escudero-Paunetto L, 2010, VIROLOGY, V401, P155, DOI 10.1016/j.virol.2010.02.023; Faria PA, 2005, MOL CELL, V17, P93, DOI 10.1016/j.molcel.2004.11.023; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; FLACH J, 1994, MOL CELL BIOL, V14, P8399, DOI 10.1128/MCB.14.12.8399; Fontaine-Rodriguez EC, 2008, J VIROL, V82, P3538, DOI 10.1128/JVI.02395-07; Fontoura BMA, 2005, IUBMB LIFE, V57, P65, DOI 10.1080/15216540500078608; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fridell RA, 1997, J CELL SCI, V110, P1325; GERACE L, 1982, J CELL BIOL, V95, P826, DOI 10.1083/jcb.95.3.826; Gruffat H, 2002, J VIROL, V76, P9635, DOI 10.1128/JVI.76.19.9635-9644.2002; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; Gustin KE, 2003, VIRUS RES, V95, P35, DOI 10.1016/S0168-1702(03)00165-5; Gustin KE, 2002, J VIROL, V76, P8787, DOI 10.1128/JVI.76.17.8787-8796.2002; Gustin KE, 2001, EMBO J, V20, P240, DOI 10.1093/emboj/20.1.240; Han Z, 2006, J VIROL, V80, P5251, DOI 10.1128/JVI.02570-05; HARDWICKE MA, 1994, J VIROL, V68, P4797, DOI 10.1128/JVI.68.8.4797-4810.1994; Hernandez FP, 2010, J VIROL, V84, P4124, DOI 10.1128/JVI.02319-09; Hiriart E, 2003, J BIOL CHEM, V278, P335, DOI 10.1074/jbc.M208656200; Hofemeister H, 2008, J VIROL, V82, P8392, DOI 10.1128/JVI.00951-08; Hutten S, 2008, MOL BIOL CELL, V19, P2300, DOI 10.1091/mbc.E07-12-1279; Johnson LA, 2009, J VIROL, V83, P6335, DOI 10.1128/JVI.00375-09; KAMBACH C, 1992, J CELL BIOL, V118, P11, DOI 10.1083/jcb.118.1.11; Koffa MD, 2001, EMBO J, V20, P5769, DOI 10.1093/emboj/20.20.5769; Larralde O, 2006, J VIROL, V80, P1588, DOI 10.1128/JVI.80.3.1588-1591.2006; Lengyel J, 2002, J VIROL, V76, P11866, DOI 10.1128/JVI.76.23.11866-11879.2002; Lengyel J, 2006, VIROLOGY, V352, P368, DOI 10.1016/j.virol.2006.04.044; Li YZ, 1998, P NATL ACAD SCI USA, V95, P4864, DOI 10.1073/pnas.95.9.4864; Lilley CE, 2001, J VIROL, V75, P4343, DOI 10.1128/JVI.75.9.4343-4356.2001; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; MACAULAY C, 1995, J BIOL CHEM, V270, P254, DOI 10.1074/jbc.270.1.254; Malik P, 2004, J BIOL CHEM, V279, P33001, DOI 10.1074/jbc.M313008200; Malik P, 2010, CELL MOL LIFE SCI, V67, P1353, DOI 10.1007/s00018-010-0257-2; MCCARTHY AM, 1989, J VIROL, V63, P18, DOI 10.1128/JVI.63.1.18-27.1989; Mears WE, 1996, J VIROL, V70, P7445, DOI 10.1128/JVI.70.11.7445-7453.1996; Mears WE, 1998, VIROLOGY, V242, P128, DOI 10.1006/viro.1997.9006; MEARS WE, 1995, J VIROL, V69, P935, DOI 10.1128/JVI.69.2.935-947.1995; MEYER BE, 1994, GENE DEV, V8, P1538, DOI 10.1101/gad.8.13.1538; MICHAEL WM, 1995, CELL, V83, P415; Nelson LM, 2003, VIROLOGY, V306, P162, DOI 10.1016/S0042-6822(02)00025-9; Park N, 2010, J BIOL CHEM, V285, P28796, DOI 10.1074/jbc.M110.143404; Pasdeloup D, 2009, J VIROL, V83, P6610, DOI 10.1128/JVI.02655-08; Pasquinelli AE, 1997, EMBO J, V16, P7500, DOI 10.1093/emboj/16.24.7500; Pearson A, 2004, J VIROL, V78, P23, DOI 10.1128/JVI.78.1.23-32.2004; Pellet P. E., 2007, FIELDS VIROLOGY, P2501; Petersen JM, 2001, P NATL ACAD SCI USA, V98, P8590, DOI 10.1073/pnas.151240998; PHELAN A, 1993, P NATL ACAD SCI USA, V90, P9056, DOI 10.1073/pnas.90.19.9056; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; Pritchard CEJ, 1999, J CELL BIOL, V145, P237, DOI 10.1083/jcb.145.2.237; RICE SA, 1988, J VIROL, V62, P3814, DOI 10.1128/JVI.62.10.3814-3823.1988; RICE SA, 1990, J VIROL, V64, P1704, DOI 10.1128/JVI.64.4.1704-1715.1990; RICE SA, 1994, J VIROL, V68, P823, DOI 10.1128/JVI.68.2.823-833.1994; RICE SA, 1993, J VIROL, V67, P1778, DOI 10.1128/JVI.67.4.1778-1787.1993; Rojas S, 2010, J VIROL, V84, P2200, DOI 10.1128/JVI.00917-09; Saavedra C, 1997, CURR BIOL, V7, P619, DOI 10.1016/S0960-9822(06)00288-0; Sandri-Goldin RM, 2008, FRONT BIOSCI-LANDMRK, V13, P5241, DOI 10.2741/3078; Satterly N, 2007, P NATL ACAD SCI USA, V104, P1853, DOI 10.1073/pnas.0610977104; Schmitt I, 2001, J BIOL CHEM, V276, P42355, DOI 10.1074/jbc.M103916200; SEKULOVICH RE, 1988, J VIROL, V62, P4510, DOI 10.1128/JVI.62.12.4510-4522.1988; SIOMI H, 1995, J CELL BIOL, V129, P551, DOI 10.1083/jcb.129.3.551; Smith RWP, 2005, BIOCHEM SOC T, V33, P499, DOI 10.1042/BST0330499; Soliman TM, 2000, J VIROL, V74, P2814, DOI 10.1128/JVI.74.6.2814-2825.2000; Soliman TM, 2000, J VIROL, V74, P7600, DOI 10.1128/JVI.74.16.7600-7609.2000; Souki SK, 2009, J VIROL, V83, P5309, DOI 10.1128/JVI.00238-09; Strambio-De-Castillia C, 2010, NAT REV MOL CELL BIO, V11, P490, DOI 10.1038/nrm2928; Strasser K, 2000, EMBO J, V19, P410, DOI 10.1093/emboj/19.3.410; Tsuji T, 2007, J BIOL CHEM, V282, P13875, DOI 10.1074/jbc.M611629200; Wagstaff KM, 2009, TRAFFIC, V10, P1188, DOI 10.1111/j.1600-0854.2009.00937.x; Wente SR, 2000, SCIENCE, V288, P1374, DOI 10.1126/science.288.5470.1374; Zhi Y, 1999, J VIROL, V73, P3246, DOI 10.1128/JVI.73.4.3246-3257.1999; Zhi Y, 1999, VIROLOGY, V257, P341, DOI 10.1006/viro.1999.9698	84	38	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12277	12292		10.1074/jbc.M111.331777	http://dx.doi.org/10.1074/jbc.M111.331777			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334672	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000302782200068
J	Choi, HS; Su, WM; Han, GS; Plote, D; Xu, Z; Carman, GM				Choi, Hyeon-Son; Su, Wen-Min; Han, Gil-Soo; Plote, Devin; Xu, Zhi; Carman, George M.			Pho85p-Pho80p Phosphorylation of Yeast Pah1p Phosphatidate Phosphatase Regulates Its Activity, Location, Abundance, and Function in Lipid Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MEMBRANE GROWTH; PROTEIN-KINASE-A; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID-SYNTHESIS; ACID-PHOSPHATASE; MULTISITE PHOSPHORYLATION; ORTHOLOGUE PAH1P; CTP SYNTHETASE; BUDDING YEAST; STABILITY	The yeast Pah1p phosphatidate phosphatase, which catalyzes the penultimate step in the synthesis of triacylglycerol and plays a role in the transcriptional regulation of phospholipid synthesis genes, is a cytosolic enzyme that associates with the nuclear/endoplasmic reticulum membrane to catalyze the dephosphorylation of phosphatidate to yield diacylglycerol. Pah1p is phosphorylated on seven (Ser-110, Ser-114, Ser-168, Ser-602, Thr-723, Ser-744, and Ser-748) sites that are targets for proline-directed protein kinases. In this work, we showed that the seven sites are phosphorylated by Pho85p-Pho80p, a protein kinase-cyclin complex known to regulate a variety of cellular processes. The phosphorylation of recombinant Pah1p was time-and dose-dependent and dependent on the concentrations of ATP (3.7 mu M) and Pah1p (0.25 mu M). Phosphorylation reduced (6-fold) the catalytic efficiency (V-max/K-m) of Pah1p and reduced (3-fold) its interaction (K-d) with liposomes. Alanine mutations of the seven sites ablated the inhibitory effect that Pho85p-Pho80p had on Pah1p activity and on the interaction with liposomes. Analysis of pho85 Delta mutant cells, phosphate-starved wild type cells, and cells expressing phosphorylation-deficient forms of Pah1p indicated that loss of Pho85p-Pho80p phosphorylation reduced Pah1p abundance. In contrast, lack of Nem1p-Spo7p, the phosphatase complex that dephosphorylates Pah1p at the nuclear/endoplasmic reticulum membrane, stabilized Pah1p abundance. Although loss of phosphorylation caused a decrease in abundance, a greater amount of Pah1p was associated with membranes when compared with phosphorylated enzyme, and the loss of phosphorylation allowed bypass of the Nem1p-Spo7p requirement for Pah1p function in the synthesis of triacylglycerol.	[Carman, George M.] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu		Plote, Devin/0000-0002-7715-4142; Su, Wen-Min/0000-0002-1861-6335	National Institutes of Health from USPHS [GM-50679]; National Institutes of Health [NS046593]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS046593] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-50679 from the USPHS.; We thank Erin O'Shea for the pho85 Delta mutant and the plasmids to express Pho85p-Pho80p. We also acknowledge Richard Ludescher for the use of the fluorometer used in the liposome binding assays. The mass spectrometry data were obtained from an Orbitrap instrument funded in part by National Institutes of Health Grant NS046593 for the support of the University of Medicine and Dentistry of New Jersey Neuroproteomics Core Facility.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; BASHFORD CL, 1979, BIOPHYS J, V25, P63, DOI 10.1016/S0006-3495(79)85278-9; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Carroll AS, 2002, TRENDS BIOCHEM SCI, V27, P87, DOI 10.1016/S0968-0004(01)02040-0; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Choi HS, 2010, J BIOL CHEM, V285, P11526, DOI 10.1074/jbc.M110.100727; Dephoure N, 2005, P NATL ACAD SCI USA, V102, P17940, DOI 10.1073/pnas.0509080102; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Eastmond PJ, 2010, PLANT CELL, V22, P2796, DOI 10.1105/tpc.109.071423; Enserink JM, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-11; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Golden A, 2009, J CELL SCI, V122, P1970, DOI 10.1242/jcs.044743; Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han GS, 2005, J BIOL CHEM, V280, P38328, DOI 10.1074/jbc.M509622200; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Henderson RJ, 1992, LIPID ANAL PRACTICAL, P65; Huang D, 2007, MOL MICROBIOL, V66, P303, DOI 10.1111/j.1365-2958.2007.05914.x; Huffman TA, 2002, P NATL ACAD SCI USA, V99, P1047, DOI 10.1073/pnas.022634399; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jeffery DA, 2001, J MOL BIOL, V306, P997, DOI 10.1006/jmbi.2000.4417; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Komeili A, 1999, SCIENCE, V284, P977, DOI 10.1126/science.284.5416.977; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li Y, 2002, J BIOL CHEM, V277, P11352, DOI 10.1074/jbc.M109062200; LIN YP, 1990, J BIOL CHEM, V265, P166; MACDONALD JIS, 1994, J BIOL CHEM, V269, P10529; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; Mah Angie S., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-22; Moffat J, 2000, Prog Cell Cycle Res, V4, P97; MORLOCK KR, 1988, J BACTERIOL, V170, P3561, DOI 10.1128/jb.170.8.3561-3566.1988; Mouillon JM, 2006, FEMS YEAST RES, V6, P171, DOI 10.1111/j.1567-1364.2006.00036.x; Nakamura Y, 2009, P NATL ACAD SCI USA, V106, P20978, DOI 10.1073/pnas.0907173106; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Reddy VS, 2008, J BIOL CHEM, V283, P8846, DOI 10.1074/jbc.M706752200; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; SCHNEIDER KR, 1994, SCIENCE, V266, P122, DOI 10.1126/science.7939631; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; SIKORSKI RS, 1989, GENETICS, V122, P19; SMITH SW, 1957, J BIOL CHEM, V228, P915; Soto-Cardalda A, 2012, J BIOL CHEM, V287, P968, DOI 10.1074/jbc.M111.313130; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Ugrankar R, 2011, MOL CELL BIOL, V31, P1646, DOI 10.1128/MCB.01335-10; Valente V, 2010, FEBS J, V277, P4775, DOI 10.1111/j.1742-4658.2010.07883.x; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; WU WI, 1994, J BIOL CHEM, V269, P29495; WU WI, 1993, J BIOL CHEM, V268, P13830; Wu WI, 1996, BIOCHEMISTRY-US, V35, P3790, DOI 10.1021/bi952808f; Xu Z, 2012, J LIPID RES, V53, P522, DOI 10.1194/jlr.M022798; YANG WL, 1995, J BIOL CHEM, V270, P14983, DOI 10.1074/jbc.270.25.14983	68	75	78	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11290	11301		10.1074/jbc.M112.346023	http://dx.doi.org/10.1074/jbc.M112.346023			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334681	Green Published, hybrid			2022-12-25	WOS:000302780100060
J	Fazly, A; Li, Q; Hu, Q; Mer, G; Horazdovsky, B; Zhang, ZG				Fazly, Ahmed; Li, Qing; Hu, Qi; Mer, Georges; Horazdovsky, Bruce; Zhang, Zhiguo			Histone Chaperone Rtt106 Promotes Nucleosome Formation Using (H3-H4)(2) Tetramers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN ASSEMBLY FACTOR-1; DNA-REPLICATION INVITRO; STRUCTURAL BASIS; H3; ACETYLATION; LYSINE-56; ASF1; PURIFICATION; SUBUNIT; REPAIR	The yeast histone chaperone Rtt106 is involved in de novo assembly of newly synthesized histones into nucleosomes during DNA replication and plays a role in regulating heterochromatin silencing and maintaining genomic integrity. The interaction of Rtt106 with H3-H4 is modulated by acetylation of H3 lysine 56 catalyzed by the lysine acetyltransferase Rtt109. Using affinity purification strategies, we demonstrate that Rtt106 interacts with (H3-H4)(2) heterotetramers in vivo. In addition, we show that Rtt106 undergoes homo-oligomerization in vivo and in vitro, and mutations in the N-terminal homodimeric domain of Rtt106 that affect formation of Rtt106 oligomers compromise the function of Rtt106 in transcriptional silencing and response to genotoxic stress and the ability of Rtt106 to bind (H3-H4)(2). These results indicate that Rtt106 deposits H3-H4 heterotetramers onto DNA and provide the first description of a H3-H4 chaperone binding to (H3-H4)(2) heterotetramers in vivo.	[Fazly, Ahmed; Li, Qing; Hu, Qi; Mer, Georges; Horazdovsky, Bruce; Zhang, Zhiguo] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic	Zhang, ZG (corresponding author), 200 1st St SW, Rochester, MN 55905 USA.	zhang.zhiguo@mayo.edu	hu, qi/K-1462-2014; Mer, Georges/AAT-4946-2021	Mer, Georges/0000-0002-1900-1578; /0000-0003-3279-0425	National Institutes of Health [GM72719, GM81838]; NATIONAL CANCER INSTITUTE [R01CA132878, P50CA108961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081838, R01GM072719] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported, in whole or in part, by National Institutes of Health Grants GM72719 and GM81838.	ALLIS C.D., 2007, EPIGENETICS; Bowman A, 2011, MOL CELL, V41, P398, DOI 10.1016/j.molcel.2011.01.025; Chodaparambil JV, 2006, E SCHERING RES FDN W, V57, P29; Das C, 2010, TRENDS BIOCHEM SCI, V35, P476, DOI 10.1016/j.tibs.2010.04.001; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; English CM, 2005, BIOCHEMISTRY-US, V44, P13673, DOI 10.1021/bi051333h; Gerard A, 2006, EMBO REP, V7, P817, DOI 10.1038/sj.embor.7400750; Han JH, 2007, J BIOL CHEM, V282, P14158, DOI 10.1074/jbc.M700611200; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Huang SB, 2005, P NATL ACAD SCI USA, V102, P13410, DOI 10.1073/pnas.0506176102; Huang SB, 2007, EMBO J, V26, P2274, DOI 10.1038/sj.emboj.7601670; Ito T, 1996, MOL CELL BIOL, V16, P3112; JACKSON V, 1981, CELL, V23, P121, DOI 10.1016/0092-8674(81)90277-4; Jasencakova Z, 2010, MOL CELL, V37, P736, DOI 10.1016/j.molcel.2010.01.033; LEFFAK IM, 1977, CELL, V12, P837, DOI 10.1016/0092-8674(77)90282-3; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; Quivy JP, 2001, EMBO J, V20, P2015, DOI 10.1093/emboj/20.8.2015; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; RUSSEV G, 1981, NUCLEIC ACIDS RES, V9, P4129, DOI 10.1093/nar/9.16.4129; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; STILLMAN B, 1986, CELL, V45, P555, DOI 10.1016/0092-8674(86)90287-4; Su D, 2012, NATURE, V483, P104, DOI 10.1038/nature10861; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; van Holde KE., 1989, SPRINGER SERIES MOL; Zhou H, 2006, BIOCHEMISTRY-US, V45, P2852, DOI 10.1021/bi0521083	29	33	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10753	10760		10.1074/jbc.M112.347450	http://dx.doi.org/10.1074/jbc.M112.347450			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22337870	Green Published, hybrid			2022-12-25	WOS:000302780100004
J	Kuo, TY; Hsi, E; Yang, IP; Tsai, PC; Wang, JY; Juo, SHH				Kuo, Tai-Yue; Hsi, Edward; Yang, I-Ping; Tsai, Pei-Chien; Wang, Jaw-Yuan; Juo, Suh-Hang Hank			Computational Analysis of mRNA Expression Profiles Identifies MicroRNA-29a/c as Predictor of Colorectal Cancer Early Recurrence	PLOS ONE			English	Article							BIOCONDUCTOR PACKAGE; MIRNAS; IMPACT; TOOLS; SURVEILLANCE; BIOMARKERS; MIRBASE; BIOLOGY; COLON	Colorectal cancer (CRC) is one of the leading malignant cancers with a rapid increase in incidence and mortality. The recurrences of CRC after curative resection are sometimes unavoidable and often take place within the first year after surgery. MicroRNAs may serve as biomarkers to predict early recurrence of CRC, but identifying them from over 1,400 known human microRNAs is challenging and costly. An alternative approach is to analyze existing expression data of messenger RNAs (mRNAs) because generally speaking the expression levels of microRNAs and their target mRNAs are inversely correlated. In this study, we extracted six mRNA expression data of CRC in four studies (GSE12032, GSE17538, GSE4526 and GSE17181) from the gene expression omnibus (GEO). We inferred microRNA expression profiles and performed computational analysis to identify microRNAs associated with CRC recurrence using the IMRE method based on the MicroCosm database that includes 568,071 microRNA-target connections between 711 microRNAs and 20,884 gene targets. Two microRNAs, miR-29a and miR-29c, were disclosed and further meta-analysis of the six mRNA expression datasets showed that these two microRNAs were highly significant based on the Fisher p-value combination (p = 9.14x10(-9) for miR-29a and p = 1.14x10(-6) for miR-29c). Furthermore, these two microRNAs were experimentally tested in 78 human CRC samples to validate their effect on early recurrence. Our empirical results showed that the two microRNAs were significantly down-regulated (p = 0.007 for miR-29a and p = 0.007 for miR-29c) in the early-recurrence patients. This study shows the feasibility of using mRNA profiles to indicate microRNAs. We also shows miR-29a/c could be potential biomarkers for CRC early recurrence.	[Kuo, Tai-Yue; Yang, I-Ping; Tsai, Pei-Chien; Wang, Jaw-Yuan; Juo, Suh-Hang Hank] Kaohsiung Med Univ, Coll Med, Dept Med Genet, Kaohsiung, Taiwan; [Hsi, Edward] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Wang, Jaw-Yuan; Juo, Suh-Hang Hank] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Hsi, Edward; Juo, Suh-Hang Hank] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan; [Wang, Jaw-Yuan] Kaohsiung Med Univ Hosp, Dept Surg, Kaohsiung, Taiwan; [Yang, I-Ping] Shu Zen Coll Med & Management, Dept Nursing, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Kuo, TY (corresponding author), Kaohsiung Med Univ, Coll Med, Dept Med Genet, Kaohsiung, Taiwan.	cy614112@ms14.hinet.net; hjuo@kmu.edu.tw	Juo, Suh-Hang/C-9545-2009; Jaw-Yuan, Wang/AFS-8845-2022; Hsi, Edward/A-1356-2013	Jaw-Yuan, Wang/0000-0002-7705-2621; Hsi, Edward/0000-0002-8272-6707; Tsai, Pei-Chien/0000-0002-5044-6727	Kaohsiung Medical University Hospital [KMUH98-8I04]; Excellence for Cancer Research Center; Department of Health, Executive Yuan, Taiwan, Republic of China [DOH100-TD-C-111-002]; National Science Council of the Republic of China [NSC 99-2320-B-037-014-MY3, NSC 94-2314B037-104]	Kaohsiung Medical University Hospital; Excellence for Cancer Research Center; Department of Health, Executive Yuan, Taiwan, Republic of China; National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the Kaohsiung Medical University Hospital (KMUH98-8I04) (http://www.kmuh.org.tw/), Excellence for Cancer Research Center Grant through funding by the Department of Health, Executive Yuan, Taiwan, Republic of China (DOH100-TD-C-111-002) (http://science.doh.gov.tw/), and the National Science Council of the Republic of China (NSC 99-2320-B-037-014-MY3 and NSC 94-2314B037-104) (http://www.nsc.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslam MI, 2009, BRIT J SURG, V96, P702, DOI 10.1002/bjs.6628; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Becker H, 1995, Praxis (Bern 1994), V84, P1371; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Brosens RP, 2010, CELL ONCOL; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fisher RA, 1932, STAT METHODS RES WOR, P4; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hammond SM, 2007, NAT GENET, V39, P582, DOI 10.1038/ng0507-582; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Joshi A, 2009, BIOINFORMATICS, V25, P490, DOI 10.1093/bioinformatics/btn658; Kobayashi H, 2007, SURGERY, V141, P67, DOI 10.1016/j.surg.2006.07.020; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Lee Y, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000730; Leslie A, 2002, BRIT J SURG, V89, P845, DOI 10.1046/j.1365-2168.2002.02120.x; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu W, 2007, WORLD J GASTROENTERO, V13, P497, DOI 10.3748/wjg.v13.i4.497; Longo WE, 2002, SURG CLIN N AM, V82, P1091, DOI 10.1016/S0039-6109(02)00050-6; Lottaz C, 2006, BIOINFORMATICS, V22, P2315, DOI 10.1093/bioinformatics/btl385; Manne U, 2010, BIOMARK MED, V4, P761, DOI 10.2217/BMM.10.87; Matsuyama T, 2010, INT J CANCER, V127, P2292, DOI 10.1002/ijc.25256; Motoyama K, 2009, INT J ONCOL, V34, P1069, DOI 10.3892/ijo_00000233; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Peng XX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-373; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Ruike Y, 2008, J HUM GENET, V53, P515, DOI 10.1007/s10038-008-0279-x; Scheid S, 2004, IEEE ACM T COMPUT BI, V1, P98, DOI 10.1109/TCBB.2004.24; Scheid S, 2005, BIOINFORMATICS, V21, P2921, DOI 10.1093/bioinformatics/bti436; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Tsai HL, 2009, INT J COLORECTAL DIS, V24, P177, DOI 10.1007/s00384-008-0594-x; Watanabe T, 2009, CANCER, V115, P283, DOI 10.1002/cncr.24023; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X; Wolpin BM, 2007, CA-CANCER J CLIN, V57, P168, DOI 10.3322/canjclin.57.3.168; Xi YG, 2007, CANCER INFORM, V3, P245; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang L, 2003, INT J CANCER, V106, P771, DOI 10.1002/ijc.11300	46	57	62	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31587	10.1371/journal.pone.0031587	http://dx.doi.org/10.1371/journal.pone.0031587			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348113	Green Published, gold, Green Submitted			2022-12-25	WOS:000302733900057
J	Lin, C; Wu, MH; Dong, JY				Lin, Chen; Wu, Menghua; Dong, Jianyong			Quercetin-4 '-O-beta-D-glucopyranoside (QODG) Inhibits Angiogenesis by Suppressing VEGFR2-Mediated Signaling in Zebrafish and Endothelial Cells	PLOS ONE			English	Article							GROWTH-FACTOR VEGF; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; FOCAL ADHESION KINASE; ACTIN-BASED MOTILITY; TUMOR ANGIOGENESIS; POLY(ADP-RIBOSE) POLYMERASE; IN-VIVO; TYROSINE KINASE; ANTICANCER THERAPY; ICE/CED-3 PROTEASE	Background: Angiogenesis plays an important role in many physiological and pathological processes. Identification of small molecules that block angiogenesis and are safe and affordable has been a challenge in drug development. Hypericum attenuatum Choisy is a Chinese herb medicine commonly used for treating hemorrhagic diseases. The present study investigates the anti-angiogenic effects of quercetin-4'-O-beta-D-glucopyranoside (QODG), a flavonoid isolated from Hypericum attenuatum Choisy, in vivo and in vitro, and clarifies the underlying mechanism of the activity. Methodology/Principal Findings: Tg(fli1:EGFP) transgenic zebrafish embryos were treated with different concentrations of quercetin-4'-O-beta-D-glucopyranoside (QODG) (20, 60, 180 mu M) from 6 hours post fertilisation (hpf) to 72 hpf, and adult zebrafish were allowed to recover in different concentrations of QODG (20, 60, 180 mu M) for 7 days post amputation (dpa) prior morphological observation and angiogenesis phenotypes assessment. Human umbilical vein endothelial cells (HUVECs) were treated with or without VEGF and different concentrations of QODG (5, 20, 60, 180 mu M), then tested for cell viability, cell migration, tube formation and apoptosis. The role of VEGFR2-mediated signaling pathway in QODG-inhibited angiogenesis was evaluated using quantitative real-time PCR (qRT-PCR) and Western blotting. Conclusion/Significance: Quercetin-4'-O-beta-D-glucopyranoside (QODG) was shown to inhibit angiogenesis in human umbilical vein endothelial cells (HUVECs) in vitro and zebrafish in vivo via suppressing VEGF-induced phosphorylation of VEGFR2. Our results further indicate that QODG inhibits angiogenesis via inhibition of VEGFR2-mediated signaling with the involvement of some key kinases such as c-Src, FAK, ERK, AKT, mTOR and S6K and induction of apoptosis. Together, this study reveals, for the first time, that QODG acts as a potent VEGFR2 kinase inhibitor, and exerts the anti-angiogenic activity at least in part through VEGFR2-mediated signaling pathway.	[Lin, Chen; Wu, Menghua; Dong, Jianyong] Wenzhou Med Coll, Sch Pharm, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University	Lin, C (corresponding author), Wenzhou Med Coll, Sch Pharm, Wenzhou, Zhejiang, Peoples R China.	jiany_d163@163.com			Science and Technology Commission of Zhejiang Province [Y2101196]; Promotion Program of Fresh Talent Program for Science and Technology Department of Zhejiang Province [2010R413042]	Science and Technology Commission of Zhejiang Province; Promotion Program of Fresh Talent Program for Science and Technology Department of Zhejiang Province	This work was supported by a grant from the Science and Technology Commission of Zhejiang Province (Ref. No. Y2101196) and a grant from the Promotion Program of Fresh Talent Program for Science and Technology Department of Zhejiang Province (Ref. No. 2010R413042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009; Ahmad S, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-15; Ali N, 2005, J PHARMACOL SCI, V98, P130, DOI 10.1254/jphs.FP0040850; Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Baek JH, 2000, ONCOGENE, V19, P4621, DOI 10.1038/sj.onc.1203814; Bayliss PE, 2006, NAT CHEM BIOL, V2, P265, DOI 10.1038/nchembio778; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; BERGER NA, 1985, BIOCHEMISTRY-US, V24, P4352, DOI 10.1021/bi00337a015; BOOCOCK CA, 1995, JNCI-J NATL CANCER I, V87, P506, DOI 10.1093/jnci/87.7.506; Buchler P, 2004, CANCER-AM CANCER SOC, V100, P201, DOI 10.1002/cncr.11873; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cheng SH, 2001, AQUAT TOXICOL, V52, P61, DOI 10.1016/S0166-445X(00)00130-2; Childs S, 2002, DEVELOPMENT, V129, P973; Chintalgattu V, 2003, J MOL CELL CARDIOL, V35, P277, DOI 10.1016/S0022-2828(03)00006-3; Cho CH, 2004, AM J PHYSIOL-HEART C, V286, pH1881, DOI 10.1152/ajpheart.00786.2003; Chou MT, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-32; Chung J, 2002, J CELL BIOL, V158, P165, DOI 10.1083/jcb.200112015; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Compagni A, 2000, BRIT J CANCER, V83, P1; Crawford TN, 2009, CURR DIABETES REV, V5, P8, DOI 10.2174/157339909787314149; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; CUNNINGHAM SA, 1995, J BIOL CHEM, V270, P20254, DOI 10.1074/jbc.270.35.20254; DeFeudis FV, 2003, FUND CLIN PHARMACOL, V17, P405, DOI 10.1046/j.1472-8206.2003.00156.x; Ding Li-li, 2010, Yaoxue Xuebao, V45, P456; Dona M, 2004, CANCER RES, V64, P6225, DOI 10.1158/0008-5472.CAN-04-0280; Dong DF, 2009, CANCER LETT, V285, P218, DOI 10.1016/j.canlet.2009.05.021; DUMONT DJ, 1995, DEV DYNAM, V203, P80, DOI 10.1002/aja.1002030109; Eberhard A, 2000, CANCER RES, V60, P1388; Edirisinghe I, 2008, FASEB J, V22, P2297, DOI 10.1096/fj.07-099481; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Ferrara N, 2004, ONCOLOGIST, V9, P2, DOI 10.1634/theoncologist.9-suppl_1-2; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Foekens JA, 2001, CANCER RES, V61, P5407; FOLKMAN J, 1974, CANCER RES, V34, P2109; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; FRANK S, 1995, J BIOL CHEM, V270, P12607, DOI 10.1074/jbc.270.21.12607; Garcia-Maceira P, 2009, ONCOGENE, V28, P313, DOI 10.1038/onc.2008.398; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanhan D, 1996, CELL, V86, P353; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Huang CC, 2009, DEV BIOL, V332, P360, DOI 10.1016/j.ydbio.2009.06.003; IIJIMA K, 1993, KIDNEY INT, V44, P959, DOI 10.1038/ki.1993.337; Itakura J, 2000, INT J CANCER, V85, P27; Ito N, 1998, J BIOL CHEM, V273, P23410, DOI 10.1074/jbc.273.36.23410; Kamba T, 2007, BRIT J CANCER, V96, P1788, DOI 10.1038/sj.bjc.6603813; Kanda S, 2007, INT J MOL MED, V20, P113; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Kerbel RS, 2004, NAT REV CANCER, V4, P423, DOI 10.1038/nrc1369; Kim BW, 2008, CELL SIGNAL, V20, P714, DOI 10.1016/j.cellsig.2007.12.009; Klagsbrun Michael, 1996, Cytokine and Growth Factor Reviews, V7, P259, DOI 10.1016/S1359-6101(96)00027-5; Kowanetz M, 2006, CLIN CANCER RES, V12, P5018, DOI 10.1158/1078-0432.CCR-06-1520; Lamalice L, 2006, J BIOL CHEM, V281, P34009, DOI 10.1074/jbc.M603928200; Lawson ND, 2002, NAT REV GENET, V3, P674, DOI 10.1038/nrg888; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Le Rhun Y, 1998, BIOCHEM BIOPH RES CO, V245, P1; Li W, 2008, ONCOL REP, V20, P713, DOI 10.3892/or_00000064; Liu BY, 2010, MOL VIS, V16, P184; Makovets'ka O Iu, 2000, Ukr Biokhim Zh (1999), V72, P110; Martinez-Poveda B, 2005, INT J CANCER, V117, P775, DOI 10.1002/ijc.21246; Matsumoto T, 2005, EMBO J, V24, P2342, DOI 10.1038/sj.emboj.7600709; Matsuo M, 2007, EUR J CANCER, V43, P1748, DOI 10.1016/j.ejca.2007.04.024; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Namiki A, 1995, J BIOL CHEM, V270, P31189, DOI 10.1074/jbc.270.52.31189; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nicoli S, 2009, J CELL MOL MED, V13, P2061, DOI 10.1111/j.1582-4934.2008.00432.x; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; NOMURA M, 1995, J BIOL CHEM, V270, P28316; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pang XF, 2010, CANCER RES, V70, P1951, DOI 10.1158/0008-5472.CAN-09-3201; Pang XF, 2009, CANCER RES, V69, P518, DOI 10.1158/0008-5472.CAN-08-2531; Patan S, 2004, CANC TREAT, V117, P3; Peterson RT, 2001, CURR BIOL, V11, P1481, DOI 10.1016/S0960-9822(01)00482-1; Petrova TV, 1999, EXP CELL RES, V253, P117, DOI 10.1006/excr.1999.4707; Pidgeon GP, 2001, BRIT J CANCER, V85, P273, DOI 10.1054/bjoc.2001.1876; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Qi JH, 2001, EXP CELL RES, V263, P173, DOI 10.1006/excr.2000.5102; Quesada AR, 2006, MED RES REV, V26, P483, DOI 10.1002/med.20059; REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531; Ren WY, 2003, MED RES REV, V23, P519, DOI 10.1002/med.10033; Roberts DM, 2004, AM J PATHOL, V164, P1531, DOI 10.1016/S0002-9440(10)63711-X; Rousseau S, 2000, J BIOL CHEM, V275, P10661, DOI 10.1074/jbc.275.14.10661; Rousseau S, 2000, TRENDS CARDIOVAS MED, V10, P321, DOI 10.1016/S1050-1738(01)00072-X; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; Sawano A, 1997, BIOCHEM BIOPH RES CO, V238, P487, DOI 10.1006/bbrc.1997.7327; Schempp CM, 2005, PLANTA MED, V71, P999, DOI 10.1055/s-2005-871303; Schlessinger J, 2000, CELL, V100, P293, DOI 10.1016/S0092-8674(00)80664-9; SEETHARAM L, 1995, ONCOGENE, V10, P135; Serbedzija G N, 1999, Angiogenesis, V3, P353, DOI 10.1023/A:1026598300052; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Shibuya M, 2006, J BIOCHEM MOL BIOL, V39, P469; Shibuya M, 2006, ENDOTHELIUM-J ENDOTH, V13, P63, DOI 10.1080/10623320600697955; Simo R, 2006, CURR DIABETES REV, V2, P71, DOI 10.2174/157339906775473671; Smith BD, 2000, J CLIN ONCOL, V18, P2046, DOI 10.1200/JCO.2000.18.10.2046; Spiekermann K, 2002, EXP HEMATOL, V30, P767, DOI 10.1016/S0301-472X(02)00837-8; SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410, DOI 10.1002/jlb.55.3.410; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Tang JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011822; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; TISCHER E, 1991, J BIOL CHEM, V266, P11947; Tufro A, 1999, J AM SOC NEPHROL, V10, P2125; Verheul HMW, 2008, CLIN CANCER RES, V14, P3589, DOI 10.1158/1078-0432.CCR-07-4306; Verheul HMW, 1997, CLIN CANCER RES, V3, P2187; Vinals F, 1999, J BIOL CHEM, V274, P26776, DOI 10.1074/jbc.274.38.26776; Wang Z, 2007, BIOCHEM BIOPH RES CO, V357, P26, DOI 10.1016/j.bbrc.2007.03.094; Wedge SR, 2002, CANCER RES, V62, P4645; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Zachary I, 2001, CARDIOVASC RES, V49, P568, DOI 10.1016/S0008-6363(00)00268-6; Zachary I, 2001, AM J PHYSIOL-CELL PH, V280, pC1375, DOI 10.1152/ajpcell.2001.280.6.C1375; Zheng LH, 2007, CANCER BIOL THER, V6, P775, DOI 10.4161/cbt.6.5.4002; Zhong HZ, 2007, CURR TOP MED CHEM, V7, P1379	117	30	33	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31708	10.1371/journal.pone.0031708	http://dx.doi.org/10.1371/journal.pone.0031708			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348123	Green Published, Green Submitted, gold			2022-12-25	WOS:000302733900060
J	Noordam, R; Jansen, SWM; Akintola, AA; Oei, NYL; Maier, AB; Pijl, H; Slagboom, PE; Westendorp, RGJ; van der Grond, J; de Craen, AJM; van Heemst, D				Noordam, Raymond; Jansen, Steffy W. M.; Akintola, Abimbola A.; Oei, Nicole Y. L.; Maier, Andrea B.; Pijl, Hanno; Slagboom, P. Eline; Westendorp, Rudi G. J.; van der Grond, Jeroen; de Craen, Anton J. M.; van Heemst, Diana		Leiden Longevity Study Grp	Familial Longevity Is Marked by Lower Diurnal Salivary Cortisol Levels: The Leiden Longevity Study	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; NONAGENARIAN SIBLINGS; DIABETES-MELLITUS; PLASMA-CORTISOL; AXIS; MEN; AGE; SENSITIVITY	Background: Reported findings are inconsistent whether hypothalamic-pituitary-adrenal (HPA) signaling becomes hyperactive with increasing age, resulting in increasing levels of cortisol. Our previous research strongly suggests that offspring from long-lived families are biologically younger. In this study we assessed whether these offspring have a lower HPA axis activity, as measured by lower levels of cortisol and higher cortisol feedback sensitivity. Methods: Salivary cortisol levels were measured at four time points within the first hour upon awakening and at two time points in the evening in a cohort comprising 149 offspring and 154 partners from the Leiden Longevity Study. A dexamethasone suppression test was performed as a measure of cortisol feedback sensitivity. Age, gender and body mass index, smoking and disease history (type 2 diabetes and hypertension) were considered as possible confounding factors. Results: Salivary cortisol secretion was lower in offspring compared to partners in the morning (Area Under the Curve = 15.6 versus 17.1 nmol/L, respectively; p = 0.048) and in the evening (Area Under the Curve = 3.32 versus 3.82 nmol/L, respectively; p = 0.024). Salivary cortisol levels were not different after dexamethasone (0.5 mg) suppression between offspring and partners (4.82 versus 5.26 nmol/L, respectively; p = 0.28). Conclusion: Offspring of nonagenarian siblings are marked by a lower HPA axis activity (reflected by lower diurnal salivary cortisol levels), but not by a difference in cortisol feedback sensitivity. Further in-depth studies aimed at characterizing the HPA axis in offspring and partners are needed.	[Noordam, Raymond; Jansen, Steffy W. M.; Akintola, Abimbola A.; Oei, Nicole Y. L.; Maier, Andrea B.; Westendorp, Rudi G. J.; de Craen, Anton J. M.; van Heemst, Diana] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Oei, Nicole Y. L.; van der Grond, Jeroen] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [Pijl, Hanno] Leiden Univ, Med Ctr, Dept Endocrinol, Leiden, Netherlands; [Slagboom, P. Eline] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Sect Mol Epidemiol, Leiden, Netherlands; [Oei, Nicole Y. L.] Leiden Inst Brain & Cognit, Leiden, Netherlands; [Maier, Andrea B.; Slagboom, P. Eline; Westendorp, Rudi G. J.; de Craen, Anton J. M.; van Heemst, Diana] Netherlands Consortium Healthy Ageing, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC)	Noordam, R (corresponding author), Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands.	d.van_heemst@lumc.nl	Akintola, Abi/T-5361-2019; Oei, Nicole/T-1219-2019; Maier, Andrea/W-7060-2019; Maier, Andrea B./Q-5548-2019; Slagboom, P. Eline/R-4790-2016; Pijl, Hanno/W-8719-2018	Maier, Andrea/0000-0001-7206-1724; Slagboom, P. Eline/0000-0002-2875-4723; Noordam, Raymond/0000-0001-7801-809X; Pijl, Hanno/0000-0002-3076-1551	European Commission [Health-F2-2010-259772]; Innovation Oriented research Program on Genomics [IGE01014, IGE5007]; Centre for Medical Systems Biology; Netherlands Genomics Initiative/Netherlands Organization for scientific research (NGI/NWO) [05040202, 050-060-810]; Netherlands Genomics Initiative [NCHA 050-060-810]	European Commission(European CommissionEuropean Commission Joint Research Centre); Innovation Oriented research Program on Genomics; Centre for Medical Systems Biology; Netherlands Genomics Initiative/Netherlands Organization for scientific research (NGI/NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Genomics Initiative	This study was funded by the European Commission funded project Switchbox (FP7, Health-F2-2010-259772), the Innovation Oriented research Program on Genomics (SenterNovem; IGE01014 and IGE5007), the Centre for Medical Systems Biology, the Netherlands Genomics Initiative/Netherlands Organization for scientific research (NGI/NWO; 05040202 and 050-060-810. NCHA). PES is supported by an unrestricted grant from the Netherlands Genomics Initiative (NCHA 050-060-810). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels M, 2003, PSYCHONEUROENDOCRINO, V28, P121, DOI 10.1016/S0306-4530(02)00003-3; BEYER HS, 1988, ENDOCRINOLOGY, V123, P2117, DOI 10.1210/endo-123-4-2117; Bruehl H, 2009, PSYCHONEUROENDOCRINO, V34, P815, DOI 10.1016/j.psyneuen.2008.12.010; DODT C, 1994, EUR J ENDOCRINOL, V131, P443, DOI 10.1530/eje.0.1310443; Hatzinger M, 2011, J PSYCHIAT RES; Heaney JL, 2011, PSYCHONEUROENDOCRINO; KIRSCHBAUM C, 1989, NEUROPSYCHOBIOLOGY, V22, P150, DOI 10.1159/000118611; Knoops AJG, 2010, ENDOCRINE, V37, P231, DOI 10.1007/s12020-009-9291-y; Miller GE, 2009, P NATL ACAD SCI USA, V106, P14716, DOI 10.1073/pnas.0902971106; Phillips DIW, 1998, J CLIN ENDOCR METAB, V83, P757, DOI 10.1210/jc.83.3.757; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Pruessner JC, 1997, LIFE SCI, V61, P2539, DOI 10.1016/S0024-3205(97)01008-4; Pruessner M, 2003, PSYCHOSOM MED, V65, P92, DOI 10.1097/01.PSY.0000040950.22044.10; ROTHUIZEN J, 1993, ENDOCRINOLOGY, V132, P161, DOI 10.1210/en.132.1.161; Rozing MP, 2009, AGING-US, V1, P714, DOI 10.18632/aging.100071; Rozing MP, 2010, J AM GERIATR SOC, V58, P564, DOI 10.1111/j.1532-5415.2010.02725.x; Schoenmaker M, 2006, EUR J HUM GENET, V14, P79, DOI 10.1038/sj.ejhg.5201508; Tafet GE, 2001, COGN AFFECT BEHAV NE, V1, P388, DOI 10.3758/CABN.1.4.388; VanCauter E, 1996, J CLIN ENDOCR METAB, V81, P2468, DOI 10.1210/jc.81.7.2468; Walker BR, 2000, J INTERN MED, V247, P198, DOI 10.1046/j.1365-2796.2000.00609.x; Walker BR, 1998, HYPERTENSION, V31, P891, DOI 10.1161/01.HYP.31.4.891; Westendorp RGJ, 2009, J AM GERIATR SOC, V57, P1634, DOI 10.1111/j.1532-5415.2009.02381.x; Wijsman CA, 2011, AGING CELL, V10, P114, DOI 10.1111/j.1474-9726.2010.00650.x; Wilhelm I, 2007, PSYCHONEUROENDOCRINO, V32, P358, DOI 10.1016/j.psyneuen.2007.01.008; Wirtz PH, 2007, PSYCHONEUROENDOCRINO, V32, P430, DOI 10.1016/j.psyneuen.2007.02.006	25	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31166	10.1371/journal.pone.0031166	http://dx.doi.org/10.1371/journal.pone.0031166			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348049	gold, Green Published			2022-12-25	WOS:000302733900027
J	Fanti, F; Currie, PJ; Badamgarav, D				Fanti, Federico; Currie, Philip J.; Badamgarav, Demchig			New Specimens of Nemegtomaia from the Baruungoyot and Nemegt Formations (Late Cretaceous) of Mongolia	PLOS ONE			English	Article							DJADOKHTA FORMATION; DINOSAUR BONE; HASANDONG FORMATION; INNER-MONGOLIA; BAYAN MANDAHU; THEROPODA; EGGS; OVIRAPTOROSAURIA; STRATIGRAPHY; DEPOSITS	Two new specimens of the oviraptorid theropod Nemegtomaia barsboldi from the Nemegt Basin of southern Mongolia are described. Specimen MPC-D 107/15 was collected from the upper beds of the Baruungoyot Formation (Campanian-Maastrichtian), and is a nest of eggs with the skeleton of the assumed parent of Nemegtomaia on top in brooding position. Much of the skeleton was damaged by colonies of dermestid coleopterans prior to its complete burial. However, diagnostic characters are recovered from the parts preserved, including the skull, partial forelimbs (including the left hand), legs, and distal portions of both feet. Nemegtomaia represents the fourth known genus of oviraptorid for which individuals have been found on nests of eggs. The second new specimen, MPC-D 107/16, was collected a few kilometers to the east in basal deposits of the Nemegt Formation, and includes both hands and femora of a smaller Nemegtomaia individual. The two formations and their diverse fossil assemblages have been considered to represent sequential time periods and different environments, but data presented here indicate partial overlap across the Baruungoyot-Nemegt transition. All other known oviraptorids from Mongolia and China are known exclusively from xeric or semi-arid environments. However, this study documents that Nemegtomaia is found in both arid/aeolian (Baruungoyot Formation) and more humid/fluvial (Nemegt Formation) facies.	[Fanti, Federico] Univ Bologna, Dipartimento Sci Terra & Geol Ambientali, Bologna, Italy; [Currie, Philip J.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Badamgarav, Demchig] Mongolian Acad Sci, Paleontol Ctr, Ulaanbaatar, Mongolia	University of Bologna; University of Alberta; Mongolian Academy of Sciences	Fanti, F (corresponding author), Univ Bologna, Dipartimento Sci Terra & Geol Ambientali, Via Zamboni, Bologna, Italy.	federico.fanti@unibo.it	Fanti, Federico/K-6624-2015; Currie, Philip J/A-2628-2014	Currie, Philip J/0000-0001-6857-3161; Fanti, Federico/0000-0002-2961-8301	Dinosaur Research Institute (Calgary); Museo Geologico Giovanni Capellini (Bologna, Italy); NSERC	Dinosaur Research Institute (Calgary); Museo Geologico Giovanni Capellini (Bologna, Italy); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported with funding by the Dinosaur Research Institute (Calgary), the Museo Geologico Giovanni Capellini (Bologna, Italy), and NSERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JF, 1985, J ZOOL, V207, P53, DOI 10.1111/j.1469-7998.1985.tb04915.x; [Anonymous], [No title captured]; [Anonymous], 1970, PALAENTOL POL; [Anonymous], 1981, T JOINT SOVIET MONGO; Bader K, 2007, GEOL SOC AM ABSTR, V39, P18; Barsbold R., 1990, P249; Barsbold R., 1986, P210; Barsbold R., 1997, ENCY DINOSAURS, P505; BENTON MJ, 2000, AGE DINOSAURS RUSSIA, P22; Britt BB, 2008, ICHNOS, V15, P59, DOI 10.1080/10420940701193284; Burns ME, 2011, CRETACEOUS RES, V32, P174, DOI 10.1016/j.cretres.2010.11.007; Campobasso CP, 2001, FORENSIC SCI INT, V120, P18, DOI 10.1016/S0379-0738(01)00411-X; Carpenter K., 1994, DINOSAUR EGGS BABIES; Cheng YN, 2008, ACTA GEOL SIN-ENGL, V82, P1089; Chiappe Luis M., 1999, Bulletin of the American Museum of Natural History, V242, P1; Clark James M., 1999, American Museum Novitates, V3265, P1; Clark JM, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)364<0001:CAOCOT>2.0.CO;2; Clark JM, 2001, J VERTEBR PALEONTOL, V21, P209, DOI 10.1671/0272-4634(2001)021[0209:TNOTOU]2.0.CO;2; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2255, DOI 10.1139/e93-196; Dashzeveg D, 2005, AM MUS NOVIT, V3498, P31; Dong ZM, 1996, CAN J EARTH SCI, V33, P631, DOI 10.1139/e96-046; Eberth David A., 2009, [Journal of the paleontological Society of Korea, 고생물학회지], V25, P1; Erickson GM, 2007, BIOL LETTERS, V3, P558, DOI 10.1098/rsbl.2007.0254; Fastovsky DE, 1997, PALAIOS, V12, P59, DOI 10.2307/3515294; GRADZINSKI R, 1977, Acta Geologica Polonica, V27, P281; GRADZINSKI R, 1974, SEDIMENT GEOL, V12, P249, DOI 10.1016/0037-0738(74)90021-9; Gradzinski R., 1974, PALAENTOL POL, V30, P111; Grellet-Tinner G, 2006, PALAEOGEOGR PALAEOCL, V232, P294, DOI 10.1016/j.palaeo.2005.10.029; Hasegawa H, 2009, J ASIAN EARTH SCI, V35, P13, DOI 10.1016/j.jseaes.2008.11.010; Hasiotis ST, 1997, COMB ROCK MOUNT SOUT, V29, p13A; Hasiotis Stephen T., 1999, P193; Hicks JF, 2001, GSA ANN M; Hopp TP, 2004, LIFE O PAST, P234; Hopp TP, 1998, DIN S AC NAT SCI PHI; JERZYKIEWICZ T, 1991, CRETACEOUS RES, V12, P345, DOI 10.1016/0195-6671(91)90015-5; JERZYKIEWICZ T, 1993, CAN J EARTH SCI, V30, P2180, DOI 10.1139/e93-190; Jerzykiewicz T., 2001, AGE DINOSAURS RUSSIA, P279; Johnston PA, 1997, CAN J EARTH SCI, V30, P2180; Khand Yo., 2000, Developments in Palaeontology and Stratigraphy, V17, P49; Kielan-Jaworowska Z., 1968, PALEONTOLOGICA POLON, V19, P171; Kielan-Jaworowska Z, 1974, PALEONTOLOGICA POLON, V30, P24; Kirkland James I., 1998, Journal of Vertebrate Paleontology, V18, p56A; Kirkland James I., 2010, P509; Kurzanov SM, 1989, DINOSAUR TRACKS TRAC; Longrich NR, 2010, PALAEONTOLOGY, V53, P945, DOI 10.1111/j.1475-4983.2010.00968.x; Lu J. C, 2005, OVIRAPTORID DINOSAUR, P1; Lu JC, 2002, J VERTEBR PALEONTOL, V22, P871, DOI 10.1671/0272-4634(2002)022[0871:ANOTOF]2.0.CO;2; Lu JC, 2005, LIFE O PAST, P256; Lu JC, 2005, ACTA PALAEONTOLOGICA, V44, P412; Lu Junchang, 2005, Bulletin of the National Science Museum Series C (Geology & Paleontology), V31, P51; Lu Junchang, 2004, Bulletin of the National Science Museum Series C (Geology & Paleontology), V30, P95; Lue Junchang, 2002, P175; Makovicky PJ, 2008, CLADISTICS, V24, P350, DOI 10.1111/j.1096-0031.2007.00184.x; MARTIN LD, 1995, PALAEOGEOGR PALAEOCL, V113, P303, DOI 10.1016/0031-0182(95)00058-T; Maryanska T, 2002, ACTA PALAEONTOL POL, V47, P97; Mikhailov Konstantin, 1994, P88; Moratalla J.J., 1994, P37; NORELL MA, 1995, NATURE, V378, P774, DOI 10.1038/378774a0; NORELL MA, 1994, SCIENCE, V266, P779, DOI 10.1126/science.266.5186.779; NORELL MA, 1997, ENCY DINOSAURS, P100; Norell Mark A., 2001, American Museum Novitates, V3315, P1, DOI 10.1206/0003-0082(2001)315<0001:AEODTF>2.0.CO;2; OSBORN H.F., 1924, AM MUS NOVIT, V144, P1; Osmfilska H., 1997, ENCY DINOSAURS, P471; Osmolska H, 2004, DINOSAURIA, 2ND EDITION, P165; OsmuElska H., 1997, ENCY DINOSAURS, P41; Paik IS, 2001, CRETACEOUS RES, V22, P627, DOI 10.1006/cres.2001.0282; Paik IS, 2000, PALAEOGEOGR PALAEOCL, V157, P213, DOI 10.1016/S0031-0182(99)00166-2; REGAL PJ, 1975, Q REV BIOL, V50, P35, DOI 10.1086/408299; Rogers R.R., 1992, Journal of Vertebrate Paleontology, V12, P528; SABATH K, 1991, Acta Palaeontologica Polonica, V36, P151; Saneyoshi M, PALAEOGEOGR IN PRESS, V311, P38; Sato T, 2005, SCIENCE, V308, P375, DOI 10.1126/science.1110578; Shuvalov V.F., 2001, AGE DINOSAURS RUSSIA, P256; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Szczechura J., 1978, PALAEONTOLOGICA POLO, V38, P65; Varricchio DJ, 2008, SCIENCE, V322, P1826, DOI 10.1126/science.1163245; Varricchio DJ, 1997, NATURE, V385, P247, DOI 10.1038/385247a0; Weishampel DB, 2008, J VERTEBR PALEONTOL, V28, P1110, DOI 10.1671/0272-4634-28.4.1110; Xu X, 2007, NATURE, V447, P844, DOI 10.1038/nature05849; Zanno LE, 2005, J VERTEBR PALEONTOL, V25, P897, DOI 10.1671/0272-4634(2005)025[0897:ANOTMF]2.0.CO;2; Zhao Zi-kui, 1975, Vertebrata Palasiatica, V13, P105	81	63	65	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31330	10.1371/journal.pone.0031330	http://dx.doi.org/10.1371/journal.pone.0031330			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347465	Green Submitted, gold, Green Published			2022-12-25	WOS:000302730100062
J	Furtado, CM; Marcondes, MC; Sola-Penna, M; de Souza, MLS; Zancan, P				Furtado, Cristiane M.; Marcondes, Mariah C.; Sola-Penna, Mauro; de Souza, Maisa L. S.; Zancan, Patricia			Clotrimazole Preferentially Inhibits Human Breast Cancer Cell Proliferation, Viability and Glycolysis	PLOS ONE			English	Article							GROWTH-FACTOR; GLUCOSE-METABOLISM; LUNG-CARCINOMA; 6-PHOSPHOFRUCTO-1-KINASE; CYTOSKELETON; EXPRESSION; APOPTOSIS; ATP; CONTRIBUTES; DETACHMENT	Background: Clotrimazole is an azole derivative with promising anti-cancer effects. This drug interferes with the activity of glycolytic enzymes altering their cellular distribution and inhibiting their activities. The aim of the present study was to analyze the effects of clotrimazole on the growth pattern of breast cancer cells correlating with their metabolic profiles. Methodology/Principal Findings: Three cell lines derived from human breast tissue (MCF10A, MCF-7 and MDA-MB-231) that present increasingly aggressive profiles were used. Clotrimazole induces a dose-dependent decrease in glucose uptake in all three cell lines, with K-i values of 114.3 +/- 11.7, 77.1 +/- 7.8 and 37.8 +/- 4.2 mu M for MCF10A, MCF-7 and MDA-MB-231, respectively. Furthermore, the drug also decreases intracellular ATP content and inhibits the major glycolytic enzymes, hexokinase, phosphofructokinase-1 and pyruvate kinase, especially in the highly metastatic cell line, MDA-MB-231. In this last cell lineage, clotrimazole attenuates the robust migratory response, an effect that is progressively attenuated in MCF-7 and MCF10A, respectively. Moreover, clotrimazole reduces the viability of breast cancer cells, which is more pronounced on MDA-MB-231. Conclusions/Significance: Clotrimazole presents deleterious effects on two human breast cancer cell lines metabolism, growth and migration, where the most aggressive cell line is more affected by the drug. Moreover, clotrimazole presents little or no effect on a non-tumor human breast cell line. These results suggest, at least for these three cell lines studied, that the more aggressive the cell is the more effective clotrimazole is.	[Furtado, Cristiane M.; Marcondes, Mariah C.; Zancan, Patricia] Univ Fed Rio de Janeiro, Fac Farm, Dept Farmacos, Oncol Mol Lab, Rio De Janeiro, Brazil; [Sola-Penna, Mauro] Univ Fed Rio de Janeiro, Fac Farm, Dept Farmacos, LabECoM, Rio De Janeiro, Brazil; [de Souza, Maisa L. S.] IFRJ, Unidade Nilopolis, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Instituto Federal do Rio de Janeiro (IFRJ)	Furtado, CM (corresponding author), Univ Fed Rio de Janeiro, Fac Farm, Dept Farmacos, Oncol Mol Lab, Rio De Janeiro, Brazil.	pzancan@ufrj.br	Zancan, Patricia/Q-6281-2016; Sola-Penna, Mauro/E-8221-2011	Zancan, Patricia/0000-0002-0503-028X; Sola-Penna, Mauro/0000-0001-9796-6829	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev IF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012304; Almeida A, 2010, P NATL ACAD SCI USA, V107, P738, DOI 10.1073/pnas.0913668107; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Boros LG, 2000, CANCER RES, V60, P1183; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chen Z, 2009, BBA-BIOENERGETICS, V1787, P553, DOI 10.1016/j.bbabio.2009.03.003; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Coelho WS, 2007, MOL GENET METAB, V92, P364, DOI 10.1016/j.ymgme.2007.07.010; El-Bacha T, 2003, MOL GENET METAB, V79, P294, DOI 10.1016/S1096-7192(03)00117-3; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Garland JM, 1997, J BIOL CHEM, V272, P4680, DOI 10.1074/jbc.272.8.4680; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Geschwind JFH, 2002, CANCER RES, V62, P3909; Gillies RJ, 2008, J NUCL MED, V49, p24S, DOI 10.2967/jnumed.107.047258; GlassMarmor L, 1996, EUR J PHARMACOL, V313, P265, DOI 10.1016/0014-2999(96)00526-2; GlassMarmor L, 1997, EUR J PHARMACOL, V328, P241, DOI 10.1016/S0014-2999(97)83051-8; Gonin-Giraud S, 2002, CELL DEATH DIFFER, V9, P1147, DOI 10.1038/sj.cdd.4401079; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Kennelly KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021365; Khaitan D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-258; Khalid MH, 2005, J NEUROSURG, V103, P79, DOI 10.3171/jns.2005.103.1.0079; Kim JW, 2007, MOL CELL BIOL, V27, P7381, DOI 10.1128/MCB.00440-07; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Ko YH, 2004, BIOCHEM BIOPH RES CO, V324, P269, DOI 10.1016/j.bbrc.2004.09.047; Lee HC, 2009, INT J MOL SCI, V10, P674, DOI 10.3390/ijms10020674; Leite TC, 2011, FEBS LETT, V585, P92, DOI 10.1016/j.febslet.2010.11.009; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002722; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Mannava S, 2008, CELL CYCLE, V7, P2392, DOI 10.4161/cc.6390; Marin-Hernandez A, 2006, FEBS J, V273, P1975, DOI 10.1111/j.1742-4658.2006.05214.x; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Meadows AL, 2008, BIOTECHNOL PROGR, V24, P334, DOI 10.1021/bp070301d; Meira DD, 2005, MOL GENET METAB, V84, P354, DOI 10.1016/j.ymgme.2004.11.012; ODDIS CV, 1995, BIOCHEM BIOPH RES CO, V213, P1002, DOI 10.1006/bbrc.1995.2228; Ouadid-Ahidouch H, 2004, BIOCHEM BIOPH RES CO, V316, P244, DOI 10.1016/j.bbrc.2004.02.041; Penso J, 2002, EUR J PHARMACOL, V451, P227, DOI 10.1016/S0014-2999(02)02103-9; Penso J, 2002, MOL GENET METAB, V76, P181, DOI 10.1016/S1096-7192(02)00046-X; Schwartz M K, 1968, Methods Biochem Anal, V16, P183, DOI 10.1002/9780470110348.ch3; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Sola-Penna M, 1998, ARCH BIOCHEM BIOPHYS, V360, P10, DOI 10.1006/abbi.1998.0906; Sola-Penna M, 2010, IUBMB LIFE, V62, P791, DOI 10.1002/iub.393; Spitz GA, 2009, BIOCHEM PHARMACOL, V77, P46, DOI 10.1016/j.bcp.2008.09.020; Telang S, 2006, ONCOGENE, V25, P7225, DOI 10.1038/sj.onc.1209709; Tong XM, 2009, P NATL ACAD SCI USA, V106, P21660, DOI 10.1073/pnas.0911316106; Tong XM, 2009, CURR OPIN GENET DEV, V19, P32, DOI 10.1016/j.gde.2009.01.002; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Zancan P, 2010, MOL GENET METAB, V100, P372, DOI 10.1016/j.ymgme.2010.04.006; Zhang WJ, 2002, DRUG METAB DISPOS, V30, P314, DOI 10.1124/dmd.30.3.314	53	78	81	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30462	10.1371/journal.pone.0030462	http://dx.doi.org/10.1371/journal.pone.0030462			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347377	Green Submitted, gold, Green Published			2022-12-25	WOS:000302730100012
J	Karatolos, N; Williamson, MS; Denholm, I; Gorman, K; Ffrench-Constant, RH; Bass, C				Karatolos, Nikos; Williamson, Martin S.; Denholm, Ian; Gorman, Kevin; Ffrench-Constant, Richard H.; Bass, Chris			Over-Expression of a Cytochrome P450 Is Associated with Resistance to Pyriproxyfen in the Greenhouse Whitefly Trialeurodes vaporariorum	PLOS ONE			English	Article							INSECT GROWTH-REGULATOR; DETOXIFICATION GENES; JUVENILE-HORMONE; AEDES-AEGYPTI; HOMOPTERA; HEMIPTERA; ALEYRODIDAE; MECHANISMS; TOLERANCE; BIOTYPE	Background: The juvenile hormone mimic, pyriproxyfen is a suppressor of insect embryogenesis and development, and is effective at controlling pests such as the greenhouse whitefly Trialeurodes vaporariorum (Westwood) which are resistant to other chemical classes of insecticides. Although there are reports of insects evolving resistance to pyriproxyfen, the underlying resistance mechanism(s) are poorly understood. Results: Bioassays against eggs of a German (TV8) population of T. vaporariorum revealed a moderate level (21-fold) of resistance to pyriproxyfen. This is the first time that pyriproxyfen resistance has been confirmed in this species. Sequential selection of TV8 rapidly generated a strain (TV8pyrsel) displaying a much higher resistance ratio (>4000-fold). The enzyme inhibitor piperonyl butoxide (PBO) suppressed this increased resistance, indicating that it was primarily mediated via metabolic detoxification. Microarray analysis identified a number of significantly over-expressed genes in TV8pyrsel as candidates for a role in resistance including cytochrome-P450 dependent monooxygenases (P450s). Quantitative PCR highlighted a single P450 gene (CYP4G61) that was highly over-expressed (81.7-fold) in TV8pyrsel. Conclusion: Over-expression of a single cytochrome P450 gene (CYP4G61) has emerged as a strong candidate for causing the enhanced resistance phenotype. Further work is needed to confirm the role of the encoded P450 enzyme CYP4G61 in detoxifying pyriproxyfen.	[Karatolos, Nikos; Williamson, Martin S.; Denholm, Ian; Gorman, Kevin; Bass, Chris] Rothamsted Res, Harpenden, Herts, England; [Ffrench-Constant, Richard H.] Univ Exeter, Penryn, Cornwall, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Exeter	Karatolos, N (corresponding author), Rothamsted Res, Harpenden, Herts, England.	nikolaos.karatolos@rothamsted.ac.uk		Denholm, Ian/0000-0001-9797-874X; Bass, Chris/0000-0002-2590-1492; GORMAN, kevin/0000-0002-2684-6974; ffrench-Constant, Richard/0000-0001-5385-9888	Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom; BBSRC [BB/G023352/1]; Bayer CropScience; BBSRC [BBS/E/C/00005193] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G023352/1, BBS/E/C/00005193] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Bayer CropScience(Bayer AG); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Nikos Karatolos was funded by a CASE PhD studentship from the Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom, with industrial support from Bayer CropScience. Chris Bass contributed funding through a fellowship grant (BB/G023352/1) from the BBSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors received funding from a commercial source (Bayer CropScience). There are no patents, products in development, or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	ANDRIGHETTI MTM, 2008, DENGUE B, V32, P186; [Anonymous], 2008, INSECT RESIST MANAG; Bi JL, 2007, PEST MANAG SCI, V63, P747, DOI 10.1002/ps.1405; BULL DL, 1994, J ECON ENTOMOL, V87, P1407, DOI 10.1093/jee/87.6.1407; BYRNE DN, 1990, WHITEFLIES : THEIR BIONOMICS, PEST STATUS AND MANAGEMENT, P227; Danforth BN, 1998, MOL BIOL EVOL, V15, P225, DOI 10.1093/oxfordjournals.molbev.a025920; Denholm I, 1998, PHILOS T R SOC B, V353, P1757, DOI 10.1098/rstb.1998.0328; Devine GJ, 1999, PESTIC SCI, V55, P405, DOI 10.1002/(SICI)1096-9063(199904)55:4<405::AID-PS923>3.0.CO;2-M; Dubrovsky EB, 2005, TRENDS ENDOCRIN MET, V16, P6, DOI 10.1016/j.tem.2004.11.003; Feyereisen R., 2005, P1; Ghanim M, 2007, PEST MANAG SCI, V63, P776, DOI 10.1002/ps.1410; Gorman K, 2007, PEST MANAG SCI, V63, P555, DOI 10.1002/ps.1364; GOTOH O, 1992, J BIOL CHEM, V267, P83; Horowitz AR, 1999, PESTIC SCI, V55, P272, DOI 10.1002/(SICI)1096-9063(199903)55:3&lt;272::AID-PS908&gt;3.0.CO;2-; ISHAAYA I, 1995, PESTIC SCI, V43, P227, DOI 10.1002/ps.2780430308; ISHAAYA I, 1992, J ECON ENTOMOL, V85, P2113, DOI 10.1093/jee/85.6.2113; ISHAAYA I, 1994, J ECON ENTOMOL, V87, P1185, DOI 10.1093/jee/87.5.1185; Jones DR, 2003, EUR J PLANT PATHOL, V109, P195, DOI 10.1023/A:1022846630513; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Karatolos N, 2010, PEST MANAG SCI, V66, P1304, DOI 10.1002/ps.2014; Karunker I, 2008, INSECT BIOCHEM MOLEC, V38, P634, DOI 10.1016/j.ibmb.2008.03.008; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Ma W, 2010, J ECON ENTOMOL, V103, P158, DOI 10.1603/EC09122; Marcombe S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-494; Nelson David R., 2009, Human Genomics, V4, P59; Oakeshott J.G, 2005, COMPREHENSIVE MOL IN, V5, P309, DOI [DOI 10.1016/B0-44-451924-6/00073-9, 10.1016/B0-44-451924-6/00073-9]; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pittendrigh B, 1997, INSECT BIOCHEM MOLEC, V27, P507, DOI 10.1016/S0965-1748(97)00025-8; Poupardin R, 2008, INSECT BIOCHEM MOLEC, V38, P540, DOI 10.1016/j.ibmb.2008.01.004; Pridgeon JW, 2003, GENE, V314, P157, DOI 10.1016/S0378-1119(03)00725-X; Puinean AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000999; Ranson H., 2005, P383; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Riaz MA, 2009, AQUAT TOXICOL, V93, P61, DOI 10.1016/j.aquatox.2009.03.005; SHEMSHEDINI L, 1990, P NATL ACAD SCI USA, V87, P2072, DOI 10.1073/pnas.87.6.2072; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wardlow LR, 1985, MED FACT LANDBOUW RI, V50, P164; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48; Zhang L, 1998, ARCH INSECT BIOCHEM, V37, P215, DOI 10.1002/(SICI)1520-6327(1998)37:3&lt;215::AID-ARCH4&gt;3.0.CO;2-R; Zhu Fang, 2008, BMC Physiology, V8, P18, DOI 10.1186/1472-6793-8-18	40	48	56	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31077	10.1371/journal.pone.0031077	http://dx.doi.org/10.1371/journal.pone.0031077			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347432	Green Submitted, Green Published, gold			2022-12-25	WOS:000302730100040
J	Teodorovic, LS; Riccardi, C; Torres, RM; Pelanda, R				Teodorovic, Lenka Sinik; Riccardi, Carlo; Torres, Raul M.; Pelanda, Roberta			Murine B Cell Development and Antibody Responses to Model Antigens Are Not Impaired in the Absence of the TNF Receptor GITR	PLOS ONE			English	Article							T-CELLS; MOUSE; EXPRESSION; IMMUNITY; FAMILY; SUPERFAMILY; PROTEIN; MARROW; LIGAND; MICE	The Glucocorticoid-Induced Tumor necrosis factor Receptor GITR, a member of the tumor necrosis factor receptor superfamily, has been shown to be important in modulating immune responses in the context of T cell immunity. B lymphocytes also express GITR, but a role of GITR in humoral immunity has not been fully explored. To address this question, we performed studies to determine the kinetics of GITR expression on naive and stimulated B cells and the capacity of B cells to develop and mount antibody responses in GITR(-/-) mice. Results of our studies indicate that all mature B cells express GITR on the cell surface, albeit at different levels. Expression of GITR on naive mature B cells is upregulated by BCR signaling, but is counteracted by helper T cell-related factors and other inflammatory signals in vitro. In line with these findings, expression of GITR on germinal center and memory B cells is lower than that on naive B cells. However, the expression of GITR is strongly upregulated in plasma cells. Despite these differences in GITR expression, the absence of GITR has no effect on T cell-dependent and T cell-independent antibody responses to model antigens in GITR(-/-) mice, or on B cell activation and proliferation in vitro. GITR deficiency manifests only with a slight reduction of mature B cell numbers and increased turnover of naive B cells, suggesting that GITR slightly contributes to mature B cell homeostasis. Overall, our data indicate that GITR does not play a significant role in B cell development and antibody responses to T-dependent and independent model antigens within the context of a GITR-deficient genetic background.	[Teodorovic, Lenka Sinik; Torres, Raul M.; Pelanda, Roberta] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO 80206 USA; [Teodorovic, Lenka Sinik; Torres, Raul M.; Pelanda, Roberta] Univ Colorado, Sch Med, Denver, CO USA; [Riccardi, Carlo] Univ Perugia, Dept Clin & Expt Med, I-06100 Perugia, Italy	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Perugia	Teodorovic, LS (corresponding author), Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO 80206 USA.	pelandar@njhealth.org	Riccardi, Carlo/N-4610-2014	Riccardi, Carlo/0000-0001-9257-3997	National Institutes of Health (NIH) [PO1 AI022295, RO1 AI052310, RO1 AI052157]; NIH; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI022295, R01AI018785, R01AI052310, R01AI052157, T32AI007405] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants PO1 AI022295, RO1 AI052310 to RP, and RO1 AI052157 to RMT. LST was partly supported by a T32 NIH training grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; ALLMAN DM, 1993, J IMMUNOL, V151, P4431; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Cote AL, 2011, J IMMUNOL, V186, P275, DOI 10.4049/jimmunol.1001308; FORSTER I, 1990, P NATL ACAD SCI USA, V87, P4781, DOI 10.1073/pnas.87.12.4781; Fulcher DA, 1997, EUR J IMMUNOL, V27, P1188, DOI 10.1002/eji.1830270521; Holl TM, 2010, J IMMUNOL METHODS, V354, P53, DOI 10.1016/j.jim.2010.01.007; Hoyer BF, 2004, J EXP MED, V199, P1577, DOI 10.1084/jem.20040168; Ko K, 2005, J EXP MED, V202, P885, DOI 10.1084/jem.20050940; La S, 2005, EXP MOL MED, V37, P193, DOI 10.1038/emm.2005.26; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Nocentini G, 2005, EUR J IMMUNOL, V35, P1016, DOI 10.1002/eji.200425818; Nocentini G, 2000, DNA CELL BIOL, V19, P205, DOI 10.1089/104454900314474; Ponte JF, 2010, IMMUNOLOGY, V130, P231, DOI 10.1111/j.1365-2567.2009.03228.x; RISSO A, 1991, J IMMUNOL, V146, P4105; Ronchetti S, 2007, J IMMUNOL, V179, P5916, DOI 10.4049/jimmunol.179.9.5916; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Snell LM, 2010, J IMMUNOL, V185, P7223, DOI 10.4049/jimmunol.1001912; Stephens GL, 2004, J IMMUNOL, V173, P5008, DOI 10.4049/jimmunol.173.8.5008; Swanson CL, 2010, J EXP MED, V207, P1485, DOI 10.1084/jem.20092695; Tone M, 2003, P NATL ACAD SCI USA, V100, P15059, DOI 10.1073/pnas.2334901100; Velez MG, 2007, J IMMUNOL, V179, P1049, DOI 10.4049/jimmunol.179.2.1049; Zhan YF, 2008, J IMMUNOL, V181, P5405, DOI 10.4049/jimmunol.181.8.5405	23	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e31632	10.1371/journal.pone.0031632	http://dx.doi.org/10.1371/journal.pone.0031632			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328941	Green Submitted, Green Published, gold			2022-12-25	WOS:000302179300027
J	Wilting, SM; Snijders, PJF; Verlaat, W; Jaspers, A; van de Wiel, MA; van Wieringen, WN; Meijer, GA; Kenter, GG; Yi, Y; le Sage, C; Agami, R; Meijer, CJLM; Steenbergen, RDM				Wilting, S. M.; Snijders, P. J. F.; Verlaat, W.; Jaspers, A.; van de Wiel, M. A.; van Wieringen, W. N.; Meijer, G. A.; Kenter, G. G.; Yi, Y.; le Sage, C.; Agami, R.; Meijer, C. J. L. M.; Steenbergen, R. D. M.			Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis	ONCOGENE			English	Article						microRNA; squamous cell carcinoma; adenocarcinoma; CIN lesion; HPV; hsa-miR-9	TUMOR-SUPPRESSIVE MICRORNAS; HUMAN-PAPILLOMAVIRUS DNA; GENE-EXPRESSION; MIRNA EXPRESSION; CELL-LINES; HIGH-RISK; CANCER; METHYLATION; LESIONS; KERATINOCYTES	Little is known about the alterations in microRNA (miRNA) expression patterns during the consecutive stages of cervical cancer development and their association with chromosomal instability. In this study, miRNA expression in normal cervical squamous epithelium, high-grade precancerous lesions (cervical intraepithelial neoplasia (CIN2-3)), squamous cell carcinomas (SCCs) and adenocarcinomas (AdCAs) was integrated with previously generated chromosomal profiles of the same samples. Significantly differential expression during the consecutive stages of cervical SCC development was observed for 106 miRNAs. Of these differentially expressed miRNAs, 27 showed early transiently altered expression in CIN2-3 lesions only, 46 miRNAs showed late altered expression in SCCs only and 33 showed continuously altered expression in both CIN2-3 and SCCs. Altered expression of five significantly differentially expressed miRNAs, hsa-miR-9 (1q23.2), hsa-miR-15b (3q25.32), hsa-miR-28-5p (3q27.3), hsa-miR-100 and hsa-miR-125b (both 11q24.1), was directly linked to frequent chromosomal alterations. Functional analyses were performed for hsa-miR-9, representing a potential oncogene with increased expression linked to a chromosomal gain of 1q. Hsa-miR-9 overexpression was found to increase cell viability, anchorage-independent growth and migration in vitro. Upon organic raft culturing, hsa-miR-9 hampered differentiation and induced proliferation in all strata of the epithelial layer. These findings support a potential oncogenic function of hsa-miR-9 in cervical cancer. In summary, differential expression of 106 miRNAs, partly associated with chromosomal alterations, was observed during cervical SCC development. Altered expression of hsa-miR-9 associated with a chromosomal gain of chromosome 1q was shown to be functionally relevant, underlining the importance of deregulated miRNA expression in cervical carcinogenesis. Oncogene (2013) 32, 106-116; doi:10.1038/onc.2012.20; published online 13 February 2012	[Steenbergen, R. D. M.] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Unit Mol Pathol, NL-1007 MB Amsterdam, Netherlands; [van de Wiel, M. A.; van Wieringen, W. N.] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [van de Wiel, M. A.; van Wieringen, W. N.] Vrije Univ Amsterdam, Dept Math, Amsterdam, Netherlands; [Kenter, G. G.] VU Univ Med Ctr Amsterdam, Dept Obstet & Gynaecol, Amsterdam, Netherlands; [Yi, Y.] Vanderbilt Univ Sch Med, Vanderbilt Ingram Canc Ctr, Div Genet Med, Nashville, TN USA; [le Sage, C.; Agami, R.] Netherlands Canc Inst, Div Gene Regulat, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vanderbilt University; Netherlands Cancer Institute	Steenbergen, RDM (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Pathol, Unit Mol Pathol, POB 7057, NL-1007 MB Amsterdam, Netherlands.	r.steenbergen@vumc.nl	van de Wiel, Mark/F-6759-2013; agami, reuven/GOG-8289-2022; van Wieringen, Wessel N/F-9850-2016	van Wieringen, Wessel N/0000-0002-5100-9123; Meijer, Gerrit/0000-0003-0330-3130; Agami, Reuven/0000-0002-2848-2473; Steenbergen, Renske/0000-0002-2327-9839; Wilting, Saskia/0000-0002-2838-841X; van de Wiel, Mark/0000-0003-4780-8472	V-ICI institute of the VU University Medical Center, Amsterdam, The Netherlands [CCA20085-04]; Dutch Cancer Society (KWF) [VU2010-4668]	V-ICI institute of the VU University Medical Center, Amsterdam, The Netherlands(Netherlands Government); Dutch Cancer Society (KWF)(KWF Kankerbestrijding)	This work was supported by the V-ICI institute of the VU University Medical Center, Amsterdam, The Netherlands (grant number CCA20085-04) and the Dutch Cancer Society (KWF, grant number VU2010-4668). We are grateful to Marlon van der Plas, Suzanne Snellenberg, Nour Makazaji and Tim Schutte for excellent technical assistance.	Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Botezatu A, 2011, MOL MED REP, V4, P121, DOI 10.3892/mmr.2010.394; Bray I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007850; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chim CS, 2011, J CELL MOL MED, V15, P2760, DOI 10.1111/j.1582-4934.2011.01274.x; Fu Y, 1989, PATHOLOGY UTERINE CE, P288; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Guo LM, 2009, FEBS J, V276, P5537, DOI 10.1111/j.1742-4658.2009.07237.x; Henson BJ, 2009, GENE CHROMOSOME CANC, V48, P569, DOI 10.1002/gcc.20666; Hildebrandt MAT, 2010, ONCOGENE, V29, P5724, DOI 10.1038/onc.2010.305; Hsu PY, 2009, CANCER RES, V69, P5936, DOI 10.1158/0008-5472.CAN-08-4914; Hu XX, 2010, CANCER RES, V70, P1441, DOI 10.1158/0008-5472.CAN-09-3289; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jacobs MV, 1997, J CLIN MICROBIOL, V35, P791, DOI 10.1128/JCM.35.3.791-795.1997; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Lee JW, 2008, CLIN CANCER RES, V14, P2535, DOI 10.1158/1078-0432.CCR-07-1231; Lehmann U, 2008, J PATHOL, V214, P17, DOI 10.1002/path.2251; Li BH, 2010, INT J GYNECOL CANCER, V20, P597, DOI 10.1111/IGC.0b013e3181d63170; Li Y, 2011, J PATHOL, V224, P484, DOI 10.1002/path.2873; Lionetti M, 2009, GENE CHROMOSOME CANC, V48, P521, DOI 10.1002/gcc.20660; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Manduchi E, 2000, BIOINFORMATICS, V16, P685, DOI 10.1093/bioinformatics/16.8.685; Martinez I, 2008, ONCOGENE, V27, P2575, DOI 10.1038/sj.onc.1210919; Mascaux C, 2009, EUR RESPIR J, V33, P352, DOI 10.1183/09031936.00084108; McCredie MRE, 2008, LANCET ONCOL, V9, P425, DOI 10.1016/S1470-2045(08)70103-7; McKenna DJ, 2010, J VIROL, V84, P10644, DOI 10.1128/JVI.00703-10; Melar-New M, 2010, J VIROL, V84, P5212, DOI 10.1128/JVI.00078-10; Muralidhar B, 2007, J PATHOL, V212, P368, DOI 10.1002/path.2179; Muralidhar B, 2011, J PATHOL, V224, P496, DOI 10.1002/path.2898; Nuovo GJ, 2010, DIAGN MOL PATHOL, V19, P135, DOI 10.1097/PDM.0b013e3181c4daaa; Overmeer RM, 2009, J PATHOL, V219, P327, DOI 10.1002/path.2598; Pereira PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011780; Pisani P, 2002, INT J CANCER, V97, P72, DOI 10.1002/ijc.1571; Rao QX, 2012, MED ONCOL, V29, P1242, DOI 10.1007/s12032-011-9830-2; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Steenbergen RDM, 2004, JNCI-J NATL CANCER I, V96, P294, DOI 10.1093/jnci/djh031; Steenbergen RDM, 1996, ONCOGENE, V13, P1249; Steenbergen RDM, 2001, JNCI-J NATL CANCER I, V93, P865, DOI 10.1093/jnci/93.11.865; Steenbergen RDM, 1998, J VIROL, V72, P749, DOI 10.1128/JVI.72.1.749-757.1998; TASE T, 1989, INT J GYNECOL PATHOL, V8, P8, DOI 10.1097/00004347-198903000-00002; van Wieringen WN, 2009, BIOMETRICS, V65, P19, DOI 10.1111/j.1541-0420.2008.01052.x; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wallin KL, 1999, NEW ENGL J MED, V341, P1633, DOI 10.1056/NEJM199911253412201; Wang X, 2009, RNA, V15, P637, DOI 10.1261/rna.1442309; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Weber B, 2007, CELL CYCLE, V6, P1001, DOI 10.4161/cc.6.9.4209; Wentzensen N, 2007, DIS MARKERS, V23, P315, DOI 10.1155/2007/678793; Wilting S, 2006, J PATHOL, V209, P220, DOI 10.1002/path.1966; Wilting SM, 2008, GENE CHROMOSOME CANC, V47, P890, DOI 10.1002/gcc.20590; Wilting SM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-167; Wilting SM, 2009, CANCER RES, V69, P647, DOI 10.1158/0008-5472.CAN-08-2478; Winer RL, 2005, J INFECT DIS, V191, P731, DOI 10.1086/427557; Woods K, 2007, J BIOL CHEM, V282, P2130, DOI 10.1074/jbc.C600252200; Yi YJ, 2005, GENOMICS, V85, P401, DOI 10.1016/j.ygeno.2004.11.011; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zielinski GD, 2001, BRIT J CANCER, V85, P398, DOI 10.1054/bjoc.2001.1926	60	117	122	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2013	32	1					106	116		10.1038/onc.2012.20	http://dx.doi.org/10.1038/onc.2012.20			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	063VG	22330141				2022-12-25	WOS:000313029500011
J	Zhang, WJ; Mendoza, MC; Pei, XL; Ilter, D; Mahoney, SJ; Zhang, YM; Ma, DL; Blenis, J; Wang, Y				Zhang, Wenjuan; Mendoza, Michelle C.; Pei, Xiaolei; Ilter, Didem; Mahoney, Sarah J.; Zhang, Yingmei; Ma, Dalong; Blenis, John; Wang, Ying			Down-regulation of CMTM8 Induces Epithelial-to-Mesenchymal Transition-like Changes via c-MET/Extracellular Signal-regulated Kinase (ERK) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; HUMAN HEPATOCELLULAR-CARCINOMA; EARLY GENE-PRODUCTS; COLORECTAL-CANCER; POOR-PROGNOSIS; PATHWAY; EXPRESSION; TRANSFORMATION; PROGRESSION; ACTIVATION	The acquisition of an invasive phenotype is a critical turning point for malignant tumor cells. CMTM8, a potential tumor suppressor, is frequently down-regulated in solid tumors, and its overexpression induces tumor cell apoptosis. Here, we identify a new role for CMTM8 in regulating tumor cell migration. Reducing CMTM8 expression in HepG2 hepatocellular carcinoma cells results in the acquisition of epithelial-to-mesenchymal transition (EMT) features, including a morphological change from organized epithelial sheets to scattered fibroblast-like shapes, reduction of the epithelial marker E-cadherin, and an increased invasive and migratory ability. These phenotypic changes are mediated in large part by the ERK-MAPK pathway, as the MEK inhibitor U0126 and shRNA-mediated knockdown of ERK2 significantly reversed these phenotypes. Hepatocyte growth factor binding to the c-MET receptor is known to induce EMT in HepG2 cells. We found that CMTM8 knockdown in HepG2 cells induced c-MET signaling and ERK activation. Inhibition of c-MET signaling with the small molecule inhibitor SU11274 or c-MET RNAi blocked the EMT-like changes following CMTM8 knockdown. CMTM8 overexpression in HepG2 cells inhibited hepatocyte growth factor-induced EMT-like morphological changes and cell motility. Down-regulation of CMTM8 also promoted an EMT-like change in MCF-10A cells, indicating a broader role for CMTM8 in regulating cellular transformation.	[Mendoza, Michelle C.; Ilter, Didem; Mahoney, Sarah J.; Blenis, John] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Zhang, Wenjuan; Pei, Xiaolei; Zhang, Yingmei; Ma, Dalong; Wang, Ying] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Key Lab Med Immunol,Minist Hlth,Dept Immunol, Beijing 100191, Peoples R China; [Zhang, Wenjuan] Capital Med Univ, Peking Univ, Hosp 9, Beijing Shijitan Hosp,Canc Res Lab, Beijing 100038, Peoples R China	Harvard University; Harvard Medical School; Peking University; Capital Medical University; Peking University	Blenis, J (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Longwood Ave, Boston, MA 02115 USA.	jblenis@hms.harvard.edu; yw@bjmu.edu.cn		Ilter, Didem/0000-0001-7506-8198	National Institutes of Health from NCI [R37CA46595]; National Natural Science Foundation of China [81071749, 30872292, 90813025]; National Basic Research Program of China [2012CB518000]; National Key New Drug Creation Program of China [2009ZX09503-004]; China Scholarship Council; Susan G. Komen for the Cure; NATIONAL CANCER INSTITUTE [R37CA046595, K01CA168850] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National Key New Drug Creation Program of China; China Scholarship Council(China Scholarship Council); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R37CA46595 from NCI (to J. B.). This work was also supported by National Natural Science Foundation of China Grants 81071749, 30872292, and 90813025; National Basic Research Program of China Grant 2012CB518000; National Key New Drug Creation Program of China Grant 2009ZX09503-004; the China Scholarship Council; and Susan G. Komen for the Cure (to M. C. M.).	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Dimitri CA, 2005, CURR BIOL, V15, P1319, DOI 10.1016/j.cub.2005.06.037; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; Hwang YH, 2004, HEPATOL RES, V29, P113, DOI 10.1016/j.hepres.2004.02.009; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Jin CN, 2007, J CELL PHYSIOL, V211, P112, DOI 10.1002/jcp.20914; Jin CN, 2005, FEBS LETT, V579, P6375, DOI 10.1016/j.febslet.2005.10.021; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kaposi-Novak P, 2006, J CLIN INVEST, V116, P1582, DOI 10.1172/JCI27236; Kondo A, 2008, J BIOL CHEM, V283, P1428, DOI 10.1074/jbc.M704999200; Lahsnig C, 2009, ONCOGENE, V28, P638, DOI 10.1038/onc.2008.418; Lee SA, 2010, HEPATOLOGY, V52, P506, DOI 10.1002/hep.23681; Li D, 2007, INT J BIOCHEM CELL B, V39, P2107, DOI 10.1016/j.biocel.2007.06.002; Li Ning, 2008, V457, P305, DOI 10.1007/978-1-59745-261-8_23; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Mendoza MC, 2011, MOL CELL, V41, P661, DOI 10.1016/j.molcel.2011.02.031; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Nagai T, 2011, MOL CANCER THER, V10, P169, DOI 10.1158/1535-7163.MCT-10-0544; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Pramanik R, 2003, J BIOL CHEM, V278, P4831, DOI 10.1074/jbc.M207732200; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Salvi A, 2007, INT J ONCOL, V31, P451; Sattler Martin, 2007, Curr Oncol Rep, V9, P102, DOI 10.1007/s11912-007-0005-4; Sattler Martin, 2009, Update Cancer Ther, V3, P109, DOI 10.1016/j.uct.2009.01.001; Schlessinger J, 2000, CELL, V100, P293, DOI 10.1016/S0092-8674(00)80664-9; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Schmitz KJ, 2008, J HEPATOL, V48, P83, DOI 10.1016/j.jhep.2007.08.018; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Tavian D, 2000, INT J CANCER, V87, P644, DOI 10.1002/1097-0215(20000901)87:5<644::AID-IJC4>3.3.CO;2-N; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Togawa A, 2010, BIOCHEM BIOPH RES CO, V400, P271, DOI 10.1016/j.bbrc.2010.08.060; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Tsukada Y, 2001, J BIOL CHEM, V276, P40968, DOI 10.1074/jbc.M010890200; Ueki T, 1997, HEPATOLOGY, V25, P862, DOI 10.1002/hep.510250413; Vincan E, 2008, CLIN EXP METASTAS, V25, P657, DOI 10.1007/s10585-008-9156-4; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Yeh JJ, 2009, MOL CANCER THER, V8, P834, DOI 10.1158/1535-7163.MCT-08-0972; Yoshida T, 2006, ONCOGENE, V25, P6056, DOI 10.1038/sj.onc.1209635; ZARNEGAR R, 1989, BIOCHEM BIOPH RES CO, V163, P1370, DOI 10.1016/0006-291X(89)91130-3	45	45	51	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11850	11858		10.1074/jbc.M111.258236	http://dx.doi.org/10.1074/jbc.M111.258236			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22337876	hybrid, Green Published			2022-12-25	WOS:000302782200024
J	Valdearcos, M; Esquinas, E; Meana, C; Pena, L; Gil-de-Gomez, L; Balsinde, J; Balboa, MA				Valdearcos, Martin; Esquinas, Esperanza; Meana, Clara; Pena, Lucia; Gil-de-Gomez, Luis; Balsinde, Jesus; Balboa, Maria A.			Lipin-2 Reduces Proinflammatory Signaling Induced by Saturated Fatty Acids in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IVA PHOSPHOLIPASE A(2); N-TERMINAL KINASE; INSULIN-RESISTANCE; PROTEIN-KINASE; SUBCELLULAR-LOCALIZATION; ADIPOSE-TISSUE; NUCLEAR-FACTOR; ACTIVATION; CELLS; GENE	Lipin-2 is a member of the lipin family of enzymes, which are key effectors in the biosynthesis of lipids. Mutations in the humanlipin-2 gene are associated with inflammatory-based disorders; however, the role of lipin-2 in cells of the immune system remains obscure. In this study, we have investigated the role of lipin-2 in the proinflammatory action of saturated fatty acids in murine and human macrophages. Depletion of lipin-2 promotes the increased expression of the proinflammatory genes Il6, Ccl2, and Tnf alpha, which depends on the overstimulation of the JNK1/c-Jun pathway by saturated fatty acids. In contrast, overexpression of lipin-2 reduces the release of proinflammatory factors. Metabolically, the absence of lipin-2 reduces the cellular content of triacylglycerol in saturated fatty acid-overloaded macrophages. Collectively, these studies demonstrate a protective role for lipin-2 in proinflammatory signaling mediated by saturated fatty acids that occurs concomitant with an enhanced cellular capacity for triacylglycerol synthesis. The data provide new insights into the role of lipin-2 in human and murine macrophage biology and may open new avenues for controlling the fatty acid-related low grade inflammation that constitutes the sine qua non of obesity and associated metabolic disorders.	[Balboa, Maria A.] CSIC, Inst Biol & Genet Mol, Valladolid 47003, Spain; Ctr Invest Biomed Red Diabet & Enfermedad Metab A, Barcelona 08036, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Balboa, MA (corresponding author), CSIC, Inst Biol & Genet Mol, Valladolid 47003, Spain.	mbalboa@ibgm.uva.es	Balsinde, Jesús/C-7833-2018; Meana, Clara/AAN-4887-2020; Balboa, María A./V-9493-2018	Balsinde, Jesús/0000-0002-4157-6714; Balboa, María A./0000-0002-2130-5298; Gil-de-Gomez, Luis/0000-0002-7864-3976; Meana, Clara/0000-0003-3580-6058; Valdearcos Contreras, Martin/0000-0002-5784-2458	Spanish Ministry of Science and Innovation [SAF2010-18831, BFU2010-18826]; Regional Government of Castile and Leon [BIO39/VA04/10]; Regional Government of Castile and Leon, Spain; Spanish National Research Council	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Regional Government of Castile and Leon; Regional Government of Castile and Leon, Spain; Spanish National Research Council	This work was supported in part by Spanish Ministry of Science and Innovation Grants SAF2010-18831 and BFU2010-18826 and Regional Government of Castile and Leon Grant BIO39/VA04/10.; Supported by a predoctoral fellowship from the Regional Government of Castile and Leon, Spain.; Supported by a predoctoral fellowship from the Spanish National Research Council (Junta de Ampliacion de Estudios Program).	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Astudillo AM, 2011, J BIOL CHEM, V286, P35299, DOI 10.1074/jbc.M111.277137; Astudillo AM, 2011, BBA-MOL CELL BIOL L, V1811, P97, DOI 10.1016/j.bbalip.2010.11.009; Aulchenko YS, 2007, DIABETES, V56, P3020, DOI 10.2337/db07-0338; BALBOA MA, 1995, J BIOL CHEM, V270, P11738, DOI 10.1074/jbc.270.20.11738; Balboa MA, 1998, J BIOL CHEM, V273, P7684, DOI 10.1074/jbc.273.13.7684; Balsinde J, 1997, BIOCHEM J, V321, P805, DOI 10.1042/bj3210805; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bremmer S, 2010, J AM ACAD DERMATOL, V63, P1058, DOI 10.1016/j.jaad.2009.09.053; Casas J, 2010, J LIPID RES, V51, P388, DOI 10.1194/jlr.M001461; Casas J, 2009, J IMMUNOL, V183, P2767, DOI 10.4049/jimmunol.0901530; Davidovici BB, 2010, J INVEST DERMATOL, V130, P1785, DOI 10.1038/jid.2010.103; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Gubern A, 2008, J BIOL CHEM, V283, P27369, DOI 10.1074/jbc.M800696200; Gubern A, 2009, J BIOL CHEM, V284, P32359, DOI 10.1074/jbc.M109.061515; Gubern A, 2009, J BIOL CHEM, V284, P5697, DOI 10.1074/jbc.M806173200; Hambleton J, 1996, P NATL ACAD SCI USA, V93, P2774, DOI 10.1073/pnas.93.7.2774; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; Koliwad SK, 2010, J CLIN INVEST, V120, P756, DOI 10.1172/JCI36066; Lindegaard B, 2007, INT J OBESITY, V31, P449, DOI 10.1038/sj.ijo.0803434; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; MACKMAN N, 1991, J EXP MED, V174, P1517, DOI 10.1084/jem.174.6.1517; Majeed HA, 2001, EUR J PEDIATR, V160, P705, DOI 10.1007/s004310100799; Milhavet F, 2008, HUM MUTAT, V29, P803, DOI 10.1002/humu.20720; NEEL JV, 1962, AM J HUM GENET, V14, P353; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Reue K, 2009, CURR OPIN LIPIDOL, V20, P165, DOI 10.1097/MOL.0b013e32832adee5; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; SMITH SW, 1957, J BIOL CHEM, V228, P915; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Valdearcos M, 2011, J IMMUNOL, V186, P6004, DOI 10.4049/jimmunol.1003279; WEINSTEIN SL, 1992, J BIOL CHEM, V267, P14955; WEISS SB, 1958, J BIOL CHEM, V231, P53	46	64	66	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10894	10904		10.1074/jbc.M112.342915	http://dx.doi.org/10.1074/jbc.M112.342915			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334674	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000302780100018
J	Menon, R; Yu, J; Basanta-Henry, P; Brou, L; Berga, SL; Fortunato, SJ; Taylor, RN				Menon, Ramkumar; Yu, Jie; Basanta-Henry, Patrice; Brou, Lina; Berga, Sarah L.; Fortunato, Stephen J.; Taylor, Robert N.			Short Fetal Leukocyte Telomere Length and Preterm Prelabor Rupture of the Membranes	PLOS ONE			English	Article							PREMATURE RUPTURE; OXIDATIVE STRESS; QUANTITATIVE PCR; INFECTION; LABOR; ATTRITION; BIOMARKER; MORTALITY; SEQUENCE; ENZYMES	Background: Rupture of the fetal membranes is a common harbinger of imminent labor and delivery. Telomere shortening is a surrogate for oxidative stress (OS) and senescence. Fetal leukocyte and placental membrane DNA telomere lengths were evaluated to determine their association with preterm prelabor rupture of the membranes (pPROM) or spontaneous preterm births with intact membranes (PTB), compared to term birth. Methods: Telomere lengths were quantified in cord blood leukocytes (n = 133) from three major groups: 1) pPROM (n = 28), 2) PTB (n = 69) and 3) uncomplicated full term births (controls, n = 35), using real-time quantitative PCR. Placental membrane specimens (n = 18) were used to correlate fetal leukocyte and placental telomere lengths. Telomere length differences among the groups were analyzed by ANOVA. Pearson correlation coefficients determined relationships between leukocyte and placental membrane telomere lengths. Results: In pregnancies with intact membranes, fetal leukocyte telomere length was inversely proportional to gestational age. The mean telomere length decreased as gestation progressed, with the shortest at term. pPROM had telomere lengths (9962 +/- 3124 bp) that were significantly shorter than gestational age-matched PTB (11546 +/- 4348 bp, p = 0.04), but comparable to term births (9011 +/- 2497 bp, p = 0.31). Secondary analyses revealed no effects of race (African American vs. Caucasian) or intraamniotic infection on telomere length. A strong Pearson's correlation was noted between fetal leukocyte and placental membrane telomere lengths (rho = 0.77; p<0.01). Conclusions: Fetal leukocyte telomere length is reduced in pPROM compared to PTB but is similar to term births. pPROM represents a placental membrane disease likely mediated by OS-induced senescence.	[Menon, Ramkumar] Univ Texas Med Branch Galveston, Dept Obstet & Gynecol, Div Maternal Fetal Med & Perinatal Res, Galveston, TX USA; [Yu, Jie; Basanta-Henry, Patrice; Berga, Sarah L.; Taylor, Robert N.] Emory Univ, Dept Gynecol & Obstet, Atlanta, GA 30322 USA; [Yu, Jie; Berga, Sarah L.; Taylor, Robert N.] Wake Forest Univ, Bowman Gray Sch Med, Dept Obstet & Gynecol, Winston Salem, NC 27103 USA; [Brou, Lina] Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA; [Fortunato, Stephen J.] Perinatal Res Ctr, Nashville, TN USA	University of Texas System; University of Texas Medical Branch Galveston; Emory University; Wake Forest University; Wake Forest Baptist Medical Center; Emory University	Menon, R (corresponding author), Univ Texas Med Branch Galveston, Dept Obstet & Gynecol, Div Maternal Fetal Med & Perinatal Res, Galveston, TX USA.	ram.menon@utmb.edu	Fortunato, Stephen J/L-7545-2013					Athayde N, 1998, AM J OBSTET GYNECOL, V179, P1248, DOI 10.1016/S0002-9378(98)70141-3; Babizhayev MA, 2010, TELOMERE LENGTH IS B; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; DRAPER D, 1995, AM J OBSTET GYNECOL, V173, P1506, DOI 10.1016/0002-9378(95)90640-1; Epel ES, 2009, HORM-INT J ENDOCRINO, V8, P7, DOI 10.14310/horm.2002.1217; Fortunato SJ, 1997, AM J OBSTET GYNECOL, V177, P731, DOI 10.1016/S0002-9378(97)70260-6; Gardner JP, 2005, CIRCULATION, V111, P2171, DOI 10.1161/01.CIR.0000163550.70487.0B; Gil ME, 2004, MOL BIOTECHNOL, V27, P169, DOI 10.1385/MB:27:2:169; Gomez R, 1997, INFECT DIS CLIN N AM, V11, P135, DOI 10.1016/S0891-5520(05)70347-0; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hayflick L, 1997, BIOCHEMISTRY-MOSCOW+, V62, P1180; Houben JMJ, 2008, FREE RADICAL BIO MED, V44, P235, DOI 10.1016/j.freeradbiomed.2007.10.001; Ilmonen P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002143; Kawanishi S, 2004, ANN NY ACAD SCI, V1019, P278, DOI 10.1196/annals.1297.047; Menon R, 2004, J SOC GYNECOL INVEST, V11, P427, DOI 10.1016/j.jsgi.2004.04.001; Menon R, 2011, PLACENTA, V32, P317, DOI 10.1016/j.placenta.2011.01.015; Menon R, 2007, BEST PRACT RES CL OB, V21, P467, DOI 10.1016/j.bpobgyn.2007.01.008; Menon R, 2006, AM J OBSTET GYNECOL, V194, P1609, DOI 10.1016/j.ajog.2006.02.052; Menon R, 2011, OBSTET GYNECOL, V118, P121, DOI 10.1097/AOG.0b013e3182204eaa; Menon R, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-62; Mercer BM, 1997, INFECT DIS CLIN N AM, V11, P177, DOI 10.1016/S0891-5520(05)70348-2; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Oikawa S, 1999, FEBS LETT, V453, P365, DOI 10.1016/S0014-5793(99)00748-6; Okuda K, 2002, PEDIATR RES, V52, P377, DOI 10.1203/01.PDR.0000022341.72856.72; Parry S, 1998, NEW ENGL J MED, V338, P663, DOI 10.1056/NEJM199803053381006; Samani NJ, 2001, LANCET, V358, P472, DOI 10.1016/S0140-6736(01)05633-1; VadilloOrtega F, 1996, AM J OBSTET GYNECOL, V174, P1371, DOI 10.1016/S0002-9378(96)70687-7	31	108	109	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31136	10.1371/journal.pone.0031136	http://dx.doi.org/10.1371/journal.pone.0031136			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348044	Green Submitted, Green Published, gold			2022-12-25	WOS:000302733900024
J	Sinha, R; Kundrotas, PJ; Vakser, IA				Sinha, Rohita; Kundrotas, Petras J.; Vakser, Ilya A.			Protein Docking by the Interface Structure Similarity: How Much Structure Is Needed?	PLOS ONE			English	Article							PREDICTING 3D STRUCTURES; BINDING-SITES; FUNCTIONAL SITES; SEQUENCE; CONSERVATION; RECOGNITION; COMPLEXES; ALGORITHM; ALIGNMENTS; CAPRI	The increasing availability of co-crystallized protein-protein complexes provides an opportunity to use template-based modeling for protein-protein docking. Structure alignment techniques are useful in detection of remote target-template similarities. The size of the structure involved in the alignment is important for the success in modeling. This paper describes a systematic large-scale study to find the optimal definition/size of the interfaces for the structure alignment-based docking applications. The results showed that structural areas corresponding to the cutoff values <12 angstrom across the interface inadequately represent structural details of the interfaces. With the increase of the cutoff beyond 12 angstrom, the success rate for the benchmark set of 99 protein complexes, did not increase significantly for higher accuracy models, and decreased for lower-accuracy models. The 12 angstrom cutoff was optimal in our interface alignment-based docking, and a likely best choice for the large-scale (e. g., on the scale of the entire genome) applications to protein interaction networks. The results provide guidelines for the docking approaches, including high-throughput applications to modeled structures.	[Sinha, Rohita; Kundrotas, Petras J.; Vakser, Ilya A.] Univ Kansas, Ctr Bioinformat, Lawrence, KS 66045 USA; [Vakser, Ilya A.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas; University of Kansas	Sinha, R (corresponding author), Univ Kansas, Ctr Bioinformat, Lawrence, KS 66045 USA.	pkundro@ku.edu; vakser@ku.edu			National Institutes of Health [R01 GM074255]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant R01 GM074255. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakaki AK, 2004, BIOINFORMATICS, V20, P1087, DOI 10.1093/bioinformatics/bth044; Aytuna AS, 2005, BIOINFORMATICS, V21, P2850, DOI 10.1093/bioinformatics/bti443; Binkowski TA, 2005, PROTEIN SCI, V14, P2972, DOI 10.1110/ps.051759005; Cammer SA, 2003, J MOL BIOL, V334, P387, DOI 10.1016/j.jmb.2003.09.062; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Douguet D, 2006, BIOINFORMATICS, V22, P2612, DOI 10.1093/bioinformatics/btl447; Fernandez-Recio J, 2005, PROTEINS, V58, P134, DOI 10.1002/prot.20285; Fetrow JS, 2001, PROTEIN SCI, V10, P1005, DOI 10.1110/ps.49201; Gao M, 2011, PROTEINS, V79, P1623, DOI 10.1002/prot.22987; Gao Y, 2007, PROTEINS, V69, P845, DOI 10.1002/prot.21714; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gunther S, 2007, PROTEINS, V69, P839, DOI 10.1002/prot.21746; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Hunjan J, 2008, PROTEINS, V72, P344, DOI 10.1002/prot.21930; Janin J, 2003, PROTEINS, V52, P2, DOI 10.1002/prot.10381; Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234; Keskin O, 2007, STRUCTURE, V15, P341, DOI 10.1016/j.str.2007.01.007; Keskin O, 2008, METHODS MOL BIOL, V484, P505, DOI 10.1007/978-1-59745-398-1_30; Konc J, 2010, BIOINFORMATICS, V26, P1160, DOI 10.1093/bioinformatics/btq100; Korkin D, 2006, PLOS COMPUT BIOL, V2, P1365, DOI 10.1371/journal.pcbi.0020153; Kozakov D, 2011, P NATL ACAD SCI USA, V108, P13528, DOI 10.1073/pnas.1101835108; Kundrotas PJ, 2008, INT J BIOL MACROMOL, V43, P198, DOI 10.1016/j.ijbiomac.2008.05.004; Kundrotas PJ, 2006, BBA-PROTEINS PROTEOM, V1764, P1498, DOI 10.1016/j.bbapap.2006.08.002; Kundrotas PJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000727; La D, 2009, BIOINFORMATICS, V25, P2843, DOI 10.1093/bioinformatics/btp542; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lensink MF, 2010, PROTEINS, V78, P3073, DOI 10.1002/prot.22818; Lu L, 2002, PROTEINS, V49, P350, DOI 10.1002/prot.10222; MITCHELL EM, 1990, J MOL BIOL, V212, P151, DOI 10.1016/0022-2836(90)90312-A; Nicola G, 2007, BIOINFORMATICS, V23, P789, DOI 10.1093/bioinformatics/btm018; Ofran Y, 2003, FEBS LETT, V544, P236, DOI 10.1016/S0014-5793(03)00456-3; Ogmen U, 2005, NUCLEIC ACIDS RES, V33, pW331, DOI 10.1093/nar/gki585; Pazos F, 2004, P NATL ACAD SCI USA, V101, P14754, DOI 10.1073/pnas.0404569101; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; Reichmann D, 2007, CURR OPIN STRUC BIOL, V17, P67, DOI 10.1016/j.sbi.2007.01.004; Rossi A, 2006, PROTEIN SCI, V15, P2366, DOI 10.1110/ps.062247506; Russell RB, 2004, CURR OPIN STRUC BIOL, V14, P313, DOI 10.1016/j.sbi.2004.04.006; Sali A, 2003, NATURE, V422, P216, DOI 10.1038/nature01513; Sinha R, 2010, PROTEINS, V78, P3235, DOI 10.1002/prot.22812; Stark A, 2004, STRUCTURE, V12, P1405, DOI 10.1016/j.str.2004.05.012; Tovchigrechko A, 2002, PROTEIN SCI, V11, P1888, DOI 10.1110/ps.4730102; Tuncbag N, 2008, J MOL BIOL, V381, P785, DOI 10.1016/j.jmb.2008.04.071; Tuncbag N, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035006; Vakser IA, 2008, CURR PHARM BIOTECHNO, V9, P57, DOI 10.2174/138920108783955209; Wilkins AD, 2010, PROTEIN SCI, V19, P1296, DOI 10.1002/pro.406; Zacharias M, 2010, CURR OPIN STRUC BIOL, V20, P180, DOI 10.1016/j.sbi.2010.02.001; Zhang QC, 2010, P NATL ACAD SCI USA, V107, P10896, DOI 10.1073/pnas.1005894107; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhou HX, 2007, BIOINFORMATICS, V23, P2203, DOI 10.1093/bioinformatics/btm323	50	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31349	10.1371/journal.pone.0031349	http://dx.doi.org/10.1371/journal.pone.0031349			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348074	Green Published, gold			2022-12-25	WOS:000302733900043
J	Thuret, S; Thallmair, M; Horky, LL; Gage, FH				Thuret, Sandrine; Thallmair, Michaela; Horky, Laura L.; Gage, Fred H.			Enhanced Functional Recovery in MRL/MpJ Mice after Spinal Cord Dorsal Hemisection	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR BETA-1; ADULT-RAT; GENE-EXPRESSION; AXONAL REGENERATION; X-IRRADIATION; MRL MICE; PROTECTIVE AUTOIMMUNITY; CELLULAR-LOCALIZATION; ACTIVE IMMUNIZATION	Adult MRL/MpJ mice have been shown to possess unique regeneration capabilities. They are able to heal an ear-punched hole or an injured heart with normal tissue architecture and without scar formation. Here we present functional and histological evidence for enhanced recovery following spinal cord injury (SCI) in MRL/MpJ mice. A control group (C57BL/6 mice) and MRL/MpJ mice underwent a dorsal hemisection at T9 (thoracic vertebra 9). Our data show that MRL/MpJ mice recovered motor function significantly faster and more completely. We observed enhanced regeneration of the corticospinal tract (CST). Furthermore, we observed a reduced astrocytic response and fewer micro-cavities at the injury site, which appear to create a more growth-permissive environment for the injured axons. Our data suggest that the reduced astrocytic response is in part due to a lower lesion-induced increase of cell proliferation post-SCI, and a reduced astrocytic differentiation of the proliferating cells. Interestingly, we also found an increased number of proliferating microglia, which could be involved in the MRL/MpJ spinal cord repair mechanisms. Finally, to evaluate the molecular basis of faster spinal cord repair, we examined the difference in gene expression changes in MRL/MpJ and C57BL/6 mice after SCI. Our microarray data support our histological findings and reveal a transcriptional profile associated with a more efficient spinal cord repair in MRL/MpJ mice.	[Thuret, Sandrine; Thallmair, Michaela; Horky, Laura L.; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	Salk Institute	Thuret, S (corresponding author), Kings Coll London, Inst Psychiat, London WC2R 2LS, England.	sandrine.1.thuret@kcl.ac.uk; gage@salk.edu	Thuret, Sandrine/Y-5784-2019	Thuret, Sandrine/0000-0003-1260-8083	Paralyzed Veterans of America Spinal Cord Research Foundation; Paralysis Project of America; Deutsche Forschungsgemeinschaft; Christopher and Dana Reeve Foundation	Paralyzed Veterans of America Spinal Cord Research Foundation; Paralysis Project of America; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Christopher and Dana Reeve Foundation	ST was supported by the Paralyzed Veterans of America Spinal Cord Research Foundation (www.pva.org) and the Paralysis Project of America (www.paralysisproject.org). MT was supported by the Deutsche Forschungsgemeinschaft (www.dfg.de/). Additional support was provided by the Christopher and Dana Reeve Foundation (www.christopherreeve.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2004, EXP NEUROL, V189, P204, DOI 10.1016/j.expneurol.2004.05.042; Aimone JB, 2004, J NEUROSCI METH, V135, P27, DOI 10.1016/j.jneumeth.2003.11.016; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Blankenhorn EP, 2003, MAMM GENOME, V14, P250, DOI 10.1007/s00335-002-2222-3; BLIGHT AR, 1992, J NEUROTRAUMA, V9, P83; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Chadwick RB, 2007, WOUND REPAIR REGEN, V15, P275, DOI 10.1111/j.1524-475X.2007.00216.x; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Choubey D, 1997, ONCOGENE, V15, P291, DOI 10.1038/sj.onc.1201184; Citron BA, 2000, EXP NEUROL, V166, P213, DOI 10.1006/exnr.2000.7523; Clark LD, 1998, CLIN IMMUNOL IMMUNOP, V88, P35, DOI 10.1006/clin.1998.4519; Datta B, 1998, MOL CELL BIOL, V18, P1074, DOI 10.1128/MCB.18.2.1074; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; Davis TA, 2005, BLOOD CELL MOL DIS, V34, P17, DOI 10.1016/j.bcmd.2004.10.001; Demjen D, 2004, NAT MED, V10, P389, DOI 10.1038/nm1007; Dimou L, 2006, J NEUROSCI, V26, P5591, DOI 10.1523/JNEUROSCI.1103-06.2006; Ellis RC, 2005, EXP NEUROL, V193, P19, DOI 10.1016/j.expneurol.2004.11.034; Ellis RC, 2004, J NEUROCHEM, V88, P689, DOI 10.1046/j.1471-4159.2003.02197.x; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Ferretti P, 2003, DEV DYNAM, V226, P245, DOI 10.1002/dvdy.10226; Fitch MT, 1999, J NEUROSCI, V19, P8182; Foote AK, 2005, BRAIN, V128, P528, DOI 10.1093/brain/awh417; Franzen R, 1998, J NEUROSCI RES, V51, P316, DOI 10.1002/(SICI)1097-4547(19980201)51:3<316::AID-JNR5>3.0.CO;2-J; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; Gourevitch DL, 2009, WOUND REPAIR REGEN, V17, P447, DOI 10.1111/j.1524-475X.2009.00492.x; Hampton DW, 2004, NEUROSCIENCE, V127, P821, DOI 10.1016/j.neuroscience.2004.05.057; Hashimoto M, 2005, ACTA NEUROPATHOL, V109, P165, DOI 10.1007/s00401-004-0926-z; Hauben E, 2000, J NEUROSCI, V20, P6421, DOI 10.1523/JNEUROSCI.20-17-06421.2000; Hauben E, 2001, J CLIN INVEST, V108, P591, DOI 10.1172/JCI200112837; Heber-Katz E, 2004, WOUND REPAIR REGEN, V12, P384, DOI 10.1111/j.1067-1927.2004.012308.x; HenrichNoack P, 1996, STROKE, V27, P1609, DOI 10.1161/01.STR.27.9.1609; HENRICHNOACK P, 1996, STROKE, V27, P1615; Horky LL, 2006, J COMP NEUROL, V498, P525, DOI 10.1002/cne.21065; Horner PJ, 2000, J NEUROSCI, V20, P2218; Ibarra A, 2004, EUR J NEUROSCI, V19, P2984, DOI 10.1111/j.0953-816X.2004.03402.x; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Jones TB, 2004, J NEUROSCI, V24, P3752, DOI 10.1523/JNEUROSCI.0406-04.2004; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; King VR, 2004, NEUROSCIENCE, V126, P173, DOI 10.1016/j.neuroscience.2004.03.035; Kostyk SK, 2008, NEUROSCIENCE, V156, P498, DOI 10.1016/j.neuroscience.2008.08.013; Leferovich JM, 2001, P NATL ACAD SCI USA, V98, P9830, DOI 10.1073/pnas.181329398; Letterio JJ, 1997, CLIN IMMUNOL IMMUNOP, V84, P244, DOI 10.1006/clin.1997.4409; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li SX, 2004, J NEUROSCI, V24, P10511, DOI 10.1523/JNEUROSCI.2828-04.2004; Li XM, 2001, HEREDITY, V86, P668, DOI 10.1046/j.1365-2540.2001.00879.x; Li XM, 2001, MAMM GENOME, V12, P52, DOI 10.1007/s003350010230; LOGAN A, 1994, EUR J NEUROSCI, V6, P355, DOI 10.1111/j.1460-9568.1994.tb00278.x; Makwana M, 2007, J NEUROSCI, V27, P11201, DOI 10.1523/JNEUROSCI.2255-07.2007; MARTINOU JC, 1990, DEV BRAIN RES, V52, P175, DOI 10.1016/0165-3806(90)90233-O; Masinde G, 2005, BIOCHEM BIOPH RES CO, V330, P117, DOI 10.1016/j.bbrc.2005.02.143; Masinde GL, 2001, GENOME RES, V11, P2027, DOI 10.1101/gr.203701; McBrearty BA, 1998, P NATL ACAD SCI USA, V95, P11792, DOI 10.1073/pnas.95.20.11792; Menet V, 2003, P NATL ACAD SCI USA, V100, P8999, DOI 10.1073/pnas.1533187100; Min W, 1996, MOL CELL BIOL, V16, P359; Mittelbronn M, 2001, ACTA NEUROPATHOL, V101, P249; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Ohta M, 2004, EXP NEUROL, V187, P266, DOI 10.1016/j.expneurol.2004.01.021; Okada S, 2004, J NEUROSCI RES, V76, P265, DOI 10.1002/jnr.20044; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; PREHN JHM, 1993, J CEREBR BLOOD F MET, V13, P521, DOI 10.1038/jcbfm.1993.67; Rajnoch C, 2003, DEV DYNAM, V226, P388, DOI 10.1002/dvdy.10242; Ramer LM, 2004, J COMP NEUROL, V473, P1, DOI 10.1002/cne.20049; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; Ridet JL, 2000, EXP NEUROL, V161, P1, DOI 10.1006/exnr.1999.7206; Schmitt Caroline, 2006, Spine J, V6, P113, DOI 10.1016/j.spinee.2005.05.379; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Schnell L, 1999, J NEUROPATH EXP NEUR, V58, P245, DOI 10.1097/00005072-199903000-00004; Schwab JM, 2001, J NEUROIMMUNOL, V119, P214, DOI 10.1016/S0165-5728(01)00375-7; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; Schwartz M, 2001, TRENDS MOL MED, V7, P252, DOI 10.1016/S1471-4914(01)01993-1; Stichel CC, 1998, PROG NEUROBIOL, V56, P119, DOI 10.1016/S0301-0082(98)00033-1; Takahashi M, 2003, J NEUROPATH EXP NEUR, V62, P185, DOI 10.1093/jnen/62.2.185; Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Thuret S, 2009, HIPPOCAMPUS, V19, P658, DOI 10.1002/hipo.20550; Tyor WR, 2002, J NEUROL SCI, V200, P33, DOI 10.1016/S0022-510X(02)00113-2; Vidal S, 1998, J CLIN INVEST, V101, P696, DOI 10.1172/JCI1817; Wang H, 1999, GENOMICS, V60, P281, DOI 10.1006/geno.1999.5923; Whiteside G, 1998, BRAIN RES PROTOC, V2, P160, DOI 10.1016/S1385-299X(97)00032-9; Yamamoto S, 2001, EXP NEUROL, V172, P115, DOI 10.1006/exnr.2001.7798; Yoles E, 2001, J NEUROSCI, V21, P3740, DOI 10.1523/JNEUROSCI.21-11-03740.2001; Zeman RJ, 2001, EXP NEUROL, V172, P228, DOI 10.1006/exnr.2001.7803; Zhang SX, 2005, HISTOL HISTOPATHOL, V20, P519, DOI 10.14670/HH-20.519	85	30	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e30904	10.1371/journal.pone.0030904	http://dx.doi.org/10.1371/journal.pone.0030904			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348029	Green Published, gold			2022-12-25	WOS:000302733900017
J	Yu, SW; Liao, FX; Wang, FM; Wen, WW; Li, JJ; Mei, HW; Luo, LJ				Yu, Shunwu; Liao, Fengxian; Wang, Feiming; Wen, Weiwei; Li, Jiajia; Mei, Hanwei; Luo, Lijun			Identification of Rice Transcription Factors Associated with Drought Tolerance Using the Ecotilling Method	PLOS ONE			English	Article							CONTRASTING MOISTURE REGIMES; INDUCED POINT MUTATIONS; GENETIC-VARIATION; FREEZING TOLERANCE; SALT TOLERANCE; ORYZA-SATIVA; MAPPING QTLS; INBRED LINES; UPLAND RICE; ARABIDOPSIS	The drought tolerance (DT) of plants is a complex quantitative trait. Under natural and artificial selection, drought tolerance represents the crop survival ability and production capacity under drought conditions (Luo, 2010). To understand the regulation mechanism of varied drought tolerance among rice genotypes, 95 diverse rice landraces or varieties were evaluated within a field screen facility based on the 'line-source soil moisture gradient', and their resistance varied from extremely resistant to sensitive. The method of Ecotype Targeting Induced Local Lesions in Genomes (Ecotilling) was used to analyze the diversity in the promoters of 24 transcription factor families. The bands separated by electrophoresis using Ecotilling were converted into molecular markers. STRUCTURE analysis revealed a value of K = 2, namely, the population with two subgroups (i.e., indica and japonica), which coincided very well with the UPGMA clusters (NTSYS-pc software) using distance-based analysis and InDel markers. Then the association analysis between the promoter diversity of these transcription factors and the DT index/level of each variety was performed. The results showed that three genes were associated with the DT index and that five genes were associated with the DT level. The sequences of these associated genes are complex and variable, especially at approximately 1000 bp upstream of the transcription initiation sites. The study illuminated that association analysis aimed at Ecotilling diversity of natural groups could facilitate the isolation of rice genes related to complex quantitative traits.	[Yu, Shunwu; Liao, Fengxian; Wang, Feiming; Wen, Weiwei; Li, Jiajia; Mei, Hanwei; Luo, Lijun] Shanghai Acad Agr Sci, Shanghai Agrobiol Gene Ctr, Shanghai, Peoples R China; [Luo, Lijun] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China	Shanghai Academy of Agricultural Sciences; Huazhong Agricultural University	Yu, SW (corresponding author), Shanghai Acad Agr Sci, Shanghai Agrobiol Gene Ctr, Shanghai, Peoples R China.	lijun@sagc.org.cn	li, jia/GVT-7587-2022; Wen, Weiwei/AAU-5240-2021		National Natural Science Foundation of China [30830071]; China National High-Tech Program (863) [2006AA02Z115, 2010AA101806]; National Key Technologies Research and Development Program [2008ZX08001-003]; Shanghai Municipal Science and Technology Commission [2009DJ1400501]; Shanghai Science and Technology Talent Project [11XD1404300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National High-Tech Program (863)(National High Technology Research and Development Program of China); National Key Technologies Research and Development Program(National Key Technology R&D Program); Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Science and Technology Talent Project	This work was supported by the National Natural Science Foundation of China (Grant No: 30830071), the China National High-Tech Program (863) (Grant No: 2006AA02Z115), the National Key Technologies Research and Development Program (Grant No: 2008ZX08001-003), the Key Basic Research Project of Shanghai Municipal Science and Technology Commission (Grant No: 2009DJ1400501), the Shanghai Science and Technology Talent Project (Grant No: 11XD1404300) and the China National High-Tech Program (863) (Grant No: 2010AA101806). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andaya VC, 2003, THEOR APPL GENET, V106, P1084, DOI 10.1007/s00122-002-1126-7; Chu ZH, 2006, GENE DEV, V20, P1250, DOI 10.1101/gad.1416306; Colbert T, 2001, PLANT PHYSIOL, V126, P480, DOI 10.1104/pp.126.2.480; Comai L, 2004, PLANT J, V37, P778, DOI 10.1111/j.0960-7412.2003.01999.x; Cooper JL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-9; Courtois B, 2000, MOL BREEDING, V6, P55, DOI 10.1023/A:1009652326121; Gady ALF, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-13; [高凤华 Gao F H], 2009, [科学通报, Chinese Science Bulletin], V54, P2305; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Hemamalini GS, 2000, EUPHYTICA, V112, P69, DOI 10.1023/A:1003854224905; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Huang XY, 2009, GENE DEV, V23, P1805, DOI 10.1101/gad.1812409; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Ishimaru K, 2001, PLANT PHYSIOL BIOCH, V39, P173, DOI 10.1016/S0981-9428(00)01232-8; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104; Kamoshita A, 2002, THEOR APPL GENET, V104, P880, DOI 10.1007/s00122-001-0837-5; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Ko JH, 2006, PLANT J, V47, P343, DOI 10.1111/j.1365-313X.2006.02782.x; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Liao F, 2009, MODERN AGR SCI, V16, P1; Liu HY, 2005, CHINESE SCI BULL, V50, P317, DOI 10.1360/982004-619; Luo LJ, 2010, J EXP BOT, V61, P3509, DOI 10.1093/jxb/erq185; McCallum CM, 2000, PLANT PHYSIOL, V123, P439, DOI 10.1104/pp.123.2.439; Moller IS, 2009, PLANT CELL, V21, P2163, DOI 10.1105/tpc.108.064568; Nag R, 2005, PLANT MOL BIOL, V59, P821, DOI 10.1007/s11103-005-1387-z; Nieto C, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-34; Park HC, 2004, PLANT PHYSIOL, V135, P2150, DOI 10.1104/pp.104.041442; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Perry JA, 2003, PLANT PHYSIOL, V131, P866, DOI 10.1104/pp.102.017384; Price AH, 2002, FIELD CROP RES, V76, P11, DOI 10.1016/S0378-4290(02)00012-6; Raghavan C, 2007, MOL BREEDING, V19, P87, DOI 10.1007/s11032-006-9046-x; Rushton PJ, 2002, PLANT CELL, V14, P749, DOI 10.1105/tpc.010412; Simpson SD, 2003, PLANT J, V33, P259, DOI 10.1046/j.1365-313X.2003.01624.x; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Sood R, 2006, METHODS, V39, P220, DOI 10.1016/j.ymeth.2006.04.012; Sun MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018385; Svensson JT, 2006, PLANT PHYSIOL, V141, P257, DOI 10.1104/pp.105.072645; Svistoonoff S, 2007, NAT GENET, V39, P792, DOI 10.1038/ng2041; Till Bradley J., 2004, BMC Plant Biology, V4, P12, DOI 10.1186/1471-2229-4-12; Wang H.H., 2004, RESILIENT CROPS WATE, P75; Wen WW, 2009, THEOR APPL GENET, V119, P459, DOI 10.1007/s00122-009-1052-z; Winkler S, 2005, GENOME RES, V15, P718, DOI 10.1101/gr.3721805; Yan JB, 2010, NAT GENET, V42, P322, DOI 10.1038/ng.551; Yu H, 2008, PLANT CELL, V20, P1134, DOI 10.1105/tpc.108.058263; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Yu X, 2005, MOL PLANT BREED, V3, P634; Yue B, 2006, GENETICS, V172, P1213, DOI 10.1534/genetics.105.045062	49	37	39	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e30765	10.1371/journal.pone.0030765	http://dx.doi.org/10.1371/journal.pone.0030765			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348023	Green Submitted, Green Published, gold			2022-12-25	WOS:000302733900013
J	Orliac, MJ; Argot, C; Gilissen, E				Orliac, Maeva J.; Argot, Christine; Gilissen, Emmanuel			Digital Cranial Endocast of Hyopsodus (Mammalia, "Condylarthra''): A Case of Paleogene Terrestrial Echolocation?	PLOS ONE			English	Article							EVOLUTION; BRAIN; SHREW; SPECIALIZATIONS; INSECTIVORA; PALEOCENE; PRIMATES	We here describe the endocranial cast of the Eocene archaic ungulate Hyopsodus lepidus AMNH 143783 (Bridgerian, North America) reconstructed from X-ray computed microtomography data. This represents the first complete cranial endocast known for Hyopsodontinae. The Hyopsodus endocast is compared to other known "condylarthran'' endocasts, i. e. those of Pleuraspidotherium (Pleuraspidotheriidae), Arctocyon (Arctocyonidae), Meniscotherium (Meniscotheriidae), Phenacodus (Phenacodontidae), as well as to basal perissodactyls (Hyracotherium) and artiodactyls (Cebochoerus, Homacodon). Hyopsodus presents one of the highest encephalization quotients of archaic ungulates and shows an "advanced version'' of the basal ungulate brain pattern, with a mosaic of archaic characters such as large olfactory bulbs, weak ventral expansion of the neopallium, and absence of neopallium fissuration, as well as more specialized ones such as the relative reduction of the cerebellum compared to cerebrum or the enlargement of the inferior colliculus. As in other archaic ungulates, Hyopsodus midbrain exposure is important, but it exhibits a dorsally protruding largely developed inferior colliculus, a feature unique among "Condylarthra''. A potential correlation between the development of the inferior colliculus in Hyopsodus and the use of terrestrial echolocation as observed in extant tenrecs and shrews is discussed. The detailed analysis of the overall morphology of the postcranial skeleton of Hyopsodus indicates a nimble, fast moving animal that likely lived in burrows. This would be compatible with terrestrial echolocation used by the animal to investigate subterranean habitat and/or to minimize predation during nocturnal exploration of the environment.	[Orliac, Maeva J.] Univ Montpellier 2, ISE M UMR 5554, Montpellier, France; [Argot, Christine] Museum Natl Hist Nat, UMR CR2P 7207, Paris, France; [Gilissen, Emmanuel] Royal Museum Cent Afr, Dept African Zool, Tervuren, Belgium; [Gilissen, Emmanuel] Univ Libre Bruxelles, Lab Histol & Neuropathol, Brussels, Belgium; [Gilissen, Emmanuel] Univ Arkansas, Dept Anthropol, Fayetteville, AR 72701 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Royal Museum for Central Africa; Universite Libre de Bruxelles; University of Arkansas System; University of Arkansas Fayetteville	Orliac, MJ (corresponding author), Univ Montpellier 2, ISE M UMR 5554, Montpellier, France.	maeva.orliac@univ-montp2.fr	Orliac, Maeva J/ABB-3310-2021	Orliac, Maeva J/0000-0002-8922-8356	ANR (ERC) [ANR-08-JCJC-0017-01]	ANR (ERC)(French National Research Agency (ANR))	This work has been conducted with the support of the ANR (ERC programme Palasiafrica (ANR-08-JCJC-0017-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman JM, 1999, EVOLVING BRAINS, P98; Archibald J. David, 1998, P292; BARTON RA, 1995, PHILOS T ROY SOC B, V348, P381, DOI 10.1098/rstb.1995.0076; Bottorff W., 1995, THRINAXODON DIGITAL; Brochu CA, 2000, J VERTEBR PALEONTOL, V20, P1, DOI 10.1671/0272-4634(2000)020[0001:ADREFT]2.0.CO;2; BUCHLER ER, 1976, ANIM BEHAV, V24, P858, DOI 10.1016/S0003-3472(76)80016-4; BUTLER AB, 1996, COMP VERTEBRATE NEUR, P514; Casseday JH, 2002, SPR HDB AUD, V15, P238; Catania KC, 2005, ANAT REC PART A, V287A, P1038, DOI 10.1002/ar.a.20265; Catania KC, 2000, BRAIN BEHAV EVOLUT, V55, P311, DOI 10.1159/000006666; Catania KC, 2006, CURR OPIN NEUROBIOL, V16, P467, DOI 10.1016/j.conb.2006.06.010; Cope ED, 1884, 3 US GEOL SURV, VIII; Damuth J, 1990, ESTIMATION BIOL IMPL, P229; DECHASEAUX C, 1969, Annales de Paleontologie Vertebres, V55, P195; Douady CJ, 2003, MOL PHYLOGENET EVOL, V28, P285, DOI 10.1016/S1055-7903(03)00119-2; Edinger T., 1929, P1; EDINGER T, 1964, AM ZOOL, V4, P5; Edinger T., 1975, Advances Anat Embryol Cell Biol, V49, P1; Edinger Tilly, 1948, MEM GEOL SOC AMER, V25, P1; EISENBERG JF, 1981, MAMMALIAN RAD, P610; Flynn J. J., 1991, AM MUS NOVIT, V3007, P1; FORSMAN KA, 1988, J ZOOL, V216, P655, DOI 10.1111/j.1469-7998.1988.tb02463.x; Franzosa J, 2005, J VERTEBR PALEONTOL, V25, P859, DOI 10.1671/0272-4634(2005)025[0859:CEOTCT]2.0.CO;2; Gazin C. L., 1968, Smithsonian Miscellaneous Collections, V153, P1; Gazin C. L., 1965, SMITHSONIAN MISCELLA, V149, P1; Gingerich Philip D., 2005, Contributions from the Museum of Paleontology University of Michigan, V31, P185; Gould E., 1969, Communications in Behavioral Biology (Ser A), V3, P11; GOULD E, 1964, J EXP ZOOL, V156, P19, DOI 10.1002/jez.1401560103; GOULD EDWIN, 1965, PROC AMER PHIL SOC, V109, P352; Jakobs C, 1943, REV GEOGR AM, V19, P307; Janis Christine M., 1998, P247; Jerison H.J., 2009, EVOLUTIONARY NEUROSC, P497; Jerison H.J., 1973, EVOLUTION BRAIN INTE, P482; Jones G, 2006, TRENDS ECOL EVOL, V21, P149, DOI 10.1016/j.tree.2006.01.001; Ladeveze S, 2010, J VERTEBR PALEONTOL, V30, P1559, DOI 10.1080/02724634.2010.501440; Larsson HCE, 2000, J VERTEBR PALEONTOL, V20, P615, DOI 10.1671/0272-4634(2000)020[0615:FEANTD]2.0.CO;2; Legendre S., 1989, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V16, P1; Macrini TE, 2007, J VERTEBR PALEONTOL, V27, P99, DOI 10.1671/0272-4634(2007)27[99:DCEOPA]2.0.CO;2; Macrini TE, 2009, J VERTEBR PALEONTOL, V29, P1199, DOI 10.1671/039.029.0413; Maisey JG, 2005, B AM MUS NAT HIST, P1; Malmierca Manuel S., 2004, Neuroembryology and Aging, V3, P215, DOI 10.1159/000096799; Malmierca MS, 2002, J NEUROSCI, V22, P10891; Marino Lori, 2003, Anatomical Record, V272B, P107, DOI 10.1002/ar.b.10018; Marino Lori, 2000, Journal of Mammalian Evolution, V7, P81, DOI 10.1023/A:1009417831601; Matthew WD, 1928, P ZOOL SOC LOND, V1927, P947; Minoprio JDL, 1954, ACTA ZOOL LILLOANA, V3, P5; Prothero D.R., 1988, Systematics Association Special Volume Series, P201; RADINSKY L, 1977, PALEOBIOLOGY, V3, P333, DOI 10.1017/S0094837300005509; RADINSKY L, 1978, AM NAT, V112, P815, DOI 10.1086/283325; RADINSKY L, 1973, BRAIN BEHAV EVOLUT, V7, P169, DOI 10.1159/000124409; RADINSKY L, 1976, Fieldiana Geology, V33, P323; RADINSKY L, 1976, SCIENCE, V194, P626, DOI 10.1126/science.790567; RADINSKY LB, 1968, J MORPHOL, V124, P167, DOI 10.1002/jmor.1051240204; REHKAMPER G, 1986, J HIRNFORSCH, V27, P391; Rose K.D., 2006, BEGINNING AGE MAMMAL, P428; ROSE KD, 1980, SCIENCE, V208, P744, DOI 10.1126/science.208.4445.744; Rose KD, 1999, J VERTEBR PALEONTOL, V19, P355, DOI 10.1080/02724634.1999.10011147; Rowe TB, 2011, SCIENCE, V332, P955, DOI 10.1126/science.1203117; RUSSELL DONALD E., 1965, MEM MUS NAT D HBT NATUR SER C SCI TERRE, V16, P1; SIMPSON GEORGE GAYLORD, 1933, AMER MUS NOVITATES, V622, P1; Starck D, 1963, ZOOL ANZ, V171, P350; Stephan H., 1991, COMP BRAIN RES MAMMA, V1, P573; Symonds MRE, 2005, BIOL REV, V80, P93, DOI 10.1017/S1464793104006566; Teeling EC, 2009, TRENDS ECOL EVOL, V24, P351, DOI 10.1016/j.tree.2009.02.012; Tilney F, 1933, B NEUROL I NEW YORK, P430; TOMASI TE, 1979, J MAMMAL, V60, P751, DOI 10.2307/1380190; van Valen L., 1978, Evolutionary Theory, V4, P45; Williamson T. E., 1992, B NEW MEXICO MUSEUM, V1, P1; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048	69	20	20	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e30000	10.1371/journal.pone.0030000	http://dx.doi.org/10.1371/journal.pone.0030000			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22347998	Green Submitted, Green Published, gold			2022-12-25	WOS:000302730900004
J	Coyle, JM; Kaschak, MP				Coyle, Jacqueline M.; Kaschak, Michael P.			Female Fertility Affects Men's Linguistic Choices	PLOS ONE			English	Article							WOMENS FERTILITY; MIMICRY; ATTRACTIVENESS; CONCEPTION; PERCEPTION; INCREASES; OVULATION; MOTIVES; RATES; RISK	We examined the influence of female fertility on the likelihood of male participants aligning their choice of syntactic construction with those of female confederates. Men interacted with women throughout their menstrual cycle. On critical trials during the interaction, the confederate described a picture to the participant using particular syntactic constructions. Immediately thereafter, the participant described to the confederate a picture that could be described using either the same construction that was used by the confederate or an alternative form of the construction. Our data show that the likelihood of men choosing the same syntactic structure as the women was inversely related to the women's level of fertility: higher levels of fertility were associated with lower levels of linguistic matching. A follow-up study revealed that female participants do not show this same change in linguistic behavior as a function of changes in their conversation partner's fertility. We interpret these findings in the context of recent data suggesting that non-conforming behavior may be a means of men displaying their fitness as a mate to women.	[Coyle, Jacqueline M.] Embry Riddle Aeronaut Univ, Human Factors & Syst Dept, Daytona Beach, FL 32114 USA; [Kaschak, Michael P.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA	Embry-Riddle Aeronautical University; State University System of Florida; Florida State University	Coyle, JM (corresponding author), Embry Riddle Aeronaut Univ, Human Factors & Syst Dept, Daytona Beach, FL 32114 USA.	coylej2@erau.edu		Kaschak, Michael/0000-0002-7704-4904	National Science Foundation [0842620]; Direct For Social, Behav & Economic Scie [0842620] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	The work reported here was supported in part by The National Science Foundation grant 0842620. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker MD, 2008, EVOL HUM BEHAV, V29, P391, DOI 10.1016/j.evolhumbehav.2008.06.001; Baker MD, 2009, J EXP SOC PSYCHOL, V45, P1136, DOI 10.1016/j.jesp.2009.06.006; Bates D., 2011, IME4 LINEAR MIXED EF; BAVELAS JB, 1988, HUM COMMUN RES, V14, P275, DOI 10.1111/j.1468-2958.1988.tb00158.x; BERGER SM, 1975, AM J PSYCHOL, V88, P263, DOI 10.2307/1421596; Blairy S, 1999, J NONVERBAL BEHAV, V23, P5, DOI 10.1023/A:1021370825283; BOCK JK, 1986, COGNITIVE PSYCHOL, V18, P355, DOI 10.1016/0010-0285(86)90004-6; Bock K, 2000, J EXP PSYCHOL GEN, V129, P177, DOI 10.1037//0096-3445.129.2.177; Branigan HP, 2000, COGNITION, V75, pB13, DOI 10.1016/S0010-0277(99)00081-5; Brennan SE, 1996, J EXP PSYCHOL LEARN, V22, P1482, DOI 10.1037/0278-7393.22.6.1482; Chang F, 2006, PSYCHOL REV, V113, P234, DOI 10.1037/0033-295X.113.2.234; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cheng CM, 2003, J PERS SOC PSYCHOL, V85, P1170, DOI 10.1037/0022-3514.85.6.1170; Clark H.H., 1996, USING LANGUAGE; Dunbar RIM, 1996, GROOMING GOSSIP EVOL; GARROD S, 1987, COGNITION, V27, P181, DOI 10.1016/0010-0277(87)90018-7; Giles H., 1991, CONTEXTS ACCOMMODATI, DOI [10.1017/CBO9780511663673.001, DOI 10.1017/CBO9780511663673.001]; Griskevicius V, 2006, J PERS SOC PSYCHOL, V91, P281, DOI 10.1037/0022-3514.91.2.281; Griskevicius V, 2006, J PERS SOC PSYCHOL, V91, P63, DOI 10.1037/0022-3514.91.1.63; Haselton MG, 2007, HORM BEHAV, V51, P40, DOI 10.1016/j.yhbeh.2006.07.007; Haselton MG, 2006, HUM NATURE-INT BIOS, V17, P50, DOI 10.1007/s12110-006-1020-0; Haselton MG, 2006, HORM BEHAV, V49, P509, DOI 10.1016/j.yhbeh.2005.10.006; Ireland ME, 2011, PSYCHOL SCI, V22, P39, DOI 10.1177/0956797610392928; Ireland ME, 2010, J PERS SOC PSYCHOL, V99, P549, DOI 10.1037/a0020386; Kaschak MP, 2007, MEM COGNITION, V35, P925, DOI 10.3758/BF03193466; Kaschak MP, 2011, PSYCHON B REV, V18, P1133, DOI 10.3758/s13423-011-0157-y; Kaschak MP, 2011, MEM COGNITION, V39, P381, DOI 10.3758/s13421-010-0042-3; Kaschak MP, LANGUAGE CO IN PRESS; Labov, 2001, PRINCIPLES LINGUISTI; Li NP, 2002, J PERS SOC PSYCHOL, V82, P947, DOI 10.1037//0022-3514.82.6.947; Miller, 2000, MATING MIND SEXUAL C; Miller SL, 2011, J PERS SOC PSYCHOL, V100, P295, DOI 10.1037/a0020930; Miller SL, 2010, J EXP SOC PSYCHOL, V46, P1081, DOI 10.1016/j.jesp.2010.07.004; Miller SL, 2010, PSYCHOL SCI, V21, P276, DOI 10.1177/0956797609357733; Navarrete CD, 2009, PSYCHOL SCI, V20, P661, DOI 10.1111/j.1467-9280.2009.02352.x; Pickering MJ, 2008, PSYCHOL BULL, V134, P427, DOI 10.1037/0033-2909.134.3.427; Pickering MJ, 2009, EUR J SOC PSYCHOL, V39, P1162, DOI 10.1002/ejsp.663; Pickering MJ, 2004, BEHAV BRAIN SCI, V27, P169; Roberts SC, 2004, P ROY SOC B-BIOL SCI, V271, pS270, DOI 10.1098/rsbl.2004.0174; Roder S, 2009, PERS INDIV DIFFER, V47, P616, DOI 10.1016/j.paid.2009.05.019; WEBB JT, 1969, LANG SPEECH, V12, P54, DOI 10.1177/002383096901200105; Wilcox AJ, 2001, CONTRACEPTION, V63, P211, DOI 10.1016/S0010-7824(01)00191-3	43	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e27971	10.1371/journal.pone.0027971	http://dx.doi.org/10.1371/journal.pone.0027971			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	924ZP	22347361	gold, Green Submitted, Green Published			2022-12-25	WOS:000302730100002
J	Kidd, MR; Duftner, N; Koblmuller, S; Sturmbauer, C; Hofmann, HA				Kidd, Michael R.; Duftner, Nina; Koblmueller, Stephan; Sturmbauer, Christian; Hofmann, Hans A.			Repeated Parallel Evolution of Parental Care Strategies within Xenotilapia, a Genus of Cichlid Fishes from Lake Tanganyika	PLOS ONE			English	Article							SYMPATRIC SPECIATION; GENETIC-VARIATION; SEXUAL SELECTION; SOCIAL-BEHAVIOR; MATING SYSTEM; SPECIES FLOCK; MALAWI; PHYLOGENY; BRAIN; POLYMORPHISM	The factors promoting the evolution of parental care strategies have been extensively studied in experiment and theory. However, most attempts to examine parental care in an evolutionary context have evaluated broad taxonomic categories. The explosive and recent diversifications of East African cichlid fishes offer exceptional opportunities to study the evolution of various life history traits based on species-level phylogenies. The Xenotilapia lineage within the endemic Lake Tanganyika cichlid tribe Ectodini comprises species that display either biparental or maternal only brood care and hence offers a unique opportunity to study the evolution of distinct parental care strategies in a phylogenetic framework. In order to reconstruct the evolutionary relationships among 16 species of this lineage we scored 2,478 Amplified Fragment Length Polymorphisms (AFLPs) across the genome. We find that the Ectodini genus Enantiopus is embedded within the genus Xenotilapia and that during 2.5 to 3 million years of evolution within the Xenotilapia clade there have been 3-5 transitions from maternal only to biparental care. While most previous models suggest that uniparental care (maternal or paternal) arose from biparental care, we conclude from our species-level analysis that the evolution of parental care strategies is not only remarkably fast, but much more labile than previously expected.	[Kidd, Michael R.; Duftner, Nina; Hofmann, Hans A.] Univ Texas Austin, Inst Neurosci, Sect Integrat Biol, Austin, TX 78712 USA; [Kidd, Michael R.] Texas A&M Int Univ, Dept Biol & Chem, Laredo, TX USA; [Koblmueller, Stephan; Sturmbauer, Christian] Graz Univ, Dept Zool, Graz, Austria; [Hofmann, Hans A.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; Texas A&M University System; Texas A&M International University; University of Graz; University of Texas System; University of Texas Austin	Kidd, MR (corresponding author), Univ Texas Austin, Inst Neurosci, Sect Integrat Biol, Austin, TX 78712 USA.	michael.kidd@tamiu.edu	Hofmann, Hans A/E-4538-2016	Hofmann, Hans A/0000-0002-3335-330X; Koblmuller, Stephan/0000-0002-1024-3220	Erwin Schrodinger postdoctoral fellowship from the FWF Austrian Science Fund; NSF [IBN-021795, IBN-0843712]; Alfred P. Sloan Foundation; Dwight W. and Blanche Faye Reeder Centennial Fellowship in Systematic and Evolutionary Biology; Institute for Cellular and Molecular Biology; Division Of Integrative Organismal Systems [0843712] Funding Source: National Science Foundation; Austrian Science Fund (FWF) [P 22737] Funding Source: researchfish	Erwin Schrodinger postdoctoral fellowship from the FWF Austrian Science Fund; NSF(National Science Foundation (NSF)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Dwight W. and Blanche Faye Reeder Centennial Fellowship in Systematic and Evolutionary Biology; Institute for Cellular and Molecular Biology; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by an Erwin Schrodinger postdoctoral fellowship from the FWF Austrian Science Fund to ND; NSF grants IBN-021795 and IBN-0843712, the Alfred P. Sloan Foundation, Dwight W. and Blanche Faye Reeder Centennial Fellowship in Systematic and Evolutionary Biology, and an Institute for Cellular and Molecular Biology Fellowship to HAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson RC, 2008, COPEIA, P689, DOI 10.1643/CG-07-217; Albertson RC, 1999, P NATL ACAD SCI USA, V96, P5107, DOI 10.1073/pnas.96.9.5107; Allender CJ, 2003, P NATL ACAD SCI USA, V100, P14074, DOI 10.1073/pnas.2332665100; ARONSON LESTER R., 1949, ZOOLOGICA [NEW YORK], V34, P133; Baerends G.P., 1950, BEHAVIOUR          S, V1, P1; BAERENDS GP, 1986, J FISH BIOL, V29, P107, DOI 10.1111/j.1095-8649.1986.tb05003.x; Balshine-Earn S, 1998, P ROY SOC B-BIOL SCI, V265, P2217, DOI 10.1098/rspb.1998.0562; BalshineEarn S, 1997, J THEOR BIOL, V184, P423, DOI 10.1006/jtbi.1996.0254; BARLOW GW, 1974, AM ZOOL, V14, P9; Barlow GW, 1991, CICHLID FISHES BEHAV, P191; Barlow GW., 2000, CICHLID FISHES NATUR; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; BAYLIS JR, 1981, ENVIRON BIOL FISH, V6, P223, DOI 10.1007/BF00002788; Bensch S, 2005, MOL ECOL, V14, P2899, DOI 10.1111/j.1365-294X.2005.02655.x; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C, DOI DOI 10.104641420-9101.1992.5040719.X; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Duponchelle F, 2008, P NATL ACAD SCI USA, V105, P15475, DOI 10.1073/pnas.0802343105; Egger B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-137; Fryer G., 1972, CICHLID FISHES GREAT; GITTLEMAN JL, 1981, ANIM BEHAV, V29, P936, DOI 10.1016/S0003-3472(81)80031-0; Gompel N, 2009, DEV BIOL, V332, P36, DOI 10.1016/j.ydbio.2009.04.040; Gonzalez-Voyer A, 2008, EVOLUTION, V62, P2015, DOI 10.1111/j.1558-5646.2008.00426.x; Goodwin NB, 1998, P ROY SOC B-BIOL SCI, V265, P2265, DOI 10.1098/rspb.1998.0569; Greenwood P.H., 1978, Bulletin of the British Museum (Natural History) Zoology, V33, P297; GROSS MR, 1985, AM ZOOL, V25, P807; Hammock EAD, 2005, SCIENCE, V308, P1630, DOI 10.1126/science.1111427; HERT E, 1990, J FISH BIOL, V36, P853, DOI 10.1111/j.1095-8649.1990.tb05633.x; HILLIS DM, 1992, J HERED, V83, P189, DOI 10.1093/oxfordjournals.jhered.a111190; Hofmann HA, 2010, P NATL ACAD SCI USA, V107, P9919, DOI 10.1073/pnas.1005137107; HOLZBERG S, 1978, Z ZOOL SYST EVOL, V16, P171; Kabelik D, 2009, HORM BEHAV, V56, P101, DOI 10.1016/j.yhbeh.2009.03.017; Keenleyside M.H.A., 1991, P191; Kellogg KA, 2000, BEHAV ECOL SOCIOBIOL, V47, P164, DOI 10.1007/s002650050007; Kidd MR, 2006, MOL ECOL, V15, P459, DOI 10.1111/j.1365-294X.2005.02787.x; Klett V, 2002, MOL BIOL EVOL, V19, P865, DOI 10.1093/oxfordjournals.molbev.a004144; Koblmuller S, 2008, HYDROBIOLOGIA, V615, P5, DOI 10.1007/s10750-008-9552-4; Koblmueller Stephan, 2007, Molecular Phylogenetics and Evolution, V44, P1295, DOI 10.1016/j.ympev.2007.02.010; Koblmuller S, 2010, MOL PHYLOGENET EVOL, V55, P318, DOI 10.1016/j.ympev.2009.09.032; Koblmuller S, 2004, J MOL EVOL, V58, P79, DOI 10.1007/s00239-003-2527-1; Kocher TD, 2003, NATURE, V423, P489, DOI 10.1038/423489a; KOCHER TD, 1993, MOL PHYLOGENET EVOL, V2, P158, DOI 10.1006/mpev.1993.1016; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Konings A, 2015, TANGANYIKA CICHLIDS; KUWAMURA T, 1986, J ETHOL, V4, P129, DOI 10.1007/BF02348115; Kuwamura T., 1997, FISH COMMUNITIES LAK, P59; Lande R, 2001, GENETICA, V112, P435, DOI 10.1023/A:1013379521338; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; LOWE ROSEMARY H., 1959, PROC ZOOL SOC LONDON, V132, P1; Machado HE, 2009, INTEGR COMP BIOL, V49, P644, DOI 10.1093/icb/icp080; Maddison WP, 2017, MESQUITE MODULAR SYS; Mank JE, 2005, EVOLUTION, V59, P1570; McKaye K.R., 1991, FISH FISHERIES SERIE, V2, P241; MCKAYE KR, 1983, ENVIRON BIOL FISH, V8, P81, DOI 10.1007/BF00005175; MORAN P, 1993, MOL BIOL EVOL, V10, P1015; Neat FC, 1999, ENVIRON BIOL FISH, V55, P333, DOI 10.1023/A:1007580619528; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nishida Mutsumi, 1997, P1; O'Connell LA, 2011, FRONT NEUROENDOCRIN, V32, P320, DOI 10.1016/j.yfrne.2010.12.004; O'Quin KE, 2010, MOL BIOL EVOL, V27, P2839, DOI 10.1093/molbev/msq171; Oldfield RG, 2012, P R SOC B IN PRESS; Oldfield RG, 2011, PHYSIOL BEHAV, V102, P296, DOI 10.1016/j.physbeh.2010.11.022; OPPENHEIMER J R, 1970, Animal Behaviour, V18, P493, DOI 10.1016/0003-3472(70)90045-X; Parker A, 1997, J MOL EVOL, V45, P70, DOI 10.1007/PL00006204; POLL M, 1986, MEM CLASSE SCI ACAD, V5, P5; Pollen AA, 2008, BRAIN BEHAV EVOLUT, V72, P145, DOI 10.1159/000151474; Pollen AA, 2007, BRAIN BEHAV EVOLUT, V70, P21, DOI 10.1159/000101067; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Rosso L, 2008, BIOL LETTERS, V4, P375, DOI 10.1098/rsbl.2008.0122; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; Schliewen Ulrich K, 2004, Front Zool, V1, P5, DOI 10.1186/1742-9994-1-5; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Seehausen O, 2003, P ROY SOC B-BIOL SCI, V270, P129, DOI 10.1098/rspb.2002.2153; Seehausen O, 1999, ECOL LETT, V2, P367; Sefc KM, 2011, INT J EVOL BIOL, P20, DOI DOI 10.4061/2011/470875; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; STURMBAUER C, 1993, MOL BIOL EVOL, V10, P751; Sturmbauer C, 2010, MOL PHYLOGENET EVOL, V57, P266, DOI 10.1016/j.ympev.2010.06.018; Summers K, 1999, BIOL J LINN SOC, V66, P515; Summers K, 1999, HERPETOLOGICA, V55, P254; Swofford D.L., 2001, PAUP PHYLOGENETIC AN; Takahashi K, 1998, MOL BIOL EVOL, V15, P391, DOI 10.1093/oxfordjournals.molbev.a025936; Takahashi T, 1997, ICHTHYOL RES, V44, P109, DOI 10.1007/BF02678689; Takahashi T, 2003, ICHTHYOL RES, V50, P36, DOI 10.1007/s102280300005; TOWNSHEND TJ, 1985, BEHAVIOUR, V95, P181, DOI 10.1163/156853985X00118; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; TURNER GF, 1999, EVOLUTION BIOL DIVER, P217; VANRHIJN JG, 1991, ANIM BEHAV, V41, P963, DOI 10.1016/S0003-3472(05)80634-7; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang ZS, 2003, EVOLUTION, V57, P2852; WERREN JH, 1980, J THEOR BIOL, V82, P619, DOI 10.1016/0022-5193(80)90182-4; YANAGISAWA Y, 1986, JPN J ICHTHYOL, V33, P249, DOI 10.1007/BF02904161	93	14	16	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31236	10.1371/journal.pone.0031236	http://dx.doi.org/10.1371/journal.pone.0031236			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347454	Green Submitted, gold, Green Published			2022-12-25	WOS:000302730100057
J	Wang, M; Shi, S; Lin, F; Hao, ZQ; Jiang, P; Dai, GH				Wang, Miao; Shi, Shuai; Lin, Fei; Hao, Zhanqing; Jiang, Ping; Dai, Guanhua			Effects of Soil Water and Nitrogen on Growth and Photosynthetic Response of Manchurian Ash (Fraxinus mandshurica) Seedlings in Northeastern China	PLOS ONE			English	Article							LEAF GAS-EXCHANGE; USE EFFICIENCY; AMINO-ACIDS; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE; CHLOROPLAST ULTRASTRUCTURE; TERRESTRIAL ECOSYSTEMS; MESOPHYLL CONDUCTANCE; CARBON ASSIMILATION; TRITICUM-AESTIVUM; CO2 ASSIMILATION	Background: Soil water and nitrogen (N) are considered to be the main environmental factors limiting plant growth and photosynthetic capacity. However, less is known about the interactive effects of soil water and N on tree growth and photosynthetic response in the temperate ecosystem. Methods/Principal Findings: We applied N and water, alone and in combination, and investigated the combined effect of different water and N regimes on growth and photosynthetic responses of Fraxinus mandshurica seedlings. The seedlings were exposed to three water regimes including natural precipitation (CK), higher precipitation (HW) (CK +30%) and lower precipitation (LW) (CK -30%), and both with and without N addition for two growing seasons. We demonstrated that water and N supply led to a significant increase in the growth and biomass production of the seedlings. LW treatment significantly decreased biomass production and leaf N content, but they showed marked increases in N addition. N addition could enhance the photosynthetic capability under HW and CK conditions. Leaf chlorophyll content and the initial activity of Rubisco were dramatically increased by N addition regardless of soil water condition. The positive relationships were found between photosynthetic capacity, leaf N content, and SLA in response to water and N supply in the seedling. Rubisco expression was up-regulated by N addition with decreasing soil water content. Immunofluorescent staining showed that the labeling for Rubisco was relatively low in leaves of the seedlings under LW condition. The accumulation of Rubisco was increased in leaf tissues of LW by N addition. Conclusions/Significance: Our study has presented better understanding of the interactions between soil water and N on the growth and photosynthetic response in F. mandschurica seedlings, which may provide novel insights on the potential responses of the forest ecosystem to climate change associated with increasing N deposition.	[Wang, Miao; Shi, Shuai; Lin, Fei; Hao, Zhanqing; Jiang, Ping; Dai, Guanhua] Chinese Acad Sci, Inst Appl Ecol, Shenyang, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS	Wang, M (corresponding author), Chinese Acad Sci, Inst Appl Ecol, Shenyang, Peoples R China.	wangmiao@iae.ac.cn			Major State Basic Research Development Program [2010CB833502]; Chinese Academy of Sciences [KSCX-YW-Z-1022]; National Natural Science Foundation of China [30590382/C011108]; Program for the National Natural Science Foundation of China [30870376]	Major State Basic Research Development Program(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was sponsored by the Major State Basic Research Development Program (2010CB833502), the Knowledge Innovation Project of the Chinese Academy of Sciences (KSCX-YW-Z-1022), the Key Program of the National Natural Science Foundation of China (30590382/C011108) and the Program for the National Natural Science Foundation of China (No. 30870376). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aber JD, 2003, BIOSCIENCE, V53, P375, DOI 10.1641/0006-3568(2003)053[0375:INDATN]2.0.CO;2; Alves AAC, 2000, CROP SCI, V40, P131, DOI 10.2135/cropsci2000.401131x; Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; Andrews M, 1999, PLANT CELL ENVIRON, V22, P949, DOI 10.1046/j.1365-3040.1999.00452.x; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Asghari R, 2006, IRAN J SCI TECHNOL A, V30, P1; Bondada BR, 2003, TREE PHYSIOL, V23, P553, DOI 10.1093/treephys/23.8.553; Bota J, 2004, NEW PHYTOL, V162, P671, DOI 10.1111/j.1469-8137.2004.01056.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRESTIC M, 1995, PLANTA, V196, P450, DOI 10.1007/BF00203643; Cabrera-Bosquet L, 2007, ANN APPL BIOL, V151, P277, DOI 10.1111/j.1744-7348.2007.00195.x; Campbell DR, 2010, AM J BOT, V97, P925, DOI 10.3732/ajb.0900387; Catovsky S, 2002, ECOL APPL, V12, P1056, DOI 10.1890/1051-0761(2002)012[1056:NAIROT]2.0.CO;2; CHANDLER JW, 1995, TREE PHYSIOL, V15, P813, DOI 10.1093/treephys/15.12.813; Chaves MM, 2004, J EXP BOT, V55, P2365, DOI 10.1093/jxb/erh269; Cheng L, 2000, J HORTIC SCI BIOTECH, V75, P383, DOI 10.1080/14620316.2000.11511255; Compton JE, 2004, FOREST ECOL MANAG, V196, P143, DOI 10.1016/j.foreco.2004.03.017; Correia CM, 2005, EUR J AGRON, V22, P337, DOI 10.1016/j.eja.2004.05.002; DaMatta FM, 2002, TREES-STRUCT FUNCT, V16, P555, DOI 10.1007/s00468-002-0205-3; Egli P, 1999, ACTA OECOL, V20, P559, DOI 10.1016/S1146-609X(00)86623-0; Eichelmann H, 1999, PLANT PHYSIOL, V119, P179, DOI 10.1104/pp.119.1.179; Ellsworth DS, 2000, TREE PHYSIOL, V20, P435; Ennahli S, 2005, CROP SCI, V45, P2374, DOI 10.2135/cropsci2005.0147; EVANS JR, 1986, PLANTA, V167, P351, DOI 10.1007/BF00391338; EVANS JR, 1983, PLANT PHYSIOL, V72, P297, DOI 10.1104/pp.72.2.297; Field C., 1986, EC PLANT FORM FUNCTI, P22; Flexas J, 2004, PLANT BIOLOGY, V6, P269, DOI 10.1055/s-2004-820867; Foyer CH, 1998, PLANT PHYSIOL, V117, P283, DOI 10.1104/pp.117.1.283; GEZELIUS K, 1986, PHYSIOL PLANTARUM, V67, P435, DOI 10.1111/j.1399-3054.1986.tb05759.x; Grassi G, 2005, PLANT CELL ENVIRON, V28, P834, DOI 10.1111/j.1365-3040.2005.01333.x; Huang YZ, 2008, CEREB CORTEX, V18, P563, DOI 10.1093/cercor/bhm087; INSKEEP WP, 1985, PLANT PHYSIOL, V77, P483, DOI 10.1104/pp.77.2.483; Kutik J, 1995, J EXP BOT, V46, P1797, DOI 10.1093/jxb/46.12.1797; Laitinen K, 2000, TREE PHYSIOL, V20, P881; Lambers H., 1998, PLANT PHYSL ECOLOGY, P540, DOI DOI 10.1007/978-1-4757-2855-2; LATHAM RE, 1992, ECOLOGY, V73, P2129, DOI 10.2307/1941461; LAUTER DJ, 1981, AGRON J, V73, P961, DOI 10.2134/agronj1981.00021962007300060013x; LAWLOR DW, 1995, J EXP BOT, V46, P1449, DOI 10.1093/jxb/46.special_issue.1449; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Liu P, 2006, APPL SOIL ECOL, V34, P266, DOI 10.1016/j.apsoil.2005.12.009; MAE T, 1983, PLANT CELL PHYSIOL, V24, P1079; MAKINO A, 1988, PLANTA, V174, P30, DOI 10.1007/BF00394870; MAKINO A, 1984, PLANT CELL PHYSIOL, V25, P429; Manter DK, 2005, TREE PHYSIOL, V25, P1015, DOI 10.1093/treephys/25.8.1015; Matson P, 2002, AMBIO, V31, P113, DOI 10.1639/0044-7447(2002)031[0113:TGONDC]2.0.CO;2; McDonald AJS, 1996, ADV BOT RES, V22, P229; MITCHELL AK, 1993, TREE PHYSIOL, V12, P403, DOI 10.1093/treephys/12.4.403; Nakaji T, 2001, TREES-STRUCT FUNCT, V15, P453, DOI 10.1007/s00468-001-0130-x; Nakano H, 1997, PLANT PHYSIOL, V115, P191, DOI 10.1104/pp.115.1.191; Naumann JC, 2008, ENVIRON EXP BOT, V63, P402, DOI 10.1016/j.envexpbot.2007.12.008; Patrick LD, 2009, PLANT CELL ENVIRON, V32, P1695, DOI 10.1111/j.1365-3040.2009.02029.x; Penuelas J, 2009, SCIENCE, V324, P887, DOI 10.1126/science.1173004; Poorter H, 2000, AUST J PLANT PHYSIOL, V27, P1191, DOI 10.1071/PP99173; POORTER H, 1990, OECOLOGIA, V83, P553, DOI 10.1007/BF00317209; REICH PB, 1995, OECOLOGIA, V104, P24, DOI 10.1007/BF00365558; Reich PB, 1998, FUNCT ECOL, V12, P395, DOI 10.1046/j.1365-2435.1998.00209.x; Reich PB, 2006, ANNU REV ECOL EVOL S, V37, P611, DOI 10.1146/annurev.ecolsys.37.091305.110039; Ripullone F, 2003, TREE PHYSIOL, V23, P137, DOI 10.1093/treephys/23.2.137; SAGE RF, 1987, PLANT PHYSIOL, V85, P355, DOI 10.1104/pp.85.2.355; Schwinning S, 2005, RANGELAND ECOL MANAG, V58, P565, DOI 10.2111/03-126.1; Shangguan ZP, 2000, ENVIRON EXP BOT, V44, P141, DOI 10.1016/S0098-8472(00)00064-2; Shaw B, 2002, PLANT GROWTH REGUL, V37, P77, DOI 10.1023/A:1020381513976; STITT M, 1994, PLANT CELL ENVIRON, V17, P465, DOI 10.1111/j.1365-3040.1994.tb00144.x; Stitt M, 1996, ADV PHOTOSYNTHESIS R, P151, DOI DOI 10.1007/0-306-48135-9_; TISSUE DT, 1993, PLANT CELL ENVIRON, V16, P859, DOI 10.1111/j.1365-3040.1993.tb00508.x; Tyree MC, 2009, FOREST ECOL MANAG, V257, P1847, DOI 10.1016/j.foreco.2009.02.001; VAITKUS MR, 1993, AM MIDL NAT, V129, P42, DOI 10.2307/2426434; van den Berg AK, 2004, FOREST ECOL MANAG, V200, P113, DOI 10.1016/j.foreco.2004.06.005; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Wang CH, 2006, SOIL BIOL BIOCHEM, V38, P1101, DOI 10.1016/j.soilbio.2005.09.009; Wang YP, 1998, AGR FOREST METEOROL, V91, P89, DOI 10.1016/S0168-1923(98)00061-6; Warren CR, 2000, J EXP BOT, V51, P1147, DOI 10.1093/jexbot/51.347.1147; Warren CR, 2003, TREES-STRUCT FUNCT, V17, P359, DOI 10.1007/s00468-003-0246-2; Warren CR, 2001, PLANT CELL ENVIRON, V24, P597, DOI 10.1046/j.1365-3040.2001.00711.x; Wendler R, 1996, TREE PHYSIOL, V16, P153; Wu FZ, 2008, PHOTOSYNTHETICA, V46, P40, DOI 10.1007/s11099-008-0008-x; Yamaguchi, 2007, Patent No. [US 2010/0180994 A1, 20100180994]; Yin CY, 2006, PHOTOSYNTHETICA, V44, P62, DOI 10.1007/s11099-005-0159-y; [张弥 Zhang Mi], 2005, [生态学杂志, Chinese Journal of Ecology], V24, P1007; Zhou XB, 2011, ENVIRON EXP BOT, V74, P1, DOI 10.1016/j.envexpbot.2010.12.005	80	41	51	2	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30754	10.1371/journal.pone.0030754	http://dx.doi.org/10.1371/journal.pone.0030754			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347401	Green Submitted, Green Published, gold			2022-12-25	WOS:000302730100024
J	Fluch, S; Kopecky, D; Burg, K; Simkova, H; Taudien, S; Petzold, A; Kubalakova, M; Platzer, M; Berenyi, M; Krainer, S; Dolezel, J; Lelley, T				Fluch, Silvia; Kopecky, Dieter; Burg, Kornel; Simkova, Hana; Taudien, Stefan; Petzold, Andreas; Kubalakova, Marie; Platzer, Matthias; Berenyi, Maria; Krainer, Siegfried; Dolezel, Jaroslav; Lelley, Tamas			Sequence Composition and Gene Content of the Short Arm of Rye (Secale cereale) Chromosome 1	PLOS ONE			English	Article							GENOME SIZE; CHLOROPLAST DNA; ISOZYME MARKERS; FLOW-CYTOMETRY; WHEAT; L.; 1R; MAP; RESISTANCE; TRANSLOCATION	Background: The purpose of the study is to elucidate the sequence composition of the short arm of rye chromosome 1 (Secale cereale) with special focus on its gene content, because this portion of the rye genome is an integrated part of several hundreds of bread wheat varieties worldwide. Methodology/Principal Findings: Multiple Displacement Amplification of 1RS DNA, obtained from flow sorted 1RS chromosomes, using 1RS ditelosomic wheat-rye addition line, and subsequent Roche 454FLX sequencing of this DNA yielded 195,313,589 bp sequence information. This quantity of sequence information resulted in 0.43 x sequence coverage of the 1RS chromosome arm, permitting the identification of genes with estimated probability of 95%. A detailed analysis revealed that more than 5% of the 1RS sequence consisted of gene space, identifying at least 3,121 gene loci representing 1,882 different gene functions. Repetitive elements comprised about 72% of the 1RS sequence, Gypsy/Sabrina (13.3%) being the most abundant. More than four thousand simple sequence repeat (SSR) sites mostly located in gene related sequence reads were identified for possible marker development. The existence of chloroplast insertions in 1RS has been verified by identifying chimeric chloroplast-genomic sequence reads. Synteny analysis of 1RS to the full genomes of Oryza sativa and Brachypodium distachyon revealed that about half of the genes of 1RS correspond to the distal end of the short arm of rice chromosome 5 and the proximal region of the long arm of Brachypodium distachyon chromosome 2. Comparison of the gene content of 1RS to 1HS barley chromosome arm revealed high conservation of genes related to chromosome 5 of rice. Conclusions: The present study revealed the gene content and potential gene functions on this chromosome arm and demonstrated numerous sequence elements like SSRs and gene-related sequences, which can be utilised for future research as well as in breeding of wheat and rye.	[Fluch, Silvia; Kopecky, Dieter; Burg, Kornel; Berenyi, Maria; Krainer, Siegfried] Austrian Inst Technol, Hlth & Environm Dept, Tulln, Austria; [Simkova, Hana; Kubalakova, Marie; Dolezel, Jaroslav] Inst Expt Bot, Ctr Reg Hana Biotechnol & Agr Res, Olomouc, Czech Republic; [Taudien, Stefan; Petzold, Andreas; Platzer, Matthias] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Lelley, Tamas] Univ Nat Resources & Appl Life Sci BOKU, Inst Biotechnol Plant Prod IFA Tulln, Dept Agrobiotechnol, Vienna, Austria	Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Natural Resources & Life Sciences, Vienna	Fluch, S (corresponding author), Austrian Inst Technol, Hlth & Environm Dept, Tulln, Austria.	kornel.burg@ait.ac.at	Dolezel, Jaroslav/B-7716-2008; Kubaláková, Marie/F-8269-2014; Simkova, Hana/F-7734-2014	Dolezel, Jaroslav/0000-0002-6263-0492; Simkova, Hana/0000-0003-4159-7619; Fluch, Silvia/0000-0001-5713-7081	Austrian Science Fund [P18414-B2, P19944-B17]; Ministry of Education, Youth and Sport of the Czech Republic; European Regional Development Fund [ED0007/01/01]	Austrian Science Fund(Austrian Science Fund (FWF)); Ministry of Education, Youth and Sport of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); European Regional Development Fund(European Commission)	This research was supported by the Austrian Science Fund (P18414-B2 and P19944-B17) and the Ministry of Education, Youth and Sport of the Czech Republic and the European Regional Development Fund (Operational Programme Research and Development for Innovations No. ED0007/01/01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2000, NATURE, V408, P354, DOI 10.1038/35042567; ALONSOBLANCO C, 1994, THEOR APPL GENET, V88, P208, DOI 10.1007/BF00225899; Anderson GR, 2003, THEOR APPL GENET, V107, P1297, DOI 10.1007/s00122-003-1358-1; Bartos J, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-95; BAUM M, 1991, CHROMOSOMA, V101, P1, DOI 10.1007/BF00360680; Berkman PJ, 2011, PLANT BIOTECHNOL J, V9, P768, DOI 10.1111/j.1467-7652.2010.00587.x; Bock R, 2008, BIOESSAYS, V30, P556, DOI 10.1002/bies.20761; Borner A, 1998, THEOR APPL GENET, V97, P1279, DOI 10.1007/s001220051020; CARVER BF, 1995, CROP SCI, V35, P1316, DOI 10.2135/cropsci1995.0011183X003500050010x; Clarke BC, 1996, CHROMOSOMA, V105, P269, DOI 10.1007/BF02524644; CONNER RL, 1991, CROP SCI, V31, P315, DOI 10.2135/cropsci1991.0011183X003100020018x; de la Bastide Melissa, 2007, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1104s17; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Devos KM, 2000, PLANT CELL, V12, P637, DOI 10.1105/tpc.12.5.637; Devos KM, 2008, 11 INT WHEAT GEN S P; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Dolezel J, 1998, ANN BOT-LONDON, V82, P17, DOI 10.1006/anbo.1998.0730; Dolezel J, 2007, CHROMOSOME RES, V15, P51, DOI 10.1007/s10577-006-1106-x; DRISCOLL C. J., 1971, Agronomy Abstracts, P6; Ehdaie B, 2003, CROP SCI, V43, P710, DOI 10.2135/cropsci2003.0710; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FLAVELL RB, 1974, BIOCHEM GENET, V12, P257, DOI 10.1007/BF00485947; Francki MG, 2001, GENOME, V44, P266, DOI 10.1139/gen-44-2-266; Gale MD, 1995, P 3 INT RIC GEN S, P77; Graybosch RA, 2001, J CEREAL SCI, V33, P3, DOI 10.1006/jcrs.2000.0336; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Guo XY, 2008, FUNCT INTEGR GENOMIC, V8, P101, DOI 10.1007/s10142-007-0067-2; GUSTAFSON JP, 1988, P NATL ACAD SCI USA, V85, P3943, DOI 10.1073/pnas.85.11.3943; Hackauf B, 2009, THEOR APPL GENET, V118, P371, DOI 10.1007/s00122-008-0906-0; Hosono S, 2003, GENOME RES, V13, P954, DOI 10.1101/gr.816903; Huang CY, 2003, NATURE, V422, P72, DOI 10.1038/nature01435; Kofler R, 2008, THEOR APPL GENET, V117, P915, DOI 10.1007/s00122-008-0831-2; Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157; Korzun V, 2001, THEOR APPL GENET, V102, P709, DOI 10.1007/s001220051701; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Kubalakova M, 2003, GENOME, V46, P893, DOI [10.1139/g03-054, 10.1139/G03-054]; LANDER E S, 1988, Genomics, V2, P231; Lelley T, 2004, J CEREAL SCI, V39, P313, DOI 10.1016/j.jcs.2003.11.003; Ma XF, 2001, THEOR APPL GENET, V102, P517, DOI 10.1007/s001220051676; Mago R, 2002, THEOR APPL GENET, V104, P1317, DOI 10.1007/s00122-002-0879-3; Masojc P, 2001, THEOR APPL GENET, V102, P1273, DOI 10.1007/s001220000512; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; Mayer KFX, 2009, PLANT PHYSIOL, V151, P496, DOI 10.1104/pp.109.142612; McIntosh R. A., 1988, Proceedings of the seventh international wheat genetics symposium, held at Cambridge, UK, 13-19 July 1988., P1225; Meyer M, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1095; Nagy ED, 2003, THEOR APPL GENET, V107, P1271, DOI 10.1007/s00122-003-1367-0; Nagy ED, 2003, EUPHYTICA, V132, P243, DOI 10.1023/A:1025002919746; Noutsos C, 2007, TRENDS GENET, V23, P597, DOI 10.1016/j.tig.2007.08.016; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Rabinovich SV, 1998, EUPHYTICA, V100, P323, DOI 10.1023/A:1018361819215; Sandhu D, 2002, PLANT PHYSIOL, V128, P803, DOI 10.1104/pp.010745; SCHLEGEL R, 1987, THEOR APPL GENET, V74, P820, DOI 10.1007/BF00247563; Sharma S, 2011, THEOR APPL GENET, V122, P759, DOI 10.1007/s00122-010-1484-5; Sharma S, 2009, THEOR APPL GENET, V119, P783, DOI 10.1007/s00122-009-1088-0; Shepherd K. W., 1973, Proceedings of the Fourth International Wheat Genetics Symposium. Cytogenetics., P745; Sheppard AE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000323; Simkova H, 2008, BMC GENOMICS, V9, DOI [10.1186/1471-2164-9-237, 10.1186/1471-2164-9-294]; SINGH NK, 1990, THEOR APPL GENET, V80, P609, DOI 10.1007/BF00224219; Smit A, 1996, REPEATMASKER OPEN 30; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tomita M, 2008, DNA RES, V15, P49, DOI 10.1093/dnares/dsm029; Tsuchida M, 2008, GENES GENET SYST, V83, P43, DOI 10.1266/ggs.83.43; Villareal RL, 1998, EUPHYTICA, V103, P195, DOI 10.1023/A:1018392002909; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; WANG ML, 1991, THEOR APPL GENET, V82, P174, DOI 10.1007/BF00226209; WANOUS MK, 1995, THEOR APPL GENET, V91, P720, DOI 10.1007/BF00220949; Wicker T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-275; Wicker T, 2009, PLANT J, V59, P712, DOI 10.1111/j.1365-313X.2009.03911.x; Zeller F. J., 1973, Proceedings of the fourth international wheat genetics symposium. Alien genetic material., P209; ZELLER FJ, 1983, Z PFLANZENZUCHT, V90, P285; Zeller FJ, 1984, P 6 INT WHEAT GEN S, P161	73	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e30784	10.1371/journal.pone.0030784	http://dx.doi.org/10.1371/journal.pone.0030784			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328922	Green Published, gold, Green Submitted			2022-12-25	WOS:000302179300008
J	Sun, H; Jiang, L; Luo, X; Jin, W; He, Q; An, J; Lui, K; Shi, J; Rong, R; Su, W; Lucchesi, C; Liu, Y; Sheikh, MS; Huang, Y				Sun, H.; Jiang, L.; Luo, X.; Jin, W.; He, Q.; An, J.; Lui, K.; Shi, J.; Rong, R.; Su, W.; Lucchesi, C.; Liu, Y.; Sheikh, M. S.; Huang, Y.			Potential tumor-suppressive role of monoglyceride lipase in human colorectal cancer	ONCOGENE			English	Article						monoglyceride lipase; gene expression; Akt; phosphatidylinositides; colorectal cancer	COLON-CANCER; APOPTOSIS; GENETICS; PROTEIN; PATHWAY; CELLS	Human monoglyceride lipase (MGL) is a recently identified lipase and very little is known about its regulation and function in cellular regulatory processes, particularly in context to human malignancy. In this study, we investigated the regulation and function of MGL in human cancer(s) and report that MGL expression was either absent or reduced in the majority of primary colorectal cancers. Immunohistochemical studies showed that reduction of MGL expression in the colorectal tumor tissues predominantly occurred in the cancerous epithelial cells. MGL was found to reside in the core surface of a cellular organelle named 'lipid body'. Furthermore, it was found to interact selectively with a number of phospholipids, including phosphatidic acid and phosphoinositol(3,4,5)P3, phosphoinositol(3,5)P2, phosphoinositol(3,4)P2 and several other phosphoinositides, and among all phosphoinositides analyzed, its interaction with P1(3,4,5)P3 was found to be the strongest. In addition, overexpression of MGL suppressed colony formation in tumor cell lines and knockdown of MGL resulted in increased Akt phosphorylation. Taken together, our results suggest that MGL plays a negative regulatory role in phosphatidylinositol-3 kinase/Akt signaling and tumor cell growth. Oncogene (2013) 32, 234-241; doi:10.1038/onc.2012.34; published online 20 February 2012	[Sun, H.; Jiang, L.; Luo, X.; Jin, W.; He, Q.; An, J.; Lui, K.; Shi, J.; Rong, R.; Su, W.; Lucchesi, C.; Liu, Y.; Sheikh, M. S.; Huang, Y.] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Huang, Y (corresponding author), SUNY Upstate Med Univ, Dept Pharmacol, 750 E Adams St, Syracuse, NY 13210 USA.	huangy@upstate.edu		Lui, Ki/0000-0002-1690-4616; Liu, Yusen/0000-0002-0994-0109; Liu, Yuxin/0000-0002-0623-2561	NIH [DK062136, CA121850]; NATIONAL CANCER INSTITUTE [R01CA121850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK062136] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH Grants DK062136 and CA121850 to YH.	Accioly MT, 2008, CANCER RES, V68, P1732, DOI 10.1158/0008-5472.CAN-07-1999; Duan RD, 2006, J FOOD NUTR S2, V50, P45; Dueck DA, 1996, MOL CELL BIOCHEM, V162, P97; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Huang Y, 2001, CANCER RES, V61, P6918; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Karakas B, 2006, BRIT J CANCER, V94, P455, DOI 10.1038/sj.bjc.6602970; Kennedy BP, 1998, CANCER RES, V58, P500; Li J, 2010, AM J PHYSIOL-CELL PH, V298, pC251, DOI 10.1152/ajpcell.00221.2009; LIU C, 2005, PATHOLOGIC BASIS DIS, P797; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Prevost N, 2009, BLOOD, V113, P447, DOI 10.1182/blood-2008-06-162032; Rong R, 2005, ONCOGENE, V24, P4867, DOI 10.1038/sj.onc.1208660; Rustgi AK, 2007, GENE DEV, V21, P2525, DOI 10.1101/gad.1593107; Sheridan AM, 2001, MOL CELL BIOL, V21, P4470, DOI 10.1128/MCB.21.14.4470-4481.2001; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245	16	34	37	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN 10	2013	32	2					234	241		10.1038/onc.2012.34	http://dx.doi.org/10.1038/onc.2012.34			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	078CK	22349814	Green Accepted			2022-12-25	WOS:000314075500011
J	Lan, L; Nakajima, S; Kapetanaki, MG; Hsieh, CL; Fagerburg, M; Thickman, K; Rodriguez-Collazo, P; Leuba, SH; Levine, AS; Rapic-Otrin, V				Lan, Li; Nakajima, Satoshi; Kapetanaki, Maria G.; Hsieh, Ching L.; Fagerburg, Matthew; Thickman, Karen; Rodriguez-Collazo, Pedro; Leuba, Sanford H.; Levine, Arthur S.; Rapic-Otrin, Vesna			Monoubiquitinated Histone H2A Destabilizes Photolesion-containing Nucleosomes with Concomitant Release of UV-damaged DNA-binding Protein E3 Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; PIGMENTOSUM GROUP-E; CYCLOBUTANE PYRIMIDINE DIMERS; CHROMATIN REMODELING COMPLEX; RING UBIQUITIN LIGASES; CORE PARTICLE; ANGSTROM RESOLUTION; CELLULAR-RESPONSE; MAMMALIAN-CELLS; GENE-PRODUCT	How the nucleotide excision repair (NER) machinery gains access to damaged chromatinized DNA templates and how the chromatin structure is modified to promote efficient repair of the non-transcribed genome remain poorly understood. The UV-damaged DNA-binding protein complex (UV-DDB, consisting of DDB1 and DDB2, the latter of which is mutated in xeroderma pigmentosum group E patients, is a substrate-recruiting module of the cullin 4B-based E3 ligase complex, DDB1-CUL4B(DDB2). We previously reported that the deficiency of UV-DDB E3 ligases in ubiquitinating histone H2A at UV-damaged DNA sites in the xeroderma pigmentosum group E cells contributes to the faulty NER in these skin cancer-prone patients. Here, we reveal the mechanism by which monoubiquitination of specific H2A lysine residues alters nucleosomal dynamics and subsequently initiates NER. We show that DDB1-CUL4B(DDB2) E3 ligase specifically binds to mononucleosomes assembled with human recombinant histone octamers and nucleosome-positioning DNA containing cyclobutane pyrimidine dimers or 6-4 photoproducts photolesions. We demonstrate functionally that ubiquitination of H2A Lys-119/Lys-120 is necessary for destabilization of nucleosomes and concomitant release of DDB1-CUL4BDDB2 from photolesion-containing DNA. Nucleosomes in which these lysines are replaced with arginines are resistant to such structural changes, and arginine mutants prevent the eviction of H2A and dissociation of polyubiquitinated DDB2 from UV-damaged nucleosomes. The partial eviction of H3 from the nucleosomes is dependent on ubiquitinated H2A Lys-119/Lys-120. Our results provide mechanistic insight into how post-translational modification of H2A at the site of a photolesion initiates the repair process and directly affects the stability of the human genome.	[Rapic-Otrin, Vesna] Univ Pittsburgh, Hillman Canc Ctr, UPCI Res Pavil, Inst Canc, Pittsburgh, PA 15213 USA; [Lan, Li; Nakajima, Satoshi; Kapetanaki, Maria G.; Hsieh, Ching L.; Thickman, Karen; Levine, Arthur S.; Rapic-Otrin, Vesna] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15213 USA; [Fagerburg, Matthew; Rodriguez-Collazo, Pedro; Leuba, Sanford H.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rapic-Otrin, V (corresponding author), Univ Pittsburgh, Hillman Canc Ctr, UPCI Res Pavil, Inst Canc, Suite 2-6,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	vesnaro@pitt.edu		Leuba, Sanford/0000-0003-0278-7997	National Institutes of Health [GM07787, CA122177, P30CA047904]; University of Pittsburgh School of Medicine; NATIONAL CANCER INSTITUTE [K01CA122177, P30CA047904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077872] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh School of Medicine(University of Pittsburgh); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM07787 (to S. H. L.) and CA122177 (to P. R.-C.). This work was also supported by a University of Pittsburgh School of Medicine start-up fund to V. R.-O.; We thank Alana Cheeks-Lomax for helping with the cloning and expression of CUL4B, Jelena Grahovac for assisting with the cloning and purifying the core histones, Dr. Jennifer Guerrero-Santoro for E3 ligase expertise, and Dr. Guillermo Calero for protein purification expertise. We appreciate the helpful discussion with our colleagues at the University of Pittsburgh Cancer Institute and members of the Program of Molecular and Cellular Cancer Biology. University of Pittsburgh Cancer Institute shared resources were supported in part by National Institutes of Health Award P30CA047904.	Alekseev S, 2005, CANCER RES, V65, P10298, DOI 10.1158/0008-5472.CAN-05-2295; Andrews AJ, 2011, ANNU REV BIOPHYS, V40, P99, DOI 10.1146/annurev-biophys-042910-155329; Andrews AJ, 2010, MOL CELL, V37, P834, DOI 10.1016/j.molcel.2010.01.037; Araki M, 2000, MUTAT RES-DNA REPAIR, V459, P147, DOI 10.1016/S0921-8777(99)00067-1; ARENTS G, 1991, P NATL ACAD SCI USA, V88, P10148, DOI 10.1073/pnas.88.22.10148; Batty D, 2000, J MOL BIOL, V300, P275, DOI 10.1006/jmbi.2000.3857; Bergink S, 2006, GENE DEV, V20, P1343, DOI 10.1101/gad.373706; Bohm V, 2011, NUCLEIC ACIDS RES, V39, P3093, DOI 10.1093/nar/gkq1279; BOHM L, 1980, EUR J BIOCHEM, V106, P525, DOI 10.1111/j.1432-1033.1980.tb04599.x; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; DAVIES N, 1994, BBA-GENE STRUCT EXPR, V1218, P187, DOI 10.1016/0167-4781(94)90009-4; Duan MR, 2010, J BIOL CHEM, V285, P26295, DOI 10.1074/jbc.M110.140087; EICKBUSH TH, 1988, J BIOL CHEM, V263, P18972; El-Mahdy MA, 2006, J BIOL CHEM, V281, P13404, DOI 10.1074/jbc.M511834200; Elderkin S, 2007, MOL CELL, V28, P107, DOI 10.1016/j.molcel.2007.08.009; Essen LO, 2006, CELL MOL LIFE SCI, V63, P1266, DOI 10.1007/s00018-005-5447-y; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Fitch ME, 2003, J BIOL CHEM, V278, P46906, DOI 10.1074/jbc.M307254200; Friedberg EC, 2005, DNA REPAIR MUTAGENES; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Gong F, 2005, DNA REPAIR, V4, P884, DOI 10.1016/j.dnarep.2005.04.007; Gong F, 2008, CELL CYCLE, V7, P1067, DOI 10.4161/cc.7.8.5647; Green CM, 2002, EMBO REP, V3, P28, DOI 10.1093/embo-reports/kvf005; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Guerrero-Santoro J, 2008, CANCER RES, V68, P5014, DOI 10.1158/0008-5472.CAN-07-6162; Hara R, 2002, MOL CELL BIOL, V22, P6779, DOI 10.1128/MCB.22.19.6779-6787.2002; Hara R, 2000, MOL CELL BIOL, V20, P9173, DOI 10.1128/MCB.20.24.9173-9181.2000; Harp JM, 2000, ACTA CRYSTALLOGR D, V56, P1513, DOI 10.1107/S0907444900011847; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Hwang BJ, 1999, P NATL ACAD SCI USA, V96, P424, DOI 10.1073/pnas.96.2.424; Jason LJM, 2005, J BIOL CHEM, V280, P4975, DOI 10.1074/jbc.M410203200; Jiang YJ, 2010, P NATL ACAD SCI USA, V107, P17274, DOI 10.1073/pnas.1008388107; Kapetanaki MG, 2006, P NATL ACAD SCI USA, V103, P2588, DOI 10.1073/pnas.0511160103; Koberle B, 2006, DNA REPAIR, V5, P641, DOI 10.1016/j.dnarep.2005.12.001; Kusumoto R, 2001, MUTAT RES-DNA REPAIR, V485, P219, DOI 10.1016/S0921-8777(00)00082-3; LI W, 1993, BIOCHEM J, V296, P737, DOI 10.1042/bj2960737; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luijsterburg MS, 2007, J CELL SCI, V120, P2706, DOI 10.1242/jcs.008367; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Marteijn JA, 2009, J CELL BIOL, V186, P835, DOI 10.1083/jcb.200902150; Matsuda N, 2005, DNA REPAIR, V4, P537, DOI 10.1016/j.dnarep.2004.12.012; Moser J, 2005, DNA REPAIR, V4, P571, DOI 10.1016/j.dnarep.2005.01.001; Naegeli H, 2011, DNA REPAIR, V10, P673, DOI 10.1016/j.dnarep.2011.04.019; Nakajima S, 1998, NUCLEIC ACIDS RES, V26, P638, DOI 10.1093/nar/26.2.638; Nakajima S, 2004, J BIOL CHEM, V279, P46674, DOI 10.1074/jbc.M406070200; NICKEL BE, 1989, BIOCHEMISTRY-US, V28, P964, DOI 10.1021/bi00429a007; Nishi R, 2009, DNA REPAIR, V8, P767, DOI 10.1016/j.dnarep.2009.02.004; Palomera-Sanchez Z, 2011, DNA REPAIR, V10, P119, DOI 10.1016/j.dnarep.2010.10.010; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Rapic-Otrin V, 2003, HUM MOL GENET, V12, P1507, DOI 10.1093/hmg/ddg174; Rapic-Otrin V, 2002, NUCLEIC ACIDS RES, V30, P2588, DOI 10.1093/nar/30.11.2588; Reed SH, 2011, DNA REPAIR, V10, P734, DOI 10.1016/j.dnarep.2011.04.029; Rodriguez-Collazo P, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp273; Scrima A, 2008, CELL, V135, P1213, DOI 10.1016/j.cell.2008.10.045; Shukla MS, 2011, NUCLEIC ACIDS RES, V39, P2559, DOI 10.1093/nar/gkq1174; SMERDON MJ, 1978, P NATL ACAD SCI USA, V75, P4238, DOI 10.1073/pnas.75.9.4238; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Takedachi A, 2010, MOL CELL BIOL, V30, P2708, DOI 10.1128/MCB.01460-09; Tomschik M, 2005, P NATL ACAD SCI USA, V102, P3278, DOI 10.1073/pnas.0500189102; Ura K, 2001, EMBO J, V20, P2004, DOI 10.1093/emboj/20.8.2004; van Holde K.E., 1988, CHROMATIN; Wakasugi M, 2002, J BIOL CHEM, V277, P1637, DOI 10.1074/jbc.C100610200; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; WEST MHP, 1980, BIOCHEMISTRY-US, V19, P3238, DOI 10.1021/bi00555a022; Wittschieben BO, 2005, J BIOL CHEM, V280, P39982, DOI 10.1074/jbc.M507854200; YASUI A, 1994, EMBO J, V13, P6143, DOI 10.1002/j.1460-2075.1994.tb06961.x; Yeh J. I., 2012, P NATL ACA IN PRESS; You YH, 2001, J BIOL CHEM, V276, P44688, DOI 10.1074/jbc.M107696200; Zhang L, 2009, CELL CYCLE, V8, P3953, DOI 10.4161/cc.8.23.10115; Zhao Q, 2009, J BIOL CHEM, V284, P30424, DOI 10.1074/jbc.M109.044982; Zhu QZ, 2010, J CELL PHYSIOL, V223, P283, DOI 10.1002/jcp.22060; Zhu QZ, 2009, DNA REPAIR, V8, P262, DOI 10.1016/j.dnarep.2008.11.007	76	45	49	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12036	12049		10.1074/jbc.M111.307058	http://dx.doi.org/10.1074/jbc.M111.307058			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334663	Green Published, hybrid			2022-12-25	WOS:000302782200041
J	Yaguchi, H; Okumura, F; Takahashi, H; Kano, T; Kameda, H; Uchigashima, M; Tanaka, S; Watanabe, M; Sasaki, H; Hatakeyama, S				Yaguchi, Hiroaki; Okumura, Fumihiko; Takahashi, Hidehisa; Kano, Takahiro; Kameda, Hiroyuki; Uchigashima, Motokazu; Tanaka, Shinya; Watanabe, Masahiko; Sasaki, Hidenao; Hatakeyama, Shigetsugu			TRIM67 Protein Negatively Regulates Ras Activity through Degradation of 80K-H and Induces Neuritogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCYSTIC LIVER-DISEASE; E3 UBIQUITIN LIGASES; RING FINGER; U-BOX; SIGNAL-TRANSDUCTION; CELLS; IDENTIFICATION; GROWTH; SYSTEM; FAMILY	Tripartite motif (TRIM)-containing proteins, which are defined by the presence of a common domain structure composed of a RING finger, one or two B-box motifs and a coiled-coil motif, are involved in many biological processes including innate immunity, viral infection, carcinogenesis, and development. Here we show that TRIM67, which has a TRIM motif, an FN3 domain and a SPRY domain, is highly expressed in the cerebellum and that TRIM67 interacts with PRG-1 and 80K-H, which is involved in the Ras-mediated signaling pathway. Ectopic expression of TRIM67 results in degradation of endogenous 80K-H and attenuation of cell proliferation and enhances neuritogenesis in the neuroblastoma cell line N1E-115. Furthermore, morphological and biological changes caused by knockdown of 80K-H are similar to those observed by overexpression of TRIM67. These findings suggest that TRIM67 regulates Ras signaling via degradation of 80K-H, leading to neural differentiation including neuritogenesis.	[Hatakeyama, Shigetsugu] Hokkaido Univ, Grad Sch Med, Dept Biochem, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Yaguchi, Hiroaki; Kano, Takahiro; Sasaki, Hidenao] Hokkaido Univ, Grad Sch Med, Dept Neurol, Sapporo, Hokkaido 0608638, Japan; [Uchigashima, Motokazu; Watanabe, Masahiko] Hokkaido Univ, Grad Sch Med, Dept Anat, Sapporo, Hokkaido 0608638, Japan; [Tanaka, Shinya] Hokkaido Univ, Grad Sch Med, Dept Pathol, Sapporo, Hokkaido 0608638, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University	Hatakeyama, S (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Biochem, Kita Ku, Kita15,Nishi7, Sapporo, Hokkaido 0608638, Japan.	hatas@med.hokudai.ac.jp	Hatakeyama, Shigetsugu/C-8333-2012; Hidehisa, Takahashi/E-2175-2012; Kano, Takahiro/G-1721-2012; Tanaka, Shinya/D-3586-2011; Uchigashima, Motokazu/C-5715-2012; WATANABE, Masahiko/A-4055-2012	Hatakeyama, Shigetsugu/0000-0002-2150-9979; WATANABE, Masahiko/0000-0001-5037-7138	Ministry of Education, Culture, Sports, Science, and Technology; Grants-in-Aid for Scientific Research [23659144] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology.	Ajioka I, 2007, CELL, V131, P378, DOI 10.1016/j.cell.2007.09.036; Alexander M, 2010, DEV CELL, V18, P961, DOI 10.1016/j.devcel.2010.05.016; Aravind L, 2000, CURR BIOL, V10, pR132, DOI 10.1016/S0960-9822(00)00398-5; Brauer AU, 2008, BBA-MOL CELL BIOL L, V1781, P595, DOI 10.1016/j.bbalip.2008.04.004; Brauer AU, 2003, NAT NEUROSCI, V6, P572, DOI 10.1038/nn1052; Caldon CE, 2010, CELL CYCLE, V9, P1918, DOI 10.4161/cc.9.10.11474; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Drenth JPH, 2003, NAT GENET, V33, P345, DOI 10.1038/ng1104; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; Goh KC, 1996, J BIOL CHEM, V271, P5832, DOI 10.1074/jbc.271.10.5832; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hao JC, 2010, DEV CELL, V18, P950, DOI 10.1016/j.devcel.2010.02.019; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Hisatsune C, 2006, J NEUROSCI, V26, P10916, DOI 10.1523/JNEUROSCI.3269-06.2006; Hodgkinson CP, 2005, BIOCHEM J, V388, P785, DOI 10.1042/BJ20041845; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kanai M, 1997, J BIOL CHEM, V272, P6621, DOI 10.1074/jbc.272.10.6621; Kawaai K, 2009, J BIOL CHEM, V284, P372, DOI 10.1074/jbc.M805828200; Kitamura T, 1998, INT J HEMATOL, V67, P351; KLINT P, 1995, J BIOL CHEM, V270, P23337, DOI 10.1074/jbc.270.40.23337; KRUMAN II, 1993, BIOCHEM BIOPH RES CO, V191, P1309, DOI 10.1006/bbrc.1993.1360; Li AR, 2003, AM J HUM GENET, V72, P691, DOI 10.1086/368295; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Mohammadi M, 1996, MOL CELL BIOL, V16, P977; Moore SW, 2008, DEVELOPMENT, V135, P2855, DOI 10.1242/dev.024133; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Peters JM, 1998, CURR OPIN CELL BIOL, V10, P759, DOI 10.1016/S0955-0674(98)80119-1; Rajsbaum R, 2008, EUR J IMMUNOL, V38, P619, DOI 10.1002/eji.200737916; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Song S, 2011, J GENET GENOMICS, V38, P1, DOI 10.1016/j.jcg.2010.12.004; Tanji K, 2010, NEUROBIOL DIS, V38, P210, DOI 10.1016/j.nbd.2010.01.007; Tokumitsu H, 2010, BIOCHEM J, V431, P81, DOI 10.1042/BJ20100637; Trimbuch T, 2009, CELL, V138, P1222, DOI 10.1016/j.cell.2009.06.050; Trombetta ES, 1996, J BIOL CHEM, V271, P27509, DOI 10.1074/jbc.271.44.27509; Yamada M, 2008, J NEUROCHEM, V106, P2375, DOI 10.1111/j.1471-4159.2008.05579.x	42	33	34	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12050	12059		10.1074/jbc.M111.307678	http://dx.doi.org/10.1074/jbc.M111.307678			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22337885	Green Published, hybrid			2022-12-25	WOS:000302782200042
J	Han, BG; Kim, KH; Lee, SJ; Jeong, KC; Cho, JW; Noh, KH; Kim, TW; Kim, SJ; Yoon, HJ; Suh, SW; Lee, S; Lee, BI				Han, Byeong-Gu; Kim, Kyoung Hoon; Lee, Sang Jae; Jeong, Kyung-Chae; Cho, Jea-Won; Noh, Kyung Hee; Kim, Tae Woo; Kim, Soon-Jong; Yoon, Hye-Jin; Suh, Se Won; Lee, Sangho; Lee, Byung Il			Helical Repeat Structure of Apoptosis Inhibitor 5 Reveals Protein-Protein Interaction Modules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINE ACETYLATION; CRYSTAL-STRUCTURE; CELL-DEATH; IAP PROTEINS; COMPLEX; AAC-11; BINDING; CONSERVATION; BROMODOMAIN; EXPRESSION	Apoptosis inhibitor 5 (API5) is an anti-apoptotic protein that is up-regulated in various cancer cells. Here, we present the crystal structure of human API5. API5 exhibits an elongated all alpha-helical structure. The N-terminal half of API5 is similar to the HEAT repeat and the C-terminal half is similar to the ARM (Armadillo-like) repeat. HEAT and ARM repeats have been implicated in protein-protein interactions, suggesting that the cellular roles of API5 may be to mediate protein-protein interactions. Various components of multiprotein complexes have been identified as API5-interacting protein partners, suggesting that API5 may act as a scaffold for multiprotein complexes. API5 exists as a monomer, and the functionally important heptad leucine repeat does not exhibit the predicted a dimeric leucine zipper. Additionally, Lys-251, which can be acetylated in cells, plays important roles in the inhibition of apoptosis under serum deprivation conditions. The acetylation of this lysine also affects the stability of API5 in cells.	[Han, Byeong-Gu; Lee, Sang Jae; Jeong, Kyung-Chae; Cho, Jea-Won; Lee, Byung Il] Natl Canc Ctr, Res Inst, Div Convergence Technol, Biomol Funct Res Branch, Goyang 410769, Gyeonggi, South Korea; [Kim, Kyoung Hoon; Yoon, Hye-Jin; Suh, Se Won] Seoul Natl Univ, Coll Nat Sci, Dept Chem, Seoul 151747, South Korea; [Kim, Kyoung Hoon; Yoon, Hye-Jin; Suh, Se Won] Seoul Natl Univ, Coll Nat Sci, Dept Biophys & Chem Biol, Seoul 151747, South Korea; [Noh, Kyung Hee; Kim, Tae Woo] Korea Univ, Grad Sch Med, Dept Biomed Sci, Seoul 136701, South Korea; [Kim, Soon-Jong] Mokpo Natl Univ, Dept Chem, Chungnam 534729, South Korea; [Han, Byeong-Gu; Lee, Sangho] Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, Gyeonggi, South Korea	National Cancer Center - Korea (NCC); Seoul National University (SNU); Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine); Mokpo National University; Sungkyunkwan University (SKKU)	Lee, BI (corresponding author), Natl Canc Ctr, Res Inst, Div Convergence Technol, Biomol Funct Res Branch, Goyang 410769, Gyeonggi, South Korea.	bilee@ncc.re.kr	Lee, Sangho/P-4204-2018; Lee, Sang Jae/AAX-7611-2021; Suh, Won/H-8306-2013	Lee, Sangho/0000-0003-3886-4579; Lee, Sang Jae/0000-0002-5366-2900; Suh, Won/0000-0002-1768-4635	National Research Foundation of Korea; Ministry of Education, Science, and Technology [2010-0020993]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by Ministry of Education, Science, and Technology Grant 2010-0020993 (to B. I. L.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Altieri DC, 2010, BIOCHEM J, V430, P199, DOI 10.1042/BJ20100814; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Choi HJ, 2009, J BIOL CHEM, V284, P31776, DOI 10.1074/jbc.M109.047928; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Clegg N, 2003, PROSTATE, V55, P55, DOI 10.1002/pros.10217; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Jung WS, 2007, J BIOL CHEM, V282, P8414, DOI 10.1074/jbc.M607143200; Kasibhatla S, 2003, MOL CANCER THER, V2, P573; Kim JW, 2000, LAB INVEST, V80, P587, DOI 10.1038/labinvest.3780063; Krejci P, 2007, J LEUKOCYTE BIOL, V82, P1363, DOI 10.1189/jlb.0607425; Le Hir H, 2008, CURR OPIN STRUC BIOL, V18, P112, DOI 10.1016/j.sbi.2007.11.002; Li XW, 2011, PLANT CELL, V23, P1416, DOI 10.1105/tpc.110.082636; Ma NF, 2008, HEPATOLOGY, V47, P503, DOI 10.1002/hep.22072; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Morris EJ, 2006, PLOS GENET, V2, P1834, DOI 10.1371/journal.pgen.0020196; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Plevin MJ, 2005, TRENDS BIOCHEM SCI, V30, P66, DOI 10.1016/j.tibs.2004.12.001; Ren K, 2010, PATHOL ONCOL RES, V16, P229, DOI 10.1007/s12253-009-9215-4; Rigou P, 2009, EMBO J, V28, P1576, DOI 10.1038/emboj.2009.106; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Sampietro J, 2006, MOL CELL, V24, P293, DOI 10.1016/j.molcel.2006.09.001; Sasaki H, 2001, LUNG CANCER-J IASLC, V34, P53, DOI 10.1016/S0169-5002(01)00213-6; Schwerk C, 2003, MOL CELL BIOL, V23, P2981, DOI 10.1128/MCB.23.8.2981-2990.2003; Scroggins BT, 2007, MOL CELL, V25, P151, DOI 10.1016/j.molcel.2006.12.008; Shen HH, 2009, BMB REP, V42, P185, DOI 10.5483/BMBRep.2009.42.4.185; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Tange TO, 2005, RNA, V11, P1869, DOI 10.1261/rna.2155905; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tewari M, 1997, CANCER RES, V57, P4063; Tu D, 2007, P NATL ACAD SCI USA, V104, P15599, DOI 10.1073/pnas.0701369104; Van den Berghe L, 2000, MOL ENDOCRINOL, V14, P1709, DOI 10.1210/me.14.11.1709; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Wang ZM, 2010, MED SCI MONITOR, V16, pCR357; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Xing Y, 2003, GENE DEV, V17, P2753, DOI 10.1101/gad.1142603; Yang SY, 2009, TRENDS MOL MED, V15, P225, DOI 10.1016/j.molmed.2009.03.003; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yang XJ, 2004, BIOESSAYS, V26, P1076, DOI 10.1002/bies.20104; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9	57	18	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10727	10737		10.1074/jbc.M111.317594	http://dx.doi.org/10.1074/jbc.M111.317594			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334682	Green Published, hybrid			2022-12-25	WOS:000302780100002
J	Rossi, M; Bolz, C; Revez, J; Javed, S; El-Najjar, N; Anderl, F; Hyytiainen, H; Vuorela, P; Gerhard, M; Hanninen, ML				Rossi, Mirko; Bolz, Christian; Revez, Joana; Javed, Sundus; El-Najjar, Nahed; Anderl, Florian; Hyytiainen, Heidi; Vuorela, Pia; Gerhard, Markus; Hanninen, Marja-Liisa			Evidence for Conserved Function of gamma-Glutamyltranspeptidase in Helicobacter Genus	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENOME SEQUENCE; CRYSTAL-STRUCTURE; BILIARY-TRACT; PYLORI; EXPRESSION; GLUTATHIONE; PROTEIN; BILE; IDENTIFICATION	The confounding consequences of Helicobacter bilis infection in experimental mice populations are well recognized, but the role of this bacterium in human diseases is less known. Limited data are available on virulence determinants of this species. In Helicobacter pylori, gamma-glutamyltranspeptidase (gamma GT) contributes to the colonization of the gastric mucosa and to the pathogenesis of peptic ulcer. The role of gamma GT in H. bilis infections remains unknown. The annotated genome sequence of H. bilis revealed two putative ggt genes and our aim was to characterize these H. bilis gamma GT paralogues. We performed a phylogenetic analysis to understand the evolution of Helicobacter gamma GTs and to predict functional activities of these two genes. In addition, both copies of H. bilis gamma GTs were expressed as recombinant proteins and their biochemical characteristics were analysed. Functional complementation of Esherichia coli deficient in gamma GT activity and deletion of gamma GT in H. bilis were performed. Finally, the inhibitory effect of T-cell and gastric cell proliferation by H. bilis gamma GT was assessed. Our results indicated that one gene is responsible for gamma GT activity, while the other showed no gamma GT activity due to lack of autoprocessing. Although both H. bilis and H. pylori gamma GTs exhibited a similar affinity to L-Glutamine and c-Glutamyl-p-nitroanilide, the H. bilis gamma GT was significantly less active. Nevertheless, H. bilis gamma GT inhibited T-cell proliferation at a similar level to that observed for H. pylori. Finally, we showed a similar suppressive influence of both H. bilis and H. pylori gamma GTs on AGS cell proliferation mediated by an apoptosis-independent mechanism. Our data suggest a conserved function of gamma GT in the Helicobacter genus. Since gamma GT is present only in a few enterohepatic Helicobacter species, its expression appears not to be essential for colonization of the lower gastrointestinal tract, but it could provide metabolic advantages in colonization capability of different niches.	[Rossi, Mirko; Revez, Joana; Hyytiainen, Heidi; Hanninen, Marja-Liisa] Univ Helsinki, Fac Vet Med, Dept Food Hyg & Environm Hlth, Helsinki, Finland; [Bolz, Christian; Javed, Sundus; Anderl, Florian; Gerhard, Markus] Tech Univ Munich, Dept Med Microbiol Immunol & Hyg, Munich, Germany; [El-Najjar, Nahed; Vuorela, Pia] Abo Akad Univ, Dept Biosci, Turku, Finland	University of Helsinki; Technical University of Munich; Abo Akademi University	Rossi, M (corresponding author), Univ Helsinki, Fac Vet Med, Dept Food Hyg & Environm Hlth, Helsinki, Finland.	mirko.rossi@helsinki.fi	Rossi, Mirko/D-1509-2012; El-Najjar, Nahed/I-2755-2019; Gerhard, Markus/N-3387-2014; Javed, Sundus/AAY-2257-2020; Gerhard, Markus/P-8996-2019; Javed, Sundus/AAS-1576-2020	Rossi, Mirko/0000-0002-1585-6384; El-Najjar, Nahed/0000-0002-2278-8586; Gerhard, Markus/0000-0001-9110-3950; Gerhard, Markus/0000-0001-9110-3950; Javed, Sundus/0000-0001-8352-8078	Academy of Finland, Center of Excellence [118602]; Academy of Finland [132940]	Academy of Finland, Center of Excellence(Academy of Finland); Academy of Finland(Academy of Finland)	This work was supported by Academy of Finland, Center of Excellence, decision number 118602, and Academy of Finland, Postdoctoral Researcher's project, decision number 132940. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhuder K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000284; Arnold IC, 2011, GENOME BIOL EVOL, V3, P302, DOI 10.1093/gbe/evr022; Barnes HA, 2007, MICROB PATHOGENESIS, V43, P198, DOI 10.1016/j.micpath.2007.05.007; Bhasin M, 2005, BIOINFORMATICS, V21, P2522, DOI 10.1093/bioinformatics/bti309; Boanca G, 2007, J BIOL CHEM, V282, P534, DOI 10.1074/jbc.M607694200; Boanca G, 2006, J BIOL CHEM, V281, P19029, DOI 10.1074/jbc.M603381200; Boyce R, 2009, NUCLEIC ACIDS RES, V37, pW222, DOI 10.1093/nar/gkp379; Busiello I, 2004, CELL MICROBIOL, V6, P255, DOI 10.1046/j.1462-5822.2004.00366.x; Chevalier C, 1999, MOL MICROBIOL, V31, P1359, DOI 10.1046/j.1365-2958.1999.01271.x; Choo KH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S15-S2; de Laureto PP, 2002, PROTEIN SCI, V11, P2932, DOI 10.1110/ps.0205802; Eppinger M, 2006, PLOS GENET, V2, P1097, DOI 10.1371/journal.pgen.0020120; Fox JG, 2007, GUT, V56, P898, DOI 10.1136/gut.2006.115428; Fox JG, 2009, J CLIN MICROBIOL, V47, P3673, DOI 10.1128/JCM.00879-09; Fox JG, 1998, GASTROENTEROLOGY, V114, P755, DOI 10.1016/S0016-5085(98)70589-X; Fox JG, 2004, COMPARATIVE MED, V54, P571; FOX JG, 1995, J CLIN MICROBIOL, V33, P445, DOI 10.1128/JCM.33.2.445-454.1995; Gong M, 2010, GASTROENTEROLOGY, V139, P564, DOI 10.1053/j.gastro.2010.03.050; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hannula M, 2007, INT J SYST EVOL MICR, V57, P444, DOI 10.1099/ijs.0.64462-0; Hynes SO, 2004, HELICOBACTER, V9, P313, DOI 10.1111/j.1083-4389.2004.00237.x; Hynes SO, 2003, INFECT IMMUN, V71, P2976, DOI 10.1128/IAI.71.5.2976-2980.2003; Jergens AE, 2007, GUT, V56, P934, DOI 10.1136/gut.2006.099242; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kostia S, 2003, J MED MICROBIOL, V52, P103, DOI 10.1099/jmm.0.04920-0; Leduc D, 2010, INFECT IMMUN, V78, P2782, DOI 10.1128/IAI.00149-10; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Liang H, 2006, NUCLEIC ACIDS RES, V34, pW382, DOI 10.1093/nar/gkl272; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Matsukura N, 2002, JPN J CANCER RES, V93, P842, DOI 10.1111/j.1349-7006.2002.tb01327.x; Maurer KJ, 2005, GASTROENTEROLOGY, V128, P1023, DOI 10.1053/j.gastro.2005.01.008; McGovern KJ, 2001, INFECT IMMUN, V69, P4168, DOI 10.1128/IAI.69.6.4168-4173.2001; Minami H, 2004, J BACTERIOL, V186, P1213, DOI 10.1128/JB.186.4.1213-1214.2004; Morrow AL, 2007, BIOCHEMISTRY-US, V46, P13407, DOI 10.1021/bi701599e; Murata H, 2004, ALIMENT PHARM THER, V20, P90, DOI 10.1111/j.1365-2036.2004.01972.x; Murray PR, 2010, ARCH DERMATOL, V146, P523, DOI 10.1001/archdermatol.2010.86; Okada T, 2006, P NATL ACAD SCI USA, V103, P6471, DOI 10.1073/pnas.0511020103; Okada T, 2007, J BIOL CHEM, V282, P2433, DOI 10.1074/jbc.M607490200; On S. L. W., 2005, BERGEYS MANUAL SYS C, V2, P1169; Ong PL, 2008, BIOCHEM BIOPH RES CO, V366, P294, DOI 10.1016/j.bbrc.2007.11.063; OTOOLE PW, 2010, BMC GENOMICS, V11, DOI DOI 10.1186/1471-2164-11-164; Rawlings ND, 2004, NUCLEIC ACIDS RES, V32, pD160, DOI 10.1093/nar/gkp971; ROMERO S, 1988, J CLIN MICROBIOL, V26, P142, DOI 10.1128/JCM.26.1.142-143.1988; Rossi M, 2008, VET MICROBIOL, V129, P304, DOI 10.1016/j.vetmic.2007.11.014; Rossi M, 2010, INT J SYST EVOL MICR, V60, P2392, DOI 10.1099/ijs.0.016287-0; Schmees C, 2007, GASTROENTEROLOGY, V132, P1820, DOI 10.1053/j.gastro.2007.02.031; Schott T, 2011, J BACTERIOL, V193, P4565, DOI 10.1128/JB.05439-11; Shibayama K, 2003, MOL MICROBIOL, V47, P443, DOI 10.1046/j.1365-2958.2003.03305.x; Shibayama K, 2007, MOL MICROBIOL, V64, P396, DOI 10.1111/j.1365-2958.2007.05661.x; Solnick JV, 2001, CLIN MICROBIOL REV, V14, P59, DOI 10.1128/CMR.14.1.59-97.2001; SUZUKI H, 1986, J BACTERIOL, V168, P1325, DOI 10.1128/jb.168.3.1325-1331.1986; Suzuki H, 2004, APPL ENVIRON MICROB, V70, P6324, DOI 10.1128/AEM.70.10.6324-6328.2004; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Vermoote M, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-51; VIEIRA J, 1991, GENE, V100, P189, DOI 10.1016/0378-1119(91)90365-I; Vorobjova T, 2006, DIGEST LIVER DIS, V38, P171, DOI 10.1016/j.dld.2005.12.008; Wachino JI, 2010, HELICOBACTER, V15, P184, DOI 10.1111/j.1523-5378.2010.00755.x; WAGNER A, 2003, ENCY LIFE SCI, DOI DOI 10.1128/AEM.02693-07; WANG Y, 1990, GENE, V94, P23, DOI 10.1016/0378-1119(90)90463-2; Whary MT, 2006, LAB ANIMAL, V35, P25, DOI 10.1038/laban0706-25; Williams K, 2009, BIOCHEMISTRY-US, V48, P2459, DOI 10.1021/bi8014955; Yamada C, 2008, APPL ENVIRON MICROB, V74, P3400, DOI 10.1128/AEM.02693-07; Young VB, 2004, INFECT IMMUN, V72, P2521, DOI 10.1128/IAI.72.5.2521-2527.2004; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604; Yu NY, 2011, NUCLEIC ACIDS RES, V39, pD241, DOI 10.1093/nar/gkq1093	68	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e30543	10.1371/journal.pone.0030543	http://dx.doi.org/10.1371/journal.pone.0030543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348013	Green Published, gold, Green Submitted			2022-12-25	WOS:000302737400002
J	Chen, SH; Luo, JJ; Hu, MY; Geng, P; Zhang, YB				Chen, Shaohua; Luo, Jianjun; Hu, Meiying; Geng, Peng; Zhang, Yanbo			Microbial Detoxification of Bifenthrin by a Novel Yeast and Its Potential for Contaminated Soils Treatment	PLOS ONE			English	Article							PYRETHROID INSECTICIDES; BIODEGRADATION; CHLORPYRIFOS; STRAIN; TOXICITY; 3,5,6-TRICHLORO-2-PYRIDINOL; DEGRADATION; HYDROLYSIS; PESTICIDES; RESIDUES	Bifenthrin is one the most widespread pollutants and has caused potential effect on aquatic life and human health, yet little is known about microbial degradation in contaminated regions. A novel yeast strain ZS-02, isolated from activated sludge and identified as Candida pelliculosa based on morphology, API test and 18S rDNA gene analysis, was found highly effective in degrading bifenthrin over a wide range of temperatures (20-40 degrees C) and pH (5-9). On the basis of response surface methodology (RSM), the optimal degradation conditions were determined to be 32.3 degrees C and pH 7.2. Under these conditions, the yeast completely metabolized bifenthrin (50 mg.L-1) within 8 days. This strain utilized bifenthrin as the sole carbon source for growth as well as co-metabolized it in the presence of glucose, and tolerated concentrations as high as 600 mg.L-1 with a q(max), K-s and K-i of 1.7015 day(-1), 86.2259 mg.L-1 and 187.2340 mg.L-1, respectively. The yeast first degraded bifenthrin by hydrolysis of the carboxylester linkage to produce cyclopropanecarboxylic acid and 2-methyl-3-biphenylyl methanol. Subsequently, 2-methyl-3-biphenylyl methanol was further transformed by biphenyl cleavage to form 4-trifluoromethoxy phenol, 2-chloro-6-fluoro benzylalcohol, and 3,5-dimethoxy phenol, resulting in its detoxification. Eventually, no persistent accumulative product was detected by gas chromatopraphy-mass spectrometry (GC-MS) analysis. This is the first report of a novel pathway of degradation of bifenthrin by hydrolysis of ester linkage and cleavage of biphenyl in a microorganism. Furthermore, strain ZS-02 degraded a variety of pyrethroids including bifenthrin, cyfluthrin, deltamethrin, fenvalerate, cypermethrin, and fenpropathrin. In different contaminated soils introduced with strain ZS-02, 65-75% of the 50 mg.kg(-1) bifenthrin was eliminated within 10 days, suggesting the yeast could be a promising candidate for remediation of environments affected by bifenthrin. Finally, this is the first described yeast capable of degrading bifenthrin.	[Chen, Shaohua; Luo, Jianjun; Hu, Meiying; Geng, Peng; Zhang, Yanbo] S China Agr Univ, Minist Educ, Key Lab Pesticide & Chem Biol, Lab Insect Toxicol, Guangzhou, Peoples R China	South China Agricultural University	Chen, SH (corresponding author), S China Agr Univ, Minist Educ, Key Lab Pesticide & Chem Biol, Lab Insect Toxicol, Guangzhou, Peoples R China.	humy@scau.edu.cn	Chen, Shaohua/AAQ-9860-2021	Chen, Shaohua/0000-0001-8306-2626	National Natural Science Foundation [30871660]; Project of Scientific Technological Planning of Guangdong Province, People's Republic of China [2009B020310005]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Project of Scientific Technological Planning of Guangdong Province, People's Republic of China	The authors gratefully acknowledge the grants from the National Natural Science Foundation (No. 30871660) and Project of Scientific Technological Planning of Guangdong Province (No. 2009B020310005), People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari RA, 2011, ECOTOX ENVIRON SAFE, V74, P150, DOI 10.1016/j.ecoenv.2010.08.036; Anwar S, 2009, J HAZARD MATER, V168, P400, DOI 10.1016/j.jhazmat.2009.02.059; BARNETT JA, 2000, YEASTS CHARACTERISTI; Baskaran S, 1999, PESTIC SCI, V55, P1222, DOI 10.1002/(SICI)1096-9063(199912)55:12<1222::AID-PS83>3.0.CO;2-7; Chen SH, 2011, APPL MICROB IN PRESS; Chen SH, 2011, BIORESOURCE TECHNOL, V102, P8110, DOI 10.1016/j.biortech.2011.06.055; Chen SH, 2011, J HAZARD MATER, V187, P433, DOI 10.1016/j.jhazmat.2011.01.049; Chen SH, 2011, APPL MICROBIOL BIOT, V90, P755, DOI 10.1007/s00253-010-3035-z; Cycon M, 2009, CHEMOSPHERE, V76, P494, DOI 10.1016/j.chemosphere.2009.03.023; Dal Bello G, 2008, J PHYTOPATHOL, V156, P257, DOI 10.1111/j.1439-0434.2007.01351.x; Dritsa V, 2009, WATER AIR SOIL POLL, V204, P19, DOI 10.1007/s11270-009-0022-z; Dutta R, 2011, TOXICOLOGY, V285, P126, DOI 10.1016/j.tox.2011.04.012; Fenlon KA, 2011, CHEMOSPHERE, V82, P163, DOI 10.1016/j.chemosphere.2010.10.027; Grant RJ, 2002, J APPL MICROBIOL, V92, P534, DOI 10.1046/j.1365-2672.2002.01558.x; Guo P, 2009, INT BIODETER BIODEGR, V63, P1107, DOI 10.1016/j.ibiod.2009.09.008; Harms H, 2011, NAT REV MICROBIOL, V9, P177, DOI 10.1038/nrmicro2519; Heidari R, 2005, INSECT BIOCHEM MOLEC, V35, P597, DOI 10.1016/j.ibmb.2005.02.018; Hintzen EP, 2009, ENVIRON POLLUT, V157, P110, DOI 10.1016/j.envpol.2008.07.023; Holmes RW, 2008, ENVIRON SCI TECHNOL, V42, P7003, DOI 10.1021/es801346g; Jin YX, 2011, FISH SHELLFISH IMMUN, V30, P1049, DOI 10.1016/j.fsi.2011.02.001; Laffin B, 2010, TOXICOLOGY, V267, P39, DOI 10.1016/j.tox.2009.10.003; Laskowski Dennis A., 2002, V174, P49; Lee S, 2004, ENVIRON TOXICOL CHEM, V23, P1, DOI 10.1897/03-114; Liu J, 2011, TOXICOLOGY, V282, P47, DOI 10.1016/j.tox.2011.01.007; MALONEY SE, 1993, APPL ENVIRON MICROB, V59, P2007, DOI 10.1128/AEM.59.7.2007-2013.1993; Mohapatra S, 2009, PESTIC RES J, V19, P110; Mohapatra Soudamini, 2007, Pesticide Research Journal, V19, P110; Perry MJ, 2007, REPROD TOXICOL, V23, P113, DOI 10.1016/j.reprotox.2006.08.005; Riederer AM, 2010, ENVIRON SCI TECHNOL, V44, P483, DOI 10.1021/es902479h; Sambrook J., 2001, MOL CLONING LAB MANU; Shafer TJ, 2005, ENVIRON HEALTH PERSP, V113, P123, DOI 10.1289/ehp.7254; Singh BK, 2006, FEMS MICROBIOL REV, V30, P428, DOI 10.1111/j.1574-6976.2006.00018.x; Singh BK, 2006, SOIL BIOL BIOCHEM, V38, P2682, DOI 10.1016/j.soilbio.2006.04.019; Singh BK, 2009, NAT REV MICROBIOL, V7, P156, DOI 10.1038/nrmicro2050; Sorensen SR, 2001, APPL ENVIRON MICROB, V67, P5403, DOI 10.1128/AEM.67.12.5403-5409.2001; Tallur PN, 2008, BIODEGRADATION, V19, P77, DOI 10.1007/s10532-007-9116-8; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tewary DK, 2005, FOOD CONTROL, V16, P231, DOI 10.1016/j.foodcont.2004.02.004; U.S. EPA, 2015, 740C15003 US EPA; Wang BZ, 2011, WORLD J MICROB BIOT, V27, P2315, DOI 10.1007/s11274-011-0698-2; Wang BZ, 2009, APPL ENVIRON MICROB, V75, P5496, DOI 10.1128/AEM.01298-09; Wang C, 2009, J ENVIRON SCI, V21, P1710, DOI 10.1016/S1001-0742(08)62477-8; Wang LM, 2007, ENVIRON SCI TECHNOL, V41, P6124, DOI 10.1021/es070220d; Wang YQ, 2009, J HAZARD MATER, V169, P1163, DOI 10.1016/j.jhazmat.2009.04.002; Weston DP, 2011, ENVIRON POLLUT, V159, P3051, DOI 10.1016/j.envpol.2011.04.008; Weston DP, 2009, ENVIRON POLLUT, V157, P287, DOI 10.1016/j.envpol.2008.06.037; WHO, 2009, WHO REC CLASS PEST H; Wolansky MJ, 2008, NEUROTOXICOL TERATOL, V30, P55, DOI 10.1016/j.ntt.2007.10.005; Xu GM, 2008, INT BIODETER BIODEGR, V62, P51, DOI 10.1016/j.ibiod.2007.12.001; Zhang C, 2011, BIORESOURCE TECHNOL, V102, P7139, DOI 10.1016/j.biortech.2011.03.086; Zhang C, 2010, BIORESOURCE TECHNOL, V101, P3423, DOI 10.1016/j.biortech.2009.12.083; Zhang SB, 2011, BIODEGRADATION, V22, P869, DOI 10.1007/s10532-010-9444-y	52	45	52	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e30862	10.1371/journal.pone.0030862	http://dx.doi.org/10.1371/journal.pone.0030862			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348025	gold, Green Submitted, Green Published			2022-12-25	WOS:000302733900014
J	Manfredi, LR; Baker, AT; Elias, DO; Dammann, JF; Zielinski, MC; Polashock, VS; Bensmaia, SJ				Manfredi, Louise R.; Baker, Andrew T.; Elias, Damian O.; Dammann, John F., III; Zielinski, Mark C.; Polashock, Vicky S.; Bensmaia, Sliman J.			The Effect of Surface Wave Propagation on Neural Responses to Vibration in Primate Glabrous Skin	PLOS ONE			English	Article							MECHANORECEPTIVE AFFERENTS; POPULATION RESPONSE; FLUTTER-VIBRATION; TACTILE; INTENSITY; STIMULUS; MODEL; DISCRIMINATION; PERCEPTION; MECHANICS	Because tactile perception relies on the response of large populations of receptors distributed across the skin, we seek to characterize how a mechanical deformation of the skin at one location affects the skin at another. To this end, we introduce a novel non-contact method to characterize the surface waves produced in the skin under a variety of stimulation conditions. Specifically, we deliver vibrations to the fingertip using a vibratory actuator and measure, using a laser Doppler vibrometer, the surface waves at different distances from the locus of stimulation. First, we show that a vibration applied to the fingertip travels at least the length of the finger and that the rate at which it decays is dependent on stimulus frequency. Furthermore, the resonant frequency of the skin matches the frequency at which a subpopulation of afferents, namely Pacinian afferents, is most sensitive. We show that this skin resonance can lead to a two-fold increase in the strength of the response of a simulated afferent population. Second, the rate at which vibrations propagate across the skin is dependent on the stimulus frequency and plateaus at 7 m/s. The resulting delay in neural activation across locations does not substantially blur the temporal patterning in simulated populations of afferents for frequencies less than 200 Hz, which has important implications about how vibratory frequency is encoded in the responses of somatosensory neurons. Third, we show that, despite the dependence of decay rate and propagation speed on frequency, the waveform of a complex vibration is well preserved as it travels across the skin. Our results suggest, then, that the propagation of surface waves promotes the encoding of spectrally complex vibrations as the entire neural population is exposed to essentially the same stimulus. We also discuss the implications of our results for biomechanical models of the skin.	[Manfredi, Louise R.; Dammann, John F., III; Zielinski, Mark C.; Bensmaia, Sliman J.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Baker, Andrew T.; Polashock, Vicky S.] Kimberly Clark Inc, Roswell, GA USA; [Elias, Damian O.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of Chicago; Kimberly-Clark; University of California System; University of California Berkeley	Manfredi, LR (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57th St, Chicago, IL 60637 USA.	sliman@uchicago.edu	Manfredi, Louise/HGA-8471-2022; Elias, Damian O/C-4954-2013	Zielinski, Mark/0000-0002-6950-6689; Manfredi, Louise Rosanna/0000-0003-0660-3980				Bensmaia S, 2005, PERCEPT PSYCHOPHYS, V67, P842, DOI 10.3758/BF03193537; Bensmaia SJ, 2003, SOMATOSENS MOT RES, V20, P33, DOI 10.1080/0899022031000083825; Bensmaia SJ, 2008, BEHAV BRAIN RES, V190, P165, DOI 10.1016/j.bbr.2008.02.044; BOLANOWSKI SJ, 1984, J NEUROPHYSIOL, V51, P793, DOI 10.1152/jn.1984.51.4.793; Brisben AJ, 1999, J NEUROPHYSIOL, V81, P1548, DOI 10.1152/jn.1999.81.4.1548; Dandekar K, 2003, J BIOMECH ENG-T ASME, V125, P682, DOI 10.1115/1.1613673; Dong Y, 2010, THESIS J HOPKINS U B; Franke EK, 1951, 6464 AIR FORC; FREEMAN AW, 1982, J PHYSIOL-LONDON, V323, P43, DOI 10.1113/jphysiol.1982.sp014060; Gerling GJ, 2008, SOMATOSENS MOT RES, V25, P61, DOI 10.1080/08990220701838996; Harvey MA, PROCESSING SPECTRALL; Hollins M, 2002, BEHAV BRAIN RES, V135, P51, DOI 10.1016/S0166-4328(02)00154-7; Hollins M, 2001, SOMATOSENS MOT RES, V18, P253; Hollins M, 2007, CAN J EXP PSYCHOL, V61, P184, DOI 10.1037/cjep2007020; JOHANSSON RS, 1983, TRENDS NEUROSCI, V6, P27, DOI 10.1016/0166-2236(83)90011-5; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V286, P283, DOI 10.1113/jphysiol.1979.sp012619; JOHNSON KO, 1974, J NEUROPHYSIOL, V37, P48, DOI 10.1152/jn.1974.37.1.48; Kim SS, 2010, J NEUROPHYSIOL, V104, P1484, DOI 10.1152/jn.00187.2010; Klatzky RL, 1999, PERCEPT PSYCHOPHYS, V61, P591, DOI 10.3758/BF03205532; LaMotte RH, 2000, J NEUROPHYSIOL, V83, P1777, DOI 10.1152/jn.2000.83.4.1777; Mihalas S., 2011, NEURAL COMPUT, V21, P704; MOUNTCASTLE VB, 1969, J NEUROPHYSIOL, V32, P452, DOI 10.1152/jn.1969.32.3.452; MRIDHA M, 1992, J BIOMECH, V25, P1213, DOI 10.1016/0021-9290(92)90077-E; Muniak MA, 2007, J NEUROSCI, V27, P11687, DOI 10.1523/JNEUROSCI.1486-07.2007; PHILLIPS JR, 1981, J NEUROPHYSIOL, V46, P1204, DOI 10.1152/jn.1981.46.6.1204; POTTS RO, 1983, J BIOMECH, V16, P365, DOI 10.1016/0021-9290(83)90070-2; PUBOLS BH, 1987, SOMATOSENS MOT RES, V4, P273, DOI 10.3109/07367228709144611; Scheibert J, 2009, SCIENCE, V323, P1503, DOI 10.1126/science.1166467; Sripati AP, 2006, J NEUROPHYSIOL, V95, P3852, DOI 10.1152/jn.01240.2005; TALBOT WH, 1968, J NEUROPHYSIOL, V31, P301, DOI 10.1152/jn.1968.31.2.301; VERRILLO RT, 1962, J ACOUST SOC AM, V34, P1768, DOI 10.1121/1.1909124; VONGIERKE HE, 1952, J APPL PHYSIOL, V4, P886, DOI 10.1152/jappl.1952.4.12.886; Wu John Z., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P55, DOI 10.1080/10255840600603641; Wu JZ, 2003, ANN BIOMED ENG, V31, P867, DOI 10.1114/1.1581290; Yau Jeffrey M, 2009, Commun Integr Biol, V2, P344; Yoshioka T, 2007, SOMATOSENS MOT RES, V24, P53, DOI 10.1080/08990220701318163	36	55	55	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31203	10.1371/journal.pone.0031203	http://dx.doi.org/10.1371/journal.pone.0031203			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348055	gold, Green Published, Green Submitted			2022-12-25	WOS:000302733900031
J	Yi, ZH; Li, ZZ; Yu, SY; Yuan, CM; Hong, W; Wang, ZW; Cui, J; Shi, TL; Fang, YR				Yi, Zhenghui; Li, Zezhi; Yu, Shunying; Yuan, Chengmei; Hong, Wu; Wang, Zuowei; Cui, Jian; Shi, Tieliu; Fang, Yiru			Blood-Based Gene Expression Profiles Models for Classification of Subsyndromal Symptomatic Depression and Major Depressive Disorder	PLOS ONE			English	Article							CLINICAL-SIGNIFICANCE; BIPOLAR DISORDER; MOOD DISORDERS; SUBTHRESHOLD DEPRESSION; MICROARRAY ANALYSIS; BEHAVIORAL-MODELS; BRAIN; SCHIZOPHRENIA; POSTMORTEM; DISEASE	Subsyndromal symptomatic depression (SSD) is a subtype of subthreshold depressive and also lead to significant psychosocial functional impairment as same as major depressive disorder (MDD). Several studies have suggested that SSD is a transitory phenomena in the depression spectrum and is thus considered a subtype of depression. However, the pathophysioloy of depression remain largely obscure and studies on SSD are limited. The present study compared the expression profile and made the classification with the leukocytes by using whole-genome cRNA microarrays among drug-free first-episode subjects with SSD, MDD, and matched controls (8 subjects in each group). Support vector machines (SVMs) were utilized for training and testing on candidate signature expression profiles from signature selection step. Firstly, we identified 63 differentially expressed SSD signatures in contrast to control (P<=5.0E-4) and 30 differentially expressed MDD signatures in contrast to control, respectively. Then, 123 gene signatures were identified with significantly differential expression level between SSD and MDD. Secondly, in order to conduct priority selection for biomarkers for SSD and MDD together, we selected top gene signatures from each group of pair-wise comparison results, and merged the signatures together to generate better profiles used for clearly classify SSD and MDD sets in the same time. In details, we tried different combination of signatures from the three pair-wise compartmental results and finally determined 48 gene expression signatures with 100% accuracy. Our finding suggested that SSD and MDD did not exhibit the same expressed genome signature with peripheral blood leukocyte, and blood cell-derived RNA of these 48 gene models may have significant value for performing diagnostic functions and classifying SSD, MDD, and healthy controls.	[Yi, Zhenghui; Li, Zezhi; Yuan, Chengmei; Hong, Wu; Wang, Zuowei; Fang, Yiru] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Div Mood Disorders, Shanghai 200030, Peoples R China; [Yu, Shunying] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Dept Genet, Shanghai 200030, Peoples R China; [Cui, Jian; Shi, Tieliu] E China Normal Univ, Coll Life Sci, Ctr Bioinformat, Shanghai 200062, Peoples R China; [Cui, Jian; Shi, Tieliu] E China Normal Univ, Coll Life Sci, Inst Biomed Sci, Shanghai 200062, Peoples R China; [Shi, Tieliu] Chinese Acad Sci, Shanghai Informat Ctr Life Sci, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; East China Normal University; East China Normal University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Information Center for Life Sciences	Yi, ZH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Div Mood Disorders, Shanghai 200030, Peoples R China.	yirufang@yahoo.com.cn	Li, Zezhi/I-5524-2018		National Natural Science Foundation of China [30971047, 81000581]; Ministry of Science and Technology of China [2006AA02Z430, 2008ZX09312, 2004BA720A21-02]; Science and Technology Commission of Shanghai Municipality [064119533]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by National Natural Science Foundation of China(30971047, 81000581), National High-tech R&D Program (863 Program, 2006AA02Z430, Ministry of Science and Technology of China), National Key Project for IND (investigational new drug)(2008ZX09312, Ministry of Science and Technology of China), "10th Five-Year Plan" of National Key Technologies R&D Program (2004BA720A21-02, Ministry of Science and Technology of China), and the "Climbing Action" Program (064119533, Science and Technology Commission of Shanghai Municipality). The funding organizations had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	American Psychiatric Association, 2001, DIAGN STAT MAN MENT; Atz M, 2007, J NEUROSCI METH, V163, P295, DOI 10.1016/j.jneumeth.2007.03.022; Ayuso-Mateos JL, 2010, BRIT J PSYCHIAT, V196, P365, DOI 10.1192/bjp.bp.109.071191; Barley K, 2009, SCHIZOPHR RES, V112, P54, DOI 10.1016/j.schres.2009.04.019; Baumeister H, 2010, AM J PSYCHIAT, V167, P866, DOI 10.1176/appi.ajp.2010.10030398; BEAN AJ, 1992, NEUROSCIENCE, V50, P259, DOI 10.1016/0306-4522(92)90421-W; Blazer DG, 2000, COMPR TEXTB PSYCHIAT, V7th, P1298; Bull TM, 2004, AM J RESP CRIT CARE, V170, P911, DOI 10.1164/rccm.200312-1686OC; Chuan SK, 2008, INT PSYCHOGERIATR, V20, P188, DOI 10.1017/S1041610207006187; Davidson JRT, 1999, J CLIN PSYCHIAT, V60, P4; Duman CH, 2007, BIOL PSYCHIAT, V61, P661, DOI 10.1016/j.biopsych.2006.05.047; Evans SJ, 2004, P NATL ACAD SCI USA, V101, P15506, DOI 10.1073/pnas.0406788101; FODOR SPA, 1993, NATURE, V364, P555, DOI 10.1038/364555a0; Forsell Y, 2007, DEPRESS ANXIETY, V24, P62, DOI 10.1002/da.20231; Gladkevich A, 2004, PROG NEURO-PSYCHOPH, V28, P559, DOI 10.1016/j.pnpbp.2004.01.009; Goldney RD, 2004, SOC PSYCH PSYCH EPID, V39, P293, DOI 10.1007/s00127-004-0745-5; Judd LL, 1998, ARCH GEN PSYCHIAT, V55, P694, DOI 10.1001/archpsyc.55.8.694; Judd LL, 1997, J AFFECT DISORDERS, V45, P5, DOI 10.1016/S0165-0327(97)00055-4; Judd LL, 1994, J CLIN PSYCHIAT, V55, pS18; Kang HJ, 2007, J NEUROSCI, V27, P13329, DOI 10.1523/JNEUROSCI.4083-07.2007; Karsten J, 2010, J AFFECT DISORDERS, V123, P230, DOI 10.1016/j.jad.2009.10.013; Katsel P, 2005, SCHIZOPHR RES, V79, P157, DOI 10.1016/j.schres.2005.06.007; Lampe JW, 2004, CANCER EPIDEM BIOMAR, V13, P445; Le Hellard S, 2010, MOL PSYCHIATR, V15, P463, DOI 10.1038/mp.2008.110; Le-Niculescu H, 2009, MOL PSYCHIATR, V14, P156, DOI 10.1038/mp.2008.11; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Ma J, 2003, J MOL CELL CARDIOL, V35, P993, DOI 10.1016/S0022-2828(03)00179-2; Madia F, 2009, J PERIPHER NERV SYST, V14, P107, DOI 10.1111/j.1529-8027.2009.00220.x; Maier W, 1997, J AFFECT DISORDERS, V45, P41, DOI 10.1016/S0165-0327(97)00058-X; Marshall A, 1998, NAT BIOTECHNOL, V16, P731; Mehta D, 2010, CURR PSYCHIAT REP, V12, P135, DOI 10.1007/s11920-010-0100-3; Pandey GN, 2008, J AM ACAD CHILD PSY, V47, P1077, DOI 10.1097/CHI.0b013e31817eecd9; Pariante CM, 2001, BIOL PSYCHIAT, V49, P391, DOI 10.1016/S0006-3223(00)01088-X; Popova T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-91; Rajkowska G, 2000, BIOL PSYCHIAT, V48, P766, DOI 10.1016/S0006-3223(00)00950-1; Reiche EMV, 2004, LANCET ONCOL, V5, P617, DOI 10.1016/S1470-2045(04)01597-9; Roy K, 2007, P NATL ACAD SCI USA, V104, P8131, DOI 10.1073/pnas.0702157104; Segman RH, 2010, MOL PSYCHIATR, V15, P93, DOI 10.1038/mp.2009.65; Shelton RC, 2011, MOL PSYCHIATR, V16, P751, DOI 10.1038/mp.2010.52; SHERBOURNE CD, 1994, AM J PSYCHIAT, V151, P1777; SHIMOJO M, 1993, NEUROSCI LETT, V151, P170, DOI 10.1016/0304-3940(93)90013-B; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Sokolov BP, 2007, INT J NEUROPSYCHOPH, V10, P547, DOI 10.1017/S1461145706007322; Spijker S, 2010, BIOL PSYCHIAT, V68, P179, DOI 10.1016/j.biopsych.2010.03.017; Struyf J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-531; Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Sun JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011351; Thase ME, 2000, COMPREHENSIVE TXB PS, P1318; Tsuang MT, 2005, AM J MED GENET B, V133B, P1, DOI 10.1002/ajmg.b.30161	50	56	61	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31283	10.1371/journal.pone.0031283	http://dx.doi.org/10.1371/journal.pone.0031283			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348066	Green Published, Green Submitted, gold			2022-12-25	WOS:000302733900038
J	Drummond, EBM; Vellend, M				Drummond, Emily B. M.; Vellend, Mark			Genotypic Diversity Effects on the Performance of Taraxacum officinale Populations Increase with Time and Environmental Favorability	PLOS ONE			English	Article							EXPERIMENTAL PLANT-COMMUNITIES; GENETIC DIVERSITY; PRODUCTIVITY RELATIONSHIPS; ECOSYSTEM FUNCTION; SPECIES-DIVERSITY; RESOURCE AVAILABILITY; BIODIVERSITY; GRASSLAND; COMPLEMENTARITY; DISTURBANCE	Within-population genetic diversity influences many ecological processes, but few studies have examined how environmental conditions may impact these short-term diversity effects. Over four growing seasons, we followed experimental populations of a clonal, ubiquitous weed, Taraxacum officinale, with different numbers of genotypes in relatively favorable fallow field and unfavorable mowed lawn environmental treatments. Population performance (measured as total leaf area, seed production or biomass) clearly and consistently increased with diversity, and this effect became stronger over the course of the experiment. Diversity effects were stronger, and with different underlying mechanisms, in the fallow field versus the mowed lawn. Large genotypes dominated in the fallow field driving overyielding (via positive selection effects), whereas in the mowed lawn, where performance was limited by regular disturbance, there was evidence for complementarity among genotypes (with one compact genotype in particular performing better in mixture than monoculture). Hence, we predict stronger genotypic diversity effects in environments where intense intraspecific competition enhances genotypic differences. Our four-year field experiment plus seedling establishment trials indicate that genotypic diversity effects have far-reaching and context-dependent consequences across generations.	[Drummond, Emily B. M.; Vellend, Mark] Univ British Columbia, Dept Bot, Biodivers Res Ctr, Vancouver, BC, Canada; [Vellend, Mark] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada	University of British Columbia; University of Sherbrooke	Drummond, EBM (corresponding author), Univ British Columbia, Dept Bot, Biodivers Res Ctr, Vancouver, BC, Canada.	ebmd@interchange.ubc.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [311785-2010]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC: http://www.nserc-crsng.gc.ca), Discovery Grant #311785-2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; BELL G, 1991, EVOLUTION, V45, P1036, DOI 10.1111/j.1558-5646.1991.tb04368.x; Booth RE, 2003, J ECOL, V91, P721, DOI 10.1046/j.1365-2745.2003.00804.x; Cardinale BJ, 2000, OIKOS, V91, P175, DOI 10.1034/j.1600-0706.2000.910117.x; Cardinale BJ, 2005, ECOLOGY, V86, P716, DOI 10.1890/03-0727; Cardinale BJ, 2002, ECOLOGY, V83, P1915; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Charmantier A, 2005, P ROY SOC B-BIOL SCI, V272, P1415, DOI 10.1098/rspb.2005.3117; Cook-Patton SC, 2011, ECOLOGY, V92, P915, DOI 10.1890/10-0999.1; Crawford KM, 2010, MOL ECOL, V19, P1253, DOI 10.1111/j.1365-294X.2010.04550.x; Crutsinger GM, 2008, ECOL LETT, V11, P16, DOI 10.1111/j.1461-0248.2007.01118.x; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; De Meester L, 2007, OECOLOGIA, V153, P431, DOI 10.1007/s00442-007-0721-3; de Roode JC, 2005, P NATL ACAD SCI USA, V102, P7624, DOI 10.1073/pnas.0500078102; Dzialowski AR, 2008, FRESHWATER BIOL, V53, P148, DOI 10.1111/j.1365-2427.2007.01883.x; Fargione J, 2003, P NATL ACAD SCI USA, V100, P8916, DOI 10.1073/pnas.1033107100; Fargione J, 2007, P ROY SOC B-BIOL SCI, V274, P871, DOI 10.1098/rspb.2006.0351; FORD H, 1981, BIOL J LINN SOC, V15, P355, DOI 10.1111/j.1095-8312.1981.tb00769.x; Fridley JD, 2007, J ECOL, V95, P908, DOI 10.1111/j.1365-2745.2007.01256.x; Fridley JD, 2010, ECOLOGY, V91, P2272, DOI 10.1890/09-1240.1; Fridley JD, 2003, J ECOL, V91, P396, DOI 10.1046/j.1365-2745.2003.00775.x; Fridley JD, 2002, OECOLOGIA, V132, P271, DOI 10.1007/s00442-002-0965-x; Gamfeldt L, 2005, ECOL LETT, V8, P696, DOI 10.1111/j.1461-0248.2005.00765.x; Gamfeldt L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021972; Griffin JN, 2009, OIKOS, V118, P1335, DOI 10.1111/j.1600-0706.2009.17572.x; He JS, 2002, OIKOS, V97, P337, DOI 10.1034/j.1600-0706.2002.970304.x; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hiddink JG, 2009, OIKOS, V118, P1892, DOI 10.1111/j.1600-0706.2009.17556.x; Hoffmann AA, 1999, TRENDS ECOL EVOL, V14, P96, DOI 10.1016/S0169-5347(99)01595-5; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Hughes AR, 2009, ECOLOGY, V90, P1412, DOI 10.1890/07-2030.1; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Johnson MTJ, 2006, ECOL LETT, V9, P24, DOI 10.1111/j.1461-0248.2005.00833.x; Kaiser J, 2000, SCIENCE, V289, P1282, DOI 10.1126/science.289.5483.1282; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; KING LM, 1993, EVOLUTION, V47, P136, DOI 10.1111/j.1558-5646.1993.tb01205.x; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Kotowska AM, 2010, J ECOL, V98, P237, DOI 10.1111/j.1365-2745.2009.01606.x; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Lecerf A, 2010, RIVER RES APPL, V26, P45, DOI 10.1002/rra.1286; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; LYMAN JC, 1984, HEREDITY, V53, P1, DOI 10.1038/hdy.1984.58; Mattila HR, 2007, SCIENCE, V317, P362, DOI 10.1126/science.1143046; Munzbergova Z, 2009, BASIC APPL ECOL, V10, P411, DOI 10.1016/j.baae.2008.10.005; Mulder CPH, 1999, ECOL LETT, V2, P237; Mulder CPH, 2001, P NATL ACAD SCI USA, V98, P6704, DOI 10.1073/pnas.111055298; Parker JD, 2010, ECOL LETT, V13, P553, DOI 10.1111/j.1461-0248.2010.01452.x; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Schweitzer JA, 2005, ECOLOGY, V86, P2834, DOI 10.1890/04-1955; Smithson JB, 1996, ANN APPL BIOL, V128, P127, DOI 10.1111/j.1744-7348.1996.tb07096.x; SOLBRIG OT, 1977, J ECOL, V65, P427, DOI 10.2307/2259492; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tylianakis JM, 2008, PLOS BIOL, V6, P947, DOI 10.1371/journal.pbio.0060122; Vavrek MC, 1996, ECOLOGY, V77, P2098, DOI 10.2307/2265704; Vellend M, 2010, OECOLOGIA, V162, P371, DOI 10.1007/s00442-009-1480-0; Vellend M, 2009, WEED SCI, V57, P410, DOI 10.1614/WS-09-004.1; Weigelt A, 2009, BIOGEOSCIENCES, V6, P1695, DOI 10.5194/bg-6-1695-2009; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Whitlock R, 2007, J ECOL, V95, P895, DOI 10.1111/j.1365-2745.2007.01275.x; Wimp GM, 2004, ECOL LETT, V7, P776, DOI 10.1111/j.1461-0248.2004.00635.x; Zhang QG, 2006, OIKOS, V114, P385, DOI 10.1111/j.2006.0030-1299.14723.x	63	34	36	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e30314	10.1371/journal.pone.0030314	http://dx.doi.org/10.1371/journal.pone.0030314			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348004	Green Published, gold, Green Submitted			2022-12-25	WOS:000302730900008
J	Yue, WF; Du, M; Zhu, MJ				Yue, Wan-Fu; Du, Min; Zhu, Mei-Jun			High Temperature in Combination with UV Irradiation Enhances Horizontal Transfer of stx2 Gene from E. coli O157:H7 to Non-Pathogenic E. coli	PLOS ONE			English	Article							ESCHERICHIA-COLI; BEEF-CATTLE; RECTOANAL JUNCTION; SKELETAL-MUSCLE; FEEDLOT CATTLE; PREVALENCE; O157-H7; NON-O157; COLONIZATION; INDUCTION	Background: Shiga toxin (stx) genes have been transferred to numerous bacteria, one of which is E. coli O157:H7. It is a common belief that stx gene is transferred by bacteriophages, because stx genes are located on lambdoid prophages in the E. coli O157: H7 genome. Both E. coli O157: H7 and non-pathogenic E. coli are highly enriched in cattle feedlots. We hypothesized that strong UV radiation in combination with high temperature accelerates stx gene transfer into nonpathogenic E. coli in feedlots. Methodology/Principal Findings: E. coli O157: H7 EDL933 strain were subjected to different UV irradiation (0 or 0.5 kJ/m(2)) combination with different temperature (22, 28, 30, 32, and 37 degrees C) treatments, and the activation of lambdoid prophages was analyzed by plaque forming unit while induction of Stx2 prophages was quantified by quantitative real-time PCR. Data showed that lambdoid prophages in E. coli O157: H7, including phages carrying stx2, were activated under UV radiation, a process enhanced by elevated temperature. Consistently, western blotting analysis indicated that the production of Shiga toxin 2 was also dramatically increased by UV irradiation and high temperature. In situ colony hybridization screening indicated that these activated Stx2 prophages were capable of converting laboratory strain of E. coli K12 into new Shiga toxigenic E. coli, which were further confirmed by PCR and ELISA analysis. Conclusions/Significance: These data implicate that high environmental temperature in combination with UV irradiation accelerates the spread of stx genes through enhancing Stx prophage induction and Stx phage mediated gene transfer. Cattle feedlot sludge are teemed with E. coli O157:H7 and non-pathogenic E. coli, and is frequently exposed to UV radiation via sunlight, which may contribute to the rapid spread of stx gene to non-pathogenic E. coli and diversity of shiga toxin producing E. coli.	[Yue, Wan-Fu; Zhu, Mei-Jun] Univ Wyoming, Dept Anim Sci, Laramie, WY 82071 USA; [Du, Min] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA	University of Wyoming; Washington State University	Yue, WF (corresponding author), Univ Wyoming, Dept Anim Sci, Laramie, WY 82071 USA.	meijun@uwyo.edu	Du, Min/H-4311-2011; Zhu, Mei-Jun/A-4248-2013	Du, Min/0000-0002-7232-072X; 	USDA AFRI [2010-65201-20599]; Agricultural Experiment Station at University of Wyoming; NIH-INBRE [P20RR016474]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016474] Funding Source: NIH RePORTER	USDA AFRI(United States Department of Agriculture (USDA)); Agricultural Experiment Station at University of Wyoming; NIH-INBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding was provided by USDA AFRI 2010-65201-20599, Agricultural Experiment Station at University of Wyoming, and NIH-INBRE P20RR016474. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MJ, 2006, J FOOD PROTECT, V69, P3018, DOI 10.4315/0362-028X-69.12.3018; Alexeyev MF, 1999, BIOTECHNIQUES, V26, P824, DOI 10.2144/99265bm05; Allison HE, 2007, FUTURE MICROBIOL, V2, P165, DOI 10.2217/17460913.2.2.165; Asadulghani M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000408; Cobbold RN, 2007, APPL ENVIRON MICROB, V73, P1563, DOI 10.1128/AEM.01742-06; Elder RO, 2000, P NATL ACAD SCI USA, V97, P2999, DOI 10.1073/pnas.060024897; ENNIS DG, 1985, P NATL ACAD SCI USA, V82, P3325, DOI 10.1073/pnas.82.10.3325; Fegan N, 2004, J APPL MICROBIOL, V97, P362, DOI 10.1111/j.1365-2672.2004.02300.x; Fey PD, 2000, EMERG INFECT DIS, V6, P530, DOI 10.3201/eid0605.000513; Furst S, 2000, J MED MICROBIOL, V49, P383, DOI 10.1099/0022-1317-49-4-383; Gabig M, 1998, MOL GEN GENET, V258, P494, DOI 10.1007/s004380050760; Hussein HS, 2007, J ANIM SCI, V85, pE63, DOI 10.2527/jas.2006-421; KIRII Y, 1987, J CLIN MICROBIOL, V25, P1962, DOI 10.1128/JCM.25.10.1962-1965.1987; LeJeune JT, 2004, APPL ENVIRON MICROB, V70, P377, DOI 10.1128/AEM.70.1.377-384.2004; Lim JY, 2007, APPL ENVIRON MICROB, V73, P1380, DOI 10.1128/AEM.02242-06; Los JM, 2010, FEMS IMMUNOL MED MIC, V58, P322, DOI 10.1111/j.1574-695X.2009.00644.x; McDonald JE, 2010, APPL ENVIRON MICROB, V76, P2360, DOI 10.1128/AEM.02923-09; OBRIEN AD, 1984, SCIENCE, V226, P694, DOI 10.1126/science.6387911; Obuchowski M, 1997, J BACTERIOL, V179, P5987, DOI 10.1128/jb.179.19.5987-5991.1997; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; Paton AW, 1998, J CLIN MICROBIOL, V36, P598, DOI 10.1128/JCM.36.2.598-602.1998; Ray PE, 2001, PEDIATR NEPHROL, V16, P823, DOI 10.1007/s004670100660; RKI, 2011, 0104H4 EHEC RKI; Yan YX, 2011, CURR MICROBIOL, V62, P458, DOI 10.1007/s00284-010-9729-8; Zhu MJ, 2008, J PHYSIOL-LONDON, V586, P2651, DOI 10.1113/jphysiol.2007.149633; Zhu MJ, 2006, J PHYSIOL-LONDON, V575, P241, DOI 10.1113/jphysiol.2006.112110; Zhu MJ, 2010, AM J PHYSIOL-REG I, V299, pR1224, DOI 10.1152/ajpregu.00309.2010	27	23	23	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31308	10.1371/journal.pone.0031308	http://dx.doi.org/10.1371/journal.pone.0031308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347461	Green Published, gold, Green Submitted			2022-12-25	WOS:000302730200019
J	Kyutoku, Y; Tada, R; Umeyama, T; Harada, K; Kikuchi, S; Watanabe, E; Liegey-Dougall, A; Dan, I				Kyutoku, Yasushi; Tada, Ryoko; Umeyama, Takahiko; Harada, Kenji; Kikuchi, Senichiro; Watanabe, Eiju; Liegey-Dougall, Angela; Dan, Ippeita			Cognitive and Psychological Reactions of the General Population Three Months After the 2011 Tohoku Earthquake and Tsunami	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; QUALITY-OF-LIFE; DISASTER VICTIMS SPEAK; MENTAL-HEALTH; MUSCULOSKELETAL PAIN; FOLLOW-UP; GROWTH; APPRAISAL; SYMPTOMS; PREDICTORS	Background: The largest earthquake on record in Japan (magnitude 9.0) occurred on March 11, 2011, and the subsequent tsunami devastated the Pacific coast of Northern Japan. These further triggered the Fukushima I nuclear power plant accidents. Such a hugely complex disaster inevitably has negative psychological effects on general populations as well as on the direct victims. While previous disaster studies enrolled descriptive approaches focusing on direct victims, the structure of the psychological adjustment process of people from the general population has remained uncertain. The current study attempted to establish a path model that sufficiently reflects the early psychological adaptation process of the general population to large-scale natural disasters. Methods and Findings: Participants from the primary disaster area (n = 1083) and other areas (n = 2372) voluntarily participated in an online questionnaire study. By constructing path models using a structural equation model procedure (SEM), we examined the structural relationship among psychological constructs known related to disasters. As post-traumatic stress symptoms (PTS) were significantly more present in people in the primarily affected area than in those in secondary-or non-affected areas, the path models were constructed for the primary victims. The parsimoniously depicted model with the best fit was achieved for the psychological-adjustment centered model with quality of life (QoL) as a final outcome. Conclusion: The paths to QoL via negative routes (from negative cognitive appraisal, PTS, and general stress) were dominant, suggesting the importance of clinical intervention for reducing negative cognitive appraisal, and for caring for general stress and PTS to maintain QoL at an early stage of psychological adaptation to a disaster. The model also depicted the presence of a positive route where positive cognitive appraisal facilitates post-traumatic growth (PTG) to achieve a higher QoL, suggesting the potential importance of positive psychological preventive care for unexpected natural disasters.	[Kyutoku, Yasushi; Dan, Ippeita] Jichi Med Univ, Funct Brain Sci Lab, Ctr Dev Adv Med Technol, Shimotsuke, Tochigi, Japan; [Tada, Ryoko; Umeyama, Takahiko; Harada, Kenji] Cross Mkt Inc, Dept Mkt & Res, Tokyo, Japan; [Kikuchi, Senichiro] Jichi Med Univ, Dept Psychiat, Shimotsuke, Tochigi, Japan; [Watanabe, Eiju] Jichi Med Univ, Dept Neurosurg, Shimotsuke, Tochigi, Japan; [Liegey-Dougall, Angela] Univ Texas Arlington, Dept Psychol, Coll Sci, Arlington, TX 76019 USA	Jichi Medical University; Jichi Medical University; Jichi Medical University; University of Texas System; University of Texas Arlington	Kyutoku, Y (corresponding author), Jichi Med Univ, Funct Brain Sci Lab, Ctr Dev Adv Med Technol, Shimotsuke, Tochigi, Japan.	qworkdog@jichi.ac.jp; dan@jichi.ac.jp	Kikuchi, Senichiro/ABI-1840-2020		Health and Labor Sciences Research Grants; Comprehensive Research on Disability Health and Welfare; Japan Society for Promotion of Science [23700921]	Health and Labor Sciences Research Grants(Ministry of Health, Labour and Welfare, Japan); Comprehensive Research on Disability Health and Welfare; Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Health and Labor Sciences Research Grants, Comprehensive Research on Disability Health and Welfare (to Dr. Dan), and the Grant-in-Aid for Scientific Research from the Japan Society for Promotion of Science (23700921) (to Dr. Kyutoku). The funding bodies had no role in study design, data collection and analysis, preparation of the manuscript, or the decision to publish.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Asukai N, 2002, J NERV MENT DIS, V190, P175, DOI 10.1097/00005053-200203000-00006; Baum A, 1987, CATACLYSMS CRISES CA; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; Brewin CR, 2003, CLIN PSYCHOL REV, V23, P339, DOI 10.1016/S0272-7358(03)00033-3; Calhoun L.G., 2006, HDB POSTTRAUMATIC GR; Cann A, 2010, J LOSS TRAUMA, V15, P151, DOI 10.1080/15325020903375826; Cao H, 2003, SOC PSYCH PSYCH EPID, V38, P204, DOI 10.1007/s00127-003-0619-2; Chen CH, 2001, PSYCHIAT CLIN NEUROS, V55, P493, DOI 10.1046/j.1440-1819.2001.00895.x; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Dekel R, 2009, HEALTH SOC WORK, V34, P87, DOI 10.1093/hsw/34.2.87; Dougall AL, 2005, PSYCHIATRY, V68, P28, DOI 10.1521/psyc.68.1.28.64188; Dysvik E, 2005, INT J NURS STUD, V42, P297, DOI 10.1016/j.ijnurstu.2004.06.009; Ehlers A, 1995, Behav Cogn Psychother, V23, P217, DOI 10.1017/S135246580001585X; Ford E, 2010, J ANXIETY DISORD, V24, P353, DOI 10.1016/j.janxdis.2010.01.008; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; Galea S, 2002, NEW ENGL J MED, V346, P982, DOI 10.1056/NEJMsa013404; Goto Toyomi, 2003, Trauma Violence Abuse, V4, P195, DOI 10.1177/1524838003004003001; Guan BQ, 2011, J AFFECT DISORDERS, V131, P293, DOI 10.1016/j.jad.2011.01.010; Hatta H., 1998, JAPANESE J PSYCHOSOM, V38, P309; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Iwahasi S, 2002, JPN J PSYCHOSOM MED, V42, P459; Johansen VA, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-26; Joksimovic L, 2002, INT J BEHAV MED, V9, P122, DOI 10.1207/S15327558IJBM0902_04; Jones DA, 2003, J PAIN, V4, P267, DOI 10.1016/S1526-5900(03)00630-8; Joseph S, 2010, CLIN PSYCHOL REV, V30, P830, DOI 10.1016/j.cpr.2010.01.002; Karatzias T, 2009, MED HYPOTHESES, V72, P444, DOI 10.1016/j.mehy.2008.10.026; Kessler TA, 1998, RES NURS HEALTH, V21, P73; Kocalevent RD, 2007, J PSYCHOSOM RES, V63, P71, DOI 10.1016/j.jpsychores.2007.02.010; Kokai M, 2004, PSYCHIAT CLIN NEUROS, V58, P110, DOI 10.1111/j.1440-1819.2003.01203.x; Kun P, 2009, PUBLIC HEALTH, V123, P703, DOI 10.1016/j.puhe.2009.09.017; Kutz I, 2006, PERS INDIV DIFFER, V40, P1579, DOI 10.1016/j.paid.2006.01.002; LAZARUS RS, 1985, AM PSYCHOL, V40, P770, DOI 10.1037/0003-066X.40.7.770; Liu AZ, 2006, CAN J PSYCHIAT, V51, P350, DOI 10.1177/070674370605100603; McAllister M, 2009, NURS EDUC TODAY, V29, P371, DOI 10.1016/j.nedt.2008.10.011; McMillen JC, 1997, J CONSULT CLIN PSYCH, V65, P733, DOI 10.1037/0022-006X.65.5.733; Mertler C, 2008, PYRCZAK PUBLISHING; Ministry of Internal Affairs and Communication, 2011, WHIT PAP 2011 INF CO; Morrill EF, 2008, PSYCHO-ONCOLOGY, V17, P948, DOI 10.1002/pon.1313; Nemeroff CB, 2006, J PSYCHIATR RES, V40, P1, DOI 10.1016/j.jpsychires.2005.07.005; Nishi D, 2010, BIOPSYCHOSOC MED, V4, DOI 10.1186/1751-0759-4-7; Noble AJ, 2008, NEUROSURGERY, V63, P1095, DOI 10.1227/01.NEU.0000327580.91345.78; Norberg MM, 2008, J ANXIETY DISORD, V22, P1516, DOI 10.1016/j.janxdis.2008.03.005; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Novotney A, 2009, MONIT PSYCHOL, V40, P40; Nunnally J.C., 1994, PSYCHOMETRIC THEORY, DOI DOI 10.1037/018882; Park CL, 2010, PSYCHOL BULL, V136, P257, DOI 10.1037/a0018301; Rajandram RK, 2010, ORAL ONCOL, V46, P791, DOI 10.1016/j.oraloncology.2010.08.010; Rosenberg SD., 2009, TREATMENT POSTTRAUMA; Ross MW, 2005, SOC SCI MED, V61, P245, DOI 10.1016/j.socscimed.2005.01.019; Setoyama J, 2011, RIPPO CHOSA, V317, P44; Stanton A. L., 2006, HDB POSTTRAUMATIC GR, P138; Sumalla EC, 2009, CLIN PSYCHOL REV, V29, P24, DOI 10.1016/j.cpr.2008.09.006; SUTHERLAND HJ, 1991, SOC SCI MED, V32, P725, DOI 10.1016/0277-9536(91)90152-3; Tabachnick B.G., 2001, USING MULTIVARIATE S, V4th ed.; Taku K, 2007, ANXIETY STRESS COPIN, V20, P353, DOI 10.1080/10615800701295007; TANAKA JS, 1989, BRIT J MATH STAT PSY, V42, P233, DOI 10.1111/j.2044-8317.1989.tb00912.x; Tazaki M, 1997, WHOQOL 26 MANUAL REV; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1002/jts.2490090305; Tedeschi RG, 2007, APPL PSYCHOL-INT REV, V56, P396, DOI 10.1111/j.1464-0597.2007.00299.x; Thompson KE, 2004, J NERV MENT DIS, V192, P146, DOI 10.1097/01.nmd.0000110286.10445.ab; Tsai KY, 2007, J PSYCHIATR RES, V41, P90, DOI 10.1016/j.jpsychires.2005.10.004; Tsutsumi A, 1998, INT J BEHAV MED, V5, P166, DOI 10.1207/s15327558ijbm0502_6; U. S. Geological Survey, 2011, MAGN 9 0 NEAR E COAS; Unruh AM, 1999, CLIN J PAIN, V15, P31, DOI 10.1097/00002508-199903000-00006; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; Wang XD, 2000, PSYCHIAT CLIN NEUROS, V54, P427, DOI 10.1046/j.1440-1819.2000.00732.x; World Health Organization [WHO], 1993, WHOQOL STUD PROT; Xie XF, 2011, RISK ANAL, V31, P450, DOI 10.1111/j.1539-6924.2010.01530.x; Xu JP, 2011, J AFFECT DISORDERS, V133, P274, DOI 10.1016/j.jad.2011.03.034; Yu XN, 2010, J AFFECT DISORDERS, V123, P327, DOI 10.1016/j.jad.2009.09.019; Zigmond AS, 1993, ACTA PSYCHITR SCAND, V67, P361; Zlotnick C, 2002, COMPR PSYCHIAT, V43, P413, DOI 10.1053/comp.2002.35900; Zoellner T, 2006, CLIN PSYCHOL REV, V26, P626, DOI 10.1016/j.cpr.2006.01.008	75	22	25	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31014	10.1371/journal.pone.0031014	http://dx.doi.org/10.1371/journal.pone.0031014			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	924ZP	22347421	Green Published, gold			2022-12-25	WOS:000302730100032
J	Su, CH; Pal, NR; Lin, KL; Chung, IF				Su, Chun-Hung; Pal, Nikhil R.; Lin, Ken-Li; Chung, I-Fang			Identification of Amino Acid Propensities That Are Strong Determinants of Linear B-cell Epitope Using Neural Networks	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; PROTEIN ANTIGENIC DETERMINANTS; FUNCTIONAL DOMAIN COMPOSITION; SUBCELLULAR-LOCALIZATION; EVOLUTION INFORMATION; CLEAVAGE SITES; WEB SERVER; TURN TYPES; PREDICTION; SEQUENCES	Background: Identification of amino acid propensities that are strong determinants of linear B-cell epitope is very important to enrich our knowledge about epitopes. This can also help to obtain better epitope prediction. Typical linear B-cell epitope prediction methods combine various propensities in different ways to improve prediction accuracies. However, fewer but better features may yield better prediction. Moreover, for a propensity, when the sequence length is k, there will be k values, which should be treated as a single unit for feature selection and hence usual feature selection method will not work. Here we use a novel Group Feature Selecting Multilayered Perceptron, GFSMLP, which treats a group of related information as a single entity and selects useful propensities related to linear B-cell epitopes, and uses them to predict epitopes. Methodology/Principal Findings: We use eight widely known propensities and four data sets. We use GFSMLP to rank propensities by the frequency with which they are selected. We find that Chou's beta-turn and Ponnuswamy's polarity are better features for prediction of linear B-cell epitope. We examine the individual and combined discriminating power of the selected propensities and analyze the correlation between paired propensities. Our results show that the selected propensities are indeed good features, which also cooperate with other propensities to enhance the discriminating power for predicting epitopes. We find that individually polarity is not the best predictor, but it collaborates with others to yield good prediction. Usual feature selection methods cannot provide such information. Conclusions/Significance: Our results confirm the effectiveness of active (group) feature selection by GFSMLP over the traditional passive approaches of evaluating various combinations of propensities. The GFSMLP-based feature selection can be extended to more than 500 remaining propensities to enhance our biological knowledge about epitopes and to obtain better prediction. A graphical-user-interface version of GFSMLP is available at: http://bio.classcloud.org/GFSMLP/.	[Su, Chun-Hung; Chung, I-Fang] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Pal, Nikhil R.] Indian Stat Inst, Elect & Commun Sci Unit, Kolkata 700035, W Bengal, India; [Lin, Ken-Li] Chung Hua Univ, Ctr Comp, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; Indian Statistical Institute; Indian Statistical Institute Kolkata; Chung Hua University	Su, CH (corresponding author), Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan.	ifchung@ym.edu.tw			National Science Council (NSC) [NSC100-2221-E-010-011]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan)	This work is supported by National Science Council (NSC) (NSC100-2221-E-010-011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARLOW DJ, 1986, NATURE, V322, P747, DOI 10.1038/322747a0; Blythe MJ, 2005, PROTEIN SCI, V14, P246, DOI 10.1110/ps.041059505; Cai YD, 2004, J THEOR BIOL, V228, P551, DOI 10.1016/j.jtbi.2004.02.019; Cai YD, 2004, J THEOR BIOL, V226, P373, DOI 10.1016/j.jtbi.2003.08.015; Cai YD, 2003, PEPTIDES, V24, P629, DOI 10.1016/S0196-9781(03)00100-1; Cai YD, 2003, PEPTIDES, V24, P159, DOI 10.1016/S0196-9781(02)00289-9; Cai YD, 2002, J COMPUT CHEM, V23, P267, DOI 10.1002/jcc.10017; Cai YD, 2002, J PEPT SCI, V8, P297, DOI 10.1002/psc.401; Chakraborty D, 2008, IEEE T NEURAL NETWOR, V19, P381, DOI 10.1109/TNN.2007.910730; Chen J, 2007, AMINO ACIDS, V33, P423, DOI 10.1007/s00726-006-0485-9; Chen L, 2010, MOLECULES, V15, P8177, DOI 10.3390/molecules15118177; Chen L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-293; Chou K.-C., 2010, NAT SCI IRVINE, V2, P1090, DOI [10.4236/ns.2010.210136, DOI 10.4236/NS.2010.210136]; Chou KC, 2002, J BIOL CHEM, V277, P45765, DOI 10.1074/jbc.M204161200; Chou KC, 2009, NAT SCI, V2, P63, DOI DOI 10.4236/NS.2009.12011; Chou KC, 2008, BIOCHEM BIOPH RES CO, V376, P321, DOI 10.1016/j.bbrc.2008.08.125; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2007, BIOCHEM BIOPH RES CO, V360, P339, DOI 10.1016/j.bbrc.2007.06.027; Chou KC, 2007, BIOCHEM BIOPH RES CO, V357, P633, DOI 10.1016/j.bbrc.2007.03.162; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Davydov YI, 2009, MOL BIOL+, V43, P150, DOI 10.1134/S0026893309010208; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; He ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009603; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; JANIN J, 1978, J MOL BIOL, V125, P357, DOI 10.1016/0022-2836(78)90408-4; KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; LERNER RA, 1982, NATURE, V299, P592, DOI 10.1038/299592a0; Mohabatkar H, 2011, J THEOR BIOL, V281, P18, DOI 10.1016/j.jtbi.2011.04.017; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; PELLEQUER JL, 1993, IMMUNOL LETT, V36, P83, DOI 10.1016/0165-2478(93)90072-A; PELLEQUER JL, 1993, J MOL GRAPH MODEL, V11, P204, DOI 10.1016/0263-7855(93)80074-2; PONNUSWAMY PK, 1980, BIOCHIM BIOPHYS ACTA, V623, P301, DOI 10.1016/0005-2795(80)90258-5; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Saha S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-79; Saha S, 2004, LECT NOTES COMPUT SC, V3239, P197; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; SCHMIDT MA, 1989, BIOTECHNOL ADV, V7, P187, DOI 10.1016/0734-9750(89)90358-3; Shen HB, 2007, BIOCHEM BIOPH RES CO, V364, P53, DOI 10.1016/j.bbrc.2007.09.098; Sollner J, 2006, J MOL RECOGNIT, V19, P209, DOI 10.1002/jmr.770; Sollner J, 2006, J MOL RECOGNIT, V19, P200, DOI 10.1002/jmr.771; Van Regenmortel MHV, 2009, METHODS MOL BIOL, V524, P3, DOI 10.1007/978-1-59745-450-6_1; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023505; WELLING GW, 1985, FEBS LETT, V188, P215, DOI 10.1016/0014-5793(85)80374-4; Xiao X, 2011, J THEOR BIOL, V284, P42, DOI 10.1016/j.jtbi.2011.06.005; Xiao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020592; Xiao XA, 2011, MOL BIOSYST, V7, P911, DOI 10.1039/c0mb00170h; Xiao Y, 2001, IMMUNOL LETT, V77, P3, DOI 10.1016/S0165-2478(01)00187-0; Zhang Q, 2008, NUCLEIC ACIDS RES, V36, pW513, DOI 10.1093/nar/gkn254	60	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30617	10.1371/journal.pone.0030617	http://dx.doi.org/10.1371/journal.pone.0030617			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347389	gold, Green Published, Green Submitted			2022-12-25	WOS:000302730100018
J	Tran, LM; Chang, CJ; Plaisier, S; Wu, SM; Dang, J; Mischel, PS; Liao, JC; Graeber, TG; Wu, H				Tran, Linh M.; Chang, Chun-Ju; Plaisier, Seema; Wu, Shumin; Dang, Julie; Mischel, Paul S.; Liao, James C.; Graeber, Thomas G.; Wu, Hong			Determining PTEN Functional Status by Network Component Deduced Transcription Factor Activities	PLOS ONE			English	Article							REGULATORY ELEMENT DATABASE; GENE-EXPRESSION SIGNATURE; TUMOR-SUPPRESSOR PTEN; NF-KAPPA-B; PROSTATE-CANCER; ESCHERICHIA-COLI; CELL-CYCLE; C-MYC; PATHWAYS; INHIBITION	PTEN-controlled PI3K-AKT-mTOR pathway represents one of the most deregulated signaling pathways in human cancers. With many small molecule inhibitors that target PI3K-AKT-mTOR pathway being exploited clinically, sensitive and reliable ways of stratifying patients according to their PTEN functional status and determining treatment outcomes are urgently needed. Heterogeneous loss of PTEN is commonly associated with human cancers and yet PTEN can also be regulated on epigenetic, transcriptional or post-translational levels, which makes the use of simple protein or gene expression-based analyses in determining PTEN status less accurate. In this study, we used network component analysis to identify 20 transcription factors (TFs) whose activities deduced from their target gene expressions were immediately altered upon the re-expression of PTEN in a PTEN-inducible system. Interestingly, PTEN controls the activities (TFA) rather than the expression levels of majority of these TFs and these PTEN-controlled TFAs are substantially altered in prostate cancer mouse models. Importantly, the activities of these TFs can be used to predict PTEN status in human prostate, breast and brain tumor samples with enhanced reliability when compared to straightforward IHC-based or expression-based analysis. Furthermore, our analysis indicates that unique sets of PTEN-controlled TFAs significantly contribute to specific tumor types. Together, our findings reveal that TFAs may be used as "signatures" for predicting PTEN functional status and elucidate the transcriptional architectures underlying human cancers caused by PTEN loss.	[Tran, Linh M.; Chang, Chun-Ju; Plaisier, Seema; Wu, Shumin; Graeber, Thomas G.; Wu, Hong] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90024 USA; [Tran, Linh M.; Wu, Shumin; Mischel, Paul S.; Graeber, Thomas G.] Univ Calif Los Angeles, Inst Mol Med, Los Angeles, CA USA; [Graeber, Thomas G.] Univ Calif Los Angeles, Crump Inst Mol Imaging, Los Angeles, CA USA; [Dang, Julie; Mischel, Paul S.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Liao, James C.] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA USA; [Mischel, Paul S.; Wu, Hong] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Tran, LM (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90024 USA.	hwu@mednet.ucla.edu		Chang, Chunju/0000-0003-2887-9603; Graeber, Thomas/0000-0001-8574-9181; Liao, James/0000-0002-4580-7276	NIH [T32 CA009056, R01 CA107166, RO1 CA121110, P50 CA092131]; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA121110, P50CA092131, R01CA107166, T32CA009056] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	LMT is supported by NIH T32 CA009056. This work has been supported in part by award from the Prostate Cancer Foundation and grant from NIH (R01 CA107166, RO1 CA121110 and P50 CA092131 to HW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abed M, 2009, METHODS MOL BIOL, V567, P155, DOI 10.1007/978-1-60327-414-2_11; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Chang CJ, 2004, J BIOL CHEM, V279, P29841, DOI 10.1074/jbc.M401488200; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chow LML, 2011, CANCER CELL, V19, P305, DOI 10.1016/j.ccr.2011.01.039; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Finnberg N, 2004, CANCER BIOL THER, V3, P614, DOI 10.4161/cbt.3.7.1057; Freeman DJ, 2003, CANCER CELL, V3, P117, DOI 10.1016/S1535-6108(03)00021-7; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; Huang H, 2001, J BIOL CHEM, V276, P38830, DOI 10.1074/jbc.M103632200; Hyduke DR, 2007, P NATL ACAD SCI USA, V104, P8484, DOI 10.1073/pnas.0610888104; Jiang C, 2007, NUCLEIC ACIDS RES, V35, pD137, DOI 10.1093/nar/gkl1041; Kao KC, 2004, P NATL ACAD SCI USA, V101, P641, DOI 10.1073/pnas.0305287101; Kao KC, 2005, J BIOL CHEM, V280, P36079, DOI 10.1074/jbc.M508202200; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lapointe J, 2007, CANCER RES, V67, P8504, DOI 10.1158/0008-5472.CAN-07-0673; Liao JC, 2003, P NATL ACAD SCI USA, V100, P15522, DOI 10.1073/pnas.2136632100; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Mosessian S, 2009, J BIOL CHEM, V284, P30159, DOI 10.1074/jbc.M109.027995; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nikiforov MA, 2002, MOL CELL BIOL, V22, P5793, DOI 10.1128/MCB.22.16.5793-5800.2002; Orloff MS, 2008, ONCOGENE, V27, P5387, DOI 10.1038/onc.2008.237; Palaskas N, 2011, CANC RES, P71; Raftopoulou M, 2004, SCIENCE, V303, P1179, DOI 10.1126/science.1092089; Rahib L, 2009, MOL GENET METAB, V96, P106, DOI 10.1016/j.ymgme.2008.11.163; ROSENWALD IB, 1993, P NATL ACAD SCI USA, V90, P6175, DOI 10.1073/pnas.90.13.6175; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Tan K, 2008, P NATL ACAD SCI USA, V105, P2934, DOI 10.1073/pnas.0708670105; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tran Hien, 2003, Sci STKE, V2003, pRE5, DOI 10.1126/stke.2003.172.re5; Tran LM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-511; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vivanco I, 2007, CANCER CELL, V11, P555, DOI 10.1016/j.ccr.2007.04.021; Vivanco I, 2010, P NATL ACAD SCI USA, V107, P6459, DOI 10.1073/pnas.0911188107; Wang B, 2010, ARTERIOSCL THROM VAS, V30, P536, DOI 10.1161/ATVBAHA.109.193821; Wang SY, 2006, P NATL ACAD SCI USA, V103, P1480, DOI 10.1073/pnas.0510652103; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Yang YL, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-90; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhang Y, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-37; Zhao F, 2005, NUCLEIC ACIDS RES, V33, pD103, DOI 10.1093/nar/gki004	55	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31053	10.1371/journal.pone.0031053	http://dx.doi.org/10.1371/journal.pone.0031053			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347425	Green Published, gold, Green Submitted			2022-12-25	WOS:000302730100034
J	Bett, JS; Kanuga, N; Richet, E; Schmidtke, G; Groettrup, M; Cheetham, ME; van der Spuy, J				Bett, John S.; Kanuga, Naheed; Richet, Emma; Schmidtke, Gunter; Groettrup, Marcus; Cheetham, Michael E.; van der Spuy, Jacqueline			The Inherited Blindness Protein AIPL1 Regulates the Ubiquitin-Like FAT10 Pathway	PLOS ONE			English	Article							LEBER CONGENITAL AMAUROSIS; PROTEASOMAL DEGRADATION; CGMP PHOSPHODIESTERASE; MODIFIER FAT10; GENE; NUB1; ROD; INTERACTS; CANCERS; EXPRESSION	Mutations in AIPL1 cause the inherited blindness Leber congenital amaurosis (LCA). AIPL1 has previously been shown to interact with NUB1, which facilitates the proteasomal degradation of proteins modified with the ubiquitin-like protein FAT10. Here we report that AIPL1 binds non-covalently to free FAT10 and FAT10ylated proteins and can form a ternary complex with FAT10 and NUB1. In addition, AIPL1 antagonised the NUB1-mediated degradation of the model FAT10 conjugate, FAT10-DHFR, and pathogenic mutations of AIPL1 were defective in inhibiting this degradation. While all AIPL1 mutants tested still bound FAT10-DHFR, there was a close correlation between the ability of the mutants to interact with NUB1 and their ability to prevent NUB1-mediated degradation. Interestingly, AIPL1 also co-immunoprecipitated the E1 activating enzyme for FAT10, UBA6, suggesting AIPL1 may have a role in directly regulating the FAT10 conjugation machinery. These studies are the first to implicate FAT10 in retinal cell biology and LCA pathogenesis, and reveal a new role of AIPL1 in regulating the FAT10 pathway.	[Bett, John S.; Kanuga, Naheed; Richet, Emma; Cheetham, Michael E.; van der Spuy, Jacqueline] UCL Inst Ophthalmol, London, England; [Schmidtke, Gunter; Groettrup, Marcus] Univ Constance, Dept Biol, Constance, Germany	University of London; University College London; University of Konstanz	Bett, JS (corresponding author), UCL Inst Ophthalmol, London, England.	j.spuy@ucl.ac.uk	Groettrup, Marcus/AAT-2623-2020	Cheetham, Michael/0000-0001-6429-654X; van der Spuy, Jacqueline/0000-0001-5906-2116	Wellcome Trust [GR077929MA]; German Research Foundation (DFG) [GR1517/2-3, GR1517/3-1]	Wellcome Trust(Wellcome TrustEuropean Commission); German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by grants from the Wellcome Trust (GR077929MA) and the German Research Foundation (DFG) (GR1517/2-3 and GR1517/3-1). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichem A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1012; Akey DT, 2002, HUM MOL GENET, V11, P2723, DOI 10.1093/hmg/11.22.2723; Canaan A, 2006, MOL CELL BIOL, V26, P5180, DOI 10.1128/MCB.00966-05; Chiu YH, 2007, MOL CELL, V27, P1014, DOI 10.1016/j.molcel.2007.08.020; Hidalgo-De-Quintana J, 2008, INVEST OPHTH VIS SCI, V49, P2878, DOI 10.1167/iovs.07-1576; Hipp MS, 2005, MOL CELL BIOL, V25, P3483, DOI 10.1128/MCB.25.9.3483-3491.2005; Hipp MS, 2004, J BIOL CHEM, V279, P16503, DOI 10.1074/jbc.M310114200; Kalveram B, 2008, J CELL SCI, V121, P4079, DOI 10.1242/jcs.035006; Kamitani T, 2001, J BIOL CHEM, V276, P46655, DOI 10.1074/jbc.M108636200; Kanaya K, 2004, BIOCHEM BIOPH RES CO, V317, P768, DOI 10.1016/j.bbrc.2004.03.108; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kolandaivelu S, 2009, J BIOL CHEM, V284, P30853, DOI 10.1074/jbc.M109.036780; Lee CGL, 2003, ONCOGENE, V22, P2592, DOI 10.1038/sj.onc.1206337; Lim CB, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-20; Liu XQ, 2004, P NATL ACAD SCI USA, V101, P13903, DOI 10.1073/pnas.0405160101; Liu YC, 1999, P NATL ACAD SCI USA, V96, P4313, DOI 10.1073/pnas.96.8.4313; Lukasiak S, 2008, ONCOGENE, V27, P6068, DOI 10.1038/onc.2008.201; Mendes HF, 2008, HUM MOL GENET, V17, P3043, DOI 10.1093/hmg/ddn202; Raasi S, 2001, J BIOL CHEM, V276, P35334, DOI 10.1074/jbc.M105139200; Ramamurthy V, 2004, P NATL ACAD SCI USA, V101, P13897, DOI 10.1073/pnas.0404197101; Ren JW, 2006, J BIOL CHEM, V281, P11413, DOI 10.1074/jbc.M507218200; Schmidtke G, 2006, J BIOL CHEM, V281, P20045, DOI 10.1074/jbc.M603063200; Schmidtke G, 2009, FEBS LETT, V583, P591, DOI 10.1016/j.febslet.2009.01.006; Sohocki MM, 2000, NAT GENET, V24, P79, DOI 10.1038/71732; van der Spuy J, 2005, MOL VIS, V11, P542; van der Spuy J, 2004, J BIOL CHEM, V279, P48038, DOI 10.1074/jbc.M407871200; van der Spuy J, 2003, INVEST OPHTH VIS SCI, V44, P5396, DOI 10.1167/iovs.03-0686; van der Spuy J, 2002, HUM MOL GENET, V11, P823, DOI 10.1093/hmg/11.7.823	28	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e30866	10.1371/journal.pone.0030866	http://dx.doi.org/10.1371/journal.pone.0030866			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347407	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000302180600016
J	Fang, XF; Wang, RQ; Ma, J; Ding, Y; Shang, WR; Sun, ZM				Fang, Xianfeng; Wang, Ruiqing; Ma, Jian; Ding, Yan; Shang, Weirong; Sun, Zuoming			Ameliorated ConA-Induced Hepatitis in the Absence of PKC-theta	PLOS ONE			English	Article							KINASE-C-THETA; NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; NK1(+) T-CELLS; NKT CELLS; CONCANAVALIN-A; MEDIATED CYTOTOXICITY; AUTOIMMUNE HEPATITIS; LIVER-INJURY; PROTEIN	Severe liver injury that occurs when immune cells mistakenly attack an individual's own liver cells leads to autoimmune hepatitis. In mice, acute hepatitis can be induced by concanavalin A (ConA) treatment, which causes rapid activation of CD1d-positive natural killer (NK) T cells. These activated NKT cells produce large amounts of cytokines, which induce strong inflammation that damages liver tissues. Here we show that PKC-theta(-/-) mice were resistant to ConA-induced hepatitis due to essential function of PKC-theta in NKT cell development and activation. A dosage of ConA (25 mg/kg) that was lethal to wildtype (WT) mice failed to induce death resulting from liver injury in PKC-theta(-/-) mice. Correspondingly, ConA-induced production of cytokines such as IFN gamma, IL-6, and TNF alpha, which mediate the inflammation responsible for liver injury, were significantly lower in PKC-theta(-/-) mice. Peripheral NKT cells had developmental defects at early stages in the thymus in PKCh-theta(-/-) mice, and as a result their frequency and number were greatly reduced. Furthermore, PKC-theta(-/-) bone marrow adoptively transferred to WT mice displayed similar defects in NKT cell development, suggesting an intrinsic requirement for PKC-theta in NKT cell development. In addition, upon stimulation with NKT cell-specific lipid ligand, peripheral PKC-theta(-/-) NKT cells produced lower levels of inflammatory cytokines than that of WT NKT cells, suggesting that activation of NKT cells also requires PKC-theta. Our results suggest PKC-theta is an essential molecule required for activation of NKT cell to induce hepatitis, and thus, is a potential drug target for prevention of autoimmune hepatitis.	[Fang, Xianfeng; Wang, Ruiqing; Ma, Jian; Ding, Yan; Sun, Zuoming] Beckman Res Inst City Hope, Div Immunol, Duarte, CA USA; [Shang, Weirong] Emory Univ, Sch Med, Dept Gynecol & Obstet, Atlanta, GA USA	City of Hope; Beckman Research Institute of City of Hope; Emory University	Fang, XF (corresponding author), Beckman Res Inst City Hope, Div Immunol, Duarte, CA USA.	zsun@coh.org	fang, xianfeng/E-6301-2012; Ma, Jian/K-5260-2012	fang, xianfeng/0000-0003-0161-0209; 	National Institutes of Health [NIH R01-AI053147, NIH R56-AI072554]; Nesvig lymphoma Fellowship and Research Fund; City of Hope; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI072554, R01AI053147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nesvig lymphoma Fellowship and Research Fund; City of Hope; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (NIH R01-AI053147, NIH R56-AI072554), the Nesvig lymphoma Fellowship and Research Fund, and the City of Hope. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman A, 2000, IMMUNOL TODAY, V21, P567, DOI 10.1016/S0167-5699(00)01749-7; Baier G, 2003, IMMUNOL REV, V192, P64, DOI 10.1034/j.1600-065X.2003.00018.x; BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Crowe NY, 2003, J IMMUNOL, V171, P4020, DOI 10.4049/jimmunol.171.8.4020; Cywin CL, 2007, BIOORG MED CHEM LETT, V17, P225, DOI 10.1016/j.bmcl.2006.09.056; Czaja AJ, 2002, HEPATOLOGY, V36, P479, DOI 10.1053/jhep.2002.34944; Czaja AJ, 1998, DIGEST DIS SCI, V43, P2149, DOI 10.1023/A:1018836004279; Diao HY, 2004, IMMUNITY, V21, P539, DOI 10.1016/j.immuni.2004.08.012; Emoto M, 2003, TRENDS IMMUNOL, V24, P364, DOI 10.1016/S1471-4906(03)00162-5; Exley MA, 2004, HEPATOLOGY, V40, P1033, DOI 10.1002/hep.20433; Faggioni R, 2000, P NATL ACAD SCI USA, V97, P2367, DOI 10.1073/pnas.040561297; Fang XF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010288; GANTNER F, 1995, HEPATOLOGY, V21, P190, DOI 10.1002/hep.1840210131; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Gumperz JE, 2001, CURR OPIN IMMUNOL, V13, P471, DOI 10.1016/S0952-7915(00)00243-0; Higuchi H, 2004, J BIOL CHEM, V279, P51, DOI 10.1074/jbc.M309476200; Ishigami M, 1999, HEPATOLOGY, V29, P1799, DOI 10.1002/hep.510290605; Kaneko Y, 2000, J EXP MED, V191, P105, DOI 10.1084/jem.191.1.105; Kato A, 2000, AM J PATHOL, V157, P297, DOI 10.1016/S0002-9440(10)64540-3; Kawano T, 1999, CANCER RES, V59, P5102; Kim CH, 2002, TRENDS IMMUNOL, V23, P516, DOI 10.1016/S1471-4906(02)02323-2; Kwon Myung-Ja, 2010, Endocrine Metabolic & Immune Disorders-Drug Targets, V10, P367; LEIST M, 1995, AM J PATHOL, V146, P1220; Li YQ, 2004, EMBO J, V23, P1112, DOI 10.1038/sj.emboj.7600125; Lin X, 2000, MOL CELL BIOL, V20, P2933, DOI 10.1128/MCB.20.8.2933-2940.2000; Malhi H, 2007, GUT, V56, P1124, DOI 10.1136/gut.2006.118059; Manicassainy S, 2007, J IMMUNOL, V178, P312, DOI 10.4049/jimmunol.178.1.312; Manicassamy S, 2006, CELL MOL IMMUNOL, V3, P263; McFarlane IG, 1999, BIOMED PHARMACOTHER, V53, P255, DOI 10.1016/S0753-3322(99)80096-1; Mosyak L, 2007, BIOCHEM SOC T, V35, P1027, DOI 10.1042/BST0351027; Nicoletti F, 2000, CYTOKINE, V12, P315, DOI 10.1006/cyto.1999.0561; Pfeifhofer C, 2003, J EXP MED, V197, P1525, DOI 10.1084/jem.20020234; Ramaiah SK, 2008, TOXICOL SCI, V103, P4, DOI 10.1093/toxsci/kfm246; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Schmidt-Supprian M, 2004, P NATL ACAD SCI USA, V101, P4566, DOI 10.1073/pnas.0400885101; Sivakumar V, 2003, J EXP MED, V197, P1613, DOI 10.1084/jem.20022234; Spangrude Gerald J, 2008, Curr Protoc Immunol, VChapter 4, DOI 10.1002/0471142735.im0406s81; Stanic AK, 2004, J IMMUNOL, V172, P4667, DOI 10.4049/jimmunol.172.8.4667; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Toyabe S, 1997, J IMMUNOL, V159, P1537; Van Deuren M., 1994, European Journal of Clinical Microbiology and Infectious Diseases, V13, pS12; Watarai H, 2008, NAT PROTOC, V3, P70, DOI 10.1038/nprot.2007.515; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4	47	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31174	10.1371/journal.pone.0031174	http://dx.doi.org/10.1371/journal.pone.0031174			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347449	Green Published, Green Submitted, gold			2022-12-25	WOS:000302180600031
J	Ishida, Y; Sekine, Y; Oguchi, H; Chihara, T; Miura, M; Ichijo, H; Takeda, K				Ishida, Yosuke; Sekine, Yusuke; Oguchi, Haruka; Chihara, Takahiro; Miura, Masayuki; Ichijo, Hidenori; Takeda, Kohsuke			Prevention of Apoptosis by Mitochondrial Phosphatase PGAM5 in the Mushroom Body Is Crucial for Heat Shock Resistance in Drosophila melanogaster	PLOS ONE			English	Article							BODIES; GENE; PROTEIN; EXPRESSION; CASPASE-2; REVEALS; NEURONS; COMPLEX; SLEEP; DEATH	The heat shock (HS) response is essential for survival of all organisms. Although the machinery of the HS response has been extensively investigated at the cellular level, it is poorly understood at the level of the organism. Here, we show the crucial role of the mushroom body (MB) in the HS response in Drosophila. Null mutants of the mitochondrial phosphatase Drosophila PGAM5 (dPGAM5) exhibited increased vulnerability to HS, which was reversed by MB-specific expression of the caspase inhibitor p35, and similar vulnerability was induced in wild-type flies by knockdown of MB dPGAM5. Elimination of the MB did not affect the HS response of wild-type flies, but did increase the resistance of dPGAM5-deficient flies to HS. Thus, the MB may possess an apoptosis-dependent toxic function, the suppression of which by dPGAM5 appears to be crucial for HS resistance.	[Ishida, Yosuke; Sekine, Yusuke; Oguchi, Haruka; Takeda, Kohsuke] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Tokyo, Japan; [Chihara, Takahiro; Miura, Masayuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Genet, Tokyo, Japan; [Chihara, Takahiro; Takeda, Kohsuke] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Saitama, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Ishida, Y (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Tokyo, Japan.	takeda@mol.f.u-tokyo.ac.jp	Chihara, Takahiro/G-7639-2019; Sekine, Yusuke/AHI-8340-2022	Chihara, Takahiro/0000-0001-9989-3619; Sekine, Yusuke/0000-0003-0345-1416; Takeda, Kohsuke/0000-0002-8359-8399; Ichijo, Hidenori/0000-0002-5005-6438	Japanese Science and Technology Agency (JST); Japanese Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT); Strategic Approach to Drug Discovery and Development in Pharmaceutical Sciences, Global Center of Excellence (GCOE); MEXT; Naito Foundation; Cosmetology Research Foundation; Tokyo Biochemical Research Foundation	Japanese Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic Approach to Drug Discovery and Development in Pharmaceutical Sciences, Global Center of Excellence (GCOE); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Cosmetology Research Foundation; Tokyo Biochemical Research Foundation	This work was supported by the Japanese Science and Technology Agency (JST) Precursory Research for Embryonic Science and Technology (PRESTO) program, Grants-in-Aid for Scientific Research (KAKENHI) from Japanese Society for the Promotion of Science (JSPS) and Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT), Strategic Approach to Drug Discovery and Development in Pharmaceutical Sciences, Global Center of Excellence (GCOE) Program, the "Understanding of molecular and environmental bases for brain health" conducted under the Strategic Research Program for Brain Sciences by MEXT, the Naito Foundation Natural Science Scholarship, the Cosmetology Research Foundation, and the Tokyo Biochemical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calleja M, 2000, DEVELOPMENT, V127, P3971; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Craig CR, 2004, EMBO REP, V5, P1058, DOI 10.1038/sj.embor.7400282; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Hammond PW, 2001, J BIOL CHEM, V276, P20898, DOI 10.1074/jbc.M011641200; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Imai Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001229; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Koto A, 2009, J CELL BIOL, V187, P219, DOI 10.1083/jcb.200905110; Lee BP, 2005, MECH DEVELOP, V122, P849, DOI 10.1016/j.mod.2005.01.002; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lo SC, 2008, EXP CELL RES, V314, P1789, DOI 10.1016/j.yexcr.2008.02.014; Lo SC, 2006, J BIOL CHEM, V281, P37893, DOI 10.1074/jbc.M606539200; Martin JR, 1998, LEARN MEMORY, V5, P179; Milleron RS, 2007, CELL MOL LIFE SCI, V64, P2329, DOI 10.1007/s00018-007-7135-6; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Perez-Garijo A, 2004, DEVELOPMENT, V131, P5591, DOI 10.1242/dev.01432; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Reddy GV, 1999, DEVELOPMENT, V126, P2083; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Rintelen F, 2003, DEVELOPMENT, V130, P3479, DOI 10.1242/dev.00568; Salinas LS, 2006, CELL DEATH DIFFER, V13, P2129, DOI 10.1038/sj.cdd.4401976; Senoo-Matsuda N, 2005, EMBO J, V24, P2700, DOI 10.1038/sj.emboj.7600721; Serway CN, 2009, J NEUROGENET, V23, P173, DOI 10.1080/01677060802572895; Shelton SN, 2010, J BIOL CHEM, V285, P40525, DOI 10.1074/jbc.M110.167635; Stramer B, 2005, J CELL BIOL, V168, P567, DOI 10.1083/jcb.200405120; Takeda K, 2009, P NATL ACAD SCI USA, V106, P12301, DOI 10.1073/pnas.0901823106; Tanaka NK, 2008, J COMP NEUROL, V508, P711, DOI 10.1002/cne.21692; Tomita J, 2011, J NEUROSCI, V31, P13137, DOI 10.1523/JNEUROSCI.5860-10.2011; Tu S, 2006, NAT CELL BIOL, V8, P72, DOI 10.1038/ncb1340; Wang X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001125; Wang YL, 2003, CURR BIOL, V13, P1900, DOI 10.1016/j.cub.2003.10.003; YANG MY, 1995, NEURON, V15, P45	36	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e30265	10.1371/journal.pone.0030265	http://dx.doi.org/10.1371/journal.pone.0030265			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347370	Green Submitted, Green Published, gold			2022-12-25	WOS:000302180600006
J	Sutcliffe, CG; Kobayashi, T; Hamapumbu, H; Shields, T; Mharakurwa, S; Thuma, PE; Louis, TA; Glass, G; Moss, WJ				Sutcliffe, Catherine G.; Kobayashi, Tamaki; Hamapumbu, Harry; Shields, Timothy; Mharakurwa, Sungano; Thuma, Philip E.; Louis, Thomas A.; Glass, Gregory; Moss, William J.			Reduced Risk of Malaria Parasitemia Following Household Screening and Treatment: A Cross-Sectional and Longitudinal Cohort Study	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTIONS; ACTIVE CASE DETECTION; DECLINING TRANSMISSION; CONTROLLED-TRIAL; SOUTHERN ZAMBIA; HIGH PREVALENCE; SCALE-UP; CHILDREN; AREA; REDUCTION	Background: In regions of declining malaria transmission, new strategies for control are needed to reduce transmission and achieve elimination. Artemisinin-combination therapy (ACT) is active against immature gametocytes and can reduce the risk of transmission. We sought to determine whether household screening and treatment of infected individuals provides protection against infection for household members. Methodology/Principal Findings: The study was conducted in two areas in Southern Province, Zambia in 2007 and 2008/2009. To determine the impact of proactive case detection, households were randomly selected either to join a longitudinal cohort, in which participants were repeatedly screened throughout the year and those infected treated with artemether-lumefantrine, or a cross-sectional survey, in which participants were visited only once. Cross-sectional surveys were conducted throughout the year. The prevalence of RDT positivity was compared between the longitudinal and cross-sectional households at baseline and during follow-up using multilevel logistic regression. In the 2007 study area, 174 and 156 participants enrolled in the cross-sectional and longitudinal groups, respectively. In the 2008/2009 study area, 917 and 234 participants enrolled in the cross-sectional and longitudinal groups, respectively. In both study areas, participants and households in the longitudinal and cross-sectional groups were similar on demographic characteristics and prevalence of RDT positivity at baseline (2007: OR = 0.97; 95% CI:0.46, 2.03 vertical bar 2008/2009: OR = 1.28; 95% CI:0.44, 3.79). After baseline, the prevalence of RDT positivity was significantly lower in longitudinal compared to cross-sectional households in both study areas (2007: OR = 0.44; 95% CI:0.20, 0.96 vertical bar 2008/2009: OR = 0.16; 95% CI:0.05, 0.55). Conclusions/Significance: Proactive case detection, consisting of screening household members with an RDT and treating those positive with ACT, can reduce transmission and provide indirect protection to household members. A targeted test and treat strategy could contribute to the elimination of malaria in regions of low transmission.	[Sutcliffe, Catherine G.; Kobayashi, Tamaki; Moss, William J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Shields, Timothy; Mharakurwa, Sungano; Glass, Gregory; Moss, William J.] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Louis, Thomas A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Hamapumbu, Harry; Mharakurwa, Sungano; Thuma, Philip E.] Malaria Res Trust, Choma, Zambia	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Sutcliffe, CG (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	wmoss@jhsph.edu		Sutcliffe, Catherine/0000-0001-8512-8326	Johns Hopkins Malaria Research Institute; Bloomberg Family Foundation	Johns Hopkins Malaria Research Institute; Bloomberg Family Foundation	This work was supported by the Johns Hopkins Malaria Research Institute and the Bloomberg Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjuik M, 2004, LANCET, V363, P9, DOI 10.1016/S0140-6736(03)15162-8; Aregawi MW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-46; Baliraine FN, 2009, J INFECT DIS, V200, P66, DOI 10.1086/599317; Barnes KI, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S1-S8; Dal-Bianco MP, 2007, AM J TROP MED HYG, V77, P939, DOI 10.4269/ajtmh.2007.77.939; ElKhyari T, MALARIA ELIMINATION; Harris I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-254; Kent RJ, 2007, AM J TROP MED HYG, V76, P267, DOI 10.4269/ajtmh.2007.76.267; LARKIN GL, 1991, AM J TROP MED HYG, V45, P587, DOI 10.4269/ajtmh.1991.45.587; Li Zizhao, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P240; Lowther SA, 2009, TROP MED INT HEALTH, V14, P70, DOI 10.1111/j.1365-3156.2008.02185.x; Mabunda S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-74; Macauley C, 2005, SOC SCI MED, V60, P563, DOI 10.1016/j.socscimed.2004.05.025; Moonen B, 2010, LANCET, V376, P1592, DOI 10.1016/S0140-6736(10)61269-X; Moss WJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-163; Ogutu B, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-30; Okell LC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-125; Okell LC, 2008, PLOS MED, V5, P1617, DOI 10.1371/journal.pmed.0050226; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Owusu-Agyei S, 2002, TROP MED INT HEALTH, V7, P421, DOI 10.1046/j.1365-3156.2002.00881.x; Price RN, 1996, LANCET, V347, P1654, DOI 10.1016/S0140-6736(96)91488-9; Stresman GH, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-265; Sutcliffe CG, 2011, MALARIA J, V10, P324, DOI DOI 10.1186/1475-2875-10-324; Sutherland CJ, 2005, PLOS MED, V2, P338, DOI 10.1371/journal.pmed.0020092; Vafa M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-17; von Seidlein L, 2003, TRENDS PARASITOL, V19, P452, DOI 10.1016/j.pt.2003.08.003; Von Seidlein L, 1998, AM J TROP MED HYG, V58, P638; von Seidlein L, 2000, LANCET, V355, P352, DOI 10.1016/S0140-6736(99)10237-X; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2009, MAL RAP DIAG TEST PE; Yip K., 2000, Parassitologia (Rome), V42, P117	31	28	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31396	10.1371/journal.pone.0031396	http://dx.doi.org/10.1371/journal.pone.0031396			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319629	Green Published, gold, Green Submitted			2022-12-25	WOS:000302178400041
J	Plum, L; Lin, HV; Aizawa, KS; Liu, YT; Accili, D				Plum, Leona; Lin, Hua V.; Aizawa, Kumiko S.; Liu, Yitian; Accili, Domenico			InsR/FoxO1 Signaling Curtails Hypothalamic POMC Neuron Number	PLOS ONE			English	Article							PROOPIOMELANOCORTIN NEURONS; ARCUATE NUCLEUS; NEUROTROPHIC FACTOR; LEPTIN SENSITIVITY; FEEDING CIRCUITS; EXPRESSION; ENERGY; BRAIN; NEUROGENESIS; POPULATIONS	Insulin receptor (InsR) signaling through transcription factor FoxO1 is important in the development of hypothalamic neuron feeding circuits, but knowledge about underlying mechanisms is limited. To investigate the role of InsR/FoxO1 signaling in the development and maintenance of these circuits, we surveyed the pool of hypothalamic neurons expressing Pomc mRNA in different mouse models of impaired hypothalamic InsR signaling. InsR ablation in the entire hypothalamus did not affect Pomc-neuron number at birth, but resulted in a 25% increase, most notably in the middle arcuate nucleus region, in young adults. Selective restoration of InsR expression in POMC neurons in these mice partly reversed the abnormality, resulting in a 10% decrease compared to age-matched controls. To establish whether FoxO1 signaling plays a role in this process, we examined POMC neuron number in mice with POMC-specific deletion of FoxO1, and detected a 23% decrease in age-matched animals, consistent with a cell-autonomous role of InsR/FoxO1 signaling in regulating POMC neuron number, distinct from its established role to activate Pomc transcription. These changes in Pomc cells occurred in the absence of marked changes in humoral factors or hypothalamic NPY neurons.	[Plum, Leona; Lin, Hua V.; Aizawa, Kumiko S.; Liu, Yitian; Accili, Domenico] Columbia Univ, Med Ctr, Dept Med, Naomi Berrie Diabet Ctr, New York, NY USA	Columbia University	Plum, L (corresponding author), Profil Inst Metab Res, Neuss, Germany.	da230@columbia.edu	Plum-Mörschel, Leona/W-9413-2019	Plum-Mörschel, Leona/0000-0002-1907-761X; Lin, Hua/0000-0001-5001-5567	Deutsche Forschungsgemeinschaft (DFG) [PL542/1-1]; Berrie Fellowship Award; NIH [DK57539, DK58282]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057539, R37DK058282, R01DK058282] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Berrie Fellowship Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by the Deutsche Forschungsgemeinschaft (DFG) grant PL542/1-1 to L. P., the Berrie Fellowship Award to H. V. L., and NIH grants DK57539 and DK58282 to D.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Bouret S, 2000, ENDOCRINOLOGY, V141, P1780, DOI 10.1210/en.141.5.1780; Bouret S, 1999, MOL BRAIN RES, V70, P155, DOI 10.1016/S0169-328X(99)00132-1; Bouret SG, 2009, J PEDIATR GASTR NUTR, V48, pS31, DOI 10.1097/MPG.0b013e3181977375; Carlo AS, 2007, ENDOCRINOLOGY, V148, P6073, DOI 10.1210/en.2007-0822; Carmody JS, 2010, RESPECTIVE CONTRIBUT; CHOWENBREED JA, 1989, ENDOCRINOLOGY, V124, P2875, DOI 10.1210/endo-124-6-2875; Cottrell EC, 2009, AM J PHYSIOL-REG I, V296, pR631, DOI 10.1152/ajpregu.90690.2008; Ferrini M, 2001, NEUROENDOCRINOLOGY, V74, P1, DOI 10.1159/000054665; Grove KL, 2003, PHYSIOL BEHAV, V79, P47, DOI 10.1016/S0031-9384(03)00104-5; HAVRANKOVA J, 1978, NATURE, V272, P827, DOI 10.1038/272827a0; Hoekman MFM, 2006, GENE EXPR PATTERNS, V6, P134, DOI 10.1016/j.modgep.2005.07.003; Jing EX, 2004, ENDOCRINOLOGY, V145, P1503, DOI 10.1210/en.2003-0834; Kaelin CB, 2004, ENDOCRINOLOGY, V145, P5798, DOI 10.1210/en.2004-0956; KITAMURA T, 2006, NAT MED; Lin HV, 2007, DIABETES, V56, P1969, DOI 10.2337/db07-0127; Lin HV, 2010, DIABETES, V59, P337, DOI 10.2337/db09-1303; Manfredsson FP, 2009, MOL THER, V17, P980, DOI 10.1038/mt.2009.45; Matsuwaki T, 2010, J REPROD DEV; Muhlhausler BS, 2007, J NEUROENDOCRINOL, V19, P67, DOI 10.1111/j.1365-2826.2006.01505.x; Nilsson I, 2005, DEV BRAIN RES, V155, P147, DOI 10.1016/j.devbrainres.2005.01.009; Okamoto H, 2005, J CLIN INVEST, V115, P1314, DOI 10.1172/JCI200523096; Okamoto H, 2004, J CLIN INVEST, V114, P214, DOI 10.1172/JCI200421645; Padilla SL, 2011, DEFINING POMC NEURON; Padilla SL, 2010, NAT MED, V16, P403, DOI 10.1038/nm.2126; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Perez-Martin M, 2010, EUR J NEUROSCI, V31, P1533, DOI 10.1111/j.1460-9568.2010.07220.x; Pierce AA, 2010, J NEUROSCI, V30, P723, DOI 10.1523/JNEUROSCI.2479-09.2010; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Plum L, 2006, J CLIN INVEST, V116, P1886, DOI 10.1172/JCI27123; Plum L, 2006, J CLIN INVEST, V116, P1761, DOI 10.1172/JCI29063; Plum L, 2009, NAT MED, V15, P1195, DOI 10.1038/nm.2026; Poston L, 2010, BEST PRACT RES CL EN, V24, P541, DOI 10.1016/j.beem.2010.05.007; Silhol M, 2005, NEUROSCIENCE, V132, P613, DOI 10.1016/j.neuroscience.2005.01.008; Steculorum SM, 2011, ENDOCRINOLOGY, V152, P4171, DOI 10.1210/en.2011-1279; Sullivan EL, 2011, NEUROENDOCRINOLOGY, V93, P1, DOI 10.1159/000322038; VANHOUTEN M, 1979, ENDOCRINOLOGY, V105, P666; WARDLAW SL, 1988, NEUROENDOCRINOLOGY, V47, P164, DOI 10.1159/000124908; Williams KW, 2010, J NEUROSCI, V30, P2472, DOI 10.1523/JNEUROSCI.3118-09.2010; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; Yuan ZQ, 2008, SCIENCE, V319, P1665, DOI 10.1126/science.1152337	43	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e31487	10.1371/journal.pone.0031487	http://dx.doi.org/10.1371/journal.pone.0031487			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319636	Green Published, gold, Green Submitted			2022-12-25	WOS:000301979000031
J	Maslov, AY; Lee, M; Gundry, M; Gravina, S; Strogonova, N; Tazearslan, C; Bendebury, A; Suh, Y; Vijg, J				Maslov, A. Y.; Lee, M.; Gundry, M.; Gravina, S.; Strogonova, N.; Tazearslan, C.; Bendebury, A.; Suh, Y.; Vijg, J.			5-Aza-2 '-deoxycytidine-induced genome rearrangements are mediated by DNMT1	ONCOGENE			English	Article						DNA methylation; 5-aza-2 '-deoxycytidine; mutations; genome rearrangements; DNMT1	BASE EXCISION-REPAIR; DNA METHYLTRANSFERASE; MASS-SPECTROMETRY; CANCER-CELLS; POLY(ADP-RIBOSE) POLYMERASE; MYELODYSPLASTIC SYNDROME; MAMMALIAN-CELLS; IN-VIVO; DEMETHYLATION; METHYLATION	Observations that genome-wide DNA hypomethylation induces genome instability and tumors in animals caution against the indiscriminate use of demethylating agents, such as 5-aza-2'-deoxycytidine (5-Aza-dC). Using primary mouse embryonic fibroblasts harboring a lacZ mutational reporter construct that allows the quantification and characterization of a wide range of mutational events, we found that, in addition to demethylation, treatment with 5-Aza-dC induces gamma-H2AX expression, a marker for DNA breaks, and both point mutations and genome rearrangements. To gain insight into the source of these mutations, we first tested the hypothesis that the mutagenic effect of 5-Aza-dC may be directly mediated through the DNA methyltransferase 1 (DNMT1) covalently trapped in 5-Aza-dC-substituted DNA. Knockdown of DNMT1 resulted in increased resistance to the cytostatic effects of 5-Aza-dC, delayed onset of g-H2AX expression and a significant reduction in the frequency of genome rearrangements. There was no effect on the 5-Aza-dC-induced point mutations. An alternative mechanism for 5-Aza-dC-induced demethylation and genome rearrangements via activation-induced cytidine deaminase (AID) followed by base excision repair (BER) was found not to be involved. That is, 5-Aza-dC treatment did not significantly induce AID expression and inhibition of BER did not reduce the frequency of genome rearrangements. Thus, our results indicate that the formation of DNMT1 adducts is the prevalent mechanism of 5-Aza-dC-induced genome rearrangements, although hypomethylation per se may still contribute. As the therapeutic effects of 5-Aza-dC greatly depend on the presence of DNMT1, the expression level of DNA methyltransferases in tumors may serve as a prognostic factor for the efficacy of 5-Aza-dC treatment. Oncogene (2012) 31, 5172--5179; doi:10.1038/onc.2012.9; published online 20 February 2012	[Maslov, A. Y.; Lee, M.; Gundry, M.; Gravina, S.; Strogonova, N.; Tazearslan, C.; Bendebury, A.; Suh, Y.; Vijg, J.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Suh, Y.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Suh, Y.] Guangdong Med Coll, Inst Aging Res, Dongguan, Peoples R China	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Guangdong Medical University	Maslov, AY (corresponding author), Albert Einstein Coll Med, Dept Genet, 1301 Morris Pk Ave, Bronx, NY 10461 USA.	alex.maslov@einstein.yu.edu; yousin.suh@einstein.yu.edu; jan.vijg@einstein.yu.edu	Gundry, Michael/AAE-7670-2020; Maslov, Alexander/AAH-3788-2019	Gundry, Michael/0000-0003-3654-1741; 	NIH [P01 AG017242, R01 AG024391]; Ellison/AFAR; NATIONAL INSTITUTE ON AGING [R01AG024391, P01AG017242] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison/AFAR; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH Grant P01 AG017242 to JV and YS; R01 AG024391 to YS. CT is a recipient of Ellison/AFAR postdoctoral fellowship.	Allinson SL, 2003, ACTA BIOCHIM POL, V50, P169; AMACHER DE, 1987, MUTAT RES, V176, P123, DOI 10.1016/0027-5107(87)90259-4; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; BOERRIGTER METI, 1995, NATURE, V377, P657, DOI 10.1038/377657a0; CHABOT GG, 1983, BIOCHEM PHARMACOL, V32, P1327, DOI 10.1016/0006-2952(83)90293-9; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Coolen MW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm662; Daskalakis M, 2002, BLOOD, V100, P2957, DOI 10.1182/blood.V100.8.2957; Dolle MET, 2002, GENOME RES, V12, P1732, DOI 10.1101/gr.125502; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Fandy TE, 2009, CURR MED CHEM, V16, P2075, DOI 10.2174/092986709788612738; Ferguson AT, 1997, J BIOL CHEM, V272, P32260, DOI 10.1074/jbc.272.51.32260; Fisher AEO, 2007, MOL CELL BIOL, V27, P5597, DOI 10.1128/MCB.02248-06; Fritz EL, 2010, GENE DEV, V24, P2107, DOI 10.1101/gad.1963010; Garcia Ana Maria, 2007, Methods Mol Biol, V371, P267; Hernandez R, 1997, CYTOGENET CELL GENET, V76, P196, DOI 10.1159/000134548; Hoglund A, 2009, BLOOD, V113, P4281, DOI 10.1182/blood-2008-10-183475; JacksonGrusby L, 1997, P NATL ACAD SCI USA, V94, P4681, DOI 10.1073/pnas.94.9.4681; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; Karpf AR, 2001, MOL PHARMACOL, V59, P751, DOI 10.1124/mol.59.4.751; Kelecsenyi Z, 2000, MUTAGENESIS, V15, P25, DOI 10.1093/mutage/15.1.25; Kuo HK, 2007, CANCER RES, V67, P8248, DOI 10.1158/0008-5472.CAN-07-1038; LANDOLPH JR, 1982, CANCER RES, V42, P817; Langer F, 2005, LEUKEMIA RES, V29, P325, DOI 10.1016/j.leukres.2004.08.004; Larijani M, 2005, MOL IMMUNOL, V42, P599, DOI 10.1016/j.molimm.2004.09.007; Lengauer C, 1997, P NATL ACAD SCI USA, V94, P2545, DOI 10.1073/pnas.94.6.2545; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Masaoka A, 2009, DNA REPAIR, V8, P1290, DOI 10.1016/j.dnarep.2009.08.004; Nakano T, 2009, J BIOL CHEM, V284, P27065, DOI 10.1074/jbc.M109.019174; Obeid S, 2010, EMBO J, V29, P1738, DOI 10.1038/emboj.2010.64; Palii SS, 2008, MOL CELL BIOL, V28, P752, DOI 10.1128/MCB.01799-07; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rogstad DK, 2009, CHEM RES TOXICOL, V22, P1194, DOI 10.1021/tx900131u; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Sampath D, 2003, ONCOGENE, V22, P9063, DOI 10.1038/sj.onc.1207229; Sandhu SK, 2010, EUR J CANCER, V46, P9, DOI 10.1016/j.ejca.2009.10.021; Sczepanski JT, 2010, P NATL ACAD SCI USA, V107, P22475, DOI 10.1073/pnas.1012860108; Sirbu BM, 2011, GENE DEV, V25, P1320, DOI 10.1101/gad.2053211; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Vodenicharov MD, 2000, NUCLEIC ACIDS RES, V28, P3887, DOI 10.1093/nar/28.20.3887; ZIMMERMANN FK, 1984, MUTAT RES, V139, P21, DOI 10.1016/0165-7992(84)90116-7	42	36	39	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	DEC	2012	31	50					5172	5179		10.1038/onc.2012.9	http://dx.doi.org/10.1038/onc.2012.9			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	055WY	22349820	Green Accepted			2022-12-25	WOS:000312449800006
J	Shahnawaz, M; Soto, C				Shahnawaz, Mohammad; Soto, Claudio			Microcin Amyloid Fibrils A Are Reservoir of Toxic Oligomeric Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; FUNCTIONAL AMYLOIDS; PROTEIN; DISEASE; E492; STABILITY; PROTOFIBRILS; BACTERIOCIN; PROTOFILAMENTS	Microcin E492 (Mcc), a low molecular weight bacteriocin produced by Klebsiella pneumoniae RYC492, has been shown to exist in two forms: soluble forms that are believed to be toxic to the bacterial cell by forming pores and non-toxic fibrillar forms that share similar biochemical and biophysical properties with amyloids associated with several human diseases. Here we report that fibrils polymerized in vitro from soluble forms sequester toxic species that can be released upon changing environmental conditions such as pH, ionic strength, and upon dilution. Our results indicate that basic pH (>= 8.5), low NaCl concentrations (<= 50 mM), and dilution (>10-fold) destabilize Mcc fibrils into more soluble species that are found to be toxic to the target cells. Additionally, we also found a similar conversion of non-toxic fibrils into highly toxic oligomers using Mcc aggregates produced in vivo. Moreover, the soluble protein released from fibrils is able to rapidly polymerize into amyloid fibrils under fibril-forming conditions and to efficiently seed aggregation of monomeric Mcc. Our findings indicate that fibrillar forms of Mcc constitute a reservoir of toxic oligomeric species that is released into the medium upon changing the environmental conditions. These findings may have substantial implications to understand the dynamic process of interconversion between toxic and non-toxic aggregated species implicated in protein misfolding diseases.	[Shahnawaz, Mohammad; Soto, Claudio] Univ Texas Houston, Sch Med, Mitchell Ctr Alzheimers Dis & Related Brain Disor, Dept Neurol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Soto, C (corresponding author), Univ Texas Houston, Sch Med, Mitchell Ctr Alzheimers Dis & Related Brain Disor, Dept Neurol, 6431 Fannin St, Houston, TX 77030 USA.	Claudio.Soto@uth.tmc.edu						Badtke MP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.280pe43; BAQUERO F, 1984, FEMS MICROBIOL LETT, V23, P117; Bieler S, 2005, J BIOL CHEM, V280, P26880, DOI 10.1074/jbc.M502031200; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Chiti F, 2001, PROTEIN SCI, V10, P2541, DOI 10.1110/ps.ps.10201; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Corsini G, 2002, BIOCHIMIE, V84, P539, DOI 10.1016/S0300-9084(02)01415-3; DELORENZO V, 1985, J ANTIBIOT, V38, P340, DOI 10.7164/antibiotics.38.340; DELORENZO V, 1984, J GEN MICROBIOL, V130, P391; DELORENZO V, 1985, ANTIMICROB AGENTS CH, V27, P666, DOI 10.1128/AAC.27.4.666; DELORENZO V, 1984, ARCH MICROBIOL, V139, P72, DOI 10.1007/BF00692715; Destoumieux-Garzon D, 2003, MOL MICROBIOL, V49, P1031, DOI 10.1046/j.1365-2958.2003.03610.x; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Hetz C, 2002, P NATL ACAD SCI USA, V99, P2696, DOI 10.1073/pnas.052709699; Hotze EM, 2002, J BIOL CHEM, V277, P11597, DOI 10.1074/jbc.M111039200; LAGOS R, 1993, FEBS LETT, V321, P145, DOI 10.1016/0014-5793(93)80096-D; Lashuel H. A., 2005, SCI AGING KNOWLEDGE, V2005, pe28; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lashuel HA, 2006, Q REV BIOPHYS, V39, P167, DOI 10.1017/S0033583506004422; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Nichols MR, 2005, J BIOL CHEM, V280, P2471, DOI 10.1074/jbc.M410553200; Orellana C, 1996, FEMS MICROBIOL LETT, V136, P297; Raman B, 2005, BIOCHEMISTRY-US, V44, P1288, DOI 10.1021/bi048029t; Riley MA, 1998, ANNU REV GENET, V32, P255, DOI 10.1146/annurev.genet.32.1.255; Riley MA, 2002, BIOCHIMIE, V84, P357, DOI 10.1016/S0300-9084(02)01421-9; Riley MA, 2003, J EVOLUTION BIOL, V16, P690, DOI 10.1046/j.1420-9101.2003.00575.x; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Shammas SL, 2011, BIOPHYS J, V100, P2783, DOI 10.1016/j.bpj.2011.04.039; Sikkink LA, 2008, BIOPHYS CHEM, V135, P25, DOI 10.1016/j.bpc.2008.02.019; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Soto C, 2001, FEBS LETT, V498, P204, DOI 10.1016/S0014-5793(01)02486-3; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; Zurdo J, 2001, J MOL BIOL, V311, P325, DOI 10.1006/jmbi.2001.4858	38	54	56	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11665	11676		10.1074/jbc.M111.282533	http://dx.doi.org/10.1074/jbc.M111.282533			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22337880	Green Published, hybrid			2022-12-25	WOS:000302782200007
J	Gao, ZH; Cox, JL; Gilmore, JM; Ormsbee, BD; Mallanna, SK; Washburn, MP; Rizzino, A				Gao, Zhiguang; Cox, Jesse L.; Gilmore, Joshua M.; Ormsbee, Briana D.; Mallanna, Sunil K.; Washburn, Michael P.; Rizzino, Angie			Determination of Protein Interactome of Transcription Factor Sox2 in Embryonic Stem Cells Engineered for Inducible Expression of Four Reprogramming Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-RENEWAL; INTERACTION NETWORK; CARCINOMA-CELLS; ES CELLS; PLURIPOTENCY; DIFFERENTIATION; MOUSE; NANOG; COMPLEX; INTEGRATION	Unbiased proteomic screens provide a powerful tool for defining protein-protein interaction networks. Previous studies employed multidimensional protein identification technology to identify the Sox2-interactome in embryonic stem cells (ESC) undergoing differentiation in response to a small increase in the expression of epitope-tagged Sox2. Thus far the Sox2-interactome in ESC has not been determined. To identify the Sox2-interactome in ESC, we engineered ESC for inducible expression of different combinations of epitope-tagged Sox2 along with Oct4, Klf4, and c-Myc. Epitope-tagged Sox2 was used to circumvent the lack of suitable Sox2 antibodies needed to perform an unbiased proteomic screen of Sox2-associated proteins. Although i-OS-ESC differentiate when both Oct4 and Sox2 are elevated, i-OSKM-ESC do not differentiate even when the levels of the four transcription factors are coordinately elevated similar to 2-3-fold. Our findings with i-OS-ESC and i-OSKM-ESC provide new insights into the reasons why ESC undergo differentiation when Sox2 and Oct4 are elevated in ESC. Importantly, the use of i-OSKM-ESC enabled us to identify the Sox2-interactome in undifferentiated ESC. Using multidimensional protein identification technology, we identified >70 proteins that associate with Sox2 in ESC. We extended these findings by testing the function of the Sox2-assoicated protein Smarcd1 and demonstrate that knockdown of Smarcd1 disrupts the self-renewal of ESC and induces their differentiation. Together, our work provides the first description of the Sox2-interactome in ESC and indicates that Sox2 along with other master regulators is part of a highly integrated protein-protein interaction landscape in ESC.	[Gao, Zhiguang; Cox, Jesse L.; Ormsbee, Briana D.; Mallanna, Sunil K.; Rizzino, Angie] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Gilmore, Joshua M.; Washburn, Michael P.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Gilmore, Joshua M.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA	University of Nebraska System; University of Nebraska Medical Center; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Rizzino, A (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, 985950 Nebraska Med Ctr, Omaha, NE 68198 USA.	arizzino@unmc.edu		Washburn, Michael/0000-0001-7568-2585	National Institutes of Health [GM 080571]; Nebraska Department of Health [2009-01]; NCI, National Institutes of Health Cancer Biology [CA009476]; NCI, National Institutes of Health Cancer Center [fCA 36727]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Department of Health; NCI, National Institutes of Health Cancer Biology; NCI, National Institutes of Health Cancer Center	This work was supported, in whole or in part, by National Institutes of Health Grant GM 080571. This work was also supported by the Nebraska Department of Health (Stem Cell 2009-01).; Supported in part by NCI, National Institutes of Health Cancer Biology Training Grant CA009476.; We thank Michelle Desler and Phillip Wilder for technical assistance. Core facilities of the UNMC Eppley Cancer Center were supported in part by NCI, National Institutes of Health Cancer Center Support Grant fCA 36727.	Bartova E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027281; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Boer B, 2007, NUCLEIC ACIDS RES, V35, P1773, DOI 10.1093/nar/gkm059; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Cox JL, 2011, J CELL SCI, V124, P2654, DOI 10.1242/jcs.083238; Ding JJ, 2012, CELL RES, V22, P155, DOI 10.1038/cr.2011.179; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Fong YW, 2011, CELL, V147, P120, DOI 10.1016/j.cell.2011.08.038; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Karantzali E, 2011, J BIOL CHEM, V286, P1037, DOI 10.1074/jbc.M110.170050; KELLY D, 1995, MOL REPROD DEV, V40, P135, DOI 10.1002/mrd.1080400202; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Mallanna SK, 2012, J CELL PHYSIOL, V227, P27, DOI 10.1002/jcp.22721; Mallanna SK, 2010, STEM CELLS, V28, P1715, DOI 10.1002/stem.494; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Moretto-Zita M, 2010, P NATL ACAD SCI USA, V107, P13312, DOI 10.1073/pnas.1005847107; Murphy CL, 2002, TISSUE ENG, V8, P551, DOI 10.1089/107632702760240472; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Rizzino A, 2009, WIRES SYST BIOL MED, V1, P228, DOI 10.1002/wsbm.12; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; Seki Y, 2010, P NATL ACAD SCI USA, V107, P10926, DOI 10.1073/pnas.0907601107; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sikorski TW, 2011, MOL CELL, V44, P397, DOI 10.1016/j.molcel.2011.09.013; Stopka T, 2003, P NATL ACAD SCI USA, V100, P14097, DOI 10.1073/pnas.2336105100; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wiebe MS, 2007, CELL HOST MICROBE, V1, P187, DOI 10.1016/j.chom.2007.03.007; Zhang PL, 2010, J BIOL CHEM, V285, P9180, DOI 10.1074/jbc.M109.077958; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999	40	51	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11384	11397		10.1074/jbc.M111.320143	http://dx.doi.org/10.1074/jbc.M111.320143			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334693	hybrid, Green Published			2022-12-25	WOS:000302780100068
J	Stohl, EA; Chan, YA; Hackett, KT; Kohler, PL; Dillard, JP; Seifert, HS				Stohl, Elizabeth A.; Chan, Yolande A.; Hackett, Kathleen T.; Kohler, Petra L.; Dillard, Joseph P.; Seifert, H. Steven			Neisseria gonorrhoeae Virulence Factor NG1686 Is a Bifunctional M23B Family Metallopeptidase That Influences Resistance to Hydrogen Peroxide and Colony Morphology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN POLYMORPHONUCLEAR LEUKOCYTES; PILIN-ANTIGENIC-VARIATION; GRAM-NEGATIVE BACTERIUM; FALLOPIAN-TUBE MUCOSA; CELL-SEPARATION; PEPTIDOGLYCAN HYDROLASE; ESCHERICHIA-COLI; HOMOLOGOUS RECOMBINATION; CAULOBACTER-CRESCENTUS; NATURAL TRANSFORMATION	Background: Deletion of N. gonorrhoeae virulence factor ng1686 results in increased sensitivity to H2O2 and PMN-mediated killing. Results: NG1686 has endopeptidase and carboxypeptidase activities. Conclusion: NG1686 is a M23B family zinc metallopeptidase with bifunctional activity. Significance: This is the first demonstration of a metallopeptidase affecting both resistance to H2O2 and PMN-mediated killing in any bacterium.	[Stohl, Elizabeth A.; Seifert, H. Steven] Feinberg Sch Med, Dept Microbiol Immunol, NW Med Sch, Chicago, IL 60611 USA; [Chan, Yolande A.; Hackett, Kathleen T.; Kohler, Petra L.; Dillard, Joseph P.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Microbiol & Immunol, Madison, WI 53706 USA	Northwestern University; Feinberg School of Medicine; University of Wisconsin System; University of Wisconsin Madison	Stohl, EA (corresponding author), Feinberg Sch Med, Dept Microbiol Immunol, NW Med Sch, 303 E Chicago Ave, Chicago, IL 60611 USA.	e-stohl@northwestern.edu			National Institutes of Health [RO1 AI44239, R37 AI33493, R01 AI047958, U19 AI01448-16, T32 AI055397]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044239, R21AI044239, R37AI033493, T32AI055397, K08AI001448, R01AI047958] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 AI44239 and R37 AI33493 (to H. S. S.), R01 AI047958 (to J. P. D.), U19 AI01448-16 (to E. A. S.), and T32 AI055397 (to P. L. K.).	BERNADSKY G, 1994, J BACTERIOL, V176, P5225, DOI 10.1128/JB.176.17.5225-5232.1994; Boneca IG, 2005, CURR OPIN MICROBIOL, V8, P46, DOI 10.1016/j.mib.2004.12.008; Bonis M, 2010, MOL MICROBIOL, V78, P809, DOI 10.1111/j.1365-2958.2010.07383.x; Burg ND, 2001, CLIN IMMUNOL, V99, P7, DOI 10.1006/clim.2001.5007; Camiade E, 2010, J BACTERIOL, V192, P2373, DOI 10.1128/JB.01546-09; Clarke TB, 2009, BIOCHEMISTRY-US, V48, P2675, DOI 10.1021/bi801993x; Cloud KA, 2004, J BACTERIOL, V186, P7811, DOI 10.1128/JB.186.22.7811-7814.2004; Cloud-Hansen KA, 2006, NAT REV MICROBIOL, V4, P710, DOI 10.1038/nrmicro1486; Criss AK, 2008, CELL MICROBIOL, V10, P2257, DOI 10.1111/j.1462-5822.2008.01205.x; Criss AK, 2009, CELL MICROBIOL, V11, P1074, DOI 10.1111/j.1462-5822.2009.01308.x; Dijkstra AJ, 1996, J BACTERIOL, V178, P5555, DOI 10.1128/jb.178.19.5555-5562.1996; Dillard JP, 2005, INFECT IMMUN, V73, P5697, DOI 10.1128/IAI.73.9.5697-5705.2005; Dillard JP, 2001, MOL MICROBIOL, V41, P263, DOI 10.1046/j.1365-2958.2001.02520.x; DOKTER WHA, 1994, J BIOL CHEM, V269, P4201; Edwards JL, 2004, CLIN MICROBIOL REV, V17, P965, DOI 10.1128/CMR.17.4.965-981.2004; FRANGIPANE JV, 1992, INFECT IMMUN, V60, P1793, DOI 10.1128/IAI.60.5.1793-1799.1992; Fussenegger M, 1996, MOL MICROBIOL, V19, P1357, DOI 10.1111/j.1365-2958.1996.tb02479.x; Garcia DL, 2006, J BACTERIOL, V188, P7211, DOI 10.1128/JB.00724-06; Goley ED, 2010, MOL MICROBIOL, V77, P56, DOI 10.1111/j.1365-2958.2010.07222.x; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; HOOK EW, 1985, ANN INTERN MED, V102, P229, DOI 10.7326/0003-4819-102-2-229; JAYASWAL RK, 1990, J BACTERIOL, V172, P5783, DOI 10.1128/jb.172.10.5783-5788.1990; Jerse AE, 2003, INFECT IMMUN, V71, P5576, DOI 10.1128/IAI.71.10.5576-5582.2003; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Layec S, 2009, MOL MICROBIOL, V71, P1205, DOI 10.1111/j.1365-2958.2009.06595.x; Lee EH, 1999, MOL MICROBIOL, V33, P839, DOI 10.1046/j.1365-2958.1999.01530.x; Lloyd AJ, 2008, J BIOL CHEM, V283, P6402, DOI 10.1074/jbc.M708105200; Mehr IJ, 1998, MOL MICROBIOL, V30, P697, DOI 10.1046/j.1365-2958.1998.01089.x; MELLY MA, 1981, J INFECT DIS, V143, P423, DOI 10.1093/infdis/143.3.423; MELLY MA, 1984, J INFECT DIS, V149, P378, DOI 10.1093/infdis/149.3.378; Moll A, 2010, MOL MICROBIOL, V77, P90, DOI 10.1111/j.1365-2958.2010.07224.x; Nambu T, 1999, J BACTERIOL, V181, P1555, DOI 10.1128/JB.181.5.1555-1561.1999; Odintsov SG, 2004, J MOL BIOL, V335, P775, DOI 10.1016/j.jmb.2003.11.009; Ohnishi R, 1999, J BACTERIOL, V181, P3178, DOI 10.1128/JB.181.10.3178-3184.1999; Poggio S, 2010, MOL MICROBIOL, V77, P74, DOI 10.1111/j.1365-2958.2010.07223.x; REST RF, 1982, INFECT IMMUN, V36, P737, DOI 10.1128/IAI.36.2.737-744.1982; ROSENTHAL RS, 1987, INFECT IMMUN, V55, P2117, DOI 10.1128/IAI.55.9.2117-2120.1987; Sechman EV, 2005, MOL MICROBIOL, V57, P468, DOI 10.1111/j.1365-2958.2005.04657.x; Seib KL, 2004, J INFECT DIS, V190, P136, DOI 10.1086/421299; Seib KL, 2005, INFECT IMMUN, V73, P5269, DOI 10.1128/IAI.73.8.5269-5272.2005; Shafer WM, 1998, P NATL ACAD SCI USA, V95, P1829, DOI 10.1073/pnas.95.4.1829; Skaar EP, 2002, P NATL ACAD SCI USA, V99, P10108, DOI 10.1073/pnas.152334799; Soler-Garcia AA, 2004, MICROB PATHOGENESIS, V37, P55, DOI 10.1016/j.micpath.2004.04.007; Stefanova ME, 2004, EUR J BIOCHEM, V271, P23, DOI 10.1046/j.1432-1033.2003.03886.x; Stefanova ME, 2003, BIOCHEMISTRY-US, V42, P14614, DOI 10.1021/bi0350607; Stentz R, 2009, MOL MICROBIOL, V72, P779, DOI 10.1111/j.1365-2958.2009.06683.x; Stohl EA, 2005, MOL MICROBIOL, V58, P520, DOI 10.1111/j.1365-2958.2005.04839.x; Stohl EA, 2001, MOL MICROBIOL, V40, P1301, DOI 10.1046/j.1365-2958.2001.02463.x; Stohl EA, 2006, J BACTERIOL, V188, P7645, DOI 10.1128/JB.00801-06; Sycuro LK, 2010, CELL, V141, P822, DOI 10.1016/j.cell.2010.03.046; Tseng HJ, 2001, MOL MICROBIOL, V40, P1175, DOI 10.1046/j.1365-2958.2001.02460.x; Turner S, 2003, BIOCHEM J, V373, P865, DOI 10.1042/BJ20030088; Uehara T, 2009, J BACTERIOL, V191, P5094, DOI 10.1128/JB.00505-09; Wang XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026845; World Health Organization, 2011, WHORHR114; Zahrl D, 2005, MICROBIOL-SGM, V151, P3455, DOI 10.1099/mic.0.28141-0	57	27	27	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11222	11233		10.1074/jbc.M111.338830	http://dx.doi.org/10.1074/jbc.M111.338830			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334697	Green Published, hybrid			2022-12-25	WOS:000302780100050
J	Castoe, TA; Poole, AW; de Koning, APJ; Jones, KL; Tomback, DF; Oyler-McCance, SJ; Fike, JA; Lance, SL; Streicher, JW; Smith, EN; Pollock, DD				Castoe, Todd A.; Poole, Alexander W.; de Koning, A. P. Jason; Jones, Kenneth L.; Tomback, Diana F.; Oyler-McCance, Sara J.; Fike, Jennifer A.; Lance, Stacey L.; Streicher, Jeffrey W.; Smith, Eric N.; Pollock, David D.			Rapid Microsatellite Identification from Illumina Paired-End Genomic Sequencing in Two Birds and a Snake	PLOS ONE			English	Article							REPEAT ARRAYS; MARKERS; SIZE	Identification of microsatellites, or simple sequence repeats (SSRs), can be a time-consuming and costly investment requiring enrichment, cloning, and sequencing of candidate loci. Recently, however, high throughput sequencing (with or without prior enrichment for specific SSR loci) has been utilized to identify SSR loci. The direct "Seq-to-SSR'' approach has an advantage over enrichment-based strategies in that it does not require a priori selection of particular motifs, or prior knowledge of genomic SSR content. It has been more expensive per SSR locus recovered, however, particularly for genomes with few SSR loci, such as bird genomes. The longer but relatively more expensive 454 reads have been preferred over less expensive Illumina reads. Here, we use Illumina paired-end sequence data to identify potentially amplifiable SSR loci (PALs) from a snake (the Burmese python, Python molurus bivittatus), and directly compare these results to those from 454 data. We also compare the python results to results from Illumina sequencing of two bird genomes (Gunnison Sage-grouse, Centrocercus minimus, and Clark's Nutcracker, Nucifraga columbiana), which have considerably fewer SSRs than the python. We show that direct Illumina Seq-to-SSR can identify and characterize thousands of potentially amplifiable SSR loci for as little as $10 per sample - a fraction of the cost of 454 sequencing. Given that Illumina Seq-to-SSR is effective, inexpensive, and reliable even for species such as birds that have few SSR loci, it seems that there are now few situations for which prior hybridization is justifiable.	[Castoe, Todd A.; Poole, Alexander W.; de Koning, A. P. Jason; Jones, Kenneth L.; Pollock, David D.] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Tomback, Diana F.] Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA; [Oyler-McCance, Sara J.; Fike, Jennifer A.] US Geol Survey Ft Collins Sci Ctr, Ft Collins, CO USA; [Lance, Stacey L.] Univ Georgia, Savannah River Ecol Lab, Aiken, SC USA; [Streicher, Jeffrey W.; Smith, Eric N.] Univ Texas Arlington, Dept Biol & Amphibian, Arlington, TX 76019 USA; [Streicher, Jeffrey W.; Smith, Eric N.] Univ Texas Arlington, Reptile Divers Res Ctr, Arlington, TX 76019 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Denver; United States Department of the Interior; United States Geological Survey; United States Department of Energy (DOE); Savannah River Ecology Laboratory; University System of Georgia; University of Georgia; University of Texas System; University of Texas Arlington; University of Texas System; University of Texas Arlington	Castoe, TA (corresponding author), Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.	David.Pollock@ucdenver.edu	Jones, Kenneth/GXF-4945-2022; Pollock, David D/M-4740-2016; Lance, Stacey/K-9203-2013	Pollock, David D/0000-0002-7627-4214; Lance, Stacey/0000-0003-2686-1733; Streicher, Jeffrey/0000-0002-3738-4162; Oyler-McCance, Sara/0000-0003-1599-8769; de Koning, A.P. Jason/0000-0001-5450-5600	National Institutes of Health [GM083127]; University of Colorado; CRISP (University of Colorado Denver, Denver campus); Department of Energy [DE-FC09-07SR22506]; Colorado Division of Wildlife; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083127] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado; CRISP (University of Colorado Denver, Denver campus); Department of Energy(United States Department of Energy (DOE)); Colorado Division of Wildlife; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge the support of the National Institutes of Health (R01, GM083127) and University of Colorado setup funds to DDP, and a CRISP Award (University of Colorado Denver, Denver campus) to DFT. SLL was partially supported by the Department of Energy under Award Number DE-FC09-07SR22506 to the University of Georgia Research Foundation. The Gunnison Sage-grouse sample was obtained as the result of previous research funded by the Colorado Division of Wildlife. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkrim J, 2009, BIOTECHNIQUES, V46, P185, DOI 10.2144/000113084; Allentoft ME, 2009, BIOTECHNIQUES, V46, P195, DOI 10.2144/000113086; Buschiazzo E, 2006, BIOESSAYS, V28, P1040, DOI 10.1002/bies.20470; Castoe TA, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-406; Castoe TA, 2011, GENOME BIOL EVOL, V3, P641, DOI 10.1093/gbe/evr043; Castoe TA, 2011, STAND GENOMIC SCI, V4, P257, DOI 10.4056/sigs.1664145; Castoe TA, 2010, MOL ECOL RESOUR, V10, P341, DOI 10.1111/j.1755-0998.2009.02750.x; De Smet WHO, 1981, ACTA ZOOL PATHOL ANT, V76, P119; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Gregory TR, 2007, NUCLEIC ACIDS RES, V35, pD332, DOI 10.1093/nar/gkl828; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hughes AL, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-12; Jennings TN, 2011, MOL ECOL RESOUR; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kelkar YD, 2008, GENOME RES, V18, P30, DOI 10.1101/gr.7113408; Meglecz E, 2010, BIOINFORMATICS, V26, P403, DOI 10.1093/bioinformatics/btp670; Rozen S, 2000, Methods Mol Biol, V132, P365; Shedlock AM, 2007, P NATL ACAD SCI USA, V104, P2767, DOI 10.1073/pnas.0606204104; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819	20	191	198	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e30953	10.1371/journal.pone.0030953	http://dx.doi.org/10.1371/journal.pone.0030953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348032	Green Published, Green Submitted, gold			2022-12-25	WOS:000302737400008
J	Wang, Z; Sokolovska, A; Seymour, R; Sundberg, JP; HogenEsch, H				Wang, Zhe; Sokolovska, Anna; Seymour, Rosemarie; Sundberg, John P.; HogenEsch, Harm			SHARPIN Is Essential for Cytokine Production, NF-kappa B Signaling, and Induction of Th1 Differentiation by Dendritic Cells	PLOS ONE			English	Article							CHRONIC PROLIFERATIVE DERMATITIS; RECEPTOR 2; PROTEIN; MICE; ACTIVATION; INFLAMMATION; EXPRESSION; TYPE-1; IL-12; DYSREGULATION	Spontaneous mutations of the Sharpin (SHANK-associated RH domain-interacting protein, other aliases: Rbckl1, Sipl1) gene in mice result in systemic inflammation that is characterized by chronic proliferative dermatitis and dysregulated secretion of T helper1 (Th1) and Th2 cytokines. The cellular and molecular mechanisms underlying this inflammatory phenotype remain elusive. Dendritic cells may contribute to the initiation and progression of the phenotype of SHARPIN-deficient mice because of their pivotal role in innate and adaptive immunity. Here we show by flow cytometry that SHARPIN-deficiency did not alter the distribution of different DC subtypes in the spleen. In response to TOLL-like receptor (TLR) agonists LPS and poly I:C, cultured bone marrow-derived dendritic cells (BMDC) from WT and mutant mice exhibited similar increases in expression of co-stimulatory molecules CD40, CD80, and CD86. However, stimulated SHARPIN-deficient BMDC had reduced transcription and secretion of pro-inflammatory mediators IL6, IL12P70, GMCSF, and nitric oxide. Mutant BMDC had defective activation of NF-kappa B signaling, whereas the MAPK1/3 (ERK1/2) and MAPK11/12/13/14 (p38 MAP kinase isoforms) and TBK1 signaling pathways were intact. A mixed lymphocyte reaction showed that mutant BMDC only induced a weak Th1 immune response but stimulated increased Th2 cytokine production from allogeneic naive CD4(+) T cells. In conclusion, loss of Sharpin in mice significantly affects the immune function of DC and this may partially account for the systemic inflammation and Th2-biased immune response.	[Wang, Zhe; Sokolovska, Anna; HogenEsch, Harm] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Seymour, Rosemarie; Sundberg, John P.] Jackson Lab, Bar Harbor, ME 04609 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Jackson Laboratory	Wang, Z (corresponding author), Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA.	hogenesch@purdue.edu	Wang, Zhe/O-6663-2016; Wang, Zhe/N-6846-2015	HogenEsch, Harm/0000-0002-2738-9189	National Institutes of Health [AR49288]; North American Hair Research Society; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North American Hair Research Society; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by the National Institutes of Health (AR49288) and a North American Hair Research Society Mentorship Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Barchet W, 2005, EUR J IMMUNOL, V35, P236, DOI 10.1002/eji.200425583; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Corinti S, 2001, J IMMUNOL, V166, P4312, DOI 10.4049/jimmunol.166.7.4312; DeSmedt T, 1997, EUR J IMMUNOL, V27, P1229, DOI 10.1002/eji.1830270526; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Garg AD, 2010, BBA-REV CANCER, V1805, P53, DOI 10.1016/j.bbcan.2009.08.003; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; GIJBELS MJJ, 1995, ULTRASTRUCT PATHOL, V19, P107, DOI 10.3109/01913129509014610; Hermans IF, 1999, J IMMUNOL, V163, P77; HOGENESCH H, 1993, AM J PATHOL, V143, P972; HogenEsch H, 1999, J IMMUNOL, V162, P3890; HogenEsch H, 2001, EUR J IMMUNOL, V31, P734, DOI 10.1002/1521-4141(200103)31:3<734::AID-IMMU734>3.0.CO;2-9; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Jiang ZF, 2004, P NATL ACAD SCI USA, V101, P3533, DOI 10.1073/pnas.0308496101; Kanangat S, 1996, J IMMUNOL, V156, P1110; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Liang Y, 2011, J DERMATOL SCI, V63, P148, DOI 10.1016/j.jdermsci.2011.04.012; Liang YH, 2011, J INVEST DERMATOL, V131, P141, DOI 10.1038/jid.2010.259; Lim S, 2001, MOL CELL NEUROSCI, V17, P385, DOI 10.1006/mcne.2000.0940; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lotze MT, 2007, IMMUNOL REV, V220, P60, DOI 10.1111/j.1600-065X.2007.00579.x; Lucey DR, 1996, CLIN MICROBIOL REV, V9, P532, DOI 10.1128/CMR.9.4.532; Luedde T, 2008, P NATL ACAD SCI USA, V105, P9733, DOI 10.1073/pnas.0800198105; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; Mattner F, 1996, EUR J IMMUNOL, V26, P1553, DOI 10.1002/eji.1830260722; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Ouaaz F, 2002, IMMUNITY, V16, P257, DOI 10.1016/S1074-7613(02)00272-8; Pagni M, 2007, NUCLEIC ACIDS RES, V35, pW433, DOI 10.1093/nar/gkm352; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Redecke V, 2004, J IMMUNOL, V172, P2739, DOI 10.4049/jimmunol.172.5.2739; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Renninger ML, 2010, EXP DERMATOL, V19, P252, DOI 10.1111/j.1600-0625.2009.00944.x; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; SIELING PA, 1994, J IMMUNOL, V153, P3639; Sieling PA, 2003, J IMMUNOL, V170, P194, DOI 10.4049/jimmunol.170.1.194; Sokolovska A, 2007, VACCINE, V25, P4575, DOI 10.1016/j.vaccine.2007.03.045; Steinman RM, 2010, EUR J IMMUNOL, V40, P2085, DOI 10.1002/eji.201040733; Thoma-Uszynski S, 2000, J IMMUNOL, V165, P3804, DOI 10.4049/jimmunol.165.7.3804; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Wang JM, 2007, J IMMUNOL, V178, P6777, DOI 10.4049/jimmunol.178.11.6777; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Zak DE, 2011, P NATL ACAD SCI USA, V108, P11536, DOI 10.1073/pnas.1107577108	56	27	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31809	10.1371/journal.pone.0031809	http://dx.doi.org/10.1371/journal.pone.0031809			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348129	Green Submitted, Green Published, gold			2022-12-25	WOS:000302737400048
J	Bekmetjev, A; VanBruggen, D; McLellan, B; DeWinkle, B; Lunderberg, E; Tintle, N				Bekmetjev, Airat; VanBruggen, Dirk; McLellan, Brian; DeWinkle, Benjamin; Lunderberg, Eric; Tintle, Nathan			The Cost-Effectiveness of Reclassification Sampling for Prevalence Estimation	PLOS ONE			English	Article							PROBABILITY MODEL; ASSOCIATION; DESIGNS; ERRORS; CLASSIFICATION; SPECIFICITY; SENSITIVITY	Background: Typically, a two-phase (double) sampling strategy is employed when classifications are subject to error and there is a gold standard (perfect) classifier available. Two-phase sampling involves classifying the entire sample with an imperfect classifier, and a subset of the sample with the gold-standard. Methodology/Principal Findings: In this paper we consider an alternative strategy termed reclassification sampling, which involves classifying individuals using the imperfect classifier more than one time. Estimates of sensitivity, specificity and prevalence are provided for reclassification sampling, when either one or two binary classifications of each individual using the imperfect classifier are available. Robustness of estimates and design decisions to model assumptions are considered. Software is provided to compute estimates and provide advice on the optimal sampling strategy. Conclusions/Significance: Reclassification sampling is shown to be cost-effective (lower standard error of estimates for the same cost) for estimating prevalence as compared to two-phase sampling in many practical situations.	[Bekmetjev, Airat; VanBruggen, Dirk; McLellan, Brian; DeWinkle, Benjamin; Lunderberg, Eric] Hope Coll, Dept Math, Holland, MI 49423 USA; [Tintle, Nathan] Dordt Coll, Dept Math Stat & Comp Sci, Sioux Ctr, IA USA	Hope College	Bekmetjev, A (corresponding author), Hope Coll, Dept Math, Holland, MI 49423 USA.	ntintle@dordt.edu		Tintle, Nathan/0000-0003-1447-9107	National Institutes of Health [R15-HG004543]; Hope College Howard Hughes Medical Institute; Michigan Space Grant Consortium; Tanis Fund for Statistics Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R15HG004543] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hope College Howard Hughes Medical Institute; Michigan Space Grant Consortium; Tanis Fund for Statistics Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This project was funded in part by a grant from the National Institutes of Health, R15-HG004543. The content is solely the responsibility of the authors and does not necessarily represent the official view of the National Human Genome Research Institute or the National Institutes of Health. Dirk Van Bruggen received support from a computational science and modeling scholar award from the Hope College Howard Hughes Medical Institute program, as well as a fellowship from the Michigan Space Grant Consortium. Additionally, this project received support from the Tanis Fund for Statistics Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borchers B, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1433; Casella G., 2002, STAT INFERENCE, V2nd; Cochran WG., 1963, SAMPLING TECHNIQUES; Fujisawa H, 2000, BIOMETRICS, V56, P706, DOI 10.1111/j.0006-341X.2000.00706.x; KOCH GG, 1969, J AM STAT ASSOC, V64, P852; McNamee R, 2003, INT J EPIDEMIOL, V32, P1072, DOI 10.1093/ije/dyg230; McNamee R, 2002, STAT MED, V21, P3609, DOI 10.1002/sim.1318; Nofuentes JAR, 2005, BIOMETRICAL J, V47, P442, DOI 10.1002/bimj.200410134; Schill W, 2006, STAT MED, V25, P1646, DOI 10.1002/sim.2307; SUTCLIFFE JP, 1965, PSYCHOMETRIKA, V30, P129, DOI 10.1007/BF02289444; SUTCLIFFE JP, 1965, PSYCHOMETRIKA, V30, P73, DOI 10.1007/BF02289748; TENENBEIN A, 1970, J AM STAT ASSOC, V65, P1350, DOI 10.2307/2284301; Tintle N, 2009, ANN HUM GENET, V73, P370, DOI 10.1111/j.1469-1809.2009.00516.x; Tintle NL, 2007, STAT APPL GENET MOL, V6; Tintle NL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S154; Wruck LM, 2006, STAT MED, V25, P3458, DOI 10.1002/sim.2451	16	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e32058	10.1371/journal.pone.0032058	http://dx.doi.org/10.1371/journal.pone.0032058			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925BB	22348146	Green Published, gold			2022-12-25	WOS:000302733900065
J	Girardi, C; De Pitta, C; Casara, S; Sales, G; Lanfranchi, G; Celotti, L; Mognato, M				Girardi, Cristina; De Pitta, Cristiano; Casara, Silvia; Sales, Gabriele; Lanfranchi, Gerolamo; Celotti, Lucia; Mognato, Maddalena			Analysis of miRNA and mRNA Expression Profiles Highlights Alterations in Ionizing Radiation Response of Human Lymphocytes under Modeled Microgravity	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; BREAST-CANCER CELLS; INTERNATIONAL-SPACE-STATION; LONG-DURATION SPACEFLIGHT; GENE-EXPRESSION; SIMULATED MICROGRAVITY; HUMAN FIBROBLASTS; CHROMOSOME-ABERRATIONS; INCREASES APOPTOSIS; TARGET RECOGNITION	Background: Ionizing radiation (IR) can be extremely harmful for human cells since an improper DNA-damage response (DDR) to IR can contribute to carcinogenesis initiation. Perturbations in DDR pathway can originate from alteration in the functionality of the microRNA-mediated gene regulation, being microRNAs (miRNAs) small noncoding RNA that act as post-transcriptional regulators of gene expression. In this study we gained insight into the role of miRNAs in the regulation of DDR to IR under microgravity, a condition of weightlessness experienced by astronauts during space missions, which could have a synergistic action on cells, increasing the risk of radiation exposure. Methodology/Principal Findings: We analyzed miRNA expression profile of human peripheral blood lymphocytes (PBL) incubated for 4 and 24 h in normal gravity (1 g) and in modeled microgravity (MMG) during the repair time after irradiation with 0.2 and 2Gy of gamma-rays. Our results show that MMG alters miRNA expression signature of irradiated PBL by decreasing the number of radio-responsive miRNAs. Moreover, let-7i*, miR-7, miR-7-1*, miR-27a, miR-144, miR-200a, miR-598, miR-650 are deregulated by the combined action of radiation and MMG. Integrated analyses of miRNA and mRNA expression profiles, carried out on PBL of the same donors, identified significant miRNA-mRNA anti-correlations of DDR pathway. Gene Ontology analysis reports that the biological category of "Response to DNA damage'' is enriched when PBL are incubated in 1 g but not in MMG. Moreover, some anti-correlated genes of p53-pathway show a different expression level between 1 g and MMG. Functional validation assays using luciferase reporter constructs confirmed miRNA-mRNA interactions derived from target prediction analyses. Conclusions/Significance: On the whole, by integrating the transcriptome and microRNome, we provide evidence that modeled microgravity can affects the DNA-damage response to IR in human PBL.	[Girardi, Cristina; De Pitta, Cristiano; Casara, Silvia; Sales, Gabriele; Lanfranchi, Gerolamo; Celotti, Lucia; Mognato, Maddalena] Univ Padua, Dipartimento Biol, Padua, Italy; [Celotti, Lucia] Ist Nazl Fis Nucl, Lab Nazl Legnaro, Padua, Italy	University of Padua; Istituto Nazionale di Fisica Nucleare (INFN)	Girardi, C (corresponding author), Univ Padua, Dipartimento Biol, Padua, Italy.	maddalena.mognato@unipd.it	De Pitta, Cristiano/AAY-7302-2020; Sales, Gabriele/K-5065-2016	De Pitta, Cristiano/0000-0001-8013-8162; Mognato, Maddalena/0000-0001-6132-1682; Sales, Gabriele/0000-0003-2078-5661	Italian Space Agency (ASI, XMAB-from Molecules to Man) [1/014/06/0]; Associazione Italiana per la Ricerca sul Cancro-AIRC [2008/6014]; University of Padova [CPDA061783]	Italian Space Agency (ASI, XMAB-from Molecules to Man); Associazione Italiana per la Ricerca sul Cancro-AIRC(Fondazione AIRC per la ricerca sul cancro); University of Padova	This work was supported by grants from the Italian Space Agency (ASI, XMAB-from Molecules to Man, 1/014/06/0) to L. C., from the Associazione Italiana per la Ricerca sul Cancro-AIRC (2008/6014) to G. L. and from the University of Padova (CPDA061783) to M. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson SA, 2000, RADIAT RES, V154, P342, DOI 10.1667/0033-7587(2000)154[0342:IOPMBI]2.0.CO;2; Baevsky RM, 2007, J APPL PHYSIOL, V103, P156, DOI 10.1152/japplphysiol.00137.2007; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bucker H, 1986, Adv Space Res, V6, P115, DOI 10.1016/0273-1177(86)90074-8; Canova S, 2005, RADIAT RES, V163, P191, DOI 10.1667/RR3304; Cha HJ, 2009, INT J ONCOL, V34, P1661, DOI 10.3892/ijo_00000297; Chaudhry MA, 2009, CANCER BIOTHER RADIO, V24, P49, DOI 10.1089/cbr.2008.0513; Chhabra R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005848; Chintharlapalli S, 2009, INT J CANCER, V125, P1965, DOI 10.1002/ijc.24530; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Cho WC, 2007, EUR J CANCER, V43, P1529; Clement Jade Q., 2008, Genomics Proteomics & Bioinformatics, V6, P8, DOI 10.1016/S1672-0229(08)60017-0; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Crawford-Young SJ, 2006, INT J DEV BIOL, V50, P183, DOI 10.1387/ijdb.052077sc; Crosby ME, 2009, CANCER RES, V69, P1221, DOI 10.1158/0008-5472.CAN-08-2516; Crucian BE, 2008, AVIAT SPACE ENVIR MD, V79, P835, DOI 10.3357/ASEM.2276.2008; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Fitts RH, 2001, J EXP BIOL, V204, P3201; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Galluzzi L, 2010, CANCER RES, V70, P1793, DOI 10.1158/0008-5472.CAN-09-3112; George K, 2001, PHYS MEDICA, V17, P222; Grimm D, 2002, FASEB J, V16, P604, DOI 10.1096/fj.01-0673fje; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Hammond SM, 2007, NAT GENET, V39, P582, DOI 10.1038/ng0507-582; Hammond TG, 2000, PHYSIOL GENOMICS, V3, P163, DOI 10.1152/physiolgenomics.2000.3.3.163; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Horneck G, 1997, RADIAT RES, V147, P376, DOI 10.2307/3579347; Horneck G, 1999, MUTAT RES-FUND MOL M, V430, P221, DOI 10.1016/S0027-5107(99)00133-5; HORNECK G, 1992, NUCL TRACKS RAD MEAS, V20, P185; Horneck G, 1996, J BIOTECHNOL, V47, P99, DOI 10.1016/0168-1656(96)01382-X; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Infanger M, 2006, APOPTOSIS, V11, P749, DOI 10.1007/s10495-006-5697-7; Josson S, 2008, PROSTATE, V68, P1599, DOI 10.1002/pros.20827; Kang CY, 2011, EUR J APPL PHYSIOL, V111, P2131, DOI 10.1007/s00421-011-1844-0; Kato M, 2009, ONCOGENE, V28, P2419, DOI 10.1038/onc.2009.106; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Keyak JH, 2009, BONE, V44, P449, DOI 10.1016/j.bone.2008.11.014; Kiefer J, 1999, MUTAT RES-FUND MOL M, V430, P299, DOI 10.1016/S0027-5107(99)00142-6; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kumari R, 2009, J CELL BIOCHEM, V107, P723, DOI 10.1002/jcb.22171; Lal A, 2009, NAT STRUCT MOL BIOL, V16, P492, DOI 10.1038/nsmb.1589; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lewis ML, 1998, FASEB J, V12, P1007, DOI 10.1096/fasebj.12.11.1007; Lewis ML, 2001, FASEB J, V15, P1783, DOI 10.1096/fj.00-0820fje; Liu R, 2011, EUR J CANCER, V47, P784, DOI 10.1016/j.ejca.2010.10.025; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma YH, 2010, CANCER LETT, V298, P150, DOI 10.1016/j.canlet.2010.06.012; Maccarrone M, 2003, J LEUKOCYTE BIOL, V73, P472, DOI 10.1189/jlb.0602295; Maes OC, 2009, J CELL PHYSIOL, V221, P109, DOI 10.1002/jcp.21834; Maes OC, 2008, J CELL BIOCHEM, V105, P824, DOI 10.1002/jcb.21878; Manti L, 2005, INT J RADIAT BIOL, V81, P147, DOI 10.1080/09553000500091188; Manti L, 2006, RADIAT ENVIRON BIOPH, V45, P1, DOI 10.1007/s00411-006-0037-4; Marsit CJ, 2006, CANCER RES, V66, P10843, DOI 10.1158/0008-5472.CAN-06-1894; Mi SL, 2007, P NATL ACAD SCI USA, V104, P19971, DOI 10.1073/pnas.0709313104; Mognato M, 2005, MUTAT RES-FUND MOL M, V578, P417, DOI 10.1016/j.mrfmmm.2005.06.011; Mognato M, 2009, MUTAT RES-FUND MOL M, V663, P32, DOI 10.1016/j.mrfmmm.2009.01.002; Moon SH, 2010, J BIOL CHEM, V285, P12935, DOI 10.1074/jbc.M109.071696; Mosesso P, 2001, PHYS MEDICA, V17, P264; Narici M, 2003, EUR J APPL PHYSIOL, V90, P275, DOI 10.1007/s00421-003-0955-7; Paul S, 2008, INT J RADIAT ONCOL, V71, P1236, DOI 10.1016/j.ijrobp.2008.03.043; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Pothof J, 2009, EMBO J, V28, P2090, DOI 10.1038/emboj.2009.156; Poy MN, 2007, DIABETES OBES METAB, V9, P67, DOI 10.1111/j.1463-1326.2007.00775.x; Pross HD, 2000, RADIAT RES, V153, P521, DOI 10.1667/0033-7587(2000)153[0521:IARODD]2.0.CO;2; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sales G, 2010, NUCLEIC ACIDS RES, V38, pW352, DOI 10.1093/nar/gkq423; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Shin S, 2009, INT J ONCOL, V35, P81, DOI 10.3892/ijo_00000315; Sibonga JD, 2007, BONE, V41, P973, DOI 10.1016/j.bone.2007.08.022; Simone NL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006377; Simons DM, 2010, J CELL BIOCHEM, V109, P1201, DOI 10.1002/jcb.22502; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Trabucchi M, 2009, RNA BIOL, V6, P536, DOI 10.4161/rna.6.5.10080; Trappe S, 2009, J APPL PHYSIOL, V106, P1159, DOI 10.1152/japplphysiol.91578.2008; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ullrich Oliver, 2008, Cell Commun Signal, V6, P9, DOI 10.1186/1478-811X-6-9; Vincenti S, 2011, RADIAT RES, V175, P535, DOI 10.1667/RR2200.1; Vo NK, 2010, P NATL ACAD SCI USA, V107, P19231, DOI 10.1073/pnas.1013162107; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang HY, 2009, J THEOR BIOL, V259, P793, DOI 10.1016/j.jtbi.2009.05.007; Wang H, 2007, RNA, V13, P151, DOI 10.1261/rna.234507; Weidhaas JB, 2007, CANCER RES, V67, P11111, DOI 10.1158/0008-5472.CAN-07-2858; Wiemer EAC, 2007, EUR J CANCER, V43, P1529, DOI 10.1016/j.ejca.2007.04.002; Wu S, 2010, ONCOGENE, V29, P2302, DOI 10.1038/onc.2010.34; Xin FX, 2009, BIOINFORMATICS, V25, P430, DOI 10.1093/bioinformatics/btn646; Yatagai F, 2011, RADIAT ENVIRON BIOPH, V50, P125, DOI 10.1007/s00411-010-0348-3; Zhang XN, 2011, MOL CELL, V41, P371, DOI 10.1016/j.molcel.2011.01.020	94	75	79	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31293	10.1371/journal.pone.0031293	http://dx.doi.org/10.1371/journal.pone.0031293			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347458	gold, Green Published, Green Submitted			2022-12-25	WOS:000302730200017
J	Liu, LS; Papa, EF; Dooner, MS; Machan, JT; Johnson, KW; Goldberg, LR; Quesenberry, PJ; Colvin, GA				Liu, Liansheng; Papa, Elaine F.; Dooner, Mark S.; Machan, Jason T.; Johnson, Kevin W.; Goldberg, Laura R.; Quesenberry, Peter J.; Colvin, Gerald A.			Homing and Long-Term Engraftment of Long- and Short-Term Renewal Hematopoietic Stem Cells	PLOS ONE			English	Article							COMMON LYMPHOID PROGENITORS; CYTOKINE-INDUCED DEFECT; MURINE MARROW-CELLS; GENE-EXPRESSION; BONE-MARROW; INTRAFEMORAL TRANSPLANTATION; LINEAGE COMMITMENT; CYCLE KINETICS; IDENTIFICATION; PHENOTYPE	Long-term hematopoietic stem cells (LT-HSC) and short-term hematopoietic stem cells (ST-HSC) have been characterized as having markedly different in vivo repopulation, but similar in vitro growth in liquid culture. These differences could be due to differences in marrow homing. We evaluated this by comparing results when purified ST-HSC and LT-HSC were administered to irradiated mice by three different routes: intravenous, intraperitoneal, and directly into the femur. Purified stem cells derived from B6. SJL mice were competed with marrow cells from C57BL/6J mice into lethally irradiated C57BL/6J mice. Serial transplants into secondary recipients were also carried out. We found no advantage for ST-HSC engraftment when the cells were administered intraperitoneally or directly into femur. However, to our surprise, we found that the purified ST-HSC were not short-term in nature but rather gave long-term multilineage engraftment out to 387 days, albeit at a lower level than the LT-HSC. The ST-HSC also gave secondary engraftment. These observations challenge current models of the stem cell hierarchy and suggest that stem cells are in a continuum of change.	[Liu, Liansheng; Papa, Elaine F.; Dooner, Mark S.; Johnson, Kevin W.; Goldberg, Laura R.; Quesenberry, Peter J.; Colvin, Gerald A.] Rhode Isl Hosp, Dept Med, Div Hematol Oncol, Providence, RI 02903 USA; [Machan, Jason T.] Rhode Isl Hosp, Dept Biostat, Providence, RI USA; [Machan, Jason T.] Brown Univ, Warren Alpert Med Sch, Dept Orthopaed, Providence, RI 02912 USA; [Machan, Jason T.] Brown Univ, Dept Surg, Warren Alpert Med Sch, Providence, RI 02912 USA	Lifespan Health Rhode Island; Rhode Island Hospital; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University	Liu, LS (corresponding author), Rhode Isl Hosp, Dept Med, Div Hematol Oncol, Providence, RI 02903 USA.	pquesenberry@lifespan.org	Machan, Jason/D-3897-2013	Machan, Jason/0000-0003-2048-4914; Dooner, Mark/0000-0003-0653-6562	National Institutes of Health: NCRR COBRE [P20RR025179]; NIDDK [K08DK064980, R01DK061858]; Herbert W. Savitt Research Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR025179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061858, K08DK064980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104937] Funding Source: NIH RePORTER	National Institutes of Health: NCRR COBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Herbert W. Savitt Research Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health: NCRR COBRE P20RR025179, NIDDK K08DK064980, NIDDK R01DK061858, and Herbert W. Savitt Research Fund. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Arber C, 2003, BLOOD, V102, P421, DOI 10.1182/blood-2002-12-3834; Becker PS, 1999, EXP HEMATOL, V27, P533, DOI 10.1016/S0301-472X(98)00037-X; Berrios VM, 2001, EXP HEMATOL, V29, P1326, DOI 10.1016/S0301-472X(01)00734-2; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Cerny J, 2002, J HEMATOTH STEM CELL, V11, P913, DOI 10.1089/152581602321080574; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Colvin GA, 2004, LEUKEMIA, V18, P575, DOI 10.1038/sj.leu.2403268; Colvin GA, 2004, J CELL PHYSIOL, V199, P20, DOI 10.1002/jcp.10436; Colvin GA, 2002, IN VITRO CELL DEV-AN, V38, P343; Colvin GA, 2007, EXP HEMATOL, V35, P96, DOI 10.1016/j.exphem.2006.09.005; Colvin GA, 2010, J CELL PHYSIOL, V222, P57, DOI 10.1002/jcp.21918; D'Hondt L, 2004, J CELL PHYSIOL, V200, P63, DOI 10.1002/jcp.20032; Dooner GJ, 2008, J CELL PHYSIOL, V214, P786, DOI 10.1002/jcp.21273; Forsberg EC, 2006, STEM CELL REV, V2, P23, DOI 10.1007/s12015-006-0005-z; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; Gilner JB, 2007, STEM CELLS, V25, P279, DOI 10.1634/stemcells.2006-0076; Habibian HK, 1998, J EXP MED, V188, P393, DOI 10.1084/jem.188.2.393; HOLM S, 1979, SCAND J STAT, V6, P65; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kittler ELW, 1997, BLOOD, V90, P865, DOI 10.1182/blood.V90.2.865.865_865_872; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kondo M, 2001, CURR OPIN GENET DEV, V11, P520, DOI 10.1016/S0959-437X(00)00227-6; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; Kushida T, 2001, BLOOD, V97, P3292, DOI 10.1182/blood.V97.10.3292; Lambert JF, 2003, J EXP MED, V197, P1563, DOI 10.1084/jem.20030031; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; Mazurier F, 2003, NAT MED, V9, P959, DOI 10.1038/nm886; McKenzie JL, 2005, BLOOD, V106, P1259, DOI 10.1182/blood-2005-03-1081; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; *NAT RES COUNC, 1996, GUID CAR US LAB AN; NECAS E, 1987, EXP HEMATOL, V15, P759; Pang LZ, 2003, J CELL PHYSIOL, V197, P251, DOI 10.1002/jcp.10357; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; PETERS SO, 1995, EXP HEMATOL, V23, P461; Peters SO, 1996, BLOOD, V87, P30; Quesenberry PJ, 2009, EXP HEMATOL, V37, P775, DOI 10.1016/j.exphem.2009.05.003; Randall TD, 1996, BLOOD, V87, P4057, DOI 10.1182/blood.V87.10.4057.bloodjournal87104057; Reddy GPV, 2002, EXP HEMATOL, V30, P792, DOI 10.1016/S0301-472X(02)00814-7; Reddy GPV, 1997, BLOOD, V90, P2293; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Wagers AJ, 2006, STEM CELLS, V24, P1087, DOI 10.1634/stemcells.2005-0396; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Weksberg DC, 2008, BLOOD, V111, P2444, DOI 10.1182/blood-2007-09-115006	49	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31300	10.1371/journal.pone.0031300	http://dx.doi.org/10.1371/journal.pone.0031300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347459	Green Submitted, Green Published, gold			2022-12-25	WOS:000302730200018
J	Chiyo, PI; Moss, CJ; Alberts, SC				Chiyo, Patrick I.; Moss, Cynthia J.; Alberts, Susan C.			The Influence of Life History Milestones and Association Networks on Crop-Raiding Behavior in Male African Elephants	PLOS ONE			English	Article							PREDATION RISK; SOCIAL-ORGANIZATION; REPRODUCTIVE EFFORT; PATERNITY SUCCESS; NATIONAL-PARK; INFORMATION; ANIMALS; AGE; CONFLICT; PATTERNS	Factors that influence learning and the spread of behavior in wild animal populations are important for understanding species responses to changing environments and for species conservation. In populations of wildlife species that come into conflict with humans by raiding cultivated crops, simple models of exposure of individual animals to crops do not entirely explain the prevalence of crop raiding behavior. We investigated the influence of life history milestones using age and association patterns on the probability of being a crop raider among wild free ranging male African elephants; we focused on males because female elephants are not known to raid crops in our study population. We examined several features of an elephant association network; network density, community structure and association based on age similarity since they are known to influence the spread of behaviors in a population. We found that older males were more likely to be raiders than younger males, that males were more likely to be raiders when their closest associates were also raiders, and that males were more likely to be raiders when their second closest associates were raiders older than them. The male association network had sparse associations, a tendency for individuals similar in age and raiding status to associate, and a strong community structure. However, raiders were randomly distributed between communities. These features of the elephant association network may limit the spread of raiding behavior and likely determine the prevalence of raiding behavior in elephant populations. Our results suggest that social learning has a major influence on the acquisition of raiding behavior in younger males whereas life history factors are important drivers of raiding behavior in older males. Further, both life-history and network patterns may influence the acquisition and spread of complex behaviors in animal populations and provide insight on managing human-wildlife conflict.	[Chiyo, Patrick I.; Alberts, Susan C.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Chiyo, Patrick I.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Moss, Cynthia J.] Amboseli Trust Elephants, Nairobi, Kenya	Duke University; University of Notre Dame	Chiyo, PI (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	pchiyo@nd.edu			U.S. Fish and Wildlife Service [AFE-0314/6-G085]; National Science Foundation [IBN0091612]; Amboseli Trust for Elephants	U.S. Fish and Wildlife Service(US Fish & Wildlife Service); National Science Foundation(National Science Foundation (NSF)); Amboseli Trust for Elephants	Funding for this research was provided by the U.S. Fish and Wildlife Service grant number AFE-0314/6-G085, the National Science Foundation (IBN0091612) to SA, and the Amboseli Trust for Elephants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2002, CATEGORICAL DATA ANA, P710, DOI [10.1002/0471249688, DOI 10.1002/0471249688]; Ahlering MA, 2011, ANIM CONSERV, V14, P124, DOI 10.1111/j.1469-1795.2010.00400.x; Barnes RFW, 2007, AFR J ECOL, V45, P112, DOI 10.1111/j.1365-2028.2006.00689.x; Bhima R., 1998, PACHYDERM, V24, P74; Borgatti S.P., 2002, NETDRAW GRAPH VISUAL; Breck SW, 2008, J MAMMAL, V89, P428, DOI 10.1644/07-MAMM-A-028R2.1; Candolin U, 1998, P ROY SOC B-BIOL SCI, V265, P1171, DOI 10.1098/rspb.1998.0415; Centola D, 2007, PHYSICA A, V374, P449, DOI 10.1016/j.physa.2006.06.018; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Chiyo PI, 2011, ANIM BEHAV, V81, P1093, DOI 10.1016/j.anbehav.2011.02.013; Chiyo PI, 2011, J APPL ECOL, V48, P788, DOI 10.1111/j.1365-2664.2011.01967.x; Chiyo PI, 2011, BEHAV ECOL, V22, P552, DOI 10.1093/beheco/arr016; Croze Harvey, 2011, P11; Croze Harvey, 2011, P89; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Douglas-Hamilton Iain, 1998, Pachyderm, V25, P81; Duffy GA, 2009, ANIM BEHAV, V78, P371, DOI 10.1016/j.anbehav.2009.05.015; DUGATKIN LA, 1993, BEHAV ECOL, V4, P289, DOI 10.1093/beheco/4.4.289; Ekanayaka Sampath K.K., 2011, Gajah, V34, P20; Galef BG, 2005, BIOSCIENCE, V55, P489, DOI 10.1641/0006-3568(2005)055[0489:SLIAES]2.0.CO;2; Galimberti F, 2007, BEHAV ECOL SOCIOBIOL, V62, P159, DOI 10.1007/s00265-007-0450-y; Golub B, 2010, PHYS SOC; Grignolio S, 2007, J MAMMAL, V88, P1488, DOI 10.1644/06-MAMM-A-351R.1; Hilbe JM, 2009, CH CRC TEXT STAT SCI, P1; Hoare DJ, 2003, FISH FISH, V4, P269, DOI 10.1046/j.1467-2979.2003.00130.x; Hoare RE, 1999, J APPL ECOL, V36, P689, DOI 10.1046/j.1365-2664.1999.00437.x; Hockings KJ, 2007, THESIS U STIRLING SC; Hollister-Smith JA, 2007, ANIM BEHAV, V74, P287, DOI 10.1016/j.anbehav.2006.12.008; Holzhaider JC, 2010, LEARN BEHAV, V38, P206, DOI 10.3758/LB.38.3.206; Hood G.M., 2010, POPTOOLS VERSION 3 2; Jackson TR, 2008, ORYX, V42, P83, DOI 10.1017/S0030605308001117; Laland KN, 2004, LEARN BEHAV, V32, P4; Lee Phyllis C., 2011, P260; Liebhold A.M., 1998, P111; Mazur R, 2008, ANIM BEHAV, V75, P1503, DOI 10.1016/j.anbehav.2007.10.027; Moss CJ, 2001, J ZOOL, V255, P145, DOI 10.1017/S0952836901001212; Moss Cynthia, 1996, P58; Mpanduji DG, 2004, ENDANGERED ELEPHANTS, P82; Mysterud A, 2004, J ZOOL, V264, P209, DOI 10.1017/S0952836904005618; Obanda V, 2008, PACHYDERM, P54; Osborn FV, 2002, J WILDLIFE MANAGE, V66, P674, DOI 10.2307/3803133; POOLE JH, 1989, ANIM BEHAV, V37, P842, DOI 10.1016/0003-3472(89)90068-7; POOLE JH, 1981, NATURE, V292, P830, DOI 10.1038/292830a0; Rasmussen HB, 2008, BEHAV ECOL, V19, P9, DOI 10.1093/beheco/arm093; Robins G, 2009, SOC NETWORKS, V31, P105, DOI 10.1016/j.socnet.2008.10.006; Rode KD, 2006, J TROP ECOL, V22, P441, DOI 10.1017/S0266467406003233; Sargeant BL, 2009, ANIM BEHAV, V78, P715, DOI 10.1016/j.anbehav.2009.05.037; Slagsvold T, 2011, PHILOS T R SOC B, V366, P969, DOI 10.1098/rstb.2010.0343; Snijders TAB., 2002, J SOCIAL STRUCTURE, V3(2), P1, DOI DOI 10.1016/j.socnet.2006.08.001; Snijders TAB, 2006, SOCIOL METHODOL, V36, P99, DOI 10.1111/j.1467-9531.2006.00176.x; STRUM SC, 1994, REV ECOL-TERRE VIE, V49, P295; SUKUMAR R, 1995, NAT HIST, V104, P52; SUKUMAR R, 1988, ANIM BEHAV, V36, P1233, DOI 10.1016/S0003-3472(88)80084-8; SUKUMAR R, 1990, J TROP ECOL, V6, P33, DOI 10.1017/S0266467400004004; Sukumar R., 2003, LIVING ELEPHANTS EVO, P478; Thornton A, 2009, ANIM BEHAV, V78, P255, DOI 10.1016/j.anbehav.2009.04.021; Thouless CR, 1996, AFR J ECOL, V34, P284, DOI 10.1111/j.1365-2028.1996.tb00623.x; van Bergen Y, 2004, P ROY SOC B-BIOL SCI, V271, P957, DOI 10.1098/rspb.2004.2684; Wang P, 2006, PNET PROGRAM SIMULAT, P43; Ward AJW, 2008, P NATL ACAD SCI USA, V105, P6948, DOI 10.1073/pnas.0710344105; Webster MM, 2008, P ROY SOC B-BIOL SCI, V275, P2869, DOI 10.1098/rspb.2008.0817; Whitehead H, 2010, LEARN BEHAV, V38, P329, DOI 10.3758/LB.38.3.329; Williams AC, 2001, WILDLIFE SOC B, V29, P1097; Woodroffe R, 2005, CONSERV BIOL SER, V9, P388	64	53	55	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31382	10.1371/journal.pone.0031382	http://dx.doi.org/10.1371/journal.pone.0031382			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347468	Green Published, Green Submitted, gold			2022-12-25	WOS:000302730100064
J	Alvarez-Jaimes, L; Sutton, SW; Nepomuceno, D; Motley, ST; Cik, M; Stocking, E; Shoblock, J; Bonaventure, P				Alvarez-Jaimes, Lily; Sutton, Steven W.; Nepomuceno, Diane; Motley, S. Timothy; Cik, Miroslav; Stocking, Emily; Shoblock, James; Bonaventure, Pascal			In Vitro Pharmacological Characterization of RXFP3 Allosterism: An Example of Probe Dependency	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; MOUSE-BRAIN; NUCLEUS INCERTUS; CHIMERIC PEPTIDE; RELAXIN-3; GPCR142; IDENTIFICATION; MODULATION; FAMILY; LIGAND	Recent findings suggest that the relaxin-3 neural network may represent a new ascending arousal pathway able to modulate a range of neural circuits including those affecting circadian rhythm and sleep/wake states, spatial and emotional memory, motivation and reward, the response to stress, and feeding and metabolism. Therefore, the relaxin-3 receptor (RXFP3) is a potential therapeutic target for the treatment of various CNS diseases. Here we describe a novel selective RXFP3 receptor positive allosteric modulator (PAM), 3-[3,5-Bis(trifluoromethyl) phenyl]-1-(3,4-dichlorobenzyl)-1-[2-(5-methoxy-1H-indol-3-yl)ethyl] urea (135PAM1). Calcium mobilization and cAMP accumulation assays in cell lines expressing the cloned human RXFP3 receptor show the compound does not directly activate RXFP3 receptor but increases functional responses to amidated relaxin-3 or R3/I5, a chimera of the INSL5 A chain and the Relaxin-3 B chain. 135PAM1 increases calcium mobilization in the presence of relaxin-3(NH2) and R3/I5(NH2) with pEC50 values of 6.54 (6.46 to 6.64) and 6.07 (5.94 to 6.20), respectively. In the cAMP accumulation assay, 135PAM1 inhibits the CRE response to forskolin with a pIC50 of 6.12 (5.98 to 6.27) in the presence of a probe (10 nM) concentration of relaxin-3(NH2). 135PAM1 does not compete for binding with the orthosteric radioligand, [I-125] R3I5 (amide), in membranes prepared from cells expressing the cloned human RXFP3 receptor. 135PAM1 is selective for RXFP3 over RXFP4, which also responds to relaxin-3. However, when using the free acid (native) form of relaxin-3 or R3/I5, 135PAM1 doesn't activate RXFP3 indicating that the compound's effect is probe dependent. Thus one can exchange the entire A-chain of the probe peptide while retaining PAM activity, but the state of the probe's c-terminus is crucial to allosteric activity of the PAM. These data demonstrate the existence of an allosteric site for modulation of this GPCR as well as the subtlety of changes in probe molecules that can affect allosteric modulation of RXFP3.	[Alvarez-Jaimes, Lily; Sutton, Steven W.; Nepomuceno, Diane; Motley, S. Timothy; Cik, Miroslav; Stocking, Emily; Shoblock, James; Bonaventure, Pascal] Janssen Pharmaceut Companies Johnson & Johnson, San Diego, CA USA	Johnson & Johnson; Janssen Pharmaceuticals	Alvarez-Jaimes, L (corresponding author), Janssen Pharmaceut Companies Johnson & Johnson, San Diego, CA USA.	ssutton@its.jnj.com	Bonaventure, Pascal/K-3052-2015; Shoblock, James/J-7926-2015	Bonaventure, Pascal/0000-0003-2971-6152; Shoblock, James/0000-0002-7956-9560	Johnson AMP; Johnson Pharmaceutical Research and Development	Johnson AMP; Johnson Pharmaceutical Research and Development	The authors have read the journal's policy and have the following conflicts: Johnson & Johnson Pharmaceutical Research and Development funded this study. Authors are employees of Johnson & Johnson Pharmaceutical Research & Development, LLC or were employees of that firm at the time the research was performed. Studies described here were performed with materials described in Patents/Applications US 7893197 and US 2005074814. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Banerjee A, 2010, NEUROPHARMACOLOGY, V58, P145, DOI 10.1016/j.neuropharm.2009.06.019; Bathgate RA, 2006, PHARMACOL REV, V58, P7, DOI 10.1124/pr.58.1.9; Bathgate RAD, 2002, J BIOL CHEM, V277, P1148, DOI 10.1074/jbc.M107882200; Boels K, 2004, DEV BRAIN RES, V152, P265, DOI 10.1016/j.devbrainres.2004.06.002; Burford NT, 2011, BIOCHEM PHARMACOL, V81, P691, DOI 10.1016/j.bcp.2010.12.012; Chen JC, 2005, J PHARMACOL EXP THER, V312, P83, DOI 10.1124/jpet.104.073486; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Dschietzig T, 2009, J CARD FAIL, V15, P182, DOI 10.1016/j.cardfail.2009.01.008; Hida T, 2006, J RECEPT SIG TRANSD, V26, P147, DOI 10.1080/10799890600623373; Hokfelt T, 2003, LANCET NEUROL, V2, P463, DOI 10.1016/S1474-4422(03)00482-4; Holst B, 2005, MOL ENDOCRINOL, V19, P2400, DOI 10.1210/me.2005-0059; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Kenakin T, J RECEPT SIGNAL TRAN, V30, P313; Kenakin T, 2007, CURR NEUROPHARMACOL, V5, P149, DOI 10.2174/157015907781695973; Keov P, 2011, NEUROPHARMACOLOGY, V60, P24, DOI 10.1016/j.neuropharm.2010.07.010; Knudsen LB, 2007, P NATL ACAD SCI USA, V104, P937, DOI 10.1073/pnas.0605701104; Kuei C, 2007, J BIOL CHEM, V282, P25425, DOI 10.1074/jbc.M701416200; Leach K, 2011, CURRENT PROTOCOLS PH, p[1, 22, 21, 2241]; Leach K, 2011, MOL PHARMACOL, V79, P855, DOI 10.1124/mol.111.070938; Liu CL, 2005, J BIOL CHEM, V280, P292, DOI 10.1074/jbc.M409916200; Liu CL, 2005, MOL PHARMACOL, V67, P231, DOI 10.1124/mol.104.006700; Liu CL, 2003, J BIOL CHEM, V278, P50765, DOI 10.1074/jbc.M308996200; Liu CL, 2003, J BIOL CHEM, V278, P50754, DOI 10.1074/jbc.M308995200; Ma S, 2010, RELAXIN 3 RECEPTOR A, pP809824; Ma S, 2009, J COMP NEUROL, V517, P856, DOI 10.1002/cne.22197; Ma S, 2009, LEARN MEMORY, V16, P730, DOI 10.1101/lm.1438109; Matsumoto M, 2000, GENE, V248, P183, DOI 10.1016/S0378-1119(00)00123-2; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; McGowan BMC, 2009, ANN NY ACAD SCI, V1160, P250, DOI 10.1111/j.1749-6632.2008.03796.x; RIVIER J, 1984, SCIENCE, V224, P889, DOI 10.1126/science.6326264; Rosengren KJ, 2006, J BIOL CHEM, V281, P5845, DOI 10.1074/jbc.M511210200; Royce SG, 2009, ENDOCRINOLOGY, V150, P2692, DOI 10.1210/en.2008-1457; Sherwood OD, 2004, ENDOCR REV, V25, P205, DOI 10.1210/er.2003-0013; Shimizu N, 2000, GENE, V259, P199, DOI 10.1016/S0378-1119(00)00432-7; Smith CM, 2011, J CHEM NEUROANAT, V42, P262, DOI 10.1016/j.jchemneu.2011.05.013; Smith CM, 2010, J COMP NEUROL, V518, P4016, DOI 10.1002/cne.22442; Suratman S, 2011, BRIT J PHARMACOL, V162, P1659, DOI 10.1111/j.1476-5381.2010.01184.x; Sutton SW, 2005, NEUROENDOCRINOLOGY, V82, P139, DOI 10.1159/000091267; Sutton SW, 2004, NEUROENDOCRINOLOGY, V80, P298, DOI 10.1159/000083656; Vale W, 1986, ASSAY GROWTH HORMONE, P389; van der Westhuizen ET, 2008, DRUG DISCOV TODAY, V13, P640, DOI 10.1016/j.drudis.2008.04.002; van der Westhuizen ET, 2007, MOL PHARMACOL, V71, P1618, DOI 10.1124/mol.106.032763; Van Der Westhuizen ET, 2005, ANN NY ACAD SCI, V1041, P332, DOI 10.1196/annals.1282.053; Wade JD, 2009, ANN NY ACAD SCI, V1160, P11, DOI 10.1111/j.1749-6632.2009.03951.x; Watson C, 2005, MOL PHARMACOL, V67, P1268, DOI 10.1124/mol.104.008565; Wootten D, 2011, J PHARMACOL EXP THER, V336, P540, DOI 10.1124/jpet.110.176362	49	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e30792	10.1371/journal.pone.0030792	http://dx.doi.org/10.1371/journal.pone.0030792			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347403	Green Published, gold			2022-12-25	WOS:000302180600015
J	Baker, ES; Luckner, SR; Krause, KL; Lambden, PR; Clarke, IN; Ward, VK				Baker, Estelle S.; Luckner, Sylvia R.; Krause, Kurt L.; Lambden, Paul R.; Clarke, Ian N.; Ward, Vernon K.			Inherent Structural Disorder and Dimerisation of Murine Norovirus NS1-2 Protein	PLOS ONE			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; CIRCULAR-DICHROISM SPECTROSCOPY; NATIVELY UNFOLDED PROTEINS; NORWALK-LIKE VIRUS; SECONDARY STRUCTURE; NONSTRUCTURAL POLYPROTEIN; MOLECULAR RECOGNITION; FUNCTIONAL ANTHOLOGY; REPLICATION COMPLEX; GEL-FILTRATION	Human noroviruses are highly infectious viruses that cause the majority of acute, non-bacterial epidemic gastroenteritis cases worldwide. The first open reading frame of the norovirus RNA genome encodes for a polyprotein that is cleaved by the viral protease into six non-structural proteins. The first non-structural protein, NS1-2, lacks any significant sequence similarity to other viral or cellular proteins and limited information is available about the function and biophysical characteristics of this protein. Bioinformatic analyses identified an inherently disordered region (residues 1-142) in the highly divergent N-terminal region of the norovirus NS1-2 protein. Expression and purification of the NS1-2 protein of Murine norovirus confirmed these predictions by identifying several features typical of an inherently disordered protein. These were a biased amino acid composition with enrichment in the disorder promoting residues serine and proline, a lack of predicted secondary structure, a hydrophilic nature, an aberrant electrophoretic migration, an increased Stokes radius similar to that predicted for a protein from the pre-molten globule family, a high sensitivity to thermolysin proteolysis and a circular dichroism spectrum typical of an inherently disordered protein. The purification of the NS1-2 protein also identified the presence of an NS1-2 dimer in Escherichia coli and transfected HEK293T cells. Inherent disorder provides significant advantages including structural flexibility and the ability to bind to numerous targets allowing a single protein to have multiple functions. These advantages combined with the potential functional advantages of multimerisation suggest a multi-functional role for the NS1-2 protein.	[Baker, Estelle S.; Ward, Vernon K.] Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand; [Luckner, Sylvia R.; Krause, Kurt L.] Univ Otago, Sch Med Sci, Dept Biochem, Dunedin, New Zealand; [Lambden, Paul R.; Clarke, Ian N.] Univ Southampton, Sch Med, Southampton, Hants, England	University of Otago; University of Otago; University of Southampton	Baker, ES (corresponding author), Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand.	vernon.ward@otago.ac.nz	Krause, Kurt/N-4886-2014	Krause, Kurt/0000-0002-3525-1112; Ward, Vernon/0000-0001-8692-5116; Clarke, Ian/0000-0002-4938-1620	New Zealand Lottery Grants Board [10/135]; Health Research Council of New Zealand [10/050]; Wellcome Trust UK; University of Otago, New Zealand	New Zealand Lottery Grants Board; Health Research Council of New Zealand(Health Research Council of New Zealand); Wellcome Trust UK(Wellcome Trust); University of Otago, New Zealand	This research was supported by the New Zealand Lottery Grants Board (Grant 10/135), the Health Research Council of New Zealand (Grant 10/050), the Wellcome Trust UK, and the University of Otago, New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atmar RL, 2001, CLIN MICROBIOL REV, V14, P15, DOI 10.1128/CMR.14.1.15-37.2001; Bailey D, 2010, J GEN VIROL, V91, P739, DOI 10.1099/vir.0.016279-0; Belliot G, 2003, J VIROL, V77, P10957, DOI 10.1128/JVI.77.20.10957-10974.2003; Brown CJ, 2002, J MOL EVOL, V55, P104, DOI 10.1007/s00239-001-2309-6; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Campen A, 2008, PROTEIN PEPTIDE LETT, V15, P956, DOI 10.2174/092986608785849164; Chen JW, 2006, J PROTEOME RES, V5, P879, DOI 10.1021/pr060048x; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Drake JW, 1998, GENETICS, V148, P1667; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Ettayebi K, 2003, J VIROL, V77, P11790, DOI 10.1128/JVI.77.21.11790-11797.2003; Fankhauser RL, 2002, J INFECT DIS, V186, P1, DOI 10.1086/341085; Fauquet CM, 2005, VIR TAX 8 INT COMM T, P725; Fernandez-Vega V, 2004, J VIROL, V78, P4827, DOI 10.1128/JVI.78.9.4827-4837.2004; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Habchi J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011684; He Y., 2006, HEPATITIS C VIRUSES, P267; Hebrard E, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-23; Hogbom M, 2009, J GEN VIROL, V90, P281, DOI 10.1099/vir.0.005629-0; Hughes PJ, 2000, J GEN VIROL, V81, P201, DOI 10.1099/0022-1317-81-1-201; Hyde JL, 2010, VIROLOGY, V406, P138, DOI 10.1016/j.virol.2010.06.047; Hyde JL, 2009, J VIROL, V83, P9709, DOI 10.1128/JVI.00600-09; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Kim MJ, 2011, J PEDIATR GASTR NUTR, V52, P314, DOI 10.1097/MPG.0b013e3181ebfa01; Kirkwood CD, 2008, J CLIN VIROL, V43, P346, DOI 10.1016/j.jcv.2008.08.001; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Lieutaud P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S25; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Lopman B, 2008, PLOS MED, V5, P187, DOI 10.1371/journal.pmed.0050042; Meszaros B, 2007, J MOL BIOL, V372, P549, DOI 10.1016/j.jmb.2007.07.004; Meszaros B, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035003; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Ming Tan, 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000348; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; NETTLES RE, 2011, HEPATOLOGY; Nugent T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-159; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Pfister T, 2001, J VIROL, V75, P1611, DOI 10.1128/JVI.75.4.1611-1619.2001; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750; Romero, 1997, Genome Inform Ser Workshop Genome Inform, V8, P110; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Sharp TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013130; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Sosnovtsev SV, 2006, J VIROL, V80, P7816, DOI 10.1128/JVI.00532-06; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 1999, PROTEIN SCI, V8, P370; Thackray LB, 2007, J VIROL, V81, P10460, DOI 10.1128/JVI.00783-07; Tokuriki N, 2009, TRENDS BIOCHEM SCI, V34, P53, DOI 10.1016/j.tibs.2008.10.009; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 1999, BIOCHEMISTRY-US, V38, P15009, DOI 10.1021/bi990752+; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2003, CELL MOL LIFE SCI, V60, P1852, DOI 10.1007/s00018-003-3096-6; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Vacic V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-211; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Wobus CE, 2006, J VIROL, V80, P5104, DOI 10.1128/JVI.02346-05; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xie HB, 2007, J PROTEOME RES, V6, P1917, DOI 10.1021/pr060394e; Xie HB, 2007, J PROTEOME RES, V6, P1882, DOI 10.1021/pr060392u; Zang ZR, 2005, BIOINFORMATICS, V21, P3369; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015; Zintz Carmelann, 2005, Infection Genetics and Evolution, V5, P281, DOI 10.1016/j.meegid.2004.06.010	80	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e30534	10.1371/journal.pone.0030534	http://dx.doi.org/10.1371/journal.pone.0030534			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347381	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000302180600009
J	Ishii, S; Suzuki, S; Norden-Krichmar, TM; Nealson, KH; Sekiguchi, Y; Gorby, YA; Bretschger, O				Ishii, Shun'ichi; Suzuki, Shino; Norden-Krichmar, Trina M.; Nealson, Kenneth H.; Sekiguchi, Yuji; Gorby, Yuri A.; Bretschger, Orianna			Functionally Stable and Phylogenetically Diverse Microbial Enrichments from Microbial Fuel Cells during Wastewater Treatment	PLOS ONE			English	Article							GEOBACTER-SULFURREDUCENS; ELECTRICITY-GENERATION; BACTERIAL COMMUNITIES; DISSIMILATORY FE(III); ENERGY; PERFORMANCE; REDUCTION; ANODE; POWER	Microbial fuel cells (MFCs) are devices that exploit microorganisms as biocatalysts to recover energy from organic matter in the form of electricity. One of the goals of MFC research is to develop the technology for cost-effective wastewater treatment. However, before practical MFC applications are implemented it is important to gain fundamental knowledge about long-term system performance, reproducibility, and the formation and maintenance of functionally-stable microbial communities. Here we report findings from a MFC operated for over 300 days using only primary clarifier effluent collected from a municipal wastewater treatment plant as the microbial resource and substrate. The system was operated in a repeat-batch mode, where the reactor solution was replaced once every two weeks with new primary effluent that consisted of different microbial and chemical compositions with every batch exchange. The turbidity of the primary clarifier effluent solution notably decreased, and 97% of biological oxygen demand (BOD) was removed after an 8-13 day residence time for each batch cycle. On average, the limiting current density was 1000 mA/m(2), the maximum power density was 13 mW/m(2), and coulombic efficiency was 25%. Interestingly, the electrochemical performance and BOD removal rates were very reproducible throughout MFC operation regardless of the sample variability associated with each wastewater exchange. While MFC performance was very reproducible, the phylogenetic analyses of anode-associated electricity-generating biofilms showed that the microbial populations temporally fluctuated and maintained a high biodiversity throughout the year-long experiment. These results suggest that MFC communities are both self-selecting and self-optimizing, thereby able to develop and maintain functional stability regardless of fluctuations in carbon source(s) and regular introduction of microbial competitors. These results contribute significantly toward the practical application of MFC systems for long-term wastewater treatment as well as demonstrating MFC technology as a useful device to enrich for functionally stable microbial populations.	[Ishii, Shun'ichi; Suzuki, Shino; Norden-Krichmar, Trina M.; Nealson, Kenneth H.; Bretschger, Orianna] J Craig Venter Inst, San Diego, CA USA; [Ishii, Shun'ichi; Sekiguchi, Yuji] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki, Japan; [Nealson, Kenneth H.; Gorby, Yuri A.] Univ So Calif, Los Angeles, CA USA; [Ishii, Shun'ichi] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan	J. Craig Venter Institute; National Institute of Advanced Industrial Science & Technology (AIST); University of Southern California; Japan Society for the Promotion of Science	Ishii, S (corresponding author), J Craig Venter Inst, San Diego, CA USA.	sishii@jcvi.org	Sekiguchi, Yuji/M-3362-2018	Sekiguchi, Yuji/0000-0002-1264-0617; Ishii, Shun'ichi/0000-0002-0203-8569	National Science Foundation-Biotechnology, Biochemical, and Biomass Engineering (NSF-BBBE) [0933145]; NSF Ecosystem Science Cluster [0918983];  [07J06446]	National Science Foundation-Biotechnology, Biochemical, and Biomass Engineering (NSF-BBBE); NSF Ecosystem Science Cluster; 	This work was supported by Grant-in-Aid for JSPS Fellows (Award no. 07J06446; http://www.jsps.go.jp/english/), National Science Foundation-Biotechnology, Biochemical, and Biomass Engineering (NSF-BBBE) (Award no. 0933145; http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=501024) and NSF Ecosystem Science Cluster (Award no. 0918983; http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=503663). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Y, 2010, BIORESOURCE TECHNOL, V101, P469, DOI 10.1016/j.biortech.2009.07.039; Bond DR, 2002, SCIENCE, V295, P483, DOI 10.1126/science.1066771; Bond DR, 2003, APPL ENVIRON MICROB, V69, P1548, DOI 10.1128/AEM.69.3.1548-1555.2003; Chae KJ, 2009, BIORESOURCE TECHNOL, V100, P3518, DOI 10.1016/j.biortech.2009.02.065; Cheng S, 2006, ENVIRON SCI TECHNOL, V40, P2426, DOI 10.1021/es051652w; Cheng S, 2006, ELECTROCHEM COMMUN, V8, P489, DOI 10.1016/j.elecom.2006.01.010; Colwell RK, 2009, ESTIMATES STAT ESTIM; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Di Lorenzo M, 2009, ENERG FUEL, V23, P5707, DOI 10.1021/ef9005934; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; Holmes DE, 2004, APPL ENVIRON MICROB, V70, P1234, DOI 10.1128/AEM.70.2.1234-1237.2004; Holmes DE, 2004, MICROB ECOL, V48, P178, DOI 10.1007/s00248-003-0004-4; Huang LP, 2008, APPL MICROBIOL BIOT, V80, P349, DOI 10.1007/s00253-008-1546-7; Ishii S, 2008, APPL ENVIRON MICROB, V74, P7348, DOI 10.1128/AEM.01639-08; Ishii S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-6; Jung S, 2007, APPL MICROBIOL BIOT, V77, P393, DOI 10.1007/s00253-007-1162-y; KARLIN S, 1990, P NATL ACAD SCI USA, V87, P2264, DOI 10.1073/pnas.87.6.2264; Karlsson FH, 2011, MICROB ECOL, V61, P473, DOI 10.1007/s00248-010-9796-1; Kiely PD, 2011, BIORESOURCE TECHNOL, V102, P388, DOI 10.1016/j.biortech.2010.05.019; Liu H, 2004, ENVIRON SCI TECHNOL, V38, P2281, DOI 10.1021/es034923g; Liu H, 2004, ENVIRON SCI TECHNOL, V38, P4040, DOI 10.1021/es0499344; Logan B. E., 2008, POWER GENERATION MIC, P44; Logan BE, 2006, ENVIRON SCI TECHNOL, V40, P5181, DOI 10.1021/es0605016; LOVLEY DR, 1991, MICROBIOL REV, V55, P259, DOI 10.1128/MMBR.55.2.259-287.1991; LOVLEY DR, 1993, ARCH MICROBIOL, V159, P336, DOI 10.1007/BF00290916; Meyer S, 2009, 970330 SDRWQCB; Pant D, 2010, BIORESOURCE TECHNOL, V101, P1533, DOI 10.1016/j.biortech.2009.10.017; Rabaey K, 2005, TRENDS BIOTECHNOL, V23, P291, DOI 10.1016/j.tibtech.2005.04.008; Reimers CE, 2006, GEOBIOLOGY, V4, P123, DOI 10.1111/j.1472-4669.2006.00071.x; Rismani-Yazdi H, 2008, J POWER SOURCES, V180, P683, DOI 10.1016/j.jpowsour.2008.02.074; RODEN EE, 1993, APPL ENVIRON MICROB, V59, P734, DOI 10.1128/AEM.59.3.734-742.1993; Rozendal RA, 2008, TRENDS BIOTECHNOL, V26, P450, DOI 10.1016/j.tibtech.2008.04.008; Rulkens W, 2008, ENERG FUEL, V22, P9, DOI 10.1021/ef700267m; Shimoyama T, 2009, MICROBES ENVIRON, V24, P188, DOI 10.1264/jsme2.ME09108; Tender LM, 2002, NAT BIOTECHNOL, V20, P821, DOI 10.1038/nbt716; Tsujimura S, 2001, PHYS CHEM CHEM PHYS, V3, P1331, DOI 10.1039/b009539g; Watanabe K, 2001, J MICROBIOL METH, V44, P253, DOI 10.1016/S0167-7012(01)00220-2; WIN, 2000, CLEAN SAF WAT 21 CEN; Xing DF, 2009, BIOSENS BIOELECTRON, V25, P105, DOI 10.1016/j.bios.2009.06.013	39	67	69	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e30495	10.1371/journal.pone.0030495	http://dx.doi.org/10.1371/journal.pone.0030495			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347379	gold, Green Submitted, Green Published			2022-12-25	WOS:000302180600008
J	Tymofiyeva, O; Hess, CP; Ziv, E; Tian, N; Bonifacio, SL; McQuillen, PS; Ferriero, DM; Barkovich, AJ; Xu, D				Tymofiyeva, Olga; Hess, Christopher P.; Ziv, Etay; Tian, Nan; Bonifacio, Sonia L.; McQuillen, Patrick S.; Ferriero, Donna M.; Barkovich, A. James; Xu, Duan			Towards the "Baby Connectome": Mapping the Structural Connectivity of the Newborn Brain	PLOS ONE			English	Article							NETWORKS; MRI	Defining the structural and functional connectivity of the human brain (the human "connectome") is a basic challenge in neuroscience. Recently, techniques for noninvasively characterizing structural connectivity networks in the adult brain have been developed using diffusion and high-resolution anatomic MRI. The purpose of this study was to establish a framework for assessing structural connectivity in the newborn brain at any stage of development and to show how network properties can be derived in a clinical cohort of six-month old infants sustaining perinatal hypoxic ischemic encephalopathy (HIE). Two different anatomically unconstrained parcellation schemes were proposed and the resulting network metrics were correlated with neurological outcome at 6 months. Elimination and correction of unreliable data, automated parcellation of the cortical surface, and assembling the large-scale baby connectome allowed an unbiased study of the network properties of the newborn brain using graph theoretic analysis. In the application to infants with HIE, a trend to declining brain network integration and segregation was observed with increasing neuromotor deficit scores.	[Tymofiyeva, Olga; Hess, Christopher P.; Ziv, Etay; Tian, Nan; Barkovich, A. James; Xu, Duan] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Bonifacio, Sonia L.; McQuillen, Patrick S.; Ferriero, Donna M.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Tymofiyeva, O (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.	olga.tymofiyeva@ucsf.edu	TIan, nan/GQP-1717-2022; McQuillen, Patrick/AAF-7119-2020; Xu, Duan/GMW-4195-2022; Xu, Duan/B-3197-2013	Xu, Duan/0000-0003-0550-4235; McQuillen, Patrick/0000-0002-8837-364X; Hess, Christopher/0000-0002-5132-5302	NIH [R01EB009756, P50NS035902, R01NS063876]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS035902, R01NS063876] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was partly funded by NIH grants R01EB009756, P50NS035902 and R01NS063876 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, NEON ENC CER PALS DE; Bang-Jensen J, 2009, SPRINGER MONOGR MATH, P1, DOI 10.1007/978-1-84800-998-1_1; Barkovich AJ, 2006, AM J NEURORADIOL, V27, P533; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; Doria V, 2010, P NATL ACAD SCI USA, V107, P20015, DOI 10.1073/pnas.1007921107; Dubois J, 2008, CEREB CORTEX, V18, P1444, DOI 10.1093/cercor/bhm180; Fan Y, 2011, NEUROIMAGE, V54, P1862, DOI 10.1016/j.neuroimage.2010.07.025; Fransson P, 2011, CEREB CORTEX, V21, P145, DOI 10.1093/cercor/bhq071; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Guye M, 2010, MAGN RESON MATER PHY, V23, P409, DOI 10.1007/s10334-010-0205-z; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hagmann P, 2010, J NEUROSCI METH, V194, P34, DOI 10.1016/j.jneumeth.2010.01.014; Hajnal BL, 1999, PEDIATR NEUROL, V21, P788, DOI 10.1016/S0887-8994(99)00101-0; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033; Jones DK, 2003, MAGN RESON MED, V49, P7, DOI 10.1002/mrm.10331; Kaiser M, 2011, NEUROIMAGE, V57, P892, DOI 10.1016/j.neuroimage.2011.05.025; Leopardi P, 2006, ELECTRON T NUMER ANA, V25, P309; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; Moldrich RX, 2010, NEUROIMAGE, V51, P1027, DOI 10.1016/j.neuroimage.2010.03.035; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smyser CD, 2011, NEUROIMAGE, V56, P1437, DOI 10.1016/j.neuroimage.2011.02.073; Sorensen AG, 2007, P INT SOC MAG RESON, V15, P3720, DOI [DOI 10.1128/MCB.25.11.4371, DOI 10.1038/SJ.IJ0.0803354]; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Storey P, 2007, MAGN RESON MED, V57, P614, DOI 10.1002/mrm.21132; Trouard TP, 1996, JMRI-J MAGN RESON IM, V6, P925, DOI 10.1002/jmri.1880060614; Vaessen MJ, 2010, NEUROIMAGE, V51, P1106, DOI 10.1016/j.neuroimage.2010.03.011; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yap PT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024678; Yo TS, 2009, LECT NOTES COMPUT SC, V5761, P886; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zhang DY, 2010, CEREB CORTEX, V20, P1187, DOI 10.1093/cercor/bhp182	40	61	62	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31029	10.1371/journal.pone.0031029	http://dx.doi.org/10.1371/journal.pone.0031029			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347423	Green Published, gold			2022-12-25	WOS:000302180600023
J	Xiong, J; Lu, XY; Zhou, ZM; Chang, Y; Yuan, DX; Tian, M; Zhou, ZG; Wang, L; Fu, CJ; Orias, E; Miao, W				Xiong, Jie; Lu, Xingyi; Zhou, Zhemin; Chang, Yue; Yuan, Dongxia; Tian, Miao; Zhou, Zhigang; Wang, Lei; Fu, Chengjie; Orias, Eduardo; Miao, Wei			Transcriptome Analysis of the Model Protozoan, Tetrahymena thermophila, Using Deep RNA Sequencing	PLOS ONE			English	Article							PROGRAMMED DNA ELIMINATION; GENOME-WIDE ANALYSIS; GENE-EXPRESSION; FUNCTIONAL GENOMICS; SPLICE JUNCTIONS; PROTEIN-KINASE; SEQ; YEAST; ANNOTATION; TOOL	Background: The ciliated protozoan Tetrahymena thermophila is a well-studied single-celled eukaryote model organism for cellular and molecular biology. However, the lack of extensive T. thermophila cDNA libraries or a large expressed sequence tag (EST) database limited the quality of the original genome annotation. Methodology/Principal Findings: This RNA-seq study describes the first deep sequencing analysis of the T. thermophila transcriptome during the three major stages of the life cycle: growth, starvation and conjugation. Uniquely mapped reads covered more than 96% of the 24,725 predicted gene models in the somatic genome. More than 1,000 new transcribed regions were identified. The great dynamic range of RNA-seq allowed detection of a nearly six order-of-magnitude range of measurable gene expression orchestrated by this cell. RNA-seq also allowed the first prediction of transcript untranslated regions (UTRs) and an updated (larger) size estimate of the T. thermophila transcriptome: 57 Mb, or about 55% of the somatic genome. Our study identified nearly 1,500 alternative splicing (AS) events distributed over 5.2% of T. thermophila genes. This percentage represents a two order-of-magnitude increase over previous EST-based estimates in Tetrahymena. Evidence of stage-specific regulation of alternative splicing was also obtained. Finally, our study allowed us to completely confirm about 26.8% of the genes originally predicted by the gene finder, to correct coding sequence boundaries and intron-exon junctions for about a third, and to reassign microarray probes and correct earlier microarray data. Conclusions/Significance: RNA-seq data significantly improve the genome annotation and provide a fully comprehensive view of the global transcriptome of T. thermophila. To our knowledge, 5.2% of T. thermophila genes with AS is the highest percentage of genes showing AS reported in a unicellular eukaryote. Tetrahymena thus becomes an excellent unicellular model eukaryote in which to investigate mechanisms of alternative splicing.	[Xiong, Jie; Lu, Xingyi; Chang, Yue; Yuan, Dongxia; Tian, Miao; Fu, Chengjie; Miao, Wei] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China; [Zhou, Zhemin; Wang, Lei] Nankai Univ, Tianjin Econ Technol Dev Area, Sch Biol Sci & Biotechnol, Tianjin 300071, Peoples R China; [Orias, Eduardo] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Zhou, Zhigang] Chinese Acad Agr Sci, Feed Res Inst, Beijing 100193, Peoples R China; [Xiong, Jie; Lu, Xingyi; Chang, Yue; Tian, Miao] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Nankai University; University of California System; University of California Santa Barbara; Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xiong, J (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China.	miaowei530@yeah.net	Zhou, Zhemin/AAX-5539-2020; Fu, Cheng-Jie/B-3679-2008; Wang, Lei/C-5176-2009	Zhou, Zhemin/0000-0001-9783-0366; Fu, Cheng-Jie/0000-0001-9357-9661; Wang, Lei/0000-0003-4427-0881; Tian, Miao/0000-0001-9086-1872; Xiong, Jie/0000-0001-8923-0424; miao, wei/0000-0003-3440-8322	Chinese Academy of Sciences [KSCX2-EW-G-6-4]; National Natural Science Foundation of China [Y11314-1-501, Y01307-1-501]; National Science Foundation, United States of America [MCB-1025069]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation, United States of America(National Science Foundation (NSF))	This work was supported by grants from the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-G-6-4), the National Natural Science Foundation of China (Y11314-1-501) to WM, and the National Natural Science Foundation of China (Y01307-1-501) to CF. EO's work was supported by grant MCB-1025069 from the National Science Foundation, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-383; Aronica L, 2008, GENE DEV, V22, P2228, DOI 10.1101/gad.481908; Asai DJ, 2000, METHODS CELL BIOL; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; BLACKBURN EH, 1978, J MOL BIOL, V120, P33, DOI 10.1016/0022-2836(78)90294-2; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Bruno VM, 2010, GENOME RES, V20, P1451, DOI 10.1101/gr.109553.110; Chacko E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S3-S11; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Couvillion MT, 2009, GENE DEV, V23, P2016, DOI 10.1101/gad.1821209; Coyne RS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-562; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Ellenrieder C, 2001, DNA CELL BIOL, V20, P413, DOI 10.1089/104454901750361479; Enslen H, 1998, J BIOL CHEM, V273, P1741, DOI 10.1074/jbc.273.3.1741; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Glockner G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-6; GOROVSKY MA, 1973, J PROTOZOOL, V20, P19, DOI 10.1111/j.1550-7408.1973.tb05995.x; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Jaillon O, 2008, NATURE, V451, P359, DOI 10.1038/nature06495; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Labadorf A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-114; Lee S, 1999, MOL BIOL CELL, V10, P771, DOI 10.1091/mbc.10.3.771; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Lu JG, 2010, MOL GENET GENOMICS, V283, P531, DOI 10.1007/s00438-010-0538-3; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Miao W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004429; Mitrovich QM, 2007, GENOME RES, V17, P492, DOI 10.1101/gr.6111907; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Modrek B, 2003, NAT GENET, V34, P177, DOI 10.1038/ng1159; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Orias E, 2011, RES MICROBIOL, V162, P578, DOI 10.1016/j.resmic.2011.05.001; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Otto TD, 2010, MOL MICROBIOL, V76, P12, DOI 10.1111/j.1365-2958.2009.07026.x; Rajagopalan V, 2009, MOL BIOL CELL, V20, P708, DOI 10.1091/mbc.E08-07-0746; Ramani AK, 2011, GENOME RES, V21, P342, DOI 10.1101/gr.114645.110; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Shen DY, 2011, CAN J MICROBIOL, V57, P84, DOI [10.1139/W10-103, 10.1139/w10-103]; Sorber K, 2011, NUCLEIC ACIDS RES, V39, P3820, DOI 10.1093/nar/gkq1223; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Taverna SD, 2002, CELL, V110, P701, DOI 10.1016/S0092-8674(02)00941-8; Tisserant E, 2011, NEW PHYTOL, V189, P883, DOI 10.1111/j.1469-8137.2010.03597.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turkewitz AP, 2002, TRENDS GENET, V18, P35, DOI 10.1016/S0168-9525(01)02560-4; Wang B, 2010, NUCLEIC ACIDS RES, V38, P5075, DOI 10.1093/nar/gkq256; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Xing Y, 2006, NAT REV GENET, V7, P499, DOI 10.1038/nrg1896; Xiong J, 2011, SCI CHINA LIFE SCI, V54, P65, DOI 10.1007/s11427-010-4114-1; Xiong LZ, 2003, PLANT CELL, V15, P745, DOI 10.1105/tpc.008714; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109	67	75	84	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e30630	10.1371/journal.pone.0030630	http://dx.doi.org/10.1371/journal.pone.0030630			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347391	Green Published, gold			2022-12-25	WOS:000302180600012
J	Thuny, F; Textoris, J; Ben Amara, A; El Filali, A; Capo, C; Habib, G; Raoult, D; Mege, JL				Thuny, Franck; Textoris, Julien; Ben Amara, Amira; El Filali, Adil; Capo, Christian; Habib, Gilbert; Raoult, Didier; Mege, Jean-Louis			The Gene Expression Analysis of Blood Reveals S100A11 and AQP9 as Potential Biomarkers of Infective Endocarditis	PLOS ONE			English	Article							DIAGNOSIS; ECHOCARDIOGRAPHY; DISEASE	Background: The diagnostic and prognostic assessments of infective endocarditis (IE) are challenging. To investigate the host response during IE and to identify potential biomarkers, we determined the circulating gene expression profile using whole genome microarray analysis. Methods and Results: A transcriptomic case-control study was performed on blood samples from patients with native valve IE (n = 39), excluded IE after an initial suspicion (n = 10) at patient's admission, and age-matched healthy controls (n = 10). Whole genome microarray analysis showed that patients with IE exhibited a specific transcriptional program with a predominance of gene categories associated with cell activation as well as innate immune and inflammatory responses. Quantitative real-time RT-PCR performed on a selection of highly modulated genes showed that the expression of the gene encoding S100 calcium binding protein A11 (S100A11) was significantly increased in patients with IE in comparison with controls (P<0.001) and patients with excluded IE (P<0.05). Interestingly, the upregulated expression of the S100A11 gene was more pronounced in staphylococcal IE than in streptococcal IE (P<0.01). These results were confirmed by serum concentrations of the S100A11 protein. Finally, we showed that in patients with IE, the upregulation of the aquaporin-9 gene (AQP9) was significantly associated with the occurrence of acute heart failure (P = 0.02). Conclusions: Using transcriptional signatures of blood samples, we identified S100A11 as a potential diagnostic marker of IE, and AQP9 as a potential prognostic factor.	[Thuny, Franck; Habib, Gilbert] Aix Marseille Univ, Hop Timone, Dept Cardiol, Marseille, France; [Thuny, Franck; Textoris, Julien; Ben Amara, Amira; El Filali, Adil; Capo, Christian; Habib, Gilbert; Raoult, Didier; Mege, Jean-Louis] Aix Marseille Univ, URMITE, CNRS, Unite Mixte Rech 6236, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Thuny, F (corresponding author), Aix Marseille Univ, Hop Timone, Dept Cardiol, Marseille, France.	jean-louis.mege@univmed.fr	Thuny, Franck/ABC-7157-2020; Thuny, Franck/GSD-2668-2022; Thuny, Franck/ABB-2408-2021; RAOULT, Didier/A-8434-2008	Thuny, Franck/0000-0002-8727-7154; Thuny, Franck/0000-0002-8727-7154; RAOULT, Didier/0000-0002-0633-5974; Textoris, Julien/0000-0002-3821-9337	Federation Francaise de Cardiologie	Federation Francaise de Cardiologie	This work was supported by a grant from the Federation Francaise de Cardiologie, to Dr. Franck Thuny. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agre P, 2003, FEBS LETT, V555, P72, DOI 10.1016/S0014-5793(03)01083-4; Apweiler R, 2000, BIOINFORMATICS, V16, P1145, DOI 10.1093/bioinformatics/16.12.1145; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Badaut J, 2010, NEUROSCIENCE, V168, P1047, DOI 10.1016/j.neuroscience.2009.10.030; Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Ben Amara A, PLOS ONE, V5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benoit M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008939; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Creagh-Brown BC, 2010, INTENS CARE MED, V36, P1644, DOI 10.1007/s00134-010-1952-z; Culhane AC, 2005, BIOINFORMATICS, V21, P2789, DOI 10.1093/bioinformatics/bti394; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Duval X, 2010, ANN INTERN MED, V152, P497, DOI 10.7326/0003-4819-152-8-201004200-00006; Evangelista A, 2004, HEART, V90, P614, DOI 10.1136/hrt.2003.029868; Feuchtner GM, 2009, J AM COLL CARDIOL, V53, P436, DOI 10.1016/j.jacc.2008.01.077; Ghavami S, 2008, J LEUKOCYTE BIOL, V83, P1484, DOI 10.1189/jlb.0607397; He HL, 2009, CELL BIOCHEM BIOPHYS, V55, P117, DOI 10.1007/s12013-009-9061-8; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Liu YW, 2009, SCAND CARDIOVASC J, V43, P318, DOI 10.1080/14017430902737940; Mohr S, 2007, TRENDS MOL MED, V13, P422, DOI 10.1016/j.molmed.2007.08.003; Mueller C, 2004, CIRCULATION, V109, P1707, DOI 10.1161/01.CIR.0000126281.52345.52; Raoult D, 2005, J CLIN MICROBIOL, V43, P5238, DOI 10.1128/JCM.43.10.5238-5242.2005; Seemann J, 1997, FEBS LETT, V413, P185, DOI 10.1016/S0014-5793(97)00911-3; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Thuny F, 2009, EUR HEART J; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Van Riet J, 2010, EUR J NUCL MED MOL I, V37, P1189, DOI 10.1007/s00259-010-1380-x; Widmer Eleonora, 2006, Curr Infect Dis Rep, V8, P271, DOI 10.1007/s11908-006-0071-z	30	36	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31490	10.1371/journal.pone.0031490	http://dx.doi.org/10.1371/journal.pone.0031490			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319637	Green Published, gold			2022-12-25	WOS:000302178400045
J	Lopes, G; Sousa, C; Silva, LR; Pinto, E; Andrade, PB; Bernardo, J; Mouga, T; Valentao, P				Lopes, Graciliana; Sousa, Carla; Silva, Luis R.; Pinto, Eugenia; Andrade, Paula B.; Bernardo, Joao; Mouga, Teresa; Valentao, Patricia			Can Phlorotannins Purified Extracts Constitute a Novel Pharmacological Alternative for Microbial Infections with Associated Inflammatory Conditions?	PLOS ONE			English	Article							BROWN ALGAL PHLOROTANNINS; ANTIOXIDANT ACTIVITY; FUCUS-VESICULOSUS; IN-VITRO; POLYPHENOLS; INHIBITION; COMPONENTS; TOXICITY; L.	Bacterial and fungal infections and the emerging multidrug resistance are driving interest in fighting these microorganisms with natural products, which have generally been considered complementary to pharmacological therapies. Phlorotannins are polyphenols restricted to brown seaweeds, recognized for their biological capacity. This study represents the first research on the antibacterial, antifungal, anti-inflammatory and antioxidant activity of phlorotannins purified extracts, which were obtained from ten dominant brown seaweeds of the occidental Portuguese coast. Phlorotannins content was determined by the specific dimethoxybenzaldehyde (DMBA) method and a yield between 75 and 969 mg/Kg phloroglucinol units (dry matter) was obtained. Fucus spiralis ranked first, followed by three Cystoseira species. The anti-inflammatory potential of the purified extracts was assessed via inhibitory effect on nitric oxide (NO) production by lipopolysaccharide-stimulated RAW 264.7 macrophage cells, Cystoseira tamariscifolia being the one showing promising activity for the treatment of inflammation. NO scavenging ability was also addressed in cell free systems, F. spiralis being the species with highest capacity. The antimicrobial potential of the extracts was checked against five Gram-positive and four Gram-negative bacteria and three fungi strains, that commonly colonize skin and mucosa and are responsible for food contamination. The different extracts were more effective against Gram-positive bacteria, Staphylococcus epidermidis being the most susceptible species. Concerning antifungal activity, Trichophyton rubrum was the most sensitive species. Although the molecular mechanisms underlying these properties remain poorly understood, the results obtained turn phlorotannins purified extracts a novel and potent pharmacological alternative for the treatment of a wide range of microbial infections, which usually also present an inflammatory component. In addition to the biological properties demonstrated herein, phlorotannins extracts may also be preferred, in order to avoid side effects and allergic reactions commonly associated with synthetic drugs.	[Lopes, Graciliana; Sousa, Carla; Silva, Luis R.; Andrade, Paula B.; Bernardo, Joao; Valentao, Patricia] Univ Porto, Fac Farm, Dept Quim, REQUIMTE Lab Farmacognosia, P-4100 Oporto, Portugal; [Pinto, Eugenia] Univ Porto, Fac Farm, Dept Ciencias Biol, CEQUIMED Lab Microbiol, P-4100 Oporto, Portugal; [Mouga, Teresa] Polytech Inst Leiria, Sch Tourism & Maritime Technol, GIRM Marine Resources Res Grp, Peniche, Portugal	Universidade do Porto; Universidade do Porto	Lopes, G (corresponding author), Univ Porto, Fac Farm, Dept Quim, REQUIMTE Lab Farmacognosia, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	valentao@ff.up.pt	Andrade, Paula B/A-5900-2008; Bernardo, Joao/A-9512-2015; Mouga, Teresa/AAK-3604-2020; Sousa, Carla/D-4989-2013; Valentão, Patrícia/D-4818-2013; Silva, Luís R./D-5485-2013; REQUIMTE, PHYTO/M-4633-2013; Pinto, Maria Eugénia Ribeiro/K-5788-2014; Lopes, Graciliana/U-1992-2019; Mouga, Teresa/F-4427-2017	Andrade, Paula B/0000-0002-9764-3920; Bernardo, Joao/0000-0002-3736-1681; Mouga, Teresa/0000-0003-4849-8840; Sousa, Carla/0000-0003-2734-7461; Valentão, Patrícia/0000-0002-0740-4396; Silva, Luís R./0000-0001-5264-3516; Pinto, Maria Eugénia Ribeiro/0000-0003-2948-5809; Mouga, Teresa/0000-0003-4849-8840	Fundacao para a Ciencia e a Tecnologia (FCT) [PEst-C/EQB/LA0006/2011, SFRH/BD/61565/2009]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	The authors thank Fundacao para a Ciencia e a Tecnologia (FCT) for grant no. PEst-C/EQB/LA0006/2011. G. Lopes (SFRH/BD/61565/2009) and J. Bernardo (BII) are indebted to FCT for their grants. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn MJ, 2004, BIOL PHARM BULL, V27, P544, DOI 10.1248/bpb.27.544; Biesalski HK, 2007, CURR OPIN CLIN NUTR, V10, P724, DOI 10.1097/MCO.0b013e3282f0cef2; Cerantola S, 2006, BOT MAR, V49, P347, DOI 10.1515/BOT.2006.042; Chkhikvishvili ID, 2000, APPL BIOCHEM MICRO+, V36, P289, DOI 10.1007/BF02742582; Clinical and Laboratory Standards Institute (CLSI), 2009, M07A8 CLSI; CLSI, 2008, M27A3 CLSI; Connan S, 2006, BOT MAR, V49, P39, DOI 10.1515/BOT.2006.005; Fairhead VA, 2005, POLAR BIOL, V28, P680, DOI 10.1007/s00300-005-0735-4; Glombitza KW, 1999, PHYTOCHEMISTRY, V51, P1095, DOI 10.1016/S0031-9422(99)00120-X; GLOMBITZA KW, 1975, PHYTOCHEMISTRY, V14, P1115, DOI 10.1016/0031-9422(75)85198-3; Kim AR, 2009, J AGR FOOD CHEM, V57, P3483, DOI 10.1021/jf900820x; Kim HK, 1999, BIOCHEM PHARMACOL, V58, P759, DOI 10.1016/S0006-2952(99)00160-4; Koivikko R, 2005, J CHEM ECOL, V31, P195, DOI 10.1007/s10886-005-0984-2; Lee R., 2008, PHYCOLOGY, VFourth, DOI DOI 10.1016/j.energy.2014.06.023; Li Y, 2008, J AGR FOOD CHEM, V56, P12073, DOI 10.1021/jf802732n; Li Y, 2009, BIOORGAN MED CHEM, V17, P1963, DOI 10.1016/j.bmc.2009.01.031; Moon C, 2008, PHYTOTHER RES, V22, P238, DOI 10.1002/ptr.2298; Nagayama K, 2002, J ANTIMICROB CHEMOTH, V50, P889, DOI 10.1093/jac/dkf222; Parys S, 2007, J NAT PROD, V70, P1865, DOI 10.1021/np070302f; Parys S, 2010, PHYTOCHEMISTRY, V71, P221, DOI 10.1016/j.phytochem.2009.10.020; Paterson DL, 2006, AM J MED, V119, pS20, DOI 10.1016/j.amjmed.2006.03.013; Richardman MD, 2003, FUNGAL INFECT DIAGNO; SCHULTZ JC, 1992, BASIC LIFE SCI, V59, P621; Shibata T, 2004, J APPL PHYCOL, V16, P291, DOI 10.1023/B:JAPH.0000047781.24993.0a; Shibata T, 2003, J APPL PHYCOL, V15, P61, DOI 10.1023/A:1022972221002; Shin HC, 2006, ARCH PHARM RES, V29, P165, DOI 10.1007/BF02974279; Sousa C, 2009, TOXICOL IN VITRO, V23, P1131, DOI 10.1016/j.tiv.2009.05.012; Sousa C, 2008, J AGR FOOD CHEM, V56, P4205, DOI 10.1021/jf072740y; Spicer JW, 2000, CLIN BACTERIOLOGY MY; Stern JL, 1996, J CHEM ECOL, V22, P1273, DOI 10.1007/BF02266965; Sterry W, 2006, DERMATOLOGY, V6th; Targett NM, 2001, CRC MAR SCI, P391; Zaragoza MC, 2008, J AGR FOOD CHEM, V56, P7773, DOI 10.1021/jf8007053	33	134	137	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e31145	10.1371/journal.pone.0031145	http://dx.doi.org/10.1371/journal.pone.0031145			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319609	Green Submitted, Green Published, gold			2022-12-25	WOS:000301979000022
J	Babbio, F; Pistore, C; Curti, L; Castiglioni, I; Kunderfranco, P; Brino, L; Oudet, P; Seiler, R; Thalman, GN; Roggero, E; Sarti, M; Pinton, S; Mello-Grand, M; Chiorino, G; Catapano, CV; Carbone, GM; Bonapace, IM				Babbio, F.; Pistore, C.; Curti, L.; Castiglioni, I.; Kunderfranco, P.; Brino, L.; Oudet, P.; Seiler, R.; Thalman, G. N.; Roggero, E.; Sarti, M.; Pinton, S.; Mello-Grand, M.; Chiorino, G.; Catapano, C. V.; Carbone, G. M.; Bonapace, I. M.			The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression	ONCOGENE			English	Article						prostate cancer; epigenetics; UHRF1; EZH2; Suv39H1	TUMOR-SUPPRESSOR GENE; DNA METHYLATION; PERICENTROMERIC HETEROCHROMATIN; TRANSCRIPTION FACTOR; CPG ISLAND; E-CADHERIN; CELLS; REPRESSION; EXPRESSION; EZH2	Epigenetic silencing of tumour suppressor genes is an important mechanism involved in cell transformation and tumour progression. The Set and RING-finger-associated domain-containing protein UHRF1 might be an important link between different epigenetic pathways. Here, we report that UHRF1 is frequently overexpressed in human prostate tumours and has an important role in prostate cancer pathogenesis and progression. Analysis of human prostate cancer samples by microarrays and immunohistochemistry showed increased expression of UHRF1 in about half of the cases. Moreover, UHRF1 expression was associated with reduced overall survival after prostatectomy in patients with organ-confined prostate tumours (P<0.0001). UHRF1 expression was negatively correlated with several tumour suppressor genes and positively with the histone methyltransferase (HMT) EZH2 both in prostate tumours and cell lines. UHRF1 knockdown reduced proliferation, clonogenic capability and anchorage-independent growth of prostate cancer cells. Depletion of UHRF1 resulted in reactivation of several tumour suppressor genes. Gene reactivation upon UHRF1 depletion was associated with changes in histone H3K9 methylation, acetylation and DNA methylation, and impaired binding of the H3K9 HMT Suv39H1 to the promoter of silenced genes. Co-immunoprecipitation experiments showed direct interaction between UHRF1 and Suv39H1. Our data support the notion that UHRF1, along with Suv39H1 and DNA methyltransferases, contributes to epigenetic gene silencing in prostate tumours. This could represent a parallel and convergent pathway to the H3K27 methylation catalyzed by EZH2 to synergistically promote inactivation of tumour suppressor genes. Deregulated expression of UHRF1 is involved in the prostate cancer pathogenesis and might represent a useful marker to distinguish indolent cancer from those at high risk of lethal progression.	[Babbio, F.; Pistore, C.; Castiglioni, I.; Bonapace, I. M.] Univ Insubria, Dept Struct & Funct Biol, I-21052 Busto Arsizio, Varese, Italy; [Curti, L.; Kunderfranco, P.; Sarti, M.; Pinton, S.; Catapano, C. V.; Carbone, G. M.] IOR, Bellinzona, Switzerland; [Curti, L.; Kunderfranco, P.; Roggero, E.; Sarti, M.; Pinton, S.; Catapano, C. V.; Carbone, G. M.] Oncol Inst So Switzerland IOSI, Bellinzona, Switzerland; [Brino, L.; Oudet, P.; Bonapace, I. M.] ULP, INSERM U596, UMR CNRS 7104, IGBMC,Dept Biol Canc, Strasbourg, France; [Brino, L.; Oudet, P.] Canc Pole Grand Est, Tranfected Cell Array Platform, Strasbourg, France; [Seiler, R.; Thalman, G. N.] Univ Bern, Inselspital, Dept Urol, Urol Res Lab, CH-3010 Bern, Switzerland; [Mello-Grand, M.; Chiorino, G.] Fondo Edo Tempia, Lab Canc Genom, Biella, Italy	University of Insubria; Institute of Oncology Research (IOR); Universita della Svizzera Italiana; Institute of Oncology Research (IOR); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Bern; University Hospital of Bern	Bonapace, IM (corresponding author), Univ Insubria, Dept Struct & Funct Biol, Via A da Giussano 12, I-21052 Busto Arsizio, Varese, Italy.	pina.carbone@irb.unisi.ch; ian.bonapace@uninsubria.it	Kunderfranco, Paolo/ABH-9294-2020; Kunderfranco, Paolo/J-7636-2016; Chiorino, Giovanna/K-5037-2016; Kunderfranco, Paolo/GUQ-8968-2022	Kunderfranco, Paolo/0000-0001-7477-8710; Kunderfranco, Paolo/0000-0003-3636-3391; Chiorino, Giovanna/0000-0002-9502-6400; Kunderfranco, Paolo/0000-0001-7477-8710; BONAPACE, IAN MARC/0000-0001-6580-8893; Catapano, Carlo V./0000-0002-7079-557X; Seiler, Roland/0000-0002-3529-2088; Brino, laurent/0000-0002-9036-1461; Castiglioni, Ilaria/0000-0003-1165-7844	Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG-10742]; Fondazione Cariplo 'Progetto Nobel'; Oncosuisse [OCS-01913-08]; Swiss National Science Foundation [FNS-31003A-118113]; Ticino Foundation for Cancer Research; Fondazione Compagnia di San Paolo; Universite de Strasbourg; Region Alsace; Conseil General du Bas Rhin; Communaute Urbaine de Strasbourg; Canceropole du Grand Est, France; Institut National du Cancer (INCa); Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC)	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Cariplo 'Progetto Nobel'(Fondazione Cariplo); Oncosuisse; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ticino Foundation for Cancer Research; Fondazione Compagnia di San Paolo(Compagnia di San Paolo); Universite de Strasbourg; Region Alsace(Region Grand-Est); Conseil General du Bas Rhin; Communaute Urbaine de Strasbourg; Canceropole du Grand Est, France(Region Grand-Est); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC)	We acknowledge Benoit Fischer, Laure Froidevaux and Amelie Weiss from the High-Throughput Screening facility (IGBMC) for their contribution to the project; Martina Mandruzzato and Giada Tamolli for their collaboration as undergraduate students; Dr Giampaolo Perletti for reviewing the manuscript and Professor Gianfranco Badaracco for constant support. Grant support: This work was supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC) project No IG-10742 and Fondazione Cariplo 'Progetto Nobel' to IMB and by Oncosuisse (OCS-01913-08), the Swiss National Science Foundation (FNS-31003A-118113) and Ticino Foundation for Cancer Research to GMC, and the Fondazione Compagnia di San Paolo to GC. Further support is acknowledged from the Universite de Strasbourg, Region Alsace, Conseil General du Bas Rhin, Communaute Urbaine de Strasbourg, Canceropole du Grand Est, France, Institut National du Cancer (INCa) and Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC).	Abdulkadir SA, 2005, ANN NY ACAD SCI, V1059, P33, DOI 10.1196/annals.1339.018; Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Bastian PJ, 2007, EUR UROL, V51, P665, DOI 10.1016/j.eururo.2006.08.008; Beke L, 2007, ONCOGENE, V26, P4590, DOI 10.1038/sj.onc.1210248; Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; Bonapace IM, 2002, J CELL BIOL, V157, P909, DOI 10.1083/jcb.200201025; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Cangemi R, 2008, ONCOGENE, V27, P2877, DOI 10.1038/sj.onc.1210953; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Cheng XD, 2010, BIOCHEMISTRY-US, V49, P2999, DOI 10.1021/bi100213t; Chuang TD, 2010, J BIOL CHEM, V285, P23598, DOI 10.1074/jbc.M109.098301; Citterio E, 2004, MOL CELL BIOL, V24, P2526, DOI 10.1128/MCB.24.6.2526-2535.2004; Coolen MW, 2010, NAT CELL BIOL, V12, P235, DOI 10.1038/ncb2023; Feinberg AP, 2004, SEMIN CANCER BIOL, V14, P427, DOI 10.1016/j.semcancer.2004.06.005; Fujii S, 2008, J BIOL CHEM, V283, P17324, DOI 10.1074/jbc.M800224200; Herranz N, 2008, MOL CELL BIOL, V28, P4772, DOI 10.1128/MCB.00323-08; Jeronimo C, 2004, CLIN CANCER RES, V10, P4010, DOI 10.1158/1078-0432.CCR-03-0643; Jeronimo C, 2011, EUR UROL, V60, P753, DOI 10.1016/j.eururo.2011.06.035; Kawano Y, 2009, BRIT J CANCER, V100, P1165, DOI 10.1038/sj.bjc.6604976; Ke XS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004687; Kim JK, 2009, NUCLEIC ACIDS RES, V37, P493, DOI 10.1093/nar/gkn961; Koizume S, 2002, NUCLEIC ACIDS RES, V30, P4770, DOI 10.1093/nar/gkf593; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Kondo Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002037; Kunderfranco P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010547; Li QA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013732; Meilinger D, 2009, EMBO REP, V10, P1259, DOI 10.1038/embor.2009.201; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Napoli S, 2009, EMBO J, V28, P1708, DOI 10.1038/emboj.2009.139; Palakurthy RK, 2009, MOL CELL, V36, P219, DOI 10.1016/j.molcel.2009.10.009; Pallante P, 2008, CANCER RES, V68, P6770, DOI 10.1158/0008-5472.CAN-08-0695; Papait R, 2008, MOL BIOL CELL, V19, P3554, DOI 10.1091/mbc.E07-10-1059; Papait R, 2007, MOL BIOL CELL, V18, P1098, DOI 10.1091/mbc.E06-09-0874; Park JY, 2007, CANCER DETECT PREV, V31, P359, DOI 10.1016/j.cdp.2007.09.002; Perry AS, 2010, NAT REV UROL, V7, P668, DOI 10.1038/nrurol.2010.185; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Prtilo A, 2005, J UROLOGY, V174, P1814, DOI 10.1097/01.ju.0000176796.47988.64; Raha T, 2005, PLOS BIOL, V3, P221, DOI 10.1371/journal.pbio.0030044; Richiardi L, 2009, J CLIN ONCOL, V27, P3161, DOI 10.1200/JCO.2008.18.2485; Sewalt RGAB, 2002, MOL CELL BIOL, V22, P5539, DOI 10.1128/MCB.22.15.5539-5553.2002; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Unoki M, 2004, ONCOGENE, V23, P7601, DOI 10.1038/sj.onc.1208053; Unoki M, 2009, BRIT J CANCER, V101, P98, DOI 10.1038/sj.bjc.6605123; Unoki M, 2009, BIOCHEM PHARMACOL, V78, P1279, DOI 10.1016/j.bcp.2009.05.035; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; van Leenders GJLH, 2007, EUR UROL, V52, P455, DOI 10.1016/j.eururo.2006.11.020; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Yang YJ, 2010, NUCLEIC ACIDS RES, V38, P382, DOI 10.1093/nar/gkp991; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498	50	91	100	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2012	31	46					4878	4887		10.1038/onc.2011.641	http://dx.doi.org/10.1038/onc.2011.641			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	038YT	22330138				2022-12-25	WOS:000311210700008
J	Zhao, HT; Wang, XX; Zhu, DD; Cui, SJ; Li, X; Cao, Y; Ma, LG				Zhao, Hongtao; Wang, Xiaoxue; Zhu, Dandan; Cui, Sujuan; Li, Xia; Cao, Ying; Ma, Ligeng			A Single Amino Acid Substitution in IIIf Subfamily of Basic Helix-Loop-Helix Transcription Factor AtMYC1 Leads to Trichome and Root Hair Patterning Defects by Abolishing Its Interaction with Partner Proteins in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-CELL DIFFERENTIATION; RECEPTOR-LIKE KINASE; FUNCTIONAL DIVERSITY; BHLH PROTEINS; FACTOR FAMILY; GENE ENCODES; MYB GENES; THALIANA; EXPRESSION; INITIATION	Plant trichomes and root hairs are powerful models for the study of cell fate determination. In Arabidopsis thaliana, trichome and root hair initiation requires a combination of three groups of proteins, including the WD40 repeat protein TRANSPARENT TESTA GLABRA1 (TTG1), R2R3 repeat MYB protein GLABRA1 (GL1), or WEREWOLF (WER) and the IIIf subfamily of basic helix-loop-helix (bHLH) protein GLABRA3 (GL3) or ENHANCER OF GLABRA3 (EGL3). The bHLH component acts as a docking site for TTG1 and MYB proteins. Here, we isolated a mutant showing defects in trichome and root hair patterning that carried a point mutation (R173H) in AtMYC1 that encodes the fourth member of IIIf bHLH family protein. Genetic analysis revealed partial redundant yet distinct function between AtMYC1 and GL3/EGL3. GLABRA2 (GL2), an important transcription factor involved in trichome and root hair control, was down-regulated in Atmyc1 plants, suggesting the requirement of AtMYC1 for appropriate GL2 transcription. Like its homologs, AtMYC1 formed a complex with TTG1 and MYB proteins but did not dimerized. In addition, the interaction of AtMYC1 with MYB proteins and TTG1 was abrogated by the R173H substitution in Atmyc1-1. We found that this amino acid (Arg) is conserved in the AtMYC1 homologs GL3/EGL3 and that it is essential for their interaction with MYB proteins and for their proper functions. Our findings indicate that AtMYC1 is an important regulator of trichome and root hair initiation, and they reveal a novel amino acid necessary for protein-protein interactions and gene function in IIIf subfamily bHLH transcription factors.	[Zhao, Hongtao; Zhu, Dandan; Cui, Sujuan; Cao, Ying; Ma, Ligeng] Hebei Normal Univ, Coll Biol Sci, Hebei Key Lab Mol Cell Biol, Shijiazhuang 050016, Hebei, Peoples R China; [Ma, Ligeng] Capital Normal Univ, Coll Life Sci, Beijing 100048, Peoples R China; [Zhao, Hongtao; Li, Xia] Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Agr Resources, State Key Lab Plant Cell & Chromosome Engn, Shijiazhuang 050021, Hebei, Peoples R China; [Wang, Xiaoxue] Natl Inst Biol Sci, Beijing 102206, Peoples R China	Hebei Normal University; Capital Normal University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; National Institute of Biological Sciences, Beijing	Ma, LG (corresponding author), Hebei Normal Univ, Coll Biol Sci, Hebei Key Lab Mol Cell Biol, Shijiazhuang 050016, Hebei, Peoples R China.	Ligeng.ma@mail.hebtu.edu.cn	li, xia/HHZ-7468-2022		China MOST 973 Project [2012CB910900, 2012CB114200]; Hebei Province key laboratory	China MOST 973 Project; Hebei Province key laboratory	This work was supported by China MOST 973 Project Grants 2012CB910900 and 2012CB114200 and by the Hebei Province key laboratory program.	Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Balkunde R, 2010, CURR TOP DEV BIOL, V91, P299, DOI 10.1016/S0070-2153(10)91010-7; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Baudry A, 2006, PLANT J, V46, P768, DOI 10.1111/j.1365-313X.2006.02733.x; Bernhardt C, 2005, DEVELOPMENT, V132, P291, DOI 10.1242/dev.01565; Bernhardt C, 2003, DEVELOPMENT, V130, P6431, DOI 10.1242/dev.00880; Cao Y, 2008, PLANT CELL, V20, P2586, DOI 10.1105/tpc.108.062760; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coletta A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-43; CONE KC, 1986, P NATL ACAD SCI USA, V83, P9631, DOI 10.1073/pnas.83.24.9631; Di Cristina M, 1996, PLANT J, V10, P393, DOI 10.1046/j.1365-313X.1996.10030393.x; Digiuni S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.54; Dolan L, 2006, J EXP BOT, V57, P51, DOI 10.1093/jxb/erj037; Esch JJ, 2004, PLANT J, V40, P860, DOI 10.1111/j.1365-313X.2004.02259.x; Esch JJ, 2003, DEVELOPMENT, V130, P5885, DOI 10.1242/dev.00812; Feller A, 2006, J BIOL CHEM, V281, P28964, DOI 10.1074/jbc.M603262200; Gallet X, 2000, J MOL BIOL, V302, P917, DOI 10.1006/jmbi.2000.4092; GOFF SA, 1992, GENE DEV, V6, P864, DOI 10.1101/gad.6.5.864; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; HULSKAMP M, 1994, CELL, V76, P555, DOI 10.1016/0092-8674(94)90118-X; Ishida T, 2008, ANNU REV PLANT BIOL, V59, P365, DOI 10.1146/annurev.arplant.59.032607.092949; Kirik V, 2005, DEVELOPMENT, V132, P1477, DOI 10.1242/dev.01708; Kirik V, 2004, PLANT MOL BIOL, V55, P389, DOI 10.1007/s11103-004-0893-8; Kirik V, 2004, DEV BIOL, V268, P506, DOI 10.1016/j.ydbio.2003.12.037; Kwak SH, 2005, SCIENCE, V307, P1111, DOI 10.1126/science.1105373; Kwak SH, 2007, DEV BIOL, V302, P118, DOI 10.1016/j.ydbio.2006.09.009; Kwak SH, 2008, PLANT SIGNAL BEHAV, V3, P110, DOI 10.4161/psb.3.2.4969; Kwak SH, 2008, CURR BIOL, V18, P1949, DOI 10.1016/j.cub.2008.10.064; Larkin JC, 1996, DEVELOPMENT, V122, P997; LARKIN JC, 1994, PLANT CELL, V6, P1065, DOI 10.1105/tpc.6.8.1065; Lee MM, 2001, DEVELOPMENT, V128, P1539; Lukowitz W, 2000, PLANT PHYSIOL, V123, P795, DOI 10.1104/pp.123.3.795; Maes L, 2008, PLANT PHYSIOL, V148, P1453, DOI 10.1104/pp.108.125385; Morohashi K, 2007, PLANT PHYSIOL, V145, P736, DOI 10.1104/pp.107.104521; Morohashi K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000396; Nesi N, 2000, PLANT CELL, V12, P1863, DOI 10.1105/tpc.12.10.1863; Ohashi Y, 2002, PLANT J, V29, P359, DOI 10.1046/j.0960-7412.2001.01214.x; Payne CT, 2000, GENETICS, V156, P1349; Pesch M, 2009, CURR OPIN PLANT BIOL, V12, P587, DOI 10.1016/j.pbi.2009.07.015; RERIE WG, 1994, GENE DEV, V8, P1388, DOI 10.1101/gad.8.12.1388; Schellmann S, 2002, EMBO J, V21, P5036, DOI 10.1093/emboj/cdf524; Simon M, 2007, DEV BIOL, V311, P566, DOI 10.1016/j.ydbio.2007.09.001; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Symonds VV, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002069; Szymanski DB, 1998, DEVELOPMENT, V125, P1161; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Tominaga R, 2008, DEVELOPMENT, V135, P1335, DOI 10.1242/dev.017947; Tominaga-Wada R, 2011, INT REV CEL MOL BIO, V286, P67, DOI 10.1016/B978-0-12-385859-7.00002-1; Urao T, 1996, PLANT MOL BIOL, V32, P571, DOI 10.1007/BF00019112; Wada T, 1997, SCIENCE, V277, P1113, DOI 10.1126/science.277.5329.1113; Wada T, 2002, DEVELOPMENT, V129, P5409, DOI 10.1242/dev.00111; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang SC, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-81; Wang ZJ, 2009, PLANT MOL BIOL, V69, P121, DOI 10.1007/s11103-008-9411-8; Wester K, 2009, DEVELOPMENT, V136, P1487, DOI 10.1242/dev.021733; Yoshida Y, 2009, DEVELOPMENT, V136, P1039, DOI 10.1242/dev.030585; Zhang F, 2003, DEVELOPMENT, V130, P4859, DOI 10.1242/dev.00681; Zhao M, 2008, DEVELOPMENT, V135, P1991, DOI 10.1242/dev.016873; Zimmermann IM, 2004, PLANT J, V40, P22, DOI 10.1111/j.1365-313X.2004.02183.x	59	56	70	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14109	14121		10.1074/jbc.M111.280735	http://dx.doi.org/10.1074/jbc.M111.280735			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22334670	Green Published, hybrid			2022-12-25	WOS:000303996300064
J	Yang, Z; Drew, DP; Jorgensen, B; Mandel, U; Bach, SS; Ulvskov, P; Levery, SB; Bennett, EP; Clausen, H; Petersen, BL				Yang, Zhang; Drew, Damian P.; Jorgensen, Bodil; Mandel, Ulla; Bach, Soren S.; Ulvskov, Peter; Levery, Steven B.; Bennett, Eric P.; Clausen, Henrik; Petersen, Bent L.			Engineering Mammalian Mucin-type O-Glycosylation in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-SUGAR TRANSPORTERS; POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; ENDOPLASMIC-RETICULUM; THERAPEUTIC PROTEINS; ARABIDOPSIS-THALIANA; GOLGI-APPARATUS; IN-VIVO; NICOTIANA-BENTHAMIANA; PROLYL 4-HYDROXYLASE; GALNAC-TRANSFERASES	Mucin-type O-glycosylation is an important post-translational modification that confers a variety of biological properties and functions to proteins. This post-translational modification has a particularly complex and differentially regulated biosynthesis rendering prediction and control of where O-glycans are attached to proteins, and which structures are formed, difficult. Because plants are devoid of GalNAc-type O-glycosylation, we have assessed requirements for establishing human GalNAc O-glycosylation de novo in plants with the aim of developing cell systems with custom-designed O-glycosylation capacity. Transient expression of a Pseudomonas aeruginosa Glc(NAc) C4-epimerase and a human polypeptide GalNActransferase in leaves of Nicotiana benthamiana resulted in GalNAc O-glycosylation of co-expressed human O-glycoprotein substrates. A chimeric YFP construct containing a 3.5 tandem repeat sequence of MUC1 was glycosylated with up to three and five GalNAc residues when co-expressed with GalNAc-T2 and a combination of GalNAc-T2 and GalNAc-T4, respectively, as determined by mass spectrometry. O-Glycosylation was furthermore demonstrated on a tandem repeat of MUC16 and interferon alpha 2b. In plants, prolines in certain classes of proteins are hydroxylated and further substituted with plant-specific O-glycosylation; unsubstituted hydroxyprolines were identified in our MUC1 construct. In summary, this study demonstrates that mammalian type O-glycosylation can be established in plants and that plants may serve as a host cell for production of recombinant O-glycoproteins with custom-designed O-glycosy-lation. The observed hydroxyproline modifications, however, call for additional future engineering efforts.	[Drew, Damian P.; Bach, Soren S.; Ulvskov, Peter; Petersen, Bent L.] Univ Copenhagen, Dept Plant Biol & Biotechnol, Fac Life Sci, DK-1871 Frederiksberg C, Denmark; [Jorgensen, Bodil] Univ Copenhagen, Dept Agr & Ecol, Fac Life Sci, DK-1871 Frederiksberg C, Denmark; [Yang, Zhang] Aarhus Univ, Fac Agr Sci, Dept Genet & Biotechnol, DK-4200 Slagelse, Denmark; [Mandel, Ulla; Levery, Steven B.; Bennett, Eric P.; Clausen, Henrik] Univ Copenhagen, Dept Cellular Med, Ctr Glyc, DK-2200 Copenhagen N, Denmark; [Mandel, Ulla; Levery, Steven B.; Bennett, Eric P.; Clausen, Henrik] Univ Copenhagen, Dept Mol Med, Ctr Glyc, DK-2200 Copenhagen N, Denmark; [Mandel, Ulla; Levery, Steven B.; Bennett, Eric P.; Clausen, Henrik] Univ Copenhagen, Fac Hlth Sci, Sch Dent, DK-2200 Copenhagen N, Denmark	University of Copenhagen; University of Copenhagen; Aarhus University; University of Copenhagen; University of Copenhagen; University of Copenhagen	Petersen, BL (corresponding author), Univ Copenhagen, Dept Plant Biol & Biotechnol, Fac Life Sci, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Denmark.	blp@life.ku.dk	Jørgensen, Bodil/F-6551-2014; Bennett, Eric/AAG-6120-2020; Petersen, Bent/H-9437-2014; clausen, henrik/AAD-8016-2021; Ulvskov, Peter/I-1228-2014; Yang, Zhang/I-8934-2016	Jørgensen, Bodil/0000-0002-0453-1277; Bennett, Eric/0000-0002-4976-0647; Petersen, Bent/0000-0002-2004-9077; Ulvskov, Peter/0000-0003-3776-818X; Clausen, Henrik/0000-0002-0915-5055; Mandel, Ulla/0000-0001-7012-9836; Yang, Zhang/0000-0002-4756-5813	Danish Council for Strategic Research [DSF 09-063090]; Danish Council for Independent Research [DFF 09-066624/274-09-0314]; University of Copenhagen	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); University of Copenhagen	This work was supported by Danish Council for Strategic Research Grant DSF 09-063090, Danish Council for Independent Research Grant DFF 09-066624/274-09-0314, and a program of excellence from the University of Copenhagen.	Alonso AP, 2010, PLANT PHYSIOL, V153, P915, DOI 10.1104/pp.110.155713; Amano K, 2008, P NATL ACAD SCI USA, V105, P3232, DOI 10.1073/pnas.0710412105; Bennett E. P., 2011, GLYCOBIOLOGY, DOI [10.1093/glcob/cwr1182, DOI 10.1093/GLCOB/CWR1182]; Bennett EP, 1998, J BIOL CHEM, V273, P30472, DOI 10.1074/jbc.273.46.30472; Berninsone P, 1998, ANN NY ACAD SCI, V842, P91, DOI 10.1111/j.1749-6632.1998.tb09636.x; Berninsone PM, 2000, CURR OPIN STRUC BIOL, V10, P542, DOI 10.1016/S0959-440X(00)00128-7; Blixt O, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2841; Castilho A, 2010, J BIOL CHEM, V285, P15923, DOI 10.1074/jbc.M109.088401; Creuzenet C, 2000, J BIOL CHEM, V275, P19060, DOI 10.1074/jbc.M001171200; Daskalova SM, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-62; de Felipe P, 2004, TRAFFIC, V5, P616, DOI 10.1111/j.1398-9219.2004.00205.x; DeFrees S, 2006, GLYCOBIOLOGY, V16, P833, DOI 10.1093/glycob/cwl004; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Egelund J, 2007, PLANT MOL BIOL, V64, P439, DOI 10.1007/s11103-007-9162-y; El Amrani A, 2004, PLANT PHYSIOL, V135, P16, DOI 10.1104/pp.103.032649; Elliott S, 2003, NAT BIOTECHNOL, V21, P414, DOI 10.1038/nbt799; Gerlach JQ, 2011, ADV EXP MED BIOL, V705, P257, DOI 10.1007/978-1-4419-7877-6_12; Gerngross TU, 2004, NAT BIOTECHNOL, V22, P1409, DOI 10.1038/nbt1028; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Gomord V, 2004, CURR OPIN PLANT BIOL, V7, P171, DOI 10.1016/j.pbi.2004.01.015; Halpin C, 2005, PLANT BIOTECHNOL J, V3, P141, DOI 10.1111/j.1467-7652.2004.00113.x; Handford M, 2006, BRAZ J MED BIOL RES, V39, P1149, DOI 10.1590/S0100-879X2006000900002; Hashimoto K, 2009, CARBOHYD RES, V344, P881, DOI 10.1016/j.carres.2009.03.001; Henrissat B., 2009, ESSENTIALS GLYCOBIOL, P89; Hieta R, 2002, J BIOL CHEM, V277, P23965, DOI 10.1074/jbc.M201865200; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; Joshi L, 2005, CURR OPIN PLANT BIOL, V8, P223, DOI 10.1016/j.pbi.2005.01.003; Karnoup AS, 2005, GLYCOBIOLOGY, V15, P965, DOI 10.1093/glycob/cwi077; Kaulfurst-Soboll H, 2011, J BIOL CHEM, V286, P22955, DOI 10.1074/jbc.M110.196097; Keskiaho K, 2007, PLANT CELL, V19, P256, DOI 10.1105/tpc.106.042739; Kieliszewski M. J., 2010, ANN PLANT REV, P321, DOI DOI 10.1002/9781444391015.CH13; Kilcoyne M, 2009, J PLANT PHYSIOL, V166, P219, DOI 10.1016/j.jplph.2008.05.007; Kishimoto T, 1999, ARCH BIOCHEM BIOPHYS, V370, P271, DOI 10.1006/abbi.1999.1406; Kuroda K, 2008, APPL ENVIRON MICROB, V74, P446, DOI 10.1128/AEM.02106-07; Lamport DTA, 2011, PLANT PHYSIOL, V156, P11, DOI 10.1104/pp.110.169011; Liang Y, 2010, PLANT PHYSIOL, V154, P632, DOI 10.1104/pp.110.160051; Liu L, 2010, SEMIN CELL DEV BIOL, V21, P600, DOI 10.1016/j.semcdb.2010.02.002; MITSUI T, 1990, PLANT CELL PHYSIOL, V31, P15; Nagels B, 2011, PLANT PHYSIOL, V155, P1103, DOI 10.1104/pp.110.168773; Nour-Eldin HH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl635; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; Pedersen JW, 2011, J BIOL CHEM, V286, P32684, DOI 10.1074/jbc.M111.273722; Petersen BL, 2009, GLYCOCONJUGATE J, V26, P1235, DOI 10.1007/s10719-009-9242-0; Pinkhasov J, 2011, PLANT BIOTECHNOL J, V9, P991, DOI 10.1111/j.1467-7652.2011.00614.x; Pogue GP, 2010, PLANT BIOTECHNOL J, V8, P638, DOI 10.1111/j.1467-7652.2009.00495.x; Reaves M. L., 2011, Research in Plant Biology, V1, P49; Sabbatini PJ, 2007, CLIN CANCER RES, V13, P4170, DOI 10.1158/1078-0432.CCR-06-2949; Sainsbury F, 2008, PLANT PHYSIOL, V148, P1212, DOI 10.1104/pp.108.126284; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Schoberer J, 2011, MOL PLANT, V4, P220, DOI 10.1093/mp/ssq082; Segawa H, 2002, EUR J BIOCHEM, V269, P128, DOI 10.1046/j.0014-2956.2001.02632.x; Seveno M, 2004, NAT BIOTECHNOL, V22, P1351, DOI 10.1038/nbt1104-1351; Shah MM, 2003, NAT BIOTECHNOL, V21, P1470, DOI 10.1038/nbt912; Sorensen AL, 2006, GLYCOBIOLOGY, V16, P96, DOI 10.1093/glycob/cwj044; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tarp MA, 2007, GLYCOBIOLOGY, V17, P197, DOI 10.1093/glycob/cwl061; Tarp MA, 2008, BBA-GEN SUBJECTS, V1780, P546, DOI 10.1016/j.bbagen.2007.09.010; Tiainen P, 2005, J BIOL CHEM, V280, P1142, DOI 10.1074/jbc.M411109200; Velasquez SM, 2011, SCIENCE, V332, P1401, DOI 10.1126/science.1206657; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wandall HH, 2010, CANCER RES, V70, P1306, DOI 10.1158/0008-5472.CAN-09-2893; WHITE T, 1995, J BIOL CHEM, V270, P24156, DOI 10.1074/jbc.270.41.24156; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Yin BJ, 2011, PROTEIN CELL, V2, P41, DOI 10.1007/s13238-011-1007-4; YIP CL, 1994, P NATL ACAD SCI USA, V91, P2723, DOI 10.1073/pnas.91.7.2723; Yuasa K, 2005, PLANT J, V41, P81, DOI 10.1111/j.1365-313X.2004.02279.x; Zeleny R, 2006, PLANTA, V224, P222, DOI 10.1007/s00425-005-0206-8	69	44	46	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11911	11923		10.1074/jbc.M111.312918	http://dx.doi.org/10.1074/jbc.M111.312918			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334671	hybrid, Green Published			2022-12-25	WOS:000302782200030
J	Culurgioni, S; Munoz, IG; Moreno, A; Palacios, A; Villate, M; Palmero, I; Montoya, G; Blanco, FJ				Culurgioni, Simone; Munoz, Ines G.; Moreno, Alberto; Palacios, Alicia; Villate, Maider; Palmero, Ignacio; Montoya, Guillermo; Blanco, Francisco J.			Crystal Structure of Inhibitor of Growth 4 (ING4) Dimerization Domain Reveals Functional Organization of ING Family of Chromatin-binding Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR ING4; HISTONE H3K4ME3 RECOGNITION; PLANT HOMEODOMAIN; SPLICE VARIANTS; COILED-COIL; CELL-GROWTH; PHD FINGER; GENE; CANCER; ACETYLATION	The protein ING4 binds to histone H3 trimethylated at Lys-4 (H3K4me3) through its C-terminal plant homeodomain, thus recruiting the HBO1 histone acetyltransferase complex to target promoters. The structure of the plant homeodomain finger bound to an H3K4me3 peptide has been described, as well as the disorder and flexibility in the ING4 central region. We report the crystal structure of the ING4 N-terminal domain, which shows an antiparallel coiled-coil homodimer with each protomer folded into a helix-loop-helix structure. This arrangement suggests that ING4 can bind simultaneously two histone tails on the same or different nucleosomes. Dimerization has a direct impact on ING4 tumor suppressor activity because monomeric mutants lose the ability to induce apoptosis after genotoxic stress. Homology modeling based on the ING4 structure suggests that other ING dimers may also exist.	[Munoz, Ines G.; Montoya, Guillermo] UAM, CSIC, Macromol Crystallog Grp, Spanish Natl Canc Ctr CNIO, E-28029 Madrid, Spain; [Moreno, Alberto; Palmero, Ignacio] UAM, CSIC, Inst Invest Biomed, E-28029 Madrid, Spain; [Blanco, Francisco J.] Basque Fdn Sci, IKERBASQUE, E-48011 Bilbao, Spain; [Culurgioni, Simone; Palacios, Alicia; Villate, Maider; Blanco, Francisco J.] CIC BioGUNE, Struct Biol Unit, E-48160 Derio, Spain	Autonomous University of Madrid; Centro Nacional de Investigaciones Oncologicas (CNIO); Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Basque Foundation for Science; CIC bioGUNE	Montoya, G (corresponding author), CNIO, Melchor Fernandez Almagro 3, E-28029 Madrid, Spain.	gmontoya@cnio.es; fblanco@cicbiogune.es	Munoz, Ines G/M-3285-2014; cancer, biogune/H-7276-2012; Blanco, Francisco J/D-4401-2009; Ortega, Alicia Palacios/F-7710-2019; Palmero, Ignacio/B-4346-2013; Ortega, Alicia Palacios/AAD-4449-2020	Munoz, Ines G/0000-0001-6732-4059; Blanco, Francisco J/0000-0003-2545-4319; Ortega, Alicia Palacios/0000-0002-7906-1417; Ortega, Alicia Palacios/0000-0002-7906-1417	Spanish Ministerio de Ciencia e Innovacion [SAF2009-09031, BFU2011-23815, CSD2006-00023, CTQ2011-28680]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by Spanish Ministerio de Ciencia e Innovacion Grants SAF2009-09031 (to I. P.), BFU2011-23815 and CSD2006-00023 (to G. M.), and CTQ2011-28680 (to F. J. B.).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Amoutzias GD, 2008, TRENDS BIOCHEM SCI, V33, P220, DOI 10.1016/j.tibs.2008.02.002; BANNER DW, 1987, J MOL BIOL, V196, P657, DOI 10.1016/0022-2836(87)90039-8; BOHRMANN B, 1993, ULTRAMICROSCOPY, V49, P235, DOI 10.1016/0304-3991(93)90230-U; Champagne KS, 2008, PROTEINS, V72, P1371, DOI 10.1002/prot.22140; Coles AH, 2009, J CELL PHYSIOL, V218, P45, DOI 10.1002/jcp.21583; Culurgioni S, 2010, ACTA CRYSTALLOGR F, V66, P567, DOI 10.1107/S1744309110010080; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Dutta K, 2001, PROTEIN SCI, V10, P2531, DOI 10.1110/ps.ps.28801; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garkavtsev I, 2004, NATURE, V428, P328, DOI 10.1038/nature02329; Goeman F, 2005, MOL CELL BIOL, V25, P422, DOI 10.1128/MCB.25.1.422-431.2005; Gonzalez L, 2006, ONCOGENE, V25, P5173, DOI 10.1038/sj.onc.1209526; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; He GHY, 2005, MOL BIOL EVOL, V22, P104, DOI 10.1093/molbev/msh256; Hung T, 2009, MOL CELL, V33, P248, DOI 10.1016/j.molcel.2008.12.016; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim S, 2004, P NATL ACAD SCI USA, V101, P16251, DOI 10.1073/pnas.0407158101; Li XM, 2009, J CANCER RES CLIN, V135, P829, DOI 10.1007/s00432-008-0519-7; Liu J, 2006, P NATL ACAD SCI USA, V103, P15457, DOI 10.1073/pnas.0604871103; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Moreno A, 2010, CARCINOGENESIS, V31, P1932, DOI 10.1093/carcin/bgq171; MORGAN RS, 1978, INT J PEPT PROT RES, V11, P209; Nozell S, 2008, MOL CELL BIOL, V28, P6632, DOI 10.1128/MCB.00697-08; Ozer A, 2005, P NATL ACAD SCI USA, V102, P7481, DOI 10.1073/pnas.0502716102; Palacios A, 2008, J BIOL CHEM, V283, P15956, DOI 10.1074/jbc.M710020200; Palacios A, 2006, FEBS LETT, V580, P6903, DOI 10.1016/j.febslet.2006.11.055; Palacios A, 2010, J MOL BIOL, V396, P1117, DOI 10.1016/j.jmb.2009.12.049; Palmero I, 2002, ONCOGENE, V21, P2939, DOI 10.1038/sj/onc/1205371; Palmero I, 2001, METHOD ENZYMOL, V333, P247; Pena PV, 2008, J MOL BIOL, V380, P303, DOI 10.1016/j.jmb.2008.04.061; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Raho G, 2007, ONCOGENE, V26, P5247, DOI 10.1038/sj.onc.1210335; Russell M, 2006, EXP CELL RES, V312, P951, DOI 10.1016/j.yexcr.2006.01.020; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Scovassi AI, 2004, BIOCHEM PHARMACOL, V68, P1041, DOI 10.1016/j.bcp.2004.04.023; Shen JC, 2007, CANCER RES, V67, P2552, DOI 10.1158/0008-5472.CAN-06-3870; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shiseki M, 2003, CANCER RES, V63, P2373; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Unoki M, 2006, J BIOL CHEM, V281, P34677, DOI 10.1074/jbc.M606296200; Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254; VIGUERA AR, 1995, BIOCHEMISTRY-US, V34, P8771, DOI 10.1021/bi00027a028; Wang YM, 2006, FEBS LETT, V580, P3787, DOI 10.1016/j.febslet.2006.05.065; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	48	19	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10876	10884		10.1074/jbc.M111.330001	http://dx.doi.org/10.1074/jbc.M111.330001			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334692	hybrid, Green Published			2022-12-25	WOS:000302780100016
J	Sun, LL; Chen, YX; Rajendran, C; Mueller, U; Panjikar, S; Wang, MT; Mindnich, R; Rosenthal, C; Penning, TM; Stoockigt, J				Sun, Lianli; Chen, Yixin; Rajendran, Chitra; Mueller, Uwe; Panjikar, Santosh; Wang, Meitian; Mindnich, Rebekka; Rosenthal, Cindy; Penning, Trevor M.; Stoeckigt, Joachim			Crystal Structure of Perakine Reductase, Founding Member of a Novel Aldo-Keto Reductase (AKR) Subfamily That Undergoes Unique Conformational Changes during NADPH Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-ANALYSIS; STRICTOSIDINE SYNTHASE; FUNCTIONAL EXPRESSION; DIFFRACTION DATA; ACTIVE-SITE; DEHYDROGENASE; ENZYME; BIOSYNTHESIS; CLONING; IDENTIFICATION	Background: Perakine reductase (PR) is an AKR involved in the Rauvolfia alkaloid biosynthetic network. Results: Three-dimensional structures of PR and the A213W mutant complex with NADPH were solved. Conclusion: PR folds as an unusual alpha(8)/beta(6) barrel and undergoes unexpected conformational changes upon NADPH binding. Significance: PR represents the founding member of the new AKR13D subfamily and provides a structural and cofactor binding template for the AKR13 family.	[Sun, Lianli; Chen, Yixin; Stoeckigt, Joachim] Zhejiang Univ, Coll Pharmaceut Sci, Inst Mat Med, Hangzhou 310058, Zhejiang, Peoples R China; [Rajendran, Chitra; Wang, Meitian] Paul Scherrer Inst, Swiss Light Source PX 3, CH-5232 Villigen, Switzerland; [Mueller, Uwe] Elektronenspeicherring BESSY II, BESSY MX, Soft Matter & Funct Mat, Macromol Crystallog, D-12489 Berlin, Germany; [Panjikar, Santosh] Australian Synchrotron, Clayton, Vic 3168, Australia; [Mindnich, Rebekka; Penning, Trevor M.] Univ Penn, Sch Med, Ctr Excellence Environm Toxicol, Philadelphia, PA 19104 USA; [Mindnich, Rebekka; Penning, Trevor M.] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Rosenthal, Cindy] Johannes Gutenberg Univ Mainz, Dept Pharmaceut Biol, Inst Pharm, D-55128 Mainz, Germany	Zhejiang University; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); University of Pennsylvania; University of Pennsylvania; Johannes Gutenberg University of Mainz	Stoockigt, J (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Inst Mat Med, Yuhangtang Rd 388, Hangzhou 310058, Zhejiang, Peoples R China.	joesto2000@yahoo.com	Panjikar, Santosh/D-2709-2012; Wang, Meitian/D-3208-2013; Mueller, Uwe/B-6293-2013	Panjikar, Santosh/0000-0001-7429-3879; Penning, Trevor/0000-0002-3937-1066; Wang, Meitian/0000-0002-5340-3036	Fonds der Chemischen Industrie (Frankfurt/Main, Germany); Deutsche Forschungsgemeinschaft (Bad Godesberg, Germany); Zhejiang University K.P. Chao's Hi-Tech Foundation (Hangzhou, China); China Postdoctoral Science Foundation [20100471745]	Fonds der Chemischen Industrie (Frankfurt/Main, Germany)(Fonds der Chemischen Industrie); Deutsche Forschungsgemeinschaft (Bad Godesberg, Germany)(German Research Foundation (DFG)); Zhejiang University K.P. Chao's Hi-Tech Foundation (Hangzhou, China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by funds from Fonds der Chemischen Industrie (Frankfurt/Main, Germany), Deutsche Forschungsgemeinschaft (Bad Godesberg, Germany), Zhejiang University K.P. Chao's Hi-Tech Foundation (Hangzhou, China; to J. S.), and China Postdoctoral Science Foundation Grant 20100471745 (to L. S.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bennett MJ, 1996, BIOCHEMISTRY-US, V35, P10702, DOI 10.1021/bi9604688; Cordell G.A., 1981, INTRO ALKALOIDS BIOG; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Di Costanzo L, 2008, J BIOL CHEM, V283, P16830, DOI 10.1074/jbc.M801778200; Edwankar RV, 2011, ORG LETT, V13, P5216, DOI 10.1021/ol202101p; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faucher F, 2006, J MOL BIOL, V364, P747, DOI 10.1016/j.jmb.2006.09.030; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Hicks MA, 2011, PROTEINS, V79, P3082, DOI 10.1002/prot.23135; Jez JM, 1997, BIOCHEM J, V326, P625, DOI 10.1042/bj3260625; Jin Y, 2007, ANNU REV PHARMACOL, V47, P263, DOI 10.1146/annurev.pharmtox.47.120505.105337; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kiesecker C, 2004, N-S ARCH PHARMACOL, V370, P423, DOI 10.1007/s00210-004-0976-8; Lee HY, 2009, CHEM BIOL, V16, P1225, DOI 10.1016/j.chembiol.2009.11.016; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Loris EA, 2007, CHEM BIOL, V14, P979, DOI 10.1016/j.chembiol.2007.08.009; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Olsen JG, 2008, PROTEINS, V71, P1572, DOI 10.1002/prot.21996; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; PERSSON B, 1991, EUR J BIOCHEM, V200, P537, DOI 10.1111/j.1432-1033.1991.tb16215.x; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Richter N, 2010, J MOL BIOL, V404, P353, DOI 10.1016/j.jmb.2010.09.049; Rosenthal C, 2006, ACTA CRYSTALLOGR F, V62, P1286, DOI 10.1107/S174430910605041X; Runguphan W, 2010, NATURE, V468, P461, DOI 10.1038/nature09524; Ruppert M, 2005, CURR ORG CHEM, V9, P1431, DOI 10.2174/138527205774370540; RYPNIEWSKI WR, 1993, BIOCHEMISTRY-US, V32, P9851, DOI 10.1021/bi00088a041; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanli G, 2001, J MOL BIOL, V309, P1209, DOI 10.1006/jmbi.2001.4739; Sauter NK, 2010, J APPL CRYSTALLOGR, V43, P611, DOI 10.1107/S0021889810010782; Schlegel BP, 1998, BIOCHEMISTRY-US, V37, P3538, DOI 10.1021/bi9723055; Scoble J, 2010, J MOL BIOL, V398, P26, DOI 10.1016/j.jmb.2010.02.021; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Simpson PJ, 2009, J MOL BIOL, V392, P465, DOI 10.1016/j.jmb.2009.07.023; Stockigt J, 2008, PLANT PHYSIOL BIOCH, V46, P340, DOI 10.1016/j.plaphy.2007.12.011; Sun LL, 2008, PLANT MOL BIOL, V67, P455, DOI 10.1007/s11103-008-9331-7; Sundaram K, 2011, BIOORG MED CHEM LETT, V21, P801, DOI 10.1016/j.bmcl.2010.11.086; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Unterlinner B, 1999, PLANT J, V18, P465, DOI 10.1046/j.1365-313X.1999.00470.x; Yang LQ, 2009, ANGEW CHEM INT EDIT, V48, P5211, DOI 10.1002/anie.200900150; Zou HB, 2010, CHEM-ASIAN J, V5, P2400, DOI 10.1002/asia.201000520; Zuckerkandl E., 1965, EVOLVING GENES PROTE, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	46	10	12	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11213	11221		10.1074/jbc.M111.335521	http://dx.doi.org/10.1074/jbc.M111.335521			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334702	Green Published, hybrid			2022-12-25	WOS:000302780100049
J	Stringer, B; Udofa, EA; Antalis, TM				Stringer, Brett; Udofa, Ekemini A.; Antalis, Toni M.			Regulation of the Human Plasminogen Activator Inhibitor Type 2 Gene COOPERATION OF AN UPSTREAM SILENCER AND TRANSACTIVATOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; TRANSCRIPTION FACTORS; CELL-PROLIFERATION; SERPIN SUPERFAMILY; JUN FAMILY; FOS-JUN; KAPPA-B; EXPRESSION; AP-1; INDUCTION	Transcriptional up-regulation of the plasminogen activator inhibitor type-2 (PAI-2) gene is a major response to cellular stress. The expression of PAI-2 is induced by a variety of cytokines and growth factors that act in a cell type-and differentiation stage-dependent manner. We previously reported that the human SERPINB2 gene promoter is controlled by three major transcription regulatory domains: an inducible proximal promoter, an upstream silencer (PAUSE-1), and a distal transactivator region between -5100 and -3300, which appears to overcome inhibition mediated by the silencer. The distal transactivator region is inducible by the phorbol ester PMA, a potent activator of the protein kinase C (PKC) pathway that is a powerful inducer of PAI-2 gene expression in monocytes, macrophages, and myelomonocytic cells as well as in epidermal keratinocytes. Here we show that a 21-bp region (-4952/-4932), containing an AP-1 element, is both necessary and sufficient for PMA-induced transactivator activity in PAI-2-expressing U937 cells. This site specifically binds FosB in PAI-2expressing U937 cells but not in HeLa cells that do not express PAI-2, and overexpression of FosB, c-Fos, or c-Jun in HeLa cells is sufficient to cause derepression of transcription from the SERPINB2 promoter. Although FosB is likely to be involved in transactivator-mediated derepression of PAI-2 transcription in macrophage-like cells, as exemplified by the U937 cell line, c-Jun may be functional in other cell types. These data suggest a model for the transcriptional control of the human PAI-2 gene and further our understanding of the molecular basis for its tissue-specific expression.	[Udofa, Ekemini A.; Antalis, Toni M.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Udofa, Ekemini A.; Antalis, Toni M.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; Univ Queensland, Brisbane, Qld 4029, Australia; Queensland Inst Med Res, Brisbane, Qld 4029, Australia	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Queensland; QIMR Berghofer Medical Research Institute	Antalis, TM (corresponding author), Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, 800 W Baltimore St, Baltimore, MD 21201 USA.	tantalis@som.umaryland.edu	Stringer, Brett/GZB-1390-2022	Riley, Ekemini/0000-0001-7040-5191; Stringer, Brett/0000-0003-4552-9736	National Institutes of Health [R01CA098369]; National Health and Medical Research Council, Australia; NATIONAL CANCER INSTITUTE [R01CA098369, P30CA134274, R56CA098369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA098369. This work was also supported by the National Health and Medical Research Council, Australia.	Andela VB, 2000, CANCER RES, V60, P6557; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; ANTALIS TM, 1991, NUCLEIC ACIDS RES, V19, P4301, DOI 10.1093/nar/19.15.4301; Antalis TM, 1996, BLOOD, V88, P3686, DOI 10.1182/blood.V88.10.3686.bloodjournal88103686; ANTALIS TM, 1993, GENE, V134, P201, DOI 10.1016/0378-1119(93)90094-J; Beikler T, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-30; Chambers SK, 1997, INT J CANCER, V74, P571, DOI 10.1002/(SICI)1097-0215(19971219)74:6<571::AID-IJC2>3.3.CO;2-Z; CHIU R, 1987, NATURE, V329, P648, DOI 10.1038/329648a0; COUSIN E, 1991, NUCLEIC ACIDS RES, V19, P3881, DOI 10.1093/nar/19.14.3881; Croucher DR, 2008, NAT REV CANCER, V8, P535, DOI 10.1038/nrc2400; DICKINSON JA, 1995, CELL IMMUNOL, V165, P92, DOI 10.1006/cimm.1995.1191; DICKINSON JL, 1995, J BIOL CHEM, V270, P27894, DOI 10.1074/jbc.270.46.27894; Doyle GAR, 1997, J BIOL CHEM, V272, P11840, DOI 10.1074/jbc.272.18.11840; EDBROOKE MR, 1989, MOL CELL BIOL, V9, P1908, DOI 10.1128/MCB.9.5.1908; GAN HX, 1995, J IMMUNOL, V155, P1304; Ganesh S, 1997, BRIT J CANCER, V75, P1793, DOI 10.1038/bjc.1997.306; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; KAWANO T, 1968, NATURE, V217, P253, DOI 10.1038/217253a0; KRUITHOF EKO, 1995, BLOOD, V86, P4007, DOI 10.1182/blood.V86.11.4007.bloodjournal86114007; KRUITHOF EKO, 1988, BIOCHEM BIOPH RES CO, V156, P383, DOI 10.1016/S0006-291X(88)80852-0; KUMAR S, 1991, J BIOL CHEM, V266, P20960; LAMPH WW, 1988, NATURE, V334, P629, DOI 10.1038/334629a0; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Liberati NT, 1999, P NATL ACAD SCI USA, V96, P4844, DOI 10.1073/pnas.96.9.4844; LYONSGIORDANO B, 1994, HISTOCHEMISTRY, V101, P105, DOI 10.1007/BF00269356; Medcalf RL, 2005, FEBS J, V272, P4858, DOI 10.1111/j.1742-4658.2005.04879.x; Medcalf RL, 2011, METHOD ENZYMOL, V499, P105, DOI 10.1016/B978-0-12-386471-0.00006-7; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; Musashi M, 2000, INT J HEMATOL, V72, P12; Nordengren J, 2002, INT J CANCER, V97, P379, DOI 10.1002/ijc.1611; Ogbourne SM, 2001, NUCLEIC ACIDS RES, V29, P3919, DOI 10.1093/nar/29.19.3919; Ohkuchi A, 2001, AM J REPROD IMMUNOL, V46, P252, DOI 10.1034/j.1600-0897.2001.d01-10.x; Park JM, 2005, IMMUNITY, V23, P319, DOI 10.1016/j.immuni.2005.08.010; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; PULVERER BJ, 1993, ONCOGENE, V8, P407; Rajaram N, 1997, EMBO J, V16, P2917, DOI 10.1093/emboj/16.10.2917; Ramirez-Carrozzi VR, 2001, J MOL BIOL, V305, P411, DOI 10.1006/jmbi.2000.4286; Risse BC, 1998, HISTOCHEM CELL BIOL, V110, P559, DOI 10.1007/s004180050318; Roes EM, 2002, AM J OBSTET GYNECOL, V187, P1019, DOI 10.1067/mob.2002.126280; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Schroder WA, 2010, PARASITE IMMUNOL, V32, P764, DOI 10.1111/j.1365-3024.2010.01241.x; Shafren DR, 1999, J VIROL, V73, P7193, DOI 10.1128/JVI.73.9.7193-7198.1999; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Smith R, 2007, WORLD J SURG, V31, P493, DOI 10.1007/s00268-006-0289-9; Welter JF, 1995, ONCOGENE, V11, P2681; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; YOSHIOKA K, 1995, P NATL ACAD SCI USA, V92, P4972, DOI 10.1073/pnas.92.11.4972; Zhou HM, 2001, CANCER RES, V61, P970	51	9	10	3	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10579	10589		10.1074/jbc.M111.318758	http://dx.doi.org/10.1074/jbc.M111.318758			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22334683	Green Published, hybrid			2022-12-25	WOS:000302167200083
J	Corkrey, R; Olley, J; Ratkowsky, D; McMeekin, T; Ross, T				Corkrey, Ross; Olley, June; Ratkowsky, David; McMeekin, Tom; Ross, Tom			Universality of Thermodynamic Constants Governing Biological Growth Rates	PLOS ONE			English	Article							PROTEIN-FOLDING THERMODYNAMICS; HEAT-CAPACITY CHANGE; TEMPERATURE-DEPENDENCE; GLOBULAR-PROTEINS; ESCHERICHIA-COLI; ELEVATED-TEMPERATURES; DENATURATION; BACTERIA; SIZE; DISSOLUTION	Background: Mathematical models exist that quantify the effect of temperature on poikilotherm growth rate. One family of such models assumes a single rate-limiting 'master reaction' using terms describing the temperature-dependent denaturation of the reaction's enzyme. We consider whether such a model can describe growth in each domain of life. Methodology/Principal Findings: A new model based on this assumption and using a hierarchical Bayesian approach fits simultaneously 95 data sets for temperature-related growth rates of diverse microorganisms from all three domains of life, Bacteria, Archaea and Eukarya. Remarkably, the model produces credible estimates of fundamental thermodynamic parameters describing protein thermal stability predicted over 20 years ago. Conclusions/Significance: The analysis lends support to the concept of universal thermodynamic limits to microbial growth rate dictated by protein thermal stability that in turn govern biological rates. This suggests that the thermal stability of proteins is a unifying property in the evolution and adaptation of life on earth. The fundamental nature of this conclusion has importance for many fields of study including microbiology, protein chemistry, thermal biology, and ecological theory including, for example, the influence of the vast microbial biomass and activity in the biosphere that is poorly described in current climate models.	[Corkrey, Ross; Olley, June; Ratkowsky, David; McMeekin, Tom; Ross, Tom] Univ Tasmania, Sch Agr Sci, Tasmanian Inst Agr, Hobart, Tas, Australia	University of Tasmania	Corkrey, R (corresponding author), Univ Tasmania, Sch Agr Sci, Tasmanian Inst Agr, Hobart, Tas, Australia.	scorkrey@utas.edu.au	Corkrey, Ross/D-8999-2012; Corkrey, Stephen/C-2424-2014	Corkrey, Stephen/0000-0002-2242-2891; Ross, Tom/0000-0001-9916-7772				[Anonymous], MARCH 2008 WORKSH; BILLING E, 1974, J APPL BACTERIOL, V37, P643, DOI 10.1111/j.1365-2672.1974.tb00488.x; Brooks SP, 1998, J ROY STAT SOC D-STA, V47, P69, DOI 10.1111/1467-9884.00117; CHIB S, 1995, AM STAT, V49, P327, DOI 10.2307/2684568; Clarke A, 2004, FUNCT ECOL, V18, P243, DOI 10.1111/j.0269-8463.2004.00841.x; COULTATE TP, 1975, J BACTERIOL, V121, P55, DOI 10.1128/JB.121.1.55-64.1975; Dell AI, 2011, P NATL ACAD SCI USA, V108, P10591, DOI 10.1073/pnas.1015178108; Franks F, DESCRIPTION CLASSIFI; Gilks W.R., 1996, MARKOV CHAIN MONTE C, P89; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gillooly JF, 2002, NATURE, V417, P70, DOI 10.1038/417070a; Graziano G, 2008, J THERM ANAL CALORIM, V93, P429, DOI 10.1007/s10973-007-8698-z; Graziano G, 1998, THERMOCHIM ACTA, V321, P23, DOI 10.1016/S0040-6031(98)00435-3; Graziano G, 1996, J AM CHEM SOC, V118, P1831, DOI 10.1021/ja9521942; Gur E, 2002, MOL MICROBIOL, V46, P1391, DOI 10.1046/j.1365-2958.2002.03257.x; Haario H, 2001, BERNOULLI, V7, P223, DOI 10.2307/3318737; Hanu FJ, 1962, J BACTERIOL, V95, P736; Honda S, 2004, STRUCTURE, V12, P1507, DOI 10.1016/j.str.2004.05.022; INGRAHAM JL, 1958, J BACTERIOL, V76, P75, DOI 10.1128/JB.76.1.75-80.1958; Isaac NJB, 2010, ECOL LETT, V13, P728, DOI 10.1111/j.1461-0248.2010.01461.x; Jiang X, 2000, PROTEIN SCI, V9, P403; JOHNSON FH, 1946, J CELL COMPAR PHYSL, V28, P47, DOI 10.1002/jcp.1030280104; Kimball J, 2006, PROTEINS; Knies JL, 2010, AM NAT, V176, P227, DOI 10.1086/653662; Liu L, 2000, BIOPHYS CHEM, V84, P239, DOI 10.1016/S0301-4622(00)00130-7; MAKHATADZE GI, 1993, J MOL BIOL, V232, P639, DOI 10.1006/jmbi.1993.1416; McCrary BS, 1996, J MOL BIOL, V264, P784, DOI 10.1006/jmbi.1996.0677; McMeekin TA, PREDICTIVE MICROBIOL; MENNETT RH, 1971, APPL MICROBIOL, V22, P772, DOI 10.1128/AEM.22.5.772-776.1971; MURPHY KP, 1990, SCIENCE, V247, P559, DOI 10.1126/science.2300815; NG H, 1962, J BACTERIOL, V84, P331, DOI 10.1128/JB.84.2.331-339.1962; Price PB, 2004, P NATL ACAD SCI USA, V101, P4631, DOI 10.1073/pnas.0400522101; PRIVALOV PL, 1988, ADV PROTEIN CHEM, V39, P191; PRIVALOV PL, 1993, J MOL BIOL, V232, P660, DOI 10.1006/jmbi.1993.1417; Ragone R, 2004, PROTEINS, V54, P323, DOI 10.1002/prot.10574; RAISON JK, 1973, J BIOENERG, V4, P285, DOI 10.1007/BF01516063; Raison JK, 1973, RATE CONTROL BIOL PR, V27, P485; Ratkowsky DA, 2005, J THEOR BIOL, V233, P351, DOI 10.1016/j.jtbi.2004.10.016; RON EZ, 1990, ANTON LEEUW INT J G, V58, P169, DOI 10.1007/BF00548929; Savage VM, 2004, AM NAT, V163, P429, DOI 10.1086/381872; Serra A, 2005, INT J FOOD MICROBIOL, V104, P257, DOI 10.1016/j.ijfoodmicro.2005.03.006; SHAW MK, 1967, J BACTERIOL, V93, P1332, DOI 10.1128/JB.93.4.1332-1336.1967; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Zhang JZ, 2000, TRENDS GENET, V16, P107, DOI 10.1016/S0168-9525(99)01922-8	44	52	52	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e32003	10.1371/journal.pone.0032003	http://dx.doi.org/10.1371/journal.pone.0032003			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348140	Green Published, Green Submitted, gold			2022-12-25	WOS:000302737400058
J	Nakamura, S; Imai, S; Ogishima, H; Tsuruma, K; Shimazawa, M; Hara, H				Nakamura, Shinsuke; Imai, Shunsuke; Ogishima, Hiromi; Tsuruma, Kazuhiro; Shimazawa, Masamitsu; Hara, Hideaki			Morphological and Functional Changes in the Retina after Chronic Oxygen-Induced Retinopathy	PLOS ONE			English	Article							OSCILLATORY POTENTIALS; DIABETIC-RETINOPATHY; MILD RETINOPATHY; B-WAVE; BARRIER FUNCTION; MUDPUPPY RETINA; TIGHT JUNCTIONS; PRIMATE RETINA; MOUSE RETINA; PREMATURITY	The mouse model of oxygen-induced retinopathy (OIR) has been widely used for studies of retinopathy of prematurity (ROP). This disorder, characterized by abnormal vascularization of the retina, tends to occur in low birth weight neonates after exposure to high supplemental oxygen. Currently, the incidence of ROP is increasing because of increased survival of these infants due to medical progress. However, little is known about changes in the chronic phase after ROP. Therefore, in this study, we examined morphological and functional changes in the retina using a chronic OIR model. Both the a- and b-waves in the OIR model recovered in a time-dependent manner at 4 weeks (w), 6 w, and 8 w, but the oscillatory potential (OP) amplitudes remained depressed following a return to normoxic conditions. Furthermore, decrease in the thicknesses of the inner plexiform layer (IPL) and inner nuclear layer (INL) at postnatal day (P) 17, 4 w, and 8 w and hyperpermeability of blood vessels were observed in conjunction with the decrease in the expression of claudin-5 and occludin at 8 w. The chronic OIR model revealed the following: (1) a decrease in OP amplitudes, (2) morphological abnormalities in the retinal cells (limited to the IPL and INL) and blood vessels, and (3) an increase in retinal vascular permeability via the impairment of the tight junction proteins. These findings suggest that the experimental animal model used in this study is suitable for elucidating the pathogenesis of ROP and may lead to the development of potential therapeutic agents for ROP treatment.	[Nakamura, Shinsuke; Imai, Shunsuke; Ogishima, Hiromi; Tsuruma, Kazuhiro; Shimazawa, Masamitsu; Hara, Hideaki] Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan	Gifu Pharmaceutical University	Nakamura, S (corresponding author), Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan.	hidehara@gifu-pu.ac.jp			Gifu Pharmaceutical University	Gifu Pharmaceutical University	Funding was provided by Gifu Pharmaceutical University. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamis AP, 2002, BRIT J OPHTHALMOL, V86, P363, DOI 10.1136/bjo.86.4.363; Akula JD, 2007, INVEST OPHTH VIS SCI, V48, P5788, DOI 10.1167/iovs.07-0881; Banin E, 2006, INVEST OPHTH VIS SCI, V47, P2125, DOI 10.1167/iovs.05-1096; Bui Bang Viet, 2002, Documenta Ophthalmologica, V104, P17, DOI 10.1023/A:1014401502915; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Chen YH, 1997, J CELL BIOL, V138, P891, DOI 10.1083/jcb.138.4.891; Chikaraishi Y, 2007, EXP EYE RES, V84, P529, DOI 10.1016/j.exer.2006.11.007; Cideciyan AV, 1996, VISION RES, V36, P2609, DOI 10.1016/0042-6989(95)00327-4; Cunha-Vaz JG, 1997, DOC OPHTHALMOL, V93, P149, DOI 10.1007/BF02569055; Dembinska O, 2001, INVEST OPHTH VIS SCI, V42, P1111; DICK E, 1978, BRAIN RES, V154, P388; Downie LE, 2007, J COMP NEUROL, V504, P404, DOI 10.1002/cne.21449; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Fulton AB, 2001, ARCH OPHTHALMOL-CHIC, V119, P499; Fulton AB, 1996, J OPT SOC AM A, V13, P566, DOI 10.1364/JOSAA.13.000566; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; GARIANO RF, 1994, INVEST OPHTH VIS SCI, V35, P3442; Gilbert C, 2001, B WORLD HEALTH ORGAN, V79, P227; Greenstein VC, 2000, INVEST OPHTH VIS SCI, V41, P3643; Hansen RM, 2000, INVEST OPHTH VIS SCI, V41, P320; HARA A, 1994, DOC OPHTHALMOL, V88, P39, DOI 10.1007/BF01203700; HEYNEN H, 1985, VISION RES, V25, P1365, DOI 10.1016/0042-6989(85)90214-7; HOLOPIGIAN K, 1992, INVEST OPHTH VIS SCI, V33, P2773; HOOD DC, 1994, INVEST OPHTH VIS SCI, V35, P2948; Imai S, 2010, J PHARMACOL EXP THER, V335, P645, DOI 10.1124/jpet.110.171298; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kaur C, 2008, PROG RETIN EYE RES, V27, P622, DOI 10.1016/j.preteyeres.2008.09.003; KOROL S, 1975, BRAIN RES, V97, P235, DOI 10.1016/0006-8993(75)90447-3; Koto T, 2007, AM J PATHOL, V170, P1389, DOI 10.2353/ajpath.2007.060693; Lelong DC, 2007, STROKE, V38, P3237, DOI 10.1161/STROKEAHA.107.499319; LI CX, 1990, J CELL SCI, V97, P231; Liu K, 2006, INVEST OPHTH VIS SCI, V47, P5447, DOI 10.1167/iovs.06-0702; Liu K, 2006, INVEST OPHTH VIS SCI, V47, P2639, DOI 10.1167/iovs.06-0016; MILLER RF, 1970, J NEUROPHYSIOL, V33, P323, DOI 10.1152/jn.1970.33.3.323; Moskowitz A, 2005, DOC OPHTHALMOL, V110, P265, DOI 10.1007/s10633-005-1983-x; Nakamura S, 2010, EXP EYE RES, V90, P137, DOI 10.1016/j.exer.2009.09.022; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Rangaswamy NV, 2006, INVEST OPHTH VIS SCI, V47, P753, DOI 10.1167/iovs.05-1051; Recchia FM, 2010, INVEST OPHTH VIS SCI, V51, P1098, DOI 10.1167/iovs.09-4006; Reisner DS, 1997, INVEST OPHTH VIS SCI, V38, P1175; REYNAUD X, 1995, INVEST OPHTH VIS SCI, V36, P2071; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; TAILOI CL, 1992, INVEST OPHTH VIS SCI, V33, P2148; Uemura AK, 2006, EXP CELL RES, V312, P676, DOI 10.1016/j.yexcr.2005.10.030; Wachtmeister L, 1998, PROG RETIN EYE RES, V17, P485, DOI 10.1016/S1350-9462(98)00006-8; Williams LA, 1999, MOL IMMUNOL, V36, P1175, DOI 10.1016/S0161-5890(99)00122-4; XU XJ, 1994, J NEUROPHYSIOL, V72, P96, DOI 10.1152/jn.1994.72.1.96; YONEMURA D, 1962, ARCH OPHTHALMOL-CHIC, V68, P19; Zhang SX, 2005, AM J PATHOL, V166, P313, DOI 10.1016/S0002-9440(10)62255-9	51	36	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e32167	10.1371/journal.pone.0032167	http://dx.doi.org/10.1371/journal.pone.0032167			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348151	Green Submitted, Green Published, gold			2022-12-25	WOS:000302737400064
J	Anderson, DE; Castan, A; Bisaillon, M; von Messling, V				Anderson, Danielle E.; Castan, Alexandre; Bisaillon, Martin; von Messling, Veronika			Elements in the Canine Distemper Virus M 3 ' UTR Contribute to Control of Replication Efficiency and Virulence	PLOS ONE			English	Article							MESSENGER-RNA; WILD-TYPE; UNTRANSLATED REGIONS; F GENE; PROTEIN EXPRESSION; MEASLES VIRUSES; GENOME REGION; DISEASE VIRUS; TRANSCRIPTION; CYTOPATHOGENICITY	Canine distemper virus (CDV) is a negative-sense, single-stranded RNA virus within the genus Morbillivirus and the family Paramyxoviridae. The Morbillivirus genome is composed of six transcriptional units that are separated by untranslated regions (UTRs), which are relatively uniform in length, with the exception of the UTR between the matrix (M) and fusion (F) genes. This UTR is at least three times longer and in the case of CDV also highly variable. Exchange of the M-F region between different CDV strains did not affect virulence or disease phenotype, demonstrating that this region is functionally interchangeable. Viruses carrying the deletions in the M 3' UTR replicated more efficiently, which correlated with a reduction of virulence, suggesting that overall length as well as specific sequence motifs distributed throughout the region contribute to virulence.	[Anderson, Danielle E.; Castan, Alexandre; von Messling, Veronika] Univ Quebec, INRS Inst Armand Frappier, Laval, PQ, Canada; [Anderson, Danielle E.; von Messling, Veronika] Duke NUS Grad Med Sch, Emerging Infect Dis Program, Singapore, Singapore; [Bisaillon, Martin] Univ Sherbrooke, Sherbrooke, PQ J1K 2R1, Canada	University of Quebec; Institut national de la recherche scientifique (INRS); National University of Singapore; University of Sherbrooke	Anderson, DE (corresponding author), Univ Quebec, INRS Inst Armand Frappier, Laval, PQ, Canada.	veronika.vonmessling@duke-nus.edu.sg	Anderson, Danielle/HCH-2004-2022	Anderson, Danielle/0000-0003-4791-5024	Canadian Institutes of Health Research (CIHR) [MOP-66989]; Canadian Foundation for Innovation (CFI) [9488]; Fonds de la Recherche en Sante Quebec (FRSQ); Fondation Armand-Frappier Scholarship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Fonds de la Recherche en Sante Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Fondation Armand-Frappier Scholarship	This work was supported by grants from the Canadian Institutes of Health Research (CIHR; MOP-66989) and the Canadian Foundation for Innovation (CFI; 9488) to V.v.M., a Fonds de la Recherche en Sante Quebec (FRSQ) fellowship to D.E.A, and a Fondation Armand-Frappier Scholarship to A.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini AAV, 2006, SCIENCE, V313, P360, DOI 10.1126/science.1125280; Anderson DE, 2008, J VIROL, V82, P10510, DOI 10.1128/JVI.01419-08; Baricevic M, 2007, VIRUS GENES, V35, P17, DOI 10.1007/s11262-006-0035-2; Bonami F, 2007, J VIROL, V81, P12066, DOI 10.1128/JVI.00818-07; CALAIN P, 1993, J VIROL, V67, P4822, DOI 10.1128/JVI.67.8.4822-4830.1993; Cathomen T, 1995, VIROLOGY, V214, P628, DOI 10.1006/viro.1995.0075; Cherpillod P, 1999, J VIROL, V73, P2263, DOI 10.1128/JVI.73.3.2263-2269.1999; Cherpillod P, 2004, ARCH VIROL, V149, P1971, DOI 10.1007/s00705-004-0342-7; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Devaux P, 2007, VIROLOGY, V360, P72, DOI 10.1016/j.virol.2006.09.049; Heider A, 1997, ARCH VIROL, V142, P2521, DOI 10.1007/s007050050259; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Kim SH, 2010, J VIROL, V84, P2629, DOI 10.1128/JVI.02049-09; Liermann H, 1998, VIRUS GENES, V17, P259, DOI 10.1023/A:1008069805011; Liu Y, 2009, BBA-GENE REGUL MECH, V1789, P495, DOI 10.1016/j.bbagrm.2009.09.007; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; Moretti S, 2008, NUCLEIC ACIDS RES, V36, pW10, DOI 10.1093/nar/gkn278; Parks GD, 2001, J VIROL, V75, P2213, DOI 10.1128/JVI.75.5.2213-2223.2001; Perez JT, 2010, P NATL ACAD SCI USA, V107, P11525, DOI 10.1073/pnas.1001984107; Plumet S, 2005, J VIROL, V79, P6900, DOI 10.1128/JVI.79.11.6900-6908.2005; Rennick LJ, 2007, J GEN VIROL, V88, P2710, DOI 10.1099/vir.0.83106-0; Rudd PA, 2006, J VIROL, V80, P9361, DOI 10.1128/JVI.01034-06; SIDHU MS, 1995, VIROLOGY, V208, P800, DOI 10.1006/viro.1995.1215; Siemetzki U, 2009, VIRUS RES, V144, P27, DOI 10.1016/j.virusres.2009.03.016; Takeda M, 2005, J VIROL, V79, P14346, DOI 10.1128/JVI.79.22.14346-14354.2005; Valsamakis A, 1998, J VIROL, V72, P7754, DOI 10.1128/JVI.72.10.7754-7761.1998; von Messling V, 2001, J VIROL, V75, P6418, DOI 10.1128/JVI.75.14.6418-6427.2001; von Messling V, 2004, P NATL ACAD SCI USA, V101, P14216, DOI 10.1073/pnas.0403597101; von Messling V, 2003, J VIROL, V77, P12579, DOI 10.1128/JVI.77.23.12579-12591.2003; von Messling V, 2002, J VIROL, V76, P4172, DOI 10.1128/JVI.76.9.4172-4180.2002; von Messling V, 1999, J CLIN MICROBIOL, V37, P1049, DOI 10.1128/JCM.37.4.1049-1056.1999; von Messling V, 2006, J VIROL, V80, P6084, DOI 10.1128/JVI.00357-06; Wiener D, 2010, VIRUS RES, V153, P234, DOI 10.1016/j.virusres.2010.08.007; Yan YQ, 2009, J VIROL, V83, P5943, DOI 10.1128/JVI.00188-09; ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181	35	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31561	10.1371/journal.pone.0031561	http://dx.doi.org/10.1371/journal.pone.0031561			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348107	Green Published, Green Submitted, gold			2022-12-25	WOS:000302733900054
J	Hensel, N; Ratzka, A; Brinkmann, H; Klimaschewski, L; Grothe, C; Claus, P				Hensel, Niko; Ratzka, Andreas; Brinkmann, Hella; Klimaschewski, Lars; Grothe, Claudia; Claus, Peter			Analysis of the Fibroblast Growth Factor System Reveals Alterations in a Mouse Model of Spinal Muscular Atrophy	PLOS ONE			English	Article							SEVERE SMA MICE; SIGNALING PATHWAYS; SURVIVAL FACTOR; NEUROTROPHIC FACTORS; MOTONEURON PROTEIN; NEURITE OUTGROWTH; SINGLE NUCLEOTIDE; FACTOR RECEPTOR-1; SKELETAL-MUSCLE; GENE-EXPRESSION	The monogenetic disease Spinal Muscular Atrophy (SMA) is characterized by a progressive loss of motoneurons leading to muscle weakness and atrophy due to severe reduction of the Survival of Motoneuron (SMN) protein. Several models of SMA show deficits in neurite outgrowth and maintenance of neuromuscular junction (NMJ) structure. Survival of motoneurons, axonal outgrowth and formation of NMJ is controlled by neurotrophic factors such as the Fibroblast Growth Factor (FGF) system. Besides their classical role as extracellular ligands, some FGFs exert also intracellular functions controlling neuronal differentiation. We have previously shown that intracellular FGF-2 binds to SMN and regulates the number of a subtype of nuclear bodies which are reduced in SMA patients. In the light of these findings, we systematically analyzed the FGF-system comprising five canonical receptors and 22 ligands in a severe mouse model of SMA. In this study, we demonstrate widespread alterations of the FGF-system in both muscle and spinal cord. Importantly, FGF-receptor 1 is upregulated in spinal cord at a pre-symptomatic stage as well as in a mouse motoneuron-like cell-line NSC34 based model of SMA. Consistent with that, phosphorylations of FGFR-downstream targets Akt and ERK are increased. Moreover, ERK hyper-phosphorylation is functionally linked to FGFR-1 as revealed by receptor inhibition experiments. Our study shows that the FGF system is dysregulated at an early stage in SMA and may contribute to the SMA pathogenesis.	[Hensel, Niko; Ratzka, Andreas; Brinkmann, Hella; Grothe, Claudia; Claus, Peter] Hannover Med Sch, Inst Neuroanat, D-3000 Hannover, Germany; [Hensel, Niko; Grothe, Claudia; Claus, Peter] Ctr Syst Neurosci, Hannover, Germany; [Klimaschewski, Lars] Innsbruck Med Univ, Div Neuroanat, Innsbruck, Austria	Hannover Medical School; Medical University of Innsbruck	Hensel, N (corresponding author), Hannover Med Sch, Inst Neuroanat, D-3000 Hannover, Germany.	claus.peter@mh-hannover.de	Ratzka, Andreas/H-7917-2012; Claus, Peter/A-7978-2008; Klimaschewski, Lars/AAR-2384-2020	Claus, Peter/0000-0003-3824-9445; Klimaschewski, Lars/0000-0003-3211-0047	German National Academic Foundation; Deutsche Forschungsgemeinschaft (DFG)	German National Academic Foundation; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The work was partially financed by the German National Academic Foundation. Publications costs were sponsored (Open Access Publication) by the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bosch-Marce M, 2011, HUM MOL GENET, V20, P1844, DOI 10.1093/hmg/ddr067; Bowerman M, 2010, HUM MOL GENET, V19, P1468, DOI 10.1093/hmg/ddq021; Bruns AF, 2009, P NATL ACAD SCI USA, V106, P12747, DOI 10.1073/pnas.0900122106; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chan YB, 2003, HUM MOL GENET, V12, P1367, DOI 10.1093/hmg/ddg157; Chang HCH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003209; Claus P, 2003, J BIOL CHEM, V278, P479, DOI 10.1074/jbc.M206056200; Claus P, 2004, BIOCHEM J, V384, P559, DOI 10.1042/BJ20040801; COLEMAN ME, 1995, J BIOL CHEM, V270, P12109, DOI 10.1074/jbc.270.20.12109; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Eash J, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-32; Ehrenreiter K, 2005, J CELL BIOL, V168, P955, DOI 10.1083/jcb.200409162; Garces A, 2000, J NEUROSCI RES, V60, P1, DOI 10.1002/(SICI)1097-4547(20000401)60:1<1::AID-JNR1>3.0.CO;2-P; Gavrilina TO, 2008, HUM MOL GENET, V17, P1063, DOI 10.1093/hmg/ddm379; Gringel S, 2004, BIOL CHEM, V385, P1203, DOI 10.1515/BC.2004.156; GROTHE C, 1992, J NEUROSCI RES, V32, P317, DOI 10.1002/jnr.490320304; Grothe C, 1996, DEV DYNAM, V206, P310, DOI 10.1002/(SICI)1097-0177(199607)206:3<310::AID-AJA8>3.0.CO;2-L; Guettier-Sigrist S, 2002, MUSCLE NERVE, V25, P700, DOI 10.1002/mus.10081; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Hausott B, 2008, NEUROSCIENCE, V153, P461, DOI 10.1016/j.neuroscience.2008.01.083; Hausott B, 2009, ANAT REC, V292, P1976, DOI 10.1002/ar.20964; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; HUGHES RA, 1993, NEURON, V10, P369, DOI 10.1016/0896-6273(93)90327-N; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; Jungnickel J, 2005, NEUROSCIENCE, V134, P1343, DOI 10.1016/j.neuroscience.2005.04.066; Kuninger D, 2006, AM J PHYSIOL-CELL PH, V291, pC699, DOI 10.1152/ajpcell.00056.2006; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Li PP, 2011, MOL BIOL CELL, V22, P2480, DOI 10.1091/mbc.E11-03-0198; Lin WF, 2009, CELL SIGNAL, V21, P1060, DOI 10.1016/j.cellsig.2009.02.009; Lingor P, 2008, BRAIN, V131, P250, DOI 10.1093/brain/awm284; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Marics I, 2002, DEVELOPMENT, V129, P4559; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Martinez-Hernandez R, 2009, J NEUROPATH EXP NEUR, V68, P474, DOI 10.1097/NEN.0b013e3181a10ea1; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; Medhurst AD, 2000, J NEUROSCI METH, V98, P9, DOI 10.1016/S0165-0270(00)00178-3; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Mutsaers CA, 2011, HUM MOL GENET, V20, P4334, DOI 10.1093/hmg/ddr360; Nakamua S, 1999, GLIA, V28, P53, DOI 10.1002/(SICI)1098-1136(199910)28:1<53::AID-GLIA7>3.0.CO;2-V; Nolle A, 2011, HUM MOL GEN IN PRESS, DOI [10.1093/hmg/ddr1425, DOI 10.1093/HMG/DDR1425]; Rajendra TK, 2007, J CELL BIOL, V176, P831, DOI 10.1083/jcb.200610053; Ratzka A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023564; Riessland M, 2010, HUM MOL GENET, V19, P1492, DOI 10.1093/hmg/ddq023; Sen A, 2011, J CELL BIOL, V192, P481, DOI 10.1083/jcb.201004016; Shafey D, 2005, EXP CELL RES, V311, P49, DOI 10.1016/j.yexcr.2005.08.019; Skaper SD, 2000, J NEUROCHEM, V75, P1520, DOI 10.1046/j.1471-4159.2000.0751520.x; Slotkin TA, 2008, BRAIN RES BULL, V76, P424, DOI 10.1016/j.brainresbull.2008.01.001; Slotkin TA, 2007, ENVIRON HEALTH PERSP, V115, P909, DOI 10.1289/ehp.9901; Soundararajan P, 2010, J NEUROSCI, V30, P6595, DOI 10.1523/JNEUROSCI.4932-09.2010; Stachowiak MK, 2003, J CELL BIOCHEM, V90, P662, DOI 10.1002/jcb.10606; Steinberg F, 2010, J BIOL CHEM, V285, P2193, DOI 10.1074/jbc.M109.058248; Stewart CEH, 1996, J BIOL CHEM, V271, P11330, DOI 10.1074/jbc.271.19.11330; Subramaniam S, 2010, FEBS J, V277, P22, DOI 10.1111/j.1742-4658.2009.07367.x; Taylor JE, 1998, EUR J HUM GENET, V6, P467, DOI 10.1038/sj.ejhg.5200210; Umemori H, 2009, DEV GROWTH DIFFER, V51, P263, DOI 10.1111/j.1440-169X.2008.01079.x; van Bergeijk J, 2007, FASEB J, V21, P1492, DOI 10.1096/fj.06-7136com; Walker MP, 2008, HUM MOL GENET, V17, P3399, DOI 10.1093/hmg/ddn234; Weinstein M, 1998, DEVELOPMENT, V125, P3615; Weston CA, 2007, J CELL SCI, V120, P868, DOI 10.1242/jcs.03367; Wirth B, 2006, HUM GENET, V119, P422, DOI 10.1007/s00439-006-0156-7; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Zhao P, 2006, J BIOL CHEM, V281, P429, DOI 10.1074/jbc.M507440200	65	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31202	10.1371/journal.pone.0031202	http://dx.doi.org/10.1371/journal.pone.0031202			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348054	Green Published, gold, Green Submitted			2022-12-25	WOS:000302733900030
J	Laarakker, MC; Reinders, NR; Bruining, H; Ophoff, RA; Kas, MJH				Laarakker, Marijke C.; Reinders, Niels R.; Bruining, Hilgo; Ophoff, Roel A.; Kas, Martien J. H.			Sex-Dependent Novelty Response in Neurexin-1 alpha Mutant Mice	PLOS ONE			English	Article							GENDER-DIFFERENCES; SYNAPSE FORMATION; ALPHA-NEUREXINS; AUTISM; SCHIZOPHRENIA; DISORDERS; NEUROLIGIN-1; IMPAIRMENTS; VALIDATION; DISRUPTION	Neurexin-1 alpha (NRXN1 alpha) belongs to the family of cell adhesion molecules (CAMs), which are involved in the formation of neuronal networks and synapses. NRXN1 alpha gene mutations have been identified in neuropsychiatric diseases including Schizophrenia (SCZ) and Autism Spectrum Disorder (ASD). In order to get a better understanding of the pleiotropic behavioral manifestations caused by NRXN1 alpha gene mutations, we performed a behavioral study of Nrxn1 alpha heterozygous knock-out (+/-) mice and observed increased responsiveness to novelty and accelerated habituation to novel environments compared to wild type (+/+) litter-mates. However, this effect was mainly observed in male mice, strongly suggesting that gender-specific mechanisms play an important role in Nrxn1 alpha-induced phenotypes.	[Laarakker, Marijke C.; Reinders, Niels R.; Bruining, Hilgo; Kas, Martien J. H.] Univ Med Ctr Utrecht, Rudolf Magnus Inst, Div Neurosci, Dept Neurosci & Pharmacol, Utrecht, Netherlands; [Bruining, Hilgo; Ophoff, Roel A.] Univ Med Ctr Utrecht, Rudolf Magnus Inst, Div Neurosci, Dept Psychiat, Utrecht, Netherlands; [Ophoff, Roel A.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA USA	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of California System; University of California Los Angeles	Laarakker, MC (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst, Div Neurosci, Dept Neurosci & Pharmacol, Utrecht, Netherlands.	m.j.h.kas@umcutrecht.nl	Reinders, Niels/ABI-6180-2020; Kas, Martien J./G-8269-2018	Kas, Martien J./0000-0002-4471-8618				Betancur C, 2009, TRENDS NEUROSCI, V32, P402, DOI 10.1016/j.tins.2009.04.003; Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; Bucan M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000536; CASTLE DJ, 1995, SCHIZOPHRENIA BULL, V21, P1; Chechik G, 1999, NEURAL COMPUT, V11, P2061, DOI 10.1162/089976699300016089; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dudanova I, 2006, J NEUROSCI, V26, P10599, DOI 10.1523/JNEUROSCI.1913-06.2006; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; Frick KM, 2003, BEHAV NEUROSCI, V117, P1283, DOI 10.1037/0735-7044.117.6.1283; Gibson JR, 2009, J NEUROSCI, V29, P13883, DOI 10.1523/JNEUROSCI.2457-09.2009; Glynn D, 2003, HUM MOL GENET, V12, P2431, DOI 10.1093/hmg/ddg249; HATA Y, 1993, NEURON, V10, P307, DOI 10.1016/0896-6273(93)90320-Q; Hata Y, 1996, J NEUROSCI, V16, P2488; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kleinhans NM, 2009, AM J PSYCHIAT, V166, P467, DOI 10.1176/appi.ajp.2008.07101681; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Ko J, 2009, EMBO J, V28, P3244, DOI 10.1038/emboj.2009.249; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Miller BH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014458; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Mori A, 2002, NEUROSCI RES, V43, P251, DOI 10.1016/S0168-0102(02)00041-X; Palanza P, 2001, PHYSIOL BEHAV, V73, P411, DOI 10.1016/S0031-9384(01)00494-2; Perry W, 2009, ARCH GEN PSYCHIAT, V66, P1072, DOI 10.1001/archgenpsychiatry.2009.58; Prado VF, 2006, NEURON, V51, P601, DOI 10.1016/j.neuron.2006.08.005; Rinehart NJ, 2011, CURR TOP BEHAV NEURO, V8, P209, DOI 10.1007/7854_2010_96; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Shah AK, 2010, NEUROSCI LETT, V475, P80, DOI 10.1016/j.neulet.2010.03.047; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Takahashi A, 2008, GENES BRAIN BEHAV, V7, P849, DOI 10.1111/j.1601-183X.2008.00419.x; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; VANENGELAND H, 1991, PSYCHIAT RES, V38, P27, DOI 10.1016/0165-1781(91)90050-Y; Vrijenhoek T, 2008, AM J HUM GENET, V83, P504, DOI 10.1016/j.ajhg.2008.09.011; Yan J, 2008, NEUROSCI LETT, V438, P368, DOI 10.1016/j.neulet.2008.04.074; Zhang X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013093; Zweier C, 2009, AM J HUM GENET, V85, P655, DOI 10.1016/j.ajhg.2009.10.004	38	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31503	10.1371/journal.pone.0031503	http://dx.doi.org/10.1371/journal.pone.0031503			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348092	Green Submitted, gold, Green Published			2022-12-25	WOS:000302733900049
J	Lock, FE; Ryan, KR; Poulter, NS; Parsons, M; Hotchin, NA				Lock, Frances E.; Ryan, Katie R.; Poulter, Natalie S.; Parsons, Maddy; Hotchin, Neil A.			Differential Regulation of Adhesion Complex Turnover by ROCK1 and ROCK2	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; VENTRAL BODY-WALL; RHO-KINASE-II; TYROSINE PHOSPHORYLATION; KERATINOCYTE DIFFERENTIATION; MATRIX ADHESIONS; MIGRATING CELLS; FOCAL CONTACTS; DISTINCT ROLES; STRESS FIBERS	Background: ROCK1 and ROCK2 are serine/threonine kinases that function downstream of the small GTP-binding protein RhoA. Rho signalling via ROCK regulates a number of cellular functions including organisation of the actin cytoskeleton, cell adhesion and cell migration. Methodology/Principal Findings: In this study we use RNAi to specifically knockdown ROCK1 and ROCK2 and analyse their role in assembly of adhesion complexes in human epidermal keratinocytes. We observe that loss of ROCK1 inhibits signalling via focal adhesion kinase resulting in a failure of immature adhesion complexes to form mature stable focal adhesions. In contrast, loss of ROCK2 expression results in a significant reduction in adhesion complex turnover leading to formation of large, stable focal adhesions. Interestingly, loss of either ROCK1 or ROCK2 expression significantly impairs cell migration indicating both ROCK isoforms are required for normal keratinocyte migration. Conclusions: ROCK1 and ROCK2 have distinct and separate roles in adhesion complex assembly and turnover in human epidermal keratinocytes.	[Lock, Frances E.; Ryan, Katie R.; Poulter, Natalie S.; Hotchin, Neil A.] Univ Birmingham, Sch Biosci, Edgbaston, England; [Parsons, Maddy] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England	University of Birmingham; University of London; King's College London	Lock, FE (corresponding author), British Columbia Canc Agcy, Integrat Oncol Dept, Vancouver, BC V5Z 4E6, Canada.	n.a.hotchin@bham.ac.uk	Parsons, Maddy/B-2203-2013	Parsons, Maddy/0000-0002-2021-8379; Hotchin, Neil/0000-0002-1844-7607; Poulter, Natalie/0000-0002-3187-2130	Cancer Research UK [C20692]	Cancer Research UK(Cancer Research UK)	This work was funded by a Cancer Research UK Project Grant (C20692) to NAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Ballestrem C, 2001, J CELL BIOL, V155, P1319, DOI 10.1083/jcb.200107107; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; Chikumi H, 2002, J BIOL CHEM, V277, P12463, DOI 10.1074/jbc.M108504200; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Croft DR, 2006, MOL CELL BIOL, V26, P4612, DOI 10.1128/MCB.02061-05; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Del Re DP, 2008, J BIOL CHEM, V283, P35622, DOI 10.1074/jbc.M804036200; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; HOTCHIN NA, 1992, J BIOL CHEM, V267, P14852; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Iwanicki MP, 2008, J CELL SCI, V121, P895, DOI 10.1242/jcs.020941; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Le Boeuf F, 2004, J BIOL CHEM, V279, P39175, DOI 10.1074/jbc.M405493200; Le Boeuf F, 2006, MOL BIOL CELL, V17, P3508, DOI 10.1091/mbc.E05-12-1158; Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194; Lock FE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008190; McMullan R, 2003, CURR BIOL, V13, P2185, DOI 10.1016/S0960-9822(03)00906-0; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nakamura K, 2001, ONCOGENE, V20, P2626, DOI 10.1038/sj.onc.1204359; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Parsons M, 2008, J CELL SCI, V121, P265, DOI 10.1242/jcs.018440; Patla I, 2010, NAT CELL BIOL, V12, P909, DOI 10.1038/ncb2095; Ren XD, 2000, J CELL SCI, V113, P3673; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Shimizu Y, 2005, J CELL BIOL, V168, P941, DOI 10.1083/jcb.200411179; Thumkeo D, 2005, GENES CELLS, V10, P825, DOI 10.1111/j.1365-2443.2005.00882.x; Tomar A, 2009, CURR OPIN CELL BIOL, V21, P676, DOI 10.1016/j.ceb.2009.05.006; Tomar A, 2009, J CELL SCI, V122, P1852, DOI 10.1242/jcs.046870; Torsoni AS, 2005, AM J PHYSIOL-HEART C, V289, pH1488, DOI 10.1152/ajpheart.00692.2004; Vega FM, 2011, J CELL BIOL, V193, P655, DOI 10.1083/jcb.201011038; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Wiseman PW, 2004, J CELL SCI, V117, P5521, DOI 10.1242/jcs.01416; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Yoneda A, 2005, J CELL BIOL, V170, P443, DOI 10.1083/jcb.200412043; Yoneda A, 2007, MOL BIOL CELL, V18, P66, DOI 10.1091/mbc.E06-08-0684; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314	45	57	58	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31423	10.1371/journal.pone.0031423	http://dx.doi.org/10.1371/journal.pone.0031423			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348083	Green Published, gold, Green Submitted			2022-12-25	WOS:000302733900046
J	Martins, YC; Zanini, GM; Frangos, JA; Carvalho, LJM				Martins, Yuri C.; Zanini, Graziela M.; Frangos, John A.; Carvalho, Leonardo J. M.			Efficacy of Different Nitric Oxide-Based Strategies in Preventing Experimental Cerebral Malaria by Plasmodium berghei ANKA	PLOS ONE			English	Article							SEVERE FALCIPARUM-MALARIA; L-ARGININE; ENDOTHELIAL DYSFUNCTION; COGNITIVE IMPAIRMENT; FUNCTIONAL RECOVERY; CHILDREN; PHARMACOKINETICS; BIOAVAILABILITY; RAT; METABOLISM	Background: Low nitric oxide (NO) bioavailability plays a role in the pathogenesis of human as well as of experimental cerebral malaria (ECM) caused by Plasmodium berghei ANKA (PbA). ECM is partially prevented by administration of the NO-donor dipropylenetriamine NONOate (DPTA-NO) at high concentration (1 mg/mouse), which also induces major side effects such as a sharp drop in blood pressure. We asked whether alternative strategies to improve NO bioavailability with minor side effects would also be effective in preventing ECM. Methodology/Principal Findings: Mice were infected with PbA and prophylactically treated twice a day with bolus injections of L-arginine, N omega-hydroxy-nor-Arginine (nor-NOHA), tetrahydrobiopterin (BH4), separately or combined, sodium nitrite, sildenafil or sildenafil plus DPTA-NO starting on day 0 of infection. L-arginine and BH4 supplementation, with or without arginase inhibition by nor-NOHA, increased plasma nitrite levels but failed to protect against ECM development. Accordingly, prophylactic treatment with continuous delivery of L-arginine using osmotic pumps also did not improve survival. Similar outcomes were observed with sodium nitrite sildenafil (aimed at inhibiting phosphodiesterase-5) or with DPTA-NO. However, sildenafil (0.1 mg/mouse) in combination with a lower dose (0.1 mg/mouse) of DPTA-NO decreased ECM incidence (82 +/- 7.4% mortality in the saline group and 38 +/- 10.6% in the treated group; p<0.05). The combined prophylactic therapy did not aggravate anemia, had delayed effects in systolic, diastolic and mean arterial blood pressure and induced lower effects in pulse pressure when compared to DPTA-NO 1 mg/mouse. Conclusions/Significance: These data show that sildenafil lowers the amount of NO-donor needed to prevent ECM, resulting also in lesser side effects. Prophylactic L-arginine when given in bolus or continuous delivery and bolus BH4 supplementation, with or without arginase inhibition, were able to increase NO bioavailability in PbA-infected mice but failed to decrease ECM incidence in the doses and protocol used.	[Martins, Yuri C.; Zanini, Graziela M.; Frangos, John A.; Carvalho, Leonardo J. M.] La Jolla Bioengn Inst, Ctr Malaria Res, San Diego, CA USA; [Martins, Yuri C.] Univ Fed Rio de Janeiro, Inst Microbiol, Lab Inflammat & Immun, BR-21941 Rio De Janeiro, Brazil; [Zanini, Graziela M.] Fiocruz MS, Evandro Chagas Clin Res Inst, Parasitol Serv, BR-21045900 Rio De Janeiro, Brazil; [Carvalho, Leonardo J. M.] Fiocruz MS, Inst Oswaldo Cruz, Malaria Res Lab, BR-21045900 Rio De Janeiro, Brazil	La Jolla Bioengineering Institute; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Martins, YC (corresponding author), La Jolla Bioengn Inst, Ctr Malaria Res, San Diego, CA USA.	ymartins@ljbi.org	Carvalho, Leonardo J. M./K-7174-2013; Martins, Yuri Chaves/E-1637-2013	Martins, Yuri/0000-0003-4220-4979; Zanini, Graziela/0000-0003-4466-3124	National Institutes of Health [R01-HL087290, R01-HL087290-1 S1, R01-AI082610]; CNPq (Brazil); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082610] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (http://www.nih.gov) grants R01-HL087290, R01-HL087290-1 S1 and R01-AI082610 (LJMC). GMZ was recipient of a CNPq (Brazil; http://www.cnpq.br) post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstey NM, 1996, J EXP MED, V184, P557, DOI 10.1084/jem.184.2.557; Astrand A, 2004, AM J PHYSIOL-REG I, V287, pR749, DOI 10.1152/ajpregu.00134.2004; Boivin MJ, 2007, PEDIATRICS, V119, pE360, DOI 10.1542/peds.2006-2027; Boivin MJ, 2002, J DEV BEHAV PEDIATR, V23, P353, DOI 10.1097/00004703-200210000-00010; Bratt JM, 2010, TOXICOL APPL PHARM, V242, P1, DOI 10.1016/j.taap.2009.09.018; Cabrales P, 2011, J INFECT DIS; Cabrales P, 2010, AM J PATHOL, V176, P1306, DOI 10.2353/ajpath.2010.090691; CAMPISTRON G, 1982, EUR J DRUG METAB PH, V7, P307, DOI 10.1007/BF03189634; CAMPISTRON G, 1982, EUR J DRUG METAB PH, V7, P315, DOI 10.1007/BF03189635; Carvalho LJM, 2010, TRENDS PARASITOL, V26, P271, DOI 10.1016/j.pt.2010.03.001; Clemmer L, 2011, ANTIMICROB AGENTS CH, V55, P1383, DOI 10.1128/AAC.01277-10; Corbin JD, 1999, J BIOL CHEM, V274, P13729, DOI 10.1074/jbc.274.20.13729; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Crabtree MJ, 2011, NITRIC OXIDE BIOL CH; CURFS JHAJ, 1989, CLIN EXP IMMUNOL, V75, P136; Davis JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017260; de Souza JB, 2010, PARASITOLOGY, V137, P755, DOI 10.1017/S0031182009991715; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; DOYLE MP, 1981, J INORG BIOCHEM, V14, P351, DOI 10.1016/S0162-0134(00)80291-3; Faiz MA, 2005, LANCET, V366, P717; Fernando SD, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-366; Gladwin MT, 2008, BLOOD, V112, P2636, DOI 10.1182/blood-2008-01-115261; Gramaglia I, 2006, NAT MED, V12, P1417, DOI 10.1038/nm1499; Halaris A, 2007, CNS DRUGS, V21, P885, DOI 10.2165/00023210-200721110-00002; Hattori Y, 2007, ARTERIOSCL THROM VAS, V27, P865, DOI 10.1161/01.ATV.0000258946.55438.0e; Hunt NH, 2010, TRENDS PARASITOL, V26, P272, DOI 10.1016/j.pt.2010.03.006; Kharitonov S, 1997, EUR RESPIR J, V10, P1683, DOI 10.1183/09031936.97.10071683; Kure S, 2004, MOL GENET METAB, V83, P150, DOI 10.1016/j.ymgme.2004.06.016; Lackner P, 2006, NEUROPATH APPL NEURO, V32, P177, DOI 10.1111/j.1365-2990.2006.00706.x; Libonati RMF, 2006, NEUROIMMUNOMODULAT, V13, P28, DOI 10.1159/000093271; Lopansri BK, 2003, LANCET, V361, P676, DOI 10.1016/S0140-6736(03)12564-0; Lue TF, 2000, NEW ENGL J MED, V342, P1802, DOI 10.1056/NEJM200006153422407; Luiking YC, 2010, CURR OPIN CLIN NUTR, V13, P97, DOI 10.1097/MCO.0b013e328332f99d; Martins YC, MALAR J, V85; Morris SM, 2007, J NUTR, V137, p1602S, DOI 10.1093/jn/137.6.1602S; Morris SM, 2009, BRIT J PHARMACOL, V157, P922, DOI 10.1111/j.1476-5381.2009.00278.x; Mun CH, 2010, ANAT CELL BIOL, V43, P230, DOI 10.5115/acb.2010.43.3.230; Pluta RM, 2005, JAMA-J AM MED ASSOC, V293, P1477, DOI 10.1001/jama.293.12.1477; Pluta RM, 2011, ACTA NEUROCHIR SUPPL, V110, P7, DOI 10.1007/978-3-7091-0353-1_2; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Renia L, 2010, TRENDS PARASITOL, V26, P275, DOI 10.1016/j.pt.2010.03.005; Riley EM, 2010, TRENDS PARASITOL, V26, P277, DOI 10.1016/j.pt.2010.03.002; Rodrigo Regina, 2006, Neuropsychiatr Dis Treat, V2, P53; Shinozaki K, 2000, CIRC RES, V87, P566, DOI 10.1161/01.RES.87.7.566; Stevenson MM, 2010, TRENDS PARASITOL, V26, P274, DOI 10.1016/j.pt.2010.03.008; VALLANCE P, 1992, J CARDIOVASC PHARM, V20, pS60, DOI 10.1097/00005344-199204002-00018; Verhaar MC, 2004, HEART, V90, P494, DOI 10.1136/hrt.2003.029405; Weinberg JB, 2008, CURR OPIN INFECT DIS, V21, P468, DOI 10.1097/QCO.0b013e32830ef5cf; Weitzberg E, 2010, ANESTHESIOLOGY, V113, P1460, DOI 10.1097/ALN.0b013e3181fcf3cc; White NJ, 2010, TRENDS PARASITOL, V26, P11, DOI 10.1016/j.pt.2009.10.007; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Yeo TW, 2008, ANTIMICROB AGENTS CH, V52, P4381, DOI 10.1128/AAC.00421-08; Yeo TW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002347; Yeo TW, 2008, J INFECT DIS, V198, P602, DOI 10.1086/590209; Yeo TW, 2007, J EXP MED, V204, P2693, DOI 10.1084/jem.20070819; Yeo TW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000868; Yeo TW, 2009, J INFECT DIS, V200, P1522, DOI 10.1086/644641; Zhang L, 2005, STROKE, V36, P847, DOI 10.1161/01.STR.0000158923.19956.73; Zhang RL, 2002, STROKE, V33, P2675, DOI 10.1161/01.STR.0000034399.95249.59	59	27	29	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e32048	10.1371/journal.pone.0032048	http://dx.doi.org/10.1371/journal.pone.0032048			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348145	Green Published, gold, Green Submitted			2022-12-25	WOS:000302733900064
J	Barboni, B; Curini, V; Russo, V; Mauro, A; Di Giacinto, O; Marchisio, M; Alfonsi, M; Mattioli, M				Barboni, Barbara; Curini, Valentina; Russo, Valentina; Mauro, Annunziata; Di Giacinto, Oriana; Marchisio, Marco; Alfonsi, Melissa; Mattioli, Mauro			Indirect Co-Culture with Tendons or Tenocytes Can Program Amniotic Epithelial Cells towards Stepwise Tenogenic Differentiation	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; IN-SITU HYBRIDIZATION; REGENERATIVE MEDICINE; CLINICAL-APPLICATIONS; ACHILLES-TENDON; SHEEP TENDON; FETAL SHEEP; OLD-AGE; SCLERAXIS; EXPRESSION	Background: Amniotic epithelial cells (AEC) have potential applications in cell-based therapy. Thus far their ability to differentiate into tenocytes has not been investigated although a cell source providing a large supply of tenocytes remains a priority target of regenerative medicine in order to respond to the poor self-repair capability of adult tendons. Starting from this premise, the present research has been designed firstly to verify whether the co-culture with adult primary tenocytes could be exploited in order to induce tenogenic differentiation in AEC, as previously demonstrated in mesenchymal stem cells. Since the co-culture systems inducing cell differentiation takes advantage of specific soluble paracrine factors released by tenocytes, the research has been then addressed to study whether the co-culture could be improved by making use of the different cell populations present within tendon explants or of the high regenerative properties of fetal derived cell/tissue. Methodology/Principal Findings: Freshly isolated AEC, obtained from ovine fetuses at mid-gestation, were co-incubated with explanted tendons or primary tenocytes obtained from fetal or adult calcaneal tendons. The morphological and functional analysis indicated that AEC possessed tenogenic differentiation potential. However, only AEC exposed to fetal-derived cell/tissues developed in vitro tendon-like three dimensional structures with an expression profile of matrix (COL1 and THSB4) and mesenchymal/tendon related genes (TNM, OCN and SCXB) similar to that recorded in native ovine tendons. The tendon-like structures displayed high levels of organization as documented by the cell morphology, the newly deposited matrix enriched in COL1 and widespread expression of gap junction proteins (Connexin 32 and 43). Conclusions/Significance: The co-culture system improves its efficiency in promoting AEC differentiation by exploiting the inductive tenogenic soluble factors released by fetal tendon cells or explants. The co-cultural system can be proposed as a low cost and easy technique to engineer tendon for biological study and cell therapy approach.	[Barboni, Barbara; Curini, Valentina; Russo, Valentina; Mauro, Annunziata; Di Giacinto, Oriana; Mattioli, Mauro] Univ Teramo, Dept Comparat Biomed Sci, Teramo, Italy; [Marchisio, Marco] Univ G dAnnunzio, Dept Biomorphol, Chieti, Italy; [Alfonsi, Melissa] Univ G dAnnunzio, Dept Biomed Sci, Chieti, Italy; [Barboni, Barbara; Curini, Valentina; Russo, Valentina; Mauro, Annunziata; Marchisio, Marco; Alfonsi, Melissa; Mattioli, Mauro] StemTeCh Grp, Chieti, Italy	University of Teramo; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Barboni, B (corresponding author), Univ Teramo, Dept Comparat Biomed Sci, Teramo, Italy.	valentinacurini@yahoo.it	Russo, Valentina/G-8209-2011; Curini, Valentina VC/C-1094-2016	Russo, Valentina/0000-0003-4368-2534; Curini, Valentina VC/0000-0002-2335-3154; Marchisio, Marco/0000-0003-3058-3422; MAURO, ANNUNZIATA/0000-0003-3907-0244	Tercas Foundation	Tercas Foundation	This work was supported by a Tercas Foundation grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG JR, 1995, DEV BIOL, V169, P242, DOI 10.1006/dbio.1995.1141; Avila M, 2001, CORNEA, V20, P414, DOI 10.1097/00003226-200105000-00016; Bailo M, 2004, TRANSPLANTATION, V78, P1439, DOI 10.1097/01.TP.0000144606.84234.49; BAKER H, 1968, BRIT J DERMATOL, V80, P367, DOI 10.1111/j.1365-2133.1968.tb12322.x; BANES A, 1999, CLIN ORTHOP RELAT R, V367, P356; Barboni B, 2009, HUM GENE THER, V20, P1494; Beredjiklian PK, 2003, ANN BIOMED ENG, V31, P1143, DOI 10.1114/1.1616931; Brent AE, 2005, DEVELOPMENT, V132, P515, DOI 10.1242/dev.01605; Canela Andres, 2007, Methods Mol Biol, V371, P45; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chen WH, 2009, ARTHRITIS RHEUM-US, V60, P450, DOI 10.1002/art.24265; Csaki C, 2009, HISTOCHEM CELL BIOL, V131, P251, DOI 10.1007/s00418-008-0524-6; CSERJESI P, 1995, DEVELOPMENT, V121, P1099; delaSena C, 1995, HEREDITAS, V123, P269; Favata M, 2006, J ORTHOP RES, V24, P2124, DOI 10.1002/jor.20271; Hampson K, 2008, TOPICS TISSUE ENG, P1; Hoffmann A, 2006, J CLIN INVEST, V116, P940, DOI 10.1172/JCI22689; HOLMPEDERSEN P, 1972, SCAND J PLAST RECON, V6, P24, DOI 10.3109/02844317209103455; Hori J, 2006, CORNEA, V25, pS53, DOI 10.1097/01.ico.0000247214.31757.5c; Hou Y, 2009, MATRIX BIOL, V28, P324, DOI 10.1016/j.matbio.2009.04.007; Jelinsky SA, 2010, J ORTHOP RES, V28, P289, DOI 10.1002/jor.20999; Kostrominova TY, 2009, HISTOL HISTOPATHOL, V24, P541, DOI 10.14670/HH-24.541; Kubo M, 2001, INVEST OPHTH VIS SCI, V42, P1539; Lee IC, 2007, BIOCHEM BIOPH RES CO, V352, P147, DOI 10.1016/j.bbrc.2006.10.170; Lejard V, 2007, J BIOL CHEM, V282, P17665, DOI 10.1074/jbc.M610113200; Li HC, 2005, INVEST OPHTH VIS SCI, V46, P900, DOI 10.1167/iovs.04-0495; Lu XY, 2010, MOL VIS, V16, P611; Luo Q, 2009, CYTOTECHNOLOGY, V61, P1, DOI 10.1007/s10616-009-9233-9; Maffulli N, 1999, CLIN J SPORT MED, V9, P157, DOI 10.1097/00042752-199907000-00007; Marongiu F, 2011, HEPATOLOGY, V53, P1719, DOI 10.1002/hep.24255; Mattioli M, 2011, CELL BIOL INT; McNeilly CM, 1996, J ANAT, V189, P593; Meeker AK, 2002, AM J PATHOL, V160, P1259, DOI 10.1016/S0002-9440(10)62553-9; MERRILEES MJ, 1980, AM J ANAT, V157, P87, DOI 10.1002/aja.1001570109; Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357; Miki T, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt66; Miscia S, 2009, NEUROBIOL AGING, V30, P394, DOI 10.1016/j.neurobiolaging.2007.07.011; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Muttini A, 2010, VET RES COMMUN, V34, pS117, DOI 10.1007/s11259-010-9396-z; NEREM RM, 1991, ANN BIOMED ENG, V19, P529, DOI 10.1007/BF02367396; Ouyang HW, 2006, TRANSPLANTATION, V82, P170, DOI 10.1097/01.tp.0000226232.79106.72; Ouyang HW, 2005, J BIOMED MATER RES B, V75B, P264, DOI 10.1002/jbm.b.30281; Parolini O, 2011, PLACENTA, V32, pS283, DOI 10.1016/j.placenta.2011.04.009; Parolini O, 2009, REGEN MED, V4, P275, DOI 10.2217/17460751.4.2.275; Pennisi E, 2002, SCIENCE, V295, P1011, DOI 10.1126/science.295.5557.1011; Perfetto SP, 2006, J IMMUNOL METHODS, V313, P199, DOI 10.1016/j.jim.2006.04.007; Piccin D, 2010, DIS MODEL MECH, V3, P421, DOI 10.1242/dmm.003137; Pittenger M., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P309; Roth GS, 1997, J GERONTOL A-BIOL, V52, pB98, DOI 10.1093/gerona/52A.2.B98; Russo V, 2006, J HISTOCHEM CYTOCHEM, V54, P443, DOI 10.1369/jhc.4A6603.2006; Sankar V, 2003, NEUROSCIENCE, V118, P11, DOI 10.1016/S0306-4522(02)00929-6; Schneider PRA, 2011, J ORTHOP RES, V29, P1351, DOI 10.1002/jor.21400; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Sharma P., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P181; Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850; Shaw SWS, 2011, CURR OPIN OBSTET GYN, V23, P109, DOI 10.1097/GCO.0b013e32834457b1; Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036; Silva H., 2008, STEMBOOK; Stalling SS, 2008, CLIN ORTHOP RELAT R, V466, P3130, DOI 10.1007/s11999-008-0391-4; Stanley RL, 2007, J ANAT, V211, P325, DOI 10.1111/j.1469-7580.2007.00781.x; STROCCHI R, 1991, FOOT ANKLE, V12, P100, DOI 10.1177/107110079101200207; Tozer Samuel, 2005, Birth Defects Research, V75, P226, DOI 10.1002/bdrc.20049; Ueta M, 2002, CLIN EXP IMMUNOL, V129, P464, DOI 10.1046/j.1365-2249.2002.01945.x; Wang JHC, 2006, J BIOMECH, V39, P1563, DOI 10.1016/j.jbiomech.2005.05.011; Wang QW, 2005, J BIOSCI BIOENG, V100, P418, DOI 10.1263/jbb.100.418; Wei XL, 2011, BIOCHEM BIOPH RES CO, V406, P204, DOI 10.1016/j.bbrc.2011.02.015; WHITBY DJ, 1991, DEVELOPMENT, V112, P651; Woo SLY, 1999, CLIN ORTHOP RELAT R, pS312; Yang JH, 2007, HUM REPROD, V22, P945, DOI 10.1093/humrep/del493; Yao L, 2006, TISSUE ENG, V12, P1843, DOI 10.1089/ten.2006.12.1843; Yin Z, 2010, EXPERT OPIN BIOL TH, V10, P689, DOI 10.1517/14712591003769824; Yuge I, 2004, TRANSPLANTATION, V77, P1452, DOI 10.1097/00007890-200405150-00023	73	52	54	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e30974	10.1371/journal.pone.0030974	http://dx.doi.org/10.1371/journal.pone.0030974			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348033	gold, Green Published, Green Submitted			2022-12-25	WOS:000302730900017
J	Bernhardsson, S; Mitarai, N; Sneppen, K				Bernhardsson, Sebastian; Mitarai, Namiko; Sneppen, Kim			Protein Localization with Flexible DNA or RNA	PLOS ONE			English	Article							NUCLEAR-MATRIX; GENE-EXPRESSION; X-CHROMOSOME; TRANSCRIPTION; CHROMATIN; IDENTIFICATION; INACTIVATION; ARCHITECTURE; DYNAMICS; MOBILITY	Localization of activity is ubiquitous in life, and also within sub-cellular compartments. Localization provides potential advantages as different proteins involved in the same cellular process may supplement each other on a fast timescale. It might also prevent proteins from being active in other regions of the cell. However localization is at odds with the spreading of unbound molecules by diffusion. We model the cost and gain for specific enzyme activity using localization strategies based on binding to sites of intermediate specificity. While such bindings in themselves decrease the activity of the protein on its target site, they may increase protein activity if stochastic motion allows the acting protein to touch both the intermediate binding site and the specific site simultaneously. We discuss this strategy in view of recent suggestions on long non-coding RNA as a facilitator of localized activity of chromatin modifiers.	[Bernhardsson, Sebastian; Mitarai, Namiko; Sneppen, Kim] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Bernhardsson, Sebastian] Swedish Def Res Agcy, FOI, Tumba, Sweden	University of Copenhagen; Niels Bohr Institute; FOI - Swedish Defence Research Agency; Saab Group	Bernhardsson, S (corresponding author), Univ Copenhagen, Niels Bohr Inst, Blegdamsvej 17, DK-2100 Copenhagen, Denmark.	sebbeb@nbi.dk	Mitarai, Namiko/AAK-8531-2021; Mitarai, Namiko/M-4575-2014	Mitarai, Namiko/0000-0003-0116-7606; Mitarai, Namiko/0000-0003-0116-7606; Sneppen, Kim/0000-0001-9820-3567	European Community [HEALTH-F4-2008-223545]; Danish National Research Foundation	European Community(European Commission); Danish National Research Foundation(Danmarks Grundforskningsfond)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement No. HEALTH-F4-2008-223545. The research is also supported by the Danish National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Brunagel G, 2002, CANCER RES, V62, P2437; BURT DW, 1982, MOL GEN GENET, V185, P468, DOI 10.1007/BF00334142; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; Hinow P, 2006, BIOPHYS J, V91, P330, DOI 10.1529/biophysj.105.078303; Katherine P, 1998, SCIENCE, V282, P1516; Lee JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003749; Lewis PJ, 2000, EMBO J, V19, P710, DOI 10.1093/emboj/19.4.710; Misteli T, 2001, SCIENCE, V291, P843, DOI 10.1126/science.291.5505.843; Moorefield KS, 2006, MOL BIOL CELL, V17, P1711, DOI 10.1091/mbc.E05-11-1063; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Navarro P, 2005, GENE DEV, V19, P1474, DOI 10.1101/gad.341105; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Rippe K, 2001, TRENDS BIOCHEM SCI, V26, P733, DOI 10.1016/S0968-0004(01)01978-8; RIPPE K, 1995, TRENDS BIOCHEM SCI, V20, P500, DOI 10.1016/S0968-0004(00)89117-3; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Sado T, 2005, DEV CELL, V9, P159, DOI 10.1016/j.devcel.2005.05.015; Sneppen K., 2005, PHYS MOL BIOL; Stein GS, 2005, AM J PATHOL, V166, P959, DOI 10.1016/S0002-9440(10)62317-6; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Sutherland H, 2009, NAT REV GENET, V10, P457, DOI 10.1038/nrg2592; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Zeng CM, 1997, P NATL ACAD SCI USA, V94, P6746, DOI 10.1073/pnas.94.13.6746; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	27	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e29218	10.1371/journal.pone.0029218	http://dx.doi.org/10.1371/journal.pone.0029218			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22347995	gold, Green Submitted, Green Published			2022-12-25	WOS:000302730900003
J	Traviss, GD; West, RM; House, AO				Traviss, Gemma D.; West, Robert M.; House, Allan O.			Maternal Mental Health and Its Association with Infant Growth at 6 Months in Ethnic Groups: Results from the Born-in-Bradford Birth Cohort Study	PLOS ONE			English	Article							LOW-INCOME COUNTRIES; FAILURE-TO-THRIVE; POSTNATAL DEPRESSION; BABIES BORN; PREGNANCY; ANXIETY; POSTPARTUM; PREVALENCE; STRESS; WEIGHT	Objective: To identify factors associated with infant growth up to 6 months, with a particular focus on maternal distress, and to explore the effect of ethnicity on any relation between maternal distress and infant growth. Methods: Cohort study recruiting White and Pakistani women in the United Kingdom (UK). Infant growth was measured at birth and 6 months. Standard assessment of mental health (GHQ-28) was undertaken in pregnancy (26-28 weeks gestation) and 6 months postpartum. Modelling included social deprivation, ethnicity, and other known influences on infant growth such as maternal smoking and alcohol consumption. Results: Maternal distress improved markedly from pregnancy to 6 months postpartum. At both times Pakistani women had more somatic and depression symptoms than White women. Depression in pregnancy (GHQ subscale D) was associated with lower infant growth at 6 months. Self-reported social dysfunction in pregnancy (GHQ subscale C) was associated with lower gestational age.. Pakistani women reported higher GHQ scores during pregnancy associated with smaller infants at birth. They lived in areas of higher social deprivation, reported less alcohol consumption and smoking postnatally, all independent influences on growth at 6 months. Conclusions: Maternal mental health in pregnancy is an independent influence on infant growth up to 6 months and is associated with ethnicity which was itself associated with deprivation in our sample. There is a complex relationship between symptoms of maternal distress, ethnicity, deprivation, health behaviours, and early infant growth. Measures should include both emotional and somatic symptoms and interventions to reduce risks of poor early growth need to include psychological and social components.	[Traviss, Gemma D.; West, Robert M.; House, Allan O.] Univ Leeds, Leeds Inst Hlth Sci, Acad Unit Psychiat & Behav Sci, Leeds, W Yorkshire, England	University of Leeds	Traviss, GD (corresponding author), Univ Leeds, Leeds Inst Hlth Sci, Acad Unit Psychiat & Behav Sci, Leeds, W Yorkshire, England.	g.traviss@leeds.ac.uk	West, Robert M/C-3834-2008	West, Robert M/0000-0001-7305-3654; House, Allan/0000-0001-8721-8026; Traviss-Turner, Gemma/0000-0002-1770-6216	National Institute for Health Research (NIHR) [RP-PG-0407-10044]; Cancer Research UK [14135] Funding Source: researchfish; National Institute for Health Research [PB-PG-0408-16119] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This publication presents independent research commissioned by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme (Grant number: RP-PG-0407-10044)(http://www.ccf.nihr.ac.uk/PGfAR/Pages/Home.aspx). The views expressed in this publication are those of the authors and not necessarily those of the National Health Service, the NIHR or the Department of Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADERIBIGBE YA, 1992, SOC PSYCH PSYCH EPID, V27, P280; [Anonymous], 2010, R LANG ENV STAT COMP; Avan B, 2010, ARCH DIS CHILD, V95, P690, DOI 10.1136/adc.2009.164848; Banks MH, 1983, PSYCHOL MED, V12, P789; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bennett HA, 2004, OBSTET GYNECOL, V103, P698, DOI 10.1097/01.AOG.0000116689.75396.5f; Blair PS, 2004, INT J EPIDEMIOL, V33, P839, DOI 10.1093/ije/dyh100; Blissett J, 2007, INT J OBESITY, V31, P1520, DOI 10.1038/sj.ijo.0803661; Cohen J., 2003, APPL MULTIPLE REGRES; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Deave T, 2008, BJOG-INT J OBSTET GY, V115, P1043, DOI 10.1111/j.1471-0528.2008.01752.x; DHAWAN S, 1995, BRIT MED J, V311, P86, DOI 10.1136/bmj.311.6997.86; Diego MA, 2005, INFANT BEHAV DEV, V28, P155, DOI 10.1016/j.infbeh.2005.02.002; Drewett R, 2004, J CHILD PSYCHOL PSYC, V45, P359, DOI 10.1111/j.1469-7610.2004.00226.x; Field T, 2011, INFANT BEHAV DEV, V34, P1, DOI 10.1016/j.infbeh.2010.09.008; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Gennaro S, 2003, JOGNN-J OBST GYN NEO, V32, P668, DOI 10.1177/0884217503257484; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Grote V, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-14; Harpham T, 2005, J EPIDEMIOL COMMUN H, V59, P1060, DOI 10.1136/jech.2005.039180; Hedegaard M, 1996, ACTA OBSTET GYN SCAN, V75, P32, DOI 10.3109/00016349609033280; Heron J, 2004, J AFFECT DISORDERS, V80, P65, DOI 10.1016/j.jad.2003.08.004; HOBFOLL SE, 1995, J CONSULT CLIN PSYCH, V63, P445, DOI 10.1037/0022-006X.63.3.445; Hurley KM, 2008, J NUTR, V138, P799, DOI 10.1093/jn/138.4.799; Institute of Medicine, 1985, PREV LOW BIRTHW SUMM; Johnson W, 2009, INT J NURS STUD, V46, P310, DOI 10.1016/j.ijnurstu.2008.10.003; Jones NA, 1998, INFANT BEHAV DEV, V21, P537; Karacam Z, 2009, MIDWIFERY, V25, P344, DOI 10.1016/j.midw.2007.03.006; Kelly RH, 2001, GEN HOSP PSYCHIAT, V23, P107, DOI 10.1016/S0163-8343(01)00129-3; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Lundy BL, 1999, INFANT BEHAV DEV, V22, P119, DOI 10.1016/S0163-6383(99)80009-5; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Margetts BM, 2002, J EPIDEMIOL COMMUN H, V56, P684, DOI 10.1136/jech.56.9.684; Meer S, BR J PSYCHIAT UNPUB; Onyango AW, 2006, ACTA PAEDIATR, V95, P38, DOI 10.1080/08035320500494464; Patel V, 2004, BMJ-BRIT MED J, V328, P820, DOI 10.1136/bmj.328.7443.820; Patel V, 2003, ARCH DIS CHILD, V88, P34, DOI 10.1136/adc.88.1.34; Rahman A, 2003, PSYCHOL MED, V33, P1161, DOI 10.1017/S0033291703008286; Raynor P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-327; Riaz H, 1998, ACTA PSYCHIAT SCAND, V97, P427, DOI 10.1111/j.1600-0447.1998.tb10027.x; Robertson E, 2004, GEN HOSP PSYCHIAT, V26, P289, DOI 10.1016/j.genhosppsych.2004.02.006; Sallow B.L., 2003, PSYCHOL HEAL MED, V8, P213, DOI [DOI 10.1080/1354850031000087591, 10.1080/1354850031000087591]; Schetter CD, 2011, ANNU REV PSYCHOL, V62, P531, DOI 10.1146/annurev.psych.031809.130727; Siefert K, 2000, AM J ORTHOPSYCHIAT, V70, P510, DOI 10.1037/h0087688; Surkan PJ, 2008, J EPIDEMIOL COMMUN H, V62, DOI 10.1136/jech.2007.065664; Swallow B L, 2004, J Obstet Gynaecol, V24, P28; Van den Bergh BRH, 2005, NEUROSCI BIOBEHAV R, V29, P237, DOI 10.1016/j.neubiorev.2004.10.007; Werneke U, 2000, PSYCHOL MED, V30, P823, DOI 10.1017/S0033291799002287; WILSON M, 1994, PSYCHOL MED, V24, P113, DOI 10.1017/S003329170002688X	51	13	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e30707	10.1371/journal.pone.0030707	http://dx.doi.org/10.1371/journal.pone.0030707			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	924ZX	22348019	Green Published, gold, Green Submitted			2022-12-25	WOS:000302730900013
J	Zhi, D; Chen, R				Zhi, Degui; Chen, Rui			Statistical Guidance for Experimental Design and Data Analysis of Mutation Detection in Rare Monogenic Mendelian Diseases by Exome Sequencing	PLOS ONE			English	Article							ASSOCIATION; VARIANTS; DEFICIENCY; STRATEGIES; DISCOVERY; CAPTURE; GENE	Recently, whole-genome sequencing, especially exome sequencing, has successfully led to the identification of causal mutations for rare monogenic Mendelian diseases. However, it is unclear whether this approach can be generalized and effectively applied to other Mendelian diseases with high locus heterogeneity. Moreover, the current exome sequencing approach has limitations such as false positive and false negative rates of mutation detection due to sequencing errors and other artifacts, but the impact of these limitations on experimental design has not been systematically analyzed. To address these questions, we present a statistical modeling framework to calculate the power, the probability of identifying truly disease-causing genes, under various inheritance models and experimental conditions, providing guidance for both proper experimental design and data analysis. Based on our model, we found that the exome sequencing approach is well-powered for mutation detection in recessive, but not dominant, Mendelian diseases with high locus heterogeneity. A disease gene responsible for as low as 5% of the disease population can be readily identified by sequencing just 200 unrelated patients. Based on these results, for identifying rare Mendelian disease genes, we propose that a viable approach is to combine, sequence, and analyze patients with the same disease together, leveraging the statistical framework presented in this work.	[Zhi, Degui] Univ Alabama, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA; [Chen, Rui] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	University of Alabama System; University of Alabama Birmingham; Baylor College of Medicine	Zhi, D (corresponding author), Univ Alabama, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA.	dzhi@ms.soph.uab.edu; ruichen@bcm.edu			National Institutes of Health (NIH) [R00 RR024163, R01EY018571]; NATIONAL CENTER FOR RESEARCH RESOURCES [R00RR024163] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018571] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by the National Institutes of Health (NIH) Grants R00 RR024163 to DZ and R01EY018571 to RC. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Bolze A, 2010, AM J HUM GENET, V87, P873, DOI 10.1016/j.ajhg.2010.10.028; Byun M, 2010, J EXP MED, V207, P2307, DOI 10.1084/jem.20101597; Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659; Cooper GM, 2010, NAT METHODS, V7, P250, DOI 10.1038/nmeth0410-250; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lalonde E, 2010, HUM MUTAT, V31, P918, DOI 10.1002/humu.21293; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li BS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000481; Liu DJJ, 2010, AM J HUM GENET, V87, P790, DOI 10.1016/j.ajhg.2010.10.025; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; Rios J, 2010, HUM MOL GENET, V19, P4313, DOI 10.1093/hmg/ddq352; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Sobreira NLM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000991; Stitziel NO, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-227; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010; Wang JL, 2010, BRAIN, V133, P3510, DOI 10.1093/brain/awq323	29	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e31358	10.1371/journal.pone.0031358	http://dx.doi.org/10.1371/journal.pone.0031358			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348076	Green Published, gold, Green Submitted			2022-12-25	WOS:000302730900025
J	Cheng, LT; Nagata, S; Hirano, K; Yamaguchi, S; Horie, S; Ainscough, J; Tada, T				Cheng, Li-Tao; Nagata, Shogo; Hirano, Kunio; Yamaguchi, Shinpei; Horie, Shigeo; Ainscough, Justin; Tada, Takashi			Cure of ADPKD by Selection for Spontaneous Genetic Repair Events in Pkd1-Mutated iPS Cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; POLYCYSTIC KIDNEY-DISEASE; GENERATION; FIBROBLASTS; MUTATIONS; NUCLEASES	Induced pluripotent stem cells (iPSCs) generated by epigenetic reprogramming of personal somatic cells have limited therapeutic capacity for patients suffering from genetic disorders. Here we demonstrate restoration of a genomic mutation heterozygous for Pkd1 (polycystic kidney disease 1) deletion (Pkd1(+/-) to Pkd1(+/R+)) by spontaneous mitotic recombination. Notably, recombination between homologous chromosomes occurred at a frequency of 1 similar to 2 per 10,000 iPSCs. Southern blot hybridization and genomic PCR analyses demonstrated that the genotype of the mutation-restored iPSCs was indistinguishable from that of the wild-type cells. Importantly, the frequency of cyst generation in kidneys of adult chimeric mice containing Pkd1(+/R+) iPSCs was significantly lower than that of adult chimeric mice with parental Pkd1(+/-) iPSCs, and indistinguishable from that of wild-type mice. This repair step could be directly incorporated into iPSC development programmes prior to cell transplantation, offering an invaluable step forward for patients carrying a wide range of genetic disorders.	[Cheng, Li-Tao; Nagata, Shogo; Hirano, Kunio; Yamaguchi, Shinpei; Tada, Takashi] Kyoto Univ, Inst Frontier Med Sci, Kyoto, Japan; [Cheng, Li-Tao] Peking Univ, Hosp 3, Dept Nephrol, Beijing 100871, Peoples R China; [Nagata, Shogo; Yamaguchi, Shinpei; Tada, Takashi] JST CREST, Kawaguchi, Saitama, Japan; [Horie, Shigeo] Teikyo Univ, Dept Urol, Tokyo 173, Japan; [Ainscough, Justin] Univ Leeds, LIGHT, Leeds, W Yorkshire, England	Kyoto University; Peking University; Japan Science & Technology Agency (JST); Teikyo University; University of Leeds	Cheng, LT (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Kyoto, Japan.	ttada@frontier.kyoto-u.ac.jp	Yamaguchi, Shinpei/HCH-5553-2022	Ainscough, Justin/0000-0003-0231-433X; Yamaguchi, Shinpei/0000-0002-9377-4835	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology; Core Research for Evolutional Science and Technology (Japan Science and Technology Agency); Takeda Science foundation; Takeda Science Foundation, JAPAN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology (Japan Science and Technology Agency)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Takeda Science foundation(Takeda Science Foundation (TSF)); Takeda Science Foundation, JAPAN(Takeda Science Foundation (TSF))	This work was funded by grants from the Japan Society for the Promotion of Science, the Ministry of Education, Culture, Sports, Science and Technology and the Core Research for Evolutional Science and Technology (Japan Science and Technology Agency) to TT, and the Takeda Science foundation to LC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr Gen Kondoh and Ms Hitomi Watanabe for generating chimeras. L. T. C. is a postdoctoral fellow supported by the Takeda Science Foundation, JAPAN. K. H is a fellow of JSPS.	Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005; Chapin HC, 2010, J CELL BIOL, V191, P701, DOI 10.1083/jcb.201006173; GARDNER KD, 1988, ANNU REV MED, V39, P185, DOI 10.1146/annurev.me.39.020188.001153; Happe H, 2011, BBA-MOL BASIS DIS, V1812, P1249, DOI 10.1016/j.bbadis.2011.05.005; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; KIPPS TJ, 1986, EMBO J, V5, P263, DOI 10.1002/j.1460-2075.1986.tb04208.x; Lefebvre L, 2001, NAT GENET, V27, P257, DOI 10.1038/85808; Liu GH, 2011, CELL STEM CELL, V8, P688, DOI 10.1016/j.stem.2011.04.019; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Matsumura H, 2007, NAT METHODS, V4, P23, DOI 10.1038/NMETH973; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Muto S, 2002, HUM MOL GENET, V11, P1731, DOI 10.1093/hmg/11.15.1731; Nagata S, 2009, GENES CELLS, V14, P1395, DOI 10.1111/j.1365-2443.2009.01356.x; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	20	10	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e32018	10.1371/journal.pone.0032018	http://dx.doi.org/10.1371/journal.pone.0032018			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347511	Green Submitted, gold, Green Published			2022-12-25	WOS:000302730200039
J	Lewis, MB				Lewis, Michael B.			A Facial Attractiveness Account of Gender Asymmetries in Interracial Marriage	PLOS ONE			English	Article							RACIAL INTERMARRIAGE; TRENDS; EDUCATION; SELECTION; PATTERNS; RACE	Background: In the US and UK, more Black men are married to White women than vice versa and there are more White men married to Asian women than vice versa. Models of interracial marriage, based on the exchange of racial status for other capital, cannot explain these asymmetries. A new explanation is offered based on the relative perceived facial attractiveness of the different race-by-gender groups. Method and Findings: This explanation was tested using a survey of perceived facial attractiveness. This found that Black males are perceived as more attractive than White or East Asian males whereas among females, it is the East Asians that are perceived as most attractive on average. Conclusions: Incorporating these attractiveness patterns into the model of marriage decisions produces asymmetries in interracial marriage similar to those in the observed data in terms of direction and relative size. This model does not require differences in status between races nor different strategies based on gender. Predictions are also generated regarding the relative attractiveness of those engaging in interracial marriage.	Cardiff Univ, Sch Psychol, Cardiff, S Glam, Wales	Cardiff University	Lewis, MB (corresponding author), Cardiff Univ, Sch Psychol, Cardiff, S Glam, Wales.	LewisMB@cf.ac.uk	Lewis, Michael/D-1488-2009	Lewis, Michael/0000-0002-5735-5318				BAGLEY C, 1972, PHYLON, V33, P373, DOI 10.2307/273684; Batson CD, 2006, J MARRIAGE FAM, V68, P658, DOI 10.1111/j.1741-3737.2006.00281.x; BECKER GS, 1973, J POLIT ECON, V81, P813, DOI 10.1086/260084; Belletti NE, 2008, RACISM IN THE 21ST CENTURY: AN EMPIRICAL ANALYSIS OF SKIN COLOR, P93, DOI 10.1007/978-0-387-79098-5_6; Belot M, 2010, ECON HUM BIOL, V8, P361, DOI 10.1016/j.ehb.2010.09.004; Buss D.M., 2006, PSIHOLOGIJSKE TEME, V15, P239; BUSS DM, 1989, BEHAV BRAIN SCI, V12, P1, DOI 10.1017/S0140525X00023992; CASSIDY ML, 1989, J COMP FAM STUD, V20, P1; Crowder KD, 2000, J MARRIAGE FAM, V62, P792, DOI 10.1111/j.1741-3737.2000.00792.x; Davis K, 1941, AM ANTHROPOL, V43, P376, DOI 10.1525/aa.1941.43.3.02a00030; EDWARDS JN, 1969, J MARRIAGE FAM, V31, P518, DOI 10.2307/349775; ELDER GH, 1969, AM SOCIOL REV, V34, P519, DOI 10.2307/2091961; Frost P., 1994, HUMAN EVOLUTION, V9, P141, DOI DOI 10.1007/BF02437260; Fryer RG, 2007, J ECON PERSPECT, V21, P71, DOI 10.1257/jep.21.2.71; Fu VK, 2001, DEMOGRAPHY, V38, P147, DOI 10.2307/3088297; Gangestad SW, 2000, BEHAV BRAIN SCI, V23, P573, DOI 10.1017/S0140525X0000337X; Gullickson A, 2006, J FAM HIST, V31, P289, DOI 10.1177/0363199006288393; Jacobs JA, 2002, SOCIOL FORUM, V17, P621, DOI 10.1023/A:1021029507937; KALMIJN M, 1993, SOC FORCES, V72, P119, DOI 10.2307/2580162; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; Lewis MB, 2011, PERS INDIV DIFFER, V50, P159, DOI 10.1016/j.paid.2010.09.018; Lewis MB, 2010, PERCEPTION, V39, P136, DOI 10.1068/p6626; Madrigal L, 2007, AM J PHYS ANTHROPOL, V132, P470, DOI 10.1002/ajpa.20453; Merton RK, 1941, PSYCHIATR, V4, P361, DOI 10.1080/00332747.1941.11022354; Muttarak R, 2010, BRIT J SOCIOL, V61, P275, DOI 10.1111/j.1468-4446.2010.01313.x; Porterfield Ernest, 1978, BLACK WHITE MIXED MA; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; STEVENS G, 1990, SOC PSYCHOL QUART, V53, P62, DOI 10.2307/2786870; VANDENBERGHE PL, 1986, ETHNIC RACIAL STUD, V9, P87, DOI 10.1080/01419870.1986.9993516; WADE TJ, 1991, BASIC APPL SOC PSYCH, V12, P405, DOI 10.1207/s15324834basp1204_3; ZOHAR A, 1989, BEHAV BRAIN SCI, V12, P38, DOI 10.1017/S0140525X00024262	31	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31703	10.1371/journal.pone.0031703	http://dx.doi.org/10.1371/journal.pone.0031703			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	924ZQ	22347504	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000302730200032
J	Sudduth, TL; Wilson, JG; Everhart, A; Colton, CA; Wilcock, DM				Sudduth, Tiffany L.; Wilson, Joan G.; Everhart, Angela; Colton, Carol A.; Wilcock, Donna M.			Lithium Treatment of APPSwDI/NOS2-/- Mice Leads to Reduced Hyperphosphorylated Tau, Increased Amyloid Deposition and Altered Inflammatory Phenotype	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; A-BETA; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; MEMORY DEFICITS; NITRIC-OXIDE; PATHOLOGY; PROTEIN; PHOSPHORYLATION; UBIQUITINATION	Lithium is an anti-psychotic that has been shown to prevent the hyperphosphorylation of tau protein through the inhibition of glycogen-synthase kinase 3-beta (GSK3 beta). We recently developed a mouse model that progresses from amyloid pathology to tau pathology and neurodegeneration due to the genetic deletion of NOS2 in an APP transgenic mouse; the APPSwDI/NOS2-/- mouse. Because this mouse develops tau pathology, amyloid pathology and neuronal loss we were interested in the effect anti-tau therapy would have on amyloid pathology, learning and memory. We administered lithium in the diets of APPSwDI/NOS2-/- mice for a period of eight months, followed by water maze testing at 12 months of age, immediately prior to sacrifice. We found that lithium significantly lowered hyperphosphorylated tau levels as measured by Western blot and immunocytochemistry. However, we found no apparent neuroprotection, no effect on spatial memory deficits and an increase in histological amyloid deposition. A beta levels measured biochemically were unaltered. We also found that lithium significantly altered the neuroinflammatory phenotype of the brain, resulting in enhanced alternative inflammatory response while concurrently lowering the classical inflammatory response. Our data suggest that lithium may be beneficial for the treatment of tauopathies but may not be beneficial for the treatment of Alzheimer's disease.	[Sudduth, Tiffany L.; Wilcock, Donna M.] Univ Kentucky, Sanders Brown Ctr Aging, Dept Physiol, Lexington, KY 40536 USA; [Wilson, Joan G.; Everhart, Angela; Colton, Carol A.] Duke Univ, Med Ctr, Dept Med, Div Neurol, Durham, NC 27710 USA	University of Kentucky; Duke University	Sudduth, TL (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, Dept Physiol, Lexington, KY 40536 USA.	donna.wilcock@uky.edu	Wilcock, Donna M/J-7517-2016	Colton, Carol/0000-0003-3305-370X	Alzheimer's Association [NIRG-09-133302]	Alzheimer's Association(Alzheimer's Association)	This work was supported by the Alzheimer's Association New Investigator Research Grant NIRG-09-133302 (DMW). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275; Bleau G, 1999, EXS, V87, P211; Bouchard M, 2011, CAN J NEUROL SCI, V38, P547, DOI 10.1017/S0317167100012087; Caccamo A, 2007, AM J PATHOL, V170, P1669, DOI 10.2353/ajpath.2007.061178; COLTON CA, 2009, CNS NEUROL DISORD DR; Davis J, 2004, J BIOL CHEM, V279, P20296, DOI 10.1074/jbc.M312946200; DiCarlo G, 2001, NEUROBIOL AGING, V22, P1007, DOI 10.1016/S0197-4580(01)00292-5; Forlenza OV, 2011, BRIT J PSYCHIAT, V198, P351, DOI 10.1192/bjp.bp.110.080044; Gong CX, 2010, DRUG AGING, V27, P351, DOI 10.2165/11536110-000000000-00000; Hampel H, 2009, J CLIN PSYCHIAT, V70, P922, DOI 10.4088/JCP.08m04606; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; Herber DL, 2006, GLIA, V53, P382, DOI 10.1002/glia.20272; Herber DL, 2004, EXP NEUROL, V190, P245, DOI 10.1016/j.expneurol.2004.07.007; Hesse M, 2001, J IMMUNOL, V167, P6533, DOI 10.4049/jimmunol.167.11.6533; HogenEsch H, 2006, EXP DERMATOL, V15, P808, DOI 10.1111/j.1600-0625.2006.00483.x; Jinwal UK, 2009, J NEUROSCI, V29, P12079, DOI 10.1523/JNEUROSCI.3345-09.2009; Laubach VE, 1998, AM J PHYSIOL-HEART C, V275, pH2211, DOI 10.1152/ajpheart.1998.275.6.H2211; Lee JW, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-37; Li HF, 2011, J CEREBR BLOOD F MET, V31, P2106, DOI 10.1038/jcbfm.2011.75; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mandelkow E, 2007, BRAIN PATHOL, V17, P83, DOI 10.1111/j.1750-3639.2007.00053.x; Masliah E, 2005, NEUROLOGY, V64, P129, DOI 10.1212/01.WNL.0000148590.39911.DF; Nakashima H, 2005, ACTA NEUROPATHOL, V110, P547, DOI 10.1007/s00401-005-1087-4; Newell KL, 1999, J NEUROPATH EXP NEUR, V58, P1147, DOI 10.1097/00005072-199911000-00004; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Phiel CJ, 2001, ANNU REV PHARMACOL, V41, P789, DOI 10.1146/annurev.pharmtox.41.1.789; Rapaport MH, 2001, BIOL PSYCHIAT, V50, P217, DOI 10.1016/S0006-3223(01)01144-1; Ren M, 2003, P NATL ACAD SCI USA, V100, P6210, DOI 10.1073/pnas.0937423100; Wagner DA, 1996, NEUROPHARMACOLOGY, V35, P29, DOI 10.1016/0028-3908(95)00177-8; Wilcock DM, 2004, J NEUROSCI, V24, P6144, DOI 10.1523/JNEUROSCI.1090-04.2004; Wilcock DM, 2004, NEUROBIOL DIS, V15, P11, DOI 10.1016/j.nbd.2003.09.015; Wilcock DM, 2003, J NEUROSCI, V23, P3745, DOI 10.1523/jneurosci.23-09-03745.2003; Wilcock DM, 2008, J NEUROSCI, V28, P1537, DOI 10.1523/JNEUROSCI.5066-07.2008; Wilcock DM, 2011, ASN NEURO, V3, DOI 10.1042/AN20110018; Wilcock DM, 2009, J NEUROSCI, V29, P7957, DOI 10.1523/JNEUROSCI.1339-09.2009	38	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31993	10.1371/journal.pone.0031993	http://dx.doi.org/10.1371/journal.pone.0031993			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347510	gold, Green Published, Green Submitted			2022-12-25	WOS:000302730200038
J	Jakesch, M; Carbon, CC				Jakesch, Martina; Carbon, Claus-Christian			The Mere Exposure Effect in the Domain of Haptics	PLOS ONE			English	Article							LIKING; MEMORY; TOUCH; STIMULI; NEED; COMBINATION; IMPLICIT; FLUENCY; OBJECTS; MUSIC	Background: Zajonc showed that the attitude towards stimuli that one had been previously exposed to is more positive than towards novel stimuli. This mere exposure effect (MEE) has been tested extensively using various visual stimuli. Research on the MEE is sparse, however, for other sensory modalities. Methodology/Principal Findings: We used objects of two material categories (stone and wood) and two complexity levels (simple and complex) to test the influence of exposure frequency (F0 = novel stimuli, F2 = stimuli exposed twice, F10 = stimuli exposed ten times) under two sensory modalities (haptics only and haptics & vision). Effects of exposure frequency were found for high complex stimuli with significantly increasing liking from F0 to F2 and F10, but only for the stone category. Analysis of "Need for Touch" data showed the MEE in participants with high need for touch, which suggests different sensitivity or saturation levels of MEE. Conclusions/Significance: This different sensitivity or saturation levels might also reflect the effects of expertise on the haptic evaluation of objects. It seems that haptic and cross-modal MEEs are influenced by factors similar to those in the visual domain indicating a common cognitive basis.	[Jakesch, Martina; Carbon, Claus-Christian] Univ Bamberg, Dept Gen Psychol & Methodol, Bamberg, Germany; [Jakesch, Martina] Univ Vienna, Dept Basic Res, Fac Psychol, Vienna, Austria	Otto Friedrich University Bamberg; University of Vienna	Jakesch, M (corresponding author), Univ Bamberg, Dept Gen Psychol & Methodol, Bamberg, Germany.	martina.jakesch@uni-bamberg.de	Carbon, Claus-Christian/A-7494-2008; Carbon, Claus-Christian/GLQ-6274-2022	Carbon, Claus-Christian/0000-0002-3446-9347; Carbon, Claus-Christian/0000-0002-3446-9347				Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; [Anonymous], 1974, STUDIES NEW EXPT AES; Ballesteros S, 1999, PSICOTHEMA, V11, P785; BALOGH RD, 1986, INFANT BEHAV DEV, V9, P395, DOI 10.1016/0163-6383(86)90013-5; Berlyne D. E., 1971, AESTHETICS PSYCHOBIO; BORNSTEIN RF, 1990, J PERS SOC PSYCHOL, V58, P791, DOI 10.1037/0022-3514.58.5.791; BORNSTEIN RF, 1994, SOC COGNITION, V12, P103, DOI 10.1521/soco.1994.12.2.103; BORNSTEIN RF, 1989, PSYCHOL BULL, V106, P265, DOI 10.1037/0033-2909.106.2.265; CARBON C.-C., 2006, PSYCHOL SCI, V48, P173; Carbon CC, 2005, APPL COGNITIVE PSYCH, V19, P587, DOI 10.1002/acp.1098; Carbon CC, 2008, RES ENG DES, V19, P143, DOI 10.1007/s00163-008-0045-2; Cox D, 2002, J ACAD MARKET SCI, V30, P119, DOI 10.1177/03079459994371; Faerber SJ, 2010, ACTA PSYCHOL, V135, P191, DOI 10.1016/j.actpsy.2010.06.006; Fang X, 2007, J CONSUM RES, V34, P97, DOI 10.1086/513050; Fechner TG, 1871, VORSCHULE ASTHETIK 1; Gepshtein S, 2003, CURR BIOL, V13, P483, DOI 10.1016/S0960-9822(03)00133-7; Gerger G, 2011, SWISS J PSYCHOL, V70, P75, DOI 10.1024/1421-0185/a000041; GORDON PC, 1983, J PERS SOC PSYCHOL, V45, P492, DOI 10.1037/0022-3514.45.3.492; Hansen T, 2001, SOC BEHAV PERSONAL, V29, P271, DOI 10.2224/sbp.2001.29.3.271; HEINGARTNER A, 1974, J PERS SOC PSYCHOL, V29, P719, DOI 10.1037/h0036121; HEYDUK RG, 1975, PERCEPT PSYCHOPHYS, V17, P84, DOI 10.3758/BF03204003; Kruglanski AW, 1996, EUR J SOC PSYCHOL, V26, P479, DOI 10.1002/(SICI)1099-0992(199605)26:3<479::AID-EJSP770>3.0.CO;2-U; KUNSTWILSON WR, 1980, SCIENCE, V207, P557, DOI 10.1126/science.7352271; Lee AY, 2001, PERS SOC PSYCHOL B, V27, P1255, DOI 10.1177/01461672012710002; LIEBERMA.LR, 1968, PERCEPT MOTOR SKILL, V26, P891, DOI 10.2466/pms.1968.26.3.891; Oppenheimer DM, 2008, TRENDS COGN SCI, V12, P237, DOI 10.1016/j.tics.2008.02.014; Oruc I, 2003, VISION RES, V43, P2451, DOI 10.1016/S0042-6989(03)00435-8; Peck J, 2006, J BUS RES, V59, P765, DOI 10.1016/j.jbusres.2006.01.014; Peck J, 2003, J CONSUM RES, V30, P430, DOI 10.1086/378619; Peck J, 2011, PSYCHOL MARKET, V28, P222, DOI 10.1002/mar.20389; Phillips F, 2009, ACTA PSYCHOL, V132, P259, DOI 10.1016/j.actpsy.2009.07.010; Prescott J, 2008, CHEMOSENS PERCEPT, V1, P2, DOI 10.1007/s12078-007-9004-y; Schaal B, 2000, CHEM SENSES, V25, P729, DOI 10.1093/chemse/25.6.729; Seamon JG, 1997, MEM COGNITION, V25, P367, DOI 10.3758/BF03211292; STANG DJ, 1974, PSYCHOL BULL, V81, P1014, DOI 10.1037/h0037419; STANG DJ, 1975, J PERS SOC PSYCHOL, V31, P7, DOI 10.1037/h0076165; STANG DJ, 1974, J PERS SOC PSYCHOL, V30, P647, DOI 10.1037/h0037418; STANG DJ, 1973, EUR J SOC PSYCHOL, V3, P351, DOI 10.1002/ejsp.2420030314; Suzuki M, 2008, COGNITION EMOTION, V22, P147, DOI 10.1080/02699930701298382; Szpunar KK, 2004, J EXP PSYCHOL LEARN, V30, P370, DOI 10.1037/0278-7393.30.2.370; Tan SL, 2006, MUSIC PERCEPT, V23, P407, DOI 10.1525/mp.2006.23.5.407; Thompson WF, 2000, MEM COGNITION, V28, P547, DOI 10.3758/BF03201245; Titchener E. B, 1910, TXB PSYCHOL; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; Whittlesea BWA, 2001, MEM COGNITION, V29, P234, DOI 10.3758/BF03194917; Winkielman P, 2001, J PERS SOC PSYCHOL, V81, P989, DOI 10.1037//0022-3514.81.6.989; Witvliet CVO, 2007, COGNITION EMOTION, V21, P3, DOI 10.1080/02699930601000672; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848; ZAJONC RB, 1972, J PERS SOC PSYCHOL, V21, P270, DOI 10.1037/h0032357	49	25	25	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31215	10.1371/journal.pone.0031215	http://dx.doi.org/10.1371/journal.pone.0031215			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	924ZP	22347451	Green Published, gold			2022-12-25	WOS:000302730100054
J	Murai, H; Qi, HB; Choudhury, B; Wild, J; Dharajiya, N; Vaidya, S; Kalita, A; Bacsi, A; Corry, D; Kurosky, A; Brasier, A; Boldogh, I; Sur, S				Murai, Hiroki; Qi, Huibin; Choudhury, Barun; Wild, Jim; Dharajiya, Nilesh; Vaidya, Swapnil; Kalita, Anjana; Bacsi, Attila; Corry, David; Kurosky, Alexander; Brasier, Allan; Boldogh, Istvan; Sur, Sanjiv			Alternaria-Induced Release of IL-18 from Damaged Airway Epithelial Cells: An NF-kappa B Dependent Mechanism of Th2 Differentiation?	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; CD4(+) T-CELLS; NUTRITION EXAMINATION SURVEY; ALLERGIC LUNG INFLAMMATION; DENDRITIC CELLS; NATIONAL-HEALTH; MOUSE MODEL; IN-VIVO; ASTHMA; INDUCTION	Background: A series of epidemiologic studies have identified the fungus Alternaria as a major risk factor for asthma. The airway epithelium plays a critical role in the pathogenesis of allergic asthma. These reports suggest that activated airway epithelial cells can produce cytokines such as IL-25, TSLP and IL-33 that induce Th2 phenotype. However the epithelium-derived products that mediate the pro-asthma effects of Alternaria are not well characterized. We hypothesized that exposure of the airway epithelium to Alternaria releasing cytokines that can induce Th2 differentiation. Methodology/Principal Finding: We used ELISA to measure human and mouse cytokines. Alternaria extract (ALT-E) induced rapid release of IL-18, but not IL-4, IL-9, IL-13, IL-25, IL-33, or TSLP from cultured normal human bronchial epithelial cells; and in the BAL fluids of naive mice after challenge with ALT-E. Both microscopic and FACS indicated that this release was associated with necrosis of epithelial cells. ALT-E induced much greater IL-18 release compared to 19 major outdoor allergens. Culture of naive CD4 cells with rmIL-18 induced Th2 differentiation in the absence of IL-4 and STAT6, and this effect was abrogated by disrupting NF-kappa B p50 or with a NEMO binding peptide inhibitor. Conclusion/Significance: Rapid and specific release of IL-18 from Alternaria-exposed damaged airway epithelial cells can directly initiate Th2 differentiation of naive CD4(+) T-cells via a unique NF-kappa B dependent pathway.	[Murai, Hiroki; Vaidya, Swapnil; Bacsi, Attila; Brasier, Allan; Sur, Sanjiv] Univ Texas Galveston, Med Branch, Dept Internal Med, Galveston, TX 77550 USA; [Corry, David] Baylor Coll Med, Dept Med, Div Pulm & Crit Care, Houston, TX 77030 USA; [Kurosky, Alexander] Univ Texas Galveston, Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77550 USA; [Boldogh, Istvan] Univ Texas Galveston, Med Branch, Dept Microbiol, Galveston, TX 77550 USA	University of Texas System; University of Texas Medical Branch Galveston; Baylor College of Medicine; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Murai, H (corresponding author), Univ Texas Galveston, Med Branch, Dept Internal Med, Galveston, TX 77550 USA.	sasur@utmb.edu	Murai, Hiroki/J-4030-2019	Murai, Hiroki/0000-0001-5291-8954; Bacsi, Attila/0000-0002-2311-2975; Brasier, Allan/0000-0002-5012-4090	National Heart, Lung, and Blood Institute (NHLBI) [RO1HL071163]; National Institute of Enviromental Health Sciences (NIEHS) [RO1-ES018948]; National Heart, Lung, and Blood Institute (NHLBI), Proteomics Center for Airway Inflammation; National Institute of Allergy and Infectious Disease (NIAID) [PO1AI062885-01, NO1-HV 00245]; National Institute of Environmental Health Science Center [P30-ES006676]; Institute for Translational Sciences - Clinical Research Center (ITS-CRC) at the University of Texas Medical Branch at Galveston; NIH [UL1RR029876]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029876] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES018948, P30ES006676] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Enviromental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Heart, Lung, and Blood Institute (NHLBI), Proteomics Center for Airway Inflammation; National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Environmental Health Science Center; Institute for Translational Sciences - Clinical Research Center (ITS-CRC) at the University of Texas Medical Branch at Galveston; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	National Heart, Lung, and Blood Institute (NHLBI) RO1HL071163 (Sur, Boldogh); National Institute of Enviromental Health Sciences (NIEHS) RO1-ES018948 (Boldogh, Sur); National Heart, Lung, and Blood Institute (NHLBI), Proteomics Center for Airway Inflammation; NO1-HV 00245 (Kurosky, Sur, Boldogh), National Institute of Allergy and Infectious Disease (NIAID) PO1AI062885-01 (Brasier, Sur, Boldogh); National Institute of Environmental Health Science Center Grant P30-ES006676 (C. Elferink, Boldogh); Institute for Translational Sciences - Clinical Research Center (ITS-CRC) at the University of Texas Medical Branch at Galveston supported in part by grant UL1RR029876 from NIH (Brasier). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Arbes SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1139, DOI 10.1016/j.jaci.2007.07.056; Boldogh I, 2005, J CLIN INVEST, V115, P2169, DOI 10.1172/JCI24422; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; GERGEN PJ, 1992, J ALLERGY CLIN IMMUN, V90, P579, DOI 10.1016/0091-6749(92)90130-T; GONG JL, 1992, J EXP MED, V175, P797, DOI 10.1084/jem.175.3.797; Halonen M, 1997, AM J RESP CRIT CARE, V155, P1356, DOI 10.1164/ajrccm.155.4.9105079; Heier I, 2011, THORAX, V66, P151, DOI 10.1136/thx.2010.149591; HOLT PG, 1981, IMMUNOLOGY, V42, P409; HOLT PG, 1993, J EXP MED, V177, P397, DOI 10.1084/jem.177.2.397; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kobayashi T, 2009, J IMMUNOL, V182, P2502, DOI 10.4049/jimmunol.0802773; Kouzaki H, 2011, J IMMUNOL, V186, P4375, DOI 10.4049/jimmunol.1003020; Kouzaki H, 2009, J IMMUNOL, V183, P1427, DOI 10.4049/jimmunol.0900904; Lambrecht BN, 2008, CURR MOL MED, V8, P393, DOI 10.2174/156652408785160916; Lambrecht BN, 2010, LANCET, V376, P835, DOI 10.1016/S0140-6736(10)61226-3; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Matsumoto S, 1997, BIOCHEM BIOPH RES CO, V234, P454, DOI 10.1006/bbrc.1997.6665; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; NELSON DJ, 1995, AM J RESP CRIT CARE, V151, P475, DOI 10.1164/ajrccm.151.2.7842209; Nelson HS, 1999, J ALLERGY CLIN IMMUN, V104, P775, DOI 10.1016/S0091-6749(99)70287-3; Omori M, 2007, J IMMUNOL, V178, P1396, DOI 10.4049/jimmunol.178.3.1396; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Porter P, 2009, MUCOSAL IMMUNOL; Reed CE, 2004, J ALLERGY CLIN IMMUN, V114, P997, DOI 10.1016/j.jaci.2004.07.060; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; SCHONHEGRAD MA, 1991, J EXP MED, V173, P1345, DOI 10.1084/jem.173.6.1345; SEDGWICK JD, 1983, IMMUNOLOGY, V50, P625; Seymour BWP, 1998, J EXP MED, V187, P721, DOI 10.1084/jem.187.5.721; Sharkhuu T, 2006, CLIN EXP ALLERGY, V36, P1575, DOI 10.1111/j.1365-2222.2006.02595.x; Smeltz RB, 2001, J EXP MED, V194, P143, DOI 10.1084/jem.194.2.143; Sur S, 1996, J IMMUNOL, V157, P4173; Sur S, 1999, J IMMUNOL, V162, P6284; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Wild JS, 2000, J IMMUNOL, V164, P2701, DOI 10.4049/jimmunol.164.5.2701; World Health Organization, 2007, GLOB SURV PREV CONTR; Yang LY, 1998, J EXP MED, V188, P1739, DOI 10.1084/jem.188.9.1739; Yoshimoto T, 2000, NAT IMMUNOL, V1, P132, DOI 10.1038/77811; Zhou BH, 2008, J IMMUNOL, V181, P6557, DOI 10.4049/jimmunol.181.9.6557	42	22	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e30280	10.1371/journal.pone.0030280	http://dx.doi.org/10.1371/journal.pone.0030280			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347372	gold, Green Published, Green Submitted			2022-12-25	WOS:000302180600007
J	Schilling, D; Bayer, C; Li, W; Molls, M; Vaupel, P; Multhoff, G				Schilling, Daniela; Bayer, Christine; Li, Wei; Molls, Michael; Vaupel, Peter; Multhoff, Gabriele			Radiosensitization of Normoxic and Hypoxic H1339 Lung Tumor Cells by Heat Shock Protein 90 Inhibition Is Independent of Hypoxia Inducible Factor-1 alpha	PLOS ONE			English	Article							MULTITARGET APPROACH; HSP90 INHIBITORS; GROWTH-FACTOR; GLIOMA-CELLS; CANCER; HIF-1-ALPHA; EXPRESSION; NVP-AUY922; INDUCTION; RADIATION	Background: Ionizing irradiation is a commonly accepted treatment modality for lung cancer patients. However, the clinical outcome is hampered by normal tissue toxicity and tumor hypoxia. Since tumors often have higher levels of active heat shock protein 90 (Hsp90) than normal tissues, targeting of Hsp90 might provide a promising strategy to sensitize tumors towards irradiation. Hsp90 client proteins include oncogenic signaling proteins, cell cycle activators, growth factor receptors and hypoxia inducible factor-1 alpha (HIF-1 alpha). Overexpression of HIF-1 alpha is assumed to promote malignant transformation and tumor progression and thus might reduce the accessibility to radiotherapy. Methodology/Principal Findings: Herein, we describe the effects of the novel Hsp90 inhibitor NVP-AUY922 and 17-allylamino-17-demethoxygeldanamycin (17-AAG), as a control, on HIF-1 alpha levels and radiosensitivity of lung carcinoma cells under normoxic and hypoxic conditions. NVP-AUY922 exhibited a similar biological activity to that of 17-AAG, but at only 1/10 of the dose. As expected, both inhibitors reduced basal and hypoxia-induced HIF-1 alpha levels in EPLC-272H lung carcinoma cells. However, despite a down-regulation of HIF-1 alpha upon Hsp90 inhibition, sensitivity towards irradiation remained unaltered in EPLC-272H cells under normoxic and hypoxic conditions. In contrast, treatment of H1339 lung carcinoma cells with NVP-AUY922 and 17-AAG resulted in a significant up-regulation of their initially high HIF-1 alpha levels and a concomitant increase in radiosensitivity. Conclusions/Significance: In summary, our data show a HIF-1 alpha-independent radiosensitization of normoxic and hypoxic H1339 lung cancer cells by Hsp90 inhibition.	[Schilling, Daniela; Bayer, Christine; Molls, Michael; Vaupel, Peter; Multhoff, Gabriele] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiat Oncol, D-8000 Munich, Germany; [Schilling, Daniela; Multhoff, Gabriele] Helmholtz Zentrum Munchen, CCG Innate Immun Tumor Biol, Munich, Germany; [Li, Wei] Univ So Calif, Keck Sch Med, Dept Dermatol, Los Angeles, CA 90033 USA	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Southern California	Schilling, D (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Radiat Oncol, D-8000 Munich, Germany.	gabriele.multhoff@lrz.tu-muenchen.de		Multhoff, Gabriele/0000-0002-2616-3137	Helmholtz Zentrum Munchen (Clinical Cooperation Group - "Innate Immunity in Tumor Biology''); Deutsche Forschungsgemeinschaft [SFB 824/1, INST 95/980-1]; BMBF (Federal Ministry of Education and Research) (MOBITUM) [01EZ0826, Kompetenzverbund Strahlenforschung, 03NUK007E, 01EX1021C]; European Union (EU-CARDIORISK) [FP7-211403]	Helmholtz Zentrum Munchen (Clinical Cooperation Group - "Innate Immunity in Tumor Biology''); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF (Federal Ministry of Education and Research) (MOBITUM)(Federal Ministry of Education & Research (BMBF)); European Union (EU-CARDIORISK)(European Commission)	This work was supported by the Helmholtz Zentrum Munchen (Clinical Cooperation Group - "Innate Immunity in Tumor Biology''), Deutsche Forschungsgemeinschaft (SFB 824/1; Cluster of Excellence 158: Munich-Centre of Advanced Photonics; INST 95/980-1 FUGG, Gulmay irradiation device), BMBF (Federal Ministry of Education and Research) (MOBITUM, 01EZ0826; Kompetenzverbund Strahlenforschung, 03NUK007E; Leading-Edge Cluster m4 - Personalized Medicine and Targeted Therapies, 01EX1021C), European Union (EU-CARDIORISK, FP7-211403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold DM, 2001, CANCER RES, V61, P2911; Akakura N, 2001, CANCER RES, V61, P6548; Artman T, 2010, INT J RADIAT ONCOL, V76, P574, DOI 10.1016/j.ijrobp.2009.08.035; Banerji U, 2005, CLIN CANCER RES, V11, P7023, DOI 10.1158/1078-0432.CCR-05-0518; Bisht KS, 2003, CANCER RES, V63, P8984; Brough PA, 2008, J MED CHEM, V51, P196, DOI 10.1021/jm701018h; Camphausen K, 2007, CLIN CANCER RES, V13, P4326, DOI 10.1158/1078-0432.CCR-07-0632; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Carroll VA, 2006, CANCER RES, V66, P6264, DOI 10.1158/0008-5472.CAN-05-2519; Choi N, 2001, LUNG CANCER, V31, P43, DOI 10.1016/S0169-5002(00)00156-2; Dungey FA, 2009, MOL CANCER THER, V8, P2243, DOI 10.1158/1535-7163.MCT-09-0201; Eccles SA, 2008, CANCER RES, V68, P2850, DOI 10.1158/0008-5472.CAN-07-5256; Ehrlich ES, 2009, P NATL ACAD SCI USA, V106, P20330, DOI 10.1073/pnas.0810571106; Fay Michael J, 2003, Mol Cancer, V2, P40, DOI 10.1186/1476-4598-2-40; Fink T, 2002, BLOOD, V99, P2077, DOI 10.1182/blood.V99.6.2077; Gardner LB, 2001, J BIOL CHEM, V276, P7919, DOI 10.1074/jbc.M010189200; Gaspar N, 2010, MOL CANCER THER, V9, P1219, DOI 10.1158/1535-7163.MCT-09-0683; Gehrmann M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001925; Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032; Ibrahim NO, 2005, CANCER RES, V65, P11094, DOI 10.1158/0008-5472.CAN-05-1877; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Kabakov AE, 2010, J MOL MED, V88, P241, DOI 10.1007/s00109-009-0562-0; Katschinski DM, 2004, CELL PHYSIOL BIOCHEM, V14, P351, DOI 10.1159/000080345; Katschinski DM, 2002, J BIOL CHEM, V277, P9262, DOI 10.1074/jbc.M110377200; Kessler J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-605; Kim WY, 2009, CANCER RES, V69, P1624, DOI 10.1158/0008-5472.CAN-08-0505; Koukourakis MI, 2002, INT J RADIAT ONCOL, V53, P1192, DOI 10.1016/S0360-3016(02)02848-1; Liu JY, 2010, EXP CELL RES, V316, P1985, DOI 10.1016/j.yexcr.2010.02.028; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Mabjeesh NJ, 2002, CANCER RES, V62, P2478; Moeller BJ, 2005, CANCER CELL, V8, P99, DOI 10.1016/j.ccr.2005.06.016; Noguchi M, 2006, BIOCHEM BIOPH RES CO, V351, P658, DOI 10.1016/j.bbrc.2006.10.094; Russell JS, 2003, CLIN CANCER RES, V9, P3749; Said Harun M, 2009, BMC Res Notes, V2, P8, DOI 10.1186/1756-0500-2-8; Sasabe E, 2005, CANCER SCI, V96, P394, DOI 10.1111/j.1349-7006.2005.00065.x; Schilling D, 2011, STRAHLENTHE IN PRESS; Schilling D, 2012, STRAHLENTHE IN PRESS; Schilling D, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-143; Schilling D, 2009, FASEB J, V23, P2467, DOI 10.1096/fj.08-125229; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Stingl L, 2010, BRIT J CANCER, V102, P1578, DOI 10.1038/sj.bjc.6605683; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; van de Sluis B, 2010, J CLIN INVEST, V120, P2119, DOI 10.1172/JCI40583; van de Sluis B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007332; Vaupel P, 2004, SEMIN RADIAT ONCOL, V14, P198, DOI 10.1016/j.semradonc.2004.04.008; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Wykoff CC, 2000, CANCER RES, V60, P7075; Yang JS, 2005, J BIOL CHEM, V280, P36047, DOI 10.1074/jbc.M501755200; Zhou J, 2004, J BIOL CHEM, V279, P13506, DOI 10.1074/jbc.M310164200	49	26	27	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31110	10.1371/journal.pone.0031110	http://dx.doi.org/10.1371/journal.pone.0031110			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347438	Green Submitted, Green Published, gold			2022-12-25	WOS:000302180600030
J	Ishida-Yamamoto, A; Kishibe, M; Murakami, M; Honma, M; Takahashi, H; Iizuka, H				Ishida-Yamamoto, Akemi; Kishibe, Mari; Murakami, Masamoto; Honma, Masaru; Takahashi, Hidetoshi; Iizuka, Hajime			Lamellar Granule Secretion Starts before the Establishment of Tight Junction Barrier for Paracellular Tracers in Mammalian Epidermis	PLOS ONE			English	Article							PROTEINS; CELLS; SKIN; ZO-1; KERATINOCYTES; DESQUAMATION; DEGRADATION; MUTATION; OCCLUDIN; MICE	Defects in epidermal barrier function and/or vesicular transport underlie severe skin diseases including ichthyosis and atopic dermatitis. Tight junctions (TJs) form a single layered network in simple epithelia. TJs are important for both barrier functions and vesicular transport. Epidermis is stratified epithelia and lamellar granules (LGs) are secreted from the stratum granulosum (SG) in a sequential manner. Previously, continuous TJs and paracellular permeability barriers were found in the second layer (SG2) of SG in mice, but their fate and correlation with LG secretion have been poorly understood. We studied epidermal TJ-related structures in humans and in mice and found occludin/ZO-1 immunoreactive multilayered networks spanning the first layer of SG (SG1) and SG2. Paracellular penetration tracer passed through some TJs in SG2, but not in SG1. LG secretion into the paracellular tracer positive spaces started below the level of TJs of SG1. Our study suggests that LG-secretion starts before the establishment of TJ barrier in the mammalian epidermis.	[Ishida-Yamamoto, Akemi; Kishibe, Mari; Murakami, Masamoto; Honma, Masaru; Takahashi, Hidetoshi; Iizuka, Hajime] Asahikawa Med Univ, Dept Dermatol, Asahikawa, Hokkaido, Japan	Asahikawa Medical College	Ishida-Yamamoto, A (corresponding author), Asahikawa Med Univ, Dept Dermatol, Asahikawa, Hokkaido, Japan.	akemi@asahikawa-med.ac.jp			Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [21791054]; Grants-in-Aid for Scientific Research [24591620, 21390323] Funding Source: KAKEN	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Ministry of Health, Labor and Welfare of Japan to A. I.-Y. and a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (21791054) to M.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandner JM, 2002, EUR J CELL BIOL, V81, P253, DOI 10.1078/0171-9335-00244; Brandner JM, 2009, EUR J PHARM BIOPHARM, V72, P289, DOI 10.1016/j.ejpb.2008.08.007; De Benedetto A, 2011, J ALLERGY CLIN IMMUN, V127, P773, DOI 10.1016/j.jaci.2010.10.018; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; ELIAS PM, 1975, J CELL BIOL, V65, P180, DOI 10.1083/jcb.65.1.180; ELIAS PM, 1983, J INVEST DERMATOL, V80, pS44, DOI 10.1038/jid.1983.12; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Guan YF, 2011, AM J PHYSIOL-CELL PH, V300, pC1404, DOI 10.1152/ajpcell.00270.2010; Hadj-Rabia S, 2004, GASTROENTEROLOGY, V127, P1386, DOI 10.1053/j.gastro.2004.07.022; HASHIMOTO K, 1971, J INVEST DERMATOL, V57, P17, DOI 10.1111/1523-1747.ep12292052; Hershkovitz D, 2008, ARCH DERMATOL, V144, P334, DOI 10.1001/archderm.144.3.334; Igawa S, 2011, EXP DERMATOL, V20, P53, DOI 10.1111/j.1600-0625.2010.01170.x; Ishida-Yamamoto A, 2004, J INVEST DERMATOL, V122, P1137, DOI 10.1111/j.0022-202X.2004.22515.x; Kirschner N, 2011, J INVEST DERMATOL, V131, P932, DOI 10.1038/jid.2010.390; Kirschner N, 2010, EUR J CELL BIOL, V89, P839, DOI 10.1016/j.ejcb.2010.07.010; Kirschner N, 2009, AM J PATHOL, V175, P1095, DOI 10.2353/ajpath.2009.080973; Kubo A, 2009, J EXP MED, V206, P2937, DOI 10.1084/jem.20091527; Kuroda S, 2010, J DERMATOL SCI, V59, P107, DOI 10.1016/j.jdermsci.2010.06.001; Langbein L, 2002, EUR J CELL BIOL, V81, P419, DOI 10.1078/0171-9335-00270; Morita K, 1998, J INVEST DERMATOL, V110, P862, DOI 10.1046/j.1523-1747.1998.00209.x; Pummi K, 2001, J INVEST DERMATOL, V117, P1050, DOI 10.1046/j.0022-202x.2001.01493.x; Schluter H, 2004, EUR J CELL BIOL, V83, P655, DOI 10.1078/0171-9335-00434; Simon M, 2001, J BIOL CHEM, V276, P20292, DOI 10.1074/jbc.M100201200; Sprecher E, 2005, AM J HUM GENET, V77, P242, DOI 10.1086/432556; Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344; Yuki T, 2011, J INVEST DERMATOL, V131, P744, DOI 10.1038/jid.2010.385	26	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e31641	10.1371/journal.pone.0031641	http://dx.doi.org/10.1371/journal.pone.0031641			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328942	Green Published, Green Submitted, gold			2022-12-25	WOS:000302179300028
J	Mattsson, N; Rajendran, L; Zetterberg, H; Gustavsson, M; Andreasson, U; Olsson, M; Brinkmalm, G; Lundkvist, J; Jacobson, LH; Perrot, L; Neumann, U; Borghys, H; Mercken, M; Dhuyvetter, D; Jeppsson, F; Blennow, K; Portelius, E				Mattsson, Niklas; Rajendran, Lawrence; Zetterberg, Henrik; Gustavsson, Mikael; Andreasson, Ulf; Olsson, Maria; Brinkmalm, Gunnar; Lundkvist, Johan; Jacobson, Laura H.; Perrot, Ludovic; Neumann, Ulf; Borghys, Herman; Mercken, Marc; Dhuyvetter, Deborah; Jeppsson, Fredrik; Blennow, Kaj; Portelius, Erik			BACE1 Inhibition Induces a Specific Cerebrospinal Fluid beta-Amyloid Pattern That Identifies Drug Effects in the Central Nervous System	PLOS ONE			English	Article							PROTEIN-CLEAVING ENZYME; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; SECRETASE ACTIVITY; PEPTIDE; EXPRESSION; CLEAVAGE; BRAIN; PURIFICATION; GENERATION	BACE1 is a key enzyme for amyloid-beta (A beta) production, and an attractive therapeutic target in Alzheimer's disease (AD). Here we report that BACE1 inhibitors have distinct effects on neuronal A beta metabolism, inducing a unique pattern of secreted Ab peptides, analyzed in cell media from amyloid precursor protein (APP) transfected cells and in cerebrospinal fluid (CSF) from dogs by immunoprecipitation-mass spectrometry, using several different BACE1 inhibitors. Besides the expected reductions in A beta 1-40 and A beta 1-42, treatment also changed the relative levels of several other A beta isoforms. In particular A beta 1-34 decreased, while A beta 5-40 increased, and these changes were more sensitive to BACE1 inhibition than the changes in A beta 1-40 and A beta 1-42. The effects on A beta 5-40 indicate the presence of a BACE1 independent pathway of APP degradation. The described CSF A beta pattern may be used as a pharmacodynamic fingerprint to detect biochemical effects of BACE1-therapies in clinical trials, which might accelerate development of novel therapies.	[Mattsson, Niklas; Zetterberg, Henrik; Gustavsson, Mikael; Andreasson, Ulf; Olsson, Maria; Brinkmalm, Gunnar; Blennow, Kaj; Portelius, Erik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Clin Neurochem Lab,Dept Psychiat & Neurochem, Molndal, Sweden; [Rajendran, Lawrence] Univ Zurich, Div Psychiat Res, Zurich, Switzerland; [Lundkvist, Johan; Jeppsson, Fredrik] AstraZeneca R&D, Innovat Med, Cent Nervous Syst & Pain iMed, Dept Neurosci, Sodertalje, Sweden; [Jacobson, Laura H.; Perrot, Ludovic; Neumann, Ulf] Novartis Inst BioMed Res, Basel, Switzerland; [Borghys, Herman; Mercken, Marc; Dhuyvetter, Deborah] Janssen Res & Dev, Neurosci Therapeut Area, Beerse, Belgium	University of Gothenburg; University of Zurich; AstraZeneca; Novartis; Johnson & Johnson; Janssen Pharmaceuticals	Mattsson, N (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Clin Neurochem Lab,Dept Psychiat & Neurochem, Molndal, Sweden.	niklas.mattsson@neuro.gu.se; erik.portelius@neuro.gu.se	Mattsson-Carlgren, Niklas/H-7597-2019; Brinkmalm, Gunnar/AAH-3914-2021; Jacobson, Laura/A-3363-2013; jacobson, laura/AAI-7429-2021	Mattsson-Carlgren, Niklas/0000-0002-8885-7724; jacobson, laura/0000-0003-2910-8659; Brinkmalm, Gunnar/0000-0001-6958-2393; Rajendran, Lawrence/0000-0002-6390-1821	Swedish State Support for Clinical Research; Stiftelsen Psykiatriska Forskningsfonden; Swiss National Science Foundation; Velux Stiftung; Novartis Research Foundation; Soderberg Foundation Stiftelsen Gamla Tjanarinnor; Magn. Bergvalls Stiftelse; Gun och Bertil Stohnes Stiftelse; Uppsala Universitets Medicinska Fakultet Stiftelse for Psykiatrisk och Neurologisk Forskning; Swedish Brain Fund; Alzheimer Foundation, Sweden; Dementia Association, Sweden; Lundbeck Foundation	Swedish State Support for Clinical Research; Stiftelsen Psykiatriska Forskningsfonden; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Velux Stiftung; Novartis Research Foundation; Soderberg Foundation Stiftelsen Gamla Tjanarinnor; Magn. Bergvalls Stiftelse; Gun och Bertil Stohnes Stiftelse; Uppsala Universitets Medicinska Fakultet Stiftelse for Psykiatrisk och Neurologisk Forskning; Swedish Brain Fund; Alzheimer Foundation, Sweden; Dementia Association, Sweden; Lundbeck Foundation(Lundbeckfonden)	The study was supported by the Lundbeck Foundation, the Swedish Research Council, Swedish State Support for Clinical Research, Stiftelsen Psykiatriska Forskningsfonden, Swiss National Science Foundation, Velux Stiftung, Novartis Research Foundation grant, the Soderberg Foundation Stiftelsen Gamla Tjanarinnor, Magn. Bergvalls Stiftelse, Gun och Bertil Stohnes Stiftelse, Uppsala Universitets Medicinska Fakultet Stiftelse for Psykiatrisk och Neurologisk Forskning, the Swedish Brain Fund, the Alzheimer Foundation, Sweden and the Dementia Association, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwal JK, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002254; BIEDLER JL, 1978, CANCER RES, V38, P3751; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Cook JJ, 2010, J NEUROSCI, V30, P6743, DOI 10.1523/JNEUROSCI.1381-10.2010; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; Falting J, 2009, ALZHEIMERS DEMENT, V5, pe5; Farah MH, J NEUROSCI, V31, P5744; Fleisher AS, 2008, ARCH NEUROL-CHICAGO, V65, P1031, DOI 10.1001/archneur.65.8.1031; Fluhrer R, 2003, J BIOL CHEM, V278, P5531, DOI 10.1074/jbc.M211485200; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Hansson O, 2010, NEUROBIOL AGING, V31, P357, DOI 10.1016/j.neurobiolaging.2008.03.027; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Holsinger RMD, 2006, NEUROLOGY, V67, P710, DOI 10.1212/01.wnl.0000229925.52203.4c; Holsinger RMD, 2004, ANN NEUROL, V55, P898, DOI 10.1002/ana.20144; John V., 2010, BACE LEAD TARGET ORC; Johnston JA, 2005, BIOCHEM SOC T, V33, P1096, DOI 10.1042/BST0331096; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Lee SF, 2002, J BIOL CHEM, V277, P45013, DOI 10.1074/jbc.M208164200; Luo Y, 2003, NEUROBIOL DIS, V14, P81, DOI 10.1016/S0969-9961(03)00104-9; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; May PC, 2011, J NEUROSCI, V31, P16507, DOI 10.1523/JNEUROSCI.3647-11.2011; MILLER DL, 1993, ARCH BIOCHEM BIOPHYS, V301, P41, DOI 10.1006/abbi.1993.1112; Miravalle L, 2005, BIOCHEMISTRY-US, V44, P10810, DOI 10.1021/bi0508237; NASLUND J, 1994, P NATL ACAD SCI USA, V91, P8378, DOI 10.1073/pnas.91.18.8378; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; PORTELIUS E, 2011, CURR PHARM DES; Portelius E, 2010, ACTA NEUROPATHOL; Portelius E, 2007, J PROTEOME RES, V6, P4433, DOI 10.1021/pr0703627; Portelius E, 2010, J ALZHEIMERS DIS, V21, P1005, DOI 10.3233/JAD-2010-100573; Portelius E, 2010, ACTA NEUROPATHOL, V120, P185, DOI 10.1007/s00401-010-0690-1; Portelius E, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt30; Portelius E, 2009, NEURODEGENER DIS, V6, P258, DOI 10.1159/000264639; Portelius E, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-2; Portelius E, 2011, NEUROBIOL AGING, V32, P1090, DOI 10.1016/j.neurobiolaging.2009.06.002; Rueeger H, 2011, 241 ACS NAT M EXP; Sankaranarayanan S, 2009, J PHARMACOL EXP THER, V328, P131, DOI 10.1124/jpet.108.143628; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shi XP, 2003, J BIOL CHEM, V278, P21286, DOI 10.1074/jbc.M209859200; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Stachel SJ, 2004, J MED CHEM, V47, P6447, DOI 10.1021/jm049379g; Takasugi N, 2011, J NEUROSCI, V31, P6850, DOI 10.1523/JNEUROSCI.6467-10.2011; Takeda K, 2004, FASEB J, V18, P1755, DOI 10.1096/fj.03-1070fje; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Verheijen JH, 2006, CLIN CHEM, V52, P1168, DOI 10.1373/clinchem.2006.066720; VIGOPELFREY C, 1993, J NEUROCHEM, V61, P1965, DOI 10.1111/j.1471-4159.1993.tb09841.x; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Yu YJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002230; Zetterberg H, 2008, ARCH NEUROL-CHICAGO, V65, P1102, DOI 10.1001/archneur.65.8.1102; Zhou LJ, 2011, J BIOL CHEM, V286, P8677, DOI 10.1074/jbc.M110.194860	57	58	58	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e31084	10.1371/journal.pone.0031084	http://dx.doi.org/10.1371/journal.pone.0031084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328928	Green Published, Green Accepted, gold			2022-12-25	WOS:000302179300014
J	Bell, PR				Bell, Phil R.			Standardized Terminology and Potential Taxonomic Utility for Hadrosaurid Skin Impressions: A Case Study for Saurolophus from Canada and Mongolia	PLOS ONE			English	Article							DINOSAUR; ORNITHISCHIA; INTEGUMENT; OSTEODERMS; SKELETON	The characterization of palaeospecies typically relies on hard-tissue anatomy, such as bones or teeth that is more readily fossilized than soft parts. Among dinosaurs, skin impressions are commonly associated with partial and complete hadrosaurid skeletons, and consist of non-imbricating tubercles or scales. Skin impressions from various parts of the body of two species of the hadrosaurine Saurolophus (S. angustirostris from Mongolia and S. osborni from Canada) are described from multiple specimens. These species, recently validated on osteological grounds, can be differentiated based solely on soft-tissue anatomy, namely scale shape and pattern. This study demonstrates for the first time the applicability of soft-tissue (i.e., scale impressions) as a means to differentiate species within the Dinosauria. Differences are most spectacular in the tail, where S. angustirostris is differentiated by the presence of vertical bands of morphologically distinct scales, a grid-like arrangement of circular feature-scales, and tabular scales along the dorsal midline. Preliminary results indicate scale architecture remained consistent throughout ontogeny in S. angustirostris. These results support previous assertions that hadrosaurid scale architecture has a positive phylogenetic signal. As such, future taxonomic descriptions should include, where possible, the standardized description of skin impressions including the position and orientation of these impressions on the body.	[Bell, Phil R.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Bell, PR (corresponding author), Pipestone Creek Dinosaur Initiat, Clairmont, AB, Canada.	pbell@countygp.ab.ca			Dinosaur Research Institute; Korean Institute of Geology and Mineralogy; Hwaseong City (Korea)	Dinosaur Research Institute; Korean Institute of Geology and Mineralogy; Hwaseong City (Korea)	Funding was provided by the Dinosaur Research Institute (travel grant; no grant number); the Korean Institute of Geology and Mineralogy, and Hwaseong City (Korea)(travel grant; no grant number). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BG, 1998, J VERTEBR PALEONTOL, V18, P739, DOI 10.1080/02724634.1998.10011102; Bell PR, 2011, CRETACEOUS RES, V32, P30, DOI 10.1016/j.cretres.2010.10.002; Bell PR, ACTA PAL PO IN PRESS, V56; Briggs DEG, 1997, J GEOL SOC LONDON, V154, P587, DOI 10.1144/gsjgs.154.4.0587; Brown B, 1913, B AM MUS NAT HIST, V32, P387; Brown B, 1912, B AM MUS NAT HIST, V31, P131; Brown B, 1916, B AM MUS NAT HIST, V35, P709; Burns ME, 2008, J VERTEBR PALEONTOL, V28, P1102, DOI 10.1671/0272-4634-28.4.1102; Coria RA, 2007, J PALEONTOL, V81, P1528, DOI 10.1666/05-150.1; Czerkas S. A., 1997, ENCY DINOSAURS, P669; CZERKAS SA, 1992, GEOLOGY, V20, P1068, DOI 10.1130/0091-7613(1992)020<1068:DODSRA>2.3.CO;2; Dodson P, 1998, J VERTEBR PALEONTOL, V18, P563, DOI 10.1080/02724634.1998.10011084; Evans DC, 2007, J VERTEBR PALEONTOL, V27, P373, DOI 10.1671/0272-4634(2007)27[373:AAROLM]2.0.CO;2; HORNER JR, 1984, J PALEONTOL, V58, P270; Ji Shuan, 1998, Geological Review (Beijing), V44, P603; Lambe L., 1914, Ottawa Naturalist, V27; Lambe L., 1914, Ottawa Naturalist, V27; Lull R.S., 1942, GEOLOGICAL SOC AM SP, V40, P242; Murphy NL., 2006, HORNS BEAKS CERATOPS, P117; Norman David B., 2000, P462; Osborn H. F., 1912, AMER MUS NAT HIST ME, V1, P33; Osborn HF., 1911, AM MUSEUM J, V2, P7; Parks WA, 1920, T ROY SOC CAN, V13, P5; Scheyer TM, 2004, J VERTEBR PALEONTOL, V24, P878; Siber H.-J., 2009, STEGOSAURS SAURIERMU; STERNBERG C. M., 1935, BULL NAT MUS CANADA, V77, P1; Wegweiser M.D., 2006, NEW MEX MUS NAT HIST, V35, P119; Xu X, 1999, NATURE, V401, P262, DOI 10.1038/45769; Xu X, 1999, NATURE, V399, P350, DOI 10.1038/20670; Xu X, 2001, NATURE, V410, P200, DOI 10.1038/35065589	30	35	36	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31295	10.1371/journal.pone.0031295	http://dx.doi.org/10.1371/journal.pone.0031295			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319623	gold, Green Published			2022-12-25	WOS:000302178400035
J	Slesiona, S; Gressler, M; Mihlan, M; Zaehle, C; Schaller, M; Barz, D; Hube, B; Jacobsen, ID; Brock, M				Slesiona, Silvia; Gressler, Markus; Mihlan, Michael; Zaehle, Christoph; Schaller, Martin; Barz, Dagmar; Hube, Bernhard; Jacobsen, Ilse D.; Brock, Matthias			Persistence versus Escape: Aspergillus terreus and Aspergillus fumigatus Employ Different Strategies during Interactions with Macrophages	PLOS ONE			English	Article							INVASIVE PULMONARY ASPERGILLOSIS; TOLL-LIKE RECEPTORS; NIDULANS WA-GENE; MONONUCLEAR PHAGOCYTES; FRANCISELLA-TULARENSIS; ALVEOLAR MACROPHAGES; MOLD INFECTIONS; CRYPTOCOCCUS-NEOFORMANS; NAPHTHOPYRONE SYNTHASE; TRANSPLANT RECIPIENTS	Invasive bronchopulmonary aspergillosis (IBPA) is a life-threatening disease in immunocompromised patients. Although Aspergillus terreus is frequently found in the environment, A. fumigatus is by far the main cause of IBPA. However, once A. terreus establishes infection in the host, disease is as fatal as A. fumigatus infections. Thus, we hypothesized that the initial steps of disease establishment might be fundamentally different between these two species. Since alveolar macrophages represent one of the first phagocytes facing inhaled conidia, we compared the interaction of A. terreus and A. fumigatus conidia with alveolar macrophages. A. terreus conidia were phagocytosed more rapidly than A. fumigatus conidia, possibly due to higher exposure of beta-1,3-glucan and galactomannan on the surface. In agreement, blocking of dectin-1 and mannose receptors significantly reduced phagocytosis of A. terreus, but had only a moderate effect on phagocytosis of A. fumigatus. Once phagocytosed, and in contrast to A. fumigatus, A. terreus did not inhibit acidification of phagolysosomes, but remained viable without signs of germination both in vitro and in immunocompetent mice. The inability of A. terreus to germinate and pierce macrophages resulted in significantly lower cytotoxicity compared to A. fumigatus. Blocking phagolysosome acidification by the v-ATPase inhibitor bafilomycin increased A. terreus germination rates and cytotoxicity. Recombinant expression of the A. nidulans wA naphthopyrone synthase, a homologue of A. fumigatus PksP, inhibited phagolysosome acidification and resulted in increased germination, macrophage damage and virulence in corticosteroid-treated mice. In summary, we show that A. terreus and A. fumigatus have evolved significantly different strategies to survive the attack of host immune cells. While A. fumigatus prevents phagocytosis and phagolysosome acidification and escapes from macrophages by germination, A. terreus is rapidly phagocytosed, but conidia show long-term persistence in macrophages even in immunocompetent hosts.	[Slesiona, Silvia; Gressler, Markus; Mihlan, Michael; Zaehle, Christoph; Hube, Bernhard; Jacobsen, Ilse D.; Brock, Matthias] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany; [Hube, Bernhard] Univ Jena, Jena, Germany; [Schaller, Martin] Univ Tubingen, Dept Dermatol, Tubingen, Germany; [Barz, Dagmar] Univ Hosp, Inst Transfus Med, Jena, Germany	Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Schiller University of Jena	Slesiona, S (corresponding author), Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany.	Ilse.jacobsen@hki-jena.de; Matthias.brock@hki-jena.de	Jacobsen, Ilse/B-3155-2011; Brock, Matthias/AAX-1430-2021	Jacobsen, Ilse/0000-0002-6033-9984; Mihlan, Michael/0000-0002-3946-6583; Brock, Matthias/0000-0003-2774-1856; Hube, Bernhard/0000-0002-6028-0425	German Science Foundation (DFG) [BR2216/4-1]; Netzwerk Grundlagenforschung of the HKI (Hans Knoell Institute)	German Science Foundation (DFG)(German Research Foundation (DFG)); Netzwerk Grundlagenforschung of the HKI (Hans Knoell Institute)	This work was financially supported by a grant from the German Science Foundation (DFG, grant BR2216/4-1) and the Netzwerk Grundlagenforschung of the HKI (Hans Knoell Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Akpogheneta O, 2003, MYCOSES, V46, P77, DOI 10.1046/j.1439-0507.2003.00852.x; ARAMAYO R, 1993, EMBO J, V12, P2039, DOI 10.1002/j.1460-2075.1993.tb05853.x; Auberger J, 2008, DIAGN MICR INFEC DIS, V62, P336, DOI 10.1016/j.diagmicrobio.2008.06.012; Baddley JW, 2001, CLIN INFECT DIS, V32, P1319, DOI 10.1086/319985; Balloy V, 2005, INFECT IMMUN, V73, P494, DOI 10.1128/IAI.73.1.494-503.2005; Ben-Ami R, 2010, BRIT J HAEMATOL, V150, P406, DOI 10.1111/j.1365-2141.2010.08283.x; BENNETT JE, 1987, J INFECT DIS, V155, P1005, DOI 10.1093/infdis/155.5.1005; Bhatia S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015943; Bignell E, 2005, MOL MICROBIOL, V55, P1072, DOI 10.1111/j.1365-2958.2004.04472.x; Brakhage AA, 2010, CURR OPIN MICROBIOL, V13, P409, DOI 10.1016/j.mib.2010.04.009; Brieland JK, 2001, INFECT IMMUN, V69, P1554, DOI 10.1128/IAI.69.3.1554-1560.2001; Buchan BW, 2009, INFECT IMMUN, V77, P2517, DOI 10.1128/IAI.00229-09; Chignard M, 2007, CLIN IMMUNOL, V124, P238, DOI 10.1016/j.clim.2007.05.004; Deak E, 2011, VIRULENCE, V2, P200, DOI 10.4161/viru.2.3.15799; Deak E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007673; Denning DW, 1998, J INFECTION, V37, P173, DOI 10.1016/S0163-4453(98)80173-4; DIAMOND RD, 1988, REV INFECT DIS, V10, pS428; Duong M, 1998, J INFECT DIS, V178, P1472, DOI 10.1086/314425; EISSENBERG LG, 1993, J EXP MED, V177, P1605, DOI 10.1084/jem.177.6.1605; Fleck CB, 2008, MOL MICROBIOL, V68, P642, DOI 10.1111/j.1365-2958.2008.06180.x; Fleck CB, 2010, EUKARYOT CELL, V9, P1120, DOI 10.1128/EC.00362-09; FORD S, 1967, J BACTERIOL, V94, P928, DOI 10.1128/JB.94.4.928-933.1967; Fujii I, 2001, CHEM BIOL, V8, P189, DOI 10.1016/S1074-5521(00)90068-1; Gersuk GM, 2006, J IMMUNOL, V176, P3717, DOI 10.4049/jimmunol.176.6.3717; Graveline R, 2007, INT IMMUNOL, V19, P375, DOI 10.1093/intimm/dxm003; GREEN F H Y, 1980, Scanning Electron Microscopy, P307; Gressler M, 2011, CHEM BIOL, V18, P198, DOI 10.1016/j.chembiol.2010.12.011; Haas A, 1998, MOL MEMBR BIOL, V15, P103, DOI 10.3109/09687689809074522; Heesemann L, 2011, INT J MED MICROBIOL, V301, P523, DOI 10.1016/j.ijmm.2011.02.003; Hoffmann E, 2010, EUR J CELL BIOL, V89, P693, DOI 10.1016/j.ejcb.2010.04.006; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Ibrahim-Granet O, 2003, INFECT IMMUN, V71, P891, DOI 10.1128/IAI.71.2.891-903.2003; Ibrahim-Granet O, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-105; Jahn B, 2002, CELL MICROBIOL, V4, P793, DOI 10.1046/j.1462-5822.2002.00228.x; Jorgensen TR, 2011, FUNGAL GENET BIOL, V48, P544, DOI 10.1016/j.fgb.2011.01.005; Jouault T, 2009, CELL MICROBIOL, V11, P1007, DOI 10.1111/j.1462-5822.2009.01318.x; KHOO SH, 1994, CLIN INFECT DIS, V19, pS41, DOI 10.1093/clinids/19.Supplement_1.S41; Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241; Krishnan N, 2010, TUBERCULOSIS, V90, P361, DOI 10.1016/j.tube.2010.08.005; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028; Langfelder K, 1998, MED MICROBIOL IMMUN, V187, P79, DOI 10.1007/s004300050077; Lass-Florl C, 2010, FUTURE MICROBIOL, V5, P789, DOI [10.2217/fmb.10.34, 10.2217/FMB.10.34]; Lass-Florl C, 1998, J ANTIMICROB CHEMOTH, V42, P497, DOI 10.1093/jac/42.4.497; Lass-Florl C, 2005, BRIT J HAEMATOL, V131, P201, DOI 10.1111/j.1365-2141.2005.05763.x; Levitz SM, 1999, INFECT IMMUN, V67, P885, DOI 10.1128/IAI.67.2.885-890.1999; Lin SJ, 2001, CLIN INFECT DIS, V32, P358, DOI 10.1086/318483; LUNDBORG M, 1972, SABOURAUD, V10, P152; Luther K, 2007, CELL MICROBIOL, V9, P368, DOI 10.1111/j.1462-5822.2006.00796.x; Luther K, 2006, J MICROBIOL METH, V66, P170, DOI 10.1016/j.mimet.2005.11.008; Malani A, 2007, INFECT CONT HOSP EP, V28, P892, DOI 10.1086/518456; Malani AN, 2007, DRUGS, V67, P1803, DOI 10.2165/00003495-200767130-00001; Marr KA, 2001, CLIN DIAGN LAB IMMUN, V8, P1240, DOI 10.1128/CDLI.8.6.1240-1247.2001; Marr KA, 2002, CLIN INFECT DIS, V34, P909, DOI 10.1086/339202; MAYORGA ME, 1990, GENETICS, V126, P73; MAYORGA ME, 1992, MOL GEN GENET, V235, P205, DOI 10.1007/BF00279362; MBAWUIKE IN, 1989, J LEUKOCYTE BIOL, V46, P119, DOI 10.1002/jlb.46.2.119; Nessa K, 1997, LETT APPL MICROBIOL, V25, P181, DOI 10.1046/j.1472-765X.1997.00200.x; Netea MG, 2006, CURR PHARM DESIGN, V12, P4195, DOI 10.2174/138161206778743538; Ogawa M, 2006, CELL MICROBIOL, V8, P177, DOI 10.1111/j.1462-5822.2005.00652.x; Okagaki LH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000953; Perfect JR, 2001, CLIN INFECT DIS, V33, P1824, DOI 10.1086/323900; Perkhofer S, 2007, MYCOPATHOLOGIA, V163, P303, DOI 10.1007/s11046-007-9013-z; Philippe B, 2003, INFECT IMMUN, V71, P3034, DOI 10.1128/IAI.71.6.3034-3042.2003; PURNELL DM, 1974, SABOURAUDIA, V12, P95; RALPH P, 1975, J IMMUNOL, V114, P898; RICHARD JL, 1975, APPL MICROBIOL, V30, P44, DOI 10.1128/AEM.30.1.44-47.1975; RIPPON JW, 1974, SABOURAUDIA, V12, P157; Roilides E, 1998, RES IMMUNOL, V149, P454, DOI 10.1016/S0923-2494(98)80769-4; ROILIDES E, 1995, J INFECT DIS, V172, P1028, DOI 10.1093/infdis/172.4.1028; Sansonetti P, 2001, SEMIN IMMUNOL, V13, P381, DOI 10.1006/smim.2001.0335; SCHAFFNER A, 1982, J CLIN INVEST, V69, P617, DOI 10.1172/JCI110489; Schulert GS, 2009, INFECT IMMUN, V77, P1324, DOI 10.1128/IAI.01318-08; Schulert GS, 2006, J LEUKOCYTE BIOL, V80, P563, DOI 10.1189/jlb.0306219; Segal BH, 2007, ONCOLOGIST, V12, P7, DOI 10.1634/theoncologist.12-S2-7; Seider K, 2010, CURR OPIN MICROBIOL, V13, P392, DOI 10.1016/j.mib.2010.05.001; Serrano-Gomez D, 2004, J IMMUNOL, V173, P5635, DOI 10.4049/jimmunol.173.9.5635; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Steinbach WJ, 2004, CLIN INFECT DIS, V39, P192, DOI 10.1086/421950; Steinberg BE, 2007, BIOCHEM SOC T, V35, P1083, DOI 10.1042/BST0351083; Stergiopoulou T, 2007, AM J CLIN PATHOL, V127, P349, DOI 10.1309/UJRV9DLC11RM3G8R; STURTEVANT JE, 1992, INFECT IMMUN, V60, P1913, DOI 10.1128/IAI.60.5.1913-1918.1992; TAPPER H, 1995, J CELL PHYSIOL, V163, P137, DOI 10.1002/jcp.1041630116; Thywissen A, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00096; Torosantucci A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005392; Tsai HF, 1998, J BACTERIOL, V180, P3031, DOI 10.1128/JB.180.12.3031-3038.1998; Vesper SJ, 2007, J WATER HEALTH, V5, P427, DOI 10.2166/wh.2007.038; Voelz K, 2009, INFECT IMMUN, V77, P3450, DOI 10.1128/IAI.00297-09; Wasylnka JA, 2005, MED MYCOL, V43, pS27, DOI 10.1080/13693780400029247; Watanabe A, 2000, FEMS MICROBIOL LETT, V192, P39, DOI 10.1111/j.1574-6968.2000.tb09356.x; Weidenmaier C, 2003, CURR DRUG TARGETS, V4, P643, DOI 10.2174/1389450033490731; Willment JA, 2008, TRENDS MICROBIOL, V16, P27, DOI 10.1016/j.tim.2007.10.012	92	64	67	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31223	10.1371/journal.pone.0031223	http://dx.doi.org/10.1371/journal.pone.0031223			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319619	gold, Green Published, Green Submitted			2022-12-25	WOS:000302178400032
J	Amaral, AR; Beheregaray, LB; Bilgmann, K; Boutov, D; Freitas, L; Robertson, KM; Sequeira, M; Stockin, KA; Coelho, MM; Moller, LM				Amaral, Ana R.; Beheregaray, Luciano B.; Bilgmann, Kerstin; Boutov, Dmitri; Freitas, Luis; Robertson, Kelly M.; Sequeira, Marina; Stockin, Karen A.; Coelho, M. Manuela; Moeller, Luciana M.			Seascape Genetics of a Globally Distributed, Highly Mobile Marine Mammal: The Short-Beaked Common Dolphin (Genus Delphinus)	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; NORTH-ATLANTIC OCEAN; WHALES ORCINUS-ORCA; SOUTH-EAST COAST; POPULATION-STRUCTURE; MICROSATELLITE LOCI; MOLECULAR ECOLOGY; FEEDING ECOLOGY; MITOCHONDRIAL; SEA	Identifying which factors shape the distribution of intraspecific genetic diversity is central in evolutionary and conservation biology. In the marine realm, the absence of obvious barriers to dispersal can make this task more difficult. Nevertheless, recent studies have provided valuable insights into which factors may be shaping genetic structure in the world's oceans. These studies were, however, generally conducted on marine organisms with larval dispersal. Here, using a seascape genetics approach, we show that marine productivity and sea surface temperature are correlated with genetic structure in a highly mobile, widely distributed marine mammal species, the short-beaked common dolphin. Isolation by distance also appears to influence population divergence over larger geographical scales (i.e. across different ocean basins). We suggest that the relationship between environmental variables and population structure may be caused by prey behaviour, which is believed to determine common dolphins' movement patterns and preferred associations with certain oceanographic conditions. Our study highlights the role of oceanography in shaping genetic structure of a highly mobile and widely distributed top marine predator. Thus, seascape genetic studies can potentially track the biological effects of ongoing climate-change at oceanographic interfaces and also inform marine reserve design in relation to the distribution and genetic connectivity of charismatic and ecologically important megafauna.	[Amaral, Ana R.; Coelho, M. Manuela] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, P-1699 Lisbon, Portugal; [Amaral, Ana R.; Beheregaray, Luciano B.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Beheregaray, Luciano B.; Moeller, Luciana M.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Bilgmann, Kerstin] Macquarie Univ, Grad Sch Environm, Sydney, NSW 2109, Australia; [Boutov, Dmitri] Univ Lisbon, Fac Ciencias, Ctr Oceanog, Lisbon, Portugal; [Freitas, Luis] Museu Baleia Madeira, Canical, Madeira, Portugal; [Robertson, Kelly M.] SW Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA USA; [Sequeira, Marina] Inst Conservacao Nat & Biodiversidade, Lisbon, Portugal; [Stockin, Karen A.] Massey Univ, Inst Nat Sci, Coastal Marine Res Grp, Auckland, New Zealand	Universidade de Lisboa; Macquarie University; Flinders University South Australia; Macquarie University; Universidade de Lisboa; National Oceanic Atmospheric Admin (NOAA) - USA; Massey University	Amaral, AR (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, P-1699 Lisbon, Portugal.	aramaral@fc.ul.pt	Beheregaray, Luciano B/A-8621-2008; Coelho, Maria M/B-8672-2009; Beheregaray, Luciano/AAY-6384-2021; Stockin, Karen A/B-4452-2010; Boutov, Dmitri/B-2720-2012; Amaral, Ana Rita/ABG-4271-2021; Amaral, Ana/D-1060-2010	Beheregaray, Luciano B/0000-0003-0944-3003; Coelho, Maria M/0000-0003-3288-1693; Beheregaray, Luciano/0000-0003-0944-3003; Boutov, Dmitri/0000-0001-8530-4369; Amaral, Ana Rita/0000-0002-0595-0086; Amaral, Ana/0000-0002-0595-0086; Stockin, Karen/0000-0002-2981-3983; Bilgmann, Kerstin/0000-0003-0681-2301; Freitas, Luis/0000-0001-5288-0853; Moller, Luciana/0000-0002-7293-5847	Fundacao para a Ciencia e Tecnologia (Portugal); Macquarie University [MQ A006162]	Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Macquarie University	Funding was provided by Fundacao para a Ciencia e Tecnologia (Portugal) through a PhD grant to AR Amaral and by Macquarie University. Sample collection in Australia was funded by Macquarie University through research grants to L. Moller, L. Beheregaray (MQ A006162) and K. Bilgmann. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARDY MT, 1994, TRENDS ECOL EVOL, V9, P267, DOI 10.1016/0169-5347(94)90297-6; Amaral AR, 2007, MAR BIOL, V151, P1967, DOI 10.1007/s00227-007-0635-y; Bailey H, 2009, MAR ECOL PROG SER, V378, P279, DOI 10.3354/meps07887; Bailleul F, 2005, MAR ECOL PROG SER, V293, P273, DOI 10.3354/meps293273; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Banks SC, 2007, ECOLOGY, V88, P3055, DOI 10.1890/07-0091.1; Banks SC, 2010, MOL ECOL, V19, P2011, DOI 10.1111/j.1365-294X.2010.04627.x; Bilgmann K, 2008, ANIM CONSERV, V11, P518, DOI 10.1111/j.1469-1795.2008.00213.x; Bilgmann K, 2007, MAR ECOL PROG SER, V341, P265, DOI 10.3354/meps341265; Bilgmann K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020103; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; Bowen BW, 1997, EVOLUTION, V51, P1601, DOI 10.1111/j.1558-5646.1997.tb01483.x; Brown DM, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-57; Canadas A, 2005, AQUAT CONSERV, V15, P495, DOI 10.1002/aqc.689; Canadas A, 2002, DEEP-SEA RES PT I, V49, P2053, DOI 10.1016/S0967-0637(02)00123-1; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; COCKCROFT VG, 1990, S AFR J MARINE SCI, V9, P371; Coughlan J, 2006, MOL ECOL NOTES, V6, P490, DOI 10.1111/j.1471-8286.2006.01284.x; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Doksaeter L, 2008, DEEP-SEA RES PT II, V55, P243, DOI 10.1016/j.dsr2.2007.09.009; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Foll M, 2006, GENETICS, V174, P875, DOI 10.1534/genetics.106.059451; Fontaine MC, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-30; Forney KA, 1998, MAR MAMMAL SCI, V14, P460, DOI 10.1111/j.1748-7692.1998.tb00737.x; Forney KA, 2000, CONSERV BIOL, V14, P1271, DOI 10.1046/j.1523-1739.2000.99412.x; Frank KT, 2007, TRENDS ECOL EVOL, V22, P236, DOI 10.1016/j.tree.2007.03.002; Fullard KJ, 2000, MOL ECOL, V9, P949, DOI 10.1046/j.1365-294x.2000.00957.x; Galindo HM, 2006, CURR BIOL, V16, P1622, DOI 10.1016/j.cub.2006.06.052; Geffen E, 2004, MOL ECOL, V13, P2481, DOI 10.1111/j.1365-294X.2004.02244.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gremillet D, 2008, J APPL ECOL, V45, P610, DOI 10.1111/j.1365-2664.2007.01447.x; Hamazaki T, 2002, MAR MAMMAL SCI, V18, P920, DOI 10.1111/j.1748-7692.2002.tb01082.x; Hardy OJ, 2003, GENETICS, V163, P1467; Hellberg ME, 2009, ANNU REV ECOL EVOL S, V40, P291, DOI 10.1146/annurev.ecolsys.110308.120223; Hoelzel A. Rus, 2009, V17, P294; Hoelzel AR, 1998, J HERED, V89, P121, DOI 10.1093/jhered/89.2.121; Holderegger R, 2008, BIOSCIENCE, V58, P199, DOI 10.1641/B580306; Hooker SK, 2004, BIOSCIENCE, V54, P27, DOI 10.1641/0006-3568(2004)054[0027:MRAATF]2.0.CO;2; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jombart T, 2009, HEREDITY, V102, P330, DOI 10.1038/hdy.2008.130; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; KASUYA T, 1988, Scientific Reports of the Whales Research Institute Tokyo, P77; KRUSKAL J.B., 1978, MULTIDIMENSIONAL SCA; Krutzen M, 2001, MOL ECOL NOTES, V1, P170, DOI 10.1046/j.1471-8278.2001.00065.x; Krutzen M, 2004, MAR MAMMAL SCI, V20, P28, DOI 10.1111/j.1748-7692.2004.tb01139.x; Lahaye V, 2005, MAR ECOL PROG SER, V305, P275, DOI 10.3354/meps305275; Legendre P, 2010, MOL ECOL RESOUR, V10, P831, DOI 10.1111/j.1755-0998.2010.02866.x; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; MANTEL N, 1967, CANCER RES, V27, P209; Mendez M, 2011, HEREDITY, V107, P349, DOI 10.1038/hdy.2011.21; Mendez M, 2010, MOL ECOL, V19, P2212, DOI 10.1111/j.1365-294X.2010.04647.x; Mirimin L, 2009, MAR BIOL, V156, P821, DOI 10.1007/s00227-008-1120-y; Moller L, 2011, MAR BIOL, V158, P113, DOI 10.1007/s00227-010-1546-x; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Nater A, 2009, MOL ECOL RESOUR, V9, P531, DOI 10.1111/j.1755-0998.2008.02246.x; Natoli A, 2005, P ROY SOC B-BIOL SCI, V272, P1217, DOI 10.1098/rspb.2005.3076; Natoli A, 2006, J EVOLUTION BIOL, V19, P943, DOI 10.1111/j.1420-9101.2005.01033.x; Natoli A, 2004, J EVOLUTION BIOL, V17, P363, DOI 10.1046/j.1420-9101.2003.00672.x; Panigada S, 2008, REMOTE SENS ENVIRON, V112, P3400, DOI 10.1016/j.rse.2007.11.017; PERRIN WF, 1987, MAR MAMMAL SCI, V3, P99, DOI 10.1111/j.1748-7692.1987.tb00158.x; Perrin WF, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P255; Pinaud D, 2007, J ANIM ECOL, V76, P9, DOI 10.1111/j.1365-2656.2006.01186.x; Pritchard JK, 2000, GENETICS, V155, P945; Pusineri C, 2007, MAR MAMMAL SCI, V23, P30, DOI 10.1111/j.1748-7692.2006.00088.x; Raufaste N, 2001, EVOLUTION, V55, P1703, DOI 10.1111/j.0014-3820.2001.tb00689.x; Rosel PE, 1996, MAR BIOL, V125, P11, DOI 10.1007/BF00350756; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Selkoe KA, 2008, FISH FISH, V9, P363, DOI 10.1111/j.1467-2979.2008.00300.x; Selkoe KA, 2010, MOL ECOL, V19, P3708, DOI 10.1111/j.1365-294X.2010.04658.x; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Storfer A, 2010, MOL ECOL, V19, P3496, DOI 10.1111/j.1365-294X.2010.04691.x; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Valsecchi E, 1996, MOL ECOL, V5, P151, DOI 10.1111/j.1365-294X.1996.tb00301.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Viricel A, 2008, BEHAV ECOL SOCIOBIOL, V63, P173, DOI 10.1007/s00265-008-0648-7; Waters JM, 2010, AUSTRAL ECOL, V35, P988, DOI 10.1111/j.1442-9993.2010.02114.x; YOUNG DD, 1994, J ZOOL, V234, P41, DOI 10.1111/j.1469-7998.1994.tb06055.x; Zacharias MA, 2001, AQUAT CONSERV, V11, P59, DOI 10.1002/aqc.429	87	65	66	0	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e31482	10.1371/journal.pone.0031482	http://dx.doi.org/10.1371/journal.pone.0031482			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319634	Green Submitted, Green Published, gold			2022-12-25	WOS:000301979000029
J	Kaufmann, R; Piontek, J; Grull, F; Kirchgessner, M; Rossa, J; Wolburg, H; Blasig, IE; Cremer, C				Kaufmann, Rainer; Piontek, Joerg; Gruell, Frederik; Kirchgessner, Manfred; Rossa, Jan; Wolburg, Hartwig; Blasig, Ingolf E.; Cremer, Christoph			Visualization and Quantitative Analysis of Reconstituted Tight Junctions Using Localization Microscopy	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; SINGLE MOLECULES; CLAUDIN; STRANDS; RESOLUTION; PHOTOACTIVATION; DETERMINANTS; BLINKING; BEHAVIOR; CELLS	Tight Junctions (TJ) regulate paracellular permeability of tissue barriers. Claudins (Cld) form the backbone of TJ-strands. Pore-forming claudins determine the permeability for ions, whereas that for solutes and macromolecules is assumed to be crucially restricted by the strand morphology (i.e., density, branching and continuity). To investigate determinants of the morphology of TJ-strands we established a novel approach using localization microscopy. TJ-strands were reconstituted by stable transfection of HEK293 cells with the barrier-forming Cld3 or Cld5. Strands were investigated at cell-cell contacts by Spectral Position Determination Microscopy (SPDM), a method of localization microscopy using standard fluorophores. Extended TJ-networks of Cld3-YFP and Cld5-YFP were observed. For each network, 200,000 to 1,100,000 individual molecules were detected with a mean localization accuracy of similar to 20 nm, yielding a mean structural resolution of similar to 50 nm. Compared to conventional fluorescence microscopy, this strongly improved the visualization of strand networks and enabled quantitative morphometric analysis. Two populations of elliptic meshes (mean diameter <100 nm and 300-600 nm, respectively) were revealed. For Cld5 the two populations were more separated than for Cld3. Discrimination of non-polymeric molecules and molecules within polymeric strands was achieved. For both subtypes of claudins the mean density of detected molecules was similar and estimated to be similar to 24 times higher within the strands than outside the strands. The morphometry and single molecule information provided advances the mechanistic analysis of paracellular barriers. Applying this novel method to different TJ-proteins is expected to significantly improve the understanding of TJ on the molecular level.	[Kaufmann, Rainer; Gruell, Frederik; Kirchgessner, Manfred; Cremer, Christoph] Heidelberg Univ, Kirchhoff Inst Phys, Heidelberg, Germany; [Piontek, Joerg; Rossa, Jan; Blasig, Ingolf E.] Leibniz Inst Mol Pharmakol FMP, Berlin, Germany; [Wolburg, Hartwig] Univ Med Sch Tubingen, Inst Pathol & Neuropathol, Tubingen, Germany; [Cremer, Christoph] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Heidelberg, Germany; [Cremer, Christoph] Inst Mol Biol, Mainz, Germany	Ruprecht Karls University Heidelberg; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Ruprecht Karls University Heidelberg; Institute of Molecular Biology (IMB)	Kaufmann, R (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford, England.	piontek@fmp-berlin.de	Kaufmann, Rainer/N-8911-2014; Piontek, Joerg/K-6305-2013; Kaufmann, Rainer/U-6406-2019	Kaufmann, Rainer/0000-0002-4165-0195; Piontek, Joerg/0000-0002-0880-8915; Kaufmann, Rainer/0000-0002-4165-0195	Deutsche Forschungsgemeinschaft [PI 837/2-1, SPP1128]; University of Heidelberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Heidelberg	This work has been supported by the Deutsche Forschungsgemeinschaft (PI 837/2-1, SPP1128) and a Frontier Project grant (University of Heidelberg) to M. Wassenegger (http://www.dfg.de/index.jsp; http://www.uni-heidelberg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Angelow S, 2008, AM J PHYSIOL-RENAL, V295, pF867, DOI 10.1152/ajprenal.90264.2008; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Folling J, 2008, NAT METHODS, V5, P943, DOI 10.1038/nmeth.1257; Furuse M, 1999, J CELL BIOL, V147, P891, DOI 10.1083/jcb.147.4.891; Grull F., 2011, INT C FIELD PROGR LO; Gunkel Manuel, 2009, Biotechnology Journal, V4, P927, DOI 10.1002/biot.200900005; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Kaufmann R, 2011, J MICROSC-OXFORD, V242, P46, DOI 10.1111/j.1365-2818.2010.03436.x; Krause G, 2008, BBA-BIOMEMBRANES, V1778, P631, DOI 10.1016/j.bbamem.2007.10.018; Lemmer P, 2008, APPL PHYS B-LASERS O, V93, P1, DOI 10.1007/s00340-008-3152-x; Mack AF, 2006, BRAIN RES, V1103, P25, DOI 10.1016/j.brainres.2006.04.135; Matsuda A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012768; McAnaney TB, 2005, BIOCHEMISTRY-US, V44, P5510, DOI 10.1021/bi047581f; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Peterman EJG, 1999, J PHYS CHEM A, V103, P10553, DOI 10.1021/jp991968o; Piontek J, 2008, FASEB J, V22, P146, DOI 10.1096/fj.07-8319com; Piontek J, 2011, CELL MOL LIFE SCI, V68, P3903, DOI 10.1007/s00018-011-0680-z; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sasaki H, 2003, P NATL ACAD SCI USA, V100, P3971, DOI 10.1073/pnas.0630649100; Schuster J, 2005, OPT SPECTROSC+, V98, P712, DOI 10.1134/1.1929057; Shen L, 2008, J CELL BIOL, V181, P683, DOI 10.1083/jcb.200711165; Sinnecker D, 2005, BIOCHEMISTRY-US, V44, P7085, DOI 10.1021/bi047881x; STAEHELIN LA, 1974, INT REV CYTOL, V39, P191, DOI 10.1016/S0074-7696(08)60940-7; Steed E, 2010, TRENDS CELL BIOL, V20, P142, DOI 10.1016/j.tcb.2009.12.002; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; Winkler L, 2009, J BIOL CHEM, V284, P18863, DOI 10.1074/jbc.M109.008623; Yamazaki Y, 2011, MOL BIOL CELL, V22, P1495, DOI 10.1091/mbc.E10-12-1003	32	42	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e31128	10.1371/journal.pone.0031128	http://dx.doi.org/10.1371/journal.pone.0031128			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319608	gold, Green Submitted, Green Published			2022-12-25	WOS:000301979000021
J	Tsai, SW; Liou, HM; Lin, CJ; Kuo, KL; Hung, S; Weng, RC; Hsu, FY				Tsai, Shiao-Wen; Liou, Hau-Min; Lin, Cheng-Jie; Kuo, Ko-Liang; Hung, Sheng; Weng, Ru-Chun; Hsu, Fu-Yin			MG63 Osteoblast-Like Cells Exhibit Different Behavior when Grown on Electrospun Collagen Matrix versus Electrospun Gelatin Matrix	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; PHYSICOCHEMICAL PROPERTIES; EXTRACELLULAR MATRICES; BONE; MINERALIZATION; ADHESION; PHOSPHORYLATION; PROLIFERATION; TRANSCRIPTION; DOWNSTREAM	Electrospinning is a simple and efficient method of fabricating a non-woven polymeric nanofiber matrix. However, using fluorinated alcohols as a solvent for the electrospinning of proteins often results in protein denaturation. TEM and circular dichroism analysis indicated a massive loss of triple-helical collagen from an electrospun collagen (EC) matrix, and the random coils were similar to those found in gelatin. Nevertheless, from mechanical testing we found the Young's modulus and ultimate tensile stresses of EC matrices were significantly higher than electrospun gelatin (EG) matrices because matrix stiffness can affect many cell behaviors such as cell adhesion, proliferation and differentiation. We hypothesize that the difference of matrix stiffness between EC and EG will affect intracellular signaling through the mechano-transducers Rho kinase (ROCK) and focal adhesion kinase (FAK) and subsequently regulates the osteogenic phenotype of MG63 osteoblast-like cells. From the results, we found there was no significant difference between the EC and EG matrices with respect to either cell attachment or proliferation rate. However, the gene expression levels of OPN, type I collagen, ALP, and OCN were significantly higher in MG63 osteoblast-like cells grown on the EC than in those grown on the EG. In addition, the phosphorylation levels of Y397-FAK, ERK1/2, BSP, and OPN proteins, as well as ALP activity, were also higher on the EC than on the EG. We further inhibited ROCK activation with Y27632 during differentiation to investigate its effects on matrix-mediated osteogenic differentiation. Results showed the extent of mineralization was decreased with inhibition after induction. Moreover, there is no significant difference between EC and EG. From the results of the protein levels of phosphorylated Y397-FAK, ERK1/2, BSP and OPN, ALP activity and mineral deposition, we speculate that the mechanism that influences the osteogenic differentiation of MG63 osteoblast-like cells on EC and EG is matrix stiffness and via ROCK-FAK-ERK1/2.	[Tsai, Shiao-Wen; Lin, Cheng-Jie; Hung, Sheng] Chang Gung Univ, Inst Biochem & Biomed Engn, Tao Yuan, Taiwan; [Liou, Hau-Min; Kuo, Ko-Liang; Hung, Sheng; Weng, Ru-Chun; Hsu, Fu-Yin] Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Keelung, Taiwan; [Hsu, Fu-Yin] Natl Taiwan Ocean Univ, Dept Life Sci, Keelung, Taiwan	Chang Gung University; National Taiwan Ocean University; National Taiwan Ocean University	Tsai, SW (corresponding author), Chang Gung Univ, Inst Biochem & Biomed Engn, Tao Yuan, Taiwan.	fyhsu@mail.ntou.edu.tw		Tsai, Shiao-Wen/0000-0002-6225-6613; hsu, Fu-Yin/0000-0002-8221-4218	National Science Council of Taiwan [NSC-97-2221-E-182-045, NSC-98-2221-E-019-004]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	The authors would like to thank the National Science Council of Taiwan for financial supporting this research under contract no. NSC-97-2221-E-182-045 and NSC-98-2221-E-019-004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angele P, 2004, BIOMATERIALS, V25, P2831, DOI 10.1016/j.biomaterials.2003.09.066; Aubin JE, 1998, J CELL BIOCHEM, P73, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<73::AID-JCB11>3.0.CO;2-L; Chang YL, 2000, J BIOMED MATER RES, V52, P270, DOI 10.1002/1097-4636(200011)52:2<270::AID-JBM5>3.0.CO;2-1; Chen CS, 2004, ANNU REV BIOMED ENG, V6, P275, DOI 10.1146/annurev.bioeng.6.040803.140040; Dalby MJ, 2003, BIOMATERIALS, V24, P927, DOI 10.1016/S0142-9612(02)00427-1; Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Evans ND, 2009, EUR CELLS MATER, V18, P1; Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401; Gordon JAR, 2007, BONE, V41, P462, DOI 10.1016/j.bone.2007.04.191; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Griffin TM, 2005, EXERC SPORT SCI REV, V33, P195, DOI 10.1097/00003677-200510000-00008; Hanagata N, 2006, BIOCHEM BIOPH RES CO, V344, P1234, DOI 10.1016/j.bbrc.2006.04.021; HAUSCHKA PV, 1989, ANAT REC, V224, P180, DOI 10.1002/ar.1092240208; Hsu FY, 2010, ACTA BIOMATER, V6, P2140, DOI 10.1016/j.actbio.2009.12.023; Huang J, 2007, GENE, V404, P101, DOI 10.1016/j.gene.2007.09.007; Jiang XH, 2007, CELL SIGNAL, V19, P1000, DOI 10.1016/j.cellsig.2006.11.004; Jing Z, 2003, J CONTROL RELEASE, V92, P227, DOI 10.1016/S0168-3659(03)00372-9; KATO YP, 1989, BIOMATERIALS, V10, P38, DOI 10.1016/0142-9612(89)90007-0; Kew SJ, 2011, ACTA BIOMATER, V7, P3237, DOI 10.1016/j.actbio.2011.06.002; Khatiwala CB, 2009, J BONE MINER RES, V24, P886, DOI [10.1359/jbmr.081240, 10.1359/JBMR.081240]; Khil MS, 2003, J BIOMED MATER RES B, V67B, P675, DOI 10.1002/jbm.b.10058; Kocgozlu L, 2010, J CELL SCI, V123, P29, DOI 10.1242/jcs.053520; Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200; Liu T, 2010, J BIOMED MATER RES A, V95A, P276, DOI 10.1002/jbm.a.32831; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NUNES RW, 1982, POLYM ENG SCI, V22, P205, DOI 10.1002/pen.760220402; Pirone DM, 2006, J CELL BIOL, V174, P277, DOI 10.1083/jcb.200510062; POSER JW, 1980, J BIOL CHEM, V255, P8685; Ratanavaraporn J, 2006, J MET MATER MINER, V16, P31; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904; SCHNAPER HW, 1993, PEDIATR NEPHROL, V7, P96, DOI 10.1007/BF00861587; Schofer MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025462; Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309; Taubenberger AV, 2010, BIOMATERIALS, V31, P2827, DOI 10.1016/j.biomaterials.2009.12.051; Tsai SW, 2008, ACTA BIOMATER, V4, P1332, DOI 10.1016/j.actbio.2008.03.015; Tsai SW, 2010, J TAIWAN INST CHEM E, V41, P247, DOI 10.1016/j.jtice.2009.10.002; Tsai SW, 2010, J BIOMED MATER RES A, V93A, P115, DOI 10.1002/jbm.a.32502; Tsai SW, 2009, J BIOMED MATER RES A, V91A, P985, DOI 10.1002/jbm.a.32324; Vanderploeg EJ, 2008, OSTEOARTHR CARTILAGE, V16, P1228, DOI 10.1016/j.joca.2008.02.016; VEIS A, 1961, ARCH BIOCHEM BIOPHYS, V94, P20, DOI 10.1016/0003-9861(61)90005-4; Wang J, 2010, ACTA BIOMATER, V6, P3004, DOI 10.1016/j.actbio.2010.01.045; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; WEISS P, 1945, J EXP ZOOL, V100, P353, DOI 10.1002/jez.1401000305; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; Xu B, 2011, INT J BIOMATER, V2011, DOI 10.1155/2011/172389; Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3; Xu CY, 2004, TISSUE ENG, V10, P1160, DOI 10.1089/ten.2004.10.1160; Yang L, 2008, BIOMATERIALS, V29, P955, DOI 10.1016/j.biomaterials.2007.10.058; Zeugolis DI, 2008, J BIOMED MATER RES A, V86A, P892, DOI 10.1002/jbm.a.31694; Zeugolis DI, 2008, BIOMATERIALS, V29, P2293, DOI 10.1016/j.biomaterials.2008.02.009; Zhang RY, 2000, J BIOMED MATER RES, V52, P430, DOI 10.1002/1097-4636(200011)52:2<430::AID-JBM25>3.0.CO;2-L; Zhang ZK, 2007, BIOSCI BIOTECH BIOCH, V71, P2057, DOI 10.1271/bbb.70055	54	85	89	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e31200	10.1371/journal.pone.0031200	http://dx.doi.org/10.1371/journal.pone.0031200			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319618	gold, Green Published, Green Submitted			2022-12-25	WOS:000301979000027
J	Zhao, HS; Li, M; Fang, KC; Chen, WF; Wang, J				Zhao, Hansheng; Li, Mao; Fang, Kechi; Chen, Wenfeng; Wang, Jing			In Silico Insights into the Symbiotic Nitrogen Fixation in Sinorhizobium meliloti via Metabolic Reconstruction	PLOS ONE			English	Article							RHIZOBIUM-MELILOTI; FUNCTIONAL-CHARACTERIZATION; NUCLEOTIDE-SEQUENCE; ROOT-NODULE; LEGUME; GENES; ALFALFA; TRANSPORT; DATABASE; MUTANTS	Background: Sinorhizobium meliloti is a soil bacterium, known for its capability to establish symbiotic nitrogen fixation (SNF) with leguminous plants such as alfalfa. S. meliloti 1021 is the most extensively studied strain to understand the mechanism of SNF and further to study the legume-microbe interaction. In order to provide insight into the metabolic characteristics underlying the SNF mechanism of S. meliloti 1021, there is an increasing demand to reconstruct a metabolic network for the stage of SNF in S. meliloti 1021. Results: Through an iterative reconstruction process, a metabolic network during the stage of SNF in S. meliloti 1021 was presented, named as iHZ565, which accounts for 565 genes, 503 internal reactions, and 522 metabolites. Subjected to a novelly defined objective function, the in silico predicted flux distribution was highly consistent with the in vivo evidences reported previously, which proves the robustness of the model. Based on the model, refinement of genome annotation of S. meliloti 1021 was performed and 15 genes were re-annotated properly. There were 19.8% (112) of the 565 metabolic genes included in iHZ565 predicted to be essential for efficient SNF in bacteroids under the in silico microaerobic and nutrient sharing condition. Conclusions: As the first metabolic network during the stage of SNF in S. meliloti 1021, the manually curated model iHZ565 provides an overview of the major metabolic properties of the SNF bioprocess in S. meliloti 1021. The predicted SNF-required essential genes will facilitate understanding of the key functions in SNF and help identify key genes and design experiments for further validation. The model iHZ565 can be used as a knowledge-based framework for better understanding the symbiotic relationship between rhizobia and legumes, ultimately, uncovering the mechanism of nitrogen fixation in bacteroids and providing new strategies to efficiently improve biological nitrogen fixation.	[Zhao, Hansheng; Li, Mao; Chen, Wenfeng] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Zhao, Hansheng; Fang, Kechi; Wang, Jing] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China	China Agricultural University; Chinese Academy of Sciences; Institute of Psychology, CAS	Zhao, HS (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	chenwf@cau.edu.cn; wangjing@psych.ac.cn	zhao, hansheng/GRS-2764-2022		Ministry of Science and Technology of the People's Republic of China [2011CBA00802, 2010CB126500]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	The National Basic Research Program of China (973 Program, 2011CBA00802, 2010CB126500) from the Ministry of Science and Technology of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampe F, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r15; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Barnett MJ, 2001, P NATL ACAD SCI USA, V98, P9883, DOI 10.1073/pnas.161294798; Barnett MJ, 2004, P NATL ACAD SCI USA, V101, P16636, DOI 10.1073/pnas.0407269101; Barsch Aiko, 2004, Functional & Integrative Genomics, V4, P219, DOI 10.1007/s10142-004-0117-y; Becker A, 2004, MOL PLANT MICROBE IN, V17, P292, DOI 10.1094/MPMI.2004.17.3.292; Becker A, 2009, J BIOTECHNOL, V140, P45, DOI 10.1016/j.jbiotec.2008.11.006; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Bergersen FJ, 1997, SOIL BIOL BIOCHEM, V29, P875, DOI 10.1016/S0038-0717(96)00220-9; Capela D, 2006, MOL PLANT MICROBE IN, V19, P363, DOI 10.1094/MPMI-19-0363; Capela D, 2001, P NATL ACAD SCI USA, V98, P9877, DOI 10.1073/pnas.161294398; Cevallos MA, 1996, J BACTERIOL, V178, P1646, DOI 10.1128/jb.178.6.1646-1654.1996; Davies BW, 2007, J BACTERIOL, V189, P2101, DOI 10.1128/JB.01377-06; Davies BW, 2007, J BACTERIOL, V189, P2110, DOI 10.1128/JB.01802-06; de Bruijn FJ, 2006, ENVIRON MICROBIOL, V8, P1371, DOI 10.1111/j.1462-2920.2006.01030.x; DEBRUIJN FJ, 1989, J BACTERIOL, V171, P1673, DOI 10.1128/jb.171.3.1673-1682.1989; Delgado MJ, 2006, MICROBIOL-SGM, V152, P199, DOI 10.1099/mic.0.28347-0; Djordjevic MA, 2004, PROTEOMICS, V4, P1859, DOI 10.1002/pmic.200300802; Djordjevic MA, 2003, MOL PLANT MICROBE IN, V16, P508, DOI 10.1094/MPMI.2003.16.6.508; DRISCOLL BT, 1993, MOL MICROBIOL, V7, P865, DOI 10.1111/j.1365-2958.1993.tb01177.x; Driscoll BT, 1997, MICROBIOL-SGM, V143, P489, DOI 10.1099/00221287-143-2-489; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Dymov SI, 2004, MOL PLANT MICROBE IN, V17, P1318, DOI 10.1094/MPMI.2004.17.12.1318; Edwards JS, 2002, ENVIRON MICROBIOL, V4, P133, DOI 10.1046/j.1462-2920.2002.00282.x; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; Finan TM, 2001, P NATL ACAD SCI USA, V98, P9889, DOI 10.1073/pnas.161294698; FUJIHARA S, 1994, PLANT CELL PHYSIOL, V35, P1127, DOI 10.1093/oxfordjournals.pcp.a078705; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Hakoyama T, 2009, NATURE, V462, P514, DOI 10.1038/nature08594; Hertz-Fowler C, 2004, NUCLEIC ACIDS RES, V32, pD339, DOI 10.1093/nar/gkh007; HIRSCH AM, 1983, J BACTERIOL, V155, P367, DOI 10.1128/JB.155.1.367-380.1983; HIRSCH AM, 1987, J BACTERIOL, V169, P1137, DOI 10.1128/jb.169.3.1137-1146.1987; Hu YL, 2008, BIOCHEMISTRY-US, V47, P3973, DOI 10.1021/bi7025003; IRIGOYEN JJ, 1990, APPL ENVIRON MICROB, V56, P2587, DOI 10.1128/AEM.56.8.2587-2589.1990; Jenuth J P, 2000, Methods Mol Biol, V132, P301; Jiang GQ, 2001, J BACTERIOL, V183, P2595, DOI 10.1128/JB.183.8.2595-2604.2001; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; KAHN D, 1989, J BACTERIOL, V171, P929, DOI 10.1128/jb.171.2.929-939.1989; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; KAPP D, 1990, PLANT CELL, V2, P139, DOI 10.1105/tpc.2.2.139; Knorr AL, 2007, BIOINFORMATICS, V23, P351, DOI 10.1093/bioinformatics/btl619; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Krusell L, 2005, PLANT CELL, V17, P1625, DOI 10.1105/tpc.104.030106; Lee JM, 2006, BRIEF BIOINFORM, V7, P140, DOI 10.1093/bib/bbl007; Lodwig E, 2003, CRIT REV PLANT SCI, V22, P37, DOI 10.1080/713610850; Lodwig EM, 2003, NATURE, V422, P722, DOI 10.1038/nature01527; Ma HW, 2003, BIOINFORMATICS, V19, P270, DOI 10.1093/bioinformatics/19.2.270; Mao CH, 2005, BIOINFORMATICS, V21, P2927, DOI 10.1093/bioinformatics/bti427; MASEPOHL B, 1992, MOL GEN GENET, V233, P33, DOI 10.1007/BF00587558; Masson-Boivin C, 2009, TRENDS MICROBIOL, V17, P458, DOI 10.1016/j.tim.2009.07.004; MCRAE DG, 1989, MOL PLANT MICROBE IN, V2, P273, DOI 10.1094/MPMI-2-273; MILLER RW, 1983, PHYSIOL PLANTARUM, V58, P464, DOI 10.1111/j.1399-3054.1983.tb05728.x; OBrian MR, 1996, J BACTERIOL, V178, P2471, DOI 10.1128/jb.178.9.2471-2478.1996; Ott T, 2005, CURR BIOL, V15, P531, DOI 10.1016/j.cub.2005.01.042; Poole P, 2000, ADV MICROB PHYSIOL, V43, P117, DOI 10.1016/S0065-2911(00)43004-3; Prell J, 2006, TRENDS MICROBIOL, V14, P161, DOI 10.1016/j.tim.2006.02.005; Prell J, 2009, P NATL ACAD SCI USA, V106, P12477, DOI 10.1073/pnas.0903653106; Ramirez-Trujillo JA, 2007, J BACTERIOL, V189, P5875, DOI 10.1128/JB.00385-07; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Resendis-Antonio O, 2007, PLOS COMPUT BIOL, V3, P1887, DOI 10.1371/journal.pcbi.0030192; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Sarma AD, 2006, PROTEOMICS, V6, P3008, DOI 10.1002/pmic.200500783; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; Schomburg I, 2004, NUCLEIC ACIDS RES, V32, pD431, DOI 10.1093/nar/gkh081; Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162; Udvardi MK, 1997, ANNU REV PLANT PHYS, V48, P493, DOI 10.1146/annurev.arplant.48.1.493; Wang CX, 2007, MICROBIOL-SGM, V153, P388, DOI 10.1099/mic.0.29214-0; WATSON RJ, 1990, MOL PLANT MICROBE IN, V3, P174, DOI 10.1094/MPMI-3-174; White J, 2007, PLANT PHYSIOL, V144, P604, DOI 10.1104/pp.107.097741; Whitehead LF, 2001, AUST J PLANT PHYSIOL, V28, P675; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754; ZHOU JC, 1985, PLANTA, V163, P473, DOI 10.1007/BF00392704	74	18	21	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e31287	10.1371/journal.pone.0031287	http://dx.doi.org/10.1371/journal.pone.0031287			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22319621	Green Published, Green Submitted, gold			2022-12-25	WOS:000301977500033
J	Lee, KY; Bang, SW; Yoon, SW; Lee, SH; Yoon, JB; Hwang, DS				Lee, Kyung Yong; Bang, Sung Woong; Yoon, Sang Wook; Lee, Seung-Hoon; Yoon, Jong-Bok; Hwang, Deog Su			Phosphorylation of ORC2 Protein Dissociates Origin Recognition Complex from Chromatin and Replication Origins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLE-DEPENDENT REGULATION; DNA-REPLICATION; CELL-CYCLE; MULTIPLE MECHANISMS; RE-REPLICATION; BINDING; ATP; INITIATION; IDENTIFICATION; REREPLICATION	During the late M to the G1 phase of the cell cycle, the origin recognition complex (ORC) binds to the replication origin, leading to the assembly of the prereplicative complex for subsequent initiation of eukaryotic chromosome replication. We found that the cell cycle-dependent phosphorylation of human ORC2, one of the six subunits of ORC, dissociates ORC2, -3, -4, and -5 (ORC2-5) subunits from chromatin and replication origins. Phosphorylation at Thr-116 and Thr-226 of ORC2 occurs by cyclin-dependent kinase during the S phase and is maintained until the M phase. Phosphorylation of ORC2 at Thr-116 and Thr-226 dissociated the ORC2-5 from chromatin. Consistent with this, the phosphomimetic ORC2 protein exhibited defective binding to replication origins as well as to chromatin, whereas the phosphodefective protein persisted in binding throughout the cell cycle. These results suggest that the phosphorylation of ORC2 dissociates ORC from chromatin and replication origins and inhibits binding of ORC to newly replicated DNA.	[Lee, Kyung Yong; Bang, Sung Woong; Yoon, Sang Wook; Hwang, Deog Su] Seoul Natl Univ, Dept Biol Sci, Seoul 151742, South Korea; [Lee, Seung-Hoon; Yoon, Jong-Bok] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea	Seoul National University (SNU); Yonsei University	Hwang, DS (corresponding author), Seoul Natl Univ, Dept Biol Sci, Seoul 151742, South Korea.	dshwang@snu.ac.kr		Yoon, Jong-Bok/0000-0002-3563-0702	Ministry for Health and Welfare [1120180]; National Research Foundation of Korea [20110008014 NRF, 2009-0078699]; Brain Korea 21 Project; Korean Ministry of Science and Technology	Ministry for Health and Welfare; National Research Foundation of Korea(National Research Foundation of Korea); Brain Korea 21 Project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Korean Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea)	* This work was supported by National R&D Program for Cancer Control, Ministry for Health and Welfare, Grant 1120180; Basic Science Research Program through the National Research Foundation of Korea Grant 20110008014 NRF; and Nuclear R&D Program of National Research Foundation of Korea Grant 2009-0078699.; <SUP>1</SUP> Supported by the second stage of the Brain Korea 21 Project.; <SUP>2</SUP> Supported by a grant from the Korean Ministry of Science and Technology through the Studies on Ubiquitome Functions Project.	Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Baldinger T, 2009, MOL CELL BIOL, V29, P140, DOI 10.1128/MCB.00981-08; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Chen SY, 2011, GENE DEV, V25, P363, DOI 10.1101/gad.2011511; Delmolino LM, 2001, J BIOL CHEM, V276, P26947, DOI 10.1074/jbc.M101870200; DePamphilis ML, 2006, CURR OPIN CELL BIOL, V18, P231, DOI 10.1016/j.ceb.2006.04.001; DePamphilis ML, 2005, CELL CYCLE, V4, P70, DOI 10.4161/cc.4.1.1333; Dhar SK, 2001, CELL, V106, P287, DOI 10.1016/S0092-8674(01)00458-5; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Dutta A, 1997, ANNU REV CELL DEV BI, V13, P293, DOI 10.1146/annurev.cellbio.13.1.293; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Findeisen M, 1999, EUR J BIOCHEM, V264, P415, DOI 10.1046/j.1432-1327.1999.00613.x; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Gerhardt J, 2006, MOL CELL BIOL, V26, P7731, DOI 10.1128/MCB.01392-06; Giordano-Coltart J, 2005, P NATL ACAD SCI USA, V102, P69, DOI 10.1073/pnas.0408690102; Ishimi Y, 2000, J BIOL CHEM, V275, P16235, DOI 10.1074/jbc.M909040199; Kreitz S, 2001, J BIOL CHEM, V276, P6337, DOI 10.1074/jbc.M009473200; Ladenburger EM, 2002, MOL CELL BIOL, V22, P1036, DOI 10.1128/MCB.22.4.1036-1048.2002; Laman H, 2001, EXP CELL RES, V271, P230, DOI 10.1006/excr.2001.5360; Li CJ, 2004, MOL CELL BIOL, V24, P5875, DOI 10.1128/MCB.24.13.5875-5886.2004; Lygerou Z, 1999, J CELL SCI, V112, P3703; Makise M, 2009, J BIOL CHEM, V284, P3396, DOI 10.1074/jbc.M804293200; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Mendez J, 2002, MOL CELL, V9, P481, DOI 10.1016/S1097-2765(02)00467-7; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Noguchi K, 2006, EMBO J, V25, P5372, DOI 10.1038/sj.emboj.7601396; Ohta S, 2003, J BIOL CHEM, V278, P41535, DOI 10.1074/jbc.M307535200; Prasanth SG, 2004, EMBO J, V23, P2651, DOI 10.1038/sj.emboj.7600255; Ranjan A, 2006, P NATL ACAD SCI USA, V103, P4864, DOI 10.1073/pnas.0510305103; Remus D, 2005, J BIOL CHEM, V280, P39740, DOI 10.1074/jbc.M508515200; Saha P, 1998, MOL CELL BIOL, V18, P2758, DOI 10.1128/MCB.18.5.2758; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Siddiqui K, 2007, J BIOL CHEM, V282, P32370, DOI 10.1074/jbc.M705905200; Sugimoto N, 2004, J BIOL CHEM, V279, P19691, DOI 10.1074/jbc.M313175200; Sun WH, 2002, EMBO J, V21, P1437, DOI 10.1093/emboj/21.6.1437; Tatsumi Y, 2003, J BIOL CHEM, V278, P41528, DOI 10.1074/jbc.M307534200; Tsakraklides V, 2010, J BIOL CHEM, V285, P9437, DOI 10.1074/jbc.M109.072504; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Vas A, 2001, MOL CELL BIOL, V21, P5767, DOI 10.1128/MCB.21.17.5767-5777.2001; Vashee S, 2003, GENE DEV, V17, P1894, DOI 10.1101/gad.1084203; Vashee S, 2001, J BIOL CHEM, V276, P26666, DOI 10.1074/jbc.M102493200; Woetmann A, 1999, P NATL ACAD SCI USA, V96, P10620, DOI 10.1073/pnas.96.19.10620	46	32	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11891	11898		10.1074/jbc.M111.338467	http://dx.doi.org/10.1074/jbc.M111.338467			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334659	Green Published, hybrid			2022-12-25	WOS:000302782200028
J	Maruta, T; Noshi, M; Tanouchi, A; Tamoi, M; Yabuta, Y; Yoshimura, K; Ishikawa, T; Shigeoka, S				Maruta, Takanori; Noshi, Masahiro; Tanouchi, Aoi; Tamoi, Masahiro; Yabuta, Yukinori; Yoshimura, Kazuya; Ishikawa, Takahiro; Shigeoka, Shigeru			H2O2-triggered Retrograde Signaling from Chloroplasts to Nucleus Plays Specific Role in Response to Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASCORBATE PEROXIDASE ISOENZYMES; PROGRAMMED CELL-DEATH; OXYGEN GENE NETWORK; ARABIDOPSIS-THALIANA; HIGH-LIGHT; SINGLET OXYGEN; NEGATIVE REGULATOR; SALICYLIC-ACID; PHOTOOXIDATIVE STRESS; TRANSCRIPTION FACTOR	Recent findings have suggested that reactive oxygen species (ROS) are important signaling molecules for regulating plant responses to abiotic and biotic stress and that there exist source- and kind-specific pathways for ROS signaling. In plant cells, a major source of ROS is chloroplasts, in which thylakoid membrane-bound ascorbate peroxidase (tAPX) plays a role in the regulation of H2O2 levels. Here, to clarify the signaling function of H2O2 derived from the chloroplast, we created a conditional system for producing H2O2 in the organelle by chemical-dependent tAPX silencing using estrogen-inducible RNAi. When the expression of tAPX was silenced in leaves, levels of oxidized protein in chloroplasts increased in the absence of stress. Microarray analysis revealed that tAPX silencing affects the expression of a large set of genes, some of which are involved in the response to chilling and pathogens. In response to tAPX silencing, the transcript levels of C-repeat/DRE binding factor (CBF1), a central regulator for cold acclimation, was suppressed, resulting in a high sensitivity of tAPX-silenced plants to cold. Furthermore, tAPX silencing enhanced the levels of salicylic acid (SA) and the response to SA. Interestingly, we found that tAPX silencing-responsive genes were up-or down-regulated by high light (HL) and that tAPX silencing had a negative effect on expression of ROS-responsive genes under HL, suggesting synergistic and antagonistic roles of chloroplastic H2O2 in HL response. These findings provide a new insight into the role of H2O2-triggered retrograde signaling from chloroplasts in the response to stress in planta.	[Maruta, Takanori; Noshi, Masahiro; Tanouchi, Aoi; Tamoi, Masahiro; Shigeoka, Shigeru] Kinki Univ, Fac Agr, Dept Adv Biosci, Nara 6318505, Japan; [Yabuta, Yukinori] Tottori Univ, Sch Agr Biol & Environm Sci, Fac Agr, Tottori 6808553, Japan; [Yoshimura, Kazuya] Chubu Univ, Coll Biosci & Biotechnol, Dept Food & Nutr Sci, Kasugai, Aichi 4878501, Japan; [Ishikawa, Takahiro] Shimane Univ, Fac Life & Environm Sci, Matsue, Shimane 6908504, Japan	Kindai University (Kinki University); Tottori University; Chubu University; Shimane University	Shigeoka, S (corresponding author), Kinki Univ, Fac Agr, Dept Adv Biosci, 3327-204 Nakamachi, Nara 6318505, Japan.	shigeoka@nara.kindai.ac.jp	Ishikawa, Takahiro/AAX-5792-2021; Yabuta, Yukinori/T-3615-2019; Tamoi, Masahiro/AAJ-1054-2021	Yabuta, Yukinori/0000-0002-6982-8522; Maruta, Takanori/0000-0003-4144-7821	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [22248042]; Nara Institute of Science and Technology; Grants-in-Aid for Scientific Research [22248042] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nara Institute of Science and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research (A) 22248042 (to S. S.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and by Scientific Research for Plant Graduate Students from the Nara Institute of Science and Technology (to T. M.).	Adamiec M, 2008, ACTA BIOCHIM POL, V55, P161, DOI 10.18388/abp.2008_3176; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Ball L, 2004, PLANT CELL, V16, P2448, DOI 10.1105/tpc.104.022608; Bechtold N, 1998, METH MOL B, V82, P259; Burch-Smith Tessa M, 2007, Sci STKE, V2007, ppe46; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; Dempsey DA, 1999, CRIT REV PLANT SCI, V18, P547, DOI 10.1080/07352689991309397; Estavillo GM, 2011, PLANT CELL, V23, P3992, DOI 10.1105/tpc.111.091033; Foyer CH, 2011, PLANT PHYSIOL, V155, P93, DOI 10.1104/pp.110.166181; Fragniere C, 2011, FEBS LETT, V585, P1847, DOI 10.1016/j.febslet.2011.04.039; Gadjev I, 2006, PLANT PHYSIOL, V141, P436, DOI 10.1104/pp.106.078717; Galvez-Valdivieso G, 2009, PLANT CELL, V21, P2143, DOI 10.1105/tpc.108.061507; Garcion C, 2008, PLANT PHYSIOL, V147, P1279, DOI 10.1104/pp.108.119420; Gechev TS, 2005, IUBMB LIFE, V57, P181, DOI 10.1080/15216540500090793; Gechev TS, 2004, CELL MOL LIFE SCI, V61, P1185, DOI 10.1007/s00018-004-4067-2; Guo HS, 2003, PLANT J, V34, P383, DOI 10.1046/j.1365-313X.2003.01723.x; Ishikawa K, 2010, PLANT SIGNAL BEHAV, V5, P839, DOI [10.4161/psb.5.7.11820, 10.1104/pp.109.140442]; Ishikawa K, 2010, PLANT PHYSIOL, V152, P2000, DOI 10.1104/pp.110.153569; Karpinski S, 1997, PLANT CELL, V9, P627, DOI 10.1105/tpc.9.4.627; Kim CH, 2008, EMBO REP, V9, P435, DOI 10.1038/embor.2008.57; Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; Kruijt M, 2005, MOL PLANT PATHOL, V6, P85, DOI 10.1111/j.1364-3703.2004.00264.x; Laloi C, 2007, P NATL ACAD SCI USA, V104, P672, DOI 10.1073/pnas.0609063103; Lee KP, 2007, P NATL ACAD SCI USA, V104, P10270, DOI 10.1073/pnas.0702061104; Liu YD, 2007, PLANT J, V51, P941, DOI 10.1111/j.1365-313X.2007.03191.x; MALAMY J, 1992, PLANT CELL, V4, P359, DOI 10.1105/tpc.4.3.359; Maruta T, 2011, PLANT SCI, V180, P655, DOI 10.1016/j.plantsci.2011.01.014; Maruta T, 2010, PLANT CELL PHYSIOL, V51, P190, DOI 10.1093/pcp/pcp177; Medina J, 2011, PLANT SCI, V180, P3, DOI 10.1016/j.plantsci.2010.06.019; Meskauskiene R, 2001, P NATL ACAD SCI USA, V98, P12826, DOI 10.1073/pnas.221252798; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Moller IM, 2010, TRENDS PLANT SCI, V15, P370, DOI 10.1016/j.tplants.2010.04.008; Morishita T, 2009, PLANT CELL PHYSIOL, V50, P2210, DOI 10.1093/pcp/pcp159; Nishizawa A, 2006, PLANT J, V48, P535, DOI 10.1111/j.1365-313X.2006.02889.x; Nott A, 2006, ANNU REV PLANT BIOL, V57, P739, DOI 10.1146/annurev.arplant.57.032905.105310; Novillo F, 2004, P NATL ACAD SCI USA, V101, P3985, DOI 10.1073/pnas.0303029101; Novillo F, 2007, P NATL ACAD SCI USA, V104, P21002, DOI 10.1073/pnas.0705639105; Ogawa T, 2005, J BIOL CHEM, V280, P25277, DOI 10.1074/jbc.M503536200; op den Camp RGL, 2003, PLANT CELL, V15, P2320, DOI 10.1105/tpc.014662; Phee BK, 2004, PROTEOMICS, V4, P3560, DOI 10.1002/pmic.200400982; Pnueli L, 2003, PLANT J, V34, P187, DOI 10.1046/j.1365-313X.2003.01715.x; Reuber TL, 1998, PLANT J, V16, P473, DOI 10.1046/j.1365-313x.1998.00319.x; Rizhsky L, 2003, J BIOL CHEM, V278, P38921, DOI 10.1074/jbc.M304987200; Rossel JB, 2006, PLANT CELL ENVIRON, V29, P269, DOI 10.1111/j.1365-3040.2005.01419.x; Sagi M, 2006, PLANT PHYSIOL, V141, P336, DOI 10.1104/pp.106.078089; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; Shigeoka S, 2002, J EXP BOT, V53, P1305, DOI 10.1093/jexbot/53.372.1305; SHIGEOKA S, 1987, BIOCHEM J, V242, P511, DOI 10.1042/bj2420511; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Vandenabeele S, 2004, PLANT J, V39, P45, DOI 10.1111/j.1365-313X.2004.02105.x; Wagner D, 2004, SCIENCE, V306, P1183, DOI 10.1126/science.1103178; Weigel RR, 2001, PLANT MOL BIOL, V46, P143, DOI 10.1023/A:1010652620115; Wilson PB, 2009, PLANT J, V58, P299, DOI 10.1111/j.1365-313X.2008.03780.x; Yabuta Y, 2004, PLANT CELL PHYSIOL, V45, P1586, DOI 10.1093/pcp/pch181; Yao N, 2006, PLANT CELL, V18, P397, DOI 10.1105/tpc.105.036251; Yoshimura K, 2000, PLANT PHYSIOL, V123, P223, DOI 10.1104/pp.123.1.223; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	58	146	155	1	70	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11717	11729		10.1074/jbc.M111.292847	http://dx.doi.org/10.1074/jbc.M111.292847			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334687	Green Published, hybrid			2022-12-25	WOS:000302782200011
J	Boniecki, MT; Martinis, SA				Boniecki, Michal T.; Martinis, Susan A.			Coordination of tRNA Synthetase Active Sites for Chemical Fidelity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBONUCLEIC-ACID SYNTHETASE; AMINO-ACID; ESCHERICHIA-COLI; EDITING ACTIVITY; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; PROTEIN-SYNTHESIS; L-VALINE; DOMAIN; AMINOACYLATION	Statistical proteomes that are naturally occurring can result from mechanisms involving aminoacyl-tRNA synthetases (aaRSs) with inactivated hydrolytic editing active sites. In one case, Mycoplasma mobile leucyl-tRNA synthetase (LeuRS) is uniquely missing its entire amino acid editing domain, called CP1, which is otherwise present in all known LeuRSs and also isoleucyl-and valyl-tRNA synthetases. This hydrolytic CP1 domain was fused to a synthetic core composed of a Rossmann ATP-binding fold. The fusion event splits the primary structure of the Rossmann fold into two halves. Hybrid LeuRS chimeras using M. mobile LeuRS as a scaffold were constructed to investigate the evolutionary protein: protein fusion of the CP1 editing domain to the Rossmann fold domain that is ubiquitously found in kinases and dehydrogenases, in addition to class I aaRSs. Significantly, these results determined that the modular construction of aaRSs and their adaptation to accommodate more stringent amino acid specificities included CP1-dependent distal effects on amino acid discrimination in the synthetic core. As increasingly sophisticated protein synthesis machinery evolved, the addition of the CP1 domain increased specificity in the synthetic site, as well as provided a hydrolytic editing site.	[Boniecki, Michal T.; Martinis, Susan A.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Martinis, SA (corresponding author), Univ Illinois, Dept Biochem, 600 S Mathews Ave,401 RAL, Urbana, IL 61801 USA.	martinis@illinois.edu		Martinis, Susan/0000-0001-5730-8346	National Institutes of Health [GM063789]; National Science Foundation [MCB0843611]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063789] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [0843611] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Institutes of Health Grant GM063789 (to S. A. M. and M. T. B.). This work was also supported by National Science Foundation Grant MCB0843611.	ADAMS MJ, 1970, J MOL BIOL, V51, P31, DOI 10.1016/0022-2836(70)90267-6; BALDWIN AN, 1966, J BIOL CHEM, V241, P839; Betha AK, 2007, BIOCHEMISTRY-US, V46, P6258, DOI 10.1021/bi061965j; Bishop AC, 2002, P NATL ACAD SCI USA, V99, P585, DOI 10.1073/pnas.012611299; Boniecki MT, 2008, P NATL ACAD SCI USA, V105, P19223, DOI 10.1073/pnas.0809336105; Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351; ELDRED EW, 1972, J BIOL CHEM, V247, P2961; ENGLISCH S, 1986, NUCLEIC ACIDS RES, V14, P7529, DOI 10.1093/nar/14.19.7529; Fersht AR, 1998, SCIENCE, V280, P541, DOI 10.1126/science.280.5363.541; FERSHT AR, 1977, BIOCHEMISTRY-US, V16, P1025, DOI 10.1021/bi00624a034; Francklyn CS, 2008, METHODS, V44, P100, DOI 10.1016/j.ymeth.2007.09.007; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Fukunaga R, 2005, J BIOL CHEM, V280, P29937, DOI 10.1074/jbc.M502668200; Fukunaga R, 2004, J BIOL CHEM, V279, P8396, DOI 10.1074/jbc.M312830200; Fukunaga R, 2006, J MOL BIOL, V359, P901, DOI 10.1016/j.jmb.2006.04.025; Hale SP, 1997, SCIENCE, V276, P1250, DOI 10.1126/science.276.5316.1250; Hati S, 2006, J BIOL CHEM, V281, P27862, DOI 10.1074/jbc.M605856200; Hellmann RA, 2009, J BIOL CHEM, V284, P11478, DOI 10.1074/jbc.M807395200; Ibba M, 1999, SCIENCE, V286, P1893, DOI 10.1126/science.286.5446.1893; Karkhanis VA, 2007, J BACTERIOL, V189, P8765, DOI 10.1128/JB.01215-07; Karkhanis VA, 2006, J BIOL CHEM, V281, P33217, DOI 10.1074/jbc.M607406200; Li L, 2011, P NATL ACAD SCI USA, V108, P9378, DOI 10.1073/pnas.1016460108; Lin L, 1996, NATURE, V384, P33, DOI 10.1038/384033b0; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; LOFTFIELD RB, 1963, BIOCHEM J, V89, P82, DOI 10.1042/bj0890082; Lue SW, 2005, BIOCHEMISTRY-US, V44, P3010, DOI 10.1021/bi047901v; Mascarenhas A. P., 2008, PROTEIN ENG, P153; Mursinna RS, 2002, J AM CHEM SOC, V124, P7286, DOI 10.1021/ja025879s; Mursinna RS, 2001, BIOCHEMISTRY-US, V40, P5376, DOI 10.1021/bi002915w; Nomanbhoy TK, 1999, MOL CELL, V4, P519, DOI 10.1016/S1097-2765(00)80203-8; Nordin BE, 2003, BIOCHEMISTRY-US, V42, P12989, DOI 10.1021/bi035052q; Nureki O, 1998, SCIENCE, V280, P578, DOI 10.1126/science.280.5363.578; Pham Y, 2010, J BIOL CHEM, V285, P38590, DOI 10.1074/jbc.M110.136911; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; SCHMIDT E, 1994, SCIENCE, V264, P265, DOI 10.1126/science.8146659; Splan KE, 2008, METHODS, V44, P119, DOI 10.1016/j.ymeth.2007.10.009; SternJohn J, 2007, P NATL ACAD SCI USA, V104, P2127, DOI 10.1073/pnas.0611110104; Tukalo M, 2005, NAT STRUCT MOL BIOL, V12, P923, DOI 10.1038/nsmb986; ZELWER C, 1982, J MOL BIOL, V155, P63, DOI 10.1016/0022-2836(82)90492-2; Zhang CM, 2006, J MOL BIOL, V361, P300, DOI 10.1016/j.jmb.2006.06.015	40	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11285	11289		10.1074/jbc.C111.325795	http://dx.doi.org/10.1074/jbc.C111.325795			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334703	Green Published, hybrid			2022-12-25	WOS:000302780100059
J	Schiavinato, A; Becker, AKA; Zanetti, M; Corallo, D; Milanetto, M; Bizzotto, D; Bressan, G; Guljelmovic, M; Paulsson, M; Wagener, R; Braghetta, P; Bonaldo, P				Schiavinato, Alvise; Becker, Ann-Kathrin A.; Zanetti, Miriam; Corallo, Diana; Milanetto, Martina; Bizzotto, Dario; Bressan, Giorgio; Guljelmovic, Marija; Paulsson, Mats; Wagener, Raimund; Braghetta, Paola; Bonaldo, Paolo			EMILIN-3, Peculiar Member of Elastin Microfibril Interface-located Protein (EMILIN) Family, Has Distinct Expression Pattern, Forms Oligomeric Assemblies, and Serves as Transforming Growth Factor beta (TGF-beta) Antagonist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARIN/HEPARAN SULFATE BINDING; SECONDARY STRUCTURE; MOLECULAR-CLONING; COILED-COIL; DOMAINS; HEPARIN; PROTEOGLYCANS; GLYCOPROTEIN; MULTIMERIN; INTERACTS	EMILIN-3 is a glycoprotein of the extracellular matrix belonging to a family that contains a characteristic N-terminal cysteine-rich EMI domain. Currently, EMILIN-3 is the least characterized member of the elastin microfibril interface-located protein (EMILIN)/Multimerin family. Using RNA, immunohistochemical, and protein chemistry approaches, we carried out a detailed characterization of the expression and biochemical properties of EMILIN-3 in mouse. During embryonic and postnatal development, EMILIN-3 showed a peculiar and dynamic pattern of gene expression and protein distribution. EMILIN-3 mRNA was first detected at E8.5-E9.5 in the tail bud and in the primitive gut, and at later stages it became abundant in the developing gonads and osteogenic mesenchyme. Interestingly and in contrast to other EMILIN/Multimerin genes, EMILIN-3 was not found in the cardiovascular system. Despite the absence of the globular C1q domain, immunoprecipitation and Western blot analyses demonstrated that EMILIN-3 forms disulfide-bonded homotrimers and higher order oligomers. Circular dichroism spectroscopy indicated that the most C-terminal part of EMILIN-3 has a substantial alpha-helical content and forms coiled coil structures involved in EMILIN-3 homo-oligomerization. Transfection experiments with recombinant constructs showed that the EMI domain contributes to the higher order self-assembly but was dispensable for homotrimer formation. EMILIN-3 was found to bind heparin with high affinity, a property mediated by the EMI domain, thus revealing a new function for this domain that may contribute to the interaction of EMILIN-3 with other extracellular matrix and/or cell surface molecules. Finally, in vitro experiments showed that EMILIN-3 is able to function as an extracellular regulator of the activity of TGF-beta ligands.	[Schiavinato, Alvise; Zanetti, Miriam; Corallo, Diana; Milanetto, Martina; Bizzotto, Dario; Bressan, Giorgio; Guljelmovic, Marija; Braghetta, Paola; Bonaldo, Paolo] Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; [Becker, Ann-Kathrin A.; Paulsson, Mats; Wagener, Raimund] Univ Cologne, Ctr Biochem, Fac Med, D-50931 Cologne, Germany; [Paulsson, Mats; Wagener, Raimund] Univ Cologne, Ctr Mol Med Cologne CMMC, D-50931 Cologne, Germany; [Paulsson, Mats] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany	University of Padua; University of Cologne; University of Cologne; University of Cologne	Bonaldo, P (corresponding author), Univ Padua, Dept Biomed Sci, Viale G Colombo 3, I-35121 Padua, Italy.	bonaldo@bio.unipd.it	Corallo, Diana/K-6403-2016; Corallo, Diana/Q-4286-2019; Braghetta, Paola/K-5478-2016	Corallo, Diana/0000-0001-7075-1414; Braghetta, Paola/0000-0003-2547-8679; Bonaldo, Paolo/0000-0002-9571-8140; BIZZOTTO, Dario/0000-0002-9036-5016	University of Padova [CPDA075559]; Italian Ministry of University and Research (Progetti di Ricerca di Interesse Nazionale); German Research Council (Deutsche Forschungsgemeinschaft) [WA1338/2-6, SFB 829]	University of Padova; Italian Ministry of University and Research (Progetti di Ricerca di Interesse Nazionale)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported by the University of Padova (Grant CPDA075559), the Italian Ministry of University and Research (Progetti di Ricerca di Interesse Nazionale), and the German Research Council (Deutsche Forschungsgemeinschaft Grants WA1338/2-6 and SFB 829).	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Braghetta P, 2004, MATRIX BIOL, V22, P549, DOI 10.1016/j.matbio.2003.10.005; Braghetta P, 2002, MATRIX BIOL, V21, P603, DOI 10.1016/S0945-053X(02)00072-0; BRESSAN GM, 1993, J CELL BIOL, V121, P201, DOI 10.1083/jcb.121.1.201; Broekelmann TJ, 2005, J BIOL CHEM, V280, P40939, DOI 10.1074/jbc.M507309200; BRUNNER AM, 1989, J BIOL CHEM, V264, P13660; Cain SA, 2005, J BIOL CHEM, V280, P30526, DOI 10.1074/jbc.M501390200; Christian S, 2001, J BIOL CHEM, V276, P48588, DOI 10.1074/jbc.M106152200; COLOMBATTI A, 1988, J BIOL CHEM, V263, P17534; Corbin JG, 2008, J NEUROCHEM, V106, P2272, DOI 10.1111/j.1471-4159.2008.05522.x; Danussi C, 2008, MOL CELL BIOL, V28, P4026, DOI 10.1128/MCB.02062-07; Danussi C, 2011, J CELL BIOL, V195, P131, DOI 10.1083/jcb.201008013; Doi M, 2004, BIOCHEM BIOPH RES CO, V313, P888, DOI 10.1016/j.bbrc.2003.11.181; Doliana R, 2001, J BIOL CHEM, V276, P12003, DOI 10.1074/jbc.M011591200; Doliana R, 2000, J BIOL CHEM, V275, P785, DOI 10.1074/jbc.275.2.785; Doliana R, 2000, FEBS LETT, V484, P164, DOI 10.1016/S0014-5793(00)02140-2; Fromm JR, 1997, ARCH BIOCHEM BIOPHYS, V343, P92, DOI 10.1006/abbi.1997.0147; GREENFIELD NJ, 1993, PROTEIN SCI, V2, P1263, DOI 10.1002/pro.5560020809; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; HAYWARD CPM, 1991, BLOOD, V77, P2556; HAYWARD CPM, 1995, J BIOL CHEM, V270, P18246, DOI 10.1074/jbc.270.31.18246; HODGES R S, 1990, Peptide Research, V3, P123; Kantola AK, 2008, EXP CELL RES, V314, P2488, DOI 10.1016/j.yexcr.2008.05.010; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; Larrain J, 2000, DEVELOPMENT, V127, P821; Leimeister C, 2002, DEV BIOL, V249, P204, DOI 10.1006/dbio.2002.0764; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Massam-Wu T, 2010, J CELL SCI, V123, P3006, DOI 10.1242/jcs.073437; Milanetto M, 2008, DEV DYNAM, V237, P222, DOI 10.1002/dvdy.21402; Mongiat M, 2000, J BIOL CHEM, V275, P25471, DOI 10.1074/jbc.M001426200; Mongiat M, 2007, MOL CELL BIOL, V27, P7176, DOI 10.1128/MCB.00696-07; Parsi MK, 2010, MATRIX BIOL, V29, P393, DOI 10.1016/j.matbio.2010.03.005; Rider CC, 2006, BIOCHEM SOC T, V34, P458, DOI 10.1042/BST0340458; Sambrook J, 2001, MOL CLONING LAB MANU; Spessotto P, 2003, J BIOL CHEM, V278, P6160, DOI 10.1074/jbc.M208322200; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wilson V, 2009, DEVELOPMENT, V136, P1591, DOI 10.1242/dev.021246; Zacchigna L, 2006, CELL, V124, P929, DOI 10.1016/j.cell.2005.12.035; Zanetti M, 2004, MOL CELL BIOL, V24, P638, DOI 10.1128/MCB.24.2.638-650.2004	42	27	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11498	11515		10.1074/jbc.M111.303578	http://dx.doi.org/10.1074/jbc.M111.303578			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334695	Green Published, hybrid			2022-12-25	WOS:000302780100078
J	Wicklein, D; Leal, NR; Salamon, J; Thamer, M; Herrmann, H; Valent, P; Schumacher, U; Ullrich, S				Wicklein, Daniel; Leal, Nuno Ramos; Salamon, Johannes; Thamer, Mohammed; Herrmann, Harald; Valent, Peter; Schumacher, Udo; Ullrich, Sebastian			Nilotinib and Imatinib Are Comparably Effective in Reducing Growth of Human Eosinophil Leukemia Cells in a Newly Established Xenograft Model	PLOS ONE			English	Article							HYPEREOSINOPHILIC SYNDROME; IN-VITRO; GRANULOCYTIC SARCOMA; KINASE INHIBITOR; APOPTOSIS; FUSION; ARREST; AGENT; MICE	We developed a xenograft model of human Chronic Eosinophilic Leukemia (CEL) to study disease progression and remission-induction under therapy with tyrosine kinase inhibitors using imatinib and nilotinib as examples. The FIP1L1/PDGFRA+ human CEL cell lineEOL-1 was injected intravenously into scid mice, and MR imaging and FACS analysis of mouse blood samples were performed to monitor disease development and the effects of imatinib and nilotinib. Organ infiltration was analyzed in detail by immunohistochemistry after sacrifice. All animals developed CEL and within one week of therapy, complete remissions were seen with both imatinib and nilotinib, resulting in reduced total tumor volumes by MR-imaging and almost complete disappearance of EOL-1 cells in the peripheral blood and in tissues. The new model system is feasible for the evaluation of new tyrosine kinase inhibitors and our data suggest that nilotinib may be a valuable additional targeted drug active in patients with FIP1L1/PDGFRA+ CEL.	[Wicklein, Daniel; Leal, Nuno Ramos; Thamer, Mohammed; Schumacher, Udo; Ullrich, Sebastian] Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr, Inst Anat & Expt Morphol, Hamburg, Germany; [Wicklein, Daniel] Univ Med Ctr Hamburg Eppendorf, Inst Clin Chem, Hamburg, Germany; [Salamon, Johannes] Univ Med Ctr Hamburg Eppendorf, Dept Radiol, Hamburg, Germany; [Valent, Peter] Med Univ Vienna, Dept Internal Med 1, Div Hematol & Hemostaseol, Vienna, Austria	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Medical University of Vienna	Wicklein, D (corresponding author), Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr, Inst Anat & Expt Morphol, Hamburg, Germany.	d.wicklein@uke.de	Gamperl, Susi/V-2715-2019; Valent, Peter/B-8533-2016; Test, PV/U-9451-2019; Test, Test/Y-7921-2019; Hermann, Harald/E-7073-2018	Gamperl, Susi/0000-0003-0456-5095; Valent, Peter/0000-0003-0456-5095; Hermann, Harald/0000-0002-5095-4641				BRODSKY I, 1966, CANCER RES, V26, P198; Cools J, 2004, BLOOD, V103, P2802, DOI 10.1182/blood-2003-07-2479; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Crane MM, 2010, J ALLERGY CLIN IMMUN, V126, P179, DOI 10.1016/j.jaci.2010.03.035; Flavell DJ, 2000, BRIT J CANCER, V83, P1755, DOI 10.1054/bjoc.2000.1565; Gotlib J, 2008, LEUKEMIA, V22, P1999, DOI 10.1038/leu.2008.287; Helbig G, 2008, BRIT J HAEMATOL, V141, P200, DOI 10.1111/j.1365-2141.2008.07033.x; Helbig G, 2010, HEMATOL ONCOL, V28, P93, DOI 10.1002/hon.919; Henschler R, 2005, LEUKEMIA RES, V29, P1191, DOI 10.1016/j.leukres.2005.03.019; Ikezoe T, 2010, LEUKEMIA RES, V34, pE200, DOI 10.1016/j.leukres.2010.02.024; Ishihara K, 2008, BIOCHEM BIOPH RES CO, V366, P1007, DOI 10.1016/j.bbrc.2007.12.063; Lierman E, 2009, LEUKEMIA, V23, P845, DOI 10.1038/leu.2009.2; Ma SK, 1999, HUM PATHOL, V30, P864, DOI 10.1016/S0046-8177(99)90149-1; Manley PW, 2010, BIOORGAN MED CHEM, V18, P6977, DOI 10.1016/j.bmc.2010.08.026; Metzgeroth G, 2008, BRIT J HAEMATOL, V143, P707, DOI 10.1111/j.1365-2141.2008.07294.x; Nishioka C, 2008, BLOOD, V111, P5086, DOI 10.1182/blood-2007-06-098079; Park KU, 2001, AM J PATHOL, V159, P2011, DOI 10.1016/S0002-9440(10)63052-0; Paydas S, 2006, LEUKEMIA LYMPHOMA, V47, P2527, DOI 10.1080/10428190600967196; Roufosse FE, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-37; SAITO H, 1985, BLOOD, V66, P1233; Simon HU, 2010, J ALLERGY CLIN IMMUN, V126, P45, DOI 10.1016/j.jaci.2010.03.042; Tabouret E, 2010, LEUK RES; Tefferi A, 2010, MAYO CLIN PROC, V85, P158, DOI 10.4065/mcp.2009.0503; Thies A, 2007, BRIT J CANCER, V96, P609, DOI 10.1038/sj.bjc.6603594; Valent P, 2009, BLOOD REV, V23, P157, DOI 10.1016/j.blre.2009.01.001; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Yang J, 2007, BLOOD, V110, P2034, DOI 10.1182/blood-2007-02-073700	27	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e30567	10.1371/journal.pone.0030567	http://dx.doi.org/10.1371/journal.pone.0030567			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348015	Green Published, gold, Green Submitted			2022-12-25	WOS:000302737400003
J	Petrovic, MM; Nowacki, J; Olivo, V; Tsaneva-Atanasova, K; Randall, AD; Mellor, JR				Petrovic, Milos M.; Nowacki, Jakub; Olivo, Valeria; Tsaneva-Atanasova, Krasimira; Randall, Andrew D.; Mellor, Jack R.			Inhibition of Post-Synaptic Kv7/KCNQ/M Channels Facilitates Long-Term Potentiation in the Hippocampus	PLOS ONE			English	Article							CA1 PYRAMIDAL NEURONS; SK CHANNELS; MUSCARINIC MODULATION; SYNAPTIC PLASTICITY; DENDRITIC SPINES; RAT HIPPOCAMPUS; INTRINSIC PLASTICITY; MOUSE HIPPOCAMPUS; NMDA RECEPTORS; CLAMP ANALYSIS	Activation of muscarinic acetylcholine receptors (mAChR) facilitates the induction of synaptic plasticity and enhances cognitive function. In the hippocampus, M-1 mAChR on CA1 pyramidal cells inhibit both small conductance Ca2+-activated KCa2 potassium channels and voltage-activated Kv7 potassium channels. Inhibition of KCa2 channels facilitates long-term potentiation (LTP) by enhancing Ca2+ calcium influx through postsynaptic NMDA receptors (NMDAR). Inhibition of Kv7 channels is also reported to facilitate LTP but the mechanism of action is unclear. Here, we show that inhibition of Kv7 channels with XE-991 facilitated LTP induced by theta burst pairing at Schaffer collateral commissural synapses in rat hippocampal slices. Similarly, negating Kv7 channel conductance using dynamic clamp methodologies also facilitated LTP. Negation of Kv7 channels by XE-991 or dynamic clamp did not enhance synaptic NMDAR activation in response to theta burst synaptic stimulation. Instead, Kv7 channel inhibition increased the amplitude and duration of the after-depolarisation following a burst of action potentials. Furthermore, the effects of XE-991 were reversed by re-introducing a Kv7-like conductance with dynamic clamp. These data reveal that Kv7 channel inhibition promotes NMDAR opening during LTP induction by enhancing depolarisation during and after bursts of postsynaptic action potentials. Thus, during the induction of LTP M-1 mAChRs enhance NMDAR opening by two distinct mechanisms namely inhibition of KCa2 and Kv7 channels.	[Petrovic, Milos M.; Olivo, Valeria; Randall, Andrew D.; Mellor, Jack R.] Univ Bristol, Sch Physiol & Pharmacol, Med Res Council Ctr Synapt Plast, Bristol, Avon, England; [Nowacki, Jakub; Tsaneva-Atanasova, Krasimira] Univ Bristol, Dept Engn Math, Bristol Ctr Appl Nonlinear Math, Bristol, Avon, England; [Petrovic, Milos M.] Univ Belgrade, Sch Med, Inst Med Psychol, Belgrade, Serbia	University of Bristol; University of Bristol; University of Belgrade	Petrovic, MM (corresponding author), Univ Bristol, Sch Physiol & Pharmacol, Med Res Council Ctr Synapt Plast, Bristol, Avon, England.	Jack.Mellor@bristol.ac.uk	Tsaneva-Atanasova, Krasimira T/AAG-6766-2019; MELLOR, Jack/B-4548-2019	Tsaneva-Atanasova, Krasimira T/0000-0002-6294-7051; MELLOR, Jack/0000-0002-7706-8105; Randall, Andrew/0000-0001-8852-3671	Wellcome Trust [085354]; Engineering and Physical Sciences Research Council [EP/E032249/1]; Marie Curie Intra-European fellowship [237622]; BBSRC [BB/K000454/1] Funding Source: UKRI; EPSRC [EP/E032249/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K000454/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Marie Curie Intra-European fellowship(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Wellcome Trust, grant number 085354; Engineering and Physical Sciences Research Council, grant number EP/E032249/1; and Marie Curie Intra-European fellowship number 237622. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostaras SG, 2003, NAT NEUROSCI, V6, P51, DOI 10.1038/nn992; Aramakis VB, 1999, SYNAPSE, V32, P262, DOI 10.1002/(SICI)1098-2396(19990615)32:4<262::AID-SYN3>3.3.CO;2-A; Behnisch T, 1998, NEUROSCI LETT, V253, P91, DOI 10.1016/S0304-3940(98)00612-0; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; BODDEKE EWGM, 1992, EUR J PHARMACOL, V222, P21, DOI 10.1016/0014-2999(92)90457-F; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Brown JT, 2011, EUR J NEUROSCI, V33, P879, DOI 10.1111/j.1460-9568.2010.07565.x; Brown JT, 2009, J PHYSIOL-LONDON, V587, P1265, DOI 10.1113/jphysiol.2008.167007; Buchanan KA, 2007, J PHYSIOL-LONDON, V585, P429, DOI 10.1113/jphysiol.2007.142984; Buchanan KA, 2010, NEURON, V68, P948, DOI 10.1016/j.neuron.2010.11.018; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; Dean B, 2003, CURR MOL MED, V3, P419, DOI 10.2174/1566524033479654; Destexhe A, 2009, DYNAMIC CLAMP PRINCI; Faber ESL, 2010, J PHYSIOL-LONDON, V588, P1281, DOI 10.1113/jphysiol.2009.185645; Faber ESL, 2005, NAT NEUROSCI, V8, P635, DOI 10.1038/nn1450; Fontan-Lozano A, 2011, HIPPOCAMPUS, V21, P22, DOI 10.1002/hipo.20717; Giessel AJ, 2010, NEURON, V68, P936, DOI 10.1016/j.neuron.2010.09.004; Gu N, 2005, J PHYSIOL-LONDON, V566, P689, DOI 10.1113/jphysiol.2005.086835; Gu N, 2008, J NEUROPHYSIOL, V100, P2589, DOI 10.1152/jn.90433.2008; HARVEY J, 1993, NEUROSCI LETT, V162, P165, DOI 10.1016/0304-3940(93)90586-A; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hu H, 2007, J NEUROSCI, V27, P1853, DOI 10.1523/JNEUROSCI.4463-06.2007; Lampe BJ, 1997, NEUROSCI LETT, V222, P135, DOI 10.1016/S0304-3940(97)13347-X; LEVEY AI, 1995, J NEUROSCI, V15, P4077; Li Y, 2005, J NEUROSCI, V25, P9825, DOI 10.1523/JNEUROSCI.2597-05.2005; Ma MH, 1996, J NEUROSCI, V16, P4089; MADISON DV, 1987, J NEUROSCI, V7, P733; Marino MJ, 1998, P NATL ACAD SCI USA, V95, P11465, DOI 10.1073/pnas.95.19.11465; MARKRAM H, 1992, J PHYSIOL-LONDON, V447, P513, DOI 10.1113/jphysiol.1992.sp019015; MARRION NV, 1989, BRIT J PHARMACOL, V98, P557, DOI 10.1111/j.1476-5381.1989.tb12630.x; Martire M, 2004, J NEUROSCI, V24, P592, DOI 10.1523/JNEUROSCI.3143-03.2004; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Nowacki J, 2011, PROG BIOPHYS MOL BIO, V105, P34, DOI 10.1016/j.pbiomolbio.2010.09.020; Oh MM, 2003, J NEUROPHYSIOL, V90, P2171, DOI 10.1152/jn.01177.2002; Oldfield S, 2009, MOL PHARMACOL, V76, P1279, DOI 10.1124/mol.109.058008; Peretz A, 2007, J NEUROPHYSIOL, V97, P283, DOI 10.1152/jn.00634.2006; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; Prinz AA, 2004, TRENDS NEUROSCI, V27, P218, DOI 10.1016/j.tins.2004.02.004; Robinson HPC, 2008, J NEUROSCI METH, V169, P271, DOI 10.1016/j.jneumeth.2007.10.016; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Seol GH, 2007, NEURON, V55, P919, DOI 10.1016/j.neuron.2007.08.013; Shah MM, 2008, P NATL ACAD SCI USA, V105, P7869, DOI 10.1073/pnas.0802805105; Shinoe T, 2005, J NEUROSCI, V25, P11194, DOI 10.1523/JNEUROSCI.2338-05.2005; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Soldovieri MV, 2007, J NEUROSCI, V27, P4919, DOI 10.1523/JNEUROSCI.0580-07.2007; Song MK, 2009, NEUROSCI LETT, V461, P25, DOI 10.1016/j.neulet.2009.05.042; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Tsubokawa H, 1997, J NEUROSCI, V17, P5782; Tzingounis AV, 2010, P NATL ACAD SCI USA, V107, P10232, DOI 10.1073/pnas.1004644107; Tzingounis AV, 2008, P NATL ACAD SCI USA, V105, P19974, DOI 10.1073/pnas.0810535105; Wess J, 2004, ANNU REV PHARMACOL, V44, P423, DOI 10.1146/annurev.pharmtox.44.101802.121622; Wu WW, 2008, J NEUROPHYSIOL, V100, P1897, DOI 10.1152/jn.90346.2008; Yamasaki M, 2010, J NEUROSCI, V30, P4408, DOI 10.1523/JNEUROSCI.5719-09.2010; Yue CY, 2004, J NEUROSCI, V24, P4614, DOI 10.1523/JNEUROSCI.0765-04.2004; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	56	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e30402	10.1371/journal.pone.0030402	http://dx.doi.org/10.1371/journal.pone.0030402			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348007	Green Published, Green Submitted, gold			2022-12-25	WOS:000302733900008
J	Sorensen, SW; Sansom, SL; Brooks, JT; Marks, G; Begier, EM; Buchacz, K; DiNenno, EA; Mermin, JH; Kilmarx, PH				Sorensen, Stephen W.; Sansom, Stephanie L.; Brooks, John T.; Marks, Gary; Begier, Elizabeth M.; Buchacz, Kate; DiNenno, Elizabeth A.; Mermin, Jonathan H.; Kilmarx, Peter H.			A Mathematical Model of Comprehensive Test-and-Treat Services and HIV Incidence among Men Who Have Sex with Men in the United States	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; NEW-YORK-CITY; MALE CIRCUMCISION; MEDICAL-CARE; ANAL INTERCOURSE; PERSONS AWARE; TRANSMISSION; PREVENTION; RISK; POPULATION	Background: Early diagnosis and treatment of HIV infection and suppression of viral load are potentially powerful interventions for reducing HIV incidence. A test-and-treat strategy may have long-term effects on the epidemic among urban men who have sex with men (MSM) in the United States and may achieve the 5-year goals of the 2010 National AIDS Strategy that include: 1) lowering to 25% the annual number of new infections, 2) reducing by 30% the HIV transmission rate, 3) increasing to 90% the proportion of persons living with HIV infection who know their HIV status, 4) increasing to 85% the proportion of newly diagnosed patients linked to clinical care, and 5) increasing by 20% the proportion of HIV-infected MSM with an undetectable HIV RNA viral load. Methods and Findings: We constructed a dynamic compartmental model among MSM in an urban population (based on New York City) that projects new HIV infections over time. We compared the cumulative number of HIV infections in 20 years, assuming current annual testing rate and treatment practices, with new infections after improvements in the annual HIV testing rate, notification of test results, linkage to care, initiation of antiretroviral therapy (ART) and viral load suppression. We also assessed whether five of the national HIV prevention goals could be met by the year 2015. Over a 20-year period, improvements in test-and-treat practice decreased the cumulative number of new infections by a predicted 39.3% to 69.1% in the urban population based on New York City. Institution of intermediate improvements in services would be predicted to meet at least four of the five goals of the National HIV/AIDS Strategy by the 2015 target. Conclusions: Improving the five components of a test-and-treat strategy could substantially reduce HIV incidence among urban MSM, and meet most of the five goals of the National HIV/AIDS Strategy.	[Sorensen, Stephen W.; Sansom, Stephanie L.; Brooks, John T.; Marks, Gary; Buchacz, Kate; DiNenno, Elizabeth A.; Mermin, Jonathan H.; Kilmarx, Peter H.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA; [Begier, Elizabeth M.] New York City Dept Hlth & Mental Hyg, New York, NY USA	Centers for Disease Control & Prevention - USA; New York City Department of Health & Mental Hygiene	Sansom, SL (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.	sos9@cdc.gov	Mermin, Jonathan/J-9847-2012	Kilmarx, Peter/0000-0001-6464-3345				[Anonymous], COCHRANE DATABASE SY; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Buchacz K, 2010, AIDS, V24, P1549, DOI 10.1097/QAD.0b013e32833a3967; Burns DN, 2010, CLIN INFECT DIS, V51, P725, DOI 10.1086/655889; Cambiano V, 2010, AIDS, V24, P1153, DOI 10.1097/QAD.0b013e32833847af; Center for Disease Control and Prevention, 2010, HIV GAY BIS OTH MEN; Centers for Disease Control and Prevention, 2009, HIV SURV REP; Charlebois ED, 2011, CLIN INFECT DIS, V52, P1046, DOI 10.1093/cid/cir085; Charurat M, 2010, PATIENT RETENTION AD; Cohen MS, 2010, CLIN INFECT DIS, V51, P1323, DOI 10.1086/656810; Crepaz N, 2009, AIDS, V23, P1617, DOI 10.1097/QAD.0b013e32832effae; Crosby R, 2002, SEX TRANSM INFECT, V78, P228, DOI 10.1136/sti.78.4.228; Davis KR, 1999, FAM PLANN PERSPECT, V31, P272, DOI 10.2307/2991537; DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents, 2011, GUID US ANT AG HIV 1; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Foss AM, 2004, BRIT MED J, V329, P185, DOI 10.1136/bmj.329.7459.185; GIESECKE J, 1992, INT J STD AIDS, V3, P255, DOI 10.1177/095646249200300405; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hutchinson AB, 2006, AIDS, V20, P1597, DOI 10.1097/01.aids.0000238405.93249.16; Kalichman SC, 2010, AIDS PATIENT CARE ST, V24, P271, DOI 10.1089/apc.2009.0309; Kassler WJ, 1997, AIDS, V11, P1045, DOI 10.1097/00002030-199708000-00014; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; Long EF, 2010, ANN INTERN MED, V153, P778, DOI 10.7326/0003-4819-153-12-201012210-00004; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Marks G, 2001, J ACQ IMMUN DEF SYND, V27, P79, DOI 10.1097/00126334-200105010-00013; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Marks G, 2010, AIDS, V24, P2665, DOI 10.1097/QAD.0b013e32833f4b1b; Marks G, 2010, SEX TRANSM DIS, V37, P325, DOI 10.1097/OLQ.0b013e3181c95dac; Marks G, 2009, AIDS BEHAV, V13, P682, DOI 10.1007/s10461-008-9380-6; May M, 2007, AIDS, V21, P1185, DOI 10.1097/QAD.0b013e328133f285; Mckinney CM, 2008, SEX TRANSM DIS, V35, P814, DOI 10.1097/OLQ.0b013e318175d899; Mocroft A, 2010, ANTIVIR THER, V15, P563, DOI 10.3851/IMP1559; Mugavero MJ, 2010, AIDS PATIENT CARE ST, V24, P607, DOI 10.1089/apc.2010.0086; Mugavero Michael J, 2008, Top HIV Med, V16, P156; Nettles RE, 2005, JAMA-J AM MED ASSOC, V293, P817, DOI 10.1001/jama.293.7.817; New York City Department of Health and Mental Hygiene, 2010, NEW YORK CIT HIV AID; Nguyen TQ, 2008, AIDS, V22, P281, DOI 10.1097/QAD.0b013e3282f2ef58; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Porco TC, 2004, AIDS, V18, P81, DOI 10.1097/00002030-200401020-00010; Pund B, 2011, NATL ADAP MONITORING; Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201; Sungkanuparph S, 2005, CLIN INFECT DIS, V41, P1326, DOI 10.1086/496985; Torian LV, 2008, ARCH INTERN MED, V168, P1181, DOI 10.1001/archinte.168.11.1181; Torian LV, 2011, AIDS PATIENT CARE ST, V25, P79, DOI 10.1089/apc.2010.0151; Ulett KB, 2009, AIDS PATIENT CARE ST, V23, P41, DOI 10.1089/apc.2008.0132; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; Walensky RP, 2010, CLIN INFECT DIS, V51, P392, DOI 10.1086/655130; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411	54	62	63	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e29098	10.1371/journal.pone.0029098	http://dx.doi.org/10.1371/journal.pone.0029098			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22347994	Green Published, gold, Green Submitted			2022-12-25	WOS:000302730900002
J	Barennes, H; Empis, G; Quang, TD; Sengkhamyong, K; Phasavath, P; Harimanana, A; Sambany, EM; Koffi, PN				Barennes, Hubert; Empis, Gwenaelle; Thao Duong Quang; Sengkhamyong, Khouanheuan; Phasavath, Phonethepa; Harimanana, Aina; Sambany, Emercia M.; Koffi, Paulin N.			Breast-Milk Substitutes: A New Old-Threat for Breastfeeding Policy in Developing Countries. A Case Study in a Traditionally High Breastfeeding Country	PLOS ONE			English	Article							UNDERNUTRITION; PROMOTION	Background: Developing countries with traditionally breastfeeding are now experiencing the increasing pressure of formula milk marketing. This may endanger lives and undermine the efforts of national policies in achieving the objectives of the Millennium Development Goals. We examined the use of, and factors for use, of all available breast-milk substitutes (BMS) in a country with a traditionally high rate of breastfeeding. Methods: Randomised multi-stage sampling surveys in 90 villages in 12/17 provinces in Laos. Participants: 1057 mothers with infants under 24 months of age. Tools: 50-query questionnaire and a poster of 22 BMS (8 canned or powdered milk; 6 non-dairy; 6 formulas; 2 non-formulas). Outcome measures included: prevalence of use and age of starting BMS in relation to socio-demographic characteristics and information sources, by univariate and multivariate analyses. Results: Of 1057 mothers: 72.5% currently breastfed; 25.4% gave BMS (10.6% infant formula); 19.6% gave BMS before 6 months of age (of them: 83% non-dairy or cereals; mean age: 2.9 months; 95% Confidence interval: 2.6-3.2). One formula and one non-formula product accounted for 85% of BMS. BMS were considered as milk by the majority of mothers. Thai TV was the main source of information on BMS for mothers. Lao Loum mothers (the main ethnic group) living in concrete houses with good sanitary conditions, were more likely than others to use BMS before 6 months (OR: 1.79, (1.15-2.78), p<0.009). Mothers who fed their infants colostrum at birth were less likely to use BMS before 6 months of age (OR: 0.63, (0.41-0.99), p = 0.04). Unemployed mothers living in rural areas were less likely to consider BMS better than breast milk. Conclusion: In Laos, mothers with the highest socio-economic status are showing a tendency to give up breastfeeding. Successful educational strategies and advocacy measures should be urgently developed to promote and sustain breastfeeding in developing countries.	[Barennes, Hubert; Empis, Gwenaelle; Thao Duong Quang; Sengkhamyong, Khouanheuan; Phasavath, Phonethepa; Harimanana, Aina; Sambany, Emercia M.; Koffi, Paulin N.] Inst Francophonie Med Trop, Viangchan, Laos; [Barennes, Hubert] INSERM 897 VIH Afr VIH, VIH, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	Barennes, H (corresponding author), Inst Francophonie Med Trop, Viangchan, Laos.	barenneshub@yahoo.fr			Agence Universitaire de la Francophonie; United Nations Children's Fund; Institut Francophone pour la Medecine Tropicale	Agence Universitaire de la Francophonie; United Nations Children's Fund; Institut Francophone pour la Medecine Tropicale	Funding provided by Agence Universitaire de la Francophonie, the United Nations Children's Fund, Institut Francophone pour la Medecine Tropicale. Funding agencies had no role in the decision of publishing the paper. Opinions expressed in the paper do not represent the opinion of funding agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora S, 2008, PEDIATRICS, V1065, pE67; Barennes H, 2009, EUR J CLIN NUTR, V63, P323, DOI 10.1038/sj.ejcn.1602928; Barennes H, 2008, ARCH DIS CHILD, V953, P222; Barennes H, 2009, BMJ; Barennes H, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1379; Bhutta Z.A., 2008, LANCET, V371, P417, DOI [10.1016/S0140-6736(07)61693-6, DOI 10.1016/S0140-6736(07)61693-6]; Black MM, 2008, LANCET, V371, P454, DOI 10.1016/S0140-6736(08)60215-9; Coutinho SB, 2005, LANCET, V366, P1094, DOI 10.1016/S0140-6736(05)67421-1; Coutsoudis A, 2009, LANCET, V374, P423, DOI 10.1016/S0140-6736(09)60661-9; Foss KA, 2006, INT BREASTFEED J, V1, DOI 10.1186/1746-4358-1-10; Holmes W, 2007, ASIA PAC J CLIN NUTR, V16, P537; IBFAN, 2011, COD ESS 2 GUID POLYC, P1; IBFAN, 2009, INT COD MARK BREAST; Kuhn L, 2008, NEW ENGL J MED, V359, P130, DOI 10.1056/NEJMoa073788; Kuhn L, 2009, CURR OPIN PEDIATR, V21, P83, DOI 10.1097/MOP.0b013e328320d894; Lao voices, 2010, GOV UNICEF LAUNCH EX; Miyoshi M, 2005, EUR J CLIN NUTR, V59, P887, DOI 10.1038/sj.ejcn.1602160; National Statistic Center, 2005, POP CENS; Petrova A, 2007, BREASTFEED MED, V2, P92, DOI 10.1089/bfm.2006.0030; Phimmasone K, 1996, J TROP PEDIATRICS, V42, P5, DOI 10.1093/tropej/42.1.5; Putthakeo P, 2009, J PAEDIATR CHILD H, V45, P487, DOI 10.1111/j.1440-1754.2009.01547.x; Salud MALB, 2009, J HUM LACT, V25, P341, DOI 10.1177/0890334409334605; Sayasone Somphou, 2004, Southeast Asian J Trop Med Public Health, V35 Suppl 2, P50; Slesak G, 2008, MISUSE COFFEE CREAME; Soukaloun D, 2003, ANN TROP PAEDIATR, V23, P181, DOI 10.1179/027249303322296493; Srour LM, 2009, BMJ; Stiegler R, 2009, BMJ; Stiegler R, 2008, BMJ; UNICEF, 2006, MICS3NNS UNICEF; UNICEF, 2006, EXCL BREASTF; UNICEF, 2003, UNICEF GLOB DAT BREA; UNICEF, 2009, UNICEF GLOB DAT BREA; WHO-WORLD HEALTH ORGANIZATION, 2002, OPT DUR EXCL BREASTF; World Food Programme, 2007, LAO PDR COMPR FOOD S	34	33	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e30634	10.1371/journal.pone.0030634	http://dx.doi.org/10.1371/journal.pone.0030634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347392	Green Published, Green Submitted, gold			2022-12-25	WOS:000302730200005
J	Eguchi, M; Kim, YH; Kang, KW; Shim, CY; Jang, Y; Dorval, T; Kim, KJ; Sweeney, G				Eguchi, Megumi; Kim, Young Hwa; Kang, Keon Wook; Shim, Chi Young; Jang, Yangsoo; Dorval, Thierry; Kim, Kwang Joon; Sweeney, Gary			Ischemia-Reperfusion Injury Leads to Distinct Temporal Cardiac Remodeling in Normal versus Diabetic Mice	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; MONOCYTIC FIBROBLAST PRECURSORS; ISCHEMIA/REPERFUSION INJURY; OXIDATIVE STRESS; HEART-FAILURE; AUTOPHAGY; FIBROSIS; MECHANISMS; GLUCOSE; PATHOGENESIS	Diabetes is associated with higher incidence of myocardial infarction (MI) and increased propensity for subsequent events post-MI. Here we conducted a temporal analysis of the influence of diabetes on cardiac dysfunction and remodeling after ischemia reperfusion (IR) injury in mice. Diabetes was induced using streptozotocin and IR performed by ligating the left anterior descending coronary artery for 30 min followed by reperfusion for up to 42 days. We first evaluated changes in cardiac function using echocardiography after 24 hours reperfusion and observed IR injury significantly decreased the systolic function, such as ejection fraction, fractional shortening and end systolic left ventricular volume (LVESV) in both control and diabetic mice. The longitudinal systolic and diastolic strain rate were altered after IR, but there were no significant differences between diabetic mice and controls. However, a reduced ability to metabolize glucose was observed in the diabetic animals as determined by PET-CT scanning using 2-deoxy-2-(F-18) fluoro-D-glucose. Interestingly, after 24 hours reperfusion diabetic mice showed a reduced infarct size and less apoptosis indicated by TUNEL analysis in heart sections. This may be explained by increased levels of autophagy detected in diabetic mice hearts. Similar increases in IR-induced macrophage infiltration detected by CD68 staining indicated no change in inflammation between control and diabetic mice. Over time, control mice subjected to IR developed mild left ventricular dilation whereas diabetic mice exhibited a decrease in both end diastolic left ventricular volume and LVESV with a decreased intraventricular space and thicker left ventricular wall, indicating concentric hypertrophy. This was associated with marked increases in fibrosis, indicted by Masson trichrome staining, of heart sections in diabetic IR group. In summary, we demonstrate that diabetes principally influences distinct IR-induced chronic changes in cardiac function and remodeling, while a smaller infarct size and elevated levels of autophagy with similar cardiac function are observed in acute phase.	[Eguchi, Megumi; Dorval, Thierry; Sweeney, Gary] Inst Pasteur Korea, Seoul, South Korea; [Kim, Young Hwa; Kang, Keon Wook] Seoul Natl Univ, Coll Med, Dept Nucl Med, Seoul, South Korea; [Shim, Chi Young; Jang, Yangsoo] Yonsei Univ, Coll Med, Div Cardiol, Seoul, South Korea; [Kim, Kwang Joon] Yonsei Univ, Coll Med, Div Endocrinol, Seoul, South Korea; [Eguchi, Megumi; Sweeney, Gary] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada	Institut Pasteur Korea; Seoul National University (SNU); Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; York University - Canada	Eguchi, M (corresponding author), Inst Pasteur Korea, Seoul, South Korea.	gsweeney@yorku.ca	Kang, Keon Wook/J-1385-2012; Jang, Yang Soo/D-4803-2012; Shim, Chi Young/AAK-1057-2021	Kang, Keon Wook/0000-0003-2622-9017; Shim, Chi Young/0000-0002-6136-0136; Jang, Yangsoo/0000-0002-2169-3112	Canadian Diabetes Association; National Research Foundation of Korea (NRF); Korea government (MEST) [2011-00244]; Gyeonggi-do; KISTI; Heart and Stroke Foundation of Canada	Canadian Diabetes Association; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Gyeonggi-do; KISTI(Korea Institute of Science & Technology Information (KISTI)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by a Canadian Diabetes Association grant to GS, and by a National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2011-00244), Gyeonggi-do and KISTI. ME was supported by a Heart and Stroke Foundation of Canada postgraduate studentship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2008, PHYSIOL REV, V88, P389, DOI 10.1152/physrev.00017.2007; Aneja A, 2008, AM J MED, V121, P748, DOI 10.1016/j.amjmed.2008.03.046; Aragno M, 2008, ENDOCRINOLOGY, V149, P380, DOI 10.1210/en.2007-0877; Ban CR, 2008, VASC HEALTH RISK MAN, V4, P575; Boudina S, 2009, CIRCULATION, V119, P1272, DOI 10.1161/CIRCULATIONAHA.108.792101; Breckenridge R, 2010, DIS MODEL MECH, V3, P138, DOI 10.1242/dmm.005017; BRODERICK TL, 1993, CIRCULATION, V87, P972, DOI 10.1161/01.CIR.87.3.972; Bugger H, 2009, DIS MODEL MECH, V2, P454, DOI 10.1242/dmm.001941; Carvalho G, 2011, J CLIN ENDOCR METAB, V96, P1469, DOI 10.1210/jc.2010-1934; Cleland JGF, 2005, HEART, V91, P7, DOI 10.1136/hrt.2005.062026; Dahab GM, 2004, J GASTROEN HEPATOL, V19, P78, DOI 10.1111/j.1440-1746.2004.03183.x; FINEGAN BA, 1993, CIRCULATION, V87, P900, DOI 10.1161/01.CIR.87.3.900; Fisher BM, 1997, DIABETOLOGIA, V40, pS127, DOI 10.1007/s001250051427; Flaherty JD, 2005, JAMA-J AM MED ASSOC, V293, P1501, DOI 10.1001/jama.293.12.1501; FOY SG, 1995, EUR HEART J, V16, P770, DOI 10.1093/oxfordjournals.eurheartj.a060995; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Geyer H, 2010, J AM SOC ECHOCARDIOG, V23, P351, DOI 10.1016/j.echo.2010.02.015; Gottlieb RA, 2010, ANNU REV PHYSIOL, V72, P45, DOI 10.1146/annurev-physiol-021909-135757; Gustafsson AB, 2003, J CLIN IMMUNOL, V23, P447, DOI 10.1023/B:JOCI.0000010421.56035.60; Gustafsson AB, 2008, AUTOPHAGY, V4, P416, DOI 10.4161/auto.5655; Hamacher-Brady A, 2006, J BIOL CHEM, V281, P29776, DOI 10.1074/jbc.M603783200; Haudek SB, 2010, J MOL CELL CARDIOL, V49, P499, DOI 10.1016/j.yjmcc.2010.05.005; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kantor PF, 1999, AM J MED SCI, V318, P3, DOI 10.1097/00000441-199907000-00002; Katayama T, 2005, INT HEART J, V46, P607, DOI 10.1536/ihj.46.607; Kofoed KF, 2000, CARDIOVASC RES, V45, P321, DOI 10.1016/S0008-6363(99)00278-3; Kostin S, 2003, CIRC RES, V92, P715, DOI 10.1161/01.RES.0000067471.95890.5C; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li QA, 2010, ACTA CARDIOL, V65, P431, DOI 10.2143/AC.65.4.2053902; LOPASCHUK GD, 1988, CIRC RES, V63, P1036, DOI 10.1161/01.RES.63.6.1036; LOPASCHUK GD, 1990, CIRC RES, V66, P546, DOI 10.1161/01.RES.66.2.546; Lutz J, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-27; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Nishida K, 2009, CELL DEATH DIFFER, V16, P31, DOI 10.1038/cdd.2008.163; PFEFFER MA, 1995, ANNU REV MED, V46, P455, DOI 10.1146/annurev.med.46.1.455; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Ren JY, 2011, AM J HYPERTENS, V24, P701, DOI 10.1038/ajh.2011.42; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; SECHI LA, 1994, DIABETES, V43, P1180, DOI 10.2337/diabetes.43.10.1180; SISLEY AC, 1994, J SURG RES, V57, P192, DOI 10.1006/jsre.1994.1130; Sugimoto S, 2007, AUTOPHAGY, V3, P638, DOI 10.4161/auto.4931; Taha M, 2007, ANN MED, V39, P594, DOI 10.1080/07853890701618305; Verma A, 2007, J AM COLL CARDIOL, V50, P1238, DOI 10.1016/j.jacc.2007.06.018; Verma A, 2008, JACC-CARDIOVASC IMAG, V1, P582, DOI 10.1016/j.jcmg.2008.05.012; WEBER KT, 1991, CIRCULATION, V83, P1849, DOI 10.1161/01.CIR.83.6.1849; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; Yan L, 2005, P NATL ACAD SCI USA, V102, P13807, DOI 10.1073/pnas.0506843102; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	48	32	34	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30450	10.1371/journal.pone.0030450	http://dx.doi.org/10.1371/journal.pone.0030450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347376	Green Published, gold, Green Submitted			2022-12-25	WOS:000302730100011
J	Liu, Q; Chen, P; He, K; Kilpatrick, CW; Liu, SY; Yu, FH; Jiang, XL				Liu, Qi; Chen, Peng; He, Kai; Kilpatrick, C. William; Liu, Shao-Ying; Yu, Fa-Hong; Jiang, Xue-Long			Phylogeographic Study of Apodemus ilex (Rodentia: Muridae) in Southwest China	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; POPULATION-GROWTH; GENETIC CONSEQUENCES; MOLECULAR PHYLOGENY; TIME DEPENDENCY; ICE-AGES; COLONIZATION; DIVERGENCE; SOFTWARE; REFUGIA	Background: The Mountains of southwest China have complex river systems and a profoundly complex topography and are among the most important biodiversity hotspots in the world. However, only a few studies have shed light on how the mountains and river valleys promote genetic diversity. Apodemus ilex is a fine model for investigating this subject. Methodology/Principal Findings: To assess the genetic diversity and biogeographic patterns of Apodemus ilex, the complete cytochrome b gene sequences (1,140 bp) were determined from 203 samples of A. draco/ilex that were collected from southwest China. The results obtained suggested that A. ilex and A. draco are sistergroups and diverged from each other approximately 2.25 million years ago. A. ilex could be divided into Eastern and Western phylogroups, each containing two sub-groups and being widespread in different geographical regions of the southern Hengduan Mountains and the western Yunnan -Guizhou Plateau. The population expansions of A. ilex were roughly from 0.089 Mya to 0.023 Mya. Conclusions: Our result suggested that A. ilex is a valid species rather than synonym of A. draco. As a middle-high elevation inhabitant, the phylogenetic pattern of A. ilex was strongly related to the complex geographical structures in southwest China, particularly the existence of deep river valley systems, such as the Mekong and Salween rivers. Also, it appears that the evolutionary history of A. ilex, such as lineage divergences and population expansions were strongly affected by climate fluctuation in the Late Pleistocene.	[Liu, Qi; Chen, Peng; He, Kai; Jiang, Xue-Long] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Liu, Qi; Chen, Peng; He, Kai] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Kilpatrick, C. William] Univ Vermont, Dept Biol, Burlington, VT USA; [Liu, Shao-Ying] Sichuan Acad Forestry, Chengdu, Peoples R China; [Yu, Fa-Hong] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL USA	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Vermont; State University System of Florida; University of Florida	Liu, Q (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China.	fyu@ufl.edu; jiangxl@mail.kiz.ac.cn	He, Kai/H-3164-2019	He, Kai/0000-0002-6234-2589	National Natural Science Foundation of China [30770251]; National Basic Research Program of China [2007CB411600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (30770251) and the National Basic Research Program of China (2007CB411600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GM, 1938, ANN MUS NAT HIST NEW, V26, P1; An ZS, 1999, SCI CHINA SER D, V42, P258, DOI 10.1007/BF02878963; Assefa A, 2007, HEREDITY, V99, P133, DOI 10.1038/sj.hdy.6800974; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Axelrod D. I., 1998, HIST MODERN FLORA CH, P43; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barrett-Hamilton GEH, 1900, P ZOOL SOC LOND, V1900, P387; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Bettin O, 2007, MOL ECOL, V16, P2517, DOI 10.1111/j.1365-294X.2007.03273.x; Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Chen W, 2011, J ZOOL, V284, P215, DOI 10.1111/j.1469-7998.2011.00797.x; Chen WC, 2010, ZOOL SCI, V27, P487, DOI 10.2108/zsj.27.487; Clark MK, 2004, TECTONICS, V23, DOI 10.1029/2002TC001402; Corbet G.B., 1992, P1; CORBET G. B., 1978, MAMMALS PALAEARCTIC; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fan ZX, 2011, GENETICA, V139, P339, DOI 10.1007/s10709-011-9553-5; Forster P, 2004, PHILOS T R SOC B, V359, P255, DOI 10.1098/rstb.2003.1394; Fu YX, 1997, GENETICS, V147, P915; Gomez A, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P155, DOI 10.1007/1-4020-4904-8_5; Grill A, 2009, MOL ECOL, V18, P2687, DOI 10.1111/j.1365-294X.2009.04215.x; Gu XD, 2009, CONSERV GENET, V10, P1961, DOI 10.1007/s10592-009-9868-2; HARPENDING HC, 1994, HUM BIOL, V66, P591; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Ho SYW, 2007, SYST BIOL, V56, P515, DOI 10.1080/10635150701435401; Ho SYW, 2007, J AVIAN BIOL, V38, P409, DOI 10.1111/j.2007.0908-8857.04168.x; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Holderegger R, 2009, J BIOGEOGR, V36, P476, DOI 10.1111/j.1365-2699.2008.02027.x; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; Jiang Xue-Long, 2000, Zoological Research, V21, P473; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Li BY., 1989, J MOUNTAIN RES, V7, P13; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu XM, 2004, MOL PHYLOGENET EVOL, V33, P1, DOI 10.1016/j.ympev.2004.05.011; Martin-Suarez E, 1998, LETHAIA, V31, P161, DOI 10.1111/j.1502-3931.1998.tb00503.x; MCCORMACK JE, 2009, ENCY ISLANDS, P839; McCormack JE, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-28; Michaux JR, 2003, MOL ECOL, V12, P685, DOI 10.1046/j.1365-294X.2003.01752.x; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Musser G. G., 2005, MAMMAL SPECIES WORLD; Musser G.G., 1996, BONNER ZOOL BEITR, V46, P143; MUSSER GG, 1993, FAMILY MURIDAE, P501; Nesin Valentin A., 2001, Acta Zoologica Cracoviensia, V44, P107; NIXON KC, 1990, CLADISTICS, V6, P211, DOI 10.1111/j.1096-0031.1990.tb00541.x; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; Polzin T, 2002, LECT NOTES COMPUT SC, V2461, P795; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Qu Y, 2010, MOL ECOL, V19, P338, DOI 10.1111/j.1365-294X.2009.04445.x; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Riddle BR, 2000, P NATL ACAD SCI USA, V97, P14438, DOI 10.1073/pnas.250413397; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rull V, 2009, J BIOGEOGR, V36, P481, DOI 10.1111/j.1365-2699.2008.02023.x; Sakka H, 2010, BIOL J LINN SOC, V100, P797, DOI 10.1111/j.1095-8312.2010.01477.x; Sambrook J., 1989, MOL CLONING LAB MANU; Serizawa K, 2002, BIOCHEM GENET, V40, P149, DOI 10.1023/A:1015841424598; Song G, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-143; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stewart JR, 2009, J EVOLUTION BIOL, V22, P2363, DOI 10.1111/j.1420-9101.2009.01859.x; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stewart JR, 2003, SCIENCE, V299, P825; Suzuki H, 2003, BIOL J LINN SOC, V80, P469, DOI 10.1046/j.1095-8312.2003.00253.x; Suzuki H, 2008, BIOCHEM GENET, V46, P329, DOI 10.1007/s10528-008-9149-7; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomas O., 1922, Annals & Magazine of Natural History, V10, P391; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thompson LG, 1997, SCIENCE, V276, P1821, DOI 10.1126/science.276.5320.1821; WRIGHT S, 1978, P580; Wu CH, 2000, BIOCHEM GENET, V38, P149; Wu FY, 2008, ACTA PETROL SIN, V24, P1; Wu YQ, 2001, GEOMORPHOLOGY, V36, P203, DOI 10.1016/S0169-555X(00)00057-X; XIA W, 1984, Acta Theriologica Sinica, V4, P93; Yamada K, 2005, PALAEOGEOGR PALAEOCL, V220, P255, DOI 10.1016/j.palaeo.2005.01.006; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; [姚永慧 Yao Yonghui], 2010, [山地学报, Journal of Mountain Science], V28, P11; Yuan SL, 2006, MOL ECOL, V15, P2119, DOI 10.1111/j.1365-294X.2006.02875.x; Zhang DR, 2010, MOL ECOL, V19, P3406, DOI 10.1111/j.1365-294X.2010.04747.x; Zhang MW, 2010, MOL PHYLOGENET EVOL, V54, P47, DOI 10.1016/j.ympev.2009.10.019; Zhang R. Z., 1999, ZOOGEOGRAPHY CHINA; Zhang Rong-Zu (Yong-Zu), 2002, Acta Zoologica Sinica, V48, P141; Zhao E., 1997, AMPHIBIANS REPTILES; [赵希涛 ZHAO Xitao], 2007, [地质通报, Geological Bulletin of China], V26, P960; [赵希涛 Zhao Xitao], 2007, [第四纪研究, Quaternary Sciences], V27, P35	94	28	37	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31453	10.1371/journal.pone.0031453	http://dx.doi.org/10.1371/journal.pone.0031453			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347481	Green Published, gold, Green Submitted			2022-12-25	WOS:000302180600037
J	Powell, E; Shanle, E; Brinkman, A; Li, J; Keles, S; Wisinski, KB; Huang, W; Xu, W				Powell, Emily; Shanle, Erin; Brinkman, Ashley; Li, Jun; Keles, Sunduz; Wisinski, Kari B.; Huang, Wei; Xu, Wei			Identification of Estrogen Receptor Dimer Selective Ligands Reveals Growth-Inhibitory Effects on Cells That Co-Express ER alpha and ER beta	PLOS ONE			English	Article							BREAST-CANCER CELLS; RED-CLOVER ISOFLAVONES; HUMAN PROSTATE-CANCER; GENE-EXPRESSION; QUANTITATIVE-ANALYSIS; MESSENGER-RNA; WILD-TYPE; PROLIFERATION; TAMOXIFEN; HETERODIMERS	Estrogens play essential roles in the progression of mammary and prostatic diseases. The transcriptional effects of estrogens are transduced by two estrogen receptors, ER alpha and ER beta, which elicit opposing roles in regulating proliferation: ER alpha is proliferative while ER beta is anti-proliferative. Exogenous expression of ER beta in ER alpha-positive cancer cell lines inhibits cell proliferation in response to estrogen and reduces xenografted tumor growth in vivo, suggesting that ER beta might oppose ER alpha's proliferative effects via formation of ER alpha/beta heterodimers. Despite biochemical and cellular evidence of ER alpha/beta heterodimer formation in cells co-expressing both receptors, the biological roles of the ER alpha/beta heterodimer remain to be elucidated. Here we report the identification of two phytoestrogens that selectively activate ER alpha/beta heterodimers at specific concentrations using a cell-based, two-step high throughput small molecule screen for ER transcriptional activity and ER dimer selectivity. Using ER alpha/beta heterodimer-selective ligands at defined concentrations, we demonstrate that ER alpha/beta heterodimers are growth inhibitory in breast and prostate cells which co-express the two ER isoforms. Furthermore, using Automated Quantitative Analysis (AQUA) to examine nuclear expression of ER alpha and ER beta in human breast tissue microarrays, we demonstrate that ER alpha and ER beta are co-expressed in the same cells in breast tumors. The co-expression of ER alpha and ER beta in the same cells supports the possibility of ER alpha/beta heterodimer formation at physio- and pathological conditions, further suggesting that targeting ER alpha/beta heterodimers might be a novel therapeutic approach to the treatment of cancers which co-express ER alpha and ER beta.	[Powell, Emily; Shanle, Erin; Brinkman, Ashley; Li, Jun; Xu, Wei] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; [Keles, Sunduz] Univ Wisconsin, Dept Stat, Madison, WI 53706 USA; [Keles, Sunduz] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA; [Wisinski, Kari B.] Univ Wisconsin, Sch Med & Publ Hlth, UW Carbone Canc Ctr, Madison, WI USA; [Huang, Wei] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Powell, E (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.	wxu@oncology.wisc.edu			National Institutes of Health [R01125387, T32ES007015, T32 CA009135]; NIH/NCI [P30CA014520]; NATIONAL CANCER INSTITUTE [P30CA014520, R01CA125387, T32CA009135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work is supported by National Institutes of Health grants R01125387, T32ES007015, T32 CA009135 and in part by NIH/NCI P30CA014520 - University of Wisconsin Comprehensive Cancer Center Support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherne SA, 2002, NUTRITION, V18, P75, DOI 10.1016/S0899-9007(01)00695-5; Chang EC, 2008, MOL ENDOCRINOL, V22, P1032, DOI 10.1210/me.2007-0356; Chang EC, 2006, ENDOCRINOLOGY, V147, P4831, DOI 10.1210/en.2006-0563; Cowley SM, 1997, J BIOL CHEM, V272, P19858, DOI 10.1074/jbc.272.32.19858; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Forster C, 2002, P NATL ACAD SCI USA, V99, P15578, DOI 10.1073/pnas.192561299; Frasor J, 2006, CANCER RES, V66, P7334, DOI 10.1158/0008-5472.CAN-05-4269; FUCHS J, 1993, ARZNEIMITTELFORSCH, V43-1, P370; Grober OMV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-36; Gustavson MD, 2009, APPL IMMUNOHISTO M M, V17, P329, DOI 10.1097/PAI.0b013e318195ecaa; Heinonen SM, 2004, J AGR FOOD CHEM, V52, P6802, DOI 10.1021/jf0492767; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Helguero LA, 2005, ONCOGENE, V24, P6605, DOI 10.1038/sj.onc.1208807; Hewitt SC, 2005, ANNU REV PHYSIOL, V67, P285, DOI 10.1146/annurev.physiol.67.040403.115914; Imamov O, 2004, P NATL ACAD SCI USA, V101, P9375, DOI 10.1073/pnas.0403041101; Iwao K, 2000, CANCER, V89, P1732, DOI 10.1002/1097-0142(20001015)89:8<1732::AID-CNCR13>3.0.CO;2-2; Iwao K, 2000, INT J CANCER, V88, P733, DOI 10.1002/1097-0215(20001201)88:5<733::AID-IJC8>3.0.CO;2-M; Jarvinen TAH, 2000, AM J PATHOL, V156, P29, DOI 10.1016/S0002-9440(10)64702-5; Jones SB, 2005, CANCER EPIDEM BIOMAR, V14, P596, DOI 10.1158/1055-9965.EPI-04-0398; Ju YH, 2006, CARCINOGENESIS, V27, P1292, DOI 10.1093/carcin/bgi370; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Lau KM, 2000, CANCER RES, V60, P3175; Lazennec G, 2001, ENDOCRINOLOGY, V142, P4120, DOI 10.1210/en.142.9.4120; Lee MM, 2003, CANCER EPIDEM BIOMAR, V12, P665; Lindberg MK, 2003, MOL ENDOCRINOL, V17, P203, DOI 10.1210/me.2002-0206; McPherson SJ, 2007, ERNST SCHERING FOUND, V1, P131, DOI 10.1007/2789_2006_020; Mentor-Marcel R, 2005, J NUTR, V135, P989, DOI 10.1093/jn/135.5.989; Monroe DG, 2005, MOL ENDOCRINOL, V19, P1555, DOI 10.1210/me.2004-0381; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murphy LC, 2005, J MOL ENDOCRINOL, V34, P553, DOI 10.1677/jme.1.01688; Nilsson S, 2011, CLIN PHARMACOL THER, V89, P44, DOI 10.1038/clpt.2010.226; Omoto Y, 2001, CANCER LETT, V163, P207, DOI 10.1016/S0304-3835(00)00680-7; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Peeters PHM, 2003, BREAST CANCER RES TR, V77, P171, DOI 10.1023/A:1021381101632; Pettersson K, 1997, MOL ENDOCRINOL, V11, P1486, DOI 10.1210/me.11.10.1486; Pettersson K, 2000, ONCOGENE, V19, P4970, DOI 10.1038/sj.onc.1203828; Pfitscher A, 2008, J STEROID BIOCHEM, V112, P87, DOI 10.1016/j.jsbmb.2008.08.007; Powell E, 2010, BIOCHEM PHARMACOL, V80, P1221, DOI 10.1016/j.bcp.2010.06.030; Powell E, 2008, P NATL ACAD SCI USA, V105, P19012, DOI 10.1073/pnas.0807274105; Ricke WA, 2008, FASEB J, V22, P1512, DOI 10.1096/fj.07-9526com; Roger P, 2001, CANCER RES, V61, P2537; Rousseau C, 2004, MOL CANCER RES, V2, P523; Saji S, 2005, CANCER CHEMOTH PHARM, V56, pS21, DOI 10.1007/s0028-005-0107-3; Shoker BS, 1999, J PATHOL, V188, P237; Skliris GP, 2001, BRIT J CANCER, V84, P1095, DOI 10.1054/bjoc.2001.1721; Stossi F, 2004, ENDOCRINOLOGY, V145, P3473, DOI 10.1210/en.2003-1682; Strom A, 2004, P NATL ACAD SCI USA, V101, P1566, DOI 10.1073/pnas.0308319100; Sugiura H, 2007, JPN J CLIN ONCOL, V37, P820, DOI 10.1093/jjco/hym114; Tremblay GB, 1999, MOL CELL BIOL, V19, P1919; Wang HK, 1998, ADV EXP MED BIOL, V439, P191; Warren M, 2009, APPL IMMUNOHISTO M M, V17, P23, DOI 10.1097/PAI.0b013e31817c3334; Williams C, 2008, ONCOGENE, V27, P1019, DOI 10.1038/sj.onc.1210712; Wilson VS, 2004, TOXICOL SCI, V81, P69, DOI 10.1093/toxsci/kfh180; Wu XL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2844; Wu XL, 2009, CANCER RES, V69, P1722, DOI 10.1158/0008-5472.CAN-08-3933; Zhu XG, 2004, AM J PATHOL, V164, P2003, DOI 10.1016/S0002-9440(10)63760-1	56	53	56	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e30993	10.1371/journal.pone.0030993	http://dx.doi.org/10.1371/journal.pone.0030993			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347418	Green Published, gold, Green Submitted			2022-12-25	WOS:000302180600020
J	Fukada, M; Hanai, A; Nakayama, A; Suzuki, T; Miyata, N; Rodriguiz, RM; Wetsel, WC; Yao, TP; Kawaguchi, Y				Fukada, Masahide; Hanai, Atsuko; Nakayama, Atsuo; Suzuki, Takayoshi; Miyata, Naoki; Rodriguiz, Ramona M.; Wetsel, William C.; Yao, Tso-Pang; Kawaguchi, Yoshiharu			Loss of Deacetylation Activity of Hdac6 Affects Emotional Behavior in Mice	PLOS ONE			English	Article							RAPHE NUCLEUS; X-CHROMOSOME; IN-VIVO; ACETYLATION; TUBULIN; HISTONE-DEACETYLASE-6; MICROTUBULES; AUTOPHAGY; RECEPTOR; PROJECTIONS	Acetylation is mediated by acetyltransferases and deacetylases, and occurs not only on histones but also on diverse proteins. Although histone acetylation in chromatin structure and transcription has been well studied, the biological roles of non-histone acetylation remain elusive. Histone deacetylase 6 (Hdac6), a member of the histone deacetylase (HDAC) family, is a unique deacetylase that localizes to cytoplasm and functions in many cellular events by deacetylating non-histone proteins including alpha-tubulin, Hsp90, and cortactin. Since robust expression of Hdac6 is observed in brain, it would be expected that Hdac6-mediated reversible acetylation plays essential roles in CNS. Here we demonstrate the crucial roles of Hdac6 deacetylase activity in the expression of emotional behavior in mice. We found that Hdac6-deficient mice exhibit hyperactivity, less anxiety, and antidepressant-like behavior in behavioral tests. Moreover, administration of Hdac6-specific inhibitor replicated antidepressant-like behavior in mice. In good agreement with behavioral phenotypes of Hdac6-deficient mice, Hdac6 dominantly localizes to the dorsal and median raphe nuclei, which are involved in emotional behaviors. These findings suggest that HDAC6-mediated reversible acetylation might contribute to maintain proper neuronal activity in serotonergic neurons, and also provide a new therapeutic target for depression.	[Fukada, Masahide; Hanai, Atsuko; Nakayama, Atsuo; Kawaguchi, Yoshiharu] Aichi Human Serv Ctr, Inst Dev Res, Dept Embryol, Kasugai, Aichi, Japan; [Suzuki, Takayoshi; Miyata, Naoki] Nagoya City Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi, Japan; [Rodriguiz, Ramona M.; Wetsel, William C.] Duke Univ, Med Ctr, Mouse Behav & Neuroendocrine Anal Core Facil, Durham, NC USA	Nagoya City University; Duke University	Fukada, M (corresponding author), Aichi Human Serv Ctr, Inst Dev Res, Dept Embryol, Kasugai, Aichi, Japan.	kawag001@inst-hsc.jp			KAKENHI [22700408, 21500364]; Takeda Science Foundation; The Sumitomo Foundation; NOVARTIS Foundation for the Promotion of Science; Grants-in-Aid for Scientific Research [24659050] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); The Sumitomo Foundation; NOVARTIS Foundation for the Promotion of Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	KAKENHI (22700408, MF; 21500364, YK) www.jsps.go.jp/j-grantsinaid/index.html; Takeda Science Foundation (YK) www.takeda-sci.or.jp; The Sumitomo Foundation (YK) www.sumitomo.or.jp; The NOVARTIS Foundation for the Promotion of Science (YK) novartisfound.or.jp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Convington HE, 2009, J NEUROSCI, V37, P11451; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Fukada M, 2005, METHODS, V35, P54, DOI 10.1016/j.ymeth.2004.07.008; Gao YS, 2007, MOL CELL BIOL, V27, P8637, DOI 10.1128/MCB.00393-07; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Itoh Y, 2007, J MED CHEM, V50, P5425, DOI 10.1021/jm7009217; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Mahlknecht U, 2001, CYTOGENET CELL GENET, V93, P135, DOI 10.1159/000056967; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Means GD, 2000, GENOMICS, V65, P213, DOI 10.1006/geno.2000.6173; Nozawa RS, 2010, NAT CELL BIOL, V12, P719, DOI 10.1038/ncb2075; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; SAPOLSKY RM, 1990, NEUROENDOCRINOLOGY, V51, P328, DOI 10.1159/000125357; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Vertes RP, 1999, J COMP NEUROL, V407, P555; VERTES RP, 1991, J COMP NEUROL, V313, P643, DOI 10.1002/cne.903130409; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; YOUNG EA, 1991, ARCH GEN PSYCHIAT, V48, P693; Zhang XD, 2004, SCIENCE, V305, P217, DOI 10.1126/science.1097540; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06	29	90	95	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e30924	10.1371/journal.pone.0030924	http://dx.doi.org/10.1371/journal.pone.0030924			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328923	gold, Green Published, Green Submitted			2022-12-25	WOS:000302179300009
J	Walsh, MG				Walsh, Michael G.			The Role of Hydrogeography and Climate in the Landscape Epidemiology of West Nile Virus in New York State from 2000 to 2010	PLOS ONE			English	Article							MOSQUITO VECTORS; LAND-USE; ABUNDANCE; OUTBREAKS; DENSITY; DISEASE; COUNTY; COVER	The epidemiology and ecology of West Nile virus (WNV) have not yet been completely described. In particular, the specific roles of climate and water in the landscape in the occurrence of human WNV cases remain unknown. This study used Poisson regression to describe the relationships between WNV cases and temperature, precipitation, and the hydrogeography of the landscape in New York State from 2000 to 2010. Fully adjusted models showed that hydrogeographic area was significantly inversely associated with WNV cases (incidence rate ratio (IRR) = 0.99; 95% C.I. = 0.98-0.997, p = 0.04), such that each one square kilometer increase in hydrogeographic area was associated with a 1% decrease in WNV incidence. This association was independent of both temperature, which was also associated with WNV incidence (IRR = 2.06; 95% C.I. = 1.84-2.31, p < 0.001), and precipitation, which was not (IRR = 1.0; 95% C.I. = 0.99-1.01, p = 0.16). While the results are only suggestive due to the county-level aggregated data, these findings do identify a potentially important surveillance signal in the landscape epidemiology of WNV infection.	SUNY, Sch Publ Hlth, Dept Epidemiol & Biostat, New York, NY 13902 USA	State University of New York (SUNY) System; SUNY Community College; SUNY Maritime College; SUNY Optometry	Walsh, MG (corresponding author), SUNY, Sch Publ Hlth, Dept Epidemiol & Biostat, New York, NY 13902 USA.	michael.walsh@downstate.edu		Walsh, Michael/0000-0002-6441-3635				Allan BF, 2009, OECOLOGIA, V158, P699, DOI 10.1007/s00442-008-1169-9; Bowden SE, 2011, AM J TROP MED HYG, V84, P234, DOI 10.4269/ajtmh.2011.10-0134; Carpenter SJ, 1955, MOSQUITOES N AM N ME; Chase JM, 2003, ECOL LETT, V6, P1017, DOI 10.1046/j.1461-0248.2003.00533.x; Cooke William H 3rd, 2006, Int J Health Geogr, V5, P36, DOI 10.1186/1476-072X-5-36; Deichmeister JM, 2011, J VECTOR ECOL, V36, P75, DOI 10.1111/j.1948-7134.2011.00143.x; Diuk-Wasser MA, 2006, VECTOR-BORNE ZOONOT, V6, P283, DOI 10.1089/vbz.2006.6.283; Eidson M, 2005, EMERG INFECT DIS, V11, P1370; Gotham I J, 2001, J Public Health Manag Pract, V7, P75; Horsfall WR, 1955, MOSQUITOES THEIR BIO, P564; Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505; Irwin P, 2008, ECOHEALTH, V5, P49, DOI 10.1007/s10393-007-0152-y; Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010; Liu H, 2009, ENVIRON MONIT ASSESS, V159, P143, DOI 10.1007/s10661-008-0618-6; Miramontes R, 2006, AM J PREV MED, V30, P160, DOI 10.1016/j.amepre.2005.10.008; Ozdenerol E, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-12; Petersen LR, 2008, MED CLIN N AM, V92, P1307, DOI 10.1016/j.mcna.2008.07.004; Rochlin I, 2008, J MED ENTOMOL, V45, P563, DOI 10.1603/0022-2585(2008)45[563:CAODAA]2.0.CO;2; Soverow JE, 2009, ENVIRON HEALTH PERSP, V117, P1049, DOI 10.1289/ehp.0800487; Sugumaran R, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-43; Wang GM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-38	21	10	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e30620	10.1371/journal.pone.0030620	http://dx.doi.org/10.1371/journal.pone.0030620			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328919	gold, Green Published, Green Submitted			2022-12-25	WOS:000302179300005
J	Heaton, BE; Herrou, J; Blackwell, AE; Wysocki, VH; Crosson, S				Heaton, Brook E.; Herrou, Julien; Blackwell, Anne E.; Wysocki, Vicki H.; Crosson, Sean			Molecular Structure and Function of the Novel BrnT/BrnA Toxin-Antitoxin System of Brucella abortus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING SITES; ESCHERICHIA-COLI; MULTIDRUG TOLERANCE; YOEB TOXIN; F-PLASMID; YEFM-YOEB; PROTEIN; TRANSLATION; EXPRESSION; DEATH	Type II toxin-antitoxin (TA) systems are expressed from two-gene operons that encode a cytoplasmic protein toxin and its cognate protein antitoxin. These gene cassettes are often present in multiple copies on bacterial chromosomes, where they have been reported to regulate stress adaptation and persistence during antimicrobial treatment. We have identified a novel type II TA cassette in the intracellular pathogen Brucella abortus that consists of the toxin gene, brnT, and its antitoxin, brnA. BrnT is coexpressed and forms a 2: 2 tetrameric complex with BrnA, which neutralizes BrnT toxicity. The BrnT2-BrnA2 tetramer binds its own promoter via BrnA, and autorepresses its expression; its transcription is strongly induced in B. abortus by various stressors encountered by the bacterial cell during infection of a mammalian host. Although highly divergent at the primary sequence level, an atomic resolution (1.1 angstrom) crystal structure of BrnT reveals a secondary topology related to the RelE family of type II ribonuclease toxins. However, overall tertiary structural homology to other RelE family toxins is low. A functional characterization of BrnT by site-directed mutagenesis demonstrates a correspondence between its in vitro activity as a ribonuclease and control of bacteriostasis in vivo. We further present an analysis of the conserved and variable features of structure required for RNA scission in BrnT and the RelE toxin family. This structural investigation informs a model of the RelE-fold as an evolutionarily flexible scaffold that has been selected to bind structurally disparate antitoxins, and exhibit distinct toxin activities including RNA scission and DNA gyrase inhibition.	[Heaton, Brook E.; Crosson, Sean] Univ Chicago, Comm Microbiol, Chicago, IL 60637 USA; [Herrou, Julien] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Heaton, Brook E.; Crosson, Sean] Argonne Natl Lab, Howard T Ricketts Lab, Argonne, IL 60439 USA; [Blackwell, Anne E.; Wysocki, Vicki H.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA	University of Chicago; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; University of Arizona	Crosson, S (corresponding author), 929 E 57th St,GCIS W138, Chicago, IL 60637 USA.	scrosson@uchicago.edu	Crosson, Sean/AAE-2453-2022; Pacific-Southwest, RCE/B-6155-2009	Crosson, Sean/0000-0002-1727-322X; Herrou, Julien/0000-0002-8585-8043; Wysocki, Vicki/0000-0003-0495-2538	National Institutes of Health [1-U54-AI-057153]; National Science Foundation MRI; Pacific Southwest Regional Center for Excellence [1U54-AI-065359]; National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153, U54AI065359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation MRI(National Science Foundation (NSF)); Pacific Southwest Regional Center for Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1-U54-AI-057153 to the Region V "Great Lakes" Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (GLRCE) from the NIAID (to S. C.), by a National Science Foundation MRI grant for development of the custom tandem mass spectrometer, and the Pacific Southwest Regional Center for Excellence Grant 1U54-AI-065359 (to V. H. W.).; Supported by an National Science Foundation Graduate Research Fellowship.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; ANDERSON TD, 1986, VET PATHOL, V23, P219, DOI 10.1177/030098588602300301; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bailey SES, 2009, J BACTERIOL, V191, P762, DOI 10.1128/JB.01331-08; Bauerova-Hlinkova V, 2009, FEBS J, V276, P4156, DOI 10.1111/j.1742-4658.2009.07125.x; Blower TR, 2011, CURR OPIN STRUC BIOL, V21, P109, DOI 10.1016/j.sbi.2010.10.009; Brown BL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000706; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Christensen SK, 2003, J MOL BIOL, V332, P809, DOI 10.1016/S0022-2836(03)00922-7; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Dauter Z, 2002, ACTA CRYSTALLOGR D, V58, P1958, DOI 10.1107/S0907444902016645; Donegan NP, 2010, J BACTERIOL, V192, P1416, DOI 10.1128/JB.00233-09; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fiebig A, 2010, MOL MICROBIOL, V77, P236, DOI 10.1111/j.1365-2958.2010.07207.x; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; GERDES K, 1985, J BACTERIOL, V161, P292, DOI 10.1128/JB.161.1.292-298.1985; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hayes F, 2011, CRIT REV BIOCHEM MOL, V46, P386, DOI 10.3109/10409238.2011.600437; Hazan R, 2004, J BACTERIOL, V186, P3663, DOI 10.1128/JB.186.11.3663-3669.2004; HEINEMANN U, 1983, J BIOMOL STRUCT DYN, V1, P523, DOI 10.1080/07391102.1983.10507459; JAFFE A, 1985, J BACTERIOL, V163, P841; JIANG XS, 1993, CELL IMMUNOL, V151, P309, DOI 10.1006/cimm.1993.1241; Jiang Y, 2002, MOL MICROBIOL, V44, P971, DOI 10.1046/j.1365-2958.2002.02921.x; Jorgensen MG, 2009, J BACTERIOL, V191, P1191, DOI 10.1128/JB.01013-08; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Kedzierska B, 2007, NUCLEIC ACIDS RES, V35, P325, DOI 10.1093/nar/gkl1028; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Khan SR, 2008, APPL ENVIRON MICROB, V74, P5053, DOI 10.1128/AEM.01098-08; Kohler S, 2003, TRENDS MICROBIOL, V11, P215, DOI 10.1016/S0966-842X(03)00078-7; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LEHNHERR H, 1995, P NATL ACAD SCI USA, V92, P3274, DOI 10.1073/pnas.92.8.3274; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Lioy VS, 2006, MICROBIOL-SGM, V152, P2365, DOI 10.1099/mic.0.28950-0; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-19; MAKI S, 1992, J BIOL CHEM, V267, P12244; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Moreno E, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P315, DOI 10.1007/0-387-30745-1_17; MOYED HS, 1983, J BACTERIOL, V155, P768, DOI 10.1128/JB.155.2.768-775.1983; Murakami Y, 2010, NUCLEIC ACIDS RES, V38, pW412, DOI 10.1093/nar/gkq474; Mutschler H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001033; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Porte F, 1999, INFECT IMMUN, V67, P4041, DOI 10.1128/IAI.67.8.4041-4047.1999; Roop RM, 2009, MED MICROBIOL IMMUN, V198, P221, DOI 10.1007/s00430-009-0123-8; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; SEVCIK J, 1993, EUR J BIOCHEM, V216, P301, DOI 10.1111/j.1432-1033.1993.tb18145.x; TANFORD C, 1967, J AM CHEM SOC, V89, P5023, DOI 10.1021/ja00995a034; Terribilini M, 2007, NUCLEIC ACIDS RES, V35, pW578, DOI 10.1093/nar/gkm294; Tian QB, 1996, BIOCHEM BIOPH RES CO, V225, P679, DOI 10.1006/bbrc.1996.1229; TSUCHIMOTO S, 1992, J BACTERIOL, V174, P4205, DOI 10.1128/JB.174.13.4205-4211.1992; Van Melderen L, 2010, CURR OPIN MICROBIOL, V13, P781, DOI 10.1016/j.mib.2010.10.006; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; VANMELDEREN L, 1994, MOL MICROBIOL, V11, P1151; Wang LJ, 2006, NUCLEIC ACIDS RES, V34, pW243, DOI 10.1093/nar/gkl298; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; Winther KS, 2011, P NATL ACAD SCI USA, V108, P7403, DOI 10.1073/pnas.1019587108; Yakovlev GI, 2003, PROTEIN SCI, V12, P2367, DOI 10.1110/ps.03176803; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; Yuan J, 2011, J BACTERIOL, V193, P611, DOI 10.1128/JB.01185-10	67	41	44	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12098	12110		10.1074/jbc.M111.332163	http://dx.doi.org/10.1074/jbc.M111.332163			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334680	hybrid, Green Published			2022-12-25	WOS:000302782200046
J	Ishizaka, A; Mizutani, T; Kobayashi, K; Tando, T; Sakurai, K; Fujiwara, T; Iba, H				Ishizaka, Aya; Mizutani, Taketoshi; Kobayashi, Kazuyoshi; Tando, Toshio; Sakurai, Kouhei; Fujiwara, Toshinobu; Iba, Hideo			Double Plant Homeodomain (PHD) Finger Proteins DPF3a and-3b Are Required as Transcriptional Co-activators in SWI/SNF Complex-dependent Activation of NF-kappa B RelA/p50 Heterodimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN REMODELING COMPLEX; D4 GENE FAMILY; EXPRESSION; CELLS; CANCER; SUBUNIT; BRM; PHOSPHORYLATION; INFLAMMATION; HOMODIMER	We have previously shown that DPF2 (requiem/REQ) functions as a linker protein between the SWI/SNF complex and RelB/p52 NF-kappa B heterodimer and plays important roles in NF-kappa B transactivation via its noncanonical pathway. Using sensitive 293FT reporter cell clones that had integrated a SWI/SNF-dependent NF-kappa B reporter gene, we find in this study that the overexpression of DPF1, DPF2, DPF3a, DPF3b, and PHF10 significantly potentiates the transactivating activity of typical NF-kappa B dimers. Knockdown analysis using 293FT reporter cells that endogenously express these five proteins at low levels clearly showed that DPF3a and DPF3b, which are produced from the DPF3 gene by alternative splicing, are the most critical for the RelA/p50 NF-kappa B heterodimer transactivation induced by TNF-alpha stimulation. Our data further show that this transactivation requires the SWI/SNF complex. DPF3a and DPF3b are additionally shown to interact directly with RelA, p50, and several subunits of the SWI/SNF complex in vitro and to be co-immunoprecipitated with RelA/p50 and the SWI/SNF complex from the nuclear fractions of cells treated with TNF-alpha. In ChIP experiments, we further found that endogenous DPF3a/b and the SWI/SNF complex are continuously present on HIV-1 LTR, whereas the kinetics of RelA/p50 recruitment after TNF-alpha treatment correlate well with the viral transcriptional activation levels. Additionally, re-ChIP experiments showed DPF3a/b and the SWI/SNF complex associate with RelA on the endogenous IL-6 promoter after TNF-alpha treatment. In conclusion, our present data indicate that by linking RelA/p50 to the SWI/SNF complex, DPF3a/b induces the transactivation of NF-kappa B target gene promoters in relatively inactive chromatin contexts.	[Ishizaka, Aya; Mizutani, Taketoshi; Kobayashi, Kazuyoshi; Tando, Toshio; Sakurai, Kouhei; Iba, Hideo] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Host Parasite Interact,Minato Ku, Tokyo 1088639, Japan; [Mizutani, Taketoshi] Japan Sci & Technol Agcy, PRESTO, RNA & Biofunct, Kawaguchi, Saitama 3320012, Japan; [Fujiwara, Toshinobu] Inst Microbial Chem, Lab Dis Biol, Shinagawa Ku, Tokyo 1410021, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Iba, H (corresponding author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Host Parasite Interact,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	iba@ims.u-tokyo.ac.jp		Mizutani, Taketoshi/0000-0002-1329-6512; Ishizaka, Aya/0000-0003-2800-2430	Ministry of Education, Culture, Sports, Science and Technology, Japan [17016015, 22300318, 21590507]; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [21590507, 22115511] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research on Priority Areas 17016015 and for Scientific Research (B) 22300318 and (C) 21590507 from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and by a grant from the Japan Society for the Promotion of Science.	Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; BUCHMAN VL, 1992, NUCLEIC ACIDS RES, V20, P5579, DOI 10.1093/nar/20.21.5579; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Cheng SWG, 1999, NAT GENET, V22, P102, DOI 10.1038/8811; Chestkov AV, 1996, GENOMICS, V36, P174, DOI 10.1006/geno.1996.0440; GABIG TG, 1994, J BIOL CHEM, V269, P29515; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Iba H, 2003, REV MED VIROL, V13, P99, DOI 10.1002/rmv.378; Ito T, 2001, J BIOL CHEM, V276, P2852, DOI 10.1074/jbc.M009633200; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; Lange M, 2008, GENE DEV, V22, P2370, DOI 10.1101/gad.471408; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Mizutani T, 2002, J BIOL CHEM, V277, P15859, DOI 10.1074/jbc.M112421200; Mizutani T, 2009, J VIROL, V83, P11569, DOI 10.1128/JVI.00742-09; Muchardt C, 1999, J MOL BIOL, V293, P187, DOI 10.1006/jmbi.1999.2999; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Ninkina NN, 2001, MAMM GENOME, V12, P862, DOI 10.1007/s00335-001-3039-1; Pereira LA, 2000, NUCLEIC ACIDS RES, V28, P663, DOI 10.1093/nar/28.3.663; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Rohr O, 2003, J LEUKOCYTE BIOL, V74, P736, DOI 10.1189/jlb.0403180; Santoro MG, 2003, EMBO J, V22, P2552, DOI 10.1093/emboj/cdg267; Satou R, 2010, AM J PHYSIOL-CELL PH, V299, pC750, DOI 10.1152/ajpcell.00078.2010; Schmitz ML, 2004, CHEMBIOCHEM, V5, P1348, DOI 10.1002/cbic.200400144; Stevens M, 2006, MED RES REV, V26, P595, DOI 10.1002/med.20081; Tando T, 2010, J BIOL CHEM, V285, P21951, DOI 10.1074/jbc.M109.087783; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Watanabe H, 2006, ONCOGENE, V25, P470, DOI 10.1038/sj.onc.1209068; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wu ZZ, 2011, BIOCHEM PHARMACOL, V82, P1860, DOI 10.1016/j.bcp.2011.09.010; Yamamichi N, 2009, EXP CELL RES, V315, P1779, DOI 10.1016/j.yexcr.2009.01.006; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	38	25	25	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11924	11933		10.1074/jbc.M111.322792	http://dx.doi.org/10.1074/jbc.M111.322792			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334708	hybrid, Green Published			2022-12-25	WOS:000302782200031
J	Andrade, LH; Wang, YP; Andreoni, S; Silveira, CM; Alexandrino-Silva, C; Siu, ER; Nishimura, R; Anthony, JC; Gattaz, WF; Kessler, RC; Viana, MC				Andrade, Laura Helena; Wang, Yuan-Pang; Andreoni, Solange; Silveira, Camila Magalhaes; Alexandrino-Silva, Clovis; Siu, Erica Rosanna; Nishimura, Raphael; Anthony, James C.; Gattaz, Wagner Farid; Kessler, Ronald C.; Viana, Maria Carmen			Mental Disorders in Megacities: Findings from the Sao Paulo Megacity Mental Health Survey, Brazil	PLOS ONE			English	Article							DSM-IV DISORDERS; PSYCHIATRIC MORBIDITY; 12-MONTH PREVALENCE; GENERAL-POPULATION; CATCHMENT-AREA; SERVICE USE; UNMET NEED; SEVERITY; ORGANIZATION; COMORBIDITY	Background: World population growth is projected to be concentrated in megacities, with increases in social inequality and urbanization-associated stress. Sao Paulo Metropolitan Area (SPMA) provides a forewarning of the burden of mental disorders in urban settings in developing world. The aim of this study is to estimate prevalence, severity, and treatment of recently active DSM-IV mental disorders. We examined socio-demographic correlates, aspects of urban living such as internal migration, exposure to violence, and neighborhood-level social deprivation with 12-month mental disorders. Methods and Results: A representative cross-sectional household sample of 5,037 adults was interviewed face-to-face using the WHO Composite International Diagnostic Interview (CIDI), to generate diagnoses of DSM-IV mental disorders within 12 months of interview, disorder severity, and treatment. Administrative data on neighborhood social deprivation were gathered. Multiple logistic regression was used to evaluate individual and contextual correlates of disorders, severity, and treatment. Around thirty percent of respondents reported a 12-month disorder, with an even distribution across severity levels. Anxiety disorders were the most common disorders (affecting 19.9%), followed by mood (11%), impulse-control (4.3%), and substance use (3.6%) disorders. Exposure to crime was associated with all four types of disorder. Migrants had low prevalence of all four types compared to stable residents. High urbanicity was associated with impulse-control disorders and high social deprivation with substance use disorders. Vulnerable subgroups were observed: women and migrant men living in most deprived areas. Only one-third of serious cases had received treatment in the previous year. Discussion: Adults living in Sao Paulo megacity had prevalence of mental disorders at greater levels than similar surveys conducted in other areas of the world. Integration of mental health promotion and care into the rapidly expanding Brazilian primary health system should be strengthened. This strategy might become a model for poorly resourced and highly populated developing countries.	[Andrade, Laura Helena; Wang, Yuan-Pang; Silveira, Camila Magalhaes; Alexandrino-Silva, Clovis; Siu, Erica Rosanna; Viana, Maria Carmen] Univ Sao Paulo, Sch Med, Dept & Inst Psychiat, Sect Psychiat Epidemiol LIM 23, Sao Paulo, Brazil; [Andreoni, Solange] Univ Fed Sao Paulo, Dept Prevent Med, Sao Paulo, Brazil; [Nishimura, Raphael] Univ Michigan, Inst Social Res, Ann Arbor, MI USA; [Anthony, James C.] Michigan State Univ, Coll Human Med, Dept Epidemiol, E Lansing, MI 48824 USA; [Gattaz, Wagner Farid] Univ Sao Paulo, Sch Med, Dept & Inst Psychiat, Lab Neurosci LIM 27, Sao Paulo, Brazil; [Kessler, Ronald C.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); University of Michigan System; University of Michigan; Michigan State University; Michigan State University College of Human Medicine; Universidade de Sao Paulo; Harvard University; Harvard Medical School	Andrade, LH (corresponding author), Univ Sao Paulo, Sch Med, Dept & Inst Psychiat, Sect Psychiat Epidemiol LIM 23, Sao Paulo, Brazil.	Andradelhsgandr@usp.br	Gattaz, Wagner F/C-4456-2012; Andreoni, Solange/GNW-4057-2022; Silveira, Camila M/C-6467-2015; Siu, Erica R/J-9116-2012; Silveira, Camila/E-1087-2012; Anthony, Jim/H-3637-2011; Wang, Yuan-Pang/A-4863-2008; Andrade, Laura Helena S. G./F-3023-2010; Alexandrino-Silva, Clóvis/G-3154-2012; Viana, Maria Carmen/B-6047-2013	Andreoni, Solange/0000-0003-4589-9876; Silveira, Camila M/0000-0002-1598-4896; Siu, Erica R/0000-0001-7492-7579; Anthony, Jim/0000-0001-7176-0929; Wang, Yuan-Pang/0000-0001-7076-8312; Andrade, Laura Helena S. G./0000-0002-2362-3521; Viana, Maria Carmen/0000-0002-0464-4845	State of Sao Paulo Research Foundation, Brazil (FAPESP) [03/00204-3]; Secretaria de Seguranca Publica of the State of Sao Paulo, Brazil; United States National Institutes of Mental Health [R01MH070884]; John D. and Catherine T. MacArthur Foundation; Pfizer Foundation; US Public Health Service [R13-MH066849, R01-MH069864, R01 DA016558]; Fogarty International Center (FIRCA) [R03-TW006481]; Pan American Health Organization; Eli Lilly; Company Foundation; Ortho-McNeil Pharmaceutical, Inc.; GlaxoSmithKline; Bristol-Myers Squibb; Shire; FOGARTY INTERNATIONAL CENTER [R03TW006481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069864, R13MH066849, R01MH070884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016558, K05DA015799] Funding Source: NIH RePORTER	State of Sao Paulo Research Foundation, Brazil (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Secretaria de Seguranca Publica of the State of Sao Paulo, Brazil; United States National Institutes of Mental Health; John D. and Catherine T. MacArthur Foundation; Pfizer Foundation; US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Fogarty International Center (FIRCA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Pan American Health Organization; Eli Lilly(Eli Lilly); Company Foundation; Ortho-McNeil Pharmaceutical, Inc.; GlaxoSmithKline(GlaxoSmithKline); Bristol-Myers Squibb(Bristol-Myers Squibb); Shire; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The Sao Paulo Megacity Mental Health Survey was funded by the State of Sao Paulo Research Foundation, Brazil (FAPESP Grant 03/00204-3, URL: http://www.fapesp.br/materia/176/projeto-tematico/projeto-tematico.htm). Instrument development was supported by the Foundation for Science and Technology of Vitoria, Espirito Santo, Brazil (Fundo de Apoio a Ciencia e Tecnologia do Municipio de Vitoria - FACITEC 002/2003). The sub-project on violence and trauma was supported by the Secretaria de Seguranca Publica of the State of Sao Paulo, Brazil. The Sao Paulo Megacity Mental Health Survey is carried out in conjunction with the World Health Organization World Mental Health (WMH) Survey Initiative. The authors thank the WMH staff for assistance with instrumentation, fieldwork, and data analysis. The main coordination center activities, at Harvard University, were supported by the United States National Institutes of Mental Health (R01MH070884), the John D. and Catherine T. MacArthur Foundation, the Pfizer Foundation, the US Public Health Service (R13-MH066849, R01-MH069864, and R01 DA016558), the Fogarty International Center (FIRCA R03-TW006481), the Pan American Health Organization, the Eli Lilly and Company Foundation, Ortho-McNeil Pharmaceutical, Inc., GlaxoSmithKline, Bristol-Myers Squibb, and Shire. The authors declare that the funders of the SPMHS had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors also declare that the commercial funders of the Harvard coordination center had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida N, 1997, BRIT J PSYCHIAT, V171, P524, DOI 10.1192/bjp.171.6.524; Andrade L, 2002, SOC PSYCH PSYCH EPID, V37, P316, DOI 10.1007/s00127-002-0551-x; Andrade LH, 2008, SOC PSYCH PSYCH EPID, V43, P45, DOI 10.1007/s00127-007-0263-3; [Anonymous], 2000, Bull World Health Organ, V78, P413; Barbui C, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000322; BEBBINGTON P, 1995, INT J METHOD PSYCH, V5, P11; Benegal V, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000170; Bromet EJ, 2005, SOC PSYCH PSYCH EPID, V40, P681, DOI 10.1007/s00127-005-0927-9; CEM (Centro de Estudos da Metropole), MAP VULN SOC; Degenhardt L, 2008, PLOS MED, V5, P1053, DOI 10.1371/journal.pmed.0050141; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; EATON WW, 1991, J NERV MENT DIS, V179, P689, DOI 10.1097/00005053-199111000-00007; Ermínia Maricato, 2003, Estud. av., V17, P151, DOI 10.1590/S0103-40142003000200013; Feijo Mello M, 2009, EPIDEMIOLOGIA TRASTO, P101; First MB, 2002, STRUCTURED CLIN INTE; Guanais Frederico C, 2010, BMJ, V341, pc6542, DOI 10.1136/bmj.c6542; Haro JM, 2006, INT J METH PSYCH RES, V15, P167, DOI 10.1002/mpr.196; HARPHAM T, 1994, SOC SCI MED, V39, P233, DOI 10.1016/0277-9536(94)90332-8; Harris M, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4945; Hennigan T, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5453; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; IBGE, 2001, CENS DEM POP AN 2000; Kakuma R, 2011, LANCET, V378, P1654, DOI 10.1016/S0140-6736(11)61093-3; Karam EG, 2006, LANCET, V367, P1000, DOI 10.1016/S0140-6736(06)68427-4; Kawakami N, 2005, PSYCHIAT CLIN NEUROS, V59, P441, DOI 10.1111/j.1440-1819.2005.01397.x; Kendler KS, 2002, AM J PSYCHIAT, V159, P1133, DOI 10.1176/appi.ajp.159.7.1133; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kessler RC, 1997, PSYCHOL MED, V27, P861, DOI 10.1017/S0033291797004807; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2010, DEPRESS ANXIETY, V27, P351, DOI 10.1002/da.20634; Kovess-Masfety V, 2005, CAN J PSYCHIAT, V50, P926, DOI 10.1177/070674370505001407; Leon AC, 1997, INT J PSYCHIAT MED, V27, P93, DOI 10.2190/T8EM-C8YH-373N-1UWD; Llacer A, 2007, J EPIDEMIOL COMMUN H, V61, P4, DOI 10.1136/jech.2007.061770; Loch AA, 2011, EUR ARCH PSY CLIN N, V261, P519, DOI 10.1007/s00406-011-0204-8; Malmusi D, 2010, SOC SCI MED, V71, P1610, DOI 10.1016/j.socscimed.2010.07.043; Maricato E, 2008, CLUSTER CITTA DESIGN, V7, P118; Maricato Erminia, 2011, Estud. av., V25, P7, DOI 10.1590/S0103-40142011000100002; Medina-Mora ME, 2005, PSYCHOL MED, V35, P1773, DOI 10.1017/S0033291705005672; Merikangas KR, 2007, ARCH GEN PSYCHIAT, V64, P1180, DOI 10.1001/archpsyc.64.10.1180; Nascimento Andreia de Fatima, 2009, Rev Saude Publica, V43 Suppl 1, P8; Paiva CEP., 2009, ENGENHARIA, V596, P511; Patel V, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000160; Patel V, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000159; Paykel E, 2003, INT REV PSYCHIATR, V15, P97, DOI 10.1080/0954026021000046001; Peen J, 2010, ACTA PSYCHIAT SCAND, V121, P84, DOI 10.1111/j.1600-0447.2009.01438.x; Peen J, 2007, SOC PSYCH PSYCH EPID, V42, P984, DOI 10.1007/s00127-007-0256-2; Pessoto UC, 2007, CIENC SAUDE COLETIVA, V12, P351, DOI 10.1590/S1413-81232007000200011; Posada J, 2004, MEDUNAB, V7, P65; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Reichenheim ME, 2011, LANCET, V377, P1962, DOI 10.1016/S0140-6736(11)60053-6; Research Triangle Institute, 2002, SUDAAN PROF SOFTW SU; Seedat S, 2009, ARCH GEN PSYCHIAT, V66, P785, DOI 10.1001/archgenpsychiatry.2009.36; Shen YC, 2006, PSYCHOL MED, V36, P257, DOI 10.1017/S0033291705006367; SPENGLER PA, 1988, COMPR PSYCHIAT, V29, P309, DOI 10.1016/0010-440X(88)90054-5; The World Bank, GINI IND; Thornicroft G, 1999, MENT HLTH MATR MAN I; Thornicroft G, 2010, WORLD PSYCHIATRY, V9, P67; Peres MFT, 2008, REV PANAM SALUD PUBL, V23, P268; Turner RJ, 1995, J HEALTH SOC BEHAV, V36, P360, DOI 10.2307/2137325; Turner RJ, 2003, ADDICTION, V98, P305, DOI 10.1046/j.1360-0443.2003.00312.x; UN-Habitat, 2006, STAT WORLDS CIT 2006; Vaughn MG, 2010, ANN EPIDEMIOL, V20, P281, DOI 10.1016/j.annepidem.2009.11.011; Viana MC, 2009, REV BRAS PSIQUIATR, V31, P375, DOI 10.1590/S1516-44462009000400016; Vlahov D, 2002, J URBAN HEALTH, V79, pS1, DOI 10.1093/jurban/79.suppl_1.S1; Vorcaro CMR, 2001, ACTA PSYCHIAT SCAND, V104, P257, DOI 10.1034/j.1600-0447.2001.00440.x; Wang P, 2011, OXFORD TXB COMMUNITY; Wells JE, 2006, AUST NZ J PSYCHIAT, V40, P845, DOI 10.1111/j.1440-1614.2006.01903.x; WHO, 2003, PLANN BUDG DEL SERV; Williams DR, 2008, PSYCHOL MED, V38, P211, DOI 10.1017/S0033291707001420; World Health Organization, 2007, MONITORING EVALUATIO; World Health Organization, 2010, WORLD HLTH STAT HLTH; World Health Organization, 2007, OUR CIT OUR HLTH OUR	72	200	217	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31879	10.1371/journal.pone.0031879	http://dx.doi.org/10.1371/journal.pone.0031879			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925CF	22348135	Green Published, Green Submitted, gold			2022-12-25	WOS:000302737400054
J	El-Murr, N; Abidi, Z; Wanherdrick, K; Svrcek, M; Gaub, MP; Flejou, JF; Hamelin, R; Duval, A; Lesuffleur, T				El-Murr, Nizar; Abidi, Zoulira; Wanherdrick, Kristell; Svrcek, Magali; Gaub, Marie-Pierre; Flejou, Jean-Francois; Hamelin, Richard; Duval, Alex; Lesuffleur, Thecla			MiRNA Genes Constitute New Targets for Microsatellite Instability in Colorectal Cancer	PLOS ONE			English	Article							FAMILIAL PREDISPOSITION; INTERNATIONAL CRITERIA; MICRORNA BIOGENESIS; INSTITUTE WORKSHOP; REPEAT SEQUENCES; TARBP2 MUTATION; EXPRESSION; RECOGNITION; DROSHA	Mismatch repair-deficient colorectal cancers (CRC) display widespread instability at DNA microsatellite sequences (MSI). Although MSI has been reported to commonly occur at coding repeats, leading to alterations in the function of a number of genes encoding cancer-related proteins, nothing is known about the putative impact of this process on non-coding microRNAs. In miRbase V15, we identified very few human microRNA genes with mono- or di-nucleotide repeats (n = 27). A mutational analysis of these sequences in a large series of MSI CRC cell lines and primary tumors underscored instability in 15 of the 24 microRNA genes successfully studied at variable frequencies ranging from 2.5% to 100%. Following a maximum likelihood statistical method, microRNA genes were separated into two groups that differed significantly in their mutation frequencies and in their tendency to represent mutations that may or may not be under selective pressures during MSI tumoral progression. The first group included 21 genes that displayed no or few mutations in CRC. The second group contained three genes, i.e., hsa-mir-1273c, hsa-mir-1303 and hsa-mir-567, with frequent (>= 80%) and sometimes bi-allelic mutations in MSI tumors. For the only one expressed in colonic tissues, hsa-mir-1303, no direct link was found between the presence or not of mono- or bi-allelic alterations and the levels of mature miR expression in MSI cell lines, as determined by sequencing and quantitative PCR respectively. Overall, our results provide evidence that DNA repeats contained in human miRNA genes are relatively rare and preserved from mutations due to MSI in MMR-deficient cancer cells. Functional studies are now required to conclude whether mutated miRNAs, and especially the miR-1303, might have a role in MSI tumorigenesis.	[El-Murr, Nizar; Abidi, Zoulira; Wanherdrick, Kristell; Svrcek, Magali; Flejou, Jean-Francois; Hamelin, Richard; Duval, Alex; Lesuffleur, Thecla] Ctr Rech St Antoine, INSERM, UMRS 938, Equipe Instabilite Microsatellites & Canc, Paris, France; [El-Murr, Nizar; Abidi, Zoulira; Wanherdrick, Kristell; Svrcek, Magali; Flejou, Jean-Francois; Hamelin, Richard; Duval, Alex; Lesuffleur, Thecla] UPMC Univ Pierre & Marie Curie, Paris, France; [Svrcek, Magali; Flejou, Jean-Francois] Hop St Antoine, AP HP, Serv Anat & Cytol Pathol, Paris, France; [Gaub, Marie-Pierre] INSERM, U682, Strasbourg, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	El-Murr, N (corresponding author), Ctr Rech St Antoine, INSERM, UMRS 938, Equipe Instabilite Microsatellites & Canc, Paris, France.	thecla.lesuffleur@inserm.fr	lesuffleur, thecla/AAC-2980-2020	El-Murr, Nizar/0000-0001-7793-9436	LNCC (Ligue Nationale Contre le Cancer); Institut National de la Sante et de la Recherche Medicale (INSERM)	LNCC (Ligue Nationale Contre le Cancer); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	N El-Murr is a recipient of a LNCC (Ligue Nationale Contre le Cancer) fellowship. This work was supported by Institut National de la Sante et de la Recherche Medicale (INSERM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Boland CR, 1998, CANCER RES, V58, P5248; Breving K, 2010, INT J BIOCHEM CELL B, V42, P1316, DOI 10.1016/j.biocel.2009.09.016; Buhard O, 2006, J CLIN ONCOL, V24, P241, DOI 10.1200/JCO.2005.02.7227; Calin GA, 2006, ONCOGENE, V25, P6202, DOI 10.1038/sj.onc.1209910; Diosdado B, 2009, BRIT J CANCER, V101, P707, DOI 10.1038/sj.bjc.6605037; Dorard C, 2011, NAT MED, V17, P1283, DOI 10.1038/nm.2457; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Duan SW, 2009, RNA BIOL, V6, P412, DOI 10.4161/rna.6.4.8830; Duval A, 2002, CANCER RES, V62, P2447; Duval A, 2001, HUM MOL GENET, V10, P513, DOI 10.1093/hmg/10.5.513; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Garre P, 2010, NAT GENET, V42, P817, DOI 10.1038/ng1010-817; Giannini G, 2002, EMBO REP, V3, P248, DOI 10.1093/embo-reports/kvf044; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Jazdzewski K, 2009, P NATL ACAD SCI USA, V106, P1502, DOI 10.1073/pnas.0812591106; Kim MS, 2010, J PATHOL, V221, P139, DOI 10.1002/path.2683; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Melo SA, 2011, FEBS LETT IN PRESS; Melo SA, 2010, CANCER CELL, V18, P303, DOI 10.1016/j.ccr.2010.09.007; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Olena AF, 2010, J CELL PHYSIOL, V222, P540, DOI 10.1002/jcp.21993; Perucho M, 1999, CANCER RES, V59, P249; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Trujillo RD, 2010, EMBO J, V29, P3272, DOI 10.1038/emboj.2010.208; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Woerner SM, 2003, ONCOGENE, V22, P2226, DOI 10.1038/sj.onc.1206421; Wu MQ, 2008, CARCINOGENESIS, V29, P1710, DOI 10.1093/carcin/bgn073; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491; Zeng Y, 2005, J BIOL CHEM, V280, P27595, DOI 10.1074/jbc.M504714200; Zhang XX, 2010, NUCLEIC ACIDS RES, V38, P7689, DOI 10.1093/nar/gkq645	35	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31862	10.1371/journal.pone.0031862	http://dx.doi.org/10.1371/journal.pone.0031862			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348132	Green Submitted, Green Published, gold			2022-12-25	WOS:000302737400052
J	Zhang, WS; Edwards, A; Zhu, DX; Flemington, EK; Deininger, P; Zhang, K				Zhang, Wensheng; Edwards, Andrea; Zhu, Dongxiao; Flemington, Erik K.; Deininger, Prescott; Zhang, Kun			miRNA-Mediated Relationships between Cis-SNP Genotypes and Transcript Intensities in Lymphocyte Cell Lines	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; RANDOMLY MATING POPULATIONS; MICRORNA TARGET SITES; LINKAGE DISEQUILIBRIUM; GENE-EXPRESSION; HUMAN-DISEASE; PARKINSON-DISEASE; BINDING-SITE; ASSOCIATION; RESISTANCE	In metazoans, miRNAs regulate gene expression primarily through binding to target sites in the 3' UTRs (untranslated regions) of messenger RNAs (mRNAs). Cis-acting variants within, or close to, a gene are crucial in explaining the variability of gene expression measures. Single nucleotide polymorphisms (SNPs) in the 3' UTRs of genes can affect the base-pairing between miRNAs and mRNAs, and hence disrupt existing target sites (in the reference sequence) or create novel target sites, suggesting a possible mechanism for cis regulation of gene expression. Moreover, because the alleles of different SNPs within a DNA sequence of limited length tend to be in strong linkage disequilibrium (LD), we hypothesize the variants of miRNA target sites caused by SNPs potentially function as bridges linking the documented cis-SNP markers to the expression of the associated genes. A large-scale analysis was herein performed to test this hypothesis. By systematically integrating multiple latest information sources, we found 21 significant gene-level SNP-involved miRNA-mediated post-transcriptional regulation modules (SNP-MPRMs) in the form of SNP-miRNA-mRNA triplets in lymphocyte cell lines for the CEU and YRI populations. Among the cognate genes, six including ALG8, DGKE, GNA12, KLF11, LRPAP1, and MMAB are related to multiple genetic diseases such as depressive disorder and Type-II diabetes. Furthermore, we found that similar to 35% of the documented transcript intensity-related cis-SNPs (similar to 950) in a recent publication are identical to, or in significant linkage disequilibrium (LD) (p<0.01) with, one or multiple SNPs located in miRNA target sites. Based on these associations (or identities), 69 significant exon-level SNP-MPRMs and 12 disease genes were further determined for two populations. These results provide concrete in silico evidence for the proposed hypothesis. The discovered modules warrant additional follow-up in independent laboratory studies.	[Zhang, Wensheng; Edwards, Andrea; Zhang, Kun] Xavier Univ Louisiana, Dept Comp Sci, New Orleans, LA 70125 USA; [Zhu, Dongxiao] Wayne State Univ, Dept Comp Sci, Detroit, MI 48202 USA; [Flemington, Erik K.] Tulane Univ, Ctr Hlth Sci, Dept Pathol, New Orleans, LA 70118 USA; [Deininger, Prescott] Tulane Sch Publ Hlth & Trop Med, Tulane Canc Ctr, New Orleans, LA USA	Xavier University of Louisiana; Wayne State University; Tulane University; Tulane University	Zhang, WS (corresponding author), Xavier Univ Louisiana, Dept Comp Sci, New Orleans, LA 70125 USA.	kzhang@xula.edu	Zhu, Dongxiao/G-4049-2010	Deininger, Prescott/0000-0002-1067-3028	NIH [NCRR P20RR016456, RCMI 5G12RR026260-03, R21LM010137S1]; Louisiana BOR award [LEQSF(2008-11)-RD-A-32]; NSF [EPS-1006891]; NATIONAL CANCER INSTITUTE [R01CA138268] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016456, G12RR026260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101046] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana BOR award; NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants (NCRR P20RR016456, RCMI 5G12RR026260-03, R21LM010137S1 to DZ), a Louisiana BOR award to ZK (LEQSF(2008-11)-RD-A-32) and an NSF grant EPS-1006891). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Amato R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007927; Bansal A, 2007, BIOINFORMATICS GENET; Bao L, 2007, NUCLEIC ACIDS RES, V35, pD51, DOI 10.1093/nar/gkl797; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borel C, 2008, MAMM GENOME, V19, P503, DOI 10.1007/s00335-008-9137-6; Brown EM, HAPMAP HAPLOTYPE MAP, P35; Brown EM, 2007, HAPMAP HAPLOTYPE MAP, P35; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fraser HB, 2009, GENOME RES, V19, P567, DOI 10.1101/gr.083477.108; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gamazon ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013534; Gan SQ, 2008, ASIAN AUSTRAL J ANIM, V21, P928, DOI 10.5713/ajas.2008.70473; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hartl D., 1989, PRINCIPLES POPULATIO; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; HILL WG, 1974, HEREDITY, V33, P229, DOI 10.1038/hdy.1974.89; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang RS, 2007, P NATL ACAD SCI USA, V104, P9758, DOI 10.1073/pnas.0703736104; Imai S, 2005, J BIOL CHEM, V280, P39870, DOI 10.1074/jbc.M500669200; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Kim J, 2009, NAT BIOTECHNOL, V27, P472, DOI 10.1038/nbt.1540; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Li YH, 2006, AM J HUM GENET, V78, P1090, DOI 10.1086/504725; Mishra PJ, 2007, P NATL ACAD SCI USA, V104, P13513, DOI 10.1073/pnas.0706217104; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Myles S, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-22; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Plagnol V, 2009, BIOSTATISTICS, V10, P327, DOI 10.1093/biostatistics/kxn039; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Sethupathy P, 2008, TRENDS GENET, V24, P489, DOI 10.1016/j.tig.2008.07.004; Shu Y, 2010, MOL BIOL REP; Simko I, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-135; Smith WJM, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-27; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Sturm M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-292; Wang D., 2010, PLOS ONE, V5; Wang G, 2008, AM J HUM GENET, V82, P283, DOI 10.1016/j.ajhg.2007.09.021; Wang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005878; WEIR BS, 1979, HEREDITY, V42, P105, DOI 10.1038/hdy.1979.10; Weir BS, 1996, GENETIC DATA ANAL, p[xii, 445]; Yamaguchi-Kabata Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003393; Zhang W, 2009, HUM GENET, V125, P81, DOI 10.1007/s00439-008-0601-x	54	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31429	10.1371/journal.pone.0031429	http://dx.doi.org/10.1371/journal.pone.0031429			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348086	Green Submitted, gold, Green Published			2022-12-25	WOS:000302737400022
J	Granich, R; Kahn, JG; Bennett, R; Holmes, CB; Garg, N; Serenata, C; Sabin, ML; Makhlouf-Obermeyer, C; Mack, CD; Williams, P; Jones, L; Smyth, C; Kutch, KA; Lo, YR; Vitoria, M; Souteyrand, Y; Crowley, S; Korenromp, EL; Williams, BG				Granich, Reuben; Kahn, James G.; Bennett, Rod; Holmes, Charles B.; Garg, Navneet; Serenata, Celicia; Sabin, Miriam Lewis; Makhlouf-Obermeyer, Carla; Mack, Christina De Filippo; Williams, Phoebe; Jones, Louisa; Smyth, Caoimhe; Kutch, Kerry A.; Lo Ying-Ru; Vitoria, Marco; Souteyrand, Yves; Crowley, Siobhan; Korenromp, Eline L.; Williams, Brian G.			Expanding ART for Treatment and Prevention of HIV in South Africa: Estimated Cost and Cost-Effectiveness 2011-2050	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; VIRAL LOAD; HETEROSEXUAL TRANSMISSION; RISK; INFECTION; ACCESS; HAART; CARE; MORTALITY; BEHAVIOR	Background: Antiretroviral Treatment (ART) significantly reduces HIV transmission. We conducted a cost-effectiveness analysis of the impact of expanded ART in South Africa. Methods: We model a best case scenario of 90% annual HIV testing coverage in adults 15-49 years old and four ART eligibility scenarios: CD4 count <200 cells/mm(3) (current practice), CD4 count <350, CD4 count <500, all CD4 levels. 2011-2050 outcomes include deaths, disability adjusted life years (DALYs), HIV infections, cost, and cost per DALY averted. Service and ART costs reflect South African data and international generic prices. ART reduces transmission by 92%. We conducted sensitivity analyses. Results: Expanding ART to CD4 count <350 cells/mm(3) prevents an estimated 265,000 (17%) and 1.3 million (15%) new HIV infections over 5 and 40 years, respectively. Cumulative deaths decline 15%, from 12.5 to 10.6 million; DALYs by 14% from 109 to 93 million over 40 years. Costs drop $504 million over 5 years and $3.9 billion over 40 years with breakeven by 2013. Compared with the current scenario, expanding to <500 prevents an additional 585,000 and 3 million new HIV infections over 5 and 40 years, respectively. Expanding to all CD4 levels decreases HIV infections by 3.3 million (45%) and costs by $10 billion over 40 years, with breakeven by 2023. By 2050, using higher ART and monitoring costs, all CD4 levels saves $0.6 billion versus current; other ART scenarios cost $9-194 per DALY averted. If ART reduces transmission by 99%, savings from all CD4 levels reach $17.5 billion. Sensitivity analyses suggest that poor retention and predominant acute phase transmission reduce DALYs averted by 26% and savings by 7%. Conclusion: Increasing the provision of ART to <350 cells/mm(3) may significantly reduce costs while reducing the HIV burden. Feasibility including HIV testing and ART uptake, retention, and adherence should be evaluated.	[Granich, Reuben; Sabin, Miriam Lewis; Makhlouf-Obermeyer, Carla; Williams, Phoebe; Jones, Louisa; Smyth, Caoimhe; Kutch, Kerry A.; Lo Ying-Ru; Vitoria, Marco; Souteyrand, Yves; Crowley, Siobhan] World Hlth Org, HIV AIDS Dept, Geneva, Switzerland; [Kahn, James G.] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Holmes, Charles B.] Off US Global AIDS Coordinator, Dept State, Washington, DC USA; [Garg, Navneet] Vestergaard Frandsen, Lausanne, Switzerland; [Serenata, Celicia] S African Natl AIDS Council, Johannesburg, South Africa; [Mack, Christina De Filippo] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Korenromp, Eline L.] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Korenromp, Eline L.] Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands; [Williams, Brian G.] S African Ctr Epidemiol Modelling & Anal, Stellenbosch, South Africa	World Health Organization; University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; Erasmus University Rotterdam; Erasmus MC; National Research Foundation - South Africa	Granich, R (corresponding author), World Hlth Org, HIV AIDS Dept, Geneva, Switzerland.	granichr@who.int	Williams, Phoebe/GLQ-9150-2022	Williams, Phoebe CM/0000-0003-2250-0594; Williams, Brian/0000-0002-3174-4876; Sabin, Miriam/0000-0002-7758-8338	World Health Organization; U.S. National Institute of Drug Abuse [R01 DA15612]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, R37DA015612] Funding Source: NIH RePORTER	World Health Organization(World Health Organization); U.S. National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by the World Health Organization and by the U.S. National Institute of Drug Abuse, under grant number R01 DA15612. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN S, 1992, BRIT MED J, V304, P1605, DOI 10.1136/bmj.304.6842.1605; [Anonymous], PROGR REP 2011 GLOB; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bacaer N, 2008, J MATH BIOL, V57, P557, DOI 10.1007/s00285-008-0177-z; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Beck EJ, 2010, CURR OPIN HIV AIDS, V5, P215, DOI 10.1097/COH.0b013e32833860e9; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Bunnell R, 2006, JAMA-J AM MED ASSOC, V296, P855, DOI 10.1001/jama.296.7.855; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; Cohen J, 2008, SCIENCE, V321, P512, DOI 10.1126/science.321.5888.512; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; DESROSIERS R, 2008, 15 C RETR OPP INF CR; Dodd PJ, 2010, AIDS, V24, P729, DOI 10.1097/QAD.0b013e32833433fe; Donnell D, 2010, 17 C RETR OPP INF CR; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Futures Institute, 2011, FUT I SPECTR; Galarraga O, 2011, PHARMACOECONOMICS, V29, P579, DOI 10.2165/11586120-000000000-00000; Garnett GP, 2009, LANCET, V373, P9, DOI 10.1016/S0140-6736(08)61698-0; Gill VS, 2010, CLIN INFECT DIS, V50, P98, DOI 10.1086/648729; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hankins C, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000109; Harling G, 2007, JAIDS-J ACQ IMM DEF, V45, P348; Hecht R, 2010, LANCET, V376, P1254, DOI 10.1016/S0140-6736(10)61255-X; Hecht R, 2009, HEALTH AFFAIR, V28, P1591, DOI 10.1377/hlthaff.28.6.1591; Holmes Charles, 2009, COMMUNICATION   0828; Holmes Charles, 2009, COMMUNICATION   0906; Holmes CB, 2010, JAMA-J AM MED ASSOC, V304, P313, DOI 10.1001/jama.2010.993; Hontelez JAC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021919; Johnston KM, 2010, AIDS, V24, P1929, DOI 10.1097/QAD.0b013e32833af85d; Jones L, 2010, CURRENT HIV RES; Kahn J, 2009, C HIV PATH TREATM PR; Kahn JG, 2006, PLOS MED, V3, P2349, DOI 10.1371/journal.pmed.0030517; Kleijnen J, 1998, BRIT MED J, V316, P299, DOI 10.1136/bmj.316.7127.299; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Lugada E, 2010, 18 INT AIDS C 2010 V; Marseille E, 2002, LANCET, V359, P1851, DOI 10.1016/S0140-6736(02)08705-6; Marseille E, 2009, APPL HEALTH ECON HEA, V7, P229, DOI 10.2165/11318740-000000000-00000; Menzies N, 2009, AIDS, V23, P395, DOI 10.1097/QAD.0b013e328321e40b; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; Mermin J, 2008, LANCET, V371, P752, DOI 10.1016/S0140-6736(08)60345-1; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; National AIDS and STI Control Programme MoH-K, 2008, KAIS 2007 KEN AIDS I; National Department of Health South Africa, 2010, 2010 CLIN GUID MAN H; Padian NS, 2010, AIDS, V24, P621, DOI 10.1097/QAD.0b013e328337798a; Piot P, 2002, LANCET, V360, P86, DOI 10.1016/S0140-6736(02)09342-X; Potts M, 2008, SCIENCE, V320, P749, DOI 10.1126/science.1153843; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; Resch S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025310; Rieder P, 2010, AIDS, V24, P1177, DOI 10.1097/QAD.0b013e328338e4de; Rosen S, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-24; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Seranata Celicia, 2009, COMMUNICATION   0929; Seranata Celicia, 2009, COMMUNICATION   1125; Seranata Celicia, 2009, COMMUNICATION   0925; Smith RJ, 2010, SCIENCE, V327, P697, DOI 10.1126/science.1180556; South African Government Information, 2010, OUTL NAT HIV COUNS T; South African Government Information, 2008, HIV AIDS STI STRAT P; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2010, GLOBAL FUND FIGHT AI; Tovanabutra S, 2002, J ACQ IMMUN DEF SYND, V29, P275, DOI 10.1097/00126334-200203010-00008; *UNAIDS, 2009, AIDS EP UPD; UNAIDS, 2011, WORLD AIDS DAY REP 2; UNAIDS, 2011, AIDS 30 NAT CROSS RO; UNAIDS, 2007, FIN RES REQ ACH UN A; United Nations General Assembly, 2011, UN UN ACC ZER NEW HI; University of Washington, 2011, PIV STUD AFR FINDS H; USAID, 2009, COMP PROGR MAK HIV A; Velasco-Hernandez JX, 2002, LANCET INFECT DIS, V2, P487, DOI 10.1016/S1473-3099(02)00346-8; Venkatesh KK, 2010, AIDS, V24, P2687, DOI 10.1097/QAD.0b013e32833e78d4; Walensky RP, 2008, J INFECT DIS, V197, P1324, DOI 10.1086/587184; Walensky RP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000382; Walensky RP, 2011, JAIDS-J ACQ IMM DEF, V56, P26, DOI 10.1097/QAI.0b013e3181fb8f24; Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138; Weiss RA, 2008, CLIN EXP IMMUNOL, V152, P201, DOI 10.1111/j.1365-2249.2008.03645.x; WHO, 2010, ANT THER HIV INF AD; WHO CHOICE, 2010, INT AR COST EFF WHO; Williams B, SPECTRUM MODEL V 3 3; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649; World Health Organization, 2010, UN ACC SCAL PRIOR HI; World Health Organization, 2009, RAP ADV ANT THER HIV	86	104	107	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e30216	10.1371/journal.pone.0030216	http://dx.doi.org/10.1371/journal.pone.0030216			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348000	Green Published, gold			2022-12-25	WOS:000302733900004
J	Xie, BW; Mol, IM; Keereweer, S; van Beek, ER; Que, I; Snoeks, TJA; Chan, A; Kaijzel, EL; Lowik, CWGM				Xie, Bang-Wen; Mol, Isabel M.; Keereweer, Stijn; van Beek, Ermond R.; Que, Ivo; Snoeks, Thomas J. A.; Chan, Alan; Kaijzel, Eric L.; Lowik, Clemens W. G. M.			Dual-Wavelength Imaging of Tumor Progression by Activatable and Targeting Near-Infrared Fluorescent Probes in a Bioluminescent Breast Cancer Model	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; EGF RECEPTOR; MAMMARY-CARCINOMA; IN-VIVO; METASTASIS; MOUSE; AGENT; MICE; OVEREXPRESSION; ANGIOGENESIS	Bioluminescence imaging (BLI) has shown its appeal as a sensitive technique for in vivo whole body optical imaging. However, the development of injectable tumor-specific near-infrared fluorescent (NIRF) probes makes fluorescence imaging (FLI) a promising alternative to BLI in situations where BLI cannot be used or is unwanted (e.g., spontaneous transgenic tumor models, or syngeneic mice to study immune effects). In this study, we addressed the questions whether it is possible to detect tumor progression using FLI with appropriate sensitivity and how FLI correlates with BLI measurements. In addition, we explored the possibility to simultaneously detect multiple tumor characteristics by dual-wavelength FLI (similar to 700 and similar to 800 nm) in combination with spectral unmixing. Using a luciferase-expressing 4T1-luc2 mouse breast cancer model and combinations of activatable and targeting NIRF probes, we showed that the activatable NIRF probes (ProSense680 and MMPSense680) and the targeting NIRF probes (IRDye 800CW 2-DG and IRDye 800CW EGF) were either activated by or bound to 4T1-luc2 cells. In vivo, we implanted 4T1-luc2 cells orthotopically in nude mice and were able to follow tumor progression longitudinally both by BLI and dual-wavelength FLI. We were able to reveal different probe signals within the tumor, which co-localized with immuno-staining. Moreover, we observed a linear correlation between the internal BLI signals and the FLI signals obtained from the NIRF probes. Finally, we could detect pulmonary metastases both by BLI and FLI and confirmed their presence histologically. Taken together, these data suggest that dual-wavelength FLI is a feasible approach to simultaneously detect different features of one tumor and to follow tumor progression with appropriate specificity and sensitivity. This study may open up new perspectives for the detection of tumors and metastases in various experimental models and could also have clinical applications, such as image-guided surgery.	[Xie, Bang-Wen; Mol, Isabel M.; van Beek, Ermond R.; Que, Ivo; Snoeks, Thomas J. A.; Kaijzel, Eric L.; Lowik, Clemens W. G. M.] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, Leiden, Netherlands; [Keereweer, Stijn] Erasmus MC, Dept Otorhinolaryngol Head & Neck Surg, Rotterdam, Netherlands; [Chan, Alan] Univ Twente, Percuros BV, Dept Tissue Regenerat, NL-7500 AE Enschede, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; University of Twente	Xie, BW (corresponding author), Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, Leiden, Netherlands.	B.Xie@lumc.nl	Kaijzel, Eric/GZN-2333-2022; Snoeks, Thomas/E-9742-2010	Snoeks, Thomas/0000-0003-3866-346X; Chan, Alan/0000-0001-6949-9274; Kaijzel, Eric/0000-0003-3118-9910	Center for Translational Molecular Medicine [03O-202]; Dutch Cancer Society Koningin Wilhelmina Fonds [UL2007-3801]	Center for Translational Molecular Medicine; Dutch Cancer Society Koningin Wilhelmina Fonds(KWF Kankerbestrijding)	This research was performed within the framework of the Center for Translational Molecular Medicine, project MUSIS (grant 03O-202). This study is also supported by Dutch Cancer Society Koningin Wilhelmina Fonds (UL2007-3801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bharadwaj AG, 2009, AM J PATHOL, V174, P1027, DOI 10.2353/ajpath.2009.080501; Bhardwaj V, 2009, PHARM RES-DORDR, V26, P2495, DOI 10.1007/s11095-009-9965-4; Bonine-Summers AR, 2007, CANCER BIOL THER, V6, P561, DOI 10.4161/cbt.6.4.3851; Castano AP, 2006, BRIT J CANCER, V94, P391, DOI 10.1038/sj.bjc.6602953; Chen JQ, 2005, CIRCULATION, V111, P1800, DOI 10.1161/01.CIR.0000160936.91849.9F; Chia JS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-175; Ciampricotti M, 2010, J PATHOL; FLIER JS, 1987, SCIENCE, V235, P1492, DOI 10.1126/science.3103217; Frangioni JV, 2008, J CLIN ONCOL, V26, P4012, DOI 10.1200/JCO.2007.14.3065; Garcia M, 1996, STEM CELLS, V14, P642, DOI 10.1002/stem.140642; Giancotti V, 2006, CANCER LETT, V243, P145, DOI 10.1016/j.canlet.2006.01.035; Gocheva V, 2007, CELL CYCLE, V6, P60, DOI 10.4161/cc.6.1.3669; Jenkins DE, 2003, CLIN EXP METASTAS, V20, P733, DOI 10.1023/B:CLIN.0000006815.49932.98; Jiang T, 2004, P NATL ACAD SCI USA, V101, P17867, DOI 10.1073/pnas.0408191101; Kaijzel EL, 2009, CLIN EXP METASTAS, V26, P371, DOI 10.1007/s10585-008-9217-8; Ke S, 2003, CANCER RES, V63, P7870; Keereweer S, 2010, MOL IMAGING BIOL; Keppler D, 1996, BIOCHEM CELL BIOL, V74, P799, DOI 10.1139/o96-086; KIM ES, 2010, BREAST CANC RES TREA; Kim J, 1998, CELL, V94, P353, DOI 10.1016/S0092-8674(00)81478-6; Kim JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009364; Kovar JL, 2007, ANAL BIOCHEM, V367, P1, DOI 10.1016/j.ab.2007.04.011; Kovar JL, 2007, ANAL BIOCHEM, V361, P47, DOI 10.1016/j.ab.2006.11.021; Kovar JL, 2006, AM J PATHOL, V169, P1415, DOI 10.2353/ajpath.2006.060324; Kovar JL, 2009, ANAL BIOCHEM, V384, P254, DOI 10.1016/j.ab.2008.09.050; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; LACROIX H, 1989, ONCOGENE, V4, P145; Levenson RM, 2008, ILAR J, V49, P78, DOI 10.1093/ilar.49.1.78; Levitzki A, 2003, LUNG CANCER, V41, pS9, DOI 10.1016/S0169-5002(03)00134-X; Mayes PA, 2008, BIOTECHNIQUES, V45, P459, DOI 10.2144/000112946; Mezzanotte L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019277; Parker BS, 2008, J PATHOL, V214, P337, DOI 10.1002/path.2265; Patel S, 2011, CLIN BIOCH; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Pulaski BA, 1998, CANCER RES, V58, P1486; Rice BW, 2009, NAT BIOTECHNOL, V27, P624, DOI 10.1038/nbt0709-624; Schaafsma BE, 2011, J SURG ONCOL, V104, P323, DOI 10.1002/jso.21943; Stebbing J, 2011, J CLIN PATHOL; van der Vorst JR, 2011, INT J GYNECOL CANCER, V21, P1472, DOI 10.1097/IGC.0b013e31822b451d; Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123; Wendt MK, 2010, ONCOGENE, V29, P6485, DOI 10.1038/onc.2010.377; Zhang WY, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-52; Zhou HL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008051	44	35	35	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31875	10.1371/journal.pone.0031875	http://dx.doi.org/10.1371/journal.pone.0031875			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348134	Green Published, gold, Green Submitted			2022-12-25	WOS:000302733900062
J	Hosomi, A; Nakanishi, T; Fujita, T; Tamai, I				Hosomi, Atsushi; Nakanishi, Takeo; Fujita, Takuya; Tamai, Ikumi			Extra-Renal Elimination of Uric Acid via Intestinal Efflux Transporter BCRP/ABCG2	PLOS ONE			English	Article							RESISTANCE-ASSOCIATED PROTEIN-2; ORGANIC ANION TRANSPORTER-2; II RECEPTOR BLOCKERS; APICAL MEMBRANE; URATE; IDENTIFICATION; EXCRETION; DRUGS; HEMODIALYSIS; INVOLVEMENT	Urinary excretion accounts for two-thirds of total elimination of uric acid and the remainder is excreted in feces. However, the mechanism of extra-renal elimination is poorly understood. In the present study, we aimed to clarify the mechanism and the extent of elimination of uric acid through liver and intestine using oxonate-treated rats and Caco-2 cells as a model of human intestinal epithelium. In oxonate-treated rats, significant amounts of externally administered and endogenous uric acid were recovered in the intestinal lumen, while biliary excretion was minimal. Accordingly, direct intestinal secretion was thought to be a substantial contributor to extra-renal elimination of uric acid. Since human efflux transporter BCRP/ABCG2 accepts uric acid as a substrate and genetic polymorphism causing a decrease of BCRP activity is known to be associated with hyperuricemia and gout, the contribution of rBcrp to intestinal secretion was examined. rBcrp was confirmed to transport uric acid in a membrane vesicle study, and intestinal regional differences of expression of rBcrp mRNA were well correlated with uric acid secretory activity into the intestinal lumen. Bcrp1 knockout mice exhibited significantly decreased intestinal secretion and an increased plasma concentration of uric acid. Furthermore, a Bcrp inhibitor, elacridar, caused a decrease of intestinal secretion of uric acid. In Caco-2 cells, uric acid showed a polarized flux from the basolateral to apical side, and this flux was almost abolished in the presence of elacridar. These results demonstrate that BCRP contributes at least in part to the intestinal excretion of uric acid as extra-renal elimination pathway in humans and rats.	[Hosomi, Atsushi; Nakanishi, Takeo; Tamai, Ikumi] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Pharm, Dept Membrane Transport & Biopharmaceut, Kanazawa, Ishikawa, Japan; [Fujita, Takuya] Ritsumeikan Univ, Coll Pharmaceut Sci, Kusatsu, Japan	Kanazawa University; Ritsumeikan University	Hosomi, A (corresponding author), Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Pharm, Dept Membrane Transport & Biopharmaceut, Kanazawa, Ishikawa, Japan.	tamai@p.kanazawa-u.ac.jp	Nakanishi, Takeo/C-3891-2015; Fujita, Takuya/AAC-3442-2022; TAMAI, Ikumi/D-8412-2015	Nakanishi, Takeo/0000-0002-6561-7138; Fujita, Takuya/0000-0002-7724-6522; 	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Alderman MH, 1999, HYPERTENSION, V34, P144, DOI 10.1161/01.HYP.34.1.144; Anzai N, 2008, J BIOL CHEM, V283, P26834, DOI 10.1074/jbc.C800156200; Augustin R, 2004, J BIOL CHEM, V279, P16229, DOI 10.1074/jbc.M312226200; Bakhiya N, 2003, CELL PHYSIOL BIOCHEM, V13, P249, DOI 10.1159/000074539; BERGER L, 1975, AM J MED, V59, P605, DOI 10.1016/0002-9343(75)90222-3; Bibert S, 2009, AM J PHYSIOL-RENAL, V297, pF612, DOI 10.1152/ajprenal.00139.2009; Dautrey S, 1995, Drugs, V49 Suppl 2, P310; Enomoto A, 2002, J PHARMACOL EXP THER, V301, P797, DOI 10.1124/jpet.301.3.797; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; Eraly SA, 2008, PHYSIOL GENOMICS, V33, P180, DOI 10.1152/physiolgenomics.00207.2007; Garg JP, 2005, ARTHRITIS RHEUM-US, V52, P290, DOI 10.1002/art.20781; Hamada T, 2002, INTERNAL MED, V41, P793, DOI 10.2169/internalmedicine.41.793; Hooper DC, 2000, FASEB J, V14, P691, DOI 10.1096/fasebj.14.5.691; Huls M, 2008, KIDNEY INT, V73, P220, DOI 10.1038/sj.ki.5002645; Iharada M, 2010, J BIOL CHEM, V285, P26107, DOI 10.1074/jbc.M110.122721; Iwanaga T, 2007, J PHARMACOL EXP THER, V320, P211, DOI 10.1124/jpet.106.112755; Jutabha P, 2003, J BIOL CHEM, V278, P27930, DOI 10.1074/jbc.M303210200; Jutabha P, 2011, J PHARMACOL SCI, V115, P249, DOI 10.1254/jphs.10228SC; Jutabha P, 2010, J BIOL CHEM, V285, P35123, DOI 10.1074/jbc.M110.121301; Kojima R, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134848; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Kountouras J, 1996, HEPATOLOGY, V23, P229; Li Y, 2008, DRUG METAB PHARMACOK, V23, P263, DOI 10.2133/dmpk.23.263; Maliepaard M, 2001, CANCER RES, V61, P3458; Manolis AJ, 2000, CLIN THER, V22, P1186, DOI 10.1016/S0149-2918(00)83062-3; Masuo K, 2003, HYPERTENSION, V42, P474, DOI 10.1161/01.HYP.0000091371.53502.D3; Matsson P, 2009, PHARM RES-DORDR, V26, P1816, DOI 10.1007/s11095-009-9896-0; Matsuo H, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000237; Nakanishi T, 2011, DRUG METAB DISPOS, V39, P984, DOI 10.1124/dmd.111.038059; Naruhashi K, 2002, ANTIMICROB AGENTS CH, V46, P344, DOI 10.1128/AAC.46.2.344-349.2002; NICHOLLS A, 1973, BRIT MED J, V1, P449, DOI 10.1136/bmj.1.5851.449; Nozaki Y, 2007, J PHARMACOL EXP THER, V322, P1162, DOI 10.1124/jpet.107.121491; Ohno I, 2009, INTERNAL MED, V48, P415, DOI 10.2169/internalmedicine.48.1817; Poguntke M, 2010, EXPERT OPIN DRUG MET, V6, P1363, DOI 10.1517/17425255.2010.519700; Sato M, 2008, PHARM RES-DORDR, V25, P639, DOI 10.1007/s11095-007-9401-6; Sato M, 2011, BBA-BIOMEMBRANES, V1808, P1441, DOI 10.1016/j.bbamem.2010.11.002; Sato M, 2010, BIOL PHARM BULL, V33, P498, DOI 10.1248/bpb.33.498; Sekine T, 1997, J BIOL CHEM, V272, P18526, DOI 10.1074/jbc.272.30.18526; SHINOSAKI T, 1991, JPN J PHARMACOL, V55, P461, DOI 10.1254/jjp.55.461; SNAITH ML, 1971, ANN RHEUM DIS, V30, P285, DOI 10.1136/ard.30.3.285; SORENSEN LB, 1975, NEPHRON, V14, P7, DOI 10.1159/000180432; SORENSEN LEIF B., 1965, ARTHRITIS RHEUM, V8, P694, DOI 10.1002/art.1780080429; Tanaka Y, 2005, BIOCHEM BIOPH RES CO, V326, P181, DOI 10.1016/j.bbrc.2004.11.012; TSUJI A, 1987, J PHARMACOL EXP THER, V241, P594; Uchino H, 2000, BIOCHEM BIOPH RES CO, V270, P254, DOI 10.1006/bbrc.2000.2407; Van Aubel RAMH, 2005, AM J PHYSIOL-RENAL, V288, pF327, DOI 10.1152/ajprenal.00133.2004; VARELAECHAVARRIA A, 1988, FASEB J, V2, P3092, DOI 10.1096/fasebj.2.15.3192041; Woodward OM, 2009, P NATL ACAD SCI USA, V106, P10338, DOI 10.1073/pnas.0901249106; YONETANI Y, 1983, JPN J PHARMACOL, V33, P947, DOI 10.1254/jjp.33.947; YU TF, 1959, J CLIN INVEST, V38, P1298, DOI 10.1172/JCI103905	50	146	169	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e30456	10.1371/journal.pone.0030456	http://dx.doi.org/10.1371/journal.pone.0030456			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348008	Green Submitted, gold, Green Published			2022-12-25	WOS:000302730900009
J	Alt, A; Miguel-Romero, L; Donderis, J; Aristorena, M; Blanco, FJ; Round, A; Rubio, V; Bernabeu, C; Marina, A				Alt, Aaron; Miguel-Romero, Laura; Donderis, Jordi; Aristorena, Mikel; Blanco, Francisco J.; Round, Adam; Rubio, Vicente; Bernabeu, Carmelo; Marina, Alberto			Structural and Functional Insights into Endoglin Ligand Recognition and Binding	PLOS ONE			English	Article							HEREDITARY HEMORRHAGIC TELANGIECTASIA; GROWTH-FACTOR-BETA; PROTEIN-STRUCTURE PREDICTION; SUPPRESSES TUMOR-GROWTH; ENDOTHELIAL-CELLS; CELLULAR-RESPONSES; RECEPTOR COMPLEX; ANGIOGENESIS; EXPRESSION; GLYCOPROTEIN	Endoglin, a type I membrane glycoprotein expressed as a disulfide-linked homodimer on human vascular endothelial cells, is a component of the transforming growth factor (TGF)-beta receptor complex and is implicated in a dominant vascular dysplasia known as hereditary hemorrhagic telangiectasia as well as in preeclampsia. It interacts with the type I TGF-beta signaling receptor activin receptor-like kinase (ALK) 1 and modulates cellular responses to Bone Morphogenetic Protein (BMP)-9 and BMP-10. Structurally, besides carrying a zona pellucida (ZP) domain, endoglin contains at its N-terminal extracellular region a domain of unknown function and without homology to any other known protein, therefore called the orphan domain (OD). In this study, we have determined the recognition and binding ability of full length ALK1, endoglin and constructs encompassing the OD to BMP-9 using combined methods, consisting of surface plasmon resonance and cellular assays. ALK1 and endoglin ectodomains bind, independently of their glycosylation state and without cooperativity, to different sites of BMP-9. The OD comprising residues 22 to 337 was identified among the present constructs as the minimal active endoglin domain needed for partner recognition. These studies also pinpointed to Cys350 as being responsible for the dimerization of endoglin. In contrast to the complete endoglin ectodomain, the OD is a monomer and its small angle X-ray scattering characterization revealed a compact conformation in solution into which a de novo model was fitted.	[Alt, Aaron; Miguel-Romero, Laura; Donderis, Jordi; Rubio, Vicente; Marina, Alberto] Inst Biomed Valencia, Valencia, Spain; [Aristorena, Mikel; Blanco, Francisco J.; Bernabeu, Carmelo] Ctr Invest Biol, E-28006 Madrid, Spain; [Donderis, Jordi; Aristorena, Mikel; Blanco, Francisco J.; Rubio, Vicente; Bernabeu, Carmelo; Marina, Alberto] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras, Valencia, Spain; [Round, Adam] European Mol Biol Lab, F-38042 Grenoble, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; European Molecular Biology Laboratory (EMBL)	Alt, A (corresponding author), Inst Biomed Valencia, Valencia, Spain.	amarina@ibv.csic.es	Blanco, Francisco-Javier/H-3413-2012; Bernabeu, Carmelo/L-3226-2014; Rubio, Vicente/K-7919-2014; Bernabeu, Carmelo/P-4662-2019; Alt, Aaron/A-1551-2017; Marina, Alberto/H-6264-2011; Miguel-Romero, Laura/AAV-2448-2021	Blanco, Francisco-Javier/0000-0002-9929-6707; Bernabeu, Carmelo/0000-0002-1563-6162; Rubio, Vicente/0000-0001-8124-1196; Bernabeu, Carmelo/0000-0002-1563-6162; Alt, Aaron/0000-0002-6708-9826; Marina, Alberto/0000-0002-1334-5273; Miguel-Romero, Laura/0000-0002-7631-6453; Round, Adam/0000-0002-0723-8228	Ministerio de Ciencia e Innovacion of Spain [BIO2009-10872, BIO2010-15424, SAF2010-19222]; Conselleria de Sanitat of Valencian Government [AP-072/11]; Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER); Prometeo [2009/051]; Genoma Espana (MEICA); Valencian Government Prometeo [2009/051]	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Conselleria de Sanitat of Valencian Government; Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER); Prometeo; Genoma Espana (MEICA); Valencian Government Prometeo	This study was supported by grants from the Ministerio de Ciencia e Innovacion of Spain (grants BIO2009-10872 and BIO2010-15424 to AM, SAF2010-19222 to CB), Conselleria de Sanitat of Valencian Government (grant AP-072/11 to AM), Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER) (intramural grant to AM, VR and CB), Prometeo (grant 2009/051 to VR), and Genoma Espana (MEICA). CIBERER is an initiative of the Instituto de Salud Carlos III of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank R. Owens for the pOPIN suit of vectors, N. Callewaert for the HEK293S GNT1- cells, the ESRF (Grenoble) for SAXS beamline facilities, EMBO for giving AA the opportunity to attend a SAXS course, the Instituto de Agroquimica y Tecnologia de Alimentos (IATA-CSIC, Burjassot, Valencia) for allowing utilization of the BiaCore equipment, and J. Rodriguez Diaz for help with this equipment. AA was first a FEBS short-term fellow and then a JAE-Doc CSIC fellow, LM-R a fellow of the Valencian Government Prometeo grant 2009/051, and JD a CIBERER shuttle fellow.	Arthur HM, 2000, DEV BIOL, V217, P42, DOI 10.1006/dbio.1999.9534; Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; Basile G, 2009, MOL BIOTECHNOL, V41, P26, DOI 10.1007/s12033-008-9091-2; Bernabeu C, 2010, J APPL BIOMED, V8, P169, DOI 10.2478/v10136-009-0020-x; Bernabeu C, 2009, BBA-MOL BASIS DIS, V1792, P954, DOI 10.1016/j.bbadis.2009.07.003; Berrow Nick S., 2009, V498, P75, DOI 10.1007/978-1-59745-196-3_5; Blanco FJ, 2005, J CELL PHYSIOL, V204, P574, DOI 10.1002/jcp.20311; Bourdeau A, 1999, J CLIN INVEST, V104, P1343, DOI 10.1172/JCI8088; Cannon JP, 2011, METHODS MOL BIOL, V748, P51, DOI 10.1007/978-1-61779-139-0_4; Castonguay R, 2011, J BIOL CHEM, V286, P30034, DOI 10.1074/jbc.M111.260133; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; David L, 2009, CYTOKINE GROWTH F R, V20, P203, DOI 10.1016/j.cytogfr.2009.05.001; Finnson KW, 2008, J BONE MINER RES, V23, P896, DOI 10.1359/JBMR.080209; GOUGOS A, 1990, J BIOL CHEM, V265, P8361; Guerrero-Esteo M, 1999, EUR J CELL BIOL, V78, P614, DOI 10.1016/S0171-9335(99)80046-6; Guerrero-Esteo M, 2002, J BIOL CHEM, V277, P29197, DOI 10.1074/jbc.M111991200; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lastres P, 1996, J CELL BIOL, V133, P1109, DOI 10.1083/jcb.133.5.1109; Le BV, 2009, BIOCHEM BIOPH RES CO, V383, P386, DOI 10.1016/j.bbrc.2009.02.162; Lebrin F, 2008, TRENDS CARDIOVAS MED, V18, P25, DOI 10.1016/j.tcm.2007.11.003; Letamendia A, 1998, J BIOL CHEM, V273, P33011, DOI 10.1074/jbc.273.49.33011; Li CG, 2001, MICROSC RES TECHNIQ, V52, P437, DOI 10.1002/1097-0029(20010215)52:4<437::AID-JEMT1029>3.0.CO;2-G; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Lin SJ, 2011, P NATL ACAD SCI USA, V108, P5232, DOI 10.1073/pnas.1010689108; Llorca O, 2007, J MOL BIOL, V365, P694, DOI 10.1016/j.jmb.2006.10.015; Lopez-Novoa JM, 2010, AM J PHYSIOL-HEART C, V299, pH959, DOI 10.1152/ajpheart.01251.2009; Lutteke T, 2006, GLYCOBIOLOGY, V16, p71R, DOI 10.1093/glycob/cwj049; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Mitchell D, 2010, MOL CANCER THER, V9, P379, DOI 10.1158/1535-7163.MCT-09-0650; Mitra N, 2006, TRENDS BIOCHEM SCI, V31, P156, DOI 10.1016/j.tibs.2006.01.003; Pardali E, 2010, TRENDS CELL BIOL, V20, P556, DOI 10.1016/j.tcb.2010.06.006; Pernot P, 2010, J PHYS CONF SER, V247, DOI 10.1088/1742-6596/247/1/012009; Pichuantes S, 1997, TISSUE ANTIGENS, V50, P265, DOI 10.1111/j.1399-0039.1997.tb02870.x; Plaza S, 2010, TRENDS CELL BIOL, V20, P524, DOI 10.1016/j.tcb.2010.06.002; Raab U, 1999, BIOCHEM J, V339, P579, DOI 10.1042/0264-6021:3390579; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Ricard N, 2010, BLOOD, V116, P1604, DOI 10.1182/blood-2010-03-276881; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Schrodinger LLC, 2006, PYMOL MOL GRAPHICS S; Shovlin CL, 2010, BLOOD REV, V24, P203, DOI 10.1016/j.blre.2010.07.001; Suzuki Y, 2010, J CELL SCI, V123, P1684, DOI 10.1242/jcs.061556; Takacs E, 2009, FEBS LETT, V583, P865, DOI 10.1016/j.febslet.2009.02.011; Upton PD, 2009, J BIOL CHEM, V284, P15794, DOI 10.1074/jbc.M109.002881	50	73	78	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e29948	10.1371/journal.pone.0029948	http://dx.doi.org/10.1371/journal.pone.0029948			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347366	Green Published, Green Submitted, gold			2022-12-25	WOS:000302730100005
J	Creswell, KG; Sayette, MA; Manuck, SB; Ferrell, RE; Hill, SY; Dimoff, JD				Creswell, Kasey G.; Sayette, Michael A.; Manuck, Stephen B.; Ferrell, Robert E.; Hill, Shirley Y.; Dimoff, John D.			DRD4 Polymorphism Moderates the Effect of Alcohol Consumption on Social Bonding	PLOS ONE			English	Article							GENE-ENVIRONMENT INTERACTIONS; DOPAMINE D-4 RECEPTOR; VNTR POLYMORPHISM; DRUG-ADDICTION; SUBSTANCE USE; DRINKING; RISK; ASSOCIATION; EXPECTANCIES; METAANALYSIS	Development of interpersonal relationships is a fundamental human motivation, and behaviors facilitating social bonding are prized. Some individuals experience enhanced reward from alcohol in social contexts and may be at heightened risk for developing and maintaining problematic drinking. We employed a 3 (group beverage condition) 62 (genotype) design (N = 422) to test the moderating influence of the dopamine D4 receptor gene (DRD4 VNTR) polymorphism on the effects of alcohol on social bonding. A significant gene x environment interaction showed that carriers of at least one copy of the 7-repeat allele reported higher social bonding in the alcohol, relative to placebo or control conditions, whereas alcohol did not affect ratings of 7-absent allele carriers. Carriers of the 7-repeat allele were especially sensitive to alcohol's effects on social bonding. These data converge with other recent gene-environment interaction findings implicating the DRD4 polymorphism in the development of alcohol use disorders, and results suggest a specific pathway by which social factors may increase risk for problematic drinking among 7-repeat carriers. More generally, our findings highlight the potential utility of employing transdisciplinary methods that integrate genetic methodologies, social psychology, and addiction theory to improve theories of alcohol use and abuse.	[Creswell, Kasey G.; Sayette, Michael A.; Manuck, Stephen B.; Dimoff, John D.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; [Ferrell, Robert E.] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15260 USA; [Hill, Shirley Y.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Creswell, KG (corresponding author), Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA.	kgriffin@pitt.edu			National Institute on Alcohol Abuse and Alcoholism [F31AA018888, R01AA015773]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F31AA018888, R01AA015773, R01AA015168, R01AA008082, R01AA018289] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by grants from the National Institute on Alcohol Abuse and Alcoholism (F31AA018888 to Kasey Griffin and R01AA015773 to Michael Sayette). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGNOSTIC STAT MANU, V4th; ASGHARI V, 1995, J NEUROCHEM, V65, P1157, DOI 10.1046/j.1471-4159.1995.65031157.x; Bachman JG, 64 I SOC RES; Bakermans-Kranenburg MJ, 2011, DEV PSYCHOPATHOL, V23, P39, DOI 10.1017/S0954579410000635; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Beseler CL, 2008, ALCOHOL CLIN EXP RES, V32, P607, DOI 10.1111/j.1530-0277.2008.00619.x; BOLLEN KA, 1990, SOC FORCES, V69, P479, DOI 10.2307/2579670; Comings DE, 2001, CLIN GENET, V60, P107, DOI 10.1034/j.1399-0004.2001.600204.x; Congdon E, 2008, AM J MED GENET B, V147B, P27, DOI 10.1002/ajmg.b.30557; Conway KP, 2003, ADDICT BEHAV, V28, P823, DOI 10.1016/S0306-4603(02)00265-4; Cooper M.L., 1994, PSYCHOL ASSESSMENT, V6, P117, DOI [https://doi.org/10.1037/1040-3590.6.2.117, DOI 10.1037/1040-3590.6.2.117, 10.1037/1040-3590.6.2.117]; COOPER ML, 1995, J PERS SOC PSYCHOL, V69, P990, DOI 10.1037/0022-3514.69.5.990; Costa P.T., 1992, NEO FFI PERSONALITY; de Wit H, 2005, MIND ALTERING DRUGS, V1, P258; Dick DM, 2001, J ABNORM PSYCHOL, V110, P625, DOI 10.1037//0021-843X.110.4.625; Ding YC, 2002, P NATL ACAD SCI USA, V99, P309, DOI 10.1073/pnas.012464099; DOTY P, 1995, PSYCHOPHARMACOLOGY, V118, P19, DOI 10.1007/BF02245245; Dreber A, 2009, EVOL HUM BEHAV, V30, P85, DOI 10.1016/j.evolhumbehav.2008.11.001; Ducci F, 2008, ADDICTION, V103, P1414, DOI 10.1111/j.1360-0443.2008.02203.x; Eisenberg DTA, 2010, SOC COGN AFFECT NEUR, V5, P194, DOI 10.1093/scan/nsp026; Eisenegger C, 2010, BIOL PSYCHIAT, V67, P702, DOI 10.1016/j.biopsych.2009.09.021; Engels RCME, 2005, J DRUG EDUC, V35, P147, DOI 10.2190/6Q6B-3LMA-VMVA-L312; EVANS NJ, 1986, SMALL GROUP BEHAV, V17, P203, DOI 10.1177/104649648601700205; Faraone SV, 2001, AM J PSYCHIAT, V158, P1052, DOI 10.1176/appi.ajp.158.7.1052; Filbey FM, 2008, ALCOHOL CLIN EXP RES, V32, P1113, DOI 10.1111/j.1530-0277.2008.00692.x; Forbes EE, 2009, MOL PSYCHIATR, V14, P60, DOI 10.1038/sj.mp.4002086; Fromme K, 2004, ALCOHOL CLIN EXP RES, V28, P247, DOI 10.1097/01.ALC.0000113420.28472.25; Garcia JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014162; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Goldman D, 2006, FOCUS, V4, P401; Goldman M.S., 1987, PSYCHOL THEORIES DRI, P181; HARRISON GG, 1985, ANN INTERN MED, V103, P989, DOI 10.7326/0003-4819-103-6-989; Heath AC, 2002, ALCOHOL RES HEALTH, V26, P193; Hill SY, 1999, AM J MED GENET, V88, P676, DOI 10.1002/(SICI)1096-8628(19991215)88:6<676::AID-AJMG18>3.0.CO;2-S; Hutchison KE, 2002, HEALTH PSYCHOL, V21, P139, DOI 10.1037//0278-6133.21.2.139; Jovanovic V, 1999, PHARMACOGENETICS, V9, P561, DOI 10.1097/00008571-199910000-00003; Kahler CW, 2003, PSYCHOL ADDICT BEHAV, V17, P226, DOI 10.1037/0893-164X.17.3.226; Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189; Kashy D.A., 2000, HDB RES METHODS SOCI, P451, DOI DOI 10.1017/CBO9780511996481; Kendler KS, 2011, PSYCHOL MED, V41, P1507, DOI 10.1017/S003329171000190X; Kendler KS, 2011, TWIN RES HUM GENET, V14, P1, DOI 10.1375/twin.14.1.1; Kenny DA, 2002, J PERS SOC PSYCHOL, V83, P126, DOI 10.1037/0022-3514.83.1.126; Kirchner TR, 2006, J STUD ALCOHOL, V67, P785, DOI 10.15288/jsa.2006.67.785; Krach S, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00022; Kuhnen CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004362; Larsen H, 2010, PSYCHOL SCI, V21, P1064, DOI 10.1177/0956797610376654; Laucht M, 2007, J NEURAL TRANSM, V114, P1097, DOI 10.1007/s00702-007-0703-y; Laucht M, 2005, J AM ACAD CHILD PSY, V44, P477, DOI 10.1097/01.chi.0000155980.01792.7f; Le Foll B, 2009, BEHAV PHARMACOL, V20, P1, DOI 10.1097/FBP.0b013e3283242f05; Li DW, 2006, HUM MOL GENET, V15, P2276, DOI 10.1093/hmg/ddl152; LICHTER JB, 1993, HUM MOL GENET, V2, P767, DOI 10.1093/hmg/2.6.767; MacKillop J, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-11; MANN LM, 1987, J CONSULT CLIN PSYCH, V55, P411, DOI 10.1037/0022-006X.55.3.411; MARTIN CS, 1993, ALCOHOL CLIN EXP RES, V17, P140, DOI 10.1111/j.1530-0277.1993.tb00739.x; MARTIN CS, 1993, J STUD ALCOHOL, V54, P750, DOI 10.15288/jsa.1993.54.750; McGeary J, 2009, PHARMACOL BIOCHEM BE, V93, P222, DOI 10.1016/j.pbb.2009.03.010; McGue M, 2004, DECADE BEHAV, P41, DOI 10.1037/10684-003; Moffitt TE, 2006, PERSPECT PSYCHOL SCI, V1, P5, DOI 10.1111/j.1745-6916.2006.00002.x; Monroe SM, 2008, PSYCHOL SCI, V19, P947, DOI 10.1111/j.1467-9280.2008.02181.x; Munafo MR, 2008, BIOL PSYCHIAT, V63, P852, DOI 10.1016/j.biopsych.2007.08.016; Munafo MR, 2009, BIOL PSYCHIAT, V65, P211, DOI 10.1016/j.biopsych.2008.06.009; Oak JN, 2000, EUR J PHARMACOL, V405, P303, DOI 10.1016/S0014-2999(00)00562-8; Park A, 2008, PSYCHOL ADDICT BEHAV, V22, P219, DOI 10.1037/0893-164X.22.2.219; Park A, 2011, J ABNORM PSYCHOL, V120, P585, DOI 10.1037/a0022648; Patrick ME, 2011, PSYCHOL ADDICT BEHAV, V25, P330, DOI 10.1037/a0022445; Patrick ME, 2011, J STUD ALCOHOL DRUGS, V72, P106, DOI 10.15288/jsad.2011.72.106; Perez de Castro I, 1997, PHARMACOGENETICS, V7, P345; Ray LA, 2010, J ABNORM PSYCHOL, V119, P115, DOI 10.1037/a0017550; Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878; ROHSENOW DJ, 1981, ADDICT BEHAV, V6, P107, DOI 10.1016/0306-4603(81)90003-4; Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P226, DOI 10.1111/j.1469-7610.2005.01557.x; Rutter M, 2001, PSYCHOL BULL, V127, P291, DOI 10.1037//0033-2909.127.3.291; SAYETTE MA, 1993, PSYCHOL BULL, V114, P459, DOI 10.1037/0033-2909.114.3.459; Sayette MA, PSYCHOL SCI IN PRESS; Shanahan MJ, 2005, J GERONTOL B-PSYCHOL, V60, P65, DOI 10.1093/geronb/60.Special_Issue_1.65; Sher KJ, 2005, ANNU REV CLIN PSYCHO, V1, P493, DOI 10.1146/annurev.clinpsy.1.102803.144107; Sher KJ, 2005, MIND ALTERING DRUGS, P135, DOI DOI 10.1093/ACPROF:OSO/9780195165319.003.0005; Shore DM, 2011, EMOTION, V11, P169, DOI 10.1037/a0022601; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; Slutske WS, 2004, J ABNORM PSYCHOL, V113, P530, DOI 10.1037/0021-843X.113.4.530; SMITH GT, 1995, J ABNORM PSYCHOL, V104, P32, DOI 10.1037/0021-843X.104.1.32; van den Wildenberg E, 2007, ADDICT BIOL, V12, P210, DOI 10.1111/j.1369-1600.2007.00064.x; VANTOL HHM, 1992, NATURE, V358, P149; Vogul-Sprott M, 1999, PSYCHOL THEORIES DRI; Volkow ND, 2004, NAT REV NEUROSCI, V5, P963, DOI 10.1038/nrn1539; Wang E, 2004, AM J HUM GENET, V74, P931, DOI 10.1086/420854; Weiss F, 1991, NEUROPHARMACOLOGY ET, P125; Young KA, 2011, NEUROSCI BIOBEHAV R, V35, P498, DOI 10.1016/j.neubiorev.2010.06.004; Zhong SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013765	90	39	40	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e28914	10.1371/journal.pone.0028914	http://dx.doi.org/10.1371/journal.pone.0028914			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347363	Green Published, gold			2022-12-25	WOS:000302730100004
J	Bahia, PK; Bennett, ES; Taylor-Clark, TE				Bahia, Parmvir K.; Bennett, Eric S.; Taylor-Clark, Thomas E.			Reductions in External Divalent Cations Evoke Novel Voltage-Gated Currents in Sensory Neurons	PLOS ONE			English	Article							ROOT GANGLION NEURONS; CALCIUM-CHANNELS; AFFERENT NEURONS; XENOPUS OOCYTES; EXTRACELLULAR CALCIUM; POTASSIUM CHANNELS; SODIUM-CHANNELS; CA2+ CHANNEL; NA+ CHANNEL; MG2+ BLOCK	It has long been recognized that divalent cations modulate cell excitability. Sensory nerve excitability is of critical importance to peripheral diseases associated with pain, sensory dysfunction and evoked reflexes. Thus we have studied the role these cations play on dissociated sensory nerve activity. Withdrawal of both Mg2+ and Ca2+ from external solutions activates over 90% of dissociated mouse sensory neurons. Imaging studies demonstrate a Na+ influx that then causes depolarization-mediated activation of voltage-gated Ca2+ channels (Ca-V), which allows Ca2+ influx upon divalent reintroduction. Inhibition of CaV (omega-conotoxin, nifedipine) or Na-V (tetrodotoxin, lidocaine) fails to reduce the Na+ influx. The Ca2+ influx is inhibited by Ca-V inhibitors but not by TRPM7 inhibition (spermine) or store-operated channel inhibition (SKF96365). Withdrawal of either Mg2+ or Ca2+ alone fails to evoke cation influxes in vagal sensory neurons. In electrophysiological studies of dissociated mouse vagal sensory neurons, withdrawal of both Mg2+ and Ca2+ from external solutions evokes a large slowly-inactivating voltage-gated current (I-DF) that cannot be accounted for by an increased negative surface potential. Withdrawal of Ca2+ alone fails to evoke I-DF. Evidence suggests I-DF is a non-selective cation current. The IDF is not reduced by inhibition of Na-V (lidocaine, riluzole), Ca-V (cilnidipine, nifedipine), K-V (tetraethylammonium, 4-aminopyridine) or TRPM7 channels (spermine). In summary, sensory neurons express a novel voltage-gated cation channel that is inhibited by external Ca2+ (IC50 similar to 0.5 mu M) or Mg2+ (IC50 similar to 3 mu M). Activation of this putative channel evokes substantial cation fluxes in sensory neurons.	[Bahia, Parmvir K.; Bennett, Eric S.; Taylor-Clark, Thomas E.] Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Bahia, PK (corresponding author), Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA.	ttaylorc@health.usf.edu	Taylor-Clark, Thomas/I-6148-2012	Taylor-Clark, Thomas/0000-0002-5056-2699	National Heart, Lung and Blood Institute (NHLBI) [R00HL088520]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL088520] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by the National Heart, Lung and Blood Institute (NHLBI), grant number: R00HL088520. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARELLANO RO, 1995, J PHYSIOL-LONDON, V484, P593, DOI 10.1113/jphysiol.1995.sp020689; Armstrong CM, 1999, P NATL ACAD SCI USA, V96, P4154, DOI 10.1073/pnas.96.7.4154; Bosteels S, 1999, CARDIOVASC RES, V43, P417, DOI 10.1016/S0008-6363(99)00098-X; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen TY, 1998, J GEN PHYSIOL, V112, P715, DOI 10.1085/jgp.112.6.715; Cordoba-Rodriguez R, 1999, P NATL ACAD SCI USA, V96, P7650, DOI 10.1073/pnas.96.14.7650; Docherty RJ, 2006, NEUROPHARMACOLOGY, V51, P1047, DOI 10.1016/j.neuropharm.2006.06.021; Ednie AR, 2011, COMPREHENSI IN PRESS; Furukawa T, 1999, J PHARMACOL EXP THER, V291, P464; HABLITZ JJ, 1986, BIOPHYS J, V50, P753, DOI 10.1016/S0006-3495(86)83515-9; HARRIS RJ, 1981, J CEREBR BLOOD F MET, V1, P203, DOI 10.1038/jcbfm.1981.21; HAY M, 1994, BRAIN RES, V639, P333, DOI 10.1016/0006-8993(94)91749-3; HAY M, 1994, NEUROSCI LETT, V167, P179, DOI 10.1016/0304-3940(94)91056-1; Hille B., 2001, ION CHANNELS EXCITAB, P635; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Kozak JA, 2005, J GEN PHYSIOL, V126, P499, DOI 10.1085/jgp.200509324; Kozak JA, 2003, BIOPHYS J, V84, P922, DOI 10.1016/S0006-3495(03)74909-1; Kuner T, 1996, J NEUROSCI, V16, P3549; Kwong K, 2008, J PHYSIOL-LONDON, V586, P1321, DOI 10.1113/jphysiol.2007.146365; Lancaster E, 2001, J NEUROPHYSIOL, V85, P247, DOI 10.1152/jn.2001.85.1.247; LI JQ, 1994, PFLUG ARCH EUR J PHY, V429, P183, DOI 10.1007/BF00374311; Lopez-Santiago LF, 2011, J BIOL CHEM, V286, P22913, DOI 10.1074/jbc.M111.242370; LUX HD, 1990, J PHYSIOL-LONDON, V430, P159, DOI 10.1113/jphysiol.1990.sp018287; Macianskiene R, 2002, AM J PHYSIOL-HEART C, V282; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Morris M E, 1992, Magnes Res, V5, P303; Mubagwa K, 1997, J PHYSIOL-LONDON, V502, P235, DOI 10.1111/j.1469-7793.1997.235bk.x; Murakami M, 2001, EUR J PHARMACOL, V419, P175, DOI 10.1016/S0014-2999(01)00985-2; Nilius B, 2001, J BIOL CHEM, V276, P1020, DOI 10.1074/jbc.M006184200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Po SS, 1999, J CARDIOVASC PHARM, V33, P181, DOI 10.1097/00005344-199902000-00002; Sabovcik R, 1996, PFLUG ARCH EUR J PHY, V431, P599, DOI 10.1007/BF02191909; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Song JH, 1997, J PHARMACOL EXP THER, V282, P707; Tapia R, 1997, NEUROCHEM INT, V30, P137, DOI 10.1016/S0197-0186(96)00056-3; Taylor-Clark TE, 2008, BRIT J PHARMACOL, V154, P1359, DOI 10.1038/bjp.2008.196; Taylor-Clark T, 2006, J APPL PHYSIOL, V101, P950, DOI 10.1152/japplphysiol.00222.2006; Taylor-Clark TE, 2008, MOL PHARMACOL, V73, P274, DOI 10.1124/mol.107.040832; Undem BJ, 2003, J NEUROPHYSIOL, V89, P1196, DOI 10.1152/jn.00553.2002; VERNINO S, 1992, NEURON, V8, P127, DOI 10.1016/0896-6273(92)90114-S; Virginio C, 1997, NEUROPHARMACOLOGY, V36, P1285, DOI 10.1016/S0028-3908(97)00141-X; Wei WL, 2007, P NATL ACAD SCI USA, V104, P16323, DOI 10.1073/pnas.0701149104; Zhang P, 2001, J GEN PHYSIOL, V117, P563, DOI 10.1085/jgp.117.6.563; ZUFALL F, 1993, J NEUROPHYSIOL, V69, P1758, DOI 10.1152/jn.1993.69.5.1758	46	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e31585	10.1371/journal.pone.0031585	http://dx.doi.org/10.1371/journal.pone.0031585			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328938	Green Published, Green Submitted, gold			2022-12-25	WOS:000302179300024
J	Salvatori, L; Caporuscio, F; Verdina, A; Starace, G; Crispi, S; Nicotra, MR; Russo, A; Calogero, RA; Morgante, E; Natali, PG; Russo, MA; Petrangeli, E				Salvatori, Luisa; Caporuscio, Francesca; Verdina, Alessandra; Starace, Giuseppe; Crispi, Stefania; Nicotra, Maria Rita; Russo, Andrea; Calogero, Raffaele Adolfo; Morgante, Emanuela; Natali, Pier Giorgio; Russo, Matteo Antonio; Petrangeli, Elisa			Cell-to-Cell Signaling Influences the Fate of Prostate Cancer Stem Cells and Their Potential to Generate More Aggressive Tumors	PLOS ONE			English	Article							E-CADHERIN EXPRESSION; NEUROENDOCRINE CELLS; GROWTH; ADHESION; DENSITY; DIFFERENTIATION; IDENTIFICATION; NORMALIZATION; METASTASIS; VIMENTIN	An increasing number of malignancies has been shown to be initiated and propelled by small subpopulations of cancer stem cells (CSC). However, whether tumor aggressiveness is driven by CSC and by what extent this property may be relevant within the tumor mass is still unsettled. To address this issue, we isolated a rare tumor cell population on the basis of its CD44(+) CD24(-) phenotype from the human androgen-independent prostate carcinoma cell line DU145 and established its CSC properties. The behavior of selected CSC was investigated with respect to the bulk DU145 cells. The injection of CSC in nude mice generated highly vascularized tumors infiltrating the adjacent tissues, showing high density of neuroendocrine cells and expressing low levels of E-cadherin and beta-catenin as well as high levels of vimentin. On the contrary, when a comparable number of unsorted DU145 cells were injected the resulting tumors were less aggressive. To investigate the different features of tumors in vivo, the influence of differentiated tumor cells on CSC was examined in vitro by growing CSC in the absence or presence of conditioned medium from DU145 cells. CSC grown in permissive conditions differentiated into cell populations with features similar to those of cells held in aggressive tumors generated from CSC injection. Differently, conditioned medium induced CSC to differentiate into a cell phenotype comparable to cells of scarcely aggressive tumors originated from bulk DU145 cell injection. These findings show for the first time that CSC are able to generate differentiated cells expressing either highly or scarcely aggressive phenotype, thus influencing prostate cancer progression. The fate of CSC was determined by signals released from tumor environment. Moreover, using microarray analysis we selected some molecules which could be involved in this cell-to-cell signaling, hypothesizing their potential value for prognostic or therapeutic applications.	[Salvatori, Luisa; Nicotra, Maria Rita; Petrangeli, Elisa] CNR, Inst Mol Biol & Pathol, Rome, Italy; [Salvatori, Luisa; Caporuscio, Francesca; Verdina, Alessandra; Starace, Giuseppe; Petrangeli, Elisa] Regina Elena Inst Canc Res, CRS, Dept Therapeut Program Dev, Rome, Italy; [Caporuscio, Francesca; Morgante, Emanuela; Russo, Matteo Antonio; Petrangeli, Elisa] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Crispi, Stefania] CNR, Inst Genet & Biophys, Gene Express Core, Human Mol Genet Lab, I-80125 Naples, Italy; [Russo, Andrea] Regina Elena Inst Canc Res, Dept Surg Pathol, Rome, Italy; [Calogero, Raffaele Adolfo] Ctr Mol Biotechnol, Bioinformat & Genom Unit, Turin, Italy; [Natali, Pier Giorgio] Univ G dAnnunzio, CINBO Labs, Chieti, Italy; [Russo, Matteo Antonio] IRCCS San Raffaele Pisana, Dept Cellular & Mol Pathol, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; G d'Annunzio University of Chieti-Pescara; IRCCS San Raffaele Pisana	Salvatori, L (corresponding author), CNR, Inst Mol Biol & Pathol, Rome, Italy.	luisa.salvatori@ifo.it	Verdina, Alessandra/ABH-7405-2020; Salvatori, Luisa/AAK-9365-2021; Verdina, Alessandra/H-8868-2017; Calogero, Raffaele/K-9428-2019; Russo, Matteo/AAD-7733-2021	Verdina, Alessandra/0000-0001-9972-9237; Verdina, Alessandra/0000-0001-9972-9237; Calogero, Raffaele/0000-0002-2848-628X; Crispi, Stefania/0000-0002-7566-1554	Italian Ministry of Health [PRIN 2006062242]	Italian Ministry of Health(Ministry of Health, Italy)	This study was supported in part by the Italian Ministry of Health (PRIN 2006062242). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ABRAHAMSSON PA, 1993, J ANDROL, V14, P307; Abrahamsson PA, 1999, ENDOCR-RELAT CANCER, V6, P503, DOI 10.1677/erc.0.0060503; Bae KM, 2010, J UROLOGY, V183, P2045, DOI 10.1016/j.juro.2009.12.092; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BONKHOFF H, 1993, VIRCHOWS ARCH A, V423, P291, DOI 10.1007/BF01606893; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; DAMSKY CH, 1983, CELL, V34, P455, DOI 10.1016/0092-8674(83)90379-3; De Marzo AM, 1999, UROLOGY, V53, P707, DOI 10.1016/S0090-4295(98)00577-9; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Grobhotz R, 2005, HUM PATHOL, V36, P562, DOI 10.1016/j.humpath.2005.02.019; Han SH, 2003, ONCOGENE, V22, P4035, DOI 10.1038/sj.onc.1206610; Hanai J, 2005, J BIOL CHEM, V280, P13641, DOI 10.1074/jbc.M413047200; HINCK L, 1994, J CELL BIOL, V124, P729, DOI 10.1083/jcb.124.5.729; HOOSEIN NM, 1993, J UROLOGY, V149, P1209, DOI 10.1016/S0022-5347(17)36349-8; Hurt EM, 2008, BRIT J CANCER, V98, P756, DOI 10.1038/sj.bjc.6604242; Huss WJ, 2004, PROSTATE, V60, P77, DOI 10.1002/pros.20041; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jennbacken K, 2005, PROSTATE, V65, P110, DOI 10.1002/pros.20276; Kamiya N, 2008, INT J UROL, V15, P423, DOI 10.1111/j.1442-2042.2008.02015.x; KESSEL RG, 1992, INT REV CYTOL, V133, P43, DOI 10.1016/S0074-7696(08)61858-6; Lang SH, 2002, PROSTATE, V52, P253, DOI 10.1002/pros.10088; Lind AJ, 2005, PROSTATE, V62, P394, DOI 10.1002/pros.20163; Liu B, 2007, ONCOGENE, V26, P1811, DOI 10.1038/sj.onc.1209977; Morita N, 1999, BRIT J CANCER, V79, P1879, DOI 10.1038/sj.bjc.6690299; Nagakawa O, 1999, CANCER LETT, V147, P207, DOI 10.1016/S0304-3835(99)00309-2; Nicholson B, 2004, J CELL BIOCHEM, V91, P125, DOI 10.1002/jcb.10772; Orlichenko L, 2009, MOL BIOL CELL, V20, P4140, DOI 10.1091/mbc.E08-10-1043; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Pontes-Junior J, 2009, J CARCINOG, V8, P1; Ravenna L, 1996, PROSTATE, V29, P219, DOI 10.1002/(SICI)1097-0045(199610)29:4&lt;219::AID-PROS3&gt;3.0.CO;2-6; Redmer T, 2011, EMBO REP, V12, P720, DOI 10.1038/embor.2011.88; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; RIUS C, 1992, J CELL SCI, V101, P395; Sanges R, 2007, BIOINFORMATICS, V23, P3406, DOI 10.1093/bioinformatics/btm469; Shiina H, 2005, CANCER RES, V65, P2130, DOI 10.1158/0008-5472.CAN-04-3398; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sun ZJ, 2008, BRIT J CANCER, V99, P1656, DOI 10.1038/sj.bjc.6604712; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; UMBAS R, 1994, CANCER RES, V54, P3929; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Walker MR, 2009, J PATHOL, V217, P169, DOI 10.1002/path.2474; Wang J, 2010, CANCER RES, V70, P10182, DOI 10.1158/0008-5472.CAN-10-2414; Wesley UV, 2005, CANCER RES, V65, P1325, DOI 10.1158/0008-5472.CAN-04-1852; Westfall P.H., 1993, RESAMPLING BASED MUL, V279	47	30	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e31467	10.1371/journal.pone.0031467	http://dx.doi.org/10.1371/journal.pone.0031467			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328933	Green Submitted, Green Published, gold			2022-12-25	WOS:000302179300019
J	O'Halloran, DM; Hamilton, OS; Lee, JI; Gallegos, M; L'Etoile, ND				O'Halloran, Damien M.; Hamilton, O. Scott; Lee, Jin I.; Gallegos, Maria; L'Etoile, Noelle D.			Changes in cGMP Levels Affect the Localization of EGL-4 in AWC in Caenorhabditis elegans	PLOS ONE			English	Article							REGULATES OLFACTORY ADAPTATION; DEPENDENT PROTEIN-KINASE; NUCLEOTIDE-GATED CHANNEL; C-ELEGANS; CHEMOSENSORY NEURONS; CILIA; TRANSPORT; PLASTICITY; MOTORS; CELLS	The Protein Kinase G, EGL-4, is required within the C. elegans AWC sensory neurons to promote olfactory adaptation. After prolonged stimulation of these neurons, EGL-4 translocates from the cytosol to the nuclei of the AWC. This nuclear translocation event is both necessary and sufficient for adaptation of the AWC neuron to odor. A cGMP binding motif within EGL-4 and the G alpha protein ODR-3 are both required for this translocation event, while loss of the guanylyl cyclase ODR-1 was shown to result in constitutively nuclear localization of EGL-4. However, the molecular changes that are integrated over time to produce a stably adapted response in the AWC are unknown. Here we show that odor-induced fluctuations in cGMP levels in the adult cilia may be responsible in part for sending EGL-4 into the AWC nucleus to produce long-term adaptation. We found that reductions in cGMP that result from mutations in the genes encoding the cilia-localized guanylyl cyclases ODR-1 and DAF-11 result in constitutively nuclear EGL-4 even in naive animals. Conversely, increases in cGMP levels that result from mutations in cGMP phosphodiesterases block EGL-4 nuclear entry even after prolonged odor exposure. Expression of a single phosphodiesterase in adult, naive animals was sufficient to modestly increase the number of animals with nuclear EGL-4. Further, coincident acute treatment of animals with odor and the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX) decreased the number of animals with nuclear EGL-4. These data suggest that reducing cGMP levels in AWC is necessary and even partially sufficient for nuclear translocation of EGL-4 and adaptation as a result of prolonged odor exposure. Our genetic analysis and chemical treatment of C. elegans further indicate that cilia morphology, as defined by fluorescent microscopic observation of the sensory endings, may allow for odor-induced fluctuations in cGMP levels and this fluctuation may be responsible for sending EGL-4 into the AWC nucleus.	[O'Halloran, Damien M.; Hamilton, O. Scott; Lee, Jin I.; L'Etoile, Noelle D.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [O'Halloran, Damien M.; L'Etoile, Noelle D.] Univ Calif Davis, Dept Psychiat & Behav Sci, Sacramento, CA 95817 USA; [O'Halloran, Damien M.] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA; [O'Halloran, Damien M.] George Washington Univ, Inst Neurosci, Washington, DC USA; [Lee, Jin I.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Gallegos, Maria] Calif State Univ E Bay, Dept Biol Sci, Hayward, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; George Washington University; George Washington University; Fred Hutchinson Cancer Center; California State University System; California State University East Bay	O'Halloran, DM (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.	damienoh@gwu.edu	O'Halloran, Damien/F-2779-2013		National Institutes of Health/National Institute on Deafness and Other Communication Disorders [R01 DC005991]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005991] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by National Institutes of Health/National Institute on Deafness and Other Communication Disorders R01 DC005991 to NDL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardiel EL, 2008, J NEUROGENET, P1; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Ben-Shahar Y, 2003, J EXP BIOL, V206, P2507, DOI 10.1242/jeb.00442; Birnby DA, 2000, GENETICS, V155, P85; Biron D, 2006, NAT NEUROSCI, V9, P1499, DOI 10.1038/nn1796; Blacque OE, 2006, CELL MOL LIFE SCI, V63, P2145, DOI 10.1007/s00018-006-6180-x; Blacque OE, 2005, CURR BIOL, V15, P935, DOI 10.1016/j.cub.2005.04.059; BRENNER S, 1974, GENETICS, V77, P71; Calvert PD, 2006, TRENDS CELL BIOL, V16, P560, DOI 10.1016/j.tcb.2006.09.001; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; CORBIN JD, 1983, J BIOL CHEM, V258, P1391; Evans JE, 2006, J CELL BIOL, V172, P663, DOI 10.1083/jcb.200509115; Fitzpatrick MJ, 2007, NATURE, V447, P210, DOI 10.1038/nature05764; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; Hallows JL, 2003, J NEUROSCI, V23, P10633; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hong RL, 2008, P NATL ACAD SCI USA, V105, P7779, DOI 10.1073/pnas.0708406105; Isner JC, 2011, PLANT J, V65, P329, DOI 10.1111/j.1365-313X.2010.04418.x; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Johnson JLF, 2010, TRENDS CELL BIOL, V20, P435, DOI 10.1016/j.tcb.2010.05.005; Kaye JA, 2009, NEURON, V61, P57, DOI 10.1016/j.neuron.2008.11.012; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; L'Etoile ND, 2002, NEURON, V36, P1079, DOI 10.1016/S0896-6273(02)01066-8; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lans H, 2004, GENETICS, V167, P1677, DOI 10.1534/genetics.103.024786; Lee JI, 2010, P NATL ACAD SCI USA, V107, P6016, DOI 10.1073/pnas.1000866107; LINDSAY RM, 1994, TRENDS NEUROSCI, V17, P182, DOI 10.1016/0166-2236(94)90099-X; Liu J, 2010, NAT NEUROSCI, V13, P715, DOI 10.1038/nn.2540; Lucas C, 2009, P NATL ACAD SCI USA, V106, P6351, DOI 10.1073/pnas.0809463106; Luo DG, 2008, P NATL ACAD SCI USA, V105, P9855, DOI 10.1073/pnas.0708405105; Matsuki M, 2006, P NATL ACAD SCI USA, V103, P1112, DOI 10.1073/pnas.0506954103; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; Mukhopadhyay S, 2008, DEV CELL, V14, P762, DOI 10.1016/j.devcel.2008.03.002; Nausch LWM, 2008, P NATL ACAD SCI USA, V105, P365, DOI 10.1073/pnas.0710387105; Nuttley WM, 2002, P NATL ACAD SCI USA, V99, P12449, DOI 10.1073/pnas.192101699; O'Halloran DM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000761; Orozco JT, 1999, NATURE, V398, P674, DOI 10.1038/19448; Ortiz CO, 2006, GENETICS, V173, P131, DOI 10.1534/genetics.106.055749; Ou GS, 2005, NATURE, V436, P583, DOI 10.1038/nature03818; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Signor D, 1999, J CELL BIOL, V147, P519, DOI 10.1083/jcb.147.3.519; Signor D, 2000, METHODS, V22, P317, DOI 10.1006/meth.2000.1084; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0	54	25	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31614	10.1371/journal.pone.0031614	http://dx.doi.org/10.1371/journal.pone.0031614			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319638	Green Submitted, Green Published, gold			2022-12-25	WOS:000302178400046
J	Freije, A; Ceballos, L; Coisy, M; Barnes, L; Rosa, M; De Diego, E; Blanchard, JM; Gandarillas, A				Freije, A.; Ceballos, L.; Coisy, M.; Barnes, L.; Rosa, M.; De Diego, E.; Blanchard, J. M.; Gandarillas, A.			Cyclin E drives human keratinocyte growth into differentiation	ONCOGENE			English	Article						skin; stem cells; DNA damage; MYCER; cell size; endoreplication	DEPENDENT KINASE INHIBITOR; EPIDERMAL STEM-CELLS; XENOPUS EGG EXTRACTS; C-MYC; DNA-DAMAGE; TERMINAL DIFFERENTIATION; INVOLUCRIN SYNTHESIS; CHEMICAL INHIBITORS; CANCER DEVELOPMENT; G2/M TRANSITION	Human epidermis is continuously exposed to environmental mutagenic hazard and is the most frequent target of human cancer. How the epidermis coordinates proliferation with differentiation to maintain homeostasis, even in hyperproliferative conditions, is unclear. For instance, overactivation of the proto-oncogene MYC in keratinocytes stimulates differentiation. Here we explore the cell cycle regulation as proliferating human keratinocytes commit to terminal differentiation upon loss of anchorage or overactivation of MYC. The S-phase of the cell cycle is deregulated as mitotic regulators are inhibited in the onset of differentiation. Experimental inhibition of mitotic kinase cdk1 or kinases of the mitosis spindle checkpoint Aurora B or Polo-like Kinase, triggered keratinocyte terminal differentiation. Furthermore, hyperactivation of the cell cycle by overexpressing the DNA replication regulator Cyclin E induced mitosis failure and differentiation. Inhibition of Cyclin E by shRNAs attenuated the induction of differentiation by MYC. In addition, we present evidence that Cyclin E induces DNA damage and the p53 pathway. The results provide novel clues for the mechanisms committing proliferative keratinocytes to differentiate, with implications for tissue homeostasis maintenance, HPV amplification and tumorigenesis. Oncogene (2012) 31, 5180--5192; doi:10.1038/onc.2012.22; published online 20 February 2012	[Freije, A.; Ceballos, L.; Rosa, M.; Gandarillas, A.] Fdn Marques de Valdecilla IFIMAV FMDV, Res & Training Inst, Cell Cycle Stem Cell Fate & Canc Lab, Santander 39011, Spain; [Freije, A.; Ceballos, L.; Rosa, M.; Gandarillas, A.] Univ Cantabria, Dept Mol Biol, E-39005 Santander, Spain; [Coisy, M.; Barnes, L.; Blanchard, J. M.; Gandarillas, A.] Inst Genet Mol Montpellier CNRS UMPII, Montpellier, France; [De Diego, E.] HUMV, Serv Cirugia Pediat, Santander, Spain; [Gandarillas, A.] Inst Univ Rech Clin, Inserm ADR Languedoc Roussillon, Lab Dermatol Mol, UPRES EA 3754, Montpellier, France	Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; Centre National de la Recherche Scientifique (CNRS); Hospital Universitario Marques de Valdecilla (HUMV); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Gandarillas, A (corresponding author), Fdn Marques de Valdecilla IFIMAV FMDV, Res & Training Inst, Cell Cycle Stem Cell Fate & Canc Lab, Av Herrera Oria S-N, Santander 39011, Spain.	ifimav.agandarillas@fmdv.org	Rosa-Garrido, Manuel/AAE-4188-2019	Rosa-Garrido, Manuel/0000-0002-2169-3972	ARC (France); INSERM (Spain); ISCIII (Spain); ISCIII; FMDV-IFIMAV; La Ligue contre le cancer (France); Instituto de Salud Carlos III (ISCIII-Programa Regiones Emergentes); Instituto de Salud Carlos III (Fondo de Investigaciones Sanitarias; Spain) [PI080890]	ARC (France); INSERM (Spain); ISCIII (Spain)(Instituto de Salud Carlos III); ISCIII(Instituto de Salud Carlos III); FMDV-IFIMAV; La Ligue contre le cancer (France); Instituto de Salud Carlos III (ISCIII-Programa Regiones Emergentes); Instituto de Salud Carlos III (Fondo de Investigaciones Sanitarias; Spain)(Instituto de Salud Carlos III)	We are especially grateful to Jean-Claude Rossi and Javier Leon for their strong support. We thank Bruno Amati, Pierre Roux and Jonathon Pines for providing DNA constructs, J. Leon for reagents, Anne Blangy, Vjeko Dulic, Veronique Baldin and Thierry Lorca for technical advice, Daniel Fisher for helpful suggestions, Kathy Brooks and Maria Aramburu for technical support at flow cytometry, J. Leon and Philippe Pasero for critical reading of the manuscript, and Anna Solinis and Diana Solinis for reviewing the English writing. Human skin biopsies were provided with consent by St Jean and Hopital La Peronye (Montpellier, France) and by the Chirurgical Paediatric Service of Hospital Marques de Valdecilla (EdD; HMDV, Santander, Spain). MC was a recipient of a predoctoral fellowship from ARC (France). AG belongs to the INSERM (France) and the FMDV-IFIMAV (Spain) and was financially supported by the INSERM and the ISCIII (Spain). AF and LC were employed by FMDV-IFIMAV and supported by the ISCIII, MR was recipient of a postdoctoral contract by the FMDV-IFIMAV. This work was funded by ARC (AG; France), La Ligue contre le cancer (JMB; France), and Instituto de Salud Carlos III (AG; ISCIII-Programa Regiones Emergentes and Fondo de Investigaciones Sanitarias PI080890; Spain).	ADAMS JC, 1989, NATURE, V340, P307, DOI 10.1038/340307a0; BANKSSCHLEGEL S, 1981, J CELL BIOL, V90, P732, DOI 10.1083/jcb.90.3.732; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Beer S, 2004, PLOS BIOL, V2, P1785, DOI 10.1371/journal.pbio.0020332; Ben-Bassat H, 1999, J PHARMACOL EXP THER, V290, P1442; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Campaner S, 2010, NAT CELL BIOL, V12, P54, DOI 10.1038/ncb2004; Coudreuse D, 2010, NATURE, V468, P1074, DOI 10.1038/nature09543; Dazard JE, 2000, ONCOGENE, V19, P3693, DOI 10.1038/sj.onc.1203695; Dotto GP, 2000, BBA-REV CANCER, V1471, pM43, DOI 10.1016/S0304-419X(00)00019-6; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Fuchs E, 2008, GENE DEV, V22, P976, DOI 10.1101/gad.1645908; Gadea BB, 2005, MOL BIOL CELL, V16, P1305, DOI 10.1091/mbc.E04-10-0891; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Gandarillas A, 2000, EXP GERONTOL, V35, P53, DOI 10.1016/S0531-5565(99)00088-1; GANDARILLAS A, 1995, ONCOGENE, V11, P1403; Gandarillas A, 2000, ONCOGENE, V19, P3278, DOI 10.1038/sj.onc.1203630; Garcia P, 2000, ONCOGENE, V19, P1820, DOI 10.1038/sj.onc.1203494; GUADAGNO TM, 1993, SCIENCE, V262, P1572, DOI 10.1126/science.8248807; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; HANSON KD, 1994, MOL CELL BIOL, V14, P5748, DOI 10.1128/MCB.14.9.5748; Harvat BL, 1998, J CELL SCI, V111, P1185; Hauser P, 2004, MOL CANCER RES, V2, P96; Herold S, 2002, MOL CELL, V10, P509, DOI 10.1016/S1097-2765(02)00633-0; Hurlin PJ, 1995, ONCOGENE, V11, P2487; Iglesias-Ara A, 2010, ONCOGENE, V29, P5579, DOI 10.1038/onc.2010.296; Itahana Koji, 2007, Methods Mol Biol, V371, P21; JANSENDURR P, 1993, P NATL ACAD SCI USA, V90, P3685, DOI 10.1073/pnas.90.8.3685; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Kleinberger-Doron N, 1998, EXP CELL RES, V241, P340, DOI 10.1006/excr.1998.4061; Knockaert M, 2002, TRENDS PHARMACOL SCI, V23, P417, DOI 10.1016/S0165-6147(02)02071-0; Krasinska L, 2008, CELL CYCLE, V7, P1702, DOI 10.4161/cc.7.12.6101; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Lilly MA, 2005, ONCOGENE, V24, P2765, DOI 10.1038/sj.onc.1208610; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Medema RH, 1998, ONCOGENE, V16, P431, DOI 10.1038/sj.onc.1201558; Meijer L, 1996, TRENDS CELL BIOL, V6, P393, DOI 10.1016/0962-8924(96)10034-9; Munoz-Alonso MJ, 2012, J CELL PHYSIOL, V227, P2069, DOI 10.1002/jcp.22935; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Noya F, 2001, J VIROL, V75, P6121, DOI 10.1128/JVI.75.13.6121-6134.2001; Paramio JM, 1998, ONCOGENE, V17, P949, DOI 10.1038/sj.onc.1202031; Perez de Castro I, 2008, CURR OPIN PHARMACOL, V8, P375, DOI 10.1016/j.coph.2008.06.013; Planchais S, 1997, PLANT J, V12, P191, DOI 10.1046/j.1365-313X.1997.12010191.x; Planchais S, 2000, FEBS LETT, V476, P78, DOI 10.1016/S0014-5793(00)01675-6; Rheinwald JG., 1989, CELL GROWTH DIVISION, P81; Rosania GR, 1999, P NATL ACAD SCI USA, V96, P4797, DOI 10.1073/pnas.96.9.4797; Schellmann S, 2005, INT J DEV BIOL, V49, P579, DOI 10.1387/ijdb.051983ss; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Simpson CL, 2010, METHODS MOL BIOL, V585, P127, DOI 10.1007/978-1-60761-380-0_10; SUN TT, 1976, CELL, V9, P511, DOI 10.1016/0092-8674(76)90033-7; Swift LP, 2006, CANCER RES, V66, P4863, DOI 10.1158/0008-5472.CAN-05-3410; Taylor S, 2008, CURR OPIN CELL BIOL, V20, P77, DOI 10.1016/j.ceb.2007.11.008; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Ullah Z, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-10; Watt FM, 2008, NAT REV CANCER, V8, P234, DOI 10.1038/nrc2328; Watt FM, 2006, CURR OPIN GENET DEV, V16, P518, DOI 10.1016/j.gde.2006.08.006; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; WATT FM, 1981, J CELL BIOL, V90, P738, DOI 10.1083/jcb.90.3.738; Whittaker SR, 2007, CELL CYCLE, V6, P3114, DOI 10.4161/cc.6.24.5142; Yin XY, 2001, CANCER RES, V61, P6487; Zanet J, 2005, J CELL SCI, V118, P1693, DOI 10.1242/jcs.02298; Zanet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015701	65	32	33	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	DEC	2012	31	50					5180	5192		10.1038/onc.2012.22	http://dx.doi.org/10.1038/onc.2012.22			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	055WY	22349815				2022-12-25	WOS:000312449800007
J	Mian, I; Pierre-Louis, WS; Dole, N; Gilberti, RM; Dodge-Kafka, K; Tirnauer, JS				Mian, Isma; Pierre-Louis, Willythssa Stephie; Dole, Neha; Gilberti, Renee M.; Dodge-Kafka, Kimberly; Tirnauer, Jennifer S.			LKB1 Destabilizes Microtubules in Myoblasts and Contributes to Myoblast Differentiation	PLOS ONE			English	Article							MUSCLE-CELL-DIFFERENTIATION; TUMOR-SUPPRESSOR KINASE; MYOGENIC DIFFERENTIATION; GENE-PRODUCT; PROTEIN; POLARIZATION; ACTIVATION; POLARITY; DYNAMICS; STRAD	Background: Skeletal muscle myoblast differentiation and fusion into multinucleate myotubes is associated with dramatic cytoskeletal changes. We find that microtubules in differentiated myotubes are highly stabilized, but premature microtubule stabilization blocks differentiation. Factors responsible for microtubule destabilization in myoblasts have not been identified. Findings: We find that a transient decrease in microtubule stabilization early during myoblast differentiation precedes the ultimate microtubule stabilization seen in differentiated myotubes. We report a role for the serine-threonine kinase LKB1 in both microtubule destabilization and myoblast differentiation. LKB1 overexpression reduced microtubule elongation in a Nocodazole washout assay, and LKB1 RNAi increased it, showing LKB1 destabilizes microtubule assembly in myoblasts. LKB1 levels and activity increased during myoblast differentiation, along with activation of the known LKB1 substrates AMP-activated protein kinase (AMPK) and microtubule affinity regulating kinases (MARKs). LKB1 overexpression accelerated differentiation, whereas RNAi impaired it. Conclusions: Reduced microtubule stability precedes myoblast differentiation and the associated ultimate microtubule stabilization seen in myotubes. LKB1 plays a positive role in microtubule destabilization in myoblasts and in myoblast differentiation. This work suggests a model by which LKB1-induced microtubule destabilization facilitates the cytoskeletal changes required for differentiation. Transient destabilization of microtubules might be a useful strategy for enhancing and/or synchronizing myoblast differentiation.	[Mian, Isma; Pierre-Louis, Willythssa Stephie; Dole, Neha; Gilberti, Renee M.; Tirnauer, Jennifer S.] Ctr Mol Med, Farmington, CT 06030 USA; [Dodge-Kafka, Kimberly] Univ Connecticut, Ctr Hlth, Calhoun Ctr Cardiol, Farmington, CT USA	University of Connecticut	Mian, I (corresponding author), Ctr Mol Med, Farmington, CT 06030 USA.	tirnauer@uchc.edu	Gilberti, Renee M./AAN-2226-2021	Dole, Neha/0000-0003-4675-2649	University of Connecticut Health Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082705] Funding Source: NIH RePORTER	University of Connecticut Health Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded from startup funds from the University of Connecticut Health Center. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin N, 2009, P NATL ACAD SCI USA, V106, P8941, DOI 10.1073/pnas.0812469106; ANTIN PB, 1981, J CELL BIOL, V90, P300, DOI 10.1083/jcb.90.2.300; Asada N, 2007, J NEUROSCI, V27, P11769, DOI 10.1523/JNEUROSCI.1938-07.2007; Baas AF, 2004, TRENDS CELL BIOL, V14, P312, DOI 10.1016/j.tcb.2004.04.001; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; BAINS W, 1984, MOL CELL BIOL, V4, P1449, DOI 10.1128/MCB.4.8.1449; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; BELMONT LD, 1990, CELL, V62, P579, DOI 10.1016/0092-8674(90)90022-7; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Bugnard E, 2005, CELL MOTIL CYTOSKEL, V60, P1, DOI 10.1002/cm.20042; Chang W, 2002, J BIOL CHEM, V277, P30690, DOI 10.1074/jbc.M204930200; Conacci-Sorrell M, 2010, CELL, V142, P480, DOI 10.1016/j.cell.2010.06.037; Dorfman J, 2008, MOL BIOL CELL, V19, P1614, DOI 10.1091/mbc.E07-05-0454; Gammon A, 2009, BEST PRACT RES CL GA, V23, P219, DOI 10.1016/j.bpg.2009.02.007; Greco SJ, 2009, BIOCHEM BIOPH RES CO, V380, P98, DOI 10.1016/j.bbrc.2009.01.041; GUNDERSEN GG, 1989, J CELL BIOL, V109, P2275, DOI 10.1083/jcb.109.5.2275; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hezel AF, 2008, ONCOGENE, V27, P6908, DOI 10.1038/onc.2008.342; Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020; Karuman P, 2001, MOL CELL, V7, P1307, DOI 10.1016/S1097-2765(01)00258-1; Katajisto P, 2008, NAT GENET, V40, P455, DOI 10.1038/ng.98; Katajisto P, 2007, BBA-REV CANCER, V1775, P63, DOI 10.1016/j.bbcan.2006.08.003; Kojima Y, 2007, J BIOL CHEM, V282, P23532, DOI 10.1074/jbc.M700590200; Launonen V, 2005, HUM MUTAT, V26, P291, DOI 10.1002/humu.20222; Maiato H, 2004, INT REV CYTOL, V241, P53, DOI 10.1016/S0074-7696(04)41002-X; Mangan ME, 1996, DEVELOPMENT, V122, P771; Mohun Tim, 1992, Current Opinion in Cell Biology, V4, P923, DOI 10.1016/0955-0674(92)90119-W; Musa H, 2003, J MUSCLE RES CELL M, V24, P301; Nakano A, 2010, NAT CELL BIOL, V12, P583, DOI 10.1038/ncb2060; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Shelly M, 2011, DEV NEUROBIOLOGY; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Spencer JA, 2000, J CELL BIOL, V150, P771, DOI 10.1083/jcb.150.4.771; Straube A, 2007, CURR BIOL, V17, P1318, DOI 10.1016/j.cub.2007.06.058; TASSIN AM, 1985, J CELL BIOL, V100, P35, DOI 10.1083/jcb.100.1.35; Thomson M, 2007, AM J PHYSIOL-ENDOC M, V292, pE196, DOI 10.1152/ajpendo.00366.2006; Thomson DM, 2010, J APPL PHYSIOL, V108, P1775, DOI 10.1152/japplphysiol.01293.2009; Vaahtomeri K, 2008, J CELL SCI, V121, P3531, DOI 10.1242/jcs.032706; van Lier MGF, 2010, AM J GASTROENTEROL, V105, P1258, DOI 10.1038/ajg.2009.725; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Vingtdeux V, 2011, ACTA NEUROPATHOL, V121, P337, DOI 10.1007/s00401-010-0759-x; WARREN RH, 1968, J CELL BIOL, V39, P544, DOI 10.1083/jcb.39.3.544; WARREN RH, 1974, J CELL BIOL, V63, P550, DOI 10.1083/jcb.63.2.550; Wei CJ, 2005, CANCER RES, V65, P11297, DOI 10.1158/0008-5472.CAN-05-0716; Zammit PS, 2008, J CELL SCI, V121, P2975, DOI 10.1242/jcs.019661; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006; Zhang SM, 2008, CANCER RES, V68, P740, DOI 10.1158/0008-5472.CAN-07-2989; Zhang T, 2009, J CELL SCI, V122, P1401, DOI 10.1242/jcs.039255	49	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31583	10.1371/journal.pone.0031583	http://dx.doi.org/10.1371/journal.pone.0031583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348111	gold, Green Published, Green Submitted			2022-12-25	WOS:000302737400037
J	Gingaras, C; Danielson, BP; Vigil, KJ; Vey, E; Arduino, RC; Kimata, JT				Gingaras, Cosmina; Danielson, Bryan P.; Vigil, Karen J.; Vey, Elana; Arduino, Roberto C.; Kimata, Jason T.			Absence of XMRV in Peripheral Blood Mononuclear Cells of ARV-Treatment Naive HIV-1 Infected and HIV-1/HCV Coinfected Individuals and Blood Donors	PLOS ONE			English	Article							VIRUS-RELATED VIRUS; CHRONIC-FATIGUE-SYNDROME; HUMAN-IMMUNODEFICIENCY-VIRUS; PROSTATE-CANCER; INFECTIOUS RETROVIRUS; NO ASSOCIATION; MOUSE DNA; PCR; CONTAMINATION; PREVALENCE	Background: Xenotropic murine leukemia virus-related virus (XMRV) has been found in the prostatic tissue of prostate cancer patients and in the blood of chronic fatigue syndrome patients. However, numerous studies have found little to no trace of XMRV in different human cohorts. Based on evidence suggesting common transmission routes between XMRV and HIV-1, HIV-1 infected individuals may represent a high-risk group for XMRV infection and spread. Methodology/Principal Findings: DNA was isolated from the peripheral blood mononuclear cells (PBMCs) of 179 HIV-1 infected treatment naive patients, 86 of which were coinfected with HCV, and 54 healthy blood donors. DNA was screened for XMRV provirus with two sensitive, published PCR assays targeting XMRV gag and env and one sensitive, published nested PCR assay targeting env. Detection of XMRV was confirmed by DNA sequencing. One of the 179 HIV-1 infected patients tested positive for gag by non-nested PCR whereas the two other assays did not detect XMRV in any specimen. All healthy blood donors were negative for XMRV proviral sequences. Sera from 23 HIV-1 infected patients (15 HCV+) and 12 healthy donors were screened for the presence of XMRV-reactive antibodies by Western blot. Thirteen sera (57%) from HIV-1(+) patients and 6 sera (50%) from healthy donors showed reactivity to XMRV-infected cell lysate. Conclusions/Significance: The virtual absence of XMRV in PBMCs suggests that XMRV is not associated with HIV-1 infected or HIV-1/HCV coinfected patients, or blood donors. Although we noted isolated incidents of serum reactivity to XMRV, we are unable to verify the antibodies as XMRV specific.	[Gingaras, Cosmina] Baylor Coll Med, Dept Pediat, Sect Retrovirol, Houston, TX 77030 USA; [Danielson, Bryan P.; Kimata, Jason T.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Vigil, Karen J.; Vey, Elana; Arduino, Roberto C.] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Div Infect Dis, Houston, TX USA; [Gingaras, Cosmina] Baylor Coll Med, Baylor Int Pediat AIDS Initiat, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine	Gingaras, C (corresponding author), Baylor Coll Med, Dept Pediat, Sect Retrovirol, Houston, TX 77030 USA.	jkimata@bcm.edu	Vigil, Karen/HGB-5512-2022	Kimata, Jason/0000-0002-0504-0090	Dan L. Duncan Cancer Center [P30 CA125123]; Baylor-UT CFAR [P30 AI036211]; Baylor Pediatric AIDS Initiative National Institutes of Health (NIH) from the Fogarty International Center of the NIH [D43 TW001036]; NIH [T32 AI007471]; FOGARTY INTERNATIONAL CENTER [D43TW001036] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007471, P30AI036211] Funding Source: NIH RePORTER	Dan L. Duncan Cancer Center; Baylor-UT CFAR; Baylor Pediatric AIDS Initiative National Institutes of Health (NIH) from the Fogarty International Center of the NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research was supported by pilot funding from the Dan L. Duncan Cancer Center (P30 CA125123) and in part by the Baylor-UT CFAR (P30 AI036211). CG was supported by the Baylor Pediatric AIDS Initiative National Institutes of Health (NIH) training grant from the Fogarty International Center of the NIH (D43 TW001036). BD was supported in part by an NIH training grant in molecular virology (T32 AI007471). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloia AL, 2010, CANCER RES, V70, P10028, DOI 10.1158/0008-5472.CAN-10-2837; Arnold RS, 2010, UROLOGY, V75, P755, DOI 10.1016/j.urology.2010.01.038; Balada E, 2010, INT REV IMMUNOL, V29, P351, DOI 10.3109/08830185.2010.485333; Barnes E, 2010, J INFECT DIS, V202, P1482, DOI 10.1086/657167; Bogerd HP, 2011, VIROLOGY, V410, P234, DOI 10.1016/j.virol.2010.11.011; CHESEBRO B, 1983, VIROLOGY, V127, P134, DOI 10.1016/0042-6822(83)90378-1; Cornelissen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012040; CUSSENOT O, 1991, J UROLOGY, V146, P881, DOI 10.1016/S0022-5347(17)37953-3; Danielson BP, 2010, J INFECT DIS, V202, P1470, DOI 10.1086/656146; DEGEORGES A, 1995, INT J CANCER, V62, P724, DOI 10.1002/ijc.2910620613; Dupressoir A, 1997, ONCOGENE, V14, P2951, DOI 10.1038/sj.onc.1201148; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; FAUCI AS, 1988, SCIENCE, V239, P617, DOI 10.1126/science.3277274; Fischer N, 2010, EMERGING INFECT DISE, V16; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; Furuta RA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-20; Garson JA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-13; Gray ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018096; Groom HCT, 2010, P NATL ACAD SCI USA, V107, P5166, DOI 10.1073/pnas.0913650107; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Henrich TJ, 2010, J INFECT DIS, V202, P1478, DOI 10.1086/657168; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Hong P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-224; Hong SH, 2009, J VIROL, V83, P6995, DOI 10.1128/JVI.00268-09; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Hue S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-111; Kunstman KJ, 2010, AIDS, V24, P1784, DOI 10.1097/QAD.0b013e32833b76fb; Lawoko A, 2000, J MED VIROL, V62, P435, DOI 10.1002/1096-9071(200012)62:4<435::AID-JMV7>3.0.CO;2-R; Lintas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016609; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; LUEDERS KK, 1977, CELL, V12, P963, DOI 10.1016/0092-8674(77)90161-1; Maggi F, 2011, CLIN MICROBIOLOGY IN; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Martinez-Fierro ML, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-326; Mikovits JA, 2010, VIRULENCE, V1, P386, DOI 10.4161/viru.1.5.12486; Moles JP, 2003, VIRUS RES, V94, P97, DOI 10.1016/S0168-1702(03)00137-0; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Nelson PN, 2003, J CLIN PATHOL-MOL PA, V56, P11, DOI 10.1136/mp.56.1.11; Oakes B, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-109; Onlamoon N, 2011, J VIROL, V85, P4547, DOI 10.1128/JVI.02411-10; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Paprotka T, 2010, J VIROL, V84, P5719, DOI 10.1128/JVI.00134-10; Qiu X, 2011, TRANSFUSION; Robinson MJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-108; Sakuma R, 2010, VIROLOGY, V397, P1, DOI 10.1016/j.virol.2009.11.013; Sakuma T, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-23; Sato E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-110; Satterfield BC, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-14; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shin CH, 2011, J VIROL, V85, P7195, DOI 10.1128/JVI.00693-11; Singh IR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009948; Stieler K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011738; Switzer WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019065; Switzer WM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-57; Tang SX, 2011, TRANSFUSION, V51, P463, DOI 10.1111/j.1537-2995.2010.02932.x; Tuke PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019953; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; van Kuppeveld FJM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1018; Verhaegh GW, 2011, PROSTATE, V71, P415, DOI 10.1002/pros.21255	61	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31398	10.1371/journal.pone.0031398	http://dx.doi.org/10.1371/journal.pone.0031398			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348082	Green Published, Green Submitted, gold			2022-12-25	WOS:000302733900045
J	Mueller, EE; Schaier, E; Brunner, SM; Eder, W; Mayr, JA; Egger, SF; Nischler, C; Oberkofler, H; Reitsamer, HA; Patsch, W; Sperl, W; Kofler, B				Mueller, Edith E.; Schaier, Elena; Brunner, Susanne M.; Eder, Waltraud; Mayr, Johannes A.; Egger, Stefan F.; Nischler, Christian; Oberkofler, Hannes; Reitsamer, Herbert A.; Patsch, Wolfgang; Sperl, Wolfgang; Kofler, Barbara			Mitochondrial Haplogroups and Control Region Polymorphisms in Age-Related Macular Degeneration: A Case-Control Study	PLOS ONE			English	Article							PIGMENT EPITHELIAL-CELLS; COMPLEMENT FACTOR-H; DNA HAPLOGROUPS; HUMAN MTDNA; DISEASE; DYSFUNCTION; RETINOPATHY; MUTATION; CANCER; DAMAGE	Background: Onset and development of the multifactorial disease age-related macular degeneration (AMD) are highly interrelated with mitochondrial functions such as energy production and free radical turnover. Mitochondrial dysfunction and overproduction of reactive oxygen species may contribute to destruction of the retinal pigment epithelium, retinal atrophy and choroidal neovascularization, leading to AMD. Consequently, polymorphisms of the mitochondrial genome (mtDNA) are postulated to be susceptibility factors for this disease. Previous studies from Australia and the United States detected associations of mitochondrial haplogroups with AMD. The aim of the present study was to test these associations in Middle European Caucasians. Methodology/Principal Findings: Mitochondrial haplogroups (combinations of mtDNA polymorphisms) and mitochondrial CR polymorphisms were analyzed in 200 patients with wet AMD (choroidal neovascularization, CNV), in 66 patients with dry AMD, and in 385 controls from Austria by means of multiplex primer extension analysis and sequencing, respectively. In patients with CNV, haplogroup H was found to be significantly less frequent compared to controls, and haplogroup J showed a trend toward a higher frequency compared to controls. Five CR polymorphisms were found to differ significantly in the two study populations compared to controls, and all, except one (T152C), are linked to those haplogroups. Conclusions/Significance: It can be concluded that haplogroup J is a risk factor for AMD, whereas haplogroup H seems to be protective for AMD.	[Mueller, Edith E.; Schaier, Elena; Brunner, Susanne M.; Eder, Waltraud; Mayr, Johannes A.; Sperl, Wolfgang; Kofler, Barbara] Paracelsus Med Univ, Dept Pediat, Res Program Receptor Biochem & Tumor Metab, Salzburg, Austria; [Egger, Stefan F.; Nischler, Christian; Reitsamer, Herbert A.] Paracelsus Med Univ, Dept Ophthalmol, Salzburg, Austria; [Oberkofler, Hannes; Patsch, Wolfgang] Paracelsus Med Univ, Dept Lab Med, Salzburg, Austria	Paracelsus Private Medical University; Paracelsus Private Medical University; Paracelsus Private Medical University	Mueller, EE (corresponding author), Paracelsus Med Univ, Dept Pediat, Res Program Receptor Biochem & Tumor Metab, Salzburg, Austria.	b.kofler@salk.at		Kofler, Barbara/0000-0002-1198-4776; Brunner, Susanne Maria/0000-0002-9623-1115; Mayr, Johannes/0000-0001-6970-336X	Vereinigung zur Forderung Padiatrischer Forschung und Fortbildung, Salzburg	Vereinigung zur Forderung Padiatrischer Forschung und Fortbildung, Salzburg	The study was supported by the "Vereinigung zur Forderung Padiatrischer Forschung und Fortbildung, Salzburg'' (www.mito-center.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandstatter A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-191; Canter JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002091; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Ebner S, 2009, PLOS ONE IN PRESS; Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103; Isashiki Y, 1998, ACTA OPHTHALMOL SCAN, V76, P6, DOI 10.1034/j.1600-0420.1998.760103.x; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Jarrett SG, 2008, PROG RETIN EYE RES, V27, P596, DOI 10.1016/j.preteyeres.2008.09.001; Jones MM, 2007, ARCH OPHTHALMOL-CHIC, V125, P1235, DOI 10.1001/archopht.125.9.1235; King A, 2004, PHOTOCHEM PHOTOBIOL, V79, P470, DOI 10.1562/LE-03-17.1; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kofler B, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-35; Liang FQ, 2003, EXP EYE RES, V76, P397, DOI 10.1016/S0014-4835(03)00023-X; Loueslati BY, 2010, GENET MOL RES, V9, P1690, DOI 10.4238/vol9-3gmr778; Meyer S, 1999, GENETICS, V152, P1103; Mueller EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016455; Mueller EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006370; Pereira L, 2005, INT J ANDROL, V28, P241, DOI 10.1111/j.1365-2605.2005.00539.x; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; SanGiovanni JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005508; Schmuczerova J, 2009, MUTAT RES-FUND MOL M, V666, P1, DOI 10.1016/j.mrfmmm.2009.03.002; Sue CM, 1997, NEUROLOGY, V49, P1013, DOI 10.1212/WNL.49.4.1013; Udar N, 2009, INVEST OPHTH VIS SCI, V50, P2966, DOI 10.1167/iovs.08-2646; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Vives-Bauza C, 2008, J BIOL CHEM, V283, P24770, DOI 10.1074/jbc.M800706200; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wiesbauer M, 2006, ELECTROPHORESIS, V27, P3864, DOI 10.1002/elps.200600086	27	46	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e30874	10.1371/journal.pone.0030874	http://dx.doi.org/10.1371/journal.pone.0030874			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348027	gold, Green Published, Green Submitted			2022-12-25	WOS:000302733900016
J	Shetty, G; Comish, PB; Weng, CCY; Matin, A; Meistrich, ML				Shetty, Gunapala; Comish, Paul B.; Weng, Connie C. Y.; Matin, Angabin; Meistrich, Marvin L.			Fetal Radiation Exposure Induces Testicular Cancer in Genetically Susceptible Mice	PLOS ONE			English	Article							GERM-CELL TUMORS; CARCINOMA-IN-SITU; MOUSE SPERMATOGENESIS; RISK; TERATOMA; TESTIS; DMRT1; GENES; UTERO	The prevalence of testicular germ cell tumors (TGCT), a common solid tissue malignancy in young men, has been annually increasing at an alarming rate of 3%. Since the majority of testicular cancers are derived from germ cells at the stage of transformation of primordial germ cell (PGC) into gonocytes, the increase has been attributed to maternal/fetal exposures to environmental factors. We examined the effects of an estrogen (diethylstilbestrol, DES), an antiandrogen (flutamide), or radiation on the incidence of testicular germ cell tumors in genetically predisposed 129.MOLF-L1 (L1) congenic mice by exposing them to these agents on days 10.5 and 11.5 of pregnancy. Neither flutamide nor DES produced noticeable increases in testis cancer incidence at 4 weeks of age. In contrast, two doses of 0.8-Gy radiation increased the incidence of TGCT from 45% to 100% in the offspring. The percentage of mice with bilateral tumors, weights of testes with TGCT, and the percentage of tumors that were clearly teratomas were higher in the irradiated mice than in controls, indicating that irradiation induced more aggressive tumors and/or more foci of initiation sites in each testis. This radiation dose did not disrupt spermatogenesis, which was qualitatively normal in tumor-free testes although they were reduced in size. This is the first proof of induction of testicular cancer by an environmental agent and suggests that the male fetus of women exposed to radiation at about 5-6 weeks of pregnancy might have an increased risk of developing testicular cancer. Furthermore, it provides a novel tool for studying the molecular and cellular events of testicular cancer pathogenesis.	[Shetty, Gunapala; Comish, Paul B.; Weng, Connie C. Y.; Meistrich, Marvin L.] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Matin, Angabin] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Shetty, G (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA.	sgunapal@mdanderson.org		Shetty, Gunapala/0000-0001-5786-0667	National Institutes of Health [CA 16672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Florence M. Thomas Professorship in Cancer Research (to Marvin L Meistrich) and Cancer Center Support Grant CA 16672 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN LM, 1986, CANCER RES, V46, P4812; Chia VM, 2010, CANCER EPIDEM BIOMAR, V19, P1151, DOI 10.1158/1055-9965.EPI-10-0031; Committee to Assess Health Risks From Exposure to Low Levels of Ionizing Radiation Board on Radiation Effects Research Division on Earth and Life Studies National Research Council of the National Academies, 2006, HLTH RISKS EXP LOW L; Doll R, 1997, BRIT J RADIOL, V70, P130, DOI 10.1259/bjr.70.830.9135438; Gilbert D, 2011, NAT REV CANCER, V11, P278, DOI 10.1038/nrc3021; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hayashi K, 2007, SCIENCE, V316, P394, DOI 10.1126/science.1137545; Heaney JD, 2008, CANCER RES, V68, P5193, DOI 10.1158/0008-5472.CAN-08-0779; Kanetsky PA, 2009, NAT GENET, V41, P811, DOI 10.1038/ng.393; Kangasniemi M, 1996, ENDOCRINOLOGY, V137, P949, DOI 10.1210/en.137.3.949; Kimura T, 2003, DEVELOPMENT, V130, P1691, DOI 10.1242/dev.00392; Krentz AD, 2009, P NATL ACAD SCI USA, V106, P22323, DOI 10.1073/pnas.0905431106; Matin A, 1999, NAT GENET, V23, P237, DOI 10.1038/13874; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; Preston DL, 2008, JNCI-J NATL CANCER I, V100, P428, DOI 10.1093/jnci/djn045; Rajpert-De Meyts E, 2006, HUM REPROD UPDATE, V12, P303, DOI 10.1093/humupd/dmk006; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; SKAKKEBAEK NE, 1987, INT J ANDROL, V10, P19, DOI 10.1111/j.1365-2605.1987.tb00161.x; Skinner Michael K., 2007, Critical Reviews in Oncogenesis, V13, P75; STEVENS LC, 1966, J NATL CANCER I, V37, P859; Surani MA, 2010, COLD SH Q B, V75, P211, DOI 10.1101/sqb.2010.75.010; Traina ME, 2003, REPROD TOXICOL, V17, P25, DOI 10.1016/S0890-6238(02)00101-6; Turnbull C, 2010, NAT GENET, V42, P604, DOI 10.1038/ng.607; WALKER AH, 1990, BRIT J CANCER, V62, P599, DOI 10.1038/bjc.1990.337; Western PS, 2010, FASEB J, V24, P3026, DOI 10.1096/fj.09-151555; Youngren KK, 2005, NATURE, V435, P360, DOI 10.1038/nature03595; Youngren KK, 2003, HUM MOL GENET, V12, P389, DOI 10.1093/hmg/ddg036; Zhu R, 2007, MAMM GENOME, V18, P584, DOI 10.1007/s00335-007-9036-2	28	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e32064	10.1371/journal.pone.0032064	http://dx.doi.org/10.1371/journal.pone.0032064			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348147	Green Published, Green Submitted, gold			2022-12-25	WOS:000302733900066
J	Zhao, P; Dong, ZM; Duan, J; Wang, GH; Wang, LY; Li, YS; Xiang, ZH; Xia, QY				Zhao, Ping; Dong, Zhaoming; Duan, Jun; Wang, Genhong; Wang, Lingyan; Li, Youshan; Xiang, Zhonghuai; Xia, Qingyou			Genome-Wide Identification and Immune Response Analysis of Serine Protease Inhibitor Genes in the Silkworm, Bombyx mori	PLOS ONE			English	Article							KAZAL-TYPE INHIBITOR; MANDUCA-SEXTA; PROTEINASE-INHIBITORS; EXTRACELLULAR-MATRIX; ANOPHELES-GAMBIAE; CHYMOTRYPSIN INHIBITORS; MELANIZATION CASCADE; EXPRESSION ANALYSIS; DROSOPHILA-SERPINS; TRYPSIN-INHIBITORS	In most insect species, a variety of serine protease inhibitors (SPIs) have been found in multiple tissues, including integument, gonad, salivary gland, and hemolymph, and are required for preventing unwanted proteolysis. These SPIs belong to different families and have distinct inhibitory mechanisms. Herein, we predicted and characterized potential SPI genes based on the genome sequences of silkworm, Bombyx mori. As a result, a total of eighty SPI genes were identified in B. mori. These SPI genes contain 10 kinds of SPI domains, including serpin, Kunitz_BPTI, Kazal, TIL, amfpi, Bowman-Birk, Antistasin, WAP, Pacifastin, and alpha-macroglobulin. Sixty-three SPIs contain single SPI domain while the others have at least two inhibitor units. Some SPIs also contain non-inhibitor domains for protein-protein interactions, including EGF, ADAM_spacer, spondin_N, reeler, TSP_1 and other modules. Microarray analysis showed that fourteen SPI genes from lineage-specific TIL family and Group F of serpin family had enriched expression in the silk gland. The roles of SPIs in resisting pathogens were investigated in silkworms when they were infected by four pathogens. Microarray and qRT-PCR experiments revealed obvious up-regulation of 8, 4, 3 and 3 SPI genes after infection with Escherichia coli, Bacillus bombysepticus, Beauveria bassiana or B. mori nuclear polyhedrosis virus (BmNPV), respectively. On the contrary, 4, 11, 7 and 9 SPI genes were down-regulated after infection with E. coli, B. bombysepticus, B. bassiana or BmNPV, respectively. These results suggested that these SPI genes may be involved in resistance to pathogenic microorganisms. These findings may provide valuable information for further clarifying the roles of SPIs in the development, immune defence, and efficient synthesis of silk gland protein.	[Zhao, Ping; Dong, Zhaoming; Duan, Jun; Wang, Genhong; Wang, Lingyan; Li, Youshan; Xiang, Zhonghuai; Xia, Qingyou] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Duan, Jun; Wang, Genhong; Xia, Qingyou] Chongqing Univ, Inst Agr & Life Sci, Chongqing 630044, Peoples R China	Southwest University - China; Chongqing University	Zhao, P (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	xiaqy@swu.edu.cn	Dong, Zhaoming/AAK-1802-2021; Wang, Genhong/AAC-3055-2019; Dong, Zhaoming/AAW-3060-2021	Dong, Zhaoming/0000-0001-5665-9953; Wang, Genhong/0000-0002-5598-7282; Dong, Zhaoming/0000-0001-5665-9953; Duan, Jun/0000-0003-2279-9290; Xia, Qingyou/0000-0002-9263-2886	National Natural Science Foundation of China [30972147]; National Basic Research Program of China [2012CB114600]; National Hi-Tech Research and Development Program of China [2011AA100306]; Graduate Technological Innovation Foundation of Southwest University of China [kb2010003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Graduate Technological Innovation Foundation of Southwest University of China	This work was supported by grants from the National Natural Science Foundation of China (No. 30972147), the National Basic Research Program of China (No.2012CB114600), the National Hi-Tech Research and Development Program of China (No. 2011AA100306) and the Graduate Technological Innovation Foundation of Southwest University of China (No. kb2010003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham EG, 2005, P NATL ACAD SCI USA, V102, P16327, DOI 10.1073/pnas.0508335102; Aguilar R, 2005, INSECT BIOCHEM MOLEC, V35, P709, DOI 10.1016/j.ibmb.2005.02.019; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; An CJ, 2010, INSECT BIOCHEM MOLEC, V40, P683, DOI 10.1016/j.ibmb.2010.07.001; ASO Y, 1994, BIOCHEM MOL BIOL INT, V33, P751; Baton LA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-257; Bhanumathy CD, 2002, DEV DYNAM, V223, P59, DOI 10.1002/dvdy.1235; Bjork I, 1997, ADV EXP MED BIOL, V425, P17; BOIGEGRAIN RA, 1992, BIOCHEM BIOPH RES CO, V189, P790, DOI 10.1016/0006-291X(92)92271-X; Breugelmans B, 2009, INSECT BIOCHEM MOLEC, V39, P430, DOI 10.1016/j.ibmb.2009.03.005; CASTILLO GM, 1993, FEBS LETT, V318, P292, DOI 10.1016/0014-5793(93)80531-X; CHEN L, 1992, J BIOL CHEM, V267, P12380; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; COLEMAN S, 1995, INSECT BIOCHEM MOLEC, V25, P203, DOI 10.1016/0965-1748(94)00055-M; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; DENG LR, 1990, INSECT BIOCHEM, V20, P531; Duan J, 2010, NUCLEIC ACIDS RES, V38, pD453, DOI 10.1093/nar/gkp801; EGUCHI M, 1994, J BIOCHEM-TOKYO, V115, P881, DOI 10.1093/oxfordjournals.jbchem.a124434; EGUCHI M, 1993, COMP BIOCHEM PHYS B, V104, P537, DOI 10.1016/0305-0491(93)90279-E; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eum JH, 2007, DEV COMP IMMUNOL, V31, P1107, DOI 10.1016/j.dci.2007.02.002; FRIEDRICH T, 1993, J BIOL CHEM, V268, P16216; FUJII H, 1989, COMP BIOCHEM PHYS B, V94, P149, DOI 10.1016/0305-0491(89)90026-6; Fujii Hiroshi, 1996, Journal of Sericultural Science of Japan, V65, P334; Fujii Hiroshi, 1996, Journal of Sericultural Science of Japan, V65, P385; Garrett M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-489; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hamdaoui A, 1998, FEBS LETT, V422, P74, DOI 10.1016/S0014-5793(97)01585-8; HANSCHKE R, 1975, ACTA BIOL MED GER, V34, P531; Hayakawa Y, 1998, J INSECT PHYSIOL, V44, P859, DOI 10.1016/S0022-1910(98)00017-1; He NJ, 2004, BIOSCI BIOTECH BIOCH, V68, P835, DOI 10.1271/bbb.68.835; Huang LL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008098; Idoji Y, 2008, INT J MOL MED, V21, P461; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Jiang HB, 2003, INSECT BIOCHEM MOLEC, V33, P1049, DOI 10.1016/S0965-1748(03)00123-1; Jiang HB, 1997, J BIOL CHEM, V272, P1082, DOI 10.1074/jbc.272.2.1082; Jiang R, 2009, J BIOL CHEM, V284, P35652, DOI 10.1074/jbc.M109.071001; KANG SH, 1980, BIOCHIM BIOPHYS ACTA, V611, P379, DOI 10.1016/0005-2744(80)90075-3; Kanost MR, 1999, DEV COMP IMMUNOL, V23, P291, DOI 10.1016/S0145-305X(99)00012-9; KANOST MR, 1990, INSECT BIOCHEM, V20, P141, DOI 10.1016/0020-1790(90)90006-G; Kim CH, 2008, J BIOL CHEM, V283, P7599, DOI 10.1074/jbc.M710216200; Kramerova IA, 2003, DEV DYNAM, V226, P634, DOI 10.1002/dvdy.10265; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; Kurioka A, 1999, EUR J BIOCHEM, V259, P120, DOI 10.1046/j.1432-1327.1999.00030.x; Kurioka Akira, 1999, Journal of Sericultural Science of Japan, V68, P397; Kurioka Akira, 2000, Journal of Sericultural Science of Japan, V69, P63; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Ligoxygakis P, 2003, CURR BIOL, V13, P2097, DOI 10.1016/j.cub.2003.10.062; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; Ling EJ, 2009, INSECT BIOCHEM MOLEC, V39, P263, DOI 10.1016/j.ibmb.2008.12.006; Morita  T., 1961, ZOOL MAG, V70, P53; Nardi JB, 1999, INSECT BIOCHEM MOLEC, V29, P883, DOI 10.1016/S0965-1748(99)00064-8; Nirmala X, 2001, EUR J BIOCHEM, V268, P2064, DOI 10.1046/j.1432-1327.2001.02084.x; Nukumi N, 2007, CANCER LETT, V252, P65, DOI 10.1016/j.canlet.2006.12.005; Otlewski J, 1999, ACTA BIOCHIM POL, V46, P531, DOI 10.18388/abp.1999_4128; Pham TN, 1996, J BIOCHEM, V119, P428; RAMESH N, 1988, J BIOL CHEM, V263, P11523; Rawlings ND, 2004, NUCLEIC ACIDS RES, V32, pD160, DOI 10.1093/nar/gkp971; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; Reichhart JM, 2011, METHOD ENZYMOL, V499, P205, DOI 10.1016/B978-0-12-386471-0.00011-0; Reichhart JM, 2005, TRENDS CELL BIOL, V15, P659, DOI 10.1016/j.tcb.2005.10.001; Rester U, 1999, J MOL BIOL, V293, P93, DOI 10.1006/jmbi.1999.3162; SASAKI T, 1990, AGR BIOL CHEM TOKYO, V54, P131, DOI 10.1080/00021369.1990.10869888; SHINOHARA T, 1993, BIOSCI BIOTECH BIOCH, V57, P1067, DOI 10.1271/bbb.57.1067; Shirai Koji, 1997, Journal of Sericultural Science of Japan, V66, P253; Shrivastava B, 2003, INSECT BIOCHEM MOLEC, V33, P1025, DOI 10.1016/S0965-1748(03)00117-6; Silverman GA, 2010, J BIOL CHEM, V285, P24299, DOI 10.1074/jbc.R110.112771; Simonet G, 2002, COMP BIOCHEM PHYS B, V132, P247, DOI 10.1016/S1096-4959(01)00530-9; Suwanchaichinda C, 2009, GENE, V442, P47, DOI 10.1016/j.gene.2009.04.013; Tang HP, 2006, J BIOL CHEM, V281, P28097, DOI 10.1074/jbc.M601642200; THOMAS DJ, 1989, BIOCHEM J, V259, P905, DOI 10.1042/bj2590905; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tong YR, 2005, J BIOL CHEM, V280, P14923, DOI 10.1074/jbc.M500531200; Tripathi LP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-549; Tzarfati-Majar V, 2001, P NATL ACAD SCI USA, V98, P4722, DOI 10.1073/pnas.081062398; Walker LA, 2009, FUNGAL GENET BIOL, V46, P210, DOI 10.1016/j.fgb.2008.10.012; Wang J, 2005, NUCLEIC ACIDS RES, V33, pD399, DOI 10.1093/nar/gki116; Waterhouse RM, 2007, SCIENCE, V316, P1738, DOI 10.1126/science.1139862; Wilkin MB, 2000, CURR BIOL, V10, P559, DOI 10.1016/S0960-9822(00)00482-6; Xi ZY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-1; Xia QY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r162; Xiao T, 2000, PROTEIN SCI, V9, P1889, DOI 10.1110/ps.9.10.1889; Zhao P, 2007, PROTEIN J, V26, P349, DOI 10.1007/s10930-007-9077-0; Zhao P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-405; Zhao QL, 2004, J FAC AGR KYUSHU U, V49, P93; Zheng QL, 2007, COMP BIOCHEM PHYS B, V146, P234, DOI 10.1016/j.cbpb.2006.10.106; Zhu YF, 2003, J BIOL CHEM, V278, P46556, DOI 10.1074/jbc.M309682200; Zou Z, 2006, INSECT MOL BIOL, V15, P603, DOI 10.1111/j.1365-2583.2006.00684.x; Zou Z, 2005, J BIOL CHEM, V280, P14341, DOI 10.1074/jbc.M500570200; Zou Z, 2009, GENOMICS, V93, P367, DOI 10.1016/j.ygeno.2008.12.010	90	68	80	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31168	10.1371/journal.pone.0031168	http://dx.doi.org/10.1371/journal.pone.0031168			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348050	Green Submitted, Green Published, gold			2022-12-25	WOS:000302733900028
J	Alfred, R; Ahmad, AH; Payne, J; Williams, C; Ambu, LN; How, PM; Goossens, B				Alfred, Raymond; Ahmad, Abd Hamid; Payne, Junaidi; Williams, Christy; Ambu, Laurentius Nayan; Phua Mui How; Goossens, Benoit			Home Range and Ranging Behaviour of Bornean Elephant (Elephas maximus borneensis) Females	PLOS ONE			English	Article							SATELLITE TELEMETRY; NATIONAL-PARK; TRACKING; ORGANIZATION; CONSERVATION; MOVEMENTS; NAMIBIA; AFRICA; KENYA	Background: Home range is defined as the extent and location of the area covered annually by a wild animal in its natural habitat. Studies of African and Indian elephants in landscapes of largely open habitats have indicated that the sizes of the home range are determined not only by the food supplies and seasonal changes, but also by numerous other factors including availability of water sources, habitat loss and the existence of man-made barriers. The home range size for the Bornean elephant had never been investigated before. Methodology/Principal Findings: The first satellite tracking program to investigate the movement of wild Bornean elephants in Sabah was initiated in 2005. Five adult female elephants were immobilized and neck collars were fitted with tracking devices. The sizes of their home range and movement patterns were determined using location data gathered from a satellite tracking system and analyzed by using the Minimum Convex Polygon and Harmonic Mean methods. Home range size was estimated to be 250 to 400 km(2) in a non-fragmented forest and 600 km(2) in a fragmented forest. The ranging behavior was influenced by the size of the natural forest habitat and the availability of permanent water sources. The movement pattern was influenced by human disturbance and the need to move from one feeding site to another. Conclusions/Significance: Home range and movement rate were influenced by the degree of habitat fragmentation. Once habitat was cleared or converted, the availability of food plants and water sources were reduced, forcing the elephants to travel to adjacent forest areas. Therefore movement rate in fragmented forest was higher than in the non-fragmented forest. Finally, in fragmented habitat human and elephant conflict occurrences were likely to be higher, due to increased movement bringing elephants into contact more often with humans.	[Alfred, Raymond] World Wildlife Fund Malaysia, Borneo Species Programme, Kota Kinabalu, Sabah, Malaysia; [Alfred, Raymond] Borneo Conservat Trust, Sabah Wildlife Dept, Kota Kinabalu, Sabah, Malaysia; [Payne, Junaidi] Univ Malaysia Sabah, Inst Trop Biol & Conservat, Borneo Rhino Alliance BORA, Kota Kinabalu, Sabah, Malaysia; [Williams, Christy] World Wildlife Fund Int, World Wildlife Fund Asian Rhinoceros & Elephant A, Gland, Switzerland; [Phua Mui How] Univ Malaysia Sabah, Sch Int Forestry, Kota Kinabalu, Sabah, Malaysia; [Goossens, Benoit] Danau Girang Field Ctr, Sabah Wildlife Dept, Kota Kinabalu, Sabah, Malaysia; [Goossens, Benoit] Cardiff Univ, Sch Biosci, Organisms & Environm Div, Cardiff, S Glam, Wales	Universiti Malaysia Sabah; World Wildlife Fund; Universiti Malaysia Sabah; Cardiff University	Alfred, R (corresponding author), World Wildlife Fund Malaysia, Borneo Species Programme, Kota Kinabalu, Sabah, Malaysia.	raymond_alfred@yahoo.com	Goossens, Benoit R/E-8812-2010	Ahmad, Abdul Hamid/0000-0001-9658-8600; Phua, Mui-How/0000-0002-1205-3105	World Wildlife Fund-United States, United States; Fish and Wildlife Service Asian Elephant Conservation Fund; World Wildlife Fund -Netherlands; World Wildlife Fund -Germany	World Wildlife Fund-United States, United States; Fish and Wildlife Service Asian Elephant Conservation Fund; World Wildlife Fund -Netherlands; World Wildlife Fund -Germany	This specific study was supported by grants from World Wildlife Fund-United States, United States. Fish and Wildlife Service Asian Elephant Conservation Fund, World Wildlife Fund -Netherlands and World Wildlife Fund -Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blake S, 2001, AFR J ECOL, V39, P178, DOI 10.1046/j.1365-2028.2001.00296.x; Cranbrook E., 2008, SARAWAK MUS J, V63, P1; de Beer Y, 2008, J ARID ENVIRON, V72, P2017, DOI 10.1016/j.jaridenv.2008.07.002; de Beer Y, 2006, J ARID ENVIRON, V64, P412, DOI 10.1016/j.jaridenv.2005.06.015; de Boer WF, 2000, AFR J ECOL, V38, P188, DOI 10.1046/j.1365-2028.2000.00243.x; Douglas-Hamilton I, 2005, NATURWISSENSCHAFTEN, V92, P158, DOI 10.1007/s00114-004-0606-9; Fancy SG, 1988, US FISH WILDLIFE SER, P72; Fernando P, 2003, PLOS BIOL, V1, P110, DOI 10.1371/journal.pbio.0000006; Fernando P, 2008, MAMM BIOL, V73, P2, DOI 10.1016/j.mambio.2007.07.007; Galanti V, 2006, MAMM BIOL, V71, P99, DOI 10.1016/j.mambio.2005.10.001; Hanebuth T, 2000, SCIENCE, V288, P1033, DOI 10.1126/science.288.5468.1033; HARRIS RB, 1990, 30 US FISH WILDL; Jalil MF, 2008, MOL ECOL, V17, P2898, DOI 10.1111/j.1365-294X.2008.03793.x; Jalil MF, 2007, THESIS CARDIFF U; Joshua Justus, 1995, P256; Khan bin Momin Khan M., 1967, Malayan Nature Journal, V20, P18; Khan MbM, 1985, ELEPHANTS PENINSULAR; Kinahan AA, 2007, J THERM BIOL, V32, P47, DOI 10.1016/j.jtherbio.2006.09.002; LEUTHOLD W, 1977, Z SAUGETIERKD, V42, P358; LINDEQUE M, 1991, AFR J ECOL, V29, P196, DOI 10.1111/j.1365-2028.1991.tb01002.x; Olivier R., 1978, THESIS U CAMBRIDGE; Osborn Ferrel V., 2004, Pachyderm, V37, P37; Osborn FV, 2003, AFR J ECOL, V41, P68, DOI 10.1046/j.1365-2028.2003.00413.x; Stuwe M, 1998, ORYX, V32, P68, DOI 10.1046/j.1365-3008.1998.00019.x; Stuwe M, 2006, CONSERVATION GIS PRO; Sukumar R., 1989, ASIAN ELEPHANT ECOLO; SUKUMAR R, 2003, LIVING ELEPHANTS; Tchamba MN, 1995, AFR J ECOL, V33, P335, DOI 10.1111/j.1365-2028.1995.tb01043.x; Thouless CR, 1996, AFR J ECOL, V34, P284, DOI 10.1111/j.1365-2028.1996.tb00623.x; Venkataraman AB, 2005, CURR SCI INDIA, V88, P1827; Verlinden A, 1998, AFR J ECOL, V36, P105; Williams A.C., 2004, ELEPHANTS ELEPHAS MA; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	34	58	62	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31400	10.1371/journal.pone.0031400	http://dx.doi.org/10.1371/journal.pone.0031400			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347469	Green Submitted, Green Published, gold			2022-12-25	WOS:000302730100065
J	Moore, F; Santin, I; Nogueira, TC; Gurzov, EN; Marselli, L; Marchetti, P; Eizirik, DL				Moore, Fabrice; Santin, Izortze; Nogueira, Tatiane C.; Gurzov, Esteban N.; Marselli, Lorella; Marchetti, Piero; Eizirik, Decio L.			The Transcription Factor C/EBP delta Has Anti-Apoptotic and Anti-Inflammatory Roles in Pancreatic Beta Cells	PLOS ONE			English	Article							BINDING-PROTEIN-DELTA; ENDOPLASMIC-RETICULUM STRESS; FACTOR-KAPPA-B; PRO-INFLAMMATORY CYTOKINES; INSULIN-PRODUCING CELLS; NECROSIS-FACTOR-ALPHA; FREE FATTY-ACIDS; GENE-EXPRESSION; ER STRESS; IFN-GAMMA	In the course of Type 1 diabetes pro-inflammatory cytokines (e. g., IL-1 beta, IFN-gamma and TNF-alpha) produced by islet-infiltrating immune cells modify expression of key gene networks in beta-cells, leading to local inflammation and beta-cell apoptosis. Most known cytokine-induced transcription factors have pro-apoptotic effects, and little is known regarding "protective" transcription factors. To this end, we presently evaluated the role of the transcription factor CCAAT/enhancer binding protein delta (C/EBP delta) on beta-cell apoptosis and production of inflammatory mediators in the rat insulinoma INS-1E cells, in purified primary rat beta-cells and in human islets. C/EBP delta is expressed and up-regulated in response to the cytokines IL-1 beta and IFN-gamma in rat beta-cells and human islets. Small interfering RNA-mediated C/EBP delta silencing exacerbated IL-1 beta+IFN-gamma-induced caspase 9 and 3 cleavage and apoptosis in these cells. C/EBP delta deficiency increased the up-regulation of the transcription factor CHOP in response to cytokines, enhancing expression of the pro-apoptotic Bcl-2 family member BIM. Interfering with C/EBP delta and CHOP or C/EBP delta and BIM in double knockdown approaches abrogated the exacerbating effects of C/EBP delta deficiency on cytokine-induced beta-cell apoptosis, while C/EBP delta overexpression inhibited BIM expression and partially protected beta-cells against IL-1 beta+IFN-gamma-induced apoptosis. Furthermore, C/EBP delta silencing boosted cytokine-induced production of the chemokines CXCL1, 9, 10 and CCL20 in beta-cells by hampering IRF-1 up-regulation and increasing STAT1 activation in response to cytokines. These observations identify a novel function of C/EBP delta as a modulatory transcription factor that inhibits the pro-apoptotic and pro-inflammatory gene networks activated by cytokines in pancreatic beta-cells.	[Moore, Fabrice; Santin, Izortze; Nogueira, Tatiane C.; Gurzov, Esteban N.; Eizirik, Decio L.] Univ Libre Bruxelles, Expt Med Lab, Brussels, Belgium; [Marselli, Lorella; Marchetti, Piero] Univ Pisa, Metab Unit, Dept Endocrinol & Metab, Pisa, Italy	Universite Libre de Bruxelles; University of Pisa	Moore, F (corresponding author), Univ Libre Bruxelles, Expt Med Lab, Brussels, Belgium.	fmoore@ulb.ac.be; deizirik@ulb.ac.be	Santin, Izortze/AAC-4251-2019; de Araujo Nogueira, Tatiane/E-8510-2013; Santin, Izortze/C-3034-2014; Marchetti, Piero/J-7439-2013	Santin, Izortze/0000-0003-1651-6776; Marchetti, Piero/0000-0003-4907-0635; Marselli, Lorella/0000-0002-6698-2962; Gurzov, Esteban/0000-0003-4642-0273	Fonds National de la Recherche Scientifique (FNRS - FRSM) Belgium; Communaute Francaise de Belgique - Actions de Recherche Concertees (ARC); European Union (NAIMIT, European Community) [Health-F22009-241447]; Expert Center from the Dutch Diabetes Research Foundation [2008.40.001]; Belgium Program on Interuniversity Poles of Attraction [IUAP P6/40]; FNRS, Belgium; Education Department of the Basque Country; European Molecular Biology Organization (EMBO)	Fonds National de la Recherche Scientifique (FNRS - FRSM) Belgium(Fonds de la Recherche Scientifique - FNRS); Communaute Francaise de Belgique - Actions de Recherche Concertees (ARC); European Union (NAIMIT, European Community); Expert Center from the Dutch Diabetes Research Foundation; Belgium Program on Interuniversity Poles of Attraction; FNRS, Belgium(Fonds de la Recherche Scientifique - FNRS); Education Department of the Basque Country; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO))	This work was supported by grants from the Fonds National de la Recherche Scientifique (FNRS - FRSM) Belgium, the Communaute Francaise de Belgique - Actions de Recherche Concertees (ARC), the European Union (NAIMIT, Ref. Health-F22009-241447; in the Framework Programme 7 of the European Community), the Expert Center Grant 2008.40.001 from the Dutch Diabetes Research Foundation, and the Belgium Program on Interuniversity Poles of Attraction initiated by the Belgium State (IUAP P6/40). FM was the recipient of a Post-Doctoral Fellowship from FNRS, Belgium. IS was the recipient of a postdoctoral fellowship from the Education Department of the Basque Country. TCN was the recipient of a Post-Doctoral Fellowship from FNRS, Belgium. ENG was supported by a European Molecular Biology Organization (EMBO) long-term Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2007, BLOOD, V109, P3895, DOI 10.1182/blood-2006-08-040147; Allagnat F, 2011, CELL DEATH DIFFER, V18, P328, DOI 10.1038/cdd.2010.105; Allagnat F, 2010, DIABETOLOGIA, V53, P1120, DOI 10.1007/s00125-010-1699-7; Altman BJ, 2009, MOL BIOL CELL, V20, P1180, DOI 10.1091/mbc.E08-08-0829; Barthson J, 2011, J BIOL CHEM, V286, P39632, DOI 10.1074/jbc.M111.253591; Cardozo AK, 2003, DIABETOLOGIA, V46, P255, DOI 10.1007/s00125-002-1017-0; Cardozo AK, 2001, J BIOL CHEM, V276, P48879, DOI 10.1074/jbc.M108658200; Colli ML, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002267; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Eizirik DL, 2008, BIOCHEM SOC T, V36, P321, DOI 10.1042/BST0360321; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Eizirik DL, 1996, HORM METAB RES, V28, P302, DOI 10.1055/s-2007-979799; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Ejarque-Ortiz A, 2010, J NEUROSCI RES, V88, P1113, DOI 10.1002/jnr.22272; Filippi CM, 2008, DIABETES, V57, P2863, DOI 10.2337/db07-1023; Fonseca SG, 2011, TRENDS ENDOCRIN MET, V22, P266, DOI 10.1016/j.tem.2011.02.008; Fujitani Y, 2010, AM J PHYSIOL-CELL PH, V299, pC1, DOI 10.1152/ajpcell.00084.2010; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; Gigliotti AP, 2003, EXP BIOL MED, V228, P278, DOI 10.1177/153537020322800306; Gowda A, 2008, BLOOD, V111, P4723, DOI 10.1182/blood-2007-07-099531; Grey ST, 1999, J EXP MED, V190, P1135, DOI 10.1084/jem.190.8.1135; Gurzov EN, 2009, CELL DEATH DIFFER, V16, P1539, DOI 10.1038/cdd.2009.99; Gurzov EN, 2011, TRENDS CELL BIOL, V21, P424, DOI 10.1016/j.tcb.2011.03.001; Gurzov EN, 2010, J BIOL CHEM, V285, P19910, DOI 10.1074/jbc.M110.122374; Gurzov EN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003030; Gysemans C, 2008, BIOCHEM SOC T, V36, P328, DOI 10.1042/BST0360328; Hartley T, 2009, AM J PHYSIOL-ENDOC M, V296, pE1, DOI 10.1152/ajpendo.90538.2008; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Heimberg H, 2001, DIABETES, V50, P2219, DOI 10.2337/diabetes.50.10.2219; Hoorens A, 1996, J CLIN INVEST, V98, P1568, DOI 10.1172/JCI118950; Hurgin V, 2002, P NATL ACAD SCI USA, V99, P16957, DOI 10.1073/pnas.262663399; In't Veld P, 2011, ISLETS, V3, P131, DOI 10.4161/isl.3.4.15728; Karlsen AE, 2004, DIABETOLOGIA, V47, P1998, DOI 10.1007/s00125-004-1568-3; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; KINOSHITA S, 1992, P NATL ACAD SCI USA, V89, P1473, DOI 10.1073/pnas.89.4.1473; Ko CY, 2008, J BIOL CHEM, V283, P30919, DOI 10.1074/jbc.M804029200; Kutlu B, 2003, DIABETES, V52, P2701, DOI 10.2337/diabetes.52.11.2701; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Liu L, 2001, BRIT J PHARMACOL, V134, P1629, DOI 10.1038/sj.bjp.0704404; Lu YC, 2009, J IMMUNOL, V182, P7212, DOI 10.4049/jimmunol.0802971; Luedde T, 2004, HEPATOLOGY, V40, P356, DOI 10.1002/hep.20333; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Martin AP, 2008, DIABETES, V57, P3025, DOI 10.2337/db08-0625; Matsuda T, 2010, J CLIN INVEST, V120, P115, DOI 10.1172/JCI39721; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; McKenzie MD, 2010, DIABETES, V59, P644, DOI 10.2337/db09-1151; Mehmeti I, 2011, MOL CELL ENDOCRINOL, V332, P88, DOI 10.1016/j.mce.2010.09.017; Meir O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009516; Meller R, 2006, J BIOL CHEM, V281, P7429, DOI 10.1074/jbc.M512138200; Moore F, 2012, METHODS MOL BIOL, V820, P179, DOI 10.1007/978-1-61779-439-1_11; Moore F, 2011, J BIOL CHEM, V286, P929, DOI 10.1074/jbc.M110.162131; Moore F, 2009, DIABETES, V58, P1283, DOI 10.2337/db08-1510; NAGULAPALLI S, 1995, J IMMUNOL, V155, P4330; O'Rourke JP, 1999, J BIOL CHEM, V274, P16582, DOI 10.1074/jbc.274.23.16582; Ordonez Andrea Nicole, 2010, Int J Physiol Pathophysiol Pharmacol, V2, P36; Ortis F, 2008, DIABETOLOGIA, V51, P1213, DOI 10.1007/s00125-008-0999-7; Ortis F, 2006, MOL ENDOCRINOL, V20, P1867, DOI 10.1210/me.2005-0268; Ortis F, 2010, DIABETES, V59, P358, DOI 10.2337/db09-1159; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pawar SA, 2010, P NATL ACAD SCI USA, V107, P9210, DOI 10.1073/pnas.0913813107; Peng H, 2006, REV ENDOCR METAB DIS, V7, P149, DOI 10.1007/s11154-006-9024-y; Pirot P, 2007, DIABETES, V56, P1069, DOI 10.2337/db06-1253; Plaisance V, 2009, MOL CELL ENDOCRINOL, V305, P47, DOI 10.1016/j.mce.2008.12.005; Pociot F, 2010, DIABETES, V59, P1561, DOI 10.2337/db10-0076; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Ramberg V, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-34; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Rasschaert J, 2005, J BIOL CHEM, V280, P33984, DOI 10.1074/jbc.M502213200; RAY A, 1995, J BIOL CHEM, V270, P7365, DOI 10.1074/jbc.270.13.7365; Roep BO, 2010, CLIN EXP IMMUNOL, V159, P338, DOI 10.1111/j.1365-2249.2009.04087.x; Ruocco MR, 1996, J BIOL CHEM, V271, P22479, DOI 10.1074/jbc.271.37.22479; Santin I, 2011, DIABETES; Skyler JS, 2011, DIABETES, V60, P1, DOI 10.2337/db10-1114; Sterneck E, 1998, P NATL ACAD SCI USA, V95, P10908, DOI 10.1073/pnas.95.18.10908; SYLVESTER SL, 1994, J BIOL CHEM, V269, P20119; Tanabe A, 2000, BIOL PHARM BULL, V23, P1424, DOI 10.1248/bpb.23.1424; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Tang D, 2006, BREAST CANCER RES TR, V95, P161, DOI 10.1007/s10549-005-9061-3; Thomas HE, 2009, APOPTOSIS, V14, P1389, DOI 10.1007/s10495-009-0339-5; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Ubeda M, 1996, MOL CELL BIOL, V16, P1479; Wakeyama H, 2007, ANN NY ACAD SCI, V1116, P271, DOI 10.1196/annals.1402.001; Waldron-Lynch F, 2011, NAT REV DRUG DISCOV, V10, P439, DOI 10.1038/nrd3402; Wang KW, 2011, BBA-MOL CELL RES, V1813, P1395, DOI 10.1016/j.bbamcr.2011.04.004; Xie B, 2011, J NEUROSCI, V31, P5032, DOI 10.1523/JNEUROSCI.5504-10.2011; Yamada T, 1998, BIOCHEM BIOPH RES CO, V242, P88, DOI 10.1006/bbrc.1997.7915; Yang GY, 2001, J ANDROL, V22, P471; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	91	42	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31062	10.1371/journal.pone.0031062	http://dx.doi.org/10.1371/journal.pone.0031062			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347430	Green Submitted, gold, Green Published			2022-12-25	WOS:000302730100038
J	Liu, YL; Jie, HF; Qi, F; Kaleem, I; E, WW; Li, C				Liu, Yanli; Jie Huangfu; Qi, Feng; Kaleem, Imdad; E, Wenwen; Li, Chun			Effects of a Non-Conservative Sequence on the Properties of beta-glucuronidase from Aspergillus terreus Li-20	PLOS ONE			English	Article							GLYCOSYL HYDROLASES; GLYCYRRHIZIC ACID; STABILITY; EVOLUTION; ENZYME; DOMAIN; FOLD; VERSATILITY; GENE	We cloned the beta-glucuronidase gene (AtGUS) from Aspergillus terreus Li-20 encoding 657 amino acids (aa), which can transform glycyrrhizin into glycyrrhetinic acid monoglucuronide (GAMG) and glycyrrhetinic acid (GA). Based on sequence alignment, the C-terminal non-conservative sequence showed low identity with those of other species; thus, the partial sequence AtGUS(-3t) (1-592 aa) was amplified to determine the effects of the non-conservative sequence on the enzymatic properties. AtGUS and AtGUS(-3t) were expressed in E. coli BL21, producing AtGUS-E and AtGUS(-3t)-E, respectively. At the similar optimum temperature (55 degrees C) and pH (AtGUS-E, 6.6; AtGUS(-3t)-E, 7.0) conditions, the thermal stability of AtGUS(-3t)-E was enhanced at 65 degrees C, and the metal ions Co2+, Ca2+ and Ni2+ showed opposite effects on AtGUS-E and AtGUS(-3t)-E, respectively. Furthermore, Km of AtGUS(-3t)-E (1.95 mM) was just nearly one-seventh that of AtGUS-E (12.9 mM), whereas the catalytic efficiency of AtGUS(-3t)-E was 3.2 fold higher than that of AtGUS-E (7.16 vs. 2.24 mM s(-1)), revealing that the truncation of non-conservative sequence can significantly improve the catalytic efficiency of AtGUS. Conformational analysis illustrated significant difference in the secondary structure between AtGUS-E and AtGUS(-3t)-E by circular dichroism (CD). The results showed that the truncation of the non-conservative sequence could preferably alter and influence the stability and catalytic efficiency of enzyme.	[Liu, Yanli; Li, Chun] Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China; [Jie Huangfu; Qi, Feng; Kaleem, Imdad; E, Wenwen; Li, Chun] Beijing Inst Technol, Sch Life Sci, Beijing 100081, Peoples R China	Tianjin University; Beijing Institute of Technology	Liu, YL (corresponding author), Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China.	lichun@bit.edu.cn	Li, Chun/B-3292-2013		Natural Science Foundation of China [20976014, 21176028]; Key Projects Incubating Foundation of Beijing Institute of Technology [2011cx010]; Beijing Natural Science Foundation [2112035]; Ph.D. Programs Foundation of Ministry of Education of China [20091101110036]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects Incubating Foundation of Beijing Institute of Technology; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China)	This research work was financially supported by the Natural Science Foundation of China (20976014, 21176028), Key Projects Incubating Foundation of Beijing Institute of Technology (2011cx010), Beijing Natural Science Foundation (2112035) and the Ph.D. Programs Foundation of Ministry of Education of China (20091101110036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAMATSU H, 1991, PLANTA MED, V57, P119, DOI 10.1055/s-2006-960045; Akao T, 2000, BIOL PHARM BULL, V23, P1418, DOI 10.1248/bpb.23.1418; Baltina LA, 2003, CURR MED CHEM, V10, P155, DOI 10.2174/0929867033368538; CADWELL RC, 1994, PCR METH APPL, V3, pS136; CHUBACHI A, 1992, INTERNAL MED, V31, P708, DOI 10.2169/internalmedicine.31.708; Cicek M, 2000, J BIOL CHEM, V275, P20002, DOI 10.1074/jbc.M001609200; Cinatl J, 2003, LANCET, V361, P2045, DOI 10.1016/S0140-6736(03)13615-X; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Feng SJ, 2006, J MOL CATAL B-ENZYM, V43, P63, DOI 10.1016/j.molcatb.2006.06.016; Fux L, 2009, CANCER RES, V69, P1758, DOI 10.1158/0008-5472.CAN-08-1837; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; Hocker B, 2001, CURR OPIN BIOTECH, V12, P376, DOI 10.1016/S0958-1669(00)00230-5; Huisman FHA, 2010, BIOCHEM BIOPH RES CO, V393, P168, DOI 10.1016/j.bbrc.2010.01.114; Ike M, 2008, J MOL CATAL B-ENZYM, V55, P55, DOI 10.1016/j.molcatb.2007.12.020; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; Jain S, 1996, NAT STRUCT BIOL, V3, P375, DOI 10.1038/nsb0496-375; JEFFERSON RA, 1987, EMBO J, V6, P3901; Krausse R, 2004, J ANTIMICROB CHEMOTH, V54, P243, DOI 10.1093/jac/dkh287; Lu DQ, 2006, J MOL CATAL B-ENZYM, V43, P148, DOI 10.1016/j.molcatb.2006.07.011; NOSE M, 1994, PLANTA MED, V60, P136, DOI 10.1055/s-2006-959435; [宋占科 SONG Zhanke], 2008, [化工学报, Journal of Chemical Industry and Engineering (China)], V59, P3101; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Sterner R, 2005, CHEM REV, V105, P4038, DOI 10.1021/cr030191z; Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175; Wang YJ, 2009, BIORESOURCE TECHNOL, V100, P345, DOI 10.1016/j.biortech.2008.06.001; Wiederstein M, 2005, J MOL BIOL, V345, P1199, DOI 10.1016/j.jmb.2004.11.012; Xie XJ, 2009, MOL CELL BIOCHEM, V327, P241, DOI 10.1007/s11010-009-0062-0; Zhao HM, 1998, NAT BIOTECHNOL, V16, P258, DOI 10.1038/nbt0398-258	28	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e30998	10.1371/journal.pone.0030998	http://dx.doi.org/10.1371/journal.pone.0030998			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347419	Green Published, Green Submitted, gold			2022-12-25	WOS:000302180600021
J	Sedaghat, Y; Mazur, C; Sabripour, M; Hung, G; Monia, BP				Sedaghat, Yalda; Mazur, Curt; Sabripour, Mahyar; Hung, Gene; Monia, Brett P.			Genomic Analysis of wig-1 Pathways	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; AU-RICH ELEMENT; KINASE-C-EPSILON; MESSENGER-RNA; HUNTINGTONS-DISEASE; TUMOR-SUPPRESSOR; CELL-LINES; P53; GENE; EXPRESSION	Background: Wig-1 is a transcription factor regulated by p53 that can interact with hnRNP A2/B1, RNA Helicase A, and dsRNAs, which plays an important role in RNA and protein stabilization. in vitro studies have shown that wig-1 binds p53 mRNA and stabilizes it by protecting it from deadenylation. Furthermore, p53 has been implicated as a causal factor in neurodegenerative diseases based in part on its selective regulatory function on gene expression, including genes which, in turn, also possess regulatory functions on gene expression. In this study we focused on the wig-1 transcription factor as a downstream p53 regulated gene and characterized the effects of wig-1 down regulation on gene expression in mouse liver and brain. Methods and Results: Antisense oligonucleotides (ASOs) were identified that specifically target mouse wig-1 mRNA and produce a dose-dependent reduction in wig-1 mRNA levels in cell culture. These wig-1 ASOs produced marked reductions in wig-1 levels in liver following intraperitoneal administration and in brain tissue following ASO administration through a single striatal bolus injection in FVB and BACHD mice. Wig-1 suppression was well tolerated and resulted in the reduction of mutant Htt protein levels in BACHD mouse brain but had no effect on normal Htt protein levels nor p53 mRNA or protein levels. Expression microarray analysis was employed to determine the effects of wig-1 suppression on genome-wide expression in mouse liver and brain. Reduction of wig-1 caused both down regulation and up regulation of several genes, and a number of wig-1 regulated genes were identified that potentially links wig-1 various signaling pathways and diseases. Conclusion: ntisense oligonucleotides can effectively reduce wig-1 levels in mouse liver and brain, which results in specific changes in gene expression for pathways relevant to both the nervous system and cancer.	[Sedaghat, Yalda; Mazur, Curt; Sabripour, Mahyar; Hung, Gene; Monia, Brett P.] Isis Pharmaceut Inc, Dept Drug Discovery, Carlsbad, CA USA	Isis Pharmaceuticals Inc	Sedaghat, Y (corresponding author), Isis Pharmaceut Inc, Dept Drug Discovery, Carlsbad, CA USA.	bmonia@isisph.com			Isis Pharmaceuticals	Isis Pharmaceuticals	Funding was provided wholly by Isis Pharmaceuticals who, through the employment of YS, CM, MS, GH and BPM, had a role in conceiving, designing and performing the experiments, and analyzing the data.	Abdelmagid SM, 2007, J CELL PHYSIOL, V210, P26, DOI 10.1002/jcp.20841; Bae BI, 2005, NEURON, V47, P29, DOI 10.1016/j.neuron.2005.06.005; Bakheet T, 2003, NUCLEIC ACIDS RES, V31, P421, DOI 10.1093/nar/gkg023; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Basu A, 2002, EXP CELL RES, V278, P209, DOI 10.1006/excr.2002.5587; Basu A, 2008, METHOD ENZYMOL, V446, P141, DOI 10.1016/S0076-6879(08)01608-X; Bedogni F, 2010, GENE EXPR PATTERNS, V10, P9, DOI 10.1016/j.gep.2009.11.005; Butler M, 2005, NEUROSCIENCE, V131, P705, DOI 10.1016/j.neuroscience.2004.11.038; Cacace AM, 1996, ONCOGENE, V13, P2517; Chen T, 2004, MOL CELL BIOL, V24, P6608, DOI 10.1128/mcb.24.15.6608-6619.2004; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Feng Z, 2006, ONCOGENE, V25, P1, DOI 10.1038/sj.onc.1209021; Geary R S, 2001, Curr Opin Investig Drugs, V2, P562; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Graeber MB, 1998, J NEUROL SCI, V153, P251, DOI 10.1016/S0022-510X(97)00295-5; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Hellborg F, 2001, ONCOGENE, V20, P5466, DOI 10.1038/sj.onc.1204722; Ho SP, 1999, CURR OPIN MOL THER, V1, P336; Islam SM, 2009, SCIENCE, V323, P388, DOI 10.1126/science.1165187; Israeli D, 1997, EMBO J, V16, P4384, DOI 10.1093/emboj/16.14.4384; Kalscheuer VM, 2007, HUM GENET, V121, P501, DOI 10.1007/s00439-006-0284-0; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; LAGNADO CA, 1994, MOL CELL BIOL, V14, P7984, DOI 10.1128/MCB.14.12.7984; Leonard JV, 2000, LANCET, V355, P389, DOI 10.1016/S0140-6736(99)05226-5; Leonard JV, 2000, LANCET, V355, P299, DOI 10.1016/S0140-6736(99)05225-3; Maestrini E, 2010, MOL PSYCHIATR, V15, P954, DOI 10.1038/mp.2009.34; Mendez-Vidal C, 2002, NUCLEIC ACIDS RES, V30, P1991, DOI 10.1093/nar/30.9.1991; Metz RL, 2005, CELL CYCLE, V4, P315; Peng SSY, 1996, MOL CELL BIOL, V16, P1490; Perletti GP, 1998, ONCOGENE, V16, P3345, DOI 10.1038/sj.onc.1201871; Petek E, 2007, MOL GENET GENOMICS, V277, P71, DOI 10.1007/s00438-006-0173-1; Prahl M, 2008, FEBS LETT, V582, P2173, DOI 10.1016/j.febslet.2008.04.065; Qian XZ, 2008, MOL ONCOL, V2, P81, DOI 10.1016/j.molonc.2008.02.002; Rose AAN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012093; Rose AAN, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1791; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; Ryan AB, 2006, NEUROBIOL DIS, V24, P419, DOI 10.1016/j.nbd.2006.08.002; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Sharif TR, 1999, INT J ONCOL, V15, P237; Spampanato J, 2008, NEUROSCIENCE, V157, P606, DOI 10.1016/j.neuroscience.2008.09.020; Sultana R, 2002, GENOMICS, V80, P129, DOI 10.1006/geno.2002.6810; Tamada A, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-29; Thompson H, 2009, DEV BIOL, V335, P418, DOI 10.1016/j.ydbio.2009.09.034; Tse KF, 2006, CLIN CANCER RES, V12, P1373, DOI 10.1158/1078-0432.CCR-05-2018; VarmehZiaie S, 1997, ONCOGENE, V15, P2699, DOI 10.1038/sj.onc.1201454; Vidal CM, 2006, FEBS LETT, V580, P4401, DOI 10.1016/j.febslet.2006.07.005; Vilborg A, 2009, P NATL ACAD SCI USA, V106, P15756, DOI 10.1073/pnas.0900862106; WETERMAN MAJ, 1995, INT J CANCER, V60, P73, DOI 10.1002/ijc.2910600111; Wu HJ, 1999, J BIOL CHEM, V274, P28270, DOI 10.1074/jbc.274.40.28270; Yang ML, 2006, BLOOD, V108, P4136, DOI 10.1182/blood-2006-06-029645; Yang XW, 2005, CURR PROTOC NEUROSCI, DOI [DOI 10.1002/0471142301.NS0520S31.CHAPTER, 10.1002/0471142301.ns0520s31, DOI 10.1002/0471142301.NS0520S31]; Zhang XD, 2009, AUTOPHAGY, V5, P339, DOI 10.4161/auto.5.3.8174; ZUBIAGA AM, 1995, MOL CELL BIOL, V15, P2219	53	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e29429	10.1371/journal.pone.0029429	http://dx.doi.org/10.1371/journal.pone.0029429			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347364	Green Published, gold, Green Submitted			2022-12-25	WOS:000302180600004
J	Henaux, V; Samuel, MD; Dusek, RJ; Fleskes, JP; Ip, HS				Henaux, Viviane; Samuel, Michael D.; Dusek, Robert J.; Fleskes, Joseph P.; Ip, Hon S.			Presence of Avian Influenza Viruses in Waterfowl and Wetlands during Summer 2010 in California: Are Resident Birds a Potential Reservoir	PLOS ONE			English	Article							A VIRUSES; ENVIRONMENTAL TRANSMISSION; WILD BIRDS; SURVEILLANCE; PERSISTENCE; PREVALENCE; PATTERNS; DUCKS; PERPETUATION; INFECTIVITY	Although wild waterfowl are the main reservoir for low pathogenic avian influenza viruses (LPAIv), the environment plays a critical role for the circulation and persistence of AIv. LPAIv may persist for extended periods in cold environments, suggesting that waterfowl breeding areas in the northern hemisphere may be an important reservoir for AIv in contrast to the warmer southern wintering areas. We evaluated whether southern wetlands, with relatively small populations (thousands) of resident waterfowl, maintain AIv in the summer, prior to the arrival of millions of migratory birds. We collected water and fecal samples at ten wetlands in two regions (Yolo Bypass and Sacramento Valley) of the California Central Valley during three bi-weekly intervals beginning in late July, 2010. We detected AIv in 29/367 fecal samples (7.9%) and 12/597 water samples (2.0%) by matrix real time Reverse Transcription Polymerase Chain Reaction (rRT-PCR). We isolated two H3N8, two H2N3, and one H4N8 among rRT-PCR positive fecal samples but no live virus from water samples. Detection of AIv RNA in fecal samples was higher from wetlands in the Sacramento Valley (11.9%) than in the Yolo Bypass (0.0%), but no difference was found for water samples (2.7 vs. 1.7%, respectively). Our study showed that low densities of hosts and unfavorable environmental conditions did not prevent LPAIv circulation during summer in California wetlands. Our findings justify further investigations to understand AIv dynamics in resident waterfowl populations, compare AIv subtypes between migratory and resident waterfowl, and assess the importance of local AIv as a source of infection for migratory birds.	[Henaux, Viviane] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA; [Samuel, Michael D.] US Geol Survey, Wisconsin Cooperat Wildlife Res Unit, Madison, WI USA; [Dusek, Robert J.; Ip, Hon S.] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI USA; [Fleskes, Joseph P.] US Geol Survey, Western Ecol Res Ctr, Dixon, CA USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Henaux, V (corresponding author), Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA.	henaux@wisc.edu		Ip, Hon/0000-0003-4844-7533; Dusek, Robert/0000-0001-6177-7479	U.S. Geological Survey-National Wildlife Health Center; Western Ecological Research Center	U.S. Geological Survey-National Wildlife Health Center(United States Geological Survey); Western Ecological Research Center	Field sampling, laboratory work, and support for V. Henaux was funded by the U.S. Geological Survey-National Wildlife Health Center (Project CDXRE) and Western Ecological Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTIN JE, 1995, BIRDS N AM, V163; Breban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000346; Brown JD, 2007, AVIAN DIS, V51, P285, DOI 10.1637/7636-042806R.1; Brown Justin D., 2008, V436, P85, DOI 10.1007/978-1-59745-279-3_11; Central Valley Joint Venture, 2006, CENTR VALL JOINT VEN; Chumpolbanchorn Kamlang, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P102; Docherty D.E., 1988, Journal of Tissue Culture Methods, V11, P165, DOI 10.1007/BF01404270; Faust C, 2009, P ROY SOC B-BIOL SCI, V276, P3727, DOI 10.1098/rspb.2009.0572; Ferro PJ, 2008, J WILDLIFE DIS, V44, P434, DOI 10.7589/0090-3558-44.2.434; Ferro PJ, 2010, EMERG INFECT DIS, V16, P1224, DOI 10.3201/eid1608.091864; Fleskes JP, 2007, J WILDLIFE MANAGE, V71, P2238, DOI 10.2193/2005-634; Fleskes JP, WETLAND HAB IN PRESS, P3; Gaidet N, 2007, EMERG INFECT DIS, V13, P626, DOI 10.3201/eid1304.061011; Heitmeyer M.E., 1989, P475; Henaux V, 2011, J WILDLIFE DIS, V47, P566, DOI 10.7589/0090-3558-47.3.566; Hill NJ, 2010, AVIAN DIS, V54, P426, DOI 10.1637/8912-043009-Reg.1; Hill NJ, 2011, CROSS SEASO IN PRESS; HINSHAW VS, 1980, CAN J MICROBIOL, V26, P622, DOI 10.1139/m80-108; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Ip HS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-71; ITO T, 1995, ARCH VIROL, V140, P1163, DOI 10.1007/BF01322743; Koehler AV, 2008, MOL ECOL, V17, P4754, DOI 10.1111/j.1365-294X.2008.03953.x; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Lang AS, 2008, J GEN VIROL, V89, P509, DOI 10.1099/vir.0.83369-0; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; McClintock BT, 2010, ECOL LETT, V13, P659, DOI 10.1111/j.1461-0248.2010.01472.x; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Nazir J, 2010, AVIAN DIS, V54, P720, DOI 10.1637/8754-033109-ResNote.1; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pasick J, 2010, AVIAN DIS, V54, P440, DOI 10.1637/8800-040109-Reg.1; Pearce JM, 2009, EVOL APPL, V2, P457, DOI 10.1111/j.1752-4571.2009.00071.x; Purchase HG, 1989, LAB MANUAL ISOLATION; Rogers K, 2009, LIVE BIRD HUNTER HAR; Rohani P, 2009, P NATL ACAD SCI USA, V106, P10365, DOI 10.1073/pnas.0809026106; Runstadler JA, 2007, ARCH VIROL, V152, P1901, DOI 10.1007/s00705-007-0994-1; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Spackman E, 2008, J VET DIAGN INVEST, V20, P612, DOI 10.1177/104063870802000512; Stallknecht DE, 2009, REV SCI TECH OIE, V28, P59; STALLKNECHT DE, 1990, AVIAN DIS, V34, P406, DOI 10.2307/1591428; STALLKNECHT DE, 1990, AVIAN DIS, V34, P412, DOI 10.2307/1591429; STALLKNECHT DE, 1990, AVIAN DIS, V34, P398, DOI 10.2307/1591427; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; Zarkov IS, 2006, REV MED VET-TOULOUSE, V157, P471	43	29	30	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e31471	10.1371/journal.pone.0031471	http://dx.doi.org/10.1371/journal.pone.0031471			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328934	gold, Green Submitted, Green Published			2022-12-25	WOS:000302179300020
J	Shahab, U; Ahmad, S; Moinuddin; Dixit, K; Habib, S; Alam, K; Ali, A				Shahab, Uzma; Ahmad, Saheem; Moinuddin; Dixit, Kiran; Habib, Safia; Alam, Khursheed; Ali, Asif			Hydroxyl Radical Modification of Collagen Type II Increases Its Arthritogenicity and Immunogenicity	PLOS ONE			English	Article							LIPID-PEROXIDATION; INDUCED ARTHRITIS; PREFERENTIAL RECOGNITION; CIRCULAR-DICHROISM; ANTIOXIDANT LEVELS; ANTIBODIES; IMMUNIZATION; GLYCATION; PRODUCTS; DISEASE	Background: The oxidation of proteins by endogenously generated free radicals causes structural modifications in the molecules that lead to generation of neo-antigenic epitopes that have implications in various autoimmune disorders, including rheumatoid arthritis (RA). Collagen induced arthritis (CIA) in rodents (rats and mice) is an accepted experimental model for RA. Methodology/Principal Findings: Hydroxyl radicals were generated by the Fenton reaction. Collagen type II (CII) was modified by (OH)-O-center dot radical (CII-OH) and analysed by ultraviolet-visible (UV-VIS), fluorescence and circular dichroism (CD) spectroscopy. The immunogenicity of native and modified CII was checked in female Lewis rats and specificity of the induced antibodies was ascertained by enzyme linked immunosorbent assay (ELISA). The extent of CIA was evaluated by visual inspection. We also estimated the oxidative and inflammatory markers in the sera of immunized rats. A slight change in the triple helical structure of CII as well as fragmentation was observed after hydroxyl radical modification. The modified CII was found to be highly arthritogenic and immunogenic as compared to the native form. The CII-OH immunized rats exhibited increased oxidative stress and inflammation as compared to the CII immunized rats in the control group. Conclusions/Significance: Neo-antigenic epitopes were generated on (OH)-O-center dot modified CII which rendered it highly immunogenic and arthritogenic as compared to the unmodified form. Since the rodent CIA model shares many features with human RA, these results illuminate the role of free radicals in human RA.	[Shahab, Uzma; Ahmad, Saheem; Moinuddin; Dixit, Kiran; Habib, Safia; Alam, Khursheed; Ali, Asif] Aligarh Muslim Univ, Dept Biochem, Fac Med, JN Med Coll, Aligarh, Uttar Pradesh, India	Aligarh Muslim University	Shahab, U (corresponding author), Aligarh Muslim Univ, Dept Biochem, Fac Med, JN Med Coll, Aligarh, Uttar Pradesh, India.	moin_u@rediffmail.com	Ahmad, Saheem/R-7016-2017; Shahab, Uzma/AAR-4332-2021; Ahmad, Saheem/T-2609-2019	Ahmad, Saheem/0000-0003-1215-0279; Ahmad, Saheem/0000-0003-1215-0279; Alam, Khursheed/0000-0001-9729-9966	Aligarh M University; University Grants Commmission, New Delhi; ICMR, New Delhi [Immuno 18/11/18/2008-ECD-I]	Aligarh M University; University Grants Commmission, New Delhi; ICMR, New Delhi(Indian Council of Medical Research (ICMR))	Funds for the study came from annual budget grant provided by the Aligarh M University to the Department. The University gets funds from the University Grants Commmission, New Delhi (www.ugc.ac.in). Part of the funds were also derived from the research grant to Dr. Moinuddin from ICMR, New Delhi [www.icmr.nic.in] (grant no.Immuno 18/11/18/2008-ECD-I). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H., 1974, METHODS ENZYMATIC AN, P673, DOI [10.1016/B978-0-12-091302-2.50032-3, DOI 10.1016/B978-0-12-091302-2.50032-3]; Ahmad S, 2011, BIOCHEM BIOPH RES CO, V407, P568, DOI 10.1016/j.bbrc.2011.03.064; ANDRIOPOULOS NA, 1976, ARTHRITIS RHEUM, V19, P613, DOI 10.1002/art.1780190314; Ansari NA, 2009, HUM IMMUNOL, V70, P417, DOI 10.1016/j.humimm.2009.03.015; Bauerova K, 1999, GEN PHYSIOL BIOPHYS, V18, P15; Bazzichi L, 2002, Clin Exp Rheumatol, V20, P761; BIEMOND P, 1988, FREE RADICAL BIO MED, V4, P185, DOI 10.1016/0891-5849(88)90026-3; BROWN FR, 1969, J MOL BIOL, V39, P307, DOI 10.1016/0022-2836(69)90319-2; Cheng FC, 2002, J CHROMATOGR B, V781, P481, DOI 10.1016/S1570-0232(02)00620-7; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Gambhir JK, 1997, CLIN BIOCHEM, V30, P351, DOI 10.1016/S0009-9120(96)00007-0; Habib S, 2009, CELL IMMUNOL, V254, P117, DOI 10.1016/j.cellimm.2008.08.002; HALLIWELL B, 1990, ARCH BIOCHEM BIOPHYS, V280, P1, DOI 10.1016/0003-9861(90)90510-6; Harris ED, 1993, TXB RHEUMATOLOGY, P833; Hassan MQ, 2001, J APPL TOXICOL, V21, P69, DOI 10.1002/jat.736; HELIOVAARA M, 1994, ANN RHEUM DIS, V53, P51, DOI 10.1136/ard.53.1.51; Hinoi E, 2005, BIOCHEM PHARMACOL, V70, P1744, DOI 10.1016/j.bcp.2005.09.010; HOLMDAHL R, 1989, J IMMUNOL, V142, P1881; HOLMDAHL R, 1985, CLIN EXP IMMUNOL, V62, P639; JENNESS DD, 1976, BIOPOLYMERS, V15, P513, DOI 10.1002/bip.1976.360150308; Jira W, 1997, CHEM PHYS LIPIDS, V87, P81, DOI 10.1016/S0009-3084(97)00030-3; Kamanh A, 2004, CELL BIOCHEM FUNCT, V22, P53, DOI 10.1002/cbf.1055; Karatas F, 2003, INDIAN J MED RES, V118, P178; Kim WU, 2004, AM J MED SCI, V327, P202, DOI 10.1097/00000441-200404000-00006; Kim WU, 2000, J RHEUMATOL, V27, P575; Kiziltunc A, 1998, SCAND J RHEUMATOL, V27, P441; LARSSON P, 1990, ARTHRITIS RHEUM, V33, P693, DOI 10.1002/art.1780330512; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; LI MH, 1993, BIOCHEMISTRY-US, V32, P7377, DOI 10.1021/bi00080a007; LONDEI M, 1989, P NATL ACAD SCI USA, V86, P636, DOI 10.1073/pnas.86.2.636; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Mori T, 2011, INT IMMUNOL, V23, P701, DOI 10.1093/intimm/dxr077; Olszowski S, 2003, ACTA BIOCHIM POL, V50, P471; STUART JM, 1983, J EXP MED, V158, P378, DOI 10.1084/jem.158.2.378; Svensson L, 1998, CLIN EXP IMMUNOL, V111, P521; Terato K, 1996, CLIN IMMUNOL IMMUNOP, V79, P142, DOI 10.1006/clin.1996.0061; Yagi K, 1988, CRC HDB FREE RADICAL, P215	40	40	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31199	10.1371/journal.pone.0031199	http://dx.doi.org/10.1371/journal.pone.0031199			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319617	Green Submitted, gold, Green Published			2022-12-25	WOS:000302178400031
J	Strack, S; Cribbs, JT				Strack, Stefan; Cribbs, J. Thomas			Allosteric Modulation of Drp1 Mechanoenzyme Assembly and Mitochondrial Fission by the Variable Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNAMIN-RELATED GTPASE; DEPENDENT PROTEIN-KINASE; PEROXISOMAL FISSION; CRYSTAL-STRUCTURE; MAMMALIAN-CELLS; S-NITROSYLATION; PHOSPHORYLATION; DEATH; TRANSLOCATION; MICROSCOPY	Background: Mechanisms of Drp1-mediated mitochondrial fission are poorly understood. Results: Substitution of the Drp1 variable domain causes a spectrum of assembly and activity phenotypes but does not compromise the stalk domain-mediated recruitment of Drp1 to the mitochondrial anchoring protein Mff. Conclusion: The variable domain modulates Drp1 activity through oligomeric assembly. Significance: Insight into Drp1 regulatory mechanisms is essential for understanding mitochondrial biology.	[Strack, Stefan] Univ Iowa, Carver Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA	University of Iowa	Strack, S (corresponding author), Univ Iowa, Carver Coll Med, Dept Pharmacol, 2-432 BSB,51 Newton Rd, Iowa City, IA 52242 USA.	stefan-strack@uiowa.edu		Strack, Stefan/0000-0002-6175-7280	National Institutes of Health [NS043254, NS056244, NS057714]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS056244, R01NS043254, R01NS056244, R01NS057714] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS043254, NS056244, and NS057714 (to S. S.)	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bossy B, 2010, J ALZHEIMERS DIS, V20, pS513, DOI 10.3233/JAD-2010-100552; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chang CR, 2010, J BIOL CHEM, V285, P32494, DOI 10.1074/jbc.M110.142430; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Cribbs JT, 2009, METHOD ENZYMOL, V457, P231, DOI 10.1016/S0076-6879(09)05013-7; De Vos KJ, 2005, CURR BIOL, V15, P678, DOI 10.1016/j.cub.2005.02.064; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Figueroa-Romero C, 2009, FASEB J, V23, P3917, DOI 10.1096/fj.09-136630; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Grabenbauer M, 2005, NAT METHODS, V2, P857, DOI 10.1038/nmeth806; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; McNally JG, 2008, METHOD CELL BIOL, V85, P329, DOI 10.1016/S0091-679X(08)85014-5; Merrill RA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000612; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Pfleger KDG, 2006, NAT PROTOC, V1, P337, DOI 10.1038/nprot.2006.52; Schmid SL, 2011, ANNU REV CELL DEV BI, V27, P79, DOI 10.1146/annurev-cellbio-100109-104016; SOUMPASIS DM, 1983, BIOPHYS J, V41, P95, DOI 10.1016/S0006-3495(83)84410-5; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Wasiak S, 2007, J CELL BIOL, V177, P439, DOI 10.1083/jcb.200610042; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341; Zunino R, 2009, J BIOL CHEM, V284, P17783, DOI 10.1074/jbc.M901902200	36	74	75	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10990	11001		10.1074/jbc.M112.342105	http://dx.doi.org/10.1074/jbc.M112.342105			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334657	Green Published, hybrid			2022-12-25	WOS:000302780100027
J	Gempe, T; Stach, S; Bienefeld, K; Beye, M				Gempe, Tanja; Stach, Silke; Bienefeld, Kaspar; Beye, Martin			Mixing of Honeybees with Different Genotypes Affects Individual Worker Behavior and Transcription of Genes in the Neuronal Substrate	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; DIVISION-OF-LABOR; HYGIENIC BEHAVIOR; TASK SPECIALIZATION; RESPONSE THRESHOLDS; FORAGING BEHAVIOR; BEE; COLONY; ORGANIZATION; HYMENOPTERA	Division of labor in social insects has made the evolution of collective traits possible that cannot be achieved by individuals alone. Differences in behavioral responses produce variation in engagement in behavioral tasks, which as a consequence, generates a division of labor. We still have little understanding of the genetic components influencing these behaviors, although several candidate genomic regions and genes influencing individual behavior have been identified. Here, we report that mixing of worker honeybees with different genotypes influences the expression of individual worker behaviors and the transcription of genes in the neuronal substrate. These indirect genetic effects arise in a colony because numerous interactions between workers produce interacting phenotypes and genotypes across organisms. We studied hygienic behavior of honeybee workers, which involves the cleaning of diseased brood cells in the colony. We mixed,500 newly emerged honeybee workers with genotypes of preferred Low (L) and High (H) hygienic behaviors. The L/H genotypic mixing affected the behavioral engagement of L worker bees in a hygienic task, the cooperation among workers in uncapping single brood cells, and switching between hygienic tasks. We found no evidence that recruiting and task-related stimuli are the primary source of the indirect genetic effects on behavior. We suggested that behavioral responsiveness of L bees was affected by genotypic mixing and found evidence for changes in the brain in terms of 943 differently expressed genes. The functional categories of cell adhesion, cellular component organization, anatomical structure development, protein localization, developmental growth and cell morphogenesis were overrepresented in this set of 943 genes, suggesting that indirect genetic effects can play a role in modulating and modifying the neuronal substrate. Our results suggest that genotypes of social partners affect the behavioral responsiveness and the neuronal substrate of individual workers, indicating a complex genetic architecture underlying the expression of behavior.	[Gempe, Tanja; Beye, Martin] Univ Dusseldorf, Dept Genet, Dusseldorf, Germany; [Stach, Silke; Bienefeld, Kaspar] Inst Bee Res, Hohen Neuendorf, Germany	Heinrich Heine University Dusseldorf	Gempe, T (corresponding author), Univ Dusseldorf, Dept Genet, Dusseldorf, Germany.	martin.beye@uni-duesseldorf.de			Deuteche Bundesstiftung Umwelt (DBU)	Deuteche Bundesstiftung Umwelt (DBU)	This work was supported by the Deuteche Bundesstiftung Umwelt (DBU) http://www.dbu.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2010, VITAM HORM, V83, P401, DOI 10.1016/S0083-6729(10)83017-1; Alaux C, 2009, P NATL ACAD SCI USA, V106, P15400, DOI 10.1073/pnas.0907043106; Arathi HS, 2001, ANIM BEHAV, V62, P57, DOI 10.1006/anbe.2000.1731; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Bienefeld K., 2001, P 37 INT AP C; Bonabeau E, 1997, TRENDS ECOL EVOL, V12, P188, DOI 10.1016/S0169-5347(97)01048-3; CALDERONE NW, 1992, BEHAV ECOL SOCIOBIOL, V30, P219, DOI 10.1007/BF00166706; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DRELLER C, 1995, NATURWISSENSCHAFTEN, V82, P243, DOI 10.1007/BF01133602; DURST C, 1994, BEHAV NEURAL BIOL, V62, P259, DOI 10.1016/S0163-1047(05)80025-1; FEWELL JH, 1993, EXPERIENTIA, V49, P1106, DOI 10.1007/BF01929923; FRUMHOFF PC, 1988, NATURE, V333, P358, DOI 10.1038/333358a0; Groh C, 2004, P NATL ACAD SCI USA, V101, P4268, DOI 10.1073/pnas.0400773101; Groh Claudia, 2010, Front Biosci (Schol Ed), V2, P268; Guzman-Novoa E, 2002, BEHAV GENET, V32, P95, DOI 10.1023/A:1015245605670; Harbison ST, 2009, NAT GENET, V41, P371, DOI 10.1038/ng.330; Holldobler B., 1990, pi; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; HUANG ZY, 1992, P NATL ACAD SCI USA, V89, P11726, DOI 10.1073/pnas.89.24.11726; Humphries MA, 2003, J NEUROBIOL, V55, P315, DOI 10.1002/neu.10209; HUNT GJ, 1995, GENETICS, V141, P1537; Hunt GJ, 1998, GENETICS, V148, P1203; Hunt GJ, 2007, NATURWISSENSCHAFTEN, V94, P247, DOI 10.1007/s00114-006-0183-1; Jones JC, 2004, SCIENCE, V305, P402, DOI 10.1126/science.1096340; Keller L, 2009, PHILOS T R SOC B, V364, P3209, DOI 10.1098/rstb.2009.0108; Lapidge KL, 2002, NATURWISSENSCHAFTEN, V89, P565, DOI 10.1007/s00114-002-0371-6; Leadbeater E, 2007, CURR BIOL, V17, pR703, DOI 10.1016/j.cub.2007.06.012; Leoncini I, 2004, P NATL ACAD SCI USA, V101, P17559, DOI 10.1073/pnas.0407652101; Linksvayer TA, 2005, Q REV BIOL, V80, P317, DOI 10.1086/432266; Linksvayer TA, 2009, AM NAT, V173, pE99, DOI 10.1086/596527; Mattila HR, 2007, SCIENCE, V317, P362, DOI 10.1126/science.1143046; MICHENER CD, 1974, SOCIAL BEHAV BEES; Moore AJ, 1997, EVOLUTION, V51, P1352, DOI 10.1111/j.1558-5646.1997.tb01458.x; MORITZ RFA, 1987, BEHAV ECOL SOCIOBIOL, V21, P53, DOI 10.1007/BF00324435; OLDROYD BP, 1992, ANN ENTOMOL SOC AM, V85, P335, DOI 10.1093/aesa/85.3.335; OLDROYD BP, 1994, BEHAV ECOL SOCIOBIOL, V34, P25, DOI 10.1007/BF00175455; Oxley PR, 2010, MOL ECOL, V19, P1452, DOI 10.1111/j.1365-294X.2010.04569.x; Page RE, 1998, J COMP PHYSIOL A, V182, P489, DOI 10.1007/s003590050196; Page RE, 2002, NATURWISSENSCHAFTEN, V89, P91, DOI 10.1007/s00114-002-0299-x; Page RE, 2000, J HERED, V91, P474, DOI 10.1093/jhered/91.6.474; Pankiw T, 1999, J COMP PHYSIOL A, V185, P207, DOI 10.1007/s003590050379; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; ROBINSON GE, 1988, NATURE, V333, P356, DOI 10.1038/333356a0; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Ross KG, 1998, P NATL ACAD SCI USA, V95, P14232, DOI 10.1073/pnas.95.24.14232; ROTHENBUHLER WC, 1964, AM ZOOL, V4, P111; Rueppell O, 2006, GENETICS, V172, P243, DOI 10.1534/genetics.105.046490; Seeley TD., 1985, HONEYBEE ECOLOGY, DOI [10.1515/9781400857876, DOI 10.1515/9781400857876]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Stone EA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000479; Tautz J, 2003, P NATL ACAD SCI USA, V100, P7343, DOI 10.1073/pnas.1232346100; Thakur RK, 1998, APIDOLOGIE, V29, P431, DOI DOI 10.1051/APIDO:19980502; Wang J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000127; Weidenmuller A, 2002, ANIM BEHAV, V63, P1065, DOI 10.1006/anbe.2002.3020; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Wilson E.O., 1971, INSECT SOC; WITHERS GS, 1993, NATURE, V364, P238, DOI 10.1038/364238a0	60	14	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31653	10.1371/journal.pone.0031653	http://dx.doi.org/10.1371/journal.pone.0031653			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348118	Green Published, gold, Green Submitted			2022-12-25	WOS:000302737400040
J	Haines, B; Li, PA				Haines, Bryan; Li, P. Andy			Overexpression of Mitochondrial Uncoupling Protein 2 Inhibits Inflammatory Cytokines and Activates Cell Survival Factors after Cerebral Ischemia	PLOS ONE			English	Article							OXYGEN-GLUCOSE DEPRIVATION; NECROSIS-FACTOR-ALPHA; BROWN ADIPOSE-TISSUE; BRAIN-INJURY; OXIDATIVE STRESS; ARTERY OCCLUSION; TRANSGENIC MICE; FOCAL ISCHEMIA; RAT-BRAIN; STROKE	Mitochondria play a critical role in cell survival and death after cerebral ischemia. Uncoupling proteins (UCPs) are inner mitochondrial membrane proteins that disperse the mitochondrial proton gradient by translocating H+ across the inner membrane in order to stabilize the inner mitochondrial membrane potential (Delta psi(m)) and reduce the formation of reactive oxygen species. Previous studies have demonstrated that mice transgenically overexpressing UCP2 (UCP2 Tg) in the brain are protected from cerebral ischemia, traumatic brain injury and epileptic challenges. This study seeks to clarify the mechanisms responsible for neuroprotection after transient focal ischemia. Our hypothesis is that UCP2 is neuroprotective by suppressing innate inflammation and regulating cell cycle mediators. PCR gene arrays and protein arrays were used to determine mechanisms of damage and protection after transient focal ischemia. Our results showed that ischemia increased the expression of inflammatory genes and suppressed the expression of anti-apoptotic and cell cycle genes. Overexpression of UCP2 blunted the ischemia-induced increase in IL-6 and decrease in Bcl2. Further, UCP2 increased the expression of cell cycle genes and protein levels of phospho-AKT, PKC and MEK after ischemia. It is concluded that the neuroprotective effects of UCP2 against ischemic brain injury are associated with inhibition of pro-inflammatory cytokines and activation of cell survival factors.	[Haines, Bryan] Buck Inst Res Aging, Novato, CA 94945 USA; [Li, P. Andy] N Carolina Cent Univ, Dept Pharmaceut Sci, BRITE, Durham, NC USA	Buck Institute for Research on Aging; University of North Carolina; North Carolina Central University	Haines, B (corresponding author), Buck Inst Res Aging, Novato, CA 94945 USA.	pli@nccu.edu			National Institutes of Health [R01DK075476-06]; Golden Leaf Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Golden Leaf Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Work was funded by the National Institutes of Health R01DK075476-06. The BRITE program is partially funded by the Golden Leaf Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acalovschi D, 2003, STROKE, V34, P1864, DOI 10.1161/01.STR.0000079815.38626.44; Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Bechmann I, 2002, BIOCHEM PHARMACOL, V64, P363, DOI 10.1016/S0006-2952(02)01166-8; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bernardi R, 2000, ONCOGENE, V19, P2447, DOI 10.1038/sj.onc.1203564; Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124; Choi K, 2009, CURR NEUROVASC RES, V6, P213, DOI 10.2174/156720209789630375; Chung H, 2007, ENDOCRINOLOGY, V148, P148, DOI 10.1210/en.2006-0991; Clark CB, 2009, FREE RADICAL BIO MED, V47, P1440, DOI 10.1016/j.freeradbiomed.2009.08.012; Craig RW, 2002, LEUKEMIA, V16, P444, DOI 10.1038/sj.leu.2402416; Dang S, 2011, NEUROL RES, V33, P520, DOI 10.1179/016164111X13007856084287; Dhodda VK, 2004, J NEUROCHEM, V89, P73, DOI 10.1111/j.1471-4159.2004.02316.x; Ding XL, 2000, AM J PATHOL, V157, P1983, DOI 10.1016/S0002-9440(10)64837-7; Elzer JG, J CEREB BLOOD FLOW M, V30, P935; Fiskum G, 2004, J BIOENERG BIOMEMBR, V36, P347, DOI 10.1023/B:JOBB.0000041766.71376.81; Gao QL, 2006, MOL THER, V13, P928, DOI 10.1016/j.ymthe.2005.12.009; GINSBERG MD, 1992, CEREBROVAS BRAIN MET, V4, P189; Horvath TL, 2003, INT J OBESITY, V27, P433, DOI 10.1038/sj.ijo.0802257; Iijima T, 2003, BRAIN RES, V993, P140, DOI 10.1016/j.brainres.2003.09.041; Ishibashi N, 2002, J IMMUNOL, V168, P1926, DOI 10.4049/jimmunol.168.4.1926; Jezek P, 2002, INT J BIOCHEM CELL B, V34, P1190, DOI 10.1016/S1357-2725(02)00061-4; Kaya D, 2005, J CEREBR BLOOD F MET, V25, P1111, DOI 10.1038/sj.jcbfm.9600109; Kim HS, 2007, DIABETES RES CLIN PR, V77, pS46, DOI 10.1016/j.diabres.2007.01.032; Lengacher S, 2004, J CEREBR BLOOD F MET, V24, P780, DOI 10.1097/01.WCB.0000122743.72175.52; Li PA, 1998, BRAIN RES, V804, P36, DOI 10.1016/S0006-8993(98)00651-9; Li Y, 1997, J CEREBR BLOOD F MET, V17, P846, DOI 10.1097/00004647-199708000-00003; Liu XQ, 2009, ACTA PHARMACOL SIN, V30, P1071, DOI 10.1038/aps.2009.105; Liu Yajun, 2009, BMC Physiology, V9, P17, DOI 10.1186/1472-6793-9-17; Lu D, 1997, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V13, P224; Macdonald K, 1999, CIRC RES, V84, P820; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; Mehta SL, 2009, J CEREBR BLOOD F MET, V29, P1069, DOI 10.1038/jcbfm.2009.4; Minami M, 2006, J PHARMACOL SCI, V100, P461, DOI 10.1254/jphs.CRJ06005X; Mori M, 2004, CELL DEATH DIFFER, V11, P1223, DOI 10.1038/sj.cdd.4401483; Nakagomi T, 1996, NEUROL RES, V18, P559; Nakase T, 2007, NEUROPATHOLOGY, V27, P442, DOI 10.1111/j.1440-1789.2007.00815.x; NICHOLLS DG, 1977, EUR J BIOCHEM, V75, P601, DOI 10.1111/j.1432-1033.1977.tb11560.x; Ouyang YB, 2004, CELL CALCIUM, V36, P303, DOI 10.1016/j.ceca.2004.02.015; Ouyang YB, 2006, CELL STRESS CHAPERON, V11, P180, DOI 10.1379/CSC-182R.1; Palgrave CJ, 2011, J VIROL, V85, P6008, DOI 10.1128/JVI.00331-11; Pignataro G, 2008, J CEREBR BLOOD F MET, V28, P232, DOI 10.1038/sj.jcbfm.9600559; Rousset S, 2006, CYTOKINE, V35, P135, DOI 10.1016/j.cyto.2006.07.012; Sawe N, 2008, J NEUROSCI RES, V86, P1659, DOI 10.1002/jnr.21604; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Sriram K, 2007, J NEUROIMMUNE PHARM, V2, P140, DOI 10.1007/s11481-007-9070-6; Teshima Y, 2003, CIRC RES, V93, P192, DOI 10.1161/01.RES.0000085581.60197.4D; Tuttolomondo A, 2008, CURR PHARM DESIGN, V14, P3574, DOI 10.2174/138161208786848739; Yano S, 2001, J CEREBR BLOOD F MET, V21, P351, DOI 10.1097/00004647-200104000-00004; Yoshitomi H, 1999, BIOCHEM J, V340, P397, DOI 10.1042/0264-6021:3400397; Zhao H, 2005, J NEUROSCI, V25, P9794, DOI 10.1523/JNEUROSCI.3163-05.2005; Zhao H, 2009, J CEREBR BLOOD F MET, V29, P873, DOI 10.1038/jcbfm.2009.13	52	29	33	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31739	10.1371/journal.pone.0031739	http://dx.doi.org/10.1371/journal.pone.0031739			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348126	Green Published, Green Submitted, gold			2022-12-25	WOS:000302737400046
J	Drotz, MK; Brodin, T; Saura, A; Giles, BE				Drotz, Marcus K.; Brodin, Tomas; Saura, Anssi; Giles, Barbara E.			Ecotype Differentiation in the Face of Gene Flow within the Diving Beetle Agabus bipustulatus (Linnaeus, 1767) in Northern Scandinavia	PLOS ONE			English	Article							ALPHA-GLYCEROPHOSPHATE DEHYDROGENASE; NATURAL-SELECTION; SYMPATRIC SPECIATION; POPULATION-STRUCTURE; COLEOPTERA; DIVERGENCE; PREFERENCE; HEMIPTERA; ONTOGENY	The repeated occurrence of habitat-specific polyphyletic evolved ecotypes throughout the ranges of widely distributed species implies that multiple, independent and parallel selection events have taken place. Ecological transitions across altitudinal gradients over short geographical distances are often associated with variation in habitat-related fitness, these patterns suggest the action of strong selective forces. Genetic markers will therefore contribute differently to differences between ecotypes in local hybrid zones. Here we have studied the adaptive divergence between ecotypes of the water beetle Agabus bipustulatus along several parallel altitudinal gradients in northern Scandinavia. This water beetle is well known for its remarkable morphological variation associated with mountain regions throughout the western Palaearctic. Two morphological ecotypes are recognised: a montane type with reduced flight muscles and a lowland type with fully developed muscles. Using a multilocus survey of allozyme variation and a morphological analysis with landmark-based morphometrics, across thirty-three populations and seven altitudinal gradients, we studied the local adaptive process of gene flow and selection in detail. Populations were sampled at three different elevations: below, at and above the tree line. The results indicate that the levels of divergence observed between ecotypes in morphology and allele frequencies at alpha-Glycerophosphate dehydrogenase relative to those shown by neutral molecular markers reflects local diversifying selection in situ. Four main lines of evidence are shown here: (1) A repeated morphological pattern of differentiation is observed across all altitudinal transects, with high reclassification probabilities. (2) Allele and genotype frequencies at the alpha-Gpdh locus are strongly correlated with altitude, in sharp contrast to the presumable neutral markers. (3) Genetic differentiation is two to three times higher among populations across the tree line than among populations at or below. (4) Genetic differentiation between ecotypes within independent mountain areas is reflected by different sets of allozymes.	[Drotz, Marcus K.] Lake Vanem Museum Nat & Cultural Hist, Lidkoping, Sweden; [Brodin, Tomas; Giles, Barbara E.] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden; [Saura, Anssi] Umea Univ, Dept Mol Biol, Umea, Sweden	Umea University; Umea University	Drotz, MK (corresponding author), Lake Vanem Museum Nat & Cultural Hist, Lidkoping, Sweden.	Marcus.Drotz@lidkoping.se		Brodin, Tomas/0000-0003-1086-7567	Sven and Lilly Lawski Foundation; Lidkopings municipality; Nilsson-Ehle Foundation	Sven and Lilly Lawski Foundation; Lidkopings municipality; Nilsson-Ehle Foundation	MKD was supported by the Sven and Lilly Lawski Foundation (www.handelsbanken.se), and the Lidkopings municipality (www.lidkoping.se) concerning wage funds. Nilsson-Ehle Foundation (http://www.fysiografen.se/stipendier/) gave financial support for sample collection, travel and analytic costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrino J, 2005, EVOLUTION, V59, P1334; Andersson J, 2005, BIOL J LINN SOC, V85, P341, DOI 10.1111/j.1095-8312.2005.00501.x; [Anonymous], 2020, ECONOMIST 0326; Aube C, 1837, ICONOGRAPHIE HIST NA, V5; Barluenga M, 2006, NATURE, V439, P719, DOI 10.1038/nature04325; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Barton NH, 2001, DISPERSAL, P330; BEWLEY GC, 1974, J INSECT PHYSIOL, V20, P153, DOI 10.1016/0022-1910(74)90130-9; Bilton David, 1994, Entomologisk Tidskrift, V115, P23; BILTON DT, 1992, HEREDITY, V69, P503, DOI 10.1038/hdy.1992.165; Bookstein FL, 1996, NATO ADV SCI INST SE, V284, P153; Coltman DW, 2005, NATURE, V433, P23, DOI 10.1038/433023a; Davy-Bowker John, 2002, Aquatic Ecology, V36, P435, DOI 10.1023/A:1016550127986; De Marzo L., 1974, Entomologica Bari, V10, P81; De Marzo L., 1973, Entomologica Bari, V9, P47; Dhuyvetter H, 2007, EVOLUTION, V61, P184, DOI 10.1111/j.1558-5646.2007.00015.x; Drotz MK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009034; Drotz MK, 2003, BIOL J LINN SOC, V79, P653, DOI 10.1046/j.1095-8312.2003.00214.x; Drotz MK, 2001, BIOL J LINN SOC, V73, P11, DOI 10.1006/bijl.2001.0491; ERIKSSON U, 1972, Acta Societatis pro Fauna et Flora Fennica, V80, P121; Falkenstrom G, 1940, ARK ZOOL, V32, P1; GOUDET J, 1994, GENETICS AND EVOLUTION OF AQUATIC ORGANISMS, P81; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Goudet J, 2004, PCAGEN; Grahame JW, 2006, EVOLUTION, V60, P268; GRELL EH, 1967, SCIENCE, V158, P1319, DOI 10.1126/science.158.3806.1319; HOLMGREN B, 1996, ECOLOGICAL B, V45, P159; Jackson D. J., 1956, Journal of the Linnean Society London, V43, P18; Jackson D. J., 1952, Proceedings of the Royal Entomological Society of London (A), V27, P57; Jackson D. J., 1956, Proceedings of the Linnean Society of London, V167, P76; Jackson DJ, 1957, T ROYAL ENTOMOLOGICA, V100, P53; JOHANNESSON K, 1995, P NATL ACAD SCI USA, V92, P2602, DOI 10.1073/pnas.92.7.2602; Johannesson K, 2001, TRENDS ECOL EVOL, V16, P148, DOI 10.1016/S0169-5347(00)02078-4; Johansson F, 2006, ICHTHYOL RES, V53, P63, DOI 10.1007/s10228-005-0316-0; Kullman L, 2001, AMBIO, V30, P72, DOI 10.1639/0044-7447(2001)030[0072:CCWATL]2.0.CO;2; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; LIEBHERR JK, 1986, ANN ENTOMOL SOC AM, V79, P424, DOI 10.1093/aesa/79.3.424; LIEBHERR JK, 1988, EVOLUTION, V42, P129, DOI [10.2307/2409121, 10.1111/j.1558-5646.1988.tb04113.x]; Lundkvist E, 2002, ANN ZOOL FENN, V39, P109; Lundmark M, 2001, INSECT SYST EVOL, V32, P241, DOI 10.1163/187631201X00182; NEI M, 1978, GENETICS, V89, P583; NILSSON A N, 1985, Notulae Entomologicae, V65, P137; Nilsson Anders N., 1995, Fauna Entomologica Scandinavica, V32, P1; Nosil P, 2005, EVOLUTION, V59, P705; Nosil P, 2008, EVOLUTION, V62, P316, DOI 10.1111/j.1558-5646.2007.00299.x; Nosil P, 2008, MOL ECOL, V17, P2103, DOI 10.1111/j.1365-294X.2008.03715.x; Nosil P, 2007, GENETICA, V129, P309, DOI 10.1007/s10709-006-0013-6; Panova M, 2006, MOL ECOL, V15, P4021, DOI 10.1111/j.1365-294X.2006.03067.x; Postma E, 2005, NATURE, V433, P65, DOI 10.1038/nature03083; PREZIOSI RF, 1992, EVOLUTION, V46, P430, DOI [10.2307/2409862, 10.1111/j.1558-5646.1992.tb02049.x]; Ribera I, 1995, CAN J ZOOL, V73, P2343, DOI 10.1139/z95-275; Rohlf F.J., 1993, CONTRIB MORPHOMETRIC, P132; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Rohlf JF, 1998, RELATIVE WARPS VERSI; Savolainen V, 2006, NATURE, V441, P210, DOI 10.1038/nature04566; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schneider P., 1986, Entomologica Basiliensia, V11, P451; Sharp D, 1882, SCI T R DUBLIN SOC Z, VZ, P17; SHAW CR, 1970, BIOCHEM GENET, V4, P297, DOI 10.1007/BF00485780; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; SLATKIN M, 1973, GENETICS, V75, P733; SMITH DS, 1964, J MORPHOL, V114, P107, DOI 10.1002/jmor.1051140106; SOUTHWOOD TRE, 1962, BIOL REV, V37, P171, DOI 10.1111/j.1469-185X.1962.tb01609.x; Storz JF, 2004, EVOLUTION, V58, P1342; Suselbeck G, 1987, THESIS A LUDWIGS U F; Umetri A, 1996, COMPUTER SOFTWARE SI; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Weir BS., 1996, GENETIC DATA ANAL; WRIGHT DA, 1969, BIOCHEM GENET, V3, P343, DOI 10.1007/BF00485718; ZERA AJ, 1981, EVOLUTION, V35, P218, DOI 10.1111/j.1558-5646.1981.tb04881.x	72	6	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31381	10.1371/journal.pone.0031381	http://dx.doi.org/10.1371/journal.pone.0031381			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348080	gold, Green Submitted, Green Published			2022-12-25	WOS:000302733900044
J	Lynd, A; Lycett, GJ				Lynd, Amy; Lycett, Gareth John			Development of the Bi-Partite Gal4-UAS System in the African Malaria Mosquito, Anopheles gambiae	PLOS ONE			English	Article							TARGETED GENE-EXPRESSION; GERMLINE TRANSFORMATION; DROSOPHILA; VECTOR; ZEBRAFISH; SUSCEPTIBILITY; TRANSGENESIS; DOWNSTREAM; PLASMODIUM; INFECTION	Functional genetic analysis in Anopheles gambiae would be greatly improved by the development of a binary expression system, which would allow the more rapid and flexible characterisation of genes influencing disease transmission, including those involved in insecticide resistance, parasite interaction, host and mate seeking behaviour. The Gal4-UAS system, widely used in Drosophila melanogaster functional genetics, has been significantly modified to achieve robust application in several different species. Towards this end, previous work generated a series of modified Gal4 constructs that were up to 20 fold more active than the native gene in An. gambiae cells. To examine the Gal4-UAS system in vivo, transgenic An. gambiae driver lines carrying a modified Gal4 gene under the control of the carboxypeptidase promoter, and responder lines carrying UAS regulated luciferase and eYFP reporter genes have been created. Crossing of the Gal4 and UAS lines resulted in progeny that expressed both reporters in the expected midgut specific pattern. Although there was minor variation in reporter gene activity between the different crosses examined, the tissue specific expression pattern was consistent regardless of the genomic location of the transgene cassettes. The results show that the modified Gal4-UAS system can be used to successfully activate expression of transgenes in a robust and tissue specific manner in Anopheles gambiae. The midgut driver and dual reporter responder constructs are the first to be developed and tested successfully in transgenic An. gambiae and provide the basis for further advancement of the system in this and other insect species.	[Lynd, Amy; Lycett, Gareth John] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool	Lynd, A (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England.	gjlycett@liv.ac.uk	Lynd, Amy/C-8938-2013; Lynd, Amy/AAE-9640-2020	Lynd, Amy/0000-0001-6054-0525; Lycett, Gareth/0000-0002-2422-053X	European Commission [223726]; Biotechnology and Biological Sciences Research Council [BB/F021933/1]; BBSRC [BB/F021933/1] Funding Source: UKRI	European Commission(European CommissionEuropean Commission Joint Research Centre); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded through the European Commission Grant No. 223726 (TransMalariaBloc) and a Biotechnology and Biological Sciences Research Council grant BB/F021933/1 awarded to G.J.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amenya DA, 2010, J INSECT PHYSIOL, V56, P1414, DOI 10.1016/j.jinsphys.2010.04.013; Arnone MI, 2004, METHOD CELL BIOL, V74, P621; Asakawa K, 2008, DEV GROWTH DIFFER, V50, P391, DOI [10.1111/j.1440-169x.2008.01044.x, 10.1111/j.1440-169X.2008.01044.x]; Baker DA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-296; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; Blandin SA, 2009, SCIENCE, V326, P147, DOI 10.1126/science.1175241; BRAND AH, 1994, GENE DEV, V8, P629, DOI 10.1101/gad.8.5.629; BRAND AH, 1993, DEVELOPMENT, V118, P401; CAI H, 1995, NATURE, V376, P533, DOI 10.1038/376533a0; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; CARTER MJ, 1993, NUCLEIC ACIDS RES, V21, P1044, DOI 10.1093/nar/21.4.1044; Catteruccia F, 2009, METHODS MOL BIOL, V555, P63, DOI 10.1007/978-1-60327-295-7_5; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Distel M, 2009, P NATL ACAD SCI USA, V106, P13365, DOI 10.1073/pnas.0903060106; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Edwards MJ, 1997, INSECT BIOCHEM MOLEC, V27, P1063, DOI 10.1016/S0965-1748(97)00093-3; Elliott David A., 2008, V420, P79, DOI 10.1007/978-1-59745-583-1_5; Enayati A, 2010, ANNU REV ENTOMOL, V55, P569, DOI 10.1146/annurev-ento-112408-085423; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; Franz AW, 2011, INSECT MOL BIOL; Grossman GL, 2001, INSECT MOL BIOL, V10, P597, DOI 10.1046/j.0962-1075.2001.00299.x; Gupta L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015410; Handler AM, 1999, INSECT MOL BIOL, V8, P449, DOI 10.1046/j.1365-2583.1999.00139.x; Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110; Isoe J, 2011, P NATL ACAD SCI USA, V108, pE211, DOI 10.1073/pnas.1102637108; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; Kim W, 2004, J MED ENTOMOL, V41, P447, DOI 10.1603/0022-2585-41.3.447; Kobayashi I, 2011, ARCH INSECT BIOCHEM, V76, P195, DOI 10.1002/arch.20402; Kokoza VA, 2011, INSECT BIOCHEM MOLEC, V41, P637, DOI 10.1016/j.ibmb.2011.04.004; Lawniczak MKN, 2010, SCIENCE, V330, P512, DOI 10.1126/science.1195755; Lawson D, 2009, NUCLEIC ACIDS RES, V37, pD583, DOI 10.1093/nar/gkn857; Lombardo Fabrizio, 2009, BMC Res Notes, V2, P24, DOI 10.1186/1756-0500-2-24; Lycett GJ, 2006, INSECT MOL BIOL, V15, P321, DOI 10.1111/j.1365-2583.2006.00647.x; Lycett GJ, 2012, INSECT MOL BIOL, V21, P79, DOI 10.1111/j.1365-2583.2011.01112.x; Lycett GJ, 2004, GENETICS, V167, P1781, DOI 10.1534/genetics.104.028175; Lynd A, 2011, INSECT MOL BIOL, V20, P599, DOI 10.1111/j.1365-2583.2011.01090.x; Mao YP, 2006, DEVELOPMENT, V133, P2539, DOI 10.1242/dev.02427; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Meredith JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014587; Moreira LA, 2000, P NATL ACAD SCI USA, V97, P10895, DOI 10.1073/pnas.97.20.10895; Moreira LA, 2002, J BIOL CHEM, V277, P40839, DOI 10.1074/jbc.M206647200; Muller P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000286; Muller HM, 1999, J BIOL CHEM, V274, P11727, DOI 10.1074/jbc.274.17.11727; Nimmo DD, 2006, INSECT MOL BIOL, V15, P129, DOI 10.1111/j.1365-2583.2006.00615.x; Nirmala X, 2005, INSECT MOL BIOL, V14, P95, DOI 10.1111/j.1365-2583.2005.00535.x; Nolan T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016471; Ogura E, 2009, DEV DYNAM, V238, P641, DOI 10.1002/dvdy.21863; ORNITZ DM, 1991, P NATL ACAD SCI USA, V88, P698, DOI 10.1073/pnas.88.3.698; Patterson G, 2001, J CELL SCI, V114, P837; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Rogers DW, 2008, P NATL ACAD SCI USA, V105, P19390, DOI 10.1073/pnas.0809723105; Roman G, 2004, BIOESSAYS, V26, P1243, DOI 10.1002/bies.20120; Rund SS, 2011, P NATL ACAD SCI US; Sarkar A, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-27; Schinko JB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-53; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; Weetman D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013140; Windbichler N, 2011, NATURE, V473, P212, DOI 10.1038/nature09937	60	34	35	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31552	10.1371/journal.pone.0031552	http://dx.doi.org/10.1371/journal.pone.0031552			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348104	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000302733900052
J	Chisholm, KM; Aubert, SD; Freese, KP; Zakian, VA; King, MC; Welcsh, PL				Chisholm, Karen M.; Aubert, Sarah D.; Freese, Krister P.; Zakian, Virginia A.; King, Mary-Claire; Welcsh, Piri L.			A Genomewide Screen for Suppressors of Alu-Mediated Rearrangements Reveals a Role for PIF1	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; BRCA1 PROMOTER REGION; BREAST-CANCER; SPORADIC BREAST; SACCHAROMYCES-CEREVISIAE; MISMATCH REPAIR; OVARIAN-CANCER; MESSENGER-RNA; MUTATIONS; GENES	Alu-mediated rearrangement of tumor suppressor genes occurs frequently during carcinogenesis. In breast cancer, this mechanism contributes to loss of the wild-type BRCA1 allele in inherited disease and to loss of heterozygosity in sporadic cancer. To identify genes required for suppression of Alu-mediated recombination we performed a genomewide screen of a collection of 4672 yeast gene deletion mutants using a direct repeat recombination assay. The primary screen and subsequent analysis identified 12 candidate genes including TSA, ELG1, and RRM3, which are known to play a significant role in maintaining genomic stability. Genetic analysis of the corresponding human homologs was performed in sporadic breast tumors and in inherited BRCA1-associated carcinomas. Sequencing of these genes in high risk breast cancer families revealed a potential role for the helicase PIF1 in cancer predisposition. PIF1 variant L319P was identified in three breast cancer families; importantly, this variant, which is predicted to be functionally damaging, was not identified in a large series of controls nor has it been reported in either dbSNP or the 1000 Genomes Project. In Schizosaccharomyces pombe, Pfh1 is required to maintain both mitochondrial and nuclear genomic integrity. Functional studies in yeast of human PIF1 L319P revealed that this variant cannot complement the essential functions of Pfh1 in either the nucleus or mitochondria. Our results provide a global view of nonessential genes involved in suppressing Alu-mediated recombination and implicate variation in PIF1 in breast cancer predisposition.	[Chisholm, Karen M.; King, Mary-Claire; Welcsh, Piri L.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Chisholm, Karen M.; Freese, Krister P.; King, Mary-Claire; Welcsh, Piri L.] Univ Washington, Div Med Genet, Dept Med, Seattle, WA 98195 USA; [Aubert, Sarah D.; Zakian, Virginia A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Princeton University	Chisholm, KM (corresponding author), Stanford Univ, Med Ctr, Dept Pathol, Palo Alto, CA 94304 USA.	piri@u.washington.edu		King, Mary-Claire/0000-0001-9426-1743; Chisholm, Karen/0000-0002-1898-1252	National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH) [F30 ES13069]; Department of Defense [BC010851]; NIH [GM43265, GM26938, R01CA157744, R01ES013160]; NATIONAL CANCER INSTITUTE [R01CA157744, Z01BC010851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F30ES013069, R01ES013160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026938, R01GM043265, R37GM026938] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by grant number F30 ES13069 for K. M. C. from the National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH). Other research support was by a Department of Defense Breast Cancer Research Program (BCRP) Idea Award BC010851 (M.-C. K. and P. L. W.). M.-C. K. is an American Cancer Society Research Professor. Other research support was by NIH grants GM43265 and GM26938 to V. A. Zakian and R01CA157744 and R01ES013160. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Antoniou AC, 2008, BRIT J CANCER, V98, P1457, DOI 10.1038/sj.bjc.6604305; Antoniou AC, 2002, BRIT J CANCER, V86, P76, DOI 10.1038/sj.bjc.6600008; Baldwin RL, 2000, CANCER RES, V60, P5329; Beckmann MW, 1996, BRIT J CANCER, V73, P1220, DOI 10.1038/bjc.1996.234; Begg CB, 2008, JAMA-J AM MED ASSOC, V299, P194, DOI 10.1001/jama.2007.55-a; Bochman ML, 2010, DNA REPAIR, V9, P237, DOI 10.1016/j.dnarep.2010.01.008; BORG A, 1994, J NATL CANCER I, V86, P792, DOI 10.1093/jnci/86.10.792; Catteau A, 1999, ONCOGENE, V18, P1957, DOI 10.1038/sj.onc.1202509; Clark-Knowles KV, 2007, EXP CELL RES, V313, P133, DOI 10.1016/j.yexcr.2006.09.026; CROPP CS, 1994, CANCER RES, V54, P2548; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; DEVILEE P, 1994, CRIT REV ONCOGENESIS, V5, P247, DOI 10.1615/CritRevOncog.v5.i2-3.70; Esteller M, 2000, JNCI-J NATL CANCER I, V92, P564, DOI 10.1093/jnci/92.7.564; Evers B, 2006, ONCOGENE, V25, P5885, DOI 10.1038/sj.onc.1209871; Frank TS, 2002, J CLIN ONCOL, V20, P1480, DOI 10.1200/JCO.20.6.1480; FUTREAL PA, 1992, CANCER RES, V52, P2624; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; Geisler JP, 2002, JNCI-J NATL CANCER I, V94, P61; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Hall MC, 1999, MOL MICROBIOL, V34, P867, DOI 10.1046/j.1365-2958.1999.01659.x; Huang J, 1996, P NATL ACAD SCI USA, V93, P9049, DOI 10.1073/pnas.93.17.9049; Huang ME, 2003, P NATL ACAD SCI USA, V100, P11529, DOI 10.1073/pnas.2035018100; JAUNIAUX JC, 1978, J BACTERIOL, V133, P1096, DOI 10.1128/JB.133.3.1096-1107.1978; Ji HP, 2001, HUM MOL GENET, V10, P2737, DOI 10.1093/hmg/10.24.2737; KANTERSMOLER G, 1994, BIOTECHNIQUES, V16, P798; Kolodner R, 1996, GENE DEV, V10, P1433, DOI 10.1101/gad.10.12.1433; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Lloyd J, 2000, J CLIN PATHOL, V53, P742, DOI 10.1136/jcp.53.10.742; Loo LWM, 2004, CANCER RES, V64, P8541, DOI 10.1158/0008-5472.CAN-04-1992; Ludwig T, 2001, GENE DEV, V15, P1188, DOI 10.1101/gad.879201; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; Miller BJ, 2003, AM J HUM GENET, V73, P748, DOI 10.1086/378522; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mueller CR, 2003, BREAST CANCER RES, V5, P45, DOI 10.1186/bcr557; Naylor TL, 2005, BREAST CANCER RES, V7, pR1186, DOI 10.1186/bcr1356; Nessling M, 2005, CANCER RES, V65, P439; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Pierga JY, 2007, BRIT J CANCER, V96, P341, DOI 10.1038/sj.bjc.6603483; Pinter SF, 2008, MOL CELL BIOL, V28, P6594, DOI 10.1128/MCB.00191-08; Rebbeck TR, 2002, ENVIRON MOL MUTAGEN, V39, P228, DOI 10.1002/em.10050; Rennstam K, 2003, CANCER RES, V63, P8861; Rice JC, 2000, CARCINOGENESIS, V21, P1761, DOI 10.1093/carcin/21.9.1761; Rio PG, 1998, INT J ONCOL, V13, P849; Russell PA, 2000, INT J CANCER, V87, P317, DOI 10.1002/1097-0215(20000801)87:3<317::AID-IJC2>3.0.CO;2-B; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Simchoni S, 2006, P NATL ACAD SCI USA, V103, P3770, DOI 10.1073/pnas.0511301103; SLUITER MD, 2010, BREAST CANC RES TREA; Smith S, 2004, P NATL ACAD SCI USA, V101, P9039, DOI 10.1073/pnas.0403093101; Smith TM, 1996, GENOME RES, V6, P1029, DOI 10.1101/gr.6.11.1029; Snow BE, 2007, MOL CELL BIOL, V27, P1017, DOI 10.1128/MCB.01866-06; Staff S, 2003, CANCER RES, V63, P4978; THOMPSON ME, 1995, NAT GENET, V9, P444, DOI 10.1038/ng0495-444; Tong D, 2000, INT J CANCER, V88, P319, DOI 10.1002/1097-0215(20001015)88:2<319::AID-IJC27>3.0.CO;2-X; Walsh T, 2006, JAMA-J AM MED ASSOC, V295, P1379, DOI 10.1001/jama.295.12.1379; Werler PJH, 2003, GENE, V304, P133, DOI 10.1016/S0378-1119(03)00402-5; Wilson CA, 1999, NAT GENET, V21, P236, DOI 10.1038/6029; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Woods R. A., 2001, METH MOL B, V177, P85; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Zhang DH, 2006, NUCLEIC ACIDS RES, V34, P1393, DOI 10.1093/nar/gkl029; Zhou JQ, 2002, MOL BIOL CELL, V13, P2180, DOI 10.1091/mbc.02-02-0021	65	47	50	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e30748	10.1371/journal.pone.0030748	http://dx.doi.org/10.1371/journal.pone.0030748			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347400	Green Submitted, Green Published, gold			2022-12-25	WOS:000302730200007
J	Ruan, XY; Kocher, JPA; Pommier, Y; Liu, HF; Reinhold, WC				Ruan, Xiaoyang; Kocher, Jean-Pierre A.; Pommier, Yves; Liu, Hongfang; Reinhold, William C.			Mass Homozygotes Accumulation in the NCI-60 Cancer Cell Lines As Compared to HapMap Trios, and Relation to Fragile Site Location	PLOS ONE			English	Article							MAINTAINS GENOMIC STABILITY; HOMOLOGOUS RECOMBINATION; MITOTIC RECOMBINATION; SUBSTRATE LENGTH; OVARIAN-CANCER; HETEROZYGOSITY; TUMOR; COMMON; EXPRESSION; IDENTIFICATION	Runs of homozygosity (ROH) represents extended length of homozygotes on a long genomic distance. In oncology, it is known as loss of heterozygosity (LOH) if identified exclusively in cancer cell rather than in matched control cell. Studies have identified several genomic regions which show consistent ROH in different kinds of carcinoma. To query whether this consistency can be observed on broader spectrum, both in more cancer types and in wider genomic regions, we investigated ROH patterns in the National Cancer Institute 60 cancer cell line panel (NCI-60) and HapMap Caucasian healthy trio families. Using results from Affymetrix 500 K SNP arrays, we report a genome wide significant association of ROH regions between the NCI-60 and HapMap samples, with much a higher level of ROH (11 fold) in the cancer cell lines. Analysis shows that more severe ROH found in cancer cells appears to be the extension of existing ROH in healthy state. In the HapMap trios, the adult subgroup had a slightly but significantly higher level (1.02 fold) of ROH than did the young subgroup. For several ROH regions we observed the co-occurrence of fragile sites (FRAs). However, FRA on the genome wide level does not show a clear relationship with ROH regions.	[Ruan, Xiaoyang; Kocher, Jean-Pierre A.; Liu, Hongfang] Mayo Clin, Coll Med, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Ruan, Xiaoyang; Pommier, Yves; Liu, Hongfang; Reinhold, William C.] NCI, Mol Pharmacol Lab, Bethesda, MD 20892 USA	Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ruan, XY (corresponding author), Mayo Clin, Coll Med, Dept Hlth Sci Res, Rochester, MN 55905 USA.	liu.hongfang@mayo.edu; wcr@mail.nih.gov	Reinhold, William/J-6704-2017	Reinhold, William/0000-0001-5513-9323	National Institutes of Health, Center for Cancer Research, National Cancer Institute; National Science Foundation [ABI: 0845523]; National Institute of Health [R01LM009959A1]; NATIONAL CANCER INSTITUTE [ZIABC006150] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009959] Funding Source: NIH RePORTER	National Institutes of Health, Center for Cancer Research, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This study was supported by the Intramural Research Program of the National Institutes of Health, Center for Cancer Research, National Cancer Institute, and also by National Science Foundation ABI: 0845523 and National Institute of Health R01LM009959A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenberg DA, 1998, J CLIN INVEST, V102, P465, DOI 10.1172/JCI3145; Arlt MF, 2002, GENE CHROMOSOME CANC, V33, P82, DOI 10.1002/gcc.10000; Assie G, 2008, JAMA-J AM MED ASSOC, V299, P1437, DOI 10.1001/jama.299.12.1437; Bacolod MD, 2008, CANCER RES, V68, P2610, DOI 10.1158/0008-5472.CAN-07-5250; Bacolod MD, 2009, CANCER RES, V69, P723, DOI 10.1158/0008-5472.CAN-08-3543; Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Barnes RL, 2007, NUCLEIC ACIDS RES, V35, P3478, DOI 10.1093/nar/gkm249; Beroukhim R, 2006, PLOS COMPUT BIOL, V2, P323, DOI 10.1371/journal.pcbi.0020041; Blackburn AC, 2004, CANCER RES, V64, P5140, DOI 10.1158/0008-5472.CAN-03-3435; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Carr LL, 2008, EXP GERONTOL, V43, P123, DOI 10.1016/j.exger.2007.10.010; Cervi D, 2008, BLOOD, V111, P1201, DOI 10.1182/blood-2007-04-084798; Condeelis J, 2005, ANNU REV CELL DEV BI, V21, P695, DOI 10.1146/annurev.cellbio.21.122303.120306; Denison SR, 2003, GENE CHROMOSOME CANC, V38, P40, DOI 10.1002/gcc.10236; Doll D, 2010, INT J COLORECTAL DIS, V25, P573, DOI 10.1007/s00384-010-0901-1; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Finnis M, 2005, HUM MOL GENET, V14, P1341, DOI 10.1093/hmg/ddi144; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; He M, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-10; Huang HJ, 1999, GENE CHROMOSOME CANC, V24, P48, DOI 10.1002/(SICI)1098-2264(199901)24:1<48::AID-GCC7>3.0.CO;2-V; Johrer K, 2005, CLIN CANCER RES, V11, P2459, DOI 10.1158/1078-0432.CCR-04-0405; Kitamura T, 2010, P NATL ACAD SCI USA, V107, P13063, DOI 10.1073/pnas.1002372107; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Ku CS, 2011, HUM GENET, V129, P1, DOI 10.1007/s00439-010-0920-6; Limongi MZ, 2003, GENOMICS, V81, P93, DOI 10.1016/S0888-7543(03)00007-7; Lorenzi PL, 2009, MOL CANCER THER, V8, P713, DOI 10.1158/1535-7163.MCT-08-0921; Lu Y, 2007, J CELL BIOCHEM, V101, P676, DOI 10.1002/jcb.21220; Moragoda L, 2002, AM J PHYSIOL-GASTR L, V282, pG932, DOI 10.1152/ajpgi.00312.2001; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ried K, 2000, HUM MOL GENET, V9, P1651, DOI 10.1093/hmg/9.11.1651; Sato E, 2007, BRIT J CANCER, V96, P1735, DOI 10.1038/sj.bjc.6603790; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Shao CS, 2001, NAT GENET, V28, P169, DOI 10.1038/88897; SHEN P, 1986, GENETICS, V112, P441; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Velickovic M, 1999, CANCER RES, V59, P1323; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wing W, 2006, ANAL GENE EXPRESSION, P120; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Wyckoff JB, 2000, CANCER RES, V60, P2504; Yan WS, 2009, J BIOL CHEM, V284, P12178, DOI 10.1074/jbc.M900994200; Yuan A, 2005, FRONT BIOSCI-LANDMRK, V10, P853, DOI 10.2741/1579; Zlotorynski E, 2003, MOL CELL BIOL, V23, P7143, DOI 10.1128/MCB.23.20.7143-7151.2003	46	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31628	10.1371/journal.pone.0031628	http://dx.doi.org/10.1371/journal.pone.0031628			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347499	gold, Green Published, Green Submitted			2022-12-25	WOS:000302730200028
J	Yi, L; Chandrasekaran, P; Venkatesan, S				Yi, Ling; Chandrasekaran, Prabha; Venkatesan, Sundararajan			TLR Signaling Paralyzes Monocyte Chemotaxis through Synergized Effects of p38 MAPK and Global Rap-1 Activation	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-2; CHEMOKINE RECEPTORS; BACTERIAL LIPOPOLYSACCHARIDE; NEUTROPHIL CHEMOTAXIS; DENDRITIC CELLS; PHOSPHOINOSITIDE 3-KINASE; VASCULAR ENDOTHELIUM; LYMPHOCYTE ARREST; GENE-EXPRESSION; TISSUE FACTOR	Toll-like receptors (TLRs) that recognize pathogen associated molecular patterns and chemoattractant receptors (CKRs) that orchestrate leukocyte migration to infected tissue are two arms of host innate immunity. Although TLR signaling induces synthesis and secretion of proinflammatory cytokines and chemokines, which recruit leukocytes, many studies have reported the paradoxical observation that TLR stimulation inhibits leukocyte chemotaxis in vitro and impairs their recruitment to tissues during sepsis. There is consensus that physical loss of chemokine receptor (CKR) at the RNA or protein level or receptor usage switching are the mechanisms underlying this effect. We show here that a brief (<15 min) stimulation with LPS (lipopolysaccharide) at similar to 0.2 ng/ml inhibited chemotactic response from CCR2, CXCR4 and FPR receptors in monocytes without downmodulation of receptors. A 3 min LPS pre-treatment abolished the polarized accumulation of F-actin, integrins and PIP3 (phosphatidylinositol-3,4,5-trisphosphate) in response to chemokines in monocytes, but not in polymorphonuclear neutrophils (PMNs). If chemoattractants were added before or simultaneously with LPS, chemotactic polarization was preserved. LPS did not alter the initial G-protein signaling, or endocytosis kinetics of agonist-occupied chemoattractant receptors (CKRs). The chemotaxis arrest did not result from downmodulation of receptors or from inordinate increase in adhesion. LPS induced rapid p38 MAPK activation, global redistribution of activated Rap1 (Ras-proximate-1 or Ras-related protein 1) GTPase and Rap1GEF (guanylate exchange factor) Epac1 (exchange proteins activated by cyclic AMP) and disruption of intracellular gradient. Co-inhibition of p38 MAPK and Rap1 GTPase reversed the LPS induced breakdown of chemotaxis suggesting that LPS effect requires the combined function of p38 MAPK and Rap1 GTPase.	[Yi, Ling] NIAID, Mol Cell Biol Unit, Lab Mol Immunol, Bethesda, MD 20892 USA; NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA	Yi, L (corresponding author), NIAID, Mol Cell Biol Unit, Lab Mol Immunol, 9000 Rockville Pike, Bethesda, MD 20892 USA.	sv1s@nih.gov			Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, DHHS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000615] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, DHHS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded entirely by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, DHHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Arefieva TI, 2005, CYTOKINE, V31, P439, DOI 10.1016/j.cyto.2005.06.016; Arraes SMA, 2006, BLOOD, V108, P2906, DOI 10.1182/blood-2006-05-024638; Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004; Bradfield PF, 2008, INT IMMUNOL, V20, P247, DOI 10.1093/intimm/dxm136; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cathcart MK, 2009, J LIPID RES, V50, pS231, DOI 10.1194/jlr.R800096-JLR200; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; CREAMER HR, 1991, INFLAMMATION, V15, P201, DOI 10.1007/BF00918646; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; DOHERTY DE, 1989, J IMMUNOL, V143, P3673; Drbal K, 2000, BIOCHEM BIOPH RES CO, V275, P295, DOI 10.1006/bbrc.2000.3299; Drbal K, 2001, IMMUNOBIOLOGY, V203, P687, DOI 10.1016/S0171-2985(01)80017-6; Ebisuno Y, 2010, BLOOD, V115, P804, DOI 10.1182/blood-2009-03-211979; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Fan J, 2003, NAT MED, V9, P315, DOI 10.1038/nm832; Faure E, 2001, J IMMUNOL, V166, P2018, DOI 10.4049/jimmunol.166.3.2018; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; Ferreira AM, 2006, MICROCIRCULATION, V13, P439, DOI 10.1080/10739680600776062; Fox JM, 2010, BLOOD; Gambero A, 2002, BIOCHEM PHARMACOL, V63, P65, DOI 10.1016/S0006-2952(01)00841-3; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ghandour H, 2007, BLOOD, V110, P3682, DOI 10.1182/blood-2007-03-077628; Grabovsky V, 2000, J EXP MED, V192, P495, DOI 10.1084/jem.192.4.495; Grage-Griebenow E, 2001, J LEUKOCYTE BIOL, V69, P11; Guha M, 2001, BLOOD, V98, P1429, DOI 10.1182/blood.V98.5.1429; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; Heit B, 2002, J CELL BIOL, V159, P91, DOI 10.1083/jcb.200202114; Heit B, 2008, NAT IMMUNOL, V9, P743, DOI 10.1038/ni.1623; Heit B, 2008, J CELL SCI, V121, P205, DOI 10.1242/jcs.020412; HerreraVelit P, 1996, J IMMUNOL, V156, P1157; Hmama Z, 1999, J BIOL CHEM, V274, P1050, DOI 10.1074/jbc.274.2.1050; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Katagiri K, 2006, NAT IMMUNOL, V7, P919, DOI 10.1038/ni1374; Khan AI, 2005, MICROCIRCULATION, V12, P421, DOI 10.1080/10739680590960368; Kinashi T, 2005, IMMUNOLOGY, V116, P164, DOI 10.1111/j.1365-2567.2005.02214.x; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Lorenowicz MJ, 2006, J LEUKOCYTE BIOL, V80, P1542, DOI 10.1189/jlb.0506357; Luyendyk JP, 2008, J IMMUNOL, V180, P4218, DOI 10.4049/jimmunol.180.6.4218; Mahadeo DC, 2007, MOL BIOL CELL, V18, P512, DOI 10.1091/mbc.E06-05-0418; Mandal P, 2005, J IMMUNOL, V175, P6085, DOI 10.4049/jimmunol.175.9.6085; Marcos V, 2010, NAT MED, V16, P1018, DOI 10.1038/nm.2209; McKimmie CS, 2009, BLOOD, V113, P4224, DOI 10.1182/blood-2008-08-174698; Nakamura N, 2008, ATHEROSCLEROSIS, V196, P59, DOI 10.1016/j.atherosclerosis.2007.01.039; Palucka KA, 1999, J LEUKOCYTE BIOL, V65, P232, DOI 10.1002/jlb.65.2.232; Palucka KA, 1998, J IMMUNOL, V160, P4587; Parker LC, 2004, J IMMUNOL, V172, P4977, DOI 10.4049/jimmunol.172.8.4977; Pasvolsky R, 2007, J EXP MED, V204, P1571, DOI 10.1084/jem.20070058; Ponsioen B, 2009, MOL CELL BIOL, V29, P2521, DOI 10.1128/MCB.01630-08; Raab M, 2010, IMMUNITY, V32, P541, DOI 10.1016/j.immuni.2010.03.007; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Rose JJ, 2008, J BIOMED SCI, V15, P441, DOI 10.1007/s11373-008-9239-x; Rose JJ, 2004, J BIOL CHEM, V279, P24372, DOI 10.1074/jbc.M401364200; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Schmidt A, 2001, MOL CELL BIOL, V21, P438, DOI 10.1128/MCB.21.2.438-448.2001; Servant G, 1999, MOL BIOL CELL, V10, P1163, DOI 10.1091/mbc.10.4.1163; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; Sica A, 1997, J EXP MED, V185, P969, DOI 10.1084/jem.185.5.969; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stephens L, 2002, CURR OPIN CELL BIOL, V14, P203, DOI 10.1016/S0955-0674(02)00311-3; Tester AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000312; van Haastert PJM, 2007, J CELL BIOL, V177, P809, DOI 10.1083/jcb.200701134; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Venkatesan S, 2003, MOL BIOL CELL, V14, P3305, DOI 10.1091/mbc.e02-11-0714; Williams LM, 2000, J IMMUNOL, V164, P2028, DOI 10.4049/jimmunol.164.4.2028; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Xu L, 1997, J LEUKOCYTE BIOL, V62, P653, DOI 10.1002/jlb.62.5.653; Xu LL, 2000, EUR J IMMUNOL, V30, P227, DOI 10.1002/1521-4141(200001)30:1<227::AID-IMMU227>3.0.CO;2-X	74	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e30404	10.1371/journal.pone.0030404	http://dx.doi.org/10.1371/journal.pone.0030404			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347375	Green Published, gold, Green Submitted			2022-12-25	WOS:000302730200002
J	Brand, T; Spanagel, R; Schneider, M				Brand, Theresa; Spanagel, Rainer; Schneider, Miriam			Decreased Reward Sensitivity in Rats from the Fischer344 Strain Compared to Wistar Rats Is Paralleled by Differences in Endocannabinoid Signaling	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; NUCLEUS-ACCUMBENS DOPAMINE; ANXIETY-RELATED BEHAVIORS; PALATABLE FOOD; CB1 RECEPTOR; BRAIN REWARD; CANNABINOIDS; COCAINE; SYSTEM; DRUG	Background: The aim of the present study was to examine if differences in the endocannabinoid (ECB) system might be linked to strain specific variations in reward-related behavior in Fischer344 (Fischer) and Wistar rats. Methodology/Principal Findings: Two rat strains, the Fischer and the Wistar strain, were tested for different aspects of reward sensitivity for a palatable food reward (sweetened condensed milk, SCM) in a limited-access intake test, a progressive ratio (PR) schedule and the pleasure-attenuated startle (PAS) paradigm. Additionally, basic differences in the ECB system and cannabinoid pharmacology were examined in both rat strains. Fischer rats were found to express lower reward sensitivity towards SCM compared to Wistar rats. These differences were observed for consummatory, motivational and hedonic aspects of the palatable food reward. Western blot analysis for the CB1 receptor and the ECB degrading enzyme fatty acid amide hydrolase (FAAH) revealed a lower expression of both proteins in the hippocampus (HPC) of Fischer rats compared to the Wistar strain. Furthermore, increased cannabinoid-stimulated extracellular-regulated kinase (ERK) phosphorylation was detected in Wistar rats compared to the Fischer strain, indicating alterations in ECB signaling. These findings were further supported by the pharmacological results, where Fischer rats were found to be less sensitive towards the effects of the CB1 receptor antagonist/inverse agonist SR141716 and the cannabinoid agonist WIN 55,212-2. Conclusions/Significance: Our present findings indicate differences in the expression of the CB1 receptor and FAAH, as well as the activation of ECB signaling pathways between Fischer and Wistar rats. These basic differences in the ECB system might contribute to the pronounced differences observed in reward sensitivity between both rat strains.	[Brand, Theresa; Schneider, Miriam] Heidelberg Univ, Res Grp Dev Neuropsychopharmacol, Inst Psychopharmacol, Cent Inst Mental Hlth,Med Fac Mannheim, D-6800 Mannheim, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Brand, T (corresponding author), Heidelberg Univ, Res Grp Dev Neuropsychopharmacol, Inst Psychopharmacol, Cent Inst Mental Hlth,Med Fac Mannheim, D-6800 Mannheim, Germany.	miriam.schneider@zi-mannheim.de			Deutsche Forschungsgemeinschaft (DFG) [SP 383/5-1, SCHN 958/3-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (DFG): Reinhart-Koselleck Award SP 383/5-1 and SCHN 958/3-1. The funder had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold JC, 2001, BRAIN RES, V921, P240, DOI 10.1016/S0006-8993(01)03127-4; Arnold JC, 2010, LIFE SCI, V87, P572, DOI 10.1016/j.lfs.2010.09.018; Arnone M, 1997, PSYCHOPHARMACOLOGY, V132, P104, DOI 10.1007/s002130050326; Bagg HJ, 1920, INDIVIDUAL DIFFERENC; Benyamina A, 2010, ADDICT BIOL; Bergman J, 2008, PHYSIOL BEHAV, V93, P666, DOI 10.1016/j.physbeh.2007.11.007; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; Bert B, 2002, NEUROBIOL LEARN MEM, V78, P11, DOI 10.1006/nlme.2001.4040; Bolanos CA, 2003, BIOL PSYCHIAT, V54, P1317, DOI 10.1016/S0006-3223(03)00570-5; BOUABOULA M, 1995, BIOCHEM J, V312, P637, DOI 10.1042/bj3120637; Cota D, 2006, BRAIN RES REV, V51, P85, DOI 10.1016/j.brainresrev.2005.10.004; Deiana S, 2007, NEUROPHARMACOLOGY, V52, P646, DOI 10.1016/j.neuropharm.2006.09.007; Derkinderen P, 2003, J NEUROSCI, V23, P2371; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Egertova M, 1998, P ROY SOC B-BIOL SCI, V265, P2081, DOI 10.1098/rspb.1998.0543; Fattore L, 2007, EUR J NEUROSCI, V25, P2191, DOI 10.1111/j.1460-9568.2007.05470.x; Filbey FM, 2010, NEUROPSYCHOPHARMACOL, V35, P967, DOI 10.1038/npp.2009.200; Freeman KB, 2009, BEHAV NEUROSCI, V123, P156, DOI 10.1037/a0013727; Friemel CM, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00039; GARDNER EL, 1988, PSYCHOPHARMACOLOGY, V96, P142, DOI 10.1007/BF02431546; Gardner EL, 2005, PHARMACOL BIOCHEM BE, V81, P263, DOI 10.1016/j.pbb.2005.01.032; GOSNELL BA, 1993, PHARMACOL BIOCHEM BE, V44, P919, DOI 10.1016/0091-3057(93)90025-O; Harrold JA, 2002, BRAIN RES, V952, P232, DOI 10.1016/S0006-8993(02)03245-6; Kearns DN, 2006, BEHAV BRAIN RES, V169, P193, DOI 10.1016/j.bbr.2006.01.005; Kelley AE, 2002, PHYSIOL BEHAV, V76, P365, DOI 10.1016/S0031-9384(02)00751-5; Kirkham TC, 2009, INT REV PSYCHIATR, V21, P163, DOI 10.1080/09540260902782810; Koch M, 2000, PSYCHOPHARMACOLOGY, V152, P67, DOI 10.1007/s002130000505; Kosten TA, 1997, BRAIN RES, V778, P418, DOI 10.1016/S0006-8993(97)01205-5; Lange JHM, 2005, DRUG DISCOV TODAY, V10, P693, DOI 10.1016/S1359-6446(05)03427-6; LEPORE M, 1995, LIFE SCI, V56, P2073, DOI 10.1016/0024-3205(95)00191-8; Lopez-Moreno JA, 2010, CURR DRUG TARGETS, V11, P406, DOI 10.2174/138945010790980312; Lupica CR, 2005, NEUROPHARMACOLOGY, V48, P1105, DOI 10.1016/j.neuropharm.2005.03.016; Mahler SV, 2007, NEUROPSYCHOPHARMACOL, V32, P2267, DOI 10.1038/sj.npp.1301376; Maldonado R, 2006, TRENDS NEUROSCI, V29, P225, DOI 10.1016/j.tins.2006.01.008; McLaughlin PJ, 2006, PHARMACOL BIOCHEM BE, V83, P396, DOI 10.1016/j.pbb.2006.02.022; McLaughlin PJ, 2005, PSYCHOPHARMACOLOGY, V180, P286, DOI 10.1007/s00213-005-2171-0; Merritt LL, 2008, J PHARMACOL EXP THER, V326, P483, DOI 10.1124/jpet.108.138321; MITTLEMAN G, 1990, BEHAV NEUROSCI, V104, P399, DOI 10.1037/0735-7044.104.3.399; Palm S, 2011, ALCOHOL, V45, P607, DOI 10.1016/j.alcohol.2010.11.005; Pertwee RG, 2005, LIFE SCI, V76, P1307, DOI 10.1016/j.lfs.2004.10.025; Poncelet M, 2003, NEUROSCI LETT, V343, P216, DOI 10.1016/S0304-3940(03)00397-5; Ramos A, 1997, BEHAV BRAIN RES, V85, P57, DOI 10.1016/S0166-4328(96)00164-7; Rex A, 1996, PHARMACOL BIOCHEM BE, V54, P107, DOI 10.1016/0091-3057(95)02128-0; Rex A, 1999, BEHAV GENET, V29, P187, DOI 10.1023/A:1021644002588; RODGERS RJ, 1993, PHYSIOL BEHAV, V54, P729, DOI 10.1016/0031-9384(93)90084-S; Salamone JD, 2007, PSYCHOPHARMACOLOGY, V191, P389, DOI 10.1007/s00213-006-0623-9; Sanchis-Segura C, 2004, PSYCHOPHARMACOLOGY, V176, P223, DOI 10.1007/s00213-004-1877-8; Schmelzeis MC, 1996, BEHAV NEUROSCI, V110, P1049; Schneider M, 2008, BEHAV BRAIN RES, V189, P226, DOI 10.1016/j.bbr.2007.12.017; Schneider M, 2010, BEHAV BRAIN RES, V208, P466, DOI 10.1016/j.bbr.2009.12.013; Shepard JD, 2008, BEHAV BRAIN RES, V186, P239, DOI 10.1016/j.bbr.2007.08.013; SHOAIB M, 1995, PSYCHOPHARMACOLOGY, V117, P240, DOI 10.1007/BF02245193; Solinas M, 2008, BRIT J PHARMACOL, V154, P369, DOI 10.1038/bjp.2008.130; Solinas M, 2005, NEUROPSYCHOPHARMACOL, V30, P2035, DOI 10.1038/sj.npp.1300720; Stohr T, 1998, PHARMACOL BIOCHEM BE, V59, P813, DOI 10.1016/S0091-3057(97)00542-X; SUZUKI T, 1987, JPN J PHARMACOL, V45, P479, DOI 10.1254/jjp.45.479; Tanda G, 2000, NAT NEUROSCI, V3, P1073, DOI 10.1038/80577; Thanos PK, 2005, BEHAV BRAIN RES, V164, P206, DOI 10.1016/j.bbr.2005.06.021; Tordoff MG, 2008, PHYSIOL BEHAV, V95, P308, DOI 10.1016/j.physbeh.2008.06.010; Tracy AL, 2001, BEHAV BRAIN RES, V127, P13, DOI 10.1016/S0166-4328(01)00364-3; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Tzschentke TM, 2000, AMINO ACIDS, V19, P211, DOI 10.1007/s007260070051; van der Stelt M, 2003, EUR J PHARMACOL, V480, P133, DOI 10.1016/j.ejphar.2003.08.101; Ward SJ, 2009, BEHAV PHARMACOL, V20, P605, DOI 10.1097/FBP.0b013e328331ba30; WARTMANN M, 1995, FEBS LETT, V359, P133, DOI 10.1016/0014-5793(95)00027-7; Yilmazer-Hanke DM, 2008, BEHAV PHARMACOL, V19, P403, DOI 10.1097/FBP.0b013e32830dc0de; Zhang PW, 2004, MOL PSYCHIATR, V9, P916, DOI 10.1038/sj.mp.4001560; Zuo LJ, 2007, BIOL PSYCHIAT, V62, P616, DOI 10.1016/j.biopsych.2006.12.004; Zuo L, 2009, NEUROPSYCHOPHARMACOL, V34, P1504, DOI 10.1038/npp.2008.206	71	22	22	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31169	10.1371/journal.pone.0031169	http://dx.doi.org/10.1371/journal.pone.0031169			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347447	Green Published, gold, Green Submitted			2022-12-25	WOS:000302730100050
J	Liu, F; Jiang, CM; Thompson, WF; Xu, Y; Yang, YF; Stewart, L				Liu, Fang; Jiang, Cunmei; Thompson, William Forde; Xu, Yi; Yang, Yufang; Stewart, Lauren			The Mechanism of Speech Processing in Congenital Amusia: Evidence from Mandarin Speakers	PLOS ONE			English	Article							GRAINED PITCH DISCRIMINATION; PHONOLOGICAL AWARENESS; TONE-DEAFNESS; LEXICAL TONES; LINGUISTIC EXPERIENCE; TUNE DEAFNESS; PERCEPTION; CHINESE; INTONATION; IDENTIFICATION	Congenital amusia is a neuro-developmental disorder of pitch perception that causes severe problems with music processing but only subtle difficulties in speech processing. This study investigated speech processing in a group of Mandarin speakers with congenital amusia. Thirteen Mandarin amusics and thirteen matched controls participated in a set of tone and intonation perception tasks and two pitch threshold tasks. Compared with controls, amusics showed impaired performance on word discrimination in natural speech and their gliding tone analogs. They also performed worse than controls on discriminating gliding tone sequences derived from statements and questions, and showed elevated thresholds for pitch change detection and pitch direction discrimination. However, they performed as well as controls on word identification, and on statement-question identification and discrimination in natural speech. Overall, tasks that involved multiple acoustic cues to communicative meaning were not impacted by amusia. Only when the tasks relied mainly on pitch sensitivity did amusics show impaired performance compared to controls. These findings help explain why amusia only affects speech processing in subtle ways. Further studies on a larger sample of Mandarin amusics and on amusics of other language backgrounds are needed to consolidate these results.	[Liu, Fang] Stanford Univ, Ctr Study Language & Informat, Stanford, CA 94305 USA; [Jiang, Cunmei] Shanghai Normal Univ, Mus Coll, Shanghai, Peoples R China; [Thompson, William Forde] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia; [Xu, Yi] UCL, Dept Speech Hearing & Phonet Sci, London, England; [Yang, Yufang] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China; [Stewart, Lauren] Univ London, Dept Psychol, London, England	Stanford University; Shanghai Normal University; Macquarie University; University of London; University College London; Chinese Academy of Sciences; Institute of Psychology, CAS; University of London	Liu, F (corresponding author), Stanford Univ, Ctr Study Language & Informat, Stanford, CA 94305 USA.	liufang@uchicago.edu	Stewart, Lauren/HHC-2911-2022; Xu, Yi/C-4013-2008; Jiang, Jan/ABF-1730-2020; Liu, Fang/AAJ-7344-2021; Xu, Yi/M-9738-2019	Xu, Yi/0000-0002-8541-2658; Liu, Fang/0000-0002-7776-0222; Xu, Yi/0000-0002-8541-2658; stewart, lauren/0000-0002-6221-6064; Thompson, William/0000-0002-4256-1338; Jiang, Cunmei/0000-0002-0264-5924	Economic and Social Research Council [PTA-026-27-2480-A]; Center for the Study of Language and Information, Stanford University; ESRC [PTA-026-27-2480-A, ES/F001940/1] Funding Source: UKRI; Economic and Social Research Council [ES/F001940/1] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Center for the Study of Language and Information, Stanford University; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by the Economic and Social Research Council (grant number PTA-026-27-2480-A to FL). The authors would also like to thank Professor Patrick Suppes (Center for the Study of Language and Information, Stanford University) for his financial support to FL. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKEN EG, 1974, PERCEPT PSYCHOPHYS, V15, P449, DOI 10.3758/BF03199284; Ayotte J, 2002, BRAIN, V125, P238, DOI 10.1093/brain/awf028; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bella SD, 2009, J ACOUST SOC AM, V126, P414, DOI 10.1121/1.3132504; Bent T, 2006, J EXP PSYCHOL HUMAN, V32, P97, DOI 10.1037/0096-1523.32.1.97; Bidelman GM, 2011, J COGNITIVE NEUROSCI, V23, P425, DOI 10.1162/jocn.2009.21362; Boersma P, 2001, GLOT INT, V5, P341; Dowling W. J., 1986, MUSIC COGNITION; EADY SJ, 1982, LANG SPEECH, V25, P29, DOI 10.1177/002383098202500103; Foxton JM, 2004, BRAIN, V127, P801, DOI 10.1093/brain/awh105; Francis AL, 2003, J ACOUST SOC AM, V114, P1611, DOI 10.1121/1.1603231; Francis AL, 2008, J PHONETICS, V36, P268, DOI 10.1016/j.wocn.2007.06.005; Fu QJ, 1998, J ACOUST SOC AM, V104, P505, DOI 10.1121/1.423251; GANDOUR J, 1983, J PHONETICS, V11, P149, DOI 10.1016/S0095-4470(19)30813-7; GARDING E, 1986, LANG SPEECH, V29, P281, DOI 10.1177/002383098602900307; GIBSON EJ, 1963, ANNU REV PSYCHOL, V14, P29, DOI 10.1146/annurev.ps.14.020163.000333; Gillon G. T., 2004, PHONOLOGICAL AWARENE; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Gottfried TL, 1997, J PHONETICS, V25, P207, DOI 10.1006/jpho.1997.0042; GUION S, 2007, 2 LANGUAGE SPEECH LE, P57; Howie J. M., 1976, ACOUSTICAL STUDIES M; Hutchins S, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00236; Hyde KL, 2004, PSYCHOL SCI, V15, P356, DOI 10.1111/j.0956-7976.2004.00683.x; Jiang CM, 2011, MUSIC PERCEPT, V28, P519, DOI 10.1525/MP.2011.28.5.519; Jiang CM, 2010, NEUROPSYCHOLOGIA, V48, P2630, DOI 10.1016/j.neuropsychologia.2010.05.009; Jones JL, 2009, J COMMUN DISORD, V42, P226, DOI 10.1016/j.jcomdis.2009.01.001; Jones JL, 2009, EAR HEARING, V30, P63, DOI 10.1097/AUD.0b013e31818ff95e; KALMUS H, 1980, ANN HUM GENET, V43, P369, DOI 10.1111/j.1469-1809.1980.tb01571.x; Kishon-Rabin Liat, 2001, Journal of Basic and Clinical Physiology and Pharmacology, V12, P125; KLATT DH, 1973, J ACOUST SOC AM, V53, P8, DOI 10.1121/1.1913333; Lee CY, 2008, J PHONETICS, V36, P537, DOI 10.1016/j.wocn.2008.01.002; Liu F, 2005, PHONETICA, V62, P70, DOI 10.1159/000090090; Liu F, 2009, THESIS U CHICAGO, P187; Liu F, 2010, BRAIN, V133, P1682, DOI 10.1093/brain/awq089; Liu SY, 2004, LANG SPEECH, V47, P109, DOI 10.1177/00238309040470020101; Loui P, 2008, CURR BIOL, V18, pR331, DOI 10.1016/j.cub.2008.02.045; Loui P, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00111; Mantell JT, 2010, P 11 INT C MUS PERC, P338; Mattingly I, 1972, LANGUAGE EAR EYE, P133; Nan Y, 2010, BRAIN, V133, P2635, DOI 10.1093/brain/awq178; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; Patel AD, 2005, BRAIN COGNITION, V59, P310, DOI 10.1016/j.bandc.2004.10.003; Patel AD, 1998, BRAIN LANG, V61, P123, DOI 10.1006/brln.1997.1862; Patel AD, 2008, MUSIC PERCEPT, V25, P357, DOI 10.1525/MP.2008.25.4.357; Peretz I, 2003, ANN NY ACAD SCI, V999, P58, DOI 10.1196/annals.1284.006; Peretz I, 2003, TRENDS COGN SCI, V7, P362, DOI 10.1016/S1364-6613(03)00150-5; Pfordresher P.Q., 2009, P 7 TRIENNIAL C EURO, P425; R Development Core Team, 2009, R FDN STAT COMP; Semal C, 2006, J ACOUST SOC AM, V120, P3907, DOI 10.1121/1.2357708; Shu H, 2008, DEVELOPMENTAL SCI, V11, P171, DOI 10.1111/j.1467-7687.2007.00654.x; Siok WT, 2001, DEV PSYCHOL, V37, P886, DOI 10.1037//0012-1649.37.6.886; STAHL SA, 1994, J EDUC PSYCHOL, V86, P221, DOI 10.1037/0022-0663.86.2.221; The China National Language and Character Working Committee, 2008, LEX COMM WORDS CONT; Tillmann B, 2009, BRAIN COGNITION, V71, P259, DOI 10.1016/j.bandc.2009.08.003; WHALEN DH, 1992, PHONETICA, V49, P25, DOI 10.1159/000261901; WHALEN DH, 1987, SCIENCE, V237, P169, DOI 10.1126/science.3603014; Williamson VJ, 2010, MEMORY, V18, P657, DOI 10.1080/09658211.2010.501339; Xu Y, 1997, PSYCHOL SCI, V8, P358, DOI 10.1111/j.1467-9280.1997.tb00425.x; Xu Y, 2005, J PHONETICS, V33, P159, DOI 10.1016/j.wocn.2004.11.001; Xu Y, 1997, J PHONETICS, V25, P61, DOI 10.1006/jpho.1996.0034	60	52	54	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30374	10.1371/journal.pone.0030374	http://dx.doi.org/10.1371/journal.pone.0030374			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	924ZP	22347374	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000302730100010
J	Montegna, EA; Bhave, M; Liu, Y; Bhattacharyya, D; Glick, BS				Montegna, Elisabeth A.; Bhave, Madhura; Liu, Yang; Bhattacharyya, Dibyendu; Glick, Benjamin S.			Sec12 Binds to Sec16 at Transitional ER Sites	PLOS ONE			English	Article							PICHIA-PASTORIS; SUBUNIT INTERACTIONS; EXIT SITES; PROTEIN; YEAST; LOCALIZATION; ORGANIZATION; ENCODES; GENES; REQUIREMENTS	COPII vesicles bud from an ER domain known as the transitional ER (tER). Assembly of the COPII coat is initiated by the transmembrane guanine nucleotide exchange factor Sec12. In the budding yeast Pichia pastoris, Sec12 is concentrated at tER sites. Previously, we found that the tER localization of P. pastoris Sec12 requires a saturable binding partner. We now show that this binding partner is Sec16, a peripheral membrane protein that functions in ER export and tER organization. One line of evidence is that overexpression of Sec12 delocalizes Sec12 to the general ER, but simultaneous overexpression of Sec16 retains overexpressed Sec12 at tER sites. Additionally, when P. pastoris Sec12 is expressed in S. cerevisiae, the exogenous Sec12 localizes to the general ER, but when P. pastoris Sec16 is expressed in the same cells, the exogenous Sec12 is recruited to tER sites. In both of these experimental systems, the ability of Sec16 to recruit Sec12 to tER sites is abolished by deleting a C-terminal fragment of Sec16. Biochemical experiments confirm that this C-terminal fragment of Sec16 binds to the cytosolic domain of Sec12. Similarly, we demonstrate that human Sec12 is concentrated at tER sites, likely due to association with a C-terminal fragment of Sec16A. These results suggest that a Sec12-Sec16 interaction has a conserved role in ER export.	[Montegna, Elisabeth A.; Liu, Yang; Glick, Benjamin S.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Bhave, Madhura; Bhattacharyya, Dibyendu] Tata Mem Hosp, ACTREC, Kharghar, Navi Mumbai, India	University of Chicago; Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital	Montegna, EA (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58Th St, Chicago, IL 60637 USA.	dbhattacharyya@actrec.gov.in; bsglick@uchicago.edu	Bhave, Madhura/AAC-5297-2020; Bhattacharyya, Dibyendu/AAE-9208-2022; Bhattacharyya, Dibyendu/GRS-5261-2022	Bhave, Madhura/0000-0001-7446-9256; Bhattacharyya, Dibyendu/0000-0003-3252-7440; Bhattacharyya, Dibyendu/0000-0003-3252-7440	National Institute of Health [R01 GM061156, T32 GM7183]; ACTREC (Advanced Centre for Treatment, Research & Education in Cancer) at the Tata Memorial Centre; Council of Scientific and Industrial Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061156, T32GM007183] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ACTREC (Advanced Centre for Treatment, Research & Education in Cancer) at the Tata Memorial Centre; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research in the Glick lab was supported by National Institute of Health grant R01 GM061156 (BSG) and National Institute of Health training grant T32 GM7183 (EAM). Research in the Bhattacharyya lab was supported by startup funds provided by ACTREC (Advanced Centre for Treatment, Research & Education in Cancer) at the Tata Memorial Centre, and by an Indian government fellowship from the Council of Scientific and Industrial Research (MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannykh SI, 1997, J CELL BIOL, V138, P1, DOI 10.1083/jcb.138.1.1; BARLOWE C, 1993, NATURE, V365, P347, DOI 10.1038/365347a0; Bevis BJ, 2002, NAT CELL BIOL, V4, P750, DOI 10.1038/ncb852; Bhattacharyya D, 2007, MOL BIOL CELL, V18, P839, DOI 10.1091/mbc.E06-08-0707; Bhattacharyya D, 2010, METHODS MOL BIOL, V619, P403, DOI 10.1007/978-1-60327-412-8_24; Budnik A, 2009, FEBS LETT, V583, P3796, DOI 10.1016/j.febslet.2009.10.038; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Connerly PL, 2005, CURR BIOL, V15, P1439, DOI 10.1016/j.cub.2005.06.065; Deutschbauer AM, 2002, P NATL ACAD SCI USA, V99, P15530, DOI 10.1073/pnas.202604399; ESPENSHADE P, 1995, J CELL BIOL, V131, P311, DOI 10.1083/jcb.131.2.311; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GIMENO RE, 1995, J CELL BIOL, V131, P325, DOI 10.1083/jcb.131.2.325; Gimeno RE, 1996, MOL BIOL CELL, V7, P1815, DOI 10.1091/mbc.7.11.1815; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; GOULD SJ, 1992, YEAST, V8, P613, DOI 10.1002/yea.320080805; HARDWICK KG, 1992, EMBO J, V11, P4187, DOI 10.1002/j.1460-2075.1992.tb05512.x; Hughes H, 2008, HISTOCHEM CELL BIOL, V129, P129, DOI 10.1007/s00418-007-0363-x; Hughes H, 2009, J CELL SCI, V122, P2924, DOI 10.1242/jcs.044032; Iinuma T, 2007, J BIOL CHEM, V282, P17632, DOI 10.1074/jbc.M611237200; Ivan V, 2008, MOL BIOL CELL, V19, P4352, DOI 10.1091/mbc.E08-03-0246; JOHNSTON M, 1984, MOL CELL BIOL, V4, P1440, DOI 10.1128/MCB.4.8.1440; Kaddoum L, 2010, BIOTECHNIQUES, V49, P727, DOI 10.2144/000113512; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Lee MCS, 2007, SEMIN CELL DEV BIOL, V18, P424, DOI 10.1016/j.semcdb.2007.06.007; Lukyanov KA, 2010, PHOTOCH PHOTOBIO SCI, V9, P1301, DOI 10.1039/c0pp00114g; NISHIKAWA S, 1993, P NATL ACAD SCI USA, V90, P8179, DOI 10.1073/pnas.90.17.8179; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; Papanikou E, 2009, FEBS LETT, V583, P3746, DOI 10.1016/j.febslet.2009.10.072; Payne WE, 2000, YEAST, V16, P979; Rossanese OW, 1999, J CELL BIOL, V145, P69, DOI 10.1083/jcb.145.1.69; Russell C, 2010, TRAFFIC, V11, P303, DOI 10.1111/j.1600-0854.2009.01026.x; Sears IB, 1998, YEAST, V14, P783, DOI 10.1002/(SICI)1097-0061(19980615)14:8<783::AID-YEA272>3.0.CO;2-Y; Shaywitz DA, 1997, J BIOL CHEM, V272, P25413, DOI 10.1074/jbc.272.41.25413; Shindiapina P, 2010, MOL BIOL CELL, V21, P1530, DOI 10.1091/mbc.E09-07-0605; Soderholm J, 2004, DEV CELL, V6, P649, DOI 10.1016/S1534-5807(04)00129-7; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Watson P, 2006, TRAFFIC, V7, P1678, DOI 10.1111/j.1600-0854.2006.00493.x; Weissman JT, 2001, TRAFFIC, V2, P465, DOI 10.1034/j.1600-0854.2001.20704.x; Witte K, 2011, NAT CELL BIOL, V13, P550, DOI 10.1038/ncb2225; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	40	38	38	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31156	10.1371/journal.pone.0031156	http://dx.doi.org/10.1371/journal.pone.0031156			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347445	Green Published, gold, Green Submitted			2022-12-25	WOS:000302730100048
J	Gyetvai, G; Sonderkaer, M; Gobel, U; Basekow, R; Ballvora, A; Imhoff, M; Kersten, B; Nielsen, KL; Gebhardt, C				Gyetvai, Gabor; Sonderkaer, Mads; Goebel, Ulrike; Basekow, Rico; Ballvora, Agim; Imhoff, Maren; Kersten, Birgit; Nielsen, Kare-Lehman; Gebhardt, Christiane			The Transcriptome of Compatible and Incompatible Interactions of Potato (Solanum tuberosum) with Phytophthora infestans Revealed by DeepSAGE Analysis	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED GENES; LATE BLIGHT RESISTANCE; PATHOGENESIS-RELATED PROTEIN; BROAD-SPECTRUM RESISTANCE; QUANTITATIVE RESISTANCE; DISEASE RESISTANCE; SUBTRACTIVE HYBRIDIZATION; R1 GENE; PLANT; SEQUENCE	Late blight, caused by the oomycete Phytophthora infestans, is the most important disease of potato (Solanum tuberosum). Understanding the molecular basis of resistance and susceptibility to late blight is therefore highly relevant for developing resistant cultivars, either by marker-assissted selection or by transgenic approaches. Specific P. infestans races having the Avr1 effector gene trigger a hypersensitive resistance response in potato plants carrying the R1 resistance gene (incompatible interaction) and cause disease in plants lacking R1 (compatible interaction). The transcriptomes of the compatible and incompatible interaction were captured by DeepSAGE analysis of 44 biological samples comprising five genotypes, differing only by the presence or absence of the R1 transgene, three infection time points and three biological replicates. 30.859 unique 21 base pair sequence tags were obtained, one third of which did not match any known potato transcript sequence. Two third of the tags were expressed at low frequency (<10 tag counts/million). 20.470 unitags matched to approximately twelve thousand potato transcribed genes. Tag frequencies were compared between compatible and incompatible interactions over the infection time course and between compatible and incompatible genotypes. Transcriptional changes were more numerous in compatible than in incompatible interactions. In contrast to incompatible interactions, transcriptional changes in the compatible interaction were observed predominantly for multigene families encoding defense response genes and genes functional in photosynthesis and CO2 fixation. Numerous transcriptional differences were also observed between near isogenic genotypes prior to infection with P. infestans. Our DeepSAGE transcriptome analysis uncovered novel candidate genes for plant host pathogen interactions, examples of which are discussed with respect to possible function.	[Gyetvai, Gabor; Goebel, Ulrike; Ballvora, Agim; Gebhardt, Christiane] Max Planck Inst Plant Breeding Res, Cologne, Germany; [Sonderkaer, Mads; Nielsen, Kare-Lehman] Aalborg Univ, Dept Biotechnol Chem & Environm Engn, Aalborg, Denmark; [Basekow, Rico; Imhoff, Maren; Kersten, Birgit] Max Planck Inst Mol Plant Physiol, Potsdam, Germany	Max Planck Society; Aalborg University; Max Planck Society	Gyetvai, G (corresponding author), Max Planck Inst Plant Breeding Res, Cologne, Germany.	gebhardt@mpipz.mpg.de	Nielsen, Kåre Lehmann L/A-1181-2013; Gebhardt, Chris/HGD-6090-2022	Nielsen, Kåre Lehmann L/0000-0002-5598-4401; Sonderkaer, Mads/0000-0002-9309-7459; Kersten, Birgit/0000-0001-9900-9133	Danish Strategic Research Council [2101-07-0116, 2106-07-0021]; German Federal Ministry for Education and Research [0315065B]	Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	KLN and MS were supported by grants 2101-07-0116 and 2106-07-0021 from the Danish Strategic Research Council. BK and RB were supported by grant 0315065B from the German Federal Ministry for Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ballvora A, 2002, PLANT J, V30, P361, DOI 10.1046/j.1365-313X.2001.01292.x; Ballvora A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-112; Beissbarth T, 2004, BIOINFORMATICS, V20, P31, DOI 10.1093/bioinformatics/bth924; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beyer K, 2001, MOL PLANT PATHOL, V2, P125, DOI 10.1046/j.1364-3703.2001.00059.x; Birch PRJ, 1999, MOL PLANT MICROBE IN, V12, P356, DOI 10.1094/MPMI.1999.12.4.356; Bormann CA, 2003, GENETIC MOL ANAL QUA; Caillau M, 2005, PLANT J, V43, P1, DOI 10.1111/j.1365-313X.2005.02427.x; CATEN CE, 1968, CAN J BOTANY, V46, P329, DOI 10.1139/b68-055; CONSTABEL CP, 1992, PLANTA, V188, P289, DOI 10.1007/BF00192794; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Eschen-Lippold L, 2010, EUR J PLANT PATHOL, V127, P437, DOI 10.1007/s10658-010-9621-1; Foster SJ, 2009, MOL PLANT MICROBE IN, V22, P589, DOI 10.1094/MPMI-22-5-0589; FRITZEMEIER KH, 1987, PLANT PHYSIOL, V85, P34, DOI 10.1104/pp.85.1.34; Fry W, 2008, MOL PLANT PATHOL, V9, P385, DOI [10.1111/j.1364-3703.2007.00465.x, 10.1111/J.1364-3703.2007.00465.X]; Gebhardt C, 2001, ANNU REV PHYTOPATHOL, V39, P79, DOI 10.1146/annurev.phyto.39.1.79; Goellner K, 2008, EUR J PLANT PATHOL, V121, P233, DOI 10.1007/s10658-007-9251-4; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Heibges A, 2003, MOL GENET GENOMICS, V269, P526, DOI 10.1007/s00438-003-0860-0; Henriquez MA, 2010, J INTEGR PLANT BIOL, V52, P453, DOI 10.1111/j.1744-7909.2010.00943.x; Hoegen E, 2002, MOL PLANT PATHOL, V3, P329, DOI 10.1046/j.1364-3703.2002.00126.x; Huang SW, 2005, PLANT J, V42, P251, DOI 10.1111/j.1365-313X.2005.02365.x; Jones Jonathan D. G., 1992, Transgenic Research, V1, P285, DOI 10.1007/BF02525170; Judelson HS, 2000, PHYTOPATHOLOGY, V90, P1112, DOI 10.1094/PHYTO.2000.90.10.1112; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; LEONARDSSCHIPPERS C, 1992, MOL GEN GENET, V233, P278, DOI 10.1007/BF00587589; LEONARDSSCHIPPERS C, 1994, GENETICS, V137, P67; Lindqvist-Kreuze H, 2010, MOL PLANT PATHOL, V11, P513, DOI [10.1111/J.1364-3703.2010.00622.X, 10.1111/j.1364-3703.2010.00622.x]; Liu F, 2006, PLOS PATHOG, V2, P268, DOI 10.1371/journal.ppat.0020029; Lokossou AA, 2009, MOL PLANT MICROBE IN, V22, P630, DOI 10.1094/MPMI-22-6-0630; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mangeon A, 2010, PLANT SIGNAL BEHAV, V5, P99, DOI 10.4161/psb.5.2.10336; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Mayrose M, 2006, MOL PLANT PATHOL, V7, P593, DOI [10.1111/j.1364-3703.2006.00364.x, 10.1111/J.1364-3703.2006.00364.X]; Meyer S, 2005, NUCLEIC ACIDS RES, V33, pD666, DOI 10.1093/nar/gki018; Moehs CP, 1996, PLANT MOL BIOL, V32, P447, DOI 10.1007/BF00019096; Nielsen KL, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl714; Nielsen KL, 2008, DEEPSAGE TAG BASED T, P229; Odeny DA, 2010, PLANT CELL ENVIRON, V33, P2149, DOI 10.1111/j.1365-3040.2010.02213.x; Pajerowska-Mukhtar K, 2009, GENETICS, V181, P1115, DOI 10.1534/genetics.108.094268; Pajerowska-Mukhtar KM, 2008, PLANTA, V228, P293, DOI 10.1007/s00425-008-0737-x; Pan QL, 2000, J MOL EVOL, V50, P203, DOI 10.1007/s002399910023; Restrepo S, 2005, MOL PLANT MICROBE IN, V18, P913, DOI 10.1094/MPMI-18-0913; Rickert AM, 2003, PLANT BIOTECHNOL J, V1, P399, DOI 10.1046/j.1467-7652.2003.00036.x; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ros B, 2004, MOL PLANT PATHOL, V5, P191, DOI [10.1111/j.1364-3703.2004.00221.x, 10.1111/J.1364-3703.2004.00221.X]; Ross H., 1986, POTATO BREEDING PROB, V13, P82; Schaaf Gerben J., 2008, V387, P151; Si-Ammour A, 2003, MOL PLANT PATHOL, V4, P237, DOI 10.1046/J.1364-3703.2003.00168.X; Singh DK, 2011, TRENDS PLAN IN PRESS; Song JQ, 2003, P NATL ACAD SCI USA, V100, P9128, DOI 10.1073/pnas.1533501100; Stewart HE, 2003, PLANT PATHOL, V52, P193, DOI 10.1046/j.1365-3059.2003.00811.x; TAYLOR JL, 1990, MOL PLANT MICROBE IN, V3, P72; Trognitz F, 2002, MOL PLANT MICROBE IN, V15, P587, DOI 10.1094/MPMI.2002.15.6.587; van der Vossen E, 2003, PLANT J, V36, P867, DOI 10.1046/j.1365-313X.2003.01934.x; van der Vossen EAG, 2005, PLANT J, V44, P208, DOI 10.1111/j.1365-313X.2005.02527.x; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; van Poppel PMJA, 2008, MOL PLANT MICROBE IN, V21, P1460, DOI 10.1094/MPMI-21-11-1460; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Vleeshouwers VGAA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002875; Vlot AC, 2008, CURR OPIN PLANT BIOL, V11, P436, DOI 10.1016/j.pbi.2008.05.003; Wan Jinrong, 2002, Funct Integr Genomics, V2, P259, DOI 10.1007/s10142-002-0080-4; Wang BL, 2005, PLANT SCI, V169, P1155, DOI 10.1016/j.plantsci.2005.07.020; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Youssef A, 2010, PLANT J, V61, P436, DOI 10.1111/j.1365-313X.2009.04067.x	72	47	49	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e31526	10.1371/journal.pone.0031526	http://dx.doi.org/10.1371/journal.pone.0031526			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328937	Green Published, gold, Green Submitted			2022-12-25	WOS:000302179300023
J	Zacharias, DG; Kim, SG; Massat, AE; Bachar, AR; Oh, YK; Herrmann, J; Rodriguez-Porcel, M; Cohen, P; Lerman, LO; Lerman, A				Zacharias, David G.; Kim, Sung Gyun; Massat, Alfonso Eirin; Bachar, Adi R.; Oh, Yun K.; Herrmann, Joerg; Rodriguez-Porcel, Martin; Cohen, Pinchas; Lerman, Lilach O.; Lerman, Amir			Humanin, a Cytoprotective Peptide, Is Expressed in Carotid Artherosclerotic Plaques in Humans	PLOS ONE			English	Article							NEURONAL CELL-DEATH; APOE-DEFICIENT MICE; SMOOTH-MUSCLE-CELLS; FACTOR-KAPPA-B; ATHEROSCLEROTIC PLAQUES; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; RESCUE FACTOR; MEMORY IMPAIRMENT; JAK2/STAT3 AXIS	Objective: The mechanism of atherosclerotic plaque progression leading to instability, rupture, and ischemic manifestation involves oxidative stress and apoptosis. Humanin (HN) is a newly emerging endogenously expressed cytoprotective peptide. Our goal was to determine the presence and localization of HN in carotid atherosclerotic plaques. Methods and Results: Plaque specimens from 34 patients undergoing carotid endarterectomy were classified according to symptomatic history. Immunostaining combined with digital microscopy revealed greater expression of HN in the unstable plaques of symptomatic compared to asymptomatic patients (29.42 +/- 2.05 vs. 14.14 +/- 2.13% of plaque area, p<0.0001). These data were further confirmed by immunoblot (density of HN/beta-actin standard symptomatic vs. asymptomatic 1.32 +/- 0.14 vs. 0.79 +/- 0.11, p<0.01). TUNEL staining revealed a higher proportion of apoptotic nuclei in the plaques of symptomatic patients compared to asymptomatic (68.25 +/- 3.61 vs. 33.46 +/- 4.46% of nuclei, p, 0.01). Double immunofluorescence labeling revealed co-localization of HN with macrophages (both M1 and M2 polarization), smooth muscle cells, fibroblasts, and dendritic cells as well as with inflammatory markers MMP2 and MMP9. Conclusions: The study demonstrates a higher expression of HN in unstable carotid plaques that is localized to multiple cell types within the plaque. These data support the involvement of HN in atherosclerosis, possibly as an endogenous response to the inflammatory and apoptotic processes within the atheromatous plaque.	[Zacharias, David G.; Kim, Sung Gyun; Massat, Alfonso Eirin; Bachar, Adi R.; Oh, Yun K.; Herrmann, Joerg; Rodriguez-Porcel, Martin; Lerman, Amir] Mayo Clin, Coll Med, Dept Hypertens & Nephrol, Div Cardiovasc Dis, Rochester, MN 55902 USA; [Cohen, Pinchas] Univ Calif Los Angeles, Dept Pediat, Div Endocrinol, Mattel Childrens Hosp, Los Angeles, CA 90024 USA	Mayo Clinic; University of California System; University of California Los Angeles	Zacharias, DG (corresponding author), Mayo Clin, Coll Med, Dept Hypertens & Nephrol, Div Cardiovasc Dis, Rochester, MN 55902 USA.	lerman.amir@mayo.edu	Lerman, Lilach/M-4962-2017; 王, 强/F-4212-2011; Oh, Yun Kyu/J-5542-2012	Eirin, Alfonso/0000-0002-3864-9644	National Institutes of Health (NIH) [R00 HL88048, AG034430, GM090311, HL92954, AG31750]; National Center for Research Resources (NCRR) [1 TL1 RR024152]; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024152] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL088048, R01HL092954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031750, R01AG034430] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was supported by grants R00 HL88048 (to MR), AG034430 and GM090311 (to PC), and HL92954 and AG31750 (to AL) from the National Institutes of Health. It was also supported by Grant Number 1 TL1 RR024152 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and the NIH Roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa T, 2008, CURR MED CHEM, V15, P2086, DOI 10.2174/092986708785747616; Bachar AR, 2010, CARDIOVASC RES; Bai X, 2010, VASC PHARMACOL, V52, P224, DOI 10.1016/j.vph.2010.02.001; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; Canault M, 2006, ATHEROSCLEROSIS, V187, P82, DOI 10.1016/j.atherosclerosis.2005.08.031; Chiba T, 2009, MOL PSYCHIATR, V14, P206, DOI 10.1038/mp.2008.105; Chiba T, 2009, EXPERT OPIN THER TAR, V13, P1155, DOI 10.1517/14728220903213426; Colon E, 2006, J CELL PHYSIOL, V208, P373, DOI 10.1002/jcp.20672; de Nigris F, 2003, TRENDS MOL MED, V9, P351, DOI 10.1016/S1471-4914(03)00139-4; Devosse T, 2009, J IMMUNOL, V182, P4974, DOI 10.4049/jimmunol.0803128; Dickhout JG, 2005, ARTERIOSCL THROM VAS, V25, P2623, DOI 10.1161/01.ATV.0000189159.96900.d9; Erbel C, 2009, J IMMUNOL, V183, P8167, DOI 10.4049/jimmunol.0901126; Fearon IM, 2009, J MOL CELL CARDIOL, V47, P372, DOI 10.1016/j.yjmcc.2009.05.013; Galkina E, 2007, CURR DRUG TARGETS, V8, P1239, DOI 10.2174/138945007783220650; Galle J, 2006, ATHEROSCLEROSIS, V185, P219, DOI 10.1016/j.atherosclerosis.2005.10.005; Garrity MM, 2003, MODERN PATHOL, V16, P389, DOI 10.1097/01.MP.0000062657.30170.92; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Harada M, 2004, BIOCHEM BIOPH RES CO, V324, P255, DOI 10.1016/j.bbrc.2004.09.046; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; Hashimoto Y, 2001, BIOCHEM BIOPH RES CO, V283, P460, DOI 10.1006/bbrc.2001.4765; Hashimoto Y, 2009, MOL BIOL CELL, V20, P2864, DOI 10.1091/mbc.E09-02-0168; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hoang PT, 2010, METABOLISM, V59, P343, DOI 10.1016/j.metabol.2009.08.001; Ikonen M, 2003, P NATL ACAD SCI USA, V100, P13042, DOI 10.1073/pnas.2135111100; Jung SS, 2003, J NEUROCHEM, V84, P266, DOI 10.1046/j.1471-4159.2003.01524.x; Katsiki N, 2010, ATHEROSCLEROSIS, V211, P9, DOI 10.1016/j.atherosclerosis.2009.12.028; Kin T, 2006, J HUM GENET, V51, P555, DOI 10.1007/s10038-006-0397-2; Lee S, 2011, J AM SOC NEPHROL, V22, P317, DOI 10.1681/ASN.2009060615; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Luciano F, 2005, J BIOL CHEM, V280, P15825, DOI 10.1074/jbc.M413062200; Lue YH, 2010, ENDOCRINOLOGY, V151, P350, DOI 10.1210/en.2009-0577; Lutgens E, 1999, CARDIOVASC RES, V41, P473, DOI 10.1016/S0008-6363(98)00311-3; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68; Mannheim D, 2008, STROKE, V39, P1448, DOI 10.1161/STROKEAHA.107.503193; Mas J, 2006, NEW ENGL J MED, V355, P1660, DOI 10.1056/NEJMoa061752; Matsuoka Masaaki, 2009, Recent Pat CNS Drug Discov, V4, P37; Matsuoka M, 2010, MOL NEUROBIOL, V41, P22, DOI 10.1007/s12035-009-8090-z; Muzumdar RH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006334; Muzumdar RH, ARTERIOSCLER THROMB; Nemec KN, 2008, YONSEI MED J, V49, P689, DOI 10.3349/ymj.2008.49.5.689; Newby AC, 2009, THROMB HAEMOSTASIS, V101, P1006, DOI 10.1160/TH08-07-0469; Niikura T, 2006, CURR NEUROPHARMACOL, V4, P139, DOI 10.2174/157015906776359577; Niikura T, 2004, MOL NEUROBIOL, V30, P327, DOI 10.1385/MN:30:3:327; Niikura T, 2002, J NEUROSCI RES, V70, P380, DOI 10.1002/jnr.10354; Nishimoto I, 2004, TRENDS MOL MED, V10, P102, DOI 10.1016/j.molmed.2004.01.001; Oh YK, 2011, ATHEROSCLEROSIS, V219, P65, DOI 10.1016/j.atherosclerosis.2011.06.038; Peeters W, 2009, ARTERIOSCL THROM VAS, V29, P128, DOI 10.1161/ATVBAHA.108.173658; Redgrave JNE, 2006, CIRCULATION, V113, P2320, DOI 10.1161/CIRCULATIONAHA.105.589044; Rocha M, 2010, CURR PHARM DESIGN, V16, P3124, DOI 10.2174/138161210793292519; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sattler KJE, 2005, STROKE, V36, P14, DOI 10.1161/01.STR.0000150643.08420.78; SEEGER JM, 1995, J SURG RES, V58, P330, DOI 10.1006/jsre.1995.1051; Seimon T, 2009, J LIPID RES, V50, pS382, DOI 10.1194/jlr.R800032-JLR200; Shah PK, 2003, J AM COLL CARDIOL, V41, p15S, DOI 10.1016/S0735-1097(02)02834-6; Tajima H, 2005, J NEUROSCI RES, V79, P714, DOI 10.1002/jnr.20391; Versari D, 2006, ARTERIOSCL THROM VAS, V26, P2132, DOI 10.1161/01.ATV.0000232501.08576.73; Victor VM, 2009, CURR MED CHEM, V16, P4654, DOI 10.2174/092986709789878265; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Wang YP, 2011, J AM SOC NEPHROL, V22, P21, DOI 10.1681/ASN.2010030269; Wilson SH, 2000, ATHEROSCLEROSIS, V148, P23, DOI 10.1016/S0021-9150(99)00211-7; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; Xu F, 2009, TOHOKU J EXP MED, V218, P25, DOI 10.1620/tjem.218.25; Xu XS, 2006, STROKE, V37, P2613, DOI 10.1161/01.STR.0000242772.94277.1f; Xu XS, 2010, BRAIN RES, V1355, P189, DOI 10.1016/j.brainres.2010.07.080; Yuan XM, 2010, ATHEROSCLEROSIS, V210, P392, DOI 10.1016/j.atherosclerosis.2009.11.048; Zadelaar ASM, 2005, ATHEROSCLEROSIS, V183, P244, DOI 10.1016/j.atherosclerosis.2005.03.044; Zalewski A, 2002, CIRC RES, V91, P652, DOI 10.1161/01.RES.0000038996.97287.9A; Zhai DY, 2005, J BIOL CHEM, V280, P15815, DOI 10.1074/jbc.M411902200; Zmijewski JW, 2005, AM J PHYSIOL-HEART C, V289, pH852, DOI 10.1152/ajpheart.00015.2005	70	39	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e31065	10.1371/journal.pone.0031065	http://dx.doi.org/10.1371/journal.pone.0031065			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328926	Green Published, gold			2022-12-25	WOS:000302179300012
J	Wen, ZH; Su, YC; Lai, PL; Zhang, Y; Xu, YF; Zhao, A; Yao, GY; Jia, CH; Lin, J; Xu, S; Wang, L; Wang, XK; Liu, AL; Jiang, Y; Dai, YF; Bai, XC				Wen, Z-H; Su, Y-C; Lai, P-L; Zhang, Y.; Xu, Y-F; Zhao, A.; Yao, G-Y; Jia, C-H; Lin, J.; Xu, S.; Wang, L.; Wang, X-K; Liu, A-L; Jiang, Y.; Dai, Y-F; Bai, X-C			Critical role of arachidonic acid-activated mTOR signaling in breast carcinogenesis and angiogenesis	ONCOGENE			English	Article						mammalian target of rapamycin; arachidonic acid; breast cancer; tumorigenesis; angiogenesis	FATTY-ACIDS; PHOSPHOLIPASE A(2); CANCER PREVENTION; CELL-GROWTH; PATHWAY; METABOLISM; INHIBITION; EXPRESSION; ADHESION; MEDIATOR	The mammalian target of rapamycin (mTOR) signaling pathway is upregulated in the pathogenesis of many cancers. Arachidonic acid (AA) and its metabolites play critical role in the development of breast cancer, but the mechanisms through which AA promotes mammary tumorigenesis and progression are poorly understood. We found that the levels of AA and cytosolic phospholipase A2 (cPLA2) strongly correlated with the signaling activity of mTORC1 and mTORC2 as well as the expression levels of vascular epithelial growth factor (VEGF) in human breast tumor tissues. In cultured breast cancer cells, AA effectively activated both mTOR complex 1 (mTORC1) and mTORC2. Interestingly, AA-stimulated mTORC1 activation was independent of amino acids, phosphatidylinositol 3-kinase (PI3-K) and tuberous sclerosis complex 2 (TSC2), which suggests a novel mechanism for nnTORC1 activation. Further studies revealed that AA stimulated mTORC1 activity through destabilization of mTOR-raptor association in ras homolog enriched in brain (Rheb)-dependent mechanism. Moreover, we showed that AA-stimulated cell proliferation and angiogenesis required mTOR activity and that the effect of AA was mediated by lipoxygenase (LOX) but not cyclooxygenase-2 (COX-2). In animal models, AA-enhanced incidences of rat mammary tumorigenesis, tumor weights and angiogenesis were inhibited by rapamycin. Our findings suggest that AA is an effective intracellular stimulus of mTOR and that AA-activated mTOR plays critical roles in angiogenesis and tumorigenesis of breast cancer. Oncogene (2013) 32, 160-170; doi:10.1038/onc.2012.47; published online 20 February 2012	[Wen, Z-H; Su, Y-C; Lai, P-L; Zhang, Y.; Xu, Y-F; Jia, C-H; Lin, J.; Xu, S.; Wang, L.; Wang, X-K; Liu, A-L; Bai, X-C] So Med Univ, Sch Basic Med Sci, Dept Cell Biol, Guangzhou 510515, Guangdong, Peoples R China; [Zhao, A.; Dai, Y-F] Nanjing Med Univ, Ctr Metab Dis Res, Nanjing 201129, Jiangsu, Peoples R China; [Yao, G-Y] So Med Univ, Nanfang Hosp, Breast Ctr, Guangzhou 510515, Guangdong, Peoples R China; [Jiang, Y.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Dai, Y-F] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing 201129, Jiangsu, Peoples R China	Southern Medical University - China; Nanjing Medical University; Southern Medical University - China; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Nanjing Medical University	Dai, YF (corresponding author), Nanjing Med Univ, Ctr Metab Dis Res, Nanjing 201129, Jiangsu, Peoples R China.	yifandai08@gmail.com; baixc15@smu.edu.cn		Bai, Xiaochun/0000-0001-9631-4781	State Key Development Program for Basic Research of China [2009CB 918904]; National Natural Sciences Foundation of China [30870955, 91029727, 30900555]; Program for New Century Excellent Talents in University [NCET-08-0646]; NATIONAL CANCER INSTITUTE [R01CA129821] Funding Source: NIH RePORTER	State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We greatly appreciate the gift of TSC2<SUP>+/+</SUP> and TSC2<SUP>-/-</SUP> MEFs from Dr David J Kwiatkowski (Brigham and Women's Hospital, Boston, MA, USA). This work was supported by The State Key Development Program for Basic Research of China (No. 2009CB 918904), National Natural Sciences Foundation of China (30870955, 91029727, 30900555) and Program for New Century Excellent Talents in University (NCET-08-0646).	Agrawal A, 2008, INT J CLIN PRACT, V62, P444, DOI 10.1111/j.1742-1241.2007.01668.x; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Bai XC, 2010, CELL MOL LIFE SCI, V67, P239, DOI 10.1007/s00018-009-0163-7; BUZZARD CJ, 1993, CIRC RES, V72, P1023, DOI 10.1161/01.RES.72.5.1023; Cakir Y, 2002, INT J ONCOL, V21, P153; Camp RL, 1999, CANCER, V86, P2259, DOI 10.1002/(SICI)1097-0142(19991201)86:11<2259::AID-CNCR13>3.0.CO;2-2; Chen XX, 2006, CURR CANCER DRUG TAR, V6, P613, DOI 10.2174/156800906778742451; Duan SS, 2011, MOL CELL, V44, P317, DOI 10.1016/j.molcel.2011.09.005; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Goberdhan DCI, 2010, CURR OPIN INVEST DR, V11, P1360; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Harizi H, 2008, TRENDS MOL MED, V14, P461, DOI 10.1016/j.molmed.2008.08.005; Holmes MD, 1999, JAMA-J AM MED ASSOC, V281, P914, DOI 10.1001/jama.281.10.914; Horn L, 2009, EXPERT OPIN THER TAR, V13, P675, DOI 10.1517/14728220902915567; Hyde CAC, 2009, INT IMMUNOPHARMACOL, V9, P701, DOI 10.1016/j.intimp.2009.02.003; Hynes NE, 2006, J MAMMARY GLAND BIOL, V11, P53, DOI 10.1007/s10911-006-9012-6; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jiang WG, 2006, PROSTAG LEUKOTR ESS, V74, P125, DOI 10.1016/j.plefa.2005.10.005; Kennett SB, 2004, J BIOL CHEM, V279, P3300, DOI 10.1074/jbc.M305734200; Kim C, 2008, BMB REP, V41, P555, DOI 10.5483/BMBRep.2008.41.8.555; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kuehn HS, 2011, J BIOL CHEM, V286, P391, DOI 10.1074/jbc.M110.164772; Li M, 2010, CELL SIGNAL, V22, P1469, DOI 10.1016/j.cellsig.2010.05.015; Linkous AG, 2010, JNCI-J NATL CANCER I, V102, P1398, DOI 10.1093/jnci/djq290; Martinez-Orozco R, 2010, EUR J CELL BIOL, V89, P476, DOI 10.1016/j.ejcb.2009.12.005; MCCORMICK DL, 1987, CANCER LETT, V37, P139, DOI 10.1016/0304-3835(87)90156-X; Menna C, 2010, CURR PHARM DESIGN, V16, P725, DOI 10.2174/138161210790883822; Meyer AM, 2004, CARCINOGENESIS, V25, P1517, DOI 10.1093/carcin/bgh150; Mieulet V, 2010, TRENDS MOL MED, V16, P329, DOI 10.1016/j.molmed.2010.05.001; Nakanishi M, 2006, BBA-MOL CELL BIOL L, V1761, P1335, DOI 10.1016/j.bbalip.2006.09.005; Navarro-Tito N, 2008, EXP CELL RES, V314, P3340, DOI 10.1016/j.yexcr.2008.08.018; Navarro-Tito N, 2010, INT J BIOCHEM CELL B, V42, P306, DOI 10.1016/j.biocel.2009.11.010; Paine E, 2000, J BIOL CHEM, V275, P11284, DOI 10.1074/jbc.275.15.11284; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Pidgeon GP, 2007, CANCER METAST REV, V26, P503, DOI 10.1007/s10555-007-9098-3; Razanamahefa L, 2000, NUTR CANCER, V38, P274, DOI 10.1207/S15327914NC382_17; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Singh-Ranger G, 2008, BREAST CANCER RES TR, V109, P189, DOI 10.1007/s10549-007-9641-5; Thiebaut ACM, 2009, INT J CANCER, V124, P924, DOI 10.1002/ijc.23980; Ulrich CM, 2006, NAT REV CANCER, V6, P130, DOI 10.1038/nrc1801; Weiser-Evans MCM, 2009, CANCER RES, V69, P1733, DOI 10.1158/0008-5472.CAN-08-3766; YAMASHITA SI, 1994, BRIT J CANCER, V69, P1166, DOI 10.1038/bjc.1994.229; Ye YN, 2005, CARCINOGENESIS, V26, P827, DOI 10.1093/carcin/bgi012; Yecies JL, 2011, J MOL MED, V89, P221, DOI 10.1007/s00109-011-0726-6; Zhang BL, 2006, J BIOL CHEM, V281, P905, DOI 10.1074/jbc.M503945200; Zhang BL, 2005, CANCER RES, V65, P7283, DOI 10.1158/0008-5472.CAN-05-0633; Zhou L, 2002, J NUTR, V132, P2626, DOI 10.1093/jn/132.9.2626	50	66	71	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 10	2013	32	2					160	170		10.1038/onc.2012.47	http://dx.doi.org/10.1038/onc.2012.47			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	078CK	22349822				2022-12-25	WOS:000314075500004
J	Steichen, JM; Kuchinskas, M; Keshwani, MM; Yang, J; Adams, JA; Taylor, SS				Steichen, Jon M.; Kuchinskas, Michael; Keshwani, Malik M.; Yang, Jie; Adams, Joseph A.; Taylor, Susan S.			Structural Basis for the Regulation of Protein Kinase A by Activation Loop Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CATALYTIC SUBUNIT; MECHANISM; AUTOPHOSPHORYLATION; DOMAIN; EXCHANGE; BINDING; SITES; MODEL	The catalytic subunit of cAMP-dependent protein kinase (PKA) is a member of the AGC group of protein kinases. Whereas PKA has served as a structural model for the protein kinase superfamily, all previous structures of the catalytic subunit contain a phosphorylated activation loop. To understand the structural effects of activation loop phosphorylation at Thr-197 we used a PKA mutant that does not autophosphorylate at Thr-197. The enzyme crystallized in the apo-state, and the structure was solved to 3.0 angstrom. The N-lobe is rotated by 18 relative to the wild-type apoenzyme, which illustrates that the enzyme likely exists in a wide range of conformations in solution due to the uncoupling of the N- and C-lobes. Several regions of the protein including the activation loop are disordered in the structure, and there are alternate main chain conformations for the magnesium positioning loop and catalytic loop causing a complete loss of hydrogen bonding between these two active site structural elements. These alterations are reflected in a 20-fold decrease in the apparent phosphoryl transfer rate as measured by pre-steady-state kinetic methods.	[Steichen, Jon M.; Kuchinskas, Michael; Yang, Jie; Taylor, Susan S.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Keshwani, Malik M.; Adams, Joseph A.; Taylor, Susan S.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Keshwani, Malik M.; Taylor, Susan S.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Taylor, SS (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.	staylor@ucsd.edu			National Institutes of Health [GM19301]; University of California San Diego through National Institutes of Health from the NIGMS [T32 GM007752]; Ruth L. Kirschstein National Research Service [NIH/NCI T32 CA009523]; NATIONAL CANCER INSTITUTE [T32CA009523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752, R37GM019301, R01GM019301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Diego through National Institutes of Health from the NIGMS; Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM19301 (to S. S. T.). This work was also supported by the University of California San Diego Graduate Training Program in Cellular and Molecular Pharmacology through National Institutes of Health Institutional Training Grant T32 GM007752 from the NIGMS (to J. M. S.) and by Ruth L. Kirschstein National Research Service Award NIH/NCI T32 CA009523 (to J. M. S. and M. K.).	ADAMS JA, 1995, BIOCHEMISTRY-US, V34, P2447, DOI 10.1021/bi00008a007; Adams JA, 2003, BIOCHEMISTRY-US, V42, P601, DOI 10.1021/bi020617o; Akamine P, 2003, J MOL BIOL, V327, P159, DOI 10.1016/S0022-2836(02)01446-8; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Grant BD, 1996, BIOCHEMISTRY-US, V35, P2022, DOI 10.1021/bi952144+; HERBERG FW, 1993, PROTEIN ENG, V6, P771, DOI 10.1093/protein/6.7.771; Huang X, 2003, STRUCTURE, V11, P21, DOI 10.1016/S0969-2126(02)00937-1; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Komander D, 2005, J BIOL CHEM, V280, P18797, DOI 10.1074/jbc.M500977200; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kornev AP, 2010, BBA-PROTEINS PROTEOM, V1804, P440, DOI 10.1016/j.bbapap.2009.10.017; Lee SJ, 2009, PROTEIN SCI, V18, P304, DOI 10.1002/pro.27; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moore MJ, 2002, J BIOL CHEM, V277, P47878, DOI 10.1074/jbc.M204970200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oliver AW, 2007, TRENDS BIOCHEM SCI, V32, P351, DOI 10.1016/j.tibs.2007.06.004; Oliver AW, 2006, EMBO J, V25, P3179, DOI 10.1038/sj.emboj.7601209; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Pike ACW, 2008, EMBO J, V27, P704, DOI 10.1038/emboj.2008.8; SchulzeGahmen U, 1996, J MED CHEM, V39, P4540, DOI 10.1021/jm960402a; Steichen JM, 2010, J BIOL CHEM, V285, P3825, DOI 10.1074/jbc.M109.061820; Sunami T, 2010, J BIOL CHEM, V285, P4587, DOI 10.1074/jbc.M109.040667; Wilson KP, 1996, J BIOL CHEM, V271, P27696, DOI 10.1074/jbc.271.44.27696; Yang J, 2004, J MOL BIOL, V336, P473, DOI 10.1016/j.jmb.2003.11.044; Yang J, 2005, J MOL BIOL, V346, P191, DOI 10.1016/j.jmb.2004.11.030; Yang J, 2012, J MOL BIOL, V415, P666, DOI 10.1016/j.jmb.2011.11.035; YONEMOTO W, 1993, J BIOL CHEM, V268, P18626	31	65	66	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14672	14680		10.1074/jbc.M111.335091	http://dx.doi.org/10.1074/jbc.M111.335091			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22334660	Green Published, hybrid			2022-12-25	WOS:000304003200033
J	Guiet, R; Verollet, C; Lamsoul, I; Cougoule, C; Poincloux, R; Labrousse, A; Calderwood, DA; Glogauer, M; Lutz, PG; Maridonneau-Parini, I				Guiet, Romain; Verollet, Christel; Lamsoul, Isabelle; Cougoule, Celine; Poincloux, Renaud; Labrousse, Arnaud; Calderwood, David A.; Glogauer, Michael; Lutz, Pierre G.; Maridonneau-Parini, Isabelle			Macrophage Mesenchymal Migration Requires Podosome Stabilization by Filamin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL MIGRATION; ACTIN REORGANIZATION; PLASMA-MEMBRANE; PHOSPHORYLATION; TRIGGERS; DOMAINS; BINDING; HCK; ORGANIZATION; ARCHITECTURE	Filamin A (FLNa) is a cross-linker of actin filaments and serves as a scaffold protein mostly involved in the regulation of actin polymerization. It is distributed ubiquitously, and null mutations have strong consequences on embryonic development in humans, with organ defects which suggest deficiencies in cell migration. We have reported previously that macrophages, the archetypal migratory cells, use the protease-and podosome-dependent mesenchymal migration mode in dense three-dimensional environments, whereas they use the protease- and podosome-independent amoeboid mode in more porous matrices. Because FLNa has been shown to localize to podosomes, we hypothesized that the defects seen in patients carrying FLNa mutations could be related to the capacity of certain cell types to form podosomes. Using strategies based on FLNa knock-out, knockdown, and rescue, we show that FLNa (i) is involved in podosome stability and their organization as rosettes and three-dimensional podosomes, (ii) regulates the proteolysis of the matrix mediated by podosomes in macrophages, (iii) is required for podosome rosette formation triggered by Hck, and (iv) is necessary for mesenchymal migration but dispensable for amoeboid migration. These new functions assigned to FLNa, particularly its role in mesenchymal migration, could be directly related to the defects in cell migration described during the embryonic development in FLNa-defective patients.	[Guiet, Romain; Verollet, Christel; Lamsoul, Isabelle; Cougoule, Celine; Poincloux, Renaud; Labrousse, Arnaud; Lutz, Pierre G.; Maridonneau-Parini, Isabelle] CNRS, IPBS, UMR 5089, Toulouse, France; [Guiet, Romain; Verollet, Christel; Lamsoul, Isabelle; Cougoule, Celine; Poincloux, Renaud; Labrousse, Arnaud; Lutz, Pierre G.; Maridonneau-Parini, Isabelle] Univ Toulouse 3, Univ Toulouse, IPBS, F-31077 Toulouse, France; [Calderwood, David A.] Yale Univ, Sch Med, Dept Pharmacol & Cell Biol, New Haven, CT 06520 USA; [Calderwood, David A.] Yale Univ, Sch Med, Interdept Program Vasc Biol & Therapeut, New Haven, CT 06520 USA; [Glogauer, Michael] Univ Toronto, CIHR Grp Matrix Dynam, Toronto, ON M5S 3E2, Canada	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Yale University; Yale University; University of Toronto	Maridonneau-Parini, I (corresponding author), CNRS, IPBS, UMR 5089, 205 Route Narbonne, Toulouse, France.	Isabelle.Maridonneau-Parini@ipbs.fr	Poincloux, Renaud/AAD-4746-2019; COUGOULE, Céline/ABB-4180-2021; Calderwood, David A/AAC-6954-2019; Glogauer, Michael/D-2504-2011; Maridonneau-Parini, Isabelle/F-1985-2011; Lutz, Pierre/B-8822-2009	Poincloux, Renaud/0000-0003-2884-1744; Calderwood, David A/0000-0002-0791-4142; Lutz, Pierre/0000-0003-0590-9101; Lamsoul, Isabelle/0000-0002-7769-5627; Glogauer, Michael/0000-0002-6248-5977; Verollet, Christel/0000-0002-1079-9085; Maridonneau-Parini, Isabelle/0000-0003-0189-0976; Labrousse, Arnaud/0000-0002-6525-6627	ARC [2010-120-1733, 8505]; ANR [2010-01301]; Fondation pour la Recherche Medicale; Sidaction; National Institutes of Health [GM068600]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068600] Funding Source: NIH RePORTER	ARC(Australian Research Council); ANR(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Sidaction; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by ARC 2010-120-1733, ARC Equipement 8505, and ANR 2010-01301.; Supported by Fondation pour la Recherche Medicale.; Supported by Sidaction.; Supported by National Institutes of Health Grant GM068600.	Badowski C, 2008, MOL BIOL CELL, V19, P633, DOI 10.1091/mbc.E06-01-0088; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; Camilli TC, 2011, PIGM CELL MELANOMA R, V24, P175, DOI 10.1111/j.1755-148X.2010.00792.x; Carreno S, 2000, J BIOL CHEM, V275, P36223, DOI 10.1074/jbc.M003901200; Carreno S, 2002, J BIOL CHEM, V277, P21007, DOI 10.1074/jbc.M201212200; Cejudo-Martin P, 2011, GENESIS, V49, P209, DOI 10.1002/dvg.20732; Chabadel A, 2007, MOL BIOL CELL, V18, P4899, DOI 10.1091/mbc.E07-04-0378; Cougoule C, 2005, TRAFFIC, V6, P682, DOI 10.1111/j.1600-0854.2005.00307.x; Cougoule C, 2010, BLOOD, V115, P1444, DOI 10.1182/blood-2009-04-218735; Destaing O, 2008, MOL BIOL CELL, V19, P394, DOI 10.1091/mbc.E07-03-0227; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Gawden-Bone C, 2010, J CELL SCI, V123, P1427, DOI 10.1242/jcs.056515; Gehler S, 2009, MOL BIOL CELL, V20, P3224, DOI 10.1091/mbc.E08-12-1186; Guibal FC, 2002, J BIOL CHEM, V277, P218, DOI 10.1074/jbc.M108476200; Guiet R, 2008, EUR J CELL BIOL, V87, P527, DOI 10.1016/j.ejcb.2008.03.008; Hai CM, 2002, EXP CELL RES, V280, P64, DOI 10.1006/excr.2002.5592; Heuze ML, 2008, BLOOD, V112, P5130, DOI 10.1182/blood-2007-12-128744; Huttenlocher A, 2011, COLD SPRING HARB PER, V3; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kim H, 2011, FEBS LETT, V585, P18, DOI 10.1016/j.febslet.2010.11.033; Labernadie A, 2010, P NATL ACAD SCI USA, V107, P21016, DOI 10.1073/pnas.1007835107; Lad Y, 2007, EMBO J, V26, P3993, DOI 10.1038/sj.emboj.7601827; Leung R, 2010, J BONE MINER RES, V25, P1077, DOI 10.1359/jbmr.091114; Linder S, 2011, ANNU REV CELL DEV BI, V27, P185, DOI 10.1146/annurev-cellbio-092910-154216; Liu JS, 2011, CURR NEUROL NEUROSCI, V11, P171, DOI 10.1007/s11910-010-0176-5; Lu J, 2005, EPILEPSY BEHAV, V7, P143, DOI 10.1016/j.yebeh.2005.05.001; Luxenburg C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000179; Marzia M, 2006, J BIOL CHEM, V281, P9745, DOI 10.1074/jbc.M513516200; Moreau V, 2003, MOL CELL BIOL, V23, P6809, DOI 10.1128/MCB.23.19.6809-6822.2003; Nagano T, 2004, J NEUROSCI, V24, P9648, DOI 10.1523/JNEUROSCI.2363-04.2004; Nakamura F, 2002, J BIOL CHEM, V277, P9148, DOI 10.1074/jbc.M111297200; Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Poincloux R, 2007, J CELL PHYSIOL, V213, P212, DOI 10.1002/jcp.21112; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Robertson SP, 2003, NAT GENET, V33, P487, DOI 10.1038/ng1119; Robertson SP, 2005, CURR OPIN GENET DEV, V15, P301, DOI 10.1016/j.gde.2005.04.001; Rottiers P, 2009, J CELL SCI, V122, P4311, DOI 10.1242/jcs.057448; Sanz-Moreno V, 2010, CURR OPIN CELL BIOL, V22, P690, DOI 10.1016/j.ceb.2010.08.020; Sarkisian MR, 2008, TRENDS NEUROSCI, V31, P54, DOI 10.1016/j.tins.2007.11.009; Sharma CP, 2004, CELL BIOL INT, V28, P935, DOI 10.1016/j.cellbi.2004.09.006; Takkunen M, 2010, J CELL MOL MED, V14, P1569, DOI 10.1111/j.1582-4934.2009.00868.x; Ueda K, 2003, BIOCHEM BIOPH RES CO, V301, P886, DOI 10.1016/S0006-291X(03)00048-2; Van Goethem E, 2011, EUR J CELL BIOL, V90, P224, DOI 10.1016/j.ejcb.2010.07.011; Van Goethem E, 2010, J IMMUNOL, V184, P1049, DOI 10.4049/jimmunol.0902223; Verollet C, 2011, EUR J IMMUNOL, V41, P2805, DOI 10.1002/eji.201141538; Verollet C, 2010, J IMMUNOL, V184, P7030, DOI 10.4049/jimmunol.0903345; Vincent C, 2007, J BIOL CHEM, V282, P19565, DOI 10.1074/jbc.M701501200; WRIGHT SD, 1988, P NATL ACAD SCI USA, V85, P7734, DOI 10.1073/pnas.85.20.7734; Xu YJ, 2010, J EXP MED, V207, P2421, DOI 10.1084/jem.20100433; Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001; Zhou ST, 2006, AM J PHYSIOL-CELL PH, V290, pC463, DOI 10.1152/ajpcell.00350.2005	53	61	62	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13051	13062		10.1074/jbc.M111.307124	http://dx.doi.org/10.1074/jbc.M111.307124			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22334688	Green Published, hybrid			2022-12-25	WOS:000302903700046
J	Chiba, Y; Oshima, K; Arai, H; Ishii, M; Igarashi, Y				Chiba, Yoko; Oshima, Kenro; Arai, Hiroyuki; Ishii, Masaharu; Igarashi, Yasuo			Discovery and Analysis of Cofactor-dependent Phosphoglycerate Mutase Homologs as Novel Phosphoserine Phosphatases in Hydrogenobacter thermophilus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICARBOXYLIC-ACID CYCLE; SERINE HYDROXYMETHYLTRANSFERASE; OXIDIZING BACTERIUM; BIOSYNTHESIS; PURIFICATION; PATHWAY; CDNA; METABOLISM; ALDOLASE; SEQUENCE	Phosphoserine phosphatase (PSP) catalyzes the dephosphorylation of phosphoserine to serine and inorganic phosphate. PSPs, which have been found in all three domains of life, belong to the haloacid dehalogenase-like hydrolase superfamily. However, certain organisms, particularly bacteria, lack a classical PSP gene, although they appear to possess a functional phosphoserine synthetic pathway. The apparent lack of a PSP ortholog in Hydrogenobacter thermophilus, an obligately chemolithoautotrophic and thermophilic bacterium, represented a missing link in serine anabolism because our previous study suggested that serine should be synthesized from phosphoserine. Here, we detected PSP activity in cell-free extracts of H. thermophilus and purified two proteins with PSP activity. Surprisingly, these proteins belonged to the histidine phosphatase superfamily and had been annotated as cofactor-dependent phosphoglycerate mutase (dPGM). However, because they possessed neither mutase activity nor the residues important for the activity, we defined these proteins as novel-type PSPs. Considering the strict substrate specificity toward L-phosphoserine, kinetic parameters, and PSP activity levels in cell-free extracts, these proteins were strongly suggested to function as PSPs in vivo. We also detected PSP activity from "dPGM-like" proteins of Thermus thermophilus and Arabidopsis thaliana, suggesting that PSP activity catalyzed by dPGM-like proteins may be distributed among a broad range of organisms. In fact, a number of bacterial genera, including Firmicutes and Cyanobacteria, were proposed to be strong candidates for possessing this novel type of PSP. These findings will help to identify the missing link in serine anabolism.	[Chiba, Yoko; Arai, Hiroyuki; Ishii, Masaharu; Igarashi, Yasuo] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; [Oshima, Kenro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo; University of Tokyo	Ishii, M (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	amishii@mail.ecc.u-tokyo.ac.jp		Oshima, Kenro/0000-0001-7327-4481; Chiba, Yoko/0000-0002-2734-0836	Japan Society for the Promotion of Science (JSPS) [21248010];  [23-3030]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	This work was supported in part by Grant-in-aid for Scientific Research (A) 21248010 from the Japan Society for the Promotion of Science (JSPS) and Grant-in-aid for JSPS Fellows 23-3030.	Arai H, 2010, J BACTERIOL, V192, P2651, DOI 10.1128/JB.00158-10; BARTRONS R, 1982, BIOCHIM BIOPHYS ACTA, V708, P167, DOI 10.1016/0167-4838(82)90217-5; Bourgis F, 2005, J EXP BOT, V56, P1129, DOI 10.1093/jxb/eri105; Chiba Y, 2012, FEBS J, V279, P504, DOI 10.1111/j.1742-4658.2011.08443.x; Colman B, 1997, PHYSIOL PLANTARUM, V100, P133, DOI 10.1034/j.1399-3054.1997.1000114.x; D'Alession G, 1975, Methods Enzymol, V42, P139; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Florio R, 2011, BBA-PROTEINS PROTEOM, V1814, P1489, DOI 10.1016/j.bbapap.2010.10.010; Hart CE, 2007, AM J HUM GENET, V80, P931, DOI 10.1086/517888; Helgadottir S, 2007, J BACTERIOL, V189, P575, DOI 10.1128/JB.01269-06; Hills T, 2011, MOL BIOCHEM PARASIT, V179, P69, DOI 10.1016/j.molbiopara.2011.06.001; Ho CL, 1999, J BIOL CHEM, V274, P11007, DOI 10.1074/jbc.274.16.11007; Ho CL, 2001, AMINO ACIDS, V20, P243, DOI 10.1007/s007260170042; Hugler M, 2007, ENVIRON MICROBIOL, V9, P81, DOI 10.1111/j.1462-2920.2006.01118.x; Kameya M, 2006, J BIOSCI BIOENG, V102, P311, DOI 10.1263/jbb.102.311; Kameya M, 2010, FEBS J, V277, P1876, DOI 10.1111/j.1742-4658.2010.07604.x; KAWASUMI T, 1984, INT J SYST BACTERIOL, V34, P5, DOI 10.1099/00207713-34-1-5; KAWASUMI T, 1980, AGR BIOL CHEM TOKYO, V44, P1985, DOI 10.1080/00021369.1980.10864255; Knoop H, 2010, PLANT PHYSIOL, V154, P410, DOI 10.1104/pp.110.157198; Kuznetsova E, 2006, J BIOL CHEM, V281, P36149, DOI 10.1074/jbc.M605449200; Ogawa H, 2000, INT J BIOCHEM CELL B, V32, P289, DOI 10.1016/S1357-2725(99)00113-2; Ohno S., 1970, P1; Oshima K, 2007, MOL PLANT PATHOL, V8, P481, DOI [10.1111/j.1364-3703.2007.00408.x, 10.1111/J.1364-3703.2007.00408.X]; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Rigden DJ, 2008, BIOCHEM J, V409, P333, DOI 10.1042/BJ20071097; Rigden DJ, 2001, PROTEIN SCI, V10, P1835, DOI 10.1110/ps.15701; Rigden DJ, 1999, J MOL BIOL, V286, P1507, DOI 10.1006/jmbi.1999.2566; Seki M, 1998, PLANT J, V15, P707, DOI 10.1046/j.1365-313x.1998.00237.x; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Shapiro B., 1970, METHOD ENZYMOL, V17A, P910, DOI 10.1016/0076-6879(71)17305-3; SHIBA H, 1985, ARCH MICROBIOL, V141, P198, DOI 10.1007/BF00408058; SNELL K, 1984, ADV ENZYME REGUL, V22, P325, DOI 10.1016/0065-2571(84)90021-9; Suzuki M, 2001, ARCH MICROBIOL, V175, P75, DOI 10.1007/s002030000230; Szebenyi DME, 2004, BIOCHEMISTRY-US, V43, P6865, DOI 10.1021/bi049791y; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thaller MC, 1997, FEMS MICROBIOL LETT, V146, P191, DOI 10.1016/S0378-1097(96)00474-0; VEERANNA, 1990, NEUROCHEM RES, V15, P1203, DOI 10.1007/BF01208581; Wang WR, 2002, J MOL BIOL, V319, P421, DOI 10.1016/S0022-2836(02)00324-8; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yokoyama S, 2000, NAT STRUCT BIOL, V7, P943, DOI 10.1038/80712	40	20	23	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11934	11941		10.1074/jbc.M111.330621	http://dx.doi.org/10.1074/jbc.M111.330621			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22337887	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000302782200032
J	Stewart, AP; Gomez-Posada, JC; McGeorge, J; Rouhani, MJ; Villarroel, A; Murrell-Lagnado, RD; Edwardson, JM				Stewart, Andrew P.; Camilo Gomez-Posada, Juan; McGeorge, Jessica; Rouhani, Maral J.; Villarroel, Alvaro; Murrell-Lagnado, Ruth D.; Edwardson, J. Michael			The Kv7.2/Kv7.3 Heterotetramer Assembles with a Random Subunit Arrangement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORCE MICROSCOPY REVEALS; KCNQ2/KCNQ3 POTASSIUM CHANNELS; K+ CHANNELS; STOICHIOMETRY; DOMAIN; EXPRESSION; KCNQ2; RECEPTORS; RESIDUE	Voltage-gated K+ channels composed of Kv7.2 and Kv7.3 are the predominant contributors to the M-current, which plays a key role in controlling neuronal activity. Various lines of evidence have indicated that Kv7.2 and Kv7.3 form a heteromeric channel. However, the subunit stoichiometry and arrangement within this putative heteromer are so far unknown. Here, we have addressed this question using atomic force microscopy imaging of complexes between isolated Kv7.2/Kv7.3 channels and antibodies to epitope tags on the two subunits, Myc on Kv7.2 and HA on Kv7.3. Initially, tsA 201 cells were transiently transfected with equal amounts of cDNA for the two subunits. The heteromer was isolated through binding of either tag to immunoaffinity beads and then decorated with antibodies to the other tag. In both cases, the distribution of angles between pairs of bound antibodies had two peaks, at around 90 and around 180, and in both cases the 90 peak was about double the size of the 180 peak. These results indicate that the Kv7.2/Kv7.3 heteromer generated by cells expressing approximately equal amounts of the two subunits assembles as a tetramer with a predominantly 2: 2 subunit stoichiometry and with a random subunit arrangement. When the DNA ratio for the two subunits was varied, copurification experiments indicated that the subunit stoichiometry was variable and not fixed at 2:2. Hence, there are no constraints on either the subunit stoichiometry or the subunit arrangement.	[Stewart, Andrew P.; McGeorge, Jessica; Rouhani, Maral J.; Murrell-Lagnado, Ruth D.; Edwardson, J. Michael] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Camilo Gomez-Posada, Juan; Villarroel, Alvaro] Univ Basque Country, Ctr Mixto, Unidad Biofis, CSIC, Leioa 48940, Spain	University of Cambridge; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika	Edwardson, JM (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	jme1000@cam.ac.uk	Villarroel, Alvaro/H-5580-2015	Murrell-Lagnado, Ruth/0000-0003-2743-7977	Jean Shanks Foundation; University of Cambridge; Department of Education, Universities, and Investigation of the Basque Government; Biotechnology and Biological Sciences Research Council; European Molecular Biology Organization	Jean Shanks Foundation; University of Cambridge(University of Cambridge); Department of Education, Universities, and Investigation of the Basque Government; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	* This work was supported by the Jean Shanks Foundation and the James Baird Fund of the University of Cambridge (to A. P. S.); the Department of Education, Universities, and Investigation of the Basque Government (to J. C. G. P.); and the Biotechnology and Biological Sciences Research Council (to R. D. M. L. and J. M. E.).; <SUP>2</SUP> Recipient of a European Molecular Biology Organization short-term fellowship.	Antonio LS, 2011, BRIT J PHARMACOL, V163, P1069, DOI 10.1111/j.1476-5381.2011.01303.x; Bal M, 2008, J BIOL CHEM, V283, P30668, DOI 10.1074/jbc.M805216200; Barrera NP, 2008, MOL PHARMACOL, V73, P960, DOI 10.1124/mol.107.042481; Barrera NP, 2005, P NATL ACAD SCI USA, V102, P12595, DOI 10.1073/pnas.0503253102; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Gomez-Posada JC, 2010, J NEUROSCI, V30, P9316, DOI 10.1523/JNEUROSCI.0851-10.2010; Etxeberria A, 2008, FASEB J, V22, P1135, DOI 10.1096/fj.07-9712com; Feng S, 2008, J BIOL CHEM, V283, P28471, DOI 10.1074/jbc.M803834200; Feng S, 2011, J BIOL CHEM, V286, P18994, DOI 10.1074/jbc.M110.192286; Giamarchi A, 2010, EMBO J, V29, P1176, DOI 10.1038/emboj.2010.18; Hadley JK, 2003, J NEUROSCI, V23, P5012; Howard RJ, 2007, NEURON, V53, P663, DOI 10.1016/j.neuron.2007.02.010; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Kobori T, 2009, J BIOL CHEM, V284, P35507, DOI 10.1074/jbc.M109.060228; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Maljevic S, 2003, J PHYSIOL-LONDON, V548, P353, DOI 10.1113/jphysiol.2003.040980; Maljevic S, 2008, J PHYSIOL-LONDON, V586, P1791, DOI 10.1113/jphysiol.2008.150656; Nakajo K, 2008, J PHYSIOL-LONDON, V586, P2827, DOI 10.1113/jphysiol.2007.148601; Prole DL, 2004, BIOPHYS J, V86, P1454, DOI 10.1016/S0006-3495(04)74214-9; Schneider SW, 1998, PFLUG ARCH EUR J PHY, V435, P362, DOI 10.1007/s004240050524; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Schwake M, 2006, J NEUROSCI, V26, P3757, DOI 10.1523/JNEUROSCI.5017-05.2006; Schwake M, 2000, J BIOL CHEM, V275, P13343, DOI 10.1074/jbc.275.18.13343; Schwake M, 2003, EMBO REP, V4, P76, DOI 10.1038/sj.embor.embor715; SCOTT DW, 1979, BIOMETRIKA, V66, P605, DOI 10.1093/biomet/66.3.605; Selyanko AA, 2001, J PHYSIOL-LONDON, V534, P15, DOI 10.1111/j.1469-7793.2001.00015.x; Shah MM, 2002, J PHYSIOL-LONDON, V544, P29, DOI 10.1113/jphysiol.2002.028571; Shapiro MS, 2000, J NEUROSCI, V20, P1710; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stewart AP, 2010, BIOPHYS J, V99, P790, DOI 10.1016/j.bpj.2010.05.012; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Yang WP, 1998, J BIOL CHEM, V273, P19419, DOI 10.1074/jbc.273.31.19419	35	19	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11870	11877		10.1074/jbc.M111.336511	http://dx.doi.org/10.1074/jbc.M111.336511			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334706	Green Published, hybrid			2022-12-25	WOS:000302782200026
J	Chiarelli, LR; Morera, SM; Bianchi, P; Fermo, E; Zanella, A; Galizzi, A; Valentini, G				Chiarelli, Laurent R.; Morera, Simone M.; Bianchi, Paola; Fermo, Elisa; Zanella, Alberto; Galizzi, Alessandro; Valentini, Giovanna			Molecular Insights on Pathogenic Effects of Mutations Causing Phosphoglycerate Kinase Deficiency	PLOS ONE			English	Article							CHRONIC HEMOLYTIC-ANEMIA; HUMAN 3-PHOSPHOGLYCERATE KINASE; MYOPATHIC FORM; NEUROLOGICAL DYSFUNCTION; NUCLEOSIDE ANALOGS; MISSENSE MUTATION; PGK DEFICIENCY; VARIANT; ENZYME; GENE	Phosphoglycerate kinase (PGK) catalyzes an important ATP-generating step in glycolysis. PGK1 deficiency is an uncommon X-linked inherited disorder, generally characterized by various combinations of non-spherocytic hemolytic anemia, neurological dysfunctions, and myopathies. Patients rarely exhibit all three clinical features. To provide a molecular framework to the different pathological manifestations, all known mutations were reviewed and 16 mutant enzymes, obtained as recombinant forms, were functionally and structurally characterized. Most mutations heavily affect thermal stability and to a different extent catalytic efficiency, in line with the remarkably low PGK activity clinically observed in the patients. Mutations grossly impairing protein stability, but moderately affecting kinetic properties (p.I47N, p.L89P, p.C316R, p.S320N, and p.A354P) present the most homogeneous correlation with the clinical phenotype. Patients carrying these mutations display hemolytic anemia and neurological disorders, and, except for p.A354P variant, no myopaty. Variants highly perturbed in both catalytic efficiency (p.G158V, p.D164V, p.K191del, D285V, p.D315N, and p.T378P) and heat stability (all, but p.T378P) result to be mainly associated with myopathy alone. Finally, mutations faintly affecting molecular properties (p.R206P, p.E252A, p.I253T, p.V266M, and p.D268N) correlate with a wide spectrum of clinical symptoms. These are the first studies that correlate the clinical symptoms with the molecular properties of the mutant enzymes. All findings indicate that the different clinical manifestations associated with PGK1 deficiency chiefly depend on the distinctive type of perturbations caused by mutations in the PGK1 gene, highlighting the need for determination of the molecular properties of PGK variants to assist in prognosis and genetic counseling. However, the clinical symptoms can not be understood only on the bases of molecular properties of the mutant enzyme. Different (environmental, metabolic, genetic and/or epigenetic) intervening factors can contribute toward the expression of PGK deficient clinical phenotypes.	[Chiarelli, Laurent R.; Morera, Simone M.; Galizzi, Alessandro; Valentini, Giovanna] Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, I-27100 Pavia, Italy; [Bianchi, Paola; Fermo, Elisa; Zanella, Alberto] Fdn IRCCS Ca Granda Osped Maggiore Policlin, UO Ematol 2, Milan, Italy	University of Pavia; IRCCS Ca Granda Ospedale Maggiore Policlinico	Chiarelli, LR (corresponding author), Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, Via Palestro 3, I-27100 Pavia, Italy.	giovale@unipv.it	Chiarelli, Laurent Roberto/J-8368-2016; Fermo, Elisa/K-2282-2015; Bianchi, Paola/L-2531-2016	Chiarelli, Laurent Roberto/0000-0003-0348-9764; Fermo, Elisa/0000-0003-2812-8711; Bianchi, Paola/0000-0001-5976-5233	University of Pavia "Fondi per la Ricerca di Ateneo"	University of Pavia "Fondi per la Ricerca di Ateneo"	This study was supported by grants from the University of Pavia "Fondi per la Ricerca di Ateneo." The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasly J, 2000, EUR J NEUROL, V7, P111, DOI 10.1046/j.1468-1331.2000.00012.x; BEUTLER E, 1977, BRIT J HAEMATOL, V35, P331, DOI 10.1111/j.1365-2141.1977.tb00589.x; Beutler E, 2007, BRIT J HAEMATOL, V136, P3, DOI 10.1111/j.1365-2141.2006.06351.x; Cliff MJ, 2010, J AM CHEM SOC, V132, P6507, DOI 10.1021/ja100974t; COHENSOLAL M, 1994, BLOOD, V84, P898, DOI 10.1182/blood.V84.3.898.bloodjournal843898; Flanagan JM, 2006, BRIT J HAEMATOL, V134, P233, DOI 10.1111/j.1365-2141.2006.06143.x; FUJII H, 1980, J BIOL CHEM, V255, P6421; FUJII H, 1992, BLOOD, V79, P1582; FUJII H, 1981, P NATL ACAD SCI-BIOL, V78, P2587, DOI 10.1073/pnas.78.4.2587; FUJII H, 1980, P NATL ACAD SCI-BIOL, V77, P5461, DOI 10.1073/pnas.77.9.5461; Gallois-Montbrun S, 2004, BIOCHEM PHARMACOL, V68, P1749, DOI 10.1016/j.bcp.2004.06.012; Gondeau C, 2008, NUCLEIC ACIDS RES, V36, P3620, DOI 10.1093/nar/gkn212; Goossens M, 1981, Methods Enzymol, V76, P805; Hamano T, 2000, NEUROLOGY, V54, P1188, DOI 10.1212/WNL.54.5.1188; HJELM M, 1980, J LAB CLIN MED, V96, P1015; JINDAL HK, 1990, J BIOL CHEM, V265, P6540; Ramirez-Bajo MJ, 2011, BLOOD CELL MOL DIS, V46, P206, DOI 10.1016/j.bcmd.2010.12.009; KRAUS AP, 1968, BIOCHEM BIOPH RES CO, V30, P173, DOI 10.1016/0006-291X(68)90466-X; KRIETSCH WKG, 1980, AM J HUM GENET, V32, P364; Krishnan P, 2003, J BIOL CHEM, V278, P36726, DOI 10.1074/jbc.M307052200; Krustrup P, 2003, J PHYSIOL-LONDON, V549, P255, DOI 10.1113/jphysiol.2002.035089; Kugler W, 2000, HUM MUTAT, V15, P261, DOI 10.1002/(SICI)1098-1004(200003)15:3<261::AID-HUMU7>3.0.CO;2-T; LARSSONR.M, 1967, BIOCHIM BIOPHYS ACTA, V132, P33, DOI 10.1016/0005-2744(67)90189-1; Lay AJ, 2000, NATURE, V408, P869, DOI 10.1038/35048596; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAEDA M, 1991, BLOOD, V77, P1348; MAEDA M, 1992, BLOOD, V79, P2759; MCCARREY JR, 1987, NATURE, V326, P501, DOI 10.1038/326501a0; MICHELSON AM, 1985, P NATL ACAD SCI USA, V82, P6965, DOI 10.1073/pnas.82.20.6965; Morimoto A, 2003, BRIT J HAEMATOL, V122, P1009, DOI 10.1046/j.1365-2141.2003.04543.x; Noel N, 2006, BRIT J HAEMATOL, V132, P523, DOI 10.1111/j.1365-2141.2005.05882.x; Ookawara T, 1996, ARCH BIOCHEM BIOPHYS, V327, P35, DOI 10.1006/abbi.1996.0089; Palmai Z, 2009, PROTEINS, V77, P319, DOI 10.1002/prot.22437; Rhodes M, 2011, BRIT J HAEMATOL, V152, P500, DOI 10.1111/j.1365-2141.2010.08474.x; SCOPES RK, 1978, EUR J BIOCHEM, V85, P503, DOI 10.1111/j.1432-1033.1978.tb12266.x; Shichijo S, 2004, CLIN CANCER RES, V10, P5828, DOI 10.1158/1078-0432.CCR-04-0350; Shirakawa K, 2006, NEUROLOGY, V66, P925, DOI 10.1212/01.wnl.0000203500.63884.39; Sotiriou E, 2010, MUSCLE NERVE, V41, P707, DOI 10.1002/mus.21612; Spiegel R, 2009, NEUROMUSCULAR DISORD, V19, P207, DOI 10.1016/j.nmd.2008.12.004; Sugie H, 1998, J CHILD NEUROL, V13, P95, DOI 10.1177/088307389801300212; Svaasand EK, 2007, MUSCLE NERVE, V36, P679, DOI 10.1002/mus.20859; SVIRKLYS LG, 1986, J INHERIT METAB DIS, V9, P374, DOI 10.1007/BF01800488; Szilagyi AN, 1998, BIOCHEMISTRY-US, V37, P8551, DOI 10.1021/bi973072k; Tabatabaie L, 2010, MOL GENET METAB, V99, P256, DOI 10.1016/j.ymgme.2009.10.012; TSUJINO S, 1994, ANN NEUROL, V35, P349, DOI 10.1002/ana.410350316; TURNER G, 1995, BRIT J HAEMATOL, V91, P60, DOI 10.1111/j.1365-2141.1995.tb05245.x; Valentin C, 1998, HUM MUTAT, V12, P280, DOI 10.1002/(SICI)1098-1004(1998)12:4<280::AID-HUMU10>3.3.CO;2-Z; van Wijk R, 2005, BLOOD, V106, P4034, DOI 10.1182/blood-2005-04-1622; Vas M, 2010, CURR PROTEIN PEPT SC, V11, P118, DOI 10.2174/138920310790848403; WILLARD HF, 1985, HUM GENET, V71, P138; Yoshida A, 1995, BLOOD CELL MOL DIS, V21, P179, DOI 10.1006/bcmd.1995.0020; Zerrad L, 2011, J BIOL CHEM, V286, P14040, DOI 10.1074/jbc.M110.206813	52	49	50	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e32065	10.1371/journal.pone.0032065	http://dx.doi.org/10.1371/journal.pone.0032065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348148	Green Published, Green Submitted, gold			2022-12-25	WOS:000302737400062
J	Cleland, TP; Voegele, K; Schweitzer, MH				Cleland, Timothy P.; Voegele, Kristyn; Schweitzer, Mary H.			Empirical Evaluation of Bone Extraction Protocols	PLOS ONE			English	Article							PROTEIN SEQUENCES; OSTEOCALCIN PROTEIN; ACID RACEMIZATION; MASS SPECTROMETRY; MATRIX PROTEINS; SOFT-TISSUE; FOSSIL BONE; COLLAGEN; ELECTROPHORESIS; IDENTIFICATION	The application of high-resolution analytical techniques to characterize ancient bone proteins requires clean, efficient extraction to obtain high quality data. Here, we evaluated many different protocols from the literature on ostrich cortical bone and moa cortical bone to evaluate their yield and relative purity using the identification of antibody-antigen complexes on enzyme-linked immunosorbent assay and gel electrophoresis. Moa bone provided an ancient comparison for the effectiveness of bone extraction protocols tested on ostrich bone. For the immunological part of this study, we focused on collagen I, osteocalcin, and hemoglobin because collagen and osteocalcin are the most abundant proteins in the mineralized extracellular matrix and hemoglobin is common in the vasculature. Most of these procedures demineralize the bone first, and then the remaining organics are chemically extracted. We found that the use of hydrochloric acid, rather than ethylenediaminetetraacetic acid, for demineralization resulted in the cleanest extractions because the acid was easily removed. In contrast, the use of ethylenediaminetetraacetic acid resulted in smearing upon electrophoretic separation, possibly indicating these samples were not as pure. The denaturing agents sodium dodecyl sulfate, urea, and guanidine HCl have been used extensively for the solubilization of proteins in non-biomineralized tissue, but only the latter has been used on bone. We show that all three denaturing agents are effective for extracting bone proteins. One additional method tested uses ammonium bicarbonate as a solubilizing buffer that is more appropriate for post-extraction analyses (e.g., proteomics) by removing the need for desalting. We found that both guanidine HCl and ammonium bicarbonate were effective for extracting many bone proteins, resulting in similar electrophoretic patterns. With the increasing use of proteomics, a new generation of scientists are now interested in the study of proteins from not only extant bone but also from ancient bone.	[Cleland, Timothy P.; Schweitzer, Mary H.] N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Raleigh, NC 27695 USA; [Schweitzer, Mary H.] US Amer Coll, N Carolina Museum Nat Sci, Moorhead, MN USA	University of North Carolina; North Carolina State University	Cleland, TP (corresponding author), N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Box 8208, Raleigh, NC 27695 USA.	tpclelan@ncsu.edu	schweitzer, mary h/A-6756-2010; Cleland, Timothy/ABE-8424-2021; Cleland, Timothy/P-9960-2019; Cleland, Timothy/A-6754-2010; Schweitzer, Mary/V-8143-2019	schweitzer, mary h/0000-0002-0427-3829; Cleland, Timothy/0000-0001-9198-2828; Cleland, Timothy/0000-0001-9198-2828; Cleland, Timothy/0000-0001-9198-2828; 	National Science Foundation [DGE-0750733, EAR 0541744]; David and Lucille Packard Foundation	National Science Foundation(National Science Foundation (NSF)); David and Lucille Packard Foundation(The David & Lucile Packard Foundation)	This research was funded by the National Science Foundation (http://www.nsf.gov) (DGE-0750733 to TPC and EAR 0541744 to MHS) and the David and Lucille Packard Foundation (http://www.packard.org/) to MHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annesley TM, 2003, CLIN CHEM, V49, P1041, DOI 10.1373/49.7.1041; Asara JM, 2007, SCIENCE, V316, P280, DOI 10.1126/science.1137614; BADA JL, 1985, ANNU REV EARTH PL SC, V13, P241; Borja C, 1997, AM J PHYS ANTHROPOL, V103, P433, DOI 10.1002/(SICI)1096-8644(199708)103:4<433::AID-AJPA1>3.0.CO;2-O; Buckley M, 2011, GEOCHIM COSMOCHIM AC, V75, P2007, DOI 10.1016/j.gca.2011.01.022; Buckley M, 2008, J ARCHAEOL SCI, V35, P1756, DOI 10.1016/j.jas.2007.11.022; Buckley M, 2009, RAPID COMMUN MASS SP, V23, P3843, DOI 10.1002/rcm.4316; Buckley M, 2008, SCIENCE, V319, DOI 10.1126/science.1147046; Buckley M, 2010, J ARCHAEOL SCI, V37, P13, DOI 10.1016/j.jas.2009.08.020; Chen EI, 2007, J PROTEOME RES, V6, P2529, DOI 10.1021/pr060682a; CHILD AM, 1992, J ARCHAEOL SCI, V19, P39, DOI 10.1016/0305-4403(92)90005-N; Clementz MT, 2009, GEOL J, V44, P605, DOI 10.1002/gj.1173; Collins M., 1998, ANCIENT BIOMOLECULES, V2, P209; Collins MJ, 2000, GEOLOGY, V28, P1139, DOI 10.1130/0091-7613(2000)28<1139:SRODOO>2.0.CO;2; Collins MJ, 2002, ARCHAEOMETRY, V44, P383, DOI 10.1111/1475-4754.t01-1-00071; COLLINS MJ, 1995, J ARCHAEOL SCI, V22, P175, DOI 10.1006/jasc.1995.0019; Craig OE, 2002, J ARCHAEOL SCI, V29, P1077, DOI 10.1006/jasc.2001.0757; Daamen WF, 2001, BIOMATERIALS, V22, P1997, DOI 10.1016/S0142-9612(00)00383-5; Dobberstein RC, 2009, ARCHAEOL ANTHROP SCI, V1, P31, DOI 10.1007/s12520-009-0002-7; Embery G, 2003, CONNECT TISSUE RES, V44, P41, DOI 10.1080/03008200390152070; Fountoulakis M, 1998, J CHROMATOGR A, V826, P109, DOI 10.1016/S0021-9673(98)00721-3; FRANZEN A, 1985, BIOCHEM J, V232, P715, DOI 10.1042/bj2320715; FRANZEN A, 1984, BIOCHEM J, V224, P47, DOI 10.1042/bj2240047; Fridriksson EK, 1999, J AM SOC MASS SPECTR, V10, P453, DOI 10.1016/S1044-0305(99)00012-4; Germonpre M, 2009, J ARCHAEOL SCI, V36, P473, DOI 10.1016/j.jas.2008.09.033; GERSTENFELD LC, 1994, CALCIFIED TISSUE INT, V55, P230, DOI 10.1007/BF00425880; GREENE RF, 1974, J BIOL CHEM, V249, P5388; GURLEY LR, 1991, J PROTEIN CHEM, V10, P75, DOI 10.1007/BF01024658; HEDGES REM, 1995, J ARCHAEOL SCI, V22, P201, DOI 10.1006/jasc.1995.0022; HELFMAN PM, 1975, P NATL ACAD SCI USA, V72, P2891, DOI 10.1073/pnas.72.8.2891; Humpula JF, 2007, GEOCHIM COSMOCHIM AC, V71, P5956, DOI 10.1016/j.gca.2007.09.003; Jiang XG, 2007, J PROTEOME RES, V6, P2287, DOI 10.1021/pr070056t; Lecuyer C, 2003, PALAEOGEOGR PALAEOCL, V193, P457, DOI 10.1016/S0031-0182(03)00261-X; LOWENSTEIN JM, 1981, NATURE, V291, P409, DOI 10.1038/291409a0; LOWENSTEIN JM, 1981, PHILOS T ROY SOC B, V292, P143, DOI 10.1098/rstb.1981.0022; LOWENSTEIN JM, 1991, PHILOS T ROY SOC B, V333, P375, DOI 10.1098/rstb.1991.0087; LOWENSTEIN JM, 1985, EXPERIENTIA, V41, P1192, DOI 10.1007/BF01951724; McCarthy J, 2003, J PROTEOME RES, V2, P239, DOI 10.1021/pr025564b; Nielsen-Marsh CM, 2005, P NATL ACAD SCI USA, V102, P4409, DOI 10.1073/pnas.0500450102; Nielsen-Marsh CM, 2002, GEOLOGY, V30, P1099, DOI 10.1130/0091-7613(2002)030<1099:SPOOPA>2.0.CO;2; Organ CL, 2008, SCIENCE, V320, P499, DOI 10.1126/science.1154284; Ostrom PH, 2000, GEOCHIM COSMOCHIM AC, V64, P1043, DOI 10.1016/S0016-7037(99)00381-6; PEPINSKY RB, 1991, ANAL BIOCHEM, V195, P177, DOI 10.1016/0003-2697(91)90315-K; Prigodich RV, 1997, ARCH BIOCHEM BIOPHYS, V345, P339, DOI 10.1006/abbi.1997.0254; Rabilloud T, 1998, ELECTROPHORESIS, V19, P758, DOI 10.1002/elps.1150190526; RAINEY WE, 1984, NATURWISSENSCHAFTEN, V71, P586, DOI 10.1007/BF01189187; Richter KK, 2011, J ARCHAEOL SCI, V38, P1502, DOI 10.1016/j.jas.2011.02.014; Rutherfurd SM, 2001, AMINO ACID ANAL; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schreiweis MA, 2007, J CELL BIOCHEM, V101, P466, DOI 10.1002/jcb.21196; Schweitzer MH, 2009, SCIENCE, V324, P626, DOI 10.1126/science.1165069; Schweitzer MH, 2008, CR PALEVOL, V7, P159, DOI 10.1016/j.crpv.2008.02.005; Schweitzer MH, 2007, SCIENCE, V316, P277, DOI 10.1126/science.1138709; Schweitzer MH, 2007, P ROY SOC B-BIOL SCI, V274, P183, DOI 10.1098/rspb.2006.3705; Schweitzer MH, 2002, J MOL EVOL, V55, P696, DOI 10.1007/s00239-002-2365-6; SEMAL P, 1995, J ARCHAEOL SCI, V22, P463, DOI 10.1006/jasc.1995.0045; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SHOSHANI J, 1985, PALEOBIOLOGY, V11, P429, DOI 10.1017/S0094837300011714; Simo C, 2003, ELECTROPHORESIS, V24, P834, DOI 10.1002/elps.200390105; TERMINE JD, 1981, J BIOL CHEM, V256, P403; TERMINE JD, 1980, J BIOL CHEM, V255, P9760; Trueman CN, 2002, ARCHAEOMETRY, V44, P371, DOI 10.1111/1475-4754.t01-1-00070; Tuross N, 2002, ARCHAEOMETRY, V44, P427, DOI 10.1111/1475-4754.00075; TUROSS N, 1988, GEOCHIM COSMOCHIM AC, V52, P929, DOI 10.1016/0016-7037(88)90364-X; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; WENDEL M, 1995, J BIOL CHEM, V270, P6125, DOI 10.1074/jbc.270.11.6125; Wendel M, 1998, J CELL BIOL, V141, P839, DOI 10.1083/jcb.141.3.839; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Zylberberg L, 2004, CR PALEVOL, V3, P591, DOI 10.1016/j.crpv.2004.07.012	69	43	43	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31443	10.1371/journal.pone.0031443	http://dx.doi.org/10.1371/journal.pone.0031443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348088	Green Published, gold, Green Submitted			2022-12-25	WOS:000302737400024
J	Edelman, AJ				Edelman, Andrew J.			Positive Interactions between Desert Granivores: Localized Facilitation of Harvester Ants by Kangaroo Rats	PLOS ONE			English	Article							CHIHUAHUAN-DESERT; POGONOMYRMEX-RUGOSUS; DIPODOMYS-SPECTABILIS; SPATIAL-DISTRIBUTION; COMMUNITY STRUCTURE; NEW-MEXICO; MOUNDS; COMPETITION; RODENTS; SCALE	Facilitation, when one species enhances the environment or performance of another species, can be highly localized in space. While facilitation in plant communities has been intensely studied, the role of facilitation in shaping animal communities is less well understood. In the Chihuahuan Desert, both kangaroo rats and harvester ants depend on the abundant seeds of annual plants. Kangaroo rats, however, are hypothesized to facilitate harvester ants through soil disturbance and selective seed predation rather than competing with them. I used a spatially explicit approach to examine whether a positive or negative interaction exists between banner-tailed kangaroo rat (Dipodomys spectabilis) mounds and rough harvester ant (Pogonomyrmex rugosus) colonies. The presence of a scale-dependent interaction between mounds and colonies was tested by comparing fitted spatial point process models with and without interspecific effects. Also, the effect of proximity to a mound on colony mortality and spatial patterns of surviving colonies was examined. The spatial pattern of kangaroo rat mounds and harvester ant colonies was consistent with a positive interspecific interaction at small scales (<10 m). Mortality risk of vulnerable, recently founded harvester ant colonies was lower when located close to a kangaroo rat mound and proximity to a mound partly predicted the spatial pattern of surviving colonies. My findings support localized facilitation of harvester ants by kangaroo rats, likely mediated through ecosystem engineering and foraging effects on plant cover and composition. The scale-dependent effect of kangaroo rats on abiotic and biotic factors appears to result in greater founding and survivorship of young colonies near mounds. These results suggest that soil disturbance and foraging by rodents can have subtle impacts on the distribution and demography of other species.	[Edelman, Andrew J.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	University of New Mexico	Edelman, AJ (corresponding author), Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA.	aedelman@uwyo.edu	Edelman, Andrew J/C-2810-2012	Edelman, Andrew J/0000-0002-7980-9739	Sevilleta Long Term Ecological Research Site Graduate Student Summer Grant; American Society of Mammalogists Shadle; Southwestern Association of Naturalists; T E, Inc.	Sevilleta Long Term Ecological Research Site Graduate Student Summer Grant; American Society of Mammalogists Shadle; Southwestern Association of Naturalists; T E, Inc.	This research was funded by the Sevilleta Long Term Ecological Research Site Graduate Student Summer Grant, American Society of Mammalogists Shadle Fellowship and Grant-in-Aid, Southwestern Association of Naturalists Howard McCarley Student Research Award, T & E, Inc. Grant for Conservation Biology Research, National Science Foundation Teaching Fellowship in K-12 Education, and the University of New Mexico Gaudin Scholarship in Mammalogy, Grove Summer Scholarship, Student Research Allocation Committee Research Grant, Biology Graduate Student Organization Research Grant, Graduate Research Development Fund, Regents' Graduate Fellowship, and Biocomplexity Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, 2005, J R STAT SOC B, V67, P617, DOI 10.1111/j.1467-9868.2005.00519.x; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Baddeley A, 2006, LECT NOTES STAT, V185, P23, DOI DOI 10.1007/0-387-31144-0_2; Bronstein JL, 2009, J ECOL, V97, P1160, DOI 10.1111/j.1365-2745.2009.01566.x; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Brown JH, 1997, P NATL ACAD SCI USA, V94, P9729, DOI 10.1073/pnas.94.18.9729; BROWN JH, 1977, SCIENCE, V196, P880, DOI 10.1126/science.196.4292.880; BROWN JH, 1979, ANNU REV ECOL SYST, V10, P201, DOI 10.1146/annurev.es.10.110179.001221; Brown JH, 2001, SCIENCE, V293, P643, DOI 10.1126/science.293.5530.643; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; CHEW RM, 1992, J ARID ENVIRON, V22, P375, DOI 10.1016/S0140-1963(18)30580-9; Davidson AD, 2007, ECOGRAPHY, V30, P515, DOI 10.1111/j.0906-7590.2007.05032.x; DAVIDSON DW, 1977, ECOLOGY, V58, P711, DOI 10.2307/1936208; DAVIDSON DW, 1984, ECOLOGY, V65, P1780, DOI 10.2307/1937774; DAVIDSON DW, 1977, ECOLOGY, V58, P725, DOI 10.2307/1936209; DAVIDSON DW, 1985, ECOLOGY, V66, P486, DOI 10.2307/1940397; De la Cruz M., 2008, INTRO ANALISIS ESPAC, P76; Edelman AJ, 2011, ETHOLOGY, V117, P430, DOI 10.1111/j.1439-0310.2011.01890.x; Fortin MJ., 2005, SPATIAL ANAL GUIDE E, P365, DOI [10.1017/CBO9780511542039, DOI 10.1017/CBO9780511542039]; GORDON DM, 1992, ANN ENTOMOL SOC AM, V85, P44, DOI 10.1093/aesa/85.1.44; Gordon DM, 1998, J ANIM ECOL, V67, P141, DOI 10.1046/j.1365-2656.1998.00169.x; Gordon DM, 1996, ECOLOGY, V77, P2393, DOI 10.2307/2265741; GORDON DM, 1995, ANIM BEHAV, V49, P649, DOI 10.1016/0003-3472(95)80198-7; Guo QF, 1996, OECOLOGIA, V106, P247, DOI 10.1007/BF00328605; HESKE EJ, 1993, OECOLOGIA, V95, P520, DOI 10.1007/BF00317436; Holdenried R., 1957, Journal of Mammalogy, V38, P330, DOI 10.2307/1376232; HOLLDOBLER B, 1976, BEHAV ECOL SOCIOBIOL, V1, P3, DOI 10.1007/BF00299951; Illian J, 2008, STAT ANAL MODELLING; INOUYE RS, 1980, ECOLOGY, V61, P1344, DOI 10.2307/1939043; Johnson RA, 1998, INSECT SOC, V45, P255, DOI 10.1007/s000400050086; Johnson RA, 2000, ECOL ENTOMOL, V25, P403, DOI 10.1046/j.1365-2311.2000.00286.x; Johnson RA, 2001, ANNU REV ENTOMOL, V46, P1, DOI 10.1146/annurev.ento.46.1.1; Koontz TL, 2010, J ARID ENVIRON, V74, P1156, DOI 10.1016/j.jaridenv.2010.03.008; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Olano JM, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest:2008074; MOORHEAD DL, 1988, AM MIDL NAT, V120, P443, DOI 10.2307/2426018; MOROKA N, 1982, J RANGE MANAGE, V35, P707, DOI 10.2307/3898244; Parmenter Robert R., 1995, P196; Perry GLW, 2008, J VEG SCI, V19, P705, DOI 10.3170/2008-8-18441; REICHMAN OJ, 1985, J MAMMAL, V66, P643, DOI 10.2307/1380790; RISSING SW, 1988, ECOLOGY, V69, P809, DOI 10.2307/1941030; SAMSON DA, 1992, OIKOS, V65, P61, DOI 10.2307/3544888; Schooley RL, 2000, OECOLOGIA, V125, P142, DOI 10.1007/PL00008885; Schooley RL, 2003, J ARID ENVIRON, V53, P183, DOI 10.1006/jare.2002.1037; Schooley RL, 2001, LANDSCAPE ECOL, V16, P267, DOI 10.1023/A:1011122218548; SCHRODER GD, 1975, J MAMMAL, V56, P363, DOI 10.2307/1379366; SCHRODER GD, 1979, ECOLOGY, V60, P657, DOI 10.2307/1936601; Stoyan D, 2000, STAT SCI, V15, P61; VALONE TJ, 1994, ECOLOGY, V75, P252, DOI 10.2307/1939400; Vorhies CT, 1922, US DEP AGRIC B, V1091, P1; WHITFORD WG, 1976, INSECT SOC, V23, P117, DOI 10.1007/BF02223846; WIERNASZ DC, 1995, J ANIM ECOL, V64, P519, DOI 10.2307/5654; Woods KD, 2000, ECOLOGY, V81, P110, DOI 10.2307/177138	54	13	13	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e30914	10.1371/journal.pone.0030914	http://dx.doi.org/10.1371/journal.pone.0030914			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348030	Green Published, gold			2022-12-25	WOS:000302737400007
J	Kuhn, S; Ingham, N; Pearson, S; Gribble, SM; Clayton, S; Steel, KP; Marcotti, W				Kuhn, Stephanie; Ingham, Neil; Pearson, Selina; Gribble, Susan M.; Clayton, Stephen; Steel, Karen P.; Marcotti, Walter			Auditory Function in the Tc1 Mouse Model of Down Syndrome Suggests a Limited Region of Human Chromosome 21 Involved in Otitis Media	PLOS ONE			English	Article							POTASSIUM CURRENT; HEARING-LOSS; HAIR-CELLS; INNER; EXPRESSION; GENE; CURRENTS; MIR-96; HUMAN-CHROMOSOME-21; MATURATION	Down syndrome is one of the most common congenital disorders leading to a wide range of health problems in humans, including frequent otitis media. The Tc1 mouse carries a significant part of human chromosome 21 (Hsa21) in addition to the full set of mouse chromosomes and shares many phenotypes observed in humans affected by Down syndrome with trisomy of chromosome 21. However, it is unknown whether Tc1 mice exhibit a hearing phenotype and might thus represent a good model for understanding the hearing loss that is common in Down syndrome. In this study we carried out a structural and functional assessment of hearing in Tc1 mice. Auditory brainstem response (ABR) measurements in Tc1 mice showed normal thresholds compared to littermate controls and ABR waveform latencies and amplitudes were equivalent to controls. The gross anatomy of the middle and inner ears was also similar between Tc1 and control mice. The physiological properties of cochlear sensory receptors (inner and outer hair cells: IHCs and OHCs) were investigated using single-cell patch clamp recordings from the acutely dissected cochleae. Adult Tc1 IHCs exhibited normal resting membrane potentials and expressed all K+ currents characteristic of control hair cells. However, the size of the large conductance (BK) Ca2+ activated K+ current (I-K,I-f), which enables rapid voltage responses essential for accurate sound encoding, was increased in Tc1 IHCs. All physiological properties investigated in OHCs were indistinguishable between the two genotypes. The normal functional hearing and the gross structural anatomy of the middle and inner ears in the Tc1 mouse contrast to that observed in the Ts65Dn model of Down syndrome which shows otitis media. Genes that are trisomic in Ts65Dn but disomic in Tc1 may predispose to otitis media when an additional copy is active.	[Kuhn, Stephanie; Marcotti, Walter] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Ingham, Neil; Pearson, Selina; Gribble, Susan M.; Clayton, Stephen; Steel, Karen P.] Wellcome Trust Sanger Inst, Cambridge, England	University of Sheffield; Wellcome Trust Sanger Institute	Kuhn, S (corresponding author), Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England.	kps@sanger.ac.uk; w.marcotti@sheffield.ac.uk		, Stephanie/0000-0001-6633-9478	Wellcome Trust [088719, 077189]; Royal Society; Medical Research Council [G0300212, MC_qA137918] Funding Source: researchfish; RNID [G41] Funding Source: researchfish; MRC [G0300212, MC_qA137918] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); RNID; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Wellcome Trust (088719) and The Royal Society to WM, and a grant from the Wellcome Trust (077189) to KPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford KA, 2010, BLOOD, V115, P2928, DOI 10.1182/blood-2009-06-227629; ASHMORE JF, 1987, J PHYSIOL-LONDON, V388, P323, DOI 10.1113/jphysiol.1987.sp016617; Bilgin H, 1996, ARCH OTOLARYNGOL, V122, P271; DALLOS P, 1992, SOC GEN PHY, V47, P371; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Dunlevy L, 2010, CARDIOVASC RES, V88, P287, DOI 10.1093/cvr/cvq193; Fettiplace R, 2006, NAT REV NEUROSCI, V7, P19, DOI 10.1038/nrn1828; Gardiner K, 2003, GENE, V318, P137, DOI 10.1016/S0378-1119(03)00769-8; Han FC, 2009, INT J EXP PATHOL, V90, P480, DOI 10.1111/j.1365-2613.2009.00677.x; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Johnson SL, 2009, J PHYSIOL-LONDON, V587, P1715, DOI 10.1113/jphysiol.2009.168542; Johnson SL, 2010, NAT NEUROSCI, V13, P45, DOI 10.1038/nn.2456; Kennedy HJ, 2005, NATURE, V433, P880, DOI 10.1038/nature03367; Kros CJ, 1998, NATURE, V394, P281, DOI 10.1038/28401; Kuhn DE, 2008, BIOCHEM BIOPH RES CO, V370, P473, DOI 10.1016/j.bbrc.2008.03.120; Kuhn S, 2011, P NATL ACAD SCI USA, V108, P2355, DOI 10.1073/pnas.1016646108; Lewis MA, 2009, NAT GENET, V41, P614, DOI 10.1038/ng.369; Marcotti W, 2004, J PHYSIOL-LONDON, V560, P691, DOI 10.1113/jphysiol.2004.072868; Marcotti W, 1999, J PHYSIOL-LONDON, V520, P653, DOI 10.1111/j.1469-7793.1999.00653.x; Marcotti W, 2003, J PHYSIOL-LONDON, V552, P743, DOI 10.1113/jphysiol.2003.043612; Marcotti W, 2003, J PHYSIOL-LONDON, V548, P383, DOI 10.1113/jphysiol.2002.034801; Megarbane A, 2009, GENET MED, V11, P611, DOI 10.1097/GIM.0b013e3181b2e34c; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Mikaelian D, 1965, ACTA OTO-LARYNGOL, V59, P451, DOI DOI 10.3109/00016486509124579; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; Olah ME, 2009, J PHYSIOL-LONDON, V587, P965, DOI 10.1113/jphysiol.2008.162289; PALLANCK L, 1994, HUM MOL GENET, V3, P1239, DOI 10.1093/hmg/3.8.1239; Quina LA, 2009, J NEUROSCI, V29, P14309, DOI 10.1523/JNEUROSCI.2430-09.2009; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Ryugo D.K., 1992, Springer Handbook of Auditory Research, V1, P23; Shah YA, 2007, MOL CELL BIOL, V27, P4238, DOI 10.1128/MCB.00317-07; Shott SR, 2001, INT J PEDIATR OTORHI, V61, P199, DOI 10.1016/S0165-5876(01)00572-9; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Sturgeon X, 2011, MAMM GENOME, V22, P261, DOI 10.1007/s00335-011-9321-y; TSENGCRANK J, 1994, NEURON, V13, P1315, DOI 10.1016/0896-6273(94)90418-9; Weston MD, 2006, BRAIN RES, V1111, P95, DOI 10.1016/j.brainres.2006.07.006; Wiseman FK, 2009, HUM MOL GENET, V18, pR75, DOI 10.1093/hmg/ddp010; Yu T, 2010, HUM MOL GENET, V19, P2780, DOI 10.1093/hmg/ddq179; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	39	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31433	10.1371/journal.pone.0031433	http://dx.doi.org/10.1371/journal.pone.0031433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348087	Green Published, Green Accepted, gold			2022-12-25	WOS:000302737400023
J	Tkint, T; Verheyen, E; De Kegel, B; Helsen, P; Adriaens, D				Tkint, Tim; Verheyen, Erik; De Kegel, Barbara; Helsen, Philippe; Adriaens, Dominique			Dealing with Food and Eggs in Mouthbrooding Cichlids: Structural and Functional Trade-Offs in Fitness Related Traits	PLOS ONE			English	Article							TREWAVAS 1933 PISCES; LAKE VICTORIA; CONSTRUCTIONAL MORPHOLOGY; PHENOTYPIC PLASTICITY; HAPLOCHROMIS-PICEATUS; SEXUAL-DIMORPHISM; FISHES TELEOSTEI; PARENTAL CARE; CONSTRAINTS; CONSEQUENCES	Background: As in any vertebrate, heads of fishes are densely packed with functions. These functions often impose conflicting mechanical demands resulting in trade-offs in the species-specific phenotype. When phenotypical traits are linked to gender-specific parental behavior, we expect sexual differences in these trade-offs. This study aims to use mouthbrooding cichlids as an example to test hypotheses on evolutionary trade-offs between intricately linked traits that affect different aspects of fitness. We focused on the oral apparatus, which is not only equipped with features used to feed and breathe, but is also used for the incubation of eggs. We used this approach to study mouthbrooding as part of an integrated functional system with diverging performance requirements and to explore gender-specific selective environments within a species. Methodology/Principal Findings: Because cichlids are morphologically very diverse, we hypothesize that the implications of the added constraint of mouthbrooding will primarily depend on the dominant mode of feeding of the studied species. To test this, we compared the trade-off for two maternal mouthbrooding cichlid species: a "suction feeder'' (Haplochromis piceatus) and a "biter'' (H. fischeri). The comparison of morphology and performance of both species revealed clear interspecific and intersex differences. Our observation that females have larger heads was interpreted as a possible consequence of the fact that in both the studied species mouthbrooding is done by females only. As hypothesized, the observed sexual dimorphism in head shape is inferred as being suboptimal for some aspects of the feeding performance in each of the studied species. Our comparison also demonstrated that the suction feeding species had smaller egg clutches and more elongated eggs. Conclusions/Significance: Our findings support the hypothesis that there is a trade-off between mouthbrooding and feeding performance in the two studied haplochromine cichlids, stressing the importance of including species-specific information at the gender level when addressing interspecific functional/morphological differences.	[Tkint, Tim; De Kegel, Barbara; Adriaens, Dominique] Univ Ghent, Dept Biol, Res Grp Evolutionary Morphol Vertebrates, B-9000 Ghent, Belgium; [Verheyen, Erik; Helsen, Philippe] Royal Belgian Inst Nat Sci, Vertebrate Dept, Brussels, Belgium; [Verheyen, Erik; Helsen, Philippe] Univ Antwerp, Dept Biol, Res Grp Evolutionary Ecol, B-2020 Antwerp, Belgium	Ghent University; Royal Belgian Institute of Natural Sciences; University of Antwerp	Tkint, T (corresponding author), Univ Ghent, Dept Biol, Res Grp Evolutionary Morphol Vertebrates, B-9000 Ghent, Belgium.	Tim.tkint@Ugent.be	VERHEYEN, ERIK K/E-5550-2013; Adriaens, Dominique/G-1587-2010; Helsen, Philippe/K-8660-2018	VERHEYEN, ERIK K/0000-0001-7157-1474; Adriaens, Dominique/0000-0003-3610-2773; 	Research Foundation Flanders [1.1.A72.10.N.00, 3G014911]; Belspo project [MO/36/013]	Research Foundation Flanders(FWO); Belspo project(Belgian Federal Science Policy Office)	This study is funded by the Research Foundation Flanders (www.fwo.be)(1.1.A72.10.N.00), FWO project: 3G014911 (http://www.fwo.be), and Belspo project: MO/36/013 (http://www.belspo.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSTER HA, 1985, J COMP PHYSIOL B, V155, P685, DOI 10.1007/BF00694582; Albertson RC, 2006, HEREDITY, V97, P211, DOI 10.1038/sj.hdy.6800864; Albertson RC, 2001, J EXP ZOOL, V289, P385, DOI 10.1002/jez.1020; Alfaro ME, 2005, AM NAT, V165, pE140, DOI 10.1086/429564; ANKER GC, 1978, NETH J ZOOL, V28, P234, DOI 10.1163/002829678X00071; Balshine-Earn S, 1998, P ROY SOC B-BIOL SCI, V265, P2217, DOI 10.1098/rspb.1998.0562; BAREL CDN, 1977, NETH J ZOOL, V27, P333; BAREL CDN, 1983, NETH J ZOOL, V33, P357; BAREL CDN, 1989, ACTA MORPHOL NEER SC, V27, P83; BAREL CDN, 1984, NETH J ZOOL, V34, P439, DOI 10.1163/002829684X00263; Barnett A, 2005, MAR BIOL, V148, P205, DOI 10.1007/s00227-005-0052-z; Bouton N, 2002, BIOL J LINN SOC, V76, P39, DOI 10.1111/j.1095-8312.2002.tb01712.x; Bouton N, 2002, BIOL J LINN SOC, V77, P185, DOI 10.1046/j.1095-8312.2002.00093.x; Brakefield PM, 2006, TRENDS ECOL EVOL, V21, P362, DOI 10.1016/j.tree.2006.05.001; Cooper WJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-24; de Jong IML, 2009, J MORPHOL, V270, P519, DOI 10.1002/jmor.10716; Devaere S, 2005, J NAT HIST, V39, P1653, DOI 10.1080/00222930400020103; deVisser J, 1996, J MORPHOL, V228, P1, DOI 10.1002/(SICI)1097-4687(199604)228:1<1::AID-JMOR1>3.0.CO;2-B; Donev A, 2004, SCIENCE, V303, P990, DOI 10.1126/science.1093010; DROST MR, 1986, J ZOOL, V209, P239, DOI 10.1111/j.1469-7998.1986.tb03579.x; Duponchelle F, 2008, P NATL ACAD SCI USA, V105, P15475, DOI 10.1073/pnas.0802343105; Erlandsson A, 1997, S AFR J SCI, V93, P498; Fryer G., 1972, CICHLID FISHES GREAT; GALIS F, 1993, J EXP ZOOL, V267, P137, DOI 10.1002/jez.1402670207; Genner MJ, 2007, MOL BIOL EVOL, V24, P1269, DOI 10.1093/molbev/msm050; Gillooly JF, 2008, BIOL LETTERS, V4, P123, DOI 10.1098/rsbl.2007.0460; Goodwin NB, 1998, P ROY SOC B-BIOL SCI, V265, P2265, DOI 10.1098/rspb.1998.0569; Herler J, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-4; Herrel A, 1998, NETH J ZOOL, V48, P1; HESS HC, 1993, B MAR SCI, V52, P806; Hoogerhoud RJC, 1978, BAREL CDN INTEGRATED, P52; Hulsey CD, 2007, P ROY SOC B-BIOL SCI, V274, P1867, DOI 10.1098/rspb.2007.0444; Hulsey CD, 2006, EVOLUTION, V60, P2096, DOI 10.1111/j.0014-3820.2006.tb01847.x; Hulsey CD, 2005, FUNCT ECOL, V19, P487, DOI 10.1111/j.1365-2435.2005.00987.x; KATUNZI EFB, 1983, NETH J ZOOL, V33, P337; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Liem K.F., 1991, P231; LIEM KF, 1980, AM ZOOL, V20, P295; LIEM KF, 1973, SYST ZOOL, V22, P425, DOI 10.2307/2412950; MCKAYE KR, 1990, AM NAT, V135, P597, DOI 10.1086/285064; Okuda N, 2002, ZOOL SCI, V19, P801, DOI 10.2108/zsj.19.801; OLIVEIRA RF, 1995, J FISH BIOL, V46, P1055, DOI 10.1006/jfbi.1995.0100; Ostlund-Nilsson S, 2004, P ROY SOC B-BIOL SCI, V271, P1015, DOI 10.1098/rspb.2004.2700; OTTEN E, 1983, NETH J ZOOL, V33, P55, DOI 10.1163/002829683X00048; Parnell NF, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-122; Rice AN, 2002, J EXP BIOL, V205, P3519; Rohlf F.J., 2008, TPSDIG 2 12; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; ROHLF FJ, 2003, TPSSMALL 1 20; Schurch R, 2005, BEHAVIOUR, V142, P265, DOI 10.1163/1568539053778274; SLOOTWEG R, 1987, OECOLOGIA, V74, P193, DOI 10.1007/BF00379359; TAYLOR W R, 1985, Cybium, V9, P107; Van der Sluijs I, 2008, J EVOLUTION BIOL, V21, P480, DOI 10.1111/j.1420-9101.2007.01495.x; Van Wassenbergh S, 2007, J EXP BIOL, V210, P27, DOI 10.1242/jeb.02619; Van Wassenbergh S, 2009, J EXP BIOL, V212, P116, DOI 10.1242/jeb.023929; Verheyen E, 2003, SCIENCE, V300, P325, DOI 10.1126/science.1080699; Westneat MW, 2003, J THEOR BIOL, V223, P269, DOI 10.1016/S0022-5193(03)00058-4; WESTNEAT MW, 1990, J MORPHOL, V205, P269, DOI 10.1002/jmor.1052050304; WESTNEAT MW, 1994, ZOOMORPHOLOGY, V114, P103, DOI 10.1007/BF00396643; WITTE F, 1990, NETH J ZOOL, V40, P278; WITTE F, 1984, NETH J ZOOL, V34, P596	62	12	12	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31117	10.1371/journal.pone.0031117	http://dx.doi.org/10.1371/journal.pone.0031117			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348043	gold, Green Published, Green Submitted			2022-12-25	WOS:000302737400010
J	Yoffe, C; Lotan, T; Benayhau, Y				Yoffe, Chen; Lotan, Tamar; Benayhau, Yehuda			A Modified View on Octocorals: Heteroxenia fuscescens Nematocysts Are Diverse, Featuring Both an Ancestral and a Novel Type	PLOS ONE			English	Article							EVOLUTION; ANTHOZOA; CNIDARIA; HYDRA; CNIDOGENESIS; SYSTEMATICS; CAPSULE; PROTEIN; CORALS	Cnidarians are characterized by the presence of stinging cells containing nematocysts, a sophisticated injection system targeted mainly at prey-capture and defense. In the anthozoan subclass Octocorallia nematocytes have been considered to exist only in low numbers, to be small, and all of the ancestral atrichous-isorhiza type. This study, in contrast, revealed numerous nematocytes in the octocoral Heteroxenia fuscescens. The study demonstrates the applicability of cresyl-violet dye for differential staining and stimulating discharge of the nematocysts. In addition to the atrichous isorhiza-type of nematocysts, a novel type of macrobasic-mastigophore nematocysts was found, featuring a shaft, uniquely comprised of three loops and densely packed arrow-like spines. In contrast to the view that octocorals possess a single type of nematocyst, Heteroxenia fuscescens features two distinct types, indicating for the first time the diversification and complexity of nematocysts for Octocorallia.	[Yoffe, Chen; Benayhau, Yehuda] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, IL-69978 Tel Aviv, Israel; [Lotan, Tamar] Univ Haifa, Leon H Charney Sch Marine Sci, Dept Marine Biol, IL-31999 Haifa, Israel	Tel Aviv University; University of Haifa	Yoffe, C (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, IL-69978 Tel Aviv, Israel.	YehudaB@tauex.tau.ac.il		Lotan, Tamar/0000-0002-1679-4904	Israel Cohen Chair in Environmental Zoology	Israel Cohen Chair in Environmental Zoology	This research was in part supported by the Israel Cohen Chair in Environmental Zoology to YB. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk P, 2008, J MOL BIOL, V376, P1008, DOI 10.1016/j.jmb.2007.10.090; Aeby GS, 2006, MAR ECOL PROG SER, V318, P103, DOI 10.3354/meps318103; Barneah O, 2004, MAR ECOL PROG SER, V275, P89, DOI 10.3354/meps275089; Ben-David-Zaslow R, 1999, MAR BIOL, V133, P553, DOI 10.1007/s002270050495; CHENG TC, 1974, J INVERTEBR PATHOL, V23, P303, DOI 10.1016/0022-2011(74)90095-0; Daly M, 2003, ZOOL J LINN SOC-LOND, V139, P419, DOI 10.1046/j.1096-3642.2003.00084.x; David CN, 2008, TRENDS GENET, V24, P431, DOI 10.1016/j.tig.2008.07.001; Fautin DG, 2009, TOXICON, V54, P1054, DOI 10.1016/j.toxicon.2009.02.024; HOLSTEIN TW, 1994, SCIENCE, V265, P402, DOI 10.1126/science.265.5170.402; Hwang JS, 2008, MOL BIOL EVOL, V25, P2009, DOI 10.1093/molbev/msn154; Jimbo M, 2000, COMP BIOCHEM PHYS B, V125, P227, DOI 10.1016/S0305-0491(99)00173-X; Kass-Simon G, 2002, CAN J ZOOL, V80, P1772, DOI 10.1139/Z02-135; Mariscal R.N., 1974, pUnpaginated; MARISCAL RN, 1976, CELL TISSUE RES, V168, P465, DOI 10.1007/BF00215997; Mariscal RN, 1977, 3RD P INT COR REEF S, P127; Mcfadden CS, 2010, INTEGR COMP BIOL, V50, pE113; McFadden CS, 2006, MOL PHYLOGENET EVOL, V41, P513, DOI 10.1016/j.ympev.2006.06.010; Ozbek S, 2009, TOXICON, V54, P1038, DOI 10.1016/j.toxicon.2009.03.006; Ostman C, 2000, SCI MAR, V64, P31; Piraino S., 1993, Oebalia, V19, P67; SAMMARCO PW, 1992, MAR ECOL PROG SER, V88, P93, DOI 10.3354/meps088093; SCHLICHTER D, 1982, OECOLOGIA, V53, P40, DOI 10.1007/BF00377134; SCHMIDT H, 1982, HELGOLANDER MEERESUN, V35, P97, DOI 10.1007/BF02289837; SCHMIDT H, 1981, HELGOLANDER MEERESUN, V34, P463, DOI 10.1007/BF01995918; SEBENS KP, 1988, BIOL BULL, V175, P378, DOI 10.2307/1541729; TARDENT P, 1995, BIOESSAYS, V17, P351, DOI 10.1002/bies.950170411; Tureyen K, 2004, J NEUROSCI METH, V139, P203, DOI 10.1016/j.jneumeth.2004.04.029; Weill R, 1930, BIOL BULL, P141; WEILL ROBERT, 1934, TRAV STAT ZOOL WIMEREUX, V10, P1; Yacobovitch T, 2003, MAR BIOL, V142, P1055, DOI 10.1007/s00227-003-1035-6	30	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31902	10.1371/journal.pone.0031902	http://dx.doi.org/10.1371/journal.pone.0031902			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348137	Green Published, gold			2022-12-25	WOS:000302737400056
J	Duboue, ER; Borowsky, RL				Duboue, Erik R.; Borowsky, Richard L.			Altered Rest-Activity Patterns Evolve via Circadian Independent Mechanisms in Cave Adapted Balitorid Loaches	PLOS ONE			English	Article							SLEEP; CLOCK	Circadian rhythms and rest homeostasis are independent processes, each regulating important components of rest-activity patterns. Evolutionarily, the two are distinct from one another; total rest time is maintained unaffected even when circadian pacemaker cells are ablated. Throughout the animal kingdom, there exists a huge variation in rest-activity patterns, yet it is unclear how these behaviors have evolved. Here we show that four species of balitorid cavefish have greatly reduced rest times in comparison to rest times of their surface relatives. All four cave species retained biological rhythmicity, and in three of the four there is a pronounced 24-hour rhythm; in the fourth there is an altered rhythmicity of 38-40 hours. Thus, consistent changes in total rest have evolved in these species independent of circadian rhythmicity. Taken together, our data suggest that consistent reduction in total rest times were accomplished evolutionarily through alterations in rest homeostasis.	[Duboue, Erik R.; Borowsky, Richard L.] NYU, Dept Biol, New York, NY 10003 USA	New York University	Duboue, ER (corresponding author), NYU, Dept Biol, New York, NY 10003 USA.	rb4@nyu.edu			National Science Foundation [INT-9605200, IOS-0821982]	National Science Foundation(National Science Foundation (NSF))	This research was funded by National Science Foundation grants INT-9605200 and IOS-0821982 to RB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allada R, 2008, CURR BIOL, V18, pR670, DOI 10.1016/j.cub.2008.06.033; Borbely AA, 1996, PROG BRAIN RES, V111, P343, DOI 10.1016/S0079-6123(08)60417-3; Cavallari N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001142; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Duboue ER, 2011, CURR BIOL, V21, P671, DOI 10.1016/j.cub.2011.03.020; GARDNER GF, 1980, GENETICS, V96, P877; Horne J, 2009, NEUROSCI BIOBEHAV R, V33, P466, DOI 10.1016/j.neubiorev.2008.12.002; Jeffery WR, 2001, DEV BIOL, V231, P1, DOI 10.1006/dbio.2000.0121; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Mistlberger RE, 2005, BRAIN RES REV, V49, P429, DOI 10.1016/j.brainresrev.2005.01.005; MITSUI A, 1986, NATURE, V323, P720, DOI 10.1038/323720a0; Prober DA, 2006, J NEUROSCI, V26, P13400, DOI 10.1523/JNEUROSCI.4332-06.2006; Ruf T, 1999, BIOL RHYTHM RES, V30, P178, DOI 10.1076/brhm.30.2.178.1422; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; Trajano E, 2010, BIOLOGY OF SUBTERRANEAN FISHES, P1, DOI 10.1201/EBK1578086702-f; Trajano E, 2009, BIOL RHYTHM RES, V40, P477, DOI 10.1080/09291010902731205; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Yokogawa T, 2007, PLOS BIOL, V5, P2379, DOI 10.1371/journal.pbio.0050277; Zepelin H, 2000, PRINCIPLES PRACTICE, P82	20	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e30868	10.1371/journal.pone.0030868	http://dx.doi.org/10.1371/journal.pone.0030868			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348026	Green Submitted, Green Published, gold			2022-12-25	WOS:000302733900015
J	Mariyanna, L; Priyadarshini, P; Hofmann-Sieber, H; Krepstakies, M; Walz, N; Grundhoff, A; Buchholz, F; Hildt, E; Hauber, J				Mariyanna, Lakshmikanth; Priyadarshini, Poornima; Hofmann-Sieber, Helga; Krepstakies, Marcel; Walz, Nicole; Grundhoff, Adam; Buchholz, Frank; Hildt, Eberhard; Hauber, Joachim			Excision of HIV-1 Proviral DNA by Recombinant Cell Permeable Tre-Recombinase	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; PENETRATING PEPTIDES; MOLECULAR-MECHANISMS; PROTEIN TRANSDUCTION; MAMMALIAN-CELLS; DELIVERY; DRUG; INFECTION; CRE; VECTORS	Over the previous years, comprehensive studies on antiretroviral drugs resulted in the successful introduction of highly active antiretroviral therapy (HAART) into clinical practice for treatment of HIV/AIDS. However, there is still need for new therapeutic approaches, since HAART cannot eradicate HIV-1 from the infected organism and, unfortunately, can be associated with long-term toxicity and the development of drug resistance. In contrast, novel gene therapy strategies may have the potential to reverse the infection by eradicating HIV-1. For example, expression of long terminal repeat (LTR)0specific recombinase (Tre-recombinase) has been shown to result in chromosomal excision of proviral DNA and, in consequence, in the eradication of HIV-1 from infected cell cultures. However, the delivery of Tre-recombinase currently depends on the genetic manipulation of target cells, a process that is complicating such therapeutic approaches and, thus, might be undesirable in a clinical setting. In this report we demonstrate that E. coli expressed Tre-recombinases, tagged either with the protein transduction domain (PTD) from the HIV-1 Tat trans-activator or the translocation motif (TLM) of the Hepatitis B virus PreS2 protein, were able to translocate efficiently into cells and showed significant recombination activity on HIV-1 LTR sequences. Tre activity was observed using episomal and stable integrated reporter constructs in transfected HeLa cells. Furthermore, the TLM-tagged enzyme was able to excise the full-length proviral DNA from chromosomal integration sites of HIV-1-infected HeLa and CEM-SS cells. The presented data confirm Tre-recombinase activity on integrated HIV-1 and provide the basis for the non-genetic transient application of engineered recombinases, which may be a valuable component of future HIV eradication strategies.	[Mariyanna, Lakshmikanth; Priyadarshini, Poornima; Hofmann-Sieber, Helga; Krepstakies, Marcel; Walz, Nicole; Grundhoff, Adam; Hauber, Joachim] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany; [Buchholz, Frank] Tech Univ Dresden, Univ Hosp, Dept Med Syst Biol, Dresden, Germany; [Buchholz, Frank] Tech Univ Dresden, Med Fac Carl Gustav Carus, Dresden, Germany; [Buchholz, Frank] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Hildt, Eberhard] Paul Ehrlich Inst, Dept Virol, D-6070 Langen, Germany	Heinrich Pette Institute; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Max Planck Society; Paul Ehrlich Institute	Mariyanna, L (corresponding author), Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany.	joachim.hauber@hpi.uni-hamburg.de	Mariyanna, Lakshmikanth/ABG-4596-2021; Hildt, Eberhard/A-1040-2015; Buchholz, Frank/B-4700-2017	Mariyanna, Lakshmikanth/0000-0001-5969-1246; Buchholz, Frank/0000-0002-4577-3344; Mariyanna, Lakshmikanth/0000-0001-6561-2049; , Poornima Priyadarshini/0000-0002-7449-5777; Grundhoff, Adam/0000-0003-0940-7045	Federal Ministry of Education and Research [GO-Bio FKZ0315090]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant of the Federal Ministry of Education and Research (GO-Bio FKZ0315090; http://www.bmbf.de) to JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassiadis K, 2009, DIS MODEL MECH, V2, P508, DOI 10.1242/dmm.003087; Baum C, 2004, MOL THER, V9, P5, DOI 10.1016/j.ymthe.2003.10.013; Baum C, 2006, MOL THER, V13, P1050, DOI 10.1016/j.ymthe.2006.03.007; Bian J, 2007, CIRC RES, V100, P1626, DOI 10.1161/01.RES.0000269778.75877.68; Blackard JT, 1999, VIROLOGY, V254, P220, DOI 10.1006/viro.1998.9504; Brandenburg B, 2005, HEPATOLOGY, V42, P1300, DOI 10.1002/hep.20950; Broder S, 2010, ANTIVIR RES, V85, P1, DOI 10.1016/j.antiviral.2009.10.002; Buchholz F, 2011, METHODS, V53, P102, DOI 10.1016/j.ymeth.2010.06.014; Cafardi JA, 2011, J INVEST DERMATOL, V131, P559, DOI 10.1038/jid.2010.394; Calmy A, 2009, ANTIVIR THER, V14, P165; Cao GD, 2002, J NEUROSCI, V22, P5423; Cihlar T, 2010, ANTIVIR RES, V85, P39, DOI 10.1016/j.antiviral.2009.09.014; de Bethune MP, 2010, ANTIVIR RES, V85, P75, DOI 10.1016/j.antiviral.2009.09.008; Deeks SG, 2010, NAT BIOTECHNOL, V28, P807, DOI 10.1038/nbt0810-807; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Deshayes S, 2008, ADV DRUG DELIVER REV, V60, P537, DOI 10.1016/j.addr.2007.09.005; DiGiusto DL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000931; Douglas JT, 2007, MOL BIOTECHNOL, V36, P71, DOI 10.1007/s12033-007-0021-5; Eekels JJM, 2011, ANTIVIR RES, V89, P43, DOI 10.1016/j.antiviral.2010.11.005; Elliott G, 1997, CELL, V88, P223, DOI 10.1016/S0092-8674(00)81843-7; Escors D, 2010, ARCH IMMUNOL THER EX, V58, P107, DOI 10.1007/s00005-010-0063-4; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fonseca SB, 2009, ADV DRUG DELIVER REV, V61, P953, DOI 10.1016/j.addr.2009.06.001; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Hafner A, 2003, EMBO REP, V4, P767, DOI 10.1038/sj.embor.embor903; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Hillemann A, 2005, J HEPATOL, V43, P442, DOI 10.1016/j.jhep.2005.02.031; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kong HJ, 2007, NAT REV DRUG DISCOV, V6, P455, DOI 10.1038/nrd2309; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Lin Q, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-25; Lindsay MA, 2002, CURR OPIN PHARMACOL, V2, P587, DOI 10.1016/S1471-4892(02)00199-6; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Martin JC, 2010, ANTIVIR RES, V85, P34, DOI 10.1016/j.antiviral.2009.10.006; McColl DJ, 2010, ANTIVIR RES, V85, P101, DOI 10.1016/j.antiviral.2009.11.004; Morris MC, 2008, BIOL CELL, V100, P201, DOI 10.1042/BC20070116; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Neff CP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001581; Nienhuis AW, 2006, MOL THER, V13, P1031, DOI 10.1016/j.ymthe.2006.03.001; Oess S, 2000, GENE THER, V7, P750, DOI 10.1038/sj.gt.3301154; Opalinska JB, 2002, NAT REV DRUG DISCOV, V1, P503, DOI 10.1038/nrd837; Patsch C, 2011, METHODS, V53, P386, DOI 10.1016/j.ymeth.2010.12.018; Peitz M, 2007, GENESIS, V45, P508, DOI 10.1002/dvg.20321; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Ramalingam D, 2011, J VIROL, V85, P305, DOI 10.1128/JVI.02626-09; Rapoport M, 2009, EXPERT OPIN DRUG DEL, V6, P453, DOI [10.1517/17425240902887029, 10.1517/17425240902887029 ]; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Richman DD, 2001, NATURE, V410, P995, DOI 10.1038/35073673; Richman DD, 2006, ANTIVIR RES, V71, P117, DOI 10.1016/j.antiviral.2006.03.004; Rossi JJ, 2007, NAT BIOTECHNOL, V25, P1444, DOI 10.1038/nbt1367; Sarkar I, 2007, SCIENCE, V316, P1912, DOI 10.1126/science.1141453; Scherr Michaela, 2002, Current Gene Therapy, V2, P45, DOI 10.2174/1566523023348237; Stoeckl L, 2006, P NATL ACAD SCI USA, V103, P6730, DOI 10.1073/pnas.0509765103; ter Brake O, 2009, GENE THER, V16, P148, DOI 10.1038/gt.2008.124; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Tilton JC, 2010, ANTIVIR RES, V85, P91, DOI 10.1016/j.antiviral.2009.07.022; Torchilin VP, 2008, BIOPOLYMERS, V90, P604, DOI 10.1002/bip.20989; van Lunzen J, 2011, CURR HIV AIDS REP; Wadia JS, 2003, CURR PROTEIN PEPT SC, V4, P97, DOI 10.2174/1389203033487289; Wensing AMJ, 2010, ANTIVIR RES, V85, P59, DOI 10.1016/j.antiviral.2009.10.003; Will E, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf059	65	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31576	10.1371/journal.pone.0031576	http://dx.doi.org/10.1371/journal.pone.0031576			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348110	Green Published, gold, Green Submitted			2022-12-25	WOS:000302733900056
J	Kruijt, B; van den Berg, TJTP				Kruijt, Bastiaan; van den Berg, Thomas J. T. P.			Optical Scattering Measurements of Laser Induced Damage in the Intraocular Lens	PLOS ONE			English	Article							LIGHT-SCATTERING; STRAYLIGHT; OPACIFICATION	This study optically determines whether the amount of light scatter due to laser-induced damage to the intraocular lens (IOL) is significant in relation to normal straylight values in the human eye. Two IOLs with laser-induced damage were extracted from two donor eyes. Each IOL had 15 pits and/or cracks. The surface area of each pit was measured using a microscope. For 6 pits per intraocular lens the point spread function (PSF) in terms of straylight was measured and the total straylight for all 15 pits was estimated. The damage in the IOLs was scored as mild/moderate. The total damaged surface areas, for a 3.5 mm pupil, in the two IOLs were 0.13% (0.0127 mm(2)) and 0.66% (0.064 mm(2)), respectively. The angular dependence of the straylight caused by the damage was similar to that of the normal PSF. The total average contribution to straylight was log(s) = -0.82 and -0.42, much less than the straylight value of the normal eye. The straylight due to normal levels of laser induced damage of the IOL is much lower than normal straylight values found clinically for the normal eye and may therefore be considered not significant.	[Kruijt, Bastiaan; van den Berg, Thomas J. T. P.] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Kruijt, B (corresponding author), Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands.	t.j.vandenberg@nin.knaw.nl						Awasthi N, 2009, ARCH OPHTHALMOL-CHIC, V127, P555, DOI 10.1001/archophthalmol.2009.3; Bath P E, 1985, J Am Intraocul Implant Soc, V11, P253; BATH PE, 1987, J CATARACT REFR SURG, V13, P47, DOI 10.1016/S0886-3350(87)80010-X; BATH PE, 1987, J CATARACT REFR SURG, V13, P309, DOI 10.1016/S0886-3350(87)80076-7; Boerner C F, 1984, J Am Intraocul Implant Soc, V10, P81; Coppens JE, 2006, EXP EYE RES, V82, P688, DOI 10.1016/j.exer.2005.09.007; Dick B, 1997, KLIN MONATSBL AUGENH, V211, P263, DOI 10.1055/s-2008-1035133; Fallor M K, 1985, J Am Intraocul Implant Soc, V11, P564; Holladay J T, 1985, J Am Intraocul Implant Soc, V11, P18; MAMALIS N, 1990, J CATARACT REFR SURG, V16, P495, DOI 10.1016/S0886-3350(13)80806-1; Newland TJ, 1999, J CATARACT REFR SURG, V25, P72, DOI 10.1016/S0886-3350(99)80014-5; Smith SG, 1992, EUR J IMPLANT REFRAC, V4, P157; STARK WJ, 1985, OPHTHALMOLOGY, V92, P209; Trinavarat A, 2001, J CATARACT REFR SURG, V27, P775, DOI 10.1016/S0886-3350(00)00855-5; van Bree MCJ, 2008, J CATARACT REFR SURG, V34, P1681, DOI 10.1016/j.jcrs.2008.06.014; van Bree MCJ, 2011, INVEST OPHTH VIS SCI, V52, P5587, DOI 10.1167/iovs.10-7073; van den Berg TJTP, 2009, OPHTHAL PHYSL OPT, V29, P345, DOI 10.1111/j.1475-1313.2009.00638.x; Van den Berg TJTP., 2010, ENCY EYE, V3, P173; van der Meulen IJE, 2009, BRIT J OPHTHALMOL, V93, P830, DOI 10.1136/bjo.2008.151324; vandenBerg TJTP, 1996, INVEST OPHTH VIS SCI, V37, P1157; Vos J., 1999, CIE COLLECT, V135, P1; Vos J. J., 1984, CIE Journal, V3, P39	22	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e31764	10.1371/journal.pone.0031764	http://dx.doi.org/10.1371/journal.pone.0031764			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348128	Green Published, Green Submitted, gold			2022-12-25	WOS:000302730900029
J	Falone, S; D'Alessandro, A; Mirabilio, A; Petruccelli, G; Cacchio, M; Di Ilio, C; Di Loreto, S; Amicarelli, F				Falone, Stefano; D'Alessandro, Antonella; Mirabilio, Alessandro; Petruccelli, Giacomo; Cacchio, Marisa; Di Ilio, Carmine; Di Loreto, Silvia; Amicarelli, Fernanda			Long Term Running Biphasically Improves Methylglyoxal-Related Metabolism, Redox Homeostasis and Neurotrophic Support within Adult Mouse Brain Cortex	PLOS ONE			English	Article							OXIDATIVE STRESS MARKERS; UP-REGULATION; TRANSCRIPTION FACTORS; ANTIOXIDANT SYSTEM; SKELETAL-MUSCLE; EXERCISE; PROTEIN; DAMAGE; AGE; GLUTATHIONE	Oxidative stress and neurotrophic support decline seem to be crucially involved in brain aging. Emerging evidences indicate the pro-oxidant methylglyoxal (MG) as a key player in the age-related dicarbonyl stress and molecular damage within the central nervous system. Although exercise promotes the overproduction of reactive oxygen species, habitual exercise may retard cellular aging and reduce the age-dependent cognitive decline through hormetic adaptations, yet molecular mechanisms underlying beneficial effects of exercise are still largely unclear. In particular, whereas adaptive responses induced by exercise initiated in youth have been broadly investigated, the effects of chronic and moderate exercise begun in adult age on biochemical hallmarks of very early senescence in mammal brains have not been extensively studied. This research investigated whether a long-term, forced and moderate running initiated in adult age may affect the interplay between the redox-related profile and the oxidative-/MG-dependent molecular damage patterns in CD1 female mice cortices; as well, we investigated possible exercise-induced effects on the activity of the brain derived neurotrophic factor (BDNF)-dependent pathway. Our findings suggested that after a transient imbalance in almost all parameters investigated, the lately-initiated exercise regimen strongly reduced molecular damage profiles in brains of adult mice, by enhancing activities of the main ROS- and MG-targeting scavenging systems, as well as by preserving the BDNF-dependent signaling through the transition from adult to middle age.	[Falone, Stefano; D'Alessandro, Antonella; Mirabilio, Alessandro; Amicarelli, Fernanda] Univ Aquila, Dept Basic & Appl Biol, I-67100 Laquila, Italy; [Falone, Stefano; Di Ilio, Carmine] Univ G dAnnunzio, Dept Biomed Sci, Chieti, Italy; [Petruccelli, Giacomo; Cacchio, Marisa] Univ G dAnnunzio, Dept Basic & Appl Med Sci, Chieti, Italy; [Di Loreto, Silvia] CNR, Inst Translat Pharmacol, Laquila, Italy	University of L'Aquila; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR)	Falone, S (corresponding author), Univ Aquila, Dept Basic & Appl Biol, I-67100 Laquila, Italy.	fernanda.amicarelli@univaq.it	Falone, Stefano/D-8692-2017; Di Loreto, Silvia/R-1849-2018; Di Loreto, Silvia/AAK-3406-2021	Falone, Stefano/0000-0002-5978-0545; Amicarelli, Fernanda/0000-0003-4528-4660	Foundation of the Cassa di Risparmio dell'Aquila	Foundation of the Cassa di Risparmio dell'Aquila	This work was funded by the Foundation of the Cassa di Risparmio dell'Aquila. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Amicarelli F, 2003, FREE RADICAL BIO MED, V35, P856, DOI 10.1016/S0891-5849(03)00438-6; Amicarelli F, 2001, INT J BIOCHEM CELL B, V33, P1129, DOI 10.1016/S1357-2725(01)00010-3; Amicarelli F, 1997, MECH AGEING DEV, V97, P215, DOI 10.1016/S0047-6374(97)00061-4; Amicarelli F, 1999, BBA-MOL BASIS DIS, V1453, P105, DOI 10.1016/S0925-4439(98)00088-X; BAKER MA, 1990, ANAL BIOCHEM, V190, P360, DOI 10.1016/0003-2697(90)90208-Q; Berchtold NC, 2010, NEUROSCIENCE, V167, P588, DOI 10.1016/j.neuroscience.2010.02.050; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWNLEE M, 1986, SCIENCE, V232, P1629, DOI 10.1126/science.3487117; Castro AA, 2011, MECH AGEING IN PRESS; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Desai KM, 2010, CAN J PHYSIOL PHARM, V88, P273, DOI 10.1139/Y10-001; Desai Kaushik M., 2008, Drug Metabolism and Drug Interactions, V23, P151; Devi SA, 2004, NEUROBIOL AGING, V25, P501, DOI 10.1016/S0197-4580(03)00112-X; Di Loreto S, 2004, BRAIN RES, V1006, P157, DOI 10.1016/j.brainres.2004.01.066; Di Loreto S, 2008, INT J BIOCHEM CELL B, V40, P245, DOI 10.1016/j.biocel.2007.07.019; DIILIO C, 1983, BIOCHEM MED METAB B, V29, P143, DOI 10.1016/0006-2944(83)90034-0; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Falone S, 2010, PHYSIOL RES, V59, P953, DOI 10.33549/physiolres.931884; Fano G, 2001, J MUSCLE RES CELL M, V22, P345, DOI 10.1023/A:1013122805060; Flurkey K, 2007, FACULTY RES, P637, DOI DOI 10.1016/B978-012369454-6/50074-1; Fouquet C, 2011, NEUROBIOL AGING, V32, P1881, DOI 10.1016/j.neurobiolaging.2009.11.001; Frazzini V, 2006, BIOGERONTOLOGY, V7, P307, DOI 10.1007/s10522-006-9045-7; Fulle S, 2005, EXP GERONTOL, V40, P189, DOI 10.1016/j.exger.2004.11.006; Gomez-Cabrera MC, 2008, FREE RADICAL BIO MED, V44, P126, DOI 10.1016/j.freeradbiomed.2007.02.001; Gomez-Pinilla F, 2008, AGEING RES REV, V7, P49, DOI 10.1016/j.arr.2007.04.003; Greenwood BN, 2009, HIPPOCAMPUS, V19, P988, DOI 10.1002/hipo.20534; Griffin EW, 2009, HIPPOCAMPUS, V19, P973, DOI 10.1002/hipo.20631; GUHA MK, 1988, BIOCHEMISTRY-US, V27, P8818, DOI 10.1021/bi00424a020; Hipkiss AR, 2006, MECH AGEING DEV, V127, P8, DOI 10.1016/j.mad.2005.09.006; Hof PR, 2004, TRENDS NEUROSCI, V27, P607, DOI 10.1016/j.tins.2004.07.013; Hopkins ME, 2010, NEUROBIOL LEARN MEM, V94, P278, DOI 10.1016/j.nlm.2010.06.006; Iwata E, 1997, MOL BRAIN RES, V50, P213, DOI 10.1016/S0169-328X(97)00190-3; Ji LL, 2008, FREE RADICAL BIO MED, V44, P142, DOI 10.1016/j.freeradbiomed.2007.02.031; Kuhla B, 2006, J NEUROSCI RES, V83, P1591, DOI 10.1002/jnr.20838; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Liu YF, 2008, NEUROBIOL LEARN MEM, V90, P81, DOI 10.1016/j.nlm.2008.02.005; Luth HJ, 2005, CEREB CORTEX, V15, P211, DOI 10.1093/cercor/bhh123; Macri MA, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-14; Mannervik B, 1981, Methods Enzymol, V77, P297; MATTSON MP, 1995, J NEUROCHEM, V65, P1740; Miyata T, 1998, FEBS LETT, V437, P24, DOI 10.1016/S0014-5793(98)01079-5; Muscari A, 2010, INT J GERIATR PSYCH, V25, P1055, DOI 10.1002/gps.2462; Nicolle MM, 2001, NEUROSCIENCE, V107, P415, DOI 10.1016/S0306-4522(01)00374-8; O'Callaghan RM, 2009, HIPPOCAMPUS, V19, P1019, DOI 10.1002/hipo.20591; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Powers SK, 2000, HDB OXIDANTS ANTIOXI, P225; Rabbani N, 2008, ANN NY ACAD SCI, V1126, P124, DOI 10.1196/annals.1433.043; Radak Z, 2001, NEUROCHEM INT, V38, P17, DOI 10.1016/S0197-0186(00)00063-2; Radak Z, 2008, FREE RADICAL BIO MED, V44, P153, DOI 10.1016/j.freeradbiomed.2007.01.029; Radak Z, 2006, NEUROCHEM INT, V49, P387, DOI 10.1016/j.neuint.2006.02.004; Rolland Y, 2010, CLIN GERIATR MED, V26, P75, DOI 10.1016/j.cger.2009.11.002; Sayre LM, 2008, CHEM RES TOXICOL, V21, P172, DOI 10.1021/tx700210j; Silva-Adaya D, 2008, J NEUROCHEM, V105, P677, DOI 10.1111/j.1471-4159.2007.05174.x; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; SOMANI SM, 1995, PHARMACOL BIOCHEM BE, V50, P635, DOI 10.1016/0091-3057(94)00357-2; SUN M, 1978, ANAL BIOCHEM, V90, P81, DOI 10.1016/0003-2697(78)90010-6; Tatone C, 2008, HUM REPROD UPDATE, V14, P131, DOI 10.1093/humupd/dmm048; Thornalley Paul J., 2008, Drug Metabolism and Drug Interactions, V23, P125; Toldy A, 2005, BRAIN RES BULL, V65, P487, DOI 10.1016/j.brainresbull.2005.02.028; Tongiorgi E, 1997, J NEUROSCI, V17, P9492; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Vaynman SS, 2006, BRAIN RES, V1070, P124, DOI 10.1016/j.brainres.2005.11.062; Vina J, 2000, IUBMB LIFE, V50, P271, DOI 10.1080/15216540051080994; Williamson J, 2010, ARCH INTERN MED, V170, P124, DOI 10.1001/archinternmed.2009.491; Zou J, 2006, CELL MOL NEUROBIOL, V26, P385, DOI 10.1007/s10571-006-9045-9	70	33	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31401	10.1371/journal.pone.0031401	http://dx.doi.org/10.1371/journal.pone.0031401			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347470	Green Submitted, Green Published, gold			2022-12-25	WOS:000302730100066
J	Afify, AEMR; El-Beltagi, HS; Abd El-Salam, SM; Omran, AA				Afify, Abd El-Moneim M. R.; El-Beltagi, Hossam S.; Abd El-Salam, Samiha M.; Omran, Azza A.			Protein Solubility, Digestibility and Fractionation after Germination of Sorghum Varieties	PLOS ONE			English	Article							AMINO-ACIDS; PHYTATE; PROFILE; SEEDS; CORN; L.; FERMENTATION; CULTIVARS; DIGESTION; COOKING	The changes in crude protein, free amino acids, amino acid composition, protein solubility, protein fractionation and protein digestibility after germination of sorghum were investigated. Sorghum varieties (Dorado, Shandaweel-6, Giza-15) were soaked for 20 h followed by germination for 72 h; the results revealed that crude protein and free amino acids in raw sorghum varieties ranged from 10.62 to 12.46% and 0.66 to 1.03 mg/g, respectively. Shandaweel-6 was the highest variety in crude protein and free amino acids content. After germination, crude protein was decreased and free amino acids were increased. There was an increase in content of valine and phenylalanine amino acids after germination. On the other hand, there was a decrease in most of amino acids after germination. After germination protein solubility was significantly increased. Regarding protein fractions, there was an increase in albumin, globulin and kafirin proteins and a decrease in cross linked kafirin and cross linked glutelin after germination.	[Afify, Abd El-Moneim M. R.; El-Beltagi, Hossam S.] Cairo Univ, Fac Agr, Dept Biochem, Cairo, Egypt; [Abd El-Salam, Samiha M.; Omran, Azza A.] Agr Res Ctr, Food Technol Res Inst, Dept Crops Technol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt	Afify, AEMR (corresponding author), Cairo Univ, Fac Agr, Dept Biochem, Cairo, Egypt.	lbltg@yahoo.com	El-Beltagi, Hossam/T-2547-2018; El-Beltagi, Hossam S./L-8546-2019; Omran, Azza A. A./ABF-3888-2021; Omran, Azza A./AAY-3922-2020	El-Beltagi, Hossam/0000-0003-4433-2034; Omran, Azza A. A./0000-0002-9328-8087; Omran, Azza A./0000-0002-9328-8087	Department of Biochemistry, Faculty of Agriculture, Cairo University; Department of Crops Technology; Food Technology Research Institute; Agricultural Research Center	Department of Biochemistry, Faculty of Agriculture, Cairo University(Cairo University); Department of Crops Technology; Food Technology Research Institute; Agricultural Research Center	This work was supported by the Department of Biochemistry, Faculty of Agriculture, Cairo University, the Department of Crops Technology, the Food Technology Research Institute, and the Agricultural Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahim E. A., 2010, Electronic Journal of Environmental, Agricultural and Food Chemistry, V9, P1117; Afify Abd El-Moneim M. R., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P203, DOI 10.1016/S2221-1691(12)60042-2; Afify AMR, 2011, NOT BOT HORTI AGROBO, V39, P90; Afify AMR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025512; AKESON WR, 1964, J NUTR, V83, P257, DOI 10.1093/jn/83.3.257; Asma Abu Baker Abu Baker, 2010, Electronic Journal of Environmental, Agricultural and Food Chemistry, V9, P1495; Association of Official Analytical Chemists-AOAC, 2000, OFFICIAL METHODS ANA, V17th; CHAVAN JK, 1981, J FOOD SCI, V46, P638, DOI 10.1111/j.1365-2621.1981.tb04930.x; Coles LT, 2005, ANIM FEED SCI TECH, V123, P421, DOI 10.1016/j.anifeedsci.2005.04.021; Correia I, 2008, J SCI FOOD AGR, V88, P2598, DOI 10.1002/jsfa.3348; Correia I, 2010, J CEREAL SCI, V51, P146, DOI 10.1016/j.jcs.2009.11.005; DEWREEDE I, 1981, FRESEN Z ANAL CHEM, V308, P431; Dicko MH, 2006, AFR J BIOTECHNOL, V5, P384; Dillon SL, 2007, ANN BOT-LONDON, V100, P975, DOI 10.1093/aob/mcm192; Duodu KG, 2003, J CEREAL SCI, V38, P117, DOI 10.1016/S0733-5210(03)00016-X; Ebadi M. R., 2005, International Journal of Poultry Science, V4, P27; EJETA G, 1987, P NATL ACAD SCI USA, V84, P6016, DOI 10.1073/pnas.84.17.6016; El-Beltagi H. S., 2011, Electronic Journal of Environmental, Agricultural and Food Chemistry, V10, P2711; El-Beltagi H.S., 2011, AN UNIV ORADEA FASC, V18, P39; El-Beltagi HES, 2011, INT J FOOD SCI NUTR, V62, P453, DOI 10.3109/09637486.2010.544642; El-Beltagi HEDS, 2010, GRASAS ACEITES, V61, P143, DOI 10.3989/gya.087009; Elemo G. N., 2011, American Journal of Food Technology, V6, P413; Elkhalifa AEO, 2010, FOOD CHEM, V121, P387, DOI 10.1016/j.foodchem.2009.12.041; Fageer ASM, 2004, FOOD CHEM, V84, P613, DOI 10.1016/S0308-8146(03)00286-3; Hamaker B.R., 2003, WORKSH PROT SORGH MI; Hur SJ, 2011, FOOD CHEM, V125, P1, DOI 10.1016/j.foodchem.2010.08.036; Johnson WB, 2010, CEREAL CHEM, V87, P524, DOI 10.1094/CCHEM-06-10-0087; Kayode APP, 2006, THESIS WAGENINGEN U, P1; Khattak AB, 2007, FOOD CHEM, V104, P1074, DOI 10.1016/j.foodchem.2007.01.022; Kumar V, 2010, FOOD CHEM, V120, P945, DOI 10.1016/j.foodchem.2009.11.052; LANDRY J, 1970, B SOC CHIM BIOL, V52, P1021; Lonnerdal B, 2000, J NUTR, V130, p1378S, DOI 10.1093/jn/130.5.1378S; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McDonough CM, 2004, J CEREAL SCI, V39, P351, DOI 10.1016/j.jcs.2004.01.001; Medugu C. I., 2010, Agriculture and Biology Journal of North America, V1, P321; Mokrane H, 2010, FOOD CHEM, V121, P719, DOI 10.1016/j.foodchem.2010.01.020; Moueium ZSA, 1996, FOOD CHEM, V57, P381, DOI 10.1016/S0308-8146(96)00006-4; ROSEN H, 1957, ARCH BIOCHEM BIOPHYS, V67, P10, DOI 10.1016/0003-9861(57)90241-2; SATHE SK, 1981, J FOOD SCI, V46, P82, DOI 10.1111/j.1365-2621.1981.tb14536.x; Shaker AMH, 1995, B NUTR I, V15, P87; Shallan M. A., 2010, Australian Journal of Basic and Applied Sciences, V4, P114; Shallan M. A., 2010, Electronic Journal of Environmental, Agricultural and Food Chemistry, V9, P958; Shehab GG, 2010, NOT BOT HORTI AGROBO, V38, P139; Soetan KO., 2009, AFRICAN J FOOD SCI, V3, P123; Steiner T, 2007, ANIM FEED SCI TECH, V133, P320, DOI 10.1016/j.anifeedsci.2006.04.007; Traore T, 2004, FOOD CHEM, V88, P105, DOI 10.1016/j.foodchem.2004.01.032; Vinay BJ, 2008, FOOD CHEM, V106, P77, DOI 10.1016/j.foodchem.2007.05.048; Wedad, 2008, Pakistan Journal of Nutrition, V7, P335; Zhao R, 2008, J AGR FOOD CHEM, V56, P946, DOI 10.1021/jf072590r	49	66	66	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31154	10.1371/journal.pone.0031154	http://dx.doi.org/10.1371/journal.pone.0031154			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319611	Green Published, gold, Green Submitted			2022-12-25	WOS:000302178400029
J	Anour, R; Andrukhova, O; Ritter, E; Zeitz, U; Erben, RG				Anour, Rene; Andrukhova, Olena; Ritter, Eva; Zeitz, Ute; Erben, Reinhold G.			Klotho Lacks a Vitamin D Independent Physiological Role in Glucose Homeostasis, Bone Turnover, and Steady-State PTH Secretion In Vivo	PLOS ONE			English	Article							MINERAL ION HOMEOSTASIS; D-RECEPTOR; DEFICIENT MICE; INSULIN SENSITIVITY; FUNCTIONAL VARIANT; HORMONE KLOTHO; TRPV5 CHANNEL; GENE; MOUSE; EXPRESSION	Apart from its function as co-receptor for fibroblast growth factor-23 (FGF23), Klotho is thought to regulate insulin signaling, intracellular oxidative stress, and parathyroid hormone (PTH) secretion in an FGF23 independent fashion. Here, we crossed Klotho deficient (Kl(-/-)) mice with vitamin D receptor (VDR) mutant mice to examine further vitamin D independent functions of Klotho. All mice were fed a rescue diet enriched with calcium, phosphorus, and lactose to prevent hyperparathyroidism in VDR mutants, and were killed at 4 weeks of age after double fluorochrome labeling. Kl(-/-) mice displayed hypercalcemia, hyperphosphatemia, dwarfism, organ atrophy, azotemia, pulmonary emphysema, and osteomalacia. In addition, glucose and insulin tolerance tests revealed hypoglycemia and profoundly increased peripheral insulin sensitivity in Kl(-/-) mice. Compound mutants were normocalcemic and normophosphatemic, did not show premature aging or organ atrophy, and were phenocopies of VDR mutant mice in terms of body weight, bone mineral density, bone metabolism, serum calcium, serum phosphate, serum PTH, gene expression in parathyroid glands, as well as urinary calcium and phosphate excretion. Furthermore, ablation of vitamin D signaling in double mutants completely normalized glucose and insulin tolerance, indicating that Klotho has no vitamin D independent effects on insulin signaling. Histomorphometry of pancreas islets showed similar beta cell volume per body weight in all groups of animals. In conclusion, our findings cast doubt on a physiologically relevant vitamin D and Fgf23 independent function of Klotho in the regulation of glucose metabolism, bone turnover, and steady-state PTH secretion in vivo.	[Anour, Rene; Andrukhova, Olena; Ritter, Eva; Zeitz, Ute; Erben, Reinhold G.] Univ Vet Med, Dept Biomed Sci, Inst Physiol Pathophysiol & Biophys, Vienna, Austria	University of Veterinary Medicine Vienna	Anour, R (corresponding author), Univ Vet Med, Dept Biomed Sci, Inst Physiol Pathophysiol & Biophys, Vienna, Austria.	Reinhold.Erben@vetmeduni.ac.at	Erben, Reinhold/AAG-8007-2020	Erben, Reinhold/0000-0003-0801-6958	von Fircks Fond; University of Veterinary Medicine Vienna	von Fircks Fond; University of Veterinary Medicine Vienna	This work was supported by the "von Fircks Fond" and grants from the University of Veterinary Medicine Vienna (www.vetmeduni.ac.at) to R. G. E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RT, 2009, J AM SOC NEPHROL, V20, P2371, DOI 10.1681/ASN.2008121273; Arking DE, 2005, CIRC RES, V96, P412, DOI 10.1161/01.RES.0000157171.04054.30; Arking DE, 2003, AM J HUM GENET, V72, P1154, DOI 10.1086/375035; Arking DE, 2002, P NATL ACAD SCI USA, V99, P856, DOI 10.1073/pnas.022484299; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Erben RG, 1997, J HISTOCHEM CYTOCHEM, V45, P307, DOI 10.1177/002215549704500215; Erben RG, 2002, MOL ENDOCRINOL, V16, P1524, DOI 10.1210/me.16.7.1524; Gattineni J., 2011, AM J PHYSL RENAL PHY; Hesse M, 2007, MATRIX BIOL, V26, P75, DOI 10.1016/j.matbio.2006.10.003; Hofbauer LC, 2009, ARTHRITIS RHEUM, V60, P1427, DOI 10.1002/art.24445; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Ichikawa S, 2007, J CLIN INVEST, V117, P2684, DOI 10.1172/JCI31330; Imura A, 2007, SCIENCE, V316, P1615, DOI 10.1126/science.1135901; Kuro-o M, 2010, MECH AGEING DEV, V131, P270, DOI 10.1016/j.mad.2010.02.008; Kuro-o M, 2009, BBA-GEN SUBJECTS, V1790, P1049, DOI 10.1016/j.bbagen.2009.02.005; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Lambers TT, 2006, KIDNEY INT, V69, P650, DOI 10.1038/sj.ki.5000169; Li H, 2011, AM J PHYSIOL-ENDOC M, V300, pE508, DOI 10.1152/ajpendo.00499.2010; Li YC, 1998, ENDOCRINOLOGY, V139, P4391, DOI 10.1210/en.139.10.4391; Lorenzi O, 2010, PFLUG ARCH EUR J PHY, V459, P465, DOI 10.1007/s00424-009-0735-2; Ohnishi M, 2009, KIDNEY INT, V75, P1166, DOI 10.1038/ki.2009.24; Okano T, 2004, J STEROID BIOCHEM, V89-90, P335, DOI 10.1016/j.jsbmb.2004.03.024; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rodriguez ME, 2007, AM J PHYSIOL-RENAL, V292, pF1390, DOI 10.1152/ajprenal.00262.2006; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Sitara D, 2006, AM J PATHOL, V169, P2161, DOI 10.2353/ajpath.2006.060329; Tsujikawa H, 2003, MOL ENDOCRINOL, V17, P2393, DOI 10.1210/me.2003-0048; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Utsugi T, 2000, METABOLISM, V49, P1118, DOI 10.1053/meta.2000.8606; Voshol PJ, 2003, ENDOCRINOLOGY, V144, P3456, DOI 10.1210/en.2002-0036; Weber K, 2009, J BONE MINER RES, V24, P22, DOI [10.1359/jbmr.0080904, 10.1359/JBMR.0080904]; Yamamoto M, 2005, J BIOL CHEM, V280, P38029, DOI 10.1074/jbc.M509039200; Yoshida T, 2002, ENDOCRINOLOGY, V143, P683, DOI 10.1210/en.143.2.683; Zeitz U, 2003, FASEB J, V17, P509, DOI 10.1096/fj.02-0424fje	37	37	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31376	10.1371/journal.pone.0031376	http://dx.doi.org/10.1371/journal.pone.0031376			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319626	Green Published, gold, Green Submitted			2022-12-25	WOS:000302178400038
J	Ishikawa, FH; Souza, EA; Shoji, JY; Connolly, L; Freitag, M; Read, ND; Roca, MG				Ishikawa, Francine H.; Souza, Elaine A.; Shoji, Jun-ya; Connolly, Lanelle; Freitag, Michael; Read, Nick D.; Roca, M. Gabriela			Heterokaryon Incompatibility Is Suppressed Following Conidial Anastomosis Tube Fusion in a Fungal Plant Pathogen	PLOS ONE			English	Article							COLLETOTRICHUM-LINDEMUTHIANUM; FILAMENTOUS FUNGI; SUPERNUMERARY CHROMOSOME; HYPHAL FUSION; VEGETATIVE COMPATIBILITY; HORIZONTAL GENE; MINAS-GERAIS; GLOEOSPORIOIDES; BIOTYPES; BRAZIL	It has been hypothesized that horizontal gene/chromosome transfer and parasexual recombination following hyphal fusion between different strains may contribute to the emergence of wide genetic variability in plant pathogenic and other fungi. However, the significance of vegetative (heterokaryon) incompatibility responses, which commonly result in cell death, in preventing these processes is not known. In this study, we have assessed this issue following different types of hyphal fusion during colony initiation and in the mature colony. We used vegetatively compatible and incompatible strains of the common bean pathogen Colletotrichum lindemuthianum in which nuclei were labelled with either a green or red fluorescent protein in order to microscopically monitor the fates of nuclei and heterokaryotic cells following hyphal fusion. As opposed to fusion of hyphae in mature colonies that resulted in cell death within 3 h, fusions by conidial anastomosis tubes (CAT) between two incompatible strains during colony initiation did not induce the vegetative incompatibility response. Instead, fused conidia and germlings survived and formed heterokaryotic colonies that in turn produced uninucleate conidia that germinated to form colonies with phenotypic features different to those of either parental strain. Our results demonstrate that the vegetative incompatibility response is suppressed during colony initiation in C. lindemuthianum. Thus, CAT fusion may allow asexual fungi to increase their genetic diversity, and to acquire new pathogenic traits.	[Ishikawa, Francine H.; Souza, Elaine A.] Univ Fed Lavras, Dept Biol, Lavras, MG, Brazil; [Connolly, Lanelle; Freitag, Michael] Oregon State Univ, Dept Biochem & Biophys, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA; [Ishikawa, Francine H.; Shoji, Jun-ya; Read, Nick D.; Roca, M. Gabriela] Univ Edinburgh, Fungal Cell Biol Grp, Inst Cell Biol, Edinburgh, Midlothian, Scotland	Universidade Federal de Lavras; Oregon State University; University of Edinburgh	Ishikawa, FH (corresponding author), Univ Fed Vale Sao Francisco, Colegiado Engn Agron, Petrolina, PE, Brazil.	easouza@dbi.ufla.br	Ishikawa, Francine/F-6962-2015	Ishikawa, Francine/0000-0002-7491-2657; Read, Nick/0000-0002-2286-2862	CNPQ (Brazil); American Cancer Society [RSG-08-030-01-CCG]; Biotechnological and Biological Sciences Research Council [BB/E010741/1]; Biotechnology and Biological Sciences Research Council [BB/E010741/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097637] Funding Source: NIH RePORTER; BBSRC [BB/E010741/1] Funding Source: UKRI	CNPQ (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); American Cancer Society(American Cancer Society); Biotechnological and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants and a scholarship from CNPQ (Brazil) to Francine Ishikawa and Elaine Souza, by a grant from the American Cancer Society (RSG-08-030-01-CCG) to Michael Freitag and a grant from the Biotechnological and Biological Sciences Research Council (BB/E010741/1) to Nick Read. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi Y, 2009, EUKARYOT CELL, V8, P1732, DOI 10.1128/EC.00135-09; Barcelos QL, 2011, GENET MOL RES, V10, P230, DOI 10.4238/vol10-1gmr907; Bos C, 1985, INDUCED MUTATION SOM; Camargo OA, 2007, GENET MOL RES, V6, P607; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Ruiz-Roldan MC, 2010, EUKARYOT CELL, V9, P1216, DOI 10.1128/EC.00040-10; Castro-Prado MAA, 2007, GENET MOL RES, V6, P634; Clutterbuck AJ, 1996, J GENET, V75, P281, DOI 10.1007/BF02966308; Coleman JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000618; Freitag M, 2005, FUNGAL GENET NEWSLET, V52, P14; Glass NL, 2006, CURR OPIN MICROBIOL, V9, P553, DOI 10.1016/j.mib.2006.09.001; Glass NL, 2003, EUKARYOT CELL, V2, P1, DOI 10.1128/EC.2.1.1-8.2003; Glass NL, 2000, ANNU REV GENET, V34, P165, DOI 10.1146/annurev.genet.34.1.165; Goodwin SB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002070; HABGOOD RM, 1970, NATURE, V227, P1268, DOI 10.1038/2271268a0; Harimoto Y, 2007, MOL PLANT MICROBE IN, V20, P1463, DOI 10.1094/MPMI-20-12-1463; He CZ, 1998, GENETICS, V150, P1459; Hickey PC, 2005, METHOD MICROBIOL, V34, P63, DOI 10.1016/S0580-8517(04)3403-1; Ishikawa FH, 2008, BIOLOGIA, V63, P156, DOI 10.2478/s11756-008-0039-6; Ishikawa FH, 2010, FUNGAL BIOL-UK, V114, P2, DOI 10.1016/j.funbio.2009.11.006; Ishikawa FH, 2010, CIENC AGROTEC, V34, P74, DOI 10.1590/S1413-70542010000100009; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Mahuku GS, 2004, EUR J PLANT PATHOL, V110, P253, DOI 10.1023/B:EJPP.0000019795.18984.74; Manners JM, 2011, MYCOL PROG, V10, P383, DOI 10.1007/s11557-011-0749-y; Masel AM, 1996, MOL PLANT MICROBE IN, V9, P339, DOI 10.1094/MPMI-9-0339; McGuire JC, 2005, MOL ECOL, V14, P3657, DOI [10.1111/j.1365-294X.2005.02693.x, 10.1111/j.1356-294X.2005.02693.x]; Mehrabi R, 2011, FEMS MICROBIOL REV, V35, P542, DOI 10.1111/j.1574-6976.2010.00263.x; MIAO VP, 1991, SCIENCE, V254, P1773, DOI 10.1126/science.1763326; Milgroom MG, 2009, FUNGAL GENET BIOL, V46, P849, DOI 10.1016/j.fgb.2009.07.007; O'Sullivan D, 1998, CURR GENET, V33, P291, DOI 10.1007/s002940050339; PASTOR-CORRALES M A, 1991, Phytopathology, V81, P694; Read ND, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P260; Read ND, 2009, CURR OPIN MICROBIOL, V12, P608, DOI 10.1016/j.mib.2009.09.008; Read ND, 2006, MOL B INT U, P87; Richards TA, 2006, CURR BIOL, V16, P1857, DOI 10.1016/j.cub.2006.07.052; Richards TA, 2011, CURR BIOL, V21, pR166, DOI 10.1016/j.cub.2011.01.028; Roca MG, 2010, EUKARYOT CELL, V9, P1171, DOI 10.1128/EC.00329-09; Roca M. M. G., 2003, Fitopatologia Brasileira, V28, P367, DOI 10.1590/S0100-41582003000400004; Roca MG, 2005, FEMS MICROBIOL LETT, V249, P191, DOI 10.1016/j.femsle.2005.06.048; Roca MG, 2005, EUKARYOT CELL, V4, P911, DOI 10.1128/EC.4.5.911-919.2005; Roca MG, 2004, MYCOL RES, V108, P1320, DOI 10.1017/S0953756204000838; Roca MG, 2003, FUNGAL GENET BIOL, V40, P138, DOI 10.1016/S1087-1845(03)00088-4; Sambrook J, 2001, MOL CLONING LAB MANU; Sanchez-Leon E, 2011, EUKARYOT CELL, V10, P683, DOI 10.1128/EC.00280-10; Sanders IR, 2006, TRENDS ECOL EVOL, V21, P656, DOI 10.1016/j.tree.2006.10.006; Schoonhoven A.V., 1987, STANDARD SYSTEM EVAL; Silar P, 1995, FUNG GENET NEWSLETT, V42, P73, DOI DOI 10.4148/1941-4765.1353; Silva KJDE, 2007, J PHYTOPATHOL, V155, P241; Souza EA, 2010, GENET MOL RES, V9, P1759, DOI 10.4238/vol9-3gmr863; STROMNAES O, 1963, GENETICS, V48, P653; TU JC, 1985, MICROBIOS, V44, P87	51	62	63	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e31175	10.1371/journal.pone.0031175	http://dx.doi.org/10.1371/journal.pone.0031175			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319613	Green Published, gold			2022-12-25	WOS:000301979000025
J	Evison, SEF; Roberts, KE; Laurenson, L; Pietravalle, S; Hui, J; Biesmeijer, JC; Smith, JE; Budge, G; Hughes, WOH				Evison, Sophie E. F.; Roberts, Katherine E.; Laurenson, Lynn; Pietravalle, Stephane; Hui, Jeffrey; Biesmeijer, Jacobus C.; Smith, Judith E.; Budge, Giles; Hughes, William O. H.			Pervasiveness of Parasites in Pollinators	PLOS ONE			English	Article							APIS-MELLIFERA-CAPENSIS; COLONY COLLAPSE DISORDER; ALFALFA LEAFCUTTING BEE; RNA EXTRACTION METHODS; BUMBLEBEES HYMENOPTERA; MEGACHILE-ROTUNDATA; WOLBACHIA SYMBIONTS; FLOWERING PLANTS; VIRAL PATHOGEN; COMMUNAL BEE	Many pollinator populations are declining, with large economic and ecological implications. Parasites are known to be an important factor in the some of the population declines of honey bees and bumblebees, but little is known about the parasites afflicting most other pollinators, or the extent of interspecific transmission or vectoring of parasites. Here we carry out a preliminary screening of pollinators (honey bees, five species of bumblebee, three species of wasp, four species of hoverfly and three genera of other bees) in the UK for parasites. We used molecular methods to screen for six honey bee viruses, Ascosphaera fungi, Microsporidia, and Wolbachia intracellular bacteria. We aimed simply to detect the presence of the parasites, encompassing vectoring as well as actual infections. Many pollinators of all types were positive for Ascosphaera fungi, while Microsporidia were rarer, being most frequently found in bumblebees. We also detected that most pollinators were positive for Wolbachia, most probably indicating infection with this intracellular symbiont, and raising the possibility that it may be an important factor in influencing host sex ratios or fitness in a diversity of pollinators. Importantly, we found that about a third of bumblebees (Bombus pascuorum and Bombus terrestris) and a third of wasps (Vespula vulgaris), as well as all honey bees, were positive for deformed wing virus, but that this virus was not present in other pollinators. Deformed wing virus therefore does not appear to be a general parasite of pollinators, but does interact significantly with at least three species of bumblebee and wasp. Further work is needed to establish the identity of some of the parasites, their spatiotemporal variation, and whether they are infecting the various pollinator species or being vectored. However, these results provide a first insight into the diversity, and potential exchange, of parasites in pollinator communities.	[Evison, Sophie E. F.; Roberts, Katherine E.; Biesmeijer, Jacobus C.; Hughes, William O. H.] Univ Leeds, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England; [Laurenson, Lynn; Pietravalle, Stephane; Budge, Giles] Food & Environm Res Agcy, Natl Bee Unit, York, N Yorkshire, England; [Hui, Jeffrey] Columbia Univ, Ctr Infect & Immun, New York, NY USA; [Biesmeijer, Jacobus C.] Netherlands Ctr Biodivers NCB Nat, Leiden, Netherlands; [Smith, Judith E.] Univ Salford, Sch Environm & Life Sci, Salford M5 4WT, Lancs, England	University of Leeds; Food & Environment Research Agency; Columbia University; Naturalis Biodiversity Center; University of Salford	Evison, SEF (corresponding author), Univ Leeds, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England.	w.o.h.hughes@leeds.ac.uk	Evison, Sophie/Y-3993-2019; Hughes, William OH/A-6957-2014	Hughes, William OH/0000-0003-0951-9768; Evison, Sophie/0000-0002-6210-533X; Smith, Judith/0000-0002-2206-3534; Biesmeijer, Koos/0000-0003-0328-0573	UKPopNet; Biotechnology and Biological Sciences Research Council; Leverhulme Foundation; Waterloo Foundation	UKPopNet; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leverhulme Foundation; Waterloo Foundation	Funding for this study was provided by the UKPopNet (awarded to WOHH, JCB and JES), the Biotechnology and Biological Sciences Research Council (awarded to KR), the Leverhulme Foundation (awarded to WOHH) and the Waterloo Foundation (awarded to GB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Anderson DL, 1998, MYCOL RES, V102, P541, DOI 10.1017/S0953756297005261; Arnal C, 1999, J VIROL METHODS, V77, P17, DOI 10.1016/S0166-0934(98)00083-4; Aronstein KA, 2010, J INVERTEBR PATHOL, V103, pS20, DOI 10.1016/j.jip.2009.06.018; BAILEY L, 1964, J INSECT PATHOL, V6, P395; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Berenos C, 2009, J EVOLUTION BIOL, V22, P2049, DOI 10.1111/j.1420-9101.2009.01821.x; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Blanchard P, 2007, J VIROL METHODS, V141, P7, DOI 10.1016/j.jviromet.2006.11.021; Breeze TD, 2011, AGR ECOSYST ENVIRON, V142, P137, DOI 10.1016/j.agee.2011.03.020; Brown MJF, 2009, APIDOLOGIE, V40, P410, DOI 10.1051/apido/2009019; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Chantawannakul P, 2006, J INVERTEBR PATHOL, V91, P69, DOI 10.1016/j.jip.2005.11.001; Colla SR, 2008, BIODIVERS CONSERV, V17, P1379, DOI 10.1007/s10531-008-9340-5; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; CROSS EA, 1992, J KANSAS ENTOMOL SOC, V65, P157; DURRER S, 1995, ECOGRAPHY, V18, P114, DOI 10.1111/j.1600-0587.1995.tb00331.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontaine C, 2006, PLOS BIOL, V4, P129, DOI 10.1371/journal.pbio.0040001; Fries I, 1999, EUR J PROTISTOL, V35, P183, DOI 10.1016/S0932-4739(99)80036-4; Frost CL, 2010, MOL ECOL, V19, P4077, DOI 10.1111/j.1365-294X.2010.04764.x; Fytrou A, 2006, P R SOC B, V273, P791, DOI 10.1098/rspb.2005.3383; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Genersch E, 2006, J INVERTEBR PATHOL, V91, P61, DOI 10.1016/j.jip.2005.10.002; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Goulson D., 2003, BUMBLEBEES BEHAV ECO; Hackett K, 2009, COLONY COLLAPSE DISO; Hale AD, 1996, J VIROL METHODS, V57, P195, DOI 10.1016/0166-0934(95)01966-9; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; HERMOSO-DE-MENDOZA M, 1989, J APICULT RES, V28, P61; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2007, J INVERTEBR PATHOL, V94, P211, DOI 10.1016/j.jip.2006.11.001; Higes M, 2010, ENV MICROBIOL REP, V2, P243, DOI 10.1111/j.1758-2229.2009.00099.x; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hoy MA, 2003, APIDOLOGIE, V34, P53, DOI 10.1051/apido:2002048; Hughes WOH, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-45; Jacobs JH, 2010, ARTHROPOD-PLANT INTE, V4, P19, DOI 10.1007/s11829-009-9080-9; James RR, 2005, J INVERTEBR PATHOL, V90, P98, DOI 10.1016/j.jip.2005.08.004; Jeong G, 2009, J MICROBIOL, V47, P28, DOI 10.1007/s12275-009-0198-3; Jeyaprakash A, 2003, J INVERTEBR PATHOL, V84, P96, DOI 10.1016/j.jip.2003.08.007; Jeyaprakash A, 2009, APIDOLOGIE, V40, P178, DOI 10.1051/apido/2009002; Johnson RM, 2009, P NATL ACAD SCI USA, V106, P14790, DOI 10.1073/pnas.0906970106; Kajobe R, 2010, J INVERTEBR PATHOL, V104, P153, DOI 10.1016/j.jip.2010.02.007; Kearns CA, 1997, BIOSCIENCE, V47, P297, DOI 10.2307/1313191; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Knight TM, 2005, ANNU REV ECOL EVOL S, V36, P467, DOI 10.1146/annurev.ecolsys.36.102403.115320; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; MCMANUS WR, 1984, MYCOLOGIA, V76, P830, DOI 10.2307/3793139; Meeus I, 2011, CONSERV BIOL, V25, P662, DOI 10.1111/j.1523-1739.2011.01707.x; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Morse R.A., 1997, HONEY BEE PESTS PRED; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Otti O, 2007, J INVERTEBR PATHOL, V96, P118, DOI 10.1016/j.jip.2007.03.016; Paxton RJ, 1997, APIDOLOGIE, V28, P129, DOI 10.1051/apido:19970304; Paxton RJ, 2007, APIDOLOGIE, V38, P558, DOI 10.1051/apido:2007037; Plischuk S, 2009, ENV MICROBIOL REP, V1, P131, DOI 10.1111/j.1758-2229.2009.00018.x; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Prendini L, 2005, ORG DIVERS EVOL, V5, P203, DOI 10.1016/j.ode.2004.12.004; Ratnieks FLW, 2010, SCIENCE, V327, P152, DOI 10.1126/science.1185563; Rotenberg D, 2009, PHYTOPATHOLOGY, V99, P404, DOI 10.1094/PHYTO-99-4-0404; Russell JA, 2009, EVOLUTION, V63, P624, DOI 10.1111/j.1558-5646.2008.00579.x; Schmid-Hempel P, 2001, NATURWISSENSCHAFTEN, V88, P147, DOI 10.1007/s001140100222; Schmid-Hempel P., 1998, Parasites in social insects.; Schmid-Hempel P, 1998, APIDOLOGIE, V29, P525, DOI 10.1051/apido:19980605; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Snook RR, 2000, GENETICS, V155, P167; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Terry RS, 2004, P ROY SOC B-BIOL SCI, V271, P1783, DOI 10.1098/rspb.2004.2793; TORCHIO PF, 1992, ENVIRON ENTOMOL, V21, P1086, DOI 10.1093/ee/21.5.1086; VANDENBERG JD, 1992, J INVERTEBR PATHOL, V60, P213, DOI 10.1016/0022-2011(92)90102-A; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Walker TN, 2011, ECOL ENTOMOL, V36, P588, DOI 10.1111/j.1365-2311.2011.01312.x; Wenseleers T, 1998, P ROY SOC B-BIOL SCI, V265, P1447, DOI 10.1098/rspb.1998.0456; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Williams PH, 2009, APIDOLOGIE, V40, P367, DOI 10.1051/apido/2009025; Youssef NN, 2001, MYCOTAXON, V77, P7	76	124	128	5	162	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2012	7	1							e30641	10.1371/journal.pone.0030641	http://dx.doi.org/10.1371/journal.pone.0030641			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	911FX	22347356	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000301703800022
J	Kikuchi, K; Soundararajan, A; Zarzabal, LA; Weems, CR; Nelon, LD; Hampton, ST; Michalek, JE; Rubin, BP; Fields, AP; Keller, C				Kikuchi, K.; Soundararajan, A.; Zarzabal, L. A.; Weems, C. R.; Nelon, L. D.; Hampton, S. T.; Michalek, J. E.; Rubin, B. P.; Fields, A. P.; Keller, C.			Protein kinase C iota as a therapeutic target in alveolar rhabdomyosarcoma	ONCOGENE			English	Article						alveolar rhabdomyosarcoma; protein kinase C iota; Rac1; mitosis; aurothiomalate; vincristine	TRANSFORMED GROWTH; CELL; EXPRESSION; VINCRISTINE; ACTIVATION; PAX3-FKHR; ONCOGENE; PHARMACOKINETICS; DIFFERENTIATION; RESISTANCE	Alveolar rhabdomyosarcoma is an aggressive pediatric cancer exhibiting skeletal-muscle differentiation. New therapeutic targets are required to improve the dismal prognosis for invasive or metastatic alveolar rhabdomyosarcoma. Protein kinase C iota (PKC iota) has been shown to have an important role in tumorigenesis of many cancers, but little is known about its role in rhabdomyosarcoma. Our gene-expression studies in human tumor samples revealed overexpression of PRKCl. We confirmed overexpression of PKC iota at the mRNA and protein levels using our conditional mouse model that authentically recapitulates the progression of rhabdomyosarcoma in humans. Inhibition of Prkci by RNA interference resulted in a dramatic decrease in anchorage-independent colony formation. Interestingly, treatment of primary cell cultures using aurothiomalate (ATM), which is a gold-containing classical anti-rheumatic agent and a PKC iota-specific inhibitor, resulted in decreased interaction between PKC iota and Par6, decreased Rac1 activity and reduced cell viability at clinically relevant concentrations. Moreover, co-treatment with ATM and vincristine (VCR), a nnicrotubule inhibitor currently used in rhabdomyosarcoma treatment regimens, resulted in a combination index of 0.470-0.793 through cooperative accumulation of non-proliferative multinuclear cells in the G2/M phase, indicating that these two drugs synergize. For in vivo tumor growth inhibition studies, ATM demonstrated a trend toward enhanced VCR sensitivity. Overall, these results suggest that PKC iota is functionally important in alveolar rhabdomyosarcoma anchorage-independent growth and tumor-cell proliferation and that combination therapy with ATM and microtubule inhibitors holds promise for the treatment of alveolar rhabdomyosarcoma. Oncogene (2013) 32, 286-295; doi:10.1038/onc.2012.46; published online 20 February 2012	[Kikuchi, K.; Keller, C.] Oregon Hlth & Sci Univ, Dept Pediat, Pape Family Pediat Res Inst, Pediat Canc Biol Program, Portland, OR 97239 USA; [Soundararajan, A.; Nelon, L. D.; Hampton, S. T.] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Zarzabal, L. A.; Michalek, J. E.] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol, San Antonio, TX 78229 USA; [Zarzabal, L. A.; Michalek, J. E.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biostat, San Antonio, TX 78229 USA; [Weems, C. R.; Fields, A. P.] Mayo Clin, Ctr Comprehens Canc, Dept Canc Biol, Jacksonville, FL 32224 USA; [Rubin, B. P.] Cleveland Clin, Taussig Canc Ctr, Dept Anat Pathol, Cleveland, OH 44106 USA; [Rubin, B. P.] Cleveland Clin, Taussig Canc Ctr, Dept Mol Genet, Cleveland, OH 44106 USA; [Rubin, B. P.] Lerner Res Inst, Cleveland, OH USA	Oregon Health & Science University; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Mayo Clinic; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Keller, C (corresponding author), Oregon Hlth & Sci Univ, Dept Pediat, Pape Family Pediat Res Inst, Pediat Canc Biol Program, 3181 SW Sam Jackson Pk Rd,Mail Code L321, Portland, OR 97239 USA.	keller@ohsu.edu	Kikuchi, Ken/ABG-8290-2020	Kikuchi, Ken/0000-0003-3097-7480; Keller, Charles/0000-0003-2505-7487	NIH/NCI Grant [1R01CA133229-04, 1R01CA133229-05, 4R01CA081436-13]; V Foundation for Cancer Research; National Cancer Institute; NICHD; NATIONAL CANCER INSTITUTE [R01CA133229, R01CA081436] Funding Source: NIH RePORTER	NIH/NCI Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V Foundation for Cancer Research; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH/NCI Grant 1R01CA133229-04 and -05 awarded to CK, NIH/NCI Grant 4R01CA081436-13 and the V Foundation for Cancer Research awarded to APF. Human tissue samples were provided by the Pediatric Cooperative Human Tissue network, which is funded by the National Cancer Institute. The Developmental Studies Hybridoma Bank is developed under the auspices of the NICHD and maintained by the University of Iowa, Iowa City, IA, USA.	Ali AS, 2009, CANCER TREAT REV, V35, P1, DOI 10.1016/j.ctrv.2008.07.006; Amstutz R, 2008, CANCER RES, V68, P3767, DOI 10.1158/0008-5472.CAN-07-2447; Anderson J, 1999, GENE CHROMOSOME CANC, V26, P275, DOI 10.1002/(SICI)1098-2264(199912)26:4<275::AID-GCC1>3.0.CO;2-3; Arndt CAS, 1999, NEW ENGL J MED, V341, P342, DOI 10.1056/NEJM199907293410507; BLOCKA KLN, 1986, CLIN PHARMACOKINET, V11, P133, DOI 10.2165/00003088-198611020-00003; BOUCHE M, 1995, CELL GROWTH DIFFER, V6, P845; Breneman JC, 2003, J CLIN ONCOL, V21, P78, DOI 10.1200/JCO.2003.06.129; Cen L, 2007, MODERN PATHOL, V20, P936, DOI 10.1038/modpathol.3800834; Chen LG, 1999, GYNECOL ONCOL, V72, P171, DOI 10.1006/gyno.1998.5242; Erdogan E, 2006, J BIOL CHEM, V281, P28450, DOI 10.1074/jbc.M606054200; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Fields AP, 2007, BIOCHEM SOC T, V35, P996, DOI 10.1042/BST0350996; Fields AP, 2007, PHARMACOL RES, V55, P487, DOI 10.1016/j.phrs.2007.04.015; Fields AP, 2008, ADV ENZYME REGUL, V48, P166, DOI 10.1016/j.advenzreg.2007.11.014; GERMANI A, 1994, BIOCHEM BIOPH RES CO, V202, P17, DOI 10.1006/bbrc.1994.1887; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hayes-Jordan A, 2009, CURR OPIN PEDIATR, V21, P373, DOI 10.1097/MOP.0b013e32832b4171; HOUGHTON JA, 1982, CANCER RES, V42, P535; Ishiguro H, 2009, P NATL ACAD SCI USA, V106, P16369, DOI 10.1073/pnas.0907044106; JORDAN MA, 1991, CANCER RES, V51, P2212; Keller C, 2004, GENE DEV, V18, P2614, DOI 10.1101/gad.1244004; Keller C, 2004, GENE DEV, V18, P2608, DOI 10.1101/gad.1243904; Limatola C, 1997, BIOCHEM J, V321, P497, DOI 10.1042/bj3210497; Liu LN, 1998, CELL GROWTH DIFFER, V9, P699; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; Maroto B, 2008, ONCOGENE, V27, P4900, DOI 10.1038/onc.2008.131; Murray NR, 2011, J CELL PHYSIOL, V226, P879, DOI 10.1002/jcp.22463; Murray NR, 1997, J BIOL CHEM, V272, P27521, DOI 10.1074/jbc.272.44.27521; Murray NR, 2004, J CELL BIOL, V164, P797, DOI 10.1083/jcb.200311011; NELSON RL, 1982, MED PEDIATR ONCOL, V10, P115, DOI 10.1002/mpo.2950100202; Nishijo K, 2009, CANCER RES, V69, P2902, DOI 10.1158/0008-5472.CAN-08-3723; Regala RP, 2008, CANCER RES, V68, P5888, DOI 10.1158/0008-5472.CAN-08-0438; Regala RP, 2009, CANCER RES, V69, P7603, DOI 10.1158/0008-5472.CAN-09-2066; Regala RP, 2005, CANCER RES, V65, P8905, DOI 10.1158/0008-5472.CAN-05-2372; Regala RP, 2005, J BIOL CHEM, V280, P31109, DOI 10.1074/jbc.M505402200; Rubin BP, 2011, CANCER CELL, V19, P177, DOI 10.1016/j.ccr.2010.12.023; Scotti ML, 2010, CANCER RES, V70, P2064, DOI 10.1158/0008-5472.CAN-09-2684; Sorensen PHB, 2002, J CLIN ONCOL, V20, P2672, DOI 10.1200/JCO.2002.03.137; Stallings-Mann M, 2006, CANCER RES, V66, P1767, DOI 10.1158/0008-5472.CAN-05-3405; Sundberg C, 2004, J BIOL CHEM, V279, P51601, DOI 10.1074/jbc.M403753200; Svensson K, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-10; TENNYSON GS, 1983, CANCER TREAT REP, V67, P1113; Thimmaiah KN, 2010, CANCER RES, V70, P2000, DOI 10.1158/0008-5472.CAN-09-3693; Thompson J, 1999, CLIN CANCER RES, V5, P3617; Wachtel M, 2010, CANCER TREAT REV, V36, P318, DOI 10.1016/j.ctrv.2010.02.007; Win HY, 2009, CELL PROLIFERAT, V42, P182, DOI 10.1111/j.1365-2184.2009.00582.x; Win HY, 2008, CANCER LETT, V270, P302, DOI 10.1016/j.canlet.2008.05.023; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Woodcock SA, 2010, CURR BIOL, V20, P669, DOI 10.1016/j.cub.2010.02.033; Zhang L, 2006, CANCER RES, V66, P4627, DOI 10.1158/0008-5472.CAN-05-4527	50	26	26	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 17	2013	32	3					286	295		10.1038/onc.2012.46	http://dx.doi.org/10.1038/onc.2012.46			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	087BP	22349825	Green Accepted			2022-12-25	WOS:000314736600003
J	Seiferth, A; Ruhs, S; Mildenberger, S; Gekle, M; Grossmann, C				Seiferth, Anja; Ruhs, Stefanie; Mildenberger, Sigrid; Gekle, Michael; Grossmann, Claudia			The phosphatase calcineurin PP2BA beta mediates part of mineralocorticoid receptor transcriptional activity	FASEB JOURNAL			English	Article						aldosterone; steroid hormone; transcription factor CREB; transcription factor NFaT	GROWTH-FACTOR RECEPTOR; A-BETA; CARDIAC-HYPERTROPHY; ESTROGEN-RECEPTOR; SMOOTH-MUSCLE; IN-VITRO; ALDOSTERONE; INHIBITION; ACTIVATION; APOPTOSIS	Recently it was shown that the mineralocorticoid receptor (MR) may exert part of its transcriptional activity by mediation of calcineurin (PP2B). Here we investigated the mechanism of interaction of MR with calcineurin and provide a new MR signaling pathway with potential physiological and pathophysiological relevance. MR -> calcineurin crosstalk was assessed in a heterologous expression system (human embryonic kidney cells), which provides the opportunity for detailed mechanistic investigation. SiRNA knockdown experiments show that activated MR, but not GR, reduces CREB-and enhances NFaT-mediated transcriptional activation via the catalytic calcineurin subunit PP2BA beta but not via PP2BA alpha. Altered PP2BA beta expression, elevated cytosolic Ca2+, activation of mitogen-activated kinase [p38, extracellular signal-regulated kinase (ERK) 1/2], or protein kinase C do not seem to be involved, whereas inhibition of the chaperone heat-shock protein 90 (HSP90) abrogated the effect of MR. Coimmunoprecipitation indicates the existence of protein complexes harboring MR and PP2BA beta independent of MR activation but dependent on HSP90. Activated MR alters the subcellular distribution of PP2BA beta, enhancing its nuclear fraction, and reduces mRNA expression of the endogenous inhibitor CAIN (calcineurin inhibitor) but not of RCAN1 (regulator of calcineurin). Overall, transcriptional relevant MR -> calcineurin crosstalk occurs via the catalytic subunit PP2BA beta, enables glucocorticoid response element-independent genomic signaling of MR, and is of potential pathophysiological relevance. Mechanistically, the crosstalk results from HSP90-mediated cytosolic protein complex formation, altered subcellular distribution, and altered endogenous inhibitor expression.-Seiferth, A., Ruhs, S., Mildenberger, S., Gekle, M., Grossmann, C. The phosphatase calcineurin PP2BA beta mediates part of mineralocorticoid receptor. FASEB J. 26, 2327-2337 (2012). www.fasebj.org	[Seiferth, Anja; Ruhs, Stefanie; Mildenberger, Sigrid; Gekle, Michael; Grossmann, Claudia] Univ Halle Wittenberg, Julius Bernstein Inst Physiol, D-06112 Halle, Saale, Germany	Martin Luther University Halle Wittenberg	Gekle, M (corresponding author), Univ Halle Wittenberg, Julius Bernstein Inst Physiol, Magdeburger Str 6, D-06112 Halle, Saale, Germany.	michael.gekle@medizin.uni-halle.de			Deutsche Forschungsgemeinschaft [Ge 905/13-1, Ge 905/14-1]; Medical School, Universitat Halle-Wittenberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical School, Universitat Halle-Wittenberg	This study was supported by the Deutsche Forschungsgemeinschaft (grants Ge 905/13-1 and 14-1) and the Wilhelm-Roux program of the Medical School, Universitat Halle-Wittenberg. The authors declare no conflicts of interest.	ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; Bueno OF, 2004, CIRC RES, V94, P91, DOI 10.1161/01.RES.0000107197.99679.77; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P4586, DOI 10.1073/pnas.072647999; Chan MC, 2011, MOL CELL BIOL, V31, P517, DOI 10.1128/MCB.00884-10; Dickhout JG, 2011, CIRC RES, V108, P629, DOI 10.1161/CIRCRESAHA.110.226803; Edwards DP, 2005, ANNU REV PHYSIOL, V67, P335, DOI 10.1146/annurev.physiol.67.040403.120151; Gekle M, 2002, AM J PHYSIOL-RENAL, V282, pF669, DOI 10.1152/ajprenal.00159.2001; Gekle M, 1996, P NATL ACAD SCI USA, V93, P10500, DOI 10.1073/pnas.93.19.10500; Gomez-Sanchez CE, 2006, ENDOCRINOLOGY, V147, P1343, DOI 10.1210/en.2005-0860; Grossmann C, 2005, MOL ENDOCRINOL, V19, P1697, DOI 10.1210/me.2004-0469; Grossmann C, 2004, AM J PHYSIOL-RENAL, V286, pF1226, DOI 10.1152/ajprenal.00378.2003; Grossmann C, 2010, STEROIDS, V75, P539, DOI 10.1016/j.steroids.2009.10.006; Grossmann C, 2010, FASEB J, V24, P2010, DOI 10.1096/fj.09-146985; Guo XX, 2011, BIOCHEM BIOPH RES CO, V407, P807, DOI 10.1016/j.bbrc.2011.03.104; Hallhuber M, 2006, CIRC RES, V99, P626, DOI 10.1161/01.RES.0000243208.59795.d8; Herzig S, 2000, PHYSIOL REV, V80, P173, DOI 10.1152/physrev.2000.80.1.173; Jabr RI, 2007, AM J PHYSIOL-CELL PH, V292, pC2213, DOI 10.1152/ajpcell.00139.2005; Krug AW, 2003, J BIOL CHEM, V278, P43060, DOI 10.1074/jbc.M308134200; Kupatt C, 2004, ARTERIOSCL THROM VAS, V24, P1435, DOI 10.1161/01.ATV.0000134300.87476.d1; Levin ER, 2003, MOL ENDOCRINOL, V17, P309, DOI 10.1210/me.2002-0368; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Liu JO, 2003, BIOCHEM BIOPH RES CO, V311, P1103, DOI 10.1016/j.bbrc.2003.10.020; Losel R, 2003, NAT REV MOL CELL BIO, V4, P46, DOI 10.1038/nrm1009; Mano A, 2004, CIRCULATION, V110, P317, DOI 10.1161/01.CIR.0000135599.33787.CA; Min LJ, 2009, J MOL CELL CARDIOL, V47, P798, DOI 10.1016/j.yjmcc.2009.09.006; Nilsson-Berglund LM, 2010, ARTERIOSCL THROM VAS, V30, P218, DOI 10.1161/ATVBAHA.109.199299; Orie NN, 2009, BRIT J PHARMACOL, V157, P554, DOI 10.1111/j.1476-5381.2009.00221.x; Pedram A, 2008, ENDOCRINOLOGY, V149, P3361, DOI 10.1210/en.2008-0133; Peng YD, 2010, CELL BIOL INT, V34, P447, DOI 10.1042/CBI20090301; Pfau A, 2007, MOL CELL ENDOCRINOL, V264, P35, DOI 10.1016/j.mce.2006.10.002; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Ritter O, 2003, TRENDS MOL MED, V9, P313, DOI 10.1016/S1471-4914(03)00114-X; Rochette-Egly C, 2005, J BIOL CHEM, V280, P32565, DOI 10.1074/jbc.R500008200; Rogatsky I, 1998, J BIOL CHEM, V273, P14315, DOI 10.1074/jbc.273.23.14315; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sharp SY, 2007, CANCER RES, V67, P2206, DOI 10.1158/0008-5472.CAN-06-3473; Shibasaki F, 2002, J BIOCHEM, V131, P1, DOI 10.1093/oxfordjournals.jbchem.a003063; Someren JS, 1999, BIOCHEM BIOPH RES CO, V260, P619, DOI 10.1006/bbrc.1999.0800; Takeda Y, 2002, CIRCULATION, V105, P677, DOI 10.1161/hc0602.104675; Thomas W, 2007, BIOCHEM SOC T, V35, P1049, DOI 10.1042/BST0351049; Tumlin JA, 1997, J CLIN INVEST, V99, P1217, DOI 10.1172/JCI119278; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Wohlfarth V, 2003, KIDNEY INT, V63, pS103, DOI 10.1046/j.1523-1755.63.s84.13.x	44	6	6	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2012	26	6					2327	2337		10.1096/fj.11-199976	http://dx.doi.org/10.1096/fj.11-199976			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	955KI	22345406				2022-12-25	WOS:000305017200011
J	Rasmussen, P; Nordsborg, N; Taudorf, S; Sorensen, H; Berg, RMG; Jacobs, RA; Bailey, DM; Olsen, NV; Secher, NH; Moller, K; Lundby, C				Rasmussen, Peter; Nordsborg, Nikolai; Taudorf, Sarah; Sorensen, Henrik; Berg, Ronan M. G.; Jacobs, Robert A.; Bailey, Damian M.; Olsen, Niels V.; Secher, Niels H.; Moller, Kirsten; Lundby, Carsten			Brain and skin do not contribute to the systemic rise in erythropoietin during acute hypoxia in humans	FASEB JOURNAL			English	Article						cerebrospinal fluid; O-2 sensing; synthesis; epidermal	OXYGEN; EXERCISE	Erythropoietin (EPO) preserves arterial oxygen content by controlling red blood cell and plasma volumes. Synthesis of EPO was long thought to relate inversely to renal oxygenation, but in knockout mice, brain and skin have been identified as essential for the acute hypoxic EPO response. Whether these findings apply to humans remains unknown. We exposed healthy young subjects to hypoxia (equivalent to 3800 m) and measured EPO in arterial and jugular venous plasma and in cerebrospinal fluid. To examine the role of the skin for EPO production during hypoxia, subjects were exposed to 8 h of hypobaric hypoxia with or without breathing oxygen-enriched air to ensure systemic normoxemia. With 9 h of hypoxia, arterial EPO increased (from 6.0+/-2.2 to 22.0+/-6.0 mU/ml, n=11, P<0.0001) and jugular venous EPO displayed a similar response (to 22.2+/-6.0 mU/ml, n=11). Thus, the arterio-jugular venous EPO difference was unaffected by hypoxia and also in cerebrospinal fluid EPO remained stable following hypoxic exposure (0.33+/-0.15 mU/ml, n=9 in normoxia vs. 0.41+/-0.20 mU/ml, n=9 in hypoxia, P=0.40). No change in plasma EPO was observed when only skin was exposed to hypobaric hypoxia (n=8). Thus, neither dermal oxygen exposure nor cerebral EPO production appears to be important for the systemic EPO response to acute hypoxia in healthy humans.-Rasmussen, P., Nordsborg, N., Taudorf, S., Sorensen, H., Berg, R. M. G., Jacobs, R. A., Bailey, D. M., Olsen, N. V., Secher, N. H., Moller, K., Lundby, C. Brain and skin do not contribute to the systemic rise in erythropoietin during acute hypoxia in humans. FASEB J. 26, 1831-1834 (2012). www.fasebj.org	[Rasmussen, Peter; Jacobs, Robert A.; Lundby, Carsten] Univ Zurich, Dept Physiol, Zurich Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland; [Rasmussen, Peter; Secher, Niels H.; Lundby, Carsten] Rigshosp, Copenhagen Muscle Res Ctr, DK-2100 Copenhagen, Denmark; [Taudorf, Sarah; Berg, Ronan M. G.; Moller, Kirsten] Rigshosp, Ctr Inflammat & Metab, DK-2100 Copenhagen, Denmark; [Sorensen, Henrik; Olsen, Niels V.; Secher, Niels H.; Moller, Kirsten] Rigshosp, Dept Anesthesiol, DK-2100 Copenhagen, Denmark; [Moller, Kirsten] Bispebjerg Hosp, Dept Anesthesiol, DK-2400 Copenhagen, Denmark; [Rasmussen, Peter; Olsen, Niels V.; Moller, Kirsten] Univ Copenhagen, Dept Neurosci & Pharmacol, DK-1168 Copenhagen, Denmark; [Nordsborg, Nikolai] Univ Copenhagen, Dept Sports & Exercise Sci, DK-1168 Copenhagen, Denmark; [Bailey, Damian M.] Univ Glamorgan, Fac Hlth Sci & Sport, Neurovasc Res Lab, Cardiff, S Glam, Wales	University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; University of Copenhagen; University of South Wales	Lundby, C (corresponding author), Univ Zurich, Dept Physiol, Zurich Ctr Integrat Human Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	carsten.lundby@access.uzh.ch	Sørensen, Henrik/H-8404-2013; Ernst-Rasmussen, Peter Bonde/B-8203-2013; Bailey, Damian Miles/AAQ-1840-2020; Jacobs, Robert A/G-8439-2015; Moller, Kirsten/A-4751-2009; Nordsborg, Nikolai/O-6173-2014	Sørensen, Henrik/0000-0003-0819-106X; Ernst-Rasmussen, Peter Bonde/0000-0003-1761-4562; Jacobs, Robert A/0000-0003-0180-8266; Moller, Kirsten/0000-0003-3058-1072; Nordsborg, Nikolai/0000-0001-7077-9265; Berg, Ronan/0000-0002-5757-9506	Danish National Research Council [10-094110, 22-04-0413, 504-14, DG 02-512-555]; Anti-Doping Denmark; Copenhagen Hospital Corporation; Laerdal Foundation; AP Moller Foundation; Jens la Cour Foundation; Larsen Foundation; Hojmosegaard Foundation; P. Carl Petersen Foundation; Novo Nordisk Foundation; Lundbeck Foundation; Commission of the European Communities [LSHM-CT-2004-005272 EXGENESIS]; Hypoxianet.com [COST-STSM-TD0901-8234]	Danish National Research Council(Danmarks Grundforskningsfond); Anti-Doping Denmark; Copenhagen Hospital Corporation; Laerdal Foundation; AP Moller Foundation; Jens la Cour Foundation; Larsen Foundation; Hojmosegaard Foundation; P. Carl Petersen Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Commission of the European Communities(European Commission); Hypoxianet.com	This study was supported by grants from the Danish National Research Council (10-094110, 22-04-0413, 504-14, and DG 02-512-555), Anti-Doping Denmark, the Copenhagen Hospital Corporation, the Laerdal Foundation, the AP Moller Foundation, the Jens la Cour Foundation, the Larsen Foundation, the Hojmosegaard Foundation, the P. Carl Petersen Foundation, the Novo Nordisk Foundation, the Lundbeck Foundation, the Commission of the European Communities (contract LSHM-CT-2004-005272 EXGENESIS), and Hypoxianet.com (COST-STSM-TD0901-8234). The authors acknowledge the skillful assistance of Niels J. Aachmann-Andersen, Thomas Bonne, Birgit H. Hansen, and Merete Nielsen. The authors declare no conflicts of interest.	ABBRECHT PH, 1966, AM J PHYSIOL, V210, P237, DOI 10.1152/ajplegacy.1966.210.2.237; Bernaudin M, 2000, GLIA, V30, P271, DOI 10.1002/(SICI)1098-1136(200005)30:3<271::AID-GLIA6>3.3.CO;2-8; Bodo E, 2007, FASEB J, V21, P3346, DOI 10.1096/fj.07-8628com; Boutin AT, 2008, CELL, V133, P223, DOI 10.1016/j.cell.2008.02.038; GONZALEZ NC, 1991, J APPL PHYSIOL, V71, P1041, DOI 10.1152/jappl.1991.71.3.1041; KNAUPP W, 1992, J APPL PHYSIOL, V73, P837, DOI 10.1152/jappl.1992.73.3.837; Lundby C, 2007, J PHYSIOL-LONDON, V578, P309, DOI 10.1113/jphysiol.2006.122689; Olsen NV, 2011, J PHYSIOL-LONDON, V589, P1273, DOI 10.1113/jphysiol.2010.194241; Pellegri G, 1996, MOL BRAIN RES, V38, P191, DOI 10.1016/0169-328X(95)00305-C; Rasmussen P, 2010, J APPL PHYSIOL, V109, P476, DOI 10.1152/japplphysiol.00234.2010; Rasmussen P, 2007, J CEREBR BLOOD F MET, V27, P1082, DOI 10.1038/sj.jcbfm.9600416; Robach P, 2007, BLOOD, V109, P4724, DOI 10.1182/blood-2006-08-040006; Simmons GH, 2007, J APPL PHYSIOL, V103, P608, DOI 10.1152/japplphysiol.01443.2006; Weidemann A, 2009, J CLIN INVEST, V119, P3373, DOI 10.1172/JCI39378	14	10	10	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2012	26	5					1831	1834		10.1096/fj.11-191692	http://dx.doi.org/10.1096/fj.11-191692			4	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22321729				2022-12-25	WOS:000303680800011
J	Martinez, J; Nguyen, LD; Hinderlich, S; Zimmer, R; Tauberger, E; Reutter, W; Saenger, W; Fan, H; Moniot, S				Martinez, Jacobo; Long Duc Nguyen; Hinderlich, Stephan; Zimmer, Reinhold; Tauberger, Eva; Reutter, Werner; Saenger, Wolfram; Fan, Hua; Moniot, Sebastien			Crystal Structures of N-Acetylmannosamine Kinase Provide Insights into Enzyme Activity and Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLGLUCOSAMINE 2-EPIMERASE/N-ACETYLMANNOSAMINE KINASE; INCLUSION-BODY MYOPATHY; ATP-DEPENDENT GLUCOKINASE; UDP-GLCNAC 2-EPIMERASE; ACETYLNEURAMINIC ACID; SIALIC ACIDS; SUBSTRATE-SPECIFICITY; ESCHERICHIA-COLI; BIOSYNTHESIS; METASTASIS	Sialic acids are essential components of membrane glycoconjugates. They are responsible for the interaction, structure, and functionality of all deuterostome cells and have major functions in cellular processes in health and diseases. The key enzyme of the biosynthesis of sialic acid is the bifunctional UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase that transforms UDP-N-acetylglucosamine to N-acetylmannosamine (ManNAc) followed by its phosphorylation to ManNAc 6-phosphate and has a direct impact on the sialylation of cell surface components. Here, we present the crystal structures of the human N-acetylmannosamine kinase (MNK) domain of UDP-N-acetylglucosamine- 2-epimerase/N-acetylmannosamine kinase in complexes with ManNAc at 1.64 angstrom resolution, MNK.ManNAc.ADP (1.82 angstrom) and MNK.ManNAc 6-phosphate.ADP (2.10 angstrom). Our findings offer detailed insights in the active center of MNK and serve as a structural basis to design inhibitors. We synthesized a novel inhibitor, 6-O-acetyl-ManNAc, which is more potent than those previously tested. Specific inhibitors of sialic acid biosynthesis may serve to further study biological functions of sialic acid.	[Long Duc Nguyen; Reutter, Werner; Fan, Hua] Charite, Inst Biochem & Mol Biol, D-14195 Berlin, Germany; [Martinez, Jacobo; Tauberger, Eva; Saenger, Wolfram; Moniot, Sebastien] Free Univ Berlin, Inst Chem & Biochem Kristallog, D-14195 Berlin, Germany; [Hinderlich, Stephan] Beuth Hsch Tech Berlin, Fachbereich Life Sci & Technol, Lab Biochem, D-13347 Berlin, Germany; [Zimmer, Reinhold] Free Univ Berlin, Inst Chem & Biochem Organ Chem, D-14195 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Berliner Hochschule fur Technik; Free University of Berlin	Fan, H (corresponding author), Charite, Inst Biochem & Mol Biol, Campus Benjamin Franklin,Arnimallee 22, D-14195 Berlin, Germany.	hua.fan@charite.de; sebastien.moniot@uni-bayreuth.de			Sonnenfeld Stiftung; Roland and Elfriede Schauer Stiftung; DFG [Sonderforschungsbereich 449]; Bundesministerium fur Bildung und Forschung; German-Israeli Foundation for Research and Development; Helmholtz Zentrum Berlin fur Materialien and Energie; Freie Universitat Berlin; Humboldt-Universitat zu Berlin; Max-Delbruck Centrum; Leibniz-Institut fur Molekulare Pharmakologie	Sonnenfeld Stiftung; Roland and Elfriede Schauer Stiftung; DFG(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); German-Israeli Foundation for Research and Development(German-Israeli Foundation for Scientific Research and Development); Helmholtz Zentrum Berlin fur Materialien and Energie; Freie Universitat Berlin; Humboldt-Universitat zu Berlin; Max-Delbruck Centrum; Leibniz-Institut fur Molekulare Pharmakologie	This work was supported in part by the Sonnenfeld Stiftung, the Roland and Elfriede Schauer Stiftung, and by DFG-Sonderforschungsbereich 449.; Supported by Bundesministerium fur Bildung und Forschung and the German-Israeli Foundation for Research and Development.; We acknowledge access to beamline BL14.2 of the BESSY II storage ring (Berlin, Germany) via the Joint Berlin MX-Laboratory sponsored by the Helmholtz Zentrum Berlin fur Materialien and Energie, Freie Universitat Berlin, Humboldt-Universitat zu Berlin, Max-Delbruck Centrum, and Leibniz-Institut fur Molekulare Pharmakologie. We thank Johannes Schwan and Prof. H.-U. Reissig for help in 6-O-Ac-ManNAc synthesis.	Al-Rawi S, 2004, ANGEW CHEM INT EDIT, V43, P4366, DOI 10.1002/anie.200453863; Aleshin AE, 2000, J MOL BIOL, V296, P1001, DOI 10.1006/jmbi.1999.3494; Argov Z, 2008, NEUROTHERAPEUTICS, V5, P633, DOI 10.1016/j.nurt.2008.07.004; BHAVANANDAN V P, 1991, Glycobiology, V1, P493, DOI 10.1093/glycob/1.5.493; BRESALIER RS, 1990, CANCER RES, V50, P1299; Chen SH, 2006, METHOD ENZYMOL, V416, P371, DOI 10.1016/S0076-6879(06)16024-3; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cordeiro AT, 2007, J MOL BIOL, V372, P1215, DOI 10.1016/j.jmb.2007.07.021; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DENNIS JW, 1987, CANCER METAST REV, V5, P185, DOI 10.1007/BF00046998; Eisenberg I, 2001, NAT GENET, V29, P83, DOI 10.1038/ng718; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ghaderi D, 2007, J MOL BIOL, V369, P746, DOI 10.1016/j.jmb.2007.03.037; GRUNHOLZ HJ, 1981, CARBOHYD RES, V96, P259, DOI 10.1016/S0008-6215(00)81876-5; Hansen T, 2002, J BACTERIOL, V184, P5955, DOI 10.1128/JB.184.21.5955-5965.2002; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Hinderlich S, 1997, J BIOL CHEM, V272, P24313, DOI 10.1074/jbc.272.39.24313; Hinderlich S, 2000, EUR J BIOCHEM, V267, P3301, DOI 10.1046/j.1432-1327.2000.01360.x; Hinderlich S, 2004, FEBS LETT, V566, P105, DOI 10.1016/j.febslet.2004.04.013; Huizing M, 2009, BBA-MOL BASIS DIS, V1792, P881, DOI 10.1016/j.bbadis.2009.07.001; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelm S, 1997, INT REV CYTOL, V175, P137, DOI 10.1016/S0074-7696(08)62127-0; Keppler OT, 1999, SCIENCE, V284, P1372, DOI 10.1126/science.284.5418.1372; Kim YJ, 1997, GLYCOCONJUGATE J, V14, P569, DOI 10.1023/A:1018580324971; KORNFELD S, 1964, P NATL ACAD SCI USA, V52, P371, DOI 10.1073/pnas.52.2.371; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lawrence SM, 2000, J BIOL CHEM, V275, P17869, DOI 10.1074/jbc.M000217200; Lunin VV, 2004, J BACTERIOL, V186, P6915, DOI 10.1128/JB.186.20.6915-6927.2004; Mesak LR, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-6; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishimasu H, 2007, J BIOL CHEM, V282, P9923, DOI 10.1074/jbc.M610678200; Nocek B, 2011, J MOL BIOL, V406, P325, DOI 10.1016/j.jmb.2010.12.021; Penner J, 2006, BIOCHEMISTRY-US, V45, P2968, DOI 10.1021/bi0522504; Petit P, 2011, ACTA CRYSTALLOGR D, V67, P929, DOI 10.1107/S0907444911036729; Raval GN, 2003, ORAL DIS, V9, P119, DOI 10.1034/j.1601-0825.2003.01795.x; Reinke SO, 2009, BIOL CHEM, V390, P591, DOI 10.1515/BC.2009.073; ROSEMAN S, 1970, CHEM PHYS LIPIDS, V5, P270, DOI 10.1016/0009-3084(70)90024-1; SAWADA R, 1994, J BIOL CHEM, V269, P1425; Schauer R, 2004, ZOOLOGY, V107, P49, DOI 10.1016/j.zool.2003.10.002; Schiefner A, 2005, J BIOL CHEM, V280, P29073, DOI 10.1074/jbc.M504215200; Sinev MA, 1996, BIOCHEMISTRY-US, V35, P6425, DOI 10.1021/bi952687j; Stolz F, 2004, J ORG CHEM, V69, P665, DOI 10.1021/jo0353029; TITGEMEYER F, 1994, MICROBIOL-UK, V140, P2349, DOI 10.1099/13500872-140-9-2349; Tong YF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007165; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Varki A, 1997, FASEB J, V11, P248, DOI 10.1096/fasebj.11.4.9068613; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Varki NM, 2002, SEMIN THROMB HEMOST, V28, P53, DOI 10.1055/s-2002-20564; Weihofen WA, 2006, J MOL BIOL, V364, P388, DOI 10.1016/j.jmb.2006.08.085; WEISS P, 1989, J BIOL CHEM, V264, P17635; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; ZEITLER R, 1992, EUR J BIOCHEM, V204, P1165, DOI 10.1111/j.1432-1033.1992.tb16743.x	52	22	24	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13656	13665		10.1074/jbc.M111.318170	http://dx.doi.org/10.1074/jbc.M111.318170			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22343627	hybrid, Green Published			2022-12-25	WOS:000303996300021
J	Guo, C; Gow, CH; Li, YL; Gardner, A; Khan, S; Zhang, JS				Guo, Chun; Gow, Chien-Hung; Li, Yali; Gardner, Amanda; Khan, Sohaib; Zhang, Jinsong			Regulated Clearance of Histone Deacetylase 3 Protects Independent Formation of Nuclear Receptor Corepressor Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-COR COREPRESSORS; TRANSCRIPTIONAL REPRESSION; HORMONE RECEPTORS; SMRT COREPRESSOR; SIGNALING PATHWAYS; SILENCING MEDIATOR; DOWN-REGULATION; IN-VIVO; HDAC3; CELL	An important step in transcriptional regulation by corepressors N-CoR and SMRT is the formation of a stable and active histone deacetylase 3 (HDAC3)-containing complex. Although N-CoR and SMRT are thought to bind HDAC3 competitively, multiple studies have shown that they do not interfere with the function of each other. How this functional independence is sustained under the competitive interaction is unclear. Here, we show that the coupling of corepressor expression with HDAC3 degradation allows cells to maintain a stable level of uncomplexed HDAC3, thereby preventing mutual interference in the assembly of N-CoR and SMRT complexes. The free uncomplexed HDAC3 is highly unstable. Unexpectedly, the rate of HDAC3 degradation is inversely correlated with the expression level of corepressors. Our results indicate that reducing one corepressor accelerates HDAC3 clearance, thus preventing an increase in complex formation between HDAC3 and the other corepressor. In addition, this study also indicates that the formation of a stable and active HDAC3-corepressor complex is a stepwise process in which the C terminus of HDAC3 plays a critical role at late steps of the assembly process.	[Guo, Chun; Gow, Chien-Hung; Li, Yali; Gardner, Amanda; Khan, Sohaib; Zhang, Jinsong] Univ Cincinnati, Coll Med, Vontz Ctr Mol Studies, Dept Canc & Cell Biol, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Zhang, JS (corresponding author), Univ Cincinnati, Coll Med, Vontz Ctr Mol Studies, Dept Canc & Cell Biol, 3125 Eden Ave, Cincinnati, OH 45267 USA.	Jinsong.Zhang@uc.edu		Khan, Sohaib/0000-0002-0792-9109; Zhang, Jinsong/0000-0002-8798-7316	National Institutes of Health [R01HL093195, T32CA059268]; University of Cincinnati Cancer Center; University Research Council; NATIONAL CANCER INSTITUTE [T32CA059268] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093195] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Cincinnati Cancer Center; University Research Council; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL093195 (to J. Z.) and Training Grant T32CA059268 (to A. G.). This work was also supported by University of Cincinnati Cancer Center and University Research Council grants (to J. Z.).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Alenghat T, 2008, NATURE, V456, P997, DOI 10.1038/nature07541; Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Cohen Ronald N, 2006, Nucl Recept Signal, V4, pe003; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Frasor J, 2005, P NATL ACAD SCI USA, V102, P13153, DOI 10.1073/pnas.0502782102; Ghisletti S, 2009, GENE DEV, V23, P681, DOI 10.1101/gad.1773109; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; Guenther MG, 2000, GENE DEV, V14, P1048; Guenther MG, 2002, GENE DEV, V16, P3130, DOI 10.1101/gad.1037502; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Guo C, 2009, MOL CELL BIOL, V29, P2644, DOI 10.1128/MCB.00073-09; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Hassig CA, 1997, CURR OPIN CHEM BIOL, V1, P300, DOI 10.1016/S1367-5931(97)80066-X; Hoberg JE, 2004, MOL CELL, V16, P245, DOI 10.1016/j.molcel.2004.10.010; Hong SH, 2000, MOL CELL BIOL, V20, P6612, DOI 10.1128/MCB.20.17.6612-6625.2000; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hu QD, 2011, MOL CELL BIOL, V31, P3223, DOI 10.1128/MCB.01365-10; Hu X, 2001, MOL CELL BIOL, V21, P1747, DOI 10.1128/MCB.21.5.1747-1758.2001; Humphrey GW, 2001, J BIOL CHEM, V276, P6817, DOI 10.1074/jbc.M007372200; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Jepsen K, 2008, GENE DEV, V22, P740, DOI 10.1101/gad.1637108; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Jonas BA, 2004, J BIOL CHEM, V279, P54676, DOI 10.1074/jbc.M410128200; Karagianni P, 2007, ONCOGENE, V26, P5439, DOI 10.1038/sj.onc.1210612; Kojima T, 2001, MOL BRAIN RES, V90, P174, DOI 10.1016/S0169-328X(01)00107-3; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Martinez E, 2001, MOL CELL BIOL, V21, P6782, DOI 10.1128/MCB.21.20.6782-6795.2001; Miao J, 2009, MOL CELL BIOL, V29, P6170, DOI 10.1128/MCB.00825-09; Park EJ, 1999, P NATL ACAD SCI USA, V96, P3519, DOI 10.1073/pnas.96.7.3519; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Peterson TJ, 2007, MOL CELL BIOL, V27, P5933, DOI 10.1128/MCB.00237-07; Rajendran P, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-68; Spurling CC, 2008, MOL CARCINOGEN, V47, P137, DOI 10.1002/mc.20373; Xia Y, 2007, MOL CELL, V25, P219, DOI 10.1016/j.molcel.2007.01.005; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; You SH, 2010, MOL ENDOCRINOL, V24, P1359, DOI 10.1210/me.2009-0501; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zhang XH, 2005, GENE DEV, V19, P827, DOI 10.1101/gad.1286005; Zhao HL, 2010, BIOCHEM BIOPH RES CO, V399, P623, DOI 10.1016/j.bbrc.2010.07.127; Zhao Y, 2008, MOL CELL, V29, P92, DOI 10.1016/j.molcel.2007.12.011	48	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12111	12120		10.1074/jbc.M111.327023	http://dx.doi.org/10.1074/jbc.M111.327023			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22337871	hybrid, Green Published			2022-12-25	WOS:000302782200047
J	Tran, P; Ho, SM; Kim, BG; Vuong, TA; Leem, YE; Bae, GU; Kang, JS				Phong Tran; Ho, Seok-Man; Kim, Bok-Geon; Tuan Anh Vuong; Leem, Young-Eun; Bae, Gyu-Un; Kang, Jong-Sun			TGF-beta-activated Kinase 1 (TAK1) and Apoptosis Signal-regulating Kinase 1 (ASK1) Interact with the Promyogenic Receptor Cdo to Promote Myogenic Differentiation via Activation of p38MAPK Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; NEURONAL DIFFERENTIATION; P38-ALPHA/BETA MAPK; P38; STRESS; DEFICIENT; SURVIVAL; BINDING; MEMBER; MYOD	p38MAPK plays an essential role in the transition of myoblasts to differentiated myotubes through the activation of MyoD family transcription factors. A promyogenic cell surface molecule, Cdo, promotes myogenic differentiation mainly through activation of the p38MAPK pathway. Two MAP3Ks, TAK1 and ASK1, can activate p38MAPK via MKK6 in various cell systems. Moreover TAK1 has been shown to promote myogenic differentiation via p38MAPK activation. In this study, we hypothesized that TAK1 and ASK1 might function as MAP3Ks in Cdo-mediated p38MAPK activation during myoblast differentiation. Both ASK1 and TAK1 were expressed in myoblasts and interacted with the cytoplasmic tail of Cdo and a scaffold protein, JLP. The depletion of TAK1 or ASK1 in C2C12 cells decreased myoblast differentiation, whereas overexpression of TAK1 or ASK1 in C2C12 cells enhanced myotube formation. In agreement with this, overexpression of ASK1 or TAK1 resulted in enhanced p38MAPK activation, and their knockdown inhibited p38MAPK in C2C12 cells. Overexpression of TAK1 or ASK1 in Cdo(-/-) myoblasts and Cdo-depleted C2C12 cells restored p38MAPK activation as well as myotube formation. Furthermore, ASK1 and TAK1 compensated for each other in p38MAPK activation and myoblast differentiation. Taken together, these findings suggest that ASK1 and TAK1 function as MAP3Ks in Cdo-mediated p38MAPK activation to promote myogenic differentiation.	[Phong Tran; Ho, Seok-Man; Kim, Bok-Geon; Tuan Anh Vuong; Leem, Young-Eun; Bae, Gyu-Un; Kang, Jong-Sun] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol, Suwon 440746, South Korea; [Bae, Gyu-Un] Sookmyung Womens Univ, Coll Pharm, Seoul 140742, South Korea	Sungkyunkwan University (SKKU); Sookmyung Women's University	Bae, GU (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol, Suwon 440746, South Korea.	powerbg@skku.edu; kangj01@skku.edu	Tran, Phong/GZA-8504-2022		National Research Foundation (NRF) [2011-0030154, 2011-0017315]; Korean government (MEST)	National Research Foundation (NRF); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by National Research Foundation (NRF) Bio and Medical Technology Development Program Grant 2011-0030154 and NRF Grant 2011-0017315 (to J. S. K.) funded by the Korean government (MEST).	Bae GU, 2010, MOL BIOL CELL, V21, P2399, DOI 10.1091/mbc.E09-12-1011; Bae GU, 2009, MOL CELL BIOL, V29, P4130, DOI 10.1128/MCB.00199-09; Bhatnagar S, 2010, J BIOL CHEM, V285, P6401, DOI 10.1074/jbc.M109.064063; Cole F, 2004, DEV CELL, V7, P843, DOI 10.1016/j.devcel.2004.10.009; Cuenda A, 1999, J BIOL CHEM, V274, P4341, DOI 10.1074/jbc.274.7.4341; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; Faigle R, 2004, MOL CELL BIOL, V24, P280, DOI 10.1128/MCB.24.1.280-293.2004; Han JW, 2011, CELL SIGNAL, V23, P1162, DOI 10.1016/j.cellsig.2011.03.001; HuangFu WC, 2006, J BIOL CHEM, V281, P28802, DOI 10.1074/jbc.M603627200; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kang JS, 2008, J CELL BIOL, V182, P497, DOI 10.1083/jcb.200801119; Kang JS, 2003, P NATL ACAD SCI USA, V100, P3989, DOI 10.1073/pnas.0736565100; Kang JS, 2002, EMBO J, V21, P114, DOI 10.1093/emboj/21.1.114; Kang JS, 2004, J CELL BIOL, V167, P493, DOI 10.1083/jcb.200405039; Keren A, 2006, MOL CELL ENDOCRINOL, V252, P224, DOI 10.1016/j.mce.2006.03.017; Lee H. J., 2012, MOL BIOL CE IN PRESS; Leem YE, 2011, CELL SIGNAL, V23, P2021, DOI 10.1016/j.cellsig.2011.07.016; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; Lluis F, 2005, EMBO J, V24, P974, DOI 10.1038/sj.emboj.7600528; Lu M, 2010, P NATL ACAD SCI USA, V107, P4212, DOI 10.1073/pnas.0908883107; Meriane M, 2000, MOL BIOL CELL, V11, P2513, DOI 10.1091/mbc.11.8.2513; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; Oh JE, 2009, FASEB J, V23, P2088, DOI 10.1096/fj.08-119255; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Perdiguero E, 2007, EMBO J, V26, P1245, DOI 10.1038/sj.emboj.7601587; Ruiz-Bonilla V, 2008, CELL CYCLE, V7, P2208, DOI 10.4161/cc.7.14.6273; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sayama K, 2001, J BIOL CHEM, V276, P999, DOI 10.1074/jbc.M003425200; Sayama K, 2006, J BIOL CHEM, V281, P22013, DOI 10.1074/jbc.M601065200; Serra C, 2007, MOL CELL, V28, P200, DOI 10.1016/j.molcel.2007.08.021; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Shim JH, 2009, EMBO J, V28, P2028, DOI 10.1038/emboj.2009.162; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Takaesu G, 2006, J CELL BIOL, V175, P383, DOI 10.1083/jcb.200608031; Takeda K, 2000, J BIOL CHEM, V275, P9805, DOI 10.1074/jbc.275.13.9805; Takeda K, 2008, ANNU REV PHARMACOL, V48, P199, DOI 10.1146/annurev.pharmtox.48.113006.094606; Tang MH, 2008, J EXP MED, V205, P1611, DOI 10.1084/jem.20080297; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Zhang W, 2006, DEV CELL, V10, P657, DOI 10.1016/j.devcel.2006.04.005	45	30	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11602	11615		10.1074/jbc.M112.351601	http://dx.doi.org/10.1074/jbc.M112.351601			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22337877	hybrid, Green Published			2022-12-25	WOS:000302782200001
J	Arnold, SA; Rivera, LB; Carbon, JG; Toombs, JE; Chang, CL; Bradshaw, AD; Brekken, RA				Arnold, Shanna A.; Rivera, Lee B.; Carbon, Juliet G.; Toombs, Jason E.; Chang, Chi-Lun; Bradshaw, Amy D.; Brekken, Rolf A.			Losartan Slows Pancreatic Tumor Progression and Extends Survival of SPARC-Null Mice by Abrogating Aberrant TGF beta Activation	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; REGULATORY T-CELLS; RECEPTOR-TYPE-I; AORTIC-ANEURYSM; MARFAN-SYNDROME; MESENCHYMAL TRANSITION; ENDOTHELIAL-CELLS; MESANGIAL CELLS; MURINE MODEL; MOUSE MODEL	Pancreatic adenocarcinoma, a desmoplastic disease, is the fourth leading cause of cancer-related death in the Western world due, in large part, to locally invasive primary tumor growth and ensuing metastasis. SPARC is a matricellular protein that governs extracellular matrix (ECM) deposition and maturation during tissue remodeling, particularly, during wound healing and tumorigenesis. In the present study, we sought to determine the mechanism by which lack of host SPARC alters the tumor microenvironment and enhances invasion and metastasis of an orthotopic model of pancreatic cancer. We identified that levels of active TGF beta 1 were increased significantly in tumors grown in SPARC-null mice. TGF beta 1 contributes to many aspects of tumor development including metastasis, endothelial cell permeability, inflammation and fibrosis, all of which are altered in the absence of stromal-derived SPARC. Given these results, we performed a survival study to assess the contribution of increased TGF beta 1 activity to tumor progression in SPARC-null mice using losartan, an angiotensin II type 1 receptor antagonist that diminishes TGF beta 1 expression and activation in vivo. Tumors grown in SPARC-null mice progressed more quickly than those grown in wild-type littermates leading to a significant reduction in median survival. However, median survival of SPARC-null animals treated with losartan was extended to that of losartan-treated wild-type controls. In addition, losartan abrogated TGF beta induced gene expression, reduced local invasion and metastasis, decreased vascular permeability and altered the immune profile of tumors grown in SPARC-null mice. These data support the concept that aberrant TGF beta 1-activation in the absence of host SPARC contributes significantly to tumor progression and suggests that SPARC, by controlling ECM deposition and maturation, can regulate TGFb availability and activation.	[Arnold, Shanna A.; Rivera, Lee B.; Carbon, Juliet G.; Toombs, Jason E.; Chang, Chi-Lun; Brekken, Rolf A.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dept Surg, Div Surg Oncol, Dallas, TX 75390 USA; [Arnold, Shanna A.; Rivera, Lee B.; Carbon, Juliet G.; Toombs, Jason E.; Chang, Chi-Lun; Brekken, Rolf A.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dept Pharmacol, Dallas, TX 75390 USA; [Bradshaw, Amy D.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Medical University of South Carolina	Arnold, SA (corresponding author), Vanderbilt Univ, Ctr Med, Dept Pathol, Nashville, TN 37232 USA.	rolf.brekken@utsouthwestern.edu			Effie Marie Cain Scholarship in Angiogenesis Research; National Institutes of Health [R01 CA118240, T32 GM0070602, T32 GM008203]; NATIONAL CANCER INSTITUTE [R01CA118240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008203] Funding Source: NIH RePORTER	Effie Marie Cain Scholarship in Angiogenesis Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by The Effie Marie Cain Scholarship in Angiogenesis Research (to RAB), and the National Institutes of Health (R01 CA118240 to RAB; T32 GM0070602 to SAA; T32 GM008203 to LBR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2002, AM J KIDNEY DIS, V39, P486, DOI 10.1053/ajkd.2002.31392; An JB, 2010, HYPERTENS RES, V33, P831, DOI 10.1038/hr.2010.79; Arnold S, 2008, EXP BIOL MED, V233, P860, DOI 10.3181/0801-RM-12; Arnold SA, 2010, DIS MODEL MECH, V3, P57, DOI 10.1242/dmm.003228; Beyer M, 2009, CURR PHARM DESIGN, V15, P1879, DOI 10.2174/138161209788453211; Bornstein P, 2002, METHOD CELL BIOL, V69, P7, DOI 10.1016/S0091-679X(02)69003-X; Bradshaw AD, 2003, J INVEST DERMATOL, V120, P949, DOI 10.1046/j.1523-1747.2003.12241.x; Brekken RA, 2003, J CLIN INVEST, V111, P487, DOI 10.1172/JCI200316804; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; Bruns Christiane J., 1999, Neoplasia (New York), V1, P50, DOI 10.1038/sj.neo.7900005; Cao X, 2009, IMMUNOL RES; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; DASCH JR, 1989, J IMMUNOL, V142, P1536; de la Cruz-Merino L, 2009, CLIN TRANSL ONCOL, V11, P715, DOI 10.1007/s12094-009-0433-8; Diop-Frimpong B, 2011, P NATL ACAD SCI USA, V108, P2909, DOI 10.1073/pnas.1018892108; FORD R, 1993, EXP CELL RES, V206, P261, DOI 10.1006/excr.1993.1146; Framson PE, 2004, J CELL BIOCHEM, V92, P679, DOI 10.1002/jcb.20091; Francki A, 2004, J CELL BIOCHEM, V91, P915, DOI 10.1002/jcb.20008; Galgani M, 2009, CURR MED CHEM; Ghaneh P, 2007, GUT, V56, P1134, DOI 10.1136/gut.2006.103333; Habashi JP, 2011, SCIENCE, V332, P361, DOI 10.1126/science.1192152; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; HALLMANN R, 1995, DEV DYNAM, V202, P325, DOI 10.1002/aja.1002020402; HASSELAAR P, 1992, J CELL BIOCHEM, V49, P272, DOI 10.1002/jcb.240490310; HAUSSER H, 1994, FEBS LETT, V353, P243, DOI 10.1016/0014-5793(94)01044-7; Holm TM, 2011, SCIENCE, V332, P358, DOI 10.1126/science.1192149; Kelly RJ, 2009, J IMMUNOTOXICOL; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; Laviades C, 2000, HYPERTENSION, V36, P517, DOI 10.1161/01.HYP.36.4.517; Li HY, 2008, J MED CHEM, V51, P2302, DOI 10.1021/jm701199p; Macri L, 2007, ADV DRUG DELIVER REV, V59, P1366, DOI 10.1016/j.addr.2007.08.015; Matt P, 2009, CIRCULATION, V120, P526, DOI 10.1161/CIRCULATIONAHA.108.841981; Mazzocca A, 2009, HEPATOLOGY, V50, P1140, DOI 10.1002/hep.23118; Melisi D, 2008, MOL CANCER THER, V7, P829, DOI 10.1158/1535-7163.MCT-07-0337; Mendis DB, 1998, NEUROCHEM RES, V23, P1117, DOI 10.1023/A:1020720405428; Moo-Young TA, 2009, J IMMUNOTHER, V32, P12, DOI 10.1097/CJI.0b013e318189f13c; Mumm JB, 2008, ONCOGENE, V27, P5913, DOI 10.1038/onc.2008.275; Nadal JA, 2002, AM J PHYSIOL-HEART C, V282, pH739, DOI 10.1152/ajpheart.00656.2001; Naito T, 2004, AM J PHYSIOL-RENAL, V286, pF278, DOI 10.1152/ajprenal.00139.2003; Nam JS, 2006, CANCER RES, V66, P6327, DOI 10.1158/0008-5472.CAN-06-0068; Noguchi R, 2009, ONCOL REP, V22, P355, DOI 10.3892/or_00000445; Norose K, 1998, INVEST OPHTH VIS SCI, V39, P2674; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Pardali E, 2009, FRONT BIOSCI-LANDMRK, V14, P4848, DOI 10.2741/3573; Pavasant P, 2003, ARCH ORAL BIOL, V48, P717, DOI 10.1016/S0003-9969(03)00134-1; Pen A, 2007, GLIA, V55, P559, DOI 10.1002/glia.20481; Podhajcer OL, 2008, CANCER METAST REV, V27, P691, DOI 10.1007/s10555-008-9146-7; RAINES EW, 1992, P NATL ACAD SCI USA, V89, P1281, DOI 10.1073/pnas.89.4.1281; REED MJ, 1994, J CELL PHYSIOL, V158, P169, DOI 10.1002/jcp.1041580121; REED MJ, 1993, J HISTOCHEM CYTOCHEM, V41, P1467, DOI 10.1177/41.10.8245406; Rivera LB, 2011, J CELL BIOL, V193, P1305, DOI 10.1083/jcb.201011143; Sato N, 2003, ONCOGENE, V22, P5021, DOI 10.1038/sj.onc.1206807; Schiemann BJ, 2003, MOL BIOL CELL, V14, P3977, DOI 10.1091/mbc.E03-01-0001; Schonherr E, 1998, ARCH BIOCHEM BIOPHYS, V355, P241, DOI 10.1006/abbi.1998.0720; TAKEUCHI Y, 1994, J BIOL CHEM, V269, P32634; Tufvesson E, 2002, FEBS LETT, V530, P124, DOI 10.1016/S0014-5793(02)03439-7; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; Wendt MK, 2009, FUTURE ONCOL, V5, P1145, DOI 10.2217/FON.09.90; WRANA JL, 1991, EUR J BIOCHEM, V197, P519, DOI 10.1111/j.1432-1033.1991.tb15940.x; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yan Q, 2002, J CELL SCI, V115, P2747; Zhong ZJ, 2010, CLIN CANCER RES, V16, P1191, DOI 10.1158/1078-0432.CCR-09-1634; Zhou Y, 2006, BIOCHEM BIOPH RES CO, V339, P633, DOI 10.1016/j.bbrc.2005.11.060	64	57	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31384	10.1371/journal.pone.0031384	http://dx.doi.org/10.1371/journal.pone.0031384			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348081	Green Submitted, Green Published, gold			2022-12-25	WOS:000302737400020
J	Mei, HF; Jin, XB; Zhu, JY; Zeng, AH; Wu, Q; Lu, XM; Li, XB; Shen, J				Mei, Han-fang; Jin, Xiao-bao; Zhu, Jia-yong; Zeng, Ai-hua; Wu, Qiang; Lu, Xue-mei; Li, Xiao-bo; Shen, Juan			beta-defensin 2 as an Adjuvant Promotes Anti-Melanoma Immune Responses and Inhibits the Growth of Implanted Murine Melanoma In Vivo	PLOS ONE			English	Article							DENDRITIC CELLS; ANTITUMOR IMMUNITY; ADAPTIVE IMMUNITY; INDUCTION; VACCINE; BETA-DEFENSIN-2; ACTIVATION; INNATE; ANTIGEN; NK	beta-defensin 2 is a small antimicrobial peptide of the innate immune system and has been thought to regulate anti-tumor immunity. However, little is known on whether beta-defensin 2 could modulate melanoma-specific NK and T cell responses. In this study, we first cloned the murine beta-defensin 2 gene by RT-PCR and generated the beta-defensin 2 stably expressing B16 cells (B16-mBD2). Subsequently, we evaluated whether vaccination with irradiated B16-mBD2 could modulate the growth of implanted B16 cells and determined the potential mechanisms underlying the action of B16-mBD2 vaccine in modulating the growth of B16 tumors in C57BL/6. We found that vaccination with irradiated B16-mBD2, but not with control B16-p or parental B16, inhibited the development and progression of B16 tumors, and prolonged the survival of tumor-bearing mice. However, vaccination with irradiated B16-mBD2 failed to inhibit the development of B16 tumors in the CD4(+)- or CD8(+)-depleted recipients. Furthermore, vaccination with irradiated B16-mBD2 stimulated strong NK activity and promoted potent B16-specific CTL responses, accompanied by augmenting IFN-gamma and IL-12, but not IL-4, responses in the recipient mice. Moreover, vaccination with irradiated B16-mBD2 promoted the infiltration of CD8(+) and CD4(+) T, NK cells and macrophages in the tumor tissues. These data suggest beta-defensin 2 may act as a positive regulator, promoting anti-tumor NK and T cell responses in vivo. Therefore, beta-defensin 2 may be used for the development of immunotherapy for the intervention of melanoma.	[Mei, Han-fang; Jin, Xiao-bao; Zhu, Jia-yong; Zeng, Ai-hua; Wu, Qiang; Lu, Xue-mei; Li, Xiao-bo; Shen, Juan] Guangdong Pharmaceut Univ, Guangzhou Higher Educ Mega Ctr, Guangdong Prov Key Lab Pharmaceut Bioact Subst, Guangzhou, Guangdong, Peoples R China; [Mei, Han-fang; Jin, Xiao-bao; Wu, Qiang; Li, Xiao-bo] Guangdong Pharmaceut Univ, Guangzhou Higher Educ Mega Ctr, Sch Basic Sci, Guangzhou, Guangdong, Peoples R China; [Mei, Han-fang] Guangdong Pharmaceut Univ, Guangzhou Higher Educ Mega Ctr, Dept Biochem & Mol Biol, Guangzhou, Guangdong, Peoples R China; [Mei, Han-fang; Wu, Qiang; Lu, Xue-mei; Li, Xiao-bo; Shen, Juan] So Med Univ, Inst Trop Med & Publ Hlth, Guangzhou, Guangdong, Peoples R China	Guangdong Pharmaceutical University; Guangdong Pharmaceutical University; Guangdong Pharmaceutical University; Southern Medical University - China	Mei, HF (corresponding author), Guangdong Pharmaceut Univ, Guangzhou Higher Educ Mega Ctr, Guangdong Prov Key Lab Pharmaceut Bioact Subst, Guangzhou, Guangdong, Peoples R China.	zhujiayong2@163.com			National Natural Science Foundation of China [36071832]; Medical and Scientific Research Foundation of Guangdong Province [A2011304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical and Scientific Research Foundation of Guangdong Province	This study was supported by the grants from the National Natural Science Foundation of China (No. 36071832) and the Medical and Scientific Research Foundation of Guangdong Province (A2011304). The funders had no role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Adam C, 2005, BLOOD, V106, P338, DOI 10.1182/blood-2004-09-3775; Bennett SRM, 1997, J EXP MED, V186, P65, DOI 10.1084/jem.186.1.65; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Biragyn A, 2001, J IMMUNOL, V167, P6644, DOI 10.4049/jimmunol.167.11.6644; Bowdish DME, 2006, CURR TOP MICROBIOL, V306, P27; Jean CB, 2005, EXPERT OPIN EMERG DR, V10, P393; Kalinski P, 2006, IMMUNOL RES, V36, P137, DOI 10.1385/IR:36:1:137; Lapteva N, 2009, MOL THER, V17, P1626, DOI 10.1038/mt.2009.111; Lu Y, 2007, BIOMATERIALS, V28, P3255, DOI 10.1016/j.biomaterials.2007.03.028; Ma XT, 2006, CANCER RES, V66, P1169, DOI 10.1158/0008-5472.CAN-05-2891; Marko L, 2008, EXPERT OPIN BIOL TH, V8, P315; Mochimaru H, 2008, INVEST OPHTH VIS SCI, V49, P2172, DOI 10.1167/iovs.07-1396; Morton D L, 2004, Dev Biol (Basel), V116, P209; Rossi GR, 2005, CANCER RES, V65, P10555, DOI 10.1158/0008-5472.CAN-05-0627; Seliger B, 2001, CANCER RES, V61, P1095; WALLACK MK, 1983, J BIOL RESP MODIF, V2, P586; Wang YS, 2007, CLIN CANCER RES, V13, P6779, DOI 10.1158/1078-0432.CCR-07-1587; Xia DJ, 2003, J MOL MED, V81, P585, DOI 10.1007/s00109-003-0472-5; Xu B, 2007, GENE THER, V14, P1181, DOI 10.1038/sj.gt.3302966; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yang ZQ, 2006, CIRCULATION, V114, P2056, DOI 10.1161/CIRCULATIONAHA.106.649244; Zhang W, 2008, BIOCHEM BIOPH RES CO, V376, P10, DOI 10.1016/j.bbrc.2008.08.061	22	31	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31328	10.1371/journal.pone.0031328	http://dx.doi.org/10.1371/journal.pone.0031328			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348070	Green Submitted, Green Published, gold			2022-12-25	WOS:000302733900041
J	Roll, JD; Reuther, GW				Roll, J. Devon; Reuther, Gary W.			ALK-Activating Homologous Mutations in LTK Induce Cellular Transformation	PLOS ONE			English	Article							ANAPLASTIC LYMPHOMA KINASE; RECEPTOR TYROSINE KINASE; ACUTE MYELOID-LEUKEMIA; NON-HODGKINS-LYMPHOMA; LUNG-CANCER; GROWTH-FACTOR; MONOCLONAL-ANTIBODIES; EML4-ALK FUSION; GENE; IDENTIFICATION	Leukocyte tyrosine kinase (LTK) is a receptor tyrosine kinase reported to be overexpressed in human leukemia. Though much regarding the function of LTK remains unknown, it shares a high degree of similarity with anaplastic lymphoma kinase (ALK), which is found mutated in human cancer. In order to determine if LTK has transforming potential, we created two LTK mutants, F568L and R669Q, that correspond to two well-characterized activating mutations of ALK (F1174L and R1275Q). LTK-F568L, but not wildtype LTK or LTK-R669Q, transformed hematopoietic cells to cytokine independence. LTK-F568L exhibited a stronger ability to induce loss of contact inhibition and anchorage-independent growth of epithelial cells compared to LTK-R669Q, while wildtype LTK was non-transforming in the same cells. Likewise, LTK-F568L induced greater neurite outgrowth of PC12 cells than R669Q, while wildtype LTK could not. Correlating with transforming activity, LTK-F568L displayed significantly enhanced tyrosine phosphorylation compared to wildtype LTK and LTK-R668Q and induced activation of various signaling proteins including Shc, ERK and the JAK/STAT pathway. Expression of wildtype LTK or LTK-R669Q generally led to weaker activation of signaling proteins than expression of LTK-F568L, or no activation at all. Thus, mutating LTK at residue F568, and to a lesser extent at R669, activates the receptor tyrosine kinase, inducing cell signaling that results in transforming properties. These studies suggest that aberrant activation of LTK may contribute to neoplastic cell growth.	[Roll, J. Devon; Reuther, Gary W.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Roll, JD (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA.	gary.reuther@moffitt.org	Reuther, Gary/AFR-2892-2022	Migliaccio, Antimo/0000-0002-4197-2055	Moffitt Cancer Center	Moffitt Cancer Center	This project was funded by the Moffitt Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardini E, 2010, CANCER LETT, V299, P81, DOI 10.1016/j.canlet.2010.09.001; Bazigou E, 2007, CELL, V128, P961, DOI 10.1016/j.cell.2007.02.024; BEN-NERIAH Y, 1988, NATURE, V333, P672, DOI 10.1038/333672a0; BERNARDS A, 1990, EMBO J, V9, P2279, DOI 10.1002/j.1460-2075.1990.tb07399.x; Bilsland JG, 2008, NEUROPSYCHOPHARMACOL, V33, P685, DOI 10.1038/sj.npp.1301446; Blaikie PA, 1997, J BIOL CHEM, V272, P20671, DOI 10.1074/jbc.272.33.20671; Caren H, 2008, BIOCHEM J, V416, P153, DOI 10.1042/BJ20081834; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; DALY NL, 1995, P NATL ACAD SCI USA, V92, P6334, DOI 10.1073/pnas.92.14.6334; Di Nicolantonio F, 2006, CURR OPIN ONCOL, V18, P69, DOI 10.1097/01.cco.0000198020.91724.48; Du XL, 2007, J MOL MED, V85, P863, DOI 10.1007/s00109-007-0159-4; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Finnon R, 2002, MOL CARCINOGEN, V34, P64, DOI 10.1002/mc.10054; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Honda H, 1999, ONCOGENE, V18, P3821, DOI 10.1038/sj.onc.1202736; Inamura K, 2008, J THORAC ONCOL, V3, P13, DOI 10.1097/JTO.0b013e31815e8b60; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Jazii FR, 2006, WORLD J GASTROENTERO, V12, P7104, DOI 10.3748/wjg.v12.i44.7104; KOZUTSUMI H, 1994, ONCOGENE, V9, P2991; KOZUTSUMI H, 1993, BIOCHEM BIOPH RES CO, V190, P674, DOI 10.1006/bbrc.1993.1101; KROLEWSKI JJ, 1991, EMBO J, V10, P2911, DOI 10.1002/j.1460-2075.1991.tb07841.x; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li N, 2004, HUM MOL GENET, V13, P171, DOI 10.1093/hmg/ddh020; Lopes SS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000026; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; MARU Y, 1990, ONCOGENE RES, V5, P199; Mathivet T, 2007, CELL SIGNAL, V19, P2434, DOI 10.1016/j.cellsig.2007.07.011; Mazot P, 2011, ONCOGENE, V30, P2017, DOI 10.1038/onc.2010.595; McDermott U, 2008, CANCER RES, V68, P3389, DOI 10.1158/0008-5472.CAN-07-6186; Moog-Lutz C, 2005, J BIOL CHEM, V280, P26039, DOI 10.1074/jbc.M501972200; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Morris SW, 1997, ONCOGENE, V14, P2175, DOI 10.1038/sj.onc.1201062; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Muller-Tidow C, 2004, CLIN CANCER RES, V10, P1241, DOI 10.1158/1078-0432.CCR-0954-03; Muller-Tidow C, 2005, CANCER RES, V65, P1778, DOI 10.1158/0008-5472.CAN-04-3388; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Palmer RH, 2009, BIOCHEM J, V420, P345, DOI 10.1042/BJ20090387; Perez-Pinera P, 2007, BIOCHEM BIOPH RES CO, V358, P399, DOI 10.1016/j.bbrc.2007.04.137; Pradhan A, 2007, P NATL ACAD SCI USA, V104, P18502, DOI 10.1073/pnas.0702388104; Pradhan A, 2010, J BIOL CHEM, V285, P16651, DOI 10.1074/jbc.M109.071191; Reuther GW, 2000, MOL CELL BIOL, V20, P8655, DOI 10.1128/MCB.20.23.8655-8666.2000; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; SALCINI AE, 1994, ONCOGENE, V9, P2827; Sasaki T, 2011, CLIN CANC RES; Savage KJ, 2007, BLOOD REV, V21, P201, DOI 10.1016/j.blre.2007.03.001; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Stoica GE, 2002, J BIOL CHEM, V277, P35990, DOI 10.1074/jbc.M205749200; Stoica GE, 2001, J BIOL CHEM, V276, P16772, DOI 10.1074/jbc.M010660200; TOYOSHIMA H, 1993, P NATL ACAD SCI USA, V90, P5404, DOI 10.1073/pnas.90.12.5404; UENO H, 1995, J BIOL CHEM, V270, P20135, DOI 10.1074/jbc.270.34.20135; Ueno H, 1997, ONCOGENE, V14, P3067, DOI 10.1038/sj.onc.1201153; Ueno H, 1996, J BIOL CHEM, V271, P27707, DOI 10.1074/jbc.271.44.27707; Wang Feng-Hua, 2009, Ai Zheng, V28, P49; Webb TR, 2009, EXPERT REV ANTICANC, V9, P331, DOI 10.1586/14737140.9.3.331; Yamada S, 2008, NEUROREPORT, V19, P1733, DOI 10.1097/WNR.0b013e3283186bf8; Yuan Y, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-16	59	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31733	10.1371/journal.pone.0031733	http://dx.doi.org/10.1371/journal.pone.0031733			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347506	Green Submitted, Green Published, gold			2022-12-25	WOS:000302730200034
J	Gerhart, SV; Eble, DM; Burger, RM; Oline, SN; Vacaru, A; Sadler, KC; Jefferis, R; Iovine, MK				Gerhart, Sarah V.; Eble, Diane M.; Burger, R. Michael; Oline, Stefan N.; Vacaru, Ana; Sadler, Kirsten C.; Jefferis, Rebecca; Iovine, M. Kathryn			The Cx43-like Connexin Protein Cx40.8 Is Differentially Localized during Fin Ontogeny and Fin Regeneration	PLOS ONE			English	Article							GAP-JUNCTION CHANNELS; ZEBRAFISH FINS; HELA-CELLS; MUTATIONS; GJA1; PERMEABILITY; ENDOCYTOSIS; DISEASE; HEALTH; GROWTH	Connexins (Cx) are the subunits of gap junctions, membraneous protein channels that permit the exchange of small molecules between adjacent cells. Cx43 is required for cell proliferation in the zebrafish caudal fin. Previously, we found that a Cx43-like connexin, cx40.8, is co-expressed with cx43 in the population of proliferating cells during fin regeneration. Here we demonstrate that Cx40.8 exhibits novel differential subcellular localization in vivo, depending on the growth status of the fin. During fin ontogeny, Cx40.8 is found at the plasma membrane, but Cx40.8 is retained in the Golgi apparatus during regeneration. We next identified a 30 amino acid domain of Cx40.8 responsible for its dynamic localization. One possible explanation for the differential localization is that Cx40.8 contributes to the regulation of Cx43 in vivo, perhaps modifying channel activity during ontogenetic growth. However, we find that the voltage-gating properties of Cx40.8 are similar to Cx43. Together our findings reveal that Cx40.8 exhibits differential subcellular localization in vivo, dependent on a discrete domain in its carboxy terminus. We suggest that the dynamic localization of Cx40.8 differentially influences Cx43-dependent cell proliferation during ontogeny and regeneration.	[Gerhart, Sarah V.; Eble, Diane M.; Burger, R. Michael; Oline, Stefan N.; Jefferis, Rebecca; Iovine, M. Kathryn] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA; [Vacaru, Ana; Sadler, Kirsten C.] Mt Sinai Sch Med, Dept Regenerat & Dev Biol, Dept Med, Div Liver Dis, New York, NY USA	Lehigh University; Icahn School of Medicine at Mount Sinai	Gerhart, SV (corresponding author), Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA.	mki3@lehigh.edu	Vacaru, Ana/AAR-7370-2021	Vacaru, Ana Maria/0000-0001-7976-8992; Sadler Edepli, Kirsten/0000-0002-1100-4125; Oline, Stefan/0000-0002-7094-3800	National Institutes of Health (NIH) [R03HD06270, R01AA018886, P20AAA017067]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018886] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health (NIH) (http://www.nih.gov/): R03HD06270; NIH (http://www.nih.gov/: R01AA018886; NIH (http://www.nih.gov/: P20AAA017067. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2001, EUR J BIOCHEM, V268, P4544, DOI 10.1046/j.1432-1327.2001.02380.x; Akimenko MA, 2003, DEV DYNAM, V226, P190, DOI 10.1002/dvdy.10248; Bevans CG, 1998, J BIOL CHEM, V273, P2808, DOI 10.1074/jbc.273.5.2808; Brink PR, 1997, AM J PHYSIOL-CELL PH, V273, pC1386, DOI 10.1152/ajpcell.1997.273.4.C1386; Carette D, 2009, TRAFFIC, V10, P1272, DOI 10.1111/j.1600-0854.2009.00949.x; Cottrell GT, 2005, BBA-BIOMEMBRANES, V1711, P126, DOI 10.1016/j.bbamem.2004.11.013; Eastman SD, 2006, GENOMICS, V87, P265, DOI 10.1016/j.ygeno.2005.10.005; ELFGANG C, 1995, J CELL BIOL, V129, P805, DOI 10.1083/jcb.129.3.805; Falk MM, 2000, J CELL SCI, V113, P4109; Fiorini C, 2006, AM J PHYSIOL-CELL PH, V290, pC733, DOI 10.1152/ajpcell.00106.2005; Gerhart SV, 2009, FEBS LETT, V583, P3419, DOI 10.1016/j.febslet.2009.09.054; Gerido DA, 2004, BBA-BIOMEMBRANES, V1662, P159, DOI 10.1016/j.bbamem.2003.10.017; Giepmans BNG, 2001, CURR BIOL, V11, P1364, DOI 10.1016/S0960-9822(01)00424-9; Gilleron J, 2008, J CELL SCI, V121, P4069, DOI 10.1242/jcs.033373; Goldberg GS, 2004, BBA-BIOMEMBRANES, V1662, P96, DOI 10.1016/j.bbamem.2003.11.022; Hoptak-Solga AD, 2008, DEV BIOL, V317, P541, DOI 10.1016/j.ydbio.2008.02.051; Hoptak-Solga AD, 2007, FEBS LETT, V581, P3297, DOI 10.1016/j.febslet.2007.06.030; Hunter AW, 2003, CELL COMMUN ADHES, V10, P211, DOI 10.1080/714040429; Iovine MK, 2005, DEV BIOL, V278, P208, DOI 10.1016/j.ydbio.2004.11.005; Iovine MK, 2000, GENETICS, V155, P1321; Koval M, 1997, J CELL BIOL, V137, P847, DOI 10.1083/jcb.137.4.847; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Lauf U, 2001, FEBS LETT, V498, P11, DOI 10.1016/S0014-5793(01)02462-0; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Martin PE, 2000, BIOCHEM J, V350, P943, DOI 10.1042/0264-6021:3500943; Paznekas WA, 2003, AM J HUM GENET, V72, P408, DOI 10.1086/346090; Poss KD, 2003, DEV DYNAM, V226, P202, DOI 10.1002/dvdy.10220; Sims K, 2009, DEV BIOL, V327, P410, DOI 10.1016/j.ydbio.2008.12.027; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; White TW, 1999, ANNU REV PHYSIOL, V61, P283, DOI 10.1146/annurev.physiol.61.1.283	31	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31364	10.1371/journal.pone.0031364	http://dx.doi.org/10.1371/journal.pone.0031364			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347467	gold, Green Published, Green Submitted			2022-12-25	WOS:000302730100063
J	Iqbal, A; Lim, YAL; Surin, J; Sim, BLH				Iqbal, Asma; Lim, Yvonne A. L.; Surin, Johari; Sim, Benedict L. H.			High Diversity of Cryptosporidium Subgenotypes Identified in Malaysian HIV/AIDS Individuals Targeting gp60 Gene	PLOS ONE			English	Article							CLINICAL-MANIFESTATIONS; MOLECULAR EPIDEMIOLOGY; SUBTYPE ANALYSES; PARVUM; CHILDREN; HOMINIS; HUMANS; GENOTYPE; CATTLE; SPP.	Background: Currently, there is a lack of vital information in the genetic makeup of Cryptosporidium especially in developing countries. The present study aimed at determining the genotypes and subgenotypes of Cryptosporidium in hospitalized Malaysian human immunodeficiency virus (HIV) positive patients. Methodology/Principal Findings: In this study, 346 faecal samples collected from Malaysian HIV positive patients were genetically analysed via PCR targeting the 60 kDa glycoprotein (gp60) gene. Eighteen (5.2% of 346) isolates were determined as Cryptosporidium positive with 72.2% (of 18) identified as Cryptosporidium parvum whilst 27.7% as Cryptosporidium hominis. Further gp60 analysis revealed C. parvum belonging to subgenotypes IIaA13G1R1 (2 isolates), IIaA13G2R1 (2 isolates), IIaA14G2R1 (3 isolates), IIaA15G2R1 (5 isolates) and IIdA15G1R1 (1 isolate). C. hominis was represented by subgenotypes IaA14R1 (2 isolates), IaA18R1 (1 isolate) and IbA10G2R2 (2 isolates). Conclusions/Significance: These findings highlighted the presence of high diversity of Cryptosporidium subgenotypes among Malaysian HIV infected individuals. The predominance of the C. parvum subgenotypes signified the possibility of zoonotic as well as anthroponotic transmissions of cryptosporidiosis in HIV infected individuals.	[Iqbal, Asma; Lim, Yvonne A. L.; Surin, Johari] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia; [Iqbal, Asma] Hlth Canada, Bur Microbial Hazards, Banting Res Ctr, Ottawa, ON K1A 0L2, Canada; [Sim, Benedict L. H.] Hosp Sungai Buloh, Infect Dis Unit, Dept Med, Sungai Buloh, Selangor Darul, Malaysia	Universiti Malaya; Health Canada	Iqbal, A (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia.	limailian@um.edu.my	LIM, YVONNE AL/B-5276-2010; SURIN, JOHARI/B-5320-2010	LIM, YVONNE AL/0000-0003-4050-6332; 	University of Malaya [HIR J-00000-73587, FS 196/2008B]	University of Malaya(Universiti Malaya)	This study was funded by the research grants from University of Malaya (Research grant No. HIR J-00000-73587 and FS 196/2008B). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abe N, 2006, PARASITOL RES, V99, P303, DOI 10.1007/s00436-006-0140-0; Ajjampur SSR, 2010, J CLIN MICROBIOL, V48, P2075, DOI 10.1128/JCM.02509-09; Alves M, 2003, J EUKARYOT MICROBIOL, V50, P529, DOI 10.1111/j.1550-7408.2003.tb00619.x; Alves M, 2006, PARASITOL RES, V99, P287, DOI 10.1007/s00436-006-0164-5; Anonymous, 2010, NATL STRATEGIC PLAN; Asma L, 2011, TROP BIOMED, V28, P400; Assefa S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-155; Brook EJ, 2009, VET J, V179, P378, DOI 10.1016/j.tvjl.2007.10.023; Cama VA, 2008, EMERG INFECT DIS, V14, P1567, DOI 10.3201/eid1410.071273; Cama VA, 2007, J INFECT DIS, V196, P684, DOI 10.1086/519842; CAMPBELL AT, 1993, APPL ENVIRON MICROB, V59, P4361, DOI 10.1128/AEM.59.12.4361-4362.1993; Chalmers RM, 2005, INT J PARASITOL, V35, P397, DOI 10.1016/j.ijpara.2005.01.001; Cohen S, 2006, J CLIN MICROBIOL, V44, P589, DOI 10.1128/JCM.44.2.589-591.2006; CURRENT WL, 1991, CLIN MICROBIOL REV, V4, P325, DOI 10.1128/CMR.4.3.325-358.1991; Daryani A, 2009, Pak J Biol Sci, V12, P1277, DOI 10.3923/pjbs.2009.1277.1281; Fayer R, 2010, EXP PARASITOL, V124, P90, DOI 10.1016/j.exppara.2009.03.005; Feltus DC, 2006, J CLIN MICROBIOL, V44, P4303, DOI 10.1128/JCM.01067-06; Feng Y, 2007, APPL ENVIRON MICROB, V73, P6475, DOI 10.1128/AEM.01034-07; Florez Astrid Carolina, 2003, Biomedica, V23, P274; Gatei W, 2007, INFECT GENET EVOL, V7, P197, DOI 10.1016/j.meegid.2006.08.006; GHANI MC, 1984, J MALAYSIAN SOC HLTH, V4, P80; Glaberman S, 2002, EMERG INFECT DIS, V8, P631, DOI 10.3201/eid0806.010368; Goh K L, 1987, Med J Malaysia, V42, P58; Hall B.G., 2004, PHYLOGENETIC TREES M; Hung CC, 2007, J FORMOS MED ASSOC, V106, P31, DOI 10.1016/S0929-6646(09)60213-8; Hunter PR, 2003, J APPL MICROBIOL, V94, p37S, DOI 10.1046/j.1365-2672.94.s1.5.x; Jex AR, 2008, J CLIN MICROBIOL, V46, P2252, DOI 10.1128/JCM.00116-08; Jex AR, 2007, ELECTROPHORESIS, V28, P3875, DOI 10.1002/elps.200700279; Jex AR, 2007, ELECTROPHORESIS, V28, P2818, DOI 10.1002/elps.200600772; Jex AR, 2010, BIOTECHNOL ADV, V28, P17, DOI 10.1016/j.biotechadv.2009.08.003; Jex AR, 2008, ELECTROPHORESIS, V29, P4119, DOI 10.1002/elps.200800422; Kamel A. G. Mohamed, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P650; Leav BA, 2002, INFECT IMMUN, V70, P3881, DOI 10.1128/IAI.70.7.3881-3890.2002; Lim YAL, 2008, J WATER HEALTH, V6, P239, DOI 10.2166/wh.2008.023; Lim Y A L, 2005, Southeast Asian J Trop Med Public Health, V36 Suppl 4, P30; Lim YAL, 2011, INFECT GENET EVOL, V11, P968, DOI 10.1016/j.meegid.2011.03.007; Lim YAL, 2010, ADV PARASIT, V71, P1, DOI 10.1016/S0065-308X(10)71003-4; Mallon M, 2003, J MOL EVOL, V56, P407, DOI 10.1007/s00239-002-2412-3; Muthusamy D, 2006, J CLIN MICROBIOL, V44, P632, DOI 10.1128/JCM.44.2.632-634.2006; Navin TR, 1999, J ACQ IMMUN DEF SYND, V20, P154, DOI 10.1097/00042560-199902010-00007; Peng MM, 2003, J EUKARYOT MICROBIOL, V50, P557, DOI 10.1111/j.1550-7408.2003.tb00628.x; Peng MM, 2003, PARASITOL RES, V90, P175, DOI 10.1007/s00436-003-0834-5; Peng MM, 2001, J EUKARYOT MICROBIOL, V50, P557; Plutzer J, 2007, VET PARASITOL, V146, P357, DOI 10.1016/j.vetpar.2007.02.030; Quilez J, 2008, APPL ENVIRON MICROB, V74, P6026, DOI 10.1128/AEM.00606-08; Report G., 2010, UNAIDS REPORT GLOBAL; Smith HV, 2005, VET REC, V156, P710, DOI 10.1136/vr.156.22.710; Stantic-Pavlinic M, 2003, WIEN KLIN WOCHENSCHR, V115, P125, DOI 10.1007/BF03040292; Strong WB, 2000, INFECT IMMUN, V68, P4117, DOI 10.1128/IAI.68.7.4117-4134.2000; Sulaiman IM, 2005, J CLIN MICROBIOL, V43, P2805, DOI 10.1128/JCM.43.6.2805-2809.2005; Sulaiman IM, 2001, J EUKARYOT MICROBIOL, p24S; Thompson HP, 2007, PARASITOL RES, V100, P619, DOI 10.1007/s00436-006-0305-x; Traversa D, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-21; Trotz-Williams LA, 2006, PARASITOL RES, V99, P346, DOI 10.1007/s00436-006-0157-4; Wielinga PR, 2008, INT J PARASITOL, V38, P809, DOI 10.1016/j.ijpara.2007.10.014; Wu ZL, 2003, APPL ENVIRON MICROB, V69, P4720, DOI 10.1128/AEM.69.8.4720-4726.2003; XIAO L, 2004, CRYPTOSPORIDIUM MOL, P121; Xiao LH, 2000, APPL ENVIRON MICROB, V66, P5492, DOI 10.1128/AEM.66.12.5492-5498.2000; Xiao LH, 2004, CURR OPIN INFECT DIS, V17, P483, DOI 10.1097/00001432-200410000-00014; Xiao Lihua, 2007, P119; Xiao LH, 2007, PARASITOL RES, V100, P701, DOI 10.1007/s00436-006-0337-2; Zaidah A. R., 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P511	62	54	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31139	10.1371/journal.pone.0031139	http://dx.doi.org/10.1371/journal.pone.0031139			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347442	gold, Green Published, Green Accepted			2022-12-25	WOS:000302730100045
J	Kinjo, AR; Nakamura, H				Kinjo, Akira R.; Nakamura, Haruki			Composite Structural Motifs of Binding Sites for Delineating Biological Functions of Proteins	PLOS ONE			English	Article							LIGAND-BINDING; EVOLUTIONARY RELATIONSHIPS; CRYSTAL-STRUCTURE; ENZYME; INTERFACES; DATABASE; DOMAIN; CLASSIFICATION; SIMILARITIES; REVEALS	Most biological processes are described as a series of interactions between proteins and other molecules, and interactions are in turn described in terms of atomic structures. To annotate protein functions as sets of interaction states at atomic resolution, and thereby to better understand the relation between protein interactions and biological functions, we conducted exhaustive all-against-all atomic structure comparisons of all known binding sites for ligands including small molecules, proteins and nucleic acids, and identified recurring elementary motifs. By integrating the elementary motifs associated with each subunit, we defined composite motifs that represent context-dependent combinations of elementary motifs. It is demonstrated that function similarity can be better inferred from composite motif similarity compared to the similarity of protein sequences or of individual binding sites. By integrating the composite motifs associated with each protein function, we define meta-composite motifs each of which is regarded as a time-independent diagrammatic representation of a biological process. It is shown that meta-composite motifs provide richer annotations of biological processes than sequence clusters. The present results serve as a basis for bridging atomic structures to higher-order biological phenomena by classification and integration of binding site structures.	[Kinjo, Akira R.; Nakamura, Haruki] Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan	Osaka University	Kinjo, AR (corresponding author), Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan.	akinjo@protein.osaka-u.ac.jp		Kinjo, Akira/0000-0002-4006-8208	National Bioscience Database Center (NBDC), Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science (JSPS) [22770149, 23370071]	National Bioscience Database Center (NBDC), Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant-in-aid by National Bioscience Database Center (NBDC), the Japan Science and Technology Agency (JST). A.R.K. was supported in part by the KAKENHI Grant-in-Aid for Young Scientists B (No. 22770149) from the Japan Society for the Promotion of Science (JSPS). H.N. was supported in part by the KAKENHI Grant-in-Aid for Scientific Researches B (No. 23370071) from the JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amemiya T, 2011, J MOL BIOL, V408, P568, DOI 10.1016/j.jmb.2011.02.058; Aung Zeyar, 2008, Journal of Bioinformatics and Computational Biology, V6, P415, DOI 10.1142/S0219720008003485; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Bashton M, 2007, STRUCTURE, V15, P85, DOI 10.1016/j.str.2006.11.009; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; Bollobas B, 1998, MODERN GRAPH THEORY; Branden C., 1999, INTRO PROTEIN STRUCT; Brylinski M, 2008, P NATL ACAD SCI USA, V105, P129, DOI 10.1073/pnas.0707684105; Chen K, 2011, STRUCTURE, V19, P613, DOI 10.1016/j.str.2011.02.015; Chipman DM, 2001, CURR OPIN STRUC BIOL, V11, P694, DOI 10.1016/S0959-440X(01)00272-X; Dasgupta B, 2011, J MOL BIOL, V411, P713, DOI 10.1016/j.jmb.2011.06.027; Davis FP, 2011, MOL BIOSYST, V7, P545, DOI 10.1039/c0mb00200c; Davis FP, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000668; Dessailly BH, 2009, CURR OPIN STRUC BIOL, V19, P349, DOI 10.1016/j.sbi.2009.03.009; Fiorillo A, 2010, CRYSTAL STRUCTURE MU, DOI [10.2210/pdb3ku9/pdb, DOI 10.2210/PDB3KU9/PDB]; Friedberg I, 2006, BRIEF BIOINFORM, V7, P225, DOI 10.1093/bib/bbl004; Gold ND, 2006, J MOL BIOL, V355, P1112, DOI 10.1016/j.jmb.2005.11.044; Henrick K, 1998, TRENDS BIOCHEM SCI, V23, P358, DOI 10.1016/S0968-0004(98)01253-5; Holland TA, 2006, J MOL BIOL, V361, P562, DOI 10.1016/j.jmb.2006.05.060; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Joerger AC, 2004, J BIOL CHEM, V279, P1291, DOI 10.1074/jbc.M309732200; Kadono S, 2004, BIOCHEM BIOPH RES CO, V324, P1227, DOI 10.1016/j.bbrc.2004.09.182; Kawabata T, 2003, NUCLEIC ACIDS RES, V31, P3367, DOI 10.1093/nar/gkg581; Kawabata T, 2000, PROTEINS, V41, P108, DOI 10.1002/1097-0134(20001001)41:1<108::AID-PROT130>3.3.CO;2-J; Keskin O, 2004, PROTEIN SCI, V13, P1043, DOI 10.1110/ps.03484604; Keskin O, 2008, CHEM REV, V108, P1225, DOI 10.1021/cr040409x; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kinjo AR, 2010, J MOL BIOL, V399, P526, DOI 10.1016/j.jmb.2010.04.028; Kinjo Akira R, 2007, Biophysics (Nagoya-shi), V3, P75, DOI 10.2142/biophysics.3.75; Kinjo AR, 2009, STRUCTURE, V17, P234, DOI 10.1016/j.str.2008.11.009; Kinoshita K, 1999, PROTEIN ENG, V12, P11, DOI 10.1093/protein/12.1.11; Kinoshita K, 2004, BIOINFORMATICS, V20, P1329, DOI 10.1093/bioinformatics/bth073; Kinoshita K, 2003, PROTEIN SCI, V12, P1589, DOI 10.1110/ps.0368703; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Koike R, 2008, J MOL BIOL, V379, P397, DOI 10.1016/j.jmb.2008.04.019; Koike R, 2009, PROTEIN SCI, V18, P2060, DOI 10.1002/pro.218; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Levitt M, 2007, P NATL ACAD SCI USA, V104, P3183, DOI 10.1073/pnas.0611678104; Loewenstein Y, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-207; Louie B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007546; Mortl M, 2004, J BIOL CHEM, V279, P29718, DOI 10.1074/jbc.M401224200; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Nardini M, 2003, EMBO J, V22, P3122, DOI 10.1093/emboj/cdg283; Okazaki K, 2011, STRUCTURE, V19, P588, DOI 10.1016/j.str.2011.01.013; Pawelek PD, 2000, EMBO J, V19, P4204, DOI 10.1093/emboj/19.16.4204; Petrey D, 2009, CURR OPIN STRUC BIOL, V19, P363, DOI 10.1016/j.sbi.2009.02.001; Rausell A, 2010, P NATL ACAD SCI USA, V107, P1995, DOI 10.1073/pnas.0908044107; Redfern OC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000485; Rentzsch R, 2009, TRENDS BIOTECHNOL, V27, P210, DOI 10.1016/j.tibtech.2009.01.002; Robinson CV, 2007, NATURE, V450, P973, DOI 10.1038/nature06523; Rost B, 2002, J MOL BIOL, V318, P595, DOI 10.1016/S0022-2836(02)00016-5; Santos GM, 2011, TRENDS ENDOCRIN MET, V22, P87, DOI 10.1016/j.tem.2010.11.004; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; SCHULLER DJ, 1995, NAT STRUCT BIOL, V2, P69, DOI 10.1038/nsb0195-69; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi JH, 2004, J BIOL CHEM, V279, P24765, DOI 10.1074/jbc.M311744200; Sinha R, 2010, PROTEINS, V78, P3235, DOI 10.1002/prot.22812; Stark A, 2003, J MOL BIOL, V326, P1307, DOI 10.1016/S0022-2836(03)00045-7; Stenberg K, 1997, PROTEIN SCI, V6, P1009, DOI 10.1002/pro.5560060506; Terwilliger TC, 2009, ANNU REV BIOPHYS, V38, P371, DOI 10.1146/annurev.biophys.050708.133740; Thangudu RR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-365; Toyota E, 2001, J MOL BIOL, V305, P471, DOI 10.1006/jmbi.2000.4303; Tuncbag N, 2008, J MOL BIOL, V381, P785, DOI 10.1016/j.jmb.2008.04.071; Tuncbag N, 2011, NAT PROTOC, V6, P1341, DOI 10.1038/nprot.2011.367; Tyagi M, 2009, PROTEIN SCI, V18, P1674, DOI 10.1002/pro.181; Wallace AC, 1997, PROTEIN SCI, V6, P2308; Westbrook J, 2005, BIOINFORMATICS, V21, P988, DOI 10.1093/bioinformatics/bti082; Winter C, 2006, NUCLEIC ACIDS RES, V34, pD310, DOI 10.1093/nar/gkj099; XIA ZX, 1990, J MOL BIOL, V212, P837, DOI 10.1016/0022-2836(90)90240-M; Xie L, 2008, P NATL ACAD SCI USA, V105, P5441, DOI 10.1073/pnas.0704422105; Yang MJ, 2006, MOL CELL, V23, P377, DOI 10.1016/j.molcel.2006.07.012; Yeh JI, 2008, P NATL ACAD SCI USA, V105, P3280, DOI 10.1073/pnas.0712331105; Zhao N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019554	75	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31437	10.1371/journal.pone.0031437	http://dx.doi.org/10.1371/journal.pone.0031437			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347478	Green Published, gold, Green Submitted			2022-12-25	WOS:000302730100071
J	Salva, S; Merino, MC; Aguero, G; Gruppi, A; Alvarez, S				Salva, Susana; Cecilia Merino, Maria; Agueero, Graciela; Gruppi, Adriana; Alvarez, Susana			Dietary Supplementation with Probiotics Improves Hematopoiesis in Malnourished Mice	PLOS ONE			English	Article							PNEUMOCOCCAL RESPIRATORY-INFECTION; BONE-MARROW; MALNUTRITION; PROTEIN; LEPTIN; CELLS; CHILDREN; IMMUNITY; FUTURE	Background: Lactobacillus rhamnosus CRL1505 (Lr) administered during the repletion of immunocompromised-malnourished mice improves the resistance against intestinal and respiratory infections. This effect is associated with an increase in the number and functionality of immune cells, indicating that Lr could have some influence on myeloid and lymphoid cell production and maturation. Objective: This study analyzed the extent of the damage caused by malnutrition on myeloid and lymphoid cell development in the spleen and bone marrow (BM). We also evaluated the impact of immunobiotics on the recovery of hematopoiesis affected in malnourished mice. Methods: Protein malnourished mice were fed on a balanced conventional diet for 7 or 14 consecutive d with or without supplemental Lr or fermented goat's milk (FGM). Malnourished mice and well-nourished mice were used as controls. Histological and flow cytometry studies were carried out in BM and spleen to study myeloid and lymphoid cells. Results: Malnutrition induced quantitative alterations in spleen B and T cells; however, no alteration was observed in the ability of splenic B cells to produce immunoglobulins after challenge with LPS or CpG. The analysis of BM B cell subsets based on B220, CD24, IgM and IgD expression showed that malnutrition affected B cell development. In addition, BM myeloid cells decreased in malnourished mice. On the contrary, protein deprivation increased BM T cell number. These alterations were reverted with Lr or FGM repletion treatments since normal numbers of BM myeloid, T and B cells were observed in these groups. Conclusions: Protein malnutrition significantly alters B cell development in BM. The treatment of malnourished mice with L. rhamnosus CRL1505 was able to induce a recovery of B cells that would explain its ability to increase immunity against infections. This work highlights the possibility of using immunobiotics to accelerate the recovery of lymphopoyesis in immunocompromised-malnourished hosts.	[Salva, Susana; Alvarez, Susana] Reference Ctr Lactobacilli CERELA CONICET, San Miguel De Tucuman, Argentina; [Cecilia Merino, Maria; Gruppi, Adriana] Natl Univ Cordoba, Dept Clin Biochem, Sch Chem Sci, Cordoba, Argentina; [Agueero, Graciela; Alvarez, Susana] Natl Univ Tucuman, Sch Biochem Chem & Pharm, San Miguel De Tucuman, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Universidad Nacional de Tucuman	Salva, S (corresponding author), Reference Ctr Lactobacilli CERELA CONICET, San Miguel De Tucuman, Argentina.	salvarez@cerela.org.ar		Salva, Susana/0000-0001-9571-1259	CIUNT (Consejo de Investigaciones de la Universidad Nacional de Tucuman) [26 D/403]	CIUNT (Consejo de Investigaciones de la Universidad Nacional de Tucuman)	This work was carried out thanks to grants provided by CIUNT 26 D/403 (Consejo de Investigaciones de la Universidad Nacional de Tucuman). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez S, 2009, J NUTR SCI VITAMINOL, P1; BORELLI P, 1995, NUTR RES, V15, P1477, DOI 10.1016/0271-5317(95)02020-V; Chan JL, 2006, P NATL ACAD SCI USA, V103, P8481, DOI 10.1073/pnas.0505429103; Chandra RK, 1997, AM J CLIN NUTR, V66, P460; CHANDRA RK, 1991, AM J CLIN NUTR, V53, P1087, DOI 10.1093/ajcn/53.5.1087; Clancy R, 2003, FEMS IMMUNOL MED MIC, V38, P9, DOI 10.1016/S0928-8244(03)00147-0; Fillol F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-116; Fock RA, 2009, NUTRITION, V10, P1021; Forsythe P, 2011, CHEST, V139, P901, DOI 10.1378/chest.10-1861; Goldin BR, 2008, CLIN INFECT DIS, V46, pS96, DOI 10.1086/523333; Ishikawa LL, 2009, GENET VACCINES THER, V16, P7; Kitazawa H., 2009, CURR OPIN IMMUNOL, V3, P87; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; LOZOFF B, 1991, NEW ENGL J MED, V325, P687, DOI 10.1056/NEJM199109053251004; Monteiro JP, 2005, BRAZ J MED BIOL RES, V38, P1475, DOI 10.1590/S0100-879X2005001000004; Monteiro JP, 2005, BLOOD, V105, P1484, DOI 10.1182/blood-2004-07-2856; Montes CL, 2006, EUR J IMMUNOL, V36, P1474, DOI 10.1002/eji.200535537; Najera O, 2001, CLIN EXP IMMUNOL, V126, P461, DOI 10.1046/j.1365-2249.2001.01694.x; Vinolo MAR, 2008, NUTR RES, V28, P791, DOI 10.1016/j.nutres.2008.08.006; Reid G, 2003, CLIN MICROBIOL REV, V16, P658, DOI 10.1128/CMR.16.4.658-672.2003; Rodriguez L, 2005, CLIN DIAGN LAB IMMUN, V12, P502, DOI 10.1128/CDLI.12.4.502-507.2005; Rodriguez L, 2011, J NEUROSCI REV, V31, P8373; Salva S, 2008, FOOD AGR IMMUNOL, V19, P195, DOI 10.1080/09540100802247243; Salva S, 2011, J SCI FOOD AGR, V91, P2355, DOI 10.1002/jsfa.4467; Salva S, 2010, INT J FOOD MICROBIOL, V141, P82, DOI 10.1016/j.ijfoodmicro.2010.03.013; Savino W, 2002, EUR J CLIN NUTR, V56, pS46, DOI 10.1038/sj.ejcn.1601485; Schrimshaw NS, 1997, AM J CLIN NUTR, V66, p464S; Tanaka M, 2011, J NEUROSCI, V31, P8373, DOI 10.1523/JNEUROSCI.6562-10.2011; Villena J, 2006, BRIT J NUTR, V95, P591, DOI 10.1079/BJN20051663; Villena J, 2005, J NUTR, V135, P1462, DOI 10.1093/jn/135.6.1462; Villena J, 2011, INT IMMUNOPHARMACOL, V11, P1633, DOI 10.1016/j.intimp.2011.06.004; Villena J, 2009, MICROBIOL IMMUNOL, V53, P636, DOI 10.1111/j.1348-0421.2009.00171.x; Vituri CL, 2000, BRAZ J MED BIOL RES, V33, P889, DOI 10.1590/S0100-879X2000000800004; Woodward B, 1998, NUTR REV, V56, pS84; Xavier JG, 2007, HISTOL HISTOPATHOL, V22, P651, DOI 10.14670/HH-22.651; Zuniga E, 2005, EUR J IMMUNOL, V35, P1849, DOI 10.1002/eji.200526005	36	18	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31171	10.1371/journal.pone.0031171	http://dx.doi.org/10.1371/journal.pone.0031171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347448	Green Published, Green Submitted, gold			2022-12-25	WOS:000302730100051
J	de Castellarnau, M; Aparicio, E; Parera, M; Franco, S; Tural, C; Clotet, B; Martinez, MA				de Castellarnau, Montserrat; Aparicio, Ester; Parera, Mariona; Franco, Sandra; Tural, Cristina; Clotet, Bonaventura; Angel Martinez, Miguel			Deciphering the Interleukin 28B Variants That Better Predict Response to Pegylated Interferon-alpha and Ribavirin Therapy in HCV/HIV-1 Coinfected Patients	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; GENETIC-VARIATION; PLUS RIBAVIRIN; IL28B; PEGINTERFERON; POLYMORPHISMS; ASSOCIATION; NONRESPONSE; EXPRESSION; CLEARANCE	Previous works have documented the contribution of different IL28B-associated SNPs to spontaneous HCV clearance. This study investigated the effect of different interleukin (IL) 28B genetic variants on interferon (IFN)-based therapy response. We genotyped eight IL28B single-nucleotide polymorphisms (SNPs) in a cohort of 197 hepatitis C virus (HCV)/human immunodeficiency virus type 1 (HIV-1) coinfected patients from our clinic unit who received combined pegylated (peg)-IFN-alpha and ribavirin (RBV) therapy. This analysis included the two strongest tag predictors for HCV clearance, rs8099917 and rs12979860, and four causal variants (rs4803219, rs28416813, rs8103142, and rs4803217) located in the IL28B promoter, coding, and 3'-untranslated regions. Haplotypes carrying the major alleles at IL28B SNPs were highly associated with sustained virological responses (SVRs) after treatment with peg-IFN-alpha and RBV [odds ratio (OR) = 2.5, 95% confidence interval (CI) = 1.6-4.0, 4.0x10(-5)]. Three causal SNP genotypes (rs28416813, rs8103142, and rs4803217) displayed the highest association with SVRs (OR = 3.7, 95% CI = 2.0-6.7, p = 1.3x10(-5)). All four causal variants were in high linkage disequilibrium, both among themselves (r(2)>= 0.94) and with the rs12979860 variant (r(2)>= 0.92). In contrast, rs8099917 was in low linkage disequilibrium with the four causal variants (r(2)<= 0.45) and with the rs12979860 variant (r(2) = 0.45). These results demonstrate that rs12979860, compared to rs8099917, may be a better predictor of response to the peg- IFN/RBV treatment among HCV/HIV- 1 coinfected patients. Moreover, causal IL28B variants are strongly associated with treatment SVRs.	[de Castellarnau, Montserrat; Aparicio, Ester; Parera, Mariona; Franco, Sandra; Clotet, Bonaventura; Angel Martinez, Miguel] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Fundacio IrsiCaixa, E-08193 Barcelona, Spain; [Tural, Cristina; Clotet, Bonaventura] Hosp Badalona Germans Trias & Pujol, Fundacio Lluita Sida, Badalona, Spain	Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Hospital Germans Trias i Pujol	de Castellarnau, M (corresponding author), Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Fundacio IrsiCaixa, E-08193 Barcelona, Spain.	mmartinez@irsicaixa.es	Franco, Sandra/E-6114-2016; Franco, Sandra/S-6843-2019; Martinez, Miguel Angel/K-6435-2014	Franco, Sandra/0000-0003-4126-2202; Franco, Sandra/0000-0003-4126-2202; Martinez, Miguel Angel/0000-0002-6681-4950; de Castellarnau Serra, Montserrat/0000-0002-9643-2881; Parera Sallent, Mariona/0000-0002-0756-8307	Spanish Ministry of Science and Innovation [BFU2010-15194, SAF2010-21617]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study was supported by grants from the Spanish Ministry of Science and Innovation (BFU2010-15194 and SAF2010-21617). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013771; Balagopal A, 2010, GASTROENTEROLOGY, V139, P1865, DOI 10.1053/j.gastro.2010.10.004; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Clausen LN, 2011, J VIRAL HEPATITIS, V18, pe66, DOI 10.1111/j.1365-2893.2010.01392.x; di Iulio J, 2011, HEPATOLOGY, V53, P1446, DOI 10.1002/hep.24263; Fried MW, 2000, AM J GASTROENTEROL, V95, P3225, DOI 10.1111/j.1572-0241.2000.03433.x; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gao B, 2004, HEPATOLOGY, V39, P880, DOI 10.1002/hep.20139; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gould NS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025704; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Labarga P, 2011, AIDS, V25, P1131, DOI 10.1097/QAD.0b013e3283471d83; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Pineda JA, 2010, CLIN INFECT DIS, V51, P788, DOI 10.1086/656235; Rallon NI, 2011, AIDS, V25, P1025, DOI 10.1097/QAD.0b013e3283471cae; Rallon NI, 2010, AIDS, V24, pF23, DOI 10.1097/QAD.0b013e3283391d6d; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Walsh MJ, 2006, GUT, V55, P529, DOI 10.1136/gut.2005.069674	24	37	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e31016	10.1371/journal.pone.0031016	http://dx.doi.org/10.1371/journal.pone.0031016			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328925	Green Published, gold, Green Submitted			2022-12-25	WOS:000302179300011
J	Klanjscek, T; Nisbet, RM; Priester, JH; Holden, PA				Klanjscek, Tin; Nisbet, Roger M.; Priester, John H.; Holden, Patricia A.			Modeling Physiological Processes That Relate Toxicant Exposure and Bacterial Population Dynamics	PLOS ONE			English	Article							PSEUDOMONAS-PUTIDA; CADMIUM UPTAKE; GROWTH; RESISTANCE; TOXICITY; ADAPTATION; EXPRESSION; RESPONSES; COPPER; WATER	Quantifying effects of toxicant exposure on metabolic processes is crucial to predicting microbial growth patterns in different environments. Mechanistic models, such as those based on Dynamic Energy Budget (DEB) theory, can link physiological processes to microbial growth. Here we expand the DEB framework to include explicit consideration of the role of reactive oxygen species (ROS). Extensions considered are: (i) additional terms in the equation for the "hazard rate'' that quantifies mortality risk; (ii) a variable representing environmental degradation; (iii) a mechanistic description of toxic effects linked to increase in ROS production and aging acceleration, and to non-competitive inhibition of transport channels; (iv) a new representation of the "lag time'' based on energy required for acclimation. We estimate model parameters using calibrated Pseudomonas aeruginosa optical density growth data for seven levels of cadmium exposure. The model reproduces growth patterns for all treatments with a single common parameter set, and bacterial growth for treatments of up to 150 mg(Cd)/L can be predicted reasonably well using parameters estimated from cadmium treatments of 20 mg(Cd)/L and lower. Our approach is an important step towards connecting levels of biological organization in ecotoxicology. The presented model reveals possible connections between processes that are not obvious from purely empirical considerations, enables validation and hypothesis testing by creating testable predictions, and identifies research required to further develop the theory.	[Klanjscek, Tin; Nisbet, Roger M.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Klanjscek, Tin] Rudjer Boskovic Inst, Zagreb, Croatia; [Priester, John H.; Holden, Patricia A.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; Rudjer Boskovic Institute; University of California System; University of California Santa Barbara	Klanjscek, T (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	tin@irb.hr	Nisbet, Roger M/B-6951-2014	Klanjscek, Tin/0000-0002-9341-344X	US National Science Foundation [EF-0742521]; US Environmental Protection Agency under Cooperative [EF 0830117]; Croatian Ministry for Science, Education and Sport [098-0982934-2719]	US National Science Foundation(National Science Foundation (NSF)); US Environmental Protection Agency under Cooperative; Croatian Ministry for Science, Education and Sport(Ministry of Science, Education and Sports, Republic of Croatia)	The research was supported by US National Science Foundation under grant EF-0742521. There was also support from the US National Science Foundation and the US Environmental Protection Agency under Cooperative Agreement Number EF 0830117, and Croatian Ministry for Science, Education and Sport grant #098-0982934-2719. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baas J, 2010, SCI TOTAL ENVIRON, V408, P3735, DOI 10.1016/j.scitotenv.2009.10.066; Bandyopadhyay D, 1997, LIFE SCI, V60, P1891, DOI 10.1016/S0024-3205(97)00151-3; Banjerdkij P, 2005, APPL ENVIRON MICROB, V71, P1843, DOI 10.1128/AEM.71.4.1843-1849.2005; BARANYI J, 1994, INT J FOOD MICROBIOL, V23, P277, DOI 10.1016/0168-1605(94)90157-0; Begot C, 1996, J MICROBIOL METH, V25, P225, DOI 10.1016/0167-7012(95)00090-9; Brandt BW, 2004, WATER RES, V38, P1003, DOI 10.1016/j.watres.2003.09.037; Chang W, 2009, ENVIRON MICROBIOL, V11, P1428; Denning GM, 2003, AM J PHYSIOL-LUNG C, V285, pL584, DOI 10.1152/ajplung.00086.2003; Fedorenkova A, 2010, ENVIRON SCI TECHNOL, V44, P4328, DOI 10.1021/es9037287; Fowler BA, 2004, BIOMETALS, V17, P567, DOI 10.1023/B:BIOM.0000045740.52182.9d; Gibbons SM, 2011, APPL ENVIRON MICROB, V77, P108, DOI 10.1128/AEM.01187-10; Hajdu R, 2010, ENVIRON SCI TECHNOL, V44, P4597, DOI 10.1021/es100687h; Hanegraaf PPF, 2001, J THEOR BIOL, V212, P237, DOI 10.1006/jtbi.2001.2369; Hao ZQ, 1999, APPL ENVIRON MICROB, V65, P4741; Hassen A, 1998, BIORESOURCE TECHNOL, V65, P73, DOI 10.1016/S0960-8524(98)00011-X; Heipieper H, HDB HYDROCARBON LIPI, P1615; HIGHAM DP, 1986, ENVIRON HEALTH PERSP, V65, P5, DOI 10.2307/3430155; HILLS BP, 1995, FOOD MICROBIOL, V12, P333, DOI 10.1016/S0740-0020(95)80114-6; Jager T, 2010, P ROYAL S B IN PRESS; Jager T, 2010, ECOTOXICOLOGY, V19, P351, DOI 10.1007/s10646-009-0417-z; Jin YH, 2003, NAT GENET, V34, P326, DOI 10.1038/ng1172; Kocincova AS, 2008, BIOTECHNOL BIOENG, V100, P430, DOI 10.1002/bit.21793; Kooijman S, 2009, ECOTOXICOLOGY MODELI, V2, DOI [10.1007/978-1-4419-0197-2-9, DOI 10.1007/978-1-4419-0197-2-9]; Kooijman S.A.L.M., 2010, DYNAMIC ENERGY BUDGE; LADDAGA RA, 1985, J BACTERIOL, V162, P1100, DOI 10.1128/JB.162.3.1100-1105.1985; Li ZB, 2007, PLOS BIOL, V5, P212, DOI 10.1371/journal.pbio.0050035; McMurray CT, 2003, NAT GENET, V34, P239, DOI 10.1038/ng0703-239; Miller CD, 2009, LETT APPL MICROBIOL, V49, P775, DOI 10.1111/j.1472-765X.2009.02741.x; Muller EB, 2010, ECOTOXICOLOGY, V19, P38, DOI 10.1007/s10646-009-0384-4; Munoz-Cuevas M, 2010, APPL ENVIRON MICROB, V76, P2908, DOI 10.1128/AEM.02572-09; NIES DH, 1995, J IND MICROBIOL, V14, P186, DOI 10.1007/BF01569902; Pages D, 2007, ENVIRON MICROBIOL, V9, P2820, DOI 10.1111/j.1462-2920.2007.01394.x; Popova OB, 2008, RUSS J MAR BIOL, V34, P179, DOI 10.1134/S1063074008030073; Priester JH, 2009, ENVIRON SCI TECHNOL, V43, P2589, DOI 10.1021/es802806n; Ricklefs RE, 2002, J GERONTOL A-BIOL, V57, pB69, DOI 10.1093/gerona/57.2.B69; Silver S, 1996, ANNU REV MICROBIOL, V50, P753, DOI 10.1146/annurev.micro.50.1.753; Sousa T, 2008, PHILOS T R SOC B, V363, P2453, DOI 10.1098/rstb.2007.2230; TYNECKA Z, 1981, J BACTERIOL, V147, P305, DOI 10.1128/JB.147.2.305-312.1981; Wang AY, 2005, J BACTERIOL, V187, P3259, DOI 10.1128/JB.187.9.3259-3266.2005	39	27	28	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e26955	10.1371/journal.pone.0026955	http://dx.doi.org/10.1371/journal.pone.0026955			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328915	Green Published, Green Submitted, gold			2022-12-25	WOS:000302179300001
J	Wang, LF; Ge, HM; Hao, CY; Dong, YS; Zhang, XY				Wang, Lanfen; Ge, Hongmei; Hao, Chenyang; Dong, Yushen; Zhang, Xueyong			Identifying Loci Influencing 1,000-Kernel Weight in Wheat by Microsatellite Screening for Evidence of Selection during Breeding	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; LINEAR UNBIASED PREDICTION; SPATIAL GENETIC-STRUCTURE; SINGLE-CROSS PERFORMANCE; LINKAGE DISEQUILIBRIUM; BREAD WHEAT; POPULATION-STRUCTURE; QTL ANALYSIS; GRAIN-YIELD; ASSOCIATION	Chinese wheat mini core collection (262 accessions) was genotyped at 531 microsatellite loci representing a mean marker density of 5.1 cM. One-thousand-kernel weights (TKW) of lines were measured in five trials (three environments in four growing seasons). Structure analysis based on 42 unlinked SSR loci indicated that the materials formed two sub-populations, viz., landraces and modern varieties. A large difference in TKW (7.08 g, P < 0.001) was found between the two sub-groups. Therefore, TKW is a major yield component that was improved in the past 6 decades; it increased from a mean 31.5 g in the 1940s to 44.64 g in the 2000s, representing a 2.19 g increase in each decade. Analyses based on a mixed linear model (MLM), population structure (Q) and relative kinship (K) revealed 22 SSR loci that were significantly associated with mean TKW (MTKW) of the five trials estimated by the best linear unbiased predictor (BLUP) method. They were mainly distributed on chromosomes of homoeologous groups 1, 2, 3, 5 and 7. Six loci, cfa2234-3A, gwm156-3B, barc56-5A, gwm234-5B, wmc17-7A and cfa2257-7A individually explained more than 11.84% of the total phenotypic variation. Favored alleles for breeding at the 22 loci were inferred according to their estimated effects on MTKW based on mean difference of varieties grouped by genotypes. Statistical simulation showed that these favored alleles have additive genetic effects. Frequency changes of alleles at loci associated with TKW are much more dramatic than those at neutral loci between the sub-groups. The numbers of favored alleles in modern varieties indicate there is still considerable genetic potential for their use as markers for genome selection of TKW in wheat breeding. Alleles that can be used globally to increase TKW were inferred according to their distribution by latitude and frequency of changes between landraces and the modern varieties.	[Wang, Lanfen; Ge, Hongmei; Hao, Chenyang; Dong, Yushen; Zhang, Xueyong] Chinese Acad Agr Sci, Key Lab Crop Germplasm Resources & Utilizat, Natl Key Facil Crop Gene Resources & Genet Improv, Minist Agr,Inst Crop Sci, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs	Wang, LF (corresponding author), Chinese Acad Agr Sci, Key Lab Crop Germplasm Resources & Utilizat, Natl Key Facil Crop Gene Resources & Genet Improv, Minist Agr,Inst Crop Sci, Beijing 100193, Peoples R China.	xueyongz@caas.net.cn			Chinese Ministry of Science and Technology [2009CB118306, 2010CB125900]; Chinese Agricultural Research Service; Ministry of Agriculture [CARS-3-1-2]; National Natural Science Foundation of China [30900898]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Agricultural Research Service; Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Chinese Ministry of Science and Technology (2009CB118306 and 2010CB125900) and the Chinese Agricultural Research Service, Ministry of Agriculture (CARS-3-1-2) and National Natural Science Foundation of China (30900898). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrama HA, 2007, MOL BREEDING, V19, P341, DOI 10.1007/s11032-006-9066-6; Andolfatto P, 2001, CURR OPIN GENET DEV, V11, P635, DOI 10.1016/S0959-437X(00)00246-X; Barrero RA, 2011, FUNCT INTEGR GENOMIC, V11, P37, DOI 10.1007/s10142-010-0208-x; Bernardo R, 1996, CROP SCI, V36, P50, DOI [10.2135/cropsci1996.0011183X003600040009x, 10.2135/cropsci1996.0011183X003600040007x]; Bernardo R, 1996, THEOR APPL GENET, V93, P262, DOI 10.1007/BF00225755; Bernardo R, 1996, THEOR APPL GENET, V93, P1098, DOI 10.1007/BF00230131; Bonjean APA, 2010, CEREALS CHINA; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Crossa J, 2007, GENETICS, V177, P1889, DOI 10.1534/genetics.107.078659; Cuthbert JL, 2008, THEOR APPL GENET, V117, P595, DOI 10.1007/s00122-008-0804-5; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Dong Y.C., 2003, J PLANT GENET RESOUR, V4, P1, DOI DOI 10.13430/J.CNKI.JPGR.2003.01.001; Ersoz Elhan S., 2009, V63, P173; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Frisch M, 2010, THEOR APPL GENET, V120, P441, DOI 10.1007/s00122-009-1204-1; Ge HM, 2011, CROP SCI IN PRESS; Gennaro A, 2009, FUNCT INTEGR GENOMIC, V9, P325, DOI 10.1007/s10142-009-0115-1; Glaszmann JC, 2010, CURR OPIN PLANT BIOL, V13, P167, DOI 10.1016/j.pbi.2010.01.004; Groos C, 2003, THEOR APPL GENET, V106, P1032, DOI 10.1007/s00122-002-1111-1; Guo ZA, 2010, NEW PHYTOL, V185, P841, DOI 10.1111/j.1469-8137.2009.03099.x; Gupta PK, 2006, GENOME, V49, P565, DOI 10.1139/G06-063; Hao CY, 2008, CHINESE SCI BULL, V53, P1518, DOI 10.1007/s11434-008-0212-x; Hao CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017279; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Horvath A, 2009, THEOR APPL GENET, V119, P1523, DOI 10.1007/s00122-009-1153-8; Huang XQ, 2004, THEOR APPL GENET, V109, P933, DOI 10.1007/s00122-004-1708-7; Jiang QY, 2011, FUNCT INTEGR GENOMIC, V11, P49, DOI 10.1007/s10142-010-0188-x; Koebner RMD, 2003, TRENDS BIOTECHNOL, V21, P59, DOI 10.1016/S0167-7799(02)00036-7; Li XP, 2011, NEW PHYTOL, V189, P449, DOI 10.1111/j.1469-8137.2010.03490.x; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; Ott A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022306; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2000, GENETICS, V155, P945; Quarrie SA, 2006, J EXP BOT, V57, P2627, DOI 10.1093/jxb/erl026; Quarrie SA, 2005, THEOR APPL GENET, V110, P865, DOI 10.1007/s00122-004-1902-7; Reynolds MP, 2001, EUPHYTICA, V119, P137, DOI 10.1023/A:1017521800795; Roder MS, 1998, GENETICS, V149, P2007; Roeder MIS, 2008, FUNCT INTEGR GENOMIC, V8, P79, DOI 10.1007/s10142-007-0053-8; Schlotterer C, 2003, TRENDS GENET, V19, P32, DOI 10.1016/S0168-9525(02)00012-4; SHARP PJ, 1989, THEOR APPL GENET, V78, P342, DOI 10.1007/BF00265294; Snape JW, 2007, EUPHYTICA, V154, P401, DOI 10.1007/s10681-006-9208-2; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Su ZQ, 2011, THEOR APPL GENET, V122, P211, DOI 10.1007/s00122-010-1437-z; Sun XY, 2009, EUPHYTICA, V165, P615, DOI 10.1007/s10681-008-9794-2; Sun XC, 2010, THEOR APPL GENET, V120, P1041, DOI 10.1007/s00122-009-1232-x; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Tsilo TJ, 2010, THEOR APPL GENET, V121, P717, DOI 10.1007/s00122-010-1343-4; Wang J, 2008, J CEREAL SCI, V48, P836, DOI 10.1016/j.jcs.2008.06.005; Wang LanFen, 2007, Scientia Agricultura Sinica, V40, P2667; Wang RX, 2009, THEOR APPL GENET, V118, P313, DOI 10.1007/s00122-008-0901-5; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Xiao SH, 2003, CHINESE WHEAT IMPROV; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yan JB, 2011, CROP SCI, V51, P433, DOI 10.2135/cropsci2010.04.0233; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang XueYong, 2007, Agricultural Sciences in China, V6, P255, DOI 10.1016/S1671-2927(07)60043-1; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhuang QS., 2003, CHINESE WHEAT IMPROV	65	65	83	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e29432	10.1371/journal.pone.0029432	http://dx.doi.org/10.1371/journal.pone.0029432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328917	Green Submitted, Green Published, gold			2022-12-25	WOS:000302179300003
J	Liu, L; Cao, ZY; Chen, J; Li, R; Cao, YH; Zhu, CL; Wu, KL; Wu, JG; Liu, F; Zhu, Y				Liu, Li; Cao, Zhongying; Chen, Jing; Li, Rui; Cao, Yanhua; Zhu, Chengliang; Wu, Kailang; Wu, Jianguo; Liu, Fang; Zhu, Ying			Influenza A Virus Induces Interleukin-27 through Cyclooxygenase-2 and Protein Kinase A Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; RESPONSE ELEMENT; ANTIINFLAMMATORY PROPERTIES; VIRAL REPLICATION; PROSTAGLANDIN E-2; INTERFERON-GAMMA; IFN-ALPHA; CYTOKINE; ACTIVATION; IL-27	We previously reported that IL-27, which belongs to the IL-12 family of cytokines, is elevated in the serum of patients infected with influenza A virus (IAV). Here, we show that the expression of IL-27 was significantly up-regulated in A549 human lung epithelial cells and human peripheral blood mononuclear cells infected with IAV. Additionally, IAV triggered IL-27 expression through protein kinase A and cAMP-response element-binding protein signaling, which was mediated by cyclooxygenase-2-derived prostaglandin E-2. IL-27 inhibited IAV replication by STAT1/2/3 phosphorylation and activated antiviral factor protein kinase R phosphorylation. Clinical analysis showed that IL-27 levels were significantly elevated in a cohort of patients infected with IAV compared with healthy individuals and that circulating IL-27 levels were tightly and positively correlated with prostaglandin E-2 levels. These results indicate that IL-27 expression is one host immune factor produced in response to IAV infection and that elevated IL-27 levels inhibit viral replication.	[Liu, Li; Cao, Zhongying; Chen, Jing; Li, Rui; Cao, Yanhua; Zhu, Chengliang; Wu, Kailang; Wu, Jianguo; Liu, Fang; Zhu, Ying] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China	Wuhan University	Zhu, Y (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	yingzhu@whu.edu.cn	Li, Hongpu/B-7707-2014	Li, Hongpu/0000-0003-2323-6107; Wu, Jianguo/0000-0002-8326-2895	Major State Basic Research Development Program of China ("973" project) [2009CB522506, 2012CB518900]; National Natural Science Foundation of China [30970144, 81171654]; National Mega Project on Major Infectious Diseases Prevention [2012ZX10004503, 2012ZX10002006-003, 2012ZX10004-207]; National Mega Project on Major Drug Development [2011ZX09401-302]	Major State Basic Research Development Program of China ("973" project)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Mega Project on Major Infectious Diseases Prevention; National Mega Project on Major Drug Development	This work was supported by research grants from the Major State Basic Research Development Program of China ("973" project numbers 2009CB522506 and 2012CB518900), National Natural Science Foundation of China Grants 30970144 and 81171654, National Mega Project on Major Infectious Diseases Prevention Grants 2012ZX10004503, 2012ZX10002006-003, and 2012ZX10004-207, and National Mega Project on Major Drug Development Grant 2011ZX09401-302.	Abel T, 2008, PROG BRAIN RES, V169, P97, DOI 10.1016/S0079-6123(07)00006-4; Anderson CF, 2009, J IMMUNOL, V183, P4619, DOI 10.4049/jimmunol.0804024; Barneda-Zahonero B, 2009, MOL BIOL CELL, V20, P5051, DOI 10.1091/mbc.E09-05-0424; Batten M, 2007, J MOL MED-JMM, V85, P661, DOI 10.1007/s00109-007-0164-7; Bender H, 2009, HEPATOLOGY, V50, P585, DOI 10.1002/hep.22988; Diegelmann J, 2012, J BIOL CHEM, V287, P286, DOI 10.1074/jbc.M111.294355; Dormond O, 2002, J BIOL CHEM, V277, P45838, DOI 10.1074/jbc.M209213200; Dwivedi Y, 2011, PROG NEURO-PSYCHOPH, V35, P831, DOI 10.1016/j.pnpbp.2010.08.025; Fakruddin JM, 2007, BLOOD, V109, P1841, DOI 10.1182/blood-2006-02-001578; Frank AC, 2010, J INTERF CYTOK RES, V30, P427, DOI 10.1089/jir.2009.0093; Fujino H, 2005, MOL PHARMACOL, V68, P251, DOI 10.1124/mol.105.011833; Goodman WA, 2011, J IMMUNOL, V186, P3336, DOI 10.4049/jimmunol.1001455; Greenwell-Wild T, 2009, BLOOD, V114, P1864, DOI 10.1182/blood-2009-03-211540; Grewal SS, 2000, J BIOL CHEM, V275, P34433, DOI 10.1074/jbc.M004728200; Guzzo C, 2010, AIDS, V24, P1371, DOI 10.1097/QAD.0b013e3283391d2b; Ho MY, 2009, J IMMUNOL, V183, P6217, DOI 10.4049/jimmunol.0901272; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Imamichi T, 2008, AIDS, V22, P39, DOI 10.1097/QAD.0b013e3282f3356c; Jonges M, 2010, J CLIN MICROBIOL, V48, P928, DOI 10.1128/JCM.02045-09; Julkunen I, 2000, VACCINE, V19, pS32, DOI 10.1016/S0264-410X(00)00275-9; Julkunen I, 2001, CYTOKINE GROWTH F R, V12, P171, DOI 10.1016/S1359-6101(00)00026-5; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Laurence A, 2009, HEPATOLOGY, V50, P358, DOI 10.1002/hep.23063; Lee SMY, 2008, J INFECT DIS, V198, P525, DOI 10.1086/590499; Li JP, 2011, BRIT J HAEMATOL, V153, P764, DOI 10.1111/j.1365-2141.2010.08431.x; Li W, 2010, J IMMUNOL, V185, P5056, DOI 10.4049/jimmunol.0902667; Li W, 2009, EUR J IMMUNOL, V39, P1019, DOI 10.1002/eji.200838885; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001985; Liu L, 2011, CLIN CHIM ACTA, V412, P1081, DOI 10.1016/j.cca.2011.02.028; Liu M, 2007, FASEB J, V21, P1586, DOI 10.1096/fj.06-6589com; Merkle D, 2011, CELL SIGNAL, V23, P507, DOI 10.1016/j.cellsig.2010.08.017; Mizumura K, 2003, CLIN EXP ALLERGY, V33, P1244, DOI 10.1046/j.1365-2222.2003.01750.x; Mogensen TH, 2001, MICROBIOL MOL BIOL R, V65, P131, DOI 10.1128/MMBR.65.1.131-150.2001; Mukhtar MM, 2009, INT J BIOCHEM CELL B, V41, P554, DOI 10.1016/j.biocel.2008.07.001; Nakamura R, 2010, J VIROL, V84, P5574, DOI 10.1128/JVI.02030-09; Netea MG, 2006, PLOS MED, V3, P1310, DOI 10.1371/journal.pmed.0030277; Owaki T, 2008, J IMMUNOL, V180, P2903, DOI 10.4049/jimmunol.180.5.2903; Pirhonen J, 2007, J LEUKOCYTE BIOL, V82, P1185, DOI 10.1189/jlb.0307157; Poleganov MA, 2008, MOL IMMUNOL, V45, P2869, DOI 10.1016/j.molimm.2008.01.021; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; RONNI T, 1995, J IMMUNOL, V154, P2764; Shimizu M, 2006, J IMMUNOL, V176, P7317, DOI 10.4049/jimmunol.176.12.7317; Steer SA, 2003, VIRAL IMMUNOL, V16, P447, DOI 10.1089/088282403771926283; Ueda M, 2010, J VIROL, V84, P3068, DOI 10.1128/JVI.01923-09; Villarino AV, 2004, ARTHRITIS RES THER, V6, P225, DOI 10.1186/ar1227; Villarino AV, 2004, J IMMUNOL, V173, P715, DOI 10.4049/jimmunol.173.2.715; Wang JR, 2009, J IMMUNOL, V182, P1296, DOI 10.4049/jimmunol.182.3.1296; Xie DX, 2009, INT IMMUNOL, V21, P1251, DOI 10.1093/intimm/dxp087; Yoshida H, 2008, IMMUNOL REV, V226, P234, DOI 10.1111/j.1600-065X.2008.00710.x; Zanassi P, 2001, J BIOL CHEM, V276, P11487, DOI 10.1074/jbc.M007631200; Zou F, 2007, BIOCHEM BIOPH RES CO, V355, P494, DOI 10.1016/j.bbrc.2007.01.178	51	54	56	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11899	11910		10.1074/jbc.M111.308064	http://dx.doi.org/10.1074/jbc.M111.308064			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22343630	Green Published, hybrid			2022-12-25	WOS:000302782200029
J	Mastroianni, JR; Costales, JK; Zaksheske, J; Selsted, ME; Salzman, NH; Ouellette, AJ				Mastroianni, Jennifer R.; Costales, Jessica K.; Zaksheske, Jennifer; Selsted, Michael E.; Salzman, Nita H.; Ouellette, Andre J.			Alternative Luminal Activation Mechanisms for Paneth Cell alpha-Defensins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE SMALL-INTESTINE; PRECURSOR LIPID II; MATRIX METALLOPROTEINASE-7; ENTERIC SALMONELLOSIS; MICROBIAL ECOLOGY; HOST-DEFENSE; CRYPTDIN-4; PEPTIDES; BACTERIA; MICE	Background: Matrix metalloproteinase-7 (MMP7) processes mouse pro-alpha-defensins to bactericidal forms in Paneth cells, and MMP7(-/-) mice are considered to be alpha-defensin-null. Results: Activated alpha-defensins occur in the colonic lumen of MMP7(-/-) mice. Conclusion: alpha-Defensins are activated in MMP7(-/-) large bowel lumen by alternative proteolytic conversion mechanisms. Significance: MMP7(-/-) mice are unsuitable for studying alpha-defensin deficiency in large intestine.	[Ouellette, Andre J.] Univ So Calif, Keck Sch Med, Dept Pathol & Lab Med, USC Norris Canc Ctr, Los Angeles, CA 90089 USA; [Zaksheske, Jennifer; Salzman, Nita H.] Med Coll Wisconsin, Dept Pediat, Div Gastroenterol, Milwaukee, WI 53226 USA; [Zaksheske, Jennifer; Salzman, Nita H.] Med Coll Wisconsin, Childrens Res Inst, Milwaukee, WI 53226 USA	University of Southern California; Medical College of Wisconsin; Medical College of Wisconsin	Ouellette, AJ (corresponding author), Univ So Calif, Keck Sch Med, Dept Pathol & Lab Med, USC Norris Canc Ctr, 1450 Biggy St,NRT 7505, Los Angeles, CA 90089 USA.	aouellet@usc.edu		Salzman, Nita/0000-0003-0939-6139	National Institutes of Health [DK044632, AI059346, AI022931, AI058129, AI057757]; USC Norris Cancer Center Support [P30 CA014089]; NATIONAL CANCER INSTITUTE [P30CA014089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059346, R01AI058129, R01AI022931, R21AI057757, R37AI022931, R01AI057757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044632, R55DK044632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USC Norris Cancer Center Support; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK044632, AI059346 (to A. J. O.), AI022931, AI058129 (to M. E. S.), and AI057757 (to N. H. S.) and by the USC Norris Cancer Center Support Grant P30 CA014089.	Amid C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-606; Ayabe T, 2002, J BIOL CHEM, V277, P5219, DOI 10.1074/jbc.M109410200; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Biswas A, 2010, P NATL ACAD SCI USA, V107, P14739, DOI 10.1073/pnas.1003363107; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Croswell A, 2009, INFECT IMMUN, V77, P2741, DOI 10.1128/IAI.00006-09; de Leeuw E, 2010, FEBS LETT, V584, P1543, DOI 10.1016/j.febslet.2010.03.004; Figueredo SM, 2009, J BIOL CHEM, V284, P6826, DOI 10.1074/jbc.M807024200; Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Hadjicharalambous C, 2008, BIOCHEMISTRY-US, V47, P12626, DOI 10.1021/bi800335e; HARWIG SSL, 1995, ADV EXP MED BIOL, V371, P251; Hristova K, 1996, BIOCHEMISTRY-US, V35, P11888, DOI 10.1021/bi961100d; KAGAN BL, 1990, P NATL ACAD SCI USA, V87, P210, DOI 10.1073/pnas.87.1.210; Kamdar K, 2008, J BIOL CHEM, V283, P32361, DOI 10.1074/jbc.M805296200; Kristich CJ, 2007, PLASMID, V57, P131, DOI 10.1016/j.plasmid.2006.08.003; Maemoto A, 2004, J BIOL CHEM, V279, P44188, DOI 10.1074/jbc.M406154200; Mastroianni JR, 2009, J BIOL CHEM, V284, P27848, DOI 10.1074/jbc.M109.050773; Ouellette AJ, 2000, J BIOL CHEM, V275, P33969, DOI 10.1074/jbc.M004062200; OUELLETTE AJ, 1988, GASTROENTEROLOGY, V94, P114, DOI 10.1016/0016-5085(88)90618-X; Patil A, 2004, PHYSIOL GENOMICS, V20, P1, DOI 10.1152/physiolgenomics.00150.2004; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; Qin X, 2001, J BACTERIOL, V183, P3372, DOI 10.1128/JB.183.11.3372-3382.2001; Qu XD, 1996, INFECT IMMUN, V64, P5161, DOI 10.1128/IAI.64.12.5161-5165.1996; Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Satchell DP, 2003, PEPTIDES, V24, P1795, DOI 10.1016/j.peptides.2003.08.020; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; SCHAUER DB, 1995, J CLIN MICROBIOL, V33, P2064, DOI 10.1128/JCM.33.8.2064-2068.1995; Schmidtchen A, 2002, MOL MICROBIOL, V46, P157, DOI 10.1046/j.1365-2958.2002.03146.x; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Selsted M E, 1993, Genet Eng (N Y), V15, P131; SELSTED ME, 1992, J CELL BIOL, V118, P929, DOI 10.1083/jcb.118.4.929; Shanahan MT, 2011, INFECT IMMUN, V79, P459, DOI 10.1128/IAI.00996-10; Shim DH, 2010, BIOCHEM BIOPH RES CO, V401, P554, DOI 10.1016/j.bbrc.2010.09.100; Shirafuji Y, 2003, J BIOL CHEM, V278, P7910, DOI 10.1074/jbc.M210600200; Tanabe H, 2004, J BIOL CHEM, V279, P11976, DOI 10.1074/jbc.M310251200; Tanabe H, 2007, BIOCHEM BIOPH RES CO, V358, P349, DOI 10.1016/j.bbrc.2007.04.132; Weeks CS, 2006, J BIOL CHEM, V281, P28932, DOI 10.1074/jbc.M602041200; Wilson CL, 2009, J BIOL CHEM, V284, P8301, DOI 10.1074/jbc.M809744200; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113	44	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11205	11212		10.1074/jbc.M111.333559	http://dx.doi.org/10.1074/jbc.M111.333559			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334698	Green Published, hybrid			2022-12-25	WOS:000302780100048
J	Baucum, AJ; Strack, S; Colbran, RJ				Baucum, Anthony J., II; Strack, Stefan; Colbran, Roger J.			Age-Dependent Targeting of Protein Phosphatase 1 to Ca2+/Calmodulin-Dependent Protein Kinase II by Spinophilin in Mouse Striatum	PLOS ONE			English	Article							POSTSYNAPTIC DENSITY PROTEIN; DENDRITIC SPINE MORPHOLOGY; LONG-TERM POTENTIATION; F-ACTIN; SUBCELLULAR-LOCALIZATION; BINDING-PROTEIN; RAT-BRAIN; CAMKII; PHOSPHORYLATION; NEURABIN	Mechanisms underlying age-dependent changes of dendritic spines on striatal medium spiny neurons are poorly understood. Spinophilin is an F-actin- and protein phosphatase 1 (PP1)-binding protein that targets PP1 to multiple downstream effectors to modulate dendritic spine morphology and function. We found that calcium/calmodulin-dependent protein kinase II (CaMKII) directly and indirectly associates with N- and C-terminal domains of spinophilin, but F-actin can displace CaMKII from the N-terminal domain. Spinophilin co-localizes PP1 with CaMKII on the F-actin cytoskeleton in heterologous cells, and spinophilin co-localizes with synaptic CaMKII in neuronal cultures. Thr286 autophosphorylation enhances the binding of CaMKII to spinophilin in vitro and in vivo. Although there is no change in total levels of Thr286 autophosphorylation, maturation from postnatal day 21 into adulthood robustly enhances the levels of CaMKII that co-immunoprecipitate with spinophilin from mouse striatal extracts. Moreover, N- and C-terminal domain fragments of spinophilin bind more CaMKII from adult vs. postnatal day 21 striatal lysates. Total levels of other proteins that interact with C-terminal domains of spinophilin decrease during maturation, perhaps reducing competition for CaMKII binding to the C-terminal domain. In contrast, total levels of alpha-internexin and binding of alpha-internexin to the spinophilin N-terminal domain increases with maturation, perhaps bridging an indirect interaction with CaMKII. Moreover, there is an increase in the levels of myosin Va, alpha-internexin, spinophilin, and PP1 in striatal CaMKII immune complexes isolated from adult and aged mice compared to those from postnatal day 21. These changes in spinophilin/CaMKII interactomes may contribute to changes in striatal dendritic spine density, morphology, and function during normal postnatal maturation and aging.	[Baucum, Anthony J., II; Strack, Stefan; Colbran, Roger J.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Vanderbilt Kennedy Ctr,Ctr Mol Neurosci, Nashville, TN 37212 USA	Vanderbilt University	Baucum, AJ (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Vanderbilt Kennedy Ctr,Ctr Mol Neurosci, Nashville, TN 37212 USA.	Anthony.Baucum@vanderbilt.edu	Colbran, Roger/AAU-7708-2021; Baucum, Anthony/I-5109-2013	Colbran, Roger/0000-0001-7401-8244; Baucum, Anthony/0000-0002-4756-9865; Strack, Stefan/0000-0002-6175-7280	National Institutes of Health (NIH) [R01-MH063232, NS037508, T32-MH65215, CA68485, DK20593, DK58404, HD15052, DK59637, EY08126]; Vanderbilt-Kennedy Center; United Negro College/Merck Science Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U2CDK059637, P60DK020593, U24DK059637, P30DK020593, P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH065215, R01MH063232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037508] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt-Kennedy Center; United Negro College/Merck Science Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants R01-MH063232 and NS037508 and by a Hobbs Discovery Grant from the Vanderbilt-Kennedy Center. AJB was supported by a NIH Training Grant in Neurogenomics (T32-MH65215) and by a fellowship from the United Negro College Fund/Merck Science Initiative. Confocal microscopy was performed in the Vanderbilt University Medical Center Cell Imaging Shared Resource (supported by NIH grants CA68485, DK20593, DK58404, HD15052, DK59637, and EY08126). Immunoblot development by Odyssey system was performed in the Vanderbilt Molecular Biology Cell Resource Core. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Barnes AP, 2004, MOL BRAIN RES, V124, P105, DOI 10.1016/j.molbrainres.2003.12.020; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Baucum AJ, 2010, MOL CELL PROTEOMICS, V9, P1243, DOI 10.1074/mcp.M900387-MCP200; BENSON DL, 1992, NEUROSCIENCE, V46, P851, DOI 10.1016/0306-4522(92)90189-9; Bingol B, 2010, CELL, V140, P567, DOI 10.1016/j.cell.2010.01.024; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Bodhinathan K, 2010, J NEUROSCI, V30, P1914, DOI 10.1523/JNEUROSCI.5485-09.2010; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; BRICKEY DA, 1990, BIOCHEM BIOPH RES CO, V173, P578, DOI 10.1016/S0006-291X(05)80074-9; BROCKE L, 1995, J NEUROSCI, V15, P6797; Brown AM, 2008, J BIOL CHEM, V283, P14286, DOI 10.1074/jbc.M801377200; Brown AM, 2005, EUR J NEUROSCI, V22, P247, DOI 10.1111/j.1460-9568.2005.04190.x; Buchsbaum RJ, 2003, J BIOL CHEM, V278, P18833, DOI 10.1074/jbc.M207876200; Carmody LC, 2004, J BIOL CHEM, V279, P21714, DOI 10.1074/jbc.M402261200; Carmody LC, 2008, FASEB J, V22, P1660, DOI 10.1096/fj.07-092841; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Cheng HY, 2001, MOL CELL BIOL, V21, P6170, DOI 10.1128/MCB.21.18.6170-6180.2001; Colbran RJ, 2004, BIOCHEM J, V378, P1, DOI 10.1042/BJ20031547; Costa MCR, 1999, J BIOL CHEM, V274, P15811, DOI 10.1074/jbc.274.22.15811; DOSEMECI A, 1993, J NEUROCHEM, V61, P550; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Fleming IN, 1999, J BIOL CHEM, V274, P12753, DOI 10.1074/jbc.274.18.12753; FUKUNAGA K, 1993, J BIOL CHEM, V268, P7863; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Grossman SD, 2004, J NEUROCHEM, V90, P317, DOI 10.1111/j.1471-4159.2004.02491.x; Gustin RM, 2011, MOL CELL NEUROSCI, V47, P286, DOI 10.1016/j.mcn.2011.05.006; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hsieh-Wilson LC, 1999, BIOCHEMISTRY-US, V38, P4365, DOI 10.1021/bi982900m; Hsieh-Wilson LC, 2003, J BIOL CHEM, V278, P1186, DOI 10.1074/jbc.M205754200; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Jiao YX, 2008, J NEUROCHEM, V105, P1746, DOI 10.1111/j.1471-4159.2008.05280.x; Jiao YX, 2011, J BIOL CHEM, V286, P24806, DOI 10.1074/jbc.M110.216010; LEVINE MS, 1986, DEV BRAIN RES, V24, P47, DOI 10.1016/0165-3806(86)90172-0; LEVINE MS, 1986, NEUROBIOL AGING, V7, P277, DOI 10.1016/0197-4580(86)90008-4; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lin YC, 2008, P NATL ACAD SCI USA, V105, P15791, DOI 10.1073/pnas.0804399105; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Logue JS, 2010, FEBS J, V277, P4370, DOI 10.1111/j.1742-4658.2010.07866.x; MacMillan LB, 1999, J BIOL CHEM, V274, P35845, DOI 10.1074/jbc.274.50.35845; MCNEILL RB, 1995, J BIOL CHEM, V270, P10043, DOI 10.1074/jbc.270.17.10043; Mullasseril P, 2007, J NEUROCHEM, V103, P357, DOI 10.1111/j.1471-4159.2007.04744.x; Nikandrova YA, 2010, J BIOL CHEM, V285, P923, DOI 10.1074/jbc.M109.033985; Norris CM, 1998, J NEUROPHYSIOL, V80, P1567, DOI 10.1152/jn.1998.80.3.1567; O'Leary H, 2006, MOL BIOL CELL, V17, P4656, DOI 10.1091/mbc.E06-03-0252; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; OUIMET CC, 1995, P NATL ACAD SCI USA, V92, P3396, DOI 10.1073/pnas.92.8.3396; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Picconi B, 2004, J NEUROSCI, V24, P5283, DOI 10.1523/JNEUROSCI.1224-04.2004; Ragusa MJ, 2010, NAT STRUCT MOL BIOL, V17, P459, DOI 10.1038/nsmb.1786; Rao MV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017087; Robison AJ, 2005, J BIOL CHEM, V280, P35329, DOI 10.1074/jbc.M502191200; Ryan XZP, 2005, NEURON, V47, P85, DOI 10.1016/j.neuron.2005.05.013; Sanabria H, 2009, J BIOL CHEM, V284, P9770, DOI 10.1074/jbc.M809518200; Sarrouilhe D, 2006, BIOCHIMIE, V88, P1099, DOI 10.1016/j.biochi.2006.04.010; Satoh A, 1998, J BIOL CHEM, V273, P3470, DOI 10.1074/jbc.273.6.3470; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Shioda N, 2011, J NEUROSCI, V31, P346, DOI 10.1523/JNEUROSCI.4816-10.2011; Strack S, 1999, J COMP NEUROL, V413, P373; Strack S, 1997, J BIOL CHEM, V272, P13467, DOI 10.1074/jbc.272.21.13467; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Terry-Lorenzo RT, 2002, J BIOL CHEM, V277, P46535, DOI 10.1074/jbc.M206960200; Tolias KF, 2007, P NATL ACAD SCI USA, V104, P7265, DOI 10.1073/pnas.0702044104; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; WOODGETT JR, 1983, EUR J BIOCHEM, V136, P481, DOI 10.1111/j.1432-1033.1983.tb07766.x; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005; Yoshimura Y, 1997, J BIOL CHEM, V272, P26354, DOI 10.1074/jbc.272.42.26354; Yoshimura Y, 2000, MOL BRAIN RES, V81, P118, DOI 10.1016/S0169-328X(00)00170-4; Zhang GR, 2009, NEUROSCIENCE, V159, P308, DOI 10.1016/j.neuroscience.2008.06.068; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	72	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31554	10.1371/journal.pone.0031554	http://dx.doi.org/10.1371/journal.pone.0031554			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348105	Green Published, Green Submitted, gold			2022-12-25	WOS:000302733900053
J	Wang, DJ; Legesse-Miller, A; Johnson, EL; Coller, HA				Wang, David J.; Legesse-Miller, Aster; Johnson, Elizabeth L.; Coller, Hilary A.			Regulation of the let-7a-3 Promoter by NF-kappa B	PLOS ONE			English	Article							MICRORNA GENE-EXPRESSION; LUNG-CANCER; CELLS; BIOGENESIS; DIFFERENTIATION; BLOCKADE; LIN28; PROLIFERATION; URIDYLATION; SURVIVAL	Changes in microRNA expression have been linked to a wide array of pathological states. However, little is known about the regulation of microRNA expression. The let-7 microRNA is a tumor suppressor that inhibits cellular proliferation and promotes differentiation, and is frequently lost in tumors. We investigated the transcriptional regulation of two let-7 family members, let-7a-3 and let-7b, which form a microRNA cluster and are located 864 bp apart on chromosome 22q13.31. Previous reports present conflicting data on the role of the NF-kappa B transcription factor in regulating let-7. We cloned three fragments upstream of the let-7a-3/let-7b miRNA genomic region into a plasmid containing a luciferase reporter gene. Ectopic expression of subunits of NF-kappa B (p50 or p65/RelA) significantly increased luciferase activity in HeLa, 293, 293T and 3T3 cells, indicating that the let-7a-3/let-7b promoter is highly responsive to NF-kappa B. Mutation of a putative NF-kappa B binding site at bp -833 reduced basal promoter activity and decreased promoter activity in the presence of p50 or p65 overexpression. Mutation of a second putative binding site, at bp -947 also decreased promoter activity basally and in response to p65 induction, indicating that both sites contribute to NF-kappa B responsiveness. While the levels of the endogenous primary let-7a and let-7b transcript were induced in response to NF-kappa B overexpression in 293T cells, the levels of fully processed, mature let-7a and let-7b miRNAs did not increase. Instead, levels of Lin-28B, a protein that blocks let-7 maturation, were induced by NF-kappa B. Increased Lin-28B levels could contribute to the lack of an increase in mature let-7a and let-7b. Our results suggest that the final biological outcome of NF-kappa B activation on let-7 expression may vary depending upon the cellular context. We discuss our results in the context of NF-kappa B activity in repressing self-renewal and promoting differentiation.	[Wang, David J.; Legesse-Miller, Aster; Johnson, Elizabeth L.; Coller, Hilary A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Wang, DJ (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	hcoller@princeton.edu		Johnson, Elizabeth/0000-0002-8290-1122	PhRMA Foundation [2007RSGl9572]; NIH/NIGMS [1R01 GM081686, 1R01 GM086465]; NIH/NCI [K01 CA128887]; Chinese Professionals Association of Canada; National Science Foundation [DGE-0646086]; NIGMS Center of Excellence [P50 GM071508]; NATIONAL CANCER INSTITUTE [K01CA128887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508, R01GM081686, R01GM086465] Funding Source: NIH RePORTER	PhRMA Foundation; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Chinese Professionals Association of Canada; National Science Foundation(National Science Foundation (NSF)); NIGMS Center of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by PhRMA Foundation grant 2007RSGl9572 (http://www.phrmafoundation.org/); NIH/NIGMS 1R01 GM081686, NIH/NIGMS 1R01 GM086465, NIH/NCI K01 CA128887 to A. L. M.; a scholarship from the Chinese Professionals Association of Canada (http://www.chineseprofessionals.ca/) to D.J.W.; a National Science Foundation Graduate Research Fellowship DGE-0646086 to E.L.J.; and NIGMS Center of Excellence grant P50 GM071508. H. A. C. was the Milton E. Cassel scholar of the Rita Allen Foundation (http://www.ritaallenfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KS, 2007, CURR MOL MED, V7, P619, DOI 10.2174/156652407782564363; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Garzon R, 2007, ONCOGENE, V26, P4148, DOI 10.1038/sj.onc.1210186; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Huang SY, 2001, ONCOGENE, V20, P4188, DOI 10.1038/sj.onc.1204535; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Ibarra I, 2007, GENE DEV, V21, P3238, DOI 10.1101/gad.1616307; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lee YS, 2005, J BIOL CHEM, V280, P16635, DOI 10.1074/jbc.M412247200; Legesse-Miller A, 2009, J BIOL CHEM, V284, P6605, DOI 10.1074/jbc.C900002200; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Michlewski G, 2010, NAT STRUCT MOL BIOL, V17, P1011, DOI 10.1038/nsmb.1874; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Ravi R, 2004, DRUG RESIST UPDATE, V7, P53, DOI 10.1016/j.drup.2004.01.003; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sarkar FH, 2008, INT REV IMMUNOL, V27, P293, DOI 10.1080/08830180802276179; Seitz CS, 2000, CANCER RES, V60, P4085; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008	38	34	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31240	10.1371/journal.pone.0031240	http://dx.doi.org/10.1371/journal.pone.0031240			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348059	Green Published, gold, Green Submitted			2022-12-25	WOS:000302733900034
J	Daw, TM; Cinner, JE; McClanahan, TR; Brown, K; Stead, SM; Graham, NAJ; Maina, J				Daw, Tim M.; Cinner, Joshua E.; McClanahan, Timothy R.; Brown, Katrina; Stead, Selina M.; Graham, Nicholas A. J.; Maina, Joseph			To Fish or Not to Fish: Factors at Multiple Scales Affecting Artisanal Fishers' Readiness to Exit a Declining Fishery	PLOS ONE			English	Article							RESILIENCE; MANAGEMENT; CAPACITY; RESOURCE	Globally, fisheries are challenged by the combined impacts of overfishing, degradation of ecosystems and impacts of climate change, while fisheries livelihoods are further pressured by conservation policy imperatives. Fishers' adaptive responses to these pressures, such as exiting from a fishery to pursue alternative livelihoods, determine their own vulnerability, as well as the potential for reducing fishing effort and sustaining fisheries. The willingness and ability to make particular adaptations in response to change, such as exiting from a declining fishery, is influenced by economic, cultural and institutional factors operating at scales from individual fishers to national economies. Previous studies of exit from fisheries at single or few sites, offer limited insight into the relative importance of individual and larger-scale social and economic factors. We asked 599 fishers how they would respond to hypothetical scenarios of catch declines in 28 sites in five western Indian Ocean countries. We investigated how socioeconomic variables at the individual-, household- and site-scale affected whether they would exit fisheries. Site-level factors had the greatest influence on readiness to exit, but these relationships were contrary to common predictions. Specifically, higher levels of infrastructure development and economic vitality - expected to promote exit from fisheries - were associated with less readiness to exit. This may be due to site level histories of exit from fisheries, greater specialisation of fishing households, or higher rewards from fishing in more economically developed sites due to technology, market access, catch value and government subsidies. At the individual and household scale, fishers from households with more livelihood activities, and fishers with lower catch value were more willing to exit. These results demonstrate empirically how adaptive responses to change are influenced by factors at multiple scales, and highlight the importance of understanding natural resource-based livelihoods in the context of the wider economy and society.	[Daw, Tim M.; Brown, Katrina] Univ E Anglia, Sch Int Dev, Norwich NR4 7TJ, Norfolk, England; [Daw, Tim M.] Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden; [Cinner, Joshua E.; Graham, Nicholas A. J.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [McClanahan, Timothy R.; Maina, Joseph] Wildlife Conservat Soc, Marine Program, Bronx, NY USA; [Stead, Selina M.] Newcastle Univ, Sch Marine Sci & Technol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Maina, Joseph] Macquarie Univ, Dept Biol Sci, Computat Ecol Grp, Sydney, NSW 2109, Australia	University of East Anglia; Stockholm University; James Cook University; Wildlife Conservation Society; Newcastle University - UK; Macquarie University	Daw, TM (corresponding author), Univ E Anglia, Sch Int Dev, Norwich NR4 7TJ, Norfolk, England.	T.Daw@uea.ac.uk	McClanahan, Tim/K-4998-2019; Cinner, Joshua/AAA-6823-2021; Graham, Nicholas AJ/C-8360-2014; Cinner, Joshua e/E-8966-2011	Graham, Nicholas AJ/0000-0002-0304-7467; Cinner, Joshua e/0000-0003-2675-9317; Maina, Joseph/0000-0003-1268-6137; Daw, Tim M./0000-0001-6635-9153; McClanahan, Timothy/0000-0001-5821-3584	Western Indian Ocean Marine Science Association (WIOMSA) Marine Science for Management (MASMA); Western Indian Ocean Marine Science Association; Regional Coastal Management Programme Of The Indian Ocean Countries; ESRC [ES/F041357/1] Funding Source: UKRI; Economic and Social Research Council [ES/F041357/1] Funding Source: researchfish	Western Indian Ocean Marine Science Association (WIOMSA) Marine Science for Management (MASMA); Western Indian Ocean Marine Science Association; Regional Coastal Management Programme Of The Indian Ocean Countries; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This study was largely funded by the Western Indian Ocean Marine Science Association (WIOMSA) Marine Science for Management (MASMA) program to the Wildlife Conservation Society and based on a workshop funded by Western Indian Ocean Marine Science Association and 'Regional Coastal Management Programme Of The Indian Ocean Countries'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger WN, 2011, GLOBAL ENVIRON POLIT, V11, P1, DOI 10.1162/GLEP_a_00051; Allison EH, 2001, MAR POLICY, V25, P377, DOI 10.1016/S0308-597X(01)00023-9; [Anonymous], OCCUPATIONAL GEOGRAP; BAILEY C, 1982, SMALL SCALE FISHERIE; Bene C, 2003, WORLD DEV, V31, P949, DOI 10.1016/S0305-750X(03)00045-7; Blennow K, 2009, GLOBAL ENVIRON CHANG, V19, P100, DOI 10.1016/j.gloenvcha.2008.10.003; Brashares JS, 2011, P NATL ACAD SCI USA, V108, P13931, DOI 10.1073/pnas.1011526108; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Cinner J, 2004, OCEAN COASTAL MANAGE, V47; Cinner JE, 2009, CONSERV BIOL, V23, P124, DOI 10.1111/j.1523-1739.2008.01041.x; Cinner JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011999; Cinner JE, 2009, CURR BIOL, V19, P206, DOI 10.1016/j.cub.2008.11.055; Clark CW, 2005, J ENVIRON ECON MANAG, V50, P47, DOI 10.1016/j.jeem.2004.11.002; Coulthard S, 2008, GLOBAL ENVIRON CHANG, V18, P479, DOI 10.1016/j.gloenvcha.2008.04.003; Crona B, 2010, MAR POLICY, V34, P761, DOI 10.1016/j.marpol.2010.01.023; Cutter SL, 2008, GLOBAL ENVIRON CHANG, V18, P598, DOI 10.1016/j.gloenvcha.2008.07.013; Engle NL, 2011, GLOBAL ENVIRON CHANG, V21, P647, DOI 10.1016/j.gloenvcha.2011.01.019; Frank E, 2011, GLOBAL ENVIRON CHANG, V21, P66, DOI 10.1016/j.gloenvcha.2010.11.001; Gordon HS, 1954, J POLIT ECON, V62, P124, DOI 10.1086/257497; Grothmann T, 2005, GLOBAL ENVIRON CHANG, V15, P199, DOI 10.1016/j.gloenvcha.2005.01.002; Henry G.T., 1990, PRACTICAL SAMPLING, V21; Hill NAO, 2012, CONSERV BIOL, V26, P324, DOI 10.1111/j.1523-1739.2011.01796.x; Ikiara MM, 1999, FISHERMANS RESISTANC; Jennings S, 1995, CORAL REEFS, V14, P225, DOI 10.1007/BF00334346; Marshall NA, 2007, RURAL SOCIOL, V72, P359, DOI 10.1526/003601107781799254; Marshall NA, 2010, GLOBAL ENVIRON CHANG, V20, P36, DOI 10.1016/j.gloenvcha.2009.10.003; Mascia MB, 2009, CONSERV BIOL, V23, P16, DOI 10.1111/j.1523-1739.2008.01050.x; McClanahan TR, 2008, CONSERV LETT, V1, P53, DOI 10.1111/j.1755-263X.2008.00008_1.x; McClanahan TR, 2011, P NATL ACAD SCI USA, V108, P17230, DOI 10.1073/pnas.1106861108; McManus JW, 1997, CORAL REEFS, V16, pS121, DOI 10.1007/s003380050248; Muallil RN, 2011, FISH RES, V111, P74, DOI 10.1016/j.fishres.2011.06.013; OECD, 2007, STRUCT CHANG FISH DE; Pauly D., 2006, MAR STUD MAST, V4, P7, DOI DOI 10.1126/SCIENCE.279.5352.860.PMID:9452385; Pauly D., 1988, TROP COASTAL AREA MA, V3, P14; Pita C, 2010, J RURAL STUD, V26, P308, DOI 10.1016/j.jrurstud.2010.02.004; Pollnac RB, 2001, OCEAN COAST MANAGE, V44, P531, DOI 10.1016/S0964-5691(01)00064-3; Pollnac Richard B, RAPID ASSESSMENT MAN; Pradhan NC, 2004, FISH RES, V68, P209, DOI 10.1016/j.fishres.2003.12.006; R Core Team, 2022, R LANG ENV STAT COMP; Salayo N, 2008, MAR POLICY, V32, P692, DOI 10.1016/j.marpol.2007.12.001; Sievanen L, 2005, OCEAN COAST MANAGE, V48, P297, DOI 10.1016/j.ocecoaman.2005.04.015; Smith L. E. D., 2005, Water Policy, V7, P359; TERKLA DG, 1988, LAND ECON, V64, P73, DOI 10.2307/3146609; Vincent K, 2007, GLOBAL ENVIRON CHANG, V17, P12, DOI 10.1016/j.gloenvcha.2006.11.009; WARD JM, 1994, AM J AGR ECON, V76, P916, DOI 10.2307/1243751; World Bank, 2009, SUNK BILL EC JUST FI; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	48	133	134	0	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e31460	10.1371/journal.pone.0031460	http://dx.doi.org/10.1371/journal.pone.0031460			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	924ZX	22348090	gold, Green Published, Green Accepted			2022-12-25	WOS:000302730900027
J	Diaz-Espinoza, R; Mukherjee, A; Soto, C				Diaz-Espinoza, Rodrigo; Mukherjee, Abhisek; Soto, Claudio			Kosmotropic Anions Promote Conversion of Recombinant Prion Protein into a PrPSc-Like Misfolded Form	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; AMYLOID FIBRIL FORMATION; IN-VITRO CONVERSION; MAMMALIAN PRIONS; SCRAPIE PRION; TRUNCATED FORMS; SALTS; AGGREGATION; TRANSITION; STABILITY	Prions are self-propagating proteins involved in transmissible spongiform encephalopaties in mammals. An aberrant conformation with amyloid-like features of a cell surface protein, termed prion protein (PrP), is thought to be the essential component of the infectious particle, though accessory co-factor molecules such as lipids and nucleotides may be involved. The cellular co-factors and environmental conditions implicated in PrP misfolding are not completely understood. To address this issue, several studies have been done inducing misfolding of recombinant PrP (recPrP) into classical amyloid structures using partially denaturing conditions. In this work, we report that misfolding of recPrP into PrPSc-like aggregates can be induced by simply incubating the protein in the presence of kosmotropic salts at concentrations that are known to retain or increase the stability of the protein. We used a simple experimental reaction (protein, buffer and salts) submitted to agitation/incubation cycles at physiological temperature and pH. The formation of protease resistant-recPrP was time and salt-concentration dependent and required the presence of kosmotropic anions such as F- or SO4-2. The molecular weights of the protease resistant recPrP fragments are reminiscent of those found in degradation assays of bona fide PrPSc. The aggregates also exhibited PrPSc-like ultrastructural features including rod-shape morphology under electron microscope, high beta-sheet content and thioflavin-T positive signal. The formation of recPrP aggregates with PrPSc biochemical features under conditions closer to physiological in the absence of organic co-factor molecules provides a simple setup that may prove helpful to understand the molecular mechanism of PrP misfolding.	[Diaz-Espinoza, Rodrigo; Mukherjee, Abhisek; Soto, Claudio] Univ Texas Houston Med Sch, Mitchell Ctr Alzheimers Dis & Related Brain Disor, Dept Neurol, Houston, TX 77030 USA; [Diaz-Espinoza, Rodrigo; Mukherjee, Abhisek] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Medical Branch Galveston	Diaz-Espinoza, R (corresponding author), Univ Texas Houston Med Sch, Mitchell Ctr Alzheimers Dis & Related Brain Disor, Dept Neurol, Houston, TX 77030 USA.	Claudio.Soto@uth.tmc.edu	Diaz-Espinoza, Rodrigo/HDM-8819-2022		National Institutes of Health (NIH) [R01NS049173]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049173] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by National Institutes of Health (NIH) grant R01NS049173 to CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apetri AC, 2003, J BIOL CHEM, V278, P22187, DOI 10.1074/jbc.M302130200; Atarashi R, 2008, NAT METHODS, V5, P211, DOI 10.1038/nmeth0308-211; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Baldwin RL, 1996, BIOPHYS J, V71, P2056, DOI 10.1016/S0006-3495(96)79404-3; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Baskakov IV, 2005, BIOCHEMISTRY-US, V44, P2339, DOI 10.1021/bi048322t; BENDHEIM PE, 1984, NATURE, V310, P418, DOI 10.1038/310418a0; Benetti F, 2009, PRION, V3, P213, DOI 10.4161/pri.3.4.10181; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; CAUGHEY B, 1994, BIOCHEM SOC T, V22, P163, DOI 10.1042/bst0220163; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Colby DW, 2009, P NATL ACAD SCI USA, V106, P20417, DOI 10.1073/pnas.0910350106; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Diaz-Espinoza R, 2010, PRION, V4, P1, DOI 10.4161/pri.4.2.11960; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; GABIZON R, 1987, P NATL ACAD SCI USA, V84, P4017, DOI 10.1073/pnas.84.12.4017; Geoghegan JC, 2007, J BIOL CHEM, V282, P36341, DOI 10.1074/jbc.M704447200; Gomes MPB, 2008, PRION, V2, P64, DOI 10.4161/pri.2.2.6988; Grudzielanek S, 2005, J MOL BIOL, V351, P879, DOI 10.1016/j.jmb.2005.06.046; Jain S, 2010, BIOCHEMISTRY-US, V49, P7615, DOI 10.1021/bi100745j; Kim JI, 2010, J BIOL CHEM, V285, P14083, DOI 10.1074/jbc.C110.113464; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Lodderstedt G, 2008, BIOCHEMISTRY-US, V47, P2181, DOI 10.1021/bi701322g; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; MCKINLEY MP, 1986, J INFECT DIS, V154, P110, DOI 10.1093/infdis/154.1.110; Morillas M, 2001, BIOCHEMISTRY-US, V40, P6982, DOI 10.1021/bi010232q; Munishkina LA, 2004, BIOCHEMISTRY-US, V43, P3289, DOI 10.1021/bi034938r; Nandi PK, 2006, J MOL BIOL, V362, P810, DOI 10.1016/j.jmb.2006.07.060; Nishina K, 2004, J BIOL CHEM, V279, P40788, DOI 10.1074/jbc.M406548200; Pedersen JS, 2006, BIOPHYS J, V90, P4181, DOI 10.1529/biophysj.105.070912; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; Post K, 1998, BIOL CHEM, V379, P1307, DOI 10.1515/bchm.1998.379.11.1307; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Rezaei-Ghaleh N, 2007, ARCH BIOCHEM BIOPHYS, V457, P160, DOI 10.1016/j.abb.2006.10.031; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; ROGERS DR, 1965, AM J CLIN PATHOL, V44, P59; Ronga L, 2006, J PEPT SCI, V12, P790, DOI 10.1002/psc.818; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Satoh K, 2003, J GEN VIROL, V84, P2885, DOI 10.1099/vir.0.19236-0; Sikkink LA, 2008, BIOPHYS CHEM, V135, P25, DOI 10.1016/j.bpc.2008.02.019; Silva JL, 2008, TRENDS BIOCHEM SCI, V33, P132, DOI 10.1016/j.tibs.2007.11.003; Silva JL, 2010, FRONT BIOSCI-LANDMRK, V15, P132, DOI 10.2741/3611; Sim VL, 2009, NEUROBIOL AGING, V30, P2031, DOI 10.1016/j.neurobiolaging.2008.02.016; Singh N, 2002, FRONT BIOSCI-LANDMRK, V7, pA60, DOI 10.2741/singh; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Soto C, 2011, TRENDS BIOCHEM SCI, V36, P151, DOI 10.1016/j.tibs.2010.11.001; Supattapone S, 2010, SCIENCE, V327, P1091, DOI 10.1126/science.1187790; Swietnicki W, 2000, BIOCHEMISTRY-US, V39, P424, DOI 10.1021/bi991967m; Torrent J, 2004, BIOCHEMISTRY-US, V43, P7162, DOI 10.1021/bi049939d; Wang F, 2007, BIOCHEMISTRY-US, V46, P7045, DOI 10.1021/bi700299h; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998; Yeh V, 2010, PROTEIN SCI, V19, P47, DOI 10.1002/pro.281; Zanusso G, 2004, J BIOL CHEM, V279, P38936, DOI 10.1074/jbc.M405468200	61	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31678	10.1371/journal.pone.0031678	http://dx.doi.org/10.1371/journal.pone.0031678			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347503	Green Published, gold, Green Submitted			2022-12-25	WOS:000302730200031
J	de Breij, A; Eveillard, M; Dijkshoorn, L; van den Broek, PJ; Nibbering, PH; Joly-Guillou, ML				de Breij, Anna; Eveillard, Matthieu; Dijkshoorn, Lenie; van den Broek, Peterhans J.; Nibbering, Peter H.; Joly-Guillou, Marie-Laure			Differences in Acinetobacter baumannii Strains and Host Innate Immune Response Determine Morbidity and Mortality in Experimental Pneumonia	PLOS ONE			English	Article							BIOFILM FORMATION; EPITHELIAL-CELLS; ABIOTIC SURFACES; MICE; IDENTIFICATION; RESISTANCE; INFECTION; NEUTROPHILS; HOSPITALS; ADHERENCE	Despite many reports documenting its epidemicity, little is known on the interaction of Acinetobacter baumannii with its host. To deepen our insight into this relationship, we studied persistence of and host response to different A. baumannii strains including representatives of the European (EU) clones I-III in a mouse pneumonia model. Neutropenic mice were inoculated intratracheally with five A. baumannii strains and an A. junii strain and at several days morbidity, mortality, bacterial counts, airway inflammation, and chemo-and cytokine production in lungs and blood were determined. A. baumannii RUH875 and RUH134 (EU clone I and II, respectively) and sporadic strain LUH8326 resulted in high morbidity/mortality, whereas A. baumannii LUH5875 (EU clone III, which is less widespread than clone I and II) caused less symptoms. A. baumannii type strain RUH3023(T) and A. junii LUH5851 did not cause disease. All strains, except A. baumannii RUH3023(T) and A. junii LUH5851, survived and multiplied in the lungs for several days. Morbidity and mortality were associated with the severity of lung pathology and a specific immune response characterized by low levels of anti-inflammatory (IL-10) and specific pro-inflammatory (IL-12p40 and IL-23) cytokines at the first day of infection. Altogether, a striking difference in behaviour among the A. baumannii strains was observed with the clone I and II strains being most virulent, whereas the A. baumannii type strain, which is frequently used in virulence studies appeared harmless.	[de Breij, Anna; Dijkshoorn, Lenie; van den Broek, Peterhans J.; Nibbering, Peter H.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands; [Eveillard, Matthieu; Joly-Guillou, Marie-Laure] Univ Angers, Angers Univ Hosp, Angers Med Sch, Study Grp Host Pathogens Interact,Dept Bacteriol, Angers, France	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	de Breij, A (corresponding author), Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands.	a.de_breij@lumc.nl	Joly-Guillou, Marie-Laure/E-8206-2014	Joly-Guillou, Marie-Laure/0000-0003-2593-6684				Breslow JM, 2011, INFECT IMMUN, V79, P3317, DOI 10.1128/IAI.00069-11; de Breij A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010732; de Breij A, 2009, RES MICROBIOL, V160, P213, DOI 10.1016/j.resmic.2009.01.002; Diancourt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010034; Dijkshoorn L, 2004, ANTIMICROB AGENTS CH, V48, P4919, DOI 10.1128/AAC.48.12.4919-4921.2004; Dijkshoorn L, 1996, J CLIN MICROBIOL, V34, P1519, DOI 10.1128/JCM.34.6.1519-1525.1996; Dijkshoorn L, 1998, SYST APPL MICROBIOL, V21, P33, DOI 10.1016/S0723-2020(98)80006-4; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Eveillard M, 2010, J INFECTION, V60, P154, DOI 10.1016/j.jinf.2009.09.004; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; GREENBERGER MJ, 1995, J IMMUNOL, V155, P722; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Jeong ES, 2009, J MICROBIOL BIOTECHN, V19, P424, DOI 10.4014/jmb.0807.436; Kapetanovic R, 2007, EXPERT OPIN BIOL TH, V7, P907, DOI 10.1517/14712598.7.6.907; King LB, 2009, FEMS IMMUNOL MED MIC, V55, P414, DOI 10.1111/j.1574-695X.2009.00538.x; Knapp S, 2006, AM J RESP CRIT CARE, V173, P122, DOI 10.1164/rccm.200505-730OC; Lee HW, 2008, CLIN MICROBIOL INFEC, V14, P49, DOI 10.1111/j.1469-0691.2007.01842.x; Lee JC, 2006, RES MICROBIOL, V157, P360, DOI 10.1016/j.resmic.2005.09.011; Lee JS, 2010, J MICROBIOL, V48, P387, DOI 10.1007/s12275-010-0155-1; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Mednick AJ, 2003, EUR J IMMUNOL, V33, P1744, DOI 10.1002/eji.200323626; Mittal R, 2010, J EXP MED, V207, P1307, DOI 10.1084/jem.20092265; Nemec A, 2001, INT J SYST EVOL MICR, V51, P1891, DOI 10.1099/00207713-51-5-1891; Nwugo CC, 2011, J PROTEOMICS, V74, P44, DOI 10.1016/j.jprot.2010.07.010; Qiu HY, 2009, MICROBES INFECT, V11, P946, DOI 10.1016/j.micinf.2009.06.003; Seifert H, 1997, J CLIN MICROBIOL, V35, P2819, DOI 10.1128/JCM.35.11.2819-2825.1997; Tomaras AP, 2008, MICROBIOL-SGM, V154, P3398, DOI 10.1099/mic.0.2008/019471-0; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Turton JF, 2007, CLIN MICROBIOL INFEC, V13, P807, DOI 10.1111/j.1469-0691.2007.01759.x; van Dessel H, 2004, RES MICROBIOL, V155, P105, DOI 10.1016/j.resmic.2003.10.003; Van Faassen H, 2007, INFECT IMMUN, V75, P5597, DOI 10.1128/IAI.00762-07; Van Looveren M, 2004, CLIN MICROBIOL INFEC, V10, P684, DOI 10.1111/j.1469-0691.2004.00942.x; vanderPoll T, 1996, J INFECT DIS, V174, P994, DOI 10.1093/infdis/174.5.994; Webster C, 2000, INFECT CONT HOSP EP, V21, P246, DOI 10.1086/503214	34	37	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30673	10.1371/journal.pone.0030673	http://dx.doi.org/10.1371/journal.pone.0030673			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347396	Green Published, Green Submitted, gold			2022-12-25	WOS:000302730100021
J	Gilpin, NW; Karanikas, CA; Richardson, HN				Gilpin, Nicholas W.; Karanikas, Chrisanthi A.; Richardson, Heather N.			Adolescent Binge Drinking Leads to Changes in Alcohol Drinking, Anxiety, and Amygdalar Corticotropin Releasing Factor Cells in Adulthood in Male Rats	PLOS ONE			English	Article							ELEVATED PLUS-MAZE; WITHDRAWAL-INDUCED ANXIETY; AMINOBUTYRIC-ACID RELEASE; PITUITARY-ADRENAL AXIS; PREFERRING P RATS; ETHANOL-WITHDRAWAL; CENTRAL NUCLEUS; EPIDEMIOLOGIC SURVEY; DEPENDENT RATS; RECEPTOR ANTAGONISTS	Heavy episodic drinking early in adolescence is associated with increased risk of addiction and other stress-related disorders later in life. This suggests that adolescent alcohol abuse is an early marker of innate vulnerability and/or binge exposure impacts the developing brain to increase vulnerability to these disorders in adulthood. Animal models are ideal for clarifying the relationship between adolescent and adult alcohol abuse, but we show that methods of involuntary alcohol exposure are not effective. We describe an operant model that uses multiple bouts of intermittent access to sweetened alcohol to elicit voluntary binge alcohol drinking early in adolescence (similar to postnatal days 28-42) in genetically heterogeneous male Wistar rats. We next examined the effects of adolescent binge drinking on alcohol drinking and anxiety-like behavior in dependent and non-dependent adult rats, and counted corticotropin-releasing factor (CRF) cell in the lateral portion of the central amygdala (CeA), a region that contributes to regulation of anxiety-and alcohol-related behaviors. Adolescent binge drinking did not alter alcohol drinking under baseline drinking conditions in adulthood. However, alcohol-dependent and non-dependent adult rats with a history of adolescent alcohol binge drinking did exhibit increased alcohol drinking when access to alcohol was intermittent. Adult rats that binged alcohol during adolescence exhibited increased exploration on the open arms of the elevated plus maze (possibly indicating either decreased anxiety or increased impulsivity), an effect that was reversed by a history of alcohol dependence during adulthood. Finally, CRF cell counts were reduced in the lateral CeA of rats with adolescent alcohol binge history, suggesting semi-permanent changes in the limbic stress peptide system with this treatment. These data suggest that voluntary binge drinking during early adolescence produces long-lasting neural and behavioral effects with implications for anxiety and alcohol use disorders.	[Gilpin, Nicholas W.] Louisiana State Univ, Hlth Sci Ctr, Dept Physiol, New Orleans, LA 70112 USA; [Karanikas, Chrisanthi A.; Richardson, Heather N.] Univ Massachusetts, Dept Psychol, Div Neurosci, Ctr Neuroendocrine Studies,Neurosci & Behav Progr, Amherst, MA 01003 USA; [Karanikas, Chrisanthi A.; Richardson, Heather N.] Univ Massachusetts, Dept Psychol, Dev Div, Ctr Neuroendocrine Studies,Neurosci & Behav Progr, Amherst, MA 01003 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Gilpin, NW (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Physiol, New Orleans, LA 70112 USA.	hrichardson@cns.umass.edu	Gilpin, Nicholas/V-1266-2019; Gilpin, Nicholas/K-9528-2014	/0000-0001-7659-1212; Gilpin, Nicholas/0000-0001-8901-8917	University of Massachusetts Amherst; National Institutes of Health and the National Institute on Alcohol Abuse and Alcoholism (NIH-NIAAA) [AA06420]; NIH [2 T32 NS007490-10]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P60AA006420, P50AA006420, F32AA016436, R21AA021013] Funding Source: NIH RePORTER	University of Massachusetts Amherst; National Institutes of Health and the National Institute on Alcohol Abuse and Alcoholism (NIH-NIAAA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by start-up funds from the University of Massachusetts Amherst (HNR) and grants from the National Institutes of Health and the National Institute on Alcohol Abuse and Alcoholism (NIH-NIAAA grant AA06420-Animal Models Core: Dr. George F. Koob-PI, HNR-co-PI; NIH grant 2 T32 NS007490-10: CAK). The University of Massachusetts Amherst, National Institutes of Health and National Institute on Alcohol Abuse and Alcoholism had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN HA, 1991, PSYCHOPHARMACOLOGY, V103, P227, DOI 10.1007/BF02244208; Barr CS, 2008, ARCH GEN PSYCHIAT, V65, P934, DOI 10.1001/archpsyc.65.8.934; Blomeyer D, 2008, BIOL PSYCHIAT, V63, P146, DOI 10.1016/j.biopsych.2007.04.026; Breese GR, 2005, NEUROPSYCHOPHARMACOL, V30, P1662, DOI 10.1038/sj.npp.1300706; Carty ML, 2010, BEHAV BRAIN RES, V208, P609, DOI 10.1016/j.bbr.2010.01.007; CASSELL MD, 1986, J COMP NEUROL, V246, P478, DOI 10.1002/cne.902460406; Cassell MD, 1999, ANN NY ACAD SCI, V877, P217, DOI 10.1111/j.1749-6632.1999.tb09270.x; CHOU SP, 1992, BRIT J ADDICT, V87, P1199; Courtney KE, 2009, PSYCHOL BULL, V135, P142, DOI 10.1037/a0014414; CRUZ APM, 1994, PHARMACOL BIOCHEM BE, V49, P171, DOI 10.1016/0091-3057(94)90472-3; Dawson DA, 2008, ALCOHOL CLIN EXP RES, V32, P2149, DOI 10.1111/j.1530-0277.2008.00806.x; DeWit DJ, 2000, AM J PSYCHIAT, V157, P745, DOI 10.1176/appi.ajp.157.5.745; Donovan JE, 2008, ALCOHOL CLIN EXP RES, V32, P108, DOI 10.1111/j.1530-0277.2007.00565.x; Ehlers CL, 2006, ALCOHOL CLIN EXP RES, V30, P1856, DOI 10.1111/j.1530-0277.2006.00222.x; EHLERS CL, 1992, PSYCHOPHARMACOLOGY, V106, P359, DOI 10.1007/BF02245418; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Fernandes C, 1996, PHARMACOL BIOCHEM BE, V54, P31, DOI 10.1016/0091-3057(95)02171-X; Finn DA, 2005, PSYCHOPHARMACOLOGY, V178, P471, DOI 10.1007/s00213-004-2039-8; Fullgrabe MW, 2007, PHARMACOL BIOCHEM BE, V86, P320, DOI 10.1016/j.pbb.2006.10.004; Gilpin NW, 2008, ALCOHOL CLIN EXP RES, V32, P1535, DOI 10.1111/j.1530-0277.2008.00745.x; Gilpin NW, 2011, BIOL PSYCHIAT, V69, P1091, DOI 10.1016/j.biopsych.2011.02.004; Gilpin Nicholas W, 2008, Curr Protoc Neurosci, VChapter 9, DOI 10.1002/0471142301.ns0929s44; Gilpin NW, 2009, ALCOHOL CLIN EXP RES, V33, P2113, DOI 10.1111/j.1530-0277.2009.01051.x; Gilpin NW, 2011, NEUROSCI BIOBEHAV RE; Grant BF, 1998, J SUBST ABUSE, V10, P163, DOI 10.1016/S0899-3289(99)80131-X; Grant BF, 1998, ALCOHOL HEALTH RES W, V22, P144; Grant BF, 1997, J SUBST ABUSE, V9, P103, DOI 10.1016/S0899-3289(97)90009-2; Hill KG, 2000, ALCOHOL CLIN EXP RES, V24, P892, DOI 10.1111/j.1530-0277.2000.tb02071.x; Huang MM, 2010, J PHARMACOL EXP THER, V332, P298, DOI 10.1124/jpet.109.159186; Hwang BH, 2004, BRAIN RES, V1026, P143, DOI 10.1016/j.brainres.2004.08.042; KING JC, 1987, PEPTIDES, V8, P721, DOI 10.1016/0196-9781(87)90049-0; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; Lorang E, 1995, J NEUROSCI, V15, P5439; Lowery EG, 2010, NEUROPSYCHOPHARMACOL, V35, P1241, DOI 10.1038/npp.2009.209; MENZAGHI F, 1994, J PHARMACOL EXP THER, V269, P564; Miller JW, 2007, PEDIATRICS, V119, P76, DOI 10.1542/peds.2006-1517; Moreau JL, 1997, NEUROREPORT, V8, P1697, DOI 10.1097/00001756-199705060-00027; Mutschler NH, 1998, PSYCHOPHARMACOLOGY, V135, P161, DOI 10.1007/s002130050497; NIAAA, 2004, NIAAA COUNC APPR DEF; O'Dell LE, 2004, ALCOHOL CLIN EXP RES, V28, P1676, DOI 10.1097/01.ALC.0000145781.11923.4E; Olive MF, 2002, PHARMACOL BIOCHEM BE, V72, P213, DOI 10.1016/S0091-3057(01)00748-1; Overstreet DH, 2004, PHARMACOL BIOCHEM BE, V77, P405, DOI 10.1016/j.pbb.2003.11.010; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Paxinos G., 2004, RAT BRAIN STEREOTAXI; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Pitts MW, 2009, J NEUROSCI, V29, P7379, DOI 10.1523/JNEUROSCI.0740-09.2009; Richardson HN, 2008, EUR J NEUROSCI, V28, P1641, DOI 10.1111/j.1460-9568.2008.06455.x; Richardson HN, 2008, PHARMACOL BIOCHEM BE, V88, P497, DOI 10.1016/j.pbb.2007.10.008; Richardson HN, 1999, BRAIN RES, V817, P232, DOI 10.1016/S0006-8993(98)01255-4; Richardson HN, 2006, ENDOCRINOLOGY, V147, P2506, DOI 10.1210/en.2005-1054; Roberto M, 2010, BIOL PSYCHIAT, V67, P831, DOI 10.1016/j.biopsych.2009.11.007; Roberts AJ, 2000, NEUROPSYCHOPHARMACOL, V22, P581, DOI 10.1016/S0893-133X(99)00167-0; Rodd ZA, 2003, NEUROPSYCHOPHARMACOL, V28, P1614, DOI 10.1038/sj.npp.1300214; Rodd-Henricks ZA, 2000, ALCOHOL CLIN EXP RES, V24, P8, DOI 10.1111/j.1530-0277.2000.tb04546.x; RONCHI E, 1992, NEUROENDOCRINOLOGY, V55, P134, DOI 10.1159/000126108; RUBIN BS, 1994, ENDOCRINOLOGY, V134, P467, DOI 10.1210/en.134.1.467; Russell VA, 2011, CURR PROTOC NEUROSCI, DOI DOI 10.1002/0471142301.NS0935S54; Schramm-Sapyta NL, 2008, ALCOHOL CLIN EXP RES, V32, P754, DOI 10.1111/j.1530-0277.2008.00631.x; Schulenberg, 2007, MONITORING FUTURE NA; SCHULTEIS G, 1995, P NATL ACAD SCI USA, V92, P5880, DOI 10.1073/pnas.92.13.5880; SHIMADA S, 1989, NEUROSCIENCE, V30, P377, DOI 10.1016/0306-4522(89)90259-5; Siegmund S, 2005, ALCOHOL CLIN EXP RES, V29, P1139, DOI 10.1097/01.ALC.0000171928.40418.46; SINCLAIR JD, 1968, Q J STUD ALCOHOL, V29, P863; Sisk CL, 2005, FRONT NEUROENDOCRIN, V26, P163, DOI 10.1016/j.yfrne.2005.10.003; Smith RF, 2003, NEUROTOXICOL TERATOL, V25, P291, DOI 10.1016/S0892-0362(02)00349-5; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Strong MN, 2010, HORM BEHAV, V58, P82, DOI 10.1016/j.yhbeh.2009.10.008; Tambour S, 2008, ALCOHOL CLIN EXP RES, V32, P2100, DOI 10.1111/j.1530-0277.2008.00798.x; Treutlein J, 2006, MOL PSYCHIATR, V11, P594, DOI 10.1038/sj.mp.4001813; Truxell EM, 2007, ALCOHOL CLIN EXP RES, V31, P755, DOI 10.1111/j.1530-0277.2007.00358.x; Valdez GR, 2002, ALCOHOL CLIN EXP RES, V26, P1494, DOI 10.1097/01.ALC.0000033120.51856.F0; Valdez GR, 2003, ALCOHOL, V29, P55, DOI 10.1016/S0741-8329(03)00020-X; Vazquez DM, 2006, BRAIN RES, V1121, P83, DOI 10.1016/j.brainres.2006.08.104; VEENING JG, 1984, BRAIN RES, V303, P337, DOI 10.1016/0006-8993(84)91220-4; Vendruscolo LE, 2010, NEUROPHARMACOLOGY, V59, P388, DOI 10.1016/j.neuropharm.2010.05.015; Walker BM, 2007, ALCOHOL CLIN EXP RES, V31, P11, DOI 10.1111/j.1530-0277.2006.00259.x; Wills TA, 2010, ALCOHOL CLIN EXP RES, V34, P1603, DOI 10.1111/j.1530-0277.2010.01245.x; Windle M, 2008, PEDIATRICS, V121, pS273, DOI 10.1542/peds.2007-2243C; Zeigler DW, 2005, PREV MED, V40, P23, DOI 10.1016/j.ypmed.2004.04.044; Zorrilla EP, 2001, PSYCHOPHARMACOLOGY, V158, P374, DOI 10.1007/s002130100773	81	105	107	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31466	10.1371/journal.pone.0031466	http://dx.doi.org/10.1371/journal.pone.0031466			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347484	Green Published, gold			2022-12-25	WOS:000302730100073
J	Hatano, K; Miyamoto, Y; Mori, M; Nimura, K; Nakai, Y; Nonomura, N; Kaneda, Y				Hatano, Koji; Miyamoto, Yasuhide; Mori, Masaki; Nimura, Keisuke; Nakai, Yasutomo; Nonomura, Norio; Kaneda, Yasufumi			Androgen-Regulated Transcriptional Control of Sialyltransferases in Prostate Cancer Cells	PLOS ONE			English	Article							GAL-BETA-1,3GALNAC ALPHA-2,3-SIALYLTRANSFERASE; KAPPA-B; ANTITUMOR EFFICACY; GENOMIC STRUCTURE; CPG ISLAND; GANGLIOSIDES; RECEPTOR; DNA; PROMOTER; GENE	The expression of gangliosides is often associated with cancer progression. Sialyltransferases have received much attention in terms of their relationship with cancer because they modulate the expression of gangliosides. We previously demonstrated that GD1a production was high in castration-resistant prostate cancer cell lines, PC3 and DU145, mainly due to their high expression of beta-galactoside alpha 2,3-sialyltransferase (ST3Gal) II (not ST3Gal I), and the expression of both ST3Gals was regulated by NF-kappa B, mainly by RelB. We herein demonstrate that GD1a was produced in abundance in cancerous tissue samples from human patients with hormone-sensitive prostate cancers as well as castration-resistant prostate cancers. The expression of ST3Gal II was constitutively activated in castration-resistant prostate cancer cell lines, PC3 and DU145, because of the hypomethylation of CpG island in its promoter. However, in androgen-depleted LNCap cells, a hormone-sensitive prostate cancer cell line, the expression of ST3Gal II was silenced because of the hypermethylation of the promoter region. The expression of ST3Gal II in LNCap cells increased with testosterone treatment because of the demethylation of the CpG sites. This testosterone-dependent ST3Gal II expression was suppressed by RelB siRNA, indicating that RelB activated ST3Gal II transcription in the testosterone-induced demethylated promoter. Therefore, in hormone-sensitive prostate cancers, the production of GD1a may be regulated by androgen. This is the first report indicating that the expression of a sialyltransferase is transcriptionally regulated by androgen-dependent demethylation of the CpG sites in its gene promoter.	[Hatano, Koji; Mori, Masaki; Nimura, Keisuke; Kaneda, Yasufumi] Osaka Univ, Grad Sch Med, Div Gene Therapy Sci, Osaka, Japan; [Hatano, Koji; Nakai, Yasutomo; Nonomura, Norio] Osaka Univ, Grad Sch Med, Dept Urol, Osaka, Japan; [Miyamoto, Yasuhide] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Immunol, Osaka, Japan	Osaka University; Osaka University; Osaka Medical Center for Cancer & Cardiovascular Diseases	Hatano, K (corresponding author), Osaka Univ, Grad Sch Med, Div Gene Therapy Sci, Osaka, Japan.	kaneday@gts.med.osaka-u.ac.jp	Nimura, Keisuke/AAE-9925-2020	Hatano, Koji/0000-0002-8409-5152; Mori, Masaki/0000-0001-7632-3875	National Institute of Biomedical Innovation [10-03]; Northern Osaka (Saito) Biomedical Knowledge-Based Cluster Creation Project	National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Northern Osaka (Saito) Biomedical Knowledge-Based Cluster Creation Project	This study was supported by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (Project ID: 10-03) and by the Northern Osaka (Saito) Biomedical Knowledge-Based Cluster Creation Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birkle S, 2003, BIOCHIMIE, V85, P455, DOI 10.1016/S0300-9084(03)00006-3; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Castelo-Branco P, 2010, GENE THER, V17, P805, DOI 10.1038/gt.2010.20; Dall'Olio F, 2001, GLYCOCONJUGATE J, V18, P841, DOI 10.1023/A:1022288022969; Freytag SO, 2007, MOL THER, V15, P1042, DOI 10.1038/sj.mt.6300162; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Hatano K, 2011, INT J CANCER, V129, P1838, DOI 10.1002/ijc.25860; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; HOUGHTON AN, 1985, P NATL ACAD SCI USA, V82, P1242, DOI 10.1073/pnas.82.4.1242; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Kawaguchi Y, 2009, INT J CANCER, V124, P2478, DOI 10.1002/ijc.24234; Keller ET, 1996, J BIOL CHEM, V271, P26267, DOI 10.1074/jbc.271.42.26267; Kim MS, 2009, NATURE, V461, P1007, DOI 10.1038/nature08456; KOJIMA N, 1994, BIOCHEMISTRY-US, V33, P5772, DOI 10.1021/bi00185a014; Kono M, 1997, GLYCOBIOLOGY, V7, P469, DOI 10.1093/glycob/7.4.469; Korekane H, 2007, ANAL BIOCHEM, V364, P37, DOI 10.1016/j.ab.2007.01.034; Lang ZH, 2001, BIOCHEM BIOPH RES CO, V282, P1031, DOI 10.1006/bbrc.2001.4630; LEE YC, 1994, J BIOL CHEM, V269, P10028; Lessard L, 2005, BRIT J CANCER, V93, P1019, DOI 10.1038/sj.bjc.6602796; Li RX, 2001, J BIOL CHEM, V276, P42782, DOI 10.1074/jbc.M101481200; Li XO, 2010, J GENE MED, V12, P516, DOI 10.1002/jgm.1462; Liu YH, 2004, J BIOL CHEM, V279, P36481, DOI 10.1074/jbc.M402880200; Liu YH, 2006, CANCER RES, V66, P10408, DOI 10.1158/0008-5472.CAN-06-1572; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Nakayama M, 2003, AM J PATHOL, V163, P923, DOI 10.1016/S0002-9440(10)63452-9; Nelson WG, 2009, ENDOCRINOLOGY, V150, P3991, DOI 10.1210/en.2009-0573; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Ravindranath MH, 2005, INT J CANCER, V116, P368, DOI 10.1002/ijc.21023; Ravindranath MH, 2004, BIOCHEM BIOPH RES CO, V324, P154, DOI 10.1016/j.bbrc.2004.09.029; Ripple MO, 1999, JNCI-J NATL CANCER I, V91, P1227, DOI 10.1093/jnci/91.14.1227; Sedelaar JPM, 2009, PROSTATE, V69, P1724, DOI 10.1002/pros.21028; Sharma D, 2005, MOL ENDOCRINOL, V19, P1740, DOI 10.1210/me.2004-0011; Takashima S, 2008, BIOSCI BIOTECH BIOCH, V72, P1155, DOI 10.1271/bbb.80025; Taki T, 1997, CANCER RES, V57, P1882; Taniguchi A, 2003, BIOCHEM BIOPH RES CO, V300, P570, DOI 10.1016/S0006-291X(02)02899-1; Taniguchi A, 2001, GLYCOBIOLOGY, V11, P241, DOI 10.1093/glycob/11.3.241; Tsuji S, 1996, J BIOCHEM-TOKYO, V120, P1; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; Villar E, 2006, GLYCOCONJUGATE J, V23, P5, DOI 10.1007/s10719-006-5433-0; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Yamashita T, 1999, P NATL ACAD SCI USA, V96, P9142, DOI 10.1073/pnas.96.16.9142; Yegnasubramanian S, 2008, CANCER RES, V68, P8954, DOI 10.1158/0008-5472.CAN-07-6088; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123; Zhang SL, 1997, INT J CANCER, V73, P42, DOI 10.1002/(SICI)1097-0215(19970926)73:1<42::AID-IJC8>3.0.CO;2-1	47	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31234	10.1371/journal.pone.0031234	http://dx.doi.org/10.1371/journal.pone.0031234			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347453	Green Published, Green Submitted, gold			2022-12-25	WOS:000302730100056
J	Jayasooriya, S; Hislop, A; Peng, YC; Croom-carter, D; Jankey, Y; Bell, A; Dong, T; Rowland-Jones, S; Rickinson, A; Walther, M; Whittle, H				Jayasooriya, Shamanthi; Hislop, Andrew; Peng, Yanchun; Croom-carter, Debbie; Jankey, Ya; Bell, Andrew; Dong, Tao; Rowland-Jones, Sarah; Rickinson, Alan; Walther, Michael; Whittle, Hilton			Revisiting the Effect of Acute P. falciparum Malaria on Epstein-Barr Virus: Host Balance in the Setting of Reduced Malaria Endemicity	PLOS ONE			English	Article							T-CELL IMMUNITY; B-CELL; BURKITTS-LYMPHOMA; GAMBIAN CHILDREN; AFRICAN CHILDREN; IN-VIVO; DIFFERENTIATION; REACTIVATION; PARASITEMIA; PREVALENCE	Burkitt's lymphoma (BL), an EBV-associated tumour, occurs at high incidence in populations where malaria is holoendemic. Previous studies in one such population suggested that acute P. falciparum infection impairs EBV-specific T-cell surveillance, allowing expansion of EBV infected B-cells from which BL derives. We re-examined the situation in the same area, The Gambia, after a reduction in malaria endemicity. Cellular immune responses to EBV were measured in children with uncomplicated malaria before (day 0) and after treatment (day 28), comparing EBV genome loads in blood and EBV-specific CD8(+) T-cell numbers (assayed by MHC Class I tetramers and IFN gamma ELISPOTS) with those seen in age-and sex-matched healthy controls. No significant changes were seen in EBV genome loads, percentage of EBV-specific CD8(+) T-cells and IFN gamma producing T-cells in acute versus convalescent samples, nor any difference versus controls. Regression assays performed also no longer detected any impairment of EBV-specific T-cell surveillance. Acute uncomplicated malaria infection no longer alters EBV-specific immune responses in children in The Gambia. Given the recent decline in malaria incidence in that country, we hypothesise that gross disturbance of the EBV-host balance may be a specific effect of acute malaria only in children with a history of chronic/recurrent malaria challenge.	[Jayasooriya, Shamanthi; Jankey, Ya; Walther, Michael; Whittle, Hilton] MRC Labs, Fajara, Gambia; [Jayasooriya, Shamanthi; Hislop, Andrew; Croom-carter, Debbie; Bell, Andrew; Rickinson, Alan] Univ Birmingham, Sch Canc Studies, Birmingham, W Midlands, England; [Peng, Yanchun; Dong, Tao; Rowland-Jones, Sarah] Univ Oxford, Weatherall Inst Mol Med, Oxford, England; [Walther, Michael] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD USA; [Whittle, Hilton] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England	MRC Laboratory Molecular Biology; University of Birmingham; University of Oxford; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of London; London School of Hygiene & Tropical Medicine	Jayasooriya, S (corresponding author), MRC Labs, Fajara, Gambia.	hcwhittle@yahoo.co.uk		Jayasooriya, Shamanthi/0000-0002-1147-5744; Bell, Andrew/0000-0001-9520-4417; Dong, Tao/0000-0003-3545-3758	Medical Research Council (MRC), Gambia; MRC; MRC [MC_U190092703, G1001046, G0600520] Funding Source: UKRI; Medical Research Council [G0600520, G1001046, MC_U190092703] Funding Source: researchfish	Medical Research Council (MRC), Gambia; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Medical Research Council (MRC), Gambia and Dr S Jayasooriya was a recipient of an MRC studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLSOPP CEM, 1992, AM J HUM GENET, V50, P411; Babcock GJ, 2000, IMMUNITY, V13, P497, DOI 10.1016/S1074-7613(00)00049-2; Bunce M., 1995, TISSUE ANTIGENS, V46, P355; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242; Corran PH, 2004, INFECT IMMUN, V72, P6185, DOI 10.1128/IAI.72.10.6185-6189.2004; Donati D, 2006, J INFECT DIS, V193, P971, DOI 10.1086/500839; Finney OC, 2009, EUR J IMMUNOL, V39, P1288, DOI 10.1002/eji.200839112; Gudgeon NH, 2005, J VIROL, V79, P5477, DOI 10.1128/JVI.79.9.5477-5488.2005; Jia JY, 2003, VIROLOGY, V306, P236, DOI 10.1016/S0042-6822(02)00027-2; Lalvani A, 1997, J EXP MED, V186, P859, DOI 10.1084/jem.186.6.859; LISSE IM, 1994, T ROY SOC TROP MED H, V88, P709, DOI 10.1016/0035-9203(94)90242-9; Mackenzie G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010568; Miles DJC, 2007, J VIROL, V81, P5766, DOI 10.1128/JVI.00052-07; Miyashita EM, 1997, J VIROL, V71, P4882, DOI 10.1128/JVI.71.7.4882-4891.1997; Moormann AM, 2005, J INFECT DIS, V191, P1233, DOI 10.1086/428910; Moormann AM, 2007, J INFECT DIS, V195, P799, DOI 10.1086/511984; MOSS DJ, 1983, INT J CANCER, V31, P727, DOI 10.1002/ijc.2910310609; Njie R, 2009, J INFECT DIS, V199, P31, DOI 10.1086/594373; Nogaro SI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025582; Obaro S, 2011, LANCET, V378, P1281, DOI 10.1016/S0140-6736(11)61146-X; Rasti N, 2005, SCAND J IMMUNOL, V61, P461, DOI 10.1111/j.1365-3083.2005.01589.x; Rezk SA, 2007, HUM PATHOL, V38, P1293, DOI 10.1016/j.humpath.2007.05.020; Rickinson A, 2002, VIRUS RES, V82, P109; Rochford R, 2005, NAT REV MICROBIOL, V3, P182, DOI 10.1038/nrmicro1089; Satoguina J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-274; Sauce D, 2007, AIDS, V21, P2005, DOI 10.1097/QAD.0b013e3282eee548; Shah KM, 2009, CLIN MICROBIOL INFEC, V15, P982, DOI 10.1111/j.1469-0691.2009.03033.x; Shannon-Lowe CD, 2006, P NATL ACAD SCI USA, V103, P7065, DOI 10.1073/pnas.0510512103; Snow RW, 2010, LANCET, V376, P137, DOI 10.1016/S0140-6736(10)60577-6; Speck SH, 1997, TRENDS MICROBIOL, V5, P399, DOI 10.1016/S0966-842X(97)01129-3; THOMSON MC, 1994, T ROY SOC TROP MED H, V88, P638, DOI 10.1016/0035-9203(94)90204-6; Walther M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000364; WHITTLE HC, 1984, NATURE, V312, P449, DOI 10.1038/312449a0; WHITTLE HC, 1990, CLIN EXP IMMUNOL, V80, P213, DOI 10.1111/j.1365-2249.1990.tb05236.x; Yone CLRP, 2006, T ROY SOC TROP MED H, V100, P669, DOI 10.1016/j.trstmh.2005.08.009	36	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31142	10.1371/journal.pone.0031142	http://dx.doi.org/10.1371/journal.pone.0031142			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347443	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000302730100046
J	Yu, XZ; Machesky, LM				Yu, Xinzi; Machesky, Laura M.			Cells Assemble Invadopodia-Like Structures and Invade into Matrigel in a Matrix Metalloprotease Dependent Manner in the Circular Invasion Assay	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; TUMOR-CELLS; N-WASP; PERICELLULAR PROTEOLYSIS; FOCAL ADHESIONS; MIGRATION; MT1-MMP; DEGRADATION; DIVERSITY; PODOSOMES	The ability of tumor cells to invade is one of the hallmarks of the metastatic phenotype. To elucidate the mechanisms by which tumor cells acquire an invasive phenotype, in vitro assays have been developed that mimic the process of cancer cell invasion through basement membrane or in the stroma. We have extended the characterization of the circular invasion assay and found that it provides a simple and amenable system to study cell invasion in matrix in an environment that closely mimics 3D invasion. Furthermore, it allows detailed microscopic analysis of both live and fixed cells during the invasion process. We find that cells invade in a protease dependent manner in this assay and that they assemble focal adhesions and invadopodia that resemble structures visualized in 3D embedded cells. We propose that this is a useful assay for routine and medium throughput analysis of invasion of cancer cells in vitro and the study of cells migrating in a 3D environment.	[Yu, Xinzi; Machesky, Laura M.] Univ Glasgow, Beatson Inst Canc Res, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	Beatson Institute; University of Glasgow	Yu, XZ (corresponding author), Univ Glasgow, Beatson Inst Canc Res, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	l.machesky@beatson.gla.ac.uk	Machesky, Laura/Z-4554-2019	Machesky, Laura/0000-0002-7592-9856	Cancer Research UK; Association for International Research [11-0119]; Medical Research Council UK [G117/569]; Cancer Research UK [15673] Funding Source: researchfish; Medical Research Council [G117/569] Funding Source: researchfish; Worldwide Cancer Research [11-0119] Funding Source: researchfish; MRC [G117/569] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Association for International Research; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Worldwide Cancer Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Cancer Research UK for core funding to LMM and the Association for International Research for funding XY via a project grant to LMM (11-0119). This work was also supported by Medical Research Council UK G117/569. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbolina MV, 2008, SEMIN CELL DEV BIOL, V19, P24, DOI 10.1016/j.semcdb.2007.06.008; Benesch S, 2005, J CELL SCI, V118, P3103, DOI 10.1242/jcs.02444; Benesch S, 2002, J BIOL CHEM, V277, P37771, DOI 10.1074/jbc.M204145200; Bershadsky AD, 2006, EUR J CELL BIOL, V85, P165, DOI 10.1016/j.ejcb.2005.11.001; Bravo-Cordero JJ, 2007, EMBO J, V26, P1499, DOI 10.1038/sj.emboj.7601606; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Buccione R, 2009, CANCER METAST REV, V28, P137, DOI 10.1007/s10555-008-9176-1; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Caldieri G, 2009, INT REV CEL MOL BIO, V275, P1, DOI 10.1016/S1937-6448(09)75001-4; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; CHEN WT, 1989, J EXP ZOOL, V251, P167, DOI 10.1002/jez.1402510206; Clark ES, 2008, EUR J CELL BIOL, V87, P581, DOI 10.1016/j.ejcb.2008.01.008; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Fisher KE, 2009, J CELL SCI, V122, P4558, DOI 10.1242/jcs.050724; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Friedl P, 2009, CANCER METAST REV, V28, P129, DOI 10.1007/s10555-008-9174-3; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; HENNIGAN RF, 1994, ONCOGENE, V9, P3591; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Kam Y, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-198; KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025; Kleinman HK, 2001, INVASION ASSAYS CURR; Kubow Kristopher E, 2011, Nat Cell Biol, V13, P3, DOI 10.1038/ncb0111-3; Li A, 2010, CURR BIOL, V20, P339, DOI 10.1016/j.cub.2009.12.035; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Lizarraga F, 2009, CANCER RES, V69, P2792, DOI 10.1158/0008-5472.CAN-08-3709; Marrero-Diaz R, 2009, CELL MOTIL CYTOSKEL, V66, P48, DOI 10.1002/cm.20325; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Scott RW, 2010, J CELL BIOL, V191, P169, DOI 10.1083/jcb.201002041; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; Ueda J, 2003, ONCOGENE, V22, P8716, DOI 10.1038/sj.onc.1206962; Van Goethem E, 2010, J IMMUNOL, V184, P1049, DOI 10.4049/jimmunol.0902223; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Wolf K, 2009, CLIN EXP METASTAS, V26, P289, DOI 10.1007/s10585-008-9190-2; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	39	75	76	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30605	10.1371/journal.pone.0030605	http://dx.doi.org/10.1371/journal.pone.0030605			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347388	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000302730100017
J	Thouet, J; Quinet, M; Lutts, S; Kinet, JM; Perilleux, C				Thouet, Johanna; Quinet, Muriel; Lutts, Stanley; Kinet, Jean-Marie; Perilleux, Claire			Repression of Floral Meristem Fate Is Crucial in Shaping Tomato Inflorescence	PLOS ONE			English	Article							FLOWERING-TIME; REGULATE GROWTH; IDENTITY; TRANSITION; JOINTLESS; SIGNALS; GENES; LEAFY; FALSIFLORA; ACTIVATION	Tomato is an important crop and hence there is a great interest in understanding the genetic basis of its flowering. Several genes have been identified by mutations and we constructed a set of novel double mutants to understand how these genes interact to shape the inflorescence. It was previously suggested that the branching of the tomato inflorescence depends on the gradual transition from inflorescence meristem (IM) to flower meristem (FM): the extension of this time window allows IM to branch, as seen in the compound inflorescence (s) and falsiflora (fa) mutants that are impaired in FM maturation. We report here that JOINTLESS (J), which encodes a MADS-box protein of the same clade than SHORT VEGETATIVE PHASE (SVP) and AGAMOUS LIKE 24 (AGL24) in Arabidopsis, interferes with this timing and delays FM maturation, therefore promoting IM fate. This was inferred from the fact that j mutation suppresses the high branching inflorescence phenotype of s and fa mutants and was further supported by the expression pattern of J, which is expressed more strongly in IM than in FM. Most interestingly, FA - the orthologue of the Arabidopsis LEAFY (LFY) gene - shows the complementary expression pattern and is more active in FM than in IM. Loss of J function causes premature termination of flower formation in the inflorescence and its reversion to a vegetative program. This phenotype is enhanced in the absence of systemic florigenic protein, encoded by the SINGLE FLOWER TRUSS (SFT) gene, the tomato orthologue of FLOWERING LOCUS T (FT). These results suggest that the formation of an inflorescence in tomato requires the interaction of J and a target of SFT in the meristem, for repressing FA activity and FM fate in the IM.	[Thouet, Johanna; Perilleux, Claire] Univ Liege, Dept Life Sci, Lab Plant Physiol, Liege, Belgium; [Quinet, Muriel; Lutts, Stanley; Kinet, Jean-Marie] Catholic Univ Louvain, Earth & Life Inst, Grp Rech & Physiol Vegetale, B-1348 Louvain, Belgium	University of Liege; Universite Catholique Louvain	Thouet, J (corresponding author), Univ Liege, Dept Life Sci, Lab Plant Physiol, Liege, Belgium.	cperilleux@ulg.ac.be		Quinet, Muriel/0000-0001-5485-6582; Perilleux, Claire/0000-0001-7653-2431	Fonds pour la Recherche Fondamentale et Collective (FRFC) [2.4534.05]; Fonds pour la Recherche dans l'Industrie et l'Agriculture (FRIA); Fonds National de la Recherche Scientifique (FNRS)	Fonds pour la Recherche Fondamentale et Collective (FRFC)(Fonds de la Recherche Scientifique - FNRS); Fonds pour la Recherche dans l'Industrie et l'Agriculture (FRIA)(Fonds de la Recherche Scientifique - FNRS); Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS)	This research was funded by the Fonds pour la Recherche Fondamentale et Collective (FRFC, grant n<SUP>o</SUP> 2.4534.05). JT is grateful to the Fonds pour la Recherche dans l'Industrie et l'Agriculture (FRIA) for the award of a Ph.D fellowship. MQ is grateful to the Fonds National de la Recherche Scientifique (FNRS) for her Postdoctoral Researcher grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KD, 1996, PLANTA, V200, P254, DOI 10.1007/BF00208316; Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; Butler L, 1936, J HERED, V27, P25; Castel R, 2010, J EXP BOT, V61, P2235, DOI 10.1093/jxb/erq061; Fornara F, 2010, CELL, V141, DOI 10.1016/j.cell.2010.04.024; FULTON TM, 1995, PLANT MOL BIOL REP, V13, P207, DOI 10.1007/BF02670897; Hartmann U, 2000, PLANT J, V21, P351, DOI 10.1046/j.1365-313x.2000.00682.x; Hileman LC, 2006, MOL BIOL EVOL, V23, P2245, DOI 10.1093/molbev/msl095; HUALA E, 1992, PLANT CELL, V4, P901, DOI 10.1105/tpc.4.8.901; Irish VF, 2010, PLANT J, V61, P1014, DOI 10.1111/j.1365-313X.2009.04065.x; KINET JM, 1977, SCI HORTIC-AMSTERDAM, V6, P15, DOI 10.1016/0304-4238(77)90074-7; Krizek BA, 2005, NAT REV GENET, V6, P688, DOI 10.1038/nrg1675; Lee I, 1997, CURR BIOL, V7, P95, DOI 10.1016/S0960-9822(06)00053-4; Lee J, 2008, PLANT J, V55, P832, DOI 10.1111/j.1365-313X.2008.03552.x; Leseberg CH, 2008, J EXP BOT, V59, P2253, DOI 10.1093/jxb/ern094; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Lifschitz E, 2006, J EXP BOT, V57, P3405, DOI 10.1093/jxb/erl106; Lippman ZB, 2008, PLOS BIOL, V6, P2424, DOI 10.1371/journal.pbio.0060288; Liu C, 2008, DEVELOPMENT, V135, P1481, DOI 10.1242/dev.020255; Liu C, 2007, DEVELOPMENT, V134, P1901, DOI 10.1242/dev.003103; Liu C, 2009, DEV CELL, V16, P711, DOI 10.1016/j.devcel.2009.03.011; Lozano R, 2009, INT J DEV BIOL, V53, P1635, DOI 10.1387/ijdb.072440rl; Mao L, 2000, NATURE, V406, P910, DOI 10.1038/35022611; Mckim S, 2010, CURR OPIN GENET DEV, V20, P448, DOI 10.1016/j.gde.2010.04.007; Molinero-Rosales N, 2004, PLANTA, V218, P427, DOI 10.1007/s00425-003-1109-1; Molinero-Rosales N, 1999, PLANT J, V20, P685, DOI 10.1046/j.1365-313X.1999.00641.x; Parcy F, 1998, NATURE, V395, P561, DOI 10.1038/26903; PHILOUZE J, 1978, ANN AMELIOR PLANT, V28, P431; Prusinkiewicz P, 2007, SCIENCE, V316, P1452, DOI 10.1126/science.1140429; Quinet M, 2006, J EXP BOT, V57, P1381, DOI 10.1093/jxb/erj117; Quinet M., 2007, INT J PLANT DEV BIOL, V1, P64, DOI DOI 10.1093/JXB/ERJ117; Ratcliffe OJ, 1999, DEVELOPMENT, V126, P1109; RuizGarcia L, 1997, PLANT CELL, V9, P1921, DOI 10.1105/tpc.9.11.1921; Samach A, 2007, PLANT BIOTECHNOL-NAR, V24, P71, DOI 10.5511/plantbiotechnology.24.71; Schmitz G, 2002, P NATL ACAD SCI USA, V99, P1064, DOI 10.1073/pnas.022516199; Shalit A, 2009, P NATL ACAD SCI USA, V106, P8392, DOI 10.1073/pnas.0810810106; Szymkowiak EJ, 2006, PLANTA, V223, P646, DOI 10.1007/s00425-005-0115-x; Thouet J, 2008, PLANT PHYSIOL, V148, P61, DOI 10.1104/pp.108.124164; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Wagner D, 1999, SCIENCE, V285, P582, DOI 10.1126/science.285.5427.582; Yu H, 2004, NAT GENET, V36, P157, DOI 10.1038/ng1286	41	33	37	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31096	10.1371/journal.pone.0031096	http://dx.doi.org/10.1371/journal.pone.0031096			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347436	Green Submitted, Green Published, gold			2022-12-25	WOS:000302180600029
J	Zhang, WY; Kong, GY; Zhang, JP; Wang, T; Ye, LH; Zhang, XD				Zhang, Weiying; Kong, Guangyao; Zhang, Junping; Wang, Tao; Ye, Lihong; Zhang, Xiaodong			MicroRNA-520b Inhibits Growth of Hepatoma Cells by Targeting MEKK2 and Cyclin D1	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; CANCER; ACTIVATION; KINASE; TUMORIGENICITY; METASTASIS; APOPTOSIS; RECEPTOR; PTEN	Growing evidence indicates that the deregulation of microRNAs (miRNAs) contributes to the tumorigenesis. We previously revealed that microRNA-520b (miR-520b) was involved in the complement attack and migration of breast cancer cells. In this report, we show that miR-520b is an important miRNA in the development of hepatocellular carcinoma (HCC). Our data showed that the expression levels of miR-520b were significantly reduced in clinical HCC tissues and hepatoma cell lines. We observed that the introduction of miR-520b dramatically suppressed the growth of hepatoma cells by colony formation assays, 5-ethynyl-2-deoxyuridine (EdU) incorporation assays and 3-(4,5- dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays. Moreover, ectopic expression of miR-520b was able to inhibit the growth of hepatoma cells in nude mice. Further studies revealed that the mitogen-activated protein kinase kinase kinase 2 (MEKK2) and cyclin D1 were two of direct target genes of miR-520b. Silencing of MEKK2 or cyclin D1 was able to inhibit the growth of hepatoma cells in vitro and in vivo, which is consistent with the effect of miR-520b overexpression on the growth of hepatoma cells. In addition, miR-520b significantly decreased the phosphorylation levels of c-Jun N-terminal kinase (p-JNK, a downstream effector of MEKK2) or retinoblastoma (p-Rb, a downstream effector of cyclin D1). In conclusion, miR-520b is able to inhibit the growth of hepatoma cells by targeting MEKK2 or cyclin D1 in vitro and in vivo. Our findings provide new insights into the role of miR-520b in the development of HCC, and implicate the potential application of miR-520b in cancer therapy.	[Zhang, Weiying; Kong, Guangyao; Zhang, Junping; Wang, Tao; Zhang, Xiaodong] Nankai Univ, Dept Canc Res, Key Lab Mol Microbiol & Technol, Minist Educ,Inst Mol Biol,Coll Life Sci, Tianjin 300071, Peoples R China; [Ye, Lihong] Nankai Univ, Dept Biochem, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Zhang, WY (corresponding author), Nankai Univ, Dept Canc Res, Key Lab Mol Microbiol & Technol, Minist Educ,Inst Mol Biol,Coll Life Sci, Tianjin 300071, Peoples R China.	yelihong@nankai.edu.cn; zhangxd@nankai.edu.cn	Kong, Guangyao/L-2162-2013		National Basic Research Program of China (973 Program) [2009CB521702, 2011CB512113]; National Natural Science Foundation of China [81071624, 81000870, 81071623]; Fundamental Research Funding for the Central Universities [65010671]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funding for the Central Universities	This study was supported by grants from the National Basic Research Program of China (973 Program, No. 2009CB521702, 2011CB512113), the National Natural Science Foundation of China (81071624, 81000870, 81071623) and the Fundamental Research Funding for the Central Universities (65010671). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal P, 2010, CANCER CELL, V18, P329, DOI 10.1016/j.ccr.2010.08.012; Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Cazares LH, 2009, CLIN CANCER RES, V15, P5541, DOI 10.1158/1078-0432.CCR-08-2892; Chayama K, 2001, P NATL ACAD SCI USA, V98, P4599, DOI 10.1073/pnas.081021898; Cui W, 2010, CANCER BIOL THER, V10, P232; Dong QC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010147; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; GATT ME, 2010, BLOOD, V117, P7188; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; Hayakawa Y, 2011, P NATL ACAD SCI USA, V108, P780, DOI 10.1073/pnas.1011418108; Hu N, 2011, J BIOL CHEM, V286, P13714, DOI 10.1074/jbc.M110.204131; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Noonan EJ, 2010, ONCOTARGET, V1, P349, DOI 10.18632/oncotarget.167; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Schaefer BC, 1999, IMMUNITY, V11, P411, DOI 10.1016/S1074-7613(00)80116-8; Shan CL, 2010, CELL RES, V20, P563, DOI 10.1038/cr.2010.49; Su B, 2001, J BIOL CHEM, V276, P14784, DOI 10.1074/jbc.M010134200; Sun WY, 2003, MOL CELL BIOL, V23, P2298, DOI 10.1128/MCB.23.7.2298-2308.2003; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Winsauer G, 2008, CELL SIGNAL, V20, P2107, DOI 10.1016/j.cellsig.2008.08.004; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919	28	104	106	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31450	10.1371/journal.pone.0031450	http://dx.doi.org/10.1371/journal.pone.0031450			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319632	Green Published, gold, Green Submitted			2022-12-25	WOS:000302178400043
J	Zimmer, SM; Welke, KW; Schneider, JM				Zimmer, Stefanie M.; Welke, Klaas W.; Schneider, Jutta M.			Determinants of Natural Mating Success in the Cannibalistic Orb-Web Spider Argiope bruennichi	PLOS ONE			English	Article							SEXUAL SELECTION; DEMOGRAPHIC VARIATION; WATER STRIDERS; WEAVING SPIDER; MALE SACRIFICE; MALE SIZE; EVOLUTION; CONFLICT; WILD; BEHAVIOR	Monogynous mating systems (low male mating rates) occur in various taxa and have evolved several times independently in spiders. Monogyny is associated with remarkable male mating strategies and predicted to evolve under a male-biased sex ratio. While male reproductive strategies are well documented and male mating rates are easy to quantify, especially in sexually cannibalistic species, female reproductive strategies, the optimal female mating rate, and the factors that affect the evolution of female mating rates are still unclear. In this study, we examined natural female mating rates and tested the assumption of a male-biased sex ratio and female polyandry in a natural population of Argiope bruennichi in which we controlled female mating status prior to observations. We predicted variation in female mating frequencies as a result of spatial and temporal heterogeneity in the distribution of mature females and males. Females had a low average mating rate of 1.3 and the majority copulated only once. Polyandry did not entirely result from a male-biased sex-ratio but closely matched the rate of male bigamy. Male activity and the probability of polyandry correlated with factors affecting pheromone presence such as virgin females' density. We conclude that a strong sex ratio bias and high female mating rates are not necessary components of monogynous mating systems as long as males protect their paternity effectively and certain frequencies of bigyny stabilise the mating system.	[Zimmer, Stefanie M.; Welke, Klaas W.; Schneider, Jutta M.] Univ Hamburg, Zool Inst & Museum, Biozentrum Grindel, Hamburg, Germany	University of Hamburg	Zimmer, SM (corresponding author), Univ Hamburg, Zool Inst & Museum, Biozentrum Grindel, Hamburg, Germany.	zimmer.steffi@googlemail.com	Schneider, Jutta M/G-3727-2010	Schneider, Jutta M/0000-0001-8523-7354	DFG [SCHN 561/8-1]	DFG(German Research Foundation (DFG))	The study was supported by a DFG grant (SCHN 561/8-1) to J.M.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MCB, 1996, SCIENCE, V271, P70, DOI 10.1126/science.271.5245.70; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Arnqvist Goran, 1997, P146, DOI 10.1017/CBO9780511721946.009; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Chinta SP, 2010, ANGEW CHEM INT EDIT, V49, P2033, DOI 10.1002/anie.200906311; Foellmer MW, 2005, OECOLOGIA, V142, P653, DOI 10.1007/s00442-004-1756-3; Fromhage L, 2005, EVOLUTION, V59, P1400; Fromhage L, 2008, J THEOR BIOL, V250, P524, DOI 10.1016/j.jtbi.2007.10.008; Gaskett AC, 2007, BIOL REV, V82, P26, DOI 10.1111/j.1469-185X.2006.00002.x; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; GWYNNE DT, 1993, ECOLOGY, V74, P1406, DOI 10.2307/1940070; Haddrill PR, 2008, MOL ECOL, V17, P3189, DOI 10.1111/j.1365-294X.2008.03812.x; HALLIDAY T, 1987, ANIM BEHAV, V35, P939, DOI 10.1016/S0003-3472(87)80138-0; Higgins L, 2002, OIKOS, V99, P377, DOI 10.1034/j.1600-0706.2002.990220.x; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; Hosken DJ, 2006, CURR BIOL, V16, pR202, DOI 10.1016/j.cub.2006.02.026; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jones AG, 2002, P ROY SOC B-BIOL SCI, V269, P2533, DOI 10.1098/rspb.2002.2177; Kasumovic MM, 2009, J EVOLUTION BIOL, V22, P324, DOI 10.1111/j.1420-9101.2008.01648.x; Kasumovic MM, 2008, EVOLUTION, V62, P2316, DOI 10.1111/j.1558-5646.2008.00446.x; Kasumovic MM, 2009, ECOLOGY, V90, P2287, DOI 10.1890/08-1540.1; Kasumovic MM, 2006, CURR BIOL, V16, pR242, DOI 10.1016/j.cub.2006.03.017; Kokko H, 2008, CURR BIOL, V18, pR121, DOI 10.1016/j.cub.2007.11.063; Maklakov AA, 2005, AM NAT, V165, pS38, DOI 10.1086/429351; Miller JA, 2007, EVOLUTION, V61, P1301, DOI 10.1111/j.1558-5646.2007.00115.x; Miyashita T, 1996, J ARACHNOL, V24, P9; Nessler SH, 2007, BEHAV ECOL, V18, P174, DOI 10.1093/beheco/arl074; Nessler SH, 2009, ETHOLOGY, V115, P633, DOI 10.1111/j.1439-0310.2009.01646.x; Reinhardt K, 2007, ECOL ENTOMOL, V32, P637, DOI 10.1111/j.1365-2311.2007.00923.x; Rodriguez-Munoz R, 2010, SCIENCE, V328, P1269, DOI 10.1126/science.1188102; Rowe L, 1996, BEHAV ECOL, V7, P474, DOI 10.1093/beheco/7.4.474; ROWE L, 1994, TRENDS ECOL EVOL, V9, P289, DOI 10.1016/0169-5347(94)90032-9; Schneider J, 2011, MATING BEHAV SEXUAL, P215; Schneider J, 2010, ANIMAL BEHAVIOUR: EVOLUTION AND MECHANISMS, P441, DOI 10.1007/978-3-642-02624-9_15; Schneider JM, 2009, P ROY SOC B-BIOL SCI, V276, P3105, DOI 10.1098/rspb.2009.0694; Schulte KF, 2010, ANIM BEHAV, V80, P699, DOI 10.1016/j.anbehav.2010.07.005; Segoli M, 2008, ETHOLOGY, V114, P279, DOI 10.1111/j.1439-0310.2007.01462.x; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Wanker R, 2002, BIRD RES BREEDING; Zeh JA, 1996, P ROY SOC B-BIOL SCI, V263, P1711, DOI 10.1098/rspb.1996.0250	40	27	28	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31389	10.1371/journal.pone.0031389	http://dx.doi.org/10.1371/journal.pone.0031389			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319628	gold, Green Published, Green Submitted			2022-12-25	WOS:000302178400040
J	Townsend, KL; Suzuki, R; Huang, TL; Jing, EX; Schulz, TJ; Lee, K; Taniguchi, CM; Espinoza, DO; McDougall, LE; Zhang, HB; He, TC; Kokkotou, E; Tseng, YH				Townsend, Kristy L.; Suzuki, Ryo; Huang, Tian Lian; Jing, Enxuan; Schulz, Tim J.; Lee, Kevin; Taniguchi, Cullen M.; Espinoza, Daniel O.; McDougall, Lindsay E.; Zhang, Hongbin; He, Tong-Chuan; Kokkotou, Efi; Tseng, Yu-Hua			Bone morphogenetic protein 7 (BMP7) reverses obesity and regulates appetite through a central mTOR pathway	FASEB JOURNAL			English	Article						hypothalamus; p70S6K	NEUROTROPHIC FACTOR; MAMMALIAN TARGET; TRANSLATION MACHINERY; NERVOUS-SYSTEM; FOOD-INTAKE; STEM-CELLS; RAT MODEL; LEPTIN; EXPRESSION; DIFFERENTIATION	Body weight is regulated by coordinating energy intake and energy expenditure. Transforming growth factor beta (TGF beta)/bone morphogenetic protein (BMP) signaling has been shown to regulate energy balance in lower organisms, but whether a similar pathway exists in mammals is unknown. We have previously demonstrated that BMP7 can regulate brown adipogenesis and energy expenditure. In the current study, we have uncovered a novel role for BMP7 in appetite regulation. Systemic treatment of diet-induced obese mice with BMP7 resulted in increased energy expenditure and decreased food intake, leading to a significant reduction in body weight and improvement of metabolic syndrome. Similar degrees of weight loss with reduced appetite were also observed in BMP7-treated ob/ob mice, suggesting a leptin-independent mechanism utilized by BMP7. Intracerebroventricular administration of BMP7 to mice led to an acute decrease in food intake, which was mediated, at least in part, by a central rapamycin-sensitive mTOR-p70S6 kinase pathway. Together, these results underscore the importance of BMP7 in regulating both food intake and energy expenditure, and suggest new therapeutic approaches for obesity and its comorbidities.-Townsend, K. L., Suzuki, R., Huang, T. L., Jing, E., Schulz, T. J., Lee, K., Taniguchi, C. M., Espinoza, D. O., McDougall, L. E., Zhang, H., He, T.-C., Kokkotou, E., Tseng, Y.-H. Bone morphogenetic protein 7 (BMP7) reverses obesity and regulates appetite through a central mTOR pathway. FASEB J. 26, 2187-2196 (2012). www.fasebj.org	[Townsend, Kristy L.; Suzuki, Ryo; Huang, Tian Lian; Jing, Enxuan; Schulz, Tim J.; Lee, Kevin; Taniguchi, Cullen M.; Espinoza, Daniel O.; McDougall, Lindsay E.; Tseng, Yu-Hua] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA; [He, Tong-Chuan] Univ Chicago, Med Ctr, Mol Oncol Lab, Chicago, IL 60637 USA; [Kokkotou, Efi] Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; University of Chicago; University of Chicago Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Tseng, YH (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA.	ekokkoto@caregroup.harvard.edu; yu-hua.tseng@joslin.harvard.edu	Schulz, Tim/F-4842-2013; Tseng, Yu-Hua/G-7003-2015; Suzuki, Ryo/AAA-2736-2019	Schulz, Tim/0000-0002-8413-3972; Suzuki, Ryo/0000-0002-2965-6906; Lee, Kevin/0000-0002-1528-7417; Taniguchi, Cullen/0000-0002-8052-3316	U.S. National Institutes of Health (NIH) [NIH R01 DK077097, UL1 RR 025758-01]; Eli Lilly Research Foundation; Harvard Stem Cell Institute [NIH R01 DK080058]; NIH [T32-DK007260-33, F32-DK091996]; Joslin Diabetes and Endocrinology Center; National Institute of Diabetes and Digestive and Kidney Diseases [P30-DK036836]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, F32DK091996, R01DK077097, T32DK007260, P30DK036836, R01DK080058] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eli Lilly Research Foundation(Eli Lilly); Harvard Stem Cell Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joslin Diabetes and Endocrinology Center; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by U.S. National Institutes of Health (NIH) grants NIH R01 DK077097 and UL1 RR 025758-01 (Harvard Catalyst/The Harvard Clinical and Translational Science Center) and research grants from the Eli Lilly Research Foundation and Harvard Stem Cell Institute (to Y.-H.T.) and NIH R01 DK080058 (to E.K.). K.L.T. was supported by NIH T32-DK007260-33 and F32-DK091996. The Joslin Physiology and Special Assay Cores were supported by the Joslin Diabetes and Endocrinology Center, grant P30-DK036836 from the National Institute of Diabetes and Digestive and Kidney Diseases. The authors thank C. R. Kahn (Joslin Diabetes Center) for helpful discussion, and Andre Kleinridders (Joslin Diabetes Center) for technical advice. The authors declare no conflicts of interest. K.L.T. wrote the manuscript and conducted several of the experiments. R.S. performed most of the i.c.v. experiments. T.L.H. performed several of the in vitro and in vivo experiments. E.J. did the immunohistochemical staining. T.J.S. performed some of the LacZ staining and assisted with some of the i.c.v. studies. K.L. did the in situ hybridization and part of the LacZ staining. D.O.E. performed some of the in vitro studies and assisted with some of the i.c.v. studies. C.M.T. did the adenovirus experiments. L.E.M. assisted with the animal studies and RNA extractions. T.-C.H. provided the adenovirus and technical expertise. E.K. and Y.-H.T. designed the studies, performed the key experiments, and wrote the manuscript.	Alessi DR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe27; Ballard SL, 2010, DEV BIOL, V337, P375, DOI 10.1016/j.ydbio.2009.11.011; Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; Blouet C, 2008, CELL METAB, V8, P459, DOI 10.1016/j.cmet.2008.10.004; Bluher S, 2009, AM J CLIN NUTR, V89, p991S, DOI 10.3945/ajcn.2008.26788E; Bottcher Y, 2009, DIABETES, V58, P2119, DOI 10.2337/db08-1458; Boon M. R., 2011, CYTOKINE GROWTH F R, V7, P1; Cannon CM, 2005, EUR J NEUROSCI, V21, P2600, DOI 10.1111/j.1460-9568.2005.04077.x; Chai BX, 2010, PEPTIDES, V31, P1888, DOI 10.1016/j.peptides.2010.06.028; Chang CF, 2003, STROKE, V34, P558, DOI 10.1161/01.STR.0000051507.64423.00; Charytoniuk DA, 2000, NEUROSCIENCE, V100, P33, DOI 10.1016/S0306-4522(00)00246-3; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chou J, 2006, J NEUROL SCI, V240, P21, DOI 10.1016/j.jns.2005.08.015; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Cordeira JW, 2010, J NEUROSCI, V30, P2533, DOI 10.1523/JNEUROSCI.5768-09.2010; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Cota D, 2008, J NEUROSCI, V28, P7202, DOI 10.1523/JNEUROSCI.1389-08.2008; Dattatreyamurty B, 2001, EXP NEUROL, V172, P273, DOI 10.1006/exnr.2001.7728; Ebendal T, 1998, J NEUROSCI RES, V51, P139, DOI 10.1002/(SICI)1097-4547(19980115)51:2<139::AID-JNR2>3.0.CO;2-E; Farooqi IS, 2007, SCIENCE, V317, P1355, DOI 10.1126/science.1144599; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Godin RE, 1998, DEVELOPMENT, V125, P3473; Hayes MR, 2010, CELL METAB, V11, P77, DOI 10.1016/j.cmet.2009.10.009; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Langenfeld EM, 2005, MOL CANCER RES, V3, P679, DOI 10.1158/1541-7786.MCR-05-0124; Lebrun B, 2006, AUTON NEUROSCI-BASIC, V126, P30, DOI 10.1016/j.autneu.2006.02.027; Leinninger GM, 2011, CELL METAB, V14, P313, DOI 10.1016/j.cmet.2011.06.016; Liao L, 2007, J PROTEOME RES, V6, P1059, DOI 10.1021/pr060358f; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Marsh DJ, 1999, NAT GENET, V21, P119, DOI 10.1038/5070; Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016; Mori H, 2009, CELL METAB, V9, P362, DOI 10.1016/j.cmet.2009.03.005; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Ohyama K, 2008, DEVELOPMENT, V135, P3325, DOI 10.1242/dev.027078; PERIDES G, 1995, NEUROSCI LETT, V187, P21, DOI 10.1016/0304-3940(95)11327-S; Rajan P, 2003, J CELL BIOL, V161, P911, DOI 10.1083/jcb.200211021; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Sabo JK, 2009, NEUROSIGNALS, V17, P255, DOI 10.1159/000231892; Schleinitz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016155; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Schulz TJ, 2009, CYTOKINE GROWTH F R, V20, P523, DOI 10.1016/j.cytogfr.2009.10.019; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Shimizu H, 2007, J ENDOCRINOL, V193, P1, DOI 10.1677/JOE-06-0144; Soderstrom S, 1999, J NEUROSCI RES, V56, P482; Son JW, 2011, ENDOCR J, V58, P39, DOI 10.1507/endocrj.K10E-248; Stoica L, 2011, P NATL ACAD SCI USA, V108, P3791, DOI 10.1073/pnas.1014715108; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; Tobin JF, 2006, DRUG DISCOV TODAY, V11, P405, DOI 10.1016/j.drudis.2006.03.016; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Vacher CM, 2008, FEBS LETT, V582, P3832, DOI 10.1016/j.febslet.2008.10.018; Villanueva EC, 2009, ENDOCRINOLOGY, V150, P4541, DOI 10.1210/en.2009-0642; WANG EA, 1993, GROWTH FACTORS, V9, P57, DOI 10.3109/08977199308991582; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013; You YJ, 2008, CELL METAB, V7, P249, DOI 10.1016/j.cmet.2008.01.005; Zamani N, 2011, ENDOCR REV, V32, P387, DOI 10.1210/er.2010-0018; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888	60	75	83	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2012	26	5					2187	2196		10.1096/fj.11-199067	http://dx.doi.org/10.1096/fj.11-199067			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22331196	Green Published			2022-12-25	WOS:000303680800044
J	Pietrancosta, N; Anne, C; Prescher, H; Ruivo, R; Sagne, C; Debacker, C; Bertrand, HO; Brossmer, R; Acher, F; Gasnier, B				Pietrancosta, Nicolas; Anne, Christine; Prescher, Horst; Ruivo, Raquel; Sagne, Corinne; Debacker, Cecile; Bertrand, Hugues-Olivier; Brossmer, Reinhard; Acher, Francine; Gasnier, Bruno			Successful Prediction of Substrate-binding Pocket in SLC17 Transporter Sialin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLNEURAMINIC ACID; BIOLOGICAL PROPERTIES; PROTEIN; MECHANISM; IDENTIFICATION; INHIBITORS; TOPOLOGY; DOCKING; ANALOGS	Secondary active transporters from the SLC17 protein family are required for excitatory and purinergic synaptic transmission, sialic acid metabolism, and renal function, and several members are associated with inherited neurological or metabolic diseases. However, molecular tools to investigate their function or correct their genetic defects are limited or absent. Using structure-activity, homology modeling, molecular docking, and mutagenesis studies, we have located the substrate-binding site of sialin (SLC17A5), a lysosomal sialic acid exporter also recently implicated in exocytotic release of aspartate. Human sialin is defective in two inherited sialic acid storage diseases and is responsible for metabolic incorporation of the dietary nonhuman sialic acid N-glycolylneuraminic acid. We built cytosol-open and lumen-open three-dimensional models of sialin based on weak, but significant, sequence similarity with the glycerol-3-phosphate and fucose permeases from Escherichia coli, respectively. Molecular docking of 31 synthetic sialic acid analogues to both models was consistent with inhibition studies. Narrowing the sialic acid-binding site in the cytosol-open state by two phenylalanine to tyrosine mutations abrogated recognition of the most active analogue without impairing neuraminic acid transport. Moreover, a pilot virtual high-throughput screening of the cytosol-open model could identify a pseudopeptide competitive inhibitor showing > 100-fold higher affinity than the natural substrate. This validated model of human sialin and sialin-guided models of other SLC17 transporters should pave the way for the identification of inhibitors, glycoengineering tools, pharmacological chaperones, and fluorescent false neurotransmitters targeted to these proteins.	[Anne, Christine; Ruivo, Raquel; Sagne, Corinne; Debacker, Cecile; Gasnier, Bruno] Univ Paris 05, Ctr Natl Rech Sci, UMR 8192, F-75006 Paris, France; [Pietrancosta, Nicolas; Acher, Francine] Univ Paris 05, Ctr Natl Rech Sci, UMR 8601, F-75006 Paris, France; [Ruivo, Raquel] Univ Paris Sud, Grad Sch ED 419, F-94276 Le Kremlin Bicetre, France; [Prescher, Horst] G3 BioTec, D-69207 Sandhausen, Germany; [Bertrand, Hugues-Olivier] Parc Club Orsay Univ, Accelrys, F-91898 Orsay, France; [Brossmer, Reinhard] Heidelberg Univ, Biochem Ctr, D-69120 Heidelberg, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; BIOVIA; Ruprecht Karls University Heidelberg	Gasnier, B (corresponding author), Univ Paris 05, Ctr Natl Rech Sci, UMR 8192, 45 Rue St Peres, F-75006 Paris, France.	bruno.gasnier@parisdescartes.fr	pietrancosta, nicolas/AAC-2777-2019; Ruivo, Raquel/B-2511-2013; Gasnier, Bruno/AAD-9124-2022; Anne-Longin, Christine/M-4902-2017; pietrancosta, nicolas/B-5235-2019; Ruivo, Raquel/ABB-3175-2020; Sagné, Corinne/AAY-1819-2021; Nicolas, PIetrancosta/P-4645-2017; Sagne, Corinne/K-7601-2017	pietrancosta, nicolas/0000-0002-9934-7818; Ruivo, Raquel/0000-0003-2412-8730; Gasnier, Bruno/0000-0003-4458-6296; Anne-Longin, Christine/0000-0003-0103-4272; pietrancosta, nicolas/0000-0002-9934-7818; Ruivo, Raquel/0000-0003-2412-8730; Sagné, Corinne/0000-0001-5971-4831; Nicolas, PIetrancosta/0000-0002-9934-7818; Prescher, Horst/0000-0002-4882-2252	Centre National de la Recherche Scientifique; Universite Paris Descartes	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Paris Descartes	This work was supported by the Centre National de la Recherche Scientifique and by a transdisciplinary grant from Universite Paris Descartes (to N. P. and B. G.).	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Almqvist J, 2007, PROTEIN SCI, V16, P1819, DOI 10.1110/ps.072944707; ARAMORI I, 1993, MOL PHARMACOL, V43, P127; AUGE C, 1988, NEW J CHEM, V12, P733; Aula N, 2000, AM J HUM GENET, V67, P832, DOI 10.1086/303077; Aula N, 2002, MOL GENET METAB, V77, P99, DOI 10.1016/S1096-7192(02)00124-5; Bajorath F, 2002, NAT REV DRUG DISCOV, V1, P882, DOI 10.1038/nrd941; Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; BAUMBERGER F, 1986, HELV CHIM ACTA, V69, P1535, DOI 10.1002/hlca.19860690702; BROSSMER R, 1994, METHOD ENZYMOL, V247, P153; BROSSMER R, 1980, BIOCHEM BIOPH RES CO, V96, P1282, DOI 10.1016/0006-291X(80)90090-X; Busch AE, 1996, P NATL ACAD SCI USA, V93, P5347, DOI 10.1073/pnas.93.11.5347; Byres E, 2008, NATURE, V456, P648, DOI 10.1038/nature07428; Chaudhry FA, 2008, ANNU REV PHARMACOL, V48, P277, DOI 10.1146/annurev.pharmtox.46.120604.141146; Courville P, 2010, J BIOL CHEM, V285, P19316, DOI 10.1074/jbc.M110.130716; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; Dehghan A, 2008, LANCET, V372, P1953, DOI 10.1016/S0140-6736(08)61343-4; Du J, 2009, GLYCOBIOLOGY, V19, P1382, DOI 10.1093/glycob/cwp115; Fan JQ, 2008, BIOL CHEM, V389, P1, DOI 10.1515/BC.2008.009; GROSS HJ, 1987, EUR J BIOCHEM, V168, P595, DOI 10.1111/j.1432-1033.1987.tb13458.x; GROSS HJ, 1988, FEBS LETT, V232, P145, DOI 10.1016/0014-5793(88)80404-6; Gubernator NG, 2009, SCIENCE, V324, P1441, DOI 10.1126/science.1172278; HAGEDORN HW, 1986, HELV CHIM ACTA, V69, P2127, DOI 10.1002/hlca.19860690837; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Humphrey AJ, 2002, BIOORGAN MED CHEM, V10, P3175, DOI 10.1016/S0968-0896(02)00213-4; Iharada M, 2010, J BIOL CHEM, V285, P26107, DOI 10.1074/jbc.M110.122721; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; ISECKE R, 1995, CARBOHYD RES, V274, P303, DOI 10.1016/0008-6215(95)00133-E; ISECKE R, 1994, TETRAHEDRON, V50, P7445, DOI 10.1016/S0040-4020(01)90473-9; Juge N, 2006, J BIOL CHEM, V281, P39499, DOI 10.1074/jbc.M607670200; KELM S, 1994, GLYCOCONJUGATE J, V11, P576, DOI 10.1007/BF00731309; Kiefel MJ, 2000, BIOORGAN MED CHEM, V8, P657, DOI 10.1016/S0968-0896(99)00325-9; Kirchmair J, 2005, J CHEM INF MODEL, V45, P422, DOI 10.1021/ci049753l; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KUHN R, 1966, CHEM BER-RECL, V99, P611, DOI 10.1002/cber.19660990235; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mack H, 1998, TETRAHEDRON, V54, P4539, DOI 10.1016/S0040-4020(98)00168-9; MEINDL P, 1966, MONATSH CHEM VERW TL, V97, P1628, DOI 10.1007/BF00901442; MEINDL P, 1965, MONATSH CHEM VERW TL, V96, P802, DOI 10.1007/BF00919154; MEINDL P, 1969, MONATSH CHEM, V100, P1295, DOI 10.1007/BF00903465; Miyaji T, 2008, P NATL ACAD SCI USA, V105, P11720, DOI 10.1073/pnas.0804015105; Morin P, 2004, EMBO J, V23, P4560, DOI 10.1038/sj.emboj.7600464; Oetke C, 2002, J BIOL CHEM, V277, P6688, DOI 10.1074/jbc.M109973200; OGURA H, 1987, CARBOHYD RES, V167, P77, DOI 10.1016/0008-6215(87)80269-0; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Pawlita M., 2003, World Intellectual Property Organization Patent, Patent No. [WO/2003/016329, 2003016329]; Pietrancosta N, 2010, BIOORGAN MED CHEM, V18, P6922, DOI 10.1016/j.bmc.2010.06.069; Prescher JA, 2004, NATURE, V430, P873, DOI 10.1038/nature02791; Reimer RJ, 2004, PFLUG ARCH EUR J PHY, V447, P629, DOI 10.1007/s00424-003-1087-y; Sawada K, 2008, P NATL ACAD SCI USA, V105, P5683, DOI 10.1073/pnas.0800141105; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; SCHAUER R, 1970, H-S Z PHYSIOL CHEM, V351, P359, DOI 10.1515/bchm2.1970.351.1.359; Thompson CM, 2005, CURR MED CHEM, V12, P2041, DOI 10.2174/0929867054637635; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Varki A, 2010, P NATL ACAD SCI USA, V107, P8939, DOI 10.1073/pnas.0914634107; Verheijen FW, 1999, NAT GENET, V23, P462, DOI 10.1038/70585; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wreden CC, 2005, J BIOL CHEM, V280, P1408, DOI 10.1074/jbc.M411295200; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629; ZBIRAL E, 1988, MONATSH CHEM, V119, P127, DOI 10.1007/BF00810094	63	9	9	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11489	11497		10.1074/jbc.M111.313056	http://dx.doi.org/10.1074/jbc.M111.313056			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334707	hybrid, Green Published			2022-12-25	WOS:000302780100077
J	Babot, M; Blancard, C; Pelosi, L; Lauquin, GJM; Trezeguet, V				Babot, Marion; Blancard, Corinne; Pelosi, Ludovic; Lauquin, Guy J. -M.; Trezeguet, Veronique			The Transmembrane Prolines of the Mitochondrial ADP/ATP Carrier Are Involved in Nucleotide Binding and Transport and Its Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP ATP CARRIER; SACCHAROMYCES-CEREVISIAE; ALPHA-HELICES; CONFORMATIONAL-DYNAMICS; CYSTEINE RESIDUES; MEMBRANE; YEAST; PROTEINS; SUBSTRATE; COMPLEX	The mitochondrial ADP/ATP carrier (Ancp) is a paradigm of the mitochondrial carrier family, which allows cross-talk between mitochondria, where cell energy is mainly produced, and cytosol, where cell energy is mainly consumed. The members of this family share numerous structural and functional characteristics. Resolution of the atomic structure of the bovine Ancp, in a complex with one of its specific inhibitors, revealed interesting features and suggested the involvement of some particular residues in the movements of the protein to perform translocation of nucleotides from one side of the membrane to the other. They correspond to three prolines located in the odd-numbered transmembrane helices (TMH), Pro-27, Pro-132, and Pro-229. The corresponding residues of the yeast Ancp (Pro-43, Ser-147, and Pro-247) were mutated into alanine or leucine, one at a time and analysis of the various mutants evidenced a crucial role of Pro-43 and Pro-247 during nucleotide transport. Beside, replacement of Ser-147 with proline does not inactivate Ancp and this is discussed in view of the conservation of the three prolines at equivalent positions in the Ancp sequences. These prolines belong to the signature sequences of the mitochondrial carriers and we propose they play a dual role in the mitochondrial ADP/ATP carrier function and biogenesis. Unexpectedly their mutations cause more general effects on mitochondrial biogenesis and morphology, as evidenced by measurements of respiratory rates, cytochrome contents, and also clearly highlighted by fluorescence microscopy.	[Babot, Marion; Blancard, Corinne; Lauquin, Guy J. -M.; Trezeguet, Veronique] Univ Bordeaux, Lab Physiol Mol & Cellulaire, F-33000 Bordeaux, France; [Babot, Marion; Blancard, Corinne; Lauquin, Guy J. -M.; Trezeguet, Veronique] CNRS, IBGC, UMR 5095, F-33000 Bordeaux, France; [Pelosi, Ludovic] Univ Grenoble 1, Equipe Dynam Organelles & Plasticite Cellulaire, Lab Biol Grande Echelle BGE, iRTSV CEA Grenoble, F-38054 Grenoble 9, France	UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Trezeguet, V (corresponding author), CBMN, UMR 5248, Allee Geoffroy St Hilaire Bat B14Bis, F-33600 Pessac, France.	v.trezeguet@cbmn.u-bordeaux.fr	Pelosi, Ludovic/AAB-9832-2020; Pelosi, Ludovic/M-6406-2014	Pelosi, Ludovic/0000-0002-4198-5681; Trezeguet, Veronique/0000-0003-2487-7571	Universite Bordeaux Segalen; Centre National de la Recherche Scientifique; Region Aquitaine; French Ministere de l'Enseignement Superieur et de la Recherche	Universite Bordeaux Segalen; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Region Aquitaine(Region Nouvelle-Aquitaine); French Ministere de l'Enseignement Superieur et de la Recherche	This work was supported in part by the Universite Bordeaux Segalen, the Centre National de la Recherche Scientifique, and the Region Aquitaine.; Supported by the French Ministere de l'Enseignement Superieur et de la Recherche.	Aoki S, 2010, J BIOL CHEM, V285, P33371, DOI 10.1074/jbc.M110.153569; Ballesteros JA, 2000, BIOPHYS J, V79, P2754, DOI 10.1016/S0006-3495(00)76514-3; Berardi MJ, 2011, NATURE, V476, P109, DOI 10.1038/nature10257; BLOCK MR, 1982, BIOCHEMISTRY-US, V21, P5451, DOI 10.1021/bi00265a011; BRANDOLIN G, 1989, BIOCHEMISTRY-US, V28, P1093, DOI 10.1021/bi00429a025; BRANDOLIN G, 1993, BIOCHEM BIOPH RES CO, V192, P143, DOI 10.1006/bbrc.1993.1393; Brix J, 1999, J BIOL CHEM, V274, P16522, DOI 10.1074/jbc.274.23.16522; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Clemencon B, 2011, J BIOL CHEM, V286, P36119, DOI 10.1074/jbc.M111.277376; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Curran SP, 2002, EMBO J, V21, P942, DOI 10.1093/emboj/21.5.942; David C, 2008, BIOCHEMISTRY-US, V47, P13223, DOI 10.1021/bi8012565; De Lucas JR, 2008, MOL MEMBR BIOL, V25, P152, DOI 10.1080/09687680701697476; Decaffmeyer M, 2008, J MOL BIOL, V383, P797, DOI 10.1016/j.jmb.2008.08.076; Della Rocca BM, 2005, MOL MEMBR BIOL, V22, P443, DOI 10.1080/09687860500269335; Eilers M, 2002, BIOPHYS J, V82, P2720, DOI 10.1016/S0006-3495(02)75613-0; Endres M, 1999, EMBO J, V18, P3214, DOI 10.1093/emboj/18.12.3214; Falconi M, 2006, PROTEINS, V65, P681, DOI 10.1002/prot.21102; GRAY TM, 1984, J MOL BIOL, V175, P75, DOI 10.1016/0022-2836(84)90446-7; KOLAROV J, 1990, J BIOL CHEM, V265, P12711; Kunji ERS, 2006, BBA-BIOENERGETICS, V1757, P1237, DOI 10.1016/j.bbabio.2006.03.021; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lousa CD, 2002, BIOCHEMISTRY-US, V41, P14412, DOI 10.1021/bi02641490; MAJIMA E, 1994, BIOCHEMISTRY-US, V33, P9530, DOI 10.1021/bi00198a019; Majima E, 1998, BIOCHEMISTRY-US, V37, P424, DOI 10.1021/bi9710683; MICHEJDA J, 1990, BIOCHEM BIOPH RES CO, V171, P354, DOI 10.1016/0006-291X(90)91401-D; Morrison KL, 2001, CURR OPIN CHEM BIOL, V5, P302, DOI 10.1016/S1367-5931(00)00206-4; Nelson DR, 1998, J MOL BIOL, V277, P285, DOI 10.1006/jmbi.1997.1594; Nury H, 2006, ANNU REV BIOCHEM, V75, P713, DOI 10.1146/annurev.biochem.75.103004.142747; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Perchiniak E, 2007, BIOCHEMISTRY-US, V46, P1557, DOI 10.1021/bi062191+; Rey M, 2010, J BIOL CHEM, V285, P34981, DOI 10.1074/jbc.M110.146209; Roux R, 1996, BIOCHEMISTRY-US, V35, P16125, DOI 10.1021/bi961715a; Sanchez JF, 2012, BIOORG MED CHEM LETT, V22, P2973, DOI 10.1016/j.bmcl.2012.02.040; Sirrenberg C, 1998, NATURE, V391, P912, DOI 10.1038/36136; SOLOMON F, 1991, ANNU REV CELL BIOL, V7, P633, DOI 10.1146/annurev.cellbio.7.1.633; Thomas R, 2009, BIOCHEMISTRY-US, V48, P11883, DOI 10.1021/bi9016395; Tonazzi A, 2005, BBA-BIOMEMBRANES, V1718, P53, DOI 10.1016/j.bbamem.2005.10.007; Vasiljev A, 2004, MOL BIOL CELL, V15, P1445, DOI 10.1091/mbc.E03-05-0272; Vial S, 2002, J BIOL CHEM, V277, P36100, DOI 10.1074/jbc.M202310200; VIGNAIS PV, 1966, BIOCHIM BIOPHYS ACTA, V118, P465, DOI 10.1016/S0926-6593(66)80090-5; VONHEIJNE G, 1991, J MOL BIOL, V218, P499, DOI 10.1016/0022-2836(91)90695-3; WALKER JE, 1993, J BIOENERG BIOMEMBR, V25, P435, DOI 10.1007/BF01108401; Wang Y, 2008, P NATL ACAD SCI USA, V105, P9598, DOI 10.1073/pnas.0801786105; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; WOODS A, 1989, J CELL SCI, V93, P491; Zara V, 2007, J CELL SCI, V120, P4099, DOI 10.1242/jcs.018929	47	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10368	10378		10.1074/jbc.M111.320697	http://dx.doi.org/10.1074/jbc.M111.320697			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22334686	Green Published, hybrid			2022-12-25	WOS:000302167200064
J	Udayashankar, AP; Kossl, M; Nowotny, M				Udayashankar, Arun Palghat; Koessl, Manfred; Nowotny, Manuela			Tonotopically Arranged Traveling Waves in the Miniature Hearing Organ of Bushcrickets	PLOS ONE			English	Article							BASILAR-MEMBRANE; AUDITORY RECEPTORS; TETTIGONIIDAE ORTHOPTERA; FUNCTIONAL-ORGANIZATION; GUINEA-PIG; TRANSMISSION; EMISSIONS; MOTION	Place based frequency discrimination (tonotopy) is a fundamental property of the coiled mammalian cochlea. Sound vibrations mechanically conducted to the hearing organ manifest themselves into slow moving waves that travel along the length of the organ, also referred to as traveling waves. These traveling waves form the basis of the tonotopic frequency representation in the inner ear of mammals. However, so far, due to the secure housing of the inner ear, these waves only could be measured partially over small accessible regions of the inner ear in a living animal. Here, we demonstrate the existence of tonotopically ordered traveling waves covering most of the length of a miniature hearing organ in the leg of bushcrickets in vivo using laser Doppler vibrometery. The organ is only 1 mm long and its geometry allowed us to investigate almost the entire length with a wide range of stimuli (6 to 60 kHz). The tonotopic location of the traveling wave peak was exponentially related to stimulus frequency. The traveling wave propagated along the hearing organ from the distal (high frequency) to the proximal (low frequency) part of the leg, which is opposite to the propagation direction of incoming sound waves. In addition, we observed a non-linear compression of the velocity response to varying sound pressure levels. The waves are based on the delicate micromechanics of cellular structures different to those of mammals. Hence place based frequency discrimination by traveling waves is a physical phenomenon that presumably evolved in mammals and bushcrickets independently.	[Udayashankar, Arun Palghat; Koessl, Manfred; Nowotny, Manuela] Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, AK Neurobiol & Biosensorik, Frankfurt, Germany	Goethe University Frankfurt	Udayashankar, AP (corresponding author), Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, AK Neurobiol & Biosensorik, Frankfurt, Germany.	nowotny@bio.uni-frankfurt.de			German Research Foundation (DFG) [841/1-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG) NO 841/1-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashmore J, 2010, HEARING RES, V266, P1, DOI 10.1016/j.heares.2010.05.001; Bangert M, 1998, HEARING RES, V115, P27, DOI 10.1016/S0378-5955(97)00177-9; Bell A, 2004, PLOS BIOL, V2, P1521, DOI 10.1371/journal.pbio.0020337; Cooper NP, 1996, AUDIT NEUROSCI, V2, P207; de Boer E, 2008, J ACOUST SOC AM, V123, P1513, DOI 10.1121/1.2828064; de La Rochefoucauld O, 2007, BIOPHYS J, V93, P3434, DOI 10.1529/biophysj.107.109744; Dong W, 2008, J ACOUST SOC AM, V123, P222, DOI 10.1121/1.2816566; Emadi G, 2004, J NEUROPHYSIOL, V91, P474, DOI 10.1152/jn.00446.2003; FIELDEN A, 1960, J EXP BIOL, V37, P832; FRENCH AS, 1988, ANNU REV ENTOMOL, V33, P39, DOI 10.1146/annurev.en.33.010188.000351; Ghaffari R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1094; GOLD T, 1948, PROC R SOC SER B-BIO, V135, P492, DOI 10.1098/rspb.1948.0025; HOFFMANN E, 1995, J ACOUST SOC AM, V98, P1845, DOI 10.1121/1.413371; Hummel J, 2011, J EXP BIOL, V214, P3596, DOI 10.1242/jeb.054445; JOHNSTONE BM, 1986, HEARING RES, V22, P147, DOI 10.1016/0378-5955(86)90090-0; KEMP DT, 1978, J ACOUST SOC AM, V64, P1386, DOI 10.1121/1.382104; Kossl M, 2008, J COMP PHYSIOL A, V194, P597, DOI 10.1007/s00359-008-0344-0; Muller M, 1996, HEARING RES, V94, P148, DOI 10.1016/0378-5955(95)00230-8; Nowotny M, 2010, J COMP PHYSIOL A, V196, P939, DOI 10.1007/s00359-010-0577-6; OLDFIELD BP, 1986, J COMP PHYSIOL A, V158, P27, DOI 10.1007/BF00614517; OLDFIELD BP, 1982, J COMP PHYSIOL, V147, P461, DOI 10.1007/BF00612011; OLDFIELD BP, 1985, J EXP BIOL, V116, P493; OLDFIELD BP, 1984, J COMP PHYSIOL, V155, P689, DOI 10.1007/BF00610855; Olson ES, 1999, NATURE, V402, P526, DOI 10.1038/990092; PEAKE WT, 1980, J ACOUST SOC AM, V67, P1736, DOI 10.1121/1.384300; Ren TY, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1226; Ren TY, 2002, P NATL ACAD SCI USA, V99, P17101, DOI 10.1073/pnas.262663699; Rhode WS, 2007, J ACOUST SOC AM, V121, P2792, DOI 10.1121/1.2718397; RHODE WS, 1971, J ACOUST SOC AM, V49, P1218, DOI 10.1121/1.1912485; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Ruggero MA, 1997, J ACOUST SOC AM, V101, P2151, DOI 10.1121/1.418265; Russell IJ, 1997, P NATL ACAD SCI USA, V94, P2660, DOI 10.1073/pnas.94.6.2660; SCHUMACHER R, 1975, Z MORPHOL TIERE, V81, P209, DOI 10.1007/BF00278370; Serbetcioglu MB, 1999, ACTA OTO-LARYNGOL, V119, P537; Stolting H, 1998, CELL TISSUE RES, V294, P377, DOI 10.1007/s004410051187; Sueur J, 2006, J EXP BIOL, V209, P4115, DOI 10.1242/jeb.02460; Tsuji J, 1997, J COMP NEUROL, V381, P188; Vater M, 2011, HEARING RES, V273, P89, DOI 10.1016/j.heares.2010.05.018; von Bekesy G, 1928, PHYS Z, V29, P793; von Bekesy G, 1960, EXPT HEARING; Windmill JFC, 2005, J EXP BIOL, V208, P157, DOI 10.1242/jeb.01332; Yack JE, 2004, MICROSC RES TECHNIQ, V63, P315, DOI 10.1002/jemt.20051	42	30	31	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31008	10.1371/journal.pone.0031008	http://dx.doi.org/10.1371/journal.pone.0031008			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348035	Green Published, gold, Green Submitted			2022-12-25	WOS:000302733900019
J	Cheng, Y; Thomas, A; Mardini, F; Bianchi, SL; Tang, JXX; Peng, J; Wei, HF; Eckenhoff, MF; Eckenhoff, RG; Levy, RJ				Cheng, Ying; Thomas, Adia; Mardini, Feras; Bianchi, Shannon L.; Tang, Junxia X.; Peng, Jun; Wei, Huafeng; Eckenhoff, Maryellen F.; Eckenhoff, Roderic G.; Levy, Richard J.			Neurodevelopmental Consequences of Sub-Clinical Carbon Monoxide Exposure in Newborn Mice	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDERS; OCCURRING CELL-DEATH; CYTOCHROME-C; BRAIN-DEVELOPMENT; MATERNAL SMOKING; PASSIVE SMOKING; NERVOUS-SYSTEM; IN-VIVO; APOPTOSIS; CHILDREN	Carbon monoxide (CO) exposure at high concentrations results in overt neurotoxicity. Exposure to low CO concentrations occurs commonly yet is usually sub-clinical. Infants are uniquely vulnerable to a variety of toxins, however, the effects of postnatal sub-clinical CO exposure on the developing brain are unknown. Apoptosis occurs normally within the brain during development and is critical for synaptogenesis. Here we demonstrate that brief, postnatal sub-clinical CO exposure inhibits developmental neuroapoptosis resulting in impaired learning, memory, and social behavior. Three hour exposure to 5 ppm or 100 ppm CO impaired cytochrome c release, caspase-3 activation, and apoptosis in neocortex and hippocampus of 10 day old CD-1 mice. CO increased NeuN protein, neuronal numbers, and resulted in megalencephaly. CO-exposed mice demonstrated impaired memory and learning and reduced socialization following exposure. Thus, CO-mediated inhibition of neuroapoptosis might represent an important etiology of acquired neurocognitive impairment and behavioral disorders in children.	[Cheng, Ying; Thomas, Adia; Levy, Richard J.] George Washington Univ, Sch Med & Hlth Sci, Div Anesthesiol & Pain Med, Childrens Natl Med Ctr, Washington, DC 20052 USA; [Mardini, Feras; Bianchi, Shannon L.; Tang, Junxia X.; Peng, Jun; Wei, Huafeng; Eckenhoff, Maryellen F.; Eckenhoff, Roderic G.] Univ Penn, Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA	Children's National Health System; George Washington University; University of Pennsylvania	Cheng, Y (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Div Anesthesiol & Pain Med, Childrens Natl Med Ctr, Washington, DC 20052 USA.	rlevy@cnmc.org		Eckenhoff, Roderic/0000-0002-5581-746X	National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) [5K08GM074117-04, AG31742]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM074117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031742] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) 5K08GM074117-04 (RJL) and AG31742 (RGE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amitai Y, 1998, ARCH NEUROL-CHICAGO, V55, P845, DOI 10.1001/archneur.55.6.845; Barnard-Brak L, 2011, PEDIATR NEUROL, V44, P97, DOI 10.1016/j.pediatrneurol.2010.09.011; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Berman S, 2003, PEDIAT DECISION MAKI; Bernardini C, 2010, CELL STRESS CHAPERON, V15, P219, DOI 10.1007/s12192-009-0136-7; Bianchi SL, 2008, NEUROBIOL AGING, V29, P1002, DOI 10.1016/j.neurobiolaging.2007.02.009; Blomgren K, 2007, APOPTOSIS, V12, P993, DOI 10.1007/s10495-007-0754-4; Brodkin ES, 2004, BRAIN RES, V1002, P151, DOI 10.1016/j.brainres.2003.12.013; Chan WY, 2002, ANAT RECORD, V267, P261, DOI 10.1002/ar.10100; Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014; Courchesne E, 2011, BRAIN RES, V1380, P138, DOI 10.1016/j.brainres.2010.09.101; DIGIOVANNI V, 1993, BRAIN RES, V616, P126; Eskenazi B, 1999, ENVIRON HEALTH PERSP, V107, P991, DOI 10.1289/ehp.99107991; Farahani R, 2008, PEDIATR PULM, V43, P20, DOI 10.1002/ppul.20729; Fergusson DM, 1998, ARCH GEN PSYCHIAT, V55, P721, DOI 10.1001/archpsyc.55.8.721; FERRER I, 1990, NEUROSCIENCE, V39, P451, DOI 10.1016/0306-4522(90)90281-8; FERRER I, 1990, NEUROSCI RES, V8, P60, DOI 10.1016/0168-0102(90)90058-M; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Gomez C, 2005, PREV MED, V40, P10, DOI 10.1016/j.ypmed.2004.04.049; Gorman D, 2003, TOXICOLOGY, V187, P25, DOI 10.1016/S0300-483X(03)00005-2; Gul I, 2011, ANGIOLOGY, V62, P245, DOI 10.1177/0003319710377077; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; HAUCK H, 1984, EUR J APPL PHYSIOL O, V53, P186, DOI 10.1007/BF00422585; Herbert MR, 2010, CURR OPIN NEUROL, V23, P103, DOI 10.1097/WCO.0b013e328336a01f; Hornig M, 2004, MOL PSYCHIATR, V9, P833, DOI 10.1038/sj.mp.4001529; JACOBS EE, 1960, J BIOL CHEM, V235, P531; Jain KK, 2009, TXB HYPERBARIC MED, P111; Jiang YY, 2005, J NEUROSCI, V25, P6962, DOI 10.1523/JNEUROSCI.1446-05.2005; Jo WK, 2004, ENVIRON RES, V94, P309, DOI 10.1016/S0013-9351(03)00135-X; Kabir Z, 2011, PEDIATRICS, V128, P263, DOI 10.1542/peds.2011-0023; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kao LW, 2005, MED CLIN N AM, V89, P1161, DOI 10.1016/j.mcna.2005.06.007; Kao LW, 2004, EMERG MED CLIN N AM, V22, P985, DOI 10.1016/j.emc.2004.05.003; Kapetanaki SM, 2009, BIOCHEMISTRY-US, V48, P1613, DOI 10.1021/bi801817v; Kim NH, 2004, B KOREAN CHEM SOC, V25, P1889; Kim WR, 2011, DEV GROWTH DIFFER, V53, P225, DOI 10.1111/j.1440-169X.2010.01226.x; Klintsova AY, 2007, ALCOHOL CLIN EXP RES, V31, P2073, DOI 10.1111/j.1530-0277.2007.00528.x; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Kwon MS, 2010, KOREAN J PHYSIOL PHA, V14, P257, DOI 10.4196/kjpp.2010.14.5.257; McConnell SC, 2011, MOL CELL BIOL, V31, P876, DOI 10.1128/MCB.00725-10; Nasr V, 2010, BRIT J ANAESTH, V105, P836, DOI 10.1093/bja/aeq271; Olney Ann Haskins, 2007, Semin Pediatr Neurol, V14, P128, DOI 10.1016/j.spen.2007.07.004; OZAWA T, 1980, P NATL ACAD SCI-BIOL, V77, P5084, DOI 10.1073/pnas.77.9.5084; Paxinos G., 2007, ATLAS DEV MOUSE BRAI; Piel DA, 2007, CRIT CARE MED, V35, P2120, DOI 10.1097/01.CCM.0000278914.85340.FE; Proytcheva MA, 2009, AM J CLIN PATHOL, V131, P560, DOI 10.1309/AJCPTHBJ4I4YGZQC; Rauh Virginia A, 2010, Neoreviews, V11, P363; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Rosenberg RE, 2009, J AUTISM DEV DISORD, V39, P1099, DOI 10.1007/s10803-009-0723-6; Sanno H, 2010, J NEUROSCI, V30, P4221, DOI 10.1523/JNEUROSCI.3318-09.2010; Sarady JK, 2004, FASEB J, V18, P854, DOI 10.1096/fj.03-0643fje; Schumann CM, 2010, J NEUROSCI, V30, P4419, DOI 10.1523/JNEUROSCI.5714-09.2010; Smithline HA, 2003, RESUSCITATION, V56, P97, DOI 10.1016/S0300-9572(02)00272-1; Song RP, 2003, AM J PATHOL, V163, P231, DOI 10.1016/S0002-9440(10)63646-2; Stenqvist A, 2005, EMBO REP, V6, P973, DOI 10.1038/sj.embor.7400512; Tanaka M, 2002, J BACTERIOL, V184, P840, DOI 10.1128/JB.184.3.840-845.2002; Wang X, 2007, J BIOL CHEM, V282, P1718, DOI 10.1074/jbc.M607610200; Webber DS, 2003, J NEUROSCI RES, V74, P655, DOI 10.1002/jnr.10809; WEITZMAN M, 1992, PEDIATRICS, V90, P342; WINTER PM, 1976, JAMA-J AM MED ASSOC, V236, P1502, DOI 10.1001/jama.236.13.1502; Zhou HC, 2010, EXP BIOL MED, V235, P1236, DOI 10.1258/ebm.2010.010147	61	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e32029	10.1371/journal.pone.0032029	http://dx.doi.org/10.1371/journal.pone.0032029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348142	gold, Green Published, Green Submitted			2022-12-25	WOS:000302730900030
J	Hugentobler, F; Yam, KK; Gillard, J; Mahbuba, R; Olivier, M; Cousineau, B				Hugentobler, Felix; Yam, Karen K.; Gillard, Joshua; Mahbuba, Raya; Olivier, Martin; Cousineau, Benoit			Immunization against Leishmania major Infection Using LACK- and IL-12-Expressing Lactococcus lactis Induces Delay in Footpad Swelling	PLOS ONE			English	Article							PROTECTIVE IMMUNE-RESPONSE; TOXIN FRAGMENT-C; CUTANEOUS LEISHMANIASIS; TETANUS TOXIN; VISCERAL LEISHMANIASIS; LISTERIA-MONOCYTOGENES; ACID BACTERIA; T-CELLS; ANTIGEN; MICE	Background: Leishmania is a mammalian parasite affecting over 12 million individuals worldwide. Current treatments are expensive, cause severe side effects, and emerging drug resistance has been reported. Vaccination is the most cost-effective means to control infectious disease but currently there is no vaccine available against Leishmaniasis. Lactococcus lactis is a non-pathogenic, non-colonizing Gram-positive lactic acid bacterium commonly used in the dairy industry. Recently, L. lactis was used to express biologically active molecules including vaccine antigens and cytokines. Methodology/Principal findings: We report the generation of L. lactis strains expressing the protective Leishmania antigen, LACK, in the cytoplasm, secreted or anchored to the bacterial cell wall. L. lactis was also engineered to secrete biologically active single chain mouse IL-12. Subcutaneous immunization with live L. lactis expressing LACK anchored to the cell wall and L. lactis secreting IL-12 significantly delayed footpad swelling in Leishmania major infected BALB/c mice. The delay in footpad swelling correlated with a significant reduction of parasite burden in immunized animals compared to control groups. Immunization with these two L. lactis strains induced antigen-specific multifunctional T(H)1 CD4(+) and CD8(+) T cells and a systemic LACK-specific T(H)1 immune response. Further, protection in immunized animals correlated with a Leishmania-specific T(H)1 immune response post-challenge. L. lactis secreting mouse IL-12 was essential for directing immune responses to LACK towards a protective T(H)1 response. Conclusions/Significance: This report demonstrates the use of L. lactis as a live vaccine against L. major infection in BALB/c mice. The strains generated in this study provide the basis for the development of an inexpensive and safe vaccine against the human parasite Leishmania.	[Hugentobler, Felix; Yam, Karen K.; Gillard, Joshua; Mahbuba, Raya; Olivier, Martin; Cousineau, Benoit] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Olivier, Martin] McGill Univ, Ctr Hlth, Res Inst, Ctr Study Host Resistance, Montreal, PQ, Canada	McGill University; McGill University	Hugentobler, F (corresponding author), McGill Univ, Dept Microbiol & Immunol, 3775 Univ St, Montreal, PQ, Canada.	benoit.cousineau@mcgill.ca			Canadian Institutes of Health Research [CIHR89745]; McGill University	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); McGill University	This work was supported by a grant from the Canadian Institutes of Health Research (CIHR89745) to BC and MO. BC is a McGill University William Dawson Scholar and a Chercheur-Boursier Senior from Fonds de la Recherche en Sante du Quebec (FRSQ). FH was the recipient of a F.C. Harrison Fellowship from McGill University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Dayyeh I, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000305; Ait-Oudhia K, 2011, PARASITOL RES; Ameen M, 2010, CLIN EXP DERMATOL, V35, P699, DOI 10.1111/j.1365-2230.2010.03851.x; Bahey-El-Din M, 2010, CURR GENE THER, V10, P34, DOI 10.2174/156652310790945557; Belkaid Y, 2002, J IMMUNOL, V168, P3992, DOI 10.4049/jimmunol.168.8.3992; Bermudez-Humaran LG, 2003, INFECT IMMUN, V71, P1887, DOI 10.1128/IAI.71.4.1887-1896.2003; Braat H, 2006, CLIN GASTROENTEROL H, V4, P754, DOI 10.1016/j.cgh.2006.03.028; Casalta E, 2008, INT J FOOD MICROBIOL, V126, P271, DOI 10.1016/j.ijfoodmicro.2007.08.013; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Dondji B, 2005, INFECT IMMUN, V73, P5286, DOI 10.1128/IAI.73.8.5286-5289.2005; Gonzalez-Aseguinolaza G, 1999, EUR J BIOCHEM, V259, P909, DOI 10.1046/j.1432-1327.1999.00122.x; Gonzalo RM, 2001, MICROBES INFECT, V3, P701, DOI 10.1016/S1286-4579(01)01426-5; Grangette C, 2002, VACCINE, V20, P3304, DOI 10.1016/S0264-410X(02)00301-8; Kane MM, 2001, J IMMUNOL, V166, P1141, DOI 10.4049/jimmunol.166.2.1141; Kedzierski L, 2010, J GLOB INFECT DIS, V2, P177, DOI 10.4103/0974-777X.62881; Kelly BL, 2003, J EXP MED, V198, P1689, DOI 10.1084/jem.20031162; Kobets T, 2010, NAT PROTOC, V5, P1074, DOI 10.1038/nprot.2010.68; Lange UG, 2004, INFECT IMMUN, V72, P4924, DOI 10.1128/IAI.72.8.4924-4928.2004; Le Loir Y, 1998, J BACTERIOL, V180, P1895, DOI 10.1128/JB.180.7.1895-1903.1998; Melby PC, 2001, INFECT IMMUN, V69, P4719, DOI 10.1128/IAI.69.8.4719-4725.2001; Mierau I, 2005, APPL MICROBIOL BIOT, V68, P705, DOI 10.1007/s00253-005-0107-6; Miles SA, 2005, J EXP MED, V201, P747, DOI 10.1084/jem.20041470; MILLS DA, 1994, APPL ENVIRON MICROB, V60, P4413, DOI 10.1128/AEM.60.12.4413-4420.1994; MOUGNEAU E, 1995, SCIENCE, V268, P563, DOI 10.1126/science.7725103; Mougneau E, 2011, IMMUNOL REV, V240, P286, DOI 10.1111/j.1600-065X.2010.00983.x; Noben-Trauth N, 2003, J IMMUNOL, V170, P5152, DOI 10.4049/jimmunol.170.10.5152; Norton PM, 1996, FEMS IMMUNOL MED MIC, V14, P167, DOI 10.1111/j.1574-695X.1996.tb00284.x; Pinto EF, 2004, INFECT IMMUN, V72, P4521, DOI 10.1128/IAI.72.8.4521-4527.2004; Prina E, 1996, J IMMUNOL, V156, P4318; Ribeiro LA, 2002, APPL ENVIRON MICROB, V68, P910, DOI 10.1128/AEM.68.2.910-916.2002; Robinson K, 2004, INFECT IMMUN, V72, P2753, DOI 10.1128/IAI.72.5.2753-2761.2004; Robinson K, 1997, NAT BIOTECHNOL, V15, P653, DOI 10.1038/nbt0797-653; Rottiers P, 2009, INT REV IMMUNOL, V28, P465, DOI 10.3109/08830180903197498; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; SCHARTON TM, 1993, J EXP MED, V178, P567, DOI 10.1084/jem.178.2.567; Soussi N, 2000, INFECT IMMUN, V68, P1498, DOI 10.1128/IAI.68.3.1498-1506.2000; Soussi N, 2002, VACCINE, V20, P2702, DOI 10.1016/S0264-410X(02)00198-6; Sriraman K, 2008, APPL ENVIRON MICROB, V74, P7442, DOI 10.1128/AEM.00638-08; Stober CB, 2005, J IMMUNOL, V175, P2517, DOI 10.4049/jimmunol.175.4.2517; Tapia E, 2003, MICROBES INFECT, V5, P73, DOI 10.1016/S1286-4579(02)00077-1; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Villatoro-Hernandez J, 2011, EXPERT OPIN BIOL THE; Wells JM, 2008, NAT REV MICROBIOL, V6, P349, DOI 10.1038/nrmicro1840; Yam KK, 2008, VACCINE, V26, P2689, DOI 10.1016/j.vaccine.2008.03.024; Yam KK, 2011, J MED MICROBIOL	45	25	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e30945	10.1371/journal.pone.0030945	http://dx.doi.org/10.1371/journal.pone.0030945			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348031	gold, Green Published, Green Submitted			2022-12-25	WOS:000302730900016
J	Lee, SS; Lam, ANS; Lee, CK; Wong, NS				Lee, Shui-Shan; Lam, Agnes N. S.; Lee, Chi-Kei; Wong, Ngai-Sze			Virtual versus Physical Channel for Sex Networking in Men Having Sex with Men of Sauna Customers in the City of Hong Kong	PLOS ONE			English	Article							HIV PREVENTION; RISK BEHAVIORS; INTERNET; INFECTION; PREVALENCE; EPIDEMIC; SYPHILIS; TRANSMISSION; PARTNERS; INCREASE	Background: Advances in communication technology may affect networking pattern, thereby influencing the dynamics of sex partnership. The aim of the study is to explore the impacts of partner sourcing through internet and related channels on exposure risk to sexually transmitted infections (STI) including HIV. Methods: Using venue-based sampling, a cross-sectional questionnaire survey was conducted at saunas frequented by men having sex with men (MSM) in Hong Kong. Comparison was made between MSM sourcing partners through physical venues alone versus concomitant users of physical and virtual channels, the latter referring to internet and smart-phone applications, using bivariate logistic regression. Results: Over a 7-week study period, 299 MSM were recruited from 9 saunas. Three main types of sex partners were distinguished: steady (46.8%), regular (26.4%) and casual (96.0%) partners. Users of sauna (n = 78) were compared with concomitant users of saunas and virtual channels (n = 179) for partner sourcing. Sauna-visiting virtual channel users were younger and inclined to use selected physical venues for sourcing partners. Smart-phone users ( n = 90) were not different from other internet-users in terms of age, education level and single/mixed self-identified body appearance. Classifying respondents into high risk and low risk MSM by their frequency of condom use, concomitant use of both sauna and virtual channels accounted for a higher proportion in the high risk category (71.6% vs. 58.2%, OR = 1.81, p<0.05). In virtual channel users, partner sourcing through smart-phone was not associated with a higher practice of unprotected sex. Conclusion: MSM sauna customers commonly use virtual channels for sex partner sourcing. Unprotected sex is more prevalent in sauna customers who use virtual channel for sex partner sourcing. While the popularity of smart-phone is rising, its use is not associated with increased behavioural risk for HIV/STI transmission.	[Lee, Shui-Shan; Lam, Agnes N. S.; Lee, Chi-Kei; Wong, Ngai-Sze] Chinese Univ Hong Kong, Prince Wales Hosp, Stanley Ho Ctr Emerging Infect Dis, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital	Lee, SS (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Stanley Ho Ctr Emerging Infect Dis, Shatin, Hong Kong, Peoples R China.	sslee@cuhk.edu.hk	Lee, Shui Shan/B-9374-2008; Wong, Ngai Sze/A-3145-2012	Lee, Shui Shan/0000-0003-1448-765X; Wong, Ngai Sze/0000-0003-3788-8114	Council for the AIDS Trust Fund, Hong Kong [MSS172R]	Council for the AIDS Trust Fund, Hong Kong	The study was supported by the Council for the AIDS Trust Fund, Hong Kong (http://www.atf.gov.hk), grant number MSS172R. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, ECONOMIST; Benotsch EG, 2002, ARCH SEX BEHAV, V31, P177, DOI 10.1023/A:1014739203657; Bremer V, 2006, Euro Surveill, V11, P152; CHIN J, 1988, AIDS, V2, pS247, DOI 10.1097/00002030-198800001-00038; Jenness SM, 2010, AIDS BEHAV, V14, P1353, DOI 10.1007/s10461-010-9769-x; Lau JTF, 2003, AIDS EDUC PREV, V15, P516, DOI 10.1521/aeap.15.7.516.24046; Lee SS, 2011, PUBLIC HEALTH, V125, P433, DOI 10.1016/j.puhe.2011.03.010; Lee Shui Shan, 2009, J Infect Public Health, V2, P177, DOI 10.1016/j.jiph.2009.09.002; Liau A, 2006, SEX TRANSM DIS, V33, P576, DOI 10.1097/01.olq.0000204710.35332.c5; Likatavicius G, 2008, SEX TRANSM INFECT, V84, P499, DOI 10.1136/sti.2008.031419; Marcus U, 2005, SEX TRANSM INFECT, V81, P456, DOI 10.1136/sti.2005.014555; Quan VM, 2002, JAIDS-J ACQ IMM DEF, V31, P188, DOI 10.1097/00126334-200210010-00010; Raymond HF, 2009, AIDS BEHAV, V13, P630, DOI 10.1007/s10461-009-9574-6; Rosser BRS, 2011, AIDS BEHAV, V15, pS91, DOI 10.1007/s10461-011-9910-5; Rosser BRS, 2009, AIDS BEHAV, V13, P746, DOI 10.1007/s10461-008-9399-8; Simms I, 2005, SEX TRANSM DIS, V32, P220, DOI 10.1097/01.olq.0000149848.03733.c1; Spielmann N, 2010, SEX TRANSM INFECT, V86, P331, DOI 10.1136/sti.2009.040857; Swendeman D, 2010, CURR OPIN PSYCHIATR, V23, P139, DOI 10.1097/YCO.0b013e328336656a; Tsui HY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-232; van de Laar TJW, 2007, J INFECT DIS, V196, P230, DOI 10.1086/518796; van de Laar TJW, 2010, AIDS, V24, P1799, DOI 10.1097/QAD.0b013e32833c11a5; van Griensven F, 2010, AIDS, V24, pS30, DOI 10.1097/01.aids.0000390087.22565.b4; Wilson DP, 2009, JAIDS-J ACQ IMM DEF, V51, P356; Wolitski RJ, 2001, AM J PUBLIC HEALTH, V91, P883, DOI 10.2105/AJPH.91.6.883; Youm Y, 2010, SEX TRANSM INFECT, V86, P24, DOI 10.1136/sti.2010.044008; Zhang M, 2011, AIDS RES HUM RE 0506	26	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e31072	10.1371/journal.pone.0031072	http://dx.doi.org/10.1371/journal.pone.0031072			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348038	Green Submitted, gold, Green Published			2022-12-25	WOS:000302730900018
J	Bush, ER; Buesching, CD; Slade, EM; Macdonald, DW				Bush, Emma R.; Buesching, Christina D.; Slade, Eleanor M.; Macdonald, David W.			Woodland Recovery after Suppression of Deer: Cascade effects for Small Mammals, Wood Mice (Apodemus sylvaticus) and Bank Voles (Myodes glareolus)	PLOS ONE			English	Article							RED-BACKED VOLES; WYTHAM-WOODS; CLETHRIONOMYS-GLAREOLUS; TEMPORARY EMIGRATION; VEGETATION STRUCTURE; INCREASING NUMBERS; FOREST; IMPACTS; DENSITY; HABITAT	Over the past century, increases in both density and distribution of deer species in the Northern Hemisphere have resulted in major changes in ground flora and undergrowth vegetation of woodland habitats, and consequentially the animal communities that inhabit them. In this study, we tested whether recovery in the vegetative habitat of a woodland due to effective deer management (from a peak of 0.4-1.5 to <0.17 deer per ha) had translated to the small mammal community as an example of a higher order cascade effect. We compared deer-free exclosures with neighboring open woodland using capture-mark-recapture (CMR) methods to see if the significant difference in bank vole (Myodes glareolus) and wood mouse (Apodemus sylvaticus) numbers between these environments from 2001-2003 persisted in 2010. Using the multi-state Robust Design method in program MARK we found survival and abundance of both voles and mice to be equivalent between the open woodland and the experimental exclosures with no differences in various metrics of population structure (age structure, sex composition, reproductive activity) and individual fitness (weight), although the vole population showed variation both locally and temporally. This suggests that the vegetative habitat - having passed some threshold of complexity due to lowered deer density - has allowed recovery of the small mammal community, although patch dynamics associated with vegetation complexity still remain. We conclude that the response of small mammal communities to environmental disturbance such as intense browsing pressure can be rapidly reversed once the disturbing agent has been removed and the vegetative habitat is allowed to increase in density and complexity, although we encourage caution, as a source/sink dynamic may emerge between old growth patches and the recently disturbed habitat under harsh conditions.	[Bush, Emma R.; Buesching, Christina D.; Slade, Eleanor M.; Macdonald, David W.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Oxford OX1 3PS, England	University of Oxford	Bush, ER (corresponding author), Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, S Parks Rd, Oxford OX1 3PS, England.	emmie.bush@gmail.com	Slade, Eleanor M/O-3874-2014	Slade, Eleanor M/0000-0002-6108-1196; Bush, Emma/0000-0003-4036-125X	People's Trust for Endangered Species; HSBC through Earthwatch Institute	People's Trust for Endangered Species; HSBC through Earthwatch Institute	EB was funded by an internship grant from the People's Trust for Endangered Species. EMS was funded by the HSBC Climate Partnership Programme through the Earthwatch Institute. Additional material costs (such as equipment) were incurred by Oxford University's Wildlife Conservation Research Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar A, 2010, FORESTRY, V83, P345, DOI 10.1093/forestry/cpq017; Anderson CS, 2003, CAN J ZOOL, V81, P897, DOI 10.1139/Z03-074; Brown N, 2000, J APPL ECOL, V37, P1044, DOI 10.1046/j.1365-2664.2000.00573.x; Buesching CD, 2011, BASIC APPL ECOL, V12, P207, DOI 10.1016/j.baae.2011.02.007; Buesching CD, 2010, WYTHAM WOODS: OXFORD'S ECOLOGICAL LABORATORY, P173; Buesching CD, 2008, MAMM BIOL, V73, P318, DOI 10.1016/j.mambio.2007.09.009; Dolman Paul, 2010, British Wildlife, V21, P242; Dolman PM, 2008, WILDLIFE RES, V35, P202, DOI 10.1071/WR07114; Fisher JT, 2005, MAMMAL REV, V35, P51, DOI 10.1111/j.1365-2907.2005.00053.x; Fisher N, 2010, WYTHAM WOODS: OXFORD'S ECOLOGICAL LABORATORY, P197; FLOWERDEW JR, 1978, J ANIM ECOL, V47, P725, DOI 10.2307/3667; Flowerdew JR, 2004, MAMMAL REV, V34, P31, DOI 10.1046/j.0305-1838.2003.00025.x; Flowerdew JR, 2001, FORESTRY, V74, P277, DOI 10.1093/forestry/74.3.277; Flowerdew JR, 1993, MICE VOLES WHITTET B; Fuller RJ, 2001, FORESTRY, V74, P193, DOI 10.1093/forestry/74.3.193; Gill RMA, 2007, IBIS, V149, P119, DOI 10.1111/j.1474-919X.2007.00731.x; Gurnell J., 2006, LIVE TRAPPING SMALL, VFourth edition, revised ed.; HALAMA KJ, 1994, OIKOS, V69, P107, DOI 10.2307/3545289; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Holt CA, 2010, IBIS, V152, P335, DOI 10.1111/j.1474-919X.2010.01012.x; HUTCHINGS MJ, 1978, OIKOS, V31, P351, DOI 10.2307/3543662; ILLIUS AW, 1992, OECOLOGIA, V89, P428, DOI 10.1007/BF00317422; Kendall WL, 1997, ECOLOGY, V78, P563; KENDALL WL, 1995, BIOMETRICS, V51, P293, DOI 10.2307/2533335; Kendall WL, 1995, J APPL STAT, V22, P751, DOI 10.1080/02664769524595; Kendall WL, 2011, PROGRAM MARK GENTLE; Kirby KJ, 2000, J VEG SCI, V11, P871, DOI 10.2307/3236557; KORN H, 1986, OECOLOGIA, V68, P623, DOI 10.1007/BF00378782; Koskela E, 1997, J ANIM ECOL, V66, P341, DOI 10.2307/5980; MacDonald D.W., 1993, MAMMALS BRITAIN EURO; MACDONALD DC, 1998, PROPOSALS FUTURE MON; Mathisen KM, 2010, J VEG SCI, V21, P705, DOI 10.1111/j.1654-1103.2010.01180.x; McDonald RA, 2000, J ZOOL, V252, P363, DOI 10.1111/j.1469-7998.2000.tb00631.x; MILLS LS, 1995, CONSERV BIOL, V9, P395, DOI 10.1046/j.1523-1739.1995.9020395.x; Milner JM, 2006, J APPL ECOL, V43, P721, DOI 10.1111/j.1365-2664.2006.01183.x; Minitab I., 2007, MINITAB 15 STAT SOFT; Monamy V, 2000, AUSTRAL ECOL, V25, P580, DOI 10.1046/j.1442-9993.2000.01057.x; Morecroft MD, 2001, FORESTRY, V74, P251, DOI 10.1093/forestry/74.3.251; Morecroft MD, RECOVERY WOODL UNPUB; Moser BW, 2000, INT BIODETER BIODEGR, V45, P151, DOI 10.1016/S0964-8305(00)00036-6; OSTFELD RS, 1990, TRENDS ECOL EVOL, V5, P411, DOI 10.1016/0169-5347(90)90026-A; Perrins CM, 2001, FORESTRY, V74, P299, DOI 10.1093/forestry/74.3.299; PUTMAN RJ, 1989, BIOL CONSERV, V47, P13, DOI 10.1016/0006-3207(89)90017-7; Runge JP, 2006, AM NAT, V167, P925, DOI 10.1086/503531; Selas V, 2010, EUROPEAN J WILDLIFE, V57, P1; Sibbald S., 2006, PROPOSAL NATL MONITO; Smit R, 2001, PLANT ECOL, V155, P119, DOI 10.1023/A:1013239805915; SOUTHERN HN, 1968, J ANIM ECOL, V37, P75, DOI 10.2307/2712; Stewart AJA, 2001, FORESTRY, V74, P259, DOI 10.1093/forestry/74.3.259; Tallmon DA, 2004, CONSERV BIOL, V18, P1658, DOI 10.1111/j.1523-1739.2004.00439.x; WATKINSON AR, 1995, J ANIM ECOL, V64, P126, DOI 10.2307/5833; WATTS CHS, 1968, J ANIM ECOL, V37, P25, DOI 10.2307/2709; White G. C., 2001, WILDLIFE LAND PEOPLE, P368; Zwolak R, 2008, CAN J ZOOL, V86, P83, DOI 10.1139/Z07-126	55	24	25	2	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31404	10.1371/journal.pone.0031404	http://dx.doi.org/10.1371/journal.pone.0031404			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347472	Green Submitted, gold, Green Published			2022-12-25	WOS:000302730100068
J	Lin, IH; Ho, ML; Chen, HY; Lee, HS; Huang, CC; Chu, YH; Lin, SY; Deng, YR; He, YH; Lien, YH; Hsu, CW; Wong, RH				Lin, I-Hsin; Ho, Ming-Lin; Chen, Hsuan-Yu; Lee, Hong-Shen; Huang, Chia-Chen; Chu, Yin-Hung; Lin, Shiau-Yun; Deng, Ya-Ru; He, Yu-Hao; Lien, Yu-Hui; Hsu, Chi-Wen; Wong, Ruey-Hong			Smoking, Green Tea Consumption, Genetic Polymorphisms in the Insulin-Like Growth Factors and Lung Cancer Risk	PLOS ONE			English	Article							FACTOR-I; PROSTATE-CANCER; PLASMA-LEVELS; SERUM-LEVELS; IGF2 GENE; REPEAT; ASSOCIATION; POLYPHENOLS; AGE	Insulin-like growth factors (IGFs) are mediators of growth hormones; they have an influence on cell proliferation and differentiation. In addition, IGF-binding protein (IGFBP)-3 could suppress the mitogenic action of IGFs. Interestingly, tea polyphenols could substantially reduce IGF1 and increase IGFBP3. In this study, we evaluated the effects of smoking, green tea consumption, as well as IGF1, IGF2, and IGFBP3 polymorphisms, on lung cancer risk. Questionnaires were administered to obtain the subjects' characteristics, including smoking habits and green tea consumption from 170 primary lung cancer cases and 340 healthy controls. Genotypes for IGF1, IGF2, and IGFBP3 were identified by polymerase chain reaction. Lung cancer cases had a higher proportion of smoking, green tea consumption of less than one cup per day, exposure to cooking fumes, and family history of lung cancer than controls. After adjusting the confounding effect, an elevated risk was observed in smokers who never drank green tea, as compared to smokers who drank green tea more than one cup per day (odds ratio (OR) = 13.16, 95% confidence interval (CI) = 2.96-58.51). Interaction between smoking and green tea consumption on lung cancer risk was also observed. Among green tea drinkers who drank more than one cup per day, IGF1 (CA)(19)/(CA)(19) and (CA)(19)/X genotypes carriers had a significantly reduced risk of lung cancer (OR = 0.06, 95% CI = 0.01-0.44) compared with IGF1 X/X carriers. Smoking-induced pulmonary carcinogenesis could be modulated by green tea consumption and their growth factor environment.	[Lin, I-Hsin] Chung Shan Med Univ, Inst Publ Hlth, Taichung, Taiwan; [Ho, Ming-Lin] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Ho, Ming-Lin] Changhua Christian Hosp, Dept Internal Med, Div Pulm Med, Changhua, Taiwan; [Chen, Hsuan-Yu] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Lee, Hong-Shen; Huang, Chia-Chen; Chu, Yin-Hung; Lin, Shiau-Yun; Deng, Ya-Ru; He, Yu-Hao; Lien, Yu-Hui; Hsu, Chi-Wen; Wong, Ruey-Hong] Chung Shan Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Wong, Ruey-Hong] Chung Shan Med Univ Hosp, Dept Occupat Med, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Changhua Christian Hospital; Academia Sinica - Taiwan; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Lin, IH (corresponding author), Chung Shan Med Univ, Inst Publ Hlth, Taichung, Taiwan.	rueyhong@csmu.edu.tw	Chen, Hsuan-Yu/AAE-8428-2019		National Science Council, Taiwan [NSC-98-2815-C-040-028-B, NSC 95-2815-C-040-019-B, NSC 93-2815-C-040-008-B]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by National Science Council, Taiwan (NSC-98-2815-C-040-028-B; NSC 95-2815-C-040-019-B; NSC 93-2815-C-040-008-B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhami VM, 2004, CANCER RES, V64, P8715, DOI 10.1158/0008-5472.CAN-04-2840; Chang CH, 2009, AM J EPIDEMIOL, V170, P695, DOI 10.1093/aje/kwp019; Chen KY, 2005, CANCER-AM CANCER SOC, V103, P2566, DOI 10.1002/cncr.21087; Chen X, 2008, J HUM GENET, V53, P227, DOI 10.1007/s10038-007-0241-3; CHURCH DF, 1985, ENVIRON HEALTH PERSP, V64, P111, DOI 10.2307/3430003; Deal C, 2001, J CLIN ENDOCR METAB, V86, P1274, DOI 10.1210/jc.86.3.1274; DeLellis K, 2003, BRIT J CANCER, V88, P277, DOI 10.1038/sj.bjc.6600728; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gaunt TR, 2001, HUM MOL GENET, V10, P1491, DOI 10.1093/hmg/10.14.1491; GRAHAM HN, 1992, PREV MED, V21, P334, DOI 10.1016/0091-7435(92)90041-F; Hernandez W, 2007, CARCINOGENESIS, V28, P2154, DOI 10.1093/carcin/bgm190; Hodgson JM, 2004, BRIT J NUTR, V91, P301, DOI 10.1079/BJN20031046; Jernstrom H, 2001, MOL GENET METAB, V72, P144, DOI 10.1006/mgme.2000.3130; Jian L, 2006, PUBLIC HEALTH NUTR, V9, P928, DOI 10.1017/PHN2005919; Kaklamani VG, 1999, J CLIN ONCOL, V17, P813, DOI 10.1200/JCO.1999.17.3.813; Khan N, 2006, CANCER RES, V66, P2500, DOI 10.1158/0008-5472.CAN-05-3636; Kim YJ, 2006, BIOCHEM BIOPH RES CO, V346, P38, DOI 10.1016/j.bbrc.2006.05.080; KINLEN LJ, 1988, BRIT J CANCER, V58, P397, DOI 10.1038/bjc.1988.227; Li Q, 2008, BRIT J CANCER, V99, P1179, DOI 10.1038/sj.bjc.6604645; MACAULAY VM, 1992, BRIT J CANCER, V65, P311, DOI 10.1038/bjc.1992.65; ODell SD, 1997, INT J OBESITY, V21, P822, DOI 10.1038/sj.ijo.0800483; Ogawa K, 2003, PUBLIC HEALTH NUTR, V6, P147, DOI 10.1079/PHN2002411; Patel R, 2000, J MOL CELL CARDIOL, V32, P2369, DOI 10.1006/jmcc.2000.1267; PRYOR W A, 1987, British Journal of Cancer, V55, P19; Ren ZF, 2004, CANCER EPIDEM BIOMAR, V13, P1290; Rosen CJ, 1998, J CLIN ENDOCR METAB, V83, P2286, DOI 10.1210/jc.83.7.2286; Schildkraut JM, 2005, CANCER EPIDEM BIOMAR, V14, P403, DOI 10.1158/1055-9965.EPI-04-0426; Shankar S, 2007, FRONT BIOSCI-LANDMRK, V12, P4881, DOI 10.2741/2435; Shimizu M, 2005, BIOCHEM BIOPH RES CO, V334, P947, DOI 10.1016/j.bbrc.2005.06.182; Thun MJ, 2002, ONCOGENE, V21, P7307, DOI 10.1038/sj.onc.1205807; Tsubono Y, 2001, NEW ENGL J MED, V344, P632, DOI 10.1056/NEJM200103013440903; Wang LZ, 2003, CANCER RES, V63, P4407; World Health Organization, 1981, HIST TYP LUNG TUM; YANG CS, 1993, J NATL CANCER I, V85, P1038, DOI 10.1093/jnci/85.13.1038; Yu H, 2000, JNCI-J NATL CANCER I, V92, P1472, DOI 10.1093/jnci/92.18.1472; Yu H, 1999, JNCI-J NATL CANCER I, V91, P151, DOI 10.1093/jnci/91.2.151	36	26	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e30951	10.1371/journal.pone.0030951	http://dx.doi.org/10.1371/journal.pone.0030951			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347413	Green Published, Green Submitted, gold			2022-12-25	WOS:000302180600018
J	Weiner, B; Gomez, J; Victor, TC; Warren, RM; Sloutsky, A; Plikaytis, BB; Posey, JE; van Helden, PD; Gey van Pittius, NC; Koehrsen, M; Sisk, P; Stolte, C; White, J; Gagneux, S; Birren, B; Hung, D; Murray, M; Galagan, J				Weiner, Brian; Gomez, James; Victor, Thomas C.; Warren, Robert M.; Sloutsky, Alexander; Plikaytis, Bonnie B.; Posey, James E.; van Helden, Paul D.; Gey van Pittius, Nicolass C.; Koehrsen, Michael; Sisk, Peter; Stolte, Christian; White, Jared; Gagneux, Sebastien; Birren, Bruce; Hung, Deborah; Murray, Megan; Galagan, James			Independent Large Scale Duplications in Multiple M. tuberculosis Lineages Overlapping the Same Genomic Region	PLOS ONE			English	Article							LATERAL GENE-TRANSFER; IS6110-MEDIATED DELETION POLYMORPHISM; MYCOBACTERIUM-TUBERCULOSIS; ADAPTIVE EVOLUTION; SEQUENCE; AMPLIFICATION; ASSOCIATION; DIVERSITY; INSIGHTS; REVEALS	Mycobacterium tuberculosis, the causative agent of most human tuberculosis, infects one third of the world's population and kills an estimated 1.7 million people a year. With the world-wide emergence of drug resistance, and the finding of more functional genetic diversity than previously expected, there is a renewed interest in understanding the forces driving genome evolution of this important pathogen. Genetic diversity in M. tuberculosis is dominated by single nucleotide polymorphisms and small scale gene deletion, with little or no evidence for large scale genome rearrangements seen in other bacteria. Recently, a single report described a large scale genome duplication that was suggested to be specific to the Beijing lineage. We report here multiple independent large-scale duplications of the same genomic region of M. tuberculosis detected through whole-genome sequencing. The duplications occur in strains belonging to both M. tuberculosis lineage 2 and 4, and are thus not limited to Beijing strains. The duplications occur in both drug-resistant and drug susceptible strains. The duplicated regions also have substantially different boundaries in different strains, indicating different originating duplication events. We further identify a smaller segmental duplication of a different genomic region of a lab strain of H37Rv. The presence of multiple independent duplications of the same genomic region suggests either instability in this region, a selective advantage conferred by the duplication, or both. The identified duplications suggest that large-scale gene duplication may be more common in M. tuberculosis than previously considered.	[Weiner, Brian; Gomez, James; Koehrsen, Michael; Sisk, Peter; Stolte, Christian; White, Jared; Birren, Bruce; Hung, Deborah; Galagan, James] Broad Inst, Cambridge, MA USA; [Victor, Thomas C.; Warren, Robert M.; van Helden, Paul D.; Gey van Pittius, Nicolass C.] Univ Stellenbosch, Div Mol Biol & Human Genet, Ctr Excellence TB Res,Natl Res Fdn,Dept Biomed Sc, Med Res Council,Ctr Mol & Cellular Biol,Fac Hlth, ZA-7505 Tygerberg, South Africa; [Sloutsky, Alexander] Univ Massachusetts, Sch Med, Ctr Hlth Policy & Res, Massachusetts Supranat TB Reference Lab, Shrewsbury, MA USA; [Plikaytis, Bonnie B.; Posey, James E.] Ctr Dis Control & Prevent, Mycobacteriol Lab Branch, Div TB Eliminat, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA; [Gagneux, Sebastien] Natl Inst Med Res, Med Res Council, London NW7 1AA, England; [Murray, Megan] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Galagan, James] Boston Univ, Dept Biomed Engn & Microbiol, Boston, MA 02215 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; National Research Foundation - South Africa; South African Medical Research Council; Stellenbosch University; University of Massachusetts System; Centers for Disease Control & Prevention - USA; MRC National Institute for Medical Research; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Harvard University; Harvard T.H. Chan School of Public Health; Boston University	Weiner, B (corresponding author), Broad Inst, Cambridge, MA USA.	jgalag@bu.edu	van Pittius, Nicolaas C Gey/D-3434-2015; Gagneux, Sebastien/ABE-7909-2020	van Pittius, Nicolaas C Gey/0000-0002-8807-4105; Weiner, Brian/0000-0002-7285-4385; Gagneux, Sebastien/0000-0001-7783-9048; Galagan, James/0000-0003-0542-3291; Stolte, Christian/0000-0002-8228-4195; Warren, Robin/0000-0001-5741-7358	National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services [HHSN27220090018C]; Ellison Medical Foundation [ID-SS-0693-04]	National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ellison Medical Foundation(Lawrence Ellison Foundation)	This project has been funded in whole or in part with Federal funds from the National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services, under Contract No.: HHSN27220090018C; and Ellison Medical Foundation Grant ID-SS-0693-04. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alland D, 2007, J CLIN MICROBIOL, V45, P39, DOI 10.1128/JCM.02483-05; Andersson DI, 2009, ANNU REV GENET, V43, P167, DOI 10.1146/annurev-genet-102108-134805; Becq J, 2007, MOL BIOL EVOL, V24, P1861, DOI 10.1093/molbev/msm111; Boucher Y, 2003, ANNU REV GENET, V37, P283, DOI 10.1146/annurev.genet.37.050503.084247; Brosch R, 2000, YEAST, V17, P111, DOI 10.1002/1097-0061(20000630)17:2<111::AID-YEA17>3.0.CO;2-G; Brosch R, 2001, TRENDS MICROBIOL, V9, P452, DOI 10.1016/S0966-842X(01)02131-X; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Darling AE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000128; DeLuna A, 2008, NAT GENET, V40, P676, DOI 10.1038/ng.123; Domenech P, 2010, J BACTERIOL, V192, P4562, DOI 10.1128/JB.00536-10; EDLUND T, 1981, NATURE, V292, P269, DOI 10.1038/292269a0; Fang Z, 1999, J BACTERIOL, V181, P1014, DOI 10.1128/JB.181.3.1014-1020.1999; Fang Z, 1998, J BACTERIOL, V180, P2102, DOI 10.1128/JB.180.8.2102-2109.1998; Fang Z, 2001, J BACTERIOL, V183, P5279, DOI 10.1128/JB.183.18.5279-5284.2001; Fang ZG, 1997, J CLIN MICROBIOL, V35, P479, DOI 10.1128/JCM.35.2.479-481.1997; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Galamba A, 2001, MICROBIOL-SGM, V147, P3281, DOI 10.1099/00221287-147-12-3281; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Gray YHM, 2000, TRENDS GENET, V16, P461, DOI 10.1016/S0168-9525(00)02104-1; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gutierrez MC, 2005, PLOS PATHOG, V1, P55, DOI 10.1371/journal.ppat.0010005; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Ho TBL, 2000, YEAST, V17, P272, DOI 10.1002/1097-0061(200012)17:4&lt;272::AID-YEA48&gt;3.0.CO;2-2; Hughes AL, 2002, EMERG INFECT DIS, V8, P1342, DOI 10.3201/eid0811.020064; Jang J, 2008, TRENDS MICROBIOL, V16, P303, DOI 10.1016/j.tim.2008.04.005; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kinsella RJ, 2003, P NATL ACAD SCI USA, V100, P10320, DOI 10.1073/pnas.1737230100; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lynch M, 2000, GENETICS, V154, P459; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ohno S., 1970, EVOLUTION GENE DUPLI; ROGALL T, 1990, INT J SYST BACTERIOL, V40, P323, DOI 10.1099/00207713-40-4-323; Sampson SL, 2004, J CLIN MICROBIOL, V42, P895, DOI 10.1128/JCM.42.2.895-898.2004; Sampson SL, 2003, J BACTERIOL, V185, P2856, DOI 10.1128/JB.185.9.2856-2866.2003; Sandegren L, 2009, NAT REV MICROBIOL, V7, P578, DOI 10.1038/nrmicro2174; Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Supply P, 2003, MOL MICROBIOL, V47, P529, DOI 10.1046/j.1365-2958.2003.03315.x; Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101; Veyrier FJ, 2011, TRENDS MICROBIOL, V19, P156, DOI 10.1016/j.tim.2010.12.008	46	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e26038	10.1371/journal.pone.0026038	http://dx.doi.org/10.1371/journal.pone.0026038			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347359	Green Published, Green Accepted, gold			2022-12-25	WOS:000302180600002
J	Dotsch, A; Eckweiler, D; Schniederjans, M; Zimmermann, A; Jensen, V; Scharfe, M; Geffers, R; Haussler, S				Doetsch, Andreas; Eckweiler, Denitsa; Schniederjans, Monika; Zimmermann, Ariane; Jensen, Vanessa; Scharfe, Maren; Geffers, Robert; Haeussler, Susanne			The Pseudomonas aeruginosa Transcriptome in Planktonic Cultures and Static Biofilms Using RNA Sequencing	PLOS ONE			English	Article							SIGNAL RECOGNITION PARTICLE; GLOBAL GENE-EXPRESSION; CYSTIC-FIBROSIS LUNG; III SECRETION; DIFFERENTIAL EXPRESSION; AEROBIC RESPIRATION; BACTERIAL BIOFILMS; MATURE BIOFILMS; MECHANISMS; INFECTION	In this study, we evaluated how gene expression differs in mature Pseudomonas aeruginosa biofilms as opposed to planktonic cells by the use of RNA sequencing technology that gives rise to both quantitative and qualitative information on the transcriptome. Although a large proportion of genes were consistently regulated in both the stationary phase and biofilm cultures as opposed to the late exponential growth phase cultures, the global biofilm gene expression pattern was clearly distinct indicating that biofilms are not just surface attached cells in stationary phase. A large amount of the genes found to be biofilm specific were involved in adaptation to microaerophilic growth conditions, repression of type three secretion and production of extracellular matrix components. Additionally, we found many small RNAs to be differentially regulated most of them similarly in stationary phase cultures and biofilms. A qualitative analysis of the RNA-seq data revealed more than 3000 putative transcriptional start sites (TSS). By the use of rapid amplification of cDNA ends (5'-RACE) we confirmed the presence of three different TSS associated with the pqsABCDE operon, two in the promoter of pqsA and one upstream of the second gene, pqsB. Taken together, this study reports the first transcriptome study on P. aeruginosa that employs RNA sequencing technology and provides insights into the quantitative and qualitative transcriptome including the expression of small RNAs in P. aeruginosa biofilms.	[Doetsch, Andreas; Eckweiler, Denitsa; Schniederjans, Monika; Zimmermann, Ariane; Scharfe, Maren; Geffers, Robert; Haeussler, Susanne] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Jensen, Vanessa; Haeussler, Susanne] Ctr Clin & Expt Infect Res, Hannover, Germany	Helmholtz Association; Helmholtz-Center for Infection Research	Dotsch, A (corresponding author), Helmholtz Ctr Infect Res, Braunschweig, Germany.	andreas.doetsch@helmholtz-hzi.de	Eckweiler, Denitsa/I-9009-2019; Häussler, Susanne/I-2605-2014; Dötsch, Andreas/H-1383-2013; Dötsch, Andreas/AAL-6015-2020; Pohl, Sarah/B-3102-2016	Eckweiler, Denitsa/0000-0002-3702-8846; Häussler, Susanne/0000-0001-6141-9102; Dötsch, Andreas/0000-0001-9086-2584; Dötsch, Andreas/0000-0001-9086-2584; Pohl, Sarah/0000-0003-2655-7037	Helmholtz Gemeinschaft [VH-NG-135]; Mukoviszidose e.V. [S07/05]; European Research Council [260276]	Helmholtz Gemeinschaft(Helmholtz Association); Mukoviszidose e.V.; European Research Council(European Research Council (ERC)European Commission)	Financial support from the Helmholtz Gemeinschaft (http://www.helmholtz.de/, grant VH-NG-135), Mukoviszidose e.V. (http://muko.info/, grant S07/05) and the European Research Council (http://erc.europa.eu/, grant 260276) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Ortega C, 2007, MOL MICROBIOL, V65, P153, DOI 10.1111/j.1365-2958.2007.05772.x; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anderson GG, 2008, INFECT IMMUN, V76, P1423, DOI 10.1128/IAI.01373-07; [Anonymous], 2005, Nat Methods, V2, P629; Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665-4684.2004; Bredenbruch F, 2005, J BACTERIOL, V187, P3630, DOI 10.1128/JB.187.11.3630-3635.2005; Brencic A, 2009, MOL MICROBIOL, V73, P434, DOI 10.1111/j.1365-2958.2009.06782.x; Coleman JP, 2008, J BACTERIOL, V190, P1247, DOI 10.1128/JB.01140-07; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Costerton JW, 2001, TRENDS MICROBIOL, V9, P50, DOI 10.1016/S0966-842X(00)01918-1; Delpin MW, 2009, ISME J, V3, P1053, DOI 10.1038/ismej.2009.54; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Filiatrault MJ, 2010, J BACTERIOL, V192, P2359, DOI 10.1128/JB.01445-09; Folsom JP, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-294; Gallagher LA, 2002, J BACTERIOL, V184, P6472, DOI 10.1128/JB.184.23.6472-6480.2002; Gonzalez N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-167; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Guell M, 2011, NAT REV MICROBIOL, V9, P658, DOI 10.1038/nrmicro2620; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Hasona A, 2007, J BACTERIOL, V189, P1219, DOI 10.1128/JB.01146-06; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Hentzer M., 2005, BIOFILMS, V2, P37, DOI DOI 10.1017/S1479050505001699; Hoiby N, 2011, INT J ORAL SCI, V3, P55, DOI 10.4248/IJOS11026; Kawakami T, 2010, ENVIRON MICROBIOL, V12, P1399, DOI 10.1111/j.1462-2920.2009.02109.x; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee J, 2009, MICROB BIOTECHNOL, V2, P75, DOI 10.1111/j.1751-7915.2008.00061.x; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Livny J, 2006, NUCLEIC ACIDS RES, V34, P3484, DOI 10.1093/nar/gkl453; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Manos J, 2009, FEMS MICROBIOL LETT, V292, P107, DOI 10.1111/j.1574-6968.2008.01472.x; Manos J, 2008, J MED MICROBIOL, V57, P1454, DOI 10.1099/jmm.0.2008/005009-0; McPhee JB, 2006, J BACTERIOL, V188, P3995, DOI 10.1128/JB.00053-06; Mikkelsen H, 2009, MICROBIOL-SGM, V155, P687, DOI 10.1099/mic.0.025551-0; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Musken M, 2010, NAT PROTOC, V5, P1460, DOI 10.1038/nprot.2010.110; Musken M, 2010, MICROBIOL-SGM, V156, P431, DOI 10.1099/mic.0.033290-0; Petrova OE, 2010, J BACTERIOL, V192, P5275, DOI 10.1128/JB.00387-10; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Ryder C, 2007, CURR OPIN MICROBIOL, V10, P644, DOI 10.1016/j.mib.2007.09.010; Schembri MA, 2003, MOL MICROBIOL, V48, P253, DOI 10.1046/j.1365-2958.2003.03432.x; Schuster M, 2006, INT J MED MICROBIOL, V296, P73, DOI 10.1016/j.ijmm.2006.01.036; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sonnleitner E, 2008, MICROBIOL-SGM, V154, P3175, DOI 10.1099/mic.0.2008/019703-0; Sonnleitner E, 2011, APPL MICROBIOL BIOT, V91, P63, DOI 10.1007/s00253-011-3332-1; Sonnleitner E, 2011, MOL MICROBIOL, V80, P868, DOI 10.1111/j.1365-2958.2011.07620.x; Soper T, 2010, P NATL ACAD SCI USA, V107, P9602, DOI 10.1073/pnas.1004435107; Trevino J, 2010, MICROBIOL-SGM, V156, P1342, DOI 10.1099/mic.0.036558-0; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; Wagner VE, 2008, CLIN REV ALLERG IMMU, V35, P124, DOI 10.1007/s12016-008-8079-9; Waite RD, 2005, J BACTERIOL, V187, P6571, DOI 10.1128/JB.187.18.6571-6576.2005; Waite RD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-162; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wassarman KM, 2007, MOL MICROBIOL, V65, P1425, DOI 10.1111/j.1365-2958.2007.05894.x; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627; Winsor GL, 2009, NUCLEIC ACIDS RES, V37, pD483, DOI 10.1093/nar/gkn861; Xiao GP, 2006, MOL MICROBIOL, V62, P1689, DOI 10.1111/j.1365-2958.2006.05462.x; Yi H, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr617; Zheng XB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-361	61	163	166	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31092	10.1371/journal.pone.0031092	http://dx.doi.org/10.1371/journal.pone.0031092			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319605	Green Published, Green Submitted, gold			2022-12-25	WOS:000302178400028
J	Riolo, MT; Cooper, ZA; Holloway, MP; Cheng, Y; Bianchi, C; Yakirevich, E; Ma, L; Chin, YE; Altura, RA				Riolo, Matthew T.; Cooper, Zachary A.; Holloway, Michael P.; Cheng, Yan; Bianchi, Cesario; Yakirevich, Evgeny; Ma, Li; Chin, Y. Eugene; Altura, Rachel A.			Histone Deacetylase 6 (HDAC6) Deacetylates Survivin for Its Nuclear Export in Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2 CATALYTIC DOMAINS; ACETYLATION; APOPTOSIS; COMPLEXES; PROGNOSIS; NETWORKS	Survivin is an oncogenic protein that is highly expressed in breast cancer and has a dual function that is dependent on its subcellular localization. In the cytosol, survivin blocks programmed cell death by inactivating caspase proteins; however, in the nucleus it facilitates cell division by regulating chromosomal movement and cytokinesis. In prior work, we showed that survivin is acetylated by CREB-binding protein (CBP), which restricts its localization to the nuclear compartment and thereby inhibits its anti-apoptotic function. Here, we identify histone deacetylase 6 (HDAC6) as responsible for abrogating CBP-mediated survivin acetylation in the estrogen receptor (ER)-positive breast cancer cell line, MCF-7. HDAC6 directly binds survivin, an interaction that is enhanced by CBP. In quiescent breast cancer cells in culture and in malignant tissue sections from ER+ breast tumors, HDAC6 localizes to a perinuclear region of the cell, undergoing transport to the nucleus following CBP activation where it then deacetylates survivin. Genetically modified mouse embryonic fibroblasts that lack mhdac6 localize survivin predominantly to the nuclear compartment, whereas wild-type mouse embryonic fibroblasts localize survivin to distinct cytoplasmic structures. Together, these data imply that HDAC6 deacetylates survivin to regulate its nuclear export, a feature that may provide a novel target for patients with ER+ breast cancer.	[Altura, Rachel A.] Rhode Isl Hosp, Dept Pediat, Providence, RI 02903 USA; [Riolo, Matthew T.; Cooper, Zachary A.; Holloway, Michael P.; Cheng, Yan; Altura, Rachel A.] Brown Univ, Warren Alpert Med Sch, Dept Pediat, Providence, RI 02903 USA; [Ma, Li; Chin, Y. Eugene] Brown Univ, Warren Alpert Med Sch, Dept Surg, Providence, RI 02903 USA; [Yakirevich, Evgeny] Brown Univ, Warren Alpert Med Sch, Dept Pathol, Providence, RI 02903 USA; [Bianchi, Cesario] Brown Univ, Warren Alpert Med Sch, Dept Surg Res, Providence, RI 02903 USA	Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University; Brown University; Brown University	Altura, RA (corresponding author), Rhode Isl Hosp, Dept Pediat, Providence, RI 02903 USA.	Rachel_Altura@brown.edu	bianchi, cesario/H-6238-2012	Cooper, Zachary/0000-0003-1059-0940	National Institutes of Health [P20RR017695]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant P20RR017695 (to R. A. A.).	Aldana-Masangkay GI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/875824; Altieri DC, 2008, ONCOGENE, V27, P6276, DOI 10.1038/onc.2008.303; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Bertos NR, 2004, J BIOL CHEM, V279, P48246, DOI 10.1074/jbc.M408583200; Boyault C, 2007, ONCOGENE, V26, P5468, DOI 10.1038/sj.onc.1210614; Ceschin DG, 2011, GENE DEV, V25, P1132, DOI 10.1101/gad.619211; Chan KS, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.34; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Dickinson M, 2010, INVEST NEW DRUG, V28, pS3, DOI 10.1007/s10637-010-9596-y; Federico M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/475641; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Marks PA, 2010, BBA-GENE REGUL MECH, V1799, P717, DOI 10.1016/j.bbagrm.2010.05.008; Marks PA, 2010, EXPERT OPIN INV DRUG, V19, P1049, DOI 10.1517/13543784.2010.510514; Palijan A, 2009, J BIOL CHEM, V284, P30275, DOI 10.1074/jbc.M109.051201; Pavlyukov MS, 2011, J BIOL CHEM, V286, P23296, DOI 10.1074/jbc.M111.237586; Rey M, 2011, EUR J CELL BIOL, V90, P128, DOI 10.1016/j.ejcb.2010.09.004; Saji S, 2005, ONCOGENE, V24, P4531, DOI 10.1038/sj.onc.1208646; Verdel A, 2000, CURR BIOL, V10, P747, DOI 10.1016/S0960-9822(00)00542-X; Wang HJ, 2010, J BIOL CHEM, V285, P36129, DOI 10.1074/jbc.M110.152777; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yoshida N, 2004, CANCER SCI, V95, P496, DOI 10.1111/j.1349-7006.2004.tb03239.x; Zhang Y, 2006, J BIOL CHEM, V281, P2401, DOI 10.1074/jbc.C500241200; Zhang ZH, 2004, CLIN CANCER RES, V10, P6962, DOI 10.1158/1078-0432.CCR-04-0455; Zou H, 2006, BIOCHEM BIOPH RES CO, V341, P45, DOI 10.1016/j.bbrc.2005.12.144	31	53	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10885	10893		10.1074/jbc.M111.308791	http://dx.doi.org/10.1074/jbc.M111.308791			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334690	Green Published, hybrid			2022-12-25	WOS:000302780100017
J	Frange, P; Meyer, L; Deveau, C; Tran, L; Goujard, C; Ghosn, J; Girard, PM; Morlat, P; Rouzioux, C; Chaix, ML				Frange, Pierre; Meyer, Laurence; Deveau, Christiane; Tran, Laurent; Goujard, Cecile; Ghosn, Jade; Girard, Pierre-Marie; Morlat, Philippe; Rouzioux, Christine; Chaix, Marie-Laure		French ANRS CO6 PRIMO Cohort Study	Recent HIV-1 Infection Contributes to the Viral Diffusion over the French Territory with a Recent Increasing Frequency	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DRUG-RESISTANCE; TRANSMISSION EVENTS; HETEROSEXUAL TRANSMISSION; ANTIRETROVIRAL THERAPY; SEXUAL TRANSMISSION; STAGE; MEN; EPIDEMIC; RISK	Objective: To analyse the contribution of primary human immunodeficiency virus type 1 (HIV-1) infection (PHI) to the French viral epidemic. Methods: HIV-1 pol sequences included 987 PHI from the French ANRS PRIMO cohort between 1999 and 2010 and were analysed using a population-based phylogenetic approach. Clinical features, risk factors, sexual behaviour and drug resistance for clustered and nonclustered transmission events were ascertained. Results: Viruses from 125 (12.7%) of PHI cosegregated into 56 transmission chains, with increasing frequency during the last years (10.2% before 2006 versus 15.2% of clusters in 2006-2010, p = 0.02). The mean number of patients per cluster was 2.44. Compared to unique PHI, clusters involved more often men, infected through homosexual intercourse, of young age, with a high number of casual sexual partnerships and frequent previous HIV serological tests. Resistant strains were found in 16.0% and 11.1% of clusters and unique PHI, respectively (p = 0.11). Overall, 34% (n = 19) clusters included patients followed in French regions far apart, involving 13 clusters with at least one Parisian patient. Conclusions: PHIs are a significant source of onward transmission, especially in the MSM population. Recently infected people contribute to the spread of the viral epidemic throughout the French territory. Survey of transmitted drug resistance and behavioural characteristics of patients involved into clustered PHI may help to guide prevention and treatment interventions.	[Frange, Pierre; Ghosn, Jade; Rouzioux, Christine; Chaix, Marie-Laure] Univ Paris 05, Equipe Accueil 3620, Paris, France; [Frange, Pierre] Hop Necker Enfants Malad, AP HP, Unite Immunol Hematol & Rhumatol Pediat, Paris, France; [Meyer, Laurence; Deveau, Christiane; Tran, Laurent; Goujard, Cecile] Univ Paris 11, Hop Bicetre, AP HP,Fac Med Paris Sud, INSERM,U1018,Serv Epidemiol & Sante Publ, Le Kremlin Bicetre, France; [Goujard, Cecile; Ghosn, Jade] Hop Bicetre, AP HP, Serv Med Interne, Le Kremlin Bicetre, France; [Girard, Pierre-Marie] Hop St Antoine, AP HP, Serv Malad Infect & Trop, F-75571 Paris, France; [Morlat, Philippe] Univ Bordeaux Segalen, CHU Bordeaux, Serv Med Interne & Malad Infect, Bordeaux, France; [Rouzioux, Christine; Chaix, Marie-Laure] Hop Necker Enfants Malad, AP HP, Virol Lab, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Frange, P (corresponding author), Univ Paris 05, Equipe Accueil 3620, Paris, France.	pierre.frange@nck.aphp.fr	Frange, Pierre/O-6311-2017		French National Agency for Research on AIDS [ANRS PRIMO CO06]; SIDACTION [BI22-1-01851]	French National Agency for Research on AIDS(ANRS); SIDACTION	This work was supported by grants from the French National Agency for Research on AIDS (no. ANRS PRIMO CO06) and by a scholarship (to PF) from SIDACTION (no. BI22-1-01851). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2008, AIDS, V22, P1055, DOI 10.1097/QAD.0b013e3282f8af84; Bezemer D, 2010, AIDS, V24, P271, DOI 10.1097/QAD.0b013e328333ddee; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Brenner BG, 2011, J INFECT DIS, V204, P1115, DOI 10.1093/infdis/jir468; Brown AE, 2009, J INFECT DIS, V199, P427, DOI 10.1086/596049; Chaix ML, 2003, AIDS, V17, P2635, DOI 10.1097/00002030-200312050-00011; Cohen MS, 2005, J INFECT DIS, V191, P1391, DOI 10.1086/429414; Coutinho FAB, 2001, B MATH BIOL, V63, P1041, DOI 10.1006/bulm.2001.0257; Descamps D, 2005, JAIDS-J ACQ IMM DEF, V38, P545, DOI 10.1097/01.qai.0000155201.51232.2e; Felsenstein J, 1997, SYST BIOL, V46, P101, DOI 10.2307/2413638; Frange P, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-69; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Ghosn J, 2006, AIDS, V20, P159, DOI 10.1097/01.aids.0000199820.47703.a0; Ghosn J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023301; Ghosn J, 2010, J ANTIMICROB CHEMOTH, V65, P741, DOI 10.1093/jac/dkq035; Goujard C, 2006, CLIN INFECT DIS, V42, P709, DOI 10.1086/500213; Hayes RJ, 2006, J INFECT DIS, V193, P604, DOI 10.1086/499606; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Hue S, 2005, AIDS, V19, P449, DOI 10.1097/01.aids.0000161778.15568.a1; Hue S, 2004, AIDS, V18, P719, DOI [10.1097/00002030-200403260-00002, 10.1097/01.aids.0000111455.61782.c3]; JACQUEZ JA, 1994, J ACQ IMMUN DEF SYND, V7, P1169; Koopman JS, 1997, J ACQ IMMUN DEF SYND, V14, P249, DOI 10.1097/00042560-199703010-00009; Kretzschmar M, 1998, MATH BIOSCI, V148, P83, DOI 10.1016/S0025-5564(97)10008-6; Le Vu S, 2010, LANCET INFECT DIS, V10, P682, DOI 10.1016/S1473-3099(10)70167-5; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Leynaert B, 1998, AM J EPIDEMIOL, V148, P88, DOI 10.1093/oxfordjournals.aje.a009564; Lievre L, 2006, AIDS, V20, P2392, DOI 10.1097/QAD.0b013e32801104b0; Michel A. B., 2008, Bulletin Epidemiologique Hebdomadaire, P39; Pao D, 2005, AIDS, V19, P85, DOI 10.1097/00002030-200501030-00010; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Pinkerton SD, 1996, EVALUATION REV, V20, P516, DOI 10.1177/0193841X9602000502; Pinkerton SD, 2007, AIDS BEHAV, V11, P698, DOI 10.1007/s10461-006-9187-2; Pinkerton SD, 2007, AIDS, V21, P1625, DOI 10.1097/QAD.0b013e32826fb6a6; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Recordon-Pinson P, 2009, ANTIVIR THER, V14, P551; Rieder P, 2010, AIDS, V24, P1177, DOI 10.1097/QAD.0b013e328338e4de; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salomon JA, 2008, AIDS, V22, pS149, DOI 10.1097/01.aids.0000327636.82542.87; Sullivan PS, 2009, ANN EPIDEMIOL, V19, P423, DOI 10.1016/j.annepidem.2009.03.004; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Troude P, 2009, AIDS, V23, P1261, DOI 10.1097/QAD.0b013e32832b51ef; van Griensven F, 2009, CURR OPIN HIV AIDS, V4, P300, DOI 10.1097/COH.0b013e32832c3bb3; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Xiridou M, 2004, AIDS, V18, P1311, DOI 10.1097/00002030-200406180-00010; Yerly S, 2004, ANTIVIR THER, V9, P375; Yerly S, 2009, AIDS, V23, P1415, DOI 10.1097/QAD.0b013e32832d40ad	49	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31695	10.1371/journal.pone.0031695	http://dx.doi.org/10.1371/journal.pone.0031695			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348121	Green Submitted, gold, Green Published			2022-12-25	WOS:000302737400043
J	Glaw, F; Kohler, J; Townsend, TM; Vences, M				Glaw, Frank; Koehler, Joern; Townsend, Ted M.; Vences, Miguel			Rivaling the World's Smallest Reptiles: Discovery of Miniaturized and Microendemic New Species of Leaf Chameleons (Brookesia) from Northern Madagascar	PLOS ONE			English	Article							LOWER SIZE LIMIT; BODY-SIZE; NICHE CONSERVATISM; PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGENETICS; EVOLUTION; CHAMAELEONIDAE; FROGS; BIOGEOGRAPHY; PATTERNS	Background: One clade of Malagasy leaf chameleons, the Brookesia minima group, is known to contain species that rank among the smallest amniotes in the world. We report on a previously unrecognized radiation of these miniaturized lizards comprising four new species described herein. Methodology/Principal Findings: The newly discovered species appear to be restricted to single, mostly karstic, localities in extreme northern Madagascar: Brookesia confidens sp. n. from Ankarana, B. desperata sp. n. from Foret d'Ambre, B. micra sp. n. from the islet Nosy Hara, and B. tristis sp. n. from Montagne des Francais. Molecular phylogenetic analyses based on one mitochondrial and two nuclear genes of all nominal species in the B. minima group congruently support that the four new species, together with B. tuberculata from Montagne d'Ambre in northern Madagascar, form a strongly supported clade. This suggests that these species have diversified in geographical proximity in this small area. All species of the B. minima group, including the four newly described ones, are characterized by very deep genetic divergences of 18-32% in the ND2 gene and >6% in the 16S rRNA gene. Despite superficial similarities among all species of this group, their status as separate evolutionary lineages is also supported by moderate to strong differences in external morphology, and by clear differences in hemipenis structure. Conclusion/Significance: The newly discovered dwarf chameleon species represent striking cases of miniaturization and microendemism and suggest the possibility of a range size-body size relationship in Malagasy reptiles. The newly described Brookesia micra reaches a maximum snout-vent length in males of 16 mm, and its total length in both sexes is less than 30 mm, ranking it among the smallest amniote vertebrates in the world. With a distribution limited to a very small islet, this species may represent an extreme case of island dwarfism.	[Koehler, Joern] Hess Landesmuseum Darmstadt, Darmstadt, Germany; [Townsend, Ted M.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Vences, Miguel] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Div Evolutionary Biol, Braunschweig, Germany	California State University System; San Diego State University; Braunschweig University of Technology		m.vences@tu-bs.de		Kohler, Jorn/0000-0002-5250-2542; Vences, Miguel/0000-0003-0747-0817	Volkswagen Foundation; European Association of Zoos and Aquaria; Deutsche Forschungsgemeinschaft [VE247/3-1]	Volkswagen Foundation(Volkswagen); European Association of Zoos and Aquaria; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The field work for this research has been supported by the Volkswagen Foundation and the European Association of Zoos and Aquaria. Lab work received funding by the Deutsche Forschungsgemeinschaft (grant VE247/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, PHYTOPATHOLOGY, DOI DOI 10.1094/PHYTO-04-15-0101-RVW; Blackburn DC, 2008, MOL PHYLOGENET EVOL, V49, P806, DOI 10.1016/j.ympev.2008.08.015; Bloxam Q.M.C, 1987, DODO, V24, P61; Boistel R, 2010, BIOL LETTERS, V6, P740, DOI 10.1098/rsbl.2010.0322; Brygoo E. R, 1969, Bull. Mus. natn. Hist. nat. Paris, V41, P833; Brygoo E.-R., 1978, Faune de Madagascar, V47, P1; Brygoo ER, 1975, B MUS NATN HIST NAT, V267, P1769; Carpenter AI, 2005, ORYX, V39, P375, DOI 10.1017/S0030605305001201; Clarke BT, 1996, SYM ZOOL S, P201; Cuadrado M, 2001, J ZOOL, V255, P425; D'Cruze N, 2007, HERPETOL CONSERV BIO, V2, P87; D'Cruze Neil, 2008, Madagascar Conservation & Development, V3, P44; Dewar RE, 2007, P NATL ACAD SCI USA, V104, P13723, DOI 10.1073/pnas.0704346104; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Estrada AR, 1996, COPEIA, P852, DOI 10.2307/1447647; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Gaston KJ, 1996, TRENDS ECOL EVOL, V11, P197, DOI 10.1016/0169-5347(96)10027-6; Gehring Philip-Sebastian, 2008, Salamandra, V44, P129; Glaw F, 1999, J ZOOL, V247, P225, DOI 10.1111/j.1469-7998.1999.tb00986.x; Glaw F, 2007, FIELD GUIDE AMPHIBIA; Glaw F, 2010, SALAMANDRA, V46, P83; Hanken J, 1998, COPEIA, P312; HANKEN J, 1993, ANNU REV ECOL SYST, V24, P501, DOI 10.1146/annurev.es.24.110193.002441; Hedges SB, 2008, ZOOTAXA, P1; Hedges SB, 2001, CARIBB J SCI, V37, P168; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; KLAVER C, 1986, Bonner Zoologische Monographien, P1; KLAVER C. J. J, 1997, CHAMAELEONIDAE, V112; Kohler J, 2010, J ZOOL, V282, P21, DOI 10.1111/j.1469-7998.2010.00708.x; Kohler J, 2007, TROP ZOOL, V20, P215; Losos JB, 2008, ECOL LETT, V11, P1005, DOI 10.1111/j.1461-0248.2008.01232.x; Macey JR, 2000, SYST BIOL, V49, P233, DOI 10.1093/sysbio/49.2.233; Macey JR, 1997, MOL BIOL EVOL, V14, P91, DOI 10.1093/oxfordjournals.molbev.a025706; Maddison D. R., 2000, MACCLADE 4 ANAL PHYL; Metcalf CJE, 2007, TROP ZOOL, V20, P151; Miller M. A., 2010, CIPRES PORTALS; Mittermeier R.A., 2010, LEMURS MADAGASCAR; Mori A, 2006, PHOTOGRAPHIC GUIDE R; Mori Akira, 2006, Herpetological Natural History, V10, P31; Necas P, 2004, STUMMELSCHWANZCHAMAL; Pearson RG, 2009, EVOLUTION, V63, P959, DOI 10.1111/j.1558-5646.2008.00596.x; Raselimanana A.P., 2008, MALAGASY NATURE, V1, P46; Raselimanana A. P., 2003, NATURAL HIST MADAGAS, P960; Ratsoavina FM, 2010, ZOOTAXA, P62; RAXWORTHY CJ, 1994, BIOL CONSERV, V69, P65, DOI 10.1016/0006-3207(94)90329-8; Raxworthy CJ, 2002, NATURE, V415, P784, DOI 10.1038/415784a; RAXWORTHY CJ, 1995, J ZOOL, V235, P525, DOI 10.1111/j.1469-7998.1995.tb01767.x; RIEPPEL O, 1987, ZOOL J LINN SOC-LOND, V89, P41, DOI 10.1111/j.1096-3642.1987.tb01343.x; Rodriguez A, 2011, BIOL LETTERS, V7, P414, DOI 10.1098/rsbl.2010.0844; Schimmenti G, 1996, ITAL J ZOOL, V63, P193, DOI 10.1080/11250009609356129; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Townsend T, 2002, MOL PHYLOGENET EVOL, V23, P22, DOI 10.1006/mpev.2001.1076; Townsend TM, 2011, BIOL LETTERS, V7, P225, DOI 10.1098/rsbl.2010.0701; Townsend TM, 2009, SYST BIOL, V58, P641, DOI 10.1093/sysbio/syp073; Townsend TM, 2004, SYST BIOL, V53, P735, DOI 10.1080/10635150490522340; Vences M, 2005, PHILOS T R SOC B, V360, P1859, DOI 10.1098/rstb.2005.1717; Vences M, 2004, J ARID ENVIRON, V56, P329, DOI 10.1016/S0140-1963(03)00056-9; Vences Miguel, 2011, Herpetology Notes, V4, P239; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Wilme L, 2006, SCIENCE, V312, P1063, DOI 10.1126/science.1122806; Wollenberg KC, 2008, EVOLUTION, V62, P1890, DOI 10.1111/j.1558-5646.2008.00420.x; Wollenberg KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-217; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yeh J, 2002, EVOLUTION, V56, P628	66	75	77	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31314	10.1371/journal.pone.0031314	http://dx.doi.org/10.1371/journal.pone.0031314			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348069	Green Submitted, Green Published, gold			2022-12-25	WOS:000302737400014
J	Kamdem, C; Fouet, C; Etouna, J; Etoa, FX; Simard, F; Besansky, NJ; Costantini, C				Kamdem, Colince; Fouet, Caroline; Etouna, Joachim; Etoa, Francois-Xavier; Simard, Frederic; Besansky, Nora J.; Costantini, Carlo			Spatially Explicit Analyses of Anopheline Mosquitoes Indoor Resting Density: Implications for Malaria Control	PLOS ONE			English	Article							ENVIRONMENTAL-FACTORS; VECTOR CONTROL; CULICIDAE; DIPTERA; HIGHLANDS; GAMBIAE; AGGREGATION; ABUNDANCE; PATTERNS; CAMEROON	Background: The question of sampling and spatial aggregation of malaria vectors is central to vector control efforts and estimates of transmission. Spatial patterns of anopheline populations are complex because mosquitoes' habitats and behaviors are strongly heterogeneous. Analyses of spatially referenced counts provide a powerful approach to delineate complex distribution patterns, and contributions of these methods in the study and control of malaria vectors must be carefully evaluated. Methodology/Principal Findings: We used correlograms, directional variograms, Local Indicators of Spatial Association (LISA) and the Spatial Analysis by Distance IndicEs (SADIE) to examine spatial patterns of Indoor Resting Densities (IRD) in two dominant malaria vectors sampled with a 565 km grid over a 2500 km(2) area in the forest domain of Cameroon. SADIE analyses revealed that the distribution of Anopheles gambiae was different from regular or random, whereas there was no evidence of spatial pattern in Anopheles funestus (Ia = 1.644, Pa<0.05 and Ia = 1.464, Pa>0.05, respectively). Correlograms and variograms showed significant spatial autocorrelations at small distance lags, and indicated the presence of large clusters of similar values of abundance in An. gambiae while An. funestus was characterized by smaller clusters. The examination of spatial patterns at a finer spatial scale with SADIE and LISA identified several patches of higher than average IRD (hot spots) and clusters of lower than average IRD (cold spots) for the two species. Significant changes occurred in the overall spatial pattern, spatial trends and clusters when IRDs were aggregated at the house level rather than the locality level. All spatial analyses unveiled scale-dependent patterns that could not be identified by traditional aggregation indices. Conclusions/Significance: Our study illustrates the importance of spatial analyses in unraveling the complex spatial patterns of malaria vectors, and highlights the potential contributions of these methods in malaria control.	[Kamdem, Colince; Fouet, Caroline; Simard, Frederic; Costantini, Carlo] IRD, Unite Mixte Rech MIVEGEC UM1 UM2 CNRS IRD 224 529, Montpellier, France; [Kamdem, Colince; Fouet, Caroline; Costantini, Carlo] OCEAC, Lab Rech Paludisme, Yaounde, Cameroon; [Kamdem, Colince; Etoa, Francois-Xavier] Univ Yaounde I, Fac Sci, Yaounde, Cameroon; [Etouna, Joachim] INC, Dept Rech Geog, Yaounde, Cameroon; [Besansky, Nora J.] Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, Notre Dame, IN 46556 USA	Institut de Recherche pour le Developpement (IRD); University of Yaounde I; University of Notre Dame	Kamdem, C (corresponding author), IRD, Unite Mixte Rech MIVEGEC UM1 UM2 CNRS IRD 224 529, Montpellier, France.	kamdem_d@yahoo.com	Frederic, SIMARD/AFV-5001-2022; SIMARD, Frederic/J-9489-2016; Costantini, Carlo/F-3470-2012	Frederic, SIMARD/0000-0002-2871-5329; SIMARD, Frederic/0000-0002-2871-5329; Costantini, Carlo/0000-0003-1016-129X	Institut de Recherche pour le Developpement (IRD); National Institutes of Health [R01-AI063508]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063508] Funding Source: NIH RePORTER	Institut de Recherche pour le Developpement (IRD); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support was provided by the Institut de Recherche pour le Developpement (IRD) and National Institutes of Health grant No R01-AI063508 to NJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselin L, 2006, AM J PREV MED, V30, pS3, DOI 10.1016/j.amepre.2005.09.015; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Anselin L., 2005, SPATIAL REGRESSION A; Antonio-Nkondjio C, 2005, T ROY SOC TROP MED H, V99, P347, DOI 10.1016/j.trstmh.2004.07.003; Antonio-Nkondjio C, 2002, J MED ENTOMOL, V39, P350, DOI 10.1603/0022-2585-39.2.350; Antonio-Nkondjio C, 2006, J MED ENTOMOL, V43, P1215, DOI 10.1603/0022-2585(2006)43[1215:COTMVS]2.0.CO;2; Athanassiou CG, 2010, B ENTOMOL RES, V100, P395, DOI 10.1017/S000748530999037X; Atieli H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-108; Ayala D, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-307; Bivand R, 2010, SPDEP SPATIAL DEPEND; Brower JE, FIELD LAB METHODS GE, P273; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; Cliff A. D., 1969, LONDON PAPERS REGION, V1, P25; Costantini C, 1996, MED VET ENTOMOL, V10, P203, DOI 10.1111/j.1365-2915.1996.tb00733.x; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; Cressie NAC, STAT SPATIAL DATA, P920; de Souza D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009927; Dungan JL, 2002, ECOGRAPHY, V25, P626, DOI 10.1034/j.1600-0587.2002.250510.x; FONDJO E, 1992, B SOC PATHOL EXOT, V85, P57; Fortin M-J, DALE MRT SPATIAL ANA, P380; Fortin MJ, 1999, ECOSCIENCE, V6, P636, DOI 10.1080/11956860.1999.11682547; Gaudart J, 2007, REV EPIDEMIOL SANTE, V55, P297, DOI 10.1016/j.respe.2007.04.003; Gillies MT, ANOPHELINAE AFRICA S, P143; Gillies MT, ANOPHELINAE AFRICA S, P343; Gimnig JE, 2003, AM J TROP MED HYG, V68, P16, DOI 10.4269/ajtmh.2003.68.16; Gimnig JE, 2006, ENV CHANGE MALARIA R, P27; Githeko AK, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-107; Graham AJ, 2004, ACTA TROP, V91, P219, DOI 10.1016/j.actatropica.2004.05.001; Green JL, 2007, ECOL LETT, V10, P1037, DOI 10.1111/j.1461-0248.2007.01101.x; IWAO S, 1972, Researches on Population Ecology (Tokyo), V14, P97, DOI 10.1007/BF02511188; Jacob BG, 2011, ACTA TROP, V117, P61, DOI 10.1016/j.actatropica.2010.10.002; Kelly-Hope LA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-268; Kulkarni MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009396; Legendre P, NUMERICAL ECOLOGY, P853; Li L, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-50; Liebhold A. M., 1998, POPULATION COMMUNITY, P11; Lindblade KA, 2000, J MED ENTOMOL, V37, P664, DOI 10.1603/0022-2585-37.5.664; LLOYD M, 1967, J ANIM ECOL, V36, P1, DOI 10.2307/3012; Magbity EB, 2002, B ENTOMOL RES, V92, P483, DOI 10.1079/BER2002200; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.2307/2332142; Morisita M., 1959, MEM FAC SCI KYUSHU E, V2, P215; Moss WJ, 2011, ACTA TROPIC IN PRESS; National Malaria Control Centre Ministry of Health Zambia, 2007, US GEOGR INF SYST TE; Nelson TA, 2008, ECOGRAPHY, V31, P556, DOI 10.1111/j.0906-7590.2008.05548.x; Perry JN, 1999, ECOL LETT, V2, P106, DOI 10.1046/j.1461-0248.1999.22057.x; Perry JN, 2002, ECOGRAPHY, V25, P578, DOI 10.1034/j.1600-0587.2002.250507.x; PITCAIRN MJ, 1994, J MED ENTOMOL, V31, P545, DOI 10.1093/jmedent/31.4.545; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Protopopoff N, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-158; Queiroz JW, 2010, AM J TROP MED HYG, V82, P306, DOI 10.4269/ajtmh.2010.08-0675; R Development Core Team, 2009, R FDN STAT COMP; Ribeiro JMC, 1996, B WORLD HEALTH ORGAN, V74, P299; Ribeiro P.J, 2001, R NEWS, V1, P14, DOI DOI 10.1159/000323281; Ryan PA, 2004, J MED ENTOMOL, V41, P1143, DOI 10.1603/0022-2585-41.6.1143; Service MW, MOSQUITO ECOLOGY FIE, P988; Sharp BL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-52; Simard Frederic, 2009, BMC Ecology, V9, P17, DOI 10.1186/1472-6785-9-17; SMITH T, 1995, ACTA TROP, V59, P1, DOI 10.1016/0001-706X(94)00082-C; Sugumaran R, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-43; TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0; TAYLOR LR, 1984, ANNU REV ENTOMOL, V29, P321, DOI 10.1146/annurev.en.29.010184.001541; Zhou GF, 2004, J MED ENTOMOL, V41, P1001, DOI 10.1603/0022-2585-41.6.1001; Zhou G, 2007, AM J TROP MED HYG, V77, P29, DOI 10.4269/ajtmh.2007.77.29; Zhou GF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-67; Zillio T, 2010, ECOLOGY, V91, P3698, DOI 10.1890/09-2233.1	65	14	14	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31843	10.1371/journal.pone.0031843	http://dx.doi.org/10.1371/journal.pone.0031843			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348131	Green Published, gold, Green Submitted			2022-12-25	WOS:000302737400051
J	Muniategui, A; Nogales-Cadenas, R; Vazquez, M; Aranguren, XL; Agirre, X; Luttun, A; Prosper, F; Pascual-Montano, A; Rubio, A				Muniategui, Ander; Nogales-Cadenas, Ruben; Vazquez, Miguel; Aranguren, Xabier L.; Agirre, Xabier; Luttun, Aernout; Prosper, Felipe; Pascual-Montano, Alberto; Rubio, Angel			Quantification of miRNA-mRNA Interactions	PLOS ONE			English	Article							WEB-BASED TOOL; EXPRESSION PROFILES; LYMPHOBLASTIC-LEUKEMIA; MICRORNA; TARGETS; DATABASE; IDENTIFICATION; GENECODIS; RESOURCE; GENES	miRNAs are small RNA molecules (' 22nt) that interact with their corresponding target mRNAs inhibiting the translation of the mRNA into proteins and cleaving the target mRNA. This second effect diminishes the overall expression of the target mRNA. Several miRNA-mRNA relationship databases have been deployed, most of them based on sequence complementarities. However, the number of false positives in these databases is large and they do not overlap completely. Recently, it has been proposed to combine expression measurement from both miRNA and mRNA and sequence based predictions to achieve more accurate relationships. In our work, we use LASSO regression with non-positive constraints to integrate both sources of information. LASSO enforces the sparseness of the solution and the non-positive constraints restrict the search of miRNA targets to those with down-regulation effects on the mRNA expression. We named this method TaLasso (miRNA-Target LASSO). We used TaLasso on two public datasets that have paired expression levels of human miRNAs and mRNAs. The top ranked interactions recovered by TaLasso are especially enriched (more than using any other algorithm) in experimentally validated targets. The functions of the genes with mRNA transcripts in the top-ranked interactions are meaningful. This is not the case using other algorithms. TaLasso is available as Matlab or R code. There is also a web-based tool for human miRNAs at http://talasso.cnb.csic.es/.	[Muniategui, Ander; Rubio, Angel] Univ Navarra, Grp Bioinformat CEIT & TECNUN, San Sebastian, Spain; [Nogales-Cadenas, Ruben; Pascual-Montano, Alberto] Natl Ctr Biotechnol CSIC, Madrid, Spain; [Vazquez, Miguel] Spanish Natl Canc Res Ctr CNIO, Struct Biol & Biocomp Programme, Madrid, Spain; [Aranguren, Xabier L.; Luttun, Aernout] Katholieke Univ Leuven, Ctr Mol & Vasc Biol, Louvain, Belgium; [Agirre, Xabier; Prosper, Felipe] Univ Navarra, Fdn Appl Med Res, Univ Navarra Clin, Dept Hematol, E-31080 Pamplona, Spain; [Agirre, Xabier; Prosper, Felipe] Univ Navarra, Fdn Appl Med Res, Univ Navarra Clin, Area Cell Therapy, E-31080 Pamplona, Spain	University of Navarra; Consejo Superior de Investigaciones Cientificas (CSIC); Centro Nacional de Investigaciones Oncologicas (CNIO); KU Leuven; University of Navarra; University of Navarra	Muniategui, A (corresponding author), Univ Navarra, Grp Bioinformat CEIT & TECNUN, San Sebastian, Spain.	arubio@ceit.es	Agirre, Xabier/ABE-4110-2020; Luttun, Aernout/AAZ-6540-2020; Rubio, Angel/Y-8610-2019; Prosper, Felipe/H-6859-2017; Rubio, Angel/O-6348-2014; Rubio, Angel/M-7387-2019; Vazquez, Miguel/I-2593-2015	Luttun, Aernout/0000-0001-7902-9524; Prosper, Felipe/0000-0001-6115-8790; Rubio, Angel/0000-0002-3274-2450; Rubio, Angel/0000-0002-3274-2450; Vazquez, Miguel/0000-0002-5713-1058; Muniategui, Ander/0000-0002-7416-912X; Aranguren, Xabier L./0000-0002-1834-603X	Basque Government (Programas de Formacion y Perfeccionamiento de Personal Investigador); Spanish Government [BIO2010-17527]; Madrid Government [CAM - S2010/BMD-2305]; Juan de la Cierva Spanish Government	Basque Government (Programas de Formacion y Perfeccionamiento de Personal Investigador)(Basque Government); Spanish Government(Spanish GovernmentEuropean Commission); Madrid Government; Juan de la Cierva Spanish Government(Spanish Government)	The work of AM was supported by the Basque Government (Programas de Formacion y Perfeccionamiento de Personal Investigador, http://www.hezkuntza.ejgv.euskadi.net/r43-5552/es/contenidos/informacion/dib4/es_2035/bfi_c.html). AP and RNC were partially supported by Spanish Government Grant BIO2010-17527 and the Madrid Government Grant CAM - S2010/BMD-2305. RNC also acknowledges the support of the Juan de la Cierva Spanish Government Research program. The authors acknowledge support from Integromics, S.L., for their support with their software Integromics Biomaker Discovery (R) and RealTime Statminer (R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Baldus CD, 2007, J CLIN ONCOL, V25, P3739, DOI 10.1200/JCO.2007.11.5253; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Corrada H, 2009, RCPLEX R INTERFACE C; Cover TM, 2006, ELEMENTS INFORM THEO, P776; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fulci V, 2009, GENE CHROMOSOME CANC, V48, P1069, DOI 10.1002/gcc.20709; Gennarino VA, 2009, GENOME RES, V19, P481, DOI 10.1101/gr.084129.108; Goeman JJ, 2010, BIOMETRICAL J, V52, P70, DOI 10.1002/bimj.200900028; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Huang JC, 2007, J COMPUT BIOL, V14, P550, DOI 10.1089/cmb.2007.R002; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Jayaswal V, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-138; Jayaswal V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp153; Kim SJ, 2007, IEEE J-STSP, V1, P606, DOI 10.1109/JSTSP.2007.910971; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li XH, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-44; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu Y, 2011, BIOINFORMATICS; Megraw M, 2007, NUCLEIC ACIDS RES, V35, pD149, DOI 10.1093/nar/gkl904; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Ren B, 2006, ONCOGENE, V25, P1090, DOI 10.1038/sj.onc.1209134; Ruike Y, 2008, J HUM GENET, V53, P515, DOI 10.1007/s10038-008-0279-x; Saito T, 2010, NEW BIOTECHNOL, V27, P243, DOI 10.1016/j.nbt.2010.02.016; Sales G, 2010, NUCLEIC ACIDS RES, V38, pW352, DOI 10.1093/nar/gkq423; Sarver AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-401; Shahi P, 2006, NUCLEIC ACIDS RES, V34, pD115, DOI 10.1093/nar/gkj093; Wang YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-218; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yue D, 2009, CURR GENOMICS, V10, P478, DOI 10.2174/138920209789208219; Zhao HF, 2010, CRIT REV ONCOL HEMAT, V74, P149, DOI 10.1016/j.critrevonc.2009.05.001	39	60	64	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e30766	10.1371/journal.pone.0030766	http://dx.doi.org/10.1371/journal.pone.0030766			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348024	Green Published, Green Submitted, gold			2022-12-25	WOS:000302737400005
J	Pellinen, J; Szentirmai, E				Pellinen, Jacob; Szentirmai, Eva			The Effects of C75, an Inhibitor of Fatty Acid Synthase, on Sleep and Metabolism in Mice	PLOS ONE			English	Article							HORMONE SECRETAGOGUE-RECEPTOR; TUMOR-NECROSIS-FACTOR; BROWN ADIPOSE-TISSUE; FOOD-INTAKE; LITHIUM-CHLORIDE; MESSENGER-RNA; INSULIN SENSITIVITY; GHRELIN SECRETION; MOTOR-ACTIVITY; BODY-WEIGHT	Sleep is greatly affected by changes in metabolic state. A possible mechanism where energy-sensing and sleep-regulatory functions overlap is related to lipid metabolism. Fatty acid synthase (FAS) plays a central role in lipid metabolism as a key enzyme in the formation of long-chain fatty acids. We studied the effects of systemic administration of C75, an inhibitor of FAS, on sleep, behavioral activity and metabolic parameters in mice. Since the effects of C75 on feeding and metabolism are the opposite of ghrelin's and C75 suppresses ghrelin production, we also tested the role of ghrelin signaling in the actions of C75 by using ghrelin receptor knockout (KO) mice. After a transient increase in wakefulness, C75 elicited dose-dependent and long lasting inhibition of REMS, motor activity and feeding. Simultaneously, C75 significantly attenuated slow-wave activity of the electroencephalogram. Energy expenditure, body temperature and respiratory exchange ratio were suppressed. The diurnal rhythm of feeding was completely abolished by C75. There was significant correlation between the anorectic effects, the decrease in motor activity and the diminished energy expenditure after C75 injection. We found no significant difference between wild-type and ghrelin receptor KO mice in their sleep and metabolic responses to C75. The effects of C75 resemble to what was previously reported in association with visceral illness. Our findings suggest that sleep and metabolic effects of C75 in mice are independent of the ghrelin system and may be due to its aversive actions in mice.	[Pellinen, Jacob; Szentirmai, Eva] Washington State Univ, WWAMI Med Educ Program, Spokane, WA USA; [Szentirmai, Eva] Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, Spokane, WA USA; [Szentirmai, Eva] Washington State Univ, Sleep & Performance Res Ctr, Spokane, WA USA	Washington State University; Washington State University; Washington State University	Pellinen, J (corresponding author), Washington State Univ, WWAMI Med Educ Program, Spokane, WA USA.	eszentirmai@wsu.edu	Pellinen, Jacob/ABH-4718-2020	Pellinen, Jacob/0000-0002-0747-7210	Washington State University	Washington State University	This work was supported by a Faculty Seed Grant to Dr. Szentirmai by Washington State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bewick GA, 2009, DIABETES, V58, P840, DOI 10.2337/db08-1428; BORBELY AA, 1977, BRAIN RES, V124, P457, DOI 10.1016/0006-8993(77)90947-7; Clegg DJ, 2002, DIABETES, V51, P3196, DOI 10.2337/diabetes.51.11.3196; DANGUIR J, 1976, PHARMACOL BIOCHEM BE, V5, P547, DOI 10.1016/0091-3057(76)90267-7; DANGUIR J, 1989, AM J PHYSIOL, V256, pR281, DOI 10.1152/ajpregu.1989.256.1.R281; DANGUIR J, 1984, BRAIN RES, V306, P97, DOI 10.1016/0006-8993(84)90359-7; DANGUIR J, 1979, J COMP PHYSIOL PSYCH, V93, P820, DOI 10.1037/h0077616; DANGUIR J, 1979, PHYSIOL BEHAV, V22, P735, DOI 10.1016/0031-9384(79)90240-3; DANGUIR J, 1987, APPETITE, V8, P49, DOI 10.1016/S0195-6663(87)80026-0; DANGUIR J, 1978, PHYSIOL BEHAV, V21, P769, DOI 10.1016/0031-9384(78)90017-3; Esposito M, 2012, EUR J NEUROSCI, V35, P233, DOI 10.1111/j.1460-9568.2011.07946.x; Gao S, 2003, P NATL ACAD SCI USA, V100, P5628, DOI 10.1073/pnas.1031698100; GU Y, 1993, NEUROSCI LETT, V157, P49, DOI 10.1016/0304-3940(93)90640-7; Guan XM, 1997, MOL BRAIN RES, V48, P23, DOI 10.1016/S0169-328X(97)00071-5; Hu ZY, 2005, P NATL ACAD SCI USA, V102, P3972, DOI 10.1073/pnas.0500619102; Jenkins JB, 2006, PHYSIOL BEHAV, V87, P255, DOI 10.1016/j.physbeh.2005.10.010; Jerlhag E, 2008, ADDICT BIOL, V13, P358, DOI 10.1111/j.1369-1600.2008.00125.x; Jones CA, 2008, BEHAV BRAIN RES, V187, P254, DOI 10.1016/j.bbr.2007.09.017; Kageyama H, 2010, NEUROPEPTIDES, V44, P133, DOI 10.1016/j.npep.2009.11.010; KAPAS L, 1992, AM J PHYSIOL, V263, pR703, DOI 10.1152/ajpregu.1992.263.3.R703; KAPAS L, 1988, BRAIN RES, V438, P155, DOI 10.1016/0006-8993(88)91334-0; KAPAS L, 1991, PHYSIOL BEHAV, V50, P1241, DOI 10.1016/0031-9384(91)90589-G; Kim EK, 2002, AM J PHYSIOL-ENDOC M, V283, pE867, DOI 10.1152/ajpendo.00178.2002; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kuhajda FP, 2000, P NATL ACAD SCI USA, V97, P3450, DOI 10.1073/pnas.050582897; Lamprecht R, 1995, NEUROREPORT, V7, P289, DOI 10.1097/00001756-199512290-00069; Laposky AD, 2006, AM J PHYSIOL-REG I, V290, pR894, DOI 10.1152/ajpregu.00304.2005; Lin LG, 2011, AGING CELL, V10, P996, DOI 10.1111/j.1474-9726.2011.00740.x; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; Longo KA, 2008, REGUL PEPTIDES, V150, P55, DOI 10.1016/j.regpep.2008.03.011; Ma XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016391; Mano-Otagiri A, 2009, J ENDOCRINOL, V201, P341, DOI 10.1677/JOE-08-0374; MANSBACH RS, 1983, PHYSIOL BEHAV, V30, P179, DOI 10.1016/0031-9384(83)90002-1; Mansouri A, 2008, AM J PHYSIOL-REG I, V295, pR799, DOI 10.1152/ajpregu.90381.2008; Mitchell V, 2001, J COMP NEUROL, V429, P469, DOI 10.1002/1096-9861(20010115)429:3<469::AID-CNE8>3.0.CO;2-#; NACHMAN M, 1973, PHYSIOL BEHAV, V10, P73, DOI 10.1016/0031-9384(73)90089-9; Pfluger PT, 2008, AM J PHYSIOL-GASTR L, V294, pG610, DOI 10.1152/ajpgi.00321.2007; Rendina AR, 2005, BIOCHEM J, V388, P895, DOI 10.1042/BJ20041963; Rinaman L, 2007, AM J PHYSIOL-REG I, V293, pR1495, DOI 10.1152/ajpregu.00393.2007; Rohrbach KW, 2005, EUR J PHARMACOL, V511, P31, DOI 10.1016/j.ejphar.2005.01.034; Ronnett GV, 2005, PHYSIOL BEHAV, V85, P25, DOI 10.1016/j.physbeh.2005.04.014; SANGIAH S, 1982, LIFE SCI, V31, P763, DOI 10.1016/0024-3205(82)90702-0; Shemyakin A, 2001, AM J PHYSIOL-REG I, V280, pR1420, DOI 10.1152/ajpregu.2001.280.5.R1420; Shimokawa T, 2002, P NATL ACAD SCI USA, V99, P66, DOI 10.1073/pnas.012606199; SHOHAM S, 1987, AM J PHYSIOL, V253, pR142, DOI 10.1152/ajpregu.1987.253.1.R142; Sinton CM, 1999, J SLEEP RES, V8, P197, DOI 10.1046/j.1365-2869.1999.00158.x; Sun YX, 2008, ENDOCRINOLOGY, V149, P843, DOI 10.1210/en.2007-0271; Sun YX, 2004, P NATL ACAD SCI USA, V101, P4679, DOI 10.1073/pnas.0305930101; Szentirmai E, 2006, BRAIN RES, V1088, P131, DOI 10.1016/j.brainres.2006.02.072; Szentirmai E, 2007, AM J PHYSIOL-REG I, V292, pR575, DOI 10.1152/ajpregu.00448.2006; Szentirmai E, 2009, P NATL ACAD SCI USA, V106, P14069, DOI 10.1073/pnas.0903090106; Takahashi KA, 2004, ENDOCRINOLOGY, V145, P184, DOI 10.1210/en.2003-0337; Thupari JN, 2002, P NATL ACAD SCI USA, V99, P9498, DOI 10.1073/pnas.132128899; Tolle V, 2002, ENDOCRINOLOGY, V143, P1353, DOI 10.1210/en.143.4.1353; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; VENKATAKRISHNABHATT H, 1978, BRAIN RES, V152, P97, DOI 10.1016/0006-8993(78)90136-1; Wren AM, 2000, ENDOCRINOLOGY, V141, P4325, DOI 10.1210/en.141.11.4325; Yasuda T, 2003, NEUROSCI LETT, V349, P75, DOI 10.1016/S0304-3940(03)00789-4; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823	59	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e30651	10.1371/journal.pone.0030651	http://dx.doi.org/10.1371/journal.pone.0030651			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348016	gold, Green Submitted, Green Published			2022-12-25	WOS:000302733900010
J	He, Y; Zhou, Z; Hofstetter, WL; Zhou, YB; Hu, WX; Guo, CC; Wang, L; Guo, W; Pataer, A; Correa, AM; Lu, YL; Wang, J; Diao, LX; Byers, LA; Wistuba, II; Roth, JA; Swisher, SG; Heymach, JV; Fang, BL				He, Yong; Zhou, Zhen; Hofstetter, Wayne L.; Zhou, Yanbin; Hu, Wenxian; Guo, Chengcheng; Wang, Li; Guo, Wei; Pataer, Apar; Correa, Arlene M.; Lu, Yiling; Wang, Jing; Diao, Lixia; Byers, Lauren Averett; Wistuba, Ignacio I.; Roth, Jack A.; Swisher, Stephen G.; Heymach, John V.; Fang, Bingliang			Aberrant Expression of Proteins Involved in Signal Transduction and DNA Repair Pathways in Lung Cancer and Their Association with Clinical Parameters	PLOS ONE			English	Article							BREAST-CANCER; KINASE INHIBITORS; MESSENGER-RNA; ACTIVATION; MICROARRAYS; STAT5; CDNA; PROGNOSIS; DAMAGE; GENES	Background: Because cell signaling and cell metabolic pathways are executed through proteins, protein signatures in primary tumors are useful for identifying key nodes in signaling networks whose alteration is associated with malignancy and/or clinical outcomes. This study aimed to determine protein signatures in primary lung cancer tissues. Methodology/Principal Findings: We analyzed 126 proteins and/or protein phosphorylation sites in case-matched normal and tumor samples from 101 lung cancer patients with reverse-phase protein array (RPPA) assay. The results showed that 18 molecules were significantly different (p<0.05) by at least 30% between normal and tumor tissues. Most of those molecules play roles in cell proliferation, DNA repair, signal transduction and lipid metabolism, or function as cell surface/matrix proteins. We also validated RPPA results by Western blot and/or immunohistochemical analyses for some of those molecules. Statistical analyses showed that Ku80 levels were significantly higher in tumors of nonsmokers than in those of smokers. Cyclin B1 levels were significantly overexpressed in poorly differentiated tumors while Cox2 levels were significantly overexpressed in neuroendocrinal tumors. A high level of Stat5 is associated with favorable survival outcome for patients treated with surgery. Conclusions/Significance: Our results revealed that some molecules involved in DNA damage/repair, signal transductions, lipid metabolism, and cell proliferation were drastically aberrant in lung cancer tissues, and Stat5 may serve a molecular marker for prognosis of lung cancers.	[He, Yong] Third Mil Med Univ, Daping Hosp, Dept Thorac Surg, Chongqing, Peoples R China; [Zhou, Zhen] Shanghai Jiao Tong Univ, Shanghai Chest Hosp Affiliated, Shanghai Lung Tumor Clin, Med Ctr, Shanghai 200030, Peoples R China; [He, Yong; Zhou, Zhen; Hofstetter, Wayne L.; Zhou, Yanbin; Hu, Wenxian; Guo, Chengcheng; Wang, Li; Guo, Wei; Pataer, Apar; Correa, Arlene M.; Roth, Jack A.; Swisher, Stephen G.; Fang, Bingliang] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA; [Lu, Yiling] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Wang, Jing; Diao, Lixia] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Byers, Lauren Averett; Heymach, John V.] Univ Texas MD Anderson Canc Ctr, Dept Thorac, Houston, TX 77030 USA; [Byers, Lauren Averett; Heymach, John V.] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Med Oncol, Houston, TX 77030 USA; [Wistuba, Ignacio I.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	Army Medical University; Shanghai Jiao Tong University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	He, Y (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Thorac Surg, Chongqing, Peoples R China.	jheymach@mdanderson.org; bfang@mdanderson.org	Heymach, John/AAG-2361-2019	Heymach, John/0000-0001-9068-8942	National Cancer Institute [R01CA-092487, RO1CA-124951]; National Institutes of Health [3P30CA-016672-32S3]; University of Texas MD Anderson Cancer Center [CA-016672]; Homer Flower Gene Therapy Research Fund; Charles Rogers Gene Therapy Fund; Flora and Stuart Mason Lung Cancer Research Fund; Charles B. Swank Memorial Fund for Esophageal Cancer Research; Phalan Thoracic Gene Therapy Fund; Chapman Foundation; National Natural Science Foundation of China [81172113, 81071912]; Third Military Medical University of China; George O. Sweeney Fund for Esophageal Cancer Research; NATIONAL CANCER INSTITUTE [R01CA124951, P30CA016672, P50CA070907, R01CA092487] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas MD Anderson Cancer Center; Homer Flower Gene Therapy Research Fund; Charles Rogers Gene Therapy Fund; Flora and Stuart Mason Lung Cancer Research Fund; Charles B. Swank Memorial Fund for Esophageal Cancer Research; Phalan Thoracic Gene Therapy Fund; Chapman Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Third Military Medical University of China; George O. Sweeney Fund for Esophageal Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by National Cancer Institute grants: R01CA-092487 (awarded to BF), RO1CA-124951 (awarded to BF), National Institutes of Health Core Grant 3P30CA-016672-32S3, The University of Texas MD Anderson Cancer Center Support Grant CA-016672 - Lung Program and Functional Proteomics Reverse-Phase Protein Array Core facility, the Homer Flower Gene Therapy Research Fund, the Charles Rogers Gene Therapy Fund, the Flora and Stuart Mason Lung Cancer Research Fund, the Charles B. Swank Memorial Fund for Esophageal Cancer Research, the George O. Sweeney Fund for Esophageal Cancer Research, the Phalan Thoracic Gene Therapy Fund, and the M. W. Elkins Endowed Fund for Thoracic Surgical Oncology, Chapman Foundation, the National Natural Science Foundation of China (81172113, 81071912) and "1510 project'' of Third Military Medical University of China (awarded to YH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatschek S, 2004, CANCER RES, V64, P844, DOI 10.1158/0008-5472.CAN-03-2361; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bolderson E, 2009, CLIN CANCER RES, V15, P6314, DOI 10.1158/1078-0432.CCR-09-0096; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Fan T, 2007, CANCER RES, V67, P7901, DOI 10.1158/0008-5472.CAN-07-0090; Greenberg AK, 2002, AM J RESP CELL MOL, V26, P558, DOI 10.1165/ajrcmb.26.5.4689; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hida T, 1998, CANCER RES, V58, P3761; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hsiao JR, 2003, BRIT J CANCER, V89, P344, DOI 10.1038/sj.bjc.6601003; Hu J, 2007, BIOINFORMATICS, V23, P1986, DOI 10.1093/bioinformatics/btm283; Hu Jianhua, 2005, Briefings in Functional Genomics & Proteomics, V3, P322, DOI 10.1093/bfgp/3.4.322; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Janne PA, 2009, NAT REV DRUG DISCOV, V8, P709, DOI 10.1038/nrd2871; Jiang H, 2009, GENE DEV, V23, P1895, DOI 10.1101/gad.1815309; Khuri FR, 2001, CLIN CANCER RES, V7, P861; Lim JW, 2002, J BIOL CHEM, V277, P46093, DOI 10.1074/jbc.M206603200; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Migita T, 2010, AM J PATHOL, V176, P1756, DOI 10.2353/ajpath.2010.090500; Moeller BJ, 2011, CLIN CANCER RES, V17, P2035, DOI 10.1158/1078-0432.CCR-10-2641; Nanjundan M, 2010, J THORAC ONCOL, V5, P1894, DOI 10.1097/JTO.0b013e3181f2a266; Nevalainen MT, 2004, J CLIN ONCOL, V22, P2053, DOI 10.1200/JCO.2004.11.046; Nishizuka S, 2003, P NATL ACAD SCI USA, V100, P14229, DOI 10.1073/pnas.2331323100; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Parrella P, 2006, J CLIN PATHOL, V59, P1181, DOI 10.1136/jcp.2005.031088; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; Sanchez-Ceja SG, 2006, LUNG CANCER, V54, P163, DOI 10.1016/j.lungcan.2006.07.012; Soria JC, 2000, CANCER RES, V60, P4000; Sultan AS, 2005, ONCOGENE, V24, P746, DOI 10.1038/sj.onc.1208203; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wei XL, 2009, J BIOL CHEM, V284, P16948, DOI 10.1074/jbc.M109.010256; Wikman H, 2002, ONCOGENE, V21, P5804, DOI 10.1038/sj.onc.1205726; Wikman H, 2004, J PATHOL, V203, P584, DOI 10.1002/path.1552; Xing JL, 2008, CANCER-AM CANCER SOC, V112, P2756, DOI 10.1002/cncr.23533; Yamashita H, 2006, ENDOCR-RELAT CANCER, V13, P885, DOI 10.1677/erc.1.01095; Yanagisawa K, 2007, JNCI-J NATL CANCER I, V99, P858, DOI 10.1093/jnci/djk197; Zhang PL, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-14	38	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e31087	10.1371/journal.pone.0031087	http://dx.doi.org/10.1371/journal.pone.0031087			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348039	gold, Green Published, Green Submitted			2022-12-25	WOS:000302730900019
J	Kahn, JG; Muraguri, N; Harris, B; Lugada, E; Clasen, T; Grabowsky, M; Mermin, J; Shariff, S				Kahn, James G.; Muraguri, Nicholas; Harris, Brian; Lugada, Eric; Clasen, Thomas; Grabowsky, Mark; Mermin, Jonathan; Shariff, Shahnaaz			Integrated HIV Testing, Malaria, and Diarrhea Prevention Campaign in Kenya: Modeled Health Impact and Cost-Effectiveness	PLOS ONE			English	Article							INSECTICIDE-TREATED BEDNETS; RESOURCE-LIMITED SETTINGS; RURAL WESTERN KENYA; SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; DEVELOPING-COUNTRIES; COTRIMOXAZOLE PROPHYLAXIS; SOUTH-AFRICA; UGANDA; STRATEGIES	Background: Efficiently delivered interventions to reduce HIV, malaria, and diarrhea are essential to accelerating global health efforts. A 2008 community integrated prevention campaign in Western Province, Kenya, reached 47,000 individuals over 7 days, providing HIV testing and counseling, water filters, insecticide-treated bed nets, condoms, and for HIV-infected individuals cotrimoxazole prophylaxis and referral for ongoing care. We modeled the potential cost-effectiveness of a scaled-up integrated prevention campaign. Methods: We estimated averted deaths and disability-adjusted life years (DALYs) based on published data on baseline mortality and morbidity and on the protective effect of interventions, including antiretroviral therapy. We incorporate a previously estimated scaled-up campaign cost. We used published costs of medical care to estimate savings from averted illness (for all three diseases) and the added costs of initiating treatment earlier in the course of HIV disease. Results: Per 1000 participants, projected reductions in cases of diarrhea, malaria, and HIV infection avert an estimated 16.3 deaths, 359 DALYs and $85,113 in medical care costs. Earlier care for HIV-infected persons adds an estimated 82 DALYs averted (to a total of 442), at a cost of $37,097 (reducing total averted costs to $48,015). Accounting for the estimated campaign cost of $32,000, the campaign saves an estimated $16,015 per 1000 participants. In multivariate sensitivity analyses, 83% of simulations result in net savings, and 93% in a cost per DALY averted of less than $20. Discussion: A mass, rapidly implemented campaign for HIV testing, safe water, and malaria control appears economically attractive.	[Kahn, James G.; Harris, Brian] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Muraguri, Nicholas; Shariff, Shahnaaz] Govt Kenya, Minist Publ Hlth & Sanitat, Nairobi, Kenya; [Lugada, Eric] CHF Int, Nairobi, Kenya; [Clasen, Thomas] London Sch Hyg & Trop Med, London WC1, England; [Grabowsky, Mark] ESP UN Fdn, Washington, DC USA; [Mermin, Jonathan] Ctr Dis Control & Prevent Kenya, Coordinating Off Global Hlth, CDC, Nairobi, Kenya	University of California System; University of California San Francisco; University of London; London School of Hygiene & Tropical Medicine	Kahn, JG (corresponding author), Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA.	jgkahn@ucsf.edu	Mermin, Jonathan/J-9847-2012		Vestergaard Frandsen; U.S. National Institute for Drug Abuse [R01 DA15612]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, R37DA015612] Funding Source: NIH RePORTER	Vestergaard Frandsen; U.S. National Institute for Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by Vestergaard Frandsen and by the U.S. National Institute for Drug Abuse, under R01 DA15612. Neither funder exerted any editorial control. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; [Anonymous], 2004, COCHRANE DB SYST REV; [Anonymous], COST EFF RESOUR ALLO, DOI DOI 10.1186/1478-7547-7-3; Bendavid E, 2008, ARCH INTERN MED, V168, P1910, DOI 10.1001/archinternmed.2008.1; Clasen T, 2007, J WATER HEALTH, V5, P599, DOI 10.2166/wh.2007.010; Clasen T, 2009, AM J TROP MED HYG, V80, P819, DOI 10.4269/ajtmh.2009.80.819; CRAIG M., 2003, 11 FOG INT CTR NIH; Crump JA, 2005, BMJ-BRIT MED J, V331, P478, DOI 10.1136/bmj.38512.618681.E0; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Forsythe S, 2002, HEALTH POLICY PLANN, V17, P187, DOI 10.1093/heapol/17.2.187; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Grabowsky M, 2005, B WORLD HEALTH ORGAN, V83, P195; Grabowsky M, 2007, TROP MED INT HEALTH, V12, P815, DOI 10.1111/j.1365-3156.2007.01862.x; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hausler HP, 2006, B WORLD HEALTH ORGAN, V84, P528, DOI 10.2471/BLT.04.018606; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Kahn J, 2010, BMC HLTH SE IN PRESS; Kahn JG, 2006, PLOS MED, V3, P2349, DOI 10.1371/journal.pmed.0030517; Kahn JG, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6884; Kilian A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-49; Laxminarayan R, 2006, LANCET, V367, P1193, DOI 10.1016/S0140-6736(06)68440-7; Lever D, 2011, ACUTE DIARRHEA DIS M; Lopez AD, 2006, DIS CONTROL PRIORITI; Lubell Y, 2011, B WORLD HEALTH ORGAN, V89, P504, DOI 10.2471/BLT.11.085878; Lugada E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012435; Marseille E, 2009, APPL HEALTH ECON HEA, V7, P229, DOI 10.2165/11318740-000000000-00000; Masanja H, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-142; McConnel CE, 2005, SAMJ S AFR MED J, V95, P968; Menzies N, 2009, AIDS, V23, P395, DOI 10.1097/QAD.0b013e328321e40b; Mermin J, 2006, LANCET, V367, P1256, DOI 10.1016/S0140-6736(06)68541-3; Mermin J, 2006, JAIDS-J ACQ IMM DEF, V41, P129, DOI 10.1097/01.qai.0000179427.11789.a7; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; Morel CM, 2005, BMJ-BRIT MED J, V331, P1299, DOI 10.1136/bmj.38639.702384.AE; Mueller DH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-73; Mulligan JA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-32; National AIDS/STD Control Programme (NASCOP) MoHGoK, 2009, 2007 KEN AIDS IND SU; Shillcutt S, 2008, B WORLD HEALTH ORGAN, V86, P101, DOI 10.2471/BLT.07.042259; Shrestha RK, 2006, AM J TROP MED HYG, V74, P884, DOI 10.4269/ajtmh.2006.74.884; Smith DL, 2011, SCIENCE, V332, P1384, DOI 10.1126/science.1201398; Sweat M, 2000, LANCET, V356, P113, DOI 10.1016/S0140-6736(00)02447-8; Tate JE, 2009, J INFECT DIS, V200, pS76, DOI 10.1086/605058; van Eijk AM, 2008, TROP MED INT HEALTH, V13, P1314, DOI 10.1111/j.1365-3156.2008.02136.x; Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138; WHO, 2009, WHO REP GLOB TUB CON; Williams BG, 2010, P NATL ACAD SCI USA, V107, P19485, DOI 10.1073/pnas.1005660107; Yukich JO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-258	47	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31316	10.1371/journal.pone.0031316	http://dx.doi.org/10.1371/journal.pone.0031316			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347462	Green Published, gold, Green Submitted			2022-12-25	WOS:000302730100060
J	Zaman, MS; Shahryari, V; Deng, GR; Thamminana, S; Saini, S; Majid, S; Chang, I; Hirata, H; Ueno, K; Yamamura, S; Singh, K; Tanaka, Y; Tabatabai, ZL; Dahiya, R				Zaman, Mohd Saif; Shahryari, Varahram; Deng, Guoren; Thamminana, Sobha; Saini, Sharonjot; Majid, Shahana; Chang, Inik; Hirata, Hiroshi; Ueno, Koji; Yamamura, Soichiro; Singh, Kamaldeep; Tanaka, Yuichiro; Tabatabai, Z. Laura; Dahiya, Rajvir			Up-Regulation of MicroRNA-21 Correlates with Lower Kidney Cancer Survival	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; GENE-EXPRESSION; P21(WAF1/CIP1/SDI1); APOPTOSIS; BREAST; P21; CDK; TRANSCRIPTION; INHIBITION; SENESCENCE	Background: MicroRNA-21 is up-regulated in a variety of cancers like, breast, colorectal, lung, head and neck etc. However, the regulation of miR-21 in renal cell carcinoma (RCC) has not yet been studied systematically. Methods and Results: We measured miR-21 levels in 54 pairs of kidney cancers and their normal matched tissues by real-time PCR. The expression level of miR-21 was correlated with 5 year survival and the pathological stage. Functional studies were done after inhibiting miR-21 in RCC cell lines. We studied in vitro and in vivo effects of the chemo preventive agent genistein on miR-21 expression. In 48 cases (90%), miR-21 was increased. All patients with low miR-21 expression survived 5 years, while with high miR-21 expression, only 50% survived. Higher expression of miR-21 is associated with an increase in the stage of renal cancer. Functional studies after inhibiting miRNA-21 in RCC cell lines show cell cycle arrest, induction of apoptosis and reduced invasive and migratory capabilities. Western blot analysis showed an increase in the expression of p21 and p38 MAP kinase genes and a reduction in cyclin E2. Genistein inhibited the expression of miR-21 in A-498 cells and in the tumors formed after injecting genistein treated A-498 cells in nude mice besides inhibiting tumor formation. Conclusions: The current study shows a clear correlation between miR-21 expression and clinical characteristics of renal cancer. Thus we believe that miR-21 can be used as a tumor marker and its inhibition may prove to be useful in controlling cancers with up-regulated miR-21.	[Zaman, Mohd Saif] San Francisco VA Med Ctr, Dept Urol, San Francisco, CA 94121 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Zaman, MS (corresponding author), San Francisco VA Med Ctr, Dept Urol, San Francisco, CA 94121 USA.	rdahiya@urology.ucsf.edu			Veterans Association; National Institutes of Health [RO1CA130860]; NATIONAL CANCER INSTITUTE [R01CA130860] Funding Source: NIH RePORTER	Veterans Association; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Veterans Association Merit Review, Veterans Association Research Enhancement Award Program and National Institutes of Health Grant RO1CA130860 (to the principal investigator, Dr. R. Dahiya). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Avery AK, 2000, AM J SURG PATHOL, V24, P203, DOI 10.1097/00000478-200002000-00006; Bektic Jasmin, 2005, Clin Prostate Cancer, V4, P124, DOI 10.3816/CGC.2005.n.021; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291; CHEN JJ, 1995, NATURE, V374, P386, DOI 10.1038/374386a0; Chow G K, 2001, Can J Urol, V8, P1223; Coqueret O, 2000, J BIOL CHEM, V275, P18794, DOI 10.1074/jbc.M001601200; Day JK, 2002, J NUTR, V132, p2419S, DOI 10.1093/jn/132.8.2419S; Delavaine L, 1999, ONCOGENE, V18, P5381, DOI 10.1038/sj.onc.1202923; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Gartel AL, 2005, LEUKEMIA RES, V29, P1237, DOI 10.1016/j.leukres.2005.04.023; Gottifredi V, 2001, MOL CELL BIOL, V21, P1066, DOI 10.1128/MCB.21.4.1066-1076.2001; Hillman GG, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-4; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jayson M, 1998, UROLOGY, V51, P203, DOI 10.1016/S0090-4295(97)00506-2; Juan D, 2010, UROLOGY, V75, P835, DOI 10.1016/j.urology.2009.10.033; Kaneuchi M, 1999, MOL CARCINOGEN, V26, P44, DOI 10.1002/(SICI)1098-2744(199909)26:1<44::AID-MC6>3.3.CO;2-V; Kitaura H, 2000, J BIOL CHEM, V275, P10477, DOI 10.1074/jbc.275.14.10477; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; Lohr K, 2003, J BIOL CHEM, V278, P32507, DOI 10.1074/jbc.M212517200; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; LUO Y, 1995, NATURE, V375, P159, DOI 10.1038/375159a0; Magee PJ, 2004, BRIT J NUTR, V91, P513, DOI 10.1079/BJN20031075; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Nakada C, 2008, J PATHOL, V216, P418, DOI 10.1002/path.2437; Okaichi K, 1999, INT J RADIAT ONCOL, V45, P975, DOI 10.1016/S0360-3016(99)00285-0; Petillo D, 2009, INT J ONCOL, V35, P109, DOI 10.3892/ijo_00000318; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Roninson IB, 2002, CANCER LETT, V179, P1, DOI 10.1016/S0304-3835(01)00847-3; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; THOENES W, 1986, PATHOL RES PRACT, V181, P125, DOI 10.1016/S0344-0338(86)80001-2; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zava DT, 1997, NUTR CANCER, V27, P31, DOI 10.1080/01635589709514498; Zhang AM, 2011, UROLOGY, V78, DOI 10.1016/j.urology.2011.03.030	44	97	104	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31060	10.1371/journal.pone.0031060	http://dx.doi.org/10.1371/journal.pone.0031060			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347428	Green Submitted, Green Published, gold			2022-12-25	WOS:000302730100036
J	Liu, FF; Guo, FC; Zhou, Y; He, ZH; Tian, XY; Guo, CH; Ning, T; Pan, YQ; Cai, H; Ke, Y				Liu, Fangfang; Guo, Fangcen; Zhou, Yue; He, Zhonghu; Tian, Xiuyun; Guo, Chuanhai; Ning, Tao; Pan, Yaqi; Cai, Hong; Ke, Yang			The Anyang Esophageal Cancer Cohort Study: Study Design, Implementation of Fieldwork, and Use of Computer-Aided Survey System	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; RISK-FACTORS; GASTRIC CANCERS; CHINA; POPULATION; HPV; PARTICIPATION; CHALLENGES; INFECTION	Background: Human papillomavirus (HPV) has been observed repeatedly in esophageal squamous cell carcinoma (ESCC) tissues. However, the causal relationship between HPV infection and the onset of ESCC remains unknown. A large cohort study focusing on this topic is being carried out in rural Anyang, China. Methodology/Principal Findings: The Anyang Esophageal Cancer Cohort Study (AECCS) is a population-based prospective endoscopic cohort study designed to investigate the association of HPV infection and ESCC. This paper provides information regarding the design and implementation of this study. In particular we describe the recruitment strategies and quality control procedures which have been put into place, and the custom designed computer-aided survey system (CASS) used for this project. This system integrates barcode technology and unique identification numbers, and has been developed to facilitate real-time data management throughout the workflow using a wireless local area network. A total of 8,112 (75.3%) of invited subjects participated in the baseline endoscopic examination; of those invited two years later to take part in the first cycle of follow-up, 91.9% have complied. Conclusions/Significance: The AECCS study has high potential for evaluating the causal relationship between HPV infection and the occurrence of ESCC. The experience in setting up the AECCS may be beneficial for others planning to initiate similar epidemiological studies in developing countries.	[Liu, Fangfang; Guo, Fangcen; Zhou, Yue; He, Zhonghu; Tian, Xiuyun; Guo, Chuanhai; Ning, Tao; Pan, Yaqi; Cai, Hong; Ke, Yang] Peking Univ, Key Lab Carcinogenesis & Translat Res, Minist Educ, Sch Oncol,Beijing Canc Hosp & Inst, Beijing 100871, Peoples R China; [Zhou, Yue] Natl Res Inst Family Planning, Beijing, Peoples R China	Peking University; National Research Institute for Family Planning - China	Liu, FF (corresponding author), Peking Univ, Key Lab Carcinogenesis & Translat Res, Minist Educ, Sch Oncol,Beijing Canc Hosp & Inst, Beijing 100871, Peoples R China.	drhcai@gmail.com; keyang@bjmu.edu.cn			Natural Science Foundation of China [30872937, 30930102]; National Ministry of Science and Technology [2011CB504301, 2006AA2Z467]; National Ministry of Health [200902002]; Natural Science Foundation of Beijing [7100001]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Ministry of Science and Technology; National Ministry of Health; Natural Science Foundation of Beijing(Beijing Natural Science Foundation)	This work was supported by Natural Science Foundation of China 30872937 and 30930102, "973'' Project of National Ministry of Science and Technology Grant 2011CB504301,"863'' Key Projects of National Ministry of Science and Technology Grant 2006AA2Z467, Charity Project of National Ministry of Health 200902002, Natural Science Foundation of Beijing 7100001 to Dr. Ke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviles W, 2007, PLOS MED, V4, P1578, DOI 10.1371/journal.pmed.0040291; BENAMOUZIG R, 1992, INT J CANCER, V50, P549, DOI 10.1002/ijc.2910500409; BENAMOUZIG R, 1995, GASTROENTEROLOGY, V109, P1876, DOI 10.1016/0016-5085(95)90754-8; Blot W J, 1985, Natl Cancer Inst Monogr, V69, P29; Chang FJ, 2000, ANTICANCER RES, V20, P3935; Chen Z, 2008, 3 NATL SURVEY CAUSES; Farhadi M, 2005, WORLD J GASTROENTERO, V11, P1200, DOI 10.3748/wjg.v11.i8.1200; Fujita S, 2004, CLIN CANCER RES, V10, P6551, DOI 10.1158/1078-0432.CCR-04-0819; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; He Z, 2010, J HOSP INFECT, V76, P336, DOI 10.1016/j.jhin.2010.06.005; He Z, 2010, BRIT J CANCER, V103, P1085, DOI 10.1038/sj.bjc.6605843; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Koepsell TD, 2003, COHORT STUDIES EPIDE, P365; Li T, 2001, CARCINOGENESIS, V22, P929, DOI 10.1093/carcin/22.6.929; Locker D, 2000, J PUBLIC HEALTH DENT, V60, P72, DOI 10.1111/j.1752-7325.2000.tb03298.x; Mark SD, 2000, J NATL CANCER I, V92, P1753, DOI 10.1093/jnci/92.21.1753; Marshall W W, 2000, JAMA, V284, P1843, DOI 10.1001/jama.284.14.1843; O'Brien RL, 2006, J NATL MED ASSOC, V98, P674; Pourshams A, 2010, INT J EPIDEMIOL, V39, P52, DOI 10.1093/ije/dyp161; Qiao YL, 2009, JNCI-J NATL CANCER I, V101, P507, DOI 10.1093/jnci/djp037; Roberts RJ, 2000, STAT MED, V19, P1645; Schiffman Mark, 2003, J Natl Cancer Inst Monogr, P14; Shen ZY, 2002, J MED VIROL, V68, P412, DOI 10.1002/jmv.10219; Shojania K G, 2001, Evid Rep Technol Assess (Summ), pi; Slattery ML, 2007, AM J EPIDEMIOL, V166, P606, DOI 10.1093/aje/kwm109; SYRJANEN K, 1982, DIAGN HISTOPATHOL, V5, P291; Tran GD, 2005, INT J CANCER, V113, P456, DOI 10.1002/ijc.20616; Umar SB, 2008, NAT CLIN PRACT GASTR, V5, P517, DOI 10.1038/ncpgasthep1223; van Loggerenberg F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001954; Wang XQ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-19; Wei WQ, 2005, GUT, V54, P759, DOI 10.1136/gut.2004.062331; White E, 1998, EPIDEMIOL REV, V20, P43, DOI 10.1093/oxfordjournals.epirev.a017971; Zhao DH, 2011, CHINESE MED J-PEKING, V124, P2328, DOI 10.3760/cma.j.issn.0366-6999.2011.15.015	33	30	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e31602	10.1371/journal.pone.0031602	http://dx.doi.org/10.1371/journal.pone.0031602			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328939	Green Published, Green Submitted, gold			2022-12-25	WOS:000302179300025
J	Bensimon, J; Altmeyer-Morel, S; Benjelloun, H; Chevillard, S; Lebeau, J				Bensimon, J.; Altmeyer-Morel, S.; Benjelloun, H.; Chevillard, S.; Lebeau, J.			CD24(-/low) stem-like breast cancer marker defines the radiation-resistant cells involved in memorization and transmission of radiation-induced genomic instability	ONCOGENE			English	Article						radiation effects; breast cancer stem cells; genomic instability	IONIZING-RADIATION; CD24 EXPRESSION; INITIATING CELLS; GROWTH ARREST; DNA-DAMAGE; TUMOR CELL; METASTASIS; DEATH; PROPAGATION; MECHANISMS	A growing body of evidence attributes properties of chemo- and/or radiation-resistance to cancer stem cells (CSCs). Moreover, non-targeted delayed effects such as genomic instability, transmitted through many generations, can be observed in the progeny of surviving irradiated cells. As a consequence, we propose that radiation-resistance properties associated to CSCs could confer a key role to this subpopulation in the transmission of genomic instability. To test this hypothesis, we searched the CSC markers associated to radiation-resistance in breast cancer cell lines and studied the role of the resistant cells in the transmission of genomic instability. First, we show that irradiation induces a 2-4 weeks period of intense cell death leading to the emergence of chromosomal unstable cells during more than 35 population doublings. Then, among seven breast CSC markers, we identify CD24(-/low) labelling as a marker of radiation-resistance. We demonstrate that CD24(+) progeny of irradiated cells exclusively descends from CD24(-/low) cells. Finally, we show that delayed chromosomal instability is only expressed by CD24(+) cells, but is transmitted by stable surviving CD24(-/low) cells. So, for the first time a CSC marker, CD24, is associated with the transmission of genomic instability. This work may assign a new deleterious role to breast CSCs in aggressive recurrence after radiotherapy, as the transmitted genomic instability potentially leads tumour cells to acquire more aggressive characteristics. Oncogene (2013) 32, 251-258; doi:10.1038/onc.2012.31; published online 13 February 2012	[Bensimon, J.; Altmeyer-Morel, S.; Chevillard, S.; Lebeau, J.] CEA, DSV, iRCM, SREIT,LCE, F-92265 Fontenay Aux Roses, France; [Benjelloun, H.] CEA, DSV, iRCM, SCSR, F-92265 Fontenay Aux Roses, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Lebeau, J (corresponding author), CEA, DSV, iRCM, SREIT,LCE, F-92265 Fontenay Aux Roses, France.	jerome.lebeau@cea.fr		Etzol, Julie/0000-0002-5572-6197; Chevillard, Sylvie/0000-0001-5889-4041	Electricite de France (EDF); MELODI Network; DoReMi Network	Electricite de France (EDF)(Electricite de France (EDF)); MELODI Network; DoReMi Network	We thank Dr P-H. Romeo for constructive criticism on this manuscript. We also thank Drs J Baijer, D Lewandowski and P Fouchet for flow cytometry technical assistance and advices. This work was supported by grants from Electricite de France (EDF) and from MELODI and DoReMi Networks.	Abraham BK, 2005, CLIN CANCER RES, V11, P1154; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Aypar U, 2011, INT J RADIAT BIOL, V87, P179, DOI 10.3109/09553002.2010.522686; Aypar U, 2011, MUTAT RES-FUND MOL M, V707, P24, DOI 10.1016/j.mrfmmm.2010.12.003; Baumann P, 2005, CANCER RES, V65, P10783, DOI 10.1158/0008-5472.CAN-05-0619; Bircan S, 2006, PATHOL RES PRACT, V202, P569, DOI 10.1016/j.prp.2006.05.004; Bloushtain-Qimron N, 2008, P NATL ACAD SCI USA, V105, P14076, DOI 10.1073/pnas.0805206105; Debeb BG, 2009, J MAMMARY GLAND BIOL, V14, P11, DOI 10.1007/s10911-009-9114-z; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Gewirtz DA, 2000, BREAST CANCER RES TR, V62, P223, DOI 10.1023/A:1006414422919; Gewirtz DA, 2000, CELL BIOCHEM BIOPHYS, V33, P19, DOI 10.1385/CBB:33:1:19; Giatromanolaki A, 2011, MED ONCOL, V28, P745, DOI 10.1007/s12032-010-9530-3; Hernandez-Vargas H, 2011, EPIGENETICS-US, V6, P429, DOI 10.4161/epi.6.4.14515; Hwang-Verslues WW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008377; Kai K, 2010, BREAST CANCER-TOKYO, V17, P80, DOI 10.1007/s12282-009-0176-y; Kristiansen G, 2003, CLIN CANCER RES, V9, P4906; Lagadec C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2479; Lahtz C, 2011, J MOL CELL BIOL, V3, P51, DOI 10.1093/jmcb/mjq053; Little JB, 1998, INT J RADIAT BIOL, V74, P663, DOI 10.1080/095530098140925; Luce A, 2009, CARCINOGENESIS, V30, P432, DOI 10.1093/carcin/bgp008; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Morgan WF, 1996, RADIAT RES, V146, P247, DOI 10.2307/3579454; Mothersill C, 1998, MUTAGENESIS, V13, P421, DOI 10.1093/mutage/13.5.421; Nguyen NP, 2010, CANCER TREAT REV, V36, P485, DOI 10.1016/j.ctrv.2010.02.016; Olivier M, 1998, MOL CARCINOGEN, V23, P1; Pajonk F, 2010, STEM CELLS, V28, P639, DOI 10.1002/stem.318; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Ponnaiya B, 1997, RADIAT RES, V147, P288, DOI 10.2307/3579335; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Resetkova E, 2010, BREAST CANCER RES TR, V123, P97, DOI 10.1007/s10549-009-0619-3; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Rossi L, 2011, METHODS MOL BIOL, V750, P47, DOI 10.1007/978-1-61779-145-1_3; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Sudo H, 2008, RADIAT RES, V170, P23, DOI 10.1667/RR1317.1; Suzuki K, 2006, MUTAT RES-FUND MOL M, V597, P73, DOI 10.1016/j.mrfmmm.2005.04.024; Vlashi E, 2009, J CELL BIOCHEM, V108, P339, DOI 10.1002/jcb.22275; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	39	19	19	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN 10	2013	32	2					251	258		10.1038/onc.2012.31	http://dx.doi.org/10.1038/onc.2012.31			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	078CK	22330142				2022-12-25	WOS:000314075500013
J	Allende-Vega, N; Dayal, S; Agarwala, U; Sparks, A; Bourdon, JC; Saville, MK				Allende-Vega, N.; Dayal, S.; Agarwala, U.; Sparks, A.; Bourdon, J-C; Saville, M. K.			p53 is activated in response to disruption of the pre-mRNA splicing machinery	ONCOGENE			English	Article						p53; spliceosome; splicing; MdmX; Mdm2; TG003	EMERGING ROLE; PROTEIN; CANCER; TRANSCRIPTION; DEGRADATION; STRESS; DOMAIN; MDM2; PHOSPHORYLATION; LOCALIZATION	In this study, we show that interfering with the splicing machinery results in activation of the tumour-suppressor p53. The spliceosome was targeted by small interfering RNA-mediated knockdown of proteins associated with different small nuclear ribonucleoprotein complexes and by using the small-molecule splicing modulator TG003. These interventions cause: the accumulation of p53, an increase in p53 transcriptional activity and can result in p53-dependent G(1) cell cycle arrest. Mdm2 and MdmX are two key repressors of p53. We show that a decrease in MdmX protein level contributes to p53 activation in response to targeting the spliceosome. Interfering with the spliceosome also causes an increase in the rate of degradation of Mdm2. Alterations in splicing are linked with tumour development. There are frequently global changes in splicing in cancer. Our study suggests that p53 activation could participate in protection against potential tumour-promoting defects in the spliceosome. A number of known p53-activating agents affect the splicing machinery and this could contribute to their ability to upregulate p53. Preclinical studies indicate that tumours can be more sensitive than normal cells to small-molecule spliceosome inhibitors. Activation of p53 could influence the selective anti-tumour activity of this therapeutic approach. Oncogene (2013) 32, 1-14; doi:10.1038/onc.2012.38; published online 20 February 2012	[Allende-Vega, N.; Dayal, S.; Agarwala, U.; Sparks, A.; Bourdon, J-C; Saville, M. K.] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Div Canc Res, Dundee DD1 9SY, Angus, Scotland	University of Dundee	Saville, MK (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Div Canc Res, Mail Box 11, Dundee DD1 9SY, Angus, Scotland.	m.k.saville@dundee.ac.uk	JC, Bourdon/A-4439-2008	JC, Bourdon/0000-0003-4623-9386; Allende-Vega, Nerea/0000-0001-5569-6461	Cancer Research UK	Cancer Research UK(Cancer Research UK)	This work was funded by Cancer Research UK.	Alexander R, 2010, BIOCHEM SOC T, V38, P1251, DOI 10.1042/BST0381251; Allende-Vega N, 2010, ONCOGENE, V29, P432, DOI 10.1038/onc.2009.330; Andre F, 2009, LANCET ONCOL, V10, P381, DOI 10.1016/S1470-2045(09)70024-5; Bartel F, 2004, MOL CANCER RES, V2, P29; Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Brody Y, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000573; Brooks CL, 2011, FEBS LETT, V585, P2803, DOI 10.1016/j.febslet.2011.05.022; Busa R, 2010, RNA BIOL, V7, P390, DOI 10.4161/rna.7.4.12466; Cao WH, 1998, J BIOL CHEM, V273, P20629, DOI 10.1074/jbc.273.32.20629; Cass DM, 2006, BIOCHEMISTRY-US, V45, P10092, DOI 10.1021/bi060429o; Chandler DS, 2006, CANCER RES, V66, P9502, DOI 10.1158/0008-5472.CAN-05-4271; Cheok CF, 2011, NAT REV CLIN ONCOL, V8, P25, DOI 10.1038/nrclinonc.2010.174; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Dayal S, 2009, J BIOL CHEM, V284, P5030, DOI 10.1074/jbc.M805871200; Disher K, 2007, GENOME, V50, P946, DOI 10.1139/G07-074; Egecioglu DE, 2011, RNA, V17, P383, DOI 10.1261/rna.2454711; Fackenthal JD, 2008, DIS MODEL MECH, V1, P37, DOI 10.1242/dmm.000331; Ghosh G, 2011, FEBS J, V278, P587, DOI 10.1111/j.1742-4658.2010.07992.x; Giglio S, 2005, CANCER RES, V65, P9687, DOI 10.1158/0008-5472.CAN-05-0450; Golas MM, 2003, SCIENCE, V300, P980, DOI 10.1126/science.1084155; Grainger RJ, 2005, RNA, V11, P533, DOI 10.1261/rna.2220705; Grosso AR, 2008, EMBO REP, V9, P1087, DOI 10.1038/embor.2008.189; Hernandez H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007202; Hock A, 2010, INT J BIOCHEM CELL B, V42, P1618, DOI 10.1016/j.biocel.2010.06.011; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Katzenberger RJ, 2006, MOL CELL BIOL, V26, P9256, DOI 10.1128/MCB.01125-06; Kawai H, 2003, J BIOL CHEM, V278, P45946, DOI 10.1074/jbc.M308295200; Kim E, 2008, TRENDS GENET, V24, P7, DOI 10.1016/j.tig.2007.10.001; Kim MY, 2009, BMB REP, V42, P125, DOI 10.5483/BMBRep.2009.42.3.125; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Lain S, 1999, EXP CELL RES, V248, P457, DOI 10.1006/excr.1999.4433; Lane DP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001222; Lenos K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/876173; Ljungman M, 2007, CELL CYCLE, V6, P2252, DOI 10.4161/cc.6.18.4751; Makarova OV, 2001, EMBO J, V20, P2553, DOI 10.1093/emboj/20.10.2553; Marcel V, 2010, FEBS LETT, V584, P4463, DOI 10.1016/j.febslet.2010.10.005; Marine JCW, 2007, J CELL SCI, V120, P371, DOI 10.1242/jcs.03362; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Munoz MJ, 2009, CELL, V137, P708, DOI 10.1016/j.cell.2009.03.010; Muraki M, 2004, J BIOL CHEM, V279, P24246, DOI 10.1074/jbc.M314298200; Newman AJ, 2010, CURR OPIN STRUC BIOL, V20, P82, DOI 10.1016/j.sbi.2009.12.003; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Reyal F, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2192; Ritchie DB, 2009, BBA-GENE REGUL MECH, V1789, P624, DOI 10.1016/j.bbagrm.2009.08.010; Ritchie W, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000011; Schaffert N, 2004, EMBO J, V23, P3000, DOI 10.1038/sj.emboj.7600296; Singh J, 2009, NAT STRUCT MOL BIOL, V16, P1128, DOI 10.1038/nsmb.1666; Sleeman J, 2007, J CELL SCI, V120, P1540, DOI 10.1242/jcs.001529; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Svejstrup JQ, 2007, TRENDS BIOCHEM SCI, V32, P165, DOI 10.1016/j.tibs.2007.02.005; UTANS U, 1992, GENE DEV, V6, P631, DOI 10.1101/gad.6.4.631; Valadkhan S, 2010, PROTEOMICS, V10, P4128, DOI 10.1002/pmic.201000354; Venables JP, 2009, NAT STRUCT MOL BIOL, V16, P670, DOI 10.1038/nsmb.1608; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang YV, 2007, P NATL ACAD SCI USA, V104, P12365, DOI 10.1073/pnas.0701497104; Ward AJ, 2010, J PATHOL, V220, P152, DOI 10.1002/path.2649; Wilkinson CRM, 2004, CURR BIOL, V14, P2283, DOI 10.1016/j.cub.2004.11.058; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Xiao SH, 1997, GENE DEV, V11, P334, DOI 10.1101/gad.11.3.334; Zhao XL, 2007, NUCLEIC ACIDS RES, V35, P550, DOI 10.1093/nar/gkl1084	67	47	47	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2013	32	1					1	14		10.1038/onc.2012.38	http://dx.doi.org/10.1038/onc.2012.38			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	063VG	22349816				2022-12-25	WOS:000313029500001
J	Rehman, J; Zhang, HJ; Toth, PT; Zhang, YM; Marsboom, G; Hong, ZG; Salgia, R; Husain, AN; Wietholt, C; Archer, SL				Rehman, Jalees; Zhang, Hannah J.; Toth, Peter T.; Zhang, Yanmin; Marsboom, Glenn; Hong, Zhigang; Salgia, Ravi; Husain, Aliya N.; Wietholt, Christian; Archer, Stephen L.			Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer	FASEB JOURNAL			English	Article						fusion; Drp-1; mitofusin-2	DYNAMIN-RELATED PROTEIN-1; APOPTOSIS; DRP1; EXPRESSION; FUSION; METABOLISM; PROLIFERATION; DIVISION; GROWTH; OPA1	Mitochondria exist in dynamic networks that undergo fusion and fission. Mitochondrial fusion and fission are mediated by several GTPases in the outer mitochondrial membrane, notably mitofusin-2 (Mfn-2), which promotes fusion, and dynamin-related protein (Drp-1), which promotes fission. We report that human lung cancer cell lines exhibit an imbalance of Drp-1/Mfn-2 expression, which promotes a state of mitochondrial fission. Lung tumor tissue samples from patients demonstrated a similar increase in Drp-1 and decrease in Mfn-2 when compared to adjacent healthy lung. Complementary approaches to restore mitochondrial network formation in lung cancer cells by overexpression of Mfn-2, Drp-1 inhibition, or Drp-1 knock-down resulted in a marked reduction of cancer cell proliferation and an increase in spontaneous apoptosis. The number of cancer cells in S phase decreased from 32.4 +/- 0.6 to 6.4 +/- 0.3% with Drp-1 inhibition (P<0.001). In a xenotransplantation model, Mfn-2 gene therapy or Drp-1 inhibition could regress tumor growth. The tumor volume decreased from 205.6 +/- 59 to 70.6 +/- 15 mm(3) (P<0.05) with Mfn-2 overexpression and from 186.0 +/- 19 to 87.0 +/- 6 mm(3) (P<0.01) with therapeutic Drp-1 inhibition. Impaired fusion and enhanced fission contribute fundamentally to the proliferation/apoptosis imbalance in cancer and constitute promising novel therapeutic targets.-Rehman, J., Zhang, H. J., Toth, P. T., Zhang, Y., Marsboom, G., Hong, Z., Salgia, R., Husain, A. N., Wietholt, C., Archer, S. L. Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer. FASEB J. 26, 2175-2186 (2012). www.fasebj.org	[Zhang, Hannah J.; Toth, Peter T.; Marsboom, Glenn; Hong, Zhigang; Wietholt, Christian; Archer, Stephen L.] Univ Chicago, Dept Med, Cardiol Sect, Chicago, IL 60637 USA; [Salgia, Ravi] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [Husain, Aliya N.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Rehman, Jalees; Zhang, Yanmin] Univ Illinois, Dept Med, Cardiol Sect, Chicago, IL USA; [Rehman, Jalees; Zhang, Yanmin] Univ Illinois, Dept Pharmacol, Chicago, IL USA	University of Chicago; University of Chicago; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Archer, SL (corresponding author), Univ Chicago, Dept Med, Cardiol Sect, 5841 S Maryland Ave,MC6080, Chicago, IL 60637 USA.	sarcher@medicine.bsd.uchicago.edu	Rehman, Jalees/J-8258-2012; Rehman, Jalees/GVU-1981-2022; Archer, Stephen L/C-3621-2013	Rehman, Jalees/0000-0002-2787-9292; Rehman, Jalees/0000-0002-2787-9292; Marsboom, Glenn/0000-0001-6309-7557; Toth, Peter/0000-0003-2168-0124	Harold Hines Jr. Chair in Medicine; U.S. National Institutes of Health (NIH) [NIH-RO1-HL071115, 1RC1HL099462-01, NIH-K08-HL080082, NIH-R01-GM094220, NIH-R01-CA125541-04, NIH-R01-CA 129501-02]; NATIONAL CANCER INSTITUTE [R01CA125541, R01CA129501] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL099462, K08HL080082, R01HL071115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094220] Funding Source: NIH RePORTER	Harold Hines Jr. Chair in Medicine; U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported in part by the Harold Hines Jr. Chair in Medicine and U.S. National Institutes of Health (NIH) grants NIH-RO1-HL071115 (S.A.), 1RC1HL099462-01 (S.A), NIH-K08-HL080082 (J.R.), NIH-R01-GM094220 (J.R.), NIH-R01-CA125541-04 (R.S.), and NIH-R01-CA 129501-02 (R.S.). The authors thank the following colleagues for providing the tools to study mitochondrial networking: Dr. Richard Youle (NIH, Bethesda, MD, USA) for the mito-PA-GFP plasmid, Dr. Michael Frohman (Stony Brook University, Stony Brook, NY, USA) for the mito-DS-Red plasmid, Dr. S. James Remington (University of Oregon, Eugene, OR, USA) for the redox-sensitive ro-GFP plasmid, Dr. Kuang-Hueih Chen (NIH) for the adenovirus containing rat mitofusin-2 cDNA, and Dr. Frederick E. (Rick) Domann, Jr. and Dr. Shawn Flanagan (University of Iowa, Iowa City, IA, USA) for the adenovirus containing the cDNA of human mitochondrially targeted catalase.	Archer SL, 2010, CIRCULATION, V121, P2661, DOI 10.1161/CIRCULATIONAHA.109.916098; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Brenner D, 2009, CURR OPIN CELL BIOL, V21, P871, DOI 10.1016/j.ceb.2009.09.004; Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Chen KH, 2004, NAT CELL BIOL, V6, P872, DOI 10.1038/ncb1161; Chiang YY, 2009, MODERN PATHOL, V22, P1139, DOI 10.1038/modpathol.2009.83; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Fueger BJ, 2006, J NUCL MED, V47, P999; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gogvadze V, 2009, APOPTOSIS, V14, P624, DOI 10.1007/s10495-009-0323-0; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; HUDSON HM, 1994, IEEE T MED IMAGING, V13, P601, DOI 10.1109/42.363108; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Kashatus DF, 2011, NAT CELL BIOL, V13, P1108, DOI 10.1038/ncb2310; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Ma PC, 2005, CANCER RES, V65, P1479, DOI 10.1158/0008-5472.CAN-04-2650; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Ong LC, 2008, ACTA RADIOL, V49, P1145, DOI 10.1080/02841850802482486; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Pan XC, 2004, PHYS MED BIOL, V49, P4349, DOI 10.1088/0031-9155/49/18/011; Szabadkai G, 2004, MOL CELL, V16, P59, DOI 10.1016/j.molcel.2004.09.026; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Wu L, 2008, MOL CANCER THER, V7, P222, DOI 10.1158/1535-7163.MCT-07-0382; Zhao J, 2011, EMBO J, V30, P2762, DOI 10.1038/emboj.2011.198	35	378	385	2	44	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2012	26	5					2175	2186		10.1096/fj.11-196543	http://dx.doi.org/10.1096/fj.11-196543			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22321727	Green Published			2022-12-25	WOS:000303680800043
J	Shannon, LA; McBurney, TM; Wells, MA; Roth, ME; Calloway, PA; Bill, CA; Islam, S; Vines, CM				Shannon, Laura A.; McBurney, Tiffany M.; Wells, Melissa A.; Roth, Megan E.; Calloway, Psachal A.; Bill, Charles A.; Islam, Shamima; Vines, Charlotte M.			CCR7/CCL19 Controls Expression of EDG-1 in T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL LYMPHOID ORGANS; ACTIVATED PROTEIN-KINASE; CHEMOKINE RECEPTOR CCR7; DENDRITIC CELLS; SURVIVAL; NODES; ERK5; MOUSE; GENE; SLC	T lymphocytes circulate between the blood, tissues, and lymph. These T cells carry out immune functions, using the C-C chemokine receptor 7 (CCR7) and its cognate ligands, CCL19 and CCL21, to enter and travel through the lymph nodes. Distinct roles for each ligand in regulating T lymphocyte trafficking have remained elusive. We report that in the human T cell line HuT78 and in primary murine T lymphocytes, signaling from CCR7/CCL19 leads to increased expression and phosphorylation of extracellular signal-regulated kinase 5 (ERK5) within eight hours of stimulation. Within 48-72 h we observed peak levels of endothelial differentiation gene 1 (EDG-1), which mediates the egress of T lymphocytes from lymph nodes. The increased expression of EDG-1 was preceded by up-regulation of its transcription factor, Kruppel-like factor 2 (KLF-2). To determine the cellular effect of disrupting ERK5 signaling from CCR7, we examined the migration of ERK5(flox/flox)/Lck-Cre murine T cells to EDG-1 ligands. While CCL19-stimulated ERK5(flox/flox) naive T cells showed increased migration to EDG-1 ligands at 48 h, the migration of ERK5(flox/flox)/Lck-Cre T cells remained at a basal level. Accordingly, we define a novel signaling pathway that controls EDG-1 up-regulation following stimulation of T cells by CCR7/CCL19. This is the first report to link the two signaling events that control migration through the lymph nodes: CCR7 mediates entry into the lymph nodes and EDG-1 signaling controls their subsequent exit.	[Shannon, Laura A.; McBurney, Tiffany M.; Wells, Melissa A.; Roth, Megan E.; Calloway, Psachal A.; Bill, Charles A.; Islam, Shamima; Vines, Charlotte M.] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Vines, CM (corresponding author), 3901 Rainbow Blvd,MSN3029, Kansas City, KS 66160 USA.	cvines@kumc.edu		Roth, Megan/0000-0002-6657-9292	National Institutes of Health [P20RR016443, K12HD052027, K22AI060815]; KUMC Institute for Advancing Medical Innovation; KUMC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD052027] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI060815] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KUMC Institute for Advancing Medical Innovation; KUMC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants P20RR016443, K12HD052027, and K22AI060815 and a grant from the KUMC Institute for Advancing Medical Innovation, a KUMC Bridging Award, and the KUMC Biomedical Research Training Program.	Ananieva O, 2008, EUR J IMMUNOL, V38, P2534, DOI 10.1002/eji.200737867; Arcand J, 2012, ARTHRITIS RHEUM-US, V64, P826, DOI 10.1002/art.33377; Bardi G, 2001, EUR J IMMUNOL, V31, P3291, DOI 10.1002/1521-4141(200111)31:11<3291::AID-IMMU3291>3.0.CO;2-Z; Buschbeck M, 2005, J BIOL CHEM, V280, P2659, DOI 10.1074/jbc.M412599200; Byers MA, 2008, J IMMUNOL, V181, P4723, DOI 10.4049/jimmunol.181.7.4723; Cabioglu N, 2005, CLIN CANCER RES, V11, P5686, DOI 10.1158/1078-0432.CCR-05-0014; Campbell JJ, 1998, J CELL BIOL, V141, P1053, DOI 10.1083/jcb.141.4.1053; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; DAILEY MO, 1985, J MOL CELL IMMUNOL, V2, P27; Fan L, 2000, J IMMUNOL, V164, P3955, DOI 10.4049/jimmunol.164.8.3955; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Hennet T, 1995, P NATL ACAD SCI USA, V92, P12070, DOI 10.1073/pnas.92.26.12070; Huang YH, 2004, P NATL ACAD SCI USA, V101, P4936, DOI 10.1073/pnas.0401133101; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; Luther SA, 2002, J IMMUNOL, V169, P424, DOI 10.4049/jimmunol.169.1.424; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Nakano H, 1997, EUR J IMMUNOL, V27, P215, DOI 10.1002/eji.1830270132; Nakano H, 1998, BLOOD, V91, P2886, DOI 10.1182/blood.V91.8.2886.2886_2886_2895; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Nishimoto S, 2006, EMBO REP, V7, P782, DOI 10.1038/sj.embor.7400755; Otero C, 2008, J CELL SCI, V121, P2759, DOI 10.1242/jcs.029074; Otero C, 2006, J IMMUNOL, V177, P2314, DOI 10.4049/jimmunol.177.4.2314; Pham THM, 2008, IMMUNITY, V28, P122, DOI 10.1016/j.immuni.2007.11.017; Pilkington KR, 2004, J BIOL CHEM, V279, P40276, DOI 10.1074/jbc.M405808200; Rovida E, 2008, J IMMUNOL, V180, P4166, DOI 10.4049/jimmunol.180.6.4166; Schober SL, 1999, J IMMUNOL, V163, P3662; Sohn SJ, 2005, MOL CELL BIOL, V25, P8553, DOI 10.1128/MCB.25.19.8553-8566.2005; Sohn SJ, 2008, EMBO J, V27, P1896, DOI 10.1038/emboj.2008.114; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Vines CM, 2001, IMMUNITY, V15, P507, DOI 10.1016/S1074-7613(01)00221-7	38	19	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11656	11664		10.1074/jbc.M111.310045	http://dx.doi.org/10.1074/jbc.M111.310045			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334704	Green Published, hybrid			2022-12-25	WOS:000302782200006
J	Conner, MT; Conner, AC; Bland, CE; Taylor, LHJ; Brown, JEP; Parri, HR; Bill, RM				Conner, Matthew T.; Conner, Alex C.; Bland, Charlotte E.; Taylor, Luke H. J.; Brown, James E. P.; Parri, H. Rheinallt; Bill, Roslyn M.			Rapid Aquaporin Translocation Regulates Cellular Water Flow MECHANISM OF HYPOTONICITY-INDUCED SUBCELLULAR LOCALIZATION OF AQUAPORIN 1 WATER CHANNEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; PLASMA-MEMBRANE; VOLUME REGULATION; COLLECTING DUCT; CATION CHANNEL; K+ CHANNELS; NULL MICE; CELLS; TRAFFICKING; RECEPTOR	The control of cellular water flow is mediated by the aquaporin (AQP) family of membrane proteins. The structural features of the family and the mechanism of selective water passage through the AQP pore are established, but there remains a gap in our knowledge of how water transport is regulated. Two broad possibilities exist. One is controlling the passage of water through the AQP pore, but this only has been observed as a phenomenon in some plant and microbial AQPs. An alternative is controlling the number of AQPs in the cell membrane. Here, we describe a novel pathway in mammalian cells whereby a hypotonic stimulus directly induces intracellular calcium elevations through transient receptor potential channels, which trigger AQP1 translocation. This translocation, which has a direct role in cell volume regulation, occurs within 30 s and is dependent on calmodulin activation and phosphorylation of AQP1 at two threonine residues by protein kinase C. This direct mechanism provides a rationale for the changes in water transport that are required in response to constantly changing local cellular water availability. Moreover, because calcium is a pluripotent and ubiquitous second messenger in biological systems, the discovery of its role in the regulation of AQP translocation has ramifications for diverse physiological and pathophysiological processes, as well as providing an explanation for the rapid regulation of water flow that is necessary for cell homeostasis.	[Conner, Matthew T.; Bland, Charlotte E.; Brown, James E. P.; Parri, H. Rheinallt; Bill, Roslyn M.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Conner, Matthew T.; Bland, Charlotte E.; Brown, James E. P.; Parri, H. Rheinallt; Bill, Roslyn M.] Aston Univ, Aston Res Ctr Healthy Ageing, Birmingham B4 7ET, W Midlands, England; [Conner, Alex C.; Taylor, Luke H. J.] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England	Aston University; Aston University; University of Warwick	Bill, RM (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.	r.m.bill@aston.ac.uk	Bill, Roslyn M/D-4554-2012; Brown, James E/A-7503-2012; Parri, Rheinallt/D-1748-2013	Bill, Roslyn M/0000-0003-1331-0852; Parri, Rheinallt/0000-0002-1412-2688	European Commission [201924 EDICT]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by European Commission Framework Programme 7 Grant 201924 EDICT (to R. M. B.).	Acs P, 1997, J BIOL CHEM, V272, P22148, DOI 10.1074/jbc.272.35.22148; Agre Peter, 2006, Proc Am Thorac Soc, V3, P5, DOI 10.1513/pats.200510-109JH; Beech DJ, 2005, PFLUG ARCH EUR J PHY, V451, P53, DOI 10.1007/s00424-005-1441-3; Beech DJ, 2003, CELL CALCIUM, V33, P433, DOI 10.1016/S0143-4160(03)00054-X; Benfenati V, 2010, NEUROSCIENCE, V168, P926, DOI 10.1016/j.neuroscience.2009.12.017; Benfenati V, 2011, P NATL ACAD SCI USA, V108, P2563, DOI 10.1073/pnas.1012867108; BENGA G, 1986, EUR J CELL BIOL, V41, P252; Bouley R, 2009, AM J PHYSIOL-RENAL, V297, pF1575, DOI 10.1152/ajprenal.90762.2008; Brown D, 1998, AM J PHYSIOL-RENAL, V275, pF328, DOI 10.1152/ajprenal.1998.275.3.F328; Conner M, 2007, J BIOL CHEM, V282, P17405, DOI 10.1074/jbc.M702151200; Conner MT, 2010, BIOCHEMISTRY-US, V49, P821, DOI 10.1021/bi902068b; de Groot BL, 2003, J MOL BIOL, V333, P279, DOI 10.1016/j.jmb.2003.08.003; de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459; Ding YF, 2004, AM J PHYSIOL-CELL PH, V287, pC413, DOI 10.1152/ajpcell.00537.2003; Dolensek J, 2011, PHYSIOL RES, V60, pS29, DOI 10.33549/physiolres.932176; EVELOFF JL, 1987, AM J PHYSIOL, V252, pF1, DOI 10.1152/ajprenal.1987.252.1.F1; Fenton RA, 2008, P NATL ACAD SCI USA, V105, P3134, DOI 10.1073/pnas.0712338105; Fenton RA, 2008, PROG BRAIN RES, V170, P571, DOI 10.1016/S0079-6123(08)00444-5; Fisher SK, 2008, J NEUROCHEM, V106, P1998, DOI 10.1111/j.1471-4159.2008.05510.x; Gunnarson E, 2004, NEUROSCIENCE, V129, P947, DOI 10.1016/j.neuroscience.2004.08.022; HIDAKA H, 1980, MOL PHARMACOL, V17, P66; Hoffert JD, 2007, AM J PHYSIOL-RENAL, V292, pF691, DOI 10.1152/ajprenal.00284.2006; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Homann U, 2002, P NATL ACAD SCI USA, V99, P10215, DOI 10.1073/pnas.152324399; Ishikawa Y, 2002, MOL PHARMACOL, V61, P1423, DOI 10.1124/mol.61.6.1423; Jans D, 2000, PFLUG ARCH EUR J PHY, V439, P504, DOI 10.1007/s004240050970; Kocanova S, 2006, PHOTOCHEM PHOTOBIOL, V82, P720, DOI 10.1562/2005-09-26-RA-696; Krane CM, 2007, MAMM GENOME, V18, P452, DOI 10.1007/s00335-007-9041-5; LANKFORD SP, 1991, AM J PHYSIOL, V261, pF554, DOI 10.1152/ajprenal.1991.261.3.F554; Laursen M, 2009, J BIOL CHEM, V284, P13513, DOI 10.1074/jbc.C900031200; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Litman Thomas, 2009, Handb Exp Pharmacol, P327, DOI 10.1007/978-3-540-79885-9_17; Liu K, 1998, PLANT CELL, V10, P1957, DOI 10.1105/tpc.10.11.1957; Luckey AE, 2003, ARCH SURG-CHICAGO, V138, P1055, DOI 10.1001/archsurg.138.10.1055; Maric K, 2001, BIOPHYS J, V80, P1783, DOI 10.1016/S0006-3495(01)76148-6; Marinelli RA, 1997, J BIOL CHEM, V272, P12984, DOI 10.1074/jbc.272.20.12984; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; Mccoy ES, 2010, NEUROSCIENCE, V168, P971, DOI 10.1016/j.neuroscience.2009.09.020; Mccoy E, 2010, GLIA, V58, P209, DOI 10.1002/glia.20916; Nedvetsky Pavel I, 2009, Handb Exp Pharmacol, P133, DOI 10.1007/978-3-540-79885-9_6; Nesic O, 2008, J NEUROCHEM, V105, P628, DOI 10.1111/j.1471-4159.2007.05177.x; NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P7275, DOI 10.1073/pnas.90.15.7275; Nilius B, 2004, AM J PHYSIOL-CELL PH, V286, pC195, DOI 10.1152/ajpcell.00365.2003; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; Noda Y, 2005, BIOL CELL, V97, P885; Parri HR, 2010, EUR J NEUROSCI, V32, P29, DOI 10.1111/j.1460-9568.2010.07281.x; Pasantes-Morales H, 2010, NEUROSCIENCE, V168, P871, DOI 10.1016/j.neuroscience.2009.11.074; Querfurth HW, 1998, BIOCHEM J, V334, P79, DOI 10.1042/bj3340079; RANE SG, 1986, P NATL ACAD SCI USA, V83, P184, DOI 10.1073/pnas.83.1.184; Satoh J, 2007, NEUROPATHOLOGY, V27, P245, DOI 10.1111/j.1440-1789.2007.00774.x; Schnermann J, 1998, P NATL ACAD SCI USA, V95, P9660, DOI 10.1073/pnas.95.16.9660; Sidhaye VK, 2006, P NATL ACAD SCI USA, V103, P4747, DOI 10.1073/pnas.0511211103; Singh A, 2010, BRIT J PHARMACOL, V160, P1464, DOI 10.1111/j.1476-5381.2010.00786.x; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Walz Thomas, 2009, Handb Exp Pharmacol, P31, DOI 10.1007/978-3-540-79885-9_2; Wang Y, 2007, J NUTR, V137, p1509S, DOI 10.1093/jn/137.6.1509S; Yang BX, 2000, HUM GENE THER, V11, P567, DOI 10.1089/10430340050015752; Yasui H, 2008, BIOCHEM BIOPH RES CO, V373, P613, DOI 10.1016/j.bbrc.2008.06.086; Zelenina M, 2010, NEUROCHEM INT, V57, P468, DOI 10.1016/j.neuint.2010.03.022; Zhang W, 2007, J BIOL CHEM, V282, P20933, DOI 10.1074/jbc.M703858200; ZOREC R, 1993, FEBS LETT, V333, P283, DOI 10.1016/0014-5793(93)80671-G	62	64	67	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11516	11525		10.1074/jbc.M111.329219	http://dx.doi.org/10.1074/jbc.M111.329219			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334691	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000302780100079
J	Racioppi, L; Noeldner, PK; Lin, FM; Arvai, S; Means, AR				Racioppi, Luigi; Noeldner, Pamela K.; Lin, Fumin; Arvai, Stephanie; Means, Anthony R.			Calcium/Calmodulin-dependent Protein Kinase Kinase 2 Regulates Macrophage-mediated Inflammatory Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TNF-ALPHA PRODUCTION; DENDRITIC CELLS; TYROSINE PHOSPHORYLATION; ACTIN REORGANIZATION; ADHESION KINASE; PYK2; ACTIVATION; MECHANISMS; EXPRESSION; SIGNALS	Calcium/calmodulin-dependent kinase kinase 2 (CaMKK2) plays a key role in regulating food intake and energy expenditure at least in part by its actions in hypothalamic neurons. Previously, we showed that loss of CaMKK2 protected mice from high-fat diet (HFD)-induced obesity and glucose intolerance. However, although pair feeding HFD to WT mice to match food consumption of CAMKK2-null mice slowed weight gain, it failed to protect from glucose intolerance. Here we show that relative to WT mice, HFD-fed CaMKK2-null mice are protected from inflammation in adipose and remain glucose-tolerant. Moreover, loss of CaMKK2 also protected mice from endotoxin shock and fulminant hepatitis. We explored the expression of CaMKK2 in immune cells and found it to be restricted to those of the monocyte/macrophage lineage. CaMKK2-null macrophages exhibited a remarkable deficiency to spread, phagocytose bacteria, and synthesize cytokines in response to the Toll-like receptor 4 (TLR4) agonist lipopolysaccharide (LPS). Mechanistically, loss of CaMKK2 uncoupled the TLR4 cascade from activation of protein tyrosine kinase 2 (PYK2; also known as PTK2B). Our findings uncover an important function for CaMKK2 in mediating mechanisms that control the amplitude of macrophage inflammatory responses to excess nutrients or pathogen derivatives.	[Racioppi, Luigi] Duke Univ, Med Ctr, Div Cellular Therapy, Dept Med, Durham, NC 27710 USA; [Racioppi, Luigi; Noeldner, Pamela K.; Lin, Fumin; Arvai, Stephanie; Means, Anthony R.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Racioppi, Luigi; Means, Anthony R.] Univ Naples Federico II, Dept Cellular & Mol Biol & Pathol, I-80131 Naples, Italy	Duke University; Duke University; University of Naples Federico II	Racioppi, L (corresponding author), Duke Univ, Med Ctr, Div Cellular Therapy, Dept Med, 213 Res Dr,Box 3961 DUMC,245 CARL Bldg, Durham, NC 27710 USA.	luigi.racioppi@duke.edu	racioppi, luigi/GNP-0349-2022; racioppi, luigi/AGB-8665-2022; LIN, Fumin/D-5709-2015	racioppi, luigi/0000-0002-9207-6752; LIN, Fumin/0000-0003-1229-0685	National Institutes of Health [GM033976]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033976] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM033976 (to A. R. M.).	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Baldys A, 2009, BIOCHEMISTRY-US, V48, P9321, DOI 10.1021/bi900865u; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Bruzzaniti A, 2009, MOL CELL BIOL, V29, P3644, DOI 10.1128/MCB.00851-08; Colomer J., 2007, V45, P169; Duan YL, 2010, AM J RESP CELL MOL, V42, P491, DOI 10.1165/rcmb.2008-0469OC; Duong LT, 2000, CELL MOTIL CYTOSKEL, V47, P174, DOI 10.1002/1097-0169(200011)47:3<174::AID-CM2>3.0.CO;2-N; Fujimoto T, 2011, BIOCHEM BIOPH RES CO, V410, P45, DOI 10.1016/j.bbrc.2011.05.102; Gainetdinov RR, 1999, NEURON, V24, P1029, DOI 10.1016/S0896-6273(00)81048-X; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; GORDON AH, 1980, NATURE, V286, P79, DOI 10.1038/286079a0; Green MF, 2011, CELL SIGNAL, V23, P2005, DOI 10.1016/j.cellsig.2011.07.014; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; GutierrezRamos JC, 1997, IMMUNOL TODAY, V18, P329, DOI 10.1016/S0167-5699(97)01085-2; Haglund K, 2004, J CELL SCI, V117, P2557, DOI 10.1242/jcs.01148; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hazeki K, 2003, EUR J IMMUNOL, V33, P740, DOI 10.1002/eji.200323375; Herrmann TL, 2007, J LEUKOCYTE BIOL, V82, P686, DOI 10.1189/jlb.0107045; Hook SS, 2001, ANNU REV PHARMACOL, V41, P471, DOI 10.1146/annurev.pharmtox.41.1.471; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Iiizumi M, 2008, CANCER RES, V68, P7613, DOI 10.1158/0008-5472.CAN-07-6700; Illario M, 2008, BLOOD, V111, P723, DOI 10.1182/blood-2007-05-091173; Ivashkiv LB, 2009, NAT IMMUNOL, V10, P340, DOI 10.1038/ni.1706; Kelly EK, 2010, J IMMUNOL, V184, P5545, DOI 10.4049/jimmunol.0901293; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Kong L, 2009, CELL HOST MICROBE, V6, P150, DOI 10.1016/j.chom.2009.06.008; Laskin DL, 2011, ANNU REV PHARMACOL, V51, P267, DOI 10.1146/annurev.pharmtox.010909.105812; Lehrke M, 2004, NAT MED, V10, P126, DOI 10.1038/nm0204-126; LETARI O, 1991, J IMMUNOL, V147, P980; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Liu XG, 2010, J IMMUNOL, V185, P7244, DOI 10.4049/jimmunol.1001573; Liu XG, 2008, BLOOD, V112, P4961, DOI 10.1182/blood-2008-03-144022; Locati M, 2002, ALLERGY, V57, P972, DOI 10.1034/j.1398-9995.2002.02166.x; Lowell CA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002352; Lumeng CN, 2009, NAT MED, V15, P846, DOI 10.1038/nm0809-846; Matsui A, 2007, CIRCULATION, V116, P1041, DOI 10.1161/CIRCULATIONAHA.106.645416; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Nerlov C, 2010, BIOESSAYS, V32, P680, DOI 10.1002/bies.201000004; Okigaki M, 2003, P NATL ACAD SCI USA, V100, P10740, DOI 10.1073/pnas.1834348100; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Ostuni R, 2010, CELL MOL LIFE SCI, V67, P4109, DOI 10.1007/s00018-010-0464-x; Racioppi L, 2008, TRENDS IMMUNOL, V29, P600, DOI 10.1016/j.it.2008.08.005; Ray Avijit, 2010, J Vis Exp, DOI 10.3791/1488; Rosengart MR, 2002, SHOCK, V17, P109, DOI 10.1097/00024382-200202000-00005; Rosengart MR, 2000, SHOCK, V13, P183, DOI 10.1097/00024382-200003000-00003; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Sekine Y, 2007, J IMMUNOL, V179, P2397, DOI 10.4049/jimmunol.179.4.2397; Silva MT, 2010, J LEUKOCYTE BIOL, V87, P93, DOI 10.1189/jlb.0809549; Stearns-Kurosawa DJ, 2011, ANNU REV PATHOL-MECH, V6, P19, DOI 10.1146/annurev-pathol-011110-130327; Teng EC, 2011, J LEUKOCYTE BIOL, V90, P897, DOI 10.1189/jlb.0311152; Turnbull IR, 2007, NAT REV IMMUNOL, V7, P155, DOI 10.1038/nri2014; Wang HP, 2010, EMBO J, V29, P1285, DOI 10.1038/emboj.2010.10; Wang L, 2008, NAT IMMUNOL, V9, P186, DOI 10.1038/ni1548; Williams LM, 2000, J IMMUNOL, V164, P2028, DOI 10.4049/jimmunol.164.4.2028; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xi CX, 2010, J LEUKOCYTE BIOL, V87, P415, DOI 10.1189/jlb.0309125; Ye SY, 2010, J BIOL CHEM, V285, P27008, DOI 10.1074/jbc.M110.139881; Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118; Zhang XH, 2011, J LEUKOCYTE BIOL, V90, P249, DOI 10.1189/jlb.0510286	65	80	82	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11579	11591		10.1074/jbc.M111.336032	http://dx.doi.org/10.1074/jbc.M111.336032			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334678	Green Published, hybrid			2022-12-25	WOS:000302780100085
J	Dasari, VR; Velpula, KK; Alapati, K; Gujrati, M; Tsung, AJ				Dasari, Venkata Ramesh; Velpula, Kiran Kumar; Alapati, Kiranmai; Gujrati, Meena; Tsung, Andrew J.			Cord Blood Stem Cells Inhibit Epidermal Growth Factor Receptor Translocation to Mitochondria in Glioblastoma	PLOS ONE			English	Article							TYROSINE KINASES; C-SRC; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; LOCALIZED EGFR; CANCER; SURVIVAL; GLIOMA; STAT3; PHOSPHORYLATION	Background: Overexpression of EGFR is one of the most frequently diagnosed genetic aberrations of glioblastoma multiforme (GBM). EGFR signaling is involved in diverse cellular functions and is dependent on the type of preferred receptor complexes. EGFR translocation to mitochondria has been reported recently in different cancer types. However, mechanistic aspects of EGFR translocation to mitochondria in GBM have not been evaluated to date. Methodology/Principle Findings: In the present study, we analyzed the expression of EGFR in GBM-patient derived specimens using immunohistochemistry, reverse-transcription based PCR and Western blotting techniques. In clinical samples, EGFR co-localizes with FAK in mitochondria. We evaluated this previous observation in standard glioma cell lines and in vivo mice xenografts. We further analyzed the effect of human umbilical cord blood stem cells (hUCBSC) on the inhibition of EGFR expression and EGFR signaling in glioma cells and xenografts. Treatment with hUCBSC inhibited the expression of EGFR and its co-localization with FAK in glioma cells. Also, hUCBSC inhibited the co-localization of activated forms of EGFR, FAK and c-Src in mitochondria of glioma cells and xenografts. In addition, hUCBSC also inhibited EGFR signaling proteins in glioma cells both in vitro and in vivo. Conclusions/Significance: We have shown that hUCBSC treatments inhibit phosphorylation of EGFR, FAK and c-Src forms. Our findings associate EGFR expression and its localization to mitochondria with specific biological functions in GBM cells and provide relevant preclinical information that can be used for the development of effective hUCBSC-based therapies.	[Dasari, Venkata Ramesh; Velpula, Kiran Kumar; Alapati, Kiranmai] Univ Illinois, Coll Med, Dept Canc Biol, Peoria, IL 61656 USA; [Dasari, Venkata Ramesh; Velpula, Kiran Kumar; Alapati, Kiranmai] Univ Illinois, Coll Med, Dept Pharmacol, Peoria, IL 61656 USA; [Tsung, Andrew J.] Univ Illinois, Coll Med, Dept Neurosurg, Peoria, IL 61656 USA; [Gujrati, Meena] Univ Illinois, Coll Med, Dept Pathol, Peoria, IL 61656 USA; [Tsung, Andrew J.] Univ Illinois, Coll Med, Illinois Neurol Inst, Peoria, IL 61656 USA	University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria	Dasari, VR (corresponding author), Univ Illinois, Coll Med, Dept Canc Biol, Peoria, IL 61656 USA.	Andrew.J.Tsung@INI.org	Alapati, Kiranmai/F-7171-2013; Dasari, Venkata Ramesh/B-3098-2009	Dasari, Venkata Ramesh/0000-0003-0819-2935	Illinois Neurological Institute	Illinois Neurological Institute	This research is supported by a grant from Illinois Neurological Institute (to AJT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barre B, 2005, J BIOL CHEM, V280, P15673, DOI 10.1074/jbc.M413203200; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Biscardi JS, 2000, BREAST CANCER RES, V2, P203, DOI 10.1186/bcr55; Boerner JL, 2004, MOL CELL BIOL, V24, P7059, DOI 10.1128/MCB.24.16.7059-7071.2004; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; CARPENTIER JL, 1986, EXP CELL RES, V166, P312, DOI 10.1016/0014-4827(86)90479-9; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Dasari VR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010350; Dasari VR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011813; Dasari VR, 2008, NEUROBIOL DIS, V32, P486, DOI 10.1016/j.nbd.2008.09.005; Dasari VR, 2010, AGING ALBANY NY, V2, P1; Dechow TN, 2004, P NATL ACAD SCI USA, V101, P10602, DOI 10.1073/pnas.0404100101; Demory ML, 2009, J BIOL CHEM, V284, P36592, DOI 10.1074/jbc.M109.000760; Fan QW, 2005, ONCOGENE, V24, P829, DOI 10.1038/sj.onc.1208227; Frederick L, 2000, CANCER RES, V60, P1383; Friedmann BJ, 2006, MOL CANCER THER, V5, P209, DOI 10.1158/1535-7163.MCT-05-0239; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Goldenthal MJ, 2004, MOL CELL BIOCHEM, V262, P1, DOI 10.1023/B:MCBI.0000038228.85494.3b; Grandis JR, 1998, J CLIN INVEST, V102, P1385, DOI 10.1172/JCI3785; Hajnoczky G, 2007, SCIENCE, V315, P607, DOI 10.1126/science.1138825; Hatanpaa KJ, 2010, NEOPLASIA, V12, P675, DOI 10.1593/neo.10688; Heimberger AB, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-38; Huang PH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.287re6; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Ivanov VN, 2001, MOL CELL, V7, P517, DOI 10.1016/S1097-2765(01)00199-X; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Layfield LJ, 2006, APPL IMMUNOHISTO M M, V14, P91, DOI 10.1097/01.pai.0000159772.73775.2e; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Leslie K, 2006, CANCER RES, V66, P2544, DOI 10.1158/0008-5472.CAN-05-2203; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Marmor MD, 2004, INT J RADIAT ONCOL, V58, P903, DOI 10.1016/j.ijrobp.2003.06.002; Mizoguchi M, 2006, J NEUROPATH EXP NEUR, V65, P1181, DOI 10.1097/01.jnen.0000248549.14962.b2; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Olayioye MA, 1999, J BIOL CHEM, V274, P17209, DOI 10.1074/jbc.274.24.17209; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Salvi M, 2005, FREE RADICAL BIO MED, V38, P1267, DOI 10.1016/j.freeradbiomed.2005.02.006; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Smith K, 2005, CANCER RES, V65, P5221, DOI 10.1158/0008-5472.CAN-05-0169; Stupp R, 2002, J CLIN ONCOL, V20, P1375, DOI 10.1200/JCO.20.5.1375; Velpula KK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018017; Waterman H, 2001, FEBS LETT, V490, P142, DOI 10.1016/S0014-5793(01)02117-2; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Yao YA, 2010, ACTA BIOCH BIOPH SIN, V42, P763, DOI 10.1093/abbs/gmq090; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yue XJ, 2008, AUTOPHAGY, V4, P641, DOI 10.4161/auto.5971	51	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31884	10.1371/journal.pone.0031884	http://dx.doi.org/10.1371/journal.pone.0031884			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348136	Green Submitted, Green Published, gold			2022-12-25	WOS:000302737400055
J	Fisher, JB; Kim, MS; Blinka, S; Ge, ZD; Wan, TN; Duris, C; Christian, D; Twaroski, K; North, P; Auchampach, J; Lough, J				Fisher, Joseph B.; Kim, Min-Su; Blinka, Steven; Ge, Zhi-Dong; Wan, Tina; Duris, Christine; Christian, Desirae; Twaroski, Kirk; North, Paula; Auchampach, John; Lough, John			Stress-Induced Cell-Cycle Activation in Tip60 Haploinsufficient Adult Cardiomyocytes	PLOS ONE			English	Article							CARDIAC MYOCYTES; GENE-EXPRESSION; BINDING DOMAIN; DNA-SYNTHESIS; P53 PATHWAY; HEART; PROLIFERATION; APOPTOSIS; PROTEIN; REPAIR	Background: Tat-interactive protein 60 (Tip60) is a member of the MYST family of histone acetyltransferases. Studies using cultured cells have shown that Tip60 has various functions including DNA repair, apoptosis and cell-cycle regulation. We globally ablated the Tip60 gene (Htatip), observing that Tip60-null embryos die at the blastocyst stage (Hu et al. Dev. Dyn. 238:2912;2009). Although adult heterozygous (Tip60(+/-)) mice reproduce normally without a haploinsufficient phenotype, stress caused by Myc over-expression induced B-cell lymphoma in Tip60(+/-) adults, suggesting that Tip60 is a tumor suppressor (Gorrini et al. Nature 448: 1063; 2007). These findings prompted assessment of whether Tip60, alternative splicing of which generates two predominant isoforms termed Tip60 alpha and Tip60 beta, functions to suppress the cell-cycle in adult cardiomyocytes. Methodology/Principal Findings: Western blotting revealed that Tip60 alpha is the predominant Tip60 isoprotein in the embryonic heart, transitioning at neonatal stages to Tip60 beta, which is the only isoprotein in the adult heart wherein it is highly enriched. Over-expression of Tip60 beta, but not Tip60 alpha, inhibited cell proliferation in NIH3T3 cells; and, Tip60-haploinsufficient cultured neonatal cardiomyocytes exhibited increased cell-cycle activity. To address whether Tip60 beta suppresses the cardiomyocyte cell-cycle in the adult heart, hypertrophic stress was induced in Tip60(+/+) and Tip(+/-) littermates via two methods, Myc over-expression and aortic banding. Based on immunostaining cell-cycle markers and western blotting cyclin D, stress increased cardiomyocyte cell-cycle mobilization in Tip60(+/-) hearts, in comparison with Tip60(+/+) littermates. Aortic-banded Tip60(+/-) hearts also exhibited significantly decreased apoptosis. Conclusions/Significance: These findings provide evidence that Tip60 may function in a tumor suppressor pathway(s) to maintain adult cardiomyocytes in replicative senescence.	[Fisher, Joseph B.; Kim, Min-Su; Blinka, Steven; Christian, Desirae; Twaroski, Kirk; Lough, John] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Fisher, Joseph B.; Kim, Min-Su; Blinka, Steven; Ge, Zhi-Dong; Wan, Tina; Christian, Desirae; Twaroski, Kirk; Auchampach, John; Lough, John] Med Coll Wisconsin, Ctr Cardiovasc, Milwaukee, WI 53226 USA; [Ge, Zhi-Dong; Wan, Tina; Auchampach, John] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Duris, Christine; North, Paula] Med Coll Wisconsin, Dept Pathol, Div Pediat Pathol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Fisher, JB (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA.	jlough@mcw.edu		Blinka, Steven/0000-0002-0776-5677	National Institutes of Health [HL089471]; American Heart Association [0810108Z]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000055] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL089471, R01HL077707] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL089471 (JL) and by Predoctoral Fellowship #0810108Z from the American Heart Association (JBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja P, 2010, J CLIN INVEST, V120, P1494, DOI 10.1172/JCI38331; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Gehrking KM, 2011, HUM MOL GENET, V20, P2204, DOI 10.1093/hmg/ddr108; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Hass MR, 2005, J BIOL CHEM, V280, P36895, DOI 10.1074/jbc.M502861200; Hu YF, 2009, DEV DYNAM, V238, P2912, DOI 10.1002/dvdy.22110; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; IZUMO S, 1988, P NATL ACAD SCI USA, V85, P339, DOI 10.1073/pnas.85.2.339; Kajstura J, 2010, CIRC RES, V107, P1374, DOI 10.1161/CIRCRESAHA.110.231498; KIM KK, 1994, J BIOL CHEM, V269, P22607; Kim MS, 2006, J BIOL CHEM, V281, P15082, DOI 10.1074/jbc.M513593200; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Lee HJ, 2001, J BIOL CHEM, V276, P16597, DOI 10.1074/jbc.C000909200; Lee Y, 2009, APOPTOSIS, V14, P536, DOI 10.1007/s10495-008-0302-x; Legube G, 2004, J BIOL CHEM, V279, P44825, DOI 10.1074/jbc.M407478200; Legube G, 2002, EMBO J, V21, P1704, DOI 10.1093/emboj/21.7.1704; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Lough JW, 2002, DEV DYNAM, V223, P419, DOI 10.1002/dvdy.10058; MacLellan WR, 2005, MOL CELL BIOL, V25, P2486, DOI 10.1128/MCB.25.6.2486-2497.2005; McAllister D, 2002, GENE, V289, P169, DOI 10.1016/S0378-1119(02)00546-2; Meckert PC, 2005, CARDIOVASC RES, V67, P116, DOI 10.1016/j.cardiores.2005.02.017; Muckova K, 2006, AM J PHYSIOL-RENAL, V290, pF70, DOI 10.1152/ajprenal.00358.2004; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Oh H, 2001, P NATL ACAD SCI USA, V98, P10308, DOI 10.1073/pnas.191169098; Pajcini KV, 2010, CELL STEM CELL, V7, P198, DOI 10.1016/j.stem.2010.05.022; Pena AN, 2011, EXP CELL RES, V317, P1534, DOI 10.1016/j.yexcr.2011.02.001; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Sdek P, 2011, J CELL BIOL, V194, P407, DOI 10.1083/jcb.201012049; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Sun YL, 2009, NAT CELL BIOL, V11, P1376, DOI 10.1038/ncb1982; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tyteca S, 2006, MOL CELL, V24, P807, DOI 10.1016/j.molcel.2006.12.005; Voss AK, 2009, BIOESSAYS, V31, P1050, DOI 10.1002/bies.200900051; Xiao GS, 2001, CIRC RES, V89, P1122, DOI 10.1161/hh2401.100742; Yamamoto T, 1997, J BIOL CHEM, V272, P30595, DOI 10.1074/jbc.272.49.30595; Zhang YQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012559; Zhong WG, 2006, EMBO J, V25, P3869, DOI 10.1038/sj.emboj.7601252; Zhu WQ, 2009, PEDIATR CARDIOL, V30, P710, DOI 10.1007/s00246-009-9408-3	48	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31569	10.1371/journal.pone.0031569	http://dx.doi.org/10.1371/journal.pone.0031569			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348108	Green Published, Green Submitted, gold			2022-12-25	WOS:000302737400036
J	Laing, ST; Ivens, A; Butler, V; Ravikumar, SP; Laing, R; Woods, DJ; Gilleard, JS				Laing, Steven T.; Ivens, Al; Butler, Victoria; Ravikumar, Sai P.; Laing, Roz; Woods, Debra J.; Gilleard, John S.			The Transcriptional Response of Caenorhabditis elegans to Ivermectin Exposure Identifies Novel Genes Involved in the Response to Reduced Food Intake	PLOS ONE			English	Article							GATED CHLORIDE CHANNEL; ANTHELMINTIC RESISTANCE; PARASITIC NEMATODE; PHARYNGEAL MUSCLE; C-ELEGANS; EXPRESSION; GLUTAMATE; TRANSPORT; SUBUNIT; DAUER	We have examined the transcriptional response of Caenorhabditis elegans following exposure to the anthelmintic drug ivermectin (IVM) using whole genome microarrays and real-time QPCR. Our original aim was to identify candidate molecules involved in IVM metabolism and/or excretion. For this reason the IVM tolerant strain, DA1316, was used to minimise transcriptomic changes related to the phenotype of drug exposure. However, unlike equivalent work with benzimidazole drugs, very few of the induced genes were members of xenobiotic metabolising enzyme families. Instead, the transcriptional response was dominated by genes associated with fat mobilization and fatty acid metabolism including catalase, esterase, and fatty acid CoA synthetase genes. This is consistent with the reduction in pharyngeal pumping, and consequential reduction in food intake, upon exposure of DA1316 worms to IVM. Genes with the highest fold change in response to IVM exposure, cyp-37B1, mtl-1 and scl-2, were comparably up-regulated in response to short-term food withdrawal (4 hr) independent of IVM exposure, and GFP reporter constructs confirm their expression in tissues associated with fat storage (intestine and hypodermis). These experiments have serendipitously identified novel genes involved in an early response of C. elegans to reduced food intake and may provide insight into similar processes in higher organisms.	[Laing, Steven T.; Laing, Roz] Univ Glasgow, Fac Vet Med, Glasgow, Strathclyde, Scotland; [Ivens, Al] Fios Genom Ltd, Edinburgh Technol Transfer Ctr, Edinburgh, Midlothian, Scotland; [Butler, Victoria; Ravikumar, Sai P.; Gilleard, John S.] Univ Calgary, Fac Vet Med, Calgary, AB, Canada; [Woods, Debra J.] Pfizer Anim Hlth, Res & Dev, Kalamazoo, MI USA	University of Glasgow; University of Edinburgh; University of Calgary; Pfizer	Laing, ST (corresponding author), Univ Glasgow, Fac Vet Med, Glasgow, Strathclyde, Scotland.	jsgillea@ucalgary.ca		Laing, Roz/0000-0002-6191-0759; Ivens, Al/0000-0002-0112-3876; Gilleard, John/0000-0002-6787-4699	Biotechnology and Biological Sciences Research Council CASE; Biosciences Knowledge Transfer Network; Pfizer Plc.; Pfizer Animal Health PLC.	Biotechnology and Biological Sciences Research Council CASE(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biosciences Knowledge Transfer Network; Pfizer Plc.(Pfizer); Pfizer Animal Health PLC.	Dr. Steven Laing was supported by a Biotechnology and Biological Sciences Research Council CASE Studentship and the Biosciences Knowledge Transfer Network (formerly Genesis Faraday). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additional funding was supplied by Pfizer Plc. Dr. Deborah Woods, who is employed by Pfizer, provided advice and support regarding the use of the HPLC-MS, so she had technical and intellectual input into that aspect.; The authors have read the journal's policy and have the following conflicts: One author (Al Ivens) is employed by Fios Genomics Ltd and another (Deborah Woods) is employed by Prizer Animal Health. In addition, the study received some funding support from Pfizer Animal Health PLC. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Ardelli BF, 2009, VET PARASITOL, V165, P96, DOI 10.1016/j.vetpar.2009.06.043; Ashrafi Kaveh, 2007, WormBook, P1; Awadzi K, 2004, ANN TROP MED PARASIT, V98, P231, DOI 10.1179/000349804225003253; Bargmann CI., 2006, WORMBOOK, P1, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Brownlee DJA, 1997, PARASITOLOGY, V115, P553, DOI 10.1017/S0031182097001601; Churcher TS, 2009, P NATL ACAD SCI USA, V106, P16716, DOI 10.1073/pnas.0906176106; Cousins RJ, 2006, J BIOL CHEM, V281, P24085, DOI 10.1074/jbc.R600011200; Cui YX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r122; Custodia N, 2001, ANN NY ACAD SCI, V948, P32; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dent JA, 2000, P NATL ACAD SCI USA, V97, P2674, DOI 10.1073/pnas.97.6.2674; Dent JA, 1997, EMBO J, V16, P5867, DOI 10.1093/emboj/16.19.5867; Edward CL, 2008, VET REC, V162, P56, DOI 10.1136/vr.162.2.56; Etter A, 1996, J BIOL CHEM, V271, P16035, DOI 10.1074/jbc.271.27.16035; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; Fox LM, 2006, CURR OPIN INFECT DIS, V19, P588, DOI 10.1097/QCO.0b013e328010774c; FREEDMAN JH, 1993, J BIOL CHEM, V268, P2554; Gilleard JS, 2006, INT J PARASITOL, V36, P1227, DOI 10.1016/j.ijpara.2006.06.010; Canga AG, 2009, VET J, V179, P25, DOI 10.1016/j.tvjl.2007.07.011; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Holden-Dye L, 2006, INT J PARASITOL, V36, P395, DOI 10.1016/j.ijpara.2005.11.006; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; James CE, 2009, INT J PARASITOL, V39, P213, DOI 10.1016/j.ijpara.2008.06.009; Jeong PY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004162; Johnstone IL, 1999, PRACT APPROACH SER, V213, P201; Johnstone IL, 1996, EMBO J, V15, P3633, DOI 10.1002/j.1460-2075.1996.tb00732.x; Jones KT, 2009, DIS MODEL MECH, V2, P224, DOI 10.1242/dmm.001933; Kaplan RM, 2004, TRENDS PARASITOL, V20, P477, DOI 10.1016/j.pt.2004.08.001; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kondoh M, 2003, TOXICOL LETT, V143, P301, DOI 10.1016/S0378-4274(03)00195-4; Kulas J, 2008, ARCH BIOCHEM BIOPHYS, V472, P65, DOI 10.1016/j.abb.2008.02.002; Laing ST, 2010, BIOCHEM J, V432, P505, DOI 10.1042/BJ20101346; Li AR, 2004, AM J HUM GENET, V74, P817, DOI 10.1086/383228; McCavera S, 2009, MOL PHARMACOL, V75, P1347, DOI 10.1124/mol.108.053363; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Menzel R, 2007, J MOL BIOL, V370, P1, DOI 10.1016/j.jmb.2007.04.058; Mullaney BC, 2009, BBA-MOL CELL BIOL L, V1791, P474, DOI 10.1016/j.bbalip.2008.12.013; Nakano M, 2009, DRUG METAB DISPOS, V37, P2119, DOI 10.1124/dmd.109.028530; Osei-Atweneboano MY, 2007, LANCET, V369, P2021, DOI 10.1016/S0140-6736(07)60942-8; Pemberton DJ, 2001, MOL PHARMACOL, V59, P1037, DOI 10.1124/mol.59.5.1037; Reichert K, 2005, CHEMOSPHERE, V61, P229, DOI 10.1016/j.chemosphere.2005.01.077; Sargison ND, 2007, VET PARASITOL, V145, P65, DOI 10.1016/j.vetpar.2006.10.024; Shinogi M, 1999, BIOL PHARM BULL, V22, P132, DOI 10.1248/bpb.22.132; Sogawa N, 2003, METHOD FIND EXP CLIN, V25, P601, DOI 10.1358/mf.2003.25.8.778079; Stiernagle Theresa, 2006, WormBook, P1; Szewczyk NJ, 2006, J EXP BIOL, V209, P4129, DOI 10.1242/jeb.02492; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Vassilatis DK, 1997, J BIOL CHEM, V272, P33167, DOI 10.1074/jbc.272.52.33167; Wang J, 2003, DEVELOPMENT, V130, P1621, DOI 10.1242/dev.00363; Yates DM, 2003, INT J PARASITOL, V33, P1183, DOI 10.1016/S0020-7519(03)00172-3; Zheng J, 2012, INT J OBESITY, V36, P186, DOI 10.1038/ijo.2011.93	52	24	28	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31367	10.1371/journal.pone.0031367	http://dx.doi.org/10.1371/journal.pone.0031367			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348077	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000302737400018
J	Fu, J; Zhang, DF; Liu, YH; Ying, S; Shi, YS; Song, YC; Li, Y; Wang, TY				Fu, Jing; Zhang, Deng-Feng; Liu, Ying-Hui; Ying, Sheng; Shi, Yun-Su; Song, Yan-Chun; Li, Yu; Wang, Tian-Yu			Isolation and Characterization of Maize PMP3 Genes Involved in Salt Stress Tolerance	PLOS ONE			English	Article							NONSELECTIVE CATION CHANNELS; NA+/H+ ANTIPORTER GENE; PLASMA-MEMBRANE; SUPEROXIDE-DISMUTASE; ION HOMEOSTASIS; CHLOROPHYLL FLUORESCENCE; SIGNAL-TRANSDUCTION; ENHANCED TOLERANCE; ARABIDOPSIS; PROTEIN	Plasma membrane protein 3 (PMP3), a class of small hydrophobic polypeptides with high sequence similarity, is responsible for salt, drought, cold, and abscisic acid. These small hydrophobic ploypeptides play important roles in maintenance of ion homeostasis. In this study, eight ZmPMP3 genes were cloned from maize and responsive to salt, drought, cold and abscisic acid. The eight ZmPMP3s were membrane proteins and their sequences in trans-membrane regions were highly conserved. Phylogenetic analysis showed that they were categorized into three groups. All members of group II were responsive to ABA. Functional complementation showed that with the exception of ZmPMP3-6, all were capable of maintaining membrane potential, which in turn allows for regulation of intracellular ion homeostasis. This process was independent of the presence of Ca2+. Lastly, over-expression of ZmPMP3-1 enhanced growth of transgenic Arabidopsis under salt condition. Through expression analysis of deduced downstream genes in transgenic plants, expression levels of three ion transporter genes and four important antioxidant genes in ROS scavenging system were increased significantly in transgenic plants during salt stress. This tolerance was likely achieved through diminishing oxidative stress due to the possibility of ZmPMP3-1's involvement in regulation of ion homeostasis, and suggests that the modulation of these conserved small hydrophobic polypeptides could be an effective way to improve salt tolerance in plants.	[Fu, Jing] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China; [Fu, Jing; Zhang, Deng-Feng; Liu, Ying-Hui; Ying, Sheng; Shi, Yun-Su; Song, Yan-Chun; Li, Yu; Wang, Tian-Yu] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Fu, J (corresponding author), China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China.	yuli@mail.caas.net.cn; wangtianyu@263.net			Ministry of Science and Technology of China [2011CB100100, 2009CB118401]; China Natural Science Foundation [30730063]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); China Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was partly supported by grants provided by the Ministry of Science and Technology of China (2011CB100100, 2009CB118401) and the China Natural Science Foundation (30730063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apse MP, 2003, PLANT J, V36, P229, DOI 10.1046/j.1365-313X.2003.01871.x; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Badawi GH, 2004, PLANT SCI, V166, P919, DOI 10.1016/j.plantsci.2003.12.007; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Bihler H, 1998, FEBS LETT, V432, P59, DOI 10.1016/S0014-5793(98)00832-1; Brini F, 2007, J EXP BOT, V58, P301, DOI 10.1093/jxb/erl251; Chang-Qing Z, 2008, BMB REP, V41, P448, DOI 10.5483/BMBRep.2008.41.6.448; CHEESEMAN JM, 1985, PHYSIOL PLANTARUM, V65, P460, DOI 10.1111/j.1399-3054.1985.tb08674.x; Demidchik V, 2002, PLANT PHYSIOL, V128, P379, DOI 10.1104/pp.010524; Demidchik V, 2007, NEW PHYTOL, V175, P387, DOI 10.1111/j.1469-8137.2007.02128.x; Farooq S, 2006, J PLANT PHYSIOL, V163, P629, DOI 10.1016/j.jplph.2005.06.006; Feng DR, 2009, ENVIRON EXP BOT, V65, P395, DOI 10.1016/j.envexpbot.2008.12.009; Fu Y, 2005, CELL, V120, P687, DOI 10.1016/j.cell.2004.12.026; GALVEZ AF, 1993, PLANT PHYSIOL, V103, P257, DOI 10.1104/pp.103.1.257; Gaxiola RA, 2001, P NATL ACAD SCI USA, V98, P11444, DOI 10.1073/pnas.191389398; Gobert A, 2006, J EXP BOT, V57, P791, DOI 10.1093/jxb/erj064; GODDARD NJ, 1993, PLANT MOL BIOL, V23, P871, DOI 10.1007/BF00021541; GRADMANN D, 1993, J MEMBRANE BIOL, V136, P327; Guo KM, 2010, PHYSIOL PLANTARUM, V139, P303, DOI 10.1111/j.1399-3054.2010.01366.x; Halfter U, 2000, P NATL ACAD SCI USA, V97, P3735, DOI 10.1073/pnas.040577697; Harmon AC, 2000, TRENDS PLANT SCI, V5, P154, DOI 10.1016/S1360-1385(00)01577-6; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Inada M, 2005, PLANTA, V220, P395, DOI 10.1007/s00425-004-1358-7; Koike M, 2008, MOL GENET GENOMICS, V280, P41, DOI 10.1007/s00438-008-0343-4; KRAUSE GH, 1984, PHOTOSYNTH RES, V5, P139, DOI 10.1007/BF00028527; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li YZ, 2010, ENVIRON EXP BOT, V69, P158, DOI 10.1016/j.envexpbot.2010.03.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Medina J, 2007, J EXP BOT, V58, P4333, DOI 10.1093/jxb/erm285; Meloni DA, 2003, ENVIRON EXP BOT, V49, P69, DOI 10.1016/S0098-8472(02)00058-8; Mitsuya S, 2005, PLANTA, V222, P1001, DOI 10.1007/s00425-005-0043-9; Mitsuya S, 2006, PHYSIOL PLANTARUM, V128, P95, DOI 10.1111/j.1399-3054.2006.00714.x; Morales MA, 1998, J PLANT PHYSIOL, V153, P174, DOI 10.1016/S0176-1617(98)80062-X; Morsy MR, 2005, GENE, V344, P171, DOI 10.1016/j.gene.2004.09.033; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Navarre C, 2000, EMBO J, V19, P2515, DOI 10.1093/emboj/19.11.2515; NEUHAUS G, 1993, CELL, V73, P937, DOI 10.1016/0092-8674(93)90272-R; Nylander M, 2001, PLANT MOL BIOL, V45, P341, DOI 10.1023/A:1006451914231; Ohta M, 2002, FEBS LETT, V532, P279, DOI 10.1016/S0014-5793(02)03679-7; Patrick IG, 1994, PLANT PHYSIOL, V104, P799; PERLIN DS, 1988, J BIOL CHEM, V263, P18118; Rengasamy P, 2010, FUNCT PLANT BIOL, V37, P613, DOI 10.1071/FP09249; Sairam RK, 2005, BIOL PLANTARUM, V49, P85, DOI 10.1007/s10535-005-5091-2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SEEMANN JR, 1985, PLANTA, V164, P151, DOI 10.1007/BF00396077; Shi HZ, 2002, PLANT MOL BIOL, V50, P543, DOI 10.1023/A:1019859319617; Shi HZ, 2002, PLANT CELL, V14, P465, DOI 10.1105/tpc.010371; Shi HZ, 2002, NATURE, DOI [10.1083/nbt766, DOI 10.1083/NBT766]; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tseng MJ, 2007, PLANT PHYSIOL BIOCH, V45, P822, DOI 10.1016/j.plaphy.2007.07.011; Wang MY, 2007, PLANT MOL BIOL, V65, P733, DOI 10.1007/s11103-007-9238-8; Wang YH, 2004, PLANT SCI, V167, P671, DOI 10.1016/j.plantsci.2004.03.032; Yu SP, 2001, CURR OPIN CELL BIOL, V13, P405, DOI 10.1016/S0955-0674(00)00228-3; Zhang YY, 2006, PLANTA, V224, P545, DOI 10.1007/s00425-006-0242-z; Zhao JF, 2009, PLANT MOL BIOL, V69, P661, DOI 10.1007/s11103-008-9445-y; Zhu JK, 2000, PLANT PHYSIOL, V124, P941, DOI 10.1104/pp.124.3.941; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zorb C, 2005, J PLANT PHYSIOL, V162, P55, DOI 10.1016/j.jplph.2004.03.010	63	35	38	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31101	10.1371/journal.pone.0031101	http://dx.doi.org/10.1371/journal.pone.0031101			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348040	Green Published, gold, Green Submitted			2022-12-25	WOS:000302733900022
J	Koikkalainen, J; Polonen, H; Mattila, J; van Gils, M; Soininen, H; Lotjonen, J				Koikkalainen, Juha; Polonen, Harri; Mattila, Jussi; van Gils, Mark; Soininen, Hilkka; Lotjonen, Jyrki		Alzheimers Dis Neuroimaging Initia	Improved Classification of Alzheimer's Disease Data via Removal of Nuisance Variability	PLOS ONE			English	Article							PERSONALIZED MEDICINE; DIAGNOSIS	Diagnosis of Alzheimer's disease is based on the results of neuropsychological tests and available supporting biomarkers such as the results of imaging studies. The results of the tests and the values of biomarkers are dependent on the nuisance features, such as age and gender. In order to improve diagnostic power, the effects of the nuisance features have to be removed from the data. In this paper, four types of interactions between classification features and nuisance features were identified. Three methods were tested to remove these interactions from the classification data. In stratified analysis, a homogeneous subgroup was generated from a training set. Data correction method utilized linear regression model to remove the effects of nuisance features from data. The third method was a combination of these two methods. The methods were tested using all the baseline data from the Alzheimer's Disease Neuroimaging Initiative database in two classification studies: classifying control subjects from Alzheimer's disease patients and discriminating stable and progressive mild cognitive impairment subjects. The results show that both stratified analysis and data correction are able to statistically significantly improve the classification accuracy of several neuropsychological tests and imaging biomarkers. The improvements were especially large for the classification of stable and progressive mild cognitive impairment subjects, where the best improvements observed were 6% units. The data correction method gave better results for imaging biomarkers, whereas stratified analysis worked well with the neuropsychological tests. In conclusion, the study shows that the excess variability caused by nuisance features should be removed from the data to improve the classification accuracy, and therefore, the reliability of diagnosis making.	[Koikkalainen, Juha; Polonen, Harri; Mattila, Jussi; van Gils, Mark; Lotjonen, Jyrki] VTT Tech Res Ctr Finland, Tampere, Finland; [Soininen, Hilkka] Univ Eastern Finland, Dept Neurol, Kuopio, Finland; [Soininen, Hilkka] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland	VTT Technical Research Center Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Koikkalainen, J (corresponding author), VTT Tech Res Ctr Finland, Tampere, Finland.	juha.koikkalainen@vtt.fi	Hsiung, Robin/AAT-1661-2021; Preda, Adrian/K-8889-2013; Levey, Allan/F-2104-2011	Hsiung, Robin/0000-0002-8017-0856; Preda, Adrian/0000-0003-3373-2438; Levey, Allan/0000-0002-3153-502X; van Gils, Mark/0000-0002-0029-1771; , Harri/0000-0002-3270-2897	European Commission; EU [224328-PredictAD, 270259-TBIcare]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; NIH [P30 AG010129, K01 AG030514]; Dana Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000117, UL1TR001998] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013846, R01AG022374, P30AG010129, R01AG012101, K01AG030514, U19AG010483, U01AG024904, P30AG019610] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); EU(European Commission); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded under the 7th Framework Programme by the European Commission (http//cordis.europa.eu/; EU-Grant-224328-PredictAD; Name: From Patient Data to Personalized Healthcare in Alzheimer's Disease, and EU-Grant-270259-TBIcare; Name: Evidence-based Diagnostics and Treatment Planning Solution for Traumatic Brain Injuries). Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). This research was also supported by NIH grants P30 AG010129, K01 AG030514, and the Dana Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASU D, 1977, J AM STAT ASSOC, V72, P355, DOI 10.2307/2286800; Beckett LA, 2010, ALZHEIMERS DEMENT, V6, P257, DOI 10.1016/j.jalz.2010.03.002; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Cronk BB, 2010, ALZ DIS ASSOC DIS, V24, P126, DOI 10.1097/WAD.0b013e3181a6bf3f; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Dukart J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022193; Fernald GH, 2011, BIOINFORMATICS, V27, P1741, DOI 10.1093/bioinformatics/btr295; Fjell AM, 2009, J NEUROSCI, V29, P15223, DOI 10.1523/JNEUROSCI.3252-09.2009; Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304; Kohannim O, 2010, NEUROBIOL AGING, V31, P1429, DOI 10.1016/j.neurobiolaging.2010.04.022; Mattila J, 2011, J ALZHEIMERS DIS, V27, P163, DOI 10.3233/JAD-2011-110365; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Rothman K., 1998, MODERN EPIDEMIOLOGY, P253; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schilsky RL, 2010, NAT REV DRUG DISCOV, V9, P363, DOI 10.1038/nrd3181; Waldemar G, 2007, EUR J NEUROL, V14, pE1, DOI 10.1111/j.1468-1331.2006.01605.x; Wildt A., 1978, ANAL COVARIANCE	17	35	35	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31112	10.1371/journal.pone.0031112	http://dx.doi.org/10.1371/journal.pone.0031112			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348041	Green Published, gold			2022-12-25	WOS:000302733900023
J	Pirko, I; Chen, Y; Lohrey, AK; McDole, J; Gamez, JD; Allen, KS; Pavelko, KD; Lindquist, DM; Dunn, RS; Macura, SI; Johnson, AJ				Pirko, Istvan; Chen, Yi; Lohrey, Anne K.; McDole, Jeremiah; Gamez, Jeffrey D.; Allen, Kathleen S.; Pavelko, Kevin D.; Lindquist, Diana M.; Dunn, R. Scott; Macura, Slobodan I.; Johnson, Aaron J.			Contrasting Roles for CD4 vs. CD8 T-Cells in a Murine Model of Virally Induced "T1 Black Hole" Formation	PLOS ONE			English	Article							INDUCED DEMYELINATING DISEASE; ENCEPHALOMYELITIS VIRUS-INFECTION; MULTIPLE-SCLEROSIS LESIONS; SPIN-ECHO MRI; THEILERS VIRUS; HYPOINTENSE LESIONS; VASCULAR-PERMEABILITY; GAMMA-INTERFERON; MOTOR FUNCTION; C57BL/6 MICE	MRI is sensitive to tissue pathology in multiple sclerosis (MS); however, most lesional MRI findings have limited correlation with disability. Chronic T1 hypointense lesions or "T1 black holes" (T1BH), observed in a subset of MS patients and thought to represent axonal damage, show moderate to strong correlation with disability. The pathogenesis of T1BH remains unclear. We previously reported the first and as of yet only model of T1BH formation in the Theiler's murine encephalitis virus induced model of acute CNS neuroinflammation induced injury, where CD8 T-cells are critical mediators of axonal damage and related T1BH formation. The purpose of this study was to further analyze the role of CD8 and CD4 T-cells through adoptive transfer experiments and to determine if the relevant CD8 T-cells are classic epitope specific lymphocytes or different subsets. C57BL/6 mice were used as donors and RAG-1 deficient mice as hosts in our adoptive transfer experiments. In vivo 3-dimensional MRI images were acquired using a 7 Tesla small animal MRI system. For image analysis, we used semi-automated methods in Analyze 9.1; transfer efficiency was monitored using FACS of brain infiltrating lymphocytes. Using a peptide depletion method, we demonstrated that the majority of CD8 T-cells are classic epitope specific cytotoxic cells. CD8 T-cell transfer successfully restored the immune system's capability to mediate T1BH formation in animals that lack adaptive immune system, whereas CD4 T-cell transfer results in an attenuated phenotype with significantly less T1BH formation. These findings demonstrate contrasting roles for these cell types, with additional evidence for a direct pathogenic role of CD8 T-cells in our model of T1 black hole formation.	[Pirko, Istvan; Gamez, Jeffrey D.] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA; [Chen, Yi; Lohrey, Anne K.] Univ Cincinnati, Dept Neurol, Cincinnati, OH USA; [McDole, Jeremiah] Washington Univ, Dept Pathol & Immunol, St Louis, MO USA; [Allen, Kathleen S.; Pavelko, Kevin D.] Mayo Clin, Dept Immunol, Rochester, MN USA; [Lindquist, Diana M.; Dunn, R. Scott] Cincinnati Childrens Hosp, Med Ctr, Imaging Res Ctr, Cincinnati, OH USA; [Macura, Slobodan I.] Mayo Clin, Dept Biochem, NMR Core Facil, Rochester, MN USA	Mayo Clinic; University System of Ohio; University of Cincinnati; Washington University (WUSTL); Mayo Clinic; Cincinnati Children's Hospital Medical Center; Mayo Clinic	Pirko, I (corresponding author), Mayo Clin, Dept Neurol, Rochester, MN 55905 USA.	pirko@mayo.edu	Pavelko, Kevin D/K-7072-2019	Pavelko, Kevin D/0000-0001-7555-1315	National Institutes of Health, National Institute of Neurological Disorders and Stroke [R01 NS058698]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058698] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institutes of Health, National Institute of Neurological Disorders and Stroke R01 NS058698. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkhof F, 2000, NEUROIMAG CLIN N AM, V10, P739; Barkhof F, 2000, NEUROIMAG CLIN N AM, V10, pix; Bitsch A, 2000, BRAIN, V123, P1174, DOI 10.1093/brain/123.6.1174; Bitsch A, 2001, ANN NEUROL, V49, P793, DOI 10.1002/ana.1053; BORROW P, 1993, IMMUNOLOGY, V80, P502; Brahic M, 2002, VIROLOGY, V301, P1, DOI 10.1006/viro.2002.1607; Chang JR, 2000, VIROLOGY, V278, P346, DOI 10.1006/viro.2000.0646; Chitnis T, 2007, INT REV NEUROBIOL, V79, P43, DOI 10.1016/S0074-7742(07)79003-7; Deb C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012478; Denic A, 2011, NEUROTHERAPEUTICS, V8, P3, DOI 10.1007/s13311-010-0002-4; Denic Aleksandar, 2011, Pathophysiology, V18, P21, DOI 10.1016/j.pathophys.2010.04.004; Hill KE, 1998, J NEUROIMMUNOL, V85, P44, DOI 10.1016/S0165-5728(97)00263-4; Hou WQ, 2009, J EXP MED, V206, P313, DOI 10.1084/jem.20082030; Howe CL, 2007, J NEUROIMMUNOL, V188, P13, DOI 10.1016/j.jneuroim.2007.04.005; Inoue A, 1998, J IMMUNOL, V161, P5586; Johnson AJ, 2007, INT REV NEUROBIOL, V79, P73, DOI 10.1016/S0074-7742(07)79004-9; Johnson AJ, 2005, J IMMUNOL, V174, P6854, DOI 10.4049/jimmunol.174.11.6854; Johnson AJ, 1999, J VIROL, V73, P3702, DOI 10.1128/JVI.73.5.3702-3708.1999; Johnson AJ, 2001, FASEB J, V15, P2760, DOI 10.1096/fj.01-0373fje; Kang HS, 2010, J VIROL, V84, P2774, DOI 10.1128/JVI.01948-09; Karls KA, 2002, MULT SCLER J, V8, P469, DOI 10.1191/1352458502ms850oa; Kerkvliet J, 2009, J VIROL, V83, P12279, DOI 10.1128/JVI.00664-09; Losseff NA, 2001, J NEUROL, V248, P517, DOI 10.1007/s004150170163; McDole J, 2006, NEUROL RES, V28, P256, DOI 10.1179/016164106X98125; McDole JR, 2010, AM J PATHOL, V177, P1823, DOI 10.2353/ajpath.2010.100231; McDole JR, 2010, AM J PATHOL; Miller SD, 1997, NAT MED, V3, P1133, DOI 10.1038/nm1097-1133; Myoung J, 2007, VIROLOGY, V360, P159, DOI 10.1016/j.virol.2006.09.045; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Pavelko KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020217; Pirko I, 2004, NEUROIMAGE, V21, P576, DOI 10.1016/j.neuroimage.2003.09.037; Pirko I, 2011, NEUROIMAGE, V54, P802, DOI 10.1016/j.neuroimage.2010.08.055; PIRKO I, 2009, J NEUROL SCI; Pirko I, 2008, RADIOLOGY, V246, P790, DOI 10.1148/radiol.2463070338; Pirko I, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-31; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; PULLEN LC, 1994, J NEUROIMMUNOL, V55, P143, DOI 10.1016/0165-5728(94)90004-3; Robb RA, 2001, IEEE T MED IMAGING, V20, P854, DOI 10.1109/42.952724; Robb RA, 1999, ANNU REV BIOMED ENG, V1, P377, DOI 10.1146/annurev.bioeng.1.1.377; Rodriguez M, 2003, J VIROL, V77, P12252, DOI 10.1128/JVI.77.22.12252-12265.2003; Sato F, 2010, PATHOPHYSIOLOGY; Suidan GL, 2010, J IMMUNOL, V184, P1031, DOI 10.4049/jimmunol.0902773; Suidan GL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003037; Suidan GL, 2006, NEUROL RES, V28, P250, DOI 10.1179/016164106X98116; Truyen L, 1996, NEUROLOGY, V47, P1469, DOI 10.1212/WNL.47.6.1469; Tsunoda I, 2005, J VIROL, V79, P14640, DOI 10.1128/JVI.79.23.14640-14646.2005; Tsunoda I, 2002, J VIROL, V76, P12834, DOI 10.1128/JVI.76.24.12834-12844.2002; Tsunoda I, 2010, J NEUROIMMUNE PHARM, V5, P355, DOI 10.1007/s11481-009-9179-x; van Waesberghe JHTM, 1999, ANN NEUROL, V46, P747; van Walderveen MAA, 1998, NEUROLOGY, V50, P1282, DOI 10.1212/WNL.50.5.1282; VANWALDERVEEN MAA, 1995, NEUROLOGY, V45, P1684, DOI 10.1212/WNL.45.9.1684; YAMADA M, 1990, J EXP MED, V171, P1893, DOI 10.1084/jem.171.6.1893	52	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31459	10.1371/journal.pone.0031459	http://dx.doi.org/10.1371/journal.pone.0031459			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348089	Green Submitted, Green Published, gold			2022-12-25	WOS:000302733900048
J	Crespo, JA; Stockl, P; Ueberall, F; Jenny, M; Saria, A; Zernig, G				Crespo, Jose A.; Stoeckl, Petra; Ueberall, Florian; Jenny, Marcel; Saria, Alois; Zernig, Gerald			Activation of PKCzeta and PKMzeta in the Nucleus Accumbens Core Is Necessary for the Retrieval, Consolidation and Reconsolidation of Drug Memory	PLOS ONE			English	Article							PROTEIN-KINASE-C; COCAINE-SEEKING BEHAVIOR; RAT RUNWAY PROCEDURE; ACETYLCHOLINE; REINFORCEMENT; DOPAMINE; FOOD; REMIFENTANIL; INTERNEURONS; ACQUISITION	One of the greatest challenges in the treatment of substance dependence is to reverse the control that drug-associated stimuli have gained over the addict's behavior, as these drug-associated memories increase the risk of relapse even after long periods of abstinence. We report here that inhibition of the atypical protein kinase C isoform PKCzeta and its constitutively active isoform PKMzeta with the pseudosubstrate inhibitor ZIP administered locally into the nucleus accumbens core reversibly inhibited the retrieval of drug-associated memory and drug (remifentanil) seeking, whereas a scrambled ZIP peptide or staurosporine, an effective inhibitor of c/nPKC-, CaMKII-, and PKA kinases that does not affect PKCzeta/PKMzeta activity, was without effect on these memory processes. Acquisition or extinction of drug-associated memory remained unaffected by PKCzeta- and PKMzeta inhibition.	[Crespo, Jose A.; Stoeckl, Petra; Saria, Alois; Zernig, Gerald] Innsbruck Med Univ, Dept Gen Psychiat & Social Psychiat, Expt Psychiat Unit, Innsbruck, Austria; [Ueberall, Florian; Jenny, Marcel] Innsbruck Med Univ, Div Med Biochem, Innsbruck Bioctr, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck	Crespo, JA (corresponding author), Innsbruck Med Univ, Dept Gen Psychiat & Social Psychiat, Expt Psychiat Unit, Innsbruck, Austria.	gerald.zernig@i-med.ac.at			FWF [P18787-B05]; D.SwarovskiForschungsforderungsfonds [D-151840-012-011]; Verein fur Experimentelle Psychiatrie, Psychotherapie und Pharmakologie (VEPPP)	FWF(Austrian Science Fund (FWF)); D.SwarovskiForschungsforderungsfonds; Verein fur Experimentelle Psychiatrie, Psychotherapie und Pharmakologie (VEPPP)	This work was supported by FWF grant P18787-B05, by D.SwarovskiForschungsforderungsfonds grant D-151840-012-011, and by Verein fur Experimentelle Psychiatrie, Psychotherapie und Pharmakologie (VEPPP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aujla H, 2003, BEHAV BRAIN RES, V147, P41, DOI 10.1016/S0166-4328(03)00136-0; Calabresi P, 2000, TRENDS NEUROSCI, V23, P120, DOI 10.1016/S0166-2236(99)01501-5; Crespo JA, 2005, PSYCHOPHARMACOLOGY, V183, P201, DOI 10.1007/s00213-005-0180-7; Crespo JA, 2008, NEUROPSYCHOPHARMACOL, V33, P3213, DOI 10.1038/npp.2008.48; Crespo JA, 2006, ANN NY ACAD SCI, V1074, P497, DOI 10.1196/annals.1369.050; Crespo JA, 2006, J NEUROSCI, V26, P6004, DOI 10.1523/JNEUROSCI.4494-05.2006; Dekker LV, 2003, PROTEIN KINASE C; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Epstein DH, 2009, ARCH GEN PSYCHIAT, V66, P88, DOI 10.1001/archgenpsychiatry.2008.509; Ettenberg A, 2009, PHARMACOL BIOCHEM BE, V91, P271, DOI 10.1016/j.pbb.2008.11.003; GEIST TD, 1990, PHARMACOL BIOCHEM BE, V36, P703, DOI 10.1016/0091-3057(90)90278-P; Hopf FW, 2005, J NEUROSCI, V25, P985, DOI 10.1523/JNEUROSCI.3099-04.2005; Ito R, 2004, NAT NEUROSCI, V7, P389, DOI 10.1038/nn1217; Lee JLC, 2006, J NEUROSCI, V26, P5881, DOI 10.1523/JNEUROSCI.0323-06.2006; Lee JLC, 2005, NEURON, V47, P795, DOI 10.1016/j.neuron.2005.08.007; Mark GP, 1999, PSYCHOPHARMACOLOGY, V143, P47, DOI 10.1007/s002130050918; Miller CA, 2005, NEURON, V47, P873, DOI 10.1016/j.neuron.2005.08.006; Nader K, 2000, NAT REV NEUROSCI, V1, P216, DOI 10.1038/35044580; Narita M, 2001, NEUROSCIENCE, V103, P309, DOI 10.1016/S0306-4522(00)00572-8; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pratt WE, 2007, BEHAV NEUROSCI, V121, P1215, DOI 10.1037/0735-7044.121.6.1215; Pratt WE, 2004, BEHAV NEUROSCI, V118, P730, DOI 10.1037/0735-7044.118.4.730; Preston KL, 2009, PSYCHOPHARMACOLOGY, V207, P291, DOI 10.1007/s00213-009-1655-8; Rymar VV, 2004, J COMP NEUROL, V469, P325, DOI 10.1002/cne.11008; Sossin WS, 2007, LEARN MEMORY, V14, P236, DOI 10.1101/lm.469707; Theberge FRM, 2010, LEARN MEMORY, V17, P444, DOI 10.1101/lm.1757410; Wakionigg G, 2003, PHARMACOLOGY, V69, P180, DOI 10.1159/000073661; Wakonigg G, 2004, PHARMACOLOGY, V72, P225, DOI 10.1159/000080377; Wakonigg G, 2003, PSYCHOPHARMACOLOGY, V169, P52, DOI 10.1007/s00213-003-1488-9; Witten IB, 2010, SCIENCE, V330, P1677, DOI 10.1126/science.1193771; Yin HH, 2008, EUR J NEUROSCI, V28, P1437, DOI 10.1111/j.1460-9568.2008.06422.x; Zahm DS, 2000, NEUROSCI BIOBEHAV R, V24, P85, DOI 10.1016/S0149-7634(99)00065-2; Zernig G, 2008, ADDICTION, V103, P2024, DOI 10.1111/j.1360-0443.2008.02348.x; Zernig G, 2007, PHARMACOLOGY, V80, P65, DOI 10.1159/000103923; Zhou FM, 2002, J NEUROBIOL, V53, P590, DOI 10.1002/neu.10150	36	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e30502	10.1371/journal.pone.0030502	http://dx.doi.org/10.1371/journal.pone.0030502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348011	Green Published, gold, Green Submitted			2022-12-25	WOS:000302730900010
J	Ferriss, JS; Kim, YC; Duska, L; Birrer, M; Levine, DA; Moskaluk, C; Theodorescu, D; Lee, JK				Ferriss, J. Stuart; Kim, Youngchul; Duska, Linda; Birrer, Michael; Levine, Douglas A.; Moskaluk, Christopher; Theodorescu, Dan; Lee, Jae K.			Multi-Gene Expression Predictors of Single Drug Responses to Adjuvant Chemotherapy in Ovarian Carcinoma: Predicting Platinum Resistance	PLOS ONE			English	Article							GENE-EXPRESSION; MICROARRAY DATA; CANCER-CELLS; CHEMOSENSITIVITY; TRIAL; ASSAY; CLASSIFICATION; PACLITAXEL; DISCOVERY	Despite advances in radical surgery and chemotherapy delivery, ovarian cancer is the most lethal gynecologic malignancy. Standard therapy includes treatment with platinum-based combination chemotherapies yet there is no biomarker model to predict their responses to these agents. We here have developed and independently tested our multi-gene molecular predictors for forecasting patients' responses to individual drugs on a cohort of 55 ovarian cancer patients. To independently validate these molecular predictors, we performed microarray profiling on FFPE tumor samples of 55 ovarian cancer patients (UVA-55) treated with platinum-based adjuvant chemotherapy. Genome-wide chemosensitivity biomarkers were initially discovered from the in vitro drug activities and genomic expression data for carboplatin and paclitaxel, respectively. Multivariate predictors were trained with the cell line data and then evaluated with a historical patient cohort. For the UVA-55 cohort, the carboplatin, taxol, and combination predictors significantly stratified responder patients and non-responder patients (p = 0.019, 0.04, 0.014) with sensitivity = 91%, 96%, 93 and NPV = 57%, 67%, 67% in pathologic clinical response. The combination predictor also demonstrated a significant survival difference between predicted responders and non-responders with a median survival of 55.4 months vs. 32.1 months. Thus, COXEN single- and combination-drug predictors successfully stratified platinum resistance and taxane response in an independent cohort of ovarian cancer patients based on their FFPE tumor samples.	[Ferriss, J. Stuart] Temple Univ, Dept Obstet Gynecol & Reprod Sci, Philadelphia, PA 19122 USA; [Kim, Youngchul; Lee, Jae K.] Univ Virginia, Dept Publ Hlth Sci, Div Biostat & Epidemiol, Charlottesville, VA USA; [Duska, Linda] Univ Virginia, Thomton Gynecol Oncol Div, Dept Obstet & Gynecol, Charlottesville, VA USA; [Birrer, Michael] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Levine, Douglas A.] Mem Sloan Kettering Canc Ctr, Gynecol Serv, New York, NY 10021 USA; [Levine, Douglas A.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Moskaluk, Christopher] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Theodorescu, Dan] Univ Colorado, Dept Surg & Pharmacol, Aurora, CO USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Virginia; University of Virginia; Harvard University; Harvard Medical School; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Virginia; University of Colorado System; University of Colorado Anschutz Medical Campus	Ferriss, JS (corresponding author), Temple Univ, Dept Obstet Gynecol & Reprod Sci, Philadelphia, PA 19122 USA.	jkl7n@virginia.edu	Ferriss, James Stuart/I-2507-2019	Ferriss, James Stuart/0000-0002-2053-8604; Levine, Douglas/0000-0003-1038-8232	UVA Cancer Center and Experimental Therapeutics	UVA Cancer Center and Experimental Therapeutics	UVA Cancer Center and Experimental Therapeutics grants (JKL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACS, 2010, CANC FACTS FIG; Berger ML, 2010, J CLIN ONCOL, V28, pE343, DOI 10.1200/JCO.2010.28.2475; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; Bookman MA, 2009, J CLIN ONCOL, V27, P1419, DOI 10.1200/JCO.2008.19.1684; Cree IA, 2007, ANTI-CANCER DRUG, V18, P1093, DOI 10.1097/CAD.0b013e3281de727e; Dressman HK, 2007, J CLIN ONCOL, V25, P517, DOI 10.1200/JCO.2006.06.3743; Gallion H, 2006, INT J GYNECOL CANCER, V16, P194, DOI 10.1111/j.1525-1438.2006.00301.x; KERN DH, 1990, J NATL CANCER I, V82, P582, DOI 10.1093/jnci/82.7.582; Lee JK, 2007, P NATL ACAD SCI USA, V104, P13086, DOI 10.1073/pnas.0610292104; Lee JK, 2010, CLIN CANCER RES, V16, P711, DOI 10.1158/1078-0432.CCR-09-2247; Lee JK, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r82; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; Parmar MKB, 2003, LANCET, V361, P2099; Parmigiani G, 2004, CLIN CANCER RES, V10, P2922, DOI 10.1158/1078-0432.CCR-03-0490; Peters D, 2005, MOL CANCER THER, V4, P1605, DOI 10.1158/1535-7163.MCT-04-0311; Smith SC, 2010, CANCER RES, V70, P1753, DOI 10.1158/0008-5472.CAN-09-3562; Soukup M, 2005, BIOINFORMATICS, V21, pI423, DOI 10.1093/bioinformatics/bti1020; Williams PD, 2009, CANCER RES, V69, P8302, DOI 10.1158/0008-5472.CAN-09-0798; Zhou XHJ, 2005, NAT BIOTECHNOL, V23, P238, DOI 10.1038/nbt1058	19	73	73	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e30550	10.1371/journal.pone.0030550	http://dx.doi.org/10.1371/journal.pone.0030550			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348014	Green Published, Green Submitted, gold			2022-12-25	WOS:000302730900012
J	Hoogman, M; Rijpkema, M; Janss, L; Brunner, H; Fernandez, G; Buitelaar, J; Franke, B; Arias-Vasquez, A				Hoogman, Martine; Rijpkema, Mark; Janss, Luc; Brunner, Han; Fernandez, Guillen; Buitelaar, Jan; Franke, Barbara; Arias-Vasquez, Alejandro			Current Self-Reported Symptoms of Attention Deficit/Hyperactivity Disorder Are Associated with Total Brain Volume in Healthy Adults	PLOS ONE			English	Article								Background: Reduced total brain volume is a consistent finding in children with Attention Deficit/Hyperactivity Disorder (ADHD). In order to get a better understanding of the neurobiology of ADHD, we take the first step in studying the dimensionality of current self-reported adult ADHD symptoms, by looking at its relation with total brain volume. Methodology/Principal Findings: In a sample of 652 highly educated adults, the association between total brain volume, assessed with magnetic resonance imaging, and current number of self-reported ADHD symptoms was studied. The results showed an association between these self-reported ADHD symptoms and total brain volume. Post-hoc analysis revealed that the symptom domain of inattention had the strongest association with total brain volume. In addition, the threshold for impairment coincides with the threshold for brain volume reduction. Conclusions/Significance: This finding improves our understanding of the biological substrates of self-reported ADHD symptoms, and suggests total brain volume as a target intermediate phenotype for future gene-finding in ADHD.	[Hoogman, Martine; Franke, Barbara; Arias-Vasquez, Alejandro] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Psychiat, NL-6525 ED Nijmegen, Netherlands; [Hoogman, Martine; Brunner, Han; Franke, Barbara; Arias-Vasquez, Alejandro] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Rijpkema, Mark; Fernandez, Guillen] Radboud Univ Nijmegen, Ctr Cognit Neuroimaging, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Janss, Luc; Fernandez, Guillen; Buitelaar, Jan] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Hoogman, M (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Psychiat, NL-6525 ED Nijmegen, Netherlands.	m.hoogman@psy.umcn.nl	Buitelaar, J.K./AAY-7522-2020; Franke, Barbara/D-4836-2009; Buitelaar, Jan K/E-4584-2012; Brunner, Han/C-9928-2013; Vasquez, Alejandro Arias/E-4762-2012; Vasquez, A. Arias/L-4175-2015; Fernandez, Guillen/B-3771-2009; Hoogman, Martine/G-8958-2015; Rijpkema, Mark/D-1974-2010	Franke, Barbara/0000-0003-4375-6572; Buitelaar, Jan K/0000-0001-8288-7757; Vasquez, Alejandro Arias/0000-0002-4786-0169; Fernandez, Guillen/0000-0002-5522-0604; Hoogman, Martine/0000-0002-1261-7628; Rijpkema, Mark/0000-0002-8495-4703	Netherlands Organization for Scientific Research (NWO) [93511010]; Biobanking and Biomolecular Resources Research Initiative-NL (BBMRI-NL) [CP33]; Netherlands Brain Foundation (Hersenstichting Nederland) [15F07(2)27)]; NWO [480-05-003]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Biobanking and Biomolecular Resources Research Initiative-NL (BBMRI-NL); Netherlands Brain Foundation (Hersenstichting Nederland); NWO(Netherlands Organization for Scientific Research (NWO))	This study was partly funded by a Horizon Grant of the Netherlands Organization for Scientific Research (NWO; grant number 93511010, granted to AAV), a grant of the Biobanking and Biomolecular Resources Research Initiative-NL (BBMRI-NL: grant number CP33), and a grant of the Netherlands Brain Foundation (Hersenstichting Nederland, grant number 15F07(2)27). Statistical analyses were carried out on the Genetic Cluster Computer (http//www.geneticcluster.org), which is financially supported by NWO (480-05-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMEIDA LG, 2010, J PSYCHIAT RES; Montes LGA, 2010, J PSYCHIATR NEUROSCI, V35, P238, DOI 10.1503/jpn.090099; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Castellanos FX, 2002, JAMA-J AM MED ASSOC, V288, P1740, DOI 10.1001/jama.288.14.1740; Chen W, 2008, AM J MED GENET B, V147B, P1450, DOI 10.1002/ajmg.b.30672; Cuadra MB, 2005, IEEE T MED IMAGING, V24, P1548, DOI 10.1109/TMI.2005.857652; Cubillo A, 2010, EXPERT REV NEUROTHER, V10, P603, DOI 10.1586/ERN.10.4; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Fjell AM, 2010, REV NEUROSCIENCE, V21, P187, DOI 10.1515/revneuro.2010.21.3.187; Franke B, 2010, BIOL PSYCHIAT, V68, P586, DOI 10.1016/j.biopsych.2010.05.037; Franke B, 2009, HUM GENET, V126, P13, DOI 10.1007/s00439-009-0663-4; Frodl T, 2010, ACTA PSYCHIAT SCAND, V121, P111, DOI 10.1111/j.1600-0447.2009.01489.x; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Kooij JJS, 2008, J ATTEN DISORD, V11, P445, DOI 10.1177/1087054707299367; Kooij JJS, 2005, PSYCHOL MED, V35, P817, DOI 10.1017/S003329170400337X; Lubke GH, 2009, J AM ACAD CHILD PSY, V48, P1085, DOI 10.1097/CHI.0b013e3181ba3dbb; Peper JS, 2007, HUM BRAIN MAPP, V28, P464, DOI 10.1002/hbm.20398; Perlov E, 2008, J PSYCHIATR NEUROSCI, V33, P509; Poelmans G, 2011, AM J PSYCHIAT; Polanczyk G, 2007, CURR OPIN PSYCHIATR, V20, P386, DOI 10.1097/YCO.0b013e3281568d7a; Seidman LJ, 2010, BIOL PSYCHIAT; Shaw P, 2011, AM J PSYCHIAT, V168, P143, DOI 10.1176/appi.ajp.2010.10030385; Solanto MV, 2007, J ABNORM CHILD PSYCH, V35, P729, DOI 10.1007/s10802-007-9123-6; Valera EM, 2007, BIOL PSYCHIAT, V61, P1361, DOI 10.1016/j.biopsych.2006.06.011; Witelson SF, 2006, BRAIN, V129, P386, DOI 10.1093/brain/awh696	25	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e31273	10.1371/journal.pone.0031273	http://dx.doi.org/10.1371/journal.pone.0031273			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	924ZX	22348063	Green Published, gold			2022-12-25	WOS:000302730900023
J	Cheng, YX; Luo, LZ; Jiang, XF; Sappington, TW				Cheng, Yun Xia; Luo, Li Zhi; Jiang, Xing Fu; Sappington, Thomas W.			Synchronized Oviposition Triggered by Migratory Flight Intensifies Larval Outbreaks of Beet Webworm	PLOS ONE			English	Article							LOXOSTEGE-STICTICALIS LEPIDOPTERA; HISTORY TRADE-OFFS; ARMYWORM MOTH; REPRODUCTION; DISPERSAL; BEHAVIOR; CAPABILITY; INSECTS; PHYSIOLOGY; PYRALIDAE	Identifying the reproductive consequences of insect migration is critical to understanding its ecological and evolutionary significance. However, many empirical studies are seemingly contradictory, making recognition of unifying themes elusive and controversial. The beet webworm, Loxostege sticticalis L. is a long-range migratory pest of many crops in the northern temperate zone from 36 degrees N to 55 degrees N, with larval populations often exploding in regions receiving immigrants. In laboratory experiments, we examined (i) the reproductive costs of migratory flight by tethered flight, and (ii) the reproductive traits contributing to larval outbreaks of immigrant populations. Our results suggest that the beet webworm does not initiate migratory flight until the 2nd or 3rd night after emergence. Preoviposition period, lifetime fecundity, mating capacity, and egg hatch rate for adults that experienced prolonged flight after the 2nd night did not differ significantly from unflown moths, suggesting these traits are irrelevant to the severity of beet webworm outbreaks after migration. However, the period of first oviposition, a novel parameter developed in this paper measuring synchrony of first egg-laying by cohorts of post-migratory females, for moths flown on d 3 and 5 of adulthood was shorter than that of unflown moths, indicating a tightened time-window for onset of oviposition after migration. The resulting synchrony of egg-laying will serve to increase egg and subsequent larval densities. A dense population offers potential selective advantages to the individual larvae comprising it, whereas the effect from the human standpoint is intensification of damage by an outbreak population. The strategy of synchronized oviposition may be common in other migratory insect pests, such as locust and armyworm species, and warrants further study.	[Cheng, Yun Xia; Luo, Li Zhi; Jiang, Xing Fu] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China; [Sappington, Thomas W.] USDA ARS, Corn Insects & Crop Genet Res Unit, Genet Lab ISU, Ames, IA USA	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; United States Department of Agriculture (USDA)	Cheng, YX (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China.	lzluo@ippcaas.cn		Sappington, Thomas/0000-0002-4083-4101	National Natural Science Foundation of China [31071677]; National Department of Public Benefit [201003079]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Department of Public Benefit	This work was financially supported by projects of the National Natural Science Foundation of China (No: 31071677), and of the National Department of Public Benefit (No: 201003079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, ECONOMIST 0326; Bertram SM, 2007, ETHOLOGY, V113, P875, DOI 10.1111/j.1439-0310.2007.01399.x; Chen R. L., 1992, Acta Phytophylacica Sinica, V19, P171; COCKBAIN AJ, 1961, J EXP BIOL, V38, P181; DINGLE H, 1972, SCIENCE, V175, P1327, DOI 10.1126/science.175.4028.1327; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; DIXON AFG, 1993, J ANIM ECOL, V62, P182, DOI 10.2307/5492; Dyakonova V, 2008, J INSECT BEHAV, V21, P172, DOI 10.1007/s10905-008-9117-4; Feng HQ, 2004, ENVIRON ENTOMOL, V33, P1253, DOI 10.1603/0046-225X-33.5.1253; Frolov A.N., 2008, ENTOMOL REV, V88, P666; Guerra PA, 2007, J INSECT BEHAV, V20, P377, DOI 10.1007/s10905-007-9084-1; Guerra PA, 2009, BIOL LETTERS, V5, P229, DOI 10.1098/rsbl.2008.0570; GUNN A, 1989, PHYSIOL ENTOMOL, V14, P419, DOI 10.1111/j.1365-3032.1989.tb01111.x; Hanski I, 2006, J ANIM ECOL, V75, P91, DOI 10.1111/j.1365-2656.2005.01024.x; Hanski I, 2004, ECOL LETT, V7, P958, DOI 10.1111/j.1461-0248.2004.00654.x; HIGHNAM KC, 1964, J INSECT PHYSIOL, V10, P849, DOI 10.1016/0022-1910(64)90077-0; Holland RA, 2006, SCIENCE, V313, P794, DOI 10.1126/science.1127272; Hopper KR, 1999, ANNU REV ENTOMOL, V44, P535, DOI 10.1146/annurev.ento.44.1.535; Hu, 2001, CHINESE SCI ABSTRACT, V7, P662; Jiang XF, 2010, J INSECT PHYSIOL, V56, P1631, DOI 10.1016/j.jinsphys.2010.06.006; Jiang XF, 2010, ENVIRON ENTOMOL, V39, P232, DOI 10.1603/EN08315; Johnson C.G., 1969, MIGRATION DISPERSAL, P763, DOI DOI 10.1007/978-3-642-61360-9_7; KENNEDY JS, 1951, PHILOS T ROY SOC B, V235, P163, DOI 10.1098/rstb.1951.0003; Knor I. B., 1993, Entomological Review (English Translation of Entomologicheskoye Obozreniye), V72, P117; Kong HL, 2010, ENVIRON ENTOMOL, V39, P1579, DOI 10.1603/EN09314; Kong HL, 2011, ACTA ENTOMO IN PRESS, V54; Langellotto GA, 2000, ECOLOGY, V81, P865, DOI 10.1890/0012-9658(2000)081[0865:ATOBFC]2.0.CO;2; Li Ke-Bin, 2005, Acta Entomologica Sinica, V48, P155; Luo L.Z., 1992, TRANSACTION ECOLOGIC, P303; Luo L.Z., 2009, PLANT PROT BEIJING, V35, P27; Luo Li-Zhi, 1993, Acta Entomologica Sinica, V36, P332; Luo Li-Zhi, 1993, Acta Entomologica Sinica, V36, P459; Luo Lizhi, 1999, Acta Entomologica Sinica, V42, P150; LUO LZ, 1998, J NATURAL DISASTERS, V7, P158; MASON LJ, 1989, ENVIRON ENTOMOL, V18, P980, DOI 10.1093/ee/18.6.980; MCANELLY ML, 1986, BIOL BULL, V170, P378, DOI 10.2307/1541849; MIKKOLA K, 1970, J ANIM ECOL, V39, P593, DOI 10.2307/2856; Pepper JH, 1938, ECOLOGY, V19, P565, DOI 10.2307/1930934; RANKIN MA, 1992, ANNU REV ENTOMOL, V37, P533, DOI 10.1146/annurev.en.37.010192.002533; RILEY JR, 1983, ECOL ENTOMOL, V8, P395, DOI 10.1111/j.1365-2311.1983.tb00519.x; ROFF D, 1977, J ANIM ECOL, V46, P443, DOI 10.2307/3822; Rose DJW, 2000, AFRICAN ARMYWORM HDB; RYGG TD, 1966, ENTOMOL EXP APPL, V9, P74, DOI 10.1007/BF00341160; SLANSKY F, 1980, ENTOMOL EXP APPL, V28, P277, DOI 10.1007/BF00366314; Wang Chun-Rong, 2006, Chinese Bulletin of Entomology, V43, P98; Wei Q, 1987, PLANT DIS INSECT S1, P98; WILLERS JL, 1987, J INSECT PHYSIOL, V33, P803, DOI 10.1016/0022-1910(87)90027-8; Yin Jiao, 2005, Acta Ecologica Sinica, V25, P1844; Yue ZD, 1983, JILIN AGR SCI, P7881; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006; Zhang SK, 1987, PLANT DIS INSECT S1, P82; 罗礼智, 2004, [植物保护, Plant Protection], V30, P86	53	26	43	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31562	10.1371/journal.pone.0031562	http://dx.doi.org/10.1371/journal.pone.0031562			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347494	Green Published, gold, Green Submitted			2022-12-25	WOS:000302730200024
J	Ghotra, VPS; He, SN; de Bont, H; van der Ent, W; Spaink, HP; van de Water, B; Snaar-Jagalska, BE; Danen, EHJ				Ghotra, Veerander P. S.; He, Shuning; de Bont, Hans; van der Ent, Wietske; Spaink, Herman P.; van de Water, Bob; Snaar-Jagalska, B. Ewa; Danen, Erik H. J.			Automated Whole Animal Bio-Imaging Assay for Human Cancer Dissemination	PLOS ONE			English	Article							PROSTATE-CANCER; BREAST-TUMORS; CELL-LINES; ZEBRAFISH; MODEL; XENOGRAFTS; EXPRESSION; ADHESION; GROWTH; LNCAP	A quantitative bio-imaging platform is developed for analysis of human cancer dissemination in a short-term vertebrate xenotransplantation assay. Six days after implantation of cancer cells in zebrafish embryos, automated imaging in 96 well plates coupled to image analysis algorithms quantifies spreading throughout the host. Findings in this model correlate with behavior in long-term rodent xenograft models for panels of poorly-versus highly malignant cell lines derived from breast, colorectal, and prostate cancer. In addition, cancer cells with scattered mesenchymal characteristics show higher dissemination capacity than cell types with epithelial appearance. Moreover, RNA interference establishes the metastasis-suppressor role for E-cadherin in this model. This automated quantitative whole animal bio-imaging assay can serve as a first-line in vivo screening step in the anti-cancer drug target discovery pipeline.	[Ghotra, Veerander P. S.; de Bont, Hans; van de Water, Bob; Danen, Erik H. J.] Leiden Univ, Leiden Amsterdam Ctr Drug Res, Div Toxicol, Leiden, Netherlands; [He, Shuning; van der Ent, Wietske; Spaink, Herman P.; Snaar-Jagalska, B. Ewa] Leiden Univ, Inst Biol, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Ghotra, VPS (corresponding author), Leiden Univ, Leiden Amsterdam Ctr Drug Res, Div Toxicol, Leiden, Netherlands.	b.e.snaar-jagalska@biology.leidenuniv.nl; e.danen@lacdr.leidenuniv.nl	Spaink, Herman P./S-3586-2017	Spaink, Herman P./0000-0003-4128-9501; van der Ent, Wietske/0000-0003-2165-9624; danen, erik/0000-0002-0491-6345	Dutch Cancer Society [UL-2010-4670]; EU [HEALTH-F2-2008-201439]	Dutch Cancer Society(KWF Kankerbestrijding); EU(European Commission)	This work was supported by the Dutch Cancer Society (UL-2010-4670) and EU FP7 ZF Cancer project (HEALTH-F2-2008-201439). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatruda JF, 2008, INT REV CEL MOL BIO, V271, P1, DOI 10.1016/S1937-6448(08)01201-X; Amatruda JF, 2002, CANCER CELL, V1, P229, DOI 10.1016/S1535-6108(02)00052-1; Berghmans S, 2005, BIOTECHNOLOGY, V39, P27; Buck E, 2007, MOL CANCER THER, V6, P532, DOI 10.1158/1535-7163.MCT-06-0462; GIROLDI LA, 1993, CANCER METAST REV, V12, P29, DOI 10.1007/BF00689788; Haldi Maryann, 2006, Angiogenesis, V9, P139, DOI 10.1007/s10456-006-9040-2; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kukreja SD, 1998, CLIN EXP METASTAS, V6, P401; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Lam SH, 2006, CELL CYCLE, V5, P573, DOI 10.4161/cc.5.6.2550; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lee LMJ, 2005, DEV DYNAM, V233, P1560, DOI 10.1002/dvdy.20471; LIM DJ, 1993, PROSTATE, V22, P109, DOI 10.1002/pros.2990220203; Nicoli S, 2007, CANCER RES, V67, P2927, DOI 10.1158/0008-5472.CAN-06-4268; Rembrink K, 1997, PROSTATE, V31, P168; Ross DT, 2001, DIS MARKERS, V17, P99, DOI 10.1155/2001/850531; Stoletov K, 2007, P NATL ACAD SCI USA, V104, P17406, DOI 10.1073/pnas.0703446104; Stoletov K, 2010, J CELL SCI, V123, P2332, DOI 10.1242/jcs.069443; VANSLOOTEN HJ, 1995, BRIT J CANCER, V72, P22, DOI 10.1038/bjc.1995.271; WARE JL, 1982, J UROLOGY, V128, P1064, DOI 10.1016/S0022-5347(17)53345-5; Wu TT, 1998, INT J CANCER, V77, P887, DOI 10.1002/(SICI)1097-0215(19980911)77:6<887::AID-IJC15>3.0.CO;2-Z; Zhang LR, 1997, ONCOGENE, V15, P2093, DOI 10.1038/sj.onc.1201386; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	24	64	67	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31281	10.1371/journal.pone.0031281	http://dx.doi.org/10.1371/journal.pone.0031281			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347456	gold, Green Published, Green Submitted			2022-12-25	WOS:000302730100058
J	Sokolov, MV; Panyutin, IV; Neumann, RD				Sokolov, Mykyta V.; Panyutin, Irina V.; Neumann, Ronald D.			Unraveling the Global microRNAome Responses to Ionizing Radiation in Human Embryonic Stem Cells	PLOS ONE			English	Article							HUMAN FIBROBLASTS; INTEGRATIVE ANALYSIS; GENE-EXPRESSION; DOWN-REGULATION; CYCLE ARREST; DNA-REPAIR; TARGETS; DIFFERENTIATION; RNA; IDENTIFICATION	MicroRNAs (miRNA) comprise a group of short ribonucleic acid molecules implicated in regulation of key biological processes and functions at the post-transcriptional level. Ionizing radiation (IR) causes DNA damage and generally triggers cellular stress response. However, the role of miRNAs in IR-induced response in human embryonic stem cells (hESC) has not been defined yet. Here, by using system biology approaches, we show for the first time, that miRNAome undergoes global alterations in hESC (H1 and H9 lines) after IR. Interrogation of expression levels of 1,090 miRNA species in irradiated hESC showed statistically significant changes in 54 genes following 1 Gy of X-ray exposures; global miRNAome alterations were found to be highly temporally and cell line - dependent in hESC. Time-course studies showed that the 16 hr miRNAome radiation response of hESC is much more robust compared to 2 hr-response signature (only eight genes), and may be involved in regulating the cell cycle. Quantitative real-time PCR performed on some miRNA species confirms the robustness of our miRNA microarray platform. Positive regulation of differentiation-, cell cycle-, ion transport-and endomembrane system-related processes were predicted to be negatively affected by miRNAome changes in irradiated hESC. Our findings reveal a fundamental role of miRNAome in modulating the radiation response, and identify novel molecular targets of radiation in hESC.	[Sokolov, Mykyta V.; Panyutin, Irina V.; Neumann, Ronald D.] NIH, Ctr Clin, Div Nucl Med, Dept Radiol & Imaging Sci, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Sokolov, MV (corresponding author), NIH, Ctr Clin, Div Nucl Med, Dept Radiol & Imaging Sci, Bethesda, MD 20892 USA.	sokolovm@mail.nih.gov			National Institutes of Health, Clinical Center; CLINICAL CENTER [ZIACL060001] Funding Source: NIH RePORTER	National Institutes of Health, Clinical Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CLINICAL CENTER	This research was supported in part by the Intramural Research Program of the National Institutes of Health, Clinical Center. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2010, GENES CELLS, V15, P455, DOI 10.1111/j.1365-2443.2010.01400.x; Adams Bret R, 2010, Aging (Albany NY), V2, P582; Adams BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010001; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bandiera S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020746; Banuelos CA, 2008, DNA REPAIR, V7, P1471, DOI 10.1016/j.dnarep.2008.05.005; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Borgdorff V, 2010, ONCOGENE, V29, P2262, DOI 10.1038/onc.2009.497; Cao H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002820; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Cha HJ, 2009, ONCOL REP, V22, P863, DOI 10.3892/or_00000510; Cha HJ, 2009, INT J ONCOL, V34, P1661, DOI 10.3892/ijo_00000297; Chaudhry MA, 2010, DNA CELL BIOL, V29, P553, DOI 10.1089/dna.2009.0978; Chaudhry MA, 2009, CANCER BIOTHER RADIO, V24, P49, DOI 10.1089/cbr.2008.0513; Chen ZL, 2011, J BIOL CHEM, V286, P10725, DOI 10.1074/jbc.M110.165654; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fang L, 2011, ONCOGENE, V30, P806, DOI 10.1038/onc.2010.465; Foshay KM, 2009, DEV BIOL, V326, P431, DOI 10.1016/j.ydbio.2008.11.016; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Guled M, 2009, GENE CHROMOSOME CANC, V48, P615, DOI 10.1002/gcc.20669; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Jesus ABD, 2009, CELL CYCLE, V8, P394; Ji AR, 2010, EXP MOL MED, V42, P175, DOI 10.3858/emm.2010.42.3.018; Josson S, 2008, PROSTATE, V68, P1599, DOI 10.1002/pros.20827; Kovalchuk O, 2010, CARCINOGENESIS, V31, P1882, DOI 10.1093/carcin/bgq119; Lal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001864; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lal A, 2009, NAT STRUCT MOL BIOL, V16, P492, DOI 10.1038/nsmb.1589; Latronico MVG, 2009, NAT REV CARDIOL, V6, P418, DOI 10.1038/nrcardio.2009.56; Li YF, 2010, ONCOL REP, V24, P1443, DOI 10.3892/or_00001004; Lin RJ, 2010, MOL CARCINOGEN, V49, P719, DOI 10.1002/mc.20647; Maes OC, 2008, J CELL BIOCHEM, V105, P824, DOI 10.1002/jcb.21878; Maynard S, 2008, STEM CELLS, V26, P2266, DOI 10.1634/stemcells.2007-1041; Momcilovic O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013410; Momcilovic O, 2009, STEM CELLS, V27, P1822, DOI 10.1002/stem.123; Ni CW, 2011, AM J PHYSIOL-HEART C, V300, pH1762, DOI 10.1152/ajpheart.00829.2010; Niemoeller OM, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-29; Nikiforova MN, 2011, THYROID, V21, P261, DOI 10.1089/thy.2010.0376; Nishi H, 2010, J BIOL CHEM, V285, P4920, DOI 10.1074/jbc.M109.082610; Nurul-Syakima AM, 2011, INT J MOL MED; Nymark P, 2011, GENE CHROMOSOME CANC, V50, P585, DOI 10.1002/gcc.20880; Ofir M, 2011, MOL CANCER RES, V9, P440, DOI 10.1158/1541-7786.MCR-10-0344; Pan JA, 2010, ONCOL REP, V24, P105, DOI 10.3892/or_00000834; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Pilkinton M, 2007, J BIOL CHEM, V282, P168, DOI 10.1074/jbc.M609924200; Pizzimenti S, 2009, FREE RADICAL BIO MED, V46, P282, DOI 10.1016/j.freeradbiomed.2008.10.035; Qian S, 2008, BIOCHEM BIOPH RES CO, V377, P668, DOI 10.1016/j.bbrc.2008.10.052; Rizzo M, 2010, J CELL MOL MED, V14, P2633, DOI 10.1111/j.1582-4934.2010.01173.x; Saretzki G, 2008, STEM CELLS, V26, P455, DOI 10.1634/stemcells.2007-0628; Schmitz KJ, 2011, J CLIN PATHOL, V64, P529, DOI 10.1136/jcp.2010.085621; Shigoka M, 2010, PATHOL INT, V60, P351, DOI 10.1111/j.1440-1827.2010.02526.x; Shin S, 2009, INT J ONCOL, V35, P81, DOI 10.3892/ijo_00000315; Shin S, 2009, INT J ONCOL, V34, P1645, DOI 10.3892/ijo_00000295; Simone NL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006377; Sokolov MV, 2006, GENE, V382, P47, DOI 10.1016/j.gene.2006.06.008; Sokolov MV, 2011, MUTAT RES-FUND MOL M, V709-10, P40, DOI 10.1016/j.mrfmmm.2011.02.008; Sokolov MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014195; Sokolov MV, 2010, GENE, V455, P8, DOI 10.1016/j.gene.2010.01.006; Sokolov MV, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-192; SS Lo, 2011, ONCOGENE; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Templin T., 2011, INT J RAD ONCOL BIOL; Trompeter HI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016138; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; Vincenti S, 2011, RAD RES; Wagner-Ecker M, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-25; Wei GW, 2010, INT J BIOMED IMAGING, V2010, DOI 10.1155/2010/918467; Williams AE, 2008, CELL MOL LIFE SCI, V65, P545, DOI 10.1007/s00018-007-7355-9; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Yao Y, 2009, MOL MED REP, V2, P963, DOI 10.3892/mmr_00000199; Zhao JJ, 2009, CHILD NERV SYST, V25, P13, DOI 10.1007/s00381-008-0701-x	75	26	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31028	10.1371/journal.pone.0031028	http://dx.doi.org/10.1371/journal.pone.0031028			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347422	Green Submitted, Green Published, gold			2022-12-25	WOS:000302730100033
J	Metges, CC; Lang, IS; Hennig, U; Brussow, KP; Kanitz, E; Tuchscherer, M; Schneider, F; Weitzel, JM; Steinhoff-Ooster, A; Sauerwein, H; Bellmann, O; Nurnberg, G; Rehfeldt, C; Otten, W				Metges, Cornelia C.; Lang, Iris S.; Hennig, Ulf; Bruessow, Klaus-Peter; Kanitz, Ellen; Tuchscherer, Margret; Schneider, Falk; Weitzel, Joachim M.; Steinhoff-Ooster, Anika; Sauerwein, Helga; Bellmann, Olaf; Nuernberg, Gerd; Rehfeldt, Charlotte; Otten, Winfried			Intrauterine Growth Retarded Progeny of Pregnant Sows Fed High Protein:Low Carbohydrate Diet Is Related to Metabolic Energy Deficit	PLOS ONE			English	Article							WEIGHT-LOSS; LIPOPROTEIN CHOLESTEROL; COMPOSITIONAL TRAITS; STEROL-METABOLISM; BODY-COMPOSITION; GENE-EXPRESSION; EARLY GESTATION; CORTISOL; TRYPTOPHAN; PLASMA	High and low protein diets fed to pregnant adolescent sows led to intrauterine growth retardation (IUGR). To explore underlying mechanisms, sow plasma metabolite and hormone concentrations were analyzed during different pregnancy stages and correlated with litter weight (LW) at birth, sow body weight and back fat thickness. Sows were fed diets with low (6.5%, LP), adequate (12.1%, AP), and high (30%, HP) protein levels, made isoenergetic by adjusted carbohydrate content. At -5, 24, 66, and 108 days post coitum (dpc) fasted blood was collected. At 92 dpc, diurnal metabolic profiles were determined. Fasted serum urea and plasma glucagon were higher due to the HP diet. High density lipoprotein cholesterol (HDLC), %HDLC and cortisol were reduced in HP compared with AP sows. Lowest concentrations were observed for serum urea and protein, plasma insulin-like growth factor-I, low density lipoprotein cholesterol, and progesterone in LP compared with AP and HP sows. Fasted plasma glucose, insulin and leptin concentrations were unchanged. Diurnal metabolic profiles showed lower glucose in HP sows whereas non-esterified fatty acids (NEFA) concentrations were higher in HP compared with AP and LP sows. In HP and LP sows, urea concentrations were 300% and 60% of AP sows, respectively. Plasma total cholesterol was higher in LP than in AP and HP sows. In AP sows, LW correlated positively with insulin and insulin/glucose and negatively with glucagon/insulin at 66 dpc, whereas in HP sows LW associated positively with NEFA. In conclusion, IUGR in sows fed high protein:low carbohydrate diet was probably due to glucose and energy deficit whereas in sows with low protein:high carbohydrate diet it was possibly a response to a deficit of indispensable amino acids which impaired lipoprotein metabolism and favored maternal lipid disposal.	[Metges, Cornelia C.; Lang, Iris S.; Hennig, Ulf] Leibniz Inst Farm Anim Biol FBN, Res Unit Nutr Physiol Oskar Kellner, Dummerstorf, Germany; [Bruessow, Klaus-Peter; Schneider, Falk; Weitzel, Joachim M.] Leibniz Inst Farm Anim Biol FBN, Res Unit Reprod Biol, Dummerstorf, Germany; [Kanitz, Ellen; Tuchscherer, Margret; Otten, Winfried] Leibniz Inst Farm Anim Biol FBN, Res Unit Behav Physiol, Dummerstorf, Germany; [Steinhoff-Ooster, Anika; Sauerwein, Helga] Univ Bonn, Inst Anim Sci, Physiol & Hyg Unit, Bonn, Germany; [Nuernberg, Gerd] Leibniz Inst Farm Anim Biol FBN, Res Unit Genet & Biometry, Dummerstorf, Germany; [Rehfeldt, Charlotte] Leibniz Inst Farm Anim Biol FBN, Res Unit Muscle Biol & Growth, Dummerstorf, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN); University of Bonn; Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN)	Metges, CC (corresponding author), Leibniz Inst Farm Anim Biol FBN, Res Unit Nutr Physiol Oskar Kellner, Dummerstorf, Germany.	otten@fbn-dummerstorf.de	Sauerwein, Helga/R-8242-2019; Otten, Winfried/V-8376-2019	Otten, Winfried/0000-0002-5613-5356; Weitzel, Joachim/0000-0002-4073-6691	Deutsche Forschungsgemeinschaft [ME 1420/8-1, OT137/3-1, PAK 24]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by the Deutsche Forschungsgemeinschaft (www.dfg.de; grant numbers: ME 1420/8-1;OT137/3-1; PAK 24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown KR, 2007, J ANIM SCI, V85, P1687, DOI 10.2527/jas.2006-569; Christian P, 2009, NESTLE NUTR WORKS SE, V63, P59, DOI 10.1159/000209973; Divino JC, 1999, AM J PHYSIOL-ENDOC M, V277, pE693, DOI 10.1152/ajpendo.1999.277.4.E693; El Khattabi I, 2003, AM J PHYSIOL-ENDOC M, V285, pE991, DOI 10.1152/ajpendo.00037.2003; Fernandez-Twinn DS, 2003, BRIT J NUTR, V90, P815, DOI 10.1079/BJN2003967; Firk C, 2009, CLIN NUTR, V28, P266, DOI 10.1016/j.clnu.2009.03.002; Gardner D. K., 2004, Reproduction Fertility and Development, V16, P190, DOI 10.1071/RDv16n1Ab136; GfE (Gesellschaft fur Erna hrungsphysiologie), 2006, EMPF EN NAHRST SCHW; Govoni N, 2007, REPROD DOMEST ANIM, V42, P39, DOI 10.1111/j.1439-0531.2006.00722.x; GRUMMER RR, 1988, J ANIM SCI, V66, P3160; Guzik AC, 2006, J ANIM SCI, V84, P2251, DOI 10.2527/jas.2005-292; Halton TL, 2004, J AM COLL NUTR, V23, P373, DOI 10.1080/07315724.2004.10719381; Henson MC, 2006, BIOL REPROD, V74, P218, DOI 10.1095/biolreprod.105.045120; Jackson AA, 2001, AM J PHYSIOL-GASTR L, V281, pG1179, DOI 10.1152/ajpgi.2001.281.5.G1179; Jahoor F, 1996, J NUTR, V126, P1489, DOI 10.1093/jn/126.5.1489; Jia Y, 2010, J NUTR, V140, P1646, DOI 10.3945/jn.110.123034; Jindal R, 1997, J ANIM SCI, V75, P1063; Kalhan S C, 1999, Curr Opin Clin Nutr Metab Care, V2, P359, DOI 10.1097/00075197-199909000-00001; Kanitz E, 2009, PHYSIOL BEHAV, V98, P176, DOI 10.1016/j.physbeh.2009.05.007; Koopmans SJ, 2006, J ANIM SCI, V84, P963, DOI 10.2527/2006.844963x; Koopmans SJ, 2005, PHYSIOL BEHAV, V85, P469, DOI 10.1016/j.physbeh.2005.05.010; Kucia M, 2011, ANIMAL, V5, P268, DOI 10.1017/S1751731110001734; Lacroix M, 2004, AM J PHYSIOL-REG I, V287, pR934, DOI 10.1152/ajpregu.00100.2004; Lane M, 2003, BIOL REPROD, V69, P1109, DOI 10.1095/biolreprod.103.018093; Langley-Evans SC, 2001, P NUTR SOC, V60, P505, DOI 10.1079/PNS2001111; Markus CR, 2000, AM J CLIN NUTR, V71, P1536; Martens MJI, 2010, PHYSIOL BEHAV, V101, P563, DOI 10.1016/j.physbeh.2010.09.007; McConihay JA, 2000, J LIPID RES, V41, P424; McConihay JA, 2001, J LIPID RES, V42, P1111; McPherson RL, 2004, J ANIM SCI, V82, P2534; Meza-Herrera CA, 2010, REPROD DOMEST ANIM, V45, P723, DOI 10.1111/j.1439-0531.2009.01341.x; Mooradian AD, 2006, ENDOCR REV, V27, P2, DOI 10.1210/er.2005-0013; Musser RE, 2004, J ANIM SCI, V82, P3154; Nissen PM, 2005, ANIM SCI, V80, P299, DOI 10.1079/ASC40700299; Noakes M, 2005, AM J CLIN NUTR, V81, P1298; Nordmann AJ, 2006, ARCH INTERN MED, V166, P285, DOI 10.1001/archinte.166.3.285; Okereke NC, 2004, AM J PHYSIOL-ENDOC M, V287, pE472, DOI 10.1152/ajpendo.00589.2003; Peters JC, 2008, J ANIM SCI, V86, P2247, DOI 10.2527/jas.2007-0431; Rehfeldt C, 2011, J ANIM SCI, V89, P329, DOI 10.2527/jas.2010-2970; Rehfeldt C, 2001, J ANIM SCI, V79, P1789; Rehfeldt C, 2012, EUR J NUTR, V51, P151, DOI 10.1007/s00394-011-0201-8; REMESY C, 1988, J NUTR, V118, P569, DOI 10.1093/jn/118.5.569; ROBERTSON HA, 1974, J REPROD FERTIL, V40, P133, DOI 10.1530/jrf.0.0400133; RODRIGUEZ H, 1983, ACTA VET SCAND, V24, P318; Sauerwein H, 2004, LIVEST PROD SCI, V87, P189, DOI 10.1016/j.livprodsci.2003.08.001; Schneider F, 2006, REPROD FERT DEVELOP, V18, P857, DOI 10.1071/RD06027; SCHOLL TO, 1994, AM J CLIN NUTR, V60, P183, DOI 10.1093/ajcn/60.2.183; Sferruzzi-Perri AN, 2011, J PHYSIOL-LONDON, V589, P7, DOI 10.1113/jphysiol.2010.198622; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Stepien M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014664; Stepien M, 2010, J NUTR, V140, P939, DOI 10.3945/jn.109.120139; Toscano MJ, 2007, J ANIM SCI, V85, P441, DOI 10.2527/jas.2006-316; Wallace J, 2001, REPRODUCTION, V122, P347, DOI 10.1530/rep.0.1220347; Wallace JM, 2006, PLACENTA, V27, pS61, DOI 10.1016/j.placenta.2005.12.002; Wallace JM, 2010, BIOL REPROD, V82, P320, DOI 10.1095/biolreprod.109.080069; Wiseman TG, 2007, J ANIM SCI, V85, P1816, DOI 10.2527/jas.2006-406	56	35	37	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e31390	10.1371/journal.pone.0031390	http://dx.doi.org/10.1371/journal.pone.0031390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328932	gold, Green Published, Green Submitted			2022-12-25	WOS:000302179300018
J	Wang, JJ; Wang, AN; Han, ZJ; Zhang, Z; Li, F; Li, XC				Wang, Jianjun; Wang, Aina; Han, Zhaojun; Zhang, Zan; Li, Fei; Li, Xianchun			Characterization of Three Novel SINE Families with Unusual Features in Helicoverpa armigera	PLOS ONE			English	Article							DNA-SEQUENCE FAMILY; TRANSPOSABLE ELEMENTS; RNA; GENOME; GENES; MOSQUITO; LINES; RETROTRANSPOSONS; IDENTIFICATION; SUPERFAMILY	Although more than 120 families of short interspersed nuclear elements (SINEs) have been isolated from the eukaryotic genomes, little is known about SINEs in insects. Here, we characterize three novel SINEs from the cotton bollworm, Helicoverpa armigera. Two of them, HaSE1 and HaSE2, share similar 5'-structure including a tRNA-related region immediately followed by conserved central domain. The 3'-tail of HaSE1 is significantly similar to that of one LINE retrotransposon element, HaRTE1.1, in H. armigera genome. The 3'-region of HaSE2 showed high identity with one mariner-like element in H. armigera. The third family, termed HaSE3, is a 5S rRNA-derived SINE and shares both body part and 3'-tail with HaSE1, thus may represent the first example of a chimera generated by recombination between 5S rRNA and tRNA-derived SINE in insect species. Further database searches revealed the presence of these SINEs in several other related insect species, but not in the silkworm, Bombyx mori, indicating a relatively narrow distribution of these SINEs in Lepidopterans. Apart from above, we found a copy of HaSE2 in the GenBank EST entry for the cotton aphid, Aphis gossypii, suggesting the occurrence of horizontal transfer.	[Wang, Jianjun; Wang, Aina] Yangzhou Univ, Coll Hort & Plant Protect, Yangzhou, Peoples R China; [Li, Xianchun] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Li, Xianchun] Univ Arizona, Inst BIO5, Tucson, AZ USA; [Han, Zhaojun; Zhang, Zan; Li, Fei] Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China	Yangzhou University; University of Arizona; University of Arizona; Nanjing Agricultural University	Wang, JJ (corresponding author), Yangzhou Univ, Coll Hort & Plant Protect, Yangzhou, Peoples R China.	wangjj@yzu.edu.cn; lxc@email.arizona.edu	Li, Fei/B-3687-2012	Li, Fei/0000-0002-8410-5250	National Natural Science Foundation of China [30871642]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant 30871642 to JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DS, 1986, J MOL BIOL, V187, P465, DOI 10.1016/0022-2836(86)90327-X; Akasaki T, 2010, GENE, V454, P8, DOI 10.1016/j.gene.2009.11.005; Behere GT, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-117; Betley JN, 2002, CURR BIOL, V12, P1756, DOI 10.1016/S0960-9822(02)01220-4; BRADFIELD JY, 1985, DNA-J MOLEC CELL BIO, V4, P357, DOI 10.1089/dna.1985.4.357; Brosius J, 1999, GENE, V238, P115, DOI 10.1016/S0378-1119(99)00227-9; Buzdin A, 2003, NUCLEIC ACIDS RES, V31, P4385, DOI 10.1093/nar/gkg496; Buzdin AA, 2004, CELL MOL LIFE SCI, V61, P2046, DOI 10.1007/s00018-004-4041-z; Chen S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-46; d'Alencon E, 2010, P NATL ACAD SCI USA, V107, P7680, DOI 10.1073/pnas.0910413107; Deininger PL, 2003, CURR OPIN GENET DEV, V13, P651, DOI 10.1016/j.gde.2003.10.013; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Feschotte C, 2001, MOL BIOL EVOL, V18, P74, DOI 10.1093/oxfordjournals.molbev.a003721; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Gilbert N, 1999, P NATL ACAD SCI USA, V96, P2869, DOI 10.1073/pnas.96.6.2869; Gogolevsky KP, 2008, GENE, V407, P75, DOI 10.1016/j.gene.2007.09.021; Gogolevsky KP, 2009, GENOMICS, V93, P494, DOI 10.1016/j.ygeno.2009.02.001; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jurka J, 2010, REPBASE REPORTS, V10, P1055; Kajikawa M, 2002, CELL, V111, P433, DOI 10.1016/S0092-8674(02)01041-3; Kapitonov V., 2007, REPBASE REP, V7, P1180; Kapitonov VV, 2003, MOL BIOL EVOL, V20, P694, DOI 10.1093/molbev/msg075; Kosushkin SA, 2006, MOL BIOL+, V40, P378; Kramerov DA, 2005, INT REV CYTOL, V247, P165, DOI 10.1016/S0074-7696(05)47004-7; Kramerov DA, 2011, WIRES RNA, V2, P772, DOI 10.1002/wrna.91; Krull M, 2005, MOL BIOL EVOL, V22, P1702, DOI 10.1093/molbev/msi164; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Loytynoja A, 2001, BIOINFORMATICS, V17, P573, DOI 10.1093/bioinformatics/17.6.573; Luchetti A, 2005, DNA SEQUENCE, V16, P304, DOI 10.1080/10425170500061467; Luchetti A, 2011, MOL GENET GENOMICS, V285, P175, DOI 10.1007/s00438-010-0595-7; Luchetti A, 2009, J MOL EVOL, V69, P589, DOI 10.1007/s00239-009-9285-7; Matveev V, 2007, MOL BIOL EVOL, V24, P1656, DOI 10.1093/molbev/msm083; Melamed P, 2004, NAT GENET, V36, P786, DOI 10.1038/ng0804-786; Nishihara H, 2002, MOL BIOL EVOL, V19, P1964, DOI 10.1093/oxfordjournals.molbev.a004020; Nishihara H, 2006, GENOME RES, V16, P864, DOI 10.1101/gr.5255506; Ogiwara I, 2002, GENOME RES, V12, P316, DOI 10.1101/gr.212302; Ohshima K, 2005, CYTOGENET GENOME RES, V110, P475, DOI 10.1159/000084981; Piskurek O, 2007, P NATL ACAD SCI USA, V104, P12046, DOI 10.1073/pnas.0700531104; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-163; Schmitz J, 2004, GENOME RES, V14, P1911, DOI 10.1101/gr.2720104; Shedlock AM, 2000, BIOESSAYS, V22, P148, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;148::AID-BIES6&gt;3.0.CO;2-Z; Sorek R, 2002, GENOME RES, V12, P1060, DOI 10.1101/gr.229302; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tay WT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-144; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tu ZJ, 1999, MOL BIOL EVOL, V16, P760, DOI 10.1093/oxfordjournals.molbev.a026161; ULLU E, 1984, NATURE, V312, P171, DOI 10.1038/312171a0; Vassetzky NS, 2003, GENE, V319, P149, DOI 10.1016/S0378-1119(03)00805-9; Volff JN, 2006, BIOESSAYS, V28, P913, DOI 10.1002/bies.20452; Wang J, 2005, INSECT MOL BIOL, V14, P547, DOI 10.1111/j.1365-2583.2005.00585.x; Wang JJ, 2011, INSECT SCI, V18, P619, DOI 10.1111/j.1744-7917.2010.01389.x; Weiner AM, 2002, CURR OPIN CELL BIOL, V14, P343, DOI 10.1016/S0955-0674(02)00338-1; WEINER AM, 1980, CELL, V22, P209, DOI 10.1016/0092-8674(80)90169-5; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Xu JS, 2010, J GENET GENOMICS, V37, P125, DOI 10.1016/S1673-8527(09)60031-X; Yue Li-Na, 2007, Acta Entomologica Sinica, V50, P234	57	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31355	10.1371/journal.pone.0031355	http://dx.doi.org/10.1371/journal.pone.0031355			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319625	Green Submitted, gold, Green Published			2022-12-25	WOS:000302178400037
J	Sambandam, Y; Sundaram, K; Liu, A; Kirkwood, KL; Ries, WL; Reddy, SV				Sambandam, Y.; Sundaram, K.; Liu, A.; Kirkwood, K. L.; Ries, W. L.; Reddy, S. V.			CXCL13 activation of c-Myc induces RANK ligand expression in stromal/preosteoblast cells in the oral squamous cell carcinoma tumor-bone microenvironment	ONCOGENE			English	Article						oral squamous cell carcinoma; CXCL13; RANK ligand; c-Myc; osteoblast	KAPPA-B LIGAND; SOLUBLE RECEPTOR ACTIVATOR; INDUCED OSTEOLYSIS; PROSTATE-CANCER; NECK-CANCER; OSTEOCLAST DIFFERENTIATION; CHEMOKINE RECEPTORS; OSTEOBLASTS; METASTASIS; INVASION	CXC chemokine ligand-13 (CXCL13) has been implicated in oral squamous cell carcinoma (OSCC) tumor progression and osteolysis. The tumor necrosis factor family member RANKL (receptor activator of NF-kappa B ligand), a critical bone resorbing osteoclastogenic factor, has an important role in cancer invasion of bone/osteolysis. Here, we show high-level expression of CXCL13 in primary human OSCC tumor specimens; however, human bone marrow-derived stromal (SAKA-T) and murine preosteoblast (MC3T3-E1) cells produce at very low level. Recombinant CXCL13 (0-15 ng/ml) dose dependently induced CXCR5 expression in SAKA-T and MC3T3-E1 cells. Conditioned media obtained from OSCC cell lines increased the RANKL expression and an antibody against the CXCL13 specific receptor, CXCR5 markedly decreased RANKL expression in these cells. Furthermore, CXCL13 increased hRANKL-Luc promoter activity. Superarray screening identified c-Myc and NFATc3 transcription factors upregulated in CXCL13-stimulated SAKA-T cells. Immunohistochemical analysis of OSCC tumors that developed in athymic mice demonstrated RANKL and NFATc3 expression in tumor and osteoblast cells, however, showed p-c-Myc expression specific to osteoblastic cells at the tumor-bone interface. We further identified NFATc3 expression, but not c-Myc activation in primary human OSCC tumor specimens compared with adjacent normal tissue. Also, CXCL13 significantly increased p-ERK1/2 in SAKA-T and MC3T3-E1 cells. siRNA suppression of c-Myc expression markedly decreased CXCL13-induced RANKL and NFATc3 expression in preosteoblast cells. Chromatin-immuno precipitation assay confirmed p-c-Myc binding to the hRANKL promoter region. In summary, c-Myc activation through CXCL13-CXCR5 signaling axis stimulates RANKL expression in stromal/preosteoblast cells. Thus, our results implicate CXCL13 as a potential therapeutic target to prevent OSCC invasion of bone/osteolysis. Oncogene (2013) 32, 97-105; doi:10.1038/onc.2012.24; published online 13 February 2012	[Sambandam, Y.; Sundaram, K.; Reddy, S. V.] Med Univ S Carolina, Charles P Darby Childrens Res Inst, Charleston, SC 29425 USA; [Liu, A.] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Kirkwood, K. L.; Ries, W. L.] Med Univ S Carolina, Sch Dent Med, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Reddy, SV (corresponding author), Med Univ S Carolina, Charles P Darby Childrens Res Inst, 173 Ashley Ave, Charleston, SC 29425 USA.	reddysv@musc.edu	Kirkwood, Keith L/L-4728-2018; Reddy, Sakamuri/H-6419-2019	Kirkwood, Keith/0000-0003-4519-8973	National Institutes of Health from National Center for Research Resources [C06 RR015455]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER	National Institutes of Health from National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Dr Thomas E Carey, University of Michigan, Ann Arbor, MI for generously providing OSCC cells and Alfredo A Molinolo MD, PhD, NIDCR, NIH for providing the OSCC tumor tissue microarray slides. This work was conducted in a facility constructed with the support from the National Institutes of Health, Grant Number C06 RR015455 from the Extramural Research Facilities Program of the National Center for Research Resources.	Belperio JA, 2000, J LEUKOCYTE BIOL, V68, P1; Brenner JC, 2010, HEAD NECK-J SCI SPEC, V32, P417, DOI 10.1002/hed.21198; Buchholz M, 2006, EMBO J, V25, P3714, DOI 10.1038/sj.emboj.7601246; Chen G, 2006, CANCER-AM CANCER SOC, V107, P289, DOI 10.1002/cncr.21978; Choi S, 2008, J DENT RES, V87, P14, DOI 10.1177/154405910808700104; Darimont C, 2002, CELL GROWTH DIFFER, V13, P59; Deyama Y, 2008, ONCOL REP, V20, P663, DOI 10.3892/or_00000057; El-Haibi CP, 2011, CELL PROLIFERAT, V44, P311, DOI 10.1111/j.1365-2184.2011.00757.x; Funk GF, 2002, HEAD NECK-J SCI SPEC, V24, P165, DOI 10.1002/hed.10004; Habib T, 2007, J CELL BIOL, V179, P717, DOI 10.1083/jcb.200704173; Hofbauer LC, 2001, J MOL MED, V79, P243, DOI 10.1007/s001090100226; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Ishikuro M, 2008, BONE, V43, P621, DOI 10.1016/j.bone.2008.05.014; Jimi E, 2011, ORAL DIS, V17, P462, DOI 10.1111/j.1601-0825.2010.01781.x; Kayamori K, 2010, AM J PATHOL, V176, P968, DOI 10.2353/ajpath.2010.090299; Kikuchi T, 2003, J DENT RES, V82, P546, DOI 10.1177/154405910308200712; Lee SK, 2002, J IMMUNOL, V169, P2374, DOI 10.4049/jimmunol.169.5.2374; Legler DF, 1998, J EXP MED, V187, P655, DOI 10.1084/jem.187.4.655; Lisignoli G, 2004, EXP GERONTOL, V39, P659, DOI 10.1016/j.exger.2003.09.030; Lisignoli G, 2003, J CELL PHYSIOL, V194, P71, DOI 10.1002/jcp.10188; Lynch CC, 2005, CANCER CELL, V7, P485, DOI 10.1016/j.ccr.2005.04.013; Mao L, 2004, CANCER CELL, V5, P311, DOI 10.1016/S1535-6108(04)00090-X; Marampon F, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-31; Mikami S, 2009, J PATHOL, V218, P530, DOI 10.1002/path.2567; Mishra A, 2006, INT J CANCER, V119, P2840, DOI 10.1002/ijc.22262; Molinolo AA, 2007, CLIN CANCER RES, V13, P4964, DOI 10.1158/1078-0432.CCR-07-1041; Muller A, 2006, INT J CANCER, V118, P2147, DOI 10.1002/ijc.21514; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nakashima T, 2000, BIOCHEM BIOPH RES CO, V275, P768, DOI 10.1006/bbrc.2000.3379; Nomura T, 2007, ORAL ONCOL, V43, P257, DOI 10.1016/j.oraloncology.2006.03.015; Pandruvada SNM, 2010, INT J CANCER, V126, P2319, DOI 10.1002/ijc.24920; Perez-Sayans M, 2011, ORAL ONCOL, V47, P688, DOI 10.1016/j.oraloncology.2011.05.016; Roccisana JL, 2004, J BIOL CHEM, V279, P10500, DOI 10.1074/jbc.M303727200; Roux S, 2004, LEUKEMIA LYMPHOMA, V45, P1111, DOI 10.1080/10428194310001593193; Singh G, 2010, J BIOL CHEM, V285, P27241, DOI 10.1074/jbc.M110.100438; Singh S, 2009, CANCER LETT, V283, P29, DOI 10.1016/j.canlet.2009.03.022; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; Thiolloy S, 2009, CANCER RES, V69, P6747, DOI 10.1158/0008-5472.CAN-08-3949; Uchida D, 2001, INT J CANCER, V93, P489, DOI 10.1002/ijc.1368; Vachani A, 2007, CLIN CANCER RES, V13, P2905, DOI 10.1158/1078-0432.CCR-06-1670; Wilson TJ, 2008, CANCER RES, V68, P5803, DOI 10.1158/0008-5472.CAN-07-5889; Yuvaraj S, 2009, MOL CANCER RES, V7, P1399, DOI 10.1158/1541-7786.MCR-08-0589; Ziober AF, 2006, CLIN CANCER RES, V12, P5960, DOI 10.1158/1078-0432.CCR-06-0535; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	44	47	50	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2013	32	1					97	105		10.1038/onc.2012.24	http://dx.doi.org/10.1038/onc.2012.24			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	063VG	22330139	Green Accepted			2022-12-25	WOS:000313029500010
J	Johnston, TH; Millar, Z; Huot, P; Wagg, K; Thiele, S; Salomonczyk, D; Yong-Kee, CJ; Gandy, MN; McIldowie, M; Lewis, KD; Gomez-Ramirez, J; Lee, J; Fox, SH; Martin-Iverson, M; Nash, JE; Piggott, MJ; Brotchie, JM				Johnston, Tom H.; Millar, Zak; Huot, Philippe; Wagg, Keith; Thiele, Sherri; Salomonczyk, Danielle; Yong-Kee, Christopher J.; Gandy, Michael N.; McIldowie, Matthew; Lewis, Katie D.; Gomez-Ramirez, Jordi; Lee, Joohyung; Fox, Susan H.; Martin-Iverson, Mathew; Nash, Joanne E.; Piggott, Matthew J.; Brotchie, Jonathan M.			A novel MDMA analogue, UWA-101, that lacks psychoactivity and cytotoxicity, enhances L-DOPA benefit in parkinsonian primates	FASEB JOURNAL			English	Article						drug of abuse; translational medicine; methylenedioxymethamphetamine; ecstasy	3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; INDUCED DYSKINESIA; ECSTASY; SEROTONIN; DRUG; RATS; NOREPINEPHRINE; NEUROTOXICITY; FENFLURAMINE; INHIBITOR	Treatment of Parkinson's disease with dopaminergic agents, such as L-DOPA, is frequently compromised by disabling side effects, particularly dyskinesia and a shortening in duration of antiparkinsonian action. Studies in animal models and anecdotal evidence from a patient with Parkinson's disease show that the illicit drug ecstasy (MDMA) can alleviate these side effects, though with many drawbacks (e.g., psychoactivity). MDMA itself thus has little therapeutic potential. On the basis of known structure-psychoactivity relationships, we designed a series of alpha-substituted MDMA analogues, one of which, bearing an alpha-cyclopropyl substituent (UWA-101), enhanced the quality of L-DOPA actions in animal models. Indeed, UWA-101 was more effective than MDMA. Unlike MDMA, UWA-101 did not reduce viability of serotonergic cells, exhibit psychoactive properties, or reduce food intake, and did not substitute for MDMA in drug discrimination assays. UWA-101 displayed a unique receptor/transporter binding profile relative to MDMA, with a >5-fold decrease in affinity for NET and 5-HT2A receptors and a 10-fold increase in affinity for DAT. Furthermore, in a functional reuptake assay, UWA-101 inhibited both 5-HT and dopamine reuptake, while having no effect on the reuptake of noradrenaline. UWA-101 is the first selective DAT/SERT inhibitor described with comparable affinities for these two sites. These data identify a new class of therapeutic in Parkinson's disease and highlight the potential benefits of studying illicit drugs that in themselves would never be considered safe for longterm therapy.-Johnston, T. H., Millar, Z., Huot, P., Wagg, K., Thiele, S., Salomonczyk, D., Yong-Kee, C. J., Gandy, M. N., McIldowie, M., Lewis, K. D., Gomez-Ramirez, J., Lee, J., Fox, S. H., Martin-Iverson, M., Nash, J. E., Piggott, M. J., Brotchie, J. M. A novel MDMA analogue, UWA-101, that lacks psychoactivity and cytotoxicity, enhances L-DOPA benefit in parkinsonian primates. FASEB J. 26, 2154-2163 (2012). www.fasebj.org	[Johnston, Tom H.; Huot, Philippe; Gomez-Ramirez, Jordi; Lee, Joohyung; Brotchie, Jonathan M.] Univ Hlth Network, Toronto Western Hosp, Toronto Western Res Inst, Toronto, ON M5T 2S7, Canada; [Fox, Susan H.] Univ Hlth Network, Toronto Western Hosp, Movement Disorders Clin, Toronto, ON M5T 2S7, Canada; [Millar, Zak; Martin-Iverson, Mathew] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Gandy, Michael N.; McIldowie, Matthew; Lewis, Katie D.; Piggott, Matthew J.] Univ Western Australia, Sch Biomed Biomol & Chem Sci, Perth, WA 6009, Australia; [Wagg, Keith] Australian Natl Univ, Dept Chem, Canberra, ACT, Australia; [Thiele, Sherri; Salomonczyk, Danielle; Yong-Kee, Christopher J.; Nash, Joanne E.] Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Western Australia; University of Western Australia; Australian National University; University of Toronto; University Toronto Scarborough	Brotchie, JM (corresponding author), Univ Hlth Network, Toronto Western Hosp, Toronto Western Res Inst, 399 Bathurst St,MC-11-419, Toronto, ON M5T 2S7, Canada.	matthew.piggott@uwa.edu.au; brotchie@uhnres.utoronto.ca	Piggott, Matthew/K-6990-2019; Johnston, Tom H/D-2531-2018; Piggott, Matthew J/A-3251-2008	Johnston, Tom H/0000-0002-1537-8175; Piggott, Matthew/0000-0002-5857-7051; Lee, Joohyung/0000-0002-4277-3680; Brotchie, Jonathan/0000-0003-2337-0816; Martin-Iverson, Mathew/0000-0003-4855-6748	University of Western Australia; Edmond J. Safra Philanthropic Foundation; Parkinson Society Canada	University of Western Australia; Edmond J. Safra Philanthropic Foundation; Parkinson Society Canada	The authors thank the Brain Foundation (M.J.P.), the Natural Sciences and Engineering Research Council of Canada (J.E.N.), Krembil Neuroscience Fund (J.M.B.), and Johnson & Johnson Corporate Office of Science and Technology. M.N.G and K.D.L were recipients of a University of Western Australia Postgraduate Scholarship and Australian Postgraduate Award, respectively. P.H. was supported by fellowships from the Edmond J. Safra Philanthropic Foundation and the Parkinson Society Canada.	BATTAGLIA G, 1988, EUR J PHARMACOL, V149, P159, DOI 10.1016/0014-2999(88)90056-8; Baumann MH, 2007, PSYCHOPHARMACOLOGY, V189, P407, DOI 10.1007/s00213-006-0322-6; Bernschneider-Reif S, 2006, PHARMAZIE, V61, P966; Bishop C, 2006, EUR J NEUROSCI, V23, P2669, DOI 10.1111/j.1460-9568.2006.04790.x; Boyer EW, 2005, NEW ENGL J MED, V352, P1112, DOI 10.1056/NEJMra041867; Capela JP, 2007, NEUROTOXICOLOGY, V28, P868, DOI 10.1016/j.neuro.2007.04.005; Carta M, 2007, BRAIN, V130, P1819, DOI 10.1093/brain/awm082; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Colombo G, 1996, J NEUROSCI METH, V67, P83, DOI 10.1016/0165-0270(95)00154-9; Conductier G, 2005, NEUROPSYCHOPHARMACOL, V30, P1056, DOI 10.1038/sj.npp.1300662; CORRIGALL WA, 1992, PHARMACOL BIOCHEM BE, V41, P165, DOI 10.1016/0091-3057(92)90077-S; Fabbrini G, 2007, MOVEMENT DISORD, V22, P1379, DOI 10.1002/mds.21475; Gandy MN, 2010, MEDCHEMCOMM, V1, P287, DOI 10.1039/c0md00108b; Green AR, 2003, PHARMACOL REV, V55, P463, DOI 10.1124/pr.55.3.3; Hansard MJ, 2002, J PHARMACOL EXP THER, V303, P952, DOI 10.1124/jpet.102.039743; Hince DA, 2005, BEHAV NEUROSCI, V119, P66, DOI 10.1037/0735-7044.119.1.66; HOFFMAN HS, 1980, PSYCHOL REV, V87, P175, DOI 10.1037/0033-295X.87.2.175; Huot P, 2011, J NEUROSCI, V31, P7190, DOI 10.1523/JNEUROSCI.1171-11.2011; Iravani MM, 2003, J NEUROSCI, V23, P9107; Johnston TH, 2005, EXP NEUROL, V191, P243, DOI 10.1016/j.expneurol.2004.10.002; KEHNE JH, 1992, J PHARMACOL EXP THER, V260, P78; Lane EL, 2005, J PHARMACOL EXP THER, V312, P1124, DOI 10.1124/jpet.104.076554; Liechti ME, 2000, NEUROPSYCHOPHARMACOL, V23, P396, DOI 10.1016/S0893-133X(00)00126-3; Munoz A, 2008, BRAIN, V131, P3380, DOI 10.1093/brain/awn235; Poewe W, 2009, NEUROLOGY, V72, pS65, DOI 10.1212/WNL.0b013e31819908ce; RICAURTE GA, 1988, JAMA-J AM MED ASSOC, V260, P51, DOI 10.1001/jama.260.1.51; Ricaurte GA, 2000, TOXICOL LETT, V112, P143, DOI 10.1016/S0378-4274(99)00216-7; Shulgin A. T., 1991, PHENETHYL AMINES I H; Verrico CD, 2007, PSYCHOPHARMACOLOGY, V189, P489, DOI 10.1007/s00213-005-0174-5; Visanji NP, 2009, NEUROBIOL DIS, V35, P184, DOI 10.1016/j.nbd.2008.11.010; Wasik AM, 2012, INVEST NEW DRUG, V30, P1471, DOI 10.1007/s10637-011-9730-5; Yoneda F, 2001, BIOORGAN MED CHEM, V9, P1197, DOI 10.1016/S0968-0896(01)00002-5	32	14	14	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2012	26	5					2154	2163		10.1096/fj.11-195016	http://dx.doi.org/10.1096/fj.11-195016			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22345403				2022-12-25	WOS:000303680800041
J	Carrasco-Marin, E; Rodriguez-Del Rio, E; Frande-Cabanes, E; Tobes, R; Pareja, E; Lecea-Cuello, MJ; Ruiz-Saez, M; Madrazo-Toca, F; Holscher, C; Alvarez-Dominguez, C				Carrasco-Marin, Eugenio; Rodriguez-Del Rio, Estela; Frande-Cabanes, Elisabet; Tobes, Raquel; Pareja, Eduardo; Jesus Lecea-Cuello, M.; Ruiz-Saez, Marta; Madrazo-Toca, Fidel; Hoelscher, Christoph; Alvarez-Dominguez, Carmen			Phagosomes Induced by Cytokines Function as anti-Listeria Vaccines NOVEL ROLE FOR FUNCTIONAL COMPARTMENTALIZATION OF STAT-1 PROTEIN AND CATHEPSIN-D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATHEPSIN-D; MONOCYTOGENES INFECTION; IMMUNE-RESPONSES; INNATE; MICE; MACROPHAGES; DEFICIENT; CELLS; MODULATION; ACTIVATION	Phagosomes are critical compartments for innate immunity. However, their role in the protection against murine listeriosis has not been examined. We describe here that listericidal phago-receptosomes are induced by the function of IFN-gamma or IL-6 as centralized compartments for innate and adaptive immunity because they are able to confer protection against murine listeriosis. These phago-receptosomes elicited LLO(91-99)/CD8(+)- and LLO(189-201)/CD4(+)-specific immune responses and recruited mature dendritic cells to the vaccination sites controlled by T cells. Moreover, they present exceptional features as efficient vaccine vectors. First, they compartmentalize a novel listericidal STAT-1-mediated signaling pathway that confines multiple innate immune components to the same environment. Second, they show features of MHC class II antigen-loading competent compartments for cathepsin-D-mediated LLO processing. Third, murine cathepsin-D deficiencies fail to develop protective immunity after vaccination with listericidal phago-receptosomes induced by IFN-gamma or IL-6. Therefore, it appears that the connection of STAT-1 and cathepsin-D in a single compartment is relevant for protection against listeriosis.	[Carrasco-Marin, Eugenio; Rodriguez-Del Rio, Estela; Frande-Cabanes, Elisabet; Jesus Lecea-Cuello, M.; Ruiz-Saez, Marta; Madrazo-Toca, Fidel; Alvarez-Dominguez, Carmen] Fdn Marques de Valdecilla IFIMAV, Grp Genom Prote Infecc Bacterianas & Inflamac, Santander 39120, Cantabria, Spain; [Carrasco-Marin, Eugenio; Rodriguez-Del Rio, Estela; Frande-Cabanes, Elisabet; Jesus Lecea-Cuello, M.; Ruiz-Saez, Marta; Madrazo-Toca, Fidel; Alvarez-Dominguez, Carmen] Hosp Santa Cruz Liencres, Santander 39120, Cantabria, Spain; [Tobes, Raquel; Pareja, Eduardo] BIC Granada CEEI, Informat Technol SL Era7, Bioinformat Unit, Granada 18100, Spain; [Hoelscher, Christoph] Univ Lubeck, Res Ctr Borstel, D-23845 Borstel, Germany	Hospital Universitario Marques de Valdecilla (HUMV); Forschungszentrum Borstel; University of Lubeck	Alvarez-Dominguez, C (corresponding author), Fdn Marques de Valdecilla IFIMAV, Grp Genom Prote Infecc Bacterianas & Inflamac, Santander 39120, Cantabria, Spain.	calvarez@humv.es	Alvarez-Dominguez, Carmen/J-4675-2014; Hölscher, Christoph/O-1732-2018; Frande-Cabanes, Elisabet/F-9889-2016; Marin, Eugenio Carrasco/AAG-1578-2021	Alvarez-Dominguez, Carmen/0000-0002-4585-6959; Hölscher, Christoph/0000-0002-7520-9146; Frande-Cabanes, Elisabet/0000-0003-1748-0584; Marin, Eugenio Carrasco/0000-0002-3556-9227; Tobes, Raquel/0000-0001-7032-8720	Spanish Fondo de Investigaciones Sanitarias [00/3073, PI01/3128, PI03-1009, PI07-0289, PI10-0660]; Fundacion Marques de Valdecilla-IFIMAV [API2011/PI10-0660, API2010/03/SAF2009-08695]; Spanish Ministerio de Ciencia, Investigacion e Innovacion [BIO2002-0628, SAF2006-08968, SAF2009-08695]; Fondo de Investigaciones Sanitarias [PI04-0324]	Spanish Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Fundacion Marques de Valdecilla-IFIMAV; Spanish Ministerio de Ciencia, Investigacion e Innovacion; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III)	This work was supported in part by Spanish Fondo de Investigaciones Sanitarias Grants 00/3073, PI01/3128, PI03-1009, PI07-0289, and PI10-0660, Fundacion Marques de Valdecilla-IFIMAV Grant API2011/PI10-0660 (to E. C.-M.), Spanish Ministerio de Ciencia, Investigacion e Innovacion Grants BIO2002-0628, SAF2006-08968, and SAF2009-08695, Fondo de Investigaciones Sanitarias Grant PI04-0324, and Fundacion Marques de Valdecilla-IFIMAV Grant API2010/03/SAF2009-08695 (to C. A.-D.).	Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; Alvarez-Dominguez C, 2000, IMMUNOLOGY, V101, P83, DOI 10.1046/j.1365-2567.2000.00083.x; Alvarez-Dominguez C, 2008, TRAFFIC, V9, P325, DOI 10.1111/j.1600-0854.2007.00683.x; Beauvillain C, 2009, VACCINE, V27, P1750, DOI 10.1016/j.vaccine.2009.01.022; Bhattacharya M, 2006, EMBO J, V25, P2878, DOI 10.1038/sj.emboj.7601170; Brockstedt DG, 2008, EXPERT REV VACCINES, V7, P1069, DOI 10.1586/14760584.7.7.1069; Carrasco-Marin E, 2011, J BIOL CHEM, V286, P3332, DOI 10.1074/jbc.M110.146761; Carrasco-Marin E, 2009, MOL MICROBIOL, V72, P668, DOI 10.1111/j.1365-2958.2009.06673.x; CarrascoMarin E, 1996, J IMMUNOL, V156, P450; Cervantes J, 2008, CELL MICROBIOL, V10, P41, DOI 10.1111/j.1462-5822.2007.01012.x; Cheng LW, 2005, P NATL ACAD SCI USA, V102, P13646, DOI 10.1073/pnas.0506461102; Corr SC, 2009, CELL MICROBIOL, V11, P703, DOI 10.1111/j.1462-5822.2009.01294.x; del Cerro-Vadillo E, 2006, J IMMUNOL, V176, P1321, DOI 10.4049/jimmunol.176.3.1321; Dinauer MC, 1997, J IMMUNOL, V158, P5581; Forestier C, 2000, J IMMUNOL, V165, P5202, DOI 10.4049/jimmunol.165.9.5202; Hamilton SE, 2006, J IMMUNOL, V177, P4012, DOI 10.4049/jimmunol.177.6.4012; HARDING CV, 1992, J CELL BIOL, V119, P531, DOI 10.1083/jcb.119.3.531; Herskovits AA, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030051; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Jutras I, 2008, MOL CELL PROTEOMICS, V7, P697, DOI 10.1074/mcp.M700267-MCP200; Lauer P, 2008, INFECT IMMUN, V76, P3742, DOI 10.1128/IAI.00390-08; McCaffrey RL, 2004, P NATL ACAD SCI USA, V101, P11386, DOI 10.1073/pnas.0403215101; Menzel K, 2006, CLIN EXP IMMUNOL, V146, P169, DOI 10.1111/j.1365-2249.2006.03188.x; Myers JT, 2003, J IMMUNOL, V171, P5447, DOI 10.4049/jimmunol.171.10.5447; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; PORTNOY DA, 1989, J EXP MED, V170, P2141, DOI 10.1084/jem.170.6.2141; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; Prada-Delgado A, 2005, TRAFFIC, V6, P252, DOI 10.1111/j.1600-0854.2005.00265.x; Prada-Delgado A, 2001, J BIOL CHEM, V276, P19059, DOI 10.1074/jbc.M101639200; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Rodriguez-Del Rio Estela, 2011, Int J Biochem Mol Biol, V2, P207; Sauer JD, 2011, P NATL ACAD SCI USA, V108, P12419, DOI 10.1073/pnas.1019041108; Schramm M, 2008, CELL MICROBIOL, V10, P1839, DOI 10.1111/j.1462-5822.2008.01169.x; Schwegmann A, 2007, P NATL ACAD SCI USA, V104, P16251, DOI 10.1073/pnas.0703496104; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Singh V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016097; Skoberne M, 2002, J IMMUNOL, V169, P1410, DOI 10.4049/jimmunol.169.3.1410; Steinfeld R, 2006, AM J HUM GENET, V78, P988, DOI 10.1086/504159; Tsuchiya K, 2005, INFECT IMMUN, V73, P3869, DOI 10.1128/IAI.73.7.3869-3877.2005; Unanue ER, 1997, IMMUNOL REV, V158, P11, DOI 10.1111/j.1600-065X.1997.tb00988.x; Utermohlen O, 2003, J IMMUNOL, V170, P2621, DOI 10.4049/jimmunol.170.5.2621; Vieira OV, 2003, MOL CELL BIOL, V23, P2501, DOI 10.1128/MCB.23.7.2501-2514.2003; von Delwig A, 2005, SCAND J IMMUNOL, V62, P243, DOI 10.1111/j.1365-3083.2005.01664.x; Waite JC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001326; Westcott MM, 2010, INFECT IMMUN, V78, P2956, DOI 10.1128/IAI.01027-09; Zenewicz LA, 2007, MICROBES INFECT, V9, P1208, DOI 10.1016/j.micinf.2007.05.008	47	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14310	14324		10.1074/jbc.M112.348615	http://dx.doi.org/10.1074/jbc.M112.348615			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22337873	Green Published, hybrid			2022-12-25	WOS:000304003200001
J	Vessichelli, M; Ferravante, A; Zotti, T; Reale, C; Scudiero, I; Picariello, G; Vito, P; Stilo, R				Vessichelli, Mariangela; Ferravante, Angela; Zotti, Tiziana; Reale, Carla; Scudiero, Ivan; Picariello, Gianluca; Vito, Pasquale; Stilo, Romania			Neuroepithelial Transforming Gene 1 (Net1) Binds to Caspase Activation and Recruitment Domain (CARD)- and Membrane-associated Guanylate Kinase-like Domain-containing (CARMA) Proteins and Regulates Nuclear Factor kappa B Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE FACTOR NET1; T-CELL-ACTIVATION; SIGNALING PATHWAYS; HEPATOCELLULAR-CARCINOMA; CYTOKINE PRODUCTION; GASTRIC-CANCER; LYMPHOMA; EXPRESSION; BCL10; RHOA	The molecular complexes containing CARMA proteins have been recently identified as a key components in the signal transduction pathways that regulate activation of nuclear factor kappa B (NF-kappa B) transcription factor. Here, we used immunoprecipitation coupled with mass spectrometry to identify cellular binding partners of CARMA proteins. Our data indicate that the Rho guanine nucleotide exchange factor Net1 binds to CARMA1 and CARMA3 in resting and activated cells. Net1 expression induces NF-kappa B activation and cooperates with BCL10 and CARMA proteins in inducing NF-kappa B activity. Conversely, shRNA-mediated abrogation of Net1 results in impaired NF-kappa B activation following stimuli that require correct CARMA-BCL10-MALT1 complex formation and functioning. Microarray expression data are consistent with a positive role for Net1 on NF-kappa B activation. Thus, this study identifies Net1 as a CARMA-interacting molecule and brings important information on the molecular mechanisms that control NF-kappa B transcriptional activity.	[Vessichelli, Mariangela; Ferravante, Angela; Zotti, Tiziana; Reale, Carla; Scudiero, Ivan; Vito, Pasquale; Stilo, Romania] Univ Sannio, Dipartimento Sci Biol & Ambientali, I-82100 Benevento, Italy; [Vessichelli, Mariangela; Ferravante, Angela; Zotti, Tiziana; Reale, Carla; Scudiero, Ivan; Vito, Pasquale; Stilo, Romania] Biogem Consortium, I-83031 Ariano Irpino, Italy; [Picariello, Gianluca] CNR, Ist Sci Alimentaz, I-83100 Avellino, Italy	University of Sannio; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR)	Vito, P (corresponding author), Univ Sannio, Dipartimento Sci Biol & Ambientali, Via PortArsa 11, I-82100 Benevento, Italy.	vito@unisannio.it	Zotti, Tiziana/AAV-6768-2021; vito, pasquale/ABF-5505-2020; Reale, Carla/AAB-7939-2020	Zotti, Tiziana/0000-0003-4753-116X; Reale, Carla/0000-0001-7682-4784; ferravante, angela/0000-0002-4932-3877; PICARIELLO, Gianluca/0000-0003-1290-1239; scudiero, ivan/0000-0001-5559-5548; vito, pasquale/0000-0002-5721-7716	Telethon [GGP08125B]	Telethon(Fondazione Telethon)	This work was in part supported by Telethon Grant GGP08125B.	Akagi T, 1999, ONCOGENE, V18, P5785, DOI 10.1038/sj.onc.1203018; Alberts AS, 1998, EMBO J, V17, P4075, DOI 10.1093/emboj/17.14.4075; Bidere N, 2009, NATURE, V458, P92, DOI 10.1038/nature07613; Blonska M, 2011, CELL RES, V21, P55, DOI 10.1038/cr.2010.182; Carr HS, 2009, J BIOL CHEM, V284, P24269, DOI 10.1074/jbc.M109.029439; Chan AML, 1996, ONCOGENE, V12, P1259; Chen L, 2007, INT J SURG PATHOL, V15, P346, DOI 10.1177/1066896907306083; Chen YH, 2007, J IMMUNOL, V178, P49, DOI 10.4049/jimmunol.178.1.49; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Delekta PC, 2010, J BIOL CHEM, V285, P41432, DOI 10.1074/jbc.M110.158949; Dimitratos SD, 1999, BIOESSAYS, V21, P912, DOI 10.1002/(SICI)1521-1878(199911)21:11<912::AID-BIES3>3.0.CO;2-Z; Eitelhuber AC, 2011, EMBO J, V30, P594, DOI 10.1038/emboj.2010.331; Garcia-Mata R, 2007, MOL CELL BIOL, V27, P8683, DOI 10.1128/MCB.00157-07; Grabiner BC, 2007, GENE DEV, V21, P984, DOI 10.1101/gad.1502507; Gross O, 2008, BLOOD, V112, P2421, DOI 10.1182/blood-2007-11-123513; Guiet C, 2002, CELL DEATH DIFFER, V9, P138, DOI 10.1038/sj/cdd/4400947; Guiet C, 2000, J CELL BIOL, V148, P1131, DOI 10.1083/jcb.148.6.1131; Hara H, 2008, J IMMUNOL, V181, P918, DOI 10.4049/jimmunol.181.2.918; Huang YP, 2001, ONCOGENE, V20, P1094, DOI 10.1038/sj.onc.1204198; Iwanaga R, 2008, ONCOGENE, V27, P5635, DOI 10.1038/onc.2008.174; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Klemm S, 2006, J EXP MED, V203, P337, DOI 10.1084/jem.20051982; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Leyden J, 2006, BRIT J CANCER, V94, P1204, DOI 10.1038/sj.bjc.6603054; Lin X, 2004, SEMIN IMMUNOL, V16, P429, DOI 10.1016/j.smim.2004.08.022; Malarkannan S, 2007, J IMMUNOL, V179, P3752, DOI 10.4049/jimmunol.179.6.3752; McAllister-Lucas LM, 2007, P NATL ACAD SCI USA, V104, P139, DOI 10.1073/pnas.0601947103; Murray D, 2008, BRIT J CANCER, V99, P1322, DOI 10.1038/sj.bjc.6604688; Nakamura S, 2005, CANCER-AM CANCER SOC, V104, P1885, DOI 10.1002/cncr.21421; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Oeckinghaus A, 2007, EMBO J, V26, P4634, DOI 10.1038/sj.emboj.7601897; Oshiro A, 2006, BLOOD, V107, P4500, DOI 10.1182/blood-2005-09-3801; Palkowitsch L, 2011, J BIOL CHEM, V286, P7522, DOI 10.1074/jbc.M110.155895; Prasad RC, 2009, CANCER LETT, V275, P139, DOI 10.1016/j.canlet.2008.10.007; Qin HJ, 2005, J BIOL CHEM, V280, P7603, DOI 10.1074/jbc.M412141200; Scudiero I, 2011, J CELL PHYSIOL, V226, P3121, DOI 10.1002/jcp.22667; Shen SQ, 2008, MED ONCOL, V25, P341, DOI 10.1007/s12032-008-9042-6; Stilo R, 2004, J BIOL CHEM, V279, P34323, DOI 10.1074/jbc.M402244200; Stilo R, 2008, J CELL SCI, V121, P1165, DOI 10.1242/jcs.021105; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Tu YY, 2010, JPN J CLIN ONCOL, V40, P388, DOI 10.1093/jjco/hyp186; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wegener E, 2006, MOL CELL, V23, P13, DOI 10.1016/j.molcel.2006.05.027; Welteke V, 2009, EMBO REP, V10, P642, DOI 10.1038/embor.2009.64; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; Zhang QG, 1999, NAT GENET, V22, P63, DOI 10.1038/8767	46	15	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13722	13730		10.1074/jbc.M111.304436	http://dx.doi.org/10.1074/jbc.M111.304436			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22343628	Green Published, hybrid			2022-12-25	WOS:000303996300028
J	Borgegard, T; Jureus, A; Olsson, F; Rosqvist, S; Sabirsh, A; Rotticci, D; Paulsen, K; Klintenberg, R; Yan, HM; Waldman, M; Stromberg, K; Nord, J; Johansson, J; Regner, A; Parpal, S; Malinowsky, D; Radesater, AC; Li, TS; Singh, R; Eriksson, H; Lundkvist, J				Borgegard, Tomas; Jureus, Anders; Olsson, Fredrik; Rosqvist, Susanne; Sabirsh, Alan; Rotticci, Didier; Paulsen, Kim; Klintenberg, Rebecka; Yan, Hongmei; Waldman, Magnus; Stromberg, Kia; Nord, Johan; Johansson, Jonas; Regner, Anna; Parpal, Santiago; Malinowsky, David; Radesater, Ann-Cathrin; Li, Tingsheng; Singh, Rajeshwar; Eriksson, Hakan; Lundkvist, Johan			First and Second Generation gamma-Secretase Modulators (GSMs) Modulate Amyloid-beta (A beta) Peptide Production through Different Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; TRANSMEMBRANE DOMAIN; BINDING-SITES; PROTEIN; TARGET; INHIBITORS; PRESENILIN-1; EXPRESSION; FAILURE; PATTERN	gamma-Secretase-mediated cleavage of amyloid precursor protein (APP) results in the production of Alzheimer disease-related amyloid-beta (A beta) peptides. The A beta 42 peptide in particular plays a pivotal role in Alzheimer disease pathogenesis and represents a major drug target. Several gamma-secretase modulators (GSMs), such as the nonsteroidal anti-inflammatory drugs (R)-flurbiprofen and sulindac sulfide, have been suggested to modulate the Alzheimer-related A beta production by targeting the APP. Here, we describe novel GSMs that are selective for A beta modulation and do not impair processing of Notch, EphB2, or EphA4. The GSMs modulate A beta both in cell and cell-free systems as well as lower amyloidogenic A beta 42 levels in the mouse brain. Both radioligand binding and cellular cross-competition experiments reveal a competitive relationship between the AstraZeneca (AZ) GSMs and the established second generation GSM, E2012, but a noncompetitive interaction between AZ GSMs and the first generation GSMs (R)-flurbiprofen and sulindac sulfide. The binding of a H-3-labeledAZGSManalog does not co-localize with APP but overlaps anatomically with a gamma-secretase targeting inhibitor in rodent brains. Combined, these data provide compelling evidence of a growing class of in vivo active GSMs, which are selective for A beta modulation and have a different mechanism of action compared with the original class of GSMs described.	[Borgegard, Tomas; Jureus, Anders; Olsson, Fredrik; Rosqvist, Susanne; Sabirsh, Alan; Klintenberg, Rebecka; Stromberg, Kia; Nord, Johan; Regner, Anna; Parpal, Santiago; Malinowsky, David; Radesater, Ann-Cathrin; Eriksson, Hakan; Lundkvist, Johan] AstraZeneca, Dept Neurosci, CNS PAIN iMED, S-15185 Sodertalje, Sweden; [Rotticci, Didier; Paulsen, Kim; Waldman, Magnus; Johansson, Jonas] AstraZeneca, Dept Med Chem, CNS PAIN iMED, S-15185 Sodertalje, Sweden; [Yan, Hongmei] AstraZeneca, Dept Drug Metab & Pharmacokinet, CNS PAIN iMED, S-15185 Sodertalje, Sweden; [Li, Tingsheng; Singh, Rajeshwar] NAEJA Pharmaceut Inc, Edmonton, AB T6E 5V2, Canada	AstraZeneca; AstraZeneca; AstraZeneca	Lundkvist, J (corresponding author), AstraZeneca, Dept Neurosci, CNS PAIN iMED, Bldg 212 5th Fl, S-15185 Sodertalje, Sweden.	johan.lundkvist@astrazeneca.com		Jureus, Anders/0000-0002-8922-6377; Parpal, Santiago/0000-0003-2861-0516; Sabirsh, Alan/0000-0001-5310-0281				Beher D, 2004, J BIOL CHEM, V279, P43419, DOI 10.1074/jbc.M404937200; Blanchard V, 1997, BRAIN RES, V758, P209, DOI 10.1016/S0006-8993(97)00231-X; Borgegard T, 2011, ALZHEIMERS DIS RES J, V3, P29; Churcher I, 2006, BIOORG MED CHEM LETT, V16, P280, DOI 10.1016/j.bmcl.2005.10.009; Crump CJ, 2011, ACS CHEM NEUROSCI, V2, P705, DOI 10.1021/cn200098p; Ebke A, 2011, J BIOL CHEM, V286, P37181, DOI 10.1074/jbc.C111.276972; Elder GA, 1996, J NEUROSCI RES, V45, P308; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; He G, 2010, NATURE, V467, P95, DOI 10.1038/nature09325; Inoue E, 2009, J CELL BIOL, V185, P551, DOI 10.1083/jcb.200809151; Jureus A, 2010, J NEUROCHEM, V114, P784, DOI 10.1111/j.1471-4159.2010.06812.x; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Kretner B, 2011, J BIOL CHEM, V286, P15240, DOI 10.1074/jbc.M110.213587; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Litterst C, 2007, J BIOL CHEM, V282, P16155, DOI 10.1074/jbc.M611449200; Lundkvist J, 2007, CURR OPIN PHARMACOL, V7, P112, DOI 10.1016/j.coph.2006.10.002; Malmquist J, 2012, J LABELLED COMPD RAD, V55, P80, DOI 10.1002/jlcr.1955; McLendon C, 2000, FASEB J, V14, P2383; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Oehlrich D, 2011, J MED CHEM, V54, P669, DOI 10.1021/jm101168r; Ohki Y, 2011, EMBO J, V30, P4815, DOI 10.1038/emboj.2011.372; Portelius E, 2010, J ALZHEIMERS DIS, V21, P1005, DOI 10.3233/JAD-2010-100573; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Stromberg K, 2005, J NEUROCHEM, V95, P880, DOI 10.1111/j.1471-4159.2005.03415.x; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Tian GC, 2003, J BIOL CHEM, V278, P28968, DOI 10.1074/jbc.M300905200; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Wan HI, 2009, CTS-CLIN TRANSL SCI, V2, P242, DOI 10.1111/j.1752-8062.2009.00121.x; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Yan XX, 2004, J NEUROSCI, V24, P2942, DOI 10.1523/JNEUROSCI.0092-04.2004	32	58	59	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11810	11819		10.1074/jbc.M111.305227	http://dx.doi.org/10.1074/jbc.M111.305227			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334705	Green Published, hybrid			2022-12-25	WOS:000302782200020
J	Palsgaard, J; Emanuelli, B; Winnay, JN; Sumara, G; Karsenty, G; Kahn, CR				Palsgaard, Jane; Emanuelli, Brice; Winnay, Jonathon N.; Sumara, Grzegorz; Karsenty, Gerard; Kahn, C. Ronald			Cross-talk between Insulin and Wnt Signaling in Preadipocytes ROLE OF WNT CO-RECEPTOR LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-5 (LRP5)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; PROTEIN-5 LRP5; PATHWAY; PHOSPHORYLATION; ADIPOGENESIS; POLYMORPHISMS; INHIBITION; TCF7L2; BONE; GENE	Disturbed Wnt signaling has been implicated in numerous diseases, including type 2 diabetes and the metabolic syndrome. In the present study, we have investigated cross-talk between insulin and Wnt signaling pathways using preadipocytes with and without knockdown of the Wnt co-receptors LRP5 and LRP6 and with and without knock-out of insulin and IGF-1 receptors. We find that Wnt stimulation leads to phosphorylation of insulin signaling key mediators, including Akt, GSK3 beta, and ERK1/2, although with a lower fold stimulation and slower time course than observed for insulin. These Wnt effects are insulin/IGF-1 receptor-dependent and are lost in insulin/IGF-1 receptor double knock-out cells. Conversely, in LRP5 knockdown preadipocytes, insulin-induced phosphorylation of IRS1, Akt, GSK3 beta, and ERK1/2 is highly reduced. This effect is specific to insulin, as compared with IGF-1, stimulation and appears to be due to an inducible interaction between LRP5 and the insulin receptor as demonstrated by co-immunoprecipitation. These data demonstrate that Wnt and insulin signaling pathways exhibit cross-talk at multiple levels. Wnt induces phosphorylation of Akt, ERK1/2, and GSK3 beta, and this is dependent on insulin/IGF-1 receptors. Insulin signaling also involves the Wnt co-receptor LRP5, which has a positive effect on insulin signaling. Thus, altered Wnt and LRP5 activity can serve as modifiers of insulin action and insulin resistance in the pathophysiology of diabetes and metabolic syndrome.	[Palsgaard, Jane; Emanuelli, Brice; Winnay, Jonathon N.; Kahn, C. Ronald] Harvard Univ, Joslin Diabet Ctr, Sch Med, Sect Integrat Physiol & Metab, Boston, MA 02215 USA; [Sumara, Grzegorz; Karsenty, Gerard] Columbia Univ, Dept Genet & Dev, Sch Med, New York, NY 10032 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Columbia University	Kahn, CR (corresponding author), Harvard Univ, Joslin Diabet Ctr, Sch Med, Sect Integrat Physiol & Metab, 1 Joslin Pl, Boston, MA 02215 USA.	c.ronald.kahn@joslin.harvard.edu	Emanuelli, Brice/M-2097-2016; Kahn, Ronald/AAY-2435-2021	Emanuelli, Brice/0000-0001-5795-5666; Kahn, Ronald/0000-0002-7583-9228; Karsenty, Gerard/0000-0002-9253-7627; Sumara, Grzegorz/0000-0003-1502-6265	National Institutes of Health [DK31036, DK33201, DK55545]; Novo Nordisk STAR; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082659, R01DK055545, R37DK031036, R01DK031036, R01DK033201] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk STAR; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	* This work was supported, in whole or in part, by National Institutes of Health Grants DK31036, DK33201, and DK55545.; <SUP>1</SUP> Supported by a Novo Nordisk STAR International postdoctoral fellowship.	Abiola M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008509; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Boucher J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001173; Boucher J, 2010, J BIOL CHEM, V285, P17235, DOI 10.1074/jbc.M110.118620; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Desbois-Mouthon C, 2001, ONCOGENE, V20, P252, DOI 10.1038/sj.onc.1204064; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Fujino T, 2003, P NATL ACAD SCI USA, V100, P229, DOI 10.1073/pnas.0133792100; Fukumoto S, 2001, J BIOL CHEM, V276, P17479, DOI 10.1074/jbc.C000880200; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Goentoro L, 2009, MOL CELL, V36, P872, DOI 10.1016/j.molcel.2009.11.017; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Guo YF, 2006, J MED GENET, V43, P798, DOI 10.1136/jmg.2006.041715; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jin T, 2008, DIABETOLOGIA, V51, P1771, DOI 10.1007/s00125-008-1084-y; Jin T, 2008, MOL ENDOCRINOL, V22, P2383, DOI 10.1210/me.2008-0135; Jin TR, 2008, CELL SIGNAL, V20, P1697, DOI 10.1016/j.cellsig.2008.04.014; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kennell JA, 2005, J BIOL CHEM, V280, P24004, DOI 10.1074/jbc.M501080200; Kikuchi A, 2007, CELL SIGNAL, V19, P659, DOI 10.1016/j.cellsig.2006.11.001; Kruger M, 2008, P NATL ACAD SCI USA, V105, P2451, DOI 10.1073/pnas.0711713105; Lee SH, 2008, EXP DIABETES RES, DOI 10.1155/2008/728763; Longo KA, 2002, J BIOL CHEM, V277, P38239, DOI 10.1074/jbc.M206402200; Longo KA, 2004, J BIOL CHEM, V279, P35503, DOI 10.1074/jbc.M402937200; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Manolagas SC, 2007, MOL ENDOCRINOL, V21, P2605, DOI 10.1210/me.2007-0259; Manolopoulos KN, 2010, MOL PSYCHIATR, V15, P1046, DOI 10.1038/mp.2010.17; Naito AT, 2010, CIRC RES, V107, P1295, DOI 10.1161/CIRCRESAHA.110.223776; Piao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004046; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Prestwich TC, 2007, CURR OPIN CELL BIOL, V19, P612, DOI 10.1016/j.ceb.2007.09.014; Rey JP, 2010, DEV DYNAM, V239, P102, DOI 10.1002/dvdy.22181; Riancho JA, 2011, EUR J ENDOCRINOL, V164, P123, DOI 10.1530/EJE-10-0582; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Saarinen A, 2010, CLIN ENDOCRINOL, V72, P481, DOI 10.1111/j.1365-2265.2009.03680.x; Schinner S, 2009, HORM METAB RES, V41, P159, DOI 10.1055/s-0028-1119408; Sugimura R, 2010, BIRTH DEFECTS RES C, V90, P243, DOI 10.1002/bdrc.20195; Sun J, 2008, CELL SIGNAL, V20, P219, DOI 10.1016/j.cellsig.2007.10.010; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Welters HJ, 2008, TRENDS ENDOCRIN MET, V19, P349, DOI 10.1016/j.tem.2008.08.004; Wright WS, 2007, DIABETES, V56, P295, DOI 10.2337/db06-1339; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Yi FH, 2008, ENDOCRINOLOGY, V149, P2341, DOI 10.1210/en.2007-1142; Yoon JC, 2010, GENE DEV, V24, P1507, DOI 10.1101/gad.1924910; Yum S, 2009, BIOCHEM BIOPH RES CO, V381, P345, DOI 10.1016/j.bbrc.2009.02.044; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	57	68	72	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12016	12026		10.1074/jbc.M111.337048	http://dx.doi.org/10.1074/jbc.M111.337048			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22337886	hybrid, Green Published			2022-12-25	WOS:000302782200039
J	Takagi, K; Kim, S; Yukii, H; Ueno, M; Morishita, R; Endo, Y; Kato, K; Tanaka, K; Saeki, Y; Mizushima, T				Takagi, Kenji; Kim, Sangwoo; Yukii, Haruka; Ueno, Mika; Morishita, Ryo; Endo, Yaeta; Kato, Koichi; Tanaka, Keiji; Saeki, Yasushi; Mizushima, Tsunehiro			Structural Basis for Specific Recognition of Rpt1p, an ATPase Subunit of 26 S Proteasome, by Proteasome-dedicated Chaperone Hsm3p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN 20S PROTEASOMES; REGULATORY PARTICLE; MOLECULAR-GRAPHICS; ASSEMBLY PATHWAY; NMR SYSTEM; YEAST; COMPLEX; CRYSTALLOGRAPHY; MATURATION; SOFTWARE	The 26 S proteasome is a 2.5-MDa molecular machine that degrades ubiquitinated proteins in eukaryotic cells. It consists of a proteolytic core particle and two 19 S regulatory particles (RPs) composed of 6 ATPase (Rpt) and 13 non-ATPase (Rpn) subunits. Multiple proteasome-dedicated chaperones facilitate the assembly of the proteasome, but little is known about the detailed mechanisms. Hsm3, a 19 S RP dedicated chaperone, transiently binds to the C-terminal domain of the Rpt1 subunit and forms a tetrameric complex, Hsm3-Rpt1-Rpt2-Rpn1, during maturation of the ATPase ring of 19 S RP. To elucidate the structural basis of Hsm3 function, we determined the crystal structures of Hsm3 and its complex with the C-terminal domain of the Rpt1 subunit (Rpt1C). Hsm3 has a C-shaped structure that consists of 11 HEAT repeats. The structure of the Hsm3-Rpt1C complex revealed that the interacting surface between Hsm3 and Rpt1 is a hydrophobic core and a complementary charged surface. Mutations in the Hsm3-Rpt1 surface resulted in the assembly defect of the 26 S proteasome. Furthermore, a structural model of the Hsm3-Rpt ring complex and an in vitro binding assay suggest that Hsm3 can bind Rpt2 in addition to Rpt1. Collectively, our results provide the structural basis of the molecular functions of Hsm3 for the RP assembly.	[Yukii, Haruka; Ueno, Mika; Tanaka, Keiji; Saeki, Yasushi] Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Setagaya Ku, Tokyo 1568506, Japan; [Takagi, Kenji; Mizushima, Tsunehiro] Univ Hyogo, Picobiol Inst, Dept Life Sci, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan; [Takagi, Kenji; Kim, Sangwoo; Kato, Koichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Morishita, Ryo] Ehime Univ, CellFree Sci Co Ltd, Venture Business Lab 4F, Matsuyama, Ehime 7908577, Japan; [Endo, Yaeta] Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime 7908577, Japan; [Kato, Koichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Kato, Koichi] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448787, Japan	Tokyo Metropolitan Institute of Medical Science; University of Hyogo; Nagoya City University; Ehime University; Ehime University; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS)	Saeki, Y (corresponding author), Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	saeki-ys@igakuken.or.jp; mizushi@sci.u-hyogo.ac.jp	Kim, Sangwoo/F-8043-2013; Saeki, Yasushi/AAR-8198-2021	Saeki, Yasushi/0000-0002-9202-5453; Mizushima, Tsunehiro/0000-0002-6631-2889; Kato, Koichi/0000-0001-7187-9612	Ministry of Education, Culture, Sports, Science and Technology of Japan; Naito Foundation; Targeted Proteins Research program	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Targeted Proteins Research program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, grant-in-aid for scientific research on innovative areas (to T. M.), grant-in-aid for challenging exploratory research (to T. M.), The Naito Foundation (to T. M.), grant-in-aid for JSPS fellows (to K. Takagi), grant-in-aid for young scientists (to Y. S.), grant-in-aid for specially promoted Research (to K. Tanaka), and the Targeted Proteins Research program (to R. M., Y. E., K. K., K. Tanaka, and T. M.).	Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Bedford L, 2010, TRENDS CELL BIOL, V20, P391, DOI 10.1016/j.tcb.2010.03.007; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Cowtan K, 1999, ACTA CRYSTALLOGR D, V55, P1555, DOI 10.1107/S0907444999007416; DeLano W, 2002, PYMOL 0 99; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Gorbea C, 2000, J BIOL CHEM, V275, P875, DOI 10.1074/jbc.275.2.875; Goshima N, 2008, NAT METHODS, V5, P1011, DOI 10.1038/nmeth.1273; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Hirano Y, 2008, EMBO J, V27, P2204, DOI 10.1038/emboj.2008.148; Hirano Y, 2006, MOL CELL, V24, P977, DOI 10.1016/j.molcel.2006.11.015; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Kim S, 2010, J BIOL CHEM, V285, P15159, DOI 10.1074/jbc.M110.104042; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Le Tallec B, 2007, MOL CELL, V27, P660, DOI 10.1016/j.molcel.2007.06.025; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Leggett David S., 2005, V301, P57; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura Y, 2007, BIOCHEM BIOPH RES CO, V359, P503, DOI 10.1016/j.bbrc.2007.05.138; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Ramos PC, 1998, CELL, V92, P489, DOI 10.1016/S0092-8674(00)80942-3; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Sakata E, 2011, MOL CELL, V42, P637, DOI 10.1016/j.molcel.2011.04.021; Sasaki T, 2000, MOL CELL BIOL, V20, P7971, DOI 10.1128/MCB.20.21.7971-7979.2000; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; Takai K, 2010, NAT PROTOC, V5, P227, DOI 10.1038/nprot.2009.207; TANAKA K, 1988, J BIOL CHEM, V263, P16209; Tomko RJ, 2011, CELL BIOCHEM BIOPHYS, V60, P13, DOI 10.1007/s12013-011-9178-4; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Yashiroda H, 2008, NAT STRUCT MOL BIOL, V15, P228, DOI 10.1038/nsmb.1386	43	23	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12172	12182		10.1074/jbc.M112.345876	http://dx.doi.org/10.1074/jbc.M112.345876			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334676	Green Published, hybrid			2022-12-25	WOS:000302782200059
J	Sun, XY; Wei, YP; Xiong, Y; Wang, XC; Xie, AJ; Wang, XL; Yang, Y; Wang, Q; Lu, YM; Liu, R; Wang, JZ				Sun, Xu-Ying; Wei, Yu-Ping; Xiong, Yan; Wang, Xiao-Chuan; Xie, Ao-Ji; Wang, Xiu-Lian; Yang, Yang; Wang, Qun; Lu, You-Ming; Liu, Rong; Wang, Jian-Zhi			Synaptic Released Zinc Promotes Tau Hyperphosphorylation by Inhibition of Protein Phosphatase 2A (PP2A)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; MILD COGNITIVE IMPAIRMENT; PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; NEUROBLASTOMA-CELLS; RAT HIPPOCAMPUS; TRANSGENIC MICE; NEURONAL DEATH; BRAIN; PHOSPHORYLATION	Background: Tangle distribution is largely overlapped with zinc-containing glutamatergic neurons. Synaptically released zinc may be involved in tau hyperphosphorylation. Results: Increased synaptic activity induces tau hyperphosphorylation by synaptic zinc through PP2A inhibition. Conclusion: Synaptic activity promotes tau hyperphosphorylation, and synaptically released zinc plays a central role. Significance: Therapies targeted to maintaining zinc homeostasis and moderating synaptic activity may benefit AD by reducing tauopathy.	[Sun, Xu-Ying; Wei, Yu-Ping; Xiong, Yan; Wang, Xiao-Chuan; Xie, Ao-Ji; Wang, Xiu-Lian; Yang, Yang; Wang, Qun; Lu, You-Ming; Liu, Rong; Wang, Jian-Zhi] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pathophysiol, Wuhan 430030, Peoples R China; [Wang, Xiao-Chuan; Lu, You-Ming; Liu, Rong; Wang, Jian-Zhi] Minist Educ China, Key Lab Neurol Dis, Wuhan 430030, Peoples R China	Huazhong University of Science & Technology; Ministry of Education, China	Liu, R (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pathophysiol, Wuhan 430030, Peoples R China.	rong.liu@mail.hust.edu.cn	Xie, Aoji/AFT-5035-2022	Liu, Rong/0000-0001-7477-6520	Fundamental Research Funds for the Central Universities, HUST [2010MS050]; National Natural Science Foundation of China [81130079]; Alzheimer's Association [IIRG-09-133433]	Fundamental Research Funds for the Central Universities, HUST(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Alzheimer's Association(Alzheimer's Association)	This work was supported by Fundamental Research Funds for the Central Universities, HUST, (No: 2010MS050), the National Natural Science Foundation of China (No: 81130079), and Alzheimer's Association (IIRG-09-133433).	Adlard PA, 2010, J NEUROSCI, V30, P1631, DOI 10.1523/JNEUROSCI.5255-09.2010; An WL, 2005, J NEUROCHEM, V92, P1104, DOI 10.1111/j.1471-4159.2004.02948.x; BANCHER C, 1989, BRAIN RES, V477, P90, DOI 10.1016/0006-8993(89)91396-6; Bitanihirwe BKY, 2009, SYNAPSE, V63, P1029, DOI 10.1002/syn.20683; BRAUTIGAN DL, 1981, J BIOL CHEM, V256, P6519; Chen Y, 2007, NAT STRUCT MOL BIOL, V14, P527, DOI 10.1038/nsmb1254; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Deibel MA, 1996, J NEUROL SCI, V143, P137, DOI 10.1016/S0022-510X(96)00203-1; Deshpande A, 2009, J NEUROSCI, V29, P4004, DOI 10.1523/JNEUROSCI.5980-08.2009; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; FREDERICKSON CJ, 1990, PROG BRAIN RES, V83, P71; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Frederickson CJ, 2001, BIOMETALS, V14, P353, DOI 10.1023/A:1012934207456; GONG CX, 1993, J NEUROCHEM, V61, P921, DOI 10.1111/j.1471-4159.1993.tb03603.x; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; HAUSER WA, 1986, NEUROLOGY, V36, P1226, DOI 10.1212/WNL.36.9.1226; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; ISHIGURO K, 1992, J BIOL CHEM, V267, P10897; Karakas E, 2009, EMBO J, V28, P3910, DOI 10.1038/emboj.2009.338; Ketterman JK, 2008, J NEUROSCI RES, V86, P422, DOI 10.1002/jnr.21488; Kim I, 2011, NEUROREPORT, V22, P839, DOI 10.1097/WNR.0b013e32834c0a2d; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; KOPKE E, 1993, J BIOL CHEM, V268, P24374; LAFERLA FM, 1995, NAT GENET, V9, P21, DOI 10.1038/ng0195-21; Lavoie N, 2007, J PHYSIOL-LONDON, V578, P275, DOI 10.1113/jphysiol.2006.121848; Lee YI, 2005, J BIOL CHEM, V280, P22044, DOI 10.1074/jbc.M413987200; Li Y, 2001, J NEUROPHYSIOL, V86, P2597, DOI 10.1152/jn.2001.86.5.2597; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Liu R, 2005, J NEUROCHEM, V94, P1225, DOI 10.1111/j.1471-4159.2005.03270.x; Lovell MA, 2005, NEUROTOX RES, V7, P265, DOI 10.1007/BF03033884; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Mo ZY, 2009, J BIOL CHEM, V284, P34648, DOI 10.1074/jbc.M109.058883; Mount C, 2006, NAT MED, V12, P780, DOI 10.1038/nm0706-780; Religa D, 2006, NEUROLOGY, V67, P69, DOI 10.1212/01.wnl.0000223644.08653.b5; RIEDERER BM, 1992, HISTOCHEM J, V24, P783, DOI 10.1007/BF01046350; Sheline CT, 2002, NEUROBIOL DIS, V10, P41, DOI 10.1006/nbdi.2002.0497; Sindreu CB, 2003, CEREB CORTEX, V13, P823, DOI 10.1093/cercor/13.8.823; SLOMIANKA L, 1990, NEUROSCIENCE, V38, P843, DOI 10.1016/0306-4522(90)90076-G; Smith JL, 2006, NEUROSCIENCE, V140, P879, DOI 10.1016/j.neuroscience.2006.02.049; Suh SW, 2004, NEUROBIOL DIS, V16, P538, DOI 10.1016/j.nbd.2004.04.017; Takashima A, 2006, J ALZHEIMERS DIS, V9, P309; Takeda A, 2010, BRAIN RES, V1323, P59, DOI 10.1016/j.brainres.2010.01.085; Wang JZ, 2008, PROG NEUROBIOL, V85, P148, DOI 10.1016/j.pneurobio.2008.03.002; Wenzel HJ, 1997, P NATL ACAD SCI USA, V94, P12676, DOI 10.1073/pnas.94.23.12676; Yin HZ, 2002, J NEUROSCI, V22, P1273, DOI 10.1523/JNEUROSCI.22-04-01273.2002	46	99	106	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11174	11182		10.1074/jbc.M111.309070	http://dx.doi.org/10.1074/jbc.M111.309070			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334661	hybrid, Green Published			2022-12-25	WOS:000302780100045
J	Chen, CK; Sawaya, MR; Phillips, ML; Reisler, E; Quinlan, ME				Chen, Christine K.; Sawaya, Michael R.; Phillips, Martin L.; Reisler, Emil; Quinlan, Margot E.			Multiple Forms of Spire-Actin Complexes and their Functional Consequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FILAMENT NUCLEATION; EFFECTOR VOPL; WH2 DOMAINS; CORDON-BLEU; F-ACTIN; COFILIN; MECHANISM; FAMILY; CAPPUCCINO; CONTACTS	Spire is a WH2 domain-containing actin nucleator essential for establishing an actin mesh during oogenesis. In vitro, in addition to nucleating filaments, Spire can sever them and sequester actin monomers. Understanding how Spire is capable of these disparate functions and which are physiologically relevant is an important goal. To study severing, we examined the effect of Drosophila Spire on preformed filaments in bulk and single filament assays. We observed rapid depolymerization of actin filaments by Spire, which we conclude is largely due to its sequestration activity and enhanced by its weak severing activity. We also studied the solution and crystal structures of Spire-actin complexes. We find structural and functional differences between constructs containing four WH2 domains (Spir-ABCD) and two WH2 domains (Spir-CD) that may provide insight into the mechanisms of nucleation and sequestration. Intriguingly, we observed lateral interactions between actin monomers associated with Spir-ABCD, suggesting that the structures built by these four tandem WH2 domains are more complex than originally imagined. Finally, we propose that Spire-actin mixtures contain both nuclei and sequestration structures.	[Chen, Christine K.; Sawaya, Michael R.; Phillips, Martin L.; Reisler, Emil; Quinlan, Margot E.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Reisler, Emil; Quinlan, Margot E.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Quinlan, ME (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 611 Charles E Young Dr E, Los Angeles, CA 90095 USA.	margot@chem.ucla.edu			National Institutes of Health [R01 GM096133]; Burroughs-Wellcome Fund Career Award in the Biomedical Sciences; March of Dimes Foundation [5-FY10-81]; U.S. Public Health Service [GM077190]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077190, R01GM096133] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs-Wellcome Fund Career Award in the Biomedical Sciences(Burroughs Wellcome Fund); March of Dimes Foundation(March of Dimes); U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM096133, a Burroughs-Wellcome Fund Career Award in the Biomedical Sciences, and a March of Dimes Foundation, Basil O'Connor Starter Scholar Award (# 5-FY10-81) (to M. E. Q). This work was also supported by U.S. Public Health Service Grant GM077190 (to E. R.).	Ahuja R, 2007, CELL, V131, P337, DOI 10.1016/j.cell.2007.08.030; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bobkov AA, 2004, J MOL BIOL, V337, P93, DOI 10.1016/j.jmb.2004.01.014; Bobkov AA, 2002, J MOL BIOL, V323, P739, DOI 10.1016/S0022-2836(02)01008-2; Bosch M, 2007, MOL CELL, V28, P555, DOI 10.1016/j.molcel.2007.09.018; Chan AY, 2000, J CELL BIOL, V148, P531, DOI 10.1083/jcb.148.3.531; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; Chereau D, 2008, SCIENCE, V320, P239, DOI 10.1126/science.1155313; Dahlgaard K, 2007, DEV CELL, V13, P539, DOI 10.1016/j.devcel.2007.09.003; Ducka AM, 2010, P NATL ACAD SCI USA, V107, P11757, DOI 10.1073/pnas.1005347107; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; Husson C, 2011, MOL CELL, V43, P464, DOI 10.1016/j.molcel.2011.07.010; Ito T, 2011, J MOL BIOL, V408, P18, DOI 10.1016/j.jmb.2010.12.045; KHAITLINA SY, 1993, EUR J BIOCHEM, V218, P911, DOI 10.1111/j.1432-1033.1993.tb18447.x; Le Goff C, 2006, BIOL CELL, V98, P697, DOI 10.1042/BC20050095; Liverman ADB, 2007, P NATL ACAD SCI USA, V104, P17117, DOI 10.1073/pnas.0703196104; MANSEAU LJ, 1989, GENE DEV, V3, P1437, DOI 10.1101/gad.3.9.1437; Namgoong S, 2011, NAT STRUCT MOL BIOL, V18, P1060, DOI 10.1038/nsmb.2109; Pavlov D, 2007, J MOL BIOL, V365, P1350, DOI 10.1016/j.jmb.2006.10.102; Pfender S, 2011, CURR BIOL, V21, P955, DOI 10.1016/j.cub.2011.04.029; Quinlan ME, 2007, J CELL BIOL, V179, P117, DOI 10.1083/jcb.200706196; Quinlan ME, 2005, NATURE, V433, P382, DOI 10.1038/nature03241; Rebowski G, 2010, J MOL BIOL, V403, P11, DOI 10.1016/j.jmb.2010.08.040; Schuh M, 2011, NAT CELL BIOL, V13, P1431, DOI 10.1038/ncb2353; Sitar T, 2011, P NATL ACAD SCI USA, V108, P19575, DOI 10.1073/pnas.1115465108; Tam VC, 2007, CELL HOST MICROBE, V1, P95, DOI 10.1016/j.chom.2007.03.005; Tam VC, 2010, MBIO, V1, DOI 10.1128/mBio.00289-10; Vizcarra CL, 2011, P NATL ACAD SCI USA, V108, P11884, DOI 10.1073/pnas.1105703108; Yu BK, 2011, NAT STRUCT MOL BIOL, V18, P1068, DOI 10.1038/nsmb.2110; Zuchero JB, 2009, NAT CELL BIOL, V11, P451, DOI 10.1038/ncb1852	30	19	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10684	10692		10.1074/jbc.M111.317792	http://dx.doi.org/10.1074/jbc.M111.317792			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22334675	Green Published, hybrid			2022-12-25	WOS:000302167200093
J	Martinon, S; Garcia, E; Gutierrez-Ospina, G; Mestre, H; Ibarra, A				Martinon, Susana; Garcia, Elisa; Gutierrez-Ospina, Gabriel; Mestre, Humberto; Ibarra, Antonio			Development of Protective Autoimmunity by Immunization with a Neural-Derived Peptide Is Ineffective in Severe Spinal Cord Injury	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; PROMOTES RECOVERY; T-CELLS; VACCINATION; RATS; MICROGLIA; GLUTAMATE; TOXICITY; ENCEPHALOMYELITIS; ACTIVATION	Protective autoimmunity (PA) is a physiological response to central nervous system trauma that has demonstrated to promote neuroprotection after spinal cord injury (SCI). To reach its beneficial effect, PA should be boosted by immunizing with neural constituents or neural-derived peptides such as A91. Immunizing with A91 has shown to promote neuroprotection after SCI and its use has proven to be feasible in a clinical setting. The broad applications of neural-derived peptides make it important to determine the main features of this anti-A91 response. For this purpose, adult Sprague-Dawley rats were subjected to a spinal cord contusion (SCC; moderate or severe) or a spinal cord transection (SCT; complete or incomplete). Immediately after injury, animals were immunized with PBS or A91. Motor recovery, T cell-specific response against A91 and the levels of IL-4, IFN-gamma and brain-derived neurotrophic factor (BDNF) released by A91-specific T (T-A91) cells were evaluated. Rats with moderate SCC, presented a better motor recovery after A91 immunization. Animals with moderate SCC or incomplete SCT showed significant T cell proliferation against A91 that was characterized chiefly by the predominant production of IL-4 and the release of BDNF. In contrast, immunization with A91 did not promote a better motor recovery in animals with severe SCC or complete SCT. In fact, T cell proliferation against A91 was diminished in these animals. The present results suggest that the effective development of PA and, consequently, the beneficial effects of immunizing with A91 significantly depend on the severity of SCI. This could mainly be attributed to the lack of T-A91 cells which predominantly showed to have a Th2 phenotype capable of producing BDNF, further promoting neuroprotection.	[Martinon, Susana; Garcia, Elisa; Ibarra, Antonio] Ctr Invest Proyecto CAMINA AC, Mexico City, DF, Mexico; [Garcia, Elisa; Mestre, Humberto; Ibarra, Antonio] Univ Anahuac Mexico Norte, Fac Ciencias Salud, Huixquilucan, Estado De Mexic, Mexico; [Gutierrez-Ospina, Gabriel] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Celular & Fisiol, Mexico City 04510, DF, Mexico	Universidad Anahuac; Universidad Nacional Autonoma de Mexico	Martinon, S (corresponding author), Ctr Invest Proyecto CAMINA AC, Mexico City, DF, Mexico.	iantonio65@yahoo.com	Mestre, Humberto/AAO-5848-2020; Martiñón, Susana/AAE-2807-2020	Mestre, Humberto/0000-0001-5876-5397; Ibarra, Antonio/0000-0003-2489-4689; garcia vences, edna elisa/0000-0001-7588-3846; Gutierrez Ospina, Gabriel/0000-0002-6286-8281	National Council of Science and Technology of Mexico 'CONACYT) [57204]; Camina Research Center; Universidad Anahuac Mexico Norte	National Council of Science and Technology of Mexico 'CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Camina Research Center; Universidad Anahuac Mexico Norte	This work was partially supported by the National Council of Science and Technology of Mexico 'CONACYT), grant No. 57204, Camina Research Center and Universidad Anahuac Mexico Norte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni R, 2005, P NATL ACAD SCI USA, V102, P19045, DOI 10.1073/pnas.0509438102; Avidan H, 2004, EUR J IMMUNOL, V34, P3434, DOI 10.1002/eji.200424883; Bakalash S, 2002, INVEST OPHTH VIS SCI, V43, P2648; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Erdman SE, 2009, P NATL ACAD SCI USA, V106, P1027, DOI 10.1073/pnas.0812347106; Garcia E, 2011, J NEUROSCI IN PRESS; Gaur A, 1997, J NEUROIMMUNOL, V74, P149, DOI 10.1016/S0165-5728(96)00220-2; Hauben E, 2000, J NEUROSCI, V20, P6421, DOI 10.1523/JNEUROSCI.20-17-06421.2000; Hauben E, 2001, J CLIN INVEST, V108, P591, DOI 10.1172/JCI200112837; Hauben E, 2001, P NATL ACAD SCI USA, V98, P15173, DOI 10.1073/pnas.011585298; Ibarra A, 2007, SPINAL CORD, V45, P380, DOI 10.1038/sj.sc.3101972; Ibarra A, 2004, EUR J NEUROSCI, V19, P2984, DOI 10.1111/j.0953-816X.2004.03402.x; Ibarra A, 2010, NEUROSCI LETT, V476, P62, DOI 10.1016/j.neulet.2010.04.003; Jones TB, 2002, J NEUROSCI, V22, P2690, DOI 10.1523/JNEUROSCI.22-07-02690.2002; Lucin KM, 2007, EXP NEUROL, V207, P75, DOI 10.1016/j.expneurol.2007.05.019; MADDEN KS, 1995, ANNU REV PHARMACOL, V35, P417, DOI 10.1146/annurev.pharmtox.35.1.417; Martinon S, 2007, EUR J NEUROSCI, V26, P403, DOI 10.1111/j.1460-9568.2007.05650.x; Morris KR, 2009, TUBERCULOSIS, V89, P294, DOI 10.1016/j.tube.2009.03.004; Popovich PG, 2001, J NEUROTRAUM, V18, P957, DOI 10.1089/089771501750451866; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Riegger T, 2007, EUR J NEUROSCI, V25, P1743, DOI 10.1111/j.1460-9568.2007.05447.x; Schori H, 2005, TOXICOL SCI, V87, P163, DOI 10.1093/toxsci/kfi237; Schori H, 2001, J NEUROIMMUNOL, V119, P199, DOI 10.1016/S0165-5728(01)00358-7; Schwartz M, 2006, J NEUROTRAUM, V23, P360, DOI 10.1089/neu.2006.23.360; SENDTNER M, 1992, NATURE, V360, P757, DOI 10.1038/360757a0; Shaked I, 2005, J NEUROCHEM, V92, P997, DOI 10.1111/j.1471-4159.2004.02954.x; Shaked I, 2004, J NEUROIMMUNOL, V146, P84, DOI 10.1016/j.jneuroim.2003.10.049; Stier KS, 2009, J EXP BIOL, V212, P2084, DOI 10.1242/jeb.024406; YAN Q, 1992, NATURE, V360, P753, DOI 10.1038/360753a0; Yoles E, 2001, J NEUROSCI, V21, P3740, DOI 10.1523/JNEUROSCI.21-11-03740.2001	31	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e32027	10.1371/journal.pone.0032027	http://dx.doi.org/10.1371/journal.pone.0032027			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348141	Green Published, Green Submitted, gold			2022-12-25	WOS:000302737400059
J	Chen, ZF; Wang, H; Matsumura, K; Qian, PY				Chen, Zhang-Fan; Wang, Hao; Matsumura, Kiyotaka; Qian, Pei-Yuan			Expression of Calmodulin and Myosin Light Chain Kinase during Larval Settlement of the Barnacle Balanus amphitrite	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; CYPRIS LARVAE; MESSENGER-RNA; METAMORPHOSIS; GENE; PHOSPHORYLATION; PURIFICATION; INVOLVEMENT; CLONING; MODULATOR	Barnacles are one of the most common organisms in intertidal areas. Their life cycle includes seven free-swimming larval stages and sessile juvenile and adult stages. The transition from the swimming to the sessile stages, referred to as larval settlement, is crucial for their survivor success and subsequent population distribution. In this study, we focused on the involvement of calmodulin (CaM) and its binding proteins in the larval settlement of the barnacle, Balanus (=Amphibalanus) amphitrite. The full length of CaM gene was cloned from stage II nauplii of B. amphitrite (referred to as Ba-CaM), encoding 149 amino acid residues that share a high similarity with published CaMs in other organisms. Quantitative real-time PCR showed that Ba-CaM was highly expressed in cyprids, the stage at which swimming larvae are competent to attach and undergo metamorphosis. In situ hybridization revealed that the expressed Ba-CaM gene was localized in compound eyes, posterior ganglion and cement glands, all of which may have essential functions during larval settlement. Larval settlement assays showed that both the CaM inhibitor compound 48/80 and the CaM-dependent myosin light chain kinase (MLCK) inhibitor ML-7 effectively blocked barnacle larval settlement, whereas Ca2+/CaM-dependent kinase II (CaMKII) inhibitors did not show any clear effects. The subsequent real-time PCR assay showed a higher expression level of Ba-MLCK gene in larval stages than in adults, suggesting an important role of Ba-MLCK gene in larval development and competency. Overall, the results suggest that CaM and CaM-dependent MLCK function during larval settlement of B. amphitrite.	[Chen, Zhang-Fan; Wang, Hao; Matsumura, Kiyotaka; Qian, Pei-Yuan] Hong Kong Univ Sci & Technol, KAUST Global Collaborat Res Program, Div Life Sci, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Chen, ZF (corresponding author), Hong Kong Univ Sci & Technol, KAUST Global Collaborat Res Program, Div Life Sci, Hong Kong, Hong Kong, Peoples R China.	boqianpy@ust.hk	WANG, Hao/D-1063-2012	Qian, Pei-Yuan/0000-0003-4074-9078	King Abdullah University of Science and Technology [SA-C0040/UK-C0016]; Areas of Excellence (AoE) of Hong Kong Special Administrative Region [AOE/P-04/04-2-II]	King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); Areas of Excellence (AoE) of Hong Kong Special Administrative Region	This work was supported by an award (SA-C0040/UK-C0016) from King Abdullah University of Science and Technology and an Areas of Excellence (AoE) project of Hong Kong Special Administrative Region (AOE/P-04/04-2-II) to Pei-Yuan Qian. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D.T., 1994, BARNACLES STRUCTURE; BARNES H, 1977, J EXP MAR BIOL ECOL, V27, P195, DOI 10.1016/0022-0981(77)90124-1; Benaim G, 2002, EUR J BIOCHEM, V269, P3619, DOI 10.1046/j.1432-1033.2002.03038.x; BERNARD FJ, 1962, J MORPHOL, V110, P19, DOI 10.1002/jmor.1051100103; Carafoli E, 1999, CALCIUM CELLULAR REG, P656; Chen ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022913; CHIEN YH, 1984, MOL CELL BIOL, V4, P507, DOI 10.1128/MCB.4.3.507; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; CLARE AS, 1992, J EXP ZOOL, V262, P436, DOI 10.1002/jez.1402620410; Clare AS, 1996, BIOFOULING, V10, P141, DOI 10.1080/08927019609386276; CLARE AS, 1995, J EXP BIOL, V198, P655; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; Cyert MS, 2001, ANNU REV GENET, V35, P647, DOI 10.1146/annurev.genet.35.102401.091302; De Gregoris TB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-62; Di Gregorio A, 1998, DEV GROWTH DIFFER, V40, P387; Dreanno C, 2006, P ROY SOC B-BIOL SCI, V273, P2721, DOI 10.1098/rspb.2006.3649; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; FISCHER R, 1988, J BIOL CHEM, V263, P17055; Gallagher PJ, 1997, J MUSCLE RES CELL M, V18, P1, DOI 10.1023/A:1018616814417; Gao YP, 2009, COMP BIOCHEM PHYS B, V152, P216, DOI 10.1016/j.cbpb.2008.11.006; GIETZEN K, 1983, BIOCHEM J, V216, P611, DOI 10.1042/bj2160611; HARDY DO, 1988, J MOL BIOL, V199, P223, DOI 10.1016/0022-2836(88)90392-0; Harrison PJH, 1999, BIOL BULL, V197, P144, DOI 10.2307/1542611; Huo LF, 2004, ENDOCRINOLOGY, V145, P5056, DOI 10.1210/en.2004-0584; ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; KLEE CB, 1982, ADV PROTEIN CHEM, V35, P213, DOI 10.1016/S0065-3233(08)60470-2; KNIGHTJONES EW, 1953, NATURE, V171, P1109, DOI 10.1038/1711109a0; KOLODNEY MS, 1995, P NATL ACAD SCI USA, V92, P10252, DOI 10.1073/pnas.92.22.10252; Lagersson NC, 2002, MAR BIOL, V141, P513, DOI 10.1007/s00227-002-0854-1; Li HL, 2010, J EXP MAR BIOL ECOL, V389, P45, DOI 10.1016/j.jembe.2010.03.019; Li S, 2004, COMP BIOCHEM PHYS B, V138, P235, DOI 10.1016/j.cbpc.2004.03.012; Luan J, 2010, CHIN J OCEANOL LIMN, V28, P1221, DOI 10.1007/s00343-010-9035-0; Matsumura K, 1998, J EXP ZOOL, V281, P12, DOI 10.1002/(SICI)1097-010X(19980501)281:1<12::AID-JEZ3>3.3.CO;2-L; MICHAEL RH, 1992, LIFE SCI, V51, P1881, DOI 10.1016/0024-3205(92)90040-V; MOCHIZUKI H, 1993, J BIOL CHEM, V268, P9143; NOJIMA H, 1989, J MOL BIOL, V208, P269, DOI 10.1016/0022-2836(89)90388-4; NOJIMA H, 1987, J MOL BIOL, V193, P439, DOI 10.1016/0022-2836(87)90258-0; Okano K, 1996, J EXP BIOL, V199, P2131; Okazaki Y, 2000, GENE, V250, P127, DOI 10.1016/S0378-1119(00)00184-0; PEQUEUX A, 1992, MAR BIOL, V113, P65, DOI 10.1007/BF00367639; SEAMON KB, 1980, BIOCHEMISTRY-US, V19, P207, DOI 10.1021/bi00542a031; SENTERRELESENFANTS S, 1995, J CELL BIOCHEM, V58, P445, DOI 10.1002/jcb.240580407; SHRODE LD, 1995, AM J PHYSIOL-CELL PH, V269, pC257, DOI 10.1152/ajpcell.1995.269.1.C257; Soderling TR, 2001, J BIOL CHEM, V276, P3719, DOI 10.1074/jbc.R000013200; TAKENAKA M, 1993, DEV GROWTH DIFFER, V35, P245; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thiyagarajan V, 2008, PROTEOMICS, V8, P3164, DOI 10.1002/pmic.200700904; Thiyagarajan V, 2009, J PROTEOME RES, V8, P2708, DOI 10.1021/pr800976u; THOMAS WK, 1991, GENETICS, V128, P269; Toutenhoofd SL, 1998, CELL CALCIUM, V23, P323, DOI 10.1016/S0143-4160(98)90028-8; UNDERWOOD AJ, 1989, TRENDS ECOL EVOL, V4, P16, DOI 10.1016/0169-5347(89)90008-6; VOGEL HJ, 1994, BIOCHEM CELL BIOL, V72, P357, DOI 10.1139/o94-049; Walker G., 1987, Crustacean Issues, V5, P307; WATTERSON DM, 1980, J BIOL CHEM, V255, P962; Wongpanya Ratree, 2007, ScienceAsia, V33, P165, DOI 10.2306/scienceasia1513-1874.2007.33.165; WYSOLMERSKI RB, 1990, P NATL ACAD SCI USA, V87, P16, DOI 10.1073/pnas.87.1.16; Yamamoto H, 1998, J EXP ZOOL, V280, P8, DOI 10.1002/(SICI)1097-010X(19980101)280:1<8::AID-JEZ2>3.0.CO;2-S; YAMAMOTO H, 1995, ZOOL SCI, V12, P391, DOI 10.2108/zsj.12.391; Yamamoto H, 1997, J EXP ZOOL, V278, P349, DOI 10.1002/(SICI)1097-010X(19970815)278:6<349::AID-JEZ2>3.0.CO;2-O; Yamamoto H, 1996, J EXP ZOOL, V275, P339, DOI 10.1002/(SICI)1097-010X(19960801)275:5<339::AID-JEZ2>3.0.CO;2-Q; YAMANAKA MK, 1987, NUCLEIC ACIDS RES, V15, P3335, DOI 10.1093/nar/15.8.3335; YAZAWA M, 1980, J BIOCHEM, V87, P1313, DOI 10.1093/oxfordjournals.jbchem.a132869; Ye QR, 1997, GENE, V194, P63, DOI 10.1016/S0378-1119(97)00155-8	64	20	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31337	10.1371/journal.pone.0031337	http://dx.doi.org/10.1371/journal.pone.0031337			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348072	Green Published, gold, Green Submitted			2022-12-25	WOS:000302733900042
J	Muntinghe, FLH; Abdulahad, WH; Huitema, MG; Damman, J; Seelen, MA; Lems, SPM; Hepkema, BG; Navis, G; Westra, J				Muntinghe, Friso L. H.; Abdulahad, Wayel H.; Huitema, Minke G.; Damman, Jeffrey; Seelen, Marc A.; Lems, Simon P. M.; Hepkema, Bouke G.; Navis, Gerjan; Westra, Johanna			CCR5 Delta 32 Genotype Leads to a Th2 Type Directed Immune Response in ESRD Patients	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; CHEMOKINE RECEPTOR CCR5; DIALYSIS PATIENTS; NEOINTIMA FORMATION; TNF-ALPHA; T-CELLS; ATHEROSCLEROSIS; MICE; INFLAMMATION; RANTES	Background: In patients with end stage renal disease (ESRD) we observed protection from inflammation-associated mortality in CCR5 Delta 32 carriers, leading to CCR5 deficiency, suggesting impact of CCR5 Delta 32 on inflammatory processes. Animal studies have shown that CCR5 deficiency is associated with a more pronounced Th2 type immune response, suggesting that in human CCR5 Delta 32 carriers the immune response may be more Th2 type directed. So, in the present study we determined the Th1-Th2 type directed immune response in ESRD patients carrying and not carrying the CCR5 Delta 32 genetic variant after stimulation. Methodology/Principal Findings: We tested this hypothesis by determining the levels of IFN-gamma and IL-4 and the distribution of Th1, Th2 and Th17 directed circulating CD4+ and CD8+ T cells and regulatory T cells (Tregs) after stimulation in ESRD patients with (n = 10) and without (n = 9) the CCR5 Delta 32 genotype. The extracellular levels of IFN-gamma and IL-4 did not differ between CCR5 Delta 32 carriers and non carriers. However, based on their intracellular cytokine profile the percentages IL-4 secreting CD4+ and CD8+ T cells carrying the CCR5 Delta 32 genotype were significantly increased (p = 0.02, respectively p = 0.02) compared to non carriers, indicating a more Th2 type directed response. Based on their intracellular cytokine profile the percentages IFN-gamma and IL-17 secreting T cells did not differ between carriers and non-carriers nor did the percentage Tregs, indicating that the Th1, Th17 and T regulatory response was not affected by the CCR5 Delta 32 genotype. Conclusions/Significance: This first, functional human study shows a more pronounced Th2 type immune response in CCR5 Delta 32 carriers compared to non carriers. These differences may be involved in the previously observed protection from inflammation-associated mortality in ESRD patients carrying CCR5 Delta 32.	[Muntinghe, Friso L. H.; Abdulahad, Wayel H.; Huitema, Minke G.; Damman, Jeffrey; Seelen, Marc A.; Lems, Simon P. M.; Hepkema, Bouke G.; Navis, Gerjan; Westra, Johanna] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands	University of Groningen	Muntinghe, FLH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands.	f.l.h.muntinghe@umcg.nl		/0000-0003-3109-4487				Abdi R, 2002, DIABETES, V51, P2489, DOI 10.2337/diabetes.51.8.2489; Andersson J, 2010, CLIN IMMUNOL, V134, P33, DOI 10.1016/j.clim.2009.07.002; Andres PG, 2000, J IMMUNOL, V164, P6303, DOI 10.4049/jimmunol.164.12.6303; Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; Braunersreuther V, 2008, ARTERIOSCL THROM VAS, V28, P1090, DOI 10.1161/ATVBAHA.108.165423; Braunersreuther V, 2007, ARTERIOSCL THROM VAS, V27, P373, DOI 10.1161/01.ATV.0000253886.44609.ae; Carter LL, 1996, CURR OPIN IMMUNOL, V8, P336, DOI 10.1016/S0952-7915(96)80122-1; Chen SA, 2010, J INNATE IMMUN, V2, P325, DOI 10.1159/000314626; Clark VJ, 2001, HUM GENET, V108, P484, DOI 10.1007/s004390100512; DEGOULET P, 1982, NEPHRON, V31, P103, DOI 10.1159/000182627; Dehmel S, 2010, EUR J IMMUNOL, V40, P267, DOI 10.1002/eji.200939652; Fatkenheuer G, 2005, NAT MED, V11, P1170, DOI 10.1038/nm1319; Gonzalez P, 2001, GENES IMMUN, V2, P191, DOI 10.1038/sj.gene.6363760; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hendrikx TK, 2009, NEPHROL DIAL TRANSPL, V24, P1969, DOI 10.1093/ndt/gfp005; Kawai T, 1999, J IMMUNOL, V163, P3269; Kovesdy CP, 2009, J AM SOC NEPHROL, V20, P1429, DOI 10.1681/ASN.2009050510; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu YM, 2004, JAMA-J AM MED ASSOC, V291, P451, DOI 10.1001/jama.291.4.451; Muntinghe FLH, 2011, PHARMACOGENET GENOM, V21, P417, DOI 10.1097/FPC.0b013e3283472990; Muntinghe FLH, 2011, CYTOKINE, V53, P16, DOI 10.1016/j.cyto.2010.09.001; Muntinghe FLH, 2009, DIABETES RES CLIN PR, V86, P140, DOI 10.1016/j.diabres.2009.08.013; Muntinghe FLH, 2009, J AM SOC NEPHROL, V20, P1641, DOI 10.1681/ASN.2008040432; Pai JK, 2006, ATHEROSCLEROSIS, V186, P132, DOI 10.1016/j.atherosclerosis.2005.06.041; Potteaux S, 2006, ARTERIOSCL THROM VAS, V26, P1858, DOI 10.1161/01.ATV.0000231527.22762.71; Quinones Marlon P, 2007, Atherosclerosis, V195, pe92, DOI 10.1016/j.atherosclerosis.2007.03.026; Raport CJ, 1996, J BIOL CHEM, V271, P17161, DOI 10.1074/jbc.271.29.17161; Robertson AKL, 2006, ARTERIOSCL THROM VAS, V26, P2421, DOI 10.1161/01.ATV.0000245830.29764.84; Schober A, 2002, CIRCULATION, V106, P1523, DOI 10.1161/01.CIR.0000028590.02477.6F; Stenvinkel P, 2005, KIDNEY INT, V67, P1216, DOI 10.1111/j.1523-1755.2005.00200.x; Szalai C, 2001, ATHEROSCLEROSIS, V158, P233, DOI 10.1016/S0021-9150(01)00423-3; van Wanrooij EJA, 2005, ARTERIOSCL THROM VAS, V25, P2642, DOI 10.1161/01.ATV.0000192018.90021.c0; Veillard NR, 2004, CIRC RES, V94, P253, DOI 10.1161/01.RES.0000109793.17591.4E; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Wilcox J N, 1994, J Atheroscler Thromb, V1 Suppl 1, pS10; Zernecke A, 2006, BLOOD, V107, P4240, DOI 10.1182/blood-2005-09-3922	36	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31257	10.1371/journal.pone.0031257	http://dx.doi.org/10.1371/journal.pone.0031257			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348061	Green Published, gold, Green Submitted			2022-12-25	WOS:000302733900035
J	Wainszelbaum, MJ; Liu, JL; Kong, C; Srikanth, P; Samovski, D; Su, X; Stahl, PD				Wainszelbaum, Marisa J.; Liu, Jialu; Kong, Chen; Srikanth, Priya; Samovski, Dmitri; Su, Xiong; Stahl, Philip D.			TBC1D3, a Hominoid-Specific Gene, Delays IRS-1 Degradation and Promotes Insulin Signaling by Modulating p70 S6 Kinase Activity	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; COPY NUMBER VARIATION; CELL-TRANSFORMATION; REGULATORY SUBUNIT; PP2A COMPLEXES; PHOSPHORYLATION; SUBSTRATE-1; PROTEIN; CANCER; IDENTIFICATION	Insulin/IGF-1 signaling plays a pivotal role in the regulation of cellular homeostasis through its control of glucose metabolism as well as due to its effects on cell proliferation. Aberrant regulation of insulin signaling has been repeatedly implicated in uncontrolled cell growth and malignant transformations. TBC1D3 is a hominoid specific gene previously identified as an oncogene in breast and prostate cancers. Our efforts to identify the molecular mechanisms of TBC1D3-induced oncogenesis revealed the role of TBC1D3 in insulin/IGF-1 signaling pathway. We document here that TBC1D3 intensifies insulin/IGF-1-induced signal transduction through intricate, yet elegant fine-tuning of signaling mechanisms. We show that TBC1D3 expression substantially delayed ubiquitination and degradation of insulin receptor substrate-1 (IRS-1). This effect is achieved through suppression of serine phosphorylation at S636/639, S307 and S312 of IRS-1, which are key phosphorylation sites required for IRS-1 degradation. Furthermore, we report that the effect of TBC1D3 on IRS-1:S636/639 phosphorylation is mediated through TBC1D3-induced activation of protein phosphatase 2A (PP2A), followed by suppression of T389 phosphorylation on p70 S6 kinase (S6K). TBC1D3 specifically interacts with PP2A regulatory subunit B56 gamma, indicating that TBC1D3 and PP2A B56 gamma operate jointly to promote S6K:T389 dephosphorylation. These findings suggest that TBC1D3 plays an unanticipated and potentially unique role in the fine-tuning of insulin/IGF-1 signaling, while providing novel insights into the regulation of tumorigenesis by a hominoid-specific protein.	[Wainszelbaum, Marisa J.; Liu, Jialu; Kong, Chen; Srikanth, Priya; Samovski, Dmitri; Su, Xiong; Stahl, Philip D.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, Ctr Human Nutr, St Louis, MO 63110 USA; [Su, Xiong] Washington Univ, Sch Med, Dept Internal Med, Ctr Human Nutr, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Wainszelbaum, MJ (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, Ctr Human Nutr, St Louis, MO 63110 USA.	xsu@.wustl.edu; pstahl@wustl.edu	Samovski, Dmitri/AAQ-2014-2020; Samovski, Dmitri/K-3705-2019; Stahl, Philip/D-6315-2012	Samovski, Dmitri/0000-0002-6860-6688; Srikanth, Priya/0000-0002-9669-0434	National Health Institute [GM086566]; McDonnell Center for Cellular and Molecular Neurobiology and Systems Neuroscience at Washington University in St. Louis; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, R01GM086566] Funding Source: NIH RePORTER	National Health Institute; McDonnell Center for Cellular and Molecular Neurobiology and Systems Neuroscience at Washington University in St. Louis; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Health Institute grant GM086566 and a grant from the McDonnell Center for Cellular and Molecular Neurobiology and Systems Neuroscience at Washington University in St. Louis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bielinski VA, 2007, EXP CELL RES, V313, P3117, DOI 10.1016/j.yexcr.2007.05.008; BOURAHALFON S, 2008, AM J PHYSL ENDOCRINO; Carlson CJ, 2004, BIOCHEM BIOPH RES CO, V316, P533, DOI 10.1016/j.bbrc.2004.02.082; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Cho I, 2010, DNA CELL BIOL, V29, P473, DOI 10.1089/dna.2009.0997; Cho US, 2007, PLOS BIOL, V5, P1810, DOI 10.1371/journal.pbio.0050202; CHUANG LM, 1994, J BIOL CHEM, V269, P27645; Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104; Dearth RK, 2007, CELL CYCLE, V6, P705, DOI 10.4161/cc.6.6.4035; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Frittoli E, 2008, MOL BIOL CELL, V19, P1304, DOI 10.1091/mbc.E07-06-0594; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Hafen E, 2004, SWISS MED WKLY, V134, P711; Hahn K, 2010, CELL METAB, V11, P438, DOI 10.1016/j.cmet.2010.03.015; HARDIE DG, 1991, METHOD ENZYMOL, V201, P469; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hatanaka H, 2010, CANCER SCI, V101, P54, DOI 10.1111/j.1349-7006.2009.01348.x; Hodzic D, 2006, GENOMICS, V88, P731, DOI 10.1016/j.ygeno.2006.05.009; HUEBNER K, 1988, ONCOGENE, V3, P449; Kong M, 2009, MOL CELL, V36, P51, DOI 10.1016/j.molcel.2009.09.025; Kwon G, 2004, DIABETES, V53, pS225, DOI 10.2337/diabetes.53.suppl_3.S225; Marshall Stephen, 2006, Sci STKE, V2006, pre7; Molloy CA, 2000, J BIOL CHEM, V275, P12565, DOI 10.1074/jbc.275.17.12565; Morelli C, 2004, ONCOGENE, V23, P7517, DOI 10.1038/sj.onc.1208014; Morelli C, 2003, ONCOGENE, V22, P4007, DOI 10.1038/sj.onc.1206436; Muneer S, 2002, GENOMICS, V79, P344, DOI 10.1006/geno.2002.6721; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Paulding CA, 2003, P NATL ACAD SCI USA, V100, P2507, DOI 10.1073/pnas.0437015100; Pearson R B, 1995, Prog Cell Cycle Res, V1, P21; Pei L, 2002, CANCER RES, V62, P5420; Perry GH, 2008, GENOME RES, V18, P1698, DOI 10.1101/gr.082016.108; Sablina AA, 2010, CANCER RES, V70, P10474, DOI 10.1158/0008-5472.CAN-10-2855; Shah OJ, 2006, MOL CELL BIOL, V26, P6425, DOI 10.1128/MCB.01254-05; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; SKOLNIK EY, 1993, SCIENCE, V260, P1953, DOI 10.1126/science.8316835; Stanevich V, 2011, MOL CELL, V41, P331, DOI 10.1016/j.molcel.2010.12.030; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Sun XJ, 2009, VITAM HORM, V80, P351, DOI 10.1016/S0083-6729(08)00613-4; SUN XJ, 1993, MOL CELL BIOL, V13, P7418, DOI 10.1128/MCB.13.12.7418; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Wainszelbaum MJ, 2008, J BIOL CHEM, V283, P13233, DOI 10.1074/jbc.M800234200; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; Westphal RS, 1999, J BIOL CHEM, V274, P687, DOI 10.1074/jbc.274.2.687; Wu A, 2008, ONCOGENE, V27, P397, DOI 10.1038/sj.onc.1210636; Xu XS, 2008, MOL CELL, V30, P403, DOI 10.1016/j.molcel.2008.03.009; Yan GH, 2006, EMBO J, V25, P3546, DOI 10.1038/sj.emboj.7601239; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	51	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31225	10.1371/journal.pone.0031225	http://dx.doi.org/10.1371/journal.pone.0031225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348058	Green Published, gold			2022-12-25	WOS:000302733900033
J	Zanin, RF; Braganhol, E; Bergamin, LS; Campesato, LFI; Zanotto, A; Moreira, JCF; Morrone, FB; Sevigny, J; Schetinger, MRC; Wyse, ATD; Battastini, AMO				Zanin, Rafael Fernandes; Braganhol, Elizandra; Bergamin, Leticia Scussel; Ingrassia Campesato, Luis Felipe; Zanotto Filho, Alfeu; Fonseca Moreira, Jose Claudio; Morrone, Fernanda Bueno; Sevigny, Jean; Chitolina Schetinger, Maria Rosa; de Souza Wyse, Angela Terezinha; Oliveira Battastini, Ana Maria			Differential Macrophage Activation Alters the Expression Profile of NTPDase and Ecto-5 '-Nucleotidase	PLOS ONE			English	Article							MURINE REPRODUCTIVE-TRACT; PERITONEAL-MACROPHAGES; ALTERNATIVE ACTIVATION; ATP-DIPHOSPHOHYDROLASE; CYTOKINE PRODUCTION; ECTO-NUCLEOTIDASES; ENDOTHELIAL-CELLS; EXTRACELLULAR ATP; ARGINASE ISOFORMS; HUMAN MONOCYTES	Macrophages are key elements in the inflammatory process, whereas depending on the micro-environmental stimulation they exhibit a pro-inflammatory (classical/M1) or an anti-inflammatory/reparatory (alternative/M2) phenotype. Extracellular ATP can act as a danger signal whereas adenosine generally serves as a negative feedback mechanism to limit inflammation. The local increase in nucleotides communication is controlled by ectonucleotidases, such as members of the ectonucleoside triphosphate diphosphohydrolase (E-NTPDase) family and ecto-5'-nucleotidase/CD73 (ecto-5'-NT). In the present work we evaluated the presence of these enzymes in resident mice M1 (macrophages stimulated with LPS), and M2 (macrophages stimulated with IL-4) macrophages. Macrophages were collected by a lavage of the mice (6-8 weeks) peritoneal cavity and treated for 24 h with IL-4 (10 ng/mL) or LPS (10 ng/mL). Nitrite concentrations were measured using the Greiss reaction. Supernatants were harvested to determine cytokines and the ATPase, ADPase and AMPase activities were determined by the malachite green method and HPLC analysis. The expression of selected surface proteins was evaluated by flow cytometry. The results reveal that M1 macrophages presented a decreased ATP and AMP hydrolysis in agreement with a decrease in NTPDase1, -3 and ecto-5'-nucleotidase expression compared to M2. In contrast, M2 macrophages showed a higher ATP and AMP hydrolysis and increased NTPDase1, -3 and ecto-5'-nucleotidase expression compared to M1 macrophages. Therefore, macrophages of the M1 phenotype lead to an accumulation of ATP while macrophages of the M2 phenotype may rapidly convert ATP to adenosine. The results also showed that P1 and P2 purinoreceptors present the same mRNA profile in both phenotypes. In addition, M2 macrophages, which have a higher ATPase activity, were less sensitive to cell death. In conclusion, these changes in ectoenzyme activities might allow macrophages to adjust the outcome of the extracellular purinergic cascade in order to fine-tune their functions during the inflammatory set.	[Zanin, Rafael Fernandes; Braganhol, Elizandra; Bergamin, Leticia Scussel; Ingrassia Campesato, Luis Felipe; Zanotto Filho, Alfeu; Fonseca Moreira, Jose Claudio; de Souza Wyse, Angela Terezinha; Oliveira Battastini, Ana Maria] Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Dept Bioquim, Porto Alegre, RS, Brazil; [Morrone, Fernanda Bueno] Pontificia Univ Catolica Rio Grande do Sul, Fac Farm, Porto Alegre, RS, Brazil; [Sevigny, Jean] Univ Quebec, Ctr Hosp, Ctr Rech Rheumatol & Immunol, Ste Foy, PQ G1V 2M3, Canada; [Chitolina Schetinger, Maria Rosa] Univ Fed Santa Maria, Ctr Ciencias Nat & Exatas, Dept Quim, BR-97119900 Santa Maria, RS, Brazil; [Sevigny, Jean] Univ Laval, Fac Med, Dept Microbiol Infectiol & Immunol, Quebec City, PQ G1K 7P4, Canada	Universidade Federal do Rio Grande do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Laval University; University of Quebec; Universidade Federal de Santa Maria (UFSM); Laval University	Zanin, RF (corresponding author), Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Dept Bioquim, Porto Alegre, RS, Brazil.	rafaelzaninn@gmail.com	Morrone, Fernanda/AAH-6044-2020; Sévigny, Jean/AGH-9323-2022; Braganhol, Elizandra/C-6439-2013; Battastini, Ana M/E-2809-2012; moreira, jose claudio/AAO-6400-2021; Bueno Morrone, Fernanda/K-8405-2012; Sevigny, Jean/E-8039-2012; Wyse, Angela TS/K-6104-2013; ZANOTTO-FILHO, ALFEU/A-8172-2016; Schetinger, Maria Rosa Chitolina/I-7658-2019; Morrone, Fernanda B/K-7703-2015	Morrone, Fernanda/0000-0002-2709-2801; Sévigny, Jean/0000-0003-2922-1600; Battastini, Ana M/0000-0001-6068-3278; Sevigny, Jean/0000-0003-2922-1600; Wyse, Angela TS/0000-0001-8769-1147; ZANOTTO-FILHO, ALFEU/0000-0002-4188-3095; Morrone, Fernanda B/0000-0002-2709-2801; Chitolina Schetinger, Maria Rosa/0000-0002-5240-8935	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)- Brasil; CNPq; Fonds de Recherche en Sante du Quebec	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)- Brasil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)- Brasil. R. F. Zanin and E. Braganhol were recipients of CNPq fellowships and J. Sevigny of a Junior 2 scholarship from the Fonds de Recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 2007, PURINERG SIGNAL, V3, P13, DOI 10.1007/s11302-006-9033-z; Atkinson B, 2006, BLOOD CELL MOL DIS, V36, P217, DOI 10.1016/j.bcmd.2005.12.025; Bartel DL, 2006, J COMP NEUROL, V497, P1, DOI 10.1002/cne.20954; Bonder CS, 1998, J IMMUNOL, V160, P4048; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brone B, 2007, IMMUNOL LETT, V113, P83, DOI 10.1016/j.imlet.2007.07.015; CHAN KM, 1986, ANAL BIOCHEM, V157, P375, DOI 10.1016/0003-2697(86)90640-8; CHEUNG DL, 1990, IMMUNOLOGY, V71, P70; CORRALIZA IM, 1994, J IMMUNOL METHODS, V174, P231, DOI 10.1016/0022-1759(94)90027-2; Coutinho-Silva R, 2005, BIOCHEM PHARMACOL, V69, P641, DOI 10.1016/j.bcp.2004.11.012; Coutinho-Silva R, 2001, AM J PHYSIOL-CELL PH, V280, pC81, DOI 10.1152/ajpcell.2001.280.1.C81; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; del Rey A, 2006, J BIOL CHEM, V281, P35147, DOI 10.1074/jbc.M607713200; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Di Virgilio F, 2009, TRENDS NEUROSCI, V32, P79, DOI 10.1016/j.tins.2008.11.003; Dwyer KM, 2007, PURINERG SIGNAL, V3, P171, DOI 10.1007/s11302-006-9050-y; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; FENTON MJ, 1992, J IMMUNOL, V149, P1283; Ferrari D, 1999, FEBS LETT, V447, P71, DOI 10.1016/S0014-5793(99)00270-7; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; FILIPPINI A, 1990, J BIOL CHEM, V265, P334; FRASSETTO SS, 1993, MOL CELL BIOCHEM, V129, P47, DOI 10.1007/BF00926575; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gratchev A, 2001, SKIN PHARMACOL APPL, V14, P272, DOI 10.1159/000056357; Gratchev A, 2006, IMMUNOBIOLOGY, V211, P473, DOI 10.1016/j.imbio.2006.05.017; Grinthal A, 2007, BIOCHEMISTRY-US, V46, P279, DOI 10.1021/bi061052p; Hasko G, 2004, TRENDS PHARMACOL SCI, V25, P152, DOI 10.1016/j.tips.2004.01.006; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hasko G, 2000, J IMMUNOL, V164, P1013, DOI 10.4049/jimmunol.164.2.1013; Hyman MC, 2009, J CLIN INVEST, V119, P1136, DOI 10.1172/JCI36433; Kittel A, 2007, INT J DEV NEUROSCI, V25, P275, DOI 10.1016/j.ijdevneu.2007.05.007; Koszalka P, 2004, CIRC RES, V95, P814, DOI 10.1161/01.RES.0000144796.82787.6f; Koziak K, 1999, THROMB HAEMOSTASIS, V82, P1538; Krishna S, 2006, NUCLEIC ACIDS RES, V34, P2455, DOI 10.1093/nar/gkl140; Kukulski F, 2007, J LEUKOCYTE BIOL, V81, P1269, DOI 10.1189/jlb.1206758; Levesque SA, 2010, EUR J IMMUNOL, V40, P1473, DOI 10.1002/eji.200939741; Li RWS, 2008, AM J PHYSIOL-HEART C, V295, pH1177, DOI 10.1152/ajpheart.91513.2007; Linden J, 2001, ANNU REV PHARMACOL, V41, P775, DOI 10.1146/annurev.pharmtox.41.1.775; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louis CA, 1999, AM J PHYSIOL-REG I, V276, pR237, DOI 10.1152/ajpregu.1999.276.1.R237; Martin-Satue M, 2009, HISTOCHEM CELL BIOL, V131, P615, DOI 10.1007/s00418-008-0551-3; Martin-Satue M, 2010, HISTOCHEM CELL BIOL, V133, P659, DOI 10.1007/s00418-010-0704-z; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; MODOLELL M, 1995, EUR J IMMUNOL, V25, P1101, DOI 10.1002/eji.1830250436; Montesinos MC, 2007, ARTHRITIS RHEUM-US, V56, P1440, DOI 10.1002/art.22643; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Munder M, 1999, J IMMUNOL, V163, P3771; Pelegrin P, 2009, EMBO J, V28, P2114, DOI 10.1038/emboj.2009.163; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Raes G, 2002, J LEUKOCYTE BIOL, V71, P597; Raes Geert, 2002, Dev Immunol, V9, P151, DOI 10.1080/1044667031000137629; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Schebesch C, 1997, IMMUNOLOGY, V92, P478, DOI 10.1046/j.1365-2567.1997.00371.x; Sevigny J, 2002, BLOOD, V99, P2801, DOI 10.1182/blood.V99.8.2801; Sevigny J, 1997, BBA-GEN SUBJECTS, V1334, P73, DOI 10.1016/S0304-4165(96)00079-7; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; STEINBERG TH, 1987, J BIOL CHEM, V262, P3118; STUEHR DJ, 1989, J EXP MED, V169, P1543, DOI 10.1084/jem.169.5.1543; Wink MR, 2003, CANCER LETT, V198, P211, DOI 10.1016/S0304-3835(03)00308-2; Yegutkin GG, 2002, BIOCHEM J, V367, P121, DOI 10.1042/BJ20020439; Zimmermann H, 2001, DRUG DEVELOP RES, V52, P44, DOI 10.1002/ddr.1097	62	82	86	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31205	10.1371/journal.pone.0031205	http://dx.doi.org/10.1371/journal.pone.0031205			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348056	Green Submitted, Green Published, gold			2022-12-25	WOS:000302733900032
J	Joo, KM; Jin, J; Kang, BG; Lee, SJ; Kim, KH; Yang, H; Lee, YA; Cho, YJ; Im, YS; Lee, DS; Lim, DH; Kim, DH; Um, HD; Lee, SH; Lee, JI; Nam, DH				Joo, Kyeung Min; Jin, Juyoun; Kang, Bong Gu; Lee, Se Jeong; Kim, Kang Ho; Yang, Heekyoung; Lee, Young-Ae; Cho, Yu Jin; Im, Yong-Seok; Lee, Dong-Sup; Lim, Do-Hoon; Kim, Dong Hyun; Um, Hong-Duck; Lee, Sang-Hun; Lee, Jung-Ii; Nam, Do-Hyun			Trans-Differentiation of Neural Stem Cells: A Therapeutic Mechanism Against the Radiation Induced Brain Damage	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; NEUROGENESIS; RADIOTHERAPY; METASTASES; MANAGEMENT; RESECTION	Radiation therapy is an indispensable therapeutic modality for various brain diseases. Though endogenous neural stem cells (NSCs) would provide regenerative potential, many patients nevertheless suffer from radiation-induced brain damage. Accordingly, we tested beneficial effects of exogenous NSC supplementation using in vivo mouse models that received whole brain irradiation. Systemic supplementation of primarily cultured mouse fetal NSCs inhibited radiation-induced brain atrophy and thereby preserved brain functions such as short-term memory. Transplanted NSCs migrated to the irradiated brain and differentiated into neurons, astrocytes, or oligodendrocytes. In addition, neurotrophic factors such as NGF were significantly increased in the brain by NSCs, indicating that both paracrine and replacement effects could be the therapeutic mechanisms of NSCs. Interestingly, NSCs also differentiated into brain endothelial cells, which was accompanied by the restoration the cerebral blood flow that was reduced from the irradiation. Inhibition of the VEGF signaling reduced the migration and trans-differentiation of NSCs. Therefore, trans-differentiation of NSCs into brain endothelial cells by the VEGF signaling and the consequential restoration of the cerebral blood flow would also be one of the therapeutic mechanisms of NSCs. In summary, our data demonstrate that exogenous NSC supplementation could prevent radiation-induced functional loss of the brain. Therefore, successful combination of brain radiation therapy and NSC supplementation would provide a highly promising therapeutic option for patients with various brain diseases.	[Joo, Kyeung Min; Cho, Yu Jin; Lee, Dong-Sup] Seoul Natl Univ, Coll Med, Dept Anat, Seoul, South Korea; [Joo, Kyeung Min; Jin, Juyoun; Kang, Bong Gu; Lee, Se Jeong; Kim, Kang Ho; Yang, Heekyoung; Lee, Young-Ae; Nam, Do-Hyun] Sungkyunkwan Univ, Sch Med, Canc Stem Cell Res Ctr, Samsung Med Ctr, Seoul, South Korea; [Joo, Kyeung Min; Jin, Juyoun; Kang, Bong Gu; Lee, Se Jeong; Kim, Kang Ho; Yang, Heekyoung; Lee, Young-Ae; Nam, Do-Hyun] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Seoul, South Korea; [Jin, Juyoun; Kang, Bong Gu; Lee, Se Jeong; Kim, Kang Ho; Yang, Heekyoung; Lee, Young-Ae; Im, Yong-Seok; Lee, Jung-Ii; Nam, Do-Hyun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg, Seoul, South Korea; [Lim, Do-Hoon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiat Oncol, Seoul, South Korea; [Kim, Dong Hyun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Mol & Cellular Imaging, Seoul, South Korea; [Um, Hong-Duck] Korea Inst Radiol & Med Sci, Lab Radiat Tumor Physiol, Seoul, South Korea; [Lee, Sang-Hun] Hanyang Univ, Coll Med, Dept Biochem & Mol Biol, Seoul 133791, South Korea	Seoul National University (SNU); Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Korea Institute of Radiological & Medical Sciences; Hanyang University	Joo, KM (corresponding author), Seoul Natl Univ, Coll Med, Dept Anat, Seoul, South Korea.	jilee.lee@samsung.com; nsnam@skku.edu	Um, Hong-Duk/AAH-3733-2021; Lee, Dong-Sup/J-2777-2012	Kim, Dong Hyun/0000-0001-9018-2781	Future-based Technology Development Program [2010-0020232]; National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology (MEST), Republic of Korea; Samsung Biomedical Research Institute [SBRI B(C)-A7-220-3]	Future-based Technology Development Program; National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology (MEST), Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Samsung Biomedical Research Institute(Samsung)	This work was supported by the grant for the Future-based Technology Development Program (2010-0020232) funded by the National Research Foundation of Korea (NRF) of the Ministry of Education, Science and Technology (MEST), Republic of Korea (D.H. Nam) and by the Samsung Biomedical Research Institute grant, #SBRI B(C)-A7-220-3 (J.I. Lee). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah S, 2008, ANN NY ACAD SCI, V1138, P22, DOI 10.1196/annals.1414.005; Biswas G, 2006, J Cancer Res Ther, V2, P5; Butler Jerome M, 2006, Curr Treat Options Oncol, V7, P517, DOI 10.1007/s11864-006-0026-5; Ciardiello F, 2003, CLIN CANCER RES, V9, P1546; Davey P, 2002, CNS DRUGS, V16, P325, DOI 10.2165/00023210-200216050-00005; de la Torre JC, 2004, LANCET NEUROL, V3, P184, DOI 10.1016/S1474-4422(04)00683-0; DEANGELIS LM, 1989, NEUROSURGERY, V24, P798, DOI 10.1227/00006123-198906000-00002; Dohmen C, 2003, STROKE, V34, P2152, DOI 10.1161/01.STR.0000083624.74929.32; Donnelly EH, 2010, SOUTH MED J, V103, P541, DOI 10.1097/SMJ.0b013e3181ddd571; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gourmelon P., 2005, BR J RADIOL S, V78, P62; Ishii K, 2000, NEURORADIOLOGY, V42, P787, DOI 10.1007/s002340000404; Jones Jesse, 2007, Neurosurg Focus, V23, pE7; Keime-Guibert F, 1998, J NEUROL, V245, P695, DOI 10.1007/s004150050271; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Khakoo AY, 2005, ANNU REV MED, V56, P79, DOI 10.1146/annurev.med.56.090203.104149; Kim SU, 2009, J NEUROSCI RES, V87, P2183, DOI 10.1002/jnr.22054; Langer CJ, 2005, J CLIN ONCOL, V23, P6207, DOI 10.1200/JCO.2005.03.145; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; O'Neill BP, 2003, INT J RADIAT ONCOL, V55, P1169, DOI 10.1016/S0360-3016(02)04379-1; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Regine WF, 2001, INT J RADIAT ONCOL, V51, P711, DOI 10.1016/S0360-3016(01)01676-5; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Stepanova OI, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1194, DOI 10.1134/S0006297907110041; Taimur Sadaf, 2003, Curr Treat Options Oncol, V4, P89, DOI 10.1007/s11864-003-0035-6; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998; Wahlsten D, 2005, BEHAV BRAIN RES, V165, P36, DOI 10.1016/j.bbr.2005.06.047; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wardlaw JM, 2001, NEUROLOGY, V57, pS69, DOI 10.1212/WNL.57.suppl_2.S69; Wurmser AE, 2004, NATURE, V430, P350, DOI 10.1038/nature02604; Yee SH, 2005, NUCL MED COMMUN, V26, P901, DOI 10.1097/00006231-200510000-00009	37	33	34	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e25936	10.1371/journal.pone.0025936	http://dx.doi.org/10.1371/journal.pone.0025936			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22347993	Green Published, Green Submitted, gold			2022-12-25	WOS:000302730900001
J	Kubiak, RJ; McLean, AR				Kubiak, Ruben J.; McLean, Angela R.			Why Was the 2009 Influenza Pandemic in England So Small?	PLOS ONE			English	Article							A H1N1 VIRUS; TRANSMISSION	The "Swine flu'' pandemic of 2009 caused world-wide infections and deaths. Early efforts to understand its rate of spread were used to predict the probable future number of cases, but by the end of 2009 it was clear that these predictions had substantially overestimated the pandemic's eventual impact. In England, the Health Protection Agency made announcements of the number of cases of disease, which turned out to be surprisingly low for an influenza pandemic. The agency also carried out a serological survey half-way through the English epidemic. In this study, we use a mathematical model to reconcile early estimates of the rate of spread of infection, weekly data on the number of cases in the 2009 epidemic in England and the serological status of the English population at the end of the first pandemic wave. Our results reveal that if there are around 19 infections (i.e., seroconverters) for every reported case then the three data-sets are entirely consistent with each other. We go on to discuss when in the epidemic such a high ratio of seroconverters to cases of disease might have been detected, either through patterns in the case reports or through even earlier serological surveys.	[Kubiak, Ruben J.; McLean, Angela R.] Univ Oxford, Dept Zool, Oxford Martin Sch, Inst Emerging Infect, Oxford OX1 3PS, England	University of Oxford	Kubiak, RJ (corresponding author), Univ Oxford, Dept Zool, Oxford Martin Sch, Inst Emerging Infect, S Parks Rd, Oxford OX1 3PS, England.	ruben.kubiak@zoo.ox.ac.uk			Oxford Martin School; Engineering and Physical Sciences Research Council; All Souls College	Oxford Martin School; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); All Souls College	RJK gratefully acknowledges funding for this work from the Oxford Martin School and the Engineering and Physical Sciences Research Council. ARM is a Senior Research Fellow of All Souls College whose support is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Chen HW, 2009, OPT LASER TECHNOL, V41, P1, DOI 10.1016/j.optlastec.2008.05.003; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Silva UC, 2009, EUROSURVEILLANCE, V14, P11; Directgov, 2009, SCH TERM DAT; Donaldson LJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5213; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Girard MP, 2010, VACCINE, V28, P4895, DOI [10.1016/j.vaccine.2010.05.031, 10.1016/j.vaccine.2010.07.034]; Health Protection Agency, 2009, WEEKL PAND FLU MED U; Health Protection Agency, 2009, WEEKL NAT IN REP; Health Protection Agency, 2009, SYN METH US EST NUMB; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; McBryde ES, 2009, EUROSURVEILLANCE, V14, P45; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Mims CA, 2000, MIMS PATHOGENESIS IN, P474; Munayco CV, 2009, EUROSURVEILLANCE, V14, P6; Nishiura H, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-1; Office for National Statistics, 2009, 2009 POP EST ENGL; Pourbohloul B, 2009, INFLUENZA OTHER RESP, V3, P215, DOI 10.1111/j.1750-2659.2009.00100.x; Prachayangprecha S, 2010, J HEALTH POPUL NUTR, V28, P537, DOI 10.3329/jhpn.v28i6.6601; Salez N, 2011, CLIN MICROBIOL INFEC, P4; Scherer A, 2002, BRIT MED BULL, V62, P187, DOI 10.1093/bmb/62.1.187; Tuite AR, 2010, CAN MED ASSOC J, V182, P128, DOI 10.1503/cmaj.091807; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; [No title captured]	27	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e30223	10.1371/journal.pone.0030223	http://dx.doi.org/10.1371/journal.pone.0030223			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348001	gold, Green Published, Green Submitted			2022-12-25	WOS:000302730900006
J	Heil, M; Ibarra-Laclette, E; Adame-Alvarez, RM; Martinez, O; Ramirez-Chavez, E; Molina-Torres, J; Herrera-Estrella, L				Heil, Martin; Ibarra-Laclette, Enrique; Adame-Alvarez, Rosa M.; Martinez, Octavio; Ramirez-Chavez, Enrique; Molina-Torres, Jorge; Herrera-Estrella, Luis			How Plants Sense Wounds: Damaged-Self Recognition Is Based on Plant-Derived Elicitors and Induces Octadecanoid Signaling	PLOS ONE			English	Article							PROTEINASE-INHIBITOR; GENE-EXPRESSION; JASMONIC ACID; NICOTIANA-ATTENUATA; EXTRACELLULAR ATP; PARASITIC WASPS; ORAL SECRETIONS; DEFENSIVE GENES; GROWTH; RESPONSES	Background: Animal-derived elicitors can be used by plants to detect herbivory but they function only in specific insect-plant interactions. How can plants generally perceive damage caused by herbivores? Damaged-self recognition occurs when plants perceive molecular signals of damage: degraded plant molecules or molecules localized outside their original compartment. Methodology/Principal Findings: Flame wounding or applying leaf extract or solutions of sucrose or ATP to slightly wounded lima bean (Phaseolus lunatus) leaves induced the secretion of extrafloral nectar, an indirect defense mechanism. Chemically related molecules that would not be released in high concentrations from damaged plant cells (glucose, fructose, salt, and sorbitol) did not elicit a detectable response, excluding osmotic shock as an alternative explanation. Treatments inducing extrafloral nectar secretion also enhanced endogenous concentrations of the defense hormone jasmonic acid (JA). Endogenous JA was also induced by mechanically damaging leaves of lima bean, Arabidopsis, maize, strawberry, sesame and tomato. In lima bean, tomato and sesame, the application of leaf extract further increased endogenous JA content, indicating that damaged-self recognition is taxonomically widely distributed. Transcriptomic patterns obtained with untargeted 454 pyrosequencing of lima bean in response to flame wounding or the application of leaf extract or JA were highly similar to each other, but differed from the response to mere mechanical damage. We conclude that the amount or concentration of damaged-self signals can quantitatively determine the intensity of the wound response and that the full damaged-self response requires the disruption of many cells. Conclusions/Significance: Numerous compounds function as JA-inducing elicitors in different plant species. Most of them are, contain, or release, plant-derived molecular motifs. Damaged-self recognition represents a taxonomically widespread mechanism that contributes to the perception of herbivore feeding by plants. This strategy is independent of insect-derived elicitors and, therefore, allows plants to maintain evolutionary control over their interaction with herbivores.	[Heil, Martin; Adame-Alvarez, Rosa M.] Ctr Invest & Estudios Avanzados CINVESTAV, Dept Ingn Genet, Guanajuato, Mexico; [Ibarra-Laclette, Enrique; Martinez, Octavio; Herrera-Estrella, Luis] Ctr Invest & Estudios Avanzados CINVESTAV, Lab Nacl Genom Biodiversidad, Guanajuato, Mexico; [Ramirez-Chavez, Enrique; Molina-Torres, Jorge] Ctr Invest & Estudios Avanzados CINVESTAV, Dept Biotecnol & Bioquim, Guanajuato, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Heil, M (corresponding author), Ctr Invest & Estudios Avanzados CINVESTAV, Dept Ingn Genet, Guanajuato, Mexico.	mheil@ira.cinvestav.mx	Estrella, Luis R Herrera/G-7351-2011; Martinez, Octavio/F-3951-2014; Heil, Martin/AAC-2730-2022; Herrera-Estrella, Luis/ABC-7431-2020; Heil, Martin/T-3960-2019; Heil, Martin/I-1797-2012; Herrera-Estrella, Luis/AAL-2472-2020; Torres, Jorge Molina/B-9325-2019	Estrella, Luis R Herrera/0000-0001-7936-3856; Martinez, Octavio/0000-0002-7590-0041; Heil, Martin/0000-0001-8036-8697; Herrera-Estrella, Luis/0000-0001-7936-3856; Molina Torres, Jorge/0000-0003-2371-0307; Ramirez-Chavez, Enrique/0000-0003-1689-7759	CONACyT (Consejo Nacional de Ciencia y Tecnologia de Mexico) [130656]	CONACyT (Consejo Nacional de Ciencia y Tecnologia de Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The study was supported by grant no. 130656 from CONACyT (Consejo Nacional de Ciencia y Tecnologia de Mexico; www.conacyt.mx). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alborn HT, 2007, P NATL ACAD SCI USA, V104, P12976, DOI 10.1073/pnas.0705947104; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Bergey DR, 1999, P NATL ACAD SCI USA, V96, P1756, DOI 10.1073/pnas.96.4.1756; Bonaventure G, 2011, TRENDS PLANT SCI, V16, P294, DOI 10.1016/j.tplants.2011.01.006; Bonaventure Gustavo, 2010, Commun Integr Biol, V3, P313; Bonaventure G, 2010, PLANT SIGNAL BEHAV, V5, P287, DOI 10.4161/psb.5.3.10713; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chini A, 2009, FEBS J, V276, P4682, DOI 10.1111/j.1742-4658.2009.07194.x; Coker JS, 2005, PHYSIOL PLANTARUM, V124, P311, DOI 10.1111/j.1399-3054.2005.00488.x; Creelman RA, 1997, PLANT CELL, V9, P1211, DOI 10.1105/tpc.9.7.1211; Davies E, 1997, ACTA PHYSIOL PLANT, V19, P571, DOI 10.1007/s11738-997-0055-0; DOARES SH, 1995, P NATL ACAD SCI USA, V92, P4095, DOI 10.1073/pnas.92.10.4095; Doss RP, 2000, P NATL ACAD SCI USA, V97, P6218, DOI 10.1073/pnas.110054697; Felton GW, 2008, CURR OPIN PLANT BIOL, V11, P457, DOI 10.1016/j.pbi.2008.07.001; Franco G R, 1997, DNA Res, V4, P231, DOI 10.1093/dnares/4.3.231; GREEN TR, 1972, SCIENCE, V175, P776, DOI 10.1126/science.175.4023.776; Halitschke R, 2001, PLANT PHYSIOL, V125, P711, DOI 10.1104/pp.125.2.711; Heil M, 2001, P NATL ACAD SCI USA, V98, P1083, DOI 10.1073/pnas.031563398; Heil M, 2008, TRENDS PLANT SCI, V13, P264, DOI 10.1016/j.tplants.2008.03.005; Heil M, 2008, NEW PHYTOL, V178, P41, DOI 10.1111/j.1469-8137.2007.02330.x; Heil M, 2009, TRENDS PLANT SCI, V14, P356, DOI 10.1016/j.tplants.2009.04.002; Huffaker A, 2007, P NATL ACAD SCI USA, V104, P10732, DOI 10.1073/pnas.0703343104; Katari MS, 2010, PLANT PHYSIOL, V152, P500, DOI 10.1104/pp.109.147025; LEE NH, 1995, P NATL ACAD SCI USA, V92, P8303, DOI 10.1073/pnas.92.18.8303; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martinez O, 2008, P NATL ACAD SCI USA, V105, P9709, DOI 10.1073/pnas.0803479105; MATTIACCI L, 1995, P NATL ACAD SCI USA, V92, P2036, DOI 10.1073/pnas.92.6.2036; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Mithofer A, 2008, PLANT PHYSIOL, V146, P825, DOI 10.1104/pp.107.113118; MUELLER MJ, 1994, ANAL BIOCHEM, V218, P425, DOI 10.1006/abio.1994.1202; OKUBO K, 1992, NAT GENET, V2, P173, DOI 10.1038/ng1192-173; Pearce G, 2007, J BIOL CHEM, V282, P17777, DOI 10.1074/jbc.M701543200; Pearce G, 2010, P NATL ACAD SCI USA, V107, P14921, DOI 10.1073/pnas.1007568107; Peiffer M, 2009, J CHEM ECOL, V35, P326, DOI 10.1007/s10886-009-9604-x; Pluskota WE, 2007, J EXP BOT, V58, P4071, DOI 10.1093/jxb/erm263; Radhika V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009265; Ramirez-Chavez E, 2004, PLANT PHYSIOL, V134, P1058, DOI 10.1104/pp.103.034553; Reinbothe C, 2009, FEBS J, V276, P4666, DOI 10.1111/j.1742-4658.2009.07193.x; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Roux SJ, 2007, TRENDS PLANT SCI, V12, P522, DOI 10.1016/j.tplants.2007.09.003; Ryan CA, 2003, P NATL ACAD SCI USA, V100, P14577, DOI 10.1073/pnas.1934788100; RYAN CA, 1974, PLANT PHYSIOL, V54, P328, DOI 10.1104/pp.54.3.328; Schmelz EA, 2006, P NATL ACAD SCI USA, V103, P8894, DOI 10.1073/pnas.0602328103; Schmelz EA, 2009, P NATL ACAD SCI USA, V106, P653, DOI 10.1073/pnas.0811861106; Schwiebert EM, 2003, BBA-BIOMEMBRANES, V1615, P7, DOI 10.1016/S0005-2736(03)00210-4; Stankovic B, 1996, FEBS LETT, V390, P275, DOI 10.1016/0014-5793(96)00672-2; Stankovic B, 1998, PLANT CELL PHYSIOL, V39, P268, DOI 10.1093/oxfordjournals.pcp.a029367; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; TURLINGS TCJ, 1993, J CHEM ECOL, V19, P411, DOI 10.1007/BF00994314; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Wu JQ, 2010, ANNU REV GENET, V44, P1, DOI 10.1146/annurev-genet-102209-163500; Zhang S, 2012, SCIENCE, V12, P234; Zimmermann MR, 2009, PLANTA, V229, P539, DOI 10.1007/s00425-008-0850-x	53	91	93	0	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e30537	10.1371/journal.pone.0030537	http://dx.doi.org/10.1371/journal.pone.0030537			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347382	Green Submitted, Green Published, gold			2022-12-25	WOS:000302730200003
J	Nogales-Gadea, G; Consuegra-Garcia, I; Rubio, JC; Arenas, J; Cuadros, M; Camara, Y; Torres-Torronteras, J; Fiuza-Luces, C; Lucia, A; Martin, MA; Garcia-Arumi, E; Andreu, AL				Nogales-Gadea, Gisela; Consuegra-Garcia, Ines; Rubio, Juan C.; Arenas, Joaquin; Cuadros, Marc; Camara, Yolanda; Torres-Torronteras, Javier; Fiuza-Luces, Carmen; Lucia, Alejandro; Martin, Miguel A.; Garcia-Arumi, Elena; Andreu, Antoni L.			A Transcriptomic Approach to Search for Novel Phenotypic Regulators in McArdle Disease	PLOS ONE			English	Article							RETICULUM CA2+ ATPASE; GLYCOGEN-SYNTHASE ACTIVITY; SKELETAL-MUSCLE; BRODY-DISEASE; PHOSPHORYLASE; EXERCISE; INSULIN; SERCA1; GENE; PHOSPHOROLYSIS	McArdle disease is caused by lack of glycogen phosphorylase (GP) activity in skeletal muscle. Patients experience exercise intolerance, presenting as early fatigue and contractures. In this study, we investigated the effects produced by a lack of GP on several genes and proteins of skeletal muscle in McArdle patients. Muscle tissue of 35 patients and 7 healthy controls were used to identify abnormalities in the patients' transcriptomic profile using low-density arrays. Gene expression was analyzed for the influence of variables such as sex and clinical severity. Differences in protein expression were studied by immunoblotting and 2D electrophoresis analysis, and protein complexes were examined by two-dimensional, blue native gel electrophoresis (BN-PAGE). A number of genes including those encoding acetyl-coA carboxylase beta, m-cadherin, calpain III, creatine kinase, glycogen synthase (GS), and sarcoplasmic reticulum calcium ATPase 1 (SERCA1), were found to be downregulated in patients. Specifically, compared to controls, GS and SERCA1 proteins were reduced by 50% and 75% respectively; also, unphosphorylated GS and SERCA1 were highly downregulated. On BN-PAGE analysis, GP was present with GS in two muscle protein complexes. Our findings revealed some issues that could be important in understanding the physiological consequences of McArdle disease: (i) SERCA1 downregulation in patients could result in impaired calcium transport in type II (fast-twitch) muscle fibers, leading to early fatigability during exercise tasks involving type II fibers (which mostly use glycolytic metabolism), i. e. isometric exercise, lifting weights or intense dynamic exercise (stair climbing, bicycling, walking at a very brisk pace), (ii) GP and GS were found together in two protein complexes, which suggests a new regulatory mechanism in the activity of these glycogen enzymes.	[Nogales-Gadea, Gisela; Cuadros, Marc; Camara, Yolanda; Torres-Torronteras, Javier; Garcia-Arumi, Elena; Andreu, Antoni L.] Univ Autonoma Barcelona, Hosp Univ Vall Hebron, Inst Recerca VHIR, Dept Patol Mitocondrial & Neuromuscular, E-08193 Barcelona, Spain; [Nogales-Gadea, Gisela] Univ Autonoma Barcelona, Inst Recerca HSCSP, Expt Neurol Lab, E-08193 Barcelona, Spain; [Nogales-Gadea, Gisela; Consuegra-Garcia, Ines; Rubio, Juan C.; Arenas, Joaquin; Cuadros, Marc; Camara, Yolanda; Torres-Torronteras, Javier; Martin, Miguel A.; Garcia-Arumi, Elena; Andreu, Antoni L.] Hosp Univ 12 Octubre, Spain Ctr Invest, Inst Salud Carlos III, Spanish Network Res Rare Dis CIBERER, Madrid, Spain; [Consuegra-Garcia, Ines] Hosp Univ 12 Octubre, Inst Invest, Unidad Prote, Madrid, Spain; [Rubio, Juan C.] Hosp Univ 12 Octubre, Inst Invest, Unidad Genom, Madrid, Spain; [Fiuza-Luces, Carmen; Lucia, Alejandro] Univ Europea Madrid, Madrid, Spain; [Martin, Miguel A.] Hosp Univ 12 Octubre, Ctr Invest, Madrid, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario 12 de Octubre; Instituto de Salud Carlos III; Hospital Universitario 12 de Octubre; Hospital Universitario 12 de Octubre; European University of Madrid; Hospital Universitario 12 de Octubre	Nogales-Gadea, G (corresponding author), Univ Autonoma Barcelona, Hosp Univ Vall Hebron, Inst Recerca VHIR, Dept Patol Mitocondrial & Neuromuscular, E-08193 Barcelona, Spain.	elena.garcia@vhir.org	Torres-Torronteras, Javier/K-4974-2014; Cámara, Yolanda/P-2540-2019; Martin, Miguel A/S-2758-2018; Garcia-Arumi, Elena/ABH-4229-2020; Nogales-Gadea, Gisela/N-4004-2014; Cámara, Yolanda/K-4597-2014; Lucia, Alejandro/M-2759-2014	Torres-Torronteras, Javier/0000-0002-6092-9458; Martin, Miguel A/0000-0003-4741-772X; Nogales-Gadea, Gisela/0000-0002-7414-212X; Cámara, Yolanda/0000-0003-2458-6942; Lucia, Alejandro/0000-0002-3025-2060; Garcia-Arumi, Elena/0000-0003-0096-3336; Fiuza-Luces, Carmen/0000-0001-8131-7007; ANDREU, antonio luis/0000-0002-3936-3234; Lucia, Alejandro/0000-0002-5565-0997; Arenas, Joaquin/0000-0002-2877-5049	Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria [PS0901359, PS0900194, PI10/00036, CA08/00203, CA05/0039, PI07/00232]; Instituto de Salud Carlos III [CD10/00027]; Comunidad de Madrid	Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria(Instituto de Salud Carlos IIIEuropean Commission); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Comunidad de Madrid(Comunidad de Madrid)	This work was supported by grants PS0901359, PS0900194 and PI10/00036 from Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria. GN is a recipient of a Instituto de Salud Carlos III-Sara Borrell post-doctoral fellowship number CD10/00027. IG, JCR and MC were supported by contracts from Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria CA08/00203, CA05/0039 and PI07/00232 respectively. MAM was supported by the programme 'Intensificacion de la Actividad Investigadora' from Instituto de Salud Carlos III, and Comunidad de Madrid. IG, JCR, JA, MAM are members of Unit U723, and ALA, EGA, GN, MC, JT of Unit U701 CIBER de Enfermedades Raras. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; Benjamini Y, 1995, J ROY STAT SOC, V57, P289; CUENDA A, 1993, BIOCHEM BIOPH RES CO, V196, P1127, DOI 10.1006/bbrc.1993.2368; CUENDA A, 1991, FEBS LETT, V283, P273, DOI 10.1016/0014-5793(91)80606-4; DiMauro S., 2002, Current Molecular Medicine (Hilversum), V2, P189, DOI 10.2174/1566524024605770; Dirksen RT, 2009, APPL PHYSIOL NUTR ME, V34, P389, DOI 10.1139/H09-044; Dubowitz V., MUSCLE BIOPSY PRACTI; ELLIOT DL, 1989, MEDICINE, V68, P163, DOI 10.1097/00005792-198905000-00004; Garcia-Consuegra I, 2009, J MED GENET, V46, P198, DOI 10.1136/jmg.2008.059469; Greenberg CC, 2006, AM J PHYSIOL-ENDOC M, V291, pE1, DOI 10.1152/ajpendo.00652.2005; Haller RG, 1998, NEUROLOGY, V50, P37, DOI 10.1212/WNL.50.1.37; Jensen J, 2006, AM J PHYSIOL-ENDOC M, V290, pE154, DOI 10.1152/ajpendo.00330.2005; Lawrence JC, 1997, DIABETES, V46, P541, DOI 10.2337/diabetes.46.4.541; Lucia A, 2008, NAT CLIN PRACT NEURO, V4, P568, DOI 10.1038/ncpneuro0913; Martinuzzi A, 2003, ANN NEUROL, V53, P497, DOI 10.1002/ana.10499; MEYER F, 1970, J BIOL CHEM, V245, P6642; MOMMAERTS WFHM, 1959, P NATL ACAD SCI USA, V45, P791, DOI 10.1073/pnas.45.6.791; Mutalik VK, 2005, THEOR BIOL MED MODEL, V2, DOI 10.1186/1742-4682-2-19; Nadaj-Pakleza AA, 2009, MUSCLE NERVE, V40, P350, DOI 10.1002/mus.21351; Nielsen JN, 2002, J PHYSIOL-LONDON, V541, P979, DOI 10.1113/jphysiol.2002.018044; Nielsen JN, 2002, AM J PHYSIOL-ENDOC M, V282, pE1267, DOI 10.1152/ajpendo.00526.2001; Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5; Nogales-Gadea G, 2008, HUM MUTAT, V29, P277, DOI 10.1002/humu.20649; Nogales-Gadea G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013164; Nogues M, 1996, Z NATURFORSCH C, V51, P591; Odermatt A, 1996, NAT GENET, V14, P191, DOI 10.1038/ng1096-191; Odermatt A, 2000, HUM GENET, V106, P482, DOI 10.1007/s004390000297; Pan Y, 2003, J BIOL CHEM, V278, P13367, DOI 10.1074/jbc.M213228200; Periasamy M, 2007, MUSCLE NERVE, V35, P430, DOI 10.1002/mus.20745; Rae DE, 2010, EUR J APPL PHYSIOL, V110, P1047, DOI 10.1007/s00421-010-1585-5; Rubio JC, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9474; SCHMID R, 1959, J CLIN INVEST, V38, P2044, DOI 10.1172/JCI103983; Vissing J, 2003, NEW ENGL J MED, V349, P2503, DOI 10.1056/NEJMoa031836; Weigle DS, 1997, J CLIN ENDOCR METAB, V82, P566, DOI 10.1210/jc.82.2.566; WEISS JN, 1987, SCIENCE, V238, P67, DOI 10.1126/science.2443972; Zange J, 2003, MUSCLE NERVE, V27, P728, DOI 10.1002/mus.10377	36	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31718	10.1371/journal.pone.0031718	http://dx.doi.org/10.1371/journal.pone.0031718			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347505	Green Published, Green Submitted, gold			2022-12-25	WOS:000302730200033
J	Lepore, E; Marchioro, A; Isaia, M; Buehler, MJ; Pugno, NM				Lepore, Emiliano; Marchioro, Andrea; Isaia, Marco; Buehler, Markus J.; Pugno, Nicola M.			Evidence of the Most Stretchable Egg Sac Silk Stalk, of the European Spider of the Year Meta menardi	PLOS ONE			English	Article							ORB-WEAVING SPIDERS; MECHANICAL-PROPERTIES; DRAGLINE SILK; PHYSICAL-PROPERTIES; TENSILE PROPERTIES; ARANEAE; FIBERS; STRENGTH; SEQUENCE; BIOMECHANICS	Spider silks display generally strong mechanical properties, even if differences between species and within the same species can be observed. While many different types of silks have been tested, the mechanical properties of stalks of silk taken from the egg sac of the cave spider Meta menardi have not yet been analyzed. Meta menardi has recently been chosen as the "European spider of the year 2012", from the European Society of Arachnology. Here we report a study where silk stalks were collected directly from several caves in the north-west of Italy. Field emission scanning electron microscope (FESEM) images showed that stalks are made up of a large number of threads, each of them with diameter of 6.03 +/- 0.58 mu m. The stalks were strained at the constant rate of 2 mm/min, using a tensile testing machine. The observed maximum stress, strain and toughness modulus, defined as the area under the stress-strain curve, are 0.64 GPa, 751% and 130.7 MJ/m(3), respectively. To the best of our knowledge, such an observed huge elongation has never been reported for egg sac silk stalks and suggests a huge unrolling microscopic mechanism of the macroscopic stalk that, as a continuation of the protective egg sac, is expected to be composed by fibres very densely and randomly packed. The Weibull statistics was used to analyze the results from mechanical testing, and an average value of Weibull modulus (m) is deduced to be in the range of 1.5-1.8 with a Weibull scale parameter (sigma(0)) in the range of 0.33-0.41 GPa, showing a high coefficient of correlation (R-2=0.97).	[Lepore, Emiliano; Marchioro, Andrea; Pugno, Nicola M.] Politecn Torino, Dept Struct Engn, Lab Bioinspired Nanomech Giuseppe Maria Pugno, Turin, Italy; [Isaia, Marco] Univ Turin, Dept Human & Anim Biol, Lab Ecol & Terr Ecosyst, Turin, Italy; [Buehler, Markus J.] MIT, Dept Civil & Environm Engn, Ctr Mat Sci & Engn, Lab Atomist & Mol Mech, Cambridge, MA 02139 USA; [Buehler, Markus J.] MIT, Ctr Computat Engn, Cambridge, MA 02139 USA; [Pugno, Nicola M.] Natl Labs Frascati, Natl Inst Nucl Phys, Frascati, Italy; [Pugno, Nicola M.] Natl Inst Metrol Res, Turin, Italy	Polytechnic University of Turin; University of Turin; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale di Ricerca Metrologica (INRIM)	Lepore, E (corresponding author), Politecn Torino, Dept Struct Engn, Lab Bioinspired Nanomech Giuseppe Maria Pugno, Turin, Italy.	nicola.pugno@polito.it	Buehler, Markus J./C-4580-2008; Isaia, Marco/I-1629-2015; Pugno, Nicola/C-2289-2014	Buehler, Markus J./0000-0002-4173-9659; Isaia, Marco/0000-0001-5434-2127; 	"Metrology on a Cellular and Macromolecular Scale for Regenerative Medicine" - Metregen; European Research Council under the European Union [279985]; ONR-PECASE [N00014-10-1-0562]	"Metrology on a Cellular and Macromolecular Scale for Regenerative Medicine" - Metregen; European Research Council under the European Union(European Research Council (ERC)); ONR-PECASE(Office of Naval Research)	NMP is supported by "Metrology on a Cellular and Macromolecular Scale for Regenerative Medicine" - Metregen (2009-2012), supporting theoretical research for scaffold design. The research related to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no [279985] (ERC StG Ideas Award to NMP on "Bio-inspired hierarchical super nanomaterials"; the funding will officially start in 2012). MJB acknowledges support from an ONR-PECASE award (award number N00014-10-1-0562), no role in the results reported in this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011234; Allmeling C, 2006, J CELL MOL MED, V10, P770, DOI 10.1111/j.1582-4934.2006.tb00436.x; Alvarez-Padilla F, 2009, CLADISTICS, V25, P109, DOI 10.1111/j.1096-0031.2008.00242.x; Blackledge TA, 2006, J EXP BIOL, V209, P2452, DOI 10.1242/jeb.02275; Blackledge TA, 2011, ADV INSECT PHYSIOL, V41, P175, DOI 10.1016/B978-0-12-415919-8.00004-5; Bosia F, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.056103; Boutry C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022467; Brunetta L., 2010, SPIDER SILK EVOLUTIO; Craig C.L., 2003, SPIDER WEBS SILK TRA; Craig CL, 2003, SPIDERWEBS SILK TRAC; Cunniff P.M., 1994, POLYM ADVAN TECHNOL, V5, P401; Dal Pra I, 2005, BIOMATERIALS, V26, P1987, DOI 10.1016/j.biomaterials.2004.06.036; Dal Pra I, 2006, INT J MOL MED, V18, P241; DENNY M, 1976, J EXP BIOL, V65, P483; DUNAWAY DL, 1995, J APPL POLYM SCI, V58, P675, DOI 10.1002/app.1995.070580322; Eberhard WG, 2010, J ARACHNOL, V38, P407, DOI 10.1636/B09-97.1; Elices M, 2005, JOM-US, V57, P60, DOI 10.1007/s11837-005-0218-7; Foelix R. F., 2011, BIOL SPIDERS; Foradori MJ, 2002, J MORPHOL, V252, P218, DOI 10.1002/jmor.1100; Gheysens T, 2005, J ARACHNOL, V33, P549, DOI 10.1636/CS05-12.1; GOSLINE JM, 1984, NATURE, V309, P551, DOI 10.1038/309551a0; GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9; Gosline JM, 1999, J EXP BIOL, V202, P3295; Guinea GV, 2003, POLYMER, V44, P5785, DOI 10.1016/S0032-3861(03)00625-6; Hajer J, 2009, J MORPHOL, V270, P1269, DOI 10.1002/jmor.10757; Hayashi CY, 2004, MOL BIOL EVOL, V21, P1950, DOI 10.1093/molbev/msh204; Keten S, 2010, J R SOC INTERFACE, V7, P1709, DOI 10.1098/rsif.2010.0149; Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/nmat2704, 10.1038/NMAT2704]; KOHLER T, 1995, J EXP ZOOL, V271, P1, DOI 10.1002/jez.1402710102; Kovoor J., 1987, P160; Krasnov I, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.048104; Madsen B, 1999, INT J BIOL MACROMOL, V24, P301, DOI 10.1016/S0141-8130(98)00094-4; Moore AMF, 1999, INT J BIOL MACROMOL, V24, P277, DOI 10.1016/S0141-8130(98)00090-7; Nova A, 2010, NANO LETT, V10, P2626, DOI 10.1021/nl101341w; Opell BD, 2000, BIOL J LINN SOC, V70, P107, DOI 10.1111/j.1095-8312.2000.tb00203.x; Ortlepp C, 2008, J EXP BIOL, V211, P2832, DOI 10.1242/jeb.014191; Perez-Rigueiro J, 1998, J APPL POLYM SCI, V70, P2439, DOI 10.1002/(SICI)1097-4628(19981219)70:12<2439::AID-APP16>3.0.CO;2-J; Perez-Rigueiro J, 2000, J APPL POLYM SCI, V75, P1270, DOI 10.1002/(SICI)1097-4628(20000307)75:10<1270::AID-APP8>3.3.CO;2-3; Perez-Riguero J, 2001, J APPL POLYM SCI, V82, P2245, DOI 10.1002/app.2072; Platnick N.I., 2013, WORLD SPIDER CATALOG, DOI [10.5531/db.iz.0001, DOI 10.5531/DB.IZ.0001]; Poza P, 2002, ENG FRACT MECH, V69, P1035, DOI 10.1016/S0013-7944(01)00120-5; Pugno NM, 2010, J MECH PHYS SOLIDS, V58, P1397, DOI 10.1016/j.jmps.2010.05.007; Romer L, 2008, PRION, V2, P154; Rousseau ME, 2009, BIOMACROMOLECULES, V10, P2945, DOI 10.1021/bm9007919; Sensenig A, 2010, J EVOLUTION BIOL, V23, P1839, DOI 10.1111/j.1420-9101.2010.02048.x; Shao ZZ, 1999, POLYMER, V40, P1799, DOI 10.1016/S0032-3861(98)00266-3; STAUFFER SL, 1994, J ARACHNOL, V22, P5; Swanson BO, 2006, APPL PHYS A-MATER, V82, P213, DOI 10.1007/s00339-005-3427-6; Van Nimmen E, 2005, J ARACHNOL, V33, P629, DOI 10.1636/CS05-5.1; Van Nimmen E, 2005, AUTEX RES J, V5, P120; Van Nimmen E, 2006, TEXT RES J, V76, P619, DOI 10.1177/0040517506068057; Vasanthavada K, 2007, J BIOL CHEM, V282, P35088, DOI 10.1074/jbc.M705791200; Vehoff T, 2007, BIOPHYS J, V93, P4425, DOI 10.1529/biophysj.106.099309; Vollrath F, 1996, P ROY SOC B-BIOL SCI, V263, P147, DOI 10.1098/rspb.1996.0023; Vollrath F, 2001, P ROY SOC B-BIOL SCI, V268, P2339, DOI 10.1098/rspb.2001.1590; Xiao T, 2008, COMPOS SCI TECHNOL, V68, P2937, DOI 10.1016/j.compscitech.2007.10.004; Zhao AC, 2006, BIOCHEMISTRY-US, V45, P3348, DOI 10.1021/bi052414g	57	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30500	10.1371/journal.pone.0030500	http://dx.doi.org/10.1371/journal.pone.0030500			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347380	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000302730100014
J	Couto, CR; Pannuti, CS; Paz, JP; Fink, MCD; Machado, AA; de Marchi, M; Machado, CM				Couto, Carla R.; Pannuti, Claudio S.; Paz, Jose P., Jr.; Fink, Maria C. D.; Machado, Alessandra A.; de Marchi, Michela; Machado, Clarisse M.			Fighting Misconceptions to Improve Compliance with Influenza Vaccination among Health Care Workers: An Educational Project	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; VIRUS-INFECTIONS; RAPID DIAGNOSIS; WORKING ADULTS; RATES; IMMUNIZATION; FREQUENCY; ATTITUDES; PCR	The compliance with influenza vaccination is poor among health care workers (HCWs) due to misconceptions about safety and effectiveness of influenza vaccine. We proposed an educational prospective study to demonstrate to HCWs that influenza vaccine is safe and that other respiratory viruses (RV) are the cause of respiratory symptoms in the months following influenza vaccination. 398 HCWs were surveyed for adverse events (AE) occurring within 48 h of vaccination. AE were reported by 30% of the HCWs. No severe AE was observed. A subset of 337 HCWs was followed up during four months, twice a week, for the detection of respiratory symptoms. RV was diagnosed by direct immunofluorescent assay (DFA) and real time PCR in symptomatic HCWs. Influenza A was detected in five episodes of respiratory symptoms (5.3%) and other RV in 26 (27.9%) episodes. The incidence density of influenza and other RV was 4.3 and 10.8 episodes per 100 HCW-month, respectively. The educational nature of the present study may persuade HCWs to develop a more positive attitude to influenza vaccination.	[Couto, Carla R.; Pannuti, Claudio S.; Paz, Jose P., Jr.; Fink, Maria C. D.; Machado, Alessandra A.; de Marchi, Michela; Machado, Clarisse M.] Univ Sao Paulo, Inst Trop Med, Virol Lab LIM HCFMUSP 52, Sao Paulo, Brazil	Universidade de Sao Paulo	Couto, CR (corresponding author), Univ Sao Paulo, Inst Trop Med, Virol Lab LIM HCFMUSP 52, Sao Paulo, Brazil.	clarimm@usp.br	Fink, Maria Cristina/M-8718-2015		State of Sao Paulo Secretary of Health; Aventis Pasteur	State of Sao Paulo Secretary of Health; Aventis Pasteur	This study was supported by The State of Sao Paulo Secretary of Health. CC and JP received grants from Aventis Pasteur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, MORBID MORTAL WKLY R, V59, P38; [Anonymous], SUMMARY 2010 2011 TR; ARRUDA E, 1993, MOL CELL PROBE, V7, P373, DOI 10.1006/mcpr.1993.1055; Bellei N, 2008, J MED VIROL, V80, P1824, DOI 10.1002/jmv.21295; Bishburg E, 2008, INFECT CONT HOSP EP, V29, P89, DOI 10.1086/524322; Boivin G, 2000, CLIN INFECT DIS, V31, P1166, DOI 10.1086/317425; Bridges CB, 2000, JAMA-J AM MED ASSOC, V284, P1655, DOI 10.1001/jama.284.13.1655; Christini AB, 2007, INFECT CONT HOSP EP, V28, P171, DOI 10.1086/511796; Donalisio Maria Rita, 2003, Rev. Soc. Bras. Med. Trop., V36, P467, DOI 10.1590/S0037-86822003000400006; Englund JA, 1996, J CLIN MICROBIOL, V34, P1649, DOI 10.1128/JCM.34.7.1649-1653.1996; Fiore Anthony E., 2009, Morbidity and Mortality Weekly Report, V58, P1; GROSS PA, 1995, ANN INTERN MED, V123, P518, DOI 10.7326/0003-4819-123-7-199510010-00008; Hollmeyer HG, 2009, VACCINE, V27, P3935, DOI 10.1016/j.vaccine.2009.03.056; Igari H, 2010, MICROBIOL IMMUNOL, V54, P618, DOI 10.1111/j.1348-0421.2010.00254.x; Lopes MH, 2008, INFECT CONT HOSP EP, V29, P285, DOI 10.1086/528700; Lopes MH, 2008, CLINICS, V63, P21, DOI 10.1590/S1807-59322008000100005; Machado CM, 2004, BONE MARROW TRANSPL, V34, P111, DOI 10.1038/sj.bmt.1704534; Machado CM, 2003, BONE MARROW TRANSPL, V31, P695, DOI 10.1038/sj.bmt.1703900; MARGOLIS KL, 1990, AM J MED, V88, P27, DOI 10.1016/0002-9343(90)90123-U; Morris DJ, 1996, J INFECTION, V32, P113, DOI 10.1016/S0163-4453(96)91250-5; NICHOL KL, 1995, NEW ENGL J MED, V333, P889, DOI 10.1056/NEJM199510053331401; Oliveira RR, 2008, BONE MARROW TRANSPL, V42, P265, DOI 10.1038/bmt.2008.153; Park SW, 2011, AM J INFECT CONTROL, V39, P69, DOI 10.1016/j.ajic.2010.08.007; Rothman KJ, 1998, MODERN EPIDEMIOLOGY, P29; Smedley J, 2007, OCCUP ENVIRON MED, V64, P223, DOI 10.1136/oem.2005.023564; Takayanagi IJ, 2007, AM J INFECT CONTROL, V35, P56, DOI 10.1016/j.ajic.2006.06.002; van Elden LJR, 2001, J CLIN MICROBIOL, V39, P196, DOI 10.1128/JCM.39.1.196-200.2001	27	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e30670	10.1371/journal.pone.0030670	http://dx.doi.org/10.1371/journal.pone.0030670			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328920	Green Published, gold, Green Submitted			2022-12-25	WOS:000302179300006
J	Talebian, F; Liu, JQ; Liu, ZZ; Khattabi, M; He, YK; Ganju, R; Bai, XF				Talebian, Fatemeh; Liu, Jin-Qing; Liu, Zhenzhen; Khattabi, Mazin; He, Yukai; Ganju, Ramesh; Bai, Xue-Feng			Melanoma Cell Expression of CD200 Inhibits Tumor Formation and Lung Metastasis via Inhibition of Myeloid Cell Functions	PLOS ONE			English	Article							THERAPEUTIC TARGET; EFFECTOR FUNCTION; PROGNOSTIC-FACTOR; RECEPTOR; MACROPHAGES; CANCER; RECRUITMENT; PROGRESSION; ANTIBODIES; SEVERITY	CD200 is a cell surface glycoprotein that functions through engaging CD200 receptor on cells of the myeloid lineage and inhibits their functions. Expression of CD200 has been implicated in a variety of human cancer cells including melanoma cells and has been thought to play a protumor role. To investigate the role of cancer cell expression of CD200 in tumor formation and metastasis, we generated CD200-positive and CD200-negative B16 melanoma cells. Subcutaneous injection of CD200-positive B16 melanoma cells inhibited tumor formation and growth in C57BL/6 mice but not in Rag1(-/-)C57BL/6 mice. However, i.v. injection of CD200-positive B16 melanoma cells dramatically inhibited tumor foci formation in the lungs of both C57BL/6 and Rag1(-/-)C57BL6 mice. Flow cytometry analysis revealed higher expression of CD200R in Gr1(+) myeloid cells in the lung than in peripheral myeloid cells. Depletion of Gr1(+) cells or stimulation of CD200R with an agonistic antibody in vivo dramatically inhibited tumor foci formation in the lungs. In addition, treatment with tumor antigen specific CD4 or CD8 T cells or their combination yielded a survival advantage for CD200 positive tumor bearing mice over mice bearing CD200-negative tumors. Taken together, we have revealed a novel role for CD200-CD200R interaction in inhibiting tumor formation and metastasis. Targeting CD200R may represent a novel approach for cancer immunotherapy.	[Talebian, Fatemeh; Liu, Jin-Qing; Liu, Zhenzhen; Khattabi, Mazin; Ganju, Ramesh; Bai, Xue-Feng] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Talebian, Fatemeh; Liu, Jin-Qing; Liu, Zhenzhen; Khattabi, Mazin; Ganju, Ramesh; Bai, Xue-Feng] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Talebian, Fatemeh] Ohio State Univ, Integrated Biomed Sci Grad Program, Columbus, OH 43210 USA; [Liu, Zhenzhen] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [He, Yukai] Georgia Hlth Sci Univ, Immunol Immunotherapy Program, Augusta, GA USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Georgia; Augusta University	Talebian, F (corresponding author), Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA.	Xue-Feng.Bai@osumc.edu	Bai, Xue-Feng/H-5164-2013; Bai, Xue-feng/E-2681-2011	Bai, Xue-Feng/0000-0001-9476-8376; talebian, fatemeh/0000-0003-1172-1252; Talebian, Fatemeh/0000-0002-8336-0348	National Cancer Institute [R01CA138427]; American cancer society [RSG-09-188-01-LIB]; NATIONAL CANCER INSTITUTE [R01CA138427] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American cancer society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study is supported by Grants from National Cancer Institute (R01CA138427 to XFB) and American cancer society (RSG-09-188-01-LIB to XFB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn GO, 2010, P NATL ACAD SCI USA, V107, P8363, DOI 10.1073/pnas.0911378107; Bai XF, 2003, J CLIN INVEST, V111, P1487, DOI 10.1172/JCI200317656; BARCLAY AN, 1986, BIOCHEM SOC SYMP, P149; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Dick AD, 2001, INVEST OPHTH VIS SCI, V42, P170; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Jenmalm MC, 2006, J IMMUNOL, V176, P191, DOI 10.4049/jimmunol.176.1.191; Koning N, 2009, J NEUROPATH EXP NEUR, V68, P159, DOI 10.1097/NEN.0b013e3181964113; Kretz-Rommel A, 2007, J IMMUNOL, V178, P5595, DOI 10.4049/jimmunol.178.9.5595; Kretz-Ronlmel A, 2008, J IMMUNOL, V180, P699, DOI 10.4049/jimmunol.180.2.699; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Luo YP, 2006, J CLIN INVEST, V116, P2132, DOI 10.1172/JCI27648; McWhirter JR, 2006, P NATL ACAD SCI USA, V103, P1041, DOI 10.1073/pnas.0510081103; Mihrshahi R, 2010, J IMMUNOL, V185, P7216, DOI 10.4049/jimmunol.1002858; Mihrshahi R, 2009, J IMMUNOL, V183, P4879, DOI 10.4049/jimmunol.0901531; Minas K, 2006, CRIT REV IMMUNOL, V26, P213, DOI 10.1615/CritRevImmunol.v26.i3.20; Moreaux J, 2008, BIOCHEM BIOPH RES CO, V366, P117, DOI 10.1016/j.bbrc.2007.11.103; Moreaux J, 2006, BLOOD, V108, P4194, DOI 10.1182/blood-2006-06-029355; PEKAREK LA, 1995, J EXP MED, V181, P435, DOI 10.1084/jem.181.1.435; Petermann KB, 2007, J CLIN INVEST, V117, P3922, DOI 10.1172/JCI32163; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Ragheb R, 1999, IMMUNOL LETT, V68, P311, DOI 10.1016/S0165-2478(99)00060-7; Rosenblum MD, 2004, J INVEST DERMATOL, V123, P880, DOI 10.1111/j.0022-202X.2004.23461.x; Simelyte E, 2010, CLIN EXP IMMUNOL, V162, P163, DOI 10.1111/j.1365-2249.2010.04227.x; Siva A, 2007, CANC IMMUNOL IMMUNOT; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Stumpfova M, 2010, CANCER RES, V70, P2962, DOI 10.1158/0008-5472.CAN-09-4380; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Tonks A, 2007, LEUKEMIA, V21, P566, DOI 10.1038/sj.leu.2404559; Wang LX, 2010, EUR J IMMUNOL, V40, P2569, DOI 10.1002/eji.201040472; Wright GJ, 2003, J IMMUNOL, V171, P3034, DOI 10.4049/jimmunol.171.6.3034; Wright GJ, 2001, IMMUNOLOGY, V102, P173, DOI 10.1046/j.1365-2567.2001.01163.x; Zhang SL, 2004, J IMMUNOL, V173, P6786, DOI 10.4049/jimmunol.173.11.6786; Zhou QF, 2010, J IMMUNOL, V185, P5082, DOI 10.4049/jimmunol.1001821	36	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31442	10.1371/journal.pone.0031442	http://dx.doi.org/10.1371/journal.pone.0031442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319630	Green Published, gold, Green Submitted			2022-12-25	WOS:000302178400042
J	Li, XQ; Li, L; Xiao, CH; Feng, YM				Li, Xiao-Qing; Li, Lin; Xiao, Chun-Hua; Feng, Yu-Mei			NEFL mRNA Expression Level Is a Prognostic Factor for Early-Stage Breast Cancer Patients	PLOS ONE			English	Article							SHORT ARM; PROSTATE CARCINOMAS; COLORECTAL-CANCER; CHROMOSOME 8P; ALLELIC LOSS; LUNG-CANCER; HETEROZYGOSITY; GENE; 8P12-P21; DISEASE	Neurofilament, light polypeptide (NEFL) was demonstrated to be ectopically expressed in breast cancer tissues and decreased in lymph node metastases compared to the paired primary breast cancers in our previous study. Moreover, in several studies, NEFL was regarded as a tumor suppressor gene, and its loss of heterozygosity (LOH) was related to carcinogenesis and metastasis in several types of cancer. To explore the role of NEFL in the progression of breast cancer and to evaluate its clinical significance, we detected the NEFL mRNA level in normal breast tissues, primary breast cancer samples and lymph node metastases, and then analyzed the association between the NEFL expression level and several clinicopathological parameters and disease-free survival (DFS). NEFL mRNA was found to be expressed in 92.3% of breast malignancies and down-regulated in lymph node metastases compared to the paired primary tumors. NEFL mRNA level was lower in primary breast cancers with positive lymph nodes than in cancers with negative lymph nodes. Moreover, a low expression level of NEFL mRNA indicated a poor five-year DFS for early-stage breast cancer patients. Thus, NEFL mRNA is ectopically expressed in breast malignancies and could be a potential prognostic factor for early-stage breast cancer patients.	[Li, Xiao-Qing; Li, Lin; Feng, Yu-Mei] Tianjin Med Univ Canc Inst & Hosp, Dept Biochem & Mol Biol, Tianjin, Peoples R China; [Xiao, Chun-Hua] Tianjin Med Univ Canc Inst & Hosp, Dept Breast Surg, Tianjin, Peoples R China; [Li, Xiao-Qing; Xiao, Chun-Hua; Feng, Yu-Mei] Tianjin Med Univ Canc Inst & Hosp, Minist Educ, Key Lab Breast Canc Prevent & Treatment, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Feng, YM (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Dept Biochem & Mol Biol, Tianjin, Peoples R China.	ymfeng@tijmu.edu.cn			National Natural Science Foundation of China [30872518]; Major Program of Applied Basic Research Projects of Tianjin [09JCZDJC19800]; Tianjin Health Bureau [07KZ76]; Science Technology Development Project of Colleges and Universities in Tianjin [20090134]; Program for Changjiang Scholars and Innovative Research Team in University by the Ministry of Education [URT0743]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Program of Applied Basic Research Projects of Tianjin; Tianjin Health Bureau; Science Technology Development Project of Colleges and Universities in Tianjin; Program for Changjiang Scholars and Innovative Research Team in University by the Ministry of Education(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Natural Science Foundation of China (No. 30872518), the Major Program of Applied Basic Research Projects of Tianjin (No. 09JCZDJC19800), the Science Technology Development Project of Colleges and Universities in Tianjin [20090134], the Science Technology Development Project of Tianjin Health Bureau [07KZ76], and the Program for Changjiang Scholars and Innovative Research Team in University by the Ministry of Education [URT0743]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckland PR, 2004, BBA-MOL BASIS DIS, V1690, P238, DOI 10.1016/j.bbadis.2004.06.023; Burke B, 2006, GYNECOL ONCOL, V103, P642, DOI 10.1016/j.ygyno.2006.04.015; Coon SW, 2004, INT J CANCER, V111, P206, DOI 10.1002/ijc.20254; EMI M, 1992, CANCER RES, V52, P5368; Feng YM, 2007, BREAST CANCER RES TR, V103, P319, DOI 10.1007/s10549-006-9385-7; Haggman MJ, 1997, UROLOGY, V50, P643, DOI 10.1016/S0090-4295(97)00304-X; Imbert A, 1996, GENOMICS, V32, P29, DOI 10.1006/geno.1996.0073; Julien JP, 1998, PROG NUCLEIC ACID RE, V61, P1, DOI 10.1016/S0079-6603(08)60823-5; KAGAN J, 1995, ONCOGENE, V11, P2121; KERANGUEVEN F, 1995, ONCOGENE, V10, P1023; KNOWLES MA, 1993, ONCOGENE, V8, P1357; Kochanski A, 2004, FOLIA NEUROPATHOL, V42, P187; Kurimoto F, 2001, INT J MOL MED, V8, P89; Lerebours F, 1999, INT J CANCER, V81, P854, DOI 10.1002/(SICI)1097-0215(19990611)81:6<854::AID-IJC3>3.0.CO;2-1; Lerebours F, 1999, GENE CHROMOSOME CANC, V25, P147, DOI 10.1002/(SICI)1098-2264(199906)25:2<147::AID-GCC10>3.0.CO;2-Z; Li XQ, 2007, CANCER SCI, V98, P1592, DOI 10.1111/j.1349-7006.2007.00565.x; LIEM RKH, 1978, J CELL BIOL, V79, P637, DOI 10.1083/jcb.79.3.637; MACOSKA JA, 1995, CANCER RES, V55, P5390; Mersiyanova IV, 2000, AM J HUM GENET, V67, P37, DOI 10.1086/302962; Monceviciute-Eringiene E, 2005, MED HYPOTHESES, V65, P595, DOI 10.1016/j.mehy.2005.02.033; Rogaev E., 1992, Human Molecular Genetics, V1, P781, DOI 10.1093/hmg/1.9.781; Schmidt H, 2007, Verh Dtsch Ges Pathol, V91, P302; Seitz S, 2000, EUR J CANCER, V36, P1507, DOI 10.1016/S0959-8049(00)00135-0; Takanishi DM, 1997, MOL DIAGN, V2, P3, DOI 10.1016/S1084-8592(97)80003-3; Takimoto Y, 2001, CANCER, V91, P362; Vocke CD, 1996, CANCER RES, V56, P2411; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; YAREMKO ML, 1995, GENE CHROMOSOME CANC, V13, P186, DOI 10.1002/gcc.2870130308; Yaremko ML, 1996, GENE CHROMOSOME CANC, V16, P189, DOI 10.1002/(SICI)1098-2264(199607)16:3<189::AID-GCC6>3.0.CO;2-V	30	10	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e31146	10.1371/journal.pone.0031146	http://dx.doi.org/10.1371/journal.pone.0031146			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319610	Green Published, gold, Green Submitted			2022-12-25	WOS:000301979000023
J	Xie, Z; Jiang, Y; Liao, EY; Chen, Y; Pennypacker, SD; Peng, J; Chang, SM				Xie, Z.; Jiang, Y.; Liao, E-Y; Chen, Y.; Pennypacker, S. D.; Peng, J.; Chang, S. M.			PIKE mediates EGFR proliferative signaling in squamous cell carcinoma cells	ONCOGENE			English	Article						SCC; EGFR; PLC-gamma 1; PIKE; proliferation	PROTEIN-KINASE-C; GROWTH-FACTOR RECEPTOR; HUMAN KERATINOCYTE DIFFERENTIATION; GENE COPY NUMBER; PHOSPHOLIPASE C-GAMMA-1; PHOSPHATIDYLINOSITOL 3-KINASE; NUCLEAR TRANSLOCATION; COLORECTAL-CANCER; ACTIVATES RAF-1; POOR-PROGNOSIS	One of the key drivers for squamous cell carcinoma (SCC) proliferation is activation of the epidermal growth factor receptor (EGFR), a known proto-oncogene. However, the mechanism of EGFR-dependent SCC proliferation remains unclear. Our previous studies indicate that epidermal growth factor (EGF)-induced SCC cell proliferation requires the SH3 domain of phospholipase C-gamma 1 (PLC-gamma 1), but not its catalytic activity. The SH3 domain of PLC-gamma 1 is known to activate the short form of nuclear phosphatidylinositol 3-kinase enhancer (PIKE) that enhances the activity of nuclear class Ia phosphatidylinositol 3-kinase (PI3K) required for proliferation. However, PIKE has been described for more than a decade to be present exclusively in neuronal cells. In the present study, we found that PIKE was highly expressed in malignant human keratinocytes (SCC4 and SCC12B2) but had low expression in normal human keratinocytes. Immunohistochemical analysis showed strong nuclear staining of PIKE in human epidermal and tongue SCC specimens but little staining in the adjacent non-cancerous epithelium. Treatment of SCC4 cells with EGF-induced translocation of PLC-gamma 1 to the nucleus and binding of PLC-gamma 1 to the nuclear PIKE. Knockdown of PLC-gamma 1 or PIKE blocked EGF-induced activation of class Ia PI3K and protein kinase C-zeta and phosphorylation of nucleolin in the nucleus as well as EGF-induced SCC cell proliferation. However, inhibition of the catalytic activity of PLC-gamma 1 had little effect. These data suggest that PIKE has a critical role in EGF-induced SCC cell proliferation and may function as a proto-oncogene in SCC. Oncogene (2012) 31, 5090-5098; doi:10.1038/onc.2012.10; published online 20 February 2012	[Xie, Z.; Liao, E-Y; Peng, J.] Cent S Univ, Xiangya Hosp 2, Inst Metab & Endocrinol, Changsha 410011, Hunan, Peoples R China; [Xie, Z.; Pennypacker, S. D.; Chang, S. M.] Vet Affairs Med Ctr, No Calif Inst Res & Educ, Endocrine Unit, San Francisco, CA 94121 USA; [Xie, Z.; Pennypacker, S. D.; Chang, S. M.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Jiang, Y.] Cent S Univ, Xiang Ya Hosp 2, Dept Pathol, Changsha 410011, Hunan, Peoples R China; [Chen, Y.] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China	Central South University; Northern California Institute for Research & Education; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; Central South University; China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS	Xie, Z (corresponding author), Cent S Univ, Xiangya Hosp 2, Inst Metab & Endocrinol, 139 Middle Renmin Rd, Changsha 410011, Hunan, Peoples R China.	Zhongjian.Xie@gmail.com		Yi, Jiang/0000-0002-7877-0561	National Natural Science Foundation of China [81072219]; US National Institutes of Health [1R03DE01800, 1R21DE019529]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE018001, R21DE019529] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the grant 81072219 from the National Natural Science Foundation of China and grants 1R03DE018001 and 1R21DE019529 from the US National Institutes of Health. We thank Drs Daniel D Bikle, Chia-Ling Tu and Yongmei Wang for helpful discussions. We also thank Dr Larry L Wang (Department of Pathology, Children Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles) for reviewing pathological slides.	Ahn JY, 2004, P NATL ACAD SCI USA, V101, P6993, DOI 10.1073/pnas.0400921101; Cacace AM, 1996, ONCOGENE, V13, P2517; Cai H, 1997, MOL CELL BIOL, V17, P732, DOI 10.1128/MCB.17.2.732; Calcerrada MC, 2002, FEBS LETT, V514, P361, DOI 10.1016/S0014-5793(02)02401-8; Carpenter G, 1999, EXP CELL RES, V253, P15, DOI 10.1006/excr.1999.4671; CARROLL MP, 1994, J BIOL CHEM, V269, P1249; CHEN P, 1994, J CELL BIOL, V127, P847, DOI 10.1083/jcb.127.3.847; Destro A, 2006, LUNG CANCER, V51, P207, DOI 10.1016/j.lungcan.2005.10.016; Ettl T, 2008, HISTOPATHOLOGY, V53, P567, DOI 10.1111/j.1365-2559.2008.03159.x; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; Galizia G, 2007, WORLD J SURG, V31, P1458, DOI 10.1007/s00268-007-9016-4; Ginisty H, 1999, J CELL SCI, V112, P761; Hanawa M, 2006, INT J CANCER, V118, P1173, DOI 10.1002/ijc.21454; Harris RC, 2003, EXP CELL RES, V284, P2, DOI 10.1016/S0014-4827(02)00105-2; Hiraishi Y, 2006, PATHOL ONCOL RES, V12, P87, DOI 10.1007/BF02893450; HUANG PS, 1995, FEBS LETT, V358, P287, DOI 10.1016/0014-5793(94)01453-8; Ji GS, 1998, MOL BIOL CELL, V9, P749, DOI 10.1091/mbc.9.4.749; Kim MA, 2008, HISTOPATHOLOGY, V52, P738, DOI 10.1111/j.1365-2559.2008.03021.x; Kim MJ, 2000, EXP MOL MED, V32, P101, DOI 10.1038/emm.2000.18; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Liu X, 2007, ONCOGENE, V26, P4918, DOI 10.1038/sj.onc.1210290; Livasy CA, 2006, GYNECOL ONCOL, V100, P101, DOI 10.1016/j.ygyno.2005.07.124; Lurje G, 2009, ONCOLOGY-BASEL, V77, P400, DOI 10.1159/000279388; Mizukami Y, 1997, FEBS LETT, V401, P247, DOI 10.1016/S0014-5793(96)01481-0; Neri LM, 1999, FASEB J, V13, P2299, DOI 10.1096/fasebj.13.15.2299; PILLAI S, 1988, J CELL PHYSIOL, V134, P229, DOI 10.1002/jcp.1041340208; Rakosy Z, 2007, INT J CANCER, V121, P1729, DOI 10.1002/ijc.22928; ROTIN D, 1992, J BIOL CHEM, V267, P9678; Schiff BA, 2004, CLIN CANCER RES, V10, P8594, DOI 10.1158/1078-0432.CCR-04-0690; Smith MR, 1996, BIOCHEM BIOPH RES CO, V222, P186, DOI 10.1006/bbrc.1996.0719; Spano JP, 2005, ANN ONCOL, V16, P102, DOI 10.1093/annonc/mdi006; Speake G, 2005, CURR OPIN PHARMACOL, V5, P343, DOI 10.1016/j.coph.2005.02.007; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Storck S, 2009, BIOL CELL, V101, P153, DOI 10.1042/BC20080054; Tajrishi Marjan M, 2011, Commun Integr Biol, V4, P267, DOI 10.4161/cib.4.3.14884; Thomas SM, 2003, CANCER RES, V63, P5629; TOKER A, 1994, J BIOL CHEM, V269, P32358; Tuteja R, 1998, CRIT REV BIOCHEM MOL, V33, P407, DOI 10.1080/10409239891204260; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512; Wang ZX, 1998, MOL CELL BIOL, V18, P590, DOI 10.1128/MCB.18.1.590; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Xie ZJ, 2007, J BIOL CHEM, V282, P8695, DOI 10.1074/jbc.M609135200; Xie ZJ, 2010, BIOCHEM BIOPH RES CO, V398, P719, DOI 10.1016/j.bbrc.2010.07.007; Xie ZJ, 2010, BIOCHEM BIOPH RES CO, V397, P296, DOI 10.1016/j.bbrc.2010.05.103; Xie ZJ, 2009, MOL BIOL CELL, V20, P1695, DOI 10.1091/mbc.E08-07-0756; Xie ZJ, 2005, MOL BIOL CELL, V16, P3236, DOI 10.1091/mbc.E05-02-0109; Ye KQ, 2000, CELL, V103, P919, DOI 10.1016/S0092-8674(00)00195-1; Ye KQ, 2002, NATURE, V415, P541, DOI 10.1038/415541a; Zhou GS, 1997, J BIOL CHEM, V272, P31130, DOI 10.1074/jbc.272.49.31130; Zlobec I, 2007, BRIT J CANCER, V96, P793, DOI 10.1038/sj.bjc.6603619; Zou YZ, 1996, J BIOL CHEM, V271, P33592, DOI 10.1074/jbc.271.52.33592	51	8	9	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2012	31	49					5090	5098		10.1038/onc.2012.10	http://dx.doi.org/10.1038/onc.2012.10			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	049RK	22349826				2022-12-25	WOS:000312000900005
J	Park, SY; Bae, DJ; Kim, MJ; Piao, ML; Kim, IS				Park, Seung-Yoon; Bae, Dong-Jun; Kim, Mi-Jin; Piao, Mei Lan; Kim, In-San			Extracellular Low pH Modulates Phosphatidylserine-dependent Phagocytosis in Macrophages by Increasing Stabilin-1 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALTERNATIVELY ACTIVATED MACROPHAGES; CELL CORPSE CLEARANCE; APOPTOTIC CELLS; SCAVENGER RECEPTOR; HEME OXYGENASE-1; BLOOD-FLOW; IN-VITRO; RECOGNITION; MECHANISM; ACIDOSIS	Microenvironmental acidosis is a common feature of inflammatory loci, in which clearance of apoptotic cells is necessary for the resolution of inflammation. Although it is known that a low pH environment affects immune function, its effect on apoptotic cell clearance by macrophages has not been fully investigated. Here, we show that treatment of macrophages with low pH medium resulted in increased expression of stabilin-1 out of several receptors, which are known to be involved in PS-dependent removal of apoptotic cells. Reporter assays showed that the -120/ -1 region of the mouse stabilin-1 promoter was a low pH-responsive region and provided evidence that extracellular low pH mediated transcriptional activation of stabilin-1 via Ets-2. Furthermore, extracellular low pH activated JNK, thereby inducing translocation of Ets-2 into the nucleus. When macrophages were preincubated with low pH medium, phagocytosis of phosphatidylserine-exposed red blood cells and phosphatidylserine-coated beads by macrophages was enhanced. Blockade of stabilin-1 in macrophages abolished the enhancement of phagocytic activity by low pH. Thus, our results demonstrate that a low pH microenvironment up-regulates stabilin-1 expression in macrophages, thereby modulating the phagocytic capacity of macrophages, and suggest roles for stabilin-1 and Ets-2 in the maintenance of tissue homeostasis by the immune system.	[Bae, Dong-Jun; Piao, Mei Lan; Kim, In-San] Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Cell & Matrix Res Inst, Taegu 700422, South Korea; [Park, Seung-Yoon; Kim, Mi-Jin] Dongguk Univ, Sch Med, Dept Biochem, Gyeongju 780714, South Korea; [Kim, In-San] Korea Inst Sci & Technol, Biomed Res Inst, Seoul 136791, South Korea	Kyungpook National University; Dongguk University; Korea Institute of Science & Technology (KIST)	Kim, IS (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Cell & Matrix Res Inst, 101 Dongin Dong, Taegu 700422, South Korea.	iskim@knu.ac.kr	김, 인산/I-8988-2014; Kim, Mi Jin/GXH-9639-2022; Kim, In-San/D-3956-2017		National Research Foundation of Korea; Ministry of Education, Science, and Technology [2009-0068687, 2011-0016102, R11-2008-044-03001-0]; Korea government [2010-0029206]; Converging Research Center through Ministry of Education, Science, and Technology [2010K001054]; Brain Korea 21 Project	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea government(Korean Government); Converging Research Center through Ministry of Education, Science, and Technology; Brain Korea 21 Project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by Basic Science Research Program through the National Research Foundation of Korea funded by Ministry of Education, Science, and Technology Grants 2009-0068687 and 2011-0016102; by the National Research Foundation of Korea funded by Korea government Grant 2010-0029206; by the Converging Research Center Program through Ministry of Education, Science, and Technology Grant 2010K001054; by Basic Science Research Program through the National Research Foundation of Korea funded by Ministry of Education, Science, and Technology Grant R11-2008-044-03001-0; and by the Brain Korea 21 Project.	Adachi H, 2002, J BIOL CHEM, V277, P34264, DOI 10.1074/jbc.M204277200; Bellocq A, 1998, J BIOL CHEM, V273, P5086, DOI 10.1074/jbc.273.9.5086; Bratton DL, 2008, CURR BIOL, V18, pR76, DOI 10.1016/j.cub.2007.11.024; Chung SW, 2006, J IMMUNOL, V176, P2414, DOI 10.4049/jimmunol.176.4.2414; Chung SW, 2005, J BIOL CHEM, V280, P4578, DOI 10.1074/jbc.M409125200; DUBOS RJ, 1955, LANCET, V2, P1; EDLOW DW, 1971, P SOC EXP BIOL MED, V137, P1328; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; GOERDT S, 1993, AM J PATHOL, V142, P1409; Grimshaw MJ, 2001, EUR J IMMUNOL, V31, P480, DOI 10.1002/1521-4141(200102)31:2<480::AID-IMMU480>3.0.CO;2-L; Han MF, 2008, J BIOL CHEM, V283, P32715, DOI 10.1074/jbc.M806769200; Hanly EJ, 2007, SURGERY, V142, P357, DOI 10.1016/j.surg.2007.02.017; Kim S, 2010, INT J BIOCHEM CELL B, V42, P1154, DOI 10.1016/j.biocel.2010.03.024; Kohler G, 1997, BIOCHEMISTRY-US, V36, P8189, DOI 10.1021/bi9703960; KOPANIAK MM, 1980, AM J PATHOL, V98, P485; Kzhyshkowska J, 2005, IMMUNOBIOLOGY, V210, P161, DOI 10.1016/j.imbio.2005.05.022; Kzhyshkowska J, 2006, BLOOD, V107, P3221, DOI 10.1182/blood-2005-07-2843; Kzhyshkowska J, 2008, J IMMUNOL, V180, P3028, DOI 10.4049/jimmunol.180.5.3028; Kzhyshkowska J, 2006, J CELL MOL MED, V10, P635, DOI 10.1111/j.1582-4934.2006.tb00425.x; Kzhyshkowska J, 2006, J IMMUNOL, V176, P5825, DOI 10.4049/jimmunol.176.10.5825; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Lee SJ, 2011, BLOOD, V117, P5215, DOI 10.1182/blood-2010-10-313239; Libera J, 1997, BLOOD, V90, P1684, DOI 10.1182/blood.V90.4.1684.1684_1684_1693; Martinez D, 2007, J IMMUNOL, V179, P1950, DOI 10.4049/jimmunol.179.3.1950; Mogi C, 2009, J IMMUNOL, V182, P3243, DOI 10.4049/jimmunol.0803466; Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242; Park SY, 2008, MOL CELL BIOL, V28, P5288, DOI 10.1128/MCB.01993-07; Park SY, 2009, J CELL SCI, V122, P3365, DOI 10.1242/jcs.049569; Politz O, 2002, BIOCHEM J, V362, P155, DOI 10.1042/0264-6021:3620155; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; SAVILL JS, 1989, J CLIN INVEST, V84, P1518, DOI 10.1172/JCI114328; Serrano CV, 1996, AM J PHYSIOL-CELL PH, V271, pC962, DOI 10.1152/ajpcell.1996.271.3.C962; Tamura Y, 2003, J BIOL CHEM, V278, P12613, DOI 10.1074/jbc.M210211200; TANNOCK IF, 1989, CANCER RES, V49, P4373; VANZWIETEN R, 1981, J CLIN INVEST, V68, P310, DOI 10.1172/JCI110250; VAUPEL P, 1989, CANCER RES, V49, P6449; WARD TT, 1978, AM J MED, V64, P933, DOI 10.1016/0002-9343(78)90446-1; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036; Yoshida H, 2005, NATURE, V437, P754, DOI 10.1038/nature03964	41	43	44	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11261	11271		10.1074/jbc.M111.310953	http://dx.doi.org/10.1074/jbc.M111.310953			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334667	Green Published, hybrid			2022-12-25	WOS:000302780100054
J	Sjolander, J; Westermark, GT; Renstrom, E; Blom, AM				Sjolander, Jonatan; Westermark, Gunilla T.; Renstrom, Erik; Blom, Anna M.			Islet Amyloid Polypeptide Triggers Limited Complement Activation and Binds Complement Inhibitor C4b-binding Protein, Which Enhances Fibril Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CELL APOPTOSIS; ALZHEIMERS-DISEASE; COMPONENT; C1Q; PURIFICATION; DEPOSITION; OLIGOMERS; PEPTIDE; INSULIN; REGION	Islet amyloid polypeptide (IAPP) is synthesized in pancreatic beta-cells and co-secreted with insulin. Aggregation and formation of IAPP-amyloid play a critical role in beta-cell death in type 2 diabetic patients. Because A beta-fibrils in Alzheimer disease activate the complement system, we have here investigated specific interactions between IAPP and complement factors. IAPP fibrils triggered limited activation of complement in vitro, involving both the classical and the alternative pathways. Direct binding assays confirmed that IAPP fibrils interact with globular head domains of complement initiator C1q. Furthermore, IAPP also bound complement inhibitors factor H and C4b-binding protein (C4BP). Recombinant C4BP mutants were used to show that complement control protein (CCP) domains 8 and 2 of the alpha-chain were responsible for the strong, hydrophobic binding of C4BP to IAPP. Immunostaining of pancreatic sections from type 2 diabetic patients revealed the presence of complement factors in the islets and varying degree of co-localization between IAPP fibrils and C1q, C3d, as well as C4BP and factor H but not membrane attack complex. Furthermore, C4BP enhanced formation of IAPP fibrils in vitro. We conclude that C4BP binds to IAPP thereby limiting complement activation and may be enhancing formation of IAPP fibrils from cytotoxic oligomers.	[Sjolander, Jonatan; Blom, Anna M.] Lund Univ, Dept Lab Med, Wallenberg Lab, Skane Univ Hosp, S-20502 Malmo, Sweden; [Westermark, Gunilla T.] Uppsala Univ, Dept Med Cell Biol, S-75123 Uppsala, Sweden; [Renstrom, Erik] Lund Univ, Dept Clin Sci, Clin Res Ctr, Skane Univ Hosp, S-20502 Malmo, Sweden	Lund University; Skane University Hospital; Uppsala University; Lund University; Skane University Hospital	Blom, AM (corresponding author), Lund Univ, Dept Lab Med, Wallenberg Lab, Skane Univ Hosp, S-20502 Malmo, Sweden.	anna.blom@med.lu.se	Blom, Anna/AFS-7369-2022; Blom, Anna/B-9607-2009	Blom, Anna/0000-0002-1348-1734	Swedish Research Council [2009-68X-14928-06-3, 2010-55X-20326-04-3]; Swedish Foundation for Strategic Research; Swedish Diabetes Foundation; Foundation of Osterlund; Foundation of Greta and Johan Kock; Foundation of Family Ernfors; Foundation of Knut and Alice Wallenberg; Foundation of Inga-Britt and Arne Lundberg; University Hospital in Malmo; Region Skane	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Diabetes Foundation; Foundation of Osterlund; Foundation of Greta and Johan Kock; Foundation of Family Ernfors; Foundation of Knut and Alice Wallenberg(Knut & Alice Wallenberg Foundation); Foundation of Inga-Britt and Arne Lundberg; University Hospital in Malmo; Region Skane	This work was supported by Swedish Research Council Grants 2009-68X-14928-06-3 and 2010-55X-20326-04-3, the Swedish Foundation for Strategic Research, Swedish Diabetes Foundation and the Foundations of Osterlund, Greta and Johan Kock, Family Ernfors, Knut and Alice Wallenberg, and Inga-Britt and Arne Lundberg as well as grants for clinical research from the University Hospital in Malmo and the Region Skane.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Anguiano M, 2002, BIOCHEMISTRY-US, V41, P11338, DOI 10.1021/bi020314u; BETSHOLTZ C, 1989, FEBS LETT, V251, P261, DOI 10.1016/0014-5793(89)81467-X; Blom AM, 2003, MOL IMMUNOL, V39, P547, DOI 10.1016/S0161-5890(02)00213-4; Blom AM, 2001, J BIOL CHEM, V276, P27136, DOI 10.1074/jbc.M102445200; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; DAHLBACK B, 1983, BIOCHEM J, V209, P847, DOI 10.1042/bj2090847; DAHLBACK B, 1981, P NATL ACAD SCI-BIOL, V78, P2512, DOI 10.1073/pnas.78.4.2512; DE FRUTOS PG, 1995, J BIOL CHEM, V270, P26950, DOI 10.1074/jbc.270.45.26950; Ebeling P, 2001, METABOLISM, V50, P283, DOI 10.1053/meta.2001.21032; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Guardado-Mendoza R, 2009, P NATL ACAD SCI USA, V106, P13992, DOI 10.1073/pnas.0906471106; Head E, 2001, NEUROBIOL DIS, V8, P252, DOI 10.1006/nbdi.2000.0380; Hillarp A., 1990, P NATL ACAD SCI USA, V87, P1183; Hulbert EM, 2007, NUCLEIC ACIDS RES, V35, pD742, DOI 10.1093/nar/gkl933; Jaikaran ETAS, 2001, BBA-MOL BASIS DIS, V1537, P179, DOI 10.1016/S0925-4439(01)00078-3; Jurgens CA, 2011, AM J PATHOL, V178, P2632, DOI 10.1016/j.ajpath.2011.02.036; KAHN SE, 1990, DIABETES, V39, P634, DOI 10.2337/diabetes.39.5.634; Klegeris A, 2007, BIOCHEM BIOPH RES CO, V357, P1096, DOI 10.1016/j.bbrc.2007.04.055; Koehl J, 2006, CURR OPIN MOL THER, V8, P529; Larsson A, 2007, BIOCHEM BIOPH RES CO, V361, P822, DOI 10.1016/j.bbrc.2007.06.187; LUKINIUS A, 1989, DIABETOLOGIA, V32, P240, DOI 10.1007/BF00285291; MALOY AL, 1981, HUM PATHOL, V12, P917, DOI 10.1016/S0046-8177(81)80197-9; MANDERS EMM, 1992, J CELL SCI, V103, P857; Mollnes Tom E., 2002, Trends in Immunology, V23, P61, DOI 10.1016/S1471-4906(01)02129-9; PAQUES EP, 1979, H-S Z PHYSIOL CHEM, V360, P177, DOI 10.1515/bchm2.1979.360.1.177; Pitsavos Christos, 2007, Rev Diabet Stud, V4, P98, DOI 10.1900/RDS.2007.4.98; REID KBM, 1976, BIOCHEM J, V155, P5, DOI 10.1042/bj1550005; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rostagno A, 2002, J BIOL CHEM, V277, P49782, DOI 10.1074/jbc.M206448200; Rumora L, 2002, BIOL CHEM, V383, P1751, DOI 10.1515/BC.2002.196; Sjoberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003; Sjoberg AP, 2008, MOL IMMUNOL, V45, P3213, DOI 10.1016/j.molimm.2008.02.023; Spitzer D, 2007, J IMMUNOL, V179, P2600, DOI 10.4049/jimmunol.179.4.2600; TENNER AJ, 1981, J IMMUNOL, V127, P648; Trouw LA, 2008, MOL IMMUNOL, V45, P3649, DOI 10.1016/j.molimm.2008.04.025; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Webster S, 1997, AM J PATHOL, V150, P1531; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036; ZICCARDI RJ, 1982, BIOCHEM BIOPH RES CO, V107, P618, DOI 10.1016/0006-291X(82)91536-4; Zraika S, 2010, DIABETOLOGIA, V53, P1046, DOI 10.1007/s00125-010-1671-6	42	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10824	10833		10.1074/jbc.M111.244285	http://dx.doi.org/10.1074/jbc.M111.244285			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334700	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000302780100011
J	White, HN; Meng, QH				White, Henry N.; Meng, Qing-Hai			Diversification of Specificity after Maturation of the Antibody Response to the HIV gp41 Epitope ELDKWA	PLOS ONE			English	Article							PRIMARY IMMUNE-RESPONSE; IMMUNODEFICIENCY-VIRUS TYPE-1; MEMORY B-CELLS; GERMINAL-CENTERS; AFFINITY MATURATION; IN-SITU; MONOCLONAL-ANTIBODY; SOMATIC MUTATION; VARIABLE REGION; ANTIGEN	During maturing antibody responses the increase in affinity for target antigens is achieved by genetic diversification of antibody genes followed by selection for improved binding. The effect this process has on the specificity of antibody for variants of the antigen is not well-defined, despite the potential role of antibody diversification in generating enhanced protection against pathogen escape mutants, or novel specificities after vaccination. To investigate this, a library of single amino-acid substitution epitope variants has been screened with serum obtained at different time-points after immunization of mice with the HIV gp41 peptide epitope ELDKWA. The serum IgG response is shown to mature and increase affinity for ELDKWA, and the titre and affinity of IgG against most epitope variants tested increases. Furthermore there is a bias towards high affinity serum IgG binding to variant epitopes with conservative substitutions, although underlying this trend there is also significant binding to many epitopes with non-conservative substitutions. Thus, maturation of the antibody response to a single epitope results in a broadening of the high-affinity response toward variant epitopes. This implies that many pathogen epitope escape variants that could manifest as single amino-acid substitutions would not emerge by escaping immune surveillance.	[White, Henry N.; Meng, Qing-Hai] UCL, Dept Mol Immunol, Inst Child Hlth, London, England	University of London; University College London	White, HN (corresponding author), UCL, Dept Mol Immunol, Inst Child Hlth, London, England.	harry.white@plymouth.ac.uk		white, harry/0000-0001-8186-7789	Wellcome Trust [062578]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Grant number 062578 (www.wellcome.ac.uk). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; CONLEY AJ, 1994, P NATL ACAD SCI USA, V91, P3348, DOI 10.1073/pnas.91.8.3348; Dal Porto JM, 2002, J EXP MED, V195, P1215, DOI 10.1084/jem.20011550; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; DIAMOND B, 1984, P NATL ACAD SCI-BIOL, V81, P5841, DOI 10.1073/pnas.81.18.5841; FISH S, 1991, J EXP MED, V173, P665, DOI 10.1084/jem.173.3.665; HAN SH, 1995, J EXP MED, V182, P1635, DOI 10.1084/jem.182.6.1635; HERZENBERG LA, 1980, J EXP MED, V151, P1071, DOI 10.1084/jem.151.5.1071; Hornbeck P, 1991, CURRENT PROTOCOLS IM; JACOB J, 1993, J EXP MED, V178, P1293, DOI 10.1084/jem.178.4.1293; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Kalinke U, 1996, IMMUNITY, V5, P639, DOI 10.1016/S1074-7613(00)80277-0; KUPPERS R, 1993, EMBO J, V12, P4955, DOI 10.1002/j.1460-2075.1993.tb06189.x; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; PALFREYMAN JW, 1984, J IMMUNOL METHODS, V75, P383, DOI 10.1016/0022-1759(84)90122-4; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; PULENDRAN B, 1995, NATURE, V375, P331, DOI 10.1038/375331a0; Purtha WE, 2011, J EXP MED, V208, P2599, DOI 10.1084/jem.20110740; RATHMELL JC, 1995, NATURE, V376, P181, DOI 10.1038/376181a0; RUDIKOFF S, 1982, P NATL ACAD SCI-BIOL, V79, P1979, DOI 10.1073/pnas.79.6.1979; SCHILDBACH JF, 1991, J BIOL CHEM, V266, P4640; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; SPERLING R, 1983, J IMMUNOL, V131, P882; Takahashi Y, 1998, J EXP MED, V187, P885, DOI 10.1084/jem.187.6.885; Tian Y, 2002, J PEPT RES, V59, P264, DOI 10.1034/j.1399-3011.2002.02988.x; WEISS U, 1992, EUR J IMMUNOL, V22, P511, DOI 10.1002/eji.1830220233	30	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31555	10.1371/journal.pone.0031555	http://dx.doi.org/10.1371/journal.pone.0031555			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348106	gold, Green Submitted, Green Published			2022-12-25	WOS:000302737400035
J	Tang, SN; Fu, JS; Shankar, S; Srivastava, RK				Tang, Su-Ni; Fu, Junsheng; Shankar, Sharmila; Srivastava, Rakesh K.			EGCG Enhances the Therapeutic Potential of Gemcitabine and CP690550 by Inhibiting STAT3 Signaling Pathway in Human Pancreatic Cancer	PLOS ONE			English	Article							NF-KAPPA-B; EPIDERMAL-GROWTH-FACTOR; GREEN-TEA CONSUMPTION; (-)-EPIGALLOCATECHIN GALLATE; CELL-CYCLE; MOLECULAR TARGETS; FACTOR RECEPTOR; SUPPRESSION; POLYPHENOLS; ACTIVATION	Background: Signal Transducer and Activator of Transcription 3 (STAT3) is an oncogene, which promotes cell survival, proliferation, motility and progression in cancer cells. Targeting STAT3 signaling may lead to the development of novel therapeutic approaches for human cancers. Here, we examined the effects of epigallocathechin gallate (EGCG) on STAT3 signaling in pancreatic cancer cells, and assessed the therapeutic potential of EGCG with gemcitabine or JAK3 inhibitor CP690550 (Tasocitinib) for the treatment and/or prevention of pancreatic cancer. Methodology/Principal Findings: Cell viability and apoptosis were measured by XTT assay and TUNEL staining, respectively. Gene and protein expressions were measured by qRT-PCR and Western blot analysis, respectively. The results revealed that EGCG inhibited the expression of phospho and total JAK3 and STAT3, STAT3 transcription and activation, and the expression of STAT3-regulated genes, resulting in the inhibition of cell motility, migration and invasion, and the induction of caspase-3 and PARP cleavage. The inhibition of STAT3 enhanced the inhibitory effects of EGCG on cell motility and viability. Additionally, gemcitabine and CP690550 alone inhibited STAT3 target genes and synergized with EGCG to inhibit cell viability and induce apoptosis in pancreatic cancer cells. Conclusions/Significance: Overall, these results suggest that EGCG suppresses the growth, invasion and migration of pancreatic cancer cells, and induces apoptosis by interfering with the STAT3 signaling pathway. Moreover, EGCG further enhanced the therapeutic potential of gemcitabine and CP690550 against pancreatic cancer.	[Tang, Su-Ni; Srivastava, Rakesh K.] Univ Kansas, Med Ctr, Ctr Canc, Dept Pharmacol Toxicol & Therapeut & Med, Kansas City, KS 66103 USA; [Fu, Junsheng; Shankar, Sharmila] Univ Kansas, Med Ctr, Ctr Canc, Dept Pathol & Lab Med, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Tang, SN (corresponding author), Univ Kansas, Med Ctr, Ctr Canc, Dept Pharmacol Toxicol & Therapeut & Med, Kansas City, KS 66103 USA.	rsrivastava@kumc.edu			National Institutes of Health [R01CA125262, RO1CA114469, RO1CA125262-02S1]; Kansas Bioscience Authority; NATIONAL CANCER INSTITUTE [R01CA114469, R01CA125262] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kansas Bioscience Authority; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the grants from the National Institutes of Health (R01CA125262,RO1CA114469 and RO1CA125262-02S1) and the Kansas Bioscience Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulghani J, 2008, AM J PATHOL, V172, P1717, DOI 10.2353/ajpath.2008.071054; Adhami VM, 2004, CANCER RES, V64, P8715, DOI 10.1158/0008-5472.CAN-04-2840; Aggarwal BB, 2006, ANN NY ACAD SCI, V1091, P151, DOI 10.1196/annals.1378.063; Ahmad N, 2000, BIOCHEM BIOPH RES CO, V275, P328, DOI 10.1006/bbrc.2000.3297; Ahmad N, 2000, ARCH BIOCHEM BIOPHYS, V376, P338, DOI 10.1006/abbi.2000.1742; Ahmad N, 1997, JNCI-J NATL CANCER I, V89, P1881, DOI 10.1093/jnci/89.24.1881; Ahn HY, 1999, MOL BIOL CELL, V10, P1093, DOI 10.1091/mbc.10.4.1093; Akaishi H, 1998, INT IMMUNOL, V10, P1747, DOI 10.1093/intimm/10.11.1747; ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; [Anonymous], 2004, AM J TRANSPLANT, V4, P51, DOI 10.1046/j.1600-6143.2003.00281.x; Balasubramanian S, 2010, CARCINOGENESIS, V31, P496, DOI 10.1093/carcin/bgp314; Berishaj M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1680; Bharti AC, 2003, J IMMUNOL, V171, P3863, DOI 10.4049/jimmunol.171.7.3863; Borie Dominic C, 2003, Curr Opin Investig Drugs, V4, P1297; Buettner R, 2002, CLIN CANCER RES, V8, P945; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Cao YH, 1999, NATURE, V398, P381, DOI 10.1038/18793; Changelian PS, 2008, BLOOD, V111, P2155, DOI 10.1182/blood-2007-09-115030; Chapman RS, 1999, GENE DEV, V13, P2604, DOI 10.1101/gad.13.19.2604; Chrencik JE, 2010, J MOL BIOL, V400, P413, DOI 10.1016/j.jmb.2010.05.020; Cooper JE, 2010, CLIN NEPHROL, V73, P333; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Devarajan E, 2009, CURR MOL MED, V9, P626, DOI 10.2174/156652409788488720; Dong ZG, 1997, CANCER RES, V57, P4414; Dreosti IE, 1997, CRIT REV FOOD SCI, V37, P761, DOI 10.1080/10408399709527801; Fujiki H, 2002, CANCER LETT, V188, P9, DOI 10.1016/S0304-3835(02)00379-8; Ghaneh P, 2007, GUT, V56, P1134, DOI 10.1136/gut.2006.103333; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Gupta S, 2004, ONCOGENE, V23, P2507, DOI 10.1038/sj.onc.1207353; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Ji BT, 1997, INT J CANCER, V70, P255, DOI 10.1002/(SICI)1097-0215(19970127)70:3&lt;255::AID-IJC1&gt;3.0.CO;2-W; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kayed H, 2006, PANCREAS, V32, P119, DOI 10.1097/01.mpa.0000202937.55460.0c; Kim JY, 2006, J BIOL CHEM, V281, P10865, DOI 10.1074/jbc.M513378200; Konoeda F, 2010, BIOCHEM BIOPH RES CO, V402, P500, DOI 10.1016/j.bbrc.2010.10.058; KORC M, 1992, J CLIN INVEST, V90, P1352, DOI 10.1172/JCI116001; Lee N, 2004, J COMP NEUROL, V474, P535, DOI 10.1002/cne.20140; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Liang YC, 1997, J CELL BIOCHEM, V67, P55, DOI 10.1002/(SICI)1097-4644(19971001)67:1<55::AID-JCB6>3.0.CO;2-V; Liau SS, 2008, CLIN CANCER RES, V14, P1470, DOI 10.1158/1078-0432.CCR-07-1450; Nakachi K, 2000, BIOFACTORS, V13, P49, DOI 10.1002/biof.5520130109; Nam S, 2001, J BIOL CHEM, V276, P13322, DOI 10.1074/jbc.M004209200; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Park HB, 2010, TRANSPLANTATION, V90, P825, DOI 10.1097/TP.0b013e3181f24e59; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Ren ZY, 2002, J BIOL CHEM, V277, P38486, DOI 10.1074/jbc.M112438200; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Schlieman MG, 2003, BRIT J CANCER, V89, P2110, DOI 10.1038/sj.bjc.6601396; Schreiner SJ, 2002, J BIOL CHEM, V277, P45680, DOI 10.1074/jbc.M204255200; Shankar S, 2007, FRONT BIOSCI-LANDMRK, V12, P4881, DOI 10.2741/2435; Shankar S, 2007, FRONT BIOSCI-LANDMRK, V12, P5039, DOI 10.2741/2446; Shankar S, 2008, FRONT BIOSCI-LANDMRK, V13, P440, DOI 10.2741/2691; Shimizu M, 2005, CLIN CANCER RES, V11, P2735, DOI 10.1158/1078-0432.CCR-04-2014; Siegelin MD, 2008, NEUROSCI LETT, V448, P161, DOI 10.1016/j.neulet.2008.10.036; Soriano FG, 2001, NAT MED, V7, P108, DOI 10.1038/83241; SPORN MB, 1976, CANCER RES, V36, P2699; STONER GD, 1995, J CELL BIOCHEM, P169; Syed DN, 2007, ONCOGENE, V26, P673, DOI 10.1038/sj.onc.1209829; Tak PP, 2011, ARTHRITIS RES THER, V13, DOI [10.1186/ar3096, 10.1186/1478-6354-13-S1-S5]; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Tomillero A, 2009, Methods Find Exp Clin Pharmacol, V31, P661; Welte T, 2003, P NATL ACAD SCI USA, V100, P1879, DOI 10.1073/PNAS.0237137100; West K, 2009, CURR OPIN INVEST DR, V10, P491; YU GP, 1995, CANCER CAUSE CONTROL, V6, P532, DOI 10.1007/BF00054162; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zapatka M, 2007, ONCOGENE, V26, P1417, DOI 10.1038/sj.onc.1209918	72	80	85	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31067	10.1371/journal.pone.0031067	http://dx.doi.org/10.1371/journal.pone.0031067			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348037	Green Published, gold, Green Submitted			2022-12-25	WOS:000302733900021
J	Martins, AH; Alves, JM; Perez, D; Carrasco, M; Torres-Rivera, W; Eterovic, VA; Ferchmin, PA; Ulrich, H				Martins, Antonio H.; Alves, Janaina M.; Perez, Dinely; Carrasco, Marimee; Torres-Rivera, Wilmarie; Eterovic, Vesna A.; Ferchmin, Pedro A.; Ulrich, Henning			Kinin-B2 Receptor Mediated Neuroprotection after NMDA Excitotoxicity Is Reversed in the Presence of Kinin-B1 Receptor Agonists	PLOS ONE			English	Article							METHYL-D-ASPARTATE; EMBRYONAL CARCINOMA-CELLS; ACUTE HIPPOCAMPAL SLICES; FOCAL CEREBRAL-ISCHEMIA; BRAIN EDEMA FORMATION; LF 16-0687 MS; NEURONAL DIFFERENTIATION; NICOTINIC RECEPTORS; B2 RECEPTOR; BRADYKININ	Background: Kinins, with bradykinin and des-Arg(9)-bradykinin being the most important ones, are pro-inflammatory peptides released after tissue injury including stroke. Although the actions of bradykinin are in general well characterized; it remains controversial whether the effects of bradykinin are beneficial or not. Kinin-B2 receptor activation participates in various physiological processes including hypotension, neurotransmission and neuronal differentiation. The bradykinin metabolite des-Arg(9)-bradykinin as well as Lys-des-Arg(9)-bradykinin activates the kinin-B1 receptor known to be expressed under inflammatory conditions. We have investigated the effects of kinin-B1 and B2 receptor activation on N-methyl-Daspartate (NMDA)-induced excitotoxicity measured as decreased capacity to produce synaptically evoked population spikes in the CA1 area of rat hippocampal slices. Principal Findings: Bradykinin at 10 nM and 1 mu M concentrations triggered a neuroprotective cascade via kinin-B2 receptor activation which conferred protection against NMDA-induced excitotoxicity. Recovery of population spikes induced by 10 nM bradykinin was completely abolished when the peptide was co-applied with the selective kinin-B2 receptor antagonist HOE-140. Kinin-B2 receptor activation promoted survival of hippocampal neurons via phosphatidylinositol 3-kinase, while MEK/MAPK signaling was not involved in protection against NMDA-evoked excitotoxic effects. However, 100 nM Lys-des-Arg(9)-bradykinin, a potent kinin-B1 receptor agonist, reversed bradykinin-induced population spike recovery. The inhibition of population spikes recovery was reversed by PD98059,showing that MEK/MAPK was involved in the induction of apoptosis mediated by the B1 receptor. Conclusions: Bradykinin exerted protection against NMDA-induced excitotoxicity which is reversed in the presence of a kinin-B1 receptor agonist. As bradykinin is converted to the kinin-B1 receptor metabolite des-Arg(9)-bradykinin by carboxypeptidases, present in different areas including in brain, our results provide a mechanism for the neuroprotective effect in vitro despite of the deleterious effect observed in vivo.	[Martins, Antonio H.; Ulrich, Henning] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Alves, Janaina M.] Univ Fed Sao Paulo, Dept Neurol Neurocirurgia, Sao Paulo, Brazil; [Martins, Antonio H.; Perez, Dinely; Carrasco, Marimee; Torres-Rivera, Wilmarie; Eterovic, Vesna A.; Ferchmin, Pedro A.] Univ Cent Caribe, Dept Biochem, Bayamon, PR USA	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Martins, AH (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.	ferchmin@gmail.com; henning@iq.usp.br	Ulrich, Henning/AAX-8586-2021; Ulrich, Henning/C-5245-2013	Ulrich, Henning/0000-0002-2114-3815; Ulrich, Henning/0000-0002-2114-3815	NIH [P20RR016470-AABRE, U01NS063555, U54 NS39408-SNRP, G12 RR03035-RCMI]; FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2006/61285-9]; Foundation Segarra (San Juan, Puerto Rico); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil); FAPESP; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), Brazil; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003035, P20RR016470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM050695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS063555, U54NS039408] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007583] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Foundation Segarra (San Juan, Puerto Rico); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by NIH grants P20RR016470-AABRE (AHM), U01NS063555 (PAF), U54 NS39408-SNRP (PAF and VAE) and G12 RR03035-RCMI (UCC) and FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Project No. 2006/61285-9; HU). The authors also acknowledge the generous support by Foundation Segarra (San Juan, Puerto Rico) (to VAE) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil; to HU). AHM's postdoctoral and JMA's Ph.D. thesis research was funded by FAPESP and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), Brazil, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN P, 1971, EXP BRAIN RES, V13, P208; Austinat M, 2009, STROKE, V40, P285, DOI 10.1161/STROKEAHA.108.526673; Bellucci F, 2009, BRIT J PHARMACOL, V158, P1996, DOI 10.1111/j.1476-5381.2009.00511.x; Camacho A, 2006, ARCH MED RES, V37, P11, DOI 10.1016/j.arcmed.2005.05.014; Chao J, 2005, EXP PHYSIOL, V90, P291, DOI 10.1113/expphysiol.2004.028464; Christiansen SC, 2002, J IMMUNOL, V169, P2054, DOI 10.4049/jimmunol.169.4.2054; Cruden NLM, 2008, EXPERT OPIN PHARMACO, V9, P2383, DOI [10.1517/14656566.9.13.2383, 10.1517/14656566.9.13.2383 ]; Danielisova V, 2008, NEUROCHEM RES, V33, P1057, DOI 10.1007/s11064-007-9550-3; Danielisova V, 2009, CELL MOL NEUROBIOL, V29, P871, DOI 10.1007/s10571-009-9369-3; Ehrenfeld P, 2011, CANCER LETT, V301, P106, DOI 10.1016/j.canlet.2010.09.020; Ferchmin PA, 2005, J NEUROSCI RES, V82, P631, DOI 10.1002/jnr.20666; Ferchmin PA, 2003, J PHARMACOL EXP THER, V305, P1071, DOI 10.1124/jpet.102.048173; Ferchmin PA, 2000, BRAIN RES, V859, P273, DOI 10.1016/S0006-8993(00)01973-9; Flynn RWV, 2008, NEUROPHARMACOLOGY, V55, P250, DOI 10.1016/j.neuropharm.2008.05.031; FRANCEL PC, 1992, J NEUROTRAUM, V9, pS27; Groger M, 2005, J CEREBR BLOOD F MET, V25, P978, DOI 10.1038/sj.jcbfm.9600096; HARTLEY DM, 1989, J PHARMACOL EXP THER, V250, P752; Howl J, 2003, EXPERT OPIN THER TAR, V7, P277, DOI 10.1517/eott.7.2.277.23782; Joseph K, 2005, ADV IMMUNOL, V86, P159, DOI 10.1016/S0065-2776(04)86005-X; KAMIYA T, 1993, STROKE, V24, P571, DOI 10.1161/01.STR.24.4.571; Kaplanski J, 2002, J NEUROTRAUM, V19, P953, DOI 10.1089/089771502320317104; Kohno T, 2008, J NEUROSCI, V28, P4533, DOI 10.1523/JNEUROSCI.5349-07.2008; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Martel MA, 2009, NEUROSCIENCE, V158, P334, DOI 10.1016/j.neuroscience.2008.01.080; Martins AHB, 2005, J BIOL CHEM, V280, P19576, DOI 10.1074/jbc.M502513200; Martins AH, 2008, CYTOM PART A, V73A, P361, DOI 10.1002/cyto.a.20519; Miho Y, 1999, CELL DEATH DIFFER, V6, P463, DOI 10.1038/sj.cdd.4400506; Neumann J, 2006, FASEB J, V20, P714, DOI 10.1096/fj.05-4882fje; OLNEY JW, 1994, PSYCHOPHARMACOL BULL, V30, P533; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Regoli D, 2001, BIOL CHEM, V382, P31, DOI 10.1515/BC.2001.005; SCHURR A, 1995, J NEUROSCI METH, V59, P129, DOI 10.1016/0165-0270(94)00203-S; Small DL, 1997, NEUROSCI LETT, V232, P87, DOI 10.1016/S0304-3940(97)00592-2; Trujillo CA, 2009, CYTOM PART A, V75A, P38, DOI 10.1002/cyto.a.20666; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Xia CF, 2006, HYPERTENSION, V47, P752, DOI 10.1161/01.HYP.0000214867.35632.0e; Xia CF, 2004, HYPERTENSION, V43, P452, DOI 10.1161/01.HYP.0000110905.29389.e5; Yin H, 2005, J BIOL CHEM, V280, P8022, DOI 10.1074/jbc.M407179200; Zausinger S, 2002, BRAIN RES, V950, P268, DOI 10.1016/S0006-8993(02)03053-6	39	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e30755	10.1371/journal.pone.0030755	http://dx.doi.org/10.1371/journal.pone.0030755			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348022	gold, Green Submitted, Green Published			2022-12-25	WOS:000302730900015
J	Chyu, KY; Zhao, XN; Dimayuga, PC; Zhou, JC; Li, XJ; Yano, J; Lio, WM; Chan, LF; Kirzner, J; Trinidad, P; Cercek, B; Shah, PK				Chyu, Kuang-Yuh; Zhao, Xiaoning; Dimayuga, Paul C.; Zhou, Jianchang; Li, Xiaojun; Yano, Juliana; Lio, Wai Man; Chan, Lai Fan; Kirzner, Jonathan; Trinidad, Portia; Cercek, Bojan; Shah, Prediman K.			CD8(+) T Cells Mediate the Athero-Protective Effect of Immunization with an ApoB-100 Peptide	PLOS ONE			English	Article							ATHEROSCLEROTIC LESIONS; APOLIPOPROTEIN B-100; DENDRITIC CELLS; DEFICIENT MICE; ADOPTIVE TRANSFER; IMMUNE-RESPONSES; LDL IMMUNIZATION; DENSITY; SEQUENCES; POPULATIONS	Immunization of hypercholesterolemic mice with selected apoB-100 peptide antigens reduces atherosclerosis but the precise immune mediators of athero-protection remain unclear. In this study we show that immunization of apoE (-/-) mice with p210, a 20 amino acid apoB-100 related peptide, reduced aortic atherosclerosis compared with PBS or adjuvant/carrier controls. Immunization with p210 activated CD8(+) T cells, reduced dendritic cells (DC) at the site of immunization and within the plaque with an associated reduction in plaque macrophage immunoreactivity. Adoptive transfer of CD8(+) T cells from p210 immunized mice recapitulated the athero-protective effect of p210 immunization in naive, non-immunized mice. CD8(+) T cells from p210 immunized mice developed a preferentially higher cytolytic response against p210-loaded dendritic cells in vitro. Although p210 immunization profoundly modulated DCs and cellular immune responses, it did not alter the efficacy of subsequent T cell dependent or independent immune response to other irrelevant antigens. Our data define, for the first time, a role for CD8(+) T cells in mediating the athero-protective effects of apoB-100 related peptide immunization in apoE (-/-) mice.	[Chyu, Kuang-Yuh; Zhao, Xiaoning; Dimayuga, Paul C.; Zhou, Jianchang; Li, Xiaojun; Yano, Juliana; Lio, Wai Man; Chan, Lai Fan; Kirzner, Jonathan; Trinidad, Portia; Cercek, Bojan; Shah, Prediman K.] Cedars Sinai Med Ctr, Div Cardiol, Oppenheimer Atherosclerosis Res Ctr, Cedars Sinai Heart Inst, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Chyu, KY (corresponding author), Cedars Sinai Med Ctr, Div Cardiol, Oppenheimer Atherosclerosis Res Ctr, Cedars Sinai Heart Inst, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.	ShahP@cshs.org			Heart Foundation; Shapell and Guerin Family; Feintech Family; Corday Foundation; Skirball Foundation; Cardiovax Inc.; Cardiovax	Heart Foundation; Shapell and Guerin Family; Feintech Family; Corday Foundation; Skirball Foundation; Cardiovax Inc.; Cardiovax	This work received support from the Heart Foundation, Spielberg Cardiovascular Research Fund, the Shapell and Guerin Family, the Feintech Family, the Corday Foundation, the Skirball Foundation and Cardiovax Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Shah is a co-inventor of apoB-100 peptide vaccines and has assigned patent rights to Cedars-Sinai Medical Center. Dr. Shah is a scientific advisor to Cardiovax Inc. The funding support from Cardiovax does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The other authors have no competing interests to declare.	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Ameli S, 1996, ARTERIOSCL THROM VAS, V16, P1074, DOI 10.1161/01.ATV.16.8.1074; Bobryshev YV, 2001, HISTOL HISTOPATHOL, V16, P801, DOI 10.14670/HH-16.801; Caligiuri G, 2002, J CLIN INVEST, V109, P745, DOI 10.1172/JCI200207272; Chyu KY, 2005, BIOCHEM BIOPH RES CO, V338, P1982, DOI 10.1016/j.bbrc.2005.10.141; Chyu KY, 2004, ATHEROSCLEROSIS, V176, P27, DOI 10.1016/j.atherosclerosis.2004.04.016; Dimayuga P, 2002, ARTERIOSCL THROM VAS, V22, P644, DOI 10.1161/01.ATV.0000012455.62765.BF; Dimayuga PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020214; Fredrikson GN, 2005, AUTOIMMUNITY, V38, P171, DOI 10.1080/08916930500050525; Fredrikson GN, 2003, ARTERIOSCL THROM VAS, V23, P879, DOI 10.1161/01.ATV.0000067937.93716.DB; Fredrikson GN, 2003, ARTERIOSCL THROM VAS, V23, P872, DOI 10.1161/01.ATV.0000067935.02679.B0; Fredrikson GN, 2008, J INTERN MED, P1; Freigang S, 1998, ARTERIOSCL THROM VAS, V18, P1972, DOI 10.1161/01.ATV.18.12.1972; FYFE AI, 1994, J CLIN INVEST, V94, P2516, DOI 10.1172/JCI117622; George J, 1998, ATHEROSCLEROSIS, V138, P147, DOI 10.1016/S0021-9150(98)00015-X; Hansson GK, 2002, CIRC RES, V91, P281, DOI 10.1161/01.RES.0000029784.15893.10; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Klingenberg R, 2010, ARTERIOSCL THROM VAS, V30, P946, DOI 10.1161/ATVBAHA.109.202671; Kolbus D, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-58; Lecoeur H, 2001, J IMMUNOL METHODS, V253, P177, DOI 10.1016/S0022-1759(01)00359-3; Liu P, 2008, ARTERIOSCL THROM VAS, V28, P243, DOI 10.1161/ATVBAHA.107.158675; Mor A, 2007, ARTERIOSCL THROM VAS, V27, P893, DOI 10.1161/01.ATV.0000259365.31469.89; Niessner A, 2010, CLIN IMMUNOL, V134, P25, DOI 10.1016/j.clim.2009.05.006; PALINSKI W, 1995, P NATL ACAD SCI USA, V92, P821, DOI 10.1073/pnas.92.3.821; Paulson KE, 2010, CIRC RES, V106, P383, DOI 10.1161/CIRCRESAHA.109.210781; Roselaar SE, 1996, ARTERIOSCL THROM VAS, V16, P1013, DOI 10.1161/01.ATV.16.8.1013; Sakamoto N, 2007, BLOOD, V110, P501, DOI 10.1182/blood-2007-01-066522; Schiopu A, 2004, CIRCULATION, V110, P2047, DOI 10.1161/01.CIR.0000143162.56057.B5; Shah PK, 2005, NAT CLIN PRACT CARD, V2, P639, DOI 10.1038/ncpcardio0372; Sjogren P, 2008, EUR HEART J, V29, P2218, DOI 10.1093/eurheartj/ehn336; van den Elzen P, 2005, NATURE, V437, P906, DOI 10.1038/nature04001; Wigren M, 2011, J INTERN MED, V269, P546, DOI 10.1111/j.1365-2796.2010.02311.x; Wu HZ, 2009, CIRCULATION, V119, P2708, DOI 10.1161/CIRCULATIONAHA.108.823740; Yang GX, 2008, HEPATOLOGY, V47, P1974, DOI 10.1002/hep.22226; Yang KP, 2006, CELL IMMUNOL, V243, P90, DOI 10.1016/j.cellimm.2007.01.002; Zhou XH, 2000, CIRCULATION, V102, P2919; Zhou XH, 2005, CIRC RES, V96, P427, DOI 10.1161/01.RES.0000156889.22364.f1; Zhou XH, 1996, AM J PATHOL, V149, P359; Zhou XH, 2006, ARTERIOSCL THROM VAS, V26, P864, DOI 10.1161/01.ATV.0000206122.61591.ff; Zhou XH, 2001, ARTERIOSCL THROM VAS, V21, P108, DOI 10.1161/01.ATV.21.1.108	40	69	78	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e30780	10.1371/journal.pone.0030780	http://dx.doi.org/10.1371/journal.pone.0030780			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347402	Green Submitted, Green Published, gold			2022-12-25	WOS:000302730200008
J	Kim, S; Roopra, A; Alexander, CM				Kim, Soyoung; Roopra, Avtar; Alexander, Caroline M.			A Phenotypic Mouse Model of Basaloid Breast Tumors	PLOS ONE			English	Article							CANCER STEM-CELLS; GENE-EXPRESSION PROFILES; MAMMARY-TUMORS; INITIATING CELLS; BRCA1; RECEPTOR; RESISTANCE; GLAND; P53; RADIORESISTANCE	Chemotherapeutic strategies that target basal-like breast tumors are difficult to design without understanding their cellular and molecular basis. Here, we induce tumors in mice by carcinogen administration, creating a phenocopy of tumors with the diagnostic and functional aspects of human triple negative disease (including EGFR expression/lack of erbB, estrogen-independent growth and co-clustering of the transcriptome with other basaloid models). These tumor strains are a complement to established mouse models that are based on mutations in Brca1 and/or p53. Tumors comprise two distinct cell subpopulations, basal and luminal epithelial cells. These cell fractions were purified by flow cytometry, and only basal cell fractions found to have tumor initiating activity (cancer stem cells). The phenotype of serially regenerated tumors was stable, and irrespective of tumor precursor cell. Tumors were passaged entirely in vivo and serial generations tested for their phenotypic stability. The relative chemo-sensitivity of basal and luminal cells were evaluated. Upon treatment with anthracycline, tumors were effectively de-bulked, but recurred; this correlated with maintenance of a high rate of basal cell division throughout the treatment period. Thus, these tumors grow as robust cell mixtures of basal bipotential tumor initiating cells alongside a luminal majority, and the cellular response to drug administration is dominated by the distinct biology of the two cell types. Given the ability to separate basal and luminal cells, and the discovery potential of this approach, we propose that this mouse model could be a convenient one for preclinical studies.	[Kim, Soyoung; Alexander, Caroline M.] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; [Roopra, Avtar] Univ Wisconsin, Dept Neurosci, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kim, S (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.	alexander@oncology.wisc.edu			DOD-BCRP [W81XWH-06-1-0491]; University of Wisconsin NCDDG [U19, CA113297]; NATIONAL CANCER INSTITUTE [U19CA113297, P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065067] Funding Source: NIH RePORTER	DOD-BCRP(United States Department of Defense); University of Wisconsin NCDDG; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by an Era of Hope Scholars Award from the DOD-BCRP to CMA (W81XWH-06-1-0491). Also, this project was supported by the University of Wisconsin NCDDG (U19; CA113297) and the University of Wisconsin Carbone Cancer Center that provided shared services to complete this research (P30 CA014520). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander CM, 2009, CELL STEM CELL, V5, P579, DOI 10.1016/j.stem.2009.11.008; Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594; Bade LK, 2011, J CELL SCI, V124, P3106, DOI 10.1242/jcs.082651; Badve S, 2010, MOD PATHOL; Bhargava R, 2008, AM J CLIN PATHOL, V130, P724, DOI 10.1309/AJCP3KFF1LTYWQIY; CARDIFF RD, 1988, ONCOGENE, V3, P205; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Chan MM, 2007, INT J CANCER, V121, P474, DOI 10.1002/ijc.22684; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Collis SJ, 2005, ONCOGENE, V24, P949, DOI 10.1038/sj.onc.1208332; Currier N, 2005, TOXICOL PATHOL, V33, P726, DOI 10.1080/01926230500352226; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; El-Rehim DMA, 2004, J PATHOL, V203, P661, DOI 10.1002/path.1559; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Gonzalez-Angulo AM, 2011, CLIN CANCER RES, V17, P1082, DOI 10.1158/1078-0432.CCR-10-2560; Graeser M, 2010, CLIN CANCER RES, V16, P6159, DOI 10.1158/1078-0432.CCR-10-1027; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hochgrafe F, 2010, CANCER RES, V70, P9391, DOI 10.1158/0008-5472.CAN-10-0911; Ivanov O, 2008, BREAST CANCER RES TR, V111, P411, DOI 10.1007/s10549-007-9796-0; JERRY DJ, 1994, MOL CARCINOGEN, V9, P175, DOI 10.1002/mc.2940090309; JONES LP, 2007, ONCOGENE; Kellen E, 2009, BREAST CANCER RES TR, V114, P13, DOI 10.1007/s10549-008-9990-8; Kim S, 2011, PLOS ONE, V6; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Kunigal S, 2008, CLIN CANCER RES, V14, P3617, DOI 10.1158/1078-0432.CCR-07-2060; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Lin SCJ, 2004, CANCER RES, V64, P3525, DOI 10.1158/0008-5472.CAN-03-3524; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Lomonaco SL, 2009, INT J CANCER, V125, P717, DOI 10.1002/ijc.24402; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; Martin SA, 2009, J PATHOL; Mastroianni M, 2009, CANC LETT; McDermott SP, 2006, ONCOGENE; Mehta RG, 2000, EUR J CANCER, V36, P1275, DOI 10.1016/S0959-8049(00)00100-3; Michalak EM, 2010, J MAMMARY GLAND BIOL; Millikan RC, 2008, BREAST CANCER RES TR, V109, P123, DOI 10.1007/s10549-007-9632-6; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Mote PA, 2006, ENDOCRINOLOGY, V147, P5503, DOI 10.1210/en.2006-0040; Pajic M, 2010, CELL CYCLE, V9, P3780, DOI 10.4161/cc.9.18.13002; Pasic L, 2011, GENE DEV, V25, P1641, DOI 10.1101/gad.2025611; Rakha EA, 2007, HISTOPATHOLOGY, V50, P434, DOI 10.1111/j.1365-2559.2007.02638.x; Rakha EA, 2008, MODERN PATHOL, V21, P1060, DOI 10.1038/modpathol.2008.67; Rakha EA, 2009, CLIN CANCER RES, V15, P2302, DOI 10.1158/1078-0432.CCR-08-2132; Rodriguez AA, 2010, BREAST CANCER RES TR, V123, P189, DOI 10.1007/s10549-010-0983-z; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shafee N, 2008, CANCER RES, V68, P3243, DOI 10.1158/0008-5472.CAN-07-5480; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Toft DJ, 2011, MOL ENDOCRINOL, V25, P199, DOI 10.1210/me.2010-0164; Turner NC, 2006, ONCOGENE, V25, P5846, DOI 10.1038/sj.onc.1209876; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; van de Rijn M, 2002, AM J PATHOL, V161, P1991, DOI 10.1016/S0002-9440(10)64476-8; Varela I, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r100; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Weigelt B, 2003, P NATL ACAD SCI USA, V100, P15901, DOI 10.1073/pnas.2634067100; Williams ES, 2009, CANCER RES, V69, P2100, DOI 10.1158/0008-5472.CAN-08-2854; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Yan HH, 2010, AM J PATHOL, V176, P1421, DOI 10.2353/ajpath.2010.090438; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353; Zhang M, 2010, P NATL ACAD SCI USA, V107, P3522, DOI 10.1073/pnas.0910179107	65	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e30979	10.1371/journal.pone.0030979	http://dx.doi.org/10.1371/journal.pone.0030979			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347416	Green Published, gold, Green Submitted			2022-12-25	WOS:000302730200012
J	Rodger, J; Drummond, ES; Hellstrom, M; Robertson, D; Harvey, AR				Rodger, Jennifer; Drummond, Eleanor S.; Hellstroem, Mats; Robertson, Donald; Harvey, Alan R.			Long-Term Gene Therapy Causes Transgene-Specific Changes in the Morphology of Regenerating Retinal Ganglion Cells	PLOS ONE			English	Article							PERIPHERAL-NERVE GRAFTS; LEBERS CONGENITAL AMAUROSIS; NEUROTROPHIC FACTOR; NEURITE OUTGROWTH; DENDRITIC GROWTH; PROTEASE NEXIN-1; ADULT CATS; SYMPATHETIC NEURONS; HIPPOCAMPAL-NEURONS; AXONAL REGENERATION	Recombinant adeno-associated viral (rAAV) vectors can be used to introduce neurotrophic genes into injured CNS neurons, promoting survival and axonal regeneration. Gene therapy holds much promise for the treatment of neurotrauma and neurodegenerative diseases; however, neurotrophic factors are known to alter dendritic architecture, and thus we set out to determine whether such transgenes also change the morphology of transduced neurons. We compared changes in dendritic morphology of regenerating adult rat retinal ganglion cells (RGCs) after long-term transduction with rAAV2 encoding: (i) green fluorescent protein (GFP), or (ii) bi-cistronic vectors encoding GFP and ciliary neurotrophic factor (CNTF), brain-derived neurotrophic factor (BDNF) or growth-associated protein-43 (GAP43). To enhance regeneration, rats received an autologous peripheral nerve graft onto the cut optic nerve of each rAAV2 injected eye. After 5-8 months, RGCs with regenerated axons were retrogradely labeled with fluorogold (FG). Live retinal wholemounts were prepared and GFP positive (transduced) or GFP negative (non-transduced) RGCs injected iontophoretically with 2% lucifer yellow. Dendritic morphology was analyzed using Neurolucida software. Significant changes in dendritic architecture were found, in both transduced and non-transduced populations. Multivariate analysis revealed that transgenic BDNF increased dendritic field area whereas GAP43 increased dendritic complexity. CNTF decreased complexity but only in a subset of RGCs. Sholl analysis showed changes in dendritic branching in rAAV2-BDNF-GFP and rAAV2-CNTF-GFP groups and the proportion of FG positive RGCs with aberrant morphology tripled in these groups compared to controls. RGCs in all transgene groups displayed abnormal stratification. Thus in addition to promoting cell survival and axonal regeneration, vector-mediated expression of neurotrophic factors has measurable, gene-specific effects on the morphology of injured adult neurons. Such changes will likely alter the functional properties of neurons and may need to be considered when designing vector-based protocols for the treatment of neurotrauma and neurodegeneration.	[Rodger, Jennifer] Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia; [Drummond, Eleanor S.; Hellstroem, Mats; Harvey, Alan R.] Univ Western Australia, Sch Anat & Human Biol, Perth, WA 6009, Australia; [Robertson, Donald] Univ Western Australia, Discipline Physiol, Sch Biomed & Biomol Sci, Perth, WA 6009, Australia	University of Western Australia; University of Western Australia; University of Western Australia	Rodger, J (corresponding author), Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia.	alan.harvey@uwa.edu.au	Harvey, Alan R/A-4911-2008; Drummond, Eleanor/AAB-9731-2021; Rodger, Jennifer/H-5735-2014	Rodger, Jennifer/0000-0003-3413-4229; Drummond, Eleanor/0000-0002-5466-4609; , Alan/0000-0002-2590-831X	National Health and Medical Research Council (NHMRC); WA Neurotrauma Research Program; Raine Foundation of Western Australia; International Postgraduate Student Scholarship	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); WA Neurotrauma Research Program; Raine Foundation of Western Australia; International Postgraduate Student Scholarship	The research was supported by the National Health and Medical Research Council (NHMRC) and the WA Neurotrauma Research Program. JR was funded by the Raine Foundation of Western Australia and a Senior Research Fellowship from NHMRC. MH was funded by an International Postgraduate Student Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Baumgartner BJ, 1997, J NEUROSCI, V17, P6504; BIFFO S, 1990, EUR J NEUROSCI, V2, P487, DOI 10.1111/j.1460-9568.1990.tb00440.x; Bjorklund T, 2010, MOVEMENT DISORD, V25, pS161, DOI 10.1002/mds.22785; BRAY GM, 1987, J EXP BIOL, V132, P5; Chacon PJ, 2010, MOL CELL NEUROSCI, V43, P384, DOI 10.1016/j.mcn.2010.01.005; Chiwitt C, 2011, RESTOR NEUROL NEUROS, V29, P127, DOI 10.3233/RNN-2011-0586; CHOI BH, 1995, NEUROBIOL AGING, V16, P557, DOI 10.1016/0197-4580(95)00060-R; Cideciyan AV, 2009, HUM GENE THER, V20, P999, DOI 10.1089/hum.2009.086; Cohen-Cory S, 2004, INT J DEV BIOL, V48, P947, DOI 10.1387/ijdb.041883sc; Cui Q, 2000, NEUROREPORT, V11, P3999, DOI 10.1097/00001756-200012180-00019; D Kuipers S, 2006, CURR OPIN DRUG DISC, V9, P580; de Winter W, 2001, NATURE, V409, P710, DOI 10.1038/35055547; Deplano S, 2004, DEV NEUROSCI-BASEL, V26, P396, DOI 10.1159/000082282; Deplano S, 1999, J COMP NEUROL, V405, P262, DOI 10.1002/(SICI)1096-9861(19990308)405:2<262::AID-CNE9>3.0.CO;2-4; DIAZNIDO J, 1991, J CELL SCI, V98, P409; Dijkhuizen PA, 2005, PROG BRAIN RES, V147, P17, DOI 10.1016/S0079-6123(04)47002-2; DREHER B, 1985, BRAIN BEHAV EVOLUT, V26, P10, DOI 10.1159/000118764; Du JL, 2004, NATURE, V429, P878, DOI 10.1038/nature02618; Eberling JL, 2008, NEUROLOGY, V70, P1980, DOI 10.1212/01.wnl.0000312381.29287.ff; FAMIGLIETTI EV, 1976, SCIENCE, V194, P193, DOI 10.1126/science.959847; Frey D, 2000, J CELL BIOL, V149, P1443, DOI 10.1083/jcb.149.7.1443; FUKUDA Y, 1977, BRAIN RES, V119, P327, DOI 10.1016/0006-8993(77)90314-6; Fukuda Y, 1998, VISION RES, V38, P1545, DOI 10.1016/S0042-6989(98)00005-4; Gauthier-Campbell C, 2004, MOL BIOL CELL, V15, P2205, DOI 10.1091/mbc.E03-07-0493; Germain F, 2003, EUR J NEUROSCI, V18, P1103, DOI 10.1046/j.1460-9568.2003.02842.x; Guo X, 1999, J NEUROSCI, V19, P2113; GURWITZ D, 1990, J CELL PHYSIOL, V142, P155, DOI 10.1002/jcp.1041420119; Harvey AR, 2006, PROG RETIN EYE RES, V25, P449, DOI 10.1016/j.preteyeres.2006.07.002; Hellstrom M, 2011, MOL CELL NEUROSCI, V46, P507, DOI 10.1016/j.mcn.2010.12.003; Hellstrom M, 2011, J NEUROTRAUM, V28, P2475, DOI 10.1089/neu.2011.1928; Hellstrom M, 2011, CURR GENE THER, V11, P116, DOI 10.2174/156652311794940746; Horch HW, 2004, REV NEUROSCIENCE, V15, P117; Horch HW, 2002, NAT NEUROSCI, V5, P1177, DOI 10.1038/nn927; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Huxlin KR, 1997, J COMP NEUROL, V385, P309; Kells AP, 2008, GENE THER, V15, P966, DOI 10.1038/gt.2008.23; Klein RL, 1999, BRAIN RES, V832, P136, DOI 10.1016/S0006-8993(99)01482-1; Klein RL, 1999, NEUROSCIENCE, V90, P815, DOI 10.1016/S0306-4522(98)00537-5; Kong JH, 2005, J COMP NEUROL, V489, P293, DOI 10.1002/cne.20631; Kwon M, 2011, J NEUROSCI, V31, P9735, DOI 10.1523/JNEUROSCI.6785-10.2011; Lagriffoul A, 1996, J BIOL CHEM, V271, P31508, DOI 10.1074/jbc.271.49.31508; LAU KC, 1991, RESTOR NEUROL NEUROS, V3, P235, DOI 10.3233/RNN-1991-3502; Leaver SG, 2006, GENE THER, V13, P1328, DOI 10.1038/sj.gt.3302791; Liang FQ, 2001, MOL THER, V3, P241, DOI 10.1006/mthe.2000.0252; Lin B, 2004, NEURON, V43, P475, DOI 10.1016/j.neuron.2004.08.002; Luikart BW, 2008, J NEUROSCI, V28, P7006, DOI 10.1523/JNEUROSCI.0195-08.2008; Mandel RJ, 2010, CURR OPIN MOL THER, V12, P240; Marks WJ, 2008, LANCET NEUROL, V7, P400, DOI 10.1016/S1474-4422(08)70065-6; MARTIN PR, 1986, EXP BRAIN RES, V62, P77; Meins M, 2001, J NEUROSCI, V21, P8830, DOI 10.1523/JNEUROSCI.21-22-08830.2001; Miller FD, 2003, CURR OPIN NEUROBIOL, V13, P391, DOI 10.1016/s0959-4388(03)00072-2; Milosevic NT, 2009, J THEOR BIOL, V259, P142, DOI 10.1016/j.jtbi.2009.03.011; Miyoshi T, 1999, EXP BRAIN RES, V124, P383, DOI 10.1007/s002210050635; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Niclou SP, 1998, EUR J NEUROSCI, V10, P1590, DOI 10.1046/j.1460-9568.1998.00183.x; Park KK, 2009, MOL CELL NEUROSCI, V41, P313, DOI 10.1016/j.mcn.2009.04.002; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; PERRY VH, 1979, PROC R SOC SER B-BIO, V204, P363, DOI 10.1098/rspb.1979.0033; Quan MZ, 1999, INVEST OPHTH VIS SCI, V40, P2360; Ramaswamy S, 2009, NEUROBIOL DIS, V34, P40, DOI 10.1016/j.nbd.2008.12.005; REINHARD E, 1994, J NEUROSCI RES, V37, P256, DOI 10.1002/jnr.490370211; Richardson RM, 2011, MOL THER, V19, P1048, DOI 10.1038/mt.2011.11; Robinson GA, 2004, VISION RES, V44, P2667, DOI 10.1016/j.visres.2004.06.010; Ruitenberg MJ, 2004, NEUROBIOL DIS, V15, P394, DOI 10.1016/j.nbd.2003.11.018; Sapieha PS, 2003, MOL CELL NEUROSCI, V24, P656, DOI 10.1016/S1044-7431(03)00228-8; Schmeer C, 2002, EUR J NEUROSCI, V15, P637, DOI 10.1046/j.1460-9568.2002.01893.x; SHOLL DA, 1953, J ANAT, V87, P387; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Smith PD, 2009, NEURON, V64, P617, DOI 10.1016/j.neuron.2009.11.021; Sommerfeld MT, 2000, J BIOL CHEM, V275, P8982, DOI 10.1074/jbc.275.12.8982; STRITTMATTER SM, 1994, J NEUROSCI, V14, P5503; SUIDAN HS, 1992, NEURON, V8, P363, DOI 10.1016/0896-6273(92)90302-T; Sun WZ, 2002, VISUAL NEUROSCI, V19, P483, DOI 10.1017/S0952523802194107; THANOS S, 1995, J NEUROSCI, V15, P1057, DOI 10.1523/jneurosci.15-02-01057.1995; THANOS S, 1988, CELL TISSUE RES, V254, P599; Tolwani RJ, 2002, NEUROSCIENCE, V114, P795, DOI 10.1016/S0306-4522(02)00301-9; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; WASSLE H, 1988, TRENDS NEUROSCI, V11, P87, DOI 10.1016/0166-2236(88)90147-6; WATANABE M, 1993, J NEUROSCI, V13, P2105; Weber AJ, 2008, INVEST OPHTH VIS SCI, V49, P2456, DOI 10.1167/iovs.07-1325; Wu K, 2003, HUM GENE THER, V14, P1463, DOI 10.1089/104303403769211673; Yacoubian TA, 2000, NAT NEUROSCI, V3, P342, DOI 10.1038/73911; Yang Y, 2009, J GENE MED, V11, P899, DOI 10.1002/jgm.1377; Yata T, 2007, NEUROSCIENCE, V148, P53, DOI 10.1016/j.neuroscience.2007.05.042; Zagrebelsky M, 2005, J NEUROSCI, V25, P9989, DOI 10.1523/JNEUROSCI.2492-05.2005; ZURN AD, 1988, DEV NEUROSCI-BASEL, V10, P17, DOI 10.1159/000111951	87	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31061	10.1371/journal.pone.0031061	http://dx.doi.org/10.1371/journal.pone.0031061			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347429	Green Published, Green Submitted, gold			2022-12-25	WOS:000302730100037
J	Iannaccone, S; Zhou, Y; Walterhouse, D; Taborn, G; Landini, G; Lannaccone, P				Iannaccone, Stephen; Zhou, Yue; Walterhouse, David; Taborn, Greg; Landini, Gabriel; lannaccone, Philip			Three Dimensional Visualization and Fractal Analysis of Mosaic Patches in Rat Chimeras: Cell Assortment in Liver, Adrenal Cortex and Cornea	PLOS ONE			English	Article							CENTRIPETAL MIGRATION; EPITHELIAL-CELLS; CLONAL ORIGIN; STEM-CELLS; MOUSE; PATTERN; EXPRESSION; GEOMETRY; LIMBAL; ORGANOGENESIS	The production of organ parenchyma in a rapid and reproducible manner is critical to normal development. In chimeras produced by the combination of genetically distinguishable tissues, mosaic patterns of cells derived from the combined genotypes can be visualized. These patterns comprise patches of contiguously similar genotypes and are different in different organs but similar in a given organ from individual to individual. Thus, the processes that produce the patterns are regulated and conserved. We have previously established that mosaic patches in multiple tissues are fractal, consistent with an iterative, recursive growth model with simple stereotypical division rules. Fractal dimensions of various tissues are consistent with algorithmic models in which changing a single variable (e. g. daughter cell placement after division) switches the mosaic pattern from islands to stripes of cells. Here we show that the spiral pattern previously observed in mouse cornea can also be visualized in rat chimeras. While it is generally held that the pattern is induced by stem cell division dynamics, there is an unexplained discrepancy in the speed of cellular migration and the emergence of the pattern. We demonstrate in chimeric rat corneas both island and striped patterns exist depending on the age of the animal. The patches that comprise the pattern are fractal, and the fractal dimension changes with the age of the animal and indicates the constraint in patch complexity as the spiral pattern emerges. The spiral patterns are consistent with a loxodrome. Such data are likely to be relevant to growth and cell division in organ systems and will help in understanding how organ parenchyma are generated and maintained from multipotent stem cell populations located in specific topographical locations within the organ. Ultimately, understanding algorithmic growth is likely to be essential in achieving organ regeneration in vivo or in vitro from stem cell populations.	[Iannaccone, Stephen; Walterhouse, David; Taborn, Greg; lannaccone, Philip] Northwestern Univ, Childrens Mem Res Ctr, Chicago, IL 60611 USA; [Zhou, Yue] Univ Chicago, Ctr Reprod Med & Fertil, Chicago, IL 60637 USA; [Landini, Gabriel] Univ Birmingham, Sch Dent, Birmingham, W Midlands, England	Northwestern University; University of Chicago; University of Birmingham	Iannaccone, S (corresponding author), Northwestern Univ, Childrens Mem Res Ctr, Chicago, IL 60611 USA.	pmi@northwestern.edu		Landini, Gabriel/0000-0002-9689-0989	NIH from NEI [EY020946]; George M. Eisenberg Foundation for Charities; NATIONAL EYE INSTITUTE [R21EY020946] Funding Source: NIH RePORTER	NIH from NEI; George M. Eisenberg Foundation for Charities; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported in part by NIH EY020946 from the NEI and the George M. Eisenberg Foundation for Charities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUCK RC, 1985, INVEST OPHTH VIS SCI, V26, P1296; CHAUDHURI A, 1983, VISION RES, V23, P1351, DOI 10.1016/0042-6989(83)90146-3; Collinson JM, 2004, INT J DEV BIOL, V48, P793, DOI 10.1387/ijdb.041885jc; Collinson JM, 2004, INVEST OPHTH VIS SCI, V45, P1101, DOI 10.1167/iovs.03-1118; Collinson JM, 2002, DEV DYNAM, V224, P432, DOI 10.1002/dvdy.10124; DEAMANT FD, 1987, J CELL SCI, V88, P305; Dua HS, 2009, OPHTHALMOLOGY, V116, P856, DOI 10.1016/j.ophtha.2008.12.017; Dvorscak L, 2008, INVEST OPHTH VIS SCI, V49, P910, DOI 10.1167/iovs.07-1324; Henriksson JT, 2009, INVEST OPHTH VIS SCI, V50, P3648, DOI 10.1167/iovs.08-2941; Iannaccone P, 2002, FASEB J, V16, P41, DOI 10.1096/fj.02-0451fje; Iannaccone P, 1996, FRACTAL GEOMETRY BIO; IANNACCONE PM, 1988, CELL DIFFER DEV, V25, P77, DOI 10.1016/0922-3371(88)90103-7; IANNACCONE PM, 1978, J CELL SCI, V29, P249; IANNACCONE PM, 1987, DEVELOPMENT, V99, P187; IANNACCONE PM, 1987, CELL DIFFER DEV, V21, P79, DOI 10.1016/0045-6039(87)90415-5; IANNACCONE PM, 1987, J EXP ZOOL, V243, P217, DOI 10.1002/jez.1402430207; IANNACCONE PM, 1990, FASEB J, V4, P1508, DOI 10.1096/fasebj.4.5.2307328; IANNACCONE PM, 1989, J THEOR BIOL, V141, P363, DOI 10.1016/S0022-5193(89)80119-5; Iannaccone PM, 1996, FRACTAL GEOMETRY BIO, P189; KHOKHA MK, 1994, DEV BIOL, V165, P545, DOI 10.1006/dbio.1994.1274; Landini G, 2011, J MICROSC-OXFORD, V241, P1, DOI 10.1111/j.1365-2818.2010.03454.x; Landini G, 2000, FASEB J, V14, P823, DOI 10.1096/fasebj.14.5.823; LAVKER RM, 1991, INVEST OPHTH VIS SCI, V32, P1864; Leiper LJ, 2009, INVEST OPHTH VIS SCI, V50, P1122, DOI 10.1167/iovs.08-2812; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Majo F, 2008, NATURE, V456, P250, DOI 10.1038/nature07406; MANDELBROT B, 1967, SCIENCE, V156, P636, DOI 10.1126/science.156.3775.636; MINTZ B, 1967, P NATL ACAD SCI USA, V58, P344, DOI 10.1073/pnas.58.1.344; Morley SD, 1996, MOL ENDOCRINOL, V10, P585, DOI 10.1210/me.10.5.585; Mort RL, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-4; Nagasaki T, 2003, INVEST OPHTH VIS SCI, V44, P558, DOI 10.1167/iovs.02-0705; NG YK, 1992, DEV BIOL, V151, P419, DOI 10.1016/0012-1606(92)90182-G; NG YK, 1992, CURR TOP DEV BIOL, V27, P235, DOI 10.1016/S0070-2153(08)60536-0; Novak MM, 1998, FRACTALS COMPLEXITY; PRUSINKIEWICZ P, 1990, ALGORITHMIC BEAUTY P; Sherwin T, 2010, OPHTHALMOLOGY, V117, P190, DOI 10.1016/j.ophtha.2009.08.006; Thompson DAW, 1943, GROWTH FORM, P748; WEINBERG WC, 1985, SCIENCE, V227, P524, DOI 10.1126/science.3966159; WEINBERG WC, 1987, CARCINOGENESIS, V8, P565, DOI 10.1093/carcin/8.4.565; Weisstein EW, 2011, STEREOGRAPHIC PROJEC	40	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31609	10.1371/journal.pone.0031609	http://dx.doi.org/10.1371/journal.pone.0031609			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347498	gold, Green Submitted, Green Published			2022-12-25	WOS:000302180600043
J	Sczaniecka, M; Gladstone, K; Pettersson, S; McLaren, L; Huart, AS; Wallace, M				Sczaniecka, Matylda; Gladstone, Karen; Pettersson, Susanne; McLaren, Lorna; Huart, Anne-Sophie; Wallace, Maura			MDM2 Protein-mediated Ubiquitination of NUMB Protein IDENTIFICATION OF A SECOND PHYSIOLOGICAL SUBSTRATE OF MDM2 THAT EMPLOYS A DUAL-SITE DOCKING MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN NUMB; ONCOPROTEIN MDM2; P53 STABILITY; ACIDIC DOMAIN; PTB DOMAIN; IN-VIVO; RECOGNITION; ACTIVATION; REGULATOR; PATHWAY	The E3 ubiquitin ligase, MDM2, uses a dual-site mechanism to ubiquitinate and degrade the tumor suppressor protein p53, involving interactions with the N-terminal hydrophobic pocket and the acidic domain of MDM2. The results presented here demonstrate that MDM2 also uses this same dual-site mechanism to bind to the cell fate determinant NUMB with both the N-terminal hydrophobic pocket and the acidic domain of MDM2 also involved in forming the interaction with NUMB. Furthermore, the acidic domain interactions are crucial for MDM2-mediated ubiquitination of NUMB. Contrary to p53, where two separate domains form the interface with MDM2, only one region within the phosphotyrosine binding domain of NUMB (amino acids 113-148) mediates binding to both these regions of MDM2. By binding to both domains on MDM2, NUMB disrupts the MDM2-p53 complex and MDM2-catalyzed ubiquitination of p53. Therefore, we have identified the mechanism NUMB uses to regulate the steady-state levels of the p53 in cells. By targeting the acidic domain of MDM2 using acid domain-binding ligands we can overcome MDM2-mediated ubiquitination and degradation of NUMB impacting on the stabilization of p53 in cells. Furthermore, delivery of MDM2 acid domain-binding ligands to cancer cells promotes p53-dependent growth arrest and the induction of apoptosis. This highlights the dual-site mechanism of MDM2 on another physiological substrate and identifies the acid domain as well as N terminus as a potential target for small molecules that inhibit MDM2.	[Sczaniecka, Matylda; Gladstone, Karen; Pettersson, Susanne; McLaren, Lorna; Wallace, Maura] Univ Edinburgh, Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland; [Sczaniecka, Matylda; Gladstone, Karen; Pettersson, Susanne; McLaren, Lorna; Wallace, Maura] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush EH25 9RG, Midlothian, Scotland; [Huart, Anne-Sophie] Univ Edinburgh, Div Canc Biol, Inst Genet & Mol Med, CRUK Signal Transduct Grp P53, Edinburgh EH4 2XR, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Edinburgh	Wallace, M (corresponding author), Univ Edinburgh, Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland.	maura.wallace@roslin.ed.ac.uk		Huart, Anne-Sophie/0000-0003-0913-1501	Cancer Research UK; Breast Cancer Campaign	Cancer Research UK(Cancer Research UK); Breast Cancer Campaign	This work was also supported by Cancer Research UK and the Breast Cancer Campaign.	Arumugam M, 2009, CELL CYCLE, V8, P2828; Bond GL, 2005, CURR CANCER DRUG TAR, V5, P3, DOI 10.2174/1568009053332627; Bothner B, 2001, J MOL BIOL, V314, P263, DOI 10.1006/jmbi.2001.5110; Brown C. J., TRENDS PHARM SCI, V32, P53; Carter S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-221; Cheok CF, 2007, MOL CANCER RES, V5, P1133, DOI 10.1158/1541-7786.MCR-07-0161; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Dho SE, 1998, J BIOL CHEM, V273, P9179, DOI 10.1074/jbc.273.15.9179; Gulino A, 2010, EXP CELL RES, V316, P900, DOI 10.1016/j.yexcr.2009.11.017; Harada Hiroshi, 2006, Breast Cancer, V13, P16, DOI 10.2325/jbcs.13.16; Harbour JW, 2002, ARCH OPHTHALMOL-CHIC, V120, P1341, DOI 10.1001/archopht.120.10.1341; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Huart AS, 2009, J BIOL CHEM, V284, P32384, DOI 10.1074/jbc.M109.052647; Juven-Gershon T, 1998, MOL CELL BIOL, V18, P3974, DOI 10.1128/MCB.18.7.3974; Kabouridis PS, 2003, TRENDS BIOTECHNOL, V21, P498, DOI 10.1016/j.tibtech.2003.09.008; Kawai H, 2003, MOL CELL BIOL, V23, P4939, DOI 10.1128/MCB.23.14.4939-4947.2003; Kontopidis G, 2005, P NATL ACAD SCI USA, V102, P1871, DOI 10.1073/pnas.0406540102; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Li SC, 1998, NAT STRUCT BIOL, V5, P1075, DOI 10.1038/4185; Liu WL, 2001, J MOL BIOL, V313, P711, DOI 10.1006/jmbi.2001.5082; Meek DW, 2010, SEMIN CANCER BIOL, V20, P19, DOI 10.1016/j.semcancer.2009.10.005; Meulmeester E, 2003, MOL CELL BIOL, V23, P4929, DOI 10.1128/MCB.23.14.4929-4938.2003; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Pamment J, 2002, ONCOGENE, V21, P7776, DOI 10.1038/sj.onc.1205981; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Pece S, 2011, BBA-REV CANCER, V1815, P26, DOI 10.1016/j.bbcan.2010.10.001; Pettersson S, 2009, BIOCHEM J, V418, P575, DOI 10.1042/BJ20082087; Sdek P, 2004, J BIOL CHEM, V279, P53317, DOI 10.1074/jbc.M406062200; Shimizu H, 2002, J BIOL CHEM, V277, P28446, DOI 10.1074/jbc.M202296200; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Verdi J, 1996, CURR BIOL, V6, P1134, DOI 10.1016/S0960-9822(02)70680-5; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; Wawrzynow B, 2007, J BIOL CHEM, V282, P32603, DOI 10.1074/jbc.M702767200; Yin YL, 2002, NAT CELL BIOL, V4, P462, DOI 10.1038/ncb801; Yogosawa S, 2003, BIOCHEM BIOPH RES CO, V302, P869, DOI 10.1016/S0006-291X(03)00282-1; Zhang Z, 2004, J BIOL CHEM, V279, P16000, DOI 10.1074/jbc.M312264200; Zhang Z, 2005, ANN NY ACAD SCI, V1058, P205, DOI 10.1196/annals.1359.030; Zwahlen C, 2000, EMBO J, V19, P1505, DOI 10.1093/emboj/19.7.1505	42	38	39	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14052	14068		10.1074/jbc.M111.303875	http://dx.doi.org/10.1074/jbc.M111.303875			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22337874	Green Published, hybrid			2022-12-25	WOS:000303996300059
J	Lee, SK; Potempa, M; Kolli, M; Ozen, A; Schiffer, CA; Swanstrom, R				Lee, Sook-Kyung; Potempa, Marc; Kolli, Madhavi; Ozen, Aysegul; Schiffer, Celia A.; Swanstrom, Ronald			Context Surrounding Processing Sites Is Crucial in Determining Cleavage Rate of a Subset of Processing Sites in HIV-1 Gag and Gag-Pro-Pol Polyprotein Precursors by Viral Protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; P1 AMINO-ACID; TYPE-1 PROTEASE; IN-VITRO; P2 DOMAIN; SYNTHETIC PEPTIDES; HELICAL STRUCTURE; SPACER PEPTIDE; RNA; INHIBITORS	Processing of the human immunodeficiency virus type 1 (HIV-1) Gag and Gag-Pro-Pol polyproteins by the HIV-1 protease (PR) is essential for the production of infectious particles. However, the determinants governing the rates of processing of these substrates are not clearly understood. We studied the effect of substrate context on processing by utilizing a novel protease assay in which a substrate containing HIV-1 matrix (MA) and the N-terminal domain of capsid (CA) is labeled with a FlAsH (fluorescein arsenical hairpin) reagent. When the seven cleavage sites within the Gag and Gag-Pro-Pol polyproteins were placed at the MA/CA site, the rates of cleavage changed dramatically compared with that of the cognate sites in the natural context reported previously. The rate of processing was affected the most for three sites: CA/spacer peptide 1 (SP1) (approximate to 10-fold increase), SP1/nucleocapsid (NC) (approximate to 10-30-fold decrease), and SP2/p6 (approximate to 30-fold decrease). One of two multi-drug- resistant (MDR) PR variants altered the pattern of processing rates significantly. Cleavage sites within the Pro-Pol region were cleaved in a context-independent manner, suggesting for these sites that the sequence itself was the determinant of rate. In addition, a chimera consisting of SP1/NC P4-P1 and MA/CA P1'-P4' residues (ATIM down arrow PIVQ) abolished processing by wild type and MDR proteases, and the reciprocal chimera consisting of MA/CA P4-P1 and SP1/NC P1'-4' (SQNY down arrow IQKG) was cleaved only by one of the MDR proteases. These results suggest that complex substrate interactions both beyond the active site of the enzyme and across the scissile bond contribute to defining the rate of processing by the HIV-1 PR.	[Lee, Sook-Kyung; Swanstrom, Ronald] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Lee, Sook-Kyung; Swanstrom, Ronald] Univ N Carolina, Ctr AIDS Res, Chapel Hill, NC 27599 USA; [Potempa, Marc; Swanstrom, Ronald] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Kolli, Madhavi; Ozen, Aysegul; Schiffer, Celia A.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Massachusetts System; University of Massachusetts Worcester	Swanstrom, R (corresponding author), Univ N Carolina, Dept Biochem & Biophys, CB7295 Lineberger Bldg,Rm 22-006, Chapel Hill, NC 27599 USA.	risunc@med.unc.edu		Ozen, Aysegul/0000-0002-6240-1948	National Institutes of Health [P01-GM066524]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064347, P01GM066524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01-GM066524.	Accola MA, 1998, J VIROL, V72, P2072, DOI 10.1128/JVI.72.3.2072-2078.1998; ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; BILLICH S, 1988, J BIOL CHEM, V263, P17905; Blommel PG, 2005, ANAL BIOCHEM, V336, P75, DOI 10.1016/j.ab.2004.09.023; Campbell EM, 2008, J CELL BIOL, V180, P549, DOI 10.1083/jcb.200706154; CRAVEN RC, 1993, J VIROL, V67, P6246, DOI 10.1128/JVI.67.10.6246-6252.1993; DARKE PL, 1988, BIOCHEM BIOPH RES CO, V156, P297, DOI 10.1016/S0006-291X(88)80839-8; Dauber DS, 2002, J VIROL, V76, P1359, DOI 10.1128/JVI.76.3.1359-1368.2002; ERICKSONVIITANEN S, 1989, AIDS RES HUM RETROV, V5, P577, DOI 10.1089/aid.1989.5.577; Ermolieff J, 1997, BIOCHEMISTRY-US, V36, P12364, DOI 10.1021/bi971072e; Griffin BA, 2000, METHOD ENZYMOL, V327, P565; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Hill MK, 2002, J VIROL, V76, P11245, DOI 10.1128/JVI.76.22.11245-11253.2002; Huang LQ, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-79; HYLAND LJ, 1991, BIOCHEMISTRY-US, V30, P8454, DOI 10.1021/bi00098a024; Jolley M. E., 1996, J BIOMOL SCREEN, V1, P33; Kaye JF, 1998, J VIROL, V72, P5877, DOI 10.1128/JVI.72.7.5877-5885.1998; King NM, 2002, PROTEIN SCI, V11, P418, DOI 10.1110/ps.25502; KRAUSSLICH HG, 1989, P NATL ACAD SCI USA, V86, P807, DOI 10.1073/pnas.86.3.807; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee SK, 2001, VIROLOGY, V286, P317, DOI 10.1006/viro.2001.0979; Liu ZG, 2011, PROTEIN J, V30, P173, DOI 10.1007/s10930-011-9316-2; MILLER M, 1989, NATURE, V337, P576, DOI 10.1038/337576a0; Morellet N, 2005, PROTEIN SCI, V14, P375, DOI 10.1110/ps.041087605; NAVIA MA, 1989, NATURE, V337, P615, DOI 10.1038/337615a0; Newman JL, 2004, PROTEIN SCI, V13, P2101, DOI 10.1110/ps.04614804; Ozen A, 2011, J MOL BIOL, V410, P726, DOI 10.1016/j.jmb.2011.03.053; PEARL LH, 1987, NATURE, V329, P351, DOI 10.1038/329351a0; Pettit SC, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-66; PETTIT SC, 1991, J BIOL CHEM, V266, P14539; PETTIT SC, 1994, J VIROL, V68, P8017, DOI 10.1128/JVI.68.12.8017-8027.1994; Pettit SC, 2002, J VIROL, V76, P10226, DOI 10.1128/JVI.76.20.10226-10233.2002; Prabu-Jeyabalan M, 2002, STRUCTURE, V10, P369, DOI 10.1016/S0969-2126(02)00720-7; RICHARDS AD, 1989, FEBS LETT, V247, P113, DOI 10.1016/0014-5793(89)81251-7; Roldan A, 2004, J BIOL CHEM, V279, P39886, DOI 10.1074/jbc.M405632200; Schock HB, 1996, J BIOL CHEM, V271, P31957, DOI 10.1074/jbc.271.50.31957; Sheng NJ, 1997, J VIROL, V71, P5723, DOI 10.1128/JVI.71.8.5723-5732.1997; SHENG NJ, 1994, J VIROL, V68, P6207, DOI 10.1128/JVI.68.10.6207-6214.1994; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Swanstrom R., 1997, P263; TOMASSELLI AG, 1990, BIOCHEMISTRY-US, V29, P264, DOI 10.1021/bi00453a036; TOMASZEK TA, 1992, BIOCHEMISTRY-US, V31, P10153, DOI 10.1021/bi00157a003; TOZSER J, 1991, FEBS LETT, V281, P77, DOI 10.1016/0014-5793(91)80362-7; TRITCH RJ, 1991, J VIROL, V65, P922, DOI 10.1128/JVI.65.2.922-930.1991; Wiegers K, 1998, J VIROL, V72, P2846, DOI 10.1128/JVI.72.4.2846-2854.1998	46	33	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13279	13290		10.1074/jbc.M112.339374	http://dx.doi.org/10.1074/jbc.M112.339374			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22334652	hybrid, Green Published			2022-12-25	WOS:000302903700064
J	Lagarde, WH; Blackwelder, AJ; Minges, JT; Hnat, AT; French, FS; Wilson, EM				Lagarde, William H.; Blackwelder, Amanda J.; Minges, John T.; Hnat, Andrew T.; French, Frank S.; Wilson, Elizabeth M.			Androgen Receptor Exon 1 Mutation Causes Androgen Insensitivity by Creating Phosphorylation Site and Inhibiting Melanoma Antigen-A11 Activation of NH2- and Carboxyl-terminal Interaction-dependent Transactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING-DOMAIN; PROTEIN-PROTEIN INTERACTIONS; PROSTATE-CANCER; TRANSCRIPTIONAL ACTIVITY; GENE; IDENTIFICATION; INTERDOMAIN; MAGE-11; GROWTH; DEFICIENCY	Naturally occurring germ line mutations in the X-linked human androgen receptor (AR) gene cause incomplete masculinization of the external genitalia by disrupting AR function in males with androgen insensitivity syndrome. Almost all AR missense mutations that cause androgen insensitivity syndrome are located in the highly structured DNA and ligand binding domains. In this report we investigate the functional defect associated with an AR exon 1 missense mutation, R405S, that caused partial androgen insensitivity. The 46,XX heterozygous maternal carrier had a wild-type Arg-405 CGC allele but transmitted an AGC mutant allele coding for Ser-405. At birth, the 46,XY proband had a bifid scrotum, hypospadias, and micropenis consistent with clinical stage 3 partial androgen insensitivity. Androgen-dependent transcriptional activity of AR-R405S expressed in CV1 cells was less than wild-type AR and refractory in androgen-dependent AR NH2- and carboxyl interaction transcription assays that depend on the coregulator effects of melanoma antigen-A11. This mutation created a Ser-405 phosphorylation site evident by the gel migration of an AR-R405S NH2-terminal fragment as a double band that converted to the wild-type single band after treatment with lambda-phosphatase. Detrimental effects of the R405S mutation were related to the proximity of the AR WXXLF motif (WHTLF437)-W-433 required for melanoma antigen-A11 and p300 to stimulate transcriptional activity associated with the AR NH2- and carboxyl-terminal interaction. We conclude that the coregulator effects of melanoma antigen-A11 on the AR NH2- and carboxyl-terminal interaction amplify the androgen-dependent transcriptional response to p300 required for normal human male sex development in utero.	[Blackwelder, Amanda J.; Minges, John T.; Hnat, Andrew T.; French, Frank S.; Wilson, Elizabeth M.] Univ N Carolina, Labs Reprod Biol, Chapel Hill, NC 27599 USA; [Lagarde, William H.; Blackwelder, Amanda J.; Minges, John T.; Hnat, Andrew T.; French, Frank S.; Wilson, Elizabeth M.] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA; [French, Frank S.; Wilson, Elizabeth M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Wilson, Elizabeth M.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Lagarde, William H.] WakeMed Hlth & Hosp, Childrens Diabet & Endocrinol, Raleigh, NC 27610 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Wilson, EM (corresponding author), Univ N Carolina, Labs Reprod Biol, CB7500, Chapel Hill, NC 27599 USA.	emw@med.unc.edu			National Institutes of Health [HD16910]; United States Public Health Service from NICHD, National Institutes of Health; Eunice Kennedy Shriver NICHD, National Institutes of Health as part of the Specialized Cooperative Centers [U54-HD35041]; National Cancer Institute Center [P01-CA77739]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD035041, R01HD016910, R37HD016910] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA077739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service from NICHD, National Institutes of Health; Eunice Kennedy Shriver NICHD, National Institutes of Health as part of the Specialized Cooperative Centers; National Cancer Institute Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or part, by National Institutes of Health Grant HD16910, by a United States Public Health Service grant from NICHD, National Institutes of Health, and by Cooperative Agreement U54-HD35041 from the Eunice Kennedy Shriver NICHD, National Institutes of Health as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research. This work was also supported by National Cancer Institute Center Grant P01-CA77739.	Argetsinger LS, 2004, MOL CELL BIOL, V24, P4955, DOI 10.1128/MCB.24.11.4955-4967.2004; Askew EB, 2007, J BIOL CHEM, V282, P25801, DOI 10.1074/jbc.M703268200; Askew EB, 2010, J BIOL CHEM, V285, P21824, DOI 10.1074/jbc.M110.120600; Askew EB, 2009, J BIOL CHEM, V284, P34793, DOI 10.1074/jbc.M109.065979; Bai S, 2008, MOL CELL BIOL, V28, P1947, DOI 10.1128/MCB.01672-07; Bai SX, 2005, MOL CELL BIOL, V25, P1238, DOI 10.1128/MCB.25.4.1238-1257.2005; Bhangoo A, 2010, ASIAN J ANDROL, V12, P561, DOI 10.1038/aja.2010.6; BROWN CJ, 1989, AM J HUM GENET, V44, P264; Centenera MM, 2008, MOL ENDOCRINOL, V22, P2373, DOI 10.1210/me.2008-0017; Chen SY, 2006, P NATL ACAD SCI USA, V103, P15969, DOI 10.1073/pnas.0604193103; Cheon CK, 2011, EUR J PEDIATR, V170, P1, DOI 10.1007/s00431-010-1189-4; Choong CS, 1996, J CLIN INVEST, V98, P1423, DOI 10.1172/JCI118930; Chymkowitch P, 2011, EMBO J, V30, P468, DOI 10.1038/emboj.2010.337; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; DANG CV, 1991, MOL CELL BIOL, V11, P954, DOI 10.1128/MCB.11.2.954; Deeb A, 2008, J CLIN ENDOCR METAB, V93, P3691, DOI 10.1210/jc.2008-0737; Dehm SM, 2007, CANCER RES, V67, P10067, DOI 10.1158/0008-5472.CAN-07-1267; FINKEL T, 1993, J BIOL CHEM, V268, P5; Ghali SA, 2003, J CLIN ENDOCR METAB, V88, P2185, DOI 10.1210/jc.2002-021324; Gioeli D, 2002, J BIOL CHEM, V277, P29304, DOI 10.1074/jbc.M204131200; Gioeli D, 2012, MOL CELL ENDOCRINOL, V352, P70, DOI 10.1016/j.mce.2011.07.004; Goglia U, 2011, FERTIL STERIL, V96, P1165, DOI 10.1016/j.fertnstert.2011.08.033; Gordon V, 2010, MOL ENDOCRINOL, V24, P2267, DOI 10.1210/me.2010-0238; Gottlieb B., 2011, GENEREVIEWS; He B, 2002, J BIOL CHEM, V277, P25631, DOI 10.1074/jbc.M202809200; He B, 2002, MOL GENET METAB, V75, P293, DOI 10.1016/S1096-7192(02)00009-4; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; He B, 2004, MOL CELL, V16, P425, DOI 10.1016/j.molcel.2004.09.036; He B, 2002, J BIOL CHEM, V277, P10226, DOI 10.1074/jbc.M111975200; He B, 1999, J BIOL CHEM, V274, P37219, DOI 10.1074/jbc.274.52.37219; He B, 2001, J BIOL CHEM, V276, P42293, DOI 10.1074/jbc.M107492200; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Hiort O, 2000, J CLIN ENDOCR METAB, V85, P2810, DOI 10.1210/jc.85.8.2810; Hsu FN, 2011, J BIOL CHEM, V286, P33141, DOI 10.1074/jbc.M111.252080; Huang WB, 1999, J BIOL CHEM, V274, P25756, DOI 10.1074/jbc.274.36.25756; IMPERATO.J, 1974, SCIENCE, V186, P1213, DOI 10.1126/science.186.4170.1213; Jaaskelainen J, 2006, J MOL ENDOCRINOL, V36, P361, DOI 10.1677/jme.1.01885; Jain A, 2002, MOL ENDOCRINOL, V16, P2323, DOI 10.1210/me.2002-0004; JENSTER G, 1995, J BIOL CHEM, V270, P7341, DOI 10.1074/jbc.270.13.7341; Karpf AR, 2009, MOL CANCER RES, V7, P523, DOI 10.1158/1541-7786.MCR-08-0400; Kemppainen JA, 1999, MOL ENDOCRINOL, V13, P440, DOI 10.1210/me.13.3.440; Langley E, 1998, J BIOL CHEM, V273, P92, DOI 10.1074/jbc.273.1.92; LANGLEY E, 1995, J BIOL CHEM, V270, P29983; Liu Q, 2011, J BIOL CHEM, V286, P29951, DOI 10.1074/jbc.M111.244715; Lu S, 1999, MOL ENDOCRINOL, V13, P376, DOI 10.1210/me.13.3.376; LUBAHN DB, 1988, MOL ENDOCRINOL, V2, P1265, DOI 10.1210/mend-2-12-1265; MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211; Mancini D, 1997, AM J HUM GENET, V61, P80, DOI 10.1086/513898; McEwan IJ, 2012, MOL CELL ENDOCRINOL, V348, P345, DOI 10.1016/j.mce.2011.08.035; Ponguta LA, 2008, J BIOL CHEM, V283, P20989, DOI 10.1074/jbc.M802392200; Prince FP, 2001, J ENDOCRINOL, V168, P213, DOI 10.1677/joe.0.1680213; QUARMBY VE, 1990, MOL ENDOCRINOL, V4, P1399, DOI 10.1210/mend-4-9-1399; Quigley CA, 2004, MECH AGEING DEV, V125, P683, DOI 10.1016/j.mad.2004.08.007; QUIGLEY CA, 1995, ENDOCR REV, V16, P271, DOI 10.1210/er.16.3.271; Reid J, 2002, J BIOL CHEM, V277, P20079, DOI 10.1074/jbc.M201003200; REYES FI, 1974, J CLIN ENDOCR METAB, V38, P612, DOI 10.1210/jcem-38-4-612; Robins DM, 2012, MOL CELL ENDOCRINOL, V352, P26, DOI 10.1016/j.mce.2011.06.003; Sarkar P, 2007, CLIN ENDOCRINOL, V67, P743, DOI 10.1111/j.1365-2265.2007.02955.x; Schmidt A, 2010, J BIOL CHEM, V285, P17054, DOI 10.1074/jbc.M109.099002; Shu SK, 2010, J BIOL CHEM, V285, P33045, DOI 10.1074/jbc.M110.121129; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; Steinkamp MP, 2009, CANCER RES, V69, P4434, DOI 10.1158/0008-5472.CAN-08-3605; Thompson J, 2001, MOL ENDOCRINOL, V15, P923, DOI 10.1210/me.15.6.923; Wagner BL, 1998, MOL CELL BIOL, V18, P1369, DOI 10.1128/MCB.18.3.1369; Ward RD, 2009, BIOFACTORS, V35, P528, DOI 10.1002/biof.66; Wilson EM, 2011, METHODS MOL BIOL, V776, P113, DOI 10.1007/978-1-61779-243-4_8; Wilson EM, 2009, ANDROGEN ACTION IN PROSTATE CANCER, P241, DOI 10.1007/978-0-387-69179-4_11; WILSON EM, 1976, J BIOL CHEM, V251, P5620; WILSON JD, 1993, ENDOCR REV, V14, P577, DOI 10.1210/er.14.5.577; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P605, DOI 10.1210/me.9.5.605; Zong HL, 2007, MOL CELL BIOL, V27, P7125, DOI 10.1128/MCB.01753-06	71	18	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10905	10915		10.1074/jbc.M111.336081	http://dx.doi.org/10.1074/jbc.M111.336081			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334658	Green Published, hybrid			2022-12-25	WOS:000302780100019
J	Wang, C; Liu, ZH; Huang, X				Wang, Chao; Liu, Zhonghua; Huang, Xun			Rab32 Is Important for Autophagy and Lipid Storage in Drosophila	PLOS ONE			English	Article							FAT STORAGE; DROPLETS; PROTEINS; REVEALS; ADIPOGENESIS; HOMEOSTASIS; METABOLISM; REGULATOR; PERILIPIN; DELIVERY	Lipids are essential components of all organisms. Within cells, lipids are mainly stored in a specific type of organelle, called the lipid droplet. The molecular mechanisms governing the dynamics of lipid droplets have been little explored. The protein composition of lipid droplets has been analyzed in numerous proteomic studies, and a large number of lipid droplet-associated proteins have been identified, including Rab small GTPases. Rab proteins are known to participate in many intracellular membranous events; however, their exact role in lipid droplets is largely unexplored. Here we systematically investigate the roles of Drosophila Rab family proteins in lipid storage in the larval adipose tissue, fat body. Rab32 and several other Rabs were found to affect the size of lipid droplets as well as lipid levels. Further studies showed that Rab32 and Rab32 GEF/Claret may be involved in autophagy, consequently affecting lipid storage. Loss-of-function mutants of several components in the autophagy pathway result in similar effects on lipid storage. These results highlight the potential functions of Rabs in regulating lipid metabolism.	[Wang, Chao; Liu, Zhonghua; Huang, Xun] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing, Peoples R China; [Wang, Chao] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, C (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing, Peoples R China.	xhuang@genetics.ac.cn		Huang, Xun/0000-0002-2653-8293	Ministry of Science and Technology of China (MOST) [2009CB919000]; National Natural Science Foundation of China (NSFC) [30830069, 31071253]; Chinese Academy of Sciences	Ministry of Science and Technology of China (MOST)(Ministry of Science and Technology, China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	Research reported here was supported by grants 2009CB919000 from the Ministry of Science and Technology of China (MOST) and 30830069 and 31071253 from the National Natural Science Foundation of China (NSFC). X.H. is funded by the One Hundred Talents program of Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Baerga R, 2009, AUTOPHAGY, V5, P1118, DOI 10.4161/auto.5.8.9991; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Beller M, 2006, MOL CELL PROTEOMICS, V5, P1082, DOI 10.1074/mcp.M600011-MCP200; Beller M, 2010, CELL METAB, V12, P521, DOI 10.1016/j.cmet.2010.10.001; Beller M, 2008, PLOS BIOL, V6, P2530, DOI 10.1371/journal.pbio.0060292; Berry DL, 2007, CELL, V131, P1137, DOI 10.1016/j.cell.2007.10.048; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Gronke S, 2003, CURR BIOL, V13, P603, DOI 10.1016/S0960-9822(03)00175-1; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Hirota Y, 2009, CELL MOL LIFE SCI, V66, P2913, DOI 10.1007/s00018-009-0080-9; Horton JD, 2002, COLD SPRING HARB SYM, V67, P491, DOI 10.1101/sqb.2002.67.491; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Kohler K, 2009, AUTOPHAGY, V5, P980; Kuhnlein RP, 2010, BBA-MOL CELL BIOL L, V1801, P215, DOI 10.1016/j.bbalip.2009.09.006; Kunte AS, 2006, CELL METAB, V3, P439, DOI 10.1016/j.cmet.2006.04.011; LISCOVITCH M, 1994, CELL, V77, P329, DOI 10.1016/0092-8674(94)90148-1; Liu PS, 2007, BBA-MOL CELL RES, V1773, P784, DOI 10.1016/j.bbamcr.2007.02.004; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Lloyd V, 1998, TRENDS CELL BIOL, V8, P257, DOI 10.1016/S0962-8924(98)01270-7; Ma JP, 2004, P NATL ACAD SCI USA, V101, P11652, DOI 10.1073/pnas.0401926101; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Martin S, 2005, J BIOL CHEM, V280, P42325, DOI 10.1074/jbc.M506651200; Palanker L, 2009, CELL METAB, V9, P228, DOI 10.1016/j.cmet.2009.01.009; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Schlegel A, 2007, PLOS GENET, V3, P2037, DOI 10.1371/journal.pgen.0030199; Shi YG, 2004, NAT REV DRUG DISCOV, V3, P695, DOI 10.1038/nrd1469; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Soni KG, 2009, J CELL SCI, V122, P1834, DOI 10.1242/jcs.045849; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Szendroedi J, 2009, CURR OPIN LIPIDOL, V20, P50, DOI 10.1097/MOL.0b013e328321b3a8; Tian Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001364; Wasmeier C, 2006, J CELL BIOL, V175, P271, DOI 10.1083/jcb.200606050; Zehmer JK, 2009, PROTEOMICS, V9, P914, DOI 10.1002/pmic.200800584; Zhang J, 2007, GENETICS, V176, P1307, DOI 10.1534/genetics.106.066761; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106	44	74	78	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e32086	10.1371/journal.pone.0032086	http://dx.doi.org/10.1371/journal.pone.0032086			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348149	gold, Green Published, Green Submitted			2022-12-25	WOS:000302737400063
J	Naranjo-Suarez, S; Carlson, BA; Tsuji, PA; Yoo, MH; Gladyshev, VN; Hatfield, DL				Naranjo-Suarez, Salvador; Carlson, Bradley A.; Tsuji, Petra A.; Yoo, Min-Hyuk; Gladyshev, Vadim N.; Hatfield, Dolph L.			HIF-Independent Regulation of Thioredoxin Reductase 1 Contributes to the High Levels of Reactive Oxygen Species Induced by Hypoxia	PLOS ONE			English	Article							MITOCHONDRIAL RESPIRATORY-CHAIN; INDUCIBLE FACTOR; GENE-EXPRESSION; COMPLEX-III; ACTIVATION; TRANSCRIPTION; ANGIOGENESIS; ALPHA; ROS; FACTOR-1-ALPHA	Cellular adaptation to hypoxic conditions mainly involves transcriptional changes in which hypoxia inducible factors (HIFs) play a critical role. Under hypoxic conditions, HIF protein is stabilized due to inhibition of the activity of prolyl hydroxylases (EGLNs). Because the reaction carried out by these enzymes uses oxygen as a co-substrate it is generally accepted that the hypoxic inhibition of EGLNs is due to the reduction in oxygen levels. However, several studies have reported that hypoxic generation of mitochondrial reactive oxygen species (ROS) is required for HIF stabilization. Here, we show that hypoxia downregulates thioredoxin reductase 1 (TR1) mRNA and protein levels. This hypoxic TR1 regulation is HIF independent, as HIF stabilization by EGLNs inhibitors does not affect TR1 expression and HIF deficiency does not block TR1 hypoxic-regulation, and it has an effect on TR1 function, as hypoxic conditions also reduce TR1 activity. We found that, when cultured under hypoxic conditions, TR1 deficient cells showed a larger accumulation of ROS compared to control cells, whereas TR1 over-expression was able to block the hypoxic generation of ROS. Furthermore, the changes in ROS levels observed in TR1 deficient or TR1 over-expressing cells did not affect HIF stabilization or function. These results indicate that hypoxic TR1 down-regulation is important in maintaining high levels of ROS under hypoxic conditions and that HIF stabilization and activity do not require hypoxic generation of ROS.	[Naranjo-Suarez, Salvador; Carlson, Bradley A.; Tsuji, Petra A.; Yoo, Min-Hyuk; Hatfield, Dolph L.] Natl Canc Inst, Lab Canc Prevent, Mol Biol Selenium Sect, Bethesda, MD 20892 USA; [Tsuji, Petra A.] Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Pathol, Baltimore, MD 21205 USA; [Tsuji, Petra A.] Towson Univ, Dept Biol Sci, Towson, MD USA; [Gladyshev, Vadim N.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Gladyshev, Vadim N.] Harvard Univ, Sch Med, Boston, MA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; Johns Hopkins Medicine; University System of Maryland; Towson University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Naranjo-Suarez, S (corresponding author), Natl Canc Inst, Lab Canc Prevent, Mol Biol Selenium Sect, Bethesda, MD 20892 USA.	hatfield@mail.nih.gov	Gladyshev, Vadim N/J-6187-2013; Suarez, Salvador Naranjo/K-8450-2017; Gladyshev, Vadim N/A-9894-2013	Suarez, Salvador Naranjo/0000-0002-7038-0753; Gladyshev, Vadim/0000-0002-0372-7016	Center for Cancer Research, National Cancer Institute, National Institutes of Health; NIH; NATIONAL CANCER INSTITUTE [ZIABC010889, ZIABC005317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM065204, R01GM061603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021518] Funding Source: NIH RePORTER	Center for Cancer Research, National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Intramural Research Program at the Center for Cancer Research, National Cancer Institute, National Institutes of Health (to DLH) and NIH grants (to VNG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banning A, 2005, MOL CELL BIOL, V25, P4914, DOI 10.1128/MCB.25.12.4914-4923.2005; Biaglow JE, 2005, CANCER BIOL THER, V4, P6; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chen B, 2009, SCIENCE, V323, P256, DOI 10.1126/science.1166226; Chua YL, 2010, J BIOL CHEM, V285, P31277, DOI 10.1074/jbc.M110.158485; Cormier-Regard S, 1998, J BIOL CHEM, V273, P17787, DOI 10.1074/jbc.273.28.17787; Du JA, 2006, J BIOL CHEM, V281, P37416, DOI 10.1074/jbc.M605063200; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; FU T, 1992, BIOCHEM J, V283, P347, DOI 10.1042/bj2830347; Garayoa M, 2000, MOL ENDOCRINOL, V14, P848, DOI 10.1210/me.14.6.848; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Hammond EM, 2002, MOL CELL BIOL, V22, P1834, DOI 10.1128/MCB.22.6.1834-1843.2002; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Hoffman DL, 2007, AM J PHYSIOL-HEART C, V292, pH101, DOI 10.1152/ajpheart.00699.2006; Irons R, 2010, CANCER PREV RES, V3, P630, DOI 10.1158/1940-6207.CAPR-10-0003; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Liu Q, 2004, P NATL ACAD SCI USA, V101, P4302, DOI 10.1073/pnas.0400265101; Lopez-Barneo J, 2001, ANNU REV PHYSIOL, V63, P259, DOI 10.1146/annurev.physiol.63.1.259; Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; Miller TW, 2009, CHEM REV, V109, P3099, DOI 10.1021/cr8005125; Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370; Poli G, 2004, CURR MED CHEM, V11, P1163, DOI 10.2174/0929867043365323; Powis G, 2001, ANNU REV PHARMACOL, V41, P261, DOI 10.1146/annurev.pharmtox.41.1.261; Rigoulet M, 2011, ANTIOXID REDOX SIGN, V14, P459, DOI 10.1089/ars.2010.3363; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; SETA KA, 2002, SCI STKE, V146, pRE11, DOI DOI 10.1126/STKE.2002.146.RE11; Srinivas V, 2001, J BIOL CHEM, V276, P21995, DOI 10.1074/jbc.C100177200; Ushio-Fukai M, 2006, CARDIOVASC RES, V71, P226, DOI 10.1016/j.cardiores.2006.04.015; Vaux EC, 2001, BLOOD, V98, P296, DOI 10.1182/blood.V98.2.296; Warnecke C, 2003, FASEB J, V17, P1186, DOI 10.1096/fj.02-1062fje; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Yoo MH, 2006, J BIOL CHEM, V281, P13005, DOI 10.1074/jbc.C600012200; Yoo MH, 2007, RNA, V13, P921, DOI 10.1261/rna.533007; Yoo MH, 2010, ANTIOXID REDOX SIGN, V12, P819, DOI 10.1089/ars.2009.2891; ZULUETA JJ, 1995, AM J RESP CELL MOL, V12, P41, DOI 10.1165/ajrcmb.12.1.7529030	40	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e30470	10.1371/journal.pone.0030470	http://dx.doi.org/10.1371/journal.pone.0030470			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348009	Green Published, Green Submitted, gold			2022-12-25	WOS:000302733900009
J	Wijesuriya, M; Gulliford, M; Charlton, J; Vasantharaja, L; Viberti, G; Gnudi, L; Karalliedde, J				Wijesuriya, Mahen; Gulliford, Martin; Charlton, Judith; Vasantharaja, Laksha; Viberti, Giancarlo; Gnudi, Luigi; Karalliedde, Janaka			High Prevalence of Cardio-Metabolic Risk Factors in a Young Urban Sri-Lankan Population	PLOS ONE			English	Article							INSULIN-RESISTANCE; DIABETES-MELLITUS; CHILDHOOD OBESITY; CHRONIC DISEASES; OVERWEIGHT; ADOLESCENTS; DEFINITION; CHILDREN; HEALTH	Background: South-Asian's are predisposed to early onset type 2 diabetes (T2DM). The prevalence of cardio-metabolic risk-factors in young Sri-Lankans is unknown. Methodology/Principal Findings: To determine by questionnaire and anthropometry the prevalence of first degree family history (FH) of T2DM, physical inactivity, raised waist circumference (WC) and raised body mass index (BMI) in a representative healthy urban population selected by cluster sampling. Those with >= 2 risk-factors were evaluated for metabolic syndrome (MS) and recruited for an intervention trial. Of 23,296 participants screened, 22,507 (53% Female) were eligible [8,497 aged 10-14 yrs, 4,763 aged 15-19 yrs and 9,247 aged 20-40 yrs]. 51% had none of the 4 risk-factors, 26% 1 risk-factor and 23% (5,163) >= 2 risk-factors of whom 4,532 were assessed for MS. Raised BMI was noted in 19.7% aged 10-14 yrs, 15.3% between 15-19 yrs, and between 20-40 yrs, 27.4% of males vs. 21.8% of females p<0.001. Prevalence of raised WC was greater in females for each age group: 42.7% vs. 32.1%; 28.1% vs. 16.1%; 34.5% vs. 25.7% (p<0.05 for all) as was physical inactivity: 39.9% vs. 14.5%; 51.7% vs. 20.0%; 62.7% vs. 41.3% which rose in both sexes with age (p<0.05 for all). FH of T2DM was present in 26.2%. In 4532 (50%, 16 yrs) with >= 2 risk-factors, impaired fasting glycaemia/impaired glucose tolerance (pre-diabetes) prevalence was 16%. MS was more prevalent in males [10-16 yrs (13.0% vs. 8.8%), 16-40 yrs (29.5% vs. 20.0%) p<0.001 for both]. Conclusions/Significance: There is a high prevalence of modifiable cardio-metabolic risk-factors in young urban Sri-Lankans with significant gender differences. A primary prevention intervention trial is ongoing in this cohort. Clinical Trial Registration Number SLCTR/2008/World Health Organization (WHO) international clinical trial registry platform.	[Wijesuriya, Mahen; Vasantharaja, Laksha] Natl Diabet Ctr, Diabet Assoc Sri Lanka, Colombo, Sri Lanka; [Viberti, Giancarlo; Gnudi, Luigi; Karalliedde, Janaka] Kings Coll London, Div Cardiovasc, London WC2R 2LS, England; [Gulliford, Martin; Charlton, Judith] Kings Coll London, Div Hlth & Social Care Res, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Wijesuriya, M (corresponding author), Natl Diabet Ctr, Diabet Assoc Sri Lanka, Colombo, Sri Lanka.	j.karalliedde@kcl.ac.uk	Gulliford, Martin C/I-8606-2018	Gulliford, Martin C/0000-0003-1898-9075; Karalliedde, Janaka/0000-0002-2617-8320; gnudi, luigi/0000-0002-6353-630X	BRIDGES from the International Diabetes Federation; Lilly Diabetes; Nelson R Mandela School of Medicine, Durban, South Africa; University of Pittsburgh, Pittsburgh USA	BRIDGES from the International Diabetes Federation; Lilly Diabetes; Nelson R Mandela School of Medicine, Durban, South Africa; University of Pittsburgh, Pittsburgh USA(University of Pittsburgh)	This project is supported by a BRIDGES Grant from the International Diabetes Federation. BRIDGES, an International Diabetes Federation Project, is supported by an educational grant from Lilly Diabetes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the support and advice of Professor Motala (Nelson R Mandela School of Medicine, Durban, South Africa) and Professor Linda Siminerio (University of Pittsburgh, Pittsburgh USA). We acknowledge the contribution of Dr Thilinie Jayasekera, Ms Talya Fernando, Dr Nuwan Ranawaka for their help with this work. We wish to thank Dr Varsha, Dr Mahesh (MV Diabetes Centre, WHO collaborating centre for research education and training in diabetes, Chennai India) and Dr Arambepola (University of Colombo Sri Lanka) for their advice and input as members of the DIABRISK-SL independent study advisory committee. We also wish to thank all the participants of the study.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Anjana RM, 2009, METABOLISM, V58, P344, DOI 10.1016/j.metabol.2008.10.006; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de Ferranti SD, 2004, CIRCULATION, V110, P2494, DOI 10.1161/01.CIR.0000145117.40114.C7; de Onis Mercedes, 2007, Bull World Health Organ, V85, P660; de Silva K. S. H., 2006, CEYLON MEDICAL JOURNAL, V51, P105; Department of Census and Statistics, 2001, CENS REP 2001; Genuth S, 2003, DIABETES CARE, V26, P3160; Horton R, 2007, LANCET, V370, P1881, DOI 10.1016/S0140-6736(07)61701-2; Jafar TH, 2008, ARCH DIS CHILD, V93, P373, DOI 10.1136/adc.2007.125641; Jafar TH, 2006, CAN MED ASSOC J, V175, P1071, DOI 10.1503/cmaj.060464; Katulanda P, 2008, DIABETIC MED, V25, P1062, DOI 10.1111/j.1464-5491.2008.02523.x; Katulanda P, 2010, OBES REV, V11, P751, DOI 10.1111/j.1467-789X.2010.00746.x; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mohan V, 2001, DIABETIC MED, V18, P280, DOI 10.1046/j.1464-5491.2001.00421.x; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Ramachandran A, 2007, DIABETES CARE, V30, P1828, DOI 10.2337/dc06-2097; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Simmons RK, 2010, DIABETOLOGIA, V53, P600, DOI 10.1007/s00125-009-1620-4; STERN MP, 1995, DIABETES, V44, P369, DOI 10.2337/diabetes.44.4.369; Wickramasinghe V. P., 2004, Ceylon Medical Journal, V49, P114; Wijesuriya M, 2009, PREVALENCE CENTRAL O; World Health Organization, 1999, DEF DIAGN CLASS DI 1; Zimmet P, 2007, PEDIATR DIABETES, V8, P299, DOI 10.1111/j.1399-5448.2007.00271.x	26	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31309	10.1371/journal.pone.0031309	http://dx.doi.org/10.1371/journal.pone.0031309			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348068	Green Published, gold, Green Submitted			2022-12-25	WOS:000302733900040
J	Lin, TY; Lo, YH; Tseng, PW; Chang, SF; Lin, YT; Chen, TS				Lin, Tiao-Yin; Lo, Yi-Haw; Tseng, Pin-Wei; Chang, Shun-Fu; Lin, Yann-Tsyr; Chen, Ton-Seng			A T3 and T7 Recombinant Phage Acquires Efficient Adsorption and a Broader Host Range	PLOS ONE			English	Article							DNA-BINDING-PROTEIN; COMPLETE NUCLEOTIDE-SEQUENCE; STRAND-BREAK REPAIR; ESCHERICHIA-COLI; BACTERIOPHAGE T7; DEOXYRIBONUCLEIC-ACID; GENETIC-RECOMBINATION; RNA POLYMERASES; HOMOLOGOUS DNA; INFECTION	It is usually thought that bacteriophage T7 is female specific, while phage T3 can propagate on male and female Escherichia coli. We found that the growth patterns of phages T7M and T3 do not match the above characteristics, instead showing strain dependent male exclusion. Furthermore, a T3/7 hybrid phage exhibits a broader host range relative to that of T3, T7, as well as T7M, and is able to overcome the male exclusion. The T7M sequence closely resembles that of T3. T3/7 is essentially T3 based, but a DNA fragment containing part of the tail fiber gene 17 is replaced by the T7 sequence. T3 displays inferior adsorption to strains tested herein compared to T7. The T3 and T7 recombinant phage carries altered tail fibers and acquires better adsorption efficiency than T3. How phages T3 and T7 recombine was previously unclear. This study is the first to show that recombination can occur accurately within only 8 base-pair homology, where four-way junction structures are identified. Genomic recombination models based on endonuclease I cleavages at equivalent and nonequivalent sites followed by strand annealing are proposed. Retention of pseudo-palindromes can increase recombination frequency for reviving under stress.	[Lin, Tiao-Yin; Lo, Yi-Haw; Tseng, Pin-Wei; Chang, Shun-Fu; Lin, Yann-Tsyr; Chen, Ton-Seng] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan	National Yang Ming Chiao Tung University	Lin, TY (corresponding author), Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan.	tylin@cc.nctu.edu.tw						ARAKI H, 1981, VIROLOGY, V111, P509, DOI 10.1016/0042-6822(81)90353-6; Bartel PL, 1996, NAT GENET, V12, P72, DOI 10.1038/ng0196-72; BEIER H, 1977, J VIROL, V21, P753, DOI 10.1128/JVI.21.2.753-765.1977; BEIER H, 1974, NATURE, V251, P538, DOI 10.1038/251538a0; Berry J, 2008, MOL MICROBIOL, V70, P341, DOI 10.1111/j.1365-2958.2008.06408.x; BIENKOWSKASZEWCZYK K, 1980, BIOCHIM BIOPHYS ACTA, V615, P489, DOI 10.1016/0005-2744(80)90515-X; BRUTLAG D, 1972, J BIOL CHEM, V247, P241; Cai L, 2004, J BIOCHEM, V135, P397, DOI 10.1093/jb/mvh047; Casjens S, 1992, SEMINARS VIROLOGY, V3, P383; CONDREAY JP, 1989, J MOL BIOL, V207, P543, DOI 10.1016/0022-2836(89)90463-4; CONDREAY JP, 1989, J MOL BIOL, V207, P555, DOI 10.1016/0022-2836(89)90464-6; CRAM D, 1984, MOL GEN GENET, V197, P137, DOI 10.1007/BF00327934; DAVIS RW, 1971, J MOL BIOL, V62, P287, DOI 10.1016/0022-2836(71)90428-1; DAVISON PF, 1962, J MOL BIOL, V5, P635, DOI 10.1016/S0022-2836(62)80091-6; Declais AC, 2006, J MOL BIOL, V359, P1261, DOI 10.1016/j.jmb.2006.04.037; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; DUNN JJ, 1971, NATURE-NEW BIOL, V230, P94, DOI 10.1038/newbio230094a0; DUNN JJ, 1983, J MOL BIOL, V166, P477, DOI 10.1016/S0022-2836(83)80282-4; ENGLER MJ, 1983, J BIOL CHEM, V258, P1197; HAMADA K, 1984, VIROLOGY, V139, P251, DOI 10.1016/0042-6822(84)90372-6; HAUSMANN R., 1967, J VIROL, V1, P779; Hausmann R, 1988, BACTERIOPHAGES, P259; HUBER HE, 1986, J BIOL CHEM, V261, P5006; HYMAN RW, 1973, J MOL BIOL, V77, P189, DOI 10.1016/0022-2836(73)90330-6; Kedzierska S, 1996, GENE, V168, P1, DOI 10.1016/0378-1119(95)00712-1; Kemp P, 2005, VIROLOGY, V340, P307, DOI 10.1016/j.virol.2005.06.039; KERR C, 1972, J BIOL CHEM, V247, P311; KERR C, 1975, VIROLOGY, V65, P281, DOI 10.1016/0042-6822(75)90031-8; KOIKE M, 1971, J BACTERIOL, V108, P1402, DOI 10.1128/JB.108.3.1402-1411.1971; Kong DC, 1996, EMBO J, V15, P2010, DOI 10.1002/j.1460-2075.1996.tb00552.x; Lai YT, 2000, MOL MICROBIOL, V36, P437, DOI 10.1046/j.1365-2958.2000.01861.x; Lin TY, 2004, BIOCHEMISTRY-US, V43, P945, DOI 10.1021/bi0355138; LU M, 1991, J BIOL CHEM, V266, P2531; LUNN CA, 1984, J BIOL CHEM, V259, P469; MORITA M, 1995, VIROLOGY, V211, P516, DOI 10.1006/viro.1995.1433; Pajunen MI, 2002, J MOL BIOL, V319, P1115, DOI 10.1016/S0022-2836(02)00384-4; POWLING A, 1974, MOL GEN GENET, V134, P173, DOI 10.1007/BF00268418; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; RUSSEL M, 1984, J BACTERIOL, V157, P526, DOI 10.1128/JB.157.2.526-532.1984; SCHMITT CK, 1991, J BACTERIOL, V173, P1536, DOI 10.1128/jb.173.4.1536-1543.1991; SHEN P, 1986, GENETICS, V112, P441; STEVEN AC, 1988, J MOL BIOL, V200, P351, DOI 10.1016/0022-2836(88)90246-X; STUDIER FW, 1976, J VIROL, V19, P136, DOI 10.1128/JVI.19.1.136-145.1976; STUDIER FW, 1979, VIROLOGY, V95, P70; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; WEIDEL W, 1958, ANNU REV MICROBIOL, V12, P27, DOI 10.1146/annurev.mi.12.100158.000331; YAMAGISHI M, 1985, VIROLOGY, V144, P502, DOI 10.1016/0042-6822(85)90290-9; Yu M, 2001, J BACTERIOL, V183, P1862, DOI 10.1128/JB.183.6.1862-1869.2001; Zhang X, 2004, J MOL BIOL, V340, P707, DOI 10.1016/j.jmb.2004.05.006; ZHANG X, 1995, J MOL BIOL, V250, P156, DOI 10.1006/jmbi.1995.0367	50	41	50	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e30954	10.1371/journal.pone.0030954	http://dx.doi.org/10.1371/journal.pone.0030954			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347414	gold, Green Published, Green Submitted			2022-12-25	WOS:000302730200010
J	Soriano, S; Alonso-Magdalena, P; Garcia-Arevalo, M; Novials, A; Muhammed, SJ; Salehi, A; Gustafsson, JA; Quesada, I; Nadal, A				Soriano, Sergi; Alonso-Magdalena, Paloma; Garcia-Arevalo, Marta; Novials, Anna; Muhammed, Sarheed J.; Salehi, Albert; Gustafsson, Jan-Ake; Quesada, Ivan; Nadal, Angel			Rapid Insulinotropic Action of Low Doses of Bisphenol-A on Mouse and Human Islets of Langerhans: Role of Estrogen Receptor beta	PLOS ONE			English	Article							PANCREATIC-ISLETS; INTACT ISLETS; HUMAN HEALTH; GLUCOSE; SECRETION; CELLS; ALPHA; OSCILLATIONS; ACTIVATION; MECHANISMS	Bisphenol-A (BPA) is a widespread endocrine-disrupting chemical (EDC) used as the base compound in the manufacture of polycarbonate plastics. It alters pancreatic beta-cell function and can be considered a risk factor for type 2 diabetes in rodents. Here we used ER beta(-/-) mice to study whether ER beta is involved in the rapid regulation of K-ATP channel activity, calcium signals and insulin release elicited by environmentally relevant doses of BPA (1 nM). We also investigated these effects of BPA in beta-cells and whole islets of Langerhans from humans. 1 nM BPA rapidly decreased K-ATP channel activity, increased glucose-induced [Ca2+](i) signals and insulin release in beta-cells from WT mice but not in cells from ER beta(-/-) mice. The rapid reduction in the K-ATP channel activity and the insulinotropic effect was seen in human cells and islets. BPA actions were stronger in human islets compared to mouse islets when the same BPA concentration was used. Our findings suggest that BPA behaves as a strong estrogen via nuclear ER beta and indicate that results obtained with BPA in mouse beta-cells may be extrapolated to humans. This supports that BPA should be considered as a risk factor for metabolic disorders in humans.	[Soriano, Sergi; Alonso-Magdalena, Paloma; Garcia-Arevalo, Marta; Quesada, Ivan; Nadal, Angel] Univ Miguel Hernandez Elche, Inst Bioingn, Alicante, Spain; [Soriano, Sergi; Alonso-Magdalena, Paloma; Garcia-Arevalo, Marta; Quesada, Ivan; Nadal, Angel] Univ Miguel Hernandez Elche, CIBER Diabet & Enfermedades Metab Asociadas CIBER, Alicante, Spain; [Novials, Anna] IDIBAPS, Barcelona, Spain; [Novials, Anna] CIBERDEM, Barcelona, Spain; [Muhammed, Sarheed J.; Salehi, Albert] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Gustafsson, Jan-Ake] Univ Houston, Dept Cell Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX USA	Universidad Miguel Hernandez de Elche; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Universidad Miguel Hernandez de Elche; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Lund University; University of Houston System; University of Houston	Soriano, S (corresponding author), Univ Miguel Hernandez Elche, Inst Bioingn, Alicante, Spain.	nadal@umh.es	Nadal, Angel/G-6721-2014; Ivan, Quesada/P-6541-2014; Soriano, Sergi/M-5255-2017; García-Arévalo, Marta/C-9440-2014; Alonso-Magdalena, Paloma/AAH-2076-2021; Salehi, Albert/F-7768-2018	Nadal, Angel/0000-0003-4178-2152; Ivan, Quesada/0000-0002-9808-514X; Soriano, Sergi/0000-0001-9844-7027; Salehi, Albert/0000-0001-6120-3539; Novials, Anna/0000-0003-0465-2949; ALONSO MAGDALENA, PALOMA/0000-0003-1065-5388; Garcia-Arevalo Provencio, Marta/0000-0001-7238-9498	Ministerio de Ciencia e Innovacion [BFU2008-01492, BFU2011-28358, BFU2010-21773]; Generalitat Valenciana [Prometeo/2011/080, ACOMP/2010/113]; European Commission	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	This research was supported by grants from Ministerio de Ciencia e Innovacion grants BFU2008-01492, BFU2011-28358 and BFU2010-21773, Generalitat Valenciana grants Prometeo/2011/080 and ACOMP/2010/113, the European Commission (Program PEOPLE). The "Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas" is an initiative of the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Magdalena P, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI [10.1289/ehp.8451, 10.1289/ehp.8062]; Alonso-Magdalena P, 2005, ENVIRON HEALTH PERSP, V113, P969, DOI 10.1289/ehp.8002; Alonso-Magdalena P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002069; Alonso-Magdalena P, 2011, NAT REV ENDOCRINOL, V7, P346, DOI 10.1038/nrendo.2011.56; Alonso-Magdalena P, 2010, ENVIRON HEALTH PERSP, V118, P1243, DOI 10.1289/ehp.1001993; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Balhuizen A, 2010, MOL CELL ENDOCRINOL, V320, P16, DOI 10.1016/j.mce.2010.01.030; Barbosa RM, 1998, J PHYSIOL-LONDON, V510, P135, DOI 10.1111/j.1469-7793.1998.135bz.x; Ben-Jonathan N, 2009, MOL CELL ENDOCRINOL, V304, P49, DOI 10.1016/j.mce.2009.02.022; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Bouskine A, 2009, ENVIRON HEALTH PERSP, V117, P1053, DOI 10.1289/ehp.0800367; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Dyachok O, 2008, CELL METAB, V8, P26, DOI 10.1016/j.cmet.2008.06.003; FENWICK EM, 1982, J PHYSIOL-LONDON, V331, P577, DOI 10.1113/jphysiol.1982.sp014393; GILON P, 1993, J BIOL CHEM, V268, P22265; Hectors TLM, 2011, DIABETOLOGIA, V54, P1273, DOI 10.1007/s00125-011-2109-5; Hugo ER, 2008, ENVIRON HEALTH PERSP, V116, P1642, DOI 10.1289/ehp.11537; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kumar R, 2011, ENDOCRINOLOGY, V152, P2568, DOI 10.1210/en.2010-1361; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Levin ER, 2011, MOL ENDOCRINOL, V25, P377, DOI 10.1210/me.2010-0284; Liu SH, 2009, ISLETS, V1, P273, DOI 10.4161/isl.1.3.9781; Liu SH, 2009, DIABETES, V58, P2292, DOI 10.2337/db09-0257; Melzer D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008673; Nadal A, 2004, STEROIDS, V69, P531, DOI 10.1016/j.steroids.2004.05.010; Nadal A, 1999, J PHYSIOL-LONDON, V517, P85, DOI 10.1111/j.1469-7793.1999.0085z.x; Nadal A, 2001, NEWS PHYSIOL SCI, V16, P251; Nadal A, 2011, FRONT BIOSCI-LANDMRK, V16, P251, DOI 10.2741/3686; Nadal A, 2009, MOL CELL ENDOCRINOL, V304, P63, DOI 10.1016/j.mce.2009.02.016; Neel BA, 2011, DIABETES, V60, P1838, DOI 10.2337/db11-0153; NOVIALS A, 1993, DIABETES, V42, P1514, DOI 10.2337/diabetes.42.10.1514; Park CJ, 2011, J CLIN INVEST, V121, P604, DOI 10.1172/JCI41702; Prado CL, 2004, P NATL ACAD SCI USA, V101, P2924, DOI 10.1073/pnas.0308604100; Ropero AB, 1999, J PHYSIOL-LONDON, V521, P397, DOI 10.1111/j.1469-7793.1999.00397.x; Rorsman P, 2000, NEWS PHYSIOL SCI, V15, P72; Safe SH, 2002, ENVIRON HEALTH PERSP, V110, P925, DOI 10.1289/ehp.02110s6925; SANTOS RM, 1991, PFLUG ARCH EUR J PHY, V418, P417, DOI 10.1007/BF00550880; Sato Y, 1998, DIABETES, V47, P1713, DOI 10.2337/diabetes.47.11.1713; Shankar A, 2011, J CLIN ENDOCR METAB, V96, P3822, DOI 10.1210/jc.2011-1682; Sharma G, 2011, ENDOCRINOLOGY, V152, P3030, DOI 10.1210/en.2011-0091; Sheeler CQ, 2000, ENVIRON HEALTH PERSP, V108, P97, DOI 10.2307/3454506; Soriano S, 2009, MOL ENDOCRINOL, V23, P1973, DOI 10.1210/me.2009-0287; Straub SG, 1998, DIABETES, V47, P758, DOI 10.2337/diabetes.47.5.758; Thomas C, 2011, NAT REV CANCER, V11, P597, DOI 10.1038/nrc3093; Tiano JP, 2011, J CLIN INVEST, V121, P3331, DOI 10.1172/JCI44564; VALDEOLMILLOS M, 1992, J PHYSIOL-LONDON, V455, P173, DOI 10.1113/jphysiol.1992.sp019295; vom Saal FS, 2007, REPROD TOXICOL, V24, P131, DOI 10.1016/j.reprotox.2007.07.005; vom Saal FS, 2005, TOXICOLOGY, V212, P244, DOI 10.1016/j.tox.2005.05.006; Wang TG, 2012, J CLIN ENDOCR METAB, V97, pE223, DOI 10.1210/jc.2011-1989; Wei J, 2011, ENDOCRINOLOGY, V152, P3049, DOI 10.1210/en.2011-0045; Wong WPS, 2010, P NATL ACAD SCI USA, V107, P13057, DOI 10.1073/pnas.0914501107	54	137	141	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31109	10.1371/journal.pone.0031109	http://dx.doi.org/10.1371/journal.pone.0031109			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347437	Green Submitted, Green Published, gold			2022-12-25	WOS:000302730100042
J	Vallin, E; Gallagher, J; Granger, L; Martin, E; Belougne, J; Maurizio, J; Duverger, Y; Scaglione, S; Borrel, C; Cortier, E; Abouzid, K; Carre-Pierrat, M; Gieseler, K; Segalat, L; Kuwabara, PE; Ewbank, JJ				Vallin, Elodie; Gallagher, Joseph; Granger, Laure; Martin, Edwige; Belougne, Jerome; Maurizio, Julien; Duverger, Yohann; Scaglione, Sarah; Borrel, Caroline; Cortier, Elisabeth; Abouzid, Karima; Carre-Pierrat, Maite; Gieseler, Kathrin; Segalat, Laurent; Kuwabara, Patricia E.; Ewbank, Jonathan J.			A Genome-Wide Collection of Mos1 Transposon Insertion Mutants for the C. elegans Research Community	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; MUTAGENESIS; GENERATION; WORMBASE	Methods that use homologous recombination to engineer the genome of C. elegans commonly use strains carrying specific insertions of the heterologous transposon Mos1. A large collection of known Mos1 insertion alleles would therefore be of general interest to the C. elegans research community. We describe here the optimization of a semi-automated methodology for the construction of a substantial collection of Mos1 insertion mutant strains. At peak production, more than 5,000 strains were generated per month. These strains were then subject to molecular analysis, and more than 13,300 Mos1 insertions characterized. In addition to targeting directly more than 4,700 genes, these alleles represent the potential starting point for the engineered deletion of essentially all C. elegans genes and the modification of more than 40% of them. This collection of mutants, generated under the auspices of the European NEMAGENETAG consortium, is publicly available and represents an important research resource.	[Vallin, Elodie; Granger, Laure; Martin, Edwige; Borrel, Caroline; Cortier, Elisabeth; Abouzid, Karima; Carre-Pierrat, Maite; Gieseler, Kathrin; Segalat, Laurent] CNRS, Ctr Genet & Physiol Mol & Cellulaires, UMR 5534, Villeurbanne, France; [Vallin, Elodie; Granger, Laure; Martin, Edwige; Borrel, Caroline; Cortier, Elisabeth; Abouzid, Karima; Carre-Pierrat, Maite; Gieseler, Kathrin; Segalat, Laurent] Univ Lyon 1, F-69622 Villeurbanne, France; [Gallagher, Joseph; Kuwabara, Patricia E.] Univ Bristol, Sch Biochem, Bristol, Avon, England; [Belougne, Jerome; Maurizio, Julien; Duverger, Yohann; Scaglione, Sarah; Ewbank, Jonathan J.] Aix Marseille Univ, Ctr Immunol Marseille Luminy, Marseille, France; [Belougne, Jerome; Maurizio, Julien; Duverger, Yohann; Scaglione, Sarah; Ewbank, Jonathan J.] INSERM, U1104, F-13258 Marseille, France; [Belougne, Jerome; Maurizio, Julien; Duverger, Yohann; Scaglione, Sarah; Ewbank, Jonathan J.] CNRS, UMR7280, Marseille, France; [Carre-Pierrat, Maite] CNRS, UMS3421, Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Bristol; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Vallin, E (corresponding author), CNRS, Ctr Genet & Physiol Mol & Cellulaires, UMR 5534, Campus Doua, Villeurbanne, France.	ewbank@ciml.univ-mrs.fr	Gieseler, Kathrin/Q-8161-2016; Ewbank, Jonathan J/G-4948-2010	Ewbank, Jonathan J/0000-0002-1257-6862; Kuwabara, Patricia/0000-0002-1108-7776; Maurizio, Julien/0000-0002-6387-5125; Gieseler, Kathrin/0000-0003-0222-9450	European Community; CNRS; INSERM; Reseau National des Genopoles; Marseille-Nice Genopole	European Community(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Reseau National des Genopoles; Marseille-Nice Genopole	This research was funded primarily by the European Community's FP6 STREP NEMAGENETAG, supplemented by institutional grants from the CNRS and INSERM, as well as funding from the Reseau National des Genopoles and Marseille-Nice Genopole. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazopoulou D, 2009, GENETICA, V137, P39, DOI 10.1007/s10709-009-9361-3; Bessereau JL, 2001, NATURE, V413, P70, DOI 10.1038/35092567; Boulin T, 2007, NAT PROTOC, V2, P1276, DOI 10.1038/nprot.2007.192; Duverger Y, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1046; Engelmann I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019055; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Frokjaer-Jensen C, 2010, NAT METHODS, V7, P451, DOI [10.1038/NMETH.1454, 10.1038/nmeth.1454]; Gendrel M, 2009, NATURE, V461, P992, DOI 10.1038/nature08430; Granger L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh111; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Paruzynski A, 2010, NAT PROTOC, V5, P1379, DOI 10.1038/nprot.2010.87; Pauli F, 2006, DEVELOPMENT, V133, P287, DOI 10.1242/dev.02185; Pujol N, 2008, CURR BIOL, V18, P481, DOI 10.1016/j.cub.2008.02.079; Robert V, 2007, EMBO J, V26, P170, DOI 10.1038/sj.emboj.7601463; Schwarz EM, 2006, NUCLEIC ACIDS RES, V34, pD475, DOI 10.1093/nar/gkj061; Stiernagle Theresa, 2006, WormBook, P1	17	34	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30482	10.1371/journal.pone.0030482	http://dx.doi.org/10.1371/journal.pone.0030482			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347378	Green Submitted, Green Published, gold			2022-12-25	WOS:000302730100013
J	Schuetz, JM; Daley, D; Graham, J; Berry, BR; Gallagher, RP; Connors, JM; Gascoyne, RD; Spinelli, JJ; Brooks-Wilson, AR				Schuetz, Johanna M.; Daley, Denise; Graham, Jinko; Berry, Brian R.; Gallagher, Richard P.; Connors, Joseph M.; Gascoyne, Randy D.; Spinelli, John J.; Brooks-Wilson, Angela R.			Genetic Variation in Cell Death Genes and Risk of Non-Hodgkin Lymphoma	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; SINGLE NUCLEOTIDE POLYMORPHISM; GERMINAL-CENTER; FOLLICULAR LYMPHOMA; NEGATIVE REGULATOR; GERMLINE VARIATION; GENOMIC CONTROL; MICRORNA GENES; BREAST-CANCER; ASSOCIATION	Background: Non-Hodgkin lymphomas are a heterogeneous group of solid tumours that constitute the 5th highest cause of cancer mortality in the United States and Canada. Poor control of cell death in lymphocytes can lead to autoimmune disease or cancer, making genes involved in programmed cell death of lymphocytes logical candidate genes for lymphoma susceptibility. Materials and Methods: We tested for genetic association with NHL and NHL subtypes, of SNPs in lymphocyte cell death genes using an established population-based study. 17 candidate genes were chosen based on biological function, with 123 SNPs tested. These included tagSNPs from HapMap and novel SNPs discovered by re-sequencing 47 cases in genes for which SNP representation was judged to be low. The main analysis, which estimated odds ratios by fitting data to an additive logistic regression model, used European ancestry samples that passed quality control measures (569 cases and 547 controls). A two-tiered approach for multiple testing correction was used: correction for number of tests within each gene by permutation-based methodology, followed by correction for the number of genes tested using the false discovery rate. Results: Variant rs928883, near miR-155, showed an association (OR per A-allele: 2.80 [95% CI: 1.63-4.82]; p(F) = 0.027) with marginal zone lymphoma that is significant after correction for multiple testing. Conclusions: This is the first reported association between a germline polymorphism at a miRNA locus and lymphoma.	[Schuetz, Johanna M.; Brooks-Wilson, Angela R.] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Schuetz, Johanna M.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Daley, Denise] Univ British Columbia, Fac Med, Vancouver, BC, Canada; [Graham, Jinko] Simon Fraser Univ, Dept Stat & Actuarial Sci, Burnaby, BC V5A 1S6, Canada; [Berry, Brian R.] Royal Jubilee Hosp, Dept Pathol, Victoria, BC, Canada; [Gallagher, Richard P.; Spinelli, John J.] BC Canc Agcy, Canc Control Res, Vancouver, BC, Canada; [Connors, Joseph M.] BC Canc Agcy, Div Med Oncol, Vancouver, BC, Canada; [Connors, Joseph M.; Gascoyne, Randy D.] BC Canc Agcy, Ctr Lymphoid Canc, Vancouver, BC, Canada; [Gascoyne, Randy D.] BC Canc Agcy, Dept Pathol, Vancouver, BC, Canada; [Spinelli, John J.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Brooks-Wilson, Angela R.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada	British Columbia Cancer Agency; University of British Columbia; University of British Columbia; Simon Fraser University; British Columbia Cancer Agency; British Columbia Cancer Agency; British Columbia Cancer Agency; British Columbia Cancer Agency; University of British Columbia; Simon Fraser University	Schuetz, JM (corresponding author), BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada.	abrooks-wilson@bcgsc.ca	Spinelli, John J./B-6210-2013; Brooks-Wilson, Angela/E-9399-2012; Connors, Joseph/AAF-5284-2019; Graham, JInko/ABE-1507-2021	Spinelli, John J./0000-0002-9119-3287; Brooks-Wilson, Angela/0000-0003-1009-6408; Connors, Joseph/0000-0002-1361-7531; Graham, JInko/0000-0003-4568-1228	Canadian Institutes for Health Research (CIHR); Canadian Cancer Society; Alberta Heritage Foundation for Medical Research	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	This work was supported by grants from the Canadian Institutes for Health Research (CIHR) and the Canadian Cancer Society. J.M.S. was supported by the Lionel McLeod Award of the Alberta Heritage Foundation for Medical Research and by CIHR. D. D. holds a Tier II Canadian Research Chair (Genetic Epidemiology of Common Complex Diseases). A.B.-W. is a Senior Scholar and D. D. and J.G. are Scholars of the Michael Smith Foundation for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Au WY, 2005, ANN HEMATOL, V84, P506, DOI 10.1007/s00277-005-1028-2; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berglund M, 2006, BLOOD, V108, P3623, DOI 10.1182/blood-2006-06-032367; Bond GL, 2006, CANCER RES, V66, P5104, DOI 10.1158/0008-5472.CAN-06-0180; Brooks-Wilson AR, 2004, J MED GENET, V41, P508, DOI 10.1136/jmg.2004.018275; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cattoretti G, 2006, J IMMUNOL, V177, P6930, DOI 10.4049/jimmunol.177.10.6930; Catucci I, 2010, HUM MUTAT, V31, pE1052, DOI 10.1002/humu.21141; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Danial NN, 2007, CLIN CANCER RES, V13, P7254, DOI 10.1158/1078-0432.CCR-07-1598; de Bakker PIW, 2006, NAT GENET, V38, P1298, DOI 10.1038/ng1899; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Devlin B, 2004, NAT GENET, V36, P1129, DOI 10.1038/ng1104-1129; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Devlin B, 2000, Biostatistics, V1, P369, DOI 10.1093/biostatistics/1.4.369; Do TN, 2009, CANCER GENET CYTOGEN, V195, P31, DOI 10.1016/j.cancergencyto.2009.05.009; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Eischen CM, 2004, ONCOGENE, V23, P8931, DOI 10.1038/sj.onc.1208052; Enjuanes A, 2008, CANCER RES, V68, P10178, DOI 10.1158/0008-5472.CAN-08-2221; Fernberg P, 2010, CANCER CAUSE CONTROL, V21, P759, DOI 10.1007/s10552-010-9504-y; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; Gstaiger M, 2001, P NATL ACAD SCI USA, V98, P5043, DOI 10.1073/pnas.081474898; Halaschek-Wiener J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006641; Halder I, 2008, HUM MUTAT, V29, P648, DOI 10.1002/humu.20695; Hoffman AE, 2009, CANCER RES, V69, P5970, DOI 10.1158/0008-5472.CAN-09-0236; Hu SM, 2006, J CLIN INVEST, V116, P174, DOI 10.1172/JCI25641; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Johansson A, 2007, HUM GENET, V122, P141, DOI 10.1007/s00439-007-0379-2; Jung I, 2009, BRIT J HAEMATOL, V144, P138, DOI 10.1111/j.1365-2141.2008.07424.x; Kelly JL, 2010, CANCER EPIDEM BIOMAR, V19, P2847, DOI 10.1158/1055-9965.EPI-10-0581; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Linnstaedt SD, 2010, J VIROL, V84, P11670, DOI 10.1128/JVI.01248-10; Mead S, 2008, HUM MUTAT, V29, P1452, DOI 10.1002/humu.20782; Morton LM, 2009, CANCER EPIDEM BIOMAR, V18, P1259, DOI 10.1158/1055-9965.EPI-08-1037; Rozen S, 2000, Methods Mol Biol, V132, P365; Schuetz JM, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-117; Scott K, 2008, HAEMATOL-HEMATOL J, V93, P1597, DOI 10.3324/haematol.13159; Sethupathy P, 2007, AM J HUM GENET, V81, P405, DOI 10.1086/519979; Shaffer AL, 2002, NAT REV IMMUNOL, V2, P920, DOI 10.1038/nri953; Shen J, 2009, INT J CANCER, V124, P1178, DOI 10.1002/ijc.24008; Sipahimalani P, 2007, INT J CANCER, V121, P1967, DOI 10.1002/ijc.22888; Spinelli JJ, 2007, INT J CANCER, V121, P2767, DOI 10.1002/ijc.23005; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Susova S, 2006, CANCER LETT, V238, P142, DOI 10.1016/j.canlet.2005.07.015; Teng G, 2008, IMMUNITY, V28, P621, DOI 10.1016/j.immuni.2008.03.015; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Villa-Morales M, 2010, CARCINOGENESIS, V31, P2165, DOI 10.1093/carcin/bgq201; Volinia S, 2010, GENOME RES, V20, P589, DOI 10.1101/gr.098046.109; Wang SS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005360; Willis TG, 2000, BLOOD, V96, P808, DOI 10.1182/blood.V96.3.808.015k30_808_822; Wrench D, 2009, HAEMATOL-HEMATOL J, V94, P148, DOI 10.3324/haematol.13533; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yang R, 2010, BREAST CANC RES TREA; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Yuille MR, 1999, BRIT J HAEMATOL, V107, P384, DOI 10.1046/j.1365-2141.1999.01722.x; Zenz T, 2008, HAEMATOL-HEMATOL J, V93, P1111, DOI 10.3324/haematol.12738; Zhang YW, 2005, JNCI-J NATL CANCER I, V97, P1616, DOI 10.1093/jnci/dji344; Zhao JH, 2000, HUM HERED, V50, P133, DOI 10.1159/000022901	63	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31560	10.1371/journal.pone.0031560	http://dx.doi.org/10.1371/journal.pone.0031560			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347493	Green Published, Green Submitted, gold			2022-12-25	WOS:000302180600042
J	Lyytinen, A; Mappes, J; Lindstrom, L				Lyytinen, Anne; Mappes, Johanna; Lindstrom, Leena			Variation in Hsp70 Levels after Cold Shock: Signs of Evolutionary Responses to Thermal Selection among Leptinotarsa decemlineata Populations	PLOS ONE			English	Article							COLORADO POTATO BEETLE; GENETIC-VARIATION; DROSOPHILA-MELANOGASTER; PHENOTYPIC PLASTICITY; EXPRESSION; TEMPERATURE; DIAPAUSE; THERMOTOLERANCE; ACCLIMATION; TRANSCRIPTS	Individuals of widely spread species are expected to show local adaption in temperature tolerance as they encounter a range of thermal conditions. We tracked thermal adaptations of the Colorado potato beetle (Leptinotarsa decemlineata) that invaded Europe within the last 100 years. It has occupied various conditions although, like the majority of invasive species, it lost a measurable amount of neutral genetic variation due to bottleneck effect when it invaded Europe. We exposed diapausing beetles originated from three different latitudes (54 degrees N, 59 degrees N, 60 degrees N) to cold shock (-5 degrees C, 1.5 hrs) in order to test if beetles from the northern populations express differential levels of cold-induced and constitutive Hsp70 compared to the beetles from milder temperature regime. The level of cold-induced Hsp70 was lowest in the northernmost beetle populations while the level of constitutive Hsp70 did not differ with the population. Moreover, the southernmost beetles were more plastic in their response to cold shock than the northernmost beetles. These results suggest that physiological adaptation, like the synthesis of Hsp70, can evolve very quickly.	[Lyytinen, Anne; Mappes, Johanna; Lindstrom, Leena] Univ Jyvaskyla, Dept Biol & Environm Sci, Ctr Excellence Evolutionary Res, Jyvaskyla, Finland	University of Jyvaskyla	Lyytinen, A (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Ctr Excellence Evolutionary Res, Jyvaskyla, Finland.	anne.m.lyytinen@jyu.fi	Lindstrom, Leena/B-2326-2012; Mappes, Johanna/AAZ-3627-2021	Lindstrom, Leena/0000-0002-6452-4538; Mappes, Johanna/0000-0002-1117-5629; Lyytinen, Anne/0000-0002-1281-1797	Academy of Finland [108335, 118456/131406]; Ministry of Agriculture and Forestry	Academy of Finland(Academy of Finland); Ministry of Agriculture and Forestry	This research project was supported by funds from the Academy of Finland (n:o: 108335, 118456/131406) and the Ministry of Agriculture and Forestry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barua D, 2004, J THERM BIOL, V29, P185, DOI 10.1016/j.jtherbio.2004.01.004; Boman S, 2008, BIOL INVASIONS, V10, P1135, DOI 10.1007/s10530-007-9191-0; Buckley BA, 2001, J EXP BIOL, V204, P3571; FEDER JH, 1992, GENE DEV, V6, P1402, DOI 10.1101/gad.6.8.1402; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Goto SG, 1998, J INSECT PHYSIOL, V44, P1233, DOI 10.1016/S0022-1910(98)00101-2; Grapputo A, 2005, MOL ECOL, V14, P4207, DOI 10.1111/j.1365-294X.2005.02740.x; Hiiesaar Kulli, 2001, Norwegian Journal of Entomology, V48, P87; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; Johnson C.G., 1967, EUR J PLANT PATHOL, V73, P21, DOI DOI 10.1007/BF01974421; Karl I, 2009, J EVOLUTION BIOL, V22, P172, DOI 10.1111/j.1420-9101.2008.01630.x; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; KREBS RA, 1994, FUNCT ECOL, V8, P730, DOI 10.2307/2390232; Lansing E, 2000, J THERM BIOL, V25, P443, DOI 10.1016/S0306-4565(00)00008-5; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Lyytinen A, 2008, ENTOMOL EXP APPL, V127, P157, DOI 10.1111/j.1570-7458.2008.00685.x; Maisov A.V., 2007, CELL TISSUE BIOL, V1, P434, DOI [10.1134/S1990519X07050094, DOI 10.1134/S1990519X07050094]; Piiroinen S, 2011, FUNCT ECOL, V25, P527, DOI 10.1111/j.1365-2435.2010.01804.x; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Rinehart JP, 2000, INSECT BIOCHEM MOLEC, V30, P515, DOI 10.1016/S0965-1748(00)00021-7; Sexton JP, 2002, ECOL APPL, V12, P1652, DOI 10.1890/1051-0761(2002)012[1652:PAGDMA]2.0.CO;2; Sorensen JG, 1999, HEREDITAS, V131, P155, DOI 10.1111/j.1601-5223.1999.00155.x; Sorensen JG, 2001, FUNCT ECOL, V15, P289, DOI 10.1046/j.1365-2435.2001.00525.x; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Tomanek L, 1999, J EXP BIOL, V202, P2925; Vilkova NA, 2005, PLANT PROTECTION NEW, V1, P3; Watson P, 1987, TEMPERATURE ANIMAL C, P311; Yocum GD, 2001, J INSECT PHYSIOL, V47, P1139, DOI 10.1016/S0022-1910(01)00095-6; ZACHARIASSEN KE, 1985, PHYSIOL REV, V65, P799, DOI 10.1152/physrev.1985.65.4.799; Zhang QR, 2010, J INSECT PHYSIOL, V56, P138, DOI 10.1016/j.jinsphys.2009.09.013	31	29	31	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e31446	10.1371/journal.pone.0031446	http://dx.doi.org/10.1371/journal.pone.0031446			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319631	Green Submitted, gold, Green Published			2022-12-25	WOS:000301979000028
J	Klein, J; Jupp, S; Moulos, P; Fernandez, M; Buffin-Meyer, B; Casemayou, A; Chaaya, R; Charonis, A; Bascands, JL; Stevens, R; Schanstra, JP				Klein, Julie; Jupp, Simon; Moulos, Panagiotis; Fernandez, Myriem; Buffin-Meyer, Benedicte; Casemayou, Audrey; Chaaya, Rana; Charonis, Aristidis; Bascands, Jean-Loup; Stevens, Robert; Schanstra, Joost P.			The KUPKB: a novel Web application to access multiomics data on kidney disease	FASEB JOURNAL			English	Article						renal pathophysiology; genomics; proteomics; bioinformatics; experimental data	TO-MESENCHYMAL TRANSITION; FIBROSIS; BIOINFORMATICS; CALRETICULIN; KNOWLEDGE; PATHWAYS; RESOURCE; ONTOLOGY; CELLS	The information gathered from the large number of omics experiments in renal biology is under-explored, as it is scattered over many publications or held in supplemental data. To address this, we have developed an open-source Kidney and Urinary Pathway Knowledge Base (KUPKB) that facilitates simple exploration of these omics data. The KUPKB currently comprises 220 data sets (miRNA, mRNA, proteins, and metabolites) extracted from existing publications or databases. Researchers can explore the integrated data using the iKUP browser, and a simple template is provided to submit new omics data sets to the knowledge base. As an example of iKUP's use, we show how we identified, in silico, calreticulin as a protein induced in human interstitial fibrosis and tubular atrophy (IFTA) in chronic kidney transplant rejection; a link that would have been difficult to establish using existing Web-based tools. Using immunohistochemistry, we validated in vivo this in silico result in human and rat biopsies of IFTA, thus identifying calreticulin as a potential new player in chronic kidney transplant rejection. The KUPKB provides a simple tool that enables users to quickly survey a wide range of omics data sets and has been shown to facilitate rapid hypothesis generation in the context of renal pathophysiology.-Klein, J., Jupp, S., Moulos, P., Fernandez, M., Buffin-Meyer, B., Casemayou, A., Chaaya, R., Charonis, A., Bascands, J.-L., Stevens, R., Schanstra, J. P. The KUPKB: a novel Web application to access multiomics data on kidney disease. FASEB J. 26, 2145-2153 (2012). www.fasebj.org	[Klein, Julie; Moulos, Panagiotis; Fernandez, Myriem; Buffin-Meyer, Benedicte; Casemayou, Audrey; Chaaya, Rana; Bascands, Jean-Loup; Schanstra, Joost P.] Inst Cardiovasc & Metab Dis, INSERM, U1048, F-31432 Toulouse 4, France; [Klein, Julie; Moulos, Panagiotis; Fernandez, Myriem; Buffin-Meyer, Benedicte; Casemayou, Audrey; Chaaya, Rana; Bascands, Jean-Loup; Schanstra, Joost P.] Univ Toulouse 3, F-31062 Toulouse, France; [Jupp, Simon; Stevens, Robert] Univ Manchester, Sch Comp Sci, Manchester, Lancs, England; [Charonis, Aristidis] Acad Athens, Biomed Res Fdn, Ctr Basic Res 1, Sect Histol, Athens, Greece	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Manchester; Academy of Athens	Klein, J (corresponding author), Inst Cardiovasc & Metab Dis, INSERM, U1048, 1 Ave Jean Poulhes, F-31432 Toulouse 4, France.	julie.klein64@gmail.com; joost-peter.schanstra@inserm.fr	Schanstra, Joost P/X-7724-2018; Moulos, Panagiotis/E-2335-2018; Klein, Julie/ABE-2622-2020; Buffin-Meyer, Bénédicte/X-7705-2018; Bascands, Jean-loup/G-3260-2013; Klein, Julie/M-7088-2017	Schanstra, Joost P/0000-0002-7471-372X; Moulos, Panagiotis/0000-0002-4199-0333; Klein, Julie/0000-0002-3279-0559; Buffin-Meyer, Bénédicte/0000-0002-4805-1558; Klein, Julie/0000-0002-3279-0559; Bascands, Jean-loup/0000-0002-1667-5913; Jupp, Simon/0000-0002-0643-3144; Charonis, Aristidis/0000-0001-9956-732X	FP7-PEOPLE-2009-IAPP program Protoclin [GA 251368]; INSERM; Direction Regional Clinique [Centre Hospitalier Universitaire (CHU) de Toulouse, Toulouse, France); Direction de la Recherche Medicale et Innovation (CHU de Toulouse) under the Contrat Hospitalier de Recherche Translationnelle;  [EU/FP7/ICT-2007.4.4 e-LICO]	FP7-PEOPLE-2009-IAPP program Protoclin; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Direction Regional Clinique [Centre Hospitalier Universitaire (CHU) de Toulouse, Toulouse, France); Direction de la Recherche Medicale et Innovation (CHU de Toulouse) under the Contrat Hospitalier de Recherche Translationnelle; 	The authors thank EuroKUP members for participating in the KUPO day, in particular Antonia Vlahou, Jorgen Frokaier, Alberto Ortiz, and Harry Holthofer for useful suggestions; Michael Wicks and Duncan Davidson (Medical Research Council Human Genetics Unit, Edinburgh, UK) for supplying the EuReGene data set; the RF lab (http://www.renalfibrosis.fr) for continuous support and constructive comments; and Aureja Steponaviciute. and Aurelien Despierris for artistic participation in designing the logo and website. The authors thank Celine Gales [Institut National de la Sante et de la Recherche Medicale (INSERM) 1048, Team 8, Toulouse, France] for providing the rabbit anti-HA antibody and Laurent Sicard for help with immunohistology. This work is funded by the EU/FP7/ICT-2007.4.4 e-LICO project (http://www.e-lico.eu) and by the FP7-PEOPLE-2009-IAPP program Protoclin (GA 251368). J.L.B. acknowledges support by INSERM and the Direction Regional Clinique [Centre Hospitalier Universitaire (CHU) de Toulouse, Toulouse, France) under the Interface program. J.P.S. was supported by INSERM and the Direction de la Recherche Medicale et Innovation (CHU de Toulouse) under the Contrat Hospitalier de Recherche Translationnelle program. S.J., J.K., A.C., J.-L.B., and J.P.S. are members of COST action EuroKUP (http://www.eurokup.org). The KUPKB is available online (http://www.kupkb.org).	Barati MT, 2007, AM J PHYSIOL-RENAL, V293, pF1157, DOI 10.1152/ajprenal.00411.2006; Bard J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r21; Baron D, 2011, BIOINFORMATICS, V27, P725, DOI 10.1093/bioinformatics/btq710; Belleau F, 2008, J BIOMED INFORM, V41, P706, DOI 10.1016/j.jbi.2008.03.004; Chaaya R, 2011, NEPHROL DIAL TRANSPL, V26, P489, DOI 10.1093/ndt/gfq445; Chatziioannou A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-354; Chen YX, 2010, AM J NEPHROL, V31, P24, DOI 10.1159/000253865; Davidson S B, 1995, J Comput Biol, V2, P557, DOI 10.1089/cmb.1995.2.557; European Molecular Biology Laboratory-European Bioinformatics Institute, MICROCOSM TARG VERS; Goble C, 2008, J BIOMED INFORM, V41, P687, DOI 10.1016/j.jbi.2008.01.008; Harding SD, 2011, DEVELOPMENT, V138, P2845, DOI 10.1242/dev.063594; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hayamizu TF, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r29; Hills CE, 2010, MOL ENDOCRINOL, V24, P822, DOI 10.1210/me.2009-0391; Jupp Simon, 2011, J Biomed Semantics, V2 Suppl 2, pS7, DOI 10.1186/2041-1480-2-S2-S7; Klein J, 2010, J AM SOC NEPHROL, V21, P1157, DOI 10.1681/ASN.2009090887; Kypreou KP, 2008, PROTEOMICS, V8, P2407, DOI 10.1002/pmic.200700831; Laughery MD, 2007, AM J PHYSIOL-RENAL, V292, pF1718, DOI 10.1152/ajprenal.00360.2006; Miyamoto M, 2007, J PROTEOME RES, V6, P3680, DOI 10.1021/pr070203n; Mueller CFH, 2008, BIOCHEM BIOPH RES CO, V370, P669, DOI 10.1016/j.bbrc.2008.04.011; Nakorchevsky A, 2010, J AM SOC NEPHROL, V21, P362, DOI 10.1681/ASN.2009060628; *NAT CTR BIOT INF, HOMOLOGENE; Pisitkun T, 2006, PHYSIOL GENOMICS, V25, P263, DOI 10.1152/physiolgenomics.00214.2005; Rajasekaran SA, 2010, MOL CANCER THER, V9, P1515, DOI 10.1158/1535-7163.MCT-09-0832; Renal GO Working Group, GO ANN REN SYST; Ruttenberg A. R. J., 2008, PROTOTYPE KNOWLDEGE; Shadbolt N, 2006, IEEE INTELL SYST, V21, P96, DOI 10.1109/MIS.2006.62; Stevens RD, 2004, BIOINFORMATICS, V20, P303, DOI 10.1093/bioinformatics/bth944; Stevens R, 2007, INT J HUM-COMPUT ST, V65, P583, DOI 10.1016/j.ijhcs.2007.03.006; The National Center for Biotechnology Information, ENTR GEN; Universal Protein Resource Consortium, UNIPROT KNOWL BAS; Weiss RH, 2012, NAT REV NEPHROL, V8, P22, DOI 10.1038/nrneph.2011.152; World Wide Web Consortium, W3C REC; Xu YF, 2009, J NEPHROL, V22, P403; Zeisberg M, 2001, AM J PATHOL, V159, P1313, DOI 10.1016/S0002-9440(10)62518-7	35	27	27	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2012	26	5					2145	2153		10.1096/fj.11-194381	http://dx.doi.org/10.1096/fj.11-194381			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22345404				2022-12-25	WOS:000303680800040
J	Ahn, KH; Mahmoud, MM; Kendall, DA				Ahn, Kwang H.; Mahmoud, Mariam M.; Kendall, Debra A.			Allosteric Modulator ORG27569 Induces CB1 Cannabinoid Receptor High Affinity Agonist Binding State, Receptor Internalization, and G(i) Protein-independent ERK1/2 Kinase Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTORS; SIGNAL-REGULATED KINASES; COUPLED RECEPTORS; 7-TRANSMEMBRANE RECEPTORS; SPHINGOMYELIN HYDROLYSIS; CONSTITUTIVE ACTIVATION; HORMONE RECEPTOR; DOWN-REGULATION; HELIX 8; TRANSDUCTION	The cannabinoid receptor 1 (CB1), a member of the class A G protein-coupled receptor family, is expressed in brain tissue where agonist stimulation primarily activates the pertussis toxin-sensitive inhibitory G protein (G(i)). Ligands such as CP55940 ((1R,3R,4R)-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-4-(3-hydroxypropyl)cyclohexan-1-ol) and Delta(9)-tetrahydrocannabinolare orthosteric agonists for the receptor, bind the conventional binding pocket, and trigger G(i)-mediated effects including inhibition of adenylate cyclase. ORG27569 (5-chloro-3-ethyl-1H-indole-2-carboxylic acid [2-(4-piperidin-1-yl-phenyl)ethyl]amide) has been identified as an allosteric modulator that displays positive co-operativity for CP55940 binding to CB1 yet acts as an antagonist of G protein coupling. To examine this apparent conundrum, we used the wild-type CB1 and two mutants, T210A and T210I (D'Antona, A. M., Ahn, K. H., andKendall, D. A.(2006) Biochemistry45,5606-5617), which collectively cover a spectrum of receptor states from inactive to partially active to more fully constitutively active. Using these receptors, we demonstrated that ORG27569 induces a CB1 receptor state that is characterized by enhanced agonist affinity and decreased inverse agonist affinity consistent with an active conformation. Also consistent with this conformation, the impact of ORG27569 binding was most dramatic on the inactive T210A receptor and less pronounced on the already active T210I receptor. Although ORG27569 antagonized CP55940-induced guanosine 5'-3-O-(thio)triphosphate binding, which is indicative of G protein coupling inhibition in a concentration-dependent manner, the ORG27569-induced conformational change of the CB1 receptor led to cellular internalization and downstream activation of ERK signaling, providing the first case of allosteric ligand-biased signaling via CB1. ORG27569-induced ERK phosphorylation persisted even after pertussis toxin treatment to abrogate G(i) and occurs in HEK293 and neuronal cells.	[Ahn, Kwang H.; Kendall, Debra A.] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA; [Mahmoud, Mariam M.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA	University of Connecticut; University of Connecticut	Kendall, DA (corresponding author), Univ Connecticut, Dept Pharmaceut Sci, 69 N Eagleville Rd, Storrs, CT 06269 USA.	debra.kendall@uconn.edu		Mahmoud, Mariam/0000-0002-0491-1544	National Institutes of Health [DA020763]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA020763 (to D. A. K.).	Abadji V, 1999, J NEUROCHEM, V72, P2032, DOI 10.1046/j.1471-4159.1999.0722032.x; Ahn KH, 2010, BIOCHEMISTRY-US, V49, P502, DOI 10.1021/bi901619r; Ahn KH, 2009, MOL PHARMACOL, V76, P833, DOI 10.1124/mol.109.057356; Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Ballesteros J, 1998, J BIOL CHEM, V273, P10445, DOI 10.1074/jbc.273.17.10445; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bosier B, 2008, FEBS LETT, V582, P3861, DOI 10.1016/j.febslet.2008.10.022; BOUABOULA M, 1995, BIOCHEM J, V312, P637, DOI 10.1042/bj3120637; Bouaboula M, 1999, FEBS LETT, V449, P61, DOI 10.1016/S0014-5793(99)00395-6; Brailoiu GC, 2011, J BIOL CHEM, V286, P29166, DOI 10.1074/jbc.M110.217463; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; D'Antona AM, 2006, BRAIN RES, V1108, P1, DOI 10.1016/j.brainres.2006.05.042; D'Antona AM, 2006, BIOCHEMISTRY-US, V45, P5606, DOI 10.1021/bi060067k; Daigle TL, 2008, J NEUROCHEM, V106, P70, DOI 10.1111/j.1471-4159.2008.05336.x; Davis AA, 2010, ACS CHEM NEUROSCI, V1, P542, DOI 10.1021/cn100011e; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Derkinderen P, 2003, J NEUROSCI, V23, P2371; Derkinderen P, 2001, J NEUROCHEM, V77, P957, DOI 10.1046/j.1471-4159.2001.00333.x; Dowal L, 2011, P NATL ACAD SCI USA, V108, P2951, DOI 10.1073/pnas.1014863108; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Gardner EL, 1998, NEUROBIOL DIS, V5, P502, DOI 10.1006/nbdi.1998.0219; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Gregory KJ, 2007, CURR NEUROPHARMACOL, V5, P157, DOI 10.2174/157015907781695946; Gregory KJ, 2010, J BIOL CHEM, V285, P7459, DOI 10.1074/jbc.M109.094011; Grimsey NL, 2010, BIOCHEM PHARMACOL, V80, P1050, DOI 10.1016/j.bcp.2010.06.007; Guzman M, 1999, LIFE SCI, V65, P657, DOI 10.1016/S0024-3205(99)00288-X; Harkany T, 2007, TRENDS PHARMACOL SCI, V28, P83, DOI 10.1016/j.tips.2006.12.004; Horswill JG, 2007, BRIT J PHARMACOL, V152, P805, DOI 10.1038/sj.bjp.0707347; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Howlett AC, 2005, HANDB EXP PHARMACOL, V168, P53; Howlett AC, 2000, CHEM PHYS LIPIDS, V108, P53, DOI 10.1016/S0009-3084(00)00187-0; Hsieh C, 1999, J NEUROCHEM, V73, P493, DOI 10.1046/j.1471-4159.1999.0730493.x; Jin WZ, 1999, J NEUROSCI, V19, P3773; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kendall RT, 2011, J BIOL CHEM, V286, P19880, DOI 10.1074/jbc.M111.233080; Klaasse EC, 2005, EUR J PHARMACOL, V522, P1, DOI 10.1016/j.ejphar.2005.08.052; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kreitzer AC, 2002, CURR OPIN NEUROBIOL, V12, P324, DOI 10.1016/S0959-4388(02)00328-8; Langmead CJ, 2006, TRENDS PHARMACOL SCI, V27, P475, DOI 10.1016/j.tips.2006.07.009; Leterrier C, 2006, J NEUROSCI, V26, P3141, DOI 10.1523/JNEUROSCI.5437-05.2006; Leterrier C, 2004, J BIOL CHEM, V279, P36013, DOI 10.1074/jbc.M403990200; Lim CS, 2008, CELL SIGNAL, V20, P825, DOI 10.1016/j.cellsig.2007.12.013; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Martini L, 2007, FASEB J, V21, P802, DOI 10.1096/fj.06-7132com; McDonald NA, 2007, MOL PHARMACOL, V71, P976, DOI 10.1124/mol.106.029348; Murphy JW, 2003, BIOCHEM PHARMACOL, V65, P1623, DOI 10.1016/S0006-2952(03)00155-2; Pelkey KA, 2007, NEUROPHARMACOLOGY, V52, P108, DOI 10.1016/j.neuropharm.2006.07.020; Porter AC, 2001, PHARMACOL THERAPEUT, V90, P45, DOI 10.1016/S0163-7258(01)00130-9; Price MR, 2005, MOL PHARMACOL, V68, P1484, DOI 10.1124/mol.105.016162; Przybyla JA, 2010, J PHARMACOL EXP THER, V332, P710, DOI 10.1124/jpet.109.162701; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rozenfeld R, 2008, FASEB J, V22, P2311, DOI 10.1096/fj.07-102731; Rueda D, 2000, MOL PHARMACOL, V58, P814, DOI 10.1124/mol.58.4.814; Sanchez C, 2001, MOL PHARMACOL, V59, P955, DOI 10.1124/mol.59.5.955; Sanchez C, 1998, MOL PHARMACOL, V54, P834, DOI 10.1124/mol.54.5.834; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Song XF, 2009, J BIOL CHEM, V284, P685, DOI 10.1074/jbc.M806124200; Song ZH, 1999, MOL PHARMACOL, V56, P834; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Thomas RL, 2009, J PHARMACOL EXP THER, V331, P1086, DOI 10.1124/jpet.109.160242; Tschammer N, 2011, MOL PHARMACOL, V79, P575, DOI 10.1124/mol.110.068106; Turu G, 2010, J MOL ENDOCRINOL, V44, P75, DOI 10.1677/JME-08-0190; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Zhang RD, 2005, MOL PHARMACOL, V68, P69, DOI 10.1124/mol.104.007823; Zheng H, 2008, MOL PHARMACOL, V73, P178, DOI 10.1124/mol.107.039842	74	107	111	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12070	12082		10.1074/jbc.M111.316463	http://dx.doi.org/10.1074/jbc.M111.316463			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22343625	Green Published, hybrid			2022-12-25	WOS:000302782200044
J	Zhang, T; Berrocal, JG; Yao, J; DuMond, ME; Krishnakumar, R; Ruhl, DD; Ryu, KW; Gamble, MJ; Kraus, WL				Zhang, Tong; Berrocal, Jhoanna G.; Yao, Jie; DuMond, Michelle E.; Krishnakumar, Raga; Ruhl, Donald D.; Ryu, Keun Woo; Gamble, Matthew J.; Kraus, W. Lee			Regulation of Poly(ADP-ribose) Polymerase-1-dependent Gene Expression through Promoter-directed Recruitment of a Nuclear NAD(+) Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE; COLONY-ENHANCING FACTOR; CHROMATIN-STRUCTURE; DNA-BINDING; WALLERIAN DEGENERATION; BIOSYNTHETIC ENZYME; AXON DEGENERATION; CATALYTIC DOMAINS; POLYMERASE PARP; TRANSCRIPTION	NMNAT-1 and PARP-1, two key enzymes in the NAD(+) metabolic pathway, localize to the nucleus where integration of their enzymatic activities has the potential to control a variety of nuclear processes. Using a variety of biochemical, molecular, cell-based, and genomic assays, we show that NMNAT-1 and PARP-1 physically and functionally interact at target gene promoters in MCF-7 cells. Specifically, we show that PARP-1 recruits NMNAT-1 to promoters where it produces NAD(+) to support PARP-1 catalytic activity, but also enhances the enzymatic activity of PARP-1 independently of NAD(+) production. Furthermore, using two-photon excitation microscopy, we show that NMNAT-1 catalyzes the production of NAD(+) in a nuclear pool that may be distinct from other cellular compartments. In expression microarray experiments, depletion of NMNAT-1 or PARP-1 alters the expression of about 200 protein-coding genes each, with about 10% overlap between the two gene sets. NMNAT-1 enzymatic activity is required for PARP-1-dependent poly(ADP-ribosyl)ation at the promoters of commonly regulated target genes, as well as the expression of those target genes. Collectively, our studies link the enzymatic activities of NMNAT-1 and PARP-1 to the regulation of a set of common target genes through functional interactions at target gene promoters.	[Ryu, Keun Woo; Kraus, W. Lee] Univ Texas SW Med Ctr Dallas, Cecil H & Ida Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA; [Ryu, Keun Woo; Kraus, W. Lee] Univ Texas SW Med Ctr Dallas, Dept Obstet & Gynecol, Basic Res Div, Dallas, TX 75390 USA; [Zhang, Tong; Berrocal, Jhoanna G.; Yao, Jie; DuMond, Michelle E.; Krishnakumar, Raga; Ruhl, Donald D.; Gamble, Matthew J.; Kraus, W. Lee] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Berrocal, Jhoanna G.; Yao, Jie; Krishnakumar, Raga; Kraus, W. Lee] Cornell Univ, Grad Field Biochem Mol & Cell Biol, Ithaca, NY 14853 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Cornell University; Cornell University	Kraus, WL (corresponding author), Univ Texas SW Med Ctr Dallas, Cecil H & Ida Green Ctr Reprod Biol Sci, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	lee.kraus@utsouthwestern.edu	Yao, Jie/E-2229-2017	Yao, Jie/0000-0002-7640-4840; Krishnakumar, Raga/0000-0002-2479-754X	National Institutes of Health from the NIDDK [R01 DK069710]; National Research Service from the NIDDK; Endocrine Society; New York State Health Research Science Board; American Heart Association (AHA); Susan G. Komen Breast Cancer Foundation; Alfred P. Sloan Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069710] Funding Source: NIH RePORTER	National Institutes of Health from the NIDDK; National Research Service from the NIDDK; Endocrine Society; New York State Health Research Science Board; American Heart Association (AHA)(American Heart Association); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK069710 from the NIDDK (to W. L. K.) and a National Research Service award postdoctoral fellowship from the NIDDK (to M. J. G.). This work was also supported by a grant from the Endocrine Society (to W. L. K.); postdoctoral fellowships from the New York State Health Research Science Board (to T. Z.), the American Heart Association (AHA) (to M. J. G.), and the Susan G. Komen Breast Cancer Foundation (to D. D. R.).; and predoctoral fellowships from the Alfred P. Sloan Foundation (to J. G. B.) and the AHA (to R. K.).	Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Berger F, 2007, P NATL ACAD SCI USA, V104, P3765, DOI 10.1073/pnas.0609211104; Bulger M., 1994, METH MOL G, V5, P241; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Conforti L, 2000, P NATL ACAD SCI USA, V97, P11377, DOI 10.1073/pnas.97.21.11377; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Emanuelli M, 2001, J BIOL CHEM, V276, P406, DOI 10.1074/jbc.M008700200; Frizzell KM, 2009, J BIOL CHEM, V284, P33926, DOI 10.1074/jbc.M109.023879; Grubisha O, 2005, FEBS J, V272, P4607, DOI 10.1111/j.1742-4658.2005.04862.x; Hassa PO, 2001, J BIOL CHEM, V276, P45588, DOI 10.1074/jbc.M106528200; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; KEITH G, 1990, ANAL BIOCHEM, V191, P309, DOI 10.1016/0003-2697(90)90224-W; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kininis M, 2007, MOL CELL BIOL, V27, P5090, DOI 10.1128/MCB.00083-07; Kitani T, 2003, FEBS LETT, V544, P74, DOI 10.1016/S0014-5793(03)00476-9; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; Kraus WL, 1999, STEROID NUCL RECEPTO, P167; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Krishnakumar R, 2010, MOL CELL, V39, P736, DOI 10.1016/j.molcel.2010.08.014; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Langelier MF, 2010, J BIOL CHEM, V285, P18877, DOI 10.1074/jbc.M110.105668; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200; Raffaelli N, 2002, BIOCHEM BIOPH RES CO, V297, P835, DOI 10.1016/S0006-291X(02)02285-4; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rongvaux A, 2003, BIOESSAYS, V25, P683, DOI 10.1002/bies.10297; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; Schweiger M, 2001, FEBS LETT, V492, P95, DOI 10.1016/S0014-5793(01)02180-9; Simbulan-Rosenthal CM, 2003, ONCOGENE, V22, P8460, DOI 10.1038/sj.onc.1206897; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Tulin A, 2002, GENE DEV, V16, P2108, DOI 10.1101/gad.1003902; Vishwasrao HD, 2005, J BIOL CHEM, V280, P25119, DOI 10.1074/jbc.M502475200; Wacker DA, 2007, MOL CELL BIOL, V27, P7475, DOI 10.1128/MCB.01314-07; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; WILLIAMS RM, 1994, FASEB J, V8, P804, DOI 10.1096/fasebj.8.11.8070629; Yalowitz JA, 2004, BIOCHEM J, V377, P317, DOI 10.1042/BJ20030518; Yu WQ, 2004, NAT GENET, V36, P1105, DOI 10.1038/ng1426; Zhang J, 2003, BIOESSAYS, V25, P808, DOI 10.1002/bies.10317; Zhang QH, 2002, SCIENCE, V295, P1895; Zhang T, 2010, BBA-PROTEINS PROTEOM, V1804, P1666, DOI 10.1016/j.bbapap.2009.10.022; Zhang T, 2009, J BIOL CHEM, V284, P20408, DOI 10.1074/jbc.M109.016469	51	78	82	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12405	12416		10.1074/jbc.M111.304469	http://dx.doi.org/10.1074/jbc.M111.304469			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334709	hybrid, Green Published			2022-12-25	WOS:000302782200080
J	Kleessen, S; Araujo, WL; Fernie, AR; Nikoloski, Z				Kleessen, Sabrina; Araujo, Wagner L.; Fernie, Alisdair R.; Nikoloski, Zoran			Model-based Confirmation of Alternative Substrates of Mitochondrial Electron Transport Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUX BALANCE ANALYSIS; TRANSFER FLAVOPROTEIN; TCA CYCLE; ARABIDOPSIS; METABOLISM; GROWTH; DEHYDROGENASES; OXIDOREDUCTASE; OPTIMALITY; COMPLEX	Background: There are alternative substrates to the mitochondrial respiration. Results: Data-driven model-based analysis renders predictions of alternative substrates to the mitochondrial respiration. Conclusion: Metabolomics data in conjunction with flux-based models can discriminate among hypotheses based on enzymology alone. Significance: This analysis provides a basic framework for in silico studies of alternative pathways in metabolism.	[Kleessen, Sabrina; Araujo, Wagner L.; Fernie, Alisdair R.; Nikoloski, Zoran] Max Planck Inst Mol Plant Physiol, D-14476 Potsdam, Germany; [Araujo, Wagner L.] Univ Fed Vicosa, Dept Biol Vegetal, BR-36570000 Vicosa, MG, Brazil; [Nikoloski, Zoran] Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany	Max Planck Society; Universidade Federal de Vicosa; University of Potsdam	Nikoloski, Z (corresponding author), Max Planck Inst Mol Plant Physiol, Muehlenberg 1, D-14476 Potsdam, Germany.	nikoloski@mpimp-golm.mpg.de	Araújo, Wagner L./I-3291-2013	Araújo, Wagner L./0000-0002-4796-2616; Nikoloski, Zoran/0000-0003-2671-6763	Max-Planck Society; German Ministry of Science and Education [0313924]	Max-Planck Society(Max Planck Society); German Ministry of Science and Education	Supported by the Max-Planck Society.; Supported by German Ministry of Science and Education Grant 0313924. To whom correspondence should be addressed: Max-Planck Institute of Molecular Plant Physiology, Am Muehlenberg 1, 14476 Potsdam-Golm, Germany. Tel.: 49-331-567-8630; Fax: 49-331-567-8615; E-mail: nikoloski@mpimp-golm.mpg.de.	Araujo WL, 2011, TRENDS PLANT SCI, V16, P489, DOI 10.1016/j.tplants.2011.05.008; Araujo WL, 2011, PLANT PHYSIOL, V157, P55, DOI 10.1104/pp.111.182188; Araujo WL, 2010, PLANT CELL, V22, P1549, DOI 10.1105/tpc.110.075630; Beard DA, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.37; Berkich DA, 2007, J NEUROSCI RES, V85, P3367, DOI 10.1002/jnr.21500; Caldana C, 2011, PLANT J, V67, P869, DOI 10.1111/j.1365-313X.2011.04640.x; Cameron AC, 1996, J BUS ECON STAT, V14, P209, DOI 10.2307/1392433; Cameron AC, 1997, J ECONOMETRICS, V77, P329; CUTHRELL JE, 1987, AICHE J, V33, P1257, DOI 10.1002/aic.690330804; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Dirac Paul, 1958, PRINCIPLES QUANTUM M, P58; Engqvist MKM, 2011, J BIOL CHEM, V286, P11382, DOI 10.1074/jbc.M110.194175; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Fiehn O, 2001, COMP FUNCT GENOM, V2, P155, DOI 10.1002/cfg.82; Gagneur J, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-175; Gianchandani EP, 2010, WIRES SYST BIOL MED, V2, P372, DOI 10.1002/wsbm.60; Grafahrend-Belau E, 2009, PLANT PHYSIOL, V149, P585, DOI 10.1104/pp.108.129635; HANNING I, 1993, PLANT PHYSIOL, V103, P1147, DOI 10.1104/pp.103.4.1147; Holmstrom K., 1999, ADV MODEL OPTIM, V1, P47; Ishizaki K, 2005, PLANT CELL, V17, P2587, DOI 10.1105/tpc.105.035162; Ishizaki K, 2006, PLANT J, V47, P751, DOI 10.1111/j.1365-313X.2006.02826.x; Jin GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016812; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Klamt S, 2003, TRENDS BIOTECHNOL, V21, P64, DOI 10.1016/S0167-7799(02)00034-3; Klitgord Niels, 2010, V22, P41; Luo RY, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100071; Luo RY, 2009, P NATL ACAD SCI USA, V106, P847, DOI 10.1073/pnas.0810731105; Mahadevan R, 2002, BIOPHYS J, V83, P1331, DOI 10.1016/S0006-3495(02)73903-9; Meyer RC, 2007, P NATL ACAD SCI USA, V104, P4759, DOI 10.1073/pnas.0609709104; Michaeli S, 2011, PLANT J, V67, P485, DOI 10.1111/j.1365-313X.2011.04612.x; Mintz-Oron S, 2009, BIOINFORMATICS, V25, pI247, DOI 10.1093/bioinformatics/btp209; Nagele T, 2010, PLANT PHYSIOL, V153, P260, DOI 10.1104/pp.110.154443; O'Connor G, 2009, J NEUROL, V256, P672, DOI 10.1007/s00415-009-0107-z; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Palmieri F, 2011, PLANT J, V66, P161, DOI 10.1111/j.1365-313X.2011.04516.x; Palsson B, 2009, FEBS LETT, V583, P3900, DOI 10.1016/j.febslet.2009.09.031; PASSARELLA S, 1984, BIOCHEM BIOPH RES CO, V121, P770, DOI 10.1016/0006-291X(84)90745-9; Raman K, 2009, BRIEF BIOINFORM, V10, P435, DOI 10.1093/bib/bbp011; Rasmusson AG, 2008, MITOCHONDRION, V8, P47, DOI 10.1016/j.mito.2007.10.004; Redestig H, 2011, ANNU PLANT REV, V43, P261, DOI 10.1002/9781444339956.ch9; Rios-Estepa R, 2007, PHYTOCHEMISTRY, V68, P2351, DOI 10.1016/j.phytochem.2007.04.021; Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Snitkin Evan S, 2008, Genome Inform, V20, P123; Stelling J, 2002, NATURE, V420, P190, DOI 10.1038/nature01166; Struys EA, 2005, AM J HUM GENET, V76, P358, DOI 10.1086/427890; Sweetlove LJ, 2008, BIOCHEM J, V409, P27, DOI 10.1042/BJ20071115; VARMA A, 1994, BIO-TECHNOL, V12, P994, DOI 10.1038/nbt1094-994; VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994; Villadsen JV, 1995, CHEM ENG SCI, V50, P3981, DOI 10.1016/0009-2509(96)81831-8; WAAGE P, 1986, J CHEM EDUC, V63, P1044, DOI 10.1021/ed063p1044; Watmough NJ, 2010, BBA-BIOENERGETICS, V1797, P1910, DOI 10.1016/j.bbabio.2010.10.007; Williams TCR, 2010, PLANT PHYSIOL, V154, P311, DOI 10.1104/pp.110.158535	54	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11122	11131		10.1074/jbc.M111.310383	http://dx.doi.org/10.1074/jbc.M111.310383			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334689	hybrid, Green Published			2022-12-25	WOS:000302780100040
J	Brieger, A; Plotz, G; Hinrichsen, I; Passmann, S; Adam, R; Zeuzem, S				Brieger, Angela; Plotz, Guido; Hinrichsen, Inga; Passmann, Sandra; Adam, Ronja; Zeuzem, Stefan			C-Terminal Fluorescent Labeling Impairs Functionality of DNA Mismatch Repair Proteins	PLOS ONE			English	Article							MISSENSE MUTATIONS; NUCLEAR IMPORT; HMUTL-ALPHA; HUMAN MLH1; MUTL; HMLH1; PMS2; DIMERIZATION; EXPRESSION; INTERFACE	The human DNA mismatch repair (MMR) process is crucial to maintain the integrity of the genome and requires many different proteins which interact perfectly and coordinated. Germline mutations in MMR genes are responsible for the development of the hereditary form of colorectal cancer called Lynch syndrome. Various mutations mainly in two MMR proteins, MLH1 and MSH2, have been identified so far, whereas 55% are detected within MLH1, the essential component of the heterodimer MutL alpha (MLH1 and PMS2). Most of those MLH1 variants are pathogenic but the relevance of missense mutations often remains unclear. Many different recombinant systems are applied to filter out disease-associated proteins whereby fluorescent tagged proteins are frequently used. However, dye labeling might have deleterious effects on MutL alpha's functionality. Therefore, we analyzed the consequences of N- and C-terminal fluorescent labeling on expression level, cellular localization and MMR activity of MutL alpha. Besides significant influence of GFP- or Red-fusion on protein expression we detected incorrect shuttling of single expressed C-terminal GFP-tagged PMS2 into the nucleus and found that C-terminal dye labeling impaired MMR function of MutL alpha. In contrast, N-terminal tagged MutL alpha s retained correct functionality and can be recommended both for the analysis of cellular localization and MMR efficiency.	[Brieger, Angela; Plotz, Guido; Hinrichsen, Inga; Passmann, Sandra; Adam, Ronja; Zeuzem, Stefan] Univ Frankfurt M, Dept Med 1, Frankfurt, Germany	Goethe University Frankfurt	Brieger, A (corresponding author), Univ Frankfurt M, Dept Med 1, Frankfurt, Germany.	a.brieger@em.uni-frankfurt.de	Zeuzem, Stefan/AAE-7435-2019; Plotz, Guido/K-8446-2012	Plotz, Guido/0000-0001-5314-9739	Wilhelm Sander-Stiftung [2005.085.2]; Deutsche Krebsstiftung [109651]; Goethe-University Frankfurt	Wilhelm Sander-Stiftung; Deutsche Krebsstiftung; Goethe-University Frankfurt	This work was supported by grant 2005.085.2 of the Wilhelm Sander-Stiftung, grant 109651 of the Deutsche Krebsstiftung and institutional funds of the Goethe-University Frankfurt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brieger A, 2002, GUT, V51, P677, DOI 10.1136/gut.51.5.677; Brieger A, 2005, MOL CARCINOGEN, V43, P51, DOI 10.1002/mc.20081; Brieger A, 2007, BIOCHEM BIOPH RES CO, V364, P731, DOI 10.1016/j.bbrc.2007.10.010; Brieger A, 2011, GENE CHROMOSOME CANC, V50, P59, DOI 10.1002/gcc.20832; Brieger A, 2010, PROTEOMICS, V10, P3343, DOI 10.1002/pmic.200900672; Cannavo E, 2007, J BIOL CHEM, V282, P2976, DOI 10.1074/jbc.M609989200; Castillejo A, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-12; Cejka P, 2003, EMBO J, V22, P2245, DOI 10.1093/emboj/cdg216; Christensen LL, 2009, FAM CANCER, V8, P489, DOI 10.1007/s10689-009-9274-4; Guarne A, 2004, EMBO J, V23, P4134, DOI 10.1038/sj.emboj.7600412; Guarne A, 2001, EMBO J, V20, P5521, DOI 10.1093/emboj/20.19.5521; Han WP, 2005, J BIOL CHEM, V280, P5089, DOI 10.1074/jbc.M408757200; Hardt K, 2011, FAM CANCER, V10, P273, DOI 10.1007/s10689-011-9431-4; Her CT, 2002, DNA REPAIR, V1, P719, DOI 10.1016/S1568-7864(02)00079-4; Hong Z, 2008, J CELL SCI, V121, P3146, DOI 10.1242/jcs.026393; Jager AC, 2001, ONCOGENE, V20, P3590, DOI 10.1038/sj.onc.1204467; Kosinski J, 2008, J MOL BIOL, V382, P610, DOI 10.1016/j.jmb.2008.06.056; Kosinski J, 2010, HUM MUTAT, V31, P975, DOI 10.1002/humu.21301; Leong V, 2009, MOL CARCINOGEN, V48, P742, DOI 10.1002/mc.20514; Lutzen A, 2008, MUTAT RES-FUND MOL M, V645, P44, DOI 10.1016/j.mrfmmm.2008.08.015; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Mac Partlin M, 2003, ONCOGENE, V22, P819, DOI 10.1038/sj.onc.1206252; Mohd AB, 2006, DNA REPAIR, V5, P347, DOI 10.1016/j.dnarep.2005.11.001; Motley AM, 2006, MOL BIOL CELL, V17, P5298, DOI 10.1091/mbc.E06-05-0452; Ou JH, 2009, GENE CHROMOSOME CANC, V48, P340, DOI 10.1002/gcc.20644; Plotz G, 2006, BIOCHEM BIOPH RES CO, V340, P852, DOI 10.1016/j.bbrc.2005.12.096; Plotz G, 2003, NUCLEIC ACIDS RES, V31, P3217, DOI 10.1093/nar/gkg420; Plotz G, 2006, NUCLEIC ACIDS RES, V34, P6574, DOI 10.1093/nar/gkl944; Raevaara TE, 2005, GASTROENTEROLOGY, V129, P537, DOI 10.1053/j.gastro.2005.06.005; Raevaara TE, 2004, GENE CHROMOSOME CANC, V40, P261, DOI 10.1002/gcc.20040; Raevaara TE, 2003, GASTROENTEROLOGY, V125, P501, DOI 10.1016/S0016-5085(03)00905-3; Snapp EL, 2009, TRENDS CELL BIOL, V19, P649, DOI 10.1016/j.tcb.2009.08.002; Trojan J, 2002, GASTROENTEROLOGY, V122, P211, DOI 10.1053/gast.2002.30296; Weinheimer I, 2010, BIOL CHEM, V391, P271, DOI [10.1515/BC.2010.022, 10.1515/bc.2010.022]; Wu XS, 2003, MOL CELL BIOL, V23, P3320, DOI 10.1128/MCB.23.9.3320-3328.2003	35	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31863	10.1371/journal.pone.0031863	http://dx.doi.org/10.1371/journal.pone.0031863			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348133	Green Published, Green Submitted, gold			2022-12-25	WOS:000302737400053
J	Ssematimba, A; Hagenaars, TJ; de Jong, MCM				Ssematimba, Amos; Hagenaars, Thomas J.; de Jong, Mart C. M.			Modelling the Wind-Borne Spread of Highly Pathogenic Avian Influenza Virus between Farms	PLOS ONE			English	Article							MOUTH-DISEASE VIRUS; SWINE-FEVER VIRUS; LIVESTOCK BUILDINGS; COMMERCIAL POULTRY; AIRBORNE SPREAD; A VIRUS; EPIDEMIC; FOOT; RISK; TRANSMISSION	A quantitative understanding of the spread of contaminated farm dust between locations is a prerequisite for obtaining much-needed insight into one of the possible mechanisms of disease spread between farms. Here, we develop a model to calculate the quantity of contaminated farm-dust particles deposited at various locations downwind of a source farm and apply the model to assess the possible contribution of the wind-borne route to the transmission of Highly Pathogenic Avian Influenza virus (HPAI) during the 2003 epidemic in the Netherlands. The model is obtained from a Gaussian Plume Model by incorporating the dust deposition process, pathogen decay, and a model for the infection process on exposed farms. Using poultry-and avian influenza-specific parameter values we calculate the distance-dependent probability of between-farm transmission by this route. A comparison between the transmission risk pattern predicted by the model and the pattern observed during the 2003 epidemic reveals that the wind-borne route alone is insufficient to explain the observations although it could contribute substantially to the spread over short distance ranges, for example, explaining 24% of the transmission over distances up to 25 km.	[Ssematimba, Amos; Hagenaars, Thomas J.] Univ Wageningen & Res Ctr, CVI, Dept Epidemiol Crisis Org & Diagnost, Lelystad, Netherlands; [Ssematimba, Amos; de Jong, Mart C. M.] Wageningen Univ, Dept Anim Sci, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Ssematimba, A (corresponding author), Univ Wageningen & Res Ctr, CVI, Dept Epidemiol Crisis Org & Diagnost, Lelystad, Netherlands.	amos.ssematimba@wur.nl	Ssematimba, Amos/S-3217-2019; de Jong, Mart C.M./GQQ-0825-2022	Ssematimba, Amos/0000-0002-5407-2478; de Jong, Mart C.M./0000-0002-5339-1995	Dutch Ministry of Economic Affairs, Agriculture and Innovation	Dutch Ministry of Economic Affairs, Agriculture and Innovation	This work was funded by the Dutch Ministry of Economic Affairs, Agriculture and Innovation under the framework: Fonds Economische Structuurverstrekking/Economic Challenges Fund (FES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnink A., 2007, PROCESSES FACTORS AF; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Berge WF, 2000, MATH MODELS ESTIMATI; Boender GJ, 2007, PLOS COMPUT BIOL, V3, P704, DOI 10.1371/journal.pcbi.0030071; Bos MEH, 2009, PREV VET MED, V88, P278, DOI 10.1016/j.prevetmed.2008.12.003; Bouma A, 2003, PREV VET MED, V57, P155, DOI 10.1016/S0167-5877(02)00217-9; Cannon RM, 1999, ENVIRON INT, V25, P713, DOI 10.1016/S0160-4120(99)00049-5; Davis J, 2009, TRANSBOUND EMERG DIS, V56, P31, DOI 10.1111/j.1865-1682.2008.01060.x; DAWSON JR, 1990, J AGR ENG RES, V47, P235, DOI 10.1016/0021-8634(90)80044-U; DIEKMANN O, 1990, J MATH BIOL, V28, P365; DIGIOVANNI F, 1990, J APPL METEOROL, V29, P1352, DOI 10.1175/1520-0450(1990)029&lt;1352:OTMMOP&gt;2.0.CO;2; DONALDSON AI, 1982, VET REC, V110, P53, DOI 10.1136/vr.110.3.53; DRUETT HA, 1952, NATURE, V170, P288, DOI 10.1038/170288a0; EC, 1999, OFF J EUR COMMUNITIE, V203, P53; Elbers ARW, 1999, PREV VET MED, V42, P157, DOI 10.1016/S0167-5877(99)00074-4; Ferguson NM, 2001, NATURE, V413, P542, DOI 10.1038/35097116; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Garske T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000349; GLOSTER J, 1984, VET REC, V114, P234, DOI 10.1136/vr.114.10.234; Gloster J, 2003, VET REC, V152, P525, DOI 10.1136/vr.152.17.525; GLOSTER J, 1981, VET REC, V108, P370, DOI 10.1136/vr.108.17.370; Gustafsson G, 1990, GASER DAMM FJADERFAS, V68, P68; Gustafsson G, CIGR EJOURNAL, VVIII; HALVORSON DA, 1980, AVIAN DIS, V24, P288, DOI 10.2307/1589789; Hess GD, 2008, ENVIRON MODEL ASSESS, V13, P209, DOI 10.1007/s10666-007-9097-3; Hinds W. C., 1999, AEROSOL TECHNOLOGY P; JULIAN RJ, 1989, AVIAN DIS, V33, P174, DOI 10.2307/1591084; Koerkamp PWGG, 1999, J AGR ENG RES, V73, P363, DOI 10.1006/jaer.1999.0426; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Lange A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000536; LIGHTHART B, 1987, APPL ENVIRON MICROB, V53, P1580, DOI 10.1128/AEM.53.7.1580-1583.1987; Mintiens K, 2003, PREV VET MED, V60, P27, DOI 10.1016/S0167-5877(03)00080-1; Pampori Z. A., 2007, International Journal of Poultry Science, V6, P578; PETERSON EW, 1977, MICROBIAL ECOL, V4, P67, DOI 10.1007/BF02010430; Power C. A., 2005, Bulletin of the Aquaculture Association of Canada, V105, P7; Shortridge KF, 1998, VIROLOGY, V252, P331, DOI 10.1006/viro.1998.9488; Spekreijse D, 2011, VET MICROBIOL, V147, P59, DOI 10.1016/j.vetmic.2010.06.012; Stegeman A, 2004, J INFECT DIS, V190, P2088, DOI 10.1086/425583; Stegeman JA, 2002, EPIDEMIOL INFECT, V128, P285, DOI 10.1017/S0950268801006483; Swayne DE, 2000, REV SCI TECH OIE, V19, P463; Takai H, 1998, J AGR ENG RES, V70, P59, DOI 10.1006/jaer.1997.0280; Thomas ME, 2005, PREV VET MED, V69, P1, DOI 10.1016/j.prevetmed.2004.12.001; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Yushu HE, 2006, DUST SPATIAL DISTRIB	45	48	49	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31114	10.1371/journal.pone.0031114	http://dx.doi.org/10.1371/journal.pone.0031114			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348042	Green Published, gold, Green Submitted			2022-12-25	WOS:000302737400009
J	Meng, YJ; Shao, CG				Meng, Yijun; Shao, Chaogang			Large-Scale Identification of Mirtrons in Arabidopsis and Rice	PLOS ONE			English	Article							SMALL RNAS; PARALLEL ANALYSIS; PLANT MICRORNAS; RESOURCE; BIOGENESIS; DROSOPHILA; DATABASE; TARGETS; SIRNAS; SERVER	A new catalog of microRNA (miRNA) species called mirtrons has been discovered in animals recently, which originate from spliced introns of the gene transcripts. However, only one putative mirtron, osa-MIR1429, has been identified in rice (Oryza sativa). We employed a high-throughput sequencing (HTS) data-and structure-based approach to do a genome-wide search for the mirtron candidate in both Arabidopsis (Arabidopsis thaliana) and rice. Five and eighteen candidates were discovered in the two plants respectively. To investigate their biological roles, the targets of these mirtrons were predicted and validated based on degradome sequencing data. The result indicates that the mirtrons could guide target cleavages to exert their regulatory roles post-transcriptionally, which needs further experimental validation.	[Meng, Yijun] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Shao, Chaogang] Huzhou Univ, Coll Life Sci, Huzhou, Peoples R China	Hangzhou Normal University; Huzhou University	Meng, YJ (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China.	mengyijun@zju.edu.cn; shaocg@hutc.zj.cn			National Natural Sciences Foundation of China [31100937]; Hangzhou Normal University	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Hangzhou Normal University	This work was funded by the National Natural Sciences Foundation of China [31100937], the Starting Grant funded by Hangzhou Normal University [Yijun Meng]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Berezikov E, 2007, MOL CELL, V28, P328, DOI 10.1016/j.molcel.2007.09.028; Berezikov E, 2010, NAT GENET, V42, P6, DOI 10.1038/ng0110-6; Brown JWS, 2008, TRENDS PLANT SCI, V13, P335, DOI 10.1016/j.tplants.2008.04.010; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Chung WJ, 2011, GENOME RES, V21, P286, DOI 10.1101/gr.113050.110; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; German MA, 2009, NAT PROTOC, V4, P356, DOI 10.1038/nprot.2009.8; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Huala E, 2001, NUCLEIC ACIDS RES, V29, P102, DOI 10.1093/nar/29.1.102; Johnson C, 2007, NUCLEIC ACIDS RES, V35, pD829, DOI 10.1093/nar/gkl991; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Meng YJ, 2011, BRIEF BIOINFORM, V12, P645, DOI 10.1093/bib/bbq091; Miyoshi K, 2010, MOL GENET GENOMICS, V284, P95, DOI 10.1007/s00438-010-0556-1; Nakano M, 2006, NUCLEIC ACIDS RES, V34, pD731, DOI 10.1093/nar/gkj077; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Steffen P, 2006, BIOINFORMATICS, V22, P500, DOI 10.1093/bioinformatics/btk010; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Westholm JO, 2011, BIOCHIMIE, V93, P1897, DOI 10.1016/j.biochi.2011.06.017; Yuan QP, 2003, NUCLEIC ACIDS RES, V31, P229, DOI 10.1093/nar/gkg059; Zhang YJ, 2005, NUCLEIC ACIDS RES, V33, pW701, DOI 10.1093/nar/gki383; Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107	30	44	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31163	10.1371/journal.pone.0031163	http://dx.doi.org/10.1371/journal.pone.0031163			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348048	Green Published, Green Submitted, gold			2022-12-25	WOS:000302733900026
J	Jollivet, D; Mary, J; Gagniere, N; Tanguy, A; Fontanillas, E; Boutet, I; Hourdez, S; Segurens, B; Weissenbach, J; Poch, O; Lecompte, O				Jollivet, Didier; Mary, Jean; Gagniere, Nicolas; Tanguy, Arnaud; Fontanillas, Eric; Boutet, Isabelle; Hourdez, Stephane; Segurens, Beatrice; Weissenbach, Jean; Poch, Olivier; Lecompte, Odile			Proteome Adaptation to High Temperatures in the Ectothermic Hydrothermal Vent Pompeii Worm	PLOS ONE			English	Article							SYNONYMOUS CODON USAGE; THERMAL-STABILITY; SEQUENCE-ANALYSIS; DISULFIDE BONDS; THERMOSTABILITY; EVOLUTION; SELECTION; PROTEINS; INSIGHTS; MODEL	Taking advantage of the massive genome sequencing effort made on thermophilic prokaryotes, thermal adaptation has been extensively studied by analysing amino acid replacements and codon usage in these unicellular organisms. In most cases, adaptation to thermophily is associated with greater residue hydrophobicity and more charged residues. Both of these characteristics are positively correlated with the optimal growth temperature of prokaryotes. In contrast, little information has been collected on the molecular 'adaptive' strategy of thermophilic eukaryotes. The Pompeii worm A. pompejana, whose transcriptome has recently been sequenced, is currently considered as the most thermotolerant eukaryote on Earth, withstanding the greatest thermal and chemical ranges known. We investigated the amino-acid composition bias of ribosomal proteins in the Pompeii worm when compared to other lophotrochozoans and checked for putative adaptive changes during the course of evolution using codon-based Maximum likelihood analyses. We then provided a comparative analysis of codon usage and amino-acid replacements from a greater set of orthologous genes between the Pompeii worm and Paralvinella grasslei, one of its closest relatives living in a much cooler habitat. Analyses reveal that both species display the same high GC-biased codon usage and amino-acid patterns favoring both positively-charged residues and protein hydrophobicity. These patterns may be indicative of an ancestral adaptation to the deep sea and/or thermophily. In addition, the Pompeii worm displays a set of amino-acid change patterns that may explain its greater thermotolerance, with a significant increase in Tyr, Lys and Ala against Val, Met and Gly. Present results indicate that, together with a high content in charged residues, greater proportion of smaller aliphatic residues, and especially alanine, may be a different path for metazoans to face relatively 'high' temperatures and thus a novelty in thermophilic metazoans.	[Jollivet, Didier; Mary, Jean; Tanguy, Arnaud; Fontanillas, Eric; Boutet, Isabelle; Hourdez, Stephane] CNRS, UMR 7144, Roscoff, France; [Jollivet, Didier; Mary, Jean; Tanguy, Arnaud; Fontanillas, Eric; Boutet, Isabelle; Hourdez, Stephane] Univ Paris 06, UPMC, Stn Biolog Roscoff, Roscoff, France; [Gagniere, Nicolas; Poch, Olivier; Lecompte, Odile] IGBMC, Dept Struct Biol & Genom, Illkirch Graffenstaden, France; [Segurens, Beatrice; Weissenbach, Jean] Genoscope Ctr Natl Sequencage, Evry, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Jollivet, D (corresponding author), CNRS, UMR 7144, Roscoff, France.	jollivet@sb-roscoff.fr	Mary, Jean/H-2344-2011; Lecompte, Odile/N-7992-2019; Lecompte, Odile/F-4741-2011	Mary, Jean/0000-0002-2438-8383; Lecompte, Odile/0000-0002-2005-460X; Lecompte, Odile/0000-0002-2005-460X; Boutet, Isabelle/0000-0003-0619-9316	EU [COGE-CT-2004-505403]; ANR [05-BLAN-0407]; Region Bretagne (PRIRE Amethyst)	EU(European Commission); ANR(French National Research Agency (ANR)); Region Bretagne (PRIRE Amethyst)(Region Bretagne)	This work was funded by the EU FP6 Network of Excellence "Marine Genomics Europe'' (contract EC No COGE-CT-2004-505403, coord. C. Boyen), the ANR 05-BLAN-0407 "AlviStresAdapt'' (coord. D. Jollivet) and the Region Bretagne (PRIRE Amethyst: coord. D. Jollivet). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abkevich VI, 2000, J MOL BIOL, V300, P975, DOI 10.1006/jmbi.2000.3893; ARGOS P, 1979, BIOCHEMISTRY-US, V18, P5698, DOI 10.1021/bi00592a028; Bailly X, 2002, MOL BIOL EVOL, V19, P1421, DOI 10.1093/oxfordjournals.molbev.a004205; Berezovsky IN, 2005, PLOS COMPUT BIOL, V1, P322, DOI 10.1371/journal.pcbi.0010047; Berezovsky IN, 2005, P NATL ACAD SCI USA, V102, P12742, DOI 10.1073/pnas.0503890102; Borgi MA, 2004, BIOCHIMIE, V86, P561, DOI 10.1016/j.biochi.2004.07.003; Cary SC, 1998, NATURE, V391, P545, DOI 10.1038/35286; CHEVALDONNE P, 1992, NATURE, V359, P593, DOI 10.1038/359593b0; DAHLHOFF E, 1991, PHYSIOL ZOOL, V64, P1490, DOI 10.1086/physzool.64.6.30158226; DAOPIN S, 1990, PROTEINS, V7, P198, DOI 10.1002/prot.340070208; de Vendittis E, 2008, J THEOR BIOL, V250, P156, DOI 10.1016/j.jtbi.2007.09.006; Desbruyeres D, 1998, DEEP-SEA RES PT II, V45, P383, DOI 10.1016/S0967-0645(97)00083-0; Duret L, 2002, CURR OPIN GENET DEV, V12, P640, DOI 10.1016/S0959-437X(02)00353-2; ELLIS RJ, 1991, ANNU REV BIOCHEM, V60, P321, DOI 10.1146/annurev.bi.60.070191.001541; Farias Savio T, 2003, Genet Mol Res, V2, P383; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Felsenstein J., 2002, PHYLIP PHYLOGENETIC; Gagniere N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-634; Galtier N, 1997, J MOL EVOL, V44, P632, DOI 10.1007/PL00006186; Girguis PR, 2006, SCIENCE, V312, P231, DOI 10.1126/science.1125286; Glyakina AV, 2007, BIOINFORMATICS, V23, P2231, DOI 10.1093/bioinformatics/btm345; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Haney PJ, 1999, P NATL ACAD SCI USA, V96, P3578, DOI 10.1073/pnas.96.7.3578; Harvey P.H., 1991, COMP METHOD EVOLUTIO; HAYMON RM, 1984, SCIENCE, V223, P1407, DOI 10.1126/science.223.4643.1407; Henscheid KL, 2005, BBA-GENE STRUCT EXPR, V1727, P197, DOI 10.1016/j.bbaexp.2005.01.008; Hickey DA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-117; Hourdez S, 2000, PHYSIOL BIOCHEM ZOOL, V73, P365, DOI 10.1086/316755; IKAI A, 1980, J BIOCHEM-TOKYO, V88, P1895; Isom DG, 2010, P NATL ACAD SCI USA, V107, P16096, DOI 10.1073/pnas.1004213107; JOLLIVET D, 1995, MAR ECOL PROG SER, V123, P125, DOI 10.3354/meps123125; Jollivet D, 1996, BIODIVERS CONSERV, V5, P1619, DOI 10.1007/BF00052119; Kreil DP, 2001, NUCLEIC ACIDS RES, V29, P1608, DOI 10.1093/nar/29.7.1608; Little CTS, 1999, PALAEONTOLOGY, V42, P1043, DOI 10.1111/1475-4983.00110; Lynn DJ, 2002, NUCLEIC ACIDS RES, V30, P4272, DOI 10.1093/nar/gkf546; MATTHEWS BW, 1987, P NATL ACAD SCI USA, V84, P6663, DOI 10.1073/pnas.84.19.6663; MATTHEWS BW, 1993, ANNU REV BIOCHEM, V62, P139, DOI 10.1146/annurev.bi.62.070193.001035; Nishio Y, 2003, GENOME RES, V13, P1572, DOI 10.1101/gr.1285603; Pace CN, 1996, FASEB J, V10, P75, DOI 10.1096/fasebj.10.1.8566551; Paz A, 2004, P NATL ACAD SCI USA, V101, P2951, DOI 10.1073/pnas.0308594100; PEDEN JF, 1999, THESIS U NOTTINGHAM; Piccino P, 2004, P ROY SOC B-BIOL SCI, V271, P2351, DOI 10.1098/rspb.2004.2852; Rambaut A., 1996, SEQUENCE ALIGNMENT E; Romero H, 2003, GENE, V317, P141, DOI 10.1016/S0378-1119(03)00701-7; SERRANO L, 1992, NATURE, V356, P453, DOI 10.1038/356453a0; Shin DS, 2009, J MOL BIOL, V385, P1534, DOI 10.1016/j.jmb.2008.11.031; Sicot FX, 2000, J MOL BIOL, V302, P811, DOI 10.1006/jmbi.2000.4505; Struck TH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-57; SWEET RM, 1983, J MOL BIOL, V171, P479, DOI 10.1016/0022-2836(83)90041-4; Szilagyi A, 2000, STRUCTURE, V8, P493, DOI 10.1016/S0969-2126(00)00133-7; Takano K, 1997, BIOCHEMISTRY-US, V36, P688, DOI 10.1021/bi9621829; Tanguy A, 2007, GENE, V408, P27; Thangudu RR, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-55; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson MJ, 1999, J MOL BIOL, V290, P595, DOI 10.1006/jmbi.1999.2889; Vogt G, 1997, J MOL BIOL, V269, P631, DOI 10.1006/jmbi.1997.1042; Wang GZ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-263; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Xu Z, 2003, J BACTERIOL, V185, P4038, DOI 10.1128/JB.185.14.4038-4049.2003; Yang Z., 2000, PHYLOGENETIC ANAL MA; Zeldovich KB, 2007, PLOS COMPUT BIOL, V3, P62, DOI 10.1371/journal.pcbi.0030005; Zhou XX, 2008, AMINO ACIDS, V34, P25, DOI 10.1007/s00726-007-0589-x	62	13	13	3	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e31150	10.1371/journal.pone.0031150	http://dx.doi.org/10.1371/journal.pone.0031150			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348046	gold, Green Published			2022-12-25	WOS:000302730900020
J	Laparra, JM; Olivares, M; Gallina, O; Sanz, Y				Laparra, Jose Moises; Olivares, Marta; Gallina, Onofrio; Sanz, Yolanda			Bifidobacterium longum CECT 7347 Modulates Immune Responses in a Gliadin-Induced Enteropathy Animal Model	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; REAL-TIME PCR; NF-KAPPA-B; CELIAC-DISEASE; GENE-EXPRESSION; TRANSGENIC MICE; T-CELLS; GLUTEN; RATS; INFLAMMATION	Coeliac disease (CD) is an autoimmune disorder triggered by gluten proteins (gliadin) that involves innate and adaptive immunity. In this study, we hypothesise that the administration of Bifidobacterium longum CECT 7347, previously selected for reducing gliadin immunotoxic effects in vitro, could exert protective effects in an animal model of gliadin-induced enteropathy. The effects of this bacterium were evaluated in newborn rats fed gliadin alone or sensitised with interferon (IFN)-gamma and fed gliadin. Jejunal tissue sections were collected for histological, NF kappa B mRNA expression and cytokine production analyses. Leukocyte populations and T-cell subsets were analysed in peripheral blood samples. The possible translocation of the bacterium to different organs was determined by plate counting and the composition of the colonic microbiota was quantified by real-time PCR. Feeding gliadin alone reduced enterocyte height and peripheral CD4+ cells, but increased CD4+/Foxp3+ T and CD8+ cells, while the simultaneous administration of B. longum CECT 7347 exerted opposite effects. Animals sensitised with IFN-gamma and fed gliadin showed high cellular infiltration, reduced villi width and enterocyte height. Sensitised animals also exhibited increased NF kappa B mRNA expression and TNF-alpha production in tissue sections. B. longum CECT 7347 administration increased NFkB expression and IL-10, but reduced TNF-alpha, production in the enteropathy model. In sensitised gliadin-fed animals, CD4+, CD4+/Foxp3+ and CD8+ T cells increased, whereas the administration of B. longum CECT 7347 reduced CD4+ and CD4+/Foxp3+ cell populations and increased CD8+ T cell populations. The bifidobacterial strain administered represented between 75-95% of the total bifidobacteria isolated from all treated groups, and translocation to organs was not detected. These findings indicate that B. longum attenuates the production of inflammatory cytokines and the CD4+ T-cell mediated immune response in an animal model of gliadin-induced enteropathy.	[Laparra, Jose Moises; Olivares, Marta; Gallina, Onofrio; Sanz, Yolanda] Natl Res Council IATA CSIC, Inst Agrochem & Food Technol, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA)	Laparra, JM (corresponding author), Natl Res Council IATA CSIC, Inst Agrochem & Food Technol, Valencia, Spain.	yolsanz@iata.csic.es	Sevilla, Marta Olivares/A-7691-2019; Olivares, Marta/O-9899-2019; Sanz, Yolanda/H-5498-2012; Llopis, José Moisés Laparra/AAB-6151-2019; Llopis, Jose Moises Laparra/M-2882-2015	Olivares, Marta/0000-0002-7966-2781; Sanz, Yolanda/0000-0002-1615-1976; Llopis, José Moisés Laparra/0000-0002-9378-2552; Llopis, Jose Moises Laparra/0000-0002-9378-2552	Spanish Ministry of Science and Innovation (MICINN, Spain) [AGL2007-66126-C03-01/ALI, CEN-20091006, CSD2007-00063]; Consejo Superior de Investigaciones Cientificas (CSIC, National Research Council); MICINN, Spain [CEN-20091006]	Spanish Ministry of Science and Innovation (MICINN, Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejo Superior de Investigaciones Cientificas (CSIC, National Research Council); MICINN, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grants AGL2007-66126-C03-01/ALI, CEN-20091006 and Consolider Fun-C-Food CSD2007-00063 from the Spanish Ministry of Science and Innovation (MICINN, Spain). The scholarship to Dr. Gallina from Consejo Superior de Investigaciones Cientificas (CSIC, National Research Council) is fully acknowledged. Dr. Laparra has a postdoctoral contract within the programme "Juan de la Cierva'' (MICINN, Spain) and Dr. Olivares has a contract supported by grant CEN-20091006 (MICINN, Spain), which are also acknowledged. The funders had no role in any stage of study design, data collection, execution interpretation of the results or decision to publish and preparation of the manuscript.	AKOPYANZ N, 1992, NUCLEIC ACIDS RES, V20, P5137, DOI 10.1093/nar/20.19.5137; [Anonymous], LAB RAT, VI; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Black KE, 2002, J IMMUNOL, V169, P5595, DOI 10.4049/jimmunol.169.10.5595; Collado MC, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-232; Clemente MG, 2003, GUT, V52, P218, DOI 10.1136/gut.52.2.218; Collado MC, 2009, J CLIN PATHOL, V62, P264, DOI 10.1136/jcp.2008.061366; D'Arienzo R, 2011, SCAND J IMMUNOL, V74, P335, DOI 10.1111/j.1365-3083.2011.02582.x; D'Arienzo R, 2009, EUR J IMMUNOL, V39, P3552, DOI 10.1002/eji.200839161; De Palma G, 2010, J LEUKOCYTE BIOL, V87, P765, DOI 10.1189/jlb.0709471; Frisullo G, 2009, HUM IMMUNOL, V70, P430, DOI 10.1016/j.humimm.2009.04.006; Hoffman RA, 2000, AM J PHYSIOL-GASTR L, V278, pG886, DOI 10.1152/ajpgi.2000.278.6.G886; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Jelinkova L, 2004, FEBS LETT, V571, P81, DOI 10.1016/j.febslet.2004.06.057; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kivling A, 2008, ANN NY ACAD SCI, V1150, P273, DOI 10.1196/annals.1447.018; Kozakova H, 2000, PHYSIOL RES, V49, P665; Laparra JM, 2010, J CELL BIOCHEM, V109, P801, DOI 10.1002/jcb.22459; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maiuri MC, 2003, J MOL MED-JMM, V81, P373, DOI 10.1007/s00109-003-0440-0; Malinen E, 2003, MICROBIOL-SGM, V149, P269, DOI 10.1099/mic.0.25975-0; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Medina M, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-19; Nadal I, 2007, J MED MICROBIOL, V56, P1669, DOI 10.1099/jmm.0.47410-0; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Schuppan D, 2009, GASTROENTEROLOGY, V137, P1912, DOI 10.1053/j.gastro.2009.09.008; Stepankova R, 2003, J PEDIATR GASTR NUTR, V36, P96, DOI 10.1097/00005176-200301000-00018; Stepankova R, 1996, SCAND J GASTROENTERO, V31, P551, DOI 10.3109/00365529609009127; Sutas Y, 1997, J PEDIATR GASTR NUTR, V24, P162, DOI 10.1097/00005176-199702000-00009; Terrazzano G, 2007, J IMMUNOL, V179, P372, DOI 10.4049/jimmunol.179.1.372; Thomas KE, 2006, J IMMUNOL, V176, P2512, DOI 10.4049/jimmunol.176.4.2512; TlaskalovaHogenova H, 1997, ANN NY ACAD SCI, V815, P503, DOI 10.1111/j.1749-6632.1997.tb52115.x; TRONCONE R, 1991, GUT, V32, P871, DOI 10.1136/gut.32.8.871; Verdu EF, 2008, AM J PHYSIOL-GASTR L, V294, pG217, DOI 10.1152/ajpgi.00225.2007; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Westendorf AM, 2006, GASTROENTEROLOGY, V131, P510, DOI 10.1053/j.gastro.2006.05.015; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Wieser H, 2008, CEREAL CHEM, V85, P1, DOI 10.1094/CCHEM-85-1-0001; WILLIAMS JG, 1992, J LEUKOCYTE BIOL, V52, P579, DOI 10.1002/jlb.52.6.579; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347	40	98	100	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e30744	10.1371/journal.pone.0030744	http://dx.doi.org/10.1371/journal.pone.0030744			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348021	gold, Green Published, Green Submitted			2022-12-25	WOS:000302730900014
J	Gormanns, P; Reckow, S; Poczatek, JC; Turck, CW; Lechene, C				Gormanns, Philipp; Reckow, Stefan; Poczatek, J. Collin; Turck, Christoph W.; Lechene, Claude			Segmentation of Multi-Isotope Imaging Mass Spectrometry Data for Semi-Automatic Detection of Regions of Interest	PLOS ONE			English	Article							SUPPORT; BACTERIA	Multi-isotope imaging mass spectrometry (MIMS) associates secondary ion mass spectrometry (SIMS) with detection of several atomic masses, the use of stable isotopes as labels, and affiliated quantitative image-analysis software. By associating image and measure, MIMS allows one to obtain quantitative information about biological processes in subcellular domains. MIMS can be applied to a wide range of biomedical problems, in particular metabolism and cell fate [1,2,3]. In order to obtain morphologically pertinent data from MIMS images, we have to define regions of interest (ROIs). ROIs are drawn by hand, a tedious and time-consuming process. We have developed and successfully applied a support vector machine (SVM) for segmentation of MIMS images that allows fast, semi-automatic boundary detection of regions of interests. Using the SVM, high-quality ROIs (as compared to an expert's manual delineation) were obtained for 2 types of images derived from unrelated data sets. This automation simplifies, accelerates and improves the post-processing analysis of MIMS images. This approach has been integrated into "Open MIMS,'' an ImageJ-plugin for comprehensive analysis of MIMS images that is available online at http://www.nrims.hms.harvard.edu/NRIMS_ImageJ.php.	[Gormanns, Philipp; Reckow, Stefan; Turck, Christoph W.] Max Planck Inst Psychiat, Munich, Germany; [Poczatek, J. Collin; Lechene, Claude] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Poczatek, J. Collin; Lechene, Claude] Brigham & Womens Hosp, Cambridge, MA USA	Max Planck Society; Harvard University; Harvard University; Brigham & Women's Hospital	Gormanns, P (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	cpl@harvard.edu			National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering [5P41 EB001974-10]; National Institutes of Health/National Institute on Aging [1R21AG034641-01, RFA-AG-11-001]; Ellison Medical Foundation [AG-SS-2215-08]; NIH/NCRR Center for Integrative Biomedical Computing [2P41 RR0112553-12]; DOE SciDAC Visualization and Analytics Center for Enabling Technologies [DEFC0206ER25781]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG034641] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation(Lawrence Ellison Foundation); NIH/NCRR Center for Integrative Biomedical Computing(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DOE SciDAC Visualization and Analytics Center for Enabling Technologies(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded through the following grants: National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering 5P41 EB001974-10, National Institutes of Health/National Institute on Aging 1R21AG034641-01 and RFA-AG-11-001, and Ellison Medical Foundation AG-SS-2215-08. http://www.nibib.nih.gov/ http://www.nia.nih.gov/ http://www.ellisonfoundation.org/index.jsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank R. Whitaker for suggesting and F. Kashem for implementing the Nelder-Mead parameter search, and H. Miniman for manuscript editing. Part of this work was made possible in part by software funded by the NIH/NCRR Center for Integrative Biomedical Computing, 2P41 RR0112553-12 and the DOE SciDAC Visualization and Analytics Center for Enabling Technologies, DEFC0206ER25781.	[Anonymous], IMAGEVIS3D REAL TIM; [Anonymous], SEG3D VOL IM SEGM VI; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cohen G., 2005, FLAIRS C, P431; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; El-Naqa I, 2002, IEEE T MED IMAGING, V21, P1552, DOI 10.1109/TMI.2002.806569; Frank E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007821; Guyon I, 2002, MACHINE LEARNING, V46; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; Hua SJ, 2001, J MOL BIOL, V308, P397, DOI 10.1006/jmbi.2001.4580; Kressel UHG, 1999, ADVANCES IN KERNEL METHODS, P255; Lechene Claude, 2006, J Biol, V5, P20, DOI 10.1186/jbiol42; Lechene CP, 2007, SCIENCE, V317, P1563, DOI 10.1126/science.1145557; McMahon G, 2006, J AM SOC MASS SPECTR, V17, P1181, DOI 10.1016/j.jasms.2006.04.031; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; PAL NR, 1993, PATTERN RECOGN, V26, P1277, DOI 10.1016/0031-3203(93)90135-J; Schu┬lkopf B., 2004, KERNEL METHODS COMPU; Shawe-Taylor J., 2000, INTRO SUPPORT VECTOR; Steinhauser M, NATURE IN PRESS; Szekely G, 2000, KUENSTLICHE INTELLIG, V3, P18; Zawadzki RJ, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2772658; Zhang D-S, NATURE IN PRESS; Zhang XG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-197	26	26	26	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e30576	10.1371/journal.pone.0030576	http://dx.doi.org/10.1371/journal.pone.0030576			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347386	Green Published, Green Submitted, gold			2022-12-25	WOS:000302730200004
J	Tang, Q; Qin, D; Lv, ZG; Zhu, XL; Ma, XT; Yan, Q; Zeng, Y; Guo, YY; Feng, NH; Lu, C				Tang, Qiao; Qin, Di; Lv, Zhigang; Zhu, Xiaolei; Ma, Xinting; Yan, Qin; Zeng, Yi; Guo, Yuanyuan; Feng, Ninghan; Lu, Chun			Herpes Simplex Virus Type 2 Triggers Reactivation of Kaposi's Sarcoma-Associated Herpesvirus from Latency and Collaborates with HIV-1 Tat	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NF-KAPPA-B; LYTIC CYCLE REPLICATION; LYMPHOMA CELL-LINE; GENE-EXPRESSION; INFECTION; KSHV; HUMAN-HERPESVIRUS-8; ACTIVATION; INDUCTION	Kaposi's sarcoma-associated herpesvirus (KSHV) infection was necessary but not sufficient for Kaposi's sarcoma (KS) development without other cofactors. Previously, we identified that both human immunodeficiency type 1 (HIV-1) Tat and herpes simplex virus 1 (HSV-1) were important cofactors reactivating KSHV from latency. Here, we further investigated the potential of herpes simplex virus 2 (HSV-2) to influence KSHV replication and examined the role of Tat in this procedure. We demonstrated that HSV-2 was a potentially important factor in the pathogenesis of KS, as determined by production of lytic phase mRNA transcripts, viral proteins and infectious viral particles in BCBL-1 cells. These results were further confirmed by an RNA interference experiment using small interfering RNA targeting KSHV Rta and a luciferase reporter assay testing Rta promoter-driven luciferase activity. Mechanistic studies showed that HSV-2 infection activated nuclear factor-kappa B (NF-kappa B) signaling pathway. Inhibition of NF-kappa B pathway enhanced HSV-2-mediated KSHV activation, whereas activation of NF-kappa B pathway suppressed KSHV replication in HSV-2-infected BCBL-1 cells. Additionally, ectopic expression of Tat enhanced HSV-2-induced KSHV replication. These novel findings suggest a role of HSV-2 in the pathogenesis of KS and provide the first laboratory evidence that Tat may participate HSV-2-mediated KSHV activation, implying the complicated pathogenesis of acquired immunodeficiency syndrome (AIDS)-related KS (AIDS-KS) patients.	[Tang, Qiao; Lu, Chun] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Tang, Qiao; Lu, Chun] Nanjing Med Univ, Key Lab Pathogen Biol Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Tang, Qiao; Qin, Di; Lv, Zhigang; Zhu, Xiaolei; Ma, Xinting; Yan, Qin; Guo, Yuanyuan; Lu, Chun] Nanjing Med Univ, Dept Microbiol & Immunol, Nanjing, Jiangsu, Peoples R China; [Tang, Qiao] Nanjing Med Univ, Affiliated Nanjing Hosp 1, Dept Clin Lab, Nanjing, Jiangsu, Peoples R China; [Lv, Zhigang] Jiangsu Prov Official Hosp, Dept Clin Lab, Nanjing, Jiangsu, Peoples R China; [Zeng, Yi] Youjiang Med Coll Nationalities, Dept Microbiol & Immunol, Bose, Peoples R China; [Feng, Ninghan] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Youjiang Medical University for Nationalities; Nanjing Medical University	Tang, Q (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	clu@njmu.edu.cn	Feng, ninghan/ABB-3726-2021; Feng, Ninghan/ABA-8996-2021	Lu, Chun/0000-0002-6078-9352	National Basic Research Program of China (973 Program) [2011CB504803]; National Natural Science Foundation of China [30972619, 30900064, 81071345]; Natural Science Foundation of Ministry of Education of Jiangsu Province [10KJA310032, 09KJB310007]; Research Fund for the Doctoral Program of Higher Education of China (New Teacher Fund) [20093234120004]; Nanjing Medical Science and Technique Development Foundation [ZKX10002]; Ministry of Health of Jiangsu Province [XK200731]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Ministry of Education of Jiangsu Province; Research Fund for the Doctoral Program of Higher Education of China (New Teacher Fund); Nanjing Medical Science and Technique Development Foundation; Ministry of Health of Jiangsu Province	This work was supported by grants from the National Basic Research Program of China (973 Program) (2011CB504803 http://www.973.gov.cn/English/Index.aspx), National Natural Science Foundation of China (grants 30972619 to CL, 30900064 to DQ, and 81071345 to YZ http://www.nsfc.gov.cn/Portal0/default124.htm), Natural Science Foundation of Ministry of Education of Jiangsu Province (great project 10KJA310032 to CL and grant 09KJB310007 to DQ http://www.jsjyt.gov.cn/), Research Fund for the Doctoral Program of Higher Education of China (New Teacher Fund, grant 20093234120004 to DQ http://www.cutech.edu.cn/cn/index.htm), the Key Program of Nanjing Medical Science and Technique Development Foundation (ZKX10002 to QT http://www.njh.gov.cn/), and the Ministry of Health of Jiangsu Province (grant XK200731 http://www.jswst.gov.cn/gb/jsswst/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar J, 2009, FEBS J, V276, P7228, DOI 10.1111/j.1742-4658.2009.07402.x; Arora Anita, 2007, Cancer Treat Res, V133, P21; Bergstrom T, 1996, INTERVIROLOGY, V39, P176, DOI 10.1159/000150493; Blauvelt A, 1997, NEW ENGL J MED, V336, P1837, DOI 10.1056/NEJM199706193362517; Brown HJ, 2003, J VIROL, V77, P8532, DOI 10.1128/JVI.77.15.8532-8540.2003; Canadas MP, 2010, J CLIN VIROL; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chen XY, 2009, NEOPLASIA, V11, P1272, DOI 10.1593/neo.09494; Deng H, 2007, CURR TOP MICROBIOL, V312, P157; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Ganem D, 2010, J CLIN INVEST, V120, P939, DOI 10.1172/JCI40567; Gray R, 2010, NEW ENGL J MED, V362, P1740, DOI 10.1056/NEJMc1002408; Grossmann C, 2008, VIROLOGY, V375, P94, DOI 10.1016/j.virol.2007.12.044; Hancock MH, 2010, J VIROL, V84, P1366, DOI 10.1128/JVI.01727-09; Izumiya Y, 2009, J VIROL, V83, P4435, DOI 10.1128/JVI.01999-08; Johnston C, 2008, J INFECT DIS, V198, P31, DOI 10.1086/588676; Kao YS, 1999, AM J HEMATOL, V62, P93, DOI 10.1002/(SICI)1096-8652(199910)62:2<93::AID-AJH5>3.3.CO;2-Z; Katano H, 2000, JPN J INFECT DIS, V53, P137; Kim S, 2004, J BIOL CHEM, V279, P4285, DOI 10.1074/jbc.M308383200; Kim YC, 2000, J DERMATOL SCI, V24, P38, DOI 10.1016/S0923-1811(00)00080-3; Koelle DM, 2008, ANNU REV MED, V59, P381, DOI 10.1146/annurev.med.59.061606.095540; Krishnan HH, 2004, J VIROL, V78, P3601, DOI 10.1128/JVI.78.7.3601-3620.2004; Lei XF, 2010, NAT CELL BIOL, V12, P193, DOI 10.1038/ncb2019; Li H, 2009, BIOCHEM BIOPH RES CO, V379, P686, DOI 10.1016/j.bbrc.2008.12.150; Li XD, 2011, J VIROL, V85, P715, DOI 10.1128/JVI.01742-10; Lu C, 2005, AM J PATHOL, V166, P173, DOI 10.1016/S0002-9440(10)62242-0; Malmgaard L, 2000, J GEN VIROL, V81, P3011, DOI 10.1099/0022-1317-81-12-3011; Malope BI, 2008, AIDS, V22, P519, DOI 10.1097/QAD.0b013e3282f46582; Merat R, 2002, INT J CANCER, V97, P791, DOI 10.1002/ijc.10086; Muller WJ, 2009, J GEN VIROL, V90, P1153, DOI 10.1099/vir.0.008771-0; Nikolic DS, 2010, J INVEST DERMATOL, V130, P352, DOI 10.1038/jid.2009.227; ONeill E, 1997, J VIROL, V71, P4791, DOI 10.1128/JVI.71.6.4791-4797.1997; OSTROVE JM, 1987, J VIROL, V61, P3726, DOI 10.1128/JVI.61.12.3726-3732.1987; Palliser D, 2006, NATURE, V439, P89, DOI 10.1038/nature04263; Palo G, 2001, Herpes, V8, P50; Powles T, 2009, ANN ONCOL, V20, P775, DOI 10.1093/annonc/mdn697; Qin D, 2008, CELL MICROBIOL, V10, P713, DOI 10.1111/j.1462-5822.2007.01079.x; Qin D, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-240; Sarmati L, 2007, J MED VIROL, V79, P167, DOI 10.1002/jmv.20774; Schafer SL, 1996, J VIROL, V70, P6937, DOI 10.1128/JVI.70.10.6937-6946.1996; Sgarbanti M, 2004, ONCOGENE, V23, P5770, DOI 10.1038/sj.onc.1207707; Staudt MR, 2007, CURR TOP MICROBIOL, V312, P71; Suligoi B, 2005, AM J TROP MED HYG, V72, P33, DOI 10.4269/ajtmh.2005.72.33; Sun Q, 2006, ONCOGENE, V25, P2717, DOI 10.1038/sj.onc.1209298; Sun R, 1999, J VIROL, V73, P2232, DOI 10.1128/JVI.73.3.2232-2242.1999; Sunil Meena, 2010, Curr Infect Dis Rep, V12, P147, DOI 10.1007/s11908-010-0092-5; Tan Darrell H S, 2009, Can J Infect Dis Med Microbiol, V20, pe1; Varthakavi V, 1999, J VIROL, V73, P10329, DOI 10.1128/JVI.73.12.10329-10338.1999; Varthakavi V, 2002, VIROLOGY, V297, P270, DOI 10.1006/viro.2002.1434; Vieira J, 2001, J VIROL, V75, P1378, DOI 10.1128/JVI.75.3.1378-1386.2001; Volpi A, 2004, J MED VIROL, V74, P467, DOI 10.1002/jmv.20200; Ye FC, 2008, J VIROL, V82, P4235, DOI 10.1128/JVI.02370-07; Zeng Y, 2007, J VIROL, V81, P2401, DOI 10.1128/JVI.02024-06; Zhu XL, 2011, J MOL BIOL, V410, P1035, DOI 10.1016/j.jmb.2011.03.055	54	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31652	10.1371/journal.pone.0031652	http://dx.doi.org/10.1371/journal.pone.0031652			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347501	Green Published, gold, Green Submitted			2022-12-25	WOS:000302730200029
J	Liger-Belair, G; Bourget, M; Pron, H; Polidori, G; Cilindre, C				Liger-Belair, Gerard; Bourget, Marielle; Pron, Herve; Polidori, Guillaume; Cilindre, Clara			Monitoring Gaseous CO2 and Ethanol above Champagne Glasses: Flute versus Coupe, and the Role of Temperature	PLOS ONE			English	Article							TASTING CONDITIONS; BUBBLE NUCLEATION; CARBONATED WATER; FLOW PATTERNS; PERCEPTION; WINE; ATTRIBUTES; KINETICS; LEVEL; SHAPE	In champagne tasting, gaseous CO2 and volatile organic compounds progressively invade the headspace above glasses, thus progressively modifying the chemical space perceived by the consumer. Simultaneous quantification of gaseous CO2 and ethanol was monitored through micro-gas chromatography (mu GC), all along the first 15 minutes following pouring, depending on whether a volume of 100 mL of champagne was served into a flute or into a coupe. The concentration of gaseous CO2 was found to be significantly higher above the flute than above the coupe. Moreover, a recently developed gaseous CO2 visualization technique based on infrared imaging was performed, thus confirming this tendency. The influence of champagne temperature was also tested. As could have been expected, lowering the temperature of champagne was found to decrease ethanol vapor concentrations in the headspace of a glass. Nevertheless, and quite surprisingly, this temperature decrease had no impact on the level of gaseous CO2 found above the glass. Those results were discussed on the basis of a multiparameter model which describes fluxes of gaseous CO2 escaping the liquid phase into the form of bubbles.	[Liger-Belair, Gerard] UFR Sci Exactes & Nat, CNRS, Grp Spectrometrie Mol & Atmospher, Equipe Effervescence,UMR 7331, Reims, France; [Liger-Belair, Gerard; Cilindre, Clara] Univ Reims, Lab Oenol & Chim Appl, URVVC SE UPRES EA 2069, Reims, France; [Bourget, Marielle; Pron, Herve; Polidori, Guillaume] Univ Reims, Lab Thermomecan, Grp Rech Sci Ingenieur, Reims, France; [Cilindre, Clara] Univ Reims, Lab Stress Def & Reprod Plantes, URVVC SE UPRES EA 2069, Reims, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Reims Champagne-Ardenne; Universite de Reims Champagne-Ardenne; Universite de Reims Champagne-Ardenne; Universite de Reims Champagne-Ardenne	Liger-Belair, G (corresponding author), UFR Sci Exactes & Nat, CNRS, Grp Spectrometrie Mol & Atmospher, Equipe Effervescence,UMR 7331, BP 1039, Reims, France.	gerard.liger-belair@univ-reims.fr; clara.cilindre@univ-reims.fr		Cilindre, Clara/0000-0003-0639-9078; Polidori, Guillaume/0000-0002-6078-6397	Association Recherche Oenologie Champagne et Universite (Reims, France); Region Champagne-Ardenne; Ville de Reims; Conseil General de la Marne	Association Recherche Oenologie Champagne et Universite (Reims, France); Region Champagne-Ardenne(Region Grand-Est); Ville de Reims; Conseil General de la Marne	The authors express their gratitude to the Association Recherche Oenologie Champagne et Universite (Reims, France) for financial support. The authors are also indebted to the Region Champagne-Ardenne, the Ville de Reims, and the Conseil General de la Marne for supporting their research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brand G, 2006, NEUROSCI BIOBEHAV R, V30, P908, DOI 10.1016/j.neubiorev.2006.01.002; CAIN WS, 1980, NATURE, V284, P255, DOI 10.1038/284255a0; Chandrashekar J, 2009, SCIENCE, V326, P443, DOI 10.1126/science.1174601; Cilindre C, 2011, J AGR FOOD CHEM, V59, P7317, DOI 10.1021/jf200748t; COMETTOMUNIZ JE, 1984, CHEM SENSES, V8, P315, DOI 10.1093/chemse/8.4.315; COMETTOMUNIZ JE, 1990, PERCEPT PSYCHOPHYS, V47, P391, DOI 10.3758/BF03210879; COOK JM, 1985, J CHROMATOGR SCI, V23, P57, DOI 10.1093/chromsci/23.2.57; Cowart BJ, 1998, CHEM SENSES, V23, P397, DOI 10.1093/chemse/23.4.397; Dessirier JM, 2000, CHEM SENSES, V25, P277, DOI 10.1093/chemse/25.3.277; Dunkel A, 2010, ANGEW CHEM INT EDIT, V49, P2975, DOI 10.1002/anie.200906978; Duteurtre B, 2010, CHAMPAGNE TRADITION; Etiope G, 1997, J CHROMATOGR A, V775, P243, DOI 10.1016/S0021-9673(97)00297-5; GOLDNER MC, 2009, J SENS STUD, V24, P243, DOI 10.1111/j.1745-459X.2009.00208.x; GORDGE DN, 1993, EXP FLUIDS, V14, P409, DOI 10.1007/BF00190195; GREEN BG, 1992, CHEM SENSES, V17, P435, DOI 10.1093/chemse/17.4.435; HARPER SJ, 1993, J FOOD SCI, V58, P893, DOI 10.1111/j.1365-2621.1993.tb09386.x; Hewson L, 2009, CHEMOSENS PERCEPT, V2, P94, DOI 10.1007/s12078-009-9043-7; Hummel T, 2003, APPETITE, V41, P197, DOI 10.1016/S0195-6663(03)00082-5; Kleemann AM, 2009, PHYSIOL BEHAV, V97, P401, DOI 10.1016/j.physbeh.2009.03.013; Lawless H. T., 2010, SENSORY EVALUATION F; Liger-Belair G, 2006, ANN PHYS-PARIS, V31, P1, DOI 10.1051/anphys:2006007; Liger-Belair G, 2008, CHEM SOC REV, V37, P2490, DOI 10.1039/b717798b; Liger-Belair G, 2007, LANGMUIR, V23, P10976, DOI 10.1021/la7017693; Liger-Belair G, 2007, J AGR FOOD CHEM, V55, P882, DOI 10.1021/jf062973+; Liger-Belair G, 2006, J PHYS CHEM B, V110, P21145, DOI 10.1021/jp0640427; Liger-Belair G, 2012, ANAL CHIM ACTA, V732, P1, DOI 10.1016/j.aca.2011.10.007; Liger-Belair G, 2010, J AGR FOOD CHEM, V58, P8768, DOI 10.1021/jf101239w; Liger-Belair G, 2009, P NATL ACAD SCI USA, V106, P16545, DOI 10.1073/pnas.0906483106; Liger-Belair G, 2009, J AGR FOOD CHEM, V57, P4939, DOI 10.1021/jf900804j; Liger-Belair G, 2009, J AGR FOOD CHEM, V57, P1997, DOI 10.1021/jf803278b; Livermore A, 2004, CHEM SENSES, V29, P41, DOI 10.1093/chemse/bjh013; Mattes RD, 2001, PHYSIOL BEHAV, V72, P217, DOI 10.1016/S0031-9384(00)00397-8; Meusel T, 2010, PAIN, V151, P516, DOI 10.1016/j.pain.2010.08.013; Mondini C, 2010, TALANTA, V81, P849, DOI 10.1016/j.talanta.2010.01.026; Polaskova P, 2008, CHEM SOC REV, V37, P2478, DOI 10.1039/b714455p; Polidori G, 2009, AM SCI, V97, P294, DOI 10.1511/2009.79.294; Robinson AL, 2009, J AGR FOOD CHEM, V57, P10313, DOI 10.1021/jf902586n; Ryan D, 2008, TRENDS FOOD SCI TECH, V19, P383, DOI 10.1016/j.tifs.2008.01.007; THURAUF N, 1991, NEUROSCI LETT, V128, P297, DOI 10.1016/0304-3940(91)90283-Y; Tsachaki M, 2008, J AGR FOOD CHEM, V56, P5308, DOI 10.1021/jf800225y; Vilanova M, 2008, J SENS STUD, V23, P114, DOI 10.1111/j.1745-459X.2007.00145.x; YAU NJN, 1991, CHEM SENSES, V16, P337, DOI 10.1093/chemse/16.4.337	42	26	27	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30628	10.1371/journal.pone.0030628	http://dx.doi.org/10.1371/journal.pone.0030628			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347390	Green Published, gold, Green Submitted			2022-12-25	WOS:000302730100019
J	Rentas, S; Saberianfar, R; Grewal, C; Kanippayoor, R; Mishra, M; McCollum, D; Karagiannis, J				Rentas, Stefan; Saberianfar, Reza; Grewal, Charnpal; Kanippayoor, Rachelle; Mishra, Mithilesh; McCollum, Dannel; Karagiannis, Jim			The SET Domain Protein, Set3p, Promotes the Reliable Execution of Cytokinesis in Schizosaccharomyces pombe	PLOS ONE			English	Article							SEPTATION INITIATION NETWORK; FISSION YEAST; GENOMIC EXPRESSION; CELL-DIVISION; STRESS; KINASE; PERTURBATION; TETRAPLOIDY; PROGRESSION; CHECKPOINT	In response to perturbation of the cell division machinery fission yeast cells activate regulatory networks that ensure the faithful completion of cytokinesis. For instance, when cells are treated with drugs that impede constriction of the actomyosin ring (low doses of Latrunculin A, for example) these networks ensure that cytokinesis is complete before progression into the subsequent mitosis. Here, we identify three previously uncharacterized genes, hif2, set3, and snt1, whose deletion results in hyper-sensitivity to LatA treatment and in increased rates of cytokinesis failure. Interestingly, these genes are orthologous to TBL1X, MLL5, and NCOR2, human genes that encode components of a histone deacetylase complex with a known role in cytokinesis. Through co-immunoprecipitation experiments, localization studies, and phenotypic analysis of gene deletion mutants, we provide evidence for an orthologous complex in fission yeast. Furthermore, in light of the putative role of the complex in chromatin modification, together with our results demonstrating an increase in Set3p levels upon Latrunculin A treatment, global gene expression profiles were generated. While this analysis demonstrated that the expression of cytokinesis genes was not significantly affected in set3 Delta backgrounds, it did reveal defects in the ability of the mutant to regulate genes with roles in the cellular response to stress. Taken together, these findings support the existence of a conserved, multi-protein complex with a role in promoting the successful completion of cytokinesis.	[Rentas, Stefan; Saberianfar, Reza; Grewal, Charnpal; Kanippayoor, Rachelle; Karagiannis, Jim] Univ Western Ontario, Dept Biol, London, ON, Canada; [Mishra, Mithilesh] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore; [McCollum, Dannel] Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA	Western University (University of Western Ontario); National University of Singapore; University of Massachusetts System; University of Massachusetts Worcester	Rentas, S (corresponding author), Univ Western Ontario, Dept Biol, London, ON, Canada.	jkaragia@uwo.ca		Karagiannis, Jim/0000-0002-7901-1815	National Sciences and Engineering Research Council of Canada; University of Western Ontario; Canada Foundation for Innovation	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Western Ontario; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This work was supported by the National Sciences and Engineering Research Council of Canada, the University of Western Ontario Academic Development Fund, and the Canada Foundation for Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Alejandro-Osorio AL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r57; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Balasubramanian MK, 2004, CURR BIOL, V14, pR806, DOI 10.1016/j.cub.2004.09.022; Balasubramanian MK, 1998, GENETICS, V149, P1265; Berry DB, 2008, MOL BIOL CELL, V19, P4580, DOI 10.1091/mbc.E07-07-0680; Boyer LA, 2004, NAT REV MOL CELL BIO, V5, P158, DOI 10.1038/nrm1314; Chen CT, 2008, CURR BIOL, V18, P1594, DOI 10.1016/j.cub.2008.08.067; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Choi HK, 2008, MOL ENDOCRINOL, V22, P1093, DOI 10.1210/me.2007-0396; Cohen TJ, 2008, EUKARYOT CELL, V7, P1191, DOI 10.1128/EC.00059-08; Damm F, 2011, J CLIN ONCOL, V29, P682, DOI 10.1200/JCO.2010.31.1118; Daniels MJ, 2004, SCIENCE, V306, P876, DOI 10.1126/science.1102574; Emerling BM, 2002, ONCOGENE, V21, P4849, DOI 10.1038/sj.onc.1205615; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Galipeau PC, 1996, P NATL ACAD SCI USA, V93, P7081, DOI 10.1073/pnas.93.14.7081; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Guertin DA, 2002, MICROBIOL MOL BIOL R, V66, P155, DOI 10.1128/MMBR.66.2.155-178.2002; Hachet O, 2008, GENE DEV, V22, P3205, DOI 10.1101/gad.1697208; Harris Henry, 2008, J Cell Sci, V121 Suppl 1, pv, DOI 10.1242/jcs.025759; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Karagiannis J, 2005, MOL BIOL CELL, V16, P358, DOI 10.1091/mbc.E04-06-0502; Karagiannis J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000433; King RW, 2008, BBA-REV CANCER, V1786, P4, DOI 10.1016/j.bbcan.2008.07.007; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Krapp A, 2008, BIOCHEM SOC T, V36, P411, DOI 10.1042/BST0360411; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Le Goff X, 1999, MOL GEN GENET, V262, P163; Liu JH, 2000, J CELL SCI, V113, P1223; Ma Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023422; Mazumdar M, 2006, CURR BIOL, V16, P1559, DOI 10.1016/j.cub.2006.06.029; Mishra M, 2004, J CELL SCI, V117, P3897, DOI 10.1242/jcs.01244; Olaharski AJ, 2006, CARCINOGENESIS, V27, P337, DOI 10.1093/carcin/bgi218; Pijnappel WWMP, 2001, GENE DEV, V15, P2991, DOI 10.1101/gad.207401; Pollard TD, 2010, NAT REV MOL CELL BIO, V11, P149, DOI 10.1038/nrm2834; Saberianfar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024694; Sagona AP, 2010, FEBS LETT, V584, P2652, DOI 10.1016/j.febslet.2010.03.044; Selvi B. Ruthrotha, 2009, Biotechnology Journal, V4, P375, DOI 10.1002/biot.200900032; Song L, 2005, CANCER RES, V65, P4554, DOI 10.1158/0008-5472.CAN-04-4108; Trautmann S, 2001, CURR BIOL, V11, P931, DOI 10.1016/S0960-9822(01)00268-8; Yang XL, 2004, NAT CELL BIOL, V6, P609, DOI 10.1038/ncb1140; YOSHIDA T, 1994, J CELL SCI, V107, P1725	43	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31224	10.1371/journal.pone.0031224	http://dx.doi.org/10.1371/journal.pone.0031224			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347452	gold, Green Submitted, Green Published			2022-12-25	WOS:000302730100055
J	Zhu, F; Sams, S; Moural, T; Haynes, KF; Potter, MF; Palli, SR				Zhu, Fang; Sams, Sarah; Moural, Tim; Haynes, Kenneth F.; Potter, Michael F.; Palli, Subba R.			RNA Interference of NADPH-Cytochrome P450 Reductase Results in Reduced Insecticide Resistance in the Bed Bug, Cimex lectularius	PLOS ONE			English	Article							DELTAMETHRIN RESISTANCE; 3-DIMENSIONAL STRUCTURE; ESCHERICHIA-COLI; EXPRESSION; OXIDOREDUCTASE; FMN; HEMIPTERA; FAD; BIOSYNTHESIS; INVOLVEMENT	Background: NADPH-cytochrome P450 reductase (CPR) plays a central role in cytochrome P450 action. The genes coding for P450s are not yet fully identified in the bed bug, Cimex lectularius. Hence, we decided to clone cDNA and knockdown the expression of the gene coding for CPR which is suggested to be required for the function of all P450s to determine whether or not P450s are involved in resistance of bed bugs to insecticides. Methodology/Principal Findings: The full length Cimex lectularius CPR (ClCPR) cDNA was isolated from a deltamethrin resistant bed bug population (CIN-1) using a combined PCR strategy. Bioinformatics and in silico modeling were employed to identify three conserved binding domains (FMN, FAD, NADP), a FAD binding motif, and the catalytic residues. The critical amino acids involved in FMN, FAD, NADP binding and their putative functions were also analyzed. No signal peptide but a membrane anchor domain with 21 amino acids which facilitates the localization of ClCPR on the endoplasmic reticulum was identified in ClCPR protein. Phylogenetic analysis showed that ClCPR is closer to the CPR from the body louse, Pediculus humanus corporis than to the CPRs from the other insect species studied. The ClCPR gene was ubiquitously expressed in all tissues tested but showed an increase in expression as immature stages develop into adults. We exploited the traumatic insemination mechanism of bed bugs to inject dsRNA and successfully knockdown the expression of the gene coding for ClCPR. Suppression of the ClCPR expression increased susceptibility to deltamethrin in resistant populations but not in the susceptible population of bed bugs. Conclusions/Significance: These data suggest that P450-mediated metabolic detoxification may serve as one of the resistance mechanisms in bed bugs.	[Zhu, Fang; Sams, Sarah; Haynes, Kenneth F.; Potter, Michael F.; Palli, Subba R.] Univ Kentucky, Dept Entomol, Coll Agr, Lexington, KY 40546 USA; [Sams, Sarah] Univ Kentucky, Bluegrass Community & Tech Coll, Div Nat Sci, Lexington, KY USA	University of Kentucky; University of Kentucky	Zhu, F (corresponding author), Univ Kentucky, Dept Entomol, Coll Agr, Lexington, KY 40546 USA.	RPALLI@UKY.EDU	PALLI, SUBBA REDDY/AAU-8289-2020	PALLI, SUBBA REDDY/0000-0002-0873-3247	Bayer; Kentucky Agricultural experimental station; Bayer Environmental Sciences	Bayer(Bayer AG); Kentucky Agricultural experimental station; Bayer Environmental Sciences	This work was funded by grants from Bayer and Kentucky Agricultural experimental station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Funding for this study was provided by a grant from Bayer Environmental Sciences. There are no patents, products in development or marketed product to declare. The authors' grant agreement with Bayer does not alter their adherence to all the PLoS ONE policies on sharing data and materials.	Adelman ZN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026228; ANDERSEN JF, 1994, BIOCHEMISTRY-US, V33, P2171, DOI 10.1021/bi00174a025; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Boase C., 2001, Pesticide Outlook, V12, P159, DOI 10.1039/b106301b; Carayon J., 1966, MONOGRAPH CIMICIDAE, P81, DOI DOI 10.1002/(SICI)1097-0029(19971215)39:6<506::AID-JEMT5>3.0.CO;2-B; Feyereisen R., 2005, P1; Gilbert LI, 2004, MOL CELL ENDOCRINOL, V215, P1, DOI 10.1016/j.mce.2003.11.003; Hall B. G., 2008, PHYLOGENETIC TREES M; Henderson CJ, 2003, J BIOL CHEM, V278, P13480, DOI 10.1074/jbc.M212087200; Horike N, 2000, EUR J BIOCHEM, V267, P6914, DOI 10.1046/j.1432-1033.2000.01796.x; Hovemann BT, 1997, GENE, V189, P213, DOI 10.1016/S0378-1119(96)00851-7; Hubbard PA, 2001, J BIOL CHEM, V276, P29163, DOI 10.1074/jbc.M101731200; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Ingelman M, 1997, J MOL BIOL, V268, P147, DOI 10.1006/jmbi.1997.0957; Kaewpa D, 2007, J ECON ENTOMOL, V100, P946, DOI 10.1603/0022-0493(2007)100[946:FEOMNP]2.0.CO;2; Kida Y, 1998, ARCH BIOCHEM BIOPHYS, V351, P175, DOI 10.1006/abbi.1997.0553; KOENER JF, 1993, INSECT BIOCHEM MOLEC, V23, P439, DOI 10.1016/0965-1748(93)90051-S; Lamb DC, 2006, STRUCTURE, V14, P51, DOI 10.1016/j.str.2005.09.015; Lian L-Y, 2011, PLOS ONE, V6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LU AYH, 1969, J BIOL CHEM, V244, P3714; Lycett GJ, 2006, INSECT MOL BIOL, V15, P321, DOI 10.1111/j.1365-2583.2006.00647.x; Maibeche-Coisne M, 2005, GENE, V346, P195, DOI 10.1016/j.gene.2004.11.010; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Montes C, 2002, J MED ENTOMOL, V39, P675, DOI 10.1603/0022-2585-39.4.675; Murataliev MB, 1999, INSECT BIOCHEM MOLEC, V29, P233, DOI 10.1016/S0965-1748(98)00131-3; Nishino H, 2000, ARCH BIOCHEM BIOPHYS, V374, P293, DOI 10.1006/abbi.1999.1602; ONO T, 1977, BIOCHIM BIOPHYS ACTA, V486, P401; OPRIAN DD, 1982, J BIOL CHEM, V257, P8935; Pandey AV, 2007, MOL ENDOCRINOL, V21, P2579, DOI 10.1210/me.2007-0245; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; PORTER TD, 1987, ARCH BIOCHEM BIOPHYS, V254, P353, DOI 10.1016/0003-9861(87)90111-1; Potter M. F., 2005, Pest Control Technology, V33, P82; Potter M.F., 2010, PEST WORLD       SEP, V18, P8; Reinhardt K, 2003, P ROY SOC B-BIOL SCI, V270, P2371, DOI 10.1098/rspb.2003.2515; Rewitz KF, 2007, INSECT BIOCHEM MOLEC, V37, P741, DOI 10.1016/j.ibmb.2007.02.012; Romero A, 2007, J MED ENTOMOL, V44, P175, DOI 10.1603/0022-2585(2007)44[175:IRITBB]2.0.CO;2; Romero A, 2009, J ECON ENTOMOL, V102, P2310, DOI 10.1603/029.102.0637; Romero A, 2009, J MED ENTOMOL, V46, P51, DOI 10.1603/033.046.0107; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schenkman JB, 1999, DRUG METAB REV, V31, P351, DOI 10.1081/DMR-100101923; Shen AL, 1999, J BIOL CHEM, V274, P5391, DOI 10.1074/jbc.274.9.5391; Shen AL, 2002, J BIOL CHEM, V277, P6536, DOI 10.1074/jbc.M111408200; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; VERMILION JL, 1981, J BIOL CHEM, V256, P266; Wang JL, 2003, J BIOL CHEM, V278, P20069, DOI 10.1074/jbc.M300989200; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Yoon KS, 2008, J MED ENTOMOL, V45, P1092, DOI 10.1603/0022-2585(2008)45[1092:BAMAOD]2.0.CO;2; Zhu F, 2010, P NATL ACAD SCI USA, V107, P8557, DOI 10.1073/pnas.1000059107; Zhu F, 2010, ARCH INSECT BIOCHEM, V73, P245, DOI 10.1002/arch.20355	50	51	61	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31037	10.1371/journal.pone.0031037	http://dx.doi.org/10.1371/journal.pone.0031037			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347424	Green Submitted, gold, Green Published			2022-12-25	WOS:000302180600025
J	Oswald, E; Sesarman, A; Franzke, CW; Wolfle, U; Bruckner-Tuderman, L; Jakob, T; Martin, SF; Sitaru, C				Oswald, Eva; Sesarman, Alina; Franzke, Claus-Werner; Woelfle, Ute; Bruckner-Tuderman, Leena; Jakob, Thilo; Martin, Stefan F.; Sitaru, Cassian			The Flavonoid Luteolin Inhibits Fc gamma-Dependent Respiratory Burst in Granulocytes, but Not Skin Blistering in a New Model of Pemphigoid in Adult Mice	PLOS ONE			English	Article							DERMAL-EPIDERMAL SEPARATION; HERPES-GESTATIONIS; VII COLLAGEN; IGG AUTOANTIBODIES; PASSIVE TRANSFER; ANTIGEN; COMPLEMENT; ANTIBODIES; EPITOPES; DISEASE	Bullous pemphigoid is an autoimmune blistering skin disease associated with autoantibodies against the dermal-epidermal junction. Passive transfer of antibodies against BP180/collagen (C) XVII, a major hemidesmosomal pemphigoid antigen, into neonatal mice results in dermal-epidermal separation upon applying gentle pressure to their skin, but not in spontaneous skin blistering. In addition, this neonatal mouse model precludes treatment and observation of diseased animals beyond 2-3 days. Therefore, in the present study we have developed a new disease model in mice reproducing the spontaneous blistering and the chronic course characteristic of the human condition. Adult mice were pre-immunized with rabbit IgG followed by injection of BP180/CXVII rabbit IgG. Mice pre-immunized against rabbit IgG and injected 6 times every second day with the BP180/CXVII-specific antibodies (n = 35) developed spontaneous sustained blistering of the skin, while mice pre-immunized and then treated with normal rabbit IgG (n = 5) did not. Blistering was associated with IgG and complement C3 deposits at the epidermal basement membrane and recruitment of inflammatory cells, and was partly dependent on Ly-6G-positive cells. We further used this new experimental model to investigate the therapeutic potential of luteolin, a plant flavonoid with potent anti-inflammatory and anti-oxidative properties and good safety profile, in experimental BP. Luteolin inhibited the Fc gamma-dependent respiratory burst in immune complex-stimulated granulocytes and the autoantibody-induced dermal-epidermal separation in skin cryosections, but was not effective in suppressing the skin blistering in vivo. These studies establish a robust animal model that will be a useful tool for dissecting the mechanisms of blister formation and will facilitate the development of more effective therapeutic strategies for managing pemphigoid diseases.	[Oswald, Eva; Jakob, Thilo; Martin, Stefan F.] Univ Freiburg, Dept Dermatol, Med Ctr, Allergy Res Grp, Freiburg, Germany; [Woelfle, Ute] Univ Freiburg, Dept Dermatol, Competence Ctr Skintegral, Med Ctr, Freiburg, Germany; [Oswald, Eva] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Bruckner-Tuderman, Leena; Sitaru, Cassian] BIOSS Ctr Biol Signalling Studies, Freiburg, Germany; [Bruckner-Tuderman, Leena] Freiburg Inst Adv Studies, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Oswald, E (corresponding author), Univ Freiburg, Dept Dermatol, Med Ctr, Allergy Res Grp, Hauptstr 7, Freiburg, Germany.	cassian.sitaru@uniklinik-freiburg.de	Sitaru, Cassian/E-5830-2010; Jakob, Thilo/J-1621-2012; Sesarman, Alina/F-6841-2011; Wölfle, Ute/AAG-6972-2021	Sitaru, Cassian/0000-0002-0370-1270; Sesarman, Alina/0000-0002-7491-9955; Wölfle, Ute/0000-0003-0093-560X	Deutsche Forschungsgemeinschaft [SI-1281/4-1, MA-1567/9-1, SFB850-B6]; BIOSS; Medical Faculty of the Freiburg University; Freiburg Institute for Advanced Studies	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BIOSS; Medical Faculty of the Freiburg University; Freiburg Institute for Advanced Studies	The authors acknowledge support by grants from the Deutsche Forschungsgemeinschaft SI-1281/4-1 (CS), MA-1567/9-1 (SM), SFB850-B6 (LB-T, C-WF), and BIOSS (LB-T, CS), from the Medical Faculty of the Freiburg University (CS) and by the Freiburg Institute for Advanced Studies (LB-T). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anhalt G J, 1987, Clin Dermatol, V5, P117, DOI 10.1016/0738-081X(87)90056-3; Binstadt BA, 2006, NAT IMMUNOL, V7, P284, DOI 10.1038/ni1306; Budinger L, 1998, J CLIN INVEST, V102, P2082, DOI 10.1172/JCI3335; Chen CY, 2007, LIFE SCI, V81, P1602, DOI 10.1016/j.lfs.2007.09.028; Chiriac MT, 2012, NOVEL MODEL AD UNPUB; Csorba K, 2010, CELL MOL LIFE SCI, V67, P1343, DOI 10.1007/s00018-009-0256-3; Di Zenzo G, 2008, CLIN IMMUNOL, V128, P415, DOI 10.1016/j.clim.2008.04.012; DIAZ LA, 1990, J CLIN INVEST, V86, P1088, DOI 10.1172/JCI114812; Egan CA, 1999, J INVEST DERMATOL, V112, P148, DOI 10.1046/j.1523-1747.1999.00490.x; Feliciani C, 2009, BRIT J DERMATOL, V161, P306, DOI 10.1111/j.1365-2133.2009.09266.x; GIUDICE GJ, 1993, J IMMUNOL, V151, P5742; GIUDICE GJ, 1992, J INVEST DERMATOL, V99, P243, DOI 10.1111/1523-1747.ep12616580; Haase C, 1998, J INVEST DERMATOL, V110, P282, DOI 10.1046/j.1523-1747.1998.00126.x; HALL RP, 1993, J INVEST DERMATOL, V101, P9, DOI 10.1111/1523-1747.ep12358276; Herrero-Gonzalez JE, 2006, EUR J IMMUNOL, V36, P1039, DOI 10.1002/eji.200535349; Iwata Y, 2008, ARCH DERMATOL, V144, P41, DOI 10.1001/archdermatol.2007.9; KATZ SI, 1976, J CLIN INVEST, V57, P1434, DOI 10.1172/JCI108413; Kiss M, 2005, J AUTOIMMUN, V24, P1, DOI 10.1016/j.jaut.2004.09.007; Lin MS, 1999, J IMMUNOL, V162, P4991; Liu Z, 1997, J CLIN INVEST, V100, P1256, DOI 10.1172/JCI119639; LIU Z, 1993, J CLIN INVEST, V92, P2480, DOI 10.1172/JCI116856; Liu Z, 2000, CELL, V102, P647, DOI 10.1016/S0092-8674(00)00087-8; Liu Z, 2008, J AUTOIMMUN, V31, P331, DOI 10.1016/j.jaut.2008.08.009; Mihai S, 2007, J CELL MOL MED, V11, P1117, DOI 10.1111/j.1582-4934.2007.00081.x; Mihai S, 2007, J CELL MOL MED, V11, P462, DOI 10.1111/j.1582-4934.2007.00033.x; NAGAI H, 1982, JPN J PHARMACOL, V32, P1117, DOI 10.1254/jjp.32.1117; NAITO K, 1984, J INVEST DERMATOL, V82, P227, DOI 10.1111/1523-1747.ep12260057; NEALE TJ, 1982, SPRINGER SEMIN IMMUN, V5, P221, DOI 10.1007/BF01892087; Nishie W, 2007, NAT MED, V13, P378, DOI 10.1038/nm1496; Nishie W, 2009, J IMMUNOL, V183, P4088, DOI 10.4049/jimmunol.0800389; Perriard J, 1999, J INVEST DERMATOL, V112, P141, DOI 10.1046/j.1523-1747.1999.00497.x; Schmidt E, 2000, ARCH DERMATOL, V136, P174, DOI 10.1001/archderm.136.2.174; Seelinger G, 2008, PLANTA MED, V74, P1667, DOI 10.1055/s-0028-1088314; Sesarman A, 2008, BRIT J DERMATOL, V158, P463, DOI 10.1111/j.1365-2133.2007.08388.x; Sesarman A, 2012, INTERACTION HU UNPUB; Sesarman A, 2008, J MOL MED, V86, P951, DOI 10.1007/s00109-008-0366-7; Shimanovich I, 2004, J PATHOL, V204, P519, DOI 10.1002/path.1674; Sitaru AG, 2010, J IMMUNOL, V184, P1596, DOI 10.4049/jimmunol.0901412; Sitaru C, 2005, J CLIN INVEST, V115, P870, DOI 10.1172/JCI200521386; Sitaru C, 2002, AM J PATHOL, V161, P301, DOI 10.1016/S0002-9440(10)64182-X; Sitaru C, 2002, J INVEST DERMATOL, V118, P664, DOI 10.1046/j.1523-1747.2002.01720.x; Sitaru C, 2006, J IMMUNOL, V177, P3461, DOI 10.4049/jimmunol.177.5.3461; Sitaru C, 2009, J INVEST DERMATOL, V129, P822, DOI 10.1038/jid.2009.12; STANLEY JR, 1988, J CLIN INVEST, V82, P1864, DOI 10.1172/JCI113803; STANLEY JR, 1981, CELL, V24, P897, DOI 10.1016/0092-8674(81)90115-X; Ujiie H, 2010, J IMMUNOL, V184, P2166, DOI 10.4049/jimmunol.0903101; Woelfle U, 2010, PHYTOTHER RES, V24, P1033, DOI 10.1002/ptr.3069; Yamamoto K, 2002, J INVEST DERMATOL, V118, P485, DOI 10.1046/j.0022-202x.2001.01683.x	48	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e31066	10.1371/journal.pone.0031066	http://dx.doi.org/10.1371/journal.pone.0031066			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328927	Green Published, gold, Green Submitted			2022-12-25	WOS:000302179300013
J	Lau, WKW; Chan-Yeung, MMW; Yip, BHK; Cheung, AHK; Ip, MSM; Mak, JCW				Lau, Way K. W.; Chan-Yeung, Moira M. W.; Yip, Benjamin H. K.; Cheung, Amy H. K.; Ip, Mary S. M.; Mak, Judith C. W.		COPD Study Grp Hong Kong Thoracic	The Role of Circulating Serotonin in the Development of Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							MONOAMINE-OXIDASE; TRANSPORTER GENE; PLASMA; HYPERTENSION; INHIBITOR; CHINESE	Background: Cigarette smoking is a major risk factor in the development of age-related chronic obstructive pulmonary disease (COPD). The serotonin transporter (SERT) gene polymorphism has been reported to be associated with COPD, and the degree of cigarette smoking has been shown to be a significant mediator in this relationship. The interrelation between circulating serotonin (5-hydroxytyptamine, 5-HT), cigarette smoking and COPD is however largely unknown. The current study aimed at investigating the mediation effects of plasma 5-HT on cigarette smoking-induced COPD and the relation between plasma 5-HT levels and age. Methods: The association between plasma 5-HT, age and COPD was analyzed in a total of 62 COPD patients (ever-smokers) and 117 control subjects (healthy non-smokers and ever-smokers). Plasma 5-HT levels were measured by enzyme-linked immuno assay (EIA). Results: The elevated plasma 5-HT levels were significantly associated with increased odds for COPD (OR = 1.221, 95% CI = 1.123 to 1.319, p<0.0001). The effect remained significant after being adjusted for age and pack-years smoked (OR = 1.271, 95% CI = 1.134 to 1.408, p = 0.0003). Furthermore, plasma 5-HT was found to mediate the relation between pack-years smoked and COPD. A positive correlation (r = 0.303, p = 0.017) was found between plasma 5-HT levels and age in COPD, but not in the control subjects (r = -0.149, p = 0.108). Conclusion: Our results suggest that cigarette smoke-induced COPD is partially mediated by the plasma levels of 5-HT, and that these become elevated with increased age in COPD. The elevated plasma 5-HT levels in COPD might contribute to the pathogenesis of this disease.	[Lau, Way K. W.; Chan-Yeung, Moira M. W.; Cheung, Amy H. K.; Ip, Mary S. M.; Mak, Judith C. W.] Univ Hong Kong, Dept Med, Div Resp Med, Hong Kong, Hong Kong, Peoples R China; [Yip, Benjamin H. K.] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Mak, Judith C. W.] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Lau, WKW (corresponding author), Univ Hong Kong, Dept Med, Div Resp Med, Hong Kong, Hong Kong, Peoples R China.	judithmak@hku.hk	Yip, Benjamin/AAC-7845-2019; YIP, Benjamin HK/I-2336-2013; Ip, Mary Sau Man/C-4284-2009	Yip, Benjamin/0000-0002-4749-7611; Mak, Judith/0000-0002-8234-1313; Ip, Mary Sau Man/0000-0002-8692-6933; Lau, Way/0000-0003-1493-5002	Hong Kong Lung Foundation	Hong Kong Lung Foundation	This study is supported by Hong Kong Lung Foundation Research Grant (HKLF 2007-2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Ban Y, 2007, ATHEROSCLEROSIS, V195, P153, DOI 10.1016/j.atherosclerosis.2006.09.005; Brenner B, 2007, J NEUROCHEM, V102, P206, DOI 10.1111/j.1471-4159.2007.04542.x; Chan-Yeung M, 2007, INT J TUBERC LUNG D, V11, P502; Eddahibi S, 2003, CIRCULATION, V108, P1839, DOI 10.1161/01.CIR.0000091409.53101.E8; HART CM, 1989, CLIN CHEST MED, V10, P59; Herr N., MEDIATION DICHOTOMOU; Herraiz T, 2005, BIOCHEM BIOPH RES CO, V326, P378, DOI 10.1016/j.bbrc.2004.11.033; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Ip MSM, 2006, CHEST, V129, P384, DOI 10.1378/chest.129.2.384; Ishii T, 2011, J HUM GENET, V56, P41, DOI 10.1038/jhg.2010.133; Kereveur A, 2000, ARTERIOSCL THROM VAS, V20, P2233, DOI 10.1161/01.ATV.20.10.2233; Khalil AA, 2000, CHEM RES TOXICOL, V13, P31, DOI 10.1021/tx990146f; Khalil AA, 2006, BIOORGAN MED CHEM, V14, P3392, DOI 10.1016/j.bmc.2005.12.057; Kumar AM, 1998, GERONTOLOGY, V44, P211, DOI 10.1159/000022012; Lechin F, 1996, ANN ALLERG ASTHMA IM, V77, P245, DOI 10.1016/S1081-1206(10)63263-2; Lee JJ, 2001, CLIN EXP PHARMACOL P, V28, P285, DOI 10.1046/j.1440-1681.2001.03439.x; Maclay JD, 2011, THORAX, V66, P769, DOI 10.1136/thx.2010.157529; MendezAlvarez E, 1997, LIFE SCI, V60, P1719, DOI 10.1016/S0024-3205(97)00114-8; Mercado CP, 2010, MOL INTERV, V10, P231, DOI 10.1124/mi.10.4.6; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; ORTIZ J, 1988, LIFE SCI, V43, P983, DOI 10.1016/0024-3205(88)90543-7; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Preacher KJ, CALCULATION SOBEL TE; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rabe KF, 2007, AM J RESP CRIT CARE, V175, P1222, DOI 10.1164/rccm.200704-586UP; RAUSCH JL, 1989, PROG NEURO-PSYCHOPH, V13, P907, DOI 10.1016/0278-5846(89)90042-0; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Sciurba FC, 2004, CHEST, V126, p807S, DOI 10.1378/chest.126.2_suppl_1.117S; Topsakal R, 2009, BLOOD PRESSURE, V18, P367, DOI 10.3109/08037050903350788; U.S. Census Bureau, INT DAT BAS IDB; Ulrich S, 2010, RESPIRATION, V79, P288, DOI 10.1159/000226243; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI [10.1016/j.jclinepi.2007.11.008, 10.2471/BLT.07.045120]	33	21	32	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31617	10.1371/journal.pone.0031617	http://dx.doi.org/10.1371/journal.pone.0031617			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319639	Green Submitted, Green Published, gold			2022-12-25	WOS:000302178400047
J	Arizpe, J; Kravitz, DJ; Yovel, G; Baker, CI				Arizpe, Joseph; Kravitz, Dwight J.; Yovel, Galit; Baker, Chris I.			Start Position Strongly Influences Fixation Patterns during Face Processing: Difficulties with Eye Movements as a Measure of Information Use	PLOS ONE			English	Article							PERCEPTION; RECOGNITION; EXPLORATION; FAMILIARITY; ASYMMETRIES; INVERSION; STIMULUS; REVEAL; SPAN; TASK	Fixation patterns are thought to reflect cognitive processing and, thus, index the most informative stimulus features for task performance. During face recognition, initial fixations to the center of the nose have been taken to indicate this location is optimal for information extraction. However, the use of fixations as a marker for information use rests on the assumption that fixation patterns are predominantly determined by stimulus and task, despite the fact that fixations are also influenced by visuo-motor factors. Here, we tested the effect of starting position on fixation patterns during a face recognition task with upright and inverted faces. While we observed differences in fixations between upright and inverted faces, likely reflecting differences in cognitive processing, there was also a strong effect of start position. Over the first five saccades, fixation patterns across start positions were only coarsely similar, with most fixations around the eyes. Importantly, however, the precise fixation pattern was highly dependent on start position with a strong tendency toward facial features furthest from the start position. For example, the often-reported tendency toward the left over right eye was reversed for the left starting position. Further, delayed initial saccades for central versus peripheral start positions suggest greater information processing prior to the initial saccade, highlighting the experimental bias introduced by the commonly used center start position. Finally, the precise effect of face inversion on fixation patterns was also dependent on start position. These results demonstrate the importance of a non-stimulus, non-task factor in determining fixation patterns. The patterns observed likely reflect a complex combination of visuo-motor effects and simple sampling strategies as well as cognitive factors. These different factors are very difficult to tease apart and therefore great caution must be applied when interpreting absolute fixation locations as indicative of information use, particularly at a fine spatial scale.	[Arizpe, Joseph; Kravitz, Dwight J.; Baker, Chris I.] NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA; [Arizpe, Joseph] UCL, Inst Cognit Neurosci, Visual Cognit Grp, London, England; [Yovel, Galit] Tel Aviv Univ, Dept Psychol, IL-69978 Tel Aviv, Israel	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of London; University College London; Tel Aviv University	Arizpe, J (corresponding author), NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA.	arizpej@mail.nih.gov; bakerchris@mail.nih.gov	Baker, Chris/P-8442-2019; Yovel, Galit/GPT-4409-2022; Arizpe, Joseph M/N-1399-2014; Kravitz, Dwight/B-8430-2012; Kravitz, Dwight/AAO-5860-2020	Baker, Chris/0000-0001-6861-8964; Yovel, Galit/0000-0003-0971-2357; Arizpe, Joseph M/0000-0001-8958-7757; Kravitz, Dwight/0000-0002-8108-1329	National Institutes of Mental Health; United States-Israel Binational Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002909] Funding Source: NIH RePORTER	National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Intramural Program of the National Institutes of Mental Health and by the United States-Israel Binational Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afraz A, 2010, CURR BIOL, V20, P2112, DOI 10.1016/j.cub.2010.11.017; Althoff RR, 1999, J EXP PSYCHOL LEARN, V25, P997, DOI 10.1037/0278-7393.25.4.997; Armann R, 2009, ATTEN PERCEPT PSYCHO, V71, P1107, DOI 10.3758/APP.71.5.1107; Barton JJS, 2006, PERCEPTION, V35, P1089, DOI 10.1068/p5547; Bindemann M, 2009, J VISION, V9, DOI 10.1167/9.2.7; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; Burt DM, 1997, NEUROPSYCHOLOGIA, V35, P685, DOI 10.1016/S0028-3932(96)00111-X; Butler S, 2005, NEUROPSYCHOLOGIA, V43, P52, DOI 10.1016/j.neuropsychologia.2004.06.005; Caldara R, 2011, BEHAV RES METHODS, V43, P864, DOI 10.3758/s13428-011-0092-x; Caldara R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009708; Dahl CD, 2009, CURR BIOL, V19, P509, DOI 10.1016/j.cub.2009.01.061; Findlay J. M., 2003, ACTIVE VISION PSYCHO; Findlay JM, 1997, PERCEPTION, V26, P1159, DOI 10.1068/p261159; Foulsham T, 2011, ATTEN PERCEPT PSYCHO, V73, P266, DOI 10.3758/s13414-010-0014-5; GILBERT C, 1973, NEUROPSYCHOLOGIA, V11, P355, DOI 10.1016/0028-3932(73)90049-3; Goldinger SD, 2009, J EXP PSYCHOL LEARN, V35, P1105, DOI 10.1037/a0016548; Gosselin F, 2001, VISION RES, V41, P2261, DOI 10.1016/S0042-6989(01)00097-9; Gosselin F, 2003, PSYCHOL SCI, V14, P505, DOI 10.1111/1467-9280.03452; HAITH MM, 1977, SCIENCE, V198, P853, DOI 10.1126/science.918670; Heisz JJ, 2008, J VISION, V8, DOI 10.1167/8.1.9; Henderson JM, 2005, MEM COGNITION, V33, P98, DOI 10.3758/BF03195300; HENDERSON JM, 1993, CAN J EXP PSYCHOL, V47, P79, DOI 10.1037/h0078776; Henderson JM, 2003, TRENDS COGN SCI, V7, P498, DOI 10.1016/j.tics.2003.09.006; Hsiao JHW, 2008, PSYCHOL SCI, V19, P998, DOI 10.1111/j.1467-9280.2008.02191.x; Jack RE, 2009, CURR BIOL, V19, P1543, DOI 10.1016/j.cub.2009.07.051; Jack RE, 2011, J EXP PSYCHOL GEN; JANIK SW, 1978, PERCEPT MOTOR SKILL, V47, P857, DOI 10.2466/pms.1978.47.3.857; JUST MA, 1980, PSYCHOL REV, V87, P329, DOI 10.1037/0033-295X.87.4.329; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; KAPOULA Z, 1985, VISION RES, V25, P1155, DOI 10.1016/0042-6989(85)90105-1; KAPOULA Z, 1986, VISION RES, V26, P735, DOI 10.1016/0042-6989(86)90087-8; Kealey R, 2008, J VIS, V8, P892, DOI DOI 10.1167/8.6.892; Kliemann D, 2010, J NEUROSCI, V30, P12281, DOI 10.1523/JNEUROSCI.0688-10.2010; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Kravitz DJ, 2010, CEREB CORTEX, V20, P2916, DOI 10.1093/cercor/bhq042; Leonards U, 2005, VISION RES, V45, P2677, DOI 10.1016/j.visres.2005.03.009; Leonards U, 2007, CURR BIOL, V17, pR8, DOI 10.1016/j.cub.2006.11.046; Malcolm GL, 2008, J VISION, V8, DOI 10.1167/8.8.2; MCCONKIE GW, 1988, VISION RES, V28, P1107, DOI 10.1016/0042-6989(88)90137-X; MCCONKIE GW, 1975, PERCEPT PSYCHOPHYS, V17, P578, DOI 10.3758/BF03203972; MERTENS I, 1993, NEUROPSYCHOLOGIA, V31, P989, DOI 10.1016/0028-3932(93)90154-R; Minear M, 2004, BEHAV RES METH INS C, V36, P630, DOI 10.3758/BF03206543; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Pelphrey KA, 2002, J AUTISM DEV DISORD, V32, P249, DOI 10.1023/A:1016374617369; Radach R., 1998, EYE GUIDANCE READING, P77, DOI DOI 10.1016/B978-008043361-5/50005-5; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Rayner K, 2009, PERCEPTION, V38, P895, DOI 10.1068/ldmk-ray; Renninger LW, 2007, J VISION, V7, DOI 10.1167/7.3.6; Rodger H, 2010, PERCEPTION, V39, P1491, DOI 10.1068/p6750; Rossion Bruno, 2002, Behav Cogn Neurosci Rev, V1, P63, DOI 10.1177/1534582302001001004; Stacey PC, 2005, BRIT J PSYCHOL, V96, P407, DOI 10.1348/000712605X47422; van Belle G, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00020; WALKERSMITH GJ, 1977, PERCEPTION, V6, P313, DOI 10.1068/p060313; Williams CC, 2007, MEM COGNITION, V35, P1977, DOI 10.3758/BF03192930; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474	56	60	63	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e31106	10.1371/journal.pone.0031106	http://dx.doi.org/10.1371/journal.pone.0031106			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	914UV	22319606	Green Submitted, gold, Green Published			2022-12-25	WOS:000301979000019
J	Yin, G; Alvero, AB; Craveiro, V; Holmberg, JC; Fu, HH; Montagna, MK; Yang, Y; Chefetz-Menaker, I; Nuti, S; Rossi, M; Silasi, DA; Rutherford, T; Mor, G				Yin, G.; Alvero, A. B.; Craveiro, V.; Holmberg, J. C.; Fu, H-H; Montagna, M. K.; Yang, Y.; Chefetz-Menaker, I.; Nuti, S.; Rossi, M.; Silasi, D-A; Rutherford, T.; Mor, G.			Constitutive proteasomal degradation of TWIST-1 in epithelial-ovarian cancer stem cells impacts differentiation and metastatic potential	ONCOGENE			English	Article						TWIST-1; ovarian cancer stem cells; ovarian cancer; metastasis; recurrence	TO-MESENCHYMAL TRANSITION; SIDE POPULATION; ACTIVATION; EXPRESSION; BREAST; IDENTIFICATION; PATHOGENESIS; MECHANISMS; APOPTOSIS; HYPOXIA	Epithelial-mesenchymal transition (EMT) is a critical process for embryogenesis but is abnormally activated during cancer metastasis and recurrence. This process enables epithelial cancer cells to acquire mobility and traits associated with stemness. It is unknown whether epithelial stem cells or epithelial cancer stem cells are able to undergo EMT, and what molecular mechanism regulates this process in these specific cell types. We found that epithelial-ovarian cancer stem cells (EOC stem cells) are the source of metastatic progenitor cells through a differentiation process involving EMT and mesenchymal-epithelial transition (MET). We demonstrate both in vivo and in vitro the differentiation of EOC stem cells into mesenchymal spheroid-forming cells (MSFCs) and their capacity to initiate an active carcinomatosis. Furthermore, we demonstrate that human EOC stem cells injected intraperitoneally in mice are able to form ovarian tumors, suggesting that the EOC stem cells have the ability to 'home' to the ovaries and establish tumors. Most interestingly, we found that TWIST-1 is constitutively degraded in EOC stem cells, and that the acquisition of TWIST-1 requires additional signals that will trigger the differentiation process. These findings are relevant for understanding the differentiation and metastasis process in EOC stem cells. Oncogene (2013) 32, 39-49; doi:10.1038/onc.2012.33; published online 20 February 2012	[Yin, G.; Alvero, A. B.; Craveiro, V.; Holmberg, J. C.; Fu, H-H; Montagna, M. K.; Yang, Y.; Chefetz-Menaker, I.; Nuti, S.; Rossi, M.; Silasi, D-A; Rutherford, T.; Mor, G.] Yale Univ, Sch Med, Reprod Immunol Unit, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA	Yale University	Mor, G (corresponding author), Yale Univ, Sch Med, Reprod Immunol Unit, Dept Obstet Gynecol & Reprod Sci, 333 Cedar St,LSOG 305A, New Haven, CT 06520 USA.	gil.mor@yale.edu	Chefetz, Ilana/K-7589-2019; Yang-Hartwich, Yang/B-3489-2015	Alvero, Ayesha/0000-0002-6593-3595; Holmberg, Jennie/0000-0002-1106-4718	NCI/NIH [RO1CA127913, RO1CA118678]; Janet Burros Memorial Foundation; Sands Family Foundation; Discovery To Cure Research Program; Brozman Foundation; NATIONAL CANCER INSTITUTE [R01CA112016, R01CA127913, R01CA118678, F32CA130472, R01CA111782] Funding Source: NIH RePORTER	NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Janet Burros Memorial Foundation; Sands Family Foundation; Discovery To Cure Research Program; Brozman Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by grants from NCI/NIH RO1CA127913, RO1CA118678, The Janet Burros Memorial Foundation, The Sands Family Foundation and the Discovery To Cure Research Program. GY was supported by the Brozman Foundation. Special thanks to Dr Ernst-Martin Fuchtbauer for the plasmids, pEMSV, pEMSV-TWIST1 and pEMSV-E12; and to Dr Wange Lu for the plasmid pFUIGW.	Abrahams VM, 2003, CANCER RES, V63, P5573; Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Alison MR, 2008, CELL TISSUE RES, V331, P109, DOI 10.1007/s00441-007-0510-7; Alix-Panabieres C, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2326; Alvero AB, 2011, MOL CANCER THER, V10, P1385, DOI 10.1158/1535-7163.MCT-11-0023; Alvero AB, 2009, STEM CELLS, V27, P2405, DOI 10.1002/stem.191; Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533; Bapat SA, 2005, CANCER RES, V65, P3025, DOI 10.1158/0008-5472.CAN-04-3931; Bechtel W, 2009, KIDNEY INT, V75, P1255, DOI 10.1038/ki.2009.102; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Carambula SF, 2002, ENDOCRINOLOGY, V143, P1495, DOI 10.1210/en.143.4.1495; Chaffer CL, 2007, DIFFERENTIATION, V75, P831, DOI 10.1111/j.1432-0436.2007.00210.x; CHAMBERS JT, 1986, GYNECOL ONCOL, V23, P346, DOI 10.1016/0090-8258(86)90136-8; Chefetz I, 2011, CELL CYCLE, V10, P2206, DOI 10.4161/cc.10.13.16348; Chen R, 2008, ONCOGENE, V27, P4712, DOI 10.1038/onc.2008.112; Chen R, 2007, AM J REPROD IMMUNOL, V57, P93, DOI 10.1111/j.1600-0897.2006.00441.x; Cheng GZ, 2008, J BIOL CHEM, V283, P14665, DOI 10.1074/jbc.M707429200; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clarke-Pearson DL, 2009, NEW ENGL J MED, V361, P170, DOI 10.1056/NEJMcp0901926; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Curley MD, 2011, FRONT BIOSCI-LANDMRK, V16, P368, DOI 10.2741/3693; Curley MD, 2009, STEM CELLS, V27, P2875, DOI 10.1002/stem.236; El Ghouzzi V, 2000, HUM MOL GENET, V9, P813, DOI 10.1093/hmg/9.5.813; Entz-Werle N, 2005, INT J CANCER, V117, P349, DOI 10.1002/ijc.21068; Espey DK, 2007, CANCER-AM CANCER SOC, V110, P2119, DOI 10.1002/cncr.23044; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Gao QL, 2009, ULTRASTRUCT PATHOL, V33, P175, DOI 10.1080/01913120903086072; Gort EH, 2008, ONCOGENE, V27, P1501, DOI 10.1038/sj.onc.1210795; Green JM, 2009, CANCER BIOL THER, V8, P1747, DOI 10.4161/cbt.8.18.9285; Hader C, 2010, ONCOGENE, V29, P1031, DOI 10.1038/onc.2009.397; Hartwell KA, 2006, P NATL ACAD SCI USA, V103, P18969, DOI 10.1073/pnas.0608636103; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Hollier BG, 2009, J MAMMARY GLAND BIOL, V14, P29, DOI 10.1007/s10911-009-9110-3; Horbinski C, 2010, AM J PATHOL, V177, P1044, DOI 10.2353/ajpath.2010.091270; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kamsteeg M, 2003, ONCOGENE, V22, P2611, DOI 10.1038/sj.onc.1206422; Koga K, 2009, AM J REPROD IMMUNOL, V61, P196, DOI 10.1111/j.1600-0897.2008.00682.x; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Laursen KB, 2007, J BIOL CHEM, V282, P34623, DOI 10.1074/jbc.M707085200; Lee YB, 2009, NUCLEIC ACIDS RES, V37, P123, DOI 10.1093/nar/gkn920; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mor G, 2011, CANCER BIOL THER, V11, P708, DOI 10.4161/cbt.11.8.14967; Moserle L, 2008, CANCER RES, V68, P5658, DOI 10.1158/0008-5472.CAN-07-6341; Mutch DG, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.31589; Radisky DC, 2008, CELL STEM CELL, V2, P511, DOI 10.1016/j.stem.2008.05.007; Radisky Derek C, 2008, Proc Am Thorac Soc, V5, P316, DOI 10.1513/pats.200711-166DR; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schumer ST, 2003, J CLIN ONCOL, V21, P1180, DOI 10.1200/JCO.2003.10.019; Schwartz Peter E, 2002, Cancer Treat Res, V107, P99; Sharabi AB, 2008, PLOS BIOL, V6, P2786, DOI 10.1371/journal.pbio.0060316; Shih IM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.08.003; Shintani Y, 2008, AM J RESP CELL MOL, V38, P95, DOI 10.1165/rcmb.2007-0071OC; Steffensen KD, 2011, J ONCOL, V2011, DOI 10.1155/2011/620523; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Valsesia-Wittmann S, 2004, CANCER CELL, V6, P625, DOI 10.1016/j.ccr.2004.09.033; Vergara D, 2010, CANCER LETT, V291, P59, DOI 10.1016/j.canlet.2009.09.017; Visintin I, 2008, CLIN CANCER RES, V14, P1065, DOI 10.1158/1078-0432.CCR-07-1569; Watanabe O, 2004, ANTICANCER RES, V24, P3851; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang MH, 2006, J BIOL CHEM, V281, P23598, DOI 10.1074/jbc.M602191200; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	64	60	64	0	23	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2013	32	1					39	49		10.1038/onc.2012.33	http://dx.doi.org/10.1038/onc.2012.33			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	063VG	22349827	Green Accepted			2022-12-25	WOS:000313029500004
J	Suzuki, N; Kim, YM; Fujimoto, Z; Momma, M; Okuyama, M; Mori, H; Funane, K; Kimura, A				Suzuki, Nobuhiro; Kim, Young-Min; Fujimoto, Zui; Momma, Mitsuru; Okuyama, Masayuki; Mori, Haruhide; Funane, Kazumi; Kimura, Atsuo			Structural Elucidation of Dextran Degradation Mechanism by Streptococcus mutans Dextranase Belonging to Glycoside Hydrolase Family 66	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; IMMUNOGLOBULIN SUPERFAMILY; HYDROLYZING ENZYMES; ALPHA-GALACTOSIDASE; CRYSTAL-STRUCTURES; SEQUENCE-ANALYSIS; CELL-SURFACE; GENE; BINDING; REFINEMENT	Dextranase is an enzyme that hydrolyzes dextran alpha-1,6 linkages. Streptococcus mutans dextranase belongs to glycoside hydrolase family 66, producing isomaltooligosaccharides of various sizes and consisting of at least five amino acid sequence regions. The crystal structure of the conserved fragment from Gln(100) to Ile(732) of S. mutans dextranase, devoid of its N- and C-terminal variable regions, was determined at 1.6 angstrom resolution and found to contain three structural domains. Domain N possessed an immunoglobulin-like beta-sandwich fold; domain A contained the enzyme's catalytic module, comprising a (beta/alpha)(8)-barrel; and domain C formed a beta-sandwich structure containing two Greek key motifs. Two ligand complex structures were also determined, and, in the enzyme-isomaltotriose complex structure, the bound isomaltooligosaccharide with four glucose moieties was observed in the catalytic glycone cleft and considered to be the transglycosylation product of the enzyme, indicating the presence of four subsites, -4 to -1, in the catalytic cleft. The complexed structure with 4',5'-epoxypentyl-alpha-D-glucopyranoside, a suicide substrate of the enzyme, revealed that the epoxide ring reacted to form a covalent bond with the Asp(385) side chain. These structures collectively indicated that Asp(385) was the catalytic nucleophile and that Glu(453) was the acid/base of the double displacement mechanism, in which the enzyme showed a retaining catalytic character. This is the first structural report for the enzyme belonging to glycoside hydrolase family 66, elucidating the enzyme's catalytic machinery.	[Suzuki, Nobuhiro; Kim, Young-Min; Fujimoto, Zui; Momma, Mitsuru] Natl Inst Agrobiol Sci, Biomol Res Unit, Tsukuba, Ibaraki 3058602, Japan; [Kim, Young-Min; Okuyama, Masayuki; Mori, Haruhide; Kimura, Atsuo] Hokkaido Univ, Res Fac Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan; [Funane, Kazumi] Natl Agr & Food Res Org, Natl Food Res Inst, Appl Microbiol Div, Tsukuba, Ibaraki 3058642, Japan	National Institute of Agrobiological Sciences - Japan; Hokkaido University; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan	Fujimoto, Z (corresponding author), Natl Inst Agrobiol Sci, Biomol Res Unit, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan.	zui@affrc.go.jp; kimura@abs.agr.hokudai.ac.jp	Mori, Haruhide/AAV-6374-2021; Mori, Haruhide/B-7777-2012; Okuyama, Masayuki/D-8739-2012; Suzuki, Nobuhiro/M-7238-2015	Mori, Haruhide/0000-0001-7346-9131; Okuyama, Masayuki/0000-0001-7013-6032; Suzuki, Nobuhiro/0000-0001-8420-5852; Fujimoto, Zui/0000-0002-3551-6854	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN); Japan Society for the Promotion of Science [17-05467]; Grants-in-Aid for Scientific Research [22780082] Funding Source: KAKEN	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in part, by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN).; Supported by Japan Society for the Promotion of Science Postdoctoral Fellowship for Foreign Researchers Grant-in-aid 17-05467. Present address: Korea Research Institute of Bioscience and Biotechnology, Jeonbul Branch Institute, Bioindustry Research Center, 1404 Sinjeong-dong, Jeongeup-si, Jeonbuk 580-185, Korea.	Aoki H, 1997, BIOCHEM J, V323, P859, DOI 10.1042/bj3230859; Bruel L, 2011, J BIOL CHEM, V286, P40814, DOI 10.1074/jbc.M111.286039; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; COLBY SM, 1995, MICROBIOL-SGM, V141, P2929, DOI 10.1099/13500872-141-11-2929; Copeland A, 2009, STAND GENOMIC SCI, V1, P119, DOI [10.4056/sigs.17259, 10.4056/sigs.29547]; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fredslund F, 2011, J MOL BIOL, V412, P466, DOI 10.1016/j.jmb.2011.07.057; Funane K, 2011, BBA-PROTEINS PROTEOM, V1814, P428, DOI 10.1016/j.bbapap.2010.12.009; Golubev AM, 2004, J MOL BIOL, V339, P413, DOI 10.1016/j.jmb.2004.03.062; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HAMADA S, 1980, MICROBIOL REV, V44, P331, DOI 10.1128/MMBR.44.2.331-384.1980; Hendrickson WA, 1997, METHOD ENZYMOL, V276, P494, DOI 10.1016/S0076-6879(97)76074-9; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Ichinose H, 2009, J BIOL CHEM, V284, P25097, DOI 10.1074/jbc.M109.022723; IGARASHI T, 1995, MICROBIOL IMMUNOL, V39, P387, DOI 10.1111/j.1348-0421.1995.tb02217.x; IGARASHI T, 1992, MICROBIOL IMMUNOL, V36, P969, DOI 10.1111/j.1348-0421.1992.tb02100.x; Igarashi T, 2004, ORAL MICROBIOL IMMUN, V19, P102, DOI 10.1046/j.0902-0055.2003.00123.x; Igarashi T, 2002, ORAL MICROBIOL IMMUN, V17, P193, DOI 10.1034/j.1399-302X.2002.170310.x; IWAI A, 1994, J BACTERIOL, V176, P7730, DOI 10.1128/JB.176.24.7730-7734.1994; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; Kamitori S, 2002, J MOL BIOL, V318, P443, DOI 10.1016/S0022-2836(02)00111-0; Kang H. K., 2010, J APPL GLYCOSCI, V57, P269; Khalikova E, 2005, MICROBIOL MOL BIOL R, V69, P306, DOI 10.1128/MMBR.69.2.306-325.2005; Kim YM, 2012, J BIOL CHEM, V287, P19927, DOI 10.1074/jbc.M111.339036; Kim YM, 2011, APPL MICROBIOL BIOT, V91, P329, DOI 10.1007/s00253-011-3201-y; Kim YM, 2010, APPL MICROBIOL BIOT, V85, P581, DOI 10.1007/s00253-009-2121-6; Kimura A., 2000, Journal of Applied Glycoscience, V47, P235; Kitamura M, 2005, ACTA CRYSTALLOGR F, V61, P178, DOI 10.1107/S1744309104033202; Larsbrink J, 2011, BIOCHEM J, V436, P567, DOI 10.1042/BJ20110299; Lee HS, 2002, J BIOL CHEM, V277, P21891, DOI 10.1074/jbc.M201623200; LEMASTER DM, 1985, BIOCHEMISTRY-US, V24, P7263, DOI 10.1021/bi00346a036; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lovering AL, 2005, J BIOL CHEM, V280, P2105, DOI 10.1074/jbc.M410468200; MacGregor EA, 2001, BBA-PROTEIN STRUCT M, V1546, P1, DOI 10.1016/S0167-4838(00)00302-2; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Mesnage S, 2000, EMBO J, V19, P4473, DOI 10.1093/emboj/19.17.4473; Morisaki H, 2002, LETT APPL MICROBIOL, V35, P223, DOI 10.1046/j.1472-765X.2002.01160.x; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Najmudin S, 2006, J BIOL CHEM, V281, P8815, DOI 10.1074/jbc.M510559200; Newstead S, 2005, BIOCHEMISTRY-US, V44, P9117, DOI 10.1021/bi050517t; OGUMA T, 1993, APPL MICROBIOL BIOT, V39, P197, DOI 10.1007/BF00228606; OGUMA T, 1994, FEBS LETT, V345, P135, DOI 10.1016/0014-5793(94)00418-8; Ohtaki A, 2004, J BIOL CHEM, V279, P31033, DOI 10.1074/jbc.M404311200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Suzuki N, 2011, ACTA CRYSTALLOGR F, V67, P1542, DOI 10.1107/S1744309111038425; Suzuki R., 2012, BIOCH BIOPH IN PRESS; Tailford LE, 2007, J BIOL CHEM, V282, P11291, DOI 10.1074/jbc.M610964200; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; WALKER GJ, 1981, J GEN MICROBIOL, V127, P201; WANDA SY, 1994, J BACTERIOL, V176, P3839, DOI 10.1128/JB.176.13.3839-3850.1994; WILLIAMS AF, 1989, COLD SPRING HARB SYM, V54, P637; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WITHERS SG, 1995, PROTEIN SCI, V4, P361; Yamamoto T, 2006, BIOSCI BIOTECH BIOCH, V70, P1947, DOI 10.1271/bbb.60105	61	27	35	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					19916	19926		10.1074/jbc.M112.342444	http://dx.doi.org/10.1074/jbc.M112.342444			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22337884	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000306414500014
J	Dryden, NH; Sperone, A; Martin-Almedina, S; Hannah, RL; Birdsey, GM; Khan, ST; Layhadi, JA; Mason, JC; Haskard, DO; Gottgens, B; Randi, AM				Dryden, Nicola H.; Sperone, Andrea; Martin-Almedina, Silvia; Hannah, Rebecca L.; Birdsey, Graeme M.; Khan, Samia Taufiq; Layhadi, Janice A.; Mason, Justin C.; Haskard, Dorian O.; Goettgens, Berthold; Randi, Anna M.			The Transcription Factor Erg Controls Endothelial Cell Quiescence by Repressing Activity of Nuclear Factor (NF)-kappa B p65	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INTERCELLULAR-ADHESION MOLECULE-1; TUMOR-NECROSIS-FACTOR; ICAM-1 GENE-TRANSCRIPTION; SET ENRICHMENT ANALYSIS; GENOME-WIDE ANALYSIS; ETS-FAMILY; IN-VIVO; REGULATORY ELEMENTS; EXPRESSION PROFILES	The interaction of transcription factors with specific DNA sequences is critical for activation of gene expression programs. In endothelial cells (EC), the transcription factor NF-kappa B is important in the switch from quiescence to activation, and is tightly controlled to avoid excessive inflammation and organ damage. Here we describe a novel mechanism that controls the activation of NF-kappa B in EC. The transcription factor Erg, the most highly expressed ETS member in resting EC, controls quiescence by repressing proinflammatory gene expression. Focusing on intercellular adhesion molecule 1(ICAM)-1 as a model, we identify two ETS binding sites (EBS - 118 and - 181) within the ICAM-1 promoter required for Erg-mediated repression. We show that Erg binds to both EBS - 118 and EBS - 181, the latter located within the NF-kappa B binding site. Interestingly, inhibition of Erg expression in quiescent EC results in increased NF-kappa B-dependent ICAM-1 expression, indicating that Erg represses basal NF-kappa B activity. Erg prevents NF-kappa B p65 from binding to the ICAM-1 promoter, suggesting a direct mechanism of interference. Gene set enrichment analysis of transcriptome profiles of Erg and NF-kappa B-dependent genes, together with chromatin immunoprecipitation (ChIP) studies, reveals that this mechanism is common to other proinflammatory genes, including cIAP-2 and IL-8. These results identify a role for Erg as a gatekeeper controlling vascular inflammation, thus providing an important barrier to protect against inappropriate endothelial activation.	[Dryden, Nicola H.; Sperone, Andrea; Martin-Almedina, Silvia; Birdsey, Graeme M.; Khan, Samia Taufiq; Layhadi, Janice A.; Mason, Justin C.; Haskard, Dorian O.; Randi, Anna M.] Univ London Imperial Coll Sci Technol & Med, NHLI Cardiovasc Sci Unit, Hammersmith Hosp, London W12 0NN, England; [Hannah, Rebecca L.; Goettgens, Berthold] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge CB2 0XY, England	Imperial College London; University of Cambridge	Randi, AM (corresponding author), Univ London Imperial Coll Sci Technol & Med, NHLI Cardiovasc Sci Unit, Hammersmith Hosp, Du Cane Rd, London W12 0NN, England.	a.randi@imperial.ac.uk	Layhadi, Janice/AAU-8807-2020	Layhadi, Janice/0000-0002-5242-1806; Birdsey, Graeme M./0000-0002-0981-8672; Mason, Justin/0000-0001-7783-1660	British Heart Foundation; Leukemia and Lymphoma Research; National Institute for Health Research Cambridge Bio-medical Research Centre; BBSRC [BB/I00050X/1] Funding Source: UKRI; MRC [G0800784] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I00050X/1] Funding Source: researchfish; British Heart Foundation [PG/10/94/28651] Funding Source: researchfish; Cancer Research UK [12765] Funding Source: researchfish; Medical Research Council [G0800784B, G0800784] Funding Source: researchfish; National Centre for the Replacement [G0900729/1] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Leukemia and Lymphoma Research; National Institute for Health Research Cambridge Bio-medical Research Centre(National Institute for Health Research (NIHR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement	This work was supported by grants from the British Heart Foundation (to N. H. D., S. A. M., G. M. B., S. T. K., and A. S.) and Leukemia and Lymphoma Research and the National Institute for Health Research Cambridge Biomedical Research Centre (to R. L. H. and B. G.).	Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Birdsey GM, 2008, BLOOD, V111, P3498, DOI 10.1182/blood-2007-08-105346; Birdsey GM, 2012, BLOOD, V119, P894, DOI 10.1182/blood-2011-04-350025; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Carrere S, 1998, ONCOGENE, V16, P3261, DOI 10.1038/sj.onc.1201868; Chen W, 2008, J BIOL CHEM, V283, P16293, DOI 10.1074/jbc.M801803200; Cheng C, 2011, CIRC RES, V109, P385, DOI 10.1161/CIRCRESAHA.111.243444; de Launoit Y, 1998, ONCOGENE, V16, P2065, DOI 10.1038/sj.onc.1201726; De Val S, 2008, CELL, V135, P1053, DOI 10.1016/j.cell.2008.10.049; Deramaudt BMJM, 1999, J CELL BIOCHEM, V72, P311, DOI 10.1002/(SICI)1097-4644(19990301)72:3<311::AID-JCB1>3.3.CO;2-7; Furusu A, 2001, KIDNEY INT, V60, P579, DOI 10.1046/j.1523-1755.2001.060002579.x; Goetze S, 2001, ATHEROSCLEROSIS, V159, P93, DOI 10.1016/S0021-9150(01)00497-X; GOTTSCHALK LR, 1993, J EXP MED, V178, P1681, DOI 10.1084/jem.178.5.1681; Grall F, 2003, ARTHRITIS RHEUM, V48, P1249, DOI 10.1002/art.10942; Gri G, 1998, J BIOL CHEM, V273, P6431, DOI 10.1074/jbc.273.11.6431; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hollenhorst PC, 2004, NUCLEIC ACIDS RES, V32, P5693, DOI 10.1093/nar/gkh906; HOU JZ, 1994, P NATL ACAD SCI USA, V91, P11641, DOI 10.1073/pnas.91.24.11641; HultgardhNilsson A, 1996, CIRC RES, V78, P589, DOI 10.1161/01.RES.78.4.589; Jeong BC, 2006, FEBS LETT, V580, P669, DOI 10.1016/j.febslet.2005.12.086; JOHN S, 1995, MOL CELL BIOL, V15, P1786; KARIM FD, 1990, GENE DEV, V4, P1451, DOI 10.1101/gad.4.9.1451; LEDEBUR HC, 1995, J BIOL CHEM, V270, P933, DOI 10.1074/jbc.270.2.933; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Maurer P, 2003, ONCOGENE, V22, P3319, DOI 10.1038/sj.onc.1206572; McLaughlin F, 1999, J CELL SCI, V112, P4695; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Okada Y, 2007, CIRC RES, V100, P1712, DOI 10.1161/01.RES.0000269779.10644.dc; PAN JL, 1995, J BIOL CHEM, V270, P23077, DOI 10.1074/jbc.270.39.23077; Payankaulam S, 2010, CURR BIOL, V20, pR764, DOI 10.1016/j.cub.2010.06.037; Peter M, 1997, ONCOGENE, V14, P1159, DOI 10.1038/sj.onc.1200933; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Pimanda JE, 2006, BLOOD, V107, P4737, DOI 10.1182/blood-2005-12-4929; PRASAD DDK, 1992, CANCER RES, V52, P5833; Redlich K, 2001, ARTHRITIS RHEUM, V44, P266, DOI 10.1002/1529-0131(200102)44:2<266::AID-ANR43>3.3.CO;2-7; Rocha VZ, 2009, NAT REV CARDIOL, V6, P399, DOI 10.1038/nrcardio.2009.55; ROEBUCK KA, 1995, J BIOL CHEM, V270, P18966, DOI 10.1074/jbc.270.32.18966; Rudders S, 2001, J BIOL CHEM, V276, P3302, DOI 10.1074/jbc.M006507200; Sana TR, 2005, CYTOKINE, V29, P256, DOI 10.1016/j.cyto.2004.11.003; Shiraya S, 2006, HYPERTENSION, V48, P628, DOI 10.1161/01.HYP.0000240266.26185.57; Sperone A, 2011, ARTERIOSCL THROM VAS, V31, P142, DOI 10.1161/ATVBAHA.110.216473; STRIETER RM, 1989, SCIENCE, V243, P1467, DOI 10.1126/science.2648570; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Thomas RS, 1997, ONCOGENE, V14, P2845, DOI 10.1038/sj.onc.1201125; VORABERGER G, 1991, J IMMUNOL, V147, P2777; Wang JG, 2006, BLOOD, V107, P558, DOI 10.1182/blood-2005-05-2152; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Xue JP, 2009, PHYSIOL GENOMICS, V38, P42, DOI 10.1152/physiolgenomics.00012.2009; Yang L, 2002, ONCOGENE, V21, P148, DOI 10.1038/sj.onc.1204998; Yang L, 2003, BIOCHEM J, V369, P651, DOI 10.1042/BJ20020854; Yockell-Lelievre J, 2009, BIOCHEM CELL BIOL, V87, P905, DOI [10.1139/O09-055, 10.1139/o09-055]; Yuan L, 2009, CIRC RES, V104, P1049, DOI 10.1161/CIRCRESAHA.108.190751; Zhang YX, 2008, CANCER RES, V68, P9519, DOI 10.1158/0008-5472.CAN-08-1549	59	36	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12331	12342		10.1074/jbc.M112.346791	http://dx.doi.org/10.1074/jbc.M112.346791			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22337883	Green Published, hybrid			2022-12-25	WOS:000302782200072
J	Sepramaniam, S; Ying, LK; Armugam, A; Wintour, EM; Jeyaseelan, K				Sepramaniam, Sugunavathi; Ying, Lim Kai; Armugam, Arunmozhiarasi; Wintour, E. M.; Jeyaseelan, Kandiah			MicroRNA-130a Represses Transcriptional Activity of Aquaporin 4 M1 Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CEREBRAL-ISCHEMIA; EPITHELIAL-CELLS; MAMMALIAN-CELLS; RAT ASTROCYTES; BRAIN EDEMA; GLIAL-CELLS; EXPRESSION; GENE; MIRNA	Aquaporins (AQPs) are transmembrane water channels ubiquitously expressed in mammalian tissues. They play prominent roles in maintaining cellular fluid balance. Although expression of AQP1, -3, -4, -5, -8, -9, and -11 has been reported in the central nervous system, it is AQP4 that is predominately expressed. Its importance in fluid regulation in cerebral edema conditions has been highlighted in several studies, and we have also shown that translational regulation of AQP4 by miR-320a could prove to be useful in infarct volume reduction in middle cerebral artery occluded rat brain. There is evidence for the existence of two AQP4 transcripts (M1 and M23) in the brain arising from two alternative promoters. Because the AQP4 M1 isoform exhibits greater water permeability, in this study, we explored the possibility of microRNA-based transcriptional regulation of the AQP4 M1 promoter. Using RegRNA software, we identified 34 microRNAs predicted to target the AQP4 M1 promoter region. MicroRNA profiling, quantitative stem-loop PCR, and luciferase reporter assays revealed that miR-130a, -152, -668, -939, and -1280, which were highly expressed in astrocytes, could regulate the promoter activity. Of these, miR-130a was identified as a strong transcriptional repressor of the AQP4 M1 isoform. In vivo studies revealed that LNA(TM) anti-miR-130a could up-regulate the AQP4 M1 transcript and its protein to bring about a reduction in cerebral infarct and promote recovery.	[Sepramaniam, Sugunavathi; Ying, Lim Kai; Armugam, Arunmozhiarasi; Jeyaseelan, Kandiah] Natl Univ Singapore, Natl Univ Hlth Syst, Dept Biochem, Yong Loo Lin Sch Med, Singapore 117597, Singapore; [Sepramaniam, Sugunavathi; Ying, Lim Kai; Armugam, Arunmozhiarasi; Jeyaseelan, Kandiah] Natl Univ Singapore, Natl Univ Hlth Syst, Ctr Translat Med, Yong Loo Lin Sch Med,Neurosci Res Ctr, Singapore 117597, Singapore; [Wintour, E. M.; Jeyaseelan, Kandiah] Monash Univ, Fac Med Nursing & Hlth Sci, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia	National University of Singapore; National University of Singapore; Monash University	Jeyaseelan, K (corresponding author), Natl Univ Singapore, Natl Univ Hlth Syst, Dept Biochem, Yong Loo Lin Sch Med, 8 Med Dr, Singapore 117597, Singapore.	bchjeya@nus.edu.sg		Armugam, Arunmozhiarasi/0000-0002-6064-1980	Singapore National Research Foundation [R-184-002-165-281]; National Medical Research Council [R-183-000-290-213]	Singapore National Research Foundation(National Research Foundation, Singapore); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Research Grants R-184-002-165-281 and R-183-000-290-213 from the Singapore National Research Foundation and National Medical Research Council, respectively.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Arima H, 2003, J BIOL CHEM, V278, P44525, DOI 10.1074/jbc.M304368200; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; COGSWELL JP, 1994, J IMMUNOL, V153, P712; Fenton RA, 2010, CELL MOL LIFE SCI, V67, P829, DOI 10.1007/s00018-009-0218-9; Garzon R, 2006, P NATL ACAD SCI USA, V103, P5078, DOI 10.1073/pnas.0600587103; Greco SJ, 2007, P NATL ACAD SCI USA, V104, P15484, DOI 10.1073/pnas.0703037104; Hirt L, 2009, J CEREBR BLOOD F MET, V29, P423, DOI 10.1038/jcbfm.2008.133; Huang HY, 2006, NUCLEIC ACIDS RES, V34, pW429, DOI 10.1093/nar/gkl333; Ito H, 2006, J NEUROCHEM, V99, P107, DOI 10.1111/j.1471-4159.2006.04036.x; Janowski BA, 2005, NAT CHEM BIOL, V1, P216, DOI 10.1038/nchembio725; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; JUNG JS, 1994, P NATL ACAD SCI USA, V91, P13052, DOI 10.1073/pnas.91.26.13052; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Lee Y, 2008, NAT NEUROSCI, V11, P1137, DOI 10.1038/nn.2183; Lim KY, 2010, TRANSL STROKE RES, V1, P287, DOI 10.1007/s12975-010-0035-3; Majid S, 2010, CANCER-AM CANCER SOC, V116, P5637, DOI 10.1002/cncr.25488; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; MOYNAGH PN, 1993, BIOCHEM J, V294, P343, DOI 10.1042/bj2940343; Nielsen S, 1997, J NEUROSCI, V17, P171; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Papadopoulos MC, 2005, J BIOL CHEM, V280, P13906, DOI 10.1074/jbc.M413627200; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Satoh J, 2007, NEUROPATHOLOGY, V27, P245, DOI 10.1111/j.1440-1789.2007.00774.x; Schneider A, 1999, NAT MED, V5, P554, DOI 10.1038/8432; SCOTT ML, 1993, GENE DEV, V7, P1266, DOI 10.1101/gad.7.7a.1266; Sepramaniam S, 2010, J BIOL CHEM, V285, P29223, DOI 10.1074/jbc.M110.144576; Silberstein C, 2004, AM J PHYSIOL-RENAL, V287, pF501, DOI 10.1152/ajprenal.00439.2003; Sorbo JG, 2008, BIOCHEMISTRY-US, V47, P2631, DOI 10.1021/bi702146k; Tourdias T, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-143; Umenishi F, 1998, GENOMICS, V50, P373, DOI 10.1006/geno.1998.5337; YAMASAKI Y, 1995, STROKE, V26, P676, DOI 10.1161/01.STR.26.4.676; Younger ST, 2011, NUCLEIC ACIDS RES, V39, P5682, DOI 10.1093/nar/gkr155; Zhou R, 2010, NUCLEIC ACIDS RES, V38, P3222, DOI 10.1093/nar/gkq056	36	57	66	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12006	12015		10.1074/jbc.M111.280701	http://dx.doi.org/10.1074/jbc.M111.280701			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334710	Green Published, hybrid			2022-12-25	WOS:000302782200038
J	Lefebvre, B; Klaus-Heisen, D; Pietraszewska-Bogiel, A; Herve, C; Camut, S; Auriac, MC; Gasciolli, V; Nurisso, A; Gadella, TWJ; Cullimore, J				Lefebvre, Benoit; Klaus-Heisen, Doerte; Pietraszewska-Bogiel, Anna; Herve, Christine; Camut, Sylvie; Auriac, Marie-Christine; Gasciolli, Virginie; Nurisso, Alessandra; Gadella, Theodorus W. J.; Cullimore, Julie			Role of N-Glycosylation Sites and CXC Motifs in Trafficking of Medicago truncatula Nod Factor Perception Protein to Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-LIKE KINASES; ER QUALITY-CONTROL; ENDOPLASMIC-RETICULUM; LYSM DOMAINS; FLUORESCENT PROTEINS; PLANT IMMUNITY; ARABIDOPSIS; BINDING; RECOGNITION; GENE	The lysin motif receptor-like kinase, NFP (Nod factor perception), is a key protein in the legume Medicago truncatula for the perception of lipochitooligosaccharidic Nod factors, which are secreted bacterial signals essential for establishing the nitrogen-fixing legume-rhizobia symbiosis. Predicted structural and genetic analyses strongly suggest that NFP is at least part of a Nod factor receptor, but few data are available about this protein. Characterization of a variant encoded by the mutant allele nfp-2 revealed the sensitivity of this protein to the endoplasmic reticulum quality control mechanisms, affecting its trafficking to the plasma membrane. Further analysis revealed that the extensive N-glycosylation of the protein is not essential for biological activity. In the NFP extracellular region, two CXC motifs and two other Cys residues were found to be involved in disulfide bridges, and these are necessary for correct folding and localization of the protein. Analysis of the intracellular region revealed its importance for biological activity but suggests that it does not rely on kinase activity. This work shows that NFP trafficking to the plasma membrane is highly sensitive to regulation in the endoplasmic reticulum and has identified structural features of the protein, particularly disulfide bridges involving CXC motifs in the extracellular region that are required for its biological function.	[Lefebvre, Benoit; Klaus-Heisen, Doerte; Herve, Christine; Camut, Sylvie; Auriac, Marie-Christine; Gasciolli, Virginie; Cullimore, Julie] INRA, Lab Interact Plantes Microorganismes, UMR441, F-31326 Castanet Tolosan, France; [Lefebvre, Benoit; Klaus-Heisen, Doerte; Herve, Christine; Camut, Sylvie; Auriac, Marie-Christine; Gasciolli, Virginie; Cullimore, Julie] CNRS, Lab Interact Plantes Microorganismes, UMR2594, F-31326 Castanet Tolosan, France; [Pietraszewska-Bogiel, Anna; Gadella, Theodorus W. J.] Swammerdam Inst Life Sci, NL-1098 SM Amsterdam, Netherlands; [Nurisso, Alessandra] Univ Lausanne, Univ Geneva, Sch Pharmaceut Sci, CH-1211 Geneva, Switzerland	INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; University of Amsterdam; University of Geneva; University of Lausanne	Lefebvre, B (corresponding author), INRA CNRS, Lab Plant Microbe Interact, BP 52627, F-31326 Castanet Tolosan, France.	benoit.lefebvre@toulouse.inra.fr	lefebvre, benoit/G-2028-2012	Gadella, Theodorus/0000-0002-7639-219X; Lefebvre, Benoit/0000-0002-3810-605X; Auriac, Marie-Christine/0000-0002-1202-032X; Cullimore, Julie/0000-0001-8804-4849	European Community Marie Curie Research Training Network [MRTN-CT-2006-035546 "NODPERCEPTION"]; National Research Agency [NodBindsLysM, LCOinNONLEGUMES, SYMPASIGNAL]	European Community Marie Curie Research Training Network(European Commission); National Research Agency(French National Research Agency (ANR))	This work was supported in part by the European Community Marie Curie Research Training Network Program Contract MRTN-CT-2006-035546 "NODPERCEPTION" and French National Research Agency Contracts "NodBindsLysM," "LCOinNONLEGUMES," and "SYMPASIGNAL". This work was performed in the Laboratoire des Interactions Plantes-Microorganismes, part of the " Laboratoire d'Excellence (LABEX) entitled TULIP (ANR-10-LABX-41).	Arrighi JF, 2006, PLANT PHYSIOL, V142, P265, DOI 10.1104/pp.106.084657; Bensmihen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026114; Boisson-Dernier A, 2001, MOL PLANT MICROBE IN, V14, P695, DOI 10.1094/MPMI.2001.14.6.695; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Castells E, 2007, J EXP BOT, V58, P3503, DOI 10.1093/jxb/erm226; Derewenda U, 2009, BIOCHEMISTRY-US, V48, P8664, DOI 10.1021/bi900437z; Fliegmann J, 2011, PLANT PHYSIOL BIOCH, V49, P709, DOI 10.1016/j.plaphy.2011.04.004; Gomez-Gomez L, 2001, PLANT CELL, V13, P1155, DOI 10.1105/tpc.13.5.1155; Gomord V, 2010, PLANT BIOTECHNOL J, V8, P564, DOI 10.1111/j.1467-7652.2009.00497.x; Gough C, 2011, MOL PLANT MICROBE IN, V24, P867, DOI 10.1094/MPMI-01-11-0019; Haweker H, 2010, J BIOL CHEM, V285, P4629, DOI 10.1074/jbc.M109.063073; Haseloff J, 1997, P NATL ACAD SCI USA, V94, P2122, DOI 10.1073/pnas.94.6.2122; Hong Z, 2008, PLANT CELL, V20, P3418, DOI 10.1105/tpc.108.061879; Ivanchenko M, 2000, PLANT J, V24, P79, DOI 10.1046/j.1365-313x.2000.00855.x; Jose-Estanyol M, 2004, PLANT PHYSIOL BIOCH, V42, P355, DOI 10.1016/j.plaphy.2004.03.009; Joseph PRB, 2010, J BIOL CHEM, V285, P29262, DOI 10.1074/jbc.M110.146555; Kannan N, 2005, J MOL BIOL, V351, P956, DOI 10.1016/j.jmb.2005.06.057; Klarenbeek JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019170; Klaus-Heisen D, 2011, J BIOL CHEM, V286, P11202, DOI 10.1074/jbc.M110.186171; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Lefebvre B, 2004, PLANT CELL, V16, P1772, DOI 10.1105/tpc.022277; Lerouge P, 1998, PLANT MOL BIOL, V38, P31, DOI 10.1023/A:1006012005654; Li J, 2009, P NATL ACAD SCI USA, V106, P15973, DOI 10.1073/pnas.0905532106; Lu X, 2009, P NATL ACAD SCI USA, V106, P22522, DOI 10.1073/pnas.0907711106; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; Madsen EB, 2011, PLANT J, V65, P404, DOI 10.1111/j.1365-313X.2010.04431.x; Mbengue M, 2010, PLANT CELL, V22, P3474, DOI 10.1105/tpc.110.075861; Moreau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016463; Mulder L, 2006, GLYCOBIOLOGY, V16, P801, DOI 10.1093/glycob/cwl006; Navarro-Gochicoa MT, 2003, PLANT PHYSIOL, V133, P1893, DOI 10.1104/pp.103.027680; Nekrasov V, 2009, EMBO J, V28, P3428, DOI 10.1038/emboj.2009.262; Ohnuma T, 2008, J BIOL CHEM, V283, P5178, DOI 10.1074/jbc.M707156200; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; Pattison RJ, 2009, TRENDS PLANT SCI, V14, P92, DOI 10.1016/j.tplants.2008.11.008; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Petutschnig EK, 2010, J BIOL CHEM, V285, P28902, DOI 10.1074/jbc.M110.116657; POWELL MJD, 1964, COMPUT J, V7, P155, DOI 10.1093/comjnl/7.2.155; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Radutoiu S, 2007, EMBO J, V26, P3923, DOI 10.1038/sj.emboj.7601826; Saijo Y, 2010, CELL MICROBIOL, V12, P716, DOI 10.1111/j.1462-5822.2010.01472.x; Saijo Y, 2009, EMBO J, V28, P3439, DOI 10.1038/emboj.2009.263; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Smit P, 2007, PLANT PHYSIOL, V145, P183, DOI 10.1104/pp.107.100495; Song XF, 2010, J INTEGR PLANT BIOL, V52, P774, DOI 10.1111/j.1744-7909.2010.00978.x; Timmers ACJ, 1999, DEVELOPMENT, V126, P3617; van der Hoorn RAL, 2005, PLANT CELL, V17, P1000, DOI 10.1105/tpc.104.028118; VANBOKHOVEN H, 1993, J GEN VIROL, V74, P2233, DOI 10.1099/0022-1317-74-10-2233; Vitale A, 2008, TRAFFIC, V9, P1581, DOI 10.1111/j.1600-0854.2008.00780.x; Vitha S, 1997, J HISTOCHEM CYTOCHEM, V45, P89, DOI 10.1177/002215549704500112; Waldherr-Teschner M., 1992, Advances in Scientific Visualization, P58; Woycechowsky KJ, 2003, BIOCHEMISTRY-US, V42, P5387, DOI 10.1021/bi026993q; Zhu Q, 2002, BIOCHEMISTRY-US, V41, P11488, DOI 10.1021/bi026136m	54	31	32	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10812	10823		10.1074/jbc.M111.281634	http://dx.doi.org/10.1074/jbc.M111.281634			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334694	Green Published, hybrid			2022-12-25	WOS:000302780100010
J	Mellroth, P; Daniels, R; Eberhardt, A; Ronnlund, D; Blom, H; Widengren, J; Normark, S; Henriques-Normark, B				Mellroth, Peter; Daniels, Robert; Eberhardt, Alice; Ronnlund, Daniel; Blom, Hans; Widengren, Jerker; Normark, Staffan; Henriques-Normark, Birgitta			LytA, Major Autolysin of Streptococcus pneumoniae, Requires Access to Nascent Peptidoglycan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENICILLIN RESISTANCE; PNEUMOCOCCAL AUTOLYSIN; RECOGNITION PROTEIN; SURFACE-PROTEINS; ENZYME-ACTIVITY; PNEUMOLYSIN; FRATRICIDE; VIRULENCE; GENE; ATTENUATION	Background: The regulation of cell wall hydrolysis by the pneumococcal autolysin LytA is poorly understood. Results: The cell wall is susceptible to extracellular LytA only during the stationary phase or after cell wall synthesis inhibition. Conclusion: LytA is regulated on the substrate level, where peptidoglycan modifications likely prevent LytA hydrolysis. Significance: The control of amidases is essential for bacterial survival, cell-wall synthesis, and division.	[Mellroth, Peter; Eberhardt, Alice; Normark, Staffan; Henriques-Normark, Birgitta] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden; [Daniels, Robert] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, S-10691 Stockholm, Sweden; [Ronnlund, Daniel; Blom, Hans; Widengren, Jerker] Albanova Univ Ctr, Royal Inst Technol, Dept Appl Phys, S-10691 Stockholm, Sweden; [Henriques-Normark, Birgitta] Karolinska Univ Hosp, Dept Lab Med, Div Clin Microbiol, S-17176 Stockholm, Sweden	Karolinska Institutet; Stockholm University; Royal Institute of Technology; Karolinska Institutet; Karolinska University Hospital	Mellroth, P (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden.	peter.mellroth@ki.se	Mellroth, Peter/F-8214-2013	Mellroth, Peter/0000-0002-3518-1054; Widengren, Jerker/0000-0003-3200-0374; daniels, Robert/0000-0002-5988-2920	VINNOVA; Swedish Research Council; Carl Trygger Foundation; EU; Torsten and Ragnar Soderbergs Foundation; Karolinska Institutet; Swedish Royal Academy of Sciences; Stockholm City Council	VINNOVA(Vinnova); Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Trygger Foundation; EU(European Commission); Torsten and Ragnar Soderbergs Foundation; Karolinska Institutet(Karolinska Institutet); Swedish Royal Academy of Sciences; Stockholm City Council	This work was supported by research grants from VINNOVA (to S.N. and B.H.-N.), the Swedish Research Council (to H.B., B.H.-N., and S.N.), the Carl Trygger Foundation (to R.D.), EU FP7, FLUODIAMON (to J.W.), the Torsten and Ragnar Soderbergs Foundation (to B.H.-N.), the Karolinska Institutet (to S.N. and B.H.-N.), the Swedish Royal Academy of Sciences (to B.H.-N.), and the ALF-bidrag from the Stockholm City Council (to B.H.-N.).	Avery OT, 1923, J EXP MED, V38, P199, DOI 10.1084/jem.38.2.199; Berry AM, 2000, INFECT IMMUN, V68, P133, DOI 10.1128/IAI.68.1.133-140.2000; CANVIN JR, 1995, J INFECT DIS, V172, P119, DOI 10.1093/infdis/172.1.119; Carlsson F, 2006, NATURE, V442, P943, DOI 10.1038/nature05021; Claverys JP, 2007, MOL MICROBIOL, V64, P1423, DOI 10.1111/j.1365-2958.2007.05757.x; Crisostomo MI, 2006, MOL MICROBIOL, V61, P1497, DOI 10.1111/j.1365-2958.2006.05340.x; Daniels R, 2010, J BIOL CHEM, V285, P3300, DOI 10.1074/jbc.M109.081398; DeDent A, 2008, EMBO J, V27, P2656, DOI 10.1038/emboj.2008.185; Eldholm V, 2009, MICROBIOL-SGM, V155, P2223, DOI 10.1099/mic.0.026328-0; Fernandez-Tornero C, 2001, NAT STRUCT BIOL, V8, P1020, DOI 10.1038/nsb724; Filipe SR, 2000, P NATL ACAD SCI USA, V97, P4891, DOI 10.1073/pnas.080067697; Frolet C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-190; GARCIA E, 1985, MOL GEN GENET, V201, P225, DOI 10.1007/BF00425663; GIUDICELLI S, 1984, J BACTERIOL, V158, P1188, DOI 10.1128/JB.158.3.1188-1190.1984; Goebel WF, 1929, J EXP MED, V49, P267, DOI 10.1084/jem.49.2.267; Hakenbeck R, 2009, FEMS MICROBIOL REV, V33, P572, DOI 10.1111/j.1574-6976.2009.00172.x; Havarstein LS, 2006, MOL MICROBIOL, V59, P1297, DOI 10.1111/j.1365-2958.2005.05021.x; Hirst RA, 2008, J INFECT DIS, V197, P744, DOI 10.1086/527322; HOWARD LV, 1974, J BACTERIOL, V117, P796, DOI 10.1128/JB.117.2.796-804.1974; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; LACKS S, 1960, BIOCHIM BIOPHYS ACTA, V39, P508, DOI 10.1016/0006-3002(60)90205-5; Loessner MJ, 2005, CURR OPIN MICROBIOL, V8, P480, DOI 10.1016/j.mib.2005.06.002; Martner A, 2008, INFECT IMMUN, V76, P4079, DOI 10.1128/IAI.01747-07; Martner A, 2009, INFECT IMMUN, V77, P3826, DOI 10.1128/IAI.00290-09; Mellroth P, 2003, J BIOL CHEM, V278, P7059, DOI 10.1074/jbc.M208900200; MOREILLON P, 1988, J INFECT DIS, V157, P1150, DOI 10.1093/infdis/157.6.1150; Moscoso M, 2010, MOL MICROBIOL, V77, P1052, DOI 10.1111/j.1365-2958.2010.07271.x; NEUFELD F, 1900, Z HYG INFEKTIONSKR, V34, P454; Neumann Daniel, 2010, PMC Biophys, V3, P4, DOI 10.1186/1757-5036-3-4; Royet J, 2007, NAT REV MICROBIOL, V5, P264, DOI 10.1038/nrmicro1620; SANCHEZPUELLES JM, 1986, EUR J BIOCHEM, V158, P289, DOI 10.1111/j.1432-1033.1986.tb09749.x; TOMASZ A, 1970, NATURE, V227, P138, DOI 10.1038/227138a0; TOMASZ A, 1975, P NATL ACAD SCI USA, V72, P4162, DOI 10.1073/pnas.72.10.4162; Vollmer W, 2000, J BIOL CHEM, V275, P20496, DOI 10.1074/jbc.M910189199; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Wildanger D, 2008, OPT EXPRESS, V16, P9614, DOI 10.1364/OE.16.009614; Zapun A, 2008, FEMS MICROBIOL REV, V32, P345, DOI 10.1111/j.1574-6976.2007.00098.x; Zoll S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000807	38	91	103	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11018	11029		10.1074/jbc.M111.318584	http://dx.doi.org/10.1074/jbc.M111.318584			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334685	Green Published, hybrid			2022-12-25	WOS:000302780100030
J	Benelli, D; Cialfi, S; Pinzaglia, M; Talora, C; Londei, P				Benelli, Dario; Cialfi, Samantha; Pinzaglia, Michela; Talora, Claudio; Londei, Paola			The Translation Factor eIF6 Is a Notch-Dependent Regulator of Cell Migration and Invasion	PLOS ONE			English	Article							INITIATION FACTOR-6; BINDING PROTEIN; EXPRESSION; P27(BBP); EIF-4E; GROWTH; TRANSFORMATION	A growing body of evidence indicates that protein factors controlling translation play an important role in tumorigenesis. The protein known as eIF6 is a ribosome anti-association factor that has been implicated in translational initiation and in ribosome synthesis. Over-expression of eIF6 is observed in many natural tumours, and causes developmental and differentiation defects in certain animal models. Here we show that the transcription of the gene encoding eIF6 is modulated by the receptor Notch-1, a protein involved in embryonic development and cell differentiation, as well as in many neoplasms. Inhibition of Notch-1 signalling by gamma-secretase inhibitors slowed down cell-cycle progression and reduced the amount of eIF6 in lymphoblastoid and ovarian cancer cell lines. Cultured ovarian cancer cell lines engineered to stably over-expressing eIF6 did not show significant changes in proliferation rate, but displayed an enhanced motility and invasive capacity. Inhibition of Notch-1 signalling in the cells over-expressing eIF6 was effective in slowing down the cell cycle, but did not reduce cell migration and invasion. On the whole, the results suggest that eIF6 is one of the downstream effectors of Notch-1 in the pathway that controls cell motility and invasiveness.	[Benelli, Dario; Pinzaglia, Michela; Londei, Paola] Univ Roma La Sapienza, Dept Cellular Biotechnol & Haematol, Rome, Italy; [Talora, Claudio] Univ Roma La Sapienza, Dept Mol Med, Rome, Italy; [Cialfi, Samantha] Univ Roma La Sapienza, Dept Pediat & Infantile Neuropsychiat, Rome, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome	Benelli, D (corresponding author), Univ Roma La Sapienza, Dept Cellular Biotechnol & Haematol, Rome, Italy.	londei@bce.uniroma1.it	Talora, Claduio/AIC-4932-2022; Benelli, Dario/D-3492-2012	Talora, Claduio/0000-0002-6973-2184; Benelli, Dario/0000-0002-1488-8392	Istituto Pasteur-Fondazione Cenci Bolognetti; Roma Sapienza University	Istituto Pasteur-Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Roma Sapienza University	This work was supported by funds to PL from the Istituto Pasteur-Fondazione Cenci Bolognetti project: "Translational regulation: from the Archaea to the Eukarya" and by funds from the Roma Sapienza University to PL for the project "Molecular markers in melanoma progression." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; Basu U, 2001, MOL CELL BIOL, V21, P1453, DOI 10.1128/MCB.21.5.1453-1462.2001; Biffo S, 1997, J BIOL CHEM, V272, P30314, DOI 10.1074/jbc.272.48.30314; Carotenuto R, 2005, CELL MOL LIFE SCI, V62, P1641, DOI 10.1007/s00018-005-5153-9; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Chen J, 2010, BRIT J CANCER, V102, P351, DOI 10.1038/sj.bjc.6605486; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; De Marco N, 2010, CELL DEATH DIFFER, V17, P360, DOI 10.1038/cdd.2009.128; Donadini A, 2006, FEBS LETT, V580, P1983, DOI 10.1016/j.febslet.2006.02.068; Donadini A, 2001, GENE, V266, P35, DOI 10.1016/S0378-1119(01)00370-5; Flavin RJ, 2008, MODERN PATHOL, V21, P676, DOI 10.1038/modpathol.2008.33; Gandin V, 2008, NATURE, V455, P684, DOI 10.1038/nature07267; Ji Y, 2008, ONCOGENE, V27, P755, DOI 10.1038/sj.onc.1210667; Kato H, 1997, DEVELOPMENT, V124, P4133; LAZARISKARATZAS A, 1992, MOL CELL BIOL, V12, P1234, DOI 10.1128/MCB.12.3.1234; Miluzio A, 2011, CANCER CELL, V19, P765, DOI 10.1016/j.ccr.2011.04.018; Rajasekhar VK, 2004, ONCOGENE, V23, P3248, DOI 10.1038/sj.onc.1207546; Rosenwald IB, 2004, ONCOGENE, V23, P3230, DOI 10.1038/sj.onc.1207552; ROSENWALD IB, 1993, P NATL ACAD SCI USA, V90, P6175, DOI 10.1073/pnas.90.13.6175; Rosso P, 2004, HEAD NECK-J SCI SPEC, V26, P408, DOI 10.1002/hed.10401; RUSSELL DW, 1979, J BIOL CHEM, V254, P8796; Sanvito F, 1999, J CELL BIOL, V144, P823, DOI 10.1083/jcb.144.5.823; Sanvito F, 2000, CANCER RES, V60, P510; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Talora C, 2008, BBA-MOL BASIS DIS, V1782, P489, DOI 10.1016/j.bbadis.2008.06.008; Tien AC, 2008, J CELL BIOL, V182, P1113, DOI 10.1083/jcb.200805001; Vaccaro MC, 2006, MOL REPROD DEV, V73, P482, DOI 10.1002/mrd.20449; Wang MY, 2010, MED ONCOL, V27, P1329, DOI 10.1007/s12032-009-9384-8; Wang MY, 2010, BIOCHEM BIOPH RES CO, V393, P144, DOI 10.1016/j.bbrc.2010.01.103; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160	33	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e32047	10.1371/journal.pone.0032047	http://dx.doi.org/10.1371/journal.pone.0032047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348144	Green Published, Green Submitted, gold			2022-12-25	WOS:000302737400061
J	Tsuruyama, T; Liu, WZ; Yoshikawa, K				Tsuruyama, Tatsuaki; Liu, Weizhi; Yoshikawa, Kenichi			In Vitro Murine Leukemia Retroviral Integration and Structure Fluctuation of Target DNA	PLOS ONE			English	Article							HOT-SPOTS; VIRUS; LYMPHOMAS; CANCER; GENE; MICE; SEQUENCES; PROMOTER; REGIONS; GENOME	Integration of the retroviral genome into host DNA is a critical step in the life cycle of a retrovirus. Although assays for in vitro integration have been developed, the actual DNA sequences targeted by murine leukemia retrovirus (MLV) during in vitro reproduction are unknown. While previous studies used artificial target sequences, we developed an assay using target DNA sequences from common MLV integration sites in Stat5a and c-myc in the genome of murine lymphomas and successfully integrated MLV into the target DNA in vitro. We calculated the free energy change during folding of the target sequence DNA and found a close correlation between the calculated free energy change and the number of integrations. Indeed, the integrations closely correlated with fluctuation of the structure of the target DNA segment. These data suggest that the fluctuation may generate a DNA structure favorable for in vitro integration into the target DNA. The approach described here can provide data on the biochemical properties of the integration reaction to which the target DNA structure may contribute.	[Tsuruyama, Tatsuaki] Kyoto Univ, Grad Sch Med, Dept Forens Med & Mol Pathol, Sakyo Ku, Kyoto, Japan; [Liu, Weizhi; Yoshikawa, Kenichi] Kyoto Univ, Dept Phys, Grad Sch Sci, Sakyo Ku, Kyoto 606, Japan	Kyoto University; Kyoto University	Tsuruyama, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Forens Med & Mol Pathol, Sakyo Ku, Yoshida Konoe Cho, Kyoto, Japan.	tsuruyam@kuhp.kyoto-u.ac.jp	Yoshikawa, Kenichi/N-1867-2019	Yoshikawa, Kenichi/0000-0002-2751-7136	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan [17013086]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid for Cancer Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a grant from the Ministry of Health, Labor and Welfare of Japan. Grant number is 17013086. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; BOR YC, 1995, P NATL ACAD SCI USA, V92, P10334, DOI 10.1073/pnas.92.22.10334; CARTEAU S, 1993, ARCH BIOCHEM BIOPHYS, V300, P756, DOI 10.1006/abbi.1993.1105; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hansen GM, 2000, GENOME RES, V10, P237, DOI 10.1101/gr.10.2.237; Higuchi Y, 2008, CHEM PHYS LETT, V461, P42, DOI 10.1016/j.cplett.2008.06.068; Holman AG, 2005, P NATL ACAD SCI USA, V102, P6103, DOI 10.1073/pnas.0501646102; Ishihara K, 1999, BBA-MOL CELL RES, V1451, P48, DOI 10.1016/S0167-4889(99)00090-7; Katz RA, 1998, J BIOL CHEM, V273, P24190, DOI 10.1074/jbc.273.37.24190; KITAMURA Y, 1992, P NATL ACAD SCI USA, V89, P5532, DOI 10.1073/pnas.89.12.5532; Lund AH, 2002, NAT GENET, V32, P160, DOI 10.1038/ng956; Nielsen AA, 2005, J VIROL, V79, P67, DOI 10.1128/JVI.79.1.67-78.2005; RASSART E, 1986, J VIROL, V58, P96, DOI 10.1128/JVI.58.1.96-106.1986; REICIN AS, 1995, J VIROL, V69, P5904, DOI 10.1128/JVI.69.9.5904-5907.1995; Sorensen AB, 1996, J VIROL, V70, P4063; Sundaresan N, 2006, J PHYS CHEM A, V110, P8826, DOI 10.1021/jp061774q; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tsukahara T, 2006, BIOCHEM BIOPH RES CO, V345, P1099, DOI 10.1016/j.bbrc.2006.05.007; Tsuruyama T, 2002, P NATL ACAD SCI USA, V99, P8253, DOI 10.1073/pnas.112202899; Tsuruyama T, 2011, AM J PATHOL, V178, P1374, DOI 10.1016/j.ajpath.2010.12.012; Tsuruyama T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013841; Tsuruyama T, 2010, J LEUKOCYTE BIOL, V88, P107, DOI 10.1189/jlb.1109748; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	25	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31533	10.1371/journal.pone.0031533	http://dx.doi.org/10.1371/journal.pone.0031533			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348097	Green Published, Green Submitted, gold			2022-12-25	WOS:000302737400029
J	Gu, R; Bai, J; Ling, L; Ding, L; Zhang, N; Ye, JX; Ferro, A; Xu, BA				Gu, Rong; Bai, Jian; Ling, Lin; Ding, Liang; Zhang, Na; Ye, Jiaxin; Ferro, Albert; Xu, Biao			Increased Expression of Integrin-Linked Kinase Improves Cardiac Function and Decreases Mortality in Dilated Cardiomyopathy Model of Rats	PLOS ONE			English	Article							CELL-ADHESION; IN-VITRO; HEART; GROWTH; APOPTOSIS; FAILURE; TRANSPLANTATION; HYPERTROPHY; AUTOPHAGY; SURVIVAL	Aims: Integrin-linked kinase (ILK) is a multifunctional kinase linking the extracellular matrix to intracellular signaling pathways, whose activation in the heart gives rise to a number of functional consequences. The aim of this study is to demonstrate the therapeutic and survival benefit of cardiac ILK overexpression in a rat model of dilated cardiomyopathy. Methods and Results: The dilated cardiomyopathy model was generated in rats by intraperitoneal administration of six equal doses of doxorubicin over a 2 week period. Five weeks after the first injection, echocardiographic analysis demonstrated impaired cardiac function and, at that point, recombinant adenoviral vector harboring ILK cDNA or vehicle was injected into the myocardium, and the rats re-studied 4 weeks later. Compared with vehicle injection, ILK treatment ameliorated inflammatory cell infiltration and cardiomyocyte degeneration, as well as left ventricular dilation and dysfunction. ILK treatment was also associated with a reduction in apoptosis and an increase in proliferation of cardiomyocytes, as well as decreased oxidative stress and autophagic vacuole accumulation. Importantly, mortality was lower in rats following ILK treatment than in those following vehicle injection. In cultured neonatal rat cardiomyocytes, we also found that ILK overexpression protected against doxorubicin-induced apoptosis, giving rise to an increase in their proliferation. Conclusions: These data demonstrate for the first time that ILK gene therapy improves cardiac function and survival in a model of dilated cardiomyopathy, and this may be mediated through suppression of inflammation, prevention of ventricular remodeling, inhibition of cardiomyocyte apoptosis and autophagy, and stimulation of cardiomyocyte proliferation.	[Gu, Rong; Bai, Jian; Ling, Lin; Ding, Liang; Zhang, Na; Ye, Jiaxin; Xu, Biao] Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China; [Ferro, Albert] Kings Coll London, Dept Clin Pharmacol, Div Cardiovasc, London WC2R 2LS, England	Nanjing University; University of London; King's College London	Gu, R (corresponding author), Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China.	xubiao@medmail.com.cn		Ding, Liang/0000-0002-1043-0923; Ferro, Albert/0000-0002-5486-9145	National Natural Science Foundation of China [30170370]; Jiangsu Key Laboratory for Molecular Medicine of Nanjing University [2008]; Natural Science Foundation of Jiangsu [BK2009036]; Outstanding Medical Talented Person Foundation of Jiangsu	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Key Laboratory for Molecular Medicine of Nanjing University; Natural Science Foundation of Jiangsu(Natural Science Foundation of Jiangsu Province); Outstanding Medical Talented Person Foundation of Jiangsu	This work was supported by grants to BX from the National Natural Science Foundation of China (Research Grant 30170370), Jiangsu Key Laboratory for Molecular Medicine of Nanjing University (Research Grant 2008), Natural Science Foundation of Jiangsu (BK2009036), and Outstanding Medical Talented Person Foundation of Jiangsu (2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate A, 2003, J AM COLL CARDIOL, V41, P753, DOI 10.1016/S0735-1097(02)02959-5; AMBLER GR, 1993, CARDIOVASC RES, V27, P1368, DOI 10.1093/cvr/27.7.1368; Bendig G, 2006, GENE DEV, V20, P2361, DOI 10.1101/gad.1448306; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Bryant D, 1998, CIRCULATION, V97, P1375, DOI 10.1161/01.CIR.97.14.1375; Ding L, 2009, CIRCULATION, V120, P764, DOI 10.1161/CIRCULATIONAHA.109.870725; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Hein S, 2003, CIRCULATION, V107, P984, DOI 10.1161/01.CIR.0000051865.66123.B7; Ishida M, 2004, J HEART LUNG TRANSPL, V23, P436, DOI 10.1016/S1053-2498(03)00220-1; Kalyanaraman B, 2002, MOL CELL BIOCHEM, V234, P119, DOI 10.1023/A:1015976430790; Kaye DM, 2007, NAT REV DRUG DISCOV, V6, P127, DOI 10.1038/nrd2219; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Komamura K, 2004, HYPERTENSION, V44, P365, DOI 10.1161/01.HYP.0000139916.96375.47; Li LH, 2007, LAB INVEST, V87, P440, DOI 10.1038/labinvest.3700530; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Lou H, 2004, J MOL CELL CARDIOL, V36, P683, DOI 10.1016/j.yjmcc.2004.03.004; Lu HZ, 2006, CIRCULATION, V114, P2271, DOI 10.1161/CIRCULATIONAHA.106.642330; Martinet W, 2007, TRENDS MOL MED, V13, P482, DOI 10.1016/j.molmed.2007.08.004; Matoba S, 1999, CIRCULATION, V99, P817, DOI 10.1161/01.CIR.99.6.817; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Nagaya N, 2001, CIRCULATION, V104, P1430, DOI 10.1161/hc3601.095575; Nagaya N, 2005, CIRCULATION, V112, P1128, DOI 10.1161/CIRCULATIONAHA.104.500447; Pasumarthi KBS, 2005, CIRC RES, V96, P110, DOI 10.1161/01.RES.0000152326.91223.4F; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Suzuki K, 2001, CIRCULATION, V104, pI213; Tsuneyoshi H, 2004, CIRCULATION, V110, pII174, DOI 10.1161/01.CIR.0000138348.77856.ef; Wang L, 1998, CIRC RES, V83, P516, DOI 10.1161/01.RES.83.5.516; White DE, 2006, GENE DEV, V20, P2355, DOI 10.1101/gad.1458906; Wong SCY, 1998, CIRCULATION, V98, P100, DOI 10.1161/01.CIR.98.2.100; Woo YJ, 2006, CIRCULATION, V114, pI206, DOI 10.1161/CIRCULATIONAHA.105.000455; Wu S, 2002, J MOL CELL CARDIOL, V34, P1595, DOI 10.1006/jmcc.2002.2110; Yamabi H, 2006, J THORAC CARDIOV SUR, V132, P1272, DOI 10.1016/j.jtcvs.2006.08.028; Zhang J, 2009, CIRCULATION, V119, P1776, DOI 10.1161/CIRCULATIONAHA.108.800565	36	24	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31279	10.1371/journal.pone.0031279	http://dx.doi.org/10.1371/journal.pone.0031279			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348065	Green Published, Green Submitted, gold			2022-12-25	WOS:000302733900037
J	Perez-Losada, J; Wu, D; DelRosario, R; Balmain, A; Mao, JH				Perez-Losada, Jesus; Wu, Di; DelRosario, Reyno; Balmain, Allan; Mao, Jian-Hua			Allele-Specific Deletions in Mouse Tumors Identify Fbxw7 as Germline Modifier of Tumor Susceptibility	PLOS ONE			English	Article							F-BOX PROTEIN; CYCLIN-E; UBIQUITIN LIGASE; DEPENDENT DEGRADATION; HUMAN CANCER; C-MYC; LOCI; MICE; SUPPRESSOR; NOTCH	Genome-wide association studies (GWAS) have been successful in finding associations between specific genetic variants and cancer susceptibility in human populations. These studies have identified a range of highly statistically significant associations between single nucleotide polymorphisms (SNPs) and susceptibility to development of a range of human tumors. However, the effect of each SNP in isolation is very small, and all of the SNPs combined only account for a relatively minor proportion of the total genetic risk (5-10%). There is therefore a major requirement for alternative routes to the discovery of genetic risk factors for cancer. We have previously shown using mouse models that chromosomal regions harboring susceptibility genes identified by linkage analysis frequently exhibit allele-specific genetic alterations in tumors. We demonstrate here that the Fbxw7 gene, a commonly mutated gene in a wide range of mouse and human cancers, shows allele-specific deletions in mouse lymphomas and skin tumors. Lymphomas from three different F1 hybrids show 100% allele-specificity in the patterns of allelic loss. Parental alleles from 129/Sv or Spretus/Gla mice are lost in tumors from F1 hybrids with C57BL/6 animals, due to the presence of a specific non-synonymous coding sequence polymorphism at the N-terminal portion of the gene. A specific genetic test of association between this SNP and lymphoma susceptibility in interspecific backcross mice showed a significant linkage (p = 0.001), but only in animals with a functional p53 gene. These data therefore identify Fbxw7 as a p53-dependent tumor susceptibility gene. Increased p53-dependent tumor susceptibility and allele-specific losses were also seen in a mouse skin model of skin tumor development. We propose that analysis of preferential allelic imbalances in tumors may provide an efficient means of uncovering genetic variants that affect mouse and human tumor susceptibility.	[Perez-Losada, Jesus; Wu, Di; DelRosario, Reyno; Balmain, Allan; Mao, Jian-Hua] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Canc Res Inst, San Francisco, CA 94143 USA; [Perez-Losada, Jesus] Univ Salamanca, Consejo Super Invest Cient, Inst Biol Mol & Celular Canc, E-37008 Salamanca, Spain; [Mao, Jian-Hua] Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Perez-Losada, J (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Canc Res Inst, San Francisco, CA 94143 USA.	abalmain@cc.ucsf.edu; JHMao@lbl.gov	Mao, Jian-Hua/EIZ-8595-2022; Pérez-Losada, Jesús/A-5883-2019	Mao, Jian-Hua/0000-0001-9320-6021; Pérez-Losada, Jesús/0000-0003-2400-624X	NIH/NCI [R01 CA116481, U01 CA84244]; Office of Biological & Environmental Research, of the U. S. Department of Energy [DE-AC02-05CH11231]; Laboratory Directed Research & Development Program (LDRD); MICINN [PLE2009-119]; FIS [PI10/00328]; Fundacion Eugenio Rodriguez-Pascual; DOE [DE-FG02-03ER63630]; Barbara Bass Bakar Chair of Cancer Genetics; NATIONAL CANCER INSTITUTE [U01CA084244, R01CA116481] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Office of Biological & Environmental Research, of the U. S. Department of Energy(United States Department of Energy (DOE)); Laboratory Directed Research & Development Program (LDRD); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); FIS(Instituto de Salud Carlos III); Fundacion Eugenio Rodriguez-Pascual; DOE(United States Department of Energy (DOE)); Barbara Bass Bakar Chair of Cancer Genetics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH/NCI grant R01 CA116481, Office of Biological & Environmental Research, of the U. S. Department of Energy under contract no. DE-AC02-05CH11231, and Laboratory Directed Research & Development Program (LDRD) to JHM; FEDER, MICINN (PLE2009-119), FIS (PI10/00328) and "Fundacion Eugenio Rodriguez-Pascual to JPL; and NIH/NCI grant U01 CA84244 and the DOE (DE-FG02-03ER63630) to AB. AB acknowledges support from the Barbara Bass Bakar Chair of Cancer Genetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; Balmain A, 2002, CELL, V108, P145, DOI 10.1016/S0092-8674(02)00622-0; Balmain A, 2003, NAT GENET, V33, P238, DOI 10.1038/ng1107; Ewart-Toland A, 2003, NAT GENET, V34, P403, DOI 10.1038/ng1220; Fu L, 2009, CANCER RES, V69, P8967, DOI 10.1158/0008-5472.CAN-09-2190; Fujii Y, 2006, CANCER SCI, V97, P729, DOI 10.1111/j.1349-7006.2006.00239.x; Galvan A, 2010, TRENDS GENET, V26, P132, DOI 10.1016/j.tig.2009.12.008; Ginzinger DG, 2000, CANCER RES, V60, P5405; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Hienonen T, 2006, INT J CANCER, V118, P505, DOI 10.1002/ijc.21344; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; LI FP, 1969, J NATL CANCER I, V43, P1365; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Mao JH, 2003, ONCOGENE, V22, P8379, DOI 10.1038/sj.onc.1207083; Mao JH, 2003, CURR OPIN GENET DEV, V13, P14, DOI 10.1016/S0959-437X(03)00005-4; Mao JH, 2008, SCIENCE, V321, P1499, DOI 10.1126/science.1162981; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Nagase H, 2003, CANCER RES, V63, P4849; NAGASE H, 1995, NAT GENET, V10, P424, DOI 10.1038/ng0895-424; Nagase H, 1999, P NATL ACAD SCI USA, V96, P15032, DOI 10.1073/pnas.96.26.15032; Nagase H, 2001, CANCER RES, V61, P1305; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Nigro JM, 2001, AM J PATHOL, V158, P1253, DOI 10.1016/S0002-9440(10)64076-X; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Perez-Losada J, 2005, CANCER RES, V65, P6488, DOI 10.1158/0008-5472.CAN-05-1294; Perez-Losada J, 2011, INTEGR BIOL-UK, V3, P316, DOI 10.1039/c0ib00094a; Stadler ZK, 2010, J CLIN ONCOL, V28, P4255, DOI 10.1200/JCO.2009.25.7816; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Tetzlaff MT, 2004, P NATL ACAD SCI USA, V101, P3338, DOI 10.1073/pnas.0307875101; Tripodis N, 2001, J NATL CANCER I, V93, P1484, DOI 10.1093/jnci/93.19.1484; Tsunematsu R, 2004, J BIOL CHEM, V279, P9417, DOI 10.1074/jbc.M312337200; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217	38	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31301	10.1371/journal.pone.0031301	http://dx.doi.org/10.1371/journal.pone.0031301			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348067	Green Published, gold, Green Submitted			2022-12-25	WOS:000302733900039
J	Goense, JBM; Feng, AS				Goense, Jozien B. M.; Feng, Albert S.			Effects of Noise Bandwidth and Amplitude Modulation on Masking in Frog Auditory Midbrain Neurons	PLOS ONE			English	Article							VENTRAL COCHLEAR NUCLEUS; RANA-PIPIENS COMPLEX; INFERIOR COLLICULUS; SPATIAL RELEASE; NATURAL SOUNDS; FREQUENCY-SELECTIVITY; SPECTRAL INTEGRATION; SONGBIRD FOREBRAIN; SIGNAL-DETECTION; GREY TREEFROGS	Natural auditory scenes such as frog choruses consist of multiple sound sources (i.e., individual vocalizing males) producing sounds that overlap extensively in time and spectrum, often in the presence of other biotic and abiotic background noise. Detection of a signal in such environments is challenging, but it is facilitated when the noise shares common amplitude modulations across a wide frequency range, due to a phenomenon called comodulation masking release (CMR). Here, we examined how properties of the background noise, such as its bandwidth and amplitude modulation, influence the detection threshold of a target sound (pulsed amplitude modulated tones) by single neurons in the frog auditory midbrain. We found that for both modulated and unmodulated masking noise, masking was generally stronger with increasing bandwidth, but it was weakened for the widest bandwidths. Masking was less for modulated noise than for unmodulated noise for all bandwidths. However, responses were heterogeneous, and only for a subpopulation of neurons the detection of the probe was facilitated when the bandwidth of the modulated masker was increased beyond a certain bandwidth - such neurons might contribute to CMR. We observed evidence that suggests that the dips in the noise amplitude are exploited by TS neurons, and observed strong responses to target signals occurring during such dips. However, the interactions between the probe and masker responses were nonlinear, and other mechanisms, e. g., selective suppression of the response to the noise, may also be involved in the masking release.	[Goense, Jozien B. M.; Feng, Albert S.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL USA; [Goense, Jozien B. M.; Feng, Albert S.] Univ Illinois, Beckman Inst, Urbana, IL USA; [Feng, Albert S.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Goense, JBM (corresponding author), Max Planck Inst Biol Cybernet, Dept Physiol Cognit Proc, Spemannstr 38, Tubingen, Germany.	Jozien.Goense@tuebingen.mpg.de			National Institute on Deafness and Other Communication Disorders of the National Institutes of Health [R01DC-00663, R01DC-04998]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000663, R01DC004998] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by the National Institute on Deafness and Other Communication Disorders of the National Institutes of Health (R01DC-00663, R01DC-04998). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bee MA, 2008, J COMP PSYCHOL, V122, P235, DOI 10.1037/0735-7036.122.3.235; Bee MA, 2008, ANIM BEHAV, V75, P1781, DOI 10.1016/j.anbehav.2007.10.032; Bee MA, 2007, ANIM BEHAV, V74, P549, DOI 10.1016/j.anbehav.2006.12.012; Bee MA, 2007, EUR J NEUROSCI, V26, P1979, DOI 10.1111/j.1460-9568.2007.05805.x; Biebel UW, 2002, HEARING RES, V169, P151, DOI 10.1016/S0378-5955(02)00459-8; BLAIR WF, 1964, Q REV BIOL, V39, P333, DOI 10.1086/404323; Bregman A.S., 1990, AUDITORY SCENE ANAL; BROWN LE, 1972, SCIENCE, V176, P928, DOI 10.1126/science.176.4037.928; Buschermohle M, 2007, BIOL CYBERN, V97, P397, DOI 10.1007/s00422-007-0179-8; BUUS S, 1985, J ACOUST SOC AM, V78, P1958, DOI 10.1121/1.392652; Buus S, 1996, J ACOUST SOC AM, V99, P2288, DOI 10.1121/1.415416; EGGERMONT JJ, 1989, HEARING RES, V40, P147, DOI 10.1016/0378-5955(89)90108-1; Ehret G, 1997, J COMP PHYSIOL A, V181, P635, DOI 10.1007/s003590050146; EHRET G, 1980, J COMP PHYSIOL, V141, P13, DOI 10.1007/BF00611873; Escabi MA, 2002, J NEUROSCI, V22, P4114, DOI 10.1523/JNEUROSCI.22-10-04114.2002; FANTINI DA, 1991, J ACOUST SOC AM, V90, P1876, DOI 10.1121/1.402374; Feng AS, 2000, ANNU REV PSYCHOL, V51, P699, DOI 10.1146/annurev.psych.51.1.699; Fishbach A, 2003, ADV NEURAL INFORM PR, P301; FROST JS, 1983, EVOLUTION, V37, P66, DOI 10.1111/j.1558-5646.1983.tb05514.x; FUZESSERY ZM, 1982, J COMP PHYSIOL, V146, P471, DOI 10.1007/BF00609443; Gai Y, 2006, J NEUROPHYSIOL, V96, P2451, DOI 10.1152/jn.00471.2006; GILBERT AG, 1980, HEARING RES, V2, P327, DOI 10.1016/0378-5955(80)90066-0; Gleich O, 2007, HEARING RES, V224, P101, DOI 10.1016/j.heares.2006.12.002; Goense JBM, 2005, J NEUROBIOL, V65, P22, DOI 10.1002/neu.20172; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613, DOI 10.1152/jn.1969.32.4.613; GOOLER DM, 1992, J NEUROPHYSIOL, V67, P1, DOI 10.1152/jn.1992.67.1.1; HALL JW, 1991, Q J EXP PSYCHOL-A, V43, P349, DOI 10.1080/14640749108400977; HALL JW, 1984, J ACOUST SOC AM, V76, P50, DOI 10.1121/1.391005; HALL JW, 1988, J ACOUST SOC AM, V84, P1669, DOI 10.1121/1.397182; Hawley ML, 2005, HEARING RES, V204, P101, DOI 10.1016/j.heares.2005.01.005; Hofer SB, 2003, J NEUROSCI, V23, P5732; Jiang D, 1997, J NEUROPHYSIOL, V77, P3085, DOI 10.1152/jn.1997.77.6.3085; KAPLAN HM, 1969, FED PROC, V28, P1541; Klump GM, 2001, NEUROREPORT, V12, P1825, DOI 10.1097/00001756-200107030-00013; KLUMP GM, 1995, HEARING RES, V87, P157, DOI 10.1016/0378-5955(95)00087-K; Lane CC, 2005, J NEUROPHYSIOL, V94, P1180, DOI 10.1152/jn.01112.2004; Langemann U, 2005, J COMP PHYSIOL A, V191, P889, DOI 10.1007/s00359-005-0015-3; Langemann U, 2001, EUR J NEUROSCI, V13, P1025, DOI 10.1046/j.0953-816x.2001.01464.x; Las L, 2005, J NEUROSCI, V25, P1503, DOI 10.1523/JNEUROSCI.4007-04.2005; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; MCFADDEN D, 1986, J ACOUST SOC AM, V80, P1658, DOI 10.1121/1.394277; MORTON ES, 1975, AM NAT, V109, P17, DOI 10.1086/282971; MOSS CF, 1986, J COMP PHYSIOL A, V159, P257, DOI 10.1007/BF00612308; NARINS PM, 1989, J ACOUST SOC AM, V85, P1255, DOI 10.1121/1.397456; NARINS PM, 1982, J COMP PHYSIOL, V147, P439, DOI 10.1007/BF00612008; Narins PM, 1988, EVOLUTION AMPHIBIAN; NELKEN I, 1994, J NEUROPHYSIOL, V71, P2446, DOI 10.1152/jn.1994.71.6.2446; Nelken I, 1999, NATURE, V397, P154, DOI 10.1038/16456; Nelson PC, 2007, J NEUROPHYSIOL, V97, P522, DOI 10.1152/jn.00776.2006; Neuert V, 2004, J NEUROSCI, V24, P5789, DOI 10.1523/JNEUROSCI.0450-04.2004; Nieder A, 2001, EUR J NEUROSCI, V13, P1033, DOI 10.1046/j.0953-816x.2001.01465.x; Palmer AR, 1996, J NEUROPHYSIOL, V75, P780, DOI 10.1152/jn.1996.75.2.780; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Pressnitzer D, 2001, J NEUROSCI, V21, P6377, DOI 10.1523/JNEUROSCI.21-16-06377.2001; Ratnam R, 1998, J NEUROPHYSIOL, V80, P2848, DOI 10.1152/jn.1998.80.6.2848; Rauschecker JP, 2004, J NEUROPHYSIOL, V91, P2578, DOI 10.1152/jn.00834.2003; RICHARDS DG, 1980, AM NAT, V115, P381, DOI 10.1086/283568; RICHARDS VM, 1987, J ACOUST SOC AM, V82, P1621, DOI 10.1121/1.395153; SAKITT B, 1973, NATURE, V241, P133, DOI 10.1038/241133a0; SCHALK TB, 1980, J ACOUST SOC AM, V67, P903, DOI 10.1121/1.383970; SCHOONEVELDT GP, 1987, J ACOUST SOC AM, V82, P1944, DOI 10.1121/1.395639; Schulze H, 1999, J COMP PHYSIOL A, V185, P493, DOI 10.1007/s003590050410; SCHWARTZ JJ, 1989, J COMP PHYSIOL A, V166, P37; Singh NC, 2003, J ACOUST SOC AM, V114, P3394, DOI 10.1121/1.1624067; Smalling JM, 2001, NEUROREPORT, V12, P3539, DOI 10.1097/00001756-200111160-00033; Suckow MA, 1999, PHARMACOL BIOCHEM BE, V63, P39, DOI 10.1016/S0091-3057(98)00237-8; Verhey JL, 2003, EXP BRAIN RES, V153, P405, DOI 10.1007/s00221-003-1607-1	67	16	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e31589	10.1371/journal.pone.0031589	http://dx.doi.org/10.1371/journal.pone.0031589			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348114	Green Published, gold, Green Submitted			2022-12-25	WOS:000302730900028
J	Kim, YI; Hirai, S; Goto, T; Ohyane, C; Takahashi, H; Tsugane, T; Konishi, C; Fujii, T; Inai, S; Iijima, Y; Aoki, K; Shibata, D; Takahashi, N; Kawada, T				Kim, Young-il; Hirai, Shizuka; Goto, Tsuyoshi; Ohyane, Chie; Takahashi, Haruya; Tsugane, Taneaki; Konishi, Chiaki; Fujii, Takashi; Inai, Shuji; Iijima, Yoko; Aoki, Koh; Shibata, Daisuke; Takahashi, Nobuyuki; Kawada, Teruo			Potent PPAR alpha Activator Derived from Tomato Juice, 13-oxo-9,11-Octadecadienoic Acid, Decreases Plasma and Hepatic Triglyceride in Obese Diabetic Mice	PLOS ONE			English	Article							ADIPOSE-TISSUE; INSULIN-RESISTANCE; METABOLIC SYNDROME; 3T3-L1 ADIPOCYTES; LIPID-METABOLISM; PROLIFERATOR; INFLAMMATION; RECEPTORS; EXPRESSION; MOUSE	Dyslipidemia is a major risk factor for development of several obesity-related diseases. The peroxisome proliferator-activated receptor alpha (PPAR alpha) is a ligand-activated transcription factor that regulates energy metabolism. Previously, we reported that 9-oxo-10,12-octadecadienoic acid (9-oxo-ODA) is presented in fresh tomato fruits and acts as a PPAR alpha agonist. In addition to 9-oxo-ODA, we developed that 13-oxo-9,11-octadecadienoic acid (13-oxo-ODA), which is an isomer of 9-oxo-ODA, is present only in tomato juice. In this study, we explored the possibility that 13-oxo-ODA acts as a PPAR alpha agonist in vitro and whether its effect ameliorates dyslipidemia and hepatic steatosis in vivo. In vitro luciferase assay experiments revealed that 13-oxo-ODA significantly induced PPAR alpha activation; moreover, the luciferase activity of 13-oxo-ODA was stronger than that of 9-oxo-ODA and conjugated linoleic acid (CLA), which is a precursor of 13-oxo-ODA and is well-known as a potent PPAR alpha activator. In addition to in vitro experiment, treatment with 13-oxo-ODA decreased the levels of plasma and hepatic triglycerides in obese KK-Ay mice fed a high-fat diet. In conclusion, our findings indicate that 13-oxo-ODA act as a potent PPAR alpha agonist, suggesting a possibility to improve obesity-induced dyslipidemia and hepatic steatosis.	[Kim, Young-il; Hirai, Shizuka; Goto, Tsuyoshi; Ohyane, Chie; Takahashi, Haruya; Takahashi, Nobuyuki; Kawada, Teruo] Kyoto Univ, Grad Sch Agr, Lab Mol Funct Food, Div Food Sci & Biotechnol, Kyoto, Japan; [Tsugane, Taneaki] Chiba Prefectural Agr & Forestry Res Ctr, Chiba, Japan; [Konishi, Chiaki; Fujii, Takashi; Inai, Shuji] Nippon Del Monte Corp, Gunma, Japan; [Iijima, Yoko; Aoki, Koh; Shibata, Daisuke] Kazusa DNA Res Inst, Chiba, Japan	Kyoto University; Kazusa DNA Research Institute	Kim, YI (corresponding author), Kyoto Univ, Grad Sch Agr, Lab Mol Funct Food, Div Food Sci & Biotechnol, Kyoto, Japan.	fat@kais.kyoto-u.ac.jp	Takahashi, Nobuyuki/AAX-8671-2021; Goto, Tsuyoshi/AAY-2344-2020	Takahashi, Nobuyuki/0000-0002-9705-662X; Goto, Tsuyoshi/0000-0003-1283-147X; Takahashi, Nobuyuki/0000-0003-0126-6292	Research and Development Projects for Application in Promoting New Policies Agriculture, Forestry, and Fisheries, Japan; Research and Development Program for New Bio-industry Initiatives, Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [22228001, 22380075]	Research and Development Projects for Application in Promoting New Policies Agriculture, Forestry, and Fisheries, Japan; Research and Development Program for New Bio-industry Initiatives, Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Research and Development Projects for Application in Promoting New Policies Agriculture, Forestry, and Fisheries, Japan, by the Research and Development Program for New Bio-industry Initiatives, Japan, and by Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (22228001 and 22380075). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa K, 2009, J AGR FOOD CHEM, V57, P10964, DOI 10.1021/jf902401u; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chinetti G, 2000, INFLAMM RES, V49, P497, DOI 10.1007/s000110050622; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; Duval C, 2002, TRENDS MOL MED, V8, P422, DOI 10.1016/S1471-4914(02)02385-7; Escher P, 2000, MUTAT RES-FUND MOL M, V448, P121, DOI 10.1016/S0027-5107(99)00231-6; Ginsberg HN, 2000, J CLIN INVEST, V106, P453, DOI 10.1172/JCI10762; Goldenberg I, 2008, VASC HEALTH RISK MAN, V4, P131, DOI 10.2147/vhrm.2008.04.01.131; Goto T, 2005, BIOCHEM BIOPH RES CO, V337, P440, DOI 10.1016/j.bbrc.2005.09.077; Gudbrandsen OA, 2009, BRIT J NUTR, V102, P803, DOI 10.1017/S0007114509297200; Hiuge A, 2007, ARTERIOSCL THROM VAS, V27, P635, DOI 10.1161/01.ATV.0000256469.06782.d5; Hostetler HA, 2005, J BIOL CHEM, V280, P18667, DOI 10.1074/jbc.M412062200; Ibrahim HS, 2008, J MED FOOD, V11, P551, DOI 10.1089/jmf.2007.0517; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Khan SA, 2003, J NUTR BIOCHEM, V14, P554, DOI 10.1016/S0955-2863(03)00098-6; Kim S, 2004, MOL CELL ENDOCRINOL, V220, P51, DOI 10.1016/j.mce.2004.03.011; Kim YI, 2011, MOL NUTR FOOD RES, V55, P585, DOI 10.1002/mnfr.201000264; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Miranda PJ, 2005, AM HEART J, V149, P33, DOI 10.1016/j.ahj.2004.07.013; Moya-Camarena SY, 1999, J LIPID RES, V40, P1426; Park MK, 2007, J KOREAN MED SCI, V22, P235, DOI 10.3346/jkms.2007.22.2.235; Priore P, 2007, BBA-MOL CELL BIOL L, V1771, P1299, DOI 10.1016/j.bbalip.2007.08.005; Rakhshandehroo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006796; Reilly MP, 2003, CIRCULATION, V108, P1546, DOI 10.1161/01.CIR.0000088846.10655.E0; Roepstorff C, 2005, AM J PHYSIOL-ENDOC M, V288, pE133, DOI 10.1152/ajpendo.00379.2004; Schoonjans K, 1996, J LIPID RES, V37, P907; Shen YC, 2007, J AGR FOOD CHEM, V55, P6475, DOI 10.1021/jf070799z; Suto J, 1998, EUR J ENDOCRINOL, V139, P654, DOI 10.1530/eje.0.1390654; Takahashi H, 2011, BIOSCI BIOT IN PRESS; Takahashi N, 2003, FEBS LETT, V550, P190, DOI 10.1016/S0014-5793(03)00859-7; Takahashi N, 2002, FEBS LETT, V514, P315, DOI 10.1016/S0014-5793(02)02390-6; Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358; TUGWOOD JD, 1992, EMBO J, V11, P433, DOI 10.1002/j.1460-2075.1992.tb05072.x; Uemura T, 2010, MOL NUTR FOOD RES, V54, P1596, DOI 10.1002/mnfr.200900609; Vellosillo T, 2007, PLANT CELL, V19, P831, DOI 10.1105/tpc.106.046052; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a	41	51	55	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31317	10.1371/journal.pone.0031317	http://dx.doi.org/10.1371/journal.pone.0031317			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347463	Green Published, gold, Green Submitted			2022-12-25	WOS:000302730200020
J	Pereira, SMP; Ki, M; Power, C				Pereira, Snehal M. Pinto; Ki, Myung; Power, Chris			Sedentary Behaviour and Biomarkers for Cardiovascular Disease and Diabetes in Mid-Life: The Role of Television-Viewing and Sitting at Work	PLOS ONE			English	Article							BRITISH BIRTH COHORT; TIME PHYSICAL-ACTIVITY; METABOLIC SYNDROME; EPIC-NORFOLK; RISK-FACTORS; MEAL INTAKE; ALL-CAUSE; OBESITY; ADULTS; POPULATION	Background: Knowledge of sedentary behaviour associations with health has relied mainly on television-viewing as a proxy and studies with other measures are less common. To clarify whether sedentary behaviour is associated with disease-risk, we examined associations for television-viewing and sitting at work. Methods: Using the 1958 British birth cohort (n = 7660), we analysed cross-sectional associations between television-viewing and work sitting (four categories, 0-1 to >= 3 h/d) with total, high-density lipoprotein (HDL) and low-density lipoprotein (LDL)-cholesterol, triglycerides, blood pressure, glycated haemoglobin, fibrinogen, C-reactive protein, hypertension and metabolic syndrome at 45 y. We adjusted for lifestyle and socio-demographic factors and assessed mediation of associations by body mass index (BMI) and diet. We also assessed whether the sedentary indicators are related similarly to factors linked to disease-risk. Results: There was a general trend of adverse socio-demographic and lifestyle characteristics with higher h/d television-viewing, but trends in the opposite direction for work sitting. Television-viewing was associated with most biomarkers and associations were mediated by BMI: e. g. for each category increase in television-viewing, HDL-cholesterol in men was lower by 2.3% (95% CI: 1.5%, 3.2%) and, in BMI and diet adjusted analyses, by 1.6% (0.8%, 2.4%); for women, by 2.0% (1.2%, 2.9%) and 0.9% (0.1%, 1.6%) respectively. Few, weaker associations for work sitting were found, in men only: e. g. corresponding values for HDL-cholesterol were 1.2% (0.5%, 1.9%) and 0.9% (0.3%, 1.5%). Odds for metabolic syndrome were elevated by 82% and 33% respectively for men watching television or work sitting for >= 3 vs. 0-1 h/d. Conclusions: Associations with cardiovascular disease and diabetes biomarkers in mid-adulthood differed for television-viewing and work sitting. The role of sedentary behaviour may vary by leisure and work domains or the two indicators reflect differing associations with other disease-related influences.	[Pereira, Snehal M. Pinto; Ki, Myung; Power, Chris] UCL Inst Child Hlth, MRC Ctr Epidemiol Child Hlth, London, England	University of London; University College London	Pereira, SMP (corresponding author), UCL Inst Child Hlth, MRC Ctr Epidemiol Child Hlth, London, England.	c.power@ich.ucl.ac.uk		Pinto Pereira, Snehal/0000-0002-0876-8757; Ki, Myung/0000-0001-8479-0254	Department of Health through the Public Health Research Consortium; Medical Research Council [G0000934]; Department of Health's NIHR Biomedical Research Centre; MRC [G0000934] Funding Source: UKRI	Department of Health through the Public Health Research Consortium; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health's NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Department of Health Policy Research Programme through the Public Health Research Consortium. The views expressed in the publication are those of the authors and not necessarily those of the Department of Health. Information about the wider programme of the PHRC is available from www.york.ac.uk/phrc. The Medical Research Council funded for the 45 y biomedical survey (grant: G0000934). The GOSH/UCL Institute of Child Health was supported in part by the Department of Health's NIHR Biomedical Research Centre. The Centre for Paediatric Epidemiology and Biostatistics was supported in part by the Medical Research Council in its capacity as the MRC Centre of Epidemiology for Child Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aadahl M, 2007, EUR J CARDIOV PREV R, V14, P660, DOI 10.1097/HJR.0b013e3280c284c5; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Atherton K, 2008, J EPIDEMIOL COMMUN H, V62, P216, DOI 10.1136/jech.2006.058966; Bellisle F, 2004, APPETITE, V43, P175, DOI 10.1016/j.appet.2004.04.004; Bennett WL, 2011, ANN INTERN MED, V154, P602, DOI 10.7326/0003-4819-154-9-201105030-00336; Bertrais S, 2005, OBES RES, V13, P936, DOI 10.1038/oby.2005.108; Blass EM, 2006, PHYSIOL BEHAV, V88, P597, DOI 10.1016/j.physbeh.2006.05.035; Chalmers J, 1999, CLIN EXP HYPERTENS, V21, P1009; Chang PC, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-193; Charreire H, 2011, BRIT J NUTR, V105, P902, DOI 10.1017/S000711451000440X; Clark BK, 2009, OBES REV, V10, P7, DOI 10.1111/j.1467-789X.2008.00508.x; Cole TJ, 2000, STAT MED, V19, P3109, DOI 10.1002/1097-0258(20001130)19:22<3109::AID-SIM558>3.0.CO;2-F; Dunstan DW, 2010, CIRCULATION, V121, P384, DOI 10.1161/CIRCULATIONAHA.109.894824; Dunstan DW, 2005, DIABETOLOGIA, V48, P2254, DOI 10.1007/s00125-005-1963-4; Ford ES, 2005, OBES RES, V13, P608, DOI 10.1038/oby.2005.65; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fung TT, 2000, AM J EPIDEMIOL, V152, P1171, DOI 10.1093/aje/152.12.1171; Gore Stacy A, 2003, Eat Behav, V4, P399, DOI 10.1016/S1471-0153(03)00053-9; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Healy GN, 2011, AM J PREV MED, V41, P216, DOI 10.1016/j.amepre.2011.05.005; Hetherington MM, 2006, PHYSIOL BEHAV, V88, P498, DOI 10.1016/j.physbeh.2006.04.025; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; Inoue M, 2008, ANN EPIDEMIOL, V18, P522, DOI 10.1016/j.annepidem.2008.03.008; Jakes RW, 2003, EUR J CLIN NUTR, V57, P1089, DOI 10.1038/sj.ejcn.1601648; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Ki M, 2011, ATHEROSCLEROSIS, V219, P361, DOI 10.1016/j.atherosclerosis.2011.07.109; Kronenberg F, 2000, ATHEROSCLEROSIS, V153, P433, DOI 10.1016/S0021-9150(00)00426-3; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Parsons TJ, 2009, EUR J CLIN NUTR, V63, P978, DOI 10.1038/ejcn.2009.6; Parsons TJ, 2005, INT J OBESITY, V29, P1212, DOI 10.1038/sj.ijo.0802932; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Power C, 2010, ATHEROSCLEROSIS, V211, P643, DOI 10.1016/j.atherosclerosis.2010.03.015; Sarwar N, 2007, CIRCULATION, V115, P450, DOI 10.1161/CIRCULATIONAHA.106.637793; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sisson SB, 2009, METAB SYNDR RELAT D, V7, P529, DOI 10.1089/met.2009.0023; Stamatakis E, 2011, J AM COLL CARDIOL, V57, P292, DOI 10.1016/j.jacc.2010.05.065; Stroebele N, 2004, APPETITE, V42, P111, DOI 10.1016/j.appet.2003.09.001; The Nielsen Company, 2011, STAT MED TV US TREND; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Wareham NJ, 2007, APPL PHYSIOL NUTR ME, V32, P778, DOI 10.1139/H07-032; Wareham NJ, 2002, INT J EPIDEMIOL, V31, P168, DOI 10.1093/ije/31.1.168; Warren JM, 2010, EUR J CARDIOV PREV R, V17, P127, DOI 10.1097/HJR.0b013e32832ed875; Warren TY, 2010, MED SCI SPORT EXER, V42, P879, DOI 10.1249/MSS.0b013e3181c3aa7e; Wijndaele K, 2011, INT J EPIDEMIOL, V40, P150, DOI 10.1093/ije/dyq105; Wood A, 2006, INT J EPIDEMIOL, V35, P1570, DOI 10.1093/ije/dyl233; Zhang M, 2004, CANCER CAUSE CONTROL, V15, P83, DOI 10.1023/B:CACO.0000016633.47025.2a; ZWEERS A, 1968, CLIN CHIM ACTA, V19, P267, DOI 10.1016/0009-8981(68)90335-5	51	108	109	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31132	10.1371/journal.pone.0031132	http://dx.doi.org/10.1371/journal.pone.0031132			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347441	gold, Green Published, Green Submitted			2022-12-25	WOS:000302730200014
J	van der Vlugt, LEPM; Labuda, LA; Ozir-Fazalalikhan, A; Lievers, E; Gloudemans, AK; Liu, KY; Barr, TA; Sparwasser, T; Boon, L; Ngoa, UA; Feugap, EN; Adegnika, AA; Kremsner, PG; Gray, D; Yazdanbakhsh, M; Smits, HH				van der Vlugt, Lucien E. P. M.; Labuda, Lucja A.; Ozir-Fazalalikhan, Arifa; Lievers, Ellen; Gloudemans, Anouk K.; Liu, Kit-Yeng; Barr, Tom A.; Sparwasser, Tim; Boon, Louis; Ngoa, Ulysse Ateba; Feugap, Eliane Ngoune; Adegnika, Ayola A.; Kremsner, Peter G.; Gray, David; Yazdanbakhsh, Maria; Smits, Hermelijn H.			Schistosomes Induce Regulatory Features in Human and Mouse CD1d(hi) B Cells: Inhibition of Allergic Inflammation by IL-10 and Regulatory T Cells	PLOS ONE			English	Article							AIRWAY INFLAMMATION; IMMUNE-RESPONSES; B10 CELLS; MICE; SUPPRESSION; INFECTION; AUTOIMMUNITY; CHILDREN; DISEASE; ASTHMA	Chronic helminth infections, such as schistosomes, are negatively associated with allergic disorders. Here, using B cell IL-10-deficient mice, Schistosoma mansoni-mediated protection against experimental ovalbumin-induced allergic airway inflammation (AAI) was shown to be specifically dependent on IL-10-producing B cells. To study the organs involved, we transferred B cells from lungs, mesenteric lymph nodes or spleen of OVA-infected mice to recipient OVA-sensitized mice, and showed that both lung and splenic B cells reduced AAI, but only splenic B cells in an IL-10-dependent manner. Although splenic B cell protection was accompanied by elevated levels of pulmonary FoxP3(+) regulatory T cells, in vivo ablation of FoxP3(+) T cells only moderately restored AAI, indicating an important role for the direct suppressory effect of regulatory B cells. Splenic marginal zone CD1d(+) B cells proved to be the responsible splenic B cell subset as they produced high levels of IL-10 and induced FoxP3(+) T cells in vitro. Indeed, transfer of CD1d(+) MZ-depleted splenic B cells from infected mice restored AAI. Markedly, we found a similarly elevated population of CD1d(hi) B cells in peripheral blood of Schistosoma haematobium-infected Gabonese children compared to uninfected children and these cells produced elevated levels of IL-10. Importantly, the number of IL-10-producing CD1d(hi) B cells was reduced after anti-schistosome treatment. This study points out that in both mice and men schistosomes have the capacity to drive the development of IL-10-producing regulatory CD1d(hi) B cells and furthermore, these are instrumental in reducing experimental allergic inflammation in mice.	[van der Vlugt, Lucien E. P. M.; Labuda, Lucja A.; Ozir-Fazalalikhan, Arifa; Lievers, Ellen; Gloudemans, Anouk K.; Liu, Kit-Yeng; Adegnika, Ayola A.; Yazdanbakhsh, Maria; Smits, Hermelijn H.] Leiden Univ, Dept Parasitol, Med Ctr, Leiden, Netherlands; [Gloudemans, Anouk K.] Erasmus MC, Dept Pulmonol, Rotterdam, Netherlands; [Barr, Tom A.; Gray, David] Univ Edinburgh, Inst Immunol & Infect Res, Sch Biol Sci, Edinburgh, Midlothian, Scotland; [Sparwasser, Tim] Twincore Ctr Expt & Clin Infect Res, Inst Infect Immunol, Hannover, Germany; [Boon, Louis] Bioceros BV, Dept Cell Biol, Utrecht, Netherlands; [Ngoa, Ulysse Ateba; Feugap, Eliane Ngoune; Adegnika, Ayola A.; Kremsner, Peter G.] Albert Schweitzer Hosp, Med Res Unit, Lambarene, Gabon; [Adegnika, Ayola A.; Kremsner, Peter G.] Univ Tubingen, Inst Trop Med, Tubingen, Germany	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; University of Edinburgh; Helmholtz Association; Helmholtz-Center for Infection Research; Bioceros B.V.; Eberhard Karls University of Tubingen	van der Vlugt, LEPM (corresponding author), Leiden Univ, Dept Parasitol, Med Ctr, Leiden, Netherlands.	H.H.Smits@lumc.nl	ADEGNIKA, Ayola Akim/AAK-7307-2020; Sparwasser, Tim/AAF-7085-2019; Smits, Hermelijn/V-4216-2018; Ozir-Fazalalikhan, A/V-5436-2018; Boon, Laurence/HCI-3629-2022; Gray, David/L-8295-2013; Sparwasser, Tim D/AAA-4306-2022; Yazdanbakhsh, Maria/AAI-3996-2020	Sparwasser, Tim/0000-0001-5645-902X; Smits, Hermelijn/0000-0001-9279-2890; Ozir-Fazalalikhan, A/0000-0002-0613-8372; Gray, David/0000-0003-3785-4934; Yazdanbakhsh, Maria/0000-0002-7666-1441; Boon, Louis/0000-0002-0937-9171	Netherlands Asthma Foundation (NAF) [3.2.10.072]; EU [HEALTH-F3-2009-241642]	Netherlands Asthma Foundation (NAF); EU(European Commission)	This project was supported by Netherlands Asthma Foundation (NAF grant 3.2.10.072) and EU-funded project Immunological Interplay between Poverty Related Diseases and Helminth infections: An African-European Research Initiative "IDEA" (HEALTH-F3-2009-241642). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegnika AA, 2006, AM J TROP MED HYG, V75, P798, DOI 10.4269/ajtmh.2006.75.798; Amu S, 2010, J ALLERGY CLIN IMMUN, V125, P1114, DOI 10.1016/j.jaci.2010.01.018; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Blair PA, 2009, J IMMUNOL, V182, P3492, DOI 10.4049/jimmunol.0803052; Carter NA, 2011, J IMMUNOL, V186, P5569, DOI 10.4049/jimmunol.1100284; Correale J, 2008, ANN NEUROL, V64, P187, DOI 10.1002/ana.21438; Croese J, 2006, GUT, V55, P136, DOI 10.1136/gut.2005.079129; DiLillo DJ, 2010, ANN NY ACAD SCI, V1183, P38, DOI 10.1111/j.1749-6632.2009.05137.x; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Fleming JO, 2011, J NEUROIMMUNOL, V233, P3, DOI 10.1016/j.jneuroim.2011.01.003; Hartl D, 2007, J ALLERGY CLIN IMMUN, V119, P1258, DOI 10.1016/j.jaci.2007.02.023; Hussaarts L, 2011, J ALLERGY CLIN IMMUN, V128, P733, DOI 10.1016/j.jaci.2011.05.012; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Jankovic D, 1998, J EXP MED, V187, P619, DOI 10.1084/jem.187.4.619; Karlsson MR, 2004, J EXP MED, V199, P1679, DOI 10.1084/jem.20032121; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Lahl K, 2011, METHODS MOL BIOL, V707, P157, DOI 10.1007/978-1-61737-979-6_10; Lloyd CM, 2009, IMMUNITY, V31, P438, DOI 10.1016/j.immuni.2009.08.007; Madan R, 2009, J IMMUNOL, V183, P2312, DOI 10.4049/jimmunol.0900185; Maizels Rick M., 2008, V94, P112, DOI 10.1159/000154944; Mangan NE, 2004, J IMMUNOL, V173, P6346, DOI 10.4049/jimmunol.173.10.6346; Mauri C, 2008, TRENDS IMMUNOL, V29, P34, DOI 10.1016/j.it.2007.10.004; Mizoguchi A, 2006, J IMMUNOL, V176, P705, DOI 10.4049/jimmunol.176.2.705; Park HK, 2011, EXP PARASITOL, V127, P539, DOI 10.1016/j.exppara.2010.10.004; Ronet C, 2010, J IMMUNOL, V184, P886, DOI 10.4049/jimmunol.0901114; Shreffler WG, 2009, J ALLERGY CLIN IMMUN, V123, P43, DOI [10.1016/j.jaci.2008.09.051, 10.1016/j.jaci.2008.12.1128]; Smits HH, 2007, J ALLERGY CLIN IMMUN, V120, P932, DOI 10.1016/j.jaci.2007.06.009; van den Biggelaar AHJ, 2000, LANCET, V356, P1723, DOI 10.1016/S0140-6736(00)03206-2; Velupillai P, 1997, J IMMUNOL, V158, P338; Watanabe R, 2007, AM J PATHOL, V171, P560, DOI 10.2353/ajpath.2007.061279; Wilson MS, 2010, EUR J IMMUNOL, V40, P1682, DOI 10.1002/eji.200939721; Wilson MS, 2005, J EXP MED, V202, P1199, DOI 10.1084/jem.20042572; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490	33	135	136	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30883	10.1371/journal.pone.0030883	http://dx.doi.org/10.1371/journal.pone.0030883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347409	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000302730100028
J	Van Goethem, E; Silva, EA; Xiao, H; Franc, NC				Van Goethem, Emeline; Silva, Elizabeth A.; Xiao, Hui; Franc, Nathalie C.			The Drosophila TRPP Cation Channel, PKD2 and Dmel/Ced-12 Act in Genetically Distinct Pathways during Apoptotic Cell Clearance	PLOS ONE			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; GLOBULE-EGF FACTOR-8; C-ELEGANS; CAENORHABDITIS-ELEGANS; INTRACELLULAR CALCIUM; CORPSE ENGULFMENT; CRKII/DOCK180/RAC PATHWAY; MOUSE MEGAKARYOCYTES; MALE-FERTILITY	Apoptosis, a genetically programmed cell death, allows for homeostasis and tissue remodelling during development of all multi-cellular organisms. Phagocytes swiftly recognize, engulf and digest apoptotic cells. Yet, to date the molecular mechanisms underlying this phagocytic process are still poorly understood. To delineate the molecular mechanisms of apoptotic cell clearance in Drosophila, we have carried out a deficiency screen and have identified three overlapping phagocytosis-defective mutants, which all delete the fly homologue of the ced-12 gene, known as Dmel\ced12. As anticipated, we have found that Dmel\ced-12 is required for apoptotic cell clearance, as for its C. elegans and mammalian homologues, ced-12 and elmo, respectively. However, the loss of Dmel\ced-12 did not solely account for the phenotypes of all three deficiencies, as zygotic mutations and germ line clones of Dmel\ced-12 exhibited weaker phenotypes. Using a nearby genetically interacting deficiency, we have found that the polycystic kidney disease 2 gene, pkd2, which encodes a member of the TRPP channel family, is also required for phagocytosis of apoptotic cells, thereby demonstrating a novel role for PKD2 in this process. We have also observed genetic interactions between pkd2, simu, drpr, rya-r44F, and retinophilin (rtp), also known as undertaker (uta), a gene encoding a MORN-repeat containing molecule, which we have recently found to be implicated in calcium homeostasis during phagocytosis. However, we have not found any genetic interaction between Dmel\ced-12 and simu. Based on these genetic interactions and recent reports demonstrating a role for the mammalian pkd-2 gene product in ER calcium release during store-operated calcium entry, we propose that PKD2 functions in the DRPR/RTP pathway to regulate calcium homeostasis during this process. Similarly to its C. elegans homologue, Dmel\Ced-12 appears to function in a genetically distinct pathway.	[Van Goethem, Emeline; Silva, Elizabeth A.] UCL, Med Res Council Cell Biol Unit, MRC Lab Mol Cell Biol, London, England; [Xiao, Hui; Franc, Nathalie C.] Scripps Res Inst, Dept Immunol & Microbial Sci, Dept Genet, La Jolla, CA 92037 USA; [Van Goethem, Emeline; Silva, Elizabeth A.] UCL, Dept Anat & Dev Biol, London, England	MRC Laboratory Molecular Biology; University of London; University College London; Scripps Research Institute; University of London; University College London	Van Goethem, E (corresponding author), CNRS UMR 5089, Inst Pharmacol & Biol Struct, Toulouse, France.	nfranc@scripps.edu	XIAO, HUI/H-2342-2013; xiao, hui/O-8437-2014	xiao, hui/0000-0001-5709-3365; Franc, Nathalie/0000-0002-1617-385X; Silva, Elizabeth/0000-0002-0684-9473; Silva, Elizabeth/0000-0002-0524-929X	Medical Research Council United Kingdom; Medical Research Council; Cancer Research Institute; Scripps Research Institute Advanced Discovery Institute; Novartis	Medical Research Council United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research Institute; Scripps Research Institute Advanced Discovery Institute; Novartis(Novartis)	This work was funded in part by a Programme Leader career-Track grant from the Medical Research Council United Kingdom to NCF, and Medical Research Council core support to the Medical Research Council Cell Biology Unit. HX is funded by an Irvington Institute Post-doctoral Fellowship from the Cancer Research Institute. NCF and her laboratory are funded by The Scripps Research Institute Advanced Discovery Institute start-up grant provided by Novartis to NCF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Ambudkar IS, 2007, CELL CALCIUM, V42, P213, DOI 10.1016/j.ceca.2007.01.013; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Bianco A, 2007, NATURE, V448, P362, DOI 10.1038/nature05965; Briddon SJ, 1999, BLOOD, V93, P3847, DOI 10.1182/blood.V93.11.3847.411k17_3847_3855; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Cuttell L, 2008, CELL, V135, P524, DOI 10.1016/j.cell.2008.08.033; deCathelineau AM, 2003, ESSAYS BIOCHEM, V39, P105, DOI 10.1042/bse0390105; Dewitt S, 2002, J CELL BIOL, V159, P181, DOI 10.1083/jcb.200206089; ELLIS RE, 1991, GENETICS, V129, P79; Franc NC, 1996, IMMUNITY, V4, P431, DOI 10.1016/S1074-7613(00)80410-0; Franc NC, 2002, FRONT BIOSCI-LANDMRK, V7, pD1298, DOI 10.2741/franc; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; FRIGERIO G, 1986, CELL, V47, P735, DOI 10.1016/0092-8674(86)90516-7; Gaipl US, 2006, CURR TOP MICROBIOL, V305, P161, DOI 10.1007/3-540-29714-6_8; Gao ZQ, 2004, J BIOL CHEM, V279, P14225, DOI 10.1074/jbc.M312223200; Gao ZQ, 2003, CURR BIOL, V13, P2175, DOI 10.1016/j.cub.2003.11.053; Geisbrecht ER, 2008, DEV BIOL, V314, P137, DOI 10.1016/j.ydbio.2007.11.022; GREENBERG S, 1991, J CELL BIOL, V113, P757, DOI 10.1083/jcb.113.4.757; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hauwel M, 2005, BRAIN RES REV, V48, P220, DOI 10.1016/j.brainresrev.2004.12.012; HISHIKAWA T, 1991, J CELL BIOL, V115, P59, DOI 10.1083/jcb.115.1.59; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; Kurant E, 2008, CELL, V133, P498, DOI 10.1016/j.cell.2008.02.052; Link TM, 2010, NAT IMMUNOL, V11, P232, DOI 10.1038/ni.1842; Manaka J, 2004, J BIOL CHEM, V279, P48466, DOI 10.1074/jbc.M408597200; Mangahas PM, 2005, SEMIN CELL DEV BIOL, V16, P295, DOI 10.1016/j.semcdb.2004.12.005; MCNEIL PL, 1986, J CELL BIOL, V102, P1586, DOI 10.1083/jcb.102.5.1586; Melford SK, 1997, J BIOL CHEM, V272, P27539, DOI 10.1074/jbc.272.44.27539; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Papp S, 2007, J BIOL CHEM, V282, P16585, DOI 10.1074/jbc.M701011200; Pazdera TM, 1998, DEVELOPMENT, V125, P3427; Pittoni Valerio, 2002, Autoimmunity Reviews, V1, P154, DOI 10.1016/S1568-9972(02)00032-0; RAFF MC, 1994, PHILOS T ROY SOC B, V345, P265, DOI 10.1098/rstb.1994.0104; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Rubartelli A, 1997, EUR J IMMUNOL, V27, P1893, DOI 10.1002/eji.1830270812; Santoso NG, 2011, CELL PHYSIOL BIOCHEM, V27, P715, DOI 10.1159/000330080; Savill J, 2003, SCIENCE, V302, P1516, DOI 10.1126/science.1092533; Silva E, 2007, IMMUNITY, V27, P585, DOI 10.1016/j.immuni.2007.08.016; Smits E, 1999, CURR BIOL, V9, P1351, DOI 10.1016/S0960-9822(00)80062-7; SONNENFELD MJ, 1995, J COMP NEUROL, V359, P644, DOI 10.1002/cne.903590410; Spirli C, 2011, HEPATOLOGY; Tejle K, 2002, BIOSCIENCE REP, V22, P529, DOI 10.1023/A:1022025903688; TEPASS U, 1994, DEVELOPMENT, V120, P1829; Venkatachalam K, 2008, CELL, V135, P838, DOI 10.1016/j.cell.2008.09.041; WANG XY, 1994, J BIOCHEM-TOKYO, V116, P858, DOI 10.1093/oxfordjournals.jbchem.a124607; Watnick TJ, 2003, CURR BIOL, V13, P2179, DOI 10.1016/S0960-9822(03)00913-8; Watson S, 2006, CURR DIRECT AUTOIMMU, V9, P188; Wu YC, 2001, DEV CELL, V1, P491, DOI 10.1016/S1534-5807(01)00056-9; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Wu YC, 1998, CELL, V93, P951, DOI 10.1016/S0092-8674(00)81201-5; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Yamaguchi H, 2008, J LEUKOCYTE BIOL, V83, P1300, DOI 10.1189/jlb.1107730; Yamaguchi H, 2010, EUR J IMMUNOL, V40, P1778, DOI 10.1002/eji.200940096; Zhou Z, 2001, DEV CELL, V1, P477, DOI 10.1016/S1534-5807(01)00058-2; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8; Ziegenfuss JS, 2008, NATURE, V453, P935, DOI 10.1038/nature06901	59	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31488	10.1371/journal.pone.0031488	http://dx.doi.org/10.1371/journal.pone.0031488			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347485	Green Published, Green Submitted, gold			2022-12-25	WOS:000302730100074
J	Rowell, JL; Dowling, NF; Yu, W; Yesupriya, A; Zhang, L; Gwinn, M				Rowell, Jessica L.; Dowling, Nicole F.; Yu, Wei; Yesupriya, Ajay; Zhang, Lyna; Gwinn, Marta			Trends in Population-Based Studies of Human Genetics in Infectious Diseases	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; EPIDEMIOLOGY; INFLUENZA	Pathogen genetics is already a mainstay of public health investigation and control efforts; now advances in technology make it possible to investigate the role of human genetic variation in the epidemiology of infectious diseases. To describe trends in this field, we analyzed articles that were published from 2001 through 2010 and indexed by the HuGE Navigator, a curated online database of PubMed abstracts in human genome epidemiology. We extracted the principal findings from all meta-analyses and genome-wide association studies (GWAS) with an infectious disease-related outcome. Finally, we compared the representation of diseases in HuGE Navigator with their contributions to morbidity worldwide. We identified 3,730 articles on infectious diseases, including 27 meta-analyses and 23 GWAS. The number published each year increased from 148 in 2001 to 543 in 2010 but remained a small fraction (about 7%) of all studies in human genome epidemiology. Most articles were by authors from developed countries, but the percentage by authors from resource-limited countries increased from 9% to 25% during the period studied. The most commonly studied diseases were HIV/AIDS, tuberculosis, hepatitis B infection, hepatitis C infection, sepsis, and malaria. As genomic research methods become more affordable and accessible, population-based research on infectious diseases will be able to examine the role of variation in human as well as pathogen genomes. This approach offers new opportunities for understanding infectious disease susceptibility, severity, treatment, control, and prevention.	[Rowell, Jessica L.; Dowling, Nicole F.; Yu, Wei; Yesupriya, Ajay] Ctr Dis Control & Prevent, Off Publ Hlth Genom, Off Epidemiol Surveillance & Lab Serv, Atlanta, GA 30333 USA; [Zhang, Lyna] Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA; [Gwinn, Marta] McKing Consulting Corp, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Rowell, JL (corresponding author), Ctr Dis Control & Prevent, Off Publ Hlth Genom, Off Epidemiol Surveillance & Lab Serv, Atlanta, GA 30333 USA.	jlrowel@emory.edu			Oak Ridge Institute for Science and Education (ORISE)	Oak Ridge Institute for Science and Education (ORISE)	Jessica L Rowell is a fellow funded by Oak Ridge Institute for Science and Education (ORISE). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afdhal NH, 2011, HEPATOLOGY, V53, P336, DOI 10.1002/hep.24052; Albright FS, 2008, J INFECT DIS, V197, P18, DOI 10.1086/524064; Alcais A, 2009, J CLIN INVEST, V119, P2506, DOI 10.1172/JCI38111; Bowcock AM, 2010, CRIT REV IMMUNOL, V30, P305, DOI 10.1615/CritRevImmunol.v30.i3.80; Burgner D, 2006, LANCET INFECT DIS, V6, P653, DOI 10.1016/S1473-3099(06)70601-6; Casanova JL, 2007, EMBO J, V26, P915, DOI 10.1038/sj.emboj.7601558; Centers for Disease Control and Prevention, 2010, 2008 CDCP, V20; Crawford DC, 2008, EMERG INFECT DIS, V14, P1138, DOI 10.3201/eid1407.071287; Davila S, 2009, GENOME MED, V1, DOI 10.1186/gm19; de Bakker PIW, 2010, NAT GENET, V42, P731, DOI 10.1038/ng0910-731; Dowling NF, 2009, GENOME MED, V1, DOI 10.1186/gm119; Fauci AS, 2006, CELL, V124, P665, DOI 10.1016/j.cell.2006.02.010; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001033; Foley SL, 2009, INFECT GENET EVOL, V9, P430, DOI 10.1016/j.meegid.2009.03.004; Haagmans BL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000557; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Honey K, 2009, J CLIN INVEST, V119, P2452, DOI 10.1172/JCI40662; Inoue M, 2005, POSTGRAD MED J, V81, P419, DOI 10.1136/pgmj.2004.029330; Kaslow R, GENETIC SUSCEPTIBILI, P464; Kellam P, 2006, CELL, V124, P695, DOI 10.1016/j.cell.2006.02.003; Le Clerc S, 2009, J INFECT DIS, V200, P1194, DOI 10.1086/605892; LopalcoLucia, 2010, VIRUSES, V2, P26; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; O'Brien SJ, 2004, NAT GENET, V36, P565, DOI 10.1038/ng1369; Rinaudo CD, 2009, J CLIN INVEST, V119, P2515, DOI 10.1172/JCI38330; Seib KL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000612; Singer PA, 2001, SCIENCE, V294, P87, DOI 10.1126/science.1062633; Withee J, 2007, ENVIRON MOL MUTAGEN, V48, P363, DOI 10.1002/em.20303; Wonkam A, 2011, DEV WORLD BIOETH; World Health Organization Regional Office for the Western Pacific, 2006, PREV MOTH TO CHILD T; Yu W, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-205; Yu W, 2008, NAT GENET, V40, P124, DOI 10.1038/ng0208-124; YuWei, 2007, BMC BIOINFORMATICS, V8, P436	34	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e25431	10.1371/journal.pone.0025431	http://dx.doi.org/10.1371/journal.pone.0025431			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347358	Green Submitted, Green Published, gold			2022-12-25	WOS:000302180600001
J	Kang, HW; Niepel, MW; Han, SX; Kawano, Y; Cohen, DE				Kang, Hye Won; Niepel, Michele W.; Han, Shuxin; Kawano, Yuki; Cohen, David E.			Thioesterase superfamily member 2/acyl-CoA thioesterase 13 (Them2/Acot13) regulates hepatic lipid and glucose metabolism	FASEB JOURNAL			English	Article						free fatty acid; liver; obesity	PHOSPHATIDYLCHOLINE TRANSFER PROTEIN/STARD2; ACYL-COA THIOESTERASES; BETA-OXIDATION; FATTY-ACIDS; PPAR-ALPHA; MICE; RECEPTOR; IDENTIFICATION; PEROXISOMES; CHAIN	Members of the acyl-CoA thioesterase (Acot) gene family catalyze the hydrolysis of fatty acyl-CoAs, but their biological functions remain unknown. Thioesterase superfamily member 2 (Them2; synonym Acot13) is a broadly expressed mitochondria-associated Acot. Them2 was previously identified as an interacting protein of phosphatidylcholine transfer protein (PC-TP). Pctp(-/-) mice exhibit altered fatty acid metabolism that is accompanied by reduced hepatic glucose production. To examine the role of Them2 in regulating hepatic lipid and glucose homeostasis, we generated Them2(-/-) mice. In livers of Them2(-/-) mice compared with Them2(+/+) controls, a 1.9-fold increase in the K-m of mitochondrial thioesterase activity was accompanied by a 28% increase in fatty acyl-CoA concentration. A reciprocal 23% decrease in free fatty acid concentration was associated with reduced activation of peroxisome proliferator-activated receptor alpha. However, fatty acid oxidation rates were preserved in livers of Them2(-/-) mice, suggesting that Them2 functions to limit beta-oxidation. Hepatic glucose production was also decreased by 45% in the setting of reduced hepatocyte nuclear factor 4 alpha (HNF4 alpha) expression. When fed a high-fat diet, Them2(-/-) mice were resistant to increases in hepatic glucose production and steatosis. These findings reveal key roles for Them2 in the regulation of hepatic metabolism, which are potentially mediated by PC-TP-Them2 interactions.-Kang, H. W., Niepel, M. W., Han, S., Kawano, Y., Cohen, D. E. Thioesterase superfamily member 2/acyl-CoA thioesterase 13 (Them2/Acot13) regulates hepatic lipid and glucose metabolism. FASEB J. 26, 2209-2221 (2012). www.fasebj.org	[Kang, Hye Won; Niepel, Michele W.; Han, Shuxin; Kawano, Yuki; Cohen, David E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Gastroenterol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Cohen, DE (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Gastroenterol, 77 Ave Louis Pasteur,HIM 941, Boston, MA 02115 USA.	dcohen@partners.org			U.S. National Institutes of Health [DK-56626, DK-48873]; Harvard Digestive Diseases Center [P30 DK34854]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056626, P30DK034854, R01DK048873, R29DK048873, R37DK048873] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Diseases Center; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health grants DK-56626 and DK-48873 (to D.E.C.) and Harvard Digestive Diseases Center (P30 DK34854). H.W.K. is a recipient of a Founders Affiliate Postdoctoral Fellowship from the American Heart Association. The authors thank Drs. Oliver J. Haworth and Vasile Pavlov for assisting with measurements of hepatic triglyceride secretion in mice, Drs. Elizabeth Newberry and Nicholas Davidson for advice on measuring fecal fat contents, and Dr. Richard Mitchell for interpretation of intestinal histopathology.	Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Brocker Chad, 2010, Hum Genomics, V4, P411; Cao J, 2009, BIOCHEMISTRY-US, V48, P1293, DOI 10.1021/bi801879z; Cheng ZY, 2011, ANTIOXID REDOX SIGN, V14, P649, DOI 10.1089/ars.2010.3370; Cheng ZJ, 2006, BIOCHEM BIOPH RES CO, V350, P850, DOI 10.1016/j.bbrc.2006.09.105; Cox B, 2006, NAT PROTOC, V1, P1872, DOI 10.1038/nprot.2006.273; de Brouwer APM, 2002, EXP CELL RES, V274, P100, DOI 10.1006/excr.2001.5460; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Dongol B, 2007, J LIPID RES, V48, P1781, DOI 10.1194/jlr.M700119-JLR200; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; Fisher FM, 2011, ENDOCRINOLOGY, V152, P2996, DOI 10.1210/en.2011-0281; Forwood JK, 2007, P NATL ACAD SCI USA, V104, P10382, DOI 10.1073/pnas.0700974104; He JH, 2011, EXP BIOL MED, V236, P1116, DOI 10.1258/ebm.2011.011128; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hunt MC, 2006, FASEB J, V20, P1855, DOI 10.1096/fj.06-6042com; Hunt MC, 2002, PROG LIPID RES, V41, P99, DOI 10.1016/S0163-7827(01)00017-0; Hunt MC, 1999, J BIOL CHEM, V274, P34317, DOI 10.1074/jbc.274.48.34317; Hyogo H, 2002, J BIOL CHEM, V277, P34117, DOI 10.1074/jbc.M203912200; Jump DB, 2011, CURR OPIN CLIN NUTR, V14, P115, DOI 10.1097/MCO.0b013e328342991c; Kaiyala KJ, 2010, DIABETES, V59, P1657, DOI 10.2337/db09-1582; Kang HW, 2010, TRENDS ENDOCRIN MET, V21, P449, DOI 10.1016/j.tem.2010.02.001; Kang HW, 2010, BBA-MOL CELL BIOL L, V1801, P496, DOI 10.1016/j.bbalip.2009.12.013; Kang HW, 2009, J LIPID RES, V50, P2212, DOI 10.1194/jlr.M900013-JLR200; Kanno K, 2007, J BIOL CHEM, V282, P30728, DOI 10.1074/jbc.M703745200; Kirkby B, 2010, PROG LIPID RES, V49, P366, DOI 10.1016/j.plipres.2010.04.001; Kliewer SA, 2010, AM J CLIN NUTR, V91, p254S, DOI 10.3945/ajcn.2009.28449B; Li LO, 2010, BBA-MOL CELL BIOL L, V1801, P246, DOI 10.1016/j.bbalip.2009.09.024; Li LO, 2009, J BIOL CHEM, V284, P27816, DOI 10.1074/jbc.M109.022467; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Newberry EP, 2006, HEPATOLOGY, V44, P1191, DOI 10.1002/hep.21369; Poupon V, 1999, J BIOL CHEM, V274, P19188, DOI 10.1074/jbc.274.27.19188; Scapa EF, 2008, FASEB J, V22, P2579, DOI 10.1096/fj.07-105395; Shishova EY, 2011, HEPATOLOGY, V54, P664, DOI 10.1002/hep.24393; Su X, 2009, TRENDS ENDOCRIN MET, V20, P72, DOI 10.1016/j.tem.2008.11.001; Wei J, 2009, BIOCHEM J, V421, P311, DOI 10.1042/BJ20090039; Westin MAK, 2008, CELL MOL LIFE SCI, V65, P982, DOI 10.1007/s00018-008-7576-6; Westin MAK, 2005, J BIOL CHEM, V280, P38125, DOI 10.1074/jbc.M508479200; Westin MAK, 2007, J BIOL CHEM, V282, P26707, DOI 10.1074/jbc.M703718200; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Yuan XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005609	40	46	47	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2012	26	5					2209	2221		10.1096/fj.11-202853	http://dx.doi.org/10.1096/fj.11-202853			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22345407	Green Published			2022-12-25	WOS:000303680800046
J	Arruda, DC; Santos, LCP; Melo, FM; Pereira, FV; Figueiredo, CR; Matsuo, AL; Mortara, RA; Juliano, MA; Rodrigues, EG; Dobroff, AS; Polonelli, L; Travassos, LR				Arruda, Denise C.; Santos, Luana C. P.; Melo, Filipe M.; Pereira, Felipe V.; Figueiredo, Carlos R.; Matsuo, Alisson L.; Mortara, Renato A.; Juliano, Maria A.; Rodrigues, Elaine G.; Dobroff, Andrey S.; Polonelli, Luciano; Travassos, Luiz R.			beta-Actin-binding Complementarity-determining Region 2 of Variable Heavy Chain from Monoclonal Antibody C7 Induces Apoptosis in Several Human Tumor Cells and Is Protective against Metastatic Melanoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERAPEUTIC ACTIVITY; SYNTHETIC PEPTIDE; SURFACE; POLYMERIZATION; TRANSLOCATION; CASPASE; COFILIN; YEAST; CDRS	Complementarity-determining regions (CDRs) from monoclonal antibodies tested as synthetic peptides display anti-infective and antitumor activities, independent of the specificity of the native antibody. Previously, we have shown that the synthetic peptide C7H2, based on the heavy chain CDR 2 from monoclonal antibody C7, a mAb directed to a mannoprotein of Candida albicans, significantly reduced B16F10 melanoma growth and lung colony formation by triggering tumor apoptosis. The mechanism, however, by which C7H2 induced apoptosis in tumor cells remained unknown. Here, we demonstrate that C7H2 interacts with components of the tumor cells cytoskeleton, being rapidly internalized after binding to the tumor cell surface. Mass spectrometry analysis and in vitro validation revealed that beta-actin is the receptor of C7H2 in the tumor cells. C7H2 induces beta-actin polymerization and F-actin stabilization, linked with abundant generation of superoxide anions and apoptosis. Major phenotypes following peptide binding were chromatin condensation, DNA fragmentation, annexin V binding, lamin disruption, caspase 8 and 3 activation, and organelle alterations. Finally, we evaluated the cytotoxic efficacy of C7H2 in a panel of human tumor cell lines. All tumor cell lines studied were equally susceptible to C7H2 in vitro. The C7H2 amide without further derivatization significantly reduced lung metastasis of mice endovenously challenged with B16F10-Nex2 melanoma cells. No significant cytotoxicity was observed toward nontumorigenic cell lines on short incubation in vitro or in naive mice injected with a high dose of the peptide. We believe that C7H2 is a promising peptide to be developed as an anticancer drug.	[Arruda, Denise C.; Santos, Luana C. P.; Melo, Filipe M.; Pereira, Felipe V.; Figueiredo, Carlos R.; Matsuo, Alisson L.; Rodrigues, Elaine G.; Travassos, Luiz R.] Univ Fed Sao Paulo UNIFESP, Unidade Oncol Expt UNONEX, BR-04023062 Sao Paulo, Brazil; [Mortara, Renato A.] Univ Fed Sao Paulo UNIFESP, Div Parasitol, BR-04023062 Sao Paulo, Brazil; [Juliano, Maria A.] Univ Fed Sao Paulo UNIFESP, Dept Biophys, BR-04023062 Sao Paulo, Brazil; [Matsuo, Alisson L.; Travassos, Luiz R.] Recepta Biopharma, BR-04533014 Sao Paulo, Brazil; [Dobroff, Andrey S.] Univ Texas MD Anderson Canc Ctr, David H Koch Ctr, Houston, TX 77030 USA; [Polonelli, Luciano] Univ Parma, I-43121 Parma, Italy	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); University of Texas System; UTMD Anderson Cancer Center; University of Parma	Travassos, LR (corresponding author), Univ Fed Sao Paulo UNIFESP, Unidade Oncol Expt UNONEX, Rua Botucatu 862,8 Andar, BR-04023062 Sao Paulo, Brazil.	travassos@unifesp.br	Melo, Filipe/L-8170-2019; Travassos, Luiz R/J-3631-2012; de Melo, Filipe Menegatti/J-9918-2014; Rodrigues, Elaine Guadelupe/ABB-6632-2021; Mortara, Renato A./C-1864-2012; Dobroff, Andrey/A-9814-2016; , Denise/AAD-1162-2022; Figueiredo, Carlos Rogerio de/H-1236-2014; Complexos, INCT Fluidos/H-9172-2013; Arruda, Denise C/E-2184-2013; Travassos, Luiz/V-2467-2019; Rodrigues, Elaine G/H-3688-2014	de Melo, Filipe Menegatti/0000-0002-3672-3636; Rodrigues, Elaine Guadelupe/0000-0002-3248-3081; Mortara, Renato A./0000-0002-2311-8349; Dobroff, Andrey/0000-0003-2162-9951; Figueiredo, Carlos Rogerio de/0000-0003-3680-4070; Arruda, Denise C/0000-0002-8807-8835; 	Brazilian National Research Council (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp) [06/50634-2, 10/51423-0]	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Recipients of career fellowships from the Brazilian National Research Council (CNPq).; This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp) Grants 06/50634-2 and 10/51423-0.	Barras D, 2011, CURR PHARM BIOTECHNO, V12, P1153, DOI 10.2174/138920111796117337; Bhutia SK, 2008, TRENDS BIOTECHNOL, V26, P210, DOI 10.1016/j.tibtech.2008.01.002; BUONASSISI V, 1976, P NATL ACAD SCI USA, V73, P1612, DOI 10.1073/pnas.73.5.1612; Casoli C, 2006, AIDS, V20, P975, DOI 10.1097/01.aids.0000222068.14878.0d; Cenci E, 2004, CELL MICROBIOL, V6, P953, DOI 10.1111/j.1462-5822.2004.00413.x; Chen JY, 2009, PEPTIDES, V30, P2365, DOI 10.1016/j.peptides.2009.08.019; Chernysh S, 2002, P NATL ACAD SCI USA, V99, P12628, DOI 10.1073/pnas.192301899; Chua BT, 2003, NAT CELL BIOL, V5, P1083, DOI 10.1038/ncb1070; Cozzolino R, 2005, CARCINOGENESIS, V26, P733, DOI 10.1093/carcin/bgi017; Daffre S, 2008, STUD NAT PROD CHEM, V35, P597; DesMarais V, 2005, J CELL SCI, V118, P19, DOI 10.1242/jcs.01631; Dobroff AS, 2010, TRANSL ONCOL, V3, P204, DOI 10.1593/tlo.09316; Dobroff AS, 2002, HYBRIDOMA HYBRIDOM, V21, P321, DOI 10.1089/153685902761022661; Franklin-Tong VE, 2008, BIOCHEM J, V413, P389, DOI 10.1042/BJ20080320; Gabrielli E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008187; Giammarioli AM, 2008, CANCER RES, V68, P5291, DOI 10.1158/0008-5472.CAN-08-0222; Gomes A, 2010, INDIAN J EXP BIOL, V48, P93; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Gruenbaum Y, 2003, INT REV CYTOL, V226, P1, DOI 10.1016/S0074-7696(03)01001-5; Heap CJ, 2005, J GEN VIROL, V86, P1791, DOI 10.1099/vir.0.80812-0; Janin YL, 2003, AMINO ACIDS, V25, P1, DOI 10.1007/s00726-002-0349-x; Kim BM, 2009, TOXICOL APPL PHARM, V239, P87, DOI 10.1016/j.taap.2009.05.020; Leadsham JE, 2010, CELL DEATH DIFFER, V17, P754, DOI 10.1038/cdd.2009.196; Levee MG, 1996, AM J PHYSIOL-CELL PH, V271, pC1981, DOI 10.1152/ajpcell.1996.271.6.C1981; LEVI M, 1993, P NATL ACAD SCI USA, V90, P4374, DOI 10.1073/pnas.90.10.4374; Magliani W, 2004, CURR MED CHEM, V11, P1793, DOI 10.2174/0929867043364964; Magliani W, 2009, CURR MED CHEM, V16, P2305, DOI 10.2174/092986709788453104; Miles LA, 2006, J NEUROSCI, V26, P13017, DOI 10.1523/JNEUROSCI.2070-06.2006; Moragues MD, 2003, INFECT IMMUN, V71, P5273, DOI 10.1128/IAI.71.9.5273-5279.2003; MOROIANU J, 1993, P NATL ACAD SCI USA, V90, P3815, DOI 10.1073/pnas.90.9.3815; Murray David, 2003, Am J Clin Oncol, V26, pe169, DOI 10.1097/01.coc.0000091359.11281.f4; Odaka C, 2000, CLIN DIAGN LAB IMMUN, V7, P947, DOI 10.1128/CDLI.7.6.947-952.2000; OWEN MJ, 1978, P NATL ACAD SCI USA, V75, P4484, DOI 10.1073/pnas.75.9.4484; Polonelli L, 2003, INFECT IMMUN, V71, P6205, DOI 10.1128/IAI.71.11.6205-6212.2003; Polonelli L, 2011, ANTON LEEUW INT J G, V99, P35, DOI 10.1007/s10482-010-9496-3; Polonelli L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002371; Posey SC, 1999, J BIOL CHEM, V274, P4259, DOI 10.1074/jbc.274.7.4259; Rao JY, 1999, J CELL BIOCHEM, V75, P686, DOI 10.1002/(SICI)1097-4644(19991215)75:4<686::AID-JCB14>3.0.CO;2-F; SANDERS SK, 1983, J IMMUNOL, V131, P370; Sato M, 2007, INT J ONCOL, V30, P1453; Savoia D, 2006, EXP PARASITOL, V113, P186, DOI 10.1016/j.exppara.2006.01.002; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Tang HL, 2006, BIOCHEM J, V396, P1, DOI 10.1042/BJ20060241; Wang H, 2004, CANCER RES, V64, P162, DOI 10.1158/0008-5472.CAN-03-1862; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6	45	33	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14912	14922		10.1074/jbc.M111.322362	http://dx.doi.org/10.1074/jbc.M111.322362			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22334655	Green Published, hybrid			2022-12-25	WOS:000304003200054
J	Del Coso, J; Munoz-Fernandez, VE; Munoz, G; Fernandez-Elias, VE; Ortega, JF; Hamouti, N; Barbero, JC; Munoz-Guerra, J				Del Coso, Juan; Munoz-Fernandez, Victor E.; Munoz, Gloria; Fernandez-Elias, Valentin E.; Ortega, Juan F.; Hamouti, Nassim; Barbero, Jose C.; Munoz-Guerra, Jesus			Effects of a Caffeine-Containing Energy Drink on Simulated Soccer Performance	PLOS ONE			English	Article							SUPPLEMENT USE; POWER OUTPUT; EXERCISE; INGESTION; SPORTS; CARBOHYDRATE; TIME; INCREASES; TAURINE; FITNESS	Background: To investigate the effects of a caffeine-containing energy drink on soccer performance during a simulated game. A second purpose was to assess the post-exercise urine caffeine concentration derived from the energy drink intake. Methodology/Principal Findings: Nineteen semiprofessional soccer players ingested 630 +/- 52 mL of a commercially available energy drink (sugar-free Red Bull (R)) to provide 3 mg of caffeine per kg of body mass, or a decaffeinated control drink (0 mg/kg). After sixty minutes they performed a 15-s maximal jump test, a repeated sprint test (7x30 m; 30 s of active recovery) and played a simulated soccer game. Individual running distance and speed during the game were measured using global positioning satellite (GPS) devices. In comparison to the control drink, the ingestion of the energy drink increased mean jump height in the jump test (34.7 +/- 4.7 v 35.8 +/- 5.5 cm; P<0.05), mean running speed during the sprint test (25.6 +/- 2.1 v 26.3 +/- 1.8 km . h(-1); P<0.05) and total distance covered at a speed higher than 13 km . h(-1) during the game (1205 +/- 289 v 1436 +/- 326 m; P<0.05). In addition, the energy drink increased the number of sprints during the whole game (30 +/- 10 v 24 +/- 8; P<0.05). Post-exercise urine caffeine concentration was higher after the energy drink than after the control drink (4.1 +/- 1.0 v 0.1 +/- 0.1 mu g . mL(-1); P<0.05). Conclusions/significance: A caffeine-containing energy drink in a dose equivalent to 3 mg/kg increased the ability to repeatedly sprint and the distance covered at high intensity during a simulated soccer game. In addition, the caffeinated energy drink increased jump height which may represent a meaningful improvement for headers or when players are competing for a ball.	[Del Coso, Juan] Camilo Jose Cela Univ, Exercise Physiol Lab, Madrid, Spain; [Munoz-Fernandez, Victor E.] Univ Castilla La Mancha, Exercise Training Lab, Toledo, Spain; [Munoz, Gloria; Munoz-Guerra, Jesus] Spanish Antidoping Agcy, Doping Control Lab, Madrid, Spain; [Fernandez-Elias, Valentin E.; Ortega, Juan F.; Hamouti, Nassim] Univ Castilla La Mancha, Exercise Physiol Lab, Toledo, Spain; [Barbero, Jose C.] Univ Granada, Melilla, Spain	Camilo Jose Cela University; Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; University of Granada	Del Coso, J (corresponding author), Camilo Jose Cela Univ, Exercise Physiol Lab, Madrid, Spain.	jdelcoso@ucjc.edu	Fernández-Elías, Valentín E./ABD-7398-2021; Barbero-Alvarez, Jose Carlos/ABD-1205-2021; Barbero-Alvarez, José Carlos/AAN-1205-2021; Del Coso, Juan/AAC-7117-2020; Ortega, Juan Fernando F/L-4973-2014	Fernández-Elías, Valentín E./0000-0002-1459-5442; Barbero-Alvarez, Jose Carlos/0000-0002-4055-6332; Del Coso, Juan/0000-0002-5785-984X; Ortega, Juan Fernando F/0000-0003-3884-923X				Alford C, 2001, AMINO ACIDS, V21, P139, DOI 10.1007/s007260170021; Astorino TA, 2012, AMINO ACIDS, V42, P1803, DOI 10.1007/s00726-011-0900-8; Barbero-Alvarez JC, 2007, APUNTS EDUCACION FIS, V90, P33; Barbero-Alvarez JC, 2010, J SCI MED SPORT, V13, P232, DOI 10.1016/j.jsams.2009.02.005; Bruce CR, 2000, MED SCI SPORT EXER, V32, P1958, DOI 10.1097/00005768-200011000-00021; Burke LM, 2008, APPL PHYSIOL NUTR ME, V33, P1319, DOI 10.1139/H08-130; Candow DG, 2009, J STRENGTH COND RES, V23, P1271, DOI 10.1519/JSC.0b013e3181a026c2; Carr A, 2008, J SPORT MED PHYS FIT, V48, P472; Castagna C, 2003, J STRENGTH COND RES, V17, P775; Clauson KA, 2008, J AM PHARM ASSOC, V48, pE55, DOI 10.1331/JAPhA.2008.07055; Coutts AJ, 2010, J SCI MED SPORT, V13, P133, DOI 10.1016/j.jsams.2008.09.015; Cox GR, 2002, J APPL PHYSIOL, V93, P990, DOI 10.1152/japplphysiol.00249.2002; Da Silva NP, 2007, J SPORT MED PHYS FIT, V47, P270; Del Coso J, 2008, MED SCI SPORT EXER, V40, P744, DOI 10.1249/MSS.0b013e3181621336; Del Coso J, 2011, APPL PHYSIOL NUTR ME, V36, P555, DOI [10.1139/h11-052, 10.1139/H11-052]; Del Coso J, 2009, MED SCI SPORT EXER, V41, P164, DOI 10.1249/MSS.0b013e318184f45e; DELBEKE FT, 1984, INT J SPORTS MED, V5, P179, DOI 10.1055/s-2008-1025901; Doherty M, 2004, INT J SPORT NUTR EXE, V14, P626, DOI 10.1123/ijsnem.14.6.626; Doherty M, 2004, J SPORT SCI, V22, P637, DOI 10.1080/02640410310001655741; Doherty M, 1998, INT J SPORT NUTR, V8, P95, DOI 10.1123/ijsn.8.2.95; Ferreira SE, 2004, ALCOHOL CLIN EXP RES, V28, P1408, DOI 10.1097/01.ALC.0000139822.74414.EC; Forbes SC, 2007, INT J SPORT NUTR EXE, V17, P433, DOI 10.1123/ijsnem.17.5.433; Froiland K, 2004, INT J SPORT NUTR EXE, V14, P104, DOI 10.1123/ijsnem.14.1.104; Gant N, 2010, INT J SPORT NUTR EXE, V20, P191, DOI 10.1123/ijsnem.20.3.191; Girard O, 2011, SPORTS MED, V41, P673, DOI 10.2165/11590550-000000000-00000; Glaister M, 2008, MED SCI SPORT EXER, V40, P1835, DOI 10.1249/MSS.0b013e31817a8ad2; GRAHAM TE, 1995, J APPL PHYSIOL, V78, P867, DOI 10.1152/jappl.1995.78.3.867; Hoffman JR, 2010, STRENGTH COND J, V32, P15, DOI 10.1519/SSC.0b013e3181bdafa0; Hoffman JR, 2009, J INT SOC SPORT NUTR, V6, DOI 10.1186/1550-2783-6-2; Ivy JL, 2009, INT J SPORT NUTR EXE, V19, P61, DOI 10.1123/ijsnem.19.1.61; Jenkins NT, 2008, INT J SPORT NUTR EXE, V18, P328, DOI 10.1123/ijsnem.18.3.328; Kristiansen M, 2005, INT J SPORT NUTR EXE, V15, P195, DOI 10.1123/ijsnem.15.2.195; Lara AJ, 2006, J SPORT MED PHYS FIT, V46, P419; LELO A, 1986, BRIT J CLIN PHARMACO, V22, P183, DOI 10.1111/j.1365-2125.1986.tb05247.x; Magkos F, 2005, CRIT REV FOOD SCI, V45, P535, DOI 10.1080/1040-830491379245; Mujika I, 2009, J SPORT SCI, V27, P107, DOI 10.1080/02640410802428071; PASMAN WJ, 1995, INT J SPORTS MED, V16, P225, DOI 10.1055/s-2007-972996; Pierno S, 1998, J PHARMACOL EXP THER, V286, P1183; Rampinini E, 2007, INT J SPORTS MED, V28, P1018, DOI 10.1055/s-2007-965158; Roberts SP, 2010, J SPORT SCI, V28, P833, DOI 10.1080/02640414.2010.484069; Skinner TL, 2010, MED SCI SPORT EXER, V42, P571, DOI 10.1249/MSS.0b013e3181b6668b; Stuart GR, 2005, MED SCI SPORT EXER, V37, P1998, DOI 10.1249/01.mss.0000177216.21847.8a; SUBOTICANEC K, 1990, INT J VITAM NUTR RES, V60, P81; van Nieuwenhoven MA, 2000, J APPL PHYSIOL, V89, P1079, DOI 10.1152/jappl.2000.89.3.1079; Wiles JD, 2006, J SPORT SCI, V24, P1165, DOI 10.1080/02640410500457687; Yeo SE, 2005, J APPL PHYSIOL, V99, P844, DOI 10.1152/japplphysiol.00170.2005; Zhang M, 2004, AMINO ACIDS, V26, P203, DOI 10.1007/s00726-003-0002-3	47	96	97	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31380	10.1371/journal.pone.0031380	http://dx.doi.org/10.1371/journal.pone.0031380			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348079	Green Published, Green Submitted, gold			2022-12-25	WOS:000302737400019
J	Jabbour, AM; Gordon, L; Daunt, CP; Green, BD; Kok, CH; D'Andrea, R; Ekert, PG				Jabbour, Anissa M.; Gordon, Lavinia; Daunt, Carmel P.; Green, Benjamin D.; Kok, Chung H.; D'Andrea, Richard; Ekert, Paul G.			p53-Dependent Transcriptional Responses to Interleukin-3 Signaling	PLOS ONE			English	Article							CELL-DEATH; UP-REGULATION; DNA-DAMAGE; PUMA; APOPTOSIS; GENE; P53; SURVIVAL; LEUKEMIA; KINASE	p53 is critical in the normal response to a variety of cellular stresses including DNA damage and loss of p53 function is a common feature of many cancers. In hematological malignancies, p53 deletion is less common than in solid malignancies but is associated with poor prognosis and resistance to chemotherapy. Compared to their wild-type (WT) counterparts, hematopoietic progenitor cells lacking p53 have a greater propensity to survive cytokine loss, in part, due to the failure to transcribe Puma, a proapoptotic Bcl-2 family member. Using expression arrays, we have further characterized the differences that distinguish p53(-/-) cells from WT myeloid cells in the presence of Interleukin-3 (IL-3) to determine if such differences contribute to the increased clonogenicity and survival responses observed in p53(-/-) cells. We show that p53(-/-) cells have a deregulated intracellular signaling environment and display a more rapid and sustained response to IL-3. This was accompanied by an increase in active ERK1/2 and a dependence on an intact MAP kinase signaling pathway. Contrastingly, we find that p53(-/-) cells are independent on AKT for their survival. Thus, loss of p53 in myeloid cells results in an altered transcriptional and kinase signaling environment that favors enhanced cytokine signaling.	[Jabbour, Anissa M.; Daunt, Carmel P.; Green, Benjamin D.; Ekert, Paul G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Childrens Canc Ctr, Parkville, Vic 3052, Australia; [Jabbour, Anissa M.; Daunt, Carmel P.; Green, Benjamin D.; Ekert, Paul G.] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Jabbour, Anissa M.; Green, Benjamin D.; Ekert, Paul G.] Univ Melbourne, Dept Paediat, Royal Childrens Hosp, Parkville, Vic 3052, Australia; [Gordon, Lavinia] Royal Childrens Hosp, Murdoch Childrens Res Inst, Bioinformat Unit, Parkville, Vic 3052, Australia; [Kok, Chung H.; D'Andrea, Richard] Univ Adelaide, Queen Elizabeth Hosp, Ctr Stem Cell Res, Dept Haematol SA Pathol,Dept Heamatol & Oncol, Adelaide, SA, Australia; [Kok, Chung H.; D'Andrea, Richard] Univ Adelaide, Queen Elizabeth Hosp, Ctr Stem Cell Res, Acute Leukaemia Lab, Adelaide, SA, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Walter & Eliza Hall Institute; Royal Children's Hospital Melbourne; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; SA Pathology; University of Adelaide; University of Adelaide	Jabbour, AM (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Childrens Canc Ctr, Flemington Rd, Parkville, Vic 3052, Australia.	jabbour@wehi.edu.au; ekert@wehi.edu.au	Ekert, Paul/Q-1842-2015; Gordon, Lavinia C/L-1310-2016; Ekert, Paul G/C-7247-2013	Ekert, Paul/0000-0002-2976-8617; Gordon, Lavinia C/0000-0003-3469-8489; Ekert, Paul G/0000-0002-2976-8617; Jabbour, Anissa/0000-0002-2540-0372; D'Andrea, Richard/0000-0002-4915-4612	National Health and Research Council (NHMRC) [565212]; Sylvia and Charles Viertel Senior Medical Fellowship	National Health and Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Senior Medical Fellowship	This work is supported by the National Health and Research Council (NHMRC) project grant 565212 and was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC Independent Research Institute Infrastructure Support Scheme (IRIISS). PGE is supported by the Sylvia and Charles Viertel Senior Medical Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agueli C, 2010, AM J HEMATOL, V85, P575, DOI 10.1002/ajh.21758; Amato R, 2009, J MOL MED, V87, P1221, DOI 10.1007/s00109-009-0525-5; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Ekert PG, 2006, BLOOD, V108, P1461, DOI 10.1182/blood-2006-03-014209; Ekert PG, 2004, J CELL BIOL, V165, P835, DOI 10.1083/jcb.200312031; Endo T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001211; Ferreira BI, 2008, HAEMATOLOGICA, V93, P670, DOI 10.3324/haematol.12221; Forconi F, 2008, BRIT J HAEMATOL, V143, P532, DOI 10.1111/j.1365-2141.2008.07373.x; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gudkov AV, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001180; Han JW, 2001, P NATL ACAD SCI USA, V98, P11318, DOI 10.1073/pnas.201208798; Jabbour AM, 2010, BLOOD, V115, P344, DOI 10.1182/blood-2009-07-230730; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Khandanpour C, 2010, STEM CELLS; Khatri P, 2007, NUCLEIC ACIDS RES, V35, pW206, DOI 10.1093/nar/gkm327; Kong YM, 2011, J BIOMED INFORM, V44, P48, DOI 10.1016/j.jbi.2010.05.001; Kornblau SM, 2009, BLOOD, V113, P154, DOI 10.1182/blood-2007-10-119438; Labi V, 2010, GENE DEV, V24, P1602, DOI 10.1101/gad.1940210; Letai A, 2006, MOL CELL, V21, P728, DOI 10.1016/j.molcel.2006.03.005; Liu PT, 2003, NAT IMMUNOL, V4, P525, DOI 10.1038/ni925; LOTEM J, 1993, BLOOD, V82, P1092, DOI 10.1182/blood.V82.4.1092.bloodjournal8241092; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marfe G, 2011, EXP HEMATOL; Mayo LD, 2002, TRENDS BIOCHEM SCI, V27, P462, DOI 10.1016/S0968-0004(02)02166-7; Messina DN, 2004, GENOME RES, V14, P2041, DOI 10.1101/gr.2584104; Michalak EM, 2010, GENE DEV, V24, P1608, DOI 10.1101/gad.1940110; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Moreland RT, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap004; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Pfeifer D, 2007, BLOOD, V109, P1202, DOI 10.1182/blood-2006-07-034256; Renneville A, 2008, LEUKEMIA, V22, P915, DOI 10.1038/leu.2008.19; Satterwhite E, 2001, BLOOD, V98, P3413, DOI 10.1182/blood.V98.12.3413; Shibue T, 2003, GENE DEV, V17, P2233, DOI 10.1101/gad.1103603; Song LB, 2011, CLIN CANCER RES, V17, P1839, DOI 10.1158/1078-0432.CCR-10-0720; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Yamamoto T, 2006, CURR BIOL, V16, P1171, DOI 10.1016/j.cub.2006.04.044; Yin B, 2009, BLOOD, V113, P1075, DOI 10.1182/blood-2008-03-144436; Yoshimura A, 2005, ARTHRITIS RES THER, V7, P100, DOI 10.1186/ar1741; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Zhao YX, 2008, J BIOL CHEM, V283, P36344, DOI 10.1074/jbc.M803580200; Zola H, 2007, J IMMUNOL METHODS, V319, P1, DOI 10.1016/j.jim.2006.11.001	52	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31428	10.1371/journal.pone.0031428	http://dx.doi.org/10.1371/journal.pone.0031428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348085	gold, Green Published, Green Accepted			2022-12-25	WOS:000302737400021
J	Egger, A; Samardzija, M; Sothilingam, V; Tanimoto, N; Lange, C; Salatino, S; Fang, L; Garcia-Garrido, M; Beck, S; Okoniewski, MJ; Neutzner, A; Seeliger, MW; Grimm, C; Handschin, C				Egger, Anna; Samardzija, Marijana; Sothilingam, Vithiyanjali; Tanimoto, Naoyuki; Lange, Christina; Salatino, Silvia; Fang, Lei; Garcia-Garrido, Marina; Beck, Susanne; Okoniewski, Michal J.; Neutzner, Albert; Seeliger, Mathias W.; Grimm, Christian; Handschin, Christoph			PGC-1 alpha Determines Light Damage Susceptibility of the Murine Retina	PLOS ONE			English	Article							SKELETAL-MUSCLE; ENERGY-METABOLISM; PGC-1 COACTIVATORS; PHOTORECEPTORS; EXPRESSION; EXERCISE; PGC1-ALPHA; MECHANISMS; PIGMENTOSA; APOPTOSIS	The peroxisome proliferator-activated receptor gamma coactivator 1 (PGC-1) proteins are key regulators of cellular bioenergetics and are accordingly expressed in tissues with a high energetic demand. For example, PGC-1 alpha and PGC-1 beta control organ function of brown adipose tissue, heart, brain, liver and skeletal muscle. Surprisingly, despite their prominent role in the control of mitochondrial biogenesis and oxidative metabolism, expression and function of the PGC-1 coactivators in the retina, an organ with one of the highest energy demands per tissue weight, are completely unknown. Moreover, the molecular mechanisms that coordinate energy production with repair processes in the damaged retina remain enigmatic. In the present study, we thus investigated the expression and function of the PGC-1 coactivators in the healthy and the damaged retina. We show that PGC-1 alpha and PGC-1 beta are found at high levels in different structures of the mouse retina, most prominently in the photoreceptors. Furthermore, PGC-1 alpha knockout mice suffer from a striking deterioration in retinal morphology and function upon detrimental light exposure. Gene expression studies revealed dysregulation of all major pathways involved in retinal damage and apoptosis, repair and renewal in the PGC-1 alpha knockouts. The light-induced increase in apoptosis in vivo in the absence of PGC-1 alpha was substantiated in vitro, where overexpression of PGC-1 alpha evoked strong anti-apoptotic effects. Finally, we found that retinal levels of PGC-1 expression are reduced in different mouse models for retinitis pigmentosa. We demonstrate that PGC-1 alpha is a central coordinator of energy production and, importantly, all of the major processes involved in retinal damage and subsequent repair. Together with the observed dysregulation of PGC-1 alpha and PGC-1 beta in retinitis pigmentosa mouse models, these findings thus imply that PGC-1 alpha might be an attractive target for therapeutic approaches aimed at retinal degeneration diseases.	[Egger, Anna; Salatino, Silvia; Handschin, Christoph] Univ Basel, Biozentrum, Div Pharmacol Neurobiol, Basel, Switzerland; [Samardzija, Marijana; Lange, Christina; Grimm, Christian] Univ Zurich, Dept Ophthalmol, Lab Retinal Cell Biol, Schlieren, Switzerland; [Sothilingam, Vithiyanjali; Tanimoto, Naoyuki; Beck, Susanne; Seeliger, Mathias W.] Univ Tubingen, Inst Ophthalm Res, Div Expt Ophthalmol, Tubingen, Germany; [Neutzner, Albert] Univ Basel Hosp, Dept Med, Univ Eye Clin, CH-4031 Basel, Switzerland; [Okoniewski, Michal J.] Funct Genom Ctr UNI ETH Zurich, Zurich, Switzerland	University of Basel; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Basel	Egger, A (corresponding author), Univ Basel, Biozentrum, Div Pharmacol Neurobiol, Basel, Switzerland.	christoph.handschin@unibas.ch	Neutzner, Albert/ABC-4368-2020; Samardzija, Marijana/B-9245-2008; Handschin, Christoph/E-6886-2015	Samardzija, Marijana/0000-0003-0991-4653; Handschin, Christoph/0000-0003-0603-1097; Grimm, Christian/0000-0001-9318-4352; Neutzner, Albert/0000-0001-9254-5558; Salatino, Silvia/0000-0003-1286-3076	Swiss National Science Foundation; SwissLife "Jubilaumsstiftung fur Volksgesundheit und medizinische Forschung"; Roche Research Foundation; United Mitochondrial Disease Foundation (UMDF); University of Basel	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SwissLife "Jubilaumsstiftung fur Volksgesundheit und medizinische Forschung"; Roche Research Foundation; United Mitochondrial Disease Foundation (UMDF); University of Basel	This project was funded by the Swiss National Science Foundation, the SwissLife "Jubilaumsstiftung fur Volksgesundheit und medizinische Forschung", the Roche Research Foundation, the United Mitochondrial Disease Foundation (UMDF) and the University of Basel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhihetty PJ, 2009, AM J PHYSIOL-CELL PH, V297, pC217, DOI 10.1152/ajpcell.00070.2009; AMES A, 1992, J NEUROSCI, V12, P840, DOI 10.1523/jneurosci.12-03-00840.1992; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Chang B, 2007, VISION RES, V47, P624, DOI 10.1016/j.visres.2006.11.020; D'Errico I, 2011, P NATL ACAD SCI USA, V108, P6603, DOI 10.1073/pnas.1016354108; Daniele LL, 2005, INVEST OPHTH VIS SCI, V46, P2156, DOI 10.1167/iovs.04-1427; Ershov AV, 2000, J NEUROSCI RES, V60, P328, DOI 10.1002/(SICI)1097-4547(20000501)60:3<328::AID-JNR7>3.0.CO;2-5; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507; Grimm C, 2000, NAT GENET, V25, P63, DOI 10.1038/75614; Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Handschin C, 2011, CELL METAB, V13, P351, DOI 10.1016/j.cmet.2011.03.008; Handschin C, 2009, TRENDS PHARMACOL SCI, V30, P322, DOI 10.1016/j.tips.2009.03.006; Herzlich Alexandra A, 2009, Open Biol J, V2, P141; Joly S, 2008, J NEUROSCI, V28, P13765, DOI 10.1523/JNEUROSCI.5114-08.2008; Kim HJ, 2011, ACTA BIOCH BIOPH SIN, V43, P589, DOI 10.1093/abbs/gmr053; Lamb TD, 2006, INVEST OPHTH VIS SCI, V47, P5138, DOI 10.1167/iovs.06-0849; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; NAASH MI, 1993, P NATL ACAD SCI USA, V90, P5499, DOI 10.1073/pnas.90.12.5499; Nathans J, 1987, ANNU REV NEUROSCI, V10, P2897; Okawa H, 2008, CURR BIOL, V18, P1917, DOI 10.1016/j.cub.2008.10.029; Organisciak DT, 2010, PROG RETIN EYE RES, V29, P113, DOI 10.1016/j.preteyeres.2009.11.004; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Sahel J, 2010, DEV OPHTHALMOL, V47, P160, DOI 10.1159/000320079; Samardzija M, 2006, INVEST OPHTH VIS SCI, V47, P5181, DOI 10.1167/iovs.06-0556; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Tanimoto N, 2009, FRONT BIOSCI-LANDMRK, V14, P2730, DOI 10.2741/3409; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Won JC, 2010, ARTERIOSCL THROM VAS, V30, P290, DOI 10.1161/ATVBAHA.109.198721; Wu J, 2011, CELL METAB, V13, P160, DOI 10.1016/j.cmet.2011.01.003; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yu L, 2010, NEUROSCIENCE, V169, P23, DOI 10.1016/j.neuroscience.2010.04.063; Zheng Z, 2010, DIABETES, V59, P2315, DOI 10.2337/db10-0638	41	35	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31272	10.1371/journal.pone.0031272	http://dx.doi.org/10.1371/journal.pone.0031272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348062	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000302733900036
J	Giussani, DA; Camm, EJ; Niu, YG; Richter, HG; Blanco, CE; Gottschalk, R; Blake, EZ; Horder, KA; Thakor, AS; Hansell, JA; Kane, AD; Wooding, FBP; Cross, CM; Herrera, EA				Giussani, Dino A.; Camm, Emily J.; Niu, Youguo; Richter, Hans G.; Blanco, Carlos E.; Gottschalk, Rachel; Blake, E. Zachary; Horder, Katy A.; Thakor, Avnesh S.; Hansell, Jeremy A.; Kane, Andrew D.; Wooding, F. B. Peter; Cross, Christine M.; Herrera, Emilio A.			Developmental Programming of Cardiovascular Dysfunction by Prenatal Hypoxia and Oxidative Stress	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; INTIMA-MEDIA THICKNESS; FETAL HYPOXIA; NITRIC-OXIDE; HEART SUSCEPTIBILITY; REPERFUSION INJURY; VASCULAR FUNCTION; CONTROLLED-TRIAL; PREGNANT-WOMEN; HIGH-ALTITUDE	Fetal hypoxia is a common complication of pregnancy. It has been shown to programme cardiac and endothelial dysfunction in the offspring in adult life. However, the mechanisms via which this occurs remain elusive, precluding the identification of potential therapy. Using an integrative approach at the isolated organ, cellular and molecular levels, we tested the hypothesis that oxidative stress in the fetal heart and vasculature underlies the molecular basis via which prenatal hypoxia programmes cardiovascular dysfunction in later life. In a longitudinal study, the effects of maternal treatment of hypoxic (13% O-2) pregnancy with an antioxidant on the cardiovascular system of the offspring at the end of gestation and at adulthood were studied. On day 6 of pregnancy, rats (n = 20 per group) were exposed to normoxia or hypoxia 6 vitamin C. At gestational day 20, tissues were collected from 1 male fetus per litter per group (n = 10). The remaining 10 litters per group were allowed to deliver. At 4 months, tissues from 1 male adult offspring per litter per group were either perfusion fixed, frozen, or dissected for isolated organ preparations. In the fetus, hypoxic pregnancy promoted aortic thickening with enhanced nitrotyrosine staining and an increase in cardiac HSP70 expression. By adulthood, offspring of hypoxic pregnancy had markedly impaired NO-dependent relaxation in femoral resistance arteries, and increased myocardial contractility with sympathetic dominance. Maternal vitamin C prevented these effects in fetal and adult offspring of hypoxic pregnancy. The data offer insight to mechanism and thereby possible targets for intervention against developmental origins of cardiac and peripheral vascular dysfunction in offspring of risky pregnancy.	[Giussani, Dino A.; Camm, Emily J.; Niu, Youguo; Richter, Hans G.; Blanco, Carlos E.; Gottschalk, Rachel; Blake, E. Zachary; Horder, Katy A.; Thakor, Avnesh S.; Hansell, Jeremy A.; Kane, Andrew D.; Wooding, F. B. Peter; Cross, Christine M.; Herrera, Emilio A.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Herrera, Emilio A.] Univ Chile, ICBM, Lab Func & Reactividad Vasc, Fac Med,Programa Fisiopatol, Santiago, Chile	University of Cambridge; Universidad de Chile	Giussani, DA (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	dag26@cam.ac.uk	Herrera, Emilio A/H-5992-2018; Kane, Andrew D/C-5876-2013; Richter, Hans/D-6273-2013	Herrera, Emilio A/0000-0002-6342-085X; Kane, Andrew D/0000-0001-9488-4086; Richter, Hans/0000-0002-7224-9388; Giussani, Dino/0000-0002-1308-1204	The British Heart Foundation; The Biotechnology and Biological Sciences Research Council; The Isaac Newton Trust; The Sir Jules Thorn Trust; The Lister Institute; The Wellcome Trust; The Physiological Society; British Heart Foundation [PG/10/99/28656] Funding Source: researchfish	The British Heart Foundation(British Heart Foundation); The Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); The Isaac Newton Trust; The Sir Jules Thorn Trust; The Lister Institute; The Wellcome Trust(Wellcome TrustEuropean Commission); The Physiological Society; British Heart Foundation(British Heart Foundation)	The work was supported by The British Heart Foundation, The Biotechnology and Biological Sciences Research Council, The Isaac Newton Trust, The Sir Jules Thorn Trust, The Lister Institute, The Wellcome Trust and The Physiological Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, TRENDS ENDOCRIN MET, V16, P127, DOI 10.1016/j.tem.2005.02.009; Akira M, 2006, J PEDIATR-US, V148, P49, DOI 10.1016/j.jpeds.2005.06.044; Armitage JA, 2005, J PHYSIOL-LONDON, V565, P3, DOI 10.1113/jphysiol.2004.079756; Barker DJP, 1998, MOTHERS BABIES DIS L; Basson M, 2008, NATURE, V451, P903, DOI 10.1038/451903a; Bristow MR, 2000, CIRCULATION, V101, P558, DOI 10.1161/01.CIR.101.5.558; Camm EJ, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.046; Cartwright JE, 2007, ADV EXP MED BIOL, V618, P113; Chen CA, 2010, NATURE, V468, P1115, DOI 10.1038/nature09599; Cosmi E, 2009, OBSTET GYNECOL, V114, P1109, DOI 10.1097/AOG.0b013e3181bb23d3; Crispi F, 2010, CIRCULATION, V121, P2427, DOI 10.1161/CIRCULATIONAHA.110.937995; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; Danson EJ, 2009, J MOL CELL CARDIOL, V46, P482, DOI 10.1016/j.yjmcc.2008.12.013; Fridovich I., 1978, FREE RADICALS BIOL, P239; GIUSSANI DA, 1993, J PHYSIOL-LONDON, V461, P431, DOI 10.1113/jphysiol.1993.sp019521; Giussani DA, 2006, DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE, P178, DOI 10.1017/CBO9780511544699.013; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; GOBEL FL, 1978, CIRCULATION, V57, P549, DOI 10.1161/01.CIR.57.3.549; Halliwell B, 2004, FREE RADICALS BIOL M; Hauton D, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-1; Herrera EA, 2012, J VASC RES, V49, P50, DOI 10.1159/000330666; Herrera EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009250; IRIYAMA K, 1984, ANAL BIOCHEM, V141, P238, DOI 10.1016/0003-2697(84)90451-2; Jackson TS, 1998, CIRC RES, V83, P916; Kim YH, 2005, J KOREAN MED SCI, V20, P13, DOI 10.3346/jkms.2005.20.1.13; Kissner R, 1997, CHEM RES TOXICOL, V10, P1285, DOI 10.1021/tx970160x; KITANAKA T, 1989, AM J PHYSIOL, V256, pR1348, DOI 10.1152/ajpregu.1989.256.6.R1348; Koklu E, 2006, HORM RES, V65, P269, DOI 10.1159/000092536; Kontic-Vucinic O, 2008, J PERINAT MED, V36, P282, DOI 10.1515/JPM.2008.063; Kris-Etherton PM, 2004, CIRCULATION, V110, P637, DOI 10.1161/01.CIR.0000137822.39831.F1; Li GH, 2003, J SOC GYNECOL INVEST, V10, P265, DOI 10.1016/S1071-5576(03)00074-1; LUCAS A, 1991, CIBA F SYMP, V156, P38; Massey LK, 2005, J NUTR, V135, P1673, DOI 10.1093/jn/135.7.1673; Mayhew TM, 2003, PLACENTA, V24, P191, DOI 10.1053/plac.2002.0895; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Morrison JL, 2008, CLIN EXP PHARMACOL P, V35, P730, DOI 10.1111/j.1440-1681.2008.04975.x; Morton JS, 2011, J APPL PHYSIOL, V110, P1073, DOI 10.1152/japplphysiol.01174.2010; Pagano G, 2004, CARCINOGENESIS, V25, P1899, DOI 10.1093/carcin/bgh194; Patterson AJ, 2010, CURR MOL MED, V10, P653; Patterson AJ, 2010, CIRC RES, V107, P365, DOI 10.1161/CIRCRESAHA.110.221259; Poston L, 2006, LANCET, V367, P1145, DOI 10.1016/S0140-6736(06)68433-X; Rader DJ, 2008, NATURE, V451, P904, DOI 10.1038/nature06796; Ream M, 2008, AM J PHYSIOL-REG I, V295, pR583, DOI 10.1152/ajpregu.00771.2007; Richardson BS, 1998, COMP BIOCHEM PHYS A, V119, P717, DOI 10.1016/S1095-6433(98)01010-1; Richter HG, 2009, J PINEAL RES, V46, P357, DOI 10.1111/j.1600-079X.2009.00671.x; Rouwet EV, 2002, CIRCULATION, V105, P2791, DOI 10.1161/01.CIR.0000017497.47084.06; Rueda-Clausen CF, 2011, CARDIOVASC RES, V90, P285, DOI 10.1093/cvr/cvq363; Ruijtenbeek K, 2000, CIRCULATION, V102, P2892; RUMBOLD A, 2008, COCHRANE DB SYST REV, V1; Salinas CE, 2010, J DEV ORIG HLTH DIS, V1, P60, DOI 10.1017/S2040174409990043; Skilton MR, 2005, LANCET, V365, P1484, DOI 10.1016/S0140-6736(05)66419-7; Spinnato JA, 2007, OBSTET GYNECOL, V110, P1311, DOI 10.1097/01.AOG.0000289576.43441.1f; Thakor AS, 2010, J PHYSIOL-LONDON, V588, P4235, DOI 10.1113/jphysiol.2010.196402; Thakor AS, 2010, J PINEAL RES, V49, P399, DOI 10.1111/j.1600-079X.2010.00813.x; Tintu A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005155; Villar J, 2009, BJOG-INT J OBSTET GY, V116, P780, DOI 10.1111/j.1471-0528.2009.02158.x; Williams SJ, 2005, J PHYSIOL-LONDON, V565, P125, DOI 10.1113/jphysiol.2005.084889; Witlin AG, 2002, BIOL REPROD, V67, P1025, DOI 10.1095/biolreprod.101.002196; Xue Q, 2011, CARDIOVASC RES, V89, P300, DOI 10.1093/cvr/cvq303; Xue Q, 2009, J PHARMACOL EXP THER, V330, P624, DOI 10.1124/jpet.109.153239; Zhang LB, 2005, J SOC GYNECOL INVEST, V12, P2, DOI 10.1016/j.jsgi.2004.09.004	61	196	198	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31017	10.1371/journal.pone.0031017	http://dx.doi.org/10.1371/journal.pone.0031017			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348036	Green Published, gold, Green Submitted			2022-12-25	WOS:000302733900020
J	Tinkerhess, MJ; Healy, L; Morgan, M; Sujkowski, A; Matthys, E; Zheng, L; Wessells, RJ				Tinkerhess, Martin J.; Healy, Lindsey; Morgan, Matthew; Sujkowski, Alyson; Matthys, Erin; Zheng, Li; Wessells, Robert J.			The Drosophila PGC-1 alpha Homolog spargel Modulates the Physiological Effects of Endurance Exercise	PLOS ONE			English	Article							INDUCED MITOCHONDRIAL BIOGENESIS; SKELETAL-MUSCLE; COACTIVATOR; EXPRESSION; LONGEVITY; INCREASE; PGC-1; ADAPTATIONS; MECHANISMS	Endurance exercise is an inexpensive intervention that is thought to provide substantial protection against several age-related pathologies, as well as inducing acute changes to endurance capacity and metabolism. Recently, it has been established that endurance exercise induces conserved alterations in physiological capacity in the invertebrate Drosophila model. If the genetic factors underlying these exercise-induced physiological alterations are widely conserved, then invertebrate genetic model systems will become a valuable tool for testing of genetic and pharmacological mimetics for endurance training. Here, we assess whether the Drosophila homolog of the vertebrate exercise response gene PGC-1 alpha spargel (srl) is necessary or sufficient to induce exercise-dependent phenotypes. We find that reduction of srl expression levels acutely compromises negative geotaxis ability and reduces exercise-induced improvement in both negative geotaxis and time to exhaustion. Conversely, muscle/heart specific srl overexpression improves negative geotaxis and cardiac performance in unexercised flies. In addition, we find that srl overexpression mimics some, but not all, exercise-induced phenotypes, suggesting that other factors also act in parallel to srl to regulate exercise-induced physiological changes in muscle and heart.	[Tinkerhess, Martin J.; Healy, Lindsey; Morgan, Matthew; Sujkowski, Alyson; Matthys, Erin; Zheng, Li; Wessells, Robert J.] Univ Michigan, Inst Gerontol, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Tinkerhess, MJ (corresponding author), Univ Michigan, Inst Gerontol, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA.	wessells@umich.edu	Wessells, Robert/AAG-3406-2020	Wessells, Robert/0000-0002-4516-3183; Sujkowski, Alyson/0000-0002-9909-9279	NIH [(R21) 5R21HL104262-02]; Nathan Shock Center of Excellence in the Basic Biology of Aging [NIA P30 A6013283-13]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL104262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013283] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nathan Shock Center of Excellence in the Basic Biology of Aging; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	NIH Exploratory/Developmental Research Grant Award (R21) 5R21HL104262-02; http://grants.nih.gov/grants/funding/r21.htm; Nathan Shock Center of Excellence in the Basic Biology of Aging Pilot Award NIA P30 A6013283-13; http://sitemaker.umich.edu/nsc/pilot_award_competition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007; Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105; Cornelissen VA, 2005, HYPERTENSION, V46, P667, DOI 10.1161/01.HYP.0000184225.05629.51; Davidson SR, 2006, MED SCI SPORT EXER, V38, P250, DOI 10.1249/01.mss.0000183179.86594.4f; Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005; Geng TY, 2010, AM J PHYSIOL-CELL PH, V298, pC572, DOI 10.1152/ajpcell.00481.2009; Goto M, 2000, BIOCHEM BIOPH RES CO, V274, P350, DOI 10.1006/bbrc.2000.3134; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Holloszy JO, 1997, J APPL PHYSIOL, V82, P399, DOI 10.1152/jappl.1997.82.2.399; HOLLOSZY JO, 1976, ANNU REV PHYSIOL, V38, P273, DOI 10.1146/annurev.ph.38.030176.001421; HOLLOSZY JO, 1985, J APPL PHYSIOL, V59, P826, DOI 10.1152/jappl.1985.59.3.826; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Little JP, 2011, AM J PHYSIOL-REG I, V300, pR1303, DOI 10.1152/ajpregu.00538.2010; Piazza N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005886; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rera M, 2011, CELL METAB, V14, P623, DOI 10.1016/j.cmet.2011.09.013; Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006; Sutherland LN, 2009, J PHYSIOL-LONDON, V587, P1607, DOI 10.1113/jphysiol.2008.165464; Tiefenbock SK, 2010, EMBO J, V29, P171, DOI 10.1038/emboj.2009.330; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; Wessells RJ, 2004, NAT GENET, V36, P1275, DOI 10.1038/ng1476; Winder WW, 2006, MED SCI SPORT EXER, V38, P1945, DOI 10.1249/01.mss.0000233798.62153.50; Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	27	47	48	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31633	10.1371/journal.pone.0031633	http://dx.doi.org/10.1371/journal.pone.0031633			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348115	Green Published, gold, Green Submitted			2022-12-25	WOS:000302733900058
J	Predazzi, IM; Norata, GD; Vecchione, L; Garlaschelli, K; Amati, F; Grigore, L; Cutuli, L; Pirillo, A; Tramontana, S; Romeo, F; Novelli, G; Catapano, AL				Predazzi, Irene Marta; Norata, Giuseppe Danilo; Vecchione, Lucia; Garlaschelli, Katia; Amati, Francesca; Grigore, Liliana; Cutuli, Lucia; Pirillo, Angela; Tramontana, Simona; Romeo, Francesco; Novelli, Giuseppe; Catapano, Alberico Luigi			Association between OLR1 K167N SNP and Intima Media Thickness of the Common Carotid Artery in the General Population	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; RECEPTOR; POLYMORPHISM; DISEASE; SUSCEPTIBILITY; VARIANTS; SEVERITY; LOX-1; G501C	Background and Purpose: The lectin-like oxidised LDL receptor-1 (OLR1) gene encodes a scavenger receptor implicated in the pathogenesis of atherosclerosis. Although functional roles have been suggested for two variants, epidemiological studies on OLR1 have been inconsistent. Methods - We tested the association between the non-synonymous substitution K167N (rs11053646) and intima media thickness of the common carotid artery (CCA-IMT) in 2,141 samples from the Progression of Lesions in the Intima of the Carotid (PLIC) study (a prospective population-based study). Results: Significantly increased IMT was observed in male carriers of the minor C (N) allele compared to GC and GG (KN and KK) genotype. Functional analysis on macrophages suggested a decreased association to Ox-LDL in NN carriers compared to KN and KK carriers which is also associated with a reduced OLR1 mRNA expression. Macrophages from NN carriers present also a specific inflammatory gene expression pattern compared to cells from KN and KK carriers. Conclusions: These data suggest that the 167N variant of LOX-1 receptor affects the atherogenic process in the carotid artery prior to evidence of disease through an inflammatory process.	[Predazzi, Irene Marta; Vecchione, Lucia; Amati, Francesca] Univ Roma Tor Vergata, Dept Biopathol & Diagnost Imaging, Med Genet Sect, Sch Med, Rome, Italy; [Predazzi, Irene Marta] Vanderbilt Univ, Med Ctr, Ctr Human Genet Resesarch, Nashville, TN USA; [Norata, Giuseppe Danilo; Garlaschelli, Katia; Grigore, Liliana; Pirillo, Angela; Tramontana, Simona; Catapano, Alberico Luigi] Osped Bassini, Ctr Study Atherosclerosis, Soc Italiana Studio Aterosclerosi, Gorki, Cinisello Balsa, Italy; [Norata, Giuseppe Danilo; Cutuli, Lucia] Univ Milan, Dept Pharmacol Sci, Milan, Italy; [Grigore, Liliana; Catapano, Alberico Luigi] Multimed IRCCS, Ss Giovanni, Italy; [Romeo, Francesco] Univ Roma Tor Vergata, Dept Internal Med, Rome, Italy; [Novelli, Giuseppe] Osped San Pietro FBF, Rome, Italy; [Novelli, Giuseppe] ANVUR, Natl Agcy Evaluat Univ & Res, Rome, Italy	University of Rome Tor Vergata; Vanderbilt University; University of Milan; IRCCS Multimedica; University of Rome Tor Vergata	Predazzi, IM (corresponding author), Univ Roma Tor Vergata, Dept Biopathol & Diagnost Imaging, Med Genet Sect, Sch Med, Rome, Italy.	irene.m.predazzi@Vanderbilt.Edu	Novelli, Giuseppe/T-8822-2019; Pirillo, Angela/C-4228-2014; Novelli, Giuseppe/GQB-3329-2022; Catapano, alberico/AAC-2827-2019; Amati, Francesca/J-8439-2012; Novelli, Giuseppe/A-5195-2013; Norata, Giuseppe Danilo/AAC-2863-2019	Pirillo, Angela/0000-0002-2948-6257; Novelli, Giuseppe/0000-0002-7781-602X; Catapano, alberico/0000-0002-7593-2094; Amati, Francesca/0000-0003-2209-2156; Novelli, Giuseppe/0000-0002-7781-602X; Norata, Giuseppe Danilo/0000-0002-6081-1257	Research for Drug Development; Fondazione G. B. Bietti (ONLUS); Fondazione Umberto Veronesi per il progresso delle Scienze and Societa Italiana Studio Aterosclerosi Lombardia Chapter; Istituto Nazionale Ricerca Cardiovascolari; ASPREMARE; Istituto di Ricovero e Cura a Carattere Scientifico Multimedica; National Institutes of Health [2T32HL007751-16A2]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007751] Funding Source: NIH RePORTER	Research for Drug Development; Fondazione G. B. Bietti (ONLUS); Fondazione Umberto Veronesi per il progresso delle Scienze and Societa Italiana Studio Aterosclerosi Lombardia Chapter(Fondazione Umberto Veronesi); Istituto Nazionale Ricerca Cardiovascolari; ASPREMARE; Istituto di Ricovero e Cura a Carattere Scientifico Multimedica; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The study was funded by Research for Drug Development (RE. D. D., Tor Vergata University of Rome), Fondazione G. B. Bietti (ONLUS), Fondazione Umberto Veronesi per il progresso delle Scienze and Societa Italiana Studio Aterosclerosi Lombardia Chapter, the Istituto Nazionale Ricerca Cardiovascolari, ASPREMARE, Istituto di Ricovero e Cura a Carattere Scientifico Multimedica and National Institutes of Health grant 2T32HL007751-16A2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama T, 1998, FEBS LETT, V440, P29; Biocca S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004648; Chen HW, 2008, CARDIOLOGY, V110, P252, DOI 10.1159/000112409; Cheng YM, 2011, CARDIOLOGY, V119, P90, DOI 10.1159/000330412; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cominacini L, 2000, J BIOL CHEM, V275, P12633, DOI 10.1074/jbc.275.17.12633; Dunn S, 2008, BIOCHEM J, V409, P349, DOI 10.1042/BJ20071196; Haffner SM, 1996, METABOLISM, V45, P876, DOI 10.1016/S0026-0495(96)90163-8; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hou XW, 2008, CLIN CHIM ACTA, V388, P200, DOI 10.1016/j.cca.2007.11.016; Jeannin P, 2005, IMMUNITY, V22, P551, DOI 10.1016/j.immuni.2005.03.008; Knowles JW, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-23; KODAMA T, 1990, NATURE, V343, P531, DOI 10.1038/343531a0; Li DY, 2009, CIRC RES, V104, P566, DOI 10.1161/CIRCRESAHA.109.194209; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mango R, 2005, CIRC RES, V97, P152, DOI 10.1161/01.RES.0000174563.62625.8e; Mango R, 2003, J MED GENET, V40, P933, DOI 10.1136/jmg.40.12.933; Norata GD, 2007, J INTERN MED, V262, P104, DOI 10.1111/j.1365-2796.2007.01787.x; Norata GD, 2007, EUR J ENDOCRINOL, V156, P279, DOI 10.1530/eje.1.02338; Norata GD, 2006, STROKE, V37, P1558, DOI 10.1161/01.STR.0000221803.16897.22; Norata GD, 2005, J INTERN MED, V258, P21, DOI 10.1111/j.1365-2796.2005.01509.x; Norata GD, 2007, STROKE, V38, P2844, DOI 10.1161/STROKEAHA.107.485540; Norata GD, 2010, ATHEROSCLEROSIS, V208, P177, DOI 10.1016/j.atherosclerosis.2009.06.023; Norata GD, 2009, ATHEROSCLEROSIS, V206, P556, DOI 10.1016/j.atherosclerosis.2009.03.017; Ohmori R, 2004, CLIN CARDIOL, V27, P641, DOI 10.1002/clc.4960271112; Pirillo A, 2011, ATHEROSCLEROSIS, V214, P331, DOI 10.1016/j.atherosclerosis.2010.11.006; Sawamura T, 1997, NATURE, V109, P684; Sentinelli F, 2006, NUTR METAB CARDIOVAS, V16, P345, DOI 10.1016/j.numecd.2005.06.002; Shoji T, 2000, ATHEROSCLEROSIS, V148, P171, DOI 10.1016/S0021-9150(99)00218-X; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Tatsuguchi M, 2003, BIOCHEM BIOPH RES CO, V303, P247, DOI 10.1016/S0006-291X(03)00326-7; Wang LY, 2011, STROKE, V42, P588, DOI 10.1161/STROKEAHA.110.596841; Watkins H, 2006, NAT REV GENET, V7, P163, DOI 10.1038/nrg1805; Winnier DA, 2007, GENET EPIDEMIOL, V31, P66, DOI 10.1002/gepi.20191	34	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31086	10.1371/journal.pone.0031086	http://dx.doi.org/10.1371/journal.pone.0031086			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347434	Green Submitted, Green Published, gold			2022-12-25	WOS:000302730200013
J	Talundzic, E; Shah, S; Fawole, O; Owino, S; Moore, JM; Peterson, DS				Talundzic, Eldin; Shah, Sheel; Fawole, Ope; Owino, Simon; Moore, Julie M.; Peterson, David S.			Sequence Polymorphism, Segmental Recombination and Toggling Amino Acid Residues within the DBL3X Domain of the VAR2CSA Placental Malaria Antigen	PLOS ONE			English	Article							CHONDROITIN-SULFATE-A; PREGNANCY-ASSOCIATED MALARIA; FALCIPARUM-INFECTED ERYTHROCYTES; UMBILICAL-CORD BLOOD; PLASMODIUM-FALCIPARUM; VAR GENE; DIVERSIFYING SELECTION; PROTEIN-SEQUENCE; WESTERN KENYA; BINDING SITE	Plasmodium falciparum malaria remains one of the world's foremost health problems, primarily in highly endemic regions such as Sub-Saharan Africa, where it is responsible for substantial morbidity, mortality and economic losses. Malaria is a significant cause of severe disease and death in pregnant women and newborns, with pathogenesis being associated with expression of a unique variant of the multidomain Plasmodium falciparum Erythrocyte Membrane Protein 1 (PfEMP1) called VAR2CSA. Here, we characterize the polymorphism of the DBL3X domain of VAR2CSA and identify regions under selective pressure among placental parasites from women living in endemic western Kenya. In addition to significant levels of polymorphism, our analysis reveals evidence for diversification through intra-segmental recombination and novel mutations that likely contributed to the high number of unique VAR2CSA sequence types identified in this study. Interestingly, we also identified a number of critical residues that may be implicated in immune evasion through switching (or toggling) to alternative amino acids, including an arginine residue within the predicted binding pocket in subdomain III, which was previously implicated in binding to placental CSA. Overall, these findings are important for understanding parasite diversity in pregnant women and will be useful for identifying epitopes and variants of DBL3X to be included in a vaccine against placental malaria.	[Talundzic, Eldin; Shah, Sheel; Fawole, Ope; Owino, Simon; Moore, Julie M.; Peterson, David S.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA; [Moore, Julie M.; Peterson, David S.] Univ Georgia, Ctr Trop & Emerging Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Talundzic, E (corresponding author), Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA.	dspete@uga.edu		Peterson, David/0000-0003-4394-6181	National Institutes of Health [R01 AI050240]; University of Georgia Department of Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Georgia Department of Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health grant R01 AI050240 to JMM, and University of Georgia Department of Infectious Diseases research funds to DSP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avril M, 2006, MICROBES INFECT, V8, P2863, DOI 10.1016/j.micinf.2006.09.005; Barfod L, 2007, MOL MICROBIOL, V63, P335, DOI 10.1111/j.1365-2958.2006.05503.x; Baum J, 2003, GENETICS, V163, P1327; Beck S, 2001, AM J TROP MED HYG, V65, P631, DOI 10.4269/ajtmh.2001.65.631; Bigey P, 2011, J INFECT DIS, V204, P1125, DOI 10.1093/infdis/jir499; Bockhorst J, 2007, MOL BIOCHEM PARASIT, V155, P103, DOI 10.1016/j.molbiopara.2007.06.007; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Brolin KJM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r117; Chamberlin A, 2011, BRIT J NUTR, V106, pS131, DOI 10.1017/S0007114511001826; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dahlback M, 2006, PLOS PATHOG, V2, P1069, DOI 10.1371/journal.ppat.0020124; Dahlback M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191510; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Dickinson RE, 2011, BLOOD, V118, P2656, DOI 10.1182/blood-2011-06-360313; Drummond PB, 2005, MOL BIOCHEM PARASIT, V140, P241, DOI 10.1016/j.molbiopara.2005.01.003; Duffy MF, 2006, MOL BIOCHEM PARASIT, V148, P117, DOI 10.1016/j.molbiopara.2006.03.006; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Gamain B, 2005, J INFECT DIS, V191, P1010, DOI 10.1086/428137; Gamain B, 2007, INT J PARASITOL, V37, P273, DOI 10.1016/j.ijpara.2006.11.011; Guharoy M, 2005, P NATL ACAD SCI USA, V102, P15447, DOI 10.1073/pnas.0505425102; Hannenhalli SS, 2000, J MOL BIOL, V303, P61, DOI 10.1006/jmbi.2000.4036; Higgins MK, 2008, J BIOL CHEM, V283, P21842, DOI 10.1074/jbc.C800086200; Hoffmann EHE, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-24; Hommel M, 2010, INFECT IMMUN, V78, P1963, DOI 10.1128/IAI.01365-09; Jiang HY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r33; Kassberger F, 2002, PARASITOL RES, V88, P1073, DOI 10.1007/s00436-002-0715-3; Khunrae P, 2009, J MOL BIOL, V393, P202, DOI 10.1016/j.jmb.2009.08.027; Kraemer SM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-45; Leke RFG, 2010, AM J TROP MED HYG, V83, P996, DOI 10.4269/ajtmh.2010.10-0249; Liang SD, 2006, NUCLEIC ACIDS RES, V34, P3698, DOI 10.1093/nar/gkl454; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Machado RLD, 2004, J INFECT DIS, V190, P1547, DOI 10.1086/424601; Magliery TJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-240; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Maubert B, 1999, INFECT IMMUN, V67, P5367, DOI 10.1128/IAI.67.10.5367-5371.1999; Mayengue PI, 2004, TROP MED INT HEALTH, V9, P949, DOI 10.1111/j.1365-3156.2004.01294.x; McCollum AM, 2007, ANTIMICROB AGENTS CH, V51, P2085, DOI 10.1128/AAC.01228-06; McHenry AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020192; Moore JM, 1997, J IMMUNOL METHODS, V209, P93, DOI 10.1016/S0022-1759(97)00162-2; Moore RM, 1997, AM J VET RES, V58, P1145; Ndam NGT, 2005, J INFECT DIS, V192, P331, DOI 10.1086/430933; Ndenga B, 2006, J MED ENTOMOL, V43, P200, DOI 10.1603/0022-2585(2006)043[0200:PDOMVI]2.0.CO;2; Othoro C, 2006, CLIN VACCINE IMMUNOL, V13, P568, DOI 10.1128/CVI.13.5.568-574.2006; Perrault SD, 2009, AM J TROP MED HYG, V80, P119, DOI 10.4269/ajtmh.2009.80.119; Petrova NV, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-312; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reeder JC, 1999, P NATL ACAD SCI USA, V96, P5198, DOI 10.1073/pnas.96.9.5198; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Rowe JA, 2002, J INFECT DIS, V185, P1207, DOI 10.1086/339684; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Sander AF, 2011, J INFECT DIS, V203, P1679, DOI 10.1093/infdis/jir168; Sander AF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006667; Schleiermacher D, 2001, AM J TROP MED HYG, V64, P303, DOI 10.4269/ajtmh.2001.64.303; Schleiermacher D, 2002, INFECT GENET EVOL, V2, P97, DOI 10.1016/S1567-1348(02)00085-0; Singh K, 2008, NAT STRUCT MOL BIOL, V15, P932, DOI 10.1038/nsmb.1479; Singh K, 2010, J BIOL CHEM, V285, P24855, DOI 10.1074/jbc.M110.118612; Srivastava A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020270; Srivastava A, 2010, P NATL ACAD SCI USA, V107, P4884, DOI 10.1073/pnas.1000951107; Staalsoe T, 2004, LANCET, V363, P283, DOI 10.1016/S0140-6736(03)15386-X; Tamura K, 2011, MOL BIOL EVOL; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; Viebig NK, 2005, EMBO REP, V6, P775, DOI 10.1038/sj.embor.7400466	66	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31565	10.1371/journal.pone.0031565	http://dx.doi.org/10.1371/journal.pone.0031565			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347496	Green Submitted, Green Published, gold			2022-12-25	WOS:000302730200026
J	Baitsch, L; Legat, A; Barba, L; Marraco, SAF; Rivals, JP; Baumgaertner, P; Christiansen-Jucht, C; Bouzourene, H; Rimoldi, D; Pircher, H; Rufer, N; Matter, M; Michielin, O; Speiser, DE				Baitsch, Lukas; Legat, Amandine; Barba, Leticia; Marraco, Silvia A. Fuertes; Rivals, Jean-Paul; Baumgaertner, Petra; Christiansen-Jucht, Celine; Bouzourene, Hanifa; Rimoldi, Donata; Pircher, Hanspeter; Rufer, Nathalie; Matter, Maurice; Michielin, Olivier; Speiser, Daniel E.			Extended Co-Expression of Inhibitory Receptors by Human CD8 T-Cells Depending on Differentiation, Antigen-Specificity and Anatomical Localization	PLOS ONE			English	Article							CHRONIC VIRAL-INFECTION; EFFECTOR FUNCTION; MELANOMA PATIENTS; CENTRAL MEMORY; PD-1; EXHAUSTION; EXPRESSION; RESPONSES; LYMPHOCYTES; TIM-3	Inhibitory receptors mediate CD8 T-cell hyporesponsiveness against cancer and infectious diseases. PD-1 and CTLA-4 have been extensively studied, and blocking antibodies have already shown clinical benefit for cancer patients. Only little is known on extended co-expression of inhibitory receptors and their ligands. Here we analyzed the expression of eight inhibitory receptors by tumor-antigen specific CD8 T-cells. We found that the majority of effector T-cells simultaneously expressed four or more of the inhibitory receptors BTLA, TIM-3, LAG-3, KRLG-1, 2B4, CD160, PD-1 and CTLA-4. There were major differences depending on antigen-specificity, differentiation and anatomical localization of T-cells. On the other hand, naive T-cells were only single or double positive for BTLA and TIM-3. Extended co-expression is likely relevant for effector T-cells, as we found expression of multiple ligands in metastatic lesions of melanoma patients. Together, our data suggest that naive T-cells are primarily regulated by BTLA and TIM-3, whereas effector cells interact via larger numbers of inhibitory receptors. Blocking multiple inhibitory receptors simultaneously or sequentially may improve T-cell based therapies, but further studies are necessary to clarify the role of each receptor-ligand pair.	[Baitsch, Lukas; Legat, Amandine; Barba, Leticia; Marraco, Silvia A. Fuertes; Baumgaertner, Petra; Christiansen-Jucht, Celine; Rimoldi, Donata; Rufer, Nathalie; Michielin, Olivier; Speiser, Daniel E.] Univ Lausanne, Clin Tumor Biol & Immunotherapy Unit, Ludwig Ctr, Lausanne, Switzerland; [Rivals, Jean-Paul; Bouzourene, Hanifa; Rufer, Nathalie; Matter, Maurice; Michielin, Olivier] Univ Lausanne, Univ Hosp Ctr, Lausanne, Switzerland; [Pircher, Hanspeter] Univ Freiburg, Dept Immunol, Inst Med Microbiol & Hyg, D-79106 Freiburg, Germany; [Speiser, Daniel E.] Univ Lausanne Hosp, Serv Radiat Oncol, Lausanne, Switzerland	University of Lausanne; University of Lausanne; University of Freiburg; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Baitsch, L (corresponding author), Univ Lausanne, Clin Tumor Biol & Immunotherapy Unit, Ludwig Ctr, Lausanne, Switzerland.	doc@dspeiser.ch	Speiser, Daniel E./F-2173-2013; Michielin, Olivier/ABE-7924-2020; Maurice Joseph, César Matter/J-6717-2017	Maurice Joseph, César Matter/0000-0003-1816-3003; Fuertes Marraco, Silvia A/0000-0002-3456-3317	Ludwig Institute for Cancer Research, United States of America; Cancer Research Institute, United States of America; Cancer Vaccine Collaborative, United States of America; OPO-Stiftung, Switzerland [2010/11-0039]; Swiss Cancer League [02279-08-2008]; Swiss National Science Foundation [3200B0-118123]; Swiss National Center of Competence in Research (NCCR) Molecular Oncology	Ludwig Institute for Cancer Research, United States of America; Cancer Research Institute, United States of America; Cancer Vaccine Collaborative, United States of America; OPO-Stiftung, Switzerland; Swiss Cancer League; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Center of Competence in Research (NCCR) Molecular Oncology(Swiss National Science Foundation (SNSF))	This work was supported by the Ludwig Institute for Cancer Research, the Cancer Research Institute and the Cancer Vaccine Collaborative, United States of America, the OPO-Stiftung (2010/11-0039), Switzerland, the Swiss Cancer League (02279-08-2008), the Swiss National Science Foundation (3200B0-118123), and the Swiss National Center of Competence in Research (NCCR) Molecular Oncology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Baumgaertner P, 2006, CANCER RES, V66, P1912, DOI 10.1158/0008-5472.CAN-05-3793; Bengsch B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000947; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; Demeure CE, 2001, EUR J CANCER, V37, P1709, DOI 10.1016/S0959-8049(01)00184-8; Derre L, 2010, J CLIN INVEST, V120, P157, DOI 10.1172/JCI40070; Di Giacomo AM, 2011, CANCER IMMUNOL IMMUN, V60, P467, DOI 10.1007/s00262-010-0958-2; Eggermont AMM, 2010, SEMIN ONCOL, V37, P455, DOI 10.1053/j.seminoncol.2010.09.009; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Grosso JF, 2007, J CLIN INVEST, V117, P3383, DOI 10.1172/JCI31184; Grundemann C, 2010, EUR J IMMUNOL, V40, P1303, DOI 10.1002/eji.200939771; Haining WN, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-44; Holmes S, 2005, P NATL ACAD SCI USA, V102, P5519, DOI 10.1073/pnas.0501437102; Jin HT, 2010, P NATL ACAD SCI US; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Juran BD, 2008, HEPATOLOGY, V47, P563, DOI 10.1002/hep.22048; Lienard Danielle, 2004, Cancer Immun, V4, P4; Mangsbo SM, 2010, J IMMUNOTHER, V33, P225, DOI 10.1097/CJI.0b013e3181c01fcb; Matsuzaki J, 2010, P NATL ACAD SCI USA, V107, P7875, DOI 10.1073/pnas.1003345107; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Pittet MJ, 1999, J EXP MED, V190, P705, DOI 10.1084/jem.190.5.705; Quigley M, 2010, NAT MED, V16, P1147, DOI 10.1038/nm.2232; Raziorrouh B, 2010, HEPATOLOGY, V52, P1934, DOI 10.1002/hep.23936; Ribas A, 2010, SEMIN ONCOL, V37, P450, DOI 10.1053/j.seminoncol.2010.09.010; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Samaik AA, 2011, CLIN CANCER RES, V17, P896, DOI 10.1158/1078-0432.CCR-10-2463; Shi F, 2010, INT J CANC; Speiser DE, 2005, J CLIN INVEST, V115, P739, DOI 10.1172/JCI200523373; Takamura S, 2010, J IMMUNOL, V184, P4696, DOI 10.4049/jimmunol.0903478; Tsujimura K, 2006, IMMUNOL LETT, V106, P48, DOI 10.1016/j.imlet.2006.04.006; Valsesia A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018369; Vazquez-Cintron EJ, 2010, J IMMUNOL, V185, P7133, DOI 10.4049/jimmunol.1001157; Watanabe N, 2003, NAT IMMUNOL, V4, P670, DOI 10.1038/ni944; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Willinger T, 2005, J IMMUNOL, V175, P5895, DOI 10.4049/jimmunol.175.9.5895; Zippelius A, 2004, CANCER RES, V64, P2865, DOI 10.1158/0008-5472.CAN-03-3066	43	136	153	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30852	10.1371/journal.pone.0030852	http://dx.doi.org/10.1371/journal.pone.0030852			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347406	Green Published, gold, Green Submitted			2022-12-25	WOS:000302730100026
J	Xu, H; Gao, Y; Wang, JB				Xu, Hong; Gao, Yi; Wang, Jianbo			Transcriptomic Analysis of Rice (Oryza sativa) Developing Embryos Using the RNA-Seq Technique	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; ARABIDOPSIS-THALIANA; GENOME; ANNOTATION; REVEALS; ATLAS	Rice (Oryza sativa) is an excellent model monocot with a known genome sequence for studying embryogenesis. Here we report the transcriptome profiling analysis of rice developing embryos using RNA-Seq as an attempt to gain insight into the molecular and cellular events associated with rice embryogenesis. RNA-Seq analysis generated 17,755,890 sequence reads aligned with 27,190 genes, which provided abundant data for the analysis of rice embryogenesis. A total of 23,971, 23,732, and 23,592 genes were identified from embryos at three developmental stages (3-5, 7, and 14 DAP), while an analysis between stages allowed the identification of a subset of stage-specific genes. The number of genes expressed stage-specifically was 1,131, 1,443, and 1,223, respectively. In addition, we investigated transcriptomic changes during rice embryogenesis based on our RNA-Seq data. A total of 1,011 differentially expressed genes (DEGs) (log(2)Ratio >= 1, FDR <= 0.001) were identified; thus, the transcriptome of the developing rice embryos changed considerably. A total of 672 genes with significant changes in expression were detected between 3-5 and 7 DAP; 504 DEGs were identified between 7 and 14 DAP. A large number of genes related to metabolism, transcriptional regulation, nucleic acid replication/processing, and signal transduction were expressed predominantly in the early and middle stages of embryogenesis. Protein biosynthesis-related genes accumulated predominantly in embryos at the middle stage. Genes for starch/sucrose metabolism and protein modification were highly expressed in the middle and late stages of embryogenesis. In addition, we found that many transcription factor families may play important roles at different developmental stages, not only in embryo initiation but also in other developmental processes. These results will expand our understanding of the complex molecular and cellular events in rice embryogenesis and provide a foundation for future studies on embryo development in rice and other cereal crops.	[Xu, Hong; Gao, Yi; Wang, Jianbo] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China	Wuhan University	Xu, H (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China.	jbwang@whu.edu.cn			State Key Basic Research and Development Plan of China [2007CB108700]; National Natural Science Foundation of China [30821064]	State Key Basic Research and Development Plan of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the State Key Basic Research and Development Plan of China (2007CB108700), and the National Natural Science Foundation of China (30821064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimov SV, 2008, CURR PHARM BIOTECHNO, V9, P338, DOI 10.2174/138920108785915148; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Brown JA, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100043; Chandler JW, 2007, DEVELOPMENT, V134, P1653, DOI 10.1242/dev.001016; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Colombo M, 2008, PLANT J, V54, P1037, DOI 10.1111/j.1365-313X.2008.03485.x; Eveland AL, 2010, PLANT PHYSIOL, V154, P1024, DOI 10.1104/pp.110.159673; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/NMETH.1613, 10.1038/nmeth.1613]; Guo J, 2010, PLANTA, V231, P293, DOI 10.1007/s00425-009-1051-y; Hadfi K, 1998, DEVELOPMENT, V125, P879; HECK GR, 1995, PLANT CELL, V7, P1271, DOI 10.1105/tpc.7.8.1271; Itoh J, 2005, PLANT CELL PHYSIOL, V46, P23, DOI 10.1093/pcp/pci501; Jiao YL, 2009, NAT GENET, V41, P258, DOI 10.1038/ng.282; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Lan LF, 2004, PLANT MOL BIOL, V54, P471, DOI 10.1023/B:PLAN.0000038254.58491.c7; Lee JM, 2002, FUNCT INTEGR GENOMIC, V2, P13, DOI 10.1007/s10142-002-0046-6; Luo M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002125; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Nambara E, 2000, DEV BIOL, V220, P412, DOI 10.1006/dbio.2000.9632; Nuccio ML, 1999, PLANT MOL BIOL, V39, P1153, DOI 10.1023/A:1006101404867; Ozsolak F, 2010, NAT METHODS, V7, P619, DOI [10.1038/NMETH.1480, 10.1038/nmeth.1480]; Sasaki T, 2000, CURR OPIN PLANT BIOL, V3, P138, DOI 10.1016/S1369-5266(99)00047-3; Sentoku N, 2000, DEV BIOL, V220, P358, DOI 10.1006/dbio.2000.9624; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei G, 2009, P NATL ACAD SCI USA, V106, P7695, DOI 10.1073/pnas.0902340106; Weijers D, 2006, DEV CELL, V10, P265, DOI 10.1016/j.devcel.2005.12.001; Weijers D, 2005, EMBO J, V24, P1874, DOI 10.1038/sj.emboj.7600659; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Xiang DQ, 2011, PLANT PHYSIOL, V156, P346, DOI 10.1104/pp.110.171702; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109	34	84	87	5	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30646	10.1371/journal.pone.0030646	http://dx.doi.org/10.1371/journal.pone.0030646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347394	gold, Green Submitted, Green Published			2022-12-25	WOS:000302730100020
J	Avery, JW; Smith, GM; Owino, SO; Sarr, D; Nagy, T; Mwalimu, S; Matthias, J; Kelly, LF; Poovassery, JS; Middii, JD; Abramowsky, C; Moore, JM				Avery, John W.; Smith, Geoffrey M.; Owino, Simon O.; Sarr, Demba; Nagy, Tamas; Mwalimu, Stephen; Matthias, James; Kelly, Lauren F.; Poovassery, Jayakumar S.; Middii, Joab D.; Abramowsky, Carlos; Moore, Julie M.			Maternal Malaria Induces a Procoagulant and Antifibrinolytic State That Is Embryotoxic but Responsive to Anticoagulant Therapy	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; MOLECULAR-WEIGHT HEPARINS; DISSEMINATED INTRAVASCULAR COAGULATION; INTRAUTERINE GROWTH RESTRICTION; TISSUE FACTOR; PLACENTAL MALARIA; BLOOD-COAGULATION; INFECTED ERYTHROCYTES; VENOOCCLUSIVE DISEASE; ADHESION MOLECULES	Low birth weight and fetal loss are commonly attributed to malaria in endemic areas, but the cellular and molecular mechanisms that underlie these poor birth outcomes are incompletely understood. Increasing evidence suggests that dysregulated hemostasis is important in malaria pathogenesis, but its role in placental malaria (PM), characterized by intervillous sequestration of Plasmodium falciparum, proinflammatory responses, and excessive fibrin deposition is not known. To address this question, markers of coagulation and fibrinolysis were assessed in placentae from malaria-exposed primigravid women. PM was associated with significantly elevated placental monocyte and proinflammatory marker levels, enhanced perivillous fibrin deposition, and increased markers of activated coagulation and suppressed fibrinolysis in placental plasma. Submicroscopic PM was not proinflammatory but tended to be procoagulant and antifibrinolytic. Birth weight trended downward in association with placental parasitemia and high fibrin score. To directly assess the importance of coagulation in malaria-induced compromise of pregnancy, Plasmodium chabaudi AS-infected pregnant C57BL/6 mice were treated with the anticoagulant, low molecular weight heparin. Treatment rescued pregnancy at midgestation, with substantially decreased rates of active abortion and reduced placental and embryonic hemorrhage and necrosis relative to untreated animals. Together, the results suggest that dysregulated hemostasis may represent a novel therapeutic target in malaria-compromised pregnancies.	[Avery, John W.; Smith, Geoffrey M.; Owino, Simon O.; Sarr, Demba; Mwalimu, Stephen; Kelly, Lauren F.; Poovassery, Jayakumar S.; Middii, Joab D.; Moore, Julie M.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA; [Avery, John W.; Smith, Geoffrey M.; Owino, Simon O.; Sarr, Demba; Mwalimu, Stephen; Kelly, Lauren F.; Poovassery, Jayakumar S.; Middii, Joab D.; Moore, Julie M.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Owino, Simon O.; Mwalimu, Stephen; Middii, Joab D.] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Nagy, Tamas] Univ Georgia, Dept Vet Pathol, Athens, GA 30602 USA; [Matthias, James] Univ Georgia, Dept Epidemiol & Biostat, Athens, GA 30602 USA; [Abramowsky, Carlos] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Kenya Medical Research Institute; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Emory University	Avery, JW (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	julmoore@uga.edu	Sarr, Demba/GOG-9376-2022; Sarr, Demba/AAP-7125-2020	Sarr, Demba/0000-0002-8306-0433; Collins, Lauren/0000-0002-0170-5454	National Institutes of Health [R01 AI050240, R01 HD046860]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health grants R01 AI050240 and R01 HD046860 to JMM. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases (NIAID), the National Institute of Child Health and Human Development (NICHD) or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ani B, 2010, HYPERTENSION, V55, P689, DOI 10.1161/HYPERTENSIONAHA.109.136333; Aziken ME, 2011, INT J GYNECOL OBSTET, V112, P30, DOI 10.1016/j.ijgo.2010.07.027; Badawy AM, 2008, J OBSTET GYNAECOL, V28, P280, DOI 10.1080/01443610802042688; BOROCHOV.D, 1970, BRIT MED J, V2, P710, DOI 10.1136/bmj.2.5711.710; Bowen JA, 1999, BIOL REPROD, V60, P428, DOI 10.1095/biolreprod60.2.428; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Brenner B, 2000, THROMB HAEMOSTASIS, V83, P693; Brenner B, 2005, WOMENS HEALTH, V1, P153, DOI 10.2217/17455057.1.2.153; Camerer E, 1996, THROMB RES, V81, P1, DOI 10.1016/0049-3848(95)00209-X; CARLSON J, 1992, AM J TROP MED HYG, V46, P595, DOI 10.4269/ajtmh.1992.46.595; Chaisavaneeyakorn S, 2003, CLIN DIAGN LAB IMMUN, V10, P631, DOI 10.1128/CDLI.10.4.631-636.2003; CLEMENS R, 1994, BRIT J HAEMATOL, V87, P100, DOI 10.1111/j.1365-2141.1994.tb04877.x; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Crocker IP, 2004, PLACENTA, V25, P273, DOI 10.1016/j.placenta.2003.09.010; de Jonge E, 2000, BLOOD, V95, P1124, DOI 10.1182/blood.V95.4.1124.002k20_1124_1129; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Demas A, 2011, J CLIN MICROBIOL, V49, P2411, DOI 10.1128/JCM.02603-10; DENNIS LH, 1968, LANCET, V1, P769; DENNIS LH, 1967, BLOOD-J HEMATOL, V29, P713; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Dusse LM, 2011, CLIN CHIM ACTA, V412, P17, DOI 10.1016/j.cca.2010.09.030; Estrada-Gutierrez G, 2011, AM J PATHOL, V178, P451, DOI 10.1016/j.ajpath.2010.11.003; Francischetti IMB, 2007, J THROMB HAEMOST, V5, P155, DOI 10.1111/j.1538-7836.2006.02232.x; Francischetti IM, 2011, ARTERIOSCLER THROMB; Francischetti IMB, 2008, TRENDS PARASITOL, V24, P258, DOI 10.1016/j.pt.2008.03.009; Francischetti IMB, 2008, MICROCIRCULATION, V15, P81, DOI 10.1080/10739680701451516; Freeman BD, 2003, SHOCK, V20, P5, DOI 10.1097/01.shk.0000068327.26733.10; Fried M, 1998, J IMMUNOL, V160, P2523; Greer IA, 2005, BLOOD, V106, P401, DOI 10.1182/blood-2005-02-0626; Guo YH, 2009, BLOOD, V113, P4431, DOI 10.1182/blood-2008-07-169433; Gutierrez G, 2004, AM J REPROD IMMUNOL, V51, P160, DOI 10.1046/j.8755-8920.2003.00131.x; HALL AP, 1976, BMJ-BRIT MED J, V1, P323, DOI 10.1136/bmj.1.6005.323; Havlik I, 2005, T ROY SOC TROP MED H, V99, P333, DOI 10.1016/j.trstmh.2004.05.005; HOWARD WA, 1972, LANCET, V2, P738; Imamura T, 2002, J INFECT DIS, V186, P436, DOI 10.1086/341507; Isermann B, 2001, DEVELOPMENT, V128, P827; Isermann B, 2003, NAT MED, V9, P331, DOI 10.1038/nm825; Kornblum N, 2006, OLIGONUCLEOTIDES, V16, P105, DOI 10.1089/oli.2006.16.105; Kyriacou HM, 2007, ANTIMICROB AGENTS CH, V51, P1321, DOI 10.1128/AAC.01216-06; Landis SH, 2009, EPIDEMIOL INFECT, V137, P294, DOI 10.1017/S0950268808000915; Larocca A, 2008, EXPERT OPIN BIOL TH, V8, P1201, DOI [10.1517/14712598.8.8.1201, 10.1517/14712598.8.8.1201 ]; Laskin CA, 2009, J RHEUMATOL, V36, P279, DOI [10.3899/jrheum.080763), 10.3899/jrheum.080763]; Leitgeb AM, 2011, AM J TROP MED HYG, V84, P390, DOI 10.4269/ajtmh.2011.10-0256; Levi M, 1997, EUR J CLIN INVEST, V27, P3, DOI 10.1046/j.1365-2362.1997.570614.x; Levi M, 2010, HAMOSTASEOLOGIE, V30, P10; Levi M, 2001, CRIT CARE MED, V29, pS90, DOI 10.1097/00003246-200107001-00028; Levi M, 2010, SEMIN THROMB HEMOST, V36, P550, DOI 10.1055/s-0030-1255449; Levi M, 2010, CRIT CARE MED, V38, pS26, DOI 10.1097/CCM.0b013e3181c98d21; Linhardt RJ, 1999, SEMIN THROMB HEMOST, V25, P5; Lucchi NW, 2011, PLACENTA, V32, P579, DOI 10.1016/j.placenta.2011.05.003; Lucchi NW, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-42; Luxemburger C, 2001, AM J EPIDEMIOL, V154, P459, DOI 10.1093/aje/154.5.459; Mackinnon MJ, 2002, EXP PARASITOL, V101, P121, DOI 10.1016/S0014-4894(02)00103-0; Mackintosh CL, 2004, TRENDS PARASITOL, V20, P597, DOI 10.1016/j.pt.2004.09.006; Mackman N, 2009, J THROMB HAEMOST, V7, P136, DOI 10.1111/j.1538-7836.2009.03368.x; Matthay MA, 2001, NEW ENGL J MED, V344, P759, DOI 10.1056/NEJM200103083441009; Menendez C, 2000, J INFECT DIS, V181, P1740, DOI 10.1086/315449; Merli Geno J, 2010, P T, V35, P95; Moore JM, 2004, INFECT IMMUN, V72, P7022, DOI 10.1128/IAI.72.12.7022-7029.2004; Moore JM, 2003, PLACENTA, V24, P779, DOI 10.1016/S0143-4004(03)00112-7; MUNIR M, 1980, Paediatrica Indonesiana, V20, P47; Othoro C, 2006, CLIN VACCINE IMMUNOL, V13, P568, DOI 10.1128/CVI.13.5.568-574.2006; Perrault SD, 2009, AM J TROP MED HYG, V80, P119, DOI 10.4269/ajtmh.2009.80.119; Petaja J, 2011, THROMB RES, V127, pS34, DOI 10.1016/S0049-3848(10)70153-5; Poovassery J, 2006, INFECT IMMUN, V74, P2839, DOI 10.1128/IAI.74.5.2839-2848.2006; Poovassery J, 2009, INFECT IMMUN, V77, P4998, DOI 10.1128/IAI.00617-09; Poovassery JS, 2009, J IMMUNOL, V183, P5342, DOI 10.4049/jimmunol.0901669; Prasad R, 2009, J TROP PEDIAT; Rampengan T H, 1991, Paediatr Indones, V31, P59; REID HA, 1972, LANCET, V2, P1110; REID HA, 1975, LANCET, V1, P167; Reyburn H, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2637; Richardson P, 2009, EXPERT REV HEMATOL, V2, P365, DOI 10.1586/ehm.09.30; Rogerson SJ, 2003, AM J TROP MED HYG, V68, P115, DOI 10.4269/ajtmh.2003.68.1.0680115; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Rojanasthien S, 1993, Southeast Asian J Trop Med Public Health, V24 Suppl 1, P225; Rojanasthien Sophark, 1992, Journal of the Medical Association of Thailand, V75, P190; Rowan JA, 2003, AUST NZ J OBSTET GYN, V43, P123, DOI 10.1046/j.0004-8666.2003.00034.x; ROWE A, 1994, EXP PARASITOL, V79, P506, DOI 10.1006/expr.1994.1111; Scifres CM, 2009, J PHYSIOL-LONDON, V587, P3453, DOI 10.1113/jphysiol.2009.173252; SMITSKAM.H, 1971, BRIT MED J, V1, P714, DOI 10.1136/bmj.1.5751.714; STONE WJ, 1972, ARCH INTERN MED, V129, P620, DOI 10.1001/archinte.129.4.620; Teng YC, 2009, J PERINAT MED, V37, P343, DOI 10.1515/JPM.2009.060; van Eijk AM, 2003, AIDS, V17, P595, DOI 10.1097/00002030-200303070-00015; VANDERPOLL T, 1994, J EXP MED, V179, P1253, DOI 10.1084/jem.179.4.1253; Vogetseder A, 2004, TROP MED INT HEALTH, V9, P767, DOI 10.1111/j.1365-3156.2004.01265.x; Vogt AM, 2006, PLOS PATHOG, V2, P853, DOI 10.1371/journal.ppat.0020100	87	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31090	10.1371/journal.pone.0031090	http://dx.doi.org/10.1371/journal.pone.0031090			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347435	Green Published, Green Submitted, gold			2022-12-25	WOS:000302180600028
J	Dana, CE; Glauber, KM; Chan, TA; Bridge, DM; Steele, RE				Dana, Catherine E.; Glauber, Kristine M.; Chan, Titus A.; Bridge, Diane M.; Steele, Robert E.			Incorporation of a Horizontally Transferred Gene into an Operon during Cnidarian Evolution	PLOS ONE			English	Article							TRANSFECTED BRUGIA-MALAYI; CLASS-LEVEL RELATIONSHIPS; CELL-CYCLE KINETICS; HYDRA-ATTENUATA; STEM-CELLS; CIONA-INTESTINALIS; PHYLUM CNIDARIA; MESSENGER-RNAS; GENOME; SEQUENCES	Genome sequencing has revealed examples of horizontally transferred genes, but we still know little about how such genes are incorporated into their host genomes. We have previously reported the identification of a gene (flp) that appears to have entered the Hydra genome through horizontal transfer. Here we provide additional evidence in support of our original hypothesis that the transfer was from a unicellular organism, and we show that the transfer occurred in an ancestor of two medusozoan cnidarian species. In addition we show that the gene is part of a bicistronic operon in the Hydra genome. These findings identify a new animal phylum in which trans-spliced leader addition has led to the formation of operons, and define the requirements for evolution of an operon in Hydra. The identification of operons in Hydra also provides a tool that can be exploited in the construction of transgenic Hydra strains.	[Dana, Catherine E.; Glauber, Kristine M.; Chan, Titus A.; Steele, Robert E.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Dana, Catherine E.; Glauber, Kristine M.; Chan, Titus A.; Steele, Robert E.] Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92717 USA; [Bridge, Diane M.] Elizabethtown Coll, Dept Biol, Elizabethtown, PA 17022 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Dana, CE (corresponding author), Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA.	resteele@uci.edu		Glauber, Kristine/0000-0002-1093-6481; Dana, Catherine/0000-0003-3788-7955	National Institute of General Medical Sciences [1R24GM080537-01A1]; National Institute of Aging [1RO1AG037965-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM080537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037965] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work described in this manuscript was supported by grant 1R24GM080537-01A1 to R.E.S. from the National Institute of General Medical Sciences and grant 1RO1AG037965-01 to D.M.B. from the National Institute of Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Andersson JO, 2009, ANNU REV MICROBIOL, V63, P177, DOI 10.1146/annurev.micro.091208.073203; Andersson JO, 2005, CELL MOL LIFE SCI, V62, P1182, DOI 10.1007/s00018-005-4539-z; Blumenthal Thomas, 2004, Briefings in Functional Genomics & Proteomics, V3, P199, DOI 10.1093/bfgp/3.3.199; Bode HR, 1996, J CELL SCI, V109, P1155; BONNEFOY AM, 1972, CR ACAD SCI D NAT, V275, P2163; BOSCH TCG, 1987, DEV BIOL, V121, P182, DOI 10.1016/0012-1606(87)90151-5; Bottger A, 2002, DEV GENES EVOL, V212, P302, DOI 10.1007/s00427-002-0245-0; BRIDGE D, 1995, MOL BIOL EVOL, V12, P679; BRIDGE D, 1992, P NATL ACAD SCI USA, V89, P8750, DOI 10.1073/pnas.89.18.8750; Campbell R.D., 1983, P5; CAMPBELL RD, 1974, J CELL SCI, V16, P349; Cartwright P, 2008, J MAR BIOL ASSOC UK, V88, P1663, DOI 10.1017/S0025315408002257; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Crouch MLV, 2001, ARCH MED RES, V32, P102, DOI 10.1016/S0188-4409(01)00262-4; DAVID CN, 1974, J CELL SCI, V16, P359; DAVIS LE, 1968, Z ZELLFORSCH MIK ANA, V92, P149, DOI 10.1007/BF00335643; Davis RE, 1997, MOL BIOCHEM PARASIT, V89, P25, DOI 10.1016/S0166-6851(97)00097-2; Denker E, 2008, DEV BIOL, V315, P99, DOI 10.1016/j.ydbio.2007.12.023; Derelle R, 2010, RNA, V16, P696, DOI 10.1261/rna.1975210; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FISHER DA, 1989, GENE, V84, P55, DOI 10.1016/0378-1119(89)90139-X; Frank U, 2009, STEM CELLS IN MARINE ORGANISMS, P33, DOI 10.1007/978-90-481-2767-2_3; Fraune S, 2007, P NATL ACAD SCI USA, V104, P13146, DOI 10.1073/pnas.0703375104; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Habetha M, 2005, J EXP BIOL, V208, P2157, DOI 10.1242/jeb.01571; Higazi TB, 2004, MOL BIOCHEM PARASIT, V137, P181, DOI 10.1016/j.molbiopara.2004.04.014; Huang T, 2001, MOL CELL BIOL, V21, P1111, DOI 10.1128/MCB.21.4.1111-1120.2001; HUFNAGEL LA, 1977, T AM MICROSC SOC, V96, P406, DOI 10.2307/3225874; Jackson RJ, 2005, BIOCHEM SOC T, V33, P1231, DOI 10.1042/BST0331231; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; Larsen Liza S Z, 2008, Int J Bioinform Res Appl, V4, P324, DOI 10.1504/IJBRA.2008.019578; LENHOFF H M, 1970, Laboratory Animals (London), V4, P139, DOI 10.1258/002367770781036463; Liu CH, 2007, MOL BIOCHEM PARASIT, V156, P62, DOI 10.1016/j.molbiopara.2007.07.012; Liu CH, 2010, INT J PARASITOL, V40, P63, DOI 10.1016/j.ijpara.2009.07.001; Martin VJ, 1997, BIOL BULL, V192, P345, DOI 10.2307/1542745; Martinez DE, 2010, MOL PHYLOGENET EVOL, V57, P403, DOI 10.1016/j.ympev.2010.06.016; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Satou Y, 2006, NUCLEIC ACIDS RES, V34, P3378, DOI 10.1093/nar/gkl418; Satou Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r152; Shalchian-Tabrizi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002098; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Steele RE, 2004, CURR BIOL, V14, pR298, DOI 10.1016/j.cub.2004.03.047; Stover NA, 2001, P NATL ACAD SCI USA, V98, P5693, DOI 10.1073/pnas.101049998; Swofford DL, 2003, CURR BIOL; Tannreuther GW, 1909, BIOL BULL-US, V16, P205, DOI 10.2307/1536150; TARDENT P, 1974, AM ZOOL, V14, P447; Technau U, 2005, TRENDS GENET, V21, P633, DOI 10.1016/j.tig.2005.09.007; Wittlieb J, 2006, P NATL ACAD SCI USA, V103, P6208, DOI 10.1073/pnas.0510163103; ZIHLER J, 1972, ROUX ARCH DEV BIOL, V169, P239, DOI 10.1007/BF00582555	54	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e31643	10.1371/journal.pone.0031643	http://dx.doi.org/10.1371/journal.pone.0031643			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328943	Green Published, gold			2022-12-25	WOS:000302179300029
J	Snary, EL; Ramnial, V; Breed, AC; Stephenson, B; Field, HE; Fooks, AR				Snary, Emma L.; Ramnial, Vick; Breed, Andrew C.; Stephenson, Ben; Field, Hume E.; Fooks, Anthony R.			Qualitative Release Assessment to Estimate the Likelihood of Henipavirus Entering the United Kingdom	PLOS ONE			English	Article							NIPAH-VIRUS-INFECTION; FLYING FOXES; PTEROPUS-VAMPYRUS; MOUTH-DISEASE; BATS; HENDRA; OUTBREAK; HORSES; RISK; TRANSMISSION	The genus Henipavirus includes Hendra virus (HeV) and Nipah virus (NiV), for which fruit bats (particularly those of the genus Pteropus) are considered to be the wildlife reservoir. The recognition of henipaviruses occurring across a wider geographic and host range suggests the possibility of the virus entering the United Kingdom (UK). To estimate the likelihood of henipaviruses entering the UK, a qualitative release assessment was undertaken. To facilitate the release assessment, the world was divided into four zones according to location of outbreaks of henipaviruses, isolation of henipaviruses, proximity to other countries where incidents of henipaviruses have occurred and the distribution of Pteropus spp. fruit bats. From this release assessment, the key findings are that the importation of fruit from Zone 1 and 2 and bat bushmeat from Zone 1 each have a Low annual probability of release of henipaviruses into the UK. Similarly, the importation of bat meat from Zone 2, horses and companion animals from Zone 1 and people travelling from Zone 1 and entering the UK was estimated to pose a Very Low probability of release. The annual probability of release for all other release routes was assessed to be Negligible. It is recommended that the release assessment be periodically re-assessed to reflect changes in knowledge and circumstances over time.	[Snary, Emma L.; Ramnial, Vick; Breed, Andrew C.; Stephenson, Ben] Anim Hlth & Vet Labs Agcy, Ctr Epidemiol & Risk Anal, Addlestone, Surrey, England; [Field, Hume E.] Biosecur Queensland, Queensland Ctr Emerging Infect Dis, Brisbane, Qld, Australia; [Fooks, Anthony R.] Anim Hlth & Vet Labs Agcy, Dept Virol, Wildlife Zoonoses & Vector Borne Dis Res Grp, Addlestone, Surrey, England; [Fooks, Anthony R.] Univ Liverpool, Natl Consortium Zoonosis Res, Neston, Cheshire, England	Veterinary Laboratories Agency; Queensland Department of Agriculture & Fisheries; Veterinary Laboratories Agency; University of Liverpool	Snary, EL (corresponding author), Anim Hlth & Vet Labs Agcy, Ctr Epidemiol & Risk Anal, Addlestone, Surrey, England.	emma.Snary@ahvla.gsi.gov.uk	Fooks, Anthony R/F-5418-2010; Breed, Andrew C/A-5682-2011; Snary, Emma/C-7932-2011	Breed, Andrew C/0000-0002-3439-9510; 	Science and Technology Directorate; Department of Homeland Security and Fogarty International Center; National Institutes of Health, USA	Science and Technology Directorate; Department of Homeland Security and Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)United States Department of Homeland Security (DHS)); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This release assessment was commissioned by the UK Department for Environment, Food and Rural Affairs (Defra), Project SV3700, as part of their ongoing evaluation of risks to animal health in the UK. We wish to acknowledge support from the Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, Department of Homeland Security and Fogarty International Center, National Institutes of Health, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, VET REC, V165, P303; [Anonymous], 2004, ECOLOGY HENDRA VIRUS; Australian Veterinary Emergency Plan AUSVETPLAN, 2009, RESP POL BRIEFS BRIE; Baldock F. C., 1996, Singapore Veterinary Journal, V20, P57; Breed AC, 2006, BIOL CONSERV, V131, P211, DOI 10.1016/j.biocon.2006.04.007; C?lix M., 2018, EUROPEAN RED LIST SA; Chaber AL, 2010, CONSERV LETT, V3, P317, DOI 10.1111/j.1755-263X.2010.00121.x; Chadha MS, 2006, EMERG INFECT DIS, V12, P235, DOI 10.3201/eid1202.051247; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; Defra, 2011, RESTR; Defra, 2011, BRING YOUR PET DOG C; Defra, 2009, INT TRAD IMP INF NOT; Drexler JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006367; Eaton BT, 2006, NAT REV MICROBIOL, V4, P23, DOI 10.1038/nrmicro1323; EFSA, 2007, EFSA J, V584, P1; EFSA, 2006, EFSA J, V357; Epstein JH, 2008, EMERG INFECT DIS, V14, P1309, DOI 10.3201/eid1408.071492; Epstein JH, 2006, EMERG INFECT DIS, V12, P1178, DOI 10.3201/eid1207.050799; Field HE, 2007, AUST VET J, V85, P268, DOI 10.1111/j.1751-0813.2007.00170.x; Field H, 2010, EMERG INFECT DIS, V16, P338, DOI 10.3201/eid1602.090780; Fogarty R, 2008, VIRUS RES, V132, P140, DOI 10.1016/j.virusres.2007.11.010; GALE P, 2009, EPIDEMIOL INFECT, V7, P1; Gurley ES, 2007, EMERG INFECT DIS, V13, P1031, DOI 10.3201/eid1307.061128; Hall L, 2000, AUSTR NATURAL HIST S; Hartnett E, 2007, RISK ANAL, V27, P187, DOI 10.1111/j.1539-6924.2006.00869.x; Hayman DTS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002739; Heller J, 2010, RISK ANAL, V30, P458, DOI 10.1111/j.1539-6924.2009.01342.x; Hsu VP, 2004, EMERG INFECT DIS, V10, P2082, DOI 10.3201/eid1012.040701; Iehle C, 2007, EMERG INFECT DIS, V13, P159, DOI 10.3201/eid1301.060791; Jenkins Richard K.B., 2008, Madagascar Conservation & Development, V3, P22; Johara MY, 2001, EMERG INFECT DIS, V7, P439; Li MY, 2010, VET RES, V41, DOI 10.1051/vetres/2010005; Li Y, 2008, EMERG INFECT DIS, V14, P1974, DOI 10.3201/eid1412.080359; Ling A, 1999, SINGAPORE MED J, V40; Luby SP, 2006, EMERG INFECT DIS, V12, P1888; Luby SP, 2009, CLIN INFECT DIS, V49, P1743, DOI 10.1086/647951; Mickleburgh S, 2009, ORYX, V43, P217, DOI 10.1017/S0030605308000938; Middleton DJ, 2002, J COMP PATHOL, V126, P124, DOI 10.1053/jcpa.2001.0532; Mills JN, 2009, EMERG INFECT DIS, V15, P950, DOI 10.3201/eid1506.080453; Moutou F, 2001, REV SCI TECH OIE, V20, P723, DOI 10.20506/rst.20.3.1307; Mungall BA, 2006, J VIROL, V80, P12293, DOI 10.1128/JVI.01619-06; MURRAY K, 1995, SCIENCE, V268, P94, DOI 10.1126/science.7701348; Nor M, 2000, INT COMM REG COMM OI, P237; Nor MNM, 2000, REV SCI TECH OIE, V19, P160; Office for National Statistics, 2009, TRAV TRENDS; OIE (World Organisation for animal health), 2004, HDB IMP RISK AN AN A, V1; Paton NI, 1999, LANCET, V354, P1253, DOI 10.1016/S0140-6736(99)04379-2; Pulliam JRC, 2012, J R SOC INTERFACE, V9, P89, DOI 10.1098/rsif.2011.0223; Queensland Government, 2011, GUID VET HANDL POT H; Queensland Government, 2010, HENDR VIR INF; Radostits OM., 2007, TXB DIS CATTLE HORSE, P1452; Reynes JM, 2005, EMERG INFECT DIS, V11, P1042, DOI 10.3201/eid1107.041350; Sahani M, 2001, INT J EPIDEMIOL, V30, P1017, DOI 10.1093/ije/30.5.1017; SELVEY LA, 1995, MED J AUSTRALIA, V162, P642, DOI 10.5694/j.1326-5377.1995.tb126050.x; Sendow I, 2006, EMERG INFECT DIS, V12, P711, DOI 10.3201/eid1204.051181; Sharifah SH, 2009, NEUROL ASIA, V14, P67; Shirai J, 2007, JARQ-JPN AGR RES Q, V41, P69, DOI 10.6090/jarq.41.69; Wacharapluesadee S, 2005, EMERG INFECT DIS, V11, P1949, DOI 10.3201/eid1112.050613; Wacharapluesadee S, 2010, VECTOR-BORNE ZOONOT, V10, P183, DOI 10.1089/vbz.2008.0105; WHO, 2001, NIP VIR; WHO, 2009, HENDR VIR; World Organisation for Animal Health, 2010, IMP RISK AN	63	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e27918	10.1371/journal.pone.0027918	http://dx.doi.org/10.1371/journal.pone.0027918			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328916	Green Published, gold			2022-12-25	WOS:000302179300002
J	Wood, CR; Wang, ZH; Diener, D; Zones, JM; Rosenbaum, J; Umen, JG				Wood, Christopher R.; Wang, Zhaohui; Diener, Dennis; Zones, James Matt; Rosenbaum, Joel; Umen, James G.			IFT Proteins Accumulate during Cell Division and Localize to the Cleavage Furrow in Chlamydomonas	PLOS ONE			English	Article							INTRAFLAGELLAR TRANSPORT IFT; FLAGELLAR LENGTH; PRIMARY CILIA; BASAL BODIES; MITOTIC SPINDLE; GENE-EXPRESSION; CYCLE CONTROL; KINESIN-II; MITOSIS; COMPLEX	Intraflagellar transport (IFT) proteins are well established as conserved mediators of flagellum/cilium assembly and disassembly. However, data has begun to accumulate in support of IFT protein involvement in other processes elsewhere in the cell. Here, we used synchronous cultures of Chlamydomonas to investigate the temporal patterns of accumulation and localization of IFT proteins during the cell cycle. Their mRNAs showed periodic expression that peaked during S and M phase (S/M). Unlike most proteins that are synthesized continuously during G1 phase, IFT27 and IFT46 levels were found to increase only during S/M phase. During cell division, IFT27, IFT46, IFT72, and IFT139 re-localized from the flagella and basal bodies to the cleavage furrow. IFT27 was further shown to be associated with membrane vesicles in this region. This localization pattern suggests a role for IFT in cell division.	[Wood, Christopher R.; Wang, Zhaohui; Diener, Dennis; Rosenbaum, Joel] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA; [Zones, James Matt] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Zones, James Matt; Umen, James G.] Donald Danforth Plant Sci Ctr, St Louis, MO USA	Yale University; University of California System; University of California San Diego; Donald Danforth Plant Science Center	Wood, CR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA.	jumen@danforthcenter.org	Umen, James G/K-9120-2013	Umen, James G/0000-0003-4094-9045	National Institutes of Health National Research Service [5F32GM084566-02]; American Cancer Society [RSG-05-196-01-CCG]; National Science Foundation Integrative Graduate Education [0504645]; National Institutes of Health [R01 GM 014642]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM084566, R01GM092744, R01GM014642] Funding Source: NIH RePORTER	National Institutes of Health National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); National Science Foundation Integrative Graduate Education(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health National Research Service Award Fellowship 5F32GM084566-02 to CRW, American Cancer Society grant RSG-05-196-01-CCG to JGU, National Science Foundation Integrative Graduate Education and Research Traineeship Fellowship 0504645 to JMZ, and National Institutes of Health grant R01 GM 014642 to JR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018425; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Bahler J, 2005, ANNU REV GENET, V39, P69, DOI 10.1146/annurev.genet.39.110304.095808; Baldari CT, 2010, CURR OPIN CELL BIOL, V22, P75, DOI 10.1016/j.ceb.2009.10.010; Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; Berckmans B, 2009, CURR OPIN PLANT BIOL, V12, P599, DOI 10.1016/j.pbi.2009.07.005; Bisova K, 2005, PLANT PHYSIOL, V137, P475, DOI 10.1104/pp.104.054155; Bloodgood RA, 2009, METHOD CELL BIOL, V94, P3, DOI 10.1016/S0091-679X(08)94001-2; Bradley BA, 2005, J CELL SCI, V118, P3317, DOI 10.1242/jcs.02455; Canty A., 2010, BOOT BOOTSTRAP R S P; Christensen ST, 2008, CURR TOP DEV BIOL, V85, P261, DOI 10.1016/S0070-2153(08)00810-7; Cole DG, 2003, TRAFFIC, V4, P435, DOI 10.1034/j.1600-0854.2003.t01-1-00103.x; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; COLE DG, 2008, CHLAMYDOMONAS SOURCE, V3, P71; COSS RA, 1974, J CELL BIOL, V63, P325, DOI 10.1083/jcb.63.1.325; Dagoneau N, 2009, AM J HUM GENET, V84, P706, DOI 10.1016/j.ajhg.2009.04.016; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Deane JA, 2001, CURR BIOL, V11, P1586, DOI 10.1016/S0960-9822(01)00484-5; Delaval B, 2011, NAT CELL BIOL, V13, P461, DOI 10.1038/ncb2202; EHLER LL, 1995, GENETICS, V141, P945; Fang SC, 2006, PLOS GENET, V2, P1565, DOI 10.1371/journal.pgen.0020167; Finetti F, 2009, NAT CELL BIOL, V11, P1332, DOI 10.1038/ncb1977; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Follit JA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000315; Griffiths GM, 2010, J CELL BIOL, V189, P397, DOI 10.1083/jcb.201002027; Harris E, 2008, CHLAMYDOMONAS SOURCE, V1, P65; HOLMES JA, 1989, J CELL SCI, V94, P273; Hou YQ, 2007, J CELL BIOL, V176, P653, DOI 10.1083/jcb.200608041; Jekely G, 2006, BIOESSAYS, V28, P191, DOI 10.1002/bies.20369; JOHNSON UG, 1968, J CELL BIOL, V38, P403, DOI 10.1083/jcb.38.2.403; Jonassen JA, 2008, J CELL BIOL, V183, P377, DOI 10.1083/jcb.200808137; Kohl L, 2003, EMBO J, V22, P5336, DOI 10.1093/emboj/cdg518; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Lefebvre P, 2008, CHLAMYDOMONAS SOURCE, V3, P115; LEFEBVRE PA, 1986, ANNU REV CELL BIOL, V2, P517, DOI 10.1146/annurev.cb.02.110186.002505; Mahjoub MR, 2002, J CELL SCI, V115, P1759; Marshall W, 2008, CHLAMYDOMONAS SOURCE, V3, P431; Marshall WF, 2001, J CELL BIOL, V155, P405, DOI 10.1083/jcb.200106141; Matsuura K, 2002, CELL MOTIL CYTOSKEL, V52, P195, DOI 10.1002/cm.10051; Parker JDK, 2010, CYTOSKELETON, V67, P425, DOI 10.1002/cm.20454; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pazour GJ, 1998, J CELL BIOL, V141, P979, DOI 10.1083/jcb.141.4.979; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piperno G, 1997, P NATL ACAD SCI USA, V94, P4457, DOI 10.1073/pnas.94.9.4457; Plotnikova OV, 2009, METHOD CELL BIOL, V94, P137, DOI 10.1016/S0091-679X(08)94007-3; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Qin HM, 2004, J CELL BIOL, V164, P255, DOI 10.1083/jcb.200308132; Qin HM, 2007, CURR BIOL, V17, P193, DOI 10.1016/j.cub.2006.12.040; Quarmby LM, 2005, J CELL BIOL, V169, P707, DOI 10.1083/jcb.200503053; Quarmby LM, 2008, CHLAMYDOMONAS SOURCE, V3, P43; Rasi MQ, 2009, MOL BIOL CELL, V20, P379, DOI 10.1091/mbc.E07-10-1007; RIEDER CL, 1979, J ULTRA MOL STRUCT R, V68, P173, DOI 10.1016/S0022-5320(79)90152-7; Robert A, 2007, J CELL SCI, V120, P628, DOI 10.1242/jcs.03366; ROSENBAU.JL, 1969, J CELL BIOL, V41, P600, DOI 10.1083/jcb.41.2.600; Satir P, 2008, CURR TOP DEV BIOL, V85, P63, DOI 10.1016/S0070-2153(08)00803-X; Scholey JM, 2003, ANNU REV CELL DEV BI, V19, P423, DOI 10.1146/annurev.cellbio.19.111401.091318; Sedmak T, 2010, J CELL BIOL, V189, P171, DOI 10.1083/jcb.200911095; Stolc V, 2005, P NATL ACAD SCI USA, V102, P3703, DOI 10.1073/pnas.0408358102; SUEOKA N, 1960, P NATL ACAD SCI USA, V46, P83, DOI 10.1073/pnas.46.1.83; TAMM SL, 1969, J CELL SCI, V4, P171; Team RDC, 2010, R LANG ENV STAT COMP; TUCKER RW, 1979, CELL, V17, P527, DOI 10.1016/0092-8674(79)90261-7; Tuxhorn J, 1998, CELL MOTIL CYTOSKEL, V40, P133, DOI 10.1016/j.semcdb.2008.07.005; Umen JG, 2005, CURR OPIN CELL BIOL, V17, P435, DOI 10.1016/j.ceb.2005.06.001; Umen JG, 2001, GENE DEV, V15, P1652, DOI 10.1101/gad.892101; Walczak-Sztulpa J, 2010, AM J HUM GENET, V86, P949, DOI 10.1016/j.ajhg.2010.04.012; Wang ZH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005384; Wemmer KA, 2007, INT REV CYTOL, V260, P175, DOI 10.1016/S0074-7696(06)60004-1; Wheatley DN, 1996, CELL BIOL INT, V20, P73, DOI 10.1006/cbir.1996.0011; Wittenberg C, 2005, ONCOGENE, V24, P2746, DOI 10.1038/sj.onc.1208606; Zhu WC, 2005, CELL CYCLE, V4, P633, DOI 10.4161/cc.4.5.1650	73	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e30729	10.1371/journal.pone.0030729	http://dx.doi.org/10.1371/journal.pone.0030729			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328921	Green Published, gold, Green Submitted			2022-12-25	WOS:000302179300007
J	Knoflach, M; Kiechl, S; Mantovani, A; Cuccovillo, I; Bottazzi, B; Xu, QB; Xiao, QZ; Gasperi, A; Mayr, A; Kehrer, M; Willeit, J; Wick, G				Knoflach, Michael; Kiechl, Stefan; Mantovani, Alberto; Cuccovillo, Ivan; Bottazzi, Barbara; Xu, Qingbo; Xiao, Qingzhong; Gasperi, Arno; Mayr, Agnes; Kehrer, Marlene; Willeit, Johann; Wick, Georg			Pentraxin-3 as a Marker of Advanced Atherosclerosis Results from the Bruneck, ARMY and ARFY Studies	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; LONG PENTRAXIN; VASCULAR INFLAMMATION; UNSTABLE ANGINA; PTX3; DISEASE; ASSOCIATIONS; IMMUNITY; INNATE	Objective: Pentraxins like C-reactive protein are key components of the innate immune system. Recently, pentraxin-3 (PTX3) has been proposed to be a specific marker of vascular inflammation, yet its association with atherosclerosis is still unclear. Methods and Results: PTX3 serum levels were measured in three independent studies of 132 young men (ARMY Study), 205 young women (ARFY Study) and 562 individuals 55 to 94 years old (Bruneck Study). In contrast to C-reactive protein, PTX3 showed little relationships with classic vascular risk factors and pro-inflammatory conditions. In the population based Bruneck Study, PTX3 level was independently associated with prevalent cardiovascular diseases (multivariable odds ratio [95%CI] 3.09 [1.65-5.79]; P<0.001). Moreover, PTX3 level correlated with the severity of carotid and femoral atherosclerosis and was highest in individuals with multiple vascular territories affected. In contrast, there was no association with elevated intima-media thickness, a precursor lesion of atherosclerosis, in any of the three populations investigated. Conclusions: Level of PTX3 is independently associated with atherosclerosis and manifest cardiovascular disease but not early vessel pathology. Unlike C-reactive protein, PTX3 is not a component of the classic acute phase response (systemic inflammation) but appears to be more specific for vascular inflammation.	[Knoflach, Michael; Kiechl, Stefan; Willeit, Johann] Med Univ, Dept Neurol, Innsbruck, Austria; [Mantovani, Alberto; Bottazzi, Barbara] Ist Clin Humanitas IRCCS, Milan, Italy; [Mantovani, Alberto] Univ Milan, Dept Translat Med, Milan, Italy; [Cuccovillo, Ivan] Fdn Humanitas Ric, Milan, Italy; [Xu, Qingbo; Xiao, Qingzhong] Kings Coll London, BHF Ctr, Div Cardiovasc, London WC2R 2LS, England; [Gasperi, Arno] Bruneck Hosp, Dept Neurol, Brunico, Italy; [Mayr, Agnes] Bruneck Hosp, Dept Lab Med, Brunico, Italy; [Kehrer, Marlene] Bruneck Hosp, Dept Internal Med, Brunico, Italy; [Wick, Georg] Bioctr, Lab Autoimmun, Innsbruck, Austria	Medical University of Innsbruck; IRCCS Humanitas Research Hospital; University of Milan; University of London; King's College London	Knoflach, M (corresponding author), Med Univ, Dept Neurol, Innsbruck, Austria.	michael.knoflach@i-med.ac.at	Cuccovillo, Ivan/AAN-2209-2020; bottazzi, barbara/ABH-9274-2020; Mantovani, Alberto/HCI-7449-2022	Cuccovillo, Ivan/0000-0003-0394-5539; bottazzi, barbara/0000-0002-1930-9257; Mantovani, Alberto/0000-0001-5578-236X; , Agnes Mayr/0000-0001-9363-873X; Knoflach, Michael/0000-0001-5576-6562	EU (TOLERAGE) [HEALTH-F4-2008-202156]; Austrian Ministry of Defense; Austrian Research Fund (FWF) [Austrian Research Fund (FWF Project 14741]; Austrian Ministry of Health and Women; Ministry of Social Security, Generations and Consumer Protection; Daniel Swarovski Forschungsfoerderungsfond; Pustertaler Verein zur Pravention von Herz- und Hirngefaesserkrankungen; Sanitaetseinheit Ost; "Assessorat fuer Gesundheit", Province of Bolzano, Italy; Fondazione CARIPLO [2009-2582]; British Heart Foundation [FS/09/044/28007] Funding Source: researchfish	EU (TOLERAGE); Austrian Ministry of Defense; Austrian Research Fund (FWF)(Austrian Science Fund (FWF)); Austrian Ministry of Health and Women; Ministry of Social Security, Generations and Consumer Protection; Daniel Swarovski Forschungsfoerderungsfond; Pustertaler Verein zur Pravention von Herz- und Hirngefaesserkrankungen; Sanitaetseinheit Ost; "Assessorat fuer Gesundheit", Province of Bolzano, Italy; Fondazione CARIPLO(Fondazione Cariplo); British Heart Foundation(British Heart Foundation)	The Cooperation was funded by an EU Framework Program 7, Large Scale Integrated Project: Novel approaches to reconstitute normal immune function at old age (TOLERAGE Health research grant; HEALTH-F4-2008-202156). The ARMY Study was supported by the Austrian Ministry of Defense and the Austrian Research Fund (FWF Project 14741). The ARFY Study was funded by the Austrian Ministry of Health and Women and the Ministry of Social Security, Generations and Consumer Protection as well as by "Daniel Swarovski Forschungsfoerderungsfond". The Bruneck Study was supported by "Pustertaler Verein zur Pravention von Herz- und Hirngefaesserkrankungen", "Sanitaetseinheit Ost", and "Assessorat fuer Gesundheit", Province of Bolzano, Italy. The contribution of Fondazione CARIPLO (Project 2009-2582) to AM is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back M, 2010, PROG CARDIOVASC DIS, V52, P410, DOI 10.1016/j.pcad.2009.12.002; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Hansson GK, 2002, CIRC RES, V91, P281, DOI 10.1161/01.RES.0000029784.15893.10; Inoue K, 2007, ARTERIOSCL THROM VAS, V27, P161, DOI 10.1161/01.ATV.0000252126.48375.d5; Jenny NS, 2009, ARTERIOSCL THROM VAS, V29, P594, DOI 10.1161/ATVBAHA.108.178947; Jylhava J, 2011, CLIN EXP IMMUNOL, V164, P211, DOI 10.1111/j.1365-2249.2011.04354.x; Kaess BM, 2011, NAT REV CARDIOL, V8, P246, DOI 10.1038/nrcardio.2011.50; Kanbay M, 2011, AM J NEPHROL, V33, P325, DOI 10.1159/000324916; Kiechl S, 2001, CIRCULATION, V103, P1064, DOI 10.1161/01.CIR.103.8.1064; Kiechl S, 1999, ARTERIOSCL THROM VAS, V19, P1484, DOI 10.1161/01.ATV.19.6.1484; Knoflach M, 2003, CIRCULATION, V108, P1064, DOI 10.1161/01.CIR.0000085996.95532.FF; Knoflach M, 2009, STROKE, V40, P1063, DOI 10.1161/STROKEAHA.108.525675; Latini R, 2004, CIRCULATION, V110, P2349, DOI 10.1161/01.CIR.0000145167.30987.2E; Mantovani A, 2006, VASC PHARMACOL, V45, P326, DOI 10.1016/j.vph.2006.08.011; Matsui S, 2010, ATHEROSCLEROSIS, V210, P220, DOI 10.1016/j.atherosclerosis.2009.10.033; Nishi K, 2011, RENAL FAILURE, V33, P398, DOI 10.3109/0886022X.2011.568136; Norata GD, 2009, CIRCULATION, V120, P699, DOI 10.1161/CIRCULATIONAHA.108.806547; Olson FJ, 2008, J INTERN MED, V263, P626, DOI 10.1111/j.1365-2796.2008.01927.x; Peri G, 2000, CIRCULATION, V102, P636, DOI 10.1161/01.CIR.102.6.636; Rohde LEP, 1999, AM J CARDIOL, V84, P1018, DOI 10.1016/S0002-9149(99)00491-9; Rolph MS, 2002, ARTERIOSCL THROM VAS, V22, pE10, DOI 10.1161/01.ATV.0000015595.95497.2F; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Savchenko AS, 2008, J PATHOL, V215, P48, DOI 10.1002/path.2314; Suzuki S, 2008, AM HEART J, V155, P75, DOI 10.1016/j.ahj.2007.08.013; Wick G, 2004, ANNU REV IMMUNOL, V22, P361, DOI 10.1146/annurev.immunol.22.012703.104644; Xu Y, 2011, RENAL FAILURE, V33, P998, DOI 10.3109/0886022X.2011.618969; Yilmaz MI, 2011, CLIN J AM SOC NEPHRO, V6, P785, DOI 10.2215/CJN.09231010; Yudkin JS, 2000, ATHEROSCLEROSIS, V148, P209, DOI 10.1016/S0021-9150(99)00463-3	30	52	52	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31474	10.1371/journal.pone.0031474	http://dx.doi.org/10.1371/journal.pone.0031474			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319633	Green Published, Green Submitted, gold			2022-12-25	WOS:000302178400044
J	Zhang, J; Sun, Q; Zhang, Z; Ge, S; Han, ZG; Chen, WT				Zhang, J.; Sun, Q.; Zhang, Z.; Ge, S.; Han, Z-G; Chen, W-T			Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop	ONCOGENE			English	Article						microRNA; miRNA-143/145; MDM2; p53; epithelial maligancies	MIR-143/145 CLUSTER; ANTI-ONCOMIRS; C-MYC; P53; EXPRESSION; ONCOPROTEIN; ACTIVATION; INDUCTION; MICRORNAS; ONCOGENE	Dysregulated microRNAs (miRNAs) have an important role in many malignant tumors. However, elucidating the roles of miRNAs in cancer biology, especially in epithelial cancers, remains an ongoing process. In this study, we show that both miR-143 and miR-145, which belong to the same miRNA cluster, can negatively modulate expression of their target gene, MDM2. The miR-143 and miR-145 is posttranscriptionally activated by upregulated p53, thereby generating a short miRNAs-MDM2-p53 feedback loop. Re-expression of these miRNAs suppresses cellular growth and triggers the apoptosis of epithelial cancer, in vitro and in vivo, by enhancing p53 activity via MDM2 turnover. Moreover, the miRNA-dependent MDM2 turnover contributes to the equilibrium of repeated p53 pulses in response to DNA damage stress. These findings suggest that MDM2 dysregulation caused by downregulation of miR-143 and miR-145 contributes to epithelial cancer development and has a key role in regulating cellular proliferation and apoptosis. Re-expression of miR-143 and miR-145 may be a reasonable strategy for treatment of epithelial cancers. Oncogene (2013) 32, 61-69; doi:10.1038/onc.2012.28; published online 13 February 2012	[Zhang, J.; Zhang, Z.; Chen, W-T] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Stomatol, Dept Oral & Maxillofacial Surg,Peoples Hosp 9, Shanghai 200011, Peoples R China; [Han, Z-G] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Dis & Hlth Genom, Shanghai, Peoples R China	Shanghai Jiao Tong University	Chen, WT (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Stomatol, Dept Oral & Maxillofacial Surg,Peoples Hosp 9, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.	chenwantao2002@hotmail.com	建军, 张/R-3679-2019		National Natural Science Foundation of China [30973343, 81101515]; Shanghai Science and Technology Committee [08JC1414400, 11DZ2291800, 10DZ1951300, 10XD1402500]; Shanghai Leading Academic Discipline Project [S30206]; Shanghai Municipal Education Commission [12YZ052, shjdy027]; National Basic Research Program of China [2010CB529204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); National Basic Research Program of China(National Basic Research Program of China)	This study was supported by the National Natural Science Foundation of China (Grant No. 30973343 and 81101515), Projects of the Shanghai Science and Technology Committee (Grant No. 08JC1414400, 11DZ2291800, 10DZ1951300 and 10XD1402500), the Shanghai Leading Academic Discipline Project (S30206), the Program of Shanghai Municipal Education Commission (12YZ052 and shjdy027) and National Basic Research Program of China (2010CB529204).	Akao Y, 2010, CANCER GENE THER, V17, P398, DOI 10.1038/cgt.2009.88; Araki S, 2010, J CLIN INVEST, V120, P290, DOI 10.1172/JCI39194; Arva NC, 2008, ETHN DIS S2, V18, pS2; Asslaber D, 2010, BLOOD, V115, P4191, DOI 10.1182/blood-2009-07-234823; Boucher JM, 2011, J BIOL CHEM, V286, P28312, DOI 10.1074/jbc.M111.221945; Bouska A, 2008, MOL CELL BIOL, V28, P4862, DOI 10.1128/MCB.01584-07; Brown BD, 2009, NAT REV GENET, V10, P578, DOI 10.1038/nrg2628; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chen LH, 1997, J BIOL CHEM, V272, P22966, DOI 10.1074/jbc.272.36.22966; Chen LH, 2010, J ONCOL, V2010, DOI 10.1155/2010/135632; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Chiyomaru T, 2010, BRIT J CANCER, V102, P883, DOI 10.1038/sj.bjc.6605570; Dai YM, 2011, HEAD NECK-J SCI SPEC, V33, P786, DOI 10.1002/hed.21540; Fan Chun-Yang, 2004, Curr Oncol Rep, V6, P152, DOI 10.1007/s11912-004-0027-0; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Inuzuka H, 2010, CANCER CELL, V18, P147, DOI 10.1016/j.ccr.2010.06.015; Ishimura A, 2009, BIOCHEM BIOPH RES CO, V389, P366, DOI 10.1016/j.bbrc.2009.08.155; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Kent OA, 2010, GENE DEV, V24, P2754, DOI 10.1101/gad.1950610; Kitade Y, 2010, J PHARMACOL SCI, V114, P276, DOI 10.1254/jphs.10R12FM; Langevin SM, 2011, CANCER-AM CANCER SOC, V117, P1454, DOI 10.1002/cncr.25689; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Liu G, 2005, CANCER CELL, V7, P113, DOI 10.1016/j.ccr.2005.01.019; Macias E, 2010, CANCER CELL, V18, P231, DOI 10.1016/j.ccr.2010.08.007; Manfredi JJ, 2010, GENE DEV, V24, P1580, DOI 10.1101/gad.1941710; Phelps M, 2003, CANCER RES, V63, P2616; Pichiorri F, 2010, CANCER CELL, V18, P367, DOI 10.1016/j.ccr.2010.09.005; Ries S, 2000, CELL, V103, P321, DOI 10.1016/S0092-8674(00)00123-9; Sachdeva M, 2010, CANCER RES, V70, P378, DOI 10.1158/0008-5472.CAN-09-2021; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Saha MN, 2010, CANCER BIOL THER, V9, P936, DOI 10.4161/cbt.9.11.11882; Soriano ME, 2011, CELL, V145, P15, DOI 10.1016/j.cell.2011.03.025; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Vassilev LT, 2004, CELL CYCLE, V3, P419; Zhang JJ, 2011, CANCER-AM CANCER SOC, V117, P86, DOI 10.1002/cncr.25522; Zhang JJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-211	37	114	120	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2013	32	1					61	69		10.1038/onc.2012.28	http://dx.doi.org/10.1038/onc.2012.28			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	063VG	22330136	Bronze			2022-12-25	WOS:000313029500006
J	Arrizabalaga, O; Lacerda, HM; Zubiaga, AM; Zugaza, JL				Arrizabalaga, Onetsine; Lacerda, Hadriano M.; Zubiaga, Ana M.; Zugaza, Jose L.			Rac1 Protein Regulates Glycogen Phosphorylase Activation and Controls Interleukin (IL)-2-dependent T Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-BINDING DOMAIN; RHO GTPASES; HUMAN-LIVER; GROWTH; CDC42; IL-2; IDENTIFICATION; KINASE; ISOENZYMES; 3-KINASE	Small GTPases of the Rho family have been implicated in important cellular processes such as cell migration and adhesion, protein secretion, and/or gene transcription. In the lymphoid system, these GTPases participate in the signaling cascades that are activated after engagement of antigen receptors. However, little is known about the role that Rho GTPases play in IL-2-mediated responses. Here, we show that IL-2 induces Rac1 activation in Kit 225 T cells. We identified by mass spectrometry the muscle isoform of glycogen phosphorylase (PYGM) as a novel Rac1 effector molecule in IL-2-stimulated cells. The interaction between the active form of Rac1 (Rac1-GTP) and PYGM was established directly through a domain comprising amino acids 191-270 of PYGM that exhibits significant homology with the Rac binding domain of PAK1. The integrity of this region was crucial for PYGM activation. Importantly, IL-2-dependent cellular proliferation was inhibited upon blocking both the activation of Rac1 and the activity of PYGM. These results reveal a new role for Rac1 in cell signaling, showing that this GTPase triggers T cell proliferation upon IL-2 stimulation by associating with PYGM and modulating its enzymatic activity.	[Arrizabalaga, Onetsine; Zubiaga, Ana M.; Zugaza, Jose L.] Univ Basque Country, Dept Genet Phys Anthropol & Anim Physiol, Leioa 48940, Spain; [Arrizabalaga, Onetsine; Zugaza, Jose L.] Ctr Cooperat Res CIC BioGUNE, Derio 48160, Spain; [Lacerda, Hadriano M.] Univ Turin, Dept Biomed Sci & Human Oncol, Canc Epidemiol Unit, I-10124 Turin, Italy; [Zugaza, Jose L.] Basque Fdn Sci, IKERBASQUE, Bilbao 48011, Spain	University of Basque Country; CIC bioGUNE; University of Turin; Basque Foundation for Science	Zubiaga, AM (corresponding author), Univ Basque Country, Dept Genet Phys Anthropol & Anim Physiol, Barrio Sarriena S-N, Leioa 48940, Spain.	ana.zubiaga@ehu.es; joseluis.zugaza@ehu.es	zubiaga, ana/S-3457-2019; Bustelo, Xose R./A-9526-2010	zubiaga, ana/0000-0002-2132-9708; Bustelo, Xose R./0000-0001-9398-6072; ZUGAZA GURRUCHAGA, JOSE LUIS/0000-0003-2287-6671	Spanish Ministry of Science and Innovation [SAF2005-07930-C02-02, CIT-300000-2008-8, CSD2007-00017, SAF2009-12037]; Basque Government Education Department [GIC07/157-212]; Spanish Ministry of Education and Science [FPU_AP-2004-3064]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Basque Government Education Department; Spanish Ministry of Education and Science(Spanish Government)	* This work was supported by grants from the Spanish Ministry of Science and Innovation (Grants SAF2005-07930-C02-02 and CIT-300000-2008-8 to J. L. Z. and Grants CSD2007-00017 and SAF2009-12037 to A. M. Z.) and the Basque Government Education Department (Grant GIC07/157-212 to A. M. Z.).; <SUP>1</SUP> Supported by a fellowship from the Spanish Ministry of Education and Science (Program FPU_AP-2004-3064).	Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Andersen B, 2002, BIOCHEM J, V367, P443, DOI 10.1042/BJ20020153; Arnaud M, 2004, BIOCHEM J, V382, P545, DOI 10.1042/BJ20040103; Arrieumerlou C, 1998, EUR J IMMUNOL, V28, P1877, DOI 10.1002/(SICI)1521-4141(199806)28:06<1877::AID-IMMU1877>3.3.CO;2-9; Arrieumerlou C, 2000, J IMMUNOL, V165, P3182, DOI 10.4049/jimmunol.165.6.3182; Baumer AT, 2008, J BIOL CHEM, V283, P7864, DOI 10.1074/jbc.M704997200; BARFORD D, 1992, PROTEIN SCI, V1, P472; Beier I, 2008, ATHEROSCLEROSIS, V196, P92, DOI 10.1016/j.atherosclerosis.2007.02.003; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Brennan P, 1997, IMMUNITY, V7, P679, DOI 10.1016/S1074-7613(00)80388-X; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Caloca MJ, 2008, CELL SIGNAL, V20, P758, DOI 10.1016/j.cellsig.2007.12.015; Chen CJ, 2004, J IMMUNOL, V172, P3544, DOI 10.4049/jimmunol.172.6.3544; Chiariello M, 2010, METHODS MOL BIOL, V661, P137, DOI 10.1007/978-1-60761-795-2_8; Cianferoni A, 2005, J ALLERGY CLIN IMMUN, V116, P1364, DOI 10.1016/j.jaci.2005.09.006; Frauwirth KA, 2004, J IMMUNOL, V172, P4661, DOI 10.4049/jimmunol.172.8.4661; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gerard A, 2009, BLOOD, V113, P6138, DOI 10.1182/blood-2008-07-167668; Gomez TS, 2008, ADV IMMUNOL, V97, P1, DOI 10.1016/S0065-2776(08)00001-1; Greenberg CC, 2006, AM J PHYSIOL-ENDOC M, V291, pE1, DOI 10.1152/ajpendo.00652.2005; Haddad E, 2001, BLOOD, V97, P33, DOI 10.1182/blood.V97.1.33; HIDAKA H, 1991, METHOD ENZYMOL, V201, P328; HORI T, 1987, BLOOD, V70, P1069; HUDSON JW, 1993, J MOL BIOL, V234, P700, DOI 10.1006/jmbi.1993.1621; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Joneson T, 1996, SCIENCE, V274, P1374, DOI 10.1126/science.274.5291.1374; Joneson T, 1998, J BIOL CHEM, V273, P17991, DOI 10.1074/jbc.273.29.17991; Katzav S, 2007, CANCER LETT, V255, P241, DOI 10.1016/j.canlet.2007.04.015; Kelsall IR, 2009, CELL SIGNAL, V21, P1123, DOI 10.1016/j.cellsig.2009.03.001; Kirken RA, 2000, J IMMUNOL, V165, P5097, DOI 10.4049/jimmunol.165.9.5097; Klabunde T, 2005, J MED CHEM, V48, P6178, DOI 10.1021/jm049034y; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAVIS VR, 1980, J CELL PHYSIOL, V103, P55, DOI 10.1002/jcp.1041030109; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Lin JX, 1996, J BIOL CHEM, V271, P10738, DOI 10.1074/jbc.271.18.10738; Lin Q, 2006, J BIOL CHEM, V281, P35253, DOI 10.1074/jbc.M606248200; Lord JD, 2000, J IMMUNOL, V164, P2533, DOI 10.4049/jimmunol.164.5.2533; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; McInerney M, 2002, BBA-GEN SUBJECTS, V1570, P53, DOI 10.1016/S0304-4165(02)00154-X; Moon JJ, 2001, J IMMUNOL, V167, P2714, DOI 10.4049/jimmunol.167.5.2714; Morreale A, 2000, NAT STRUCT BIOL, V7, P384; Mortellaro A, 1999, J IMMUNOL, V162, P7102; NEWGARD CB, 1988, J BIOL CHEM, V263, P3850; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Pelletier S, 2003, MOL CELL BIOL, V23, P1316, DOI 10.1128/MCB.23.4.1316-1333.2003; Poppe D, 2006, J IMMUNOL, V176, P640, DOI 10.4049/jimmunol.176.1.640; PROUX D, 1974, CLIN CHIM ACTA, V57, P211, DOI 10.1016/0009-8981(74)90399-4; PROUX D, 1973, CLIN CHIM ACTA, V48, P167, DOI 10.1016/0009-8981(73)90362-8; Rath VL, 2000, MOL CELL, V6, P139, DOI 10.1016/S1097-2765(00)00015-0; Ravichandran KS, 1996, P NATL ACAD SCI USA, V93, P5275, DOI 10.1073/pnas.93.11.5275; Ravichandran KS, 1995, ANN NY ACAD SCI, V766, P202, DOI 10.1111/j.1749-6632.1995.tb26663.x; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; Ross JA, 2010, J BIOL CHEM, V285, P3582, DOI 10.1074/jbc.M109.053843; Schnier JB, 2003, BIOCHEM BIOPH RES CO, V309, P126, DOI 10.1016/S0006-291X(03)01542-0; SEAMON KB, 1986, ADV CYCLIC NUCL PROT, V20, P1; Shen SL, 2011, BBA-MOL BASIS DIS, V1812, P703, DOI 10.1016/j.bbadis.2011.03.004; Sudo K, 2006, NEUROSCI RES, V56, P347, DOI 10.1016/j.neures.2006.08.003; Terakado M, 2011, AM J PHYSIOL-LUNG C, V300, pL56, DOI 10.1152/ajplung.00159.2010; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Villalba M, 2000, IMMUNITY, V12, P151, DOI 10.1016/S1074-7613(00)80168-5; Wery-Zennaro S, 2000, ONCOGENE, V19, P1596, DOI 10.1038/sj.onc.1203458; YUNIS AA, 1968, BIOCHEM BIOPH RES CO, V33, P119, DOI 10.1016/0006-291X(68)90265-9; Zhang JS, 2011, MOL BIOL CELL, V22, P2119, DOI 10.1091/mbc.E10-12-0969; Zugaza JL, 2004, ONCOGENE, V23, P5823, DOI 10.1038/sj.onc.1207768	68	26	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11878	11890		10.1074/jbc.M111.297804	http://dx.doi.org/10.1074/jbc.M111.297804			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22337875	hybrid, Green Published			2022-12-25	WOS:000302782200027
J	Zerbe, P; Chiang, A; Yuen, M; Hamberger, B; Hamberger, B; Draper, JA; Britton, R; Bohlmann, J				Zerbe, Philipp; Chiang, Angela; Yuen, Macaire; Hamberger, Bjoern; Hamberger, Britta; Draper, Jason A.; Britton, Robert; Bohlmann, Joerg			Bifunctional cis-Abienol Synthase from Abies balsamea Discovered by Transcriptome Sequencing and Its Implications for Diterpenoid Fragrance Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENT-KAURENE SYNTHASE; ABIETADIENOL/ABIETADIENAL OXIDASE PTAO; RESIN ACID BIOSYNTHESIS; CELL-FREE-EXTRACTS; ABIETADIENE SYNTHASE; FUNCTIONAL-CHARACTERIZATION; INITIATED CYCLIZATION; MUTATIONAL ANALYSIS; TERPENE SYNTHASES; CONIFER DEFENSE	The labdanoid diterpene alcohol cis-abienol is a major component of the aromatic oleoresin of balsam fir (Abies balsamea) and serves as a valuable bioproduct material for the fragrance industry. Using high-throughput 454 transcriptome sequencing and metabolite profiling of balsam fir bark tissue, we identified candidate diterpene synthase sequences for full-length cDNA cloning and functional characterization. We discovered a bifunctional class I/II cis-abienol synthase (AbCAS), along with the paralogous levopimaradiene/abietadiene synthase and isopimaradiene synthase, all of which are members of the gymnosperm-specific TPS-d subfamily. The AbCAS-catalyzed formation of cis-abienol proceeds via cyclization and hydroxylation at carbon C-8 of a postulated carbocation intermediate in the class II active site, followed by cleavage of the diphosphate group and termination of the reaction sequence without further cyclization in the class I active site. This reaction mechanism is distinct from that of synthases of the isopimaradiene- or levopimaradiene/abietadiene synthase type, which employ deprotonation reactions in the class II active site and secondary cyclizations in the class I active site, leading to tricyclic diterpenes. Comparative homology modeling suggested the active site residues Asp-348, Leu-617, Phe-696, and Gly-723 as potentially important for the specificity of AbCAS. As a class I/II bifunctional enzyme, AbCAS is a promising target for metabolic engineering of cis-abienol production.	[Zerbe, Philipp; Chiang, Angela; Yuen, Macaire; Hamberger, Bjoern; Hamberger, Britta; Bohlmann, Joerg] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Draper, Jason A.; Britton, Robert] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	University of British Columbia; Simon Fraser University	Bohlmann, J (corresponding author), Univ British Columbia, Michael Smith Labs, 301-2185 East Mall, Vancouver, BC V6T 1Z4, Canada.	bohlmann@msl.ubc.ca	Hamberger, Bjoern/I-2122-2012; Zerbe, Philipp/A-2590-2013; Zerbe, Philipp/H-8348-2015	Hamberger, Bjoern/0000-0003-1249-1807; Zerbe, Philipp/0000-0001-5163-9523	Genome Alberta; Genome British Columbia; Genome Quebec; Government of Canada through Genome Canada; Natural Sciences and Engineering Research Council of Canada; University of British Columbia; Novo Nordisk Fonden [NNF12OC0000798] Funding Source: researchfish	Genome Alberta; Genome British Columbia; Genome Quebec; Government of Canada through Genome Canada(Genome Canada); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of British Columbia; Novo Nordisk Fonden(Novo Nordisk Foundation)	* This research was supported by Genome Alberta, Genome British Columbia, Genome Quebec, and the Government of Canada through Genome Canada in support of the PhytoMetaSyn Project and by grants from the Natural Sciences and Engineering Research Council of Canada (to J. B.).; <SUP>2</SUP> Supported in part by the University of British Columbia Distinguished University Scholars program. To whom correspondence should be addressed. Tel.: 604-822-0282; Fax: 604-822-2114; E-mail: bohlmann@msl.ubc.ca.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BARRERO AF, 1993, TETRAHEDRON, V49, P10405, DOI 10.1016/S0040-4020(01)80567-6; Barrero RA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-600; Bleeker PM, 2011, PLANT MOL BIOL, V77, P323, DOI 10.1007/s11103-011-9813-x; Bohlmann J, 1999, ARCH BIOCHEM BIOPHYS, V368, P232, DOI 10.1006/abbi.1999.1332; Bohlmann J, 2008, PLANT J, V54, P656, DOI 10.1111/j.1365-313X.2008.03449.x; CARMAN RM, 1993, AUST J CHEM, V46, P1105, DOI 10.1071/CH9931105; CARMAN RM, 1966, AUST J CHEM, V19, P1535, DOI 10.1071/CH9661535; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; de la Bastide Melissa, 2007, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1104s17; Ding L, 2007, CHROMATOGRAPHIA, V66, P529, DOI 10.1365/s10337-007-0365-9; Falara V, 2010, PLANT PHYSIOL, V154, P301, DOI 10.1104/pp.110.159566; GRAY PS, 1964, J CHEM SOC, VS, P5822; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; GUO ZH, 1994, ARCH BIOCHEM BIOPHYS, V308, P103, DOI 10.1006/abbi.1994.1015; GUO ZH, 1995, PLANTA, V197, P627, DOI 10.1007/BF00191570; Hamberger B, 2006, BIOCHEM SOC T, V34, P1209, DOI 10.1042/BST0341209; Hamberger B, 2011, PLANT PHYSIOL, V157, P1677, DOI 10.1104/pp.111.185843; Hayashi K, 2006, FEBS LETT, V580, P6175, DOI 10.1016/j.febslet.2006.10.018; Hillwig ML, 2011, BIOPOLYMERS, V95, P71, DOI 10.1002/bip.21538; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Kawaide H, 2011, FEBS J, V278, P123, DOI 10.1111/j.1742-4658.2010.07938.x; Keeling CI, 2008, P NATL ACAD SCI USA, V105, P1085, DOI 10.1073/pnas.0709466105; Keeling CI, 2006, PHYTOCHEMISTRY, V67, P2415, DOI 10.1016/j.phytochem.2006.08.019; Keeling CI, 2011, J BIOL CHEM, V286, P21145, DOI 10.1074/jbc.M111.245951; Keeling CI, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-43; Keeling CI, 2006, NEW PHYTOL, V170, P657, DOI 10.1111/j.1469-8137.2006.01716.x; Koksal M, 2011, NATURE, V469, P116, DOI 10.1038/nature09628; Kolosova N, 2004, BIOTECHNIQUES, V36, P821, DOI 10.2144/04365ST06; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leonard E, 2010, P NATL ACAD SCI USA, V107, P13654, DOI 10.1073/pnas.1006138107; LEWINSOHN E, 1993, PLANT PHYSIOL, V101, P1021, DOI 10.1104/pp.101.3.1021; Mafu S, 2011, CHEMBIOCHEM, V12, P1984, DOI 10.1002/cbic.201100336; Martin DM, 2004, PLANT PHYSIOL, V135, P1908, DOI 10.1104/pp.104.042028; Miller B, 2005, PLANT PHYSIOL, V137, P369, DOI 10.1104/pp.104.050187; MILLS JS, 1967, J CHEM SOC C, P2514, DOI 10.1039/j39670002514; Miyazawa M, 2008, J ESSENT OIL RES, V20, P12, DOI 10.1080/10412905.2008.9699409; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; Peralta-Yahya PP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1494; Peters RJ, 2003, BIOCHEMISTRY-US, V42, P2700, DOI 10.1021/bi020492n; Peters RJ, 2002, BIOCHEMISTRY-US, V41, P1836, DOI 10.1021/bi011879d; Peters RJ, 2002, P NATL ACAD SCI USA, V99, P580, DOI 10.1073/pnas.022627099; Peters RJ, 2001, J AM CHEM SOC, V123, P8974, DOI 10.1021/ja010670k; Peters RJ, 2000, BIOCHEMISTRY-US, V39, P15592, DOI 10.1021/bi001997l; Ro DK, 2006, PHYTOCHEMISTRY, V67, P1572, DOI 10.1016/j.phytochem.2006.01.011; Ro DK, 2005, P NATL ACAD SCI USA, V102, P8060, DOI 10.1073/pnas.0500825102; Sallaud C., 2008, International Patent, Patent No. [WO/2008/007031, 2008007031]; Schalk M., 2009, International Patent, Patent No. [WO 2009/101126 A1, 2009101126]; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SEVERSON RF, 1984, J AGR FOOD CHEM, V32, P566, DOI 10.1021/jf00123a037; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Trapp S, 2001, ANNU REV PLANT PHYS, V52, P689, DOI 10.1146/annurev.arplant.52.1.689; Vlad P. F., 1974, KHIM PRIR SOEDIN, V1, P30; Vogel BS, 1996, J BIOL CHEM, V271, P23262, DOI 10.1074/jbc.271.38.23262; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wilderman PR, 2007, J AM CHEM SOC, V129, P15736, DOI 10.1021/ja074977g; Yang XW, 2010, BIOORGAN MED CHEM, V18, P744, DOI 10.1016/j.bmc.2009.11.055; Zerbe P, 2012, PHYTOCHEMISTRY, V74, P30, DOI 10.1016/j.phytochem.2011.11.004; Zhou K, 2009, PHYTOCHEMISTRY, V70, P366, DOI 10.1016/j.phytochem.2008.12.022	59	58	75	2	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12121	12131		10.1074/jbc.M111.317669	http://dx.doi.org/10.1074/jbc.M111.317669			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22337889	Green Published, hybrid			2022-12-25	WOS:000302782200048
J	Singhal, J; Agrawal, N; Vashishta, M; Priya, NG; Tiwari, BK; Singh, Y; Raman, R; Natarajan, K				Singhal, Jhalak; Agrawal, Neha; Vashishta, Mohit; Priya, N. Gayatri; Tiwari, Brijendra K.; Singh, Yogendra; Raman, Rajagopal; Natarajan, Krishnamurthy			Suppression of Dendritic Cell-mediated Responses by Genes in Calcium and Cysteine Protease Pathways during Mycobacterium tuberculosis Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTECTIVE IMMUNITY; SIGNALING PATHWAYS; BONE-MARROW; RNAI SCREEN; IN-VIVO; DC-SIGN; KINASE; EXPRESSION; INHIBITION; AUTOPHAGY	Background: RNA interference (RNAi) is a useful tool to know the function of a gene in a cell under any kind of stress. Results: RNAi-mediated knockdown of genes in dendritic cells identified unreported genes and pathways that regulate its various functions during Mycobacterium tuberculosis infection. Conclusion: The identified genes could be potential targets in drug and vaccine designing. Significance: Understanding the role of host factors that regulate priming of immune responses is crucial to study host-pathogen interactions.	[Singhal, Jhalak; Agrawal, Neha; Vashishta, Mohit; Natarajan, Krishnamurthy] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Infect Dis Immunol Lab, Delhi 110007, India; [Priya, N. Gayatri; Raman, Rajagopal] Univ Delhi, Dept Zool, Gut Biol Lab, Delhi 110007, India; [Tiwari, Brijendra K.; Singh, Yogendra] CSIR, Inst Genom & Integrat Biol, Allergy & Infect Dis Lab, Delhi 110007, India	University of Delhi; University of Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Natarajan, K (corresponding author), Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Infect Dis Immunol Lab, Delhi 110007, India.	knatarajan@acbr.du.ac.in	Tiwari, Brijesh Kumar/K-6227-2013; Singhal, Jhalak/GRE-9090-2022	Tiwari, Brijesh Kumar/0000-0002-4834-6831; Agrawal, Neha/0000-0001-8506-6559	Department of Biotechnology, Ministry of Science and Technology, Government of India	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This work was supported by grants from the Department of Biotechnology, Ministry of Science and Technology, Government of India (to K. N.).	Agrawal-Singh S, 2010, BLOOD, V115, P4507, DOI 10.1182/blood-2009-03-210070; Alenzi FQB, 2004, BRIT J BIOMED SCI, V61, P99, DOI 10.1080/09674845.2004.11732652; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; Bodnar KA, 2001, INFECT IMMUN, V69, P800, DOI 10.1128/IAI.69.2.800-809.2001; Connolly SF, 2007, IMMUNOL RES, V39, P115, DOI 10.1007/s12026-007-0076-1; Cullen LM, 2005, IMMUNOL CELL BIOL, V83, P217, DOI 10.1111/j.1440-1711.2005.01332.x; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Foote S, 1999, NAT GENET, V21, P345, DOI 10.1038/7663; Fox CJ, 2003, GENE DEV, V17, P1841, DOI 10.1101/gad.1105003; Gan-Erdene T, 2003, J BIOL CHEM, V278, P28892, DOI 10.1074/jbc.M302890200; Ganesan AK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000298; Gawenda J, 2007, BREAST CANCER RES TR, V102, P1, DOI 10.1007/s10549-006-9311-z; Gupta D, 2010, J IMMUNOL, V184, P5444, DOI 10.4049/jimmunol.0903283; Gupta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005305; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hess J, 2000, ADV IMMUNOL, V75, P1, DOI 10.1016/S0065-2776(00)75001-2; Hsing LC, 2005, IMMUNOL REV, V207, P229, DOI 10.1111/j.0105-2896.2005.00310.x; Ito M, 2005, FEBS LETT, V579, P5988, DOI 10.1016/j.febslet.2005.08.015; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; Jaleel M, 2005, FEBS LETT, V579, P1417, DOI 10.1016/j.febslet.2005.01.042; Kaufmann SHE, 2003, J EXP MED, V197, P1, DOI 10.1084/jem.20021964; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Koh KW, 2009, MOL IMMUNOL, V46, P1312, DOI 10.1016/j.molimm.2008.11.008; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Krausz C, 2006, HUM MOL GENET, V15, P2673, DOI 10.1093/hmg/ddl198; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; Latchumanan VK, 2002, J IMMUNOL, V169, P6856, DOI 10.4049/jimmunol.169.12.6856; Lee JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015394; Li ST, 2006, MOL CELL, V24, P497, DOI 10.1016/j.molcel.2006.10.015; Lin PT, 2000, J NEUROSCI, V20, P9152; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Malik ZA, 2003, J IMMUNOL, V170, P2811, DOI 10.4049/jimmunol.170.6.2811; Manabe YC, 2000, NAT MED, V6, P1327, DOI 10.1038/82139; Moffat J, 2006, NAT REV MOL CELL BIO, V7, P177, DOI 10.1038/nrm1860; Nguyen A, 2004, FEBS LETT, V572, P307, DOI 10.1016/j.febslet.2004.06.061; Noble A, 2000, J IMMUNOL, V164, P1807, DOI 10.4049/jimmunol.164.4.1807; Noss EH, 2001, J IMMUNOL, V167, P910, DOI 10.4049/jimmunol.167.2.910; Ottenhoff THM, 2009, EUR J IMMUNOL, V39, P2014, DOI 10.1002/eji.200939518; Ovcharenko D, 2007, CANCER RES, V67, P10782, DOI 10.1158/0008-5472.CAN-07-1484; Pecora ND, 2009, CELL IMMUNOL, V254, P94, DOI 10.1016/j.cellimm.2008.07.002; Pramanik K, 2009, BLOOD, V113, P1184, DOI 10.1182/blood-2008-06-162180; Salam N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002869; Sinha A, 2006, J IMMUNOL, V177, P468, DOI 10.4049/jimmunol.177.1.468; Snapinn KW, 2011, PARKINSONISM RELAT D, V17, P473, DOI 10.1016/j.parkreldis.2011.01.019; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Sousa CRE, 2001, IMMUNITY, V14, P495; Srivastava V, 2011, IMMUNOL CELL BIOL, V89, P786, DOI 10.1038/icb.2011.1; Srivastava V, 2009, J BIOL CHEM, V284, P25532, DOI 10.1074/jbc.M109.006221; Steinman R. M., 1999, FUNDAMENTAL IMMUNOLO, pE47; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; Tian T, 2005, J IMMUNOL, V175, P3268, DOI 10.4049/jimmunol.175.5.3268; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; Virgin HW, 2009, NAT IMMUNOL, V10, P461, DOI 10.1038/ni.1726; World Health Organization, 2009, WHO FACT SHEET; Yadav UCS, 2009, J IMMUNOL, V183, P4723, DOI 10.4049/jimmunol.0901177; Yan B, 2003, J BIOL CHEM, V278, P45358, DOI 10.1074/jbc.M307933200; Young DL, 2009, EUR J IMMUNOL, V39, P2011, DOI 10.1002/eji.200939542	60	16	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11108	11121		10.1074/jbc.M111.300319	http://dx.doi.org/10.1074/jbc.M111.300319			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22337888	Green Published, hybrid			2022-12-25	WOS:000302780100039
J	Kuerschner, L; Richter, D; Hannibal-Bach, HK; Gaebler, A; Shevchenko, A; Ejsing, CS; Thiele, C				Kuerschner, Lars; Richter, Doris; Hannibal-Bach, Hans Kristian; Gaebler, Anne; Shevchenko, Andrej; Ejsing, Christer S.; Thiele, Christoph			Exogenous Ether Lipids Predominantly Target Mitochondria	PLOS ONE			English	Article							HUMAN LEUKEMIC-CELLS; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; PHOSPHOLIPID EDELFOSINE; ANTITUMOR AGENTS; APOPTOSIS; ET-18-OCH3; MEMBRANE; ANALOGS; RAFTS; ACID	Ether lipids are ubiquitous constituents of cellular membranes with no discrete cell biological function assigned yet. Using fluorescent polyene-ether lipids we analyzed their intracellular distribution in living cells by microscopy. Mitochondria and the endoplasmic reticulum accumulated high amounts of ether-phosphatidylcholine and ether-phosphatidylethanolamine. Both lipids were specifically labeled using the corresponding lyso-ether lipids, which we established as supreme precursors for lipid tagging. Polyfosine, a fluorescent analogue of the anti-neoplastic ether lipid edelfosine, accumulated to mitochondria and induced morphological changes and cellular apoptosis. These data indicate that edelfosine could exert its pro-apoptotic power by targeting and damaging mitochondria and thereby inducing cellular apoptosis. In general, this study implies an important role of mitochondria in ether lipid metabolism and intracellular ether lipid trafficking.	[Kuerschner, Lars; Gaebler, Anne; Thiele, Christoph] Univ Bonn, Life & Med Sci Inst LIMES, Bonn, Germany; [Hannibal-Bach, Hans Kristian; Ejsing, Christer S.] Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Richter, Doris; Shevchenko, Andrej] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	University of Bonn; University of Southern Denmark; Max Planck Society	Kuerschner, L (corresponding author), Univ Bonn, Life & Med Sci Inst LIMES, Bonn, Germany.	lars.kuerschner@uni-bonn.de	Ejsing, Christer S/R-5922-2016	Ejsing, Christer S./0000-0003-4963-0276	Deutsche Forschungsgemeinschaft [SFB-TR 13, 83]; Danish Council for Independent Research [DOK1155860]; Lundbeckfonden [R45-A4342]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Lundbeckfonden(Lundbeckfonden)	This work was funded by the Deutsche Forschungsgemeinschaft (SFB-TR 13 and 83), the Danish Council for Independent Research (DOK1155860, CSE), and Lundbeckfonden (R45-A4342, CSE). Websites: http://www.dfg.de/en/index.jsp, http://en.fi.dk/councils-commissions/the-danish-council-for-independent-research, http://www.lundbeckfonden.dk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausili A, 2008, J PHYS CHEM B, V112, P11643, DOI 10.1021/jp802165n; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Besson P, 1996, BIOCHEM PHARMACOL, V51, P1153, DOI 10.1016/0006-2952(96)00029-9; BOGGS KP, 1995, J BIOL CHEM, V270, P7757, DOI 10.1074/jbc.270.13.7757; Brites P, 2004, BBA-MOL CELL BIOL L, V1636, P219, DOI 10.1016/j.bbalip.2003.12.010; Busto JV, 2007, BBA-BIOMEMBRANES, V1768, P1855, DOI 10.1016/j.bbamem.2007.04.025; Cereghetti GM, 2006, ONCOGENE, V25, P4717, DOI 10.1038/sj.onc.1209605; Cuvillier O, 1999, BLOOD, V94, P3583, DOI 10.1182/blood.V94.10.3583.422k31_3583_3592; Danker K, 2010, BRIT J PHARMACOL, V160, P36, DOI 10.1111/j.1476-5381.2009.00626.x; DIOMEDE L, 1993, INT J CANCER, V53, P124, DOI 10.1002/ijc.2910530123; Ejsing CS, 2006, ANAL CHEM, V78, P6202, DOI 10.1021/ac060545x; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Ekroos K, 2003, J LIPID RES, V44, P2181, DOI 10.1194/jlr.D300020-JLR200; Ekroos K, 2002, ANAL CHEM, V74, P941, DOI 10.1021/ac015655c; Gajate C, 2000, INT J CANCER, V85, P674, DOI 10.1002/(SICI)1097-0215(20000301)85:5<674::AID-IJC13>3.0.CO;2-Z; Gajate C, 2000, INT J CANCER, V86, P208, DOI 10.1002/(SICI)1097-0215(20000415)86:2<208::AID-IJC10>3.0.CO;2-E; Goonesinghe A, 2005, BIOCHEM J, V387, P109, DOI 10.1042/BJ20041389; Gorgas K, 2006, BBA-MOL CELL RES, V1763, P1511, DOI 10.1016/j.bbamcr.2006.08.038; HOFFMAN DR, 1992, BIOCHIM BIOPHYS ACTA, V1127, P74, DOI 10.1016/0005-2760(92)90203-8; HOULIHAN WJ, 1995, MED RES REV, V15, P157, DOI 10.1002/med.2610150302; Hsu FF, 2000, J MASS SPECTROM, V35, P596; Kuerschner L, 2005, NAT METHODS, V2, P39, DOI 10.1038/NMETH728; Massey JB, 1997, BIOPHYS J, V72, P1732, DOI 10.1016/S0006-3495(97)78819-2; Mollinedo F, 2004, CURR MED CHEM, V11, P3163, DOI 10.2174/0929867043363703; Mollinedo F, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.41; MOLLINEDO F, 1993, BIOCHEM BIOPH RES CO, V192, P603, DOI 10.1006/bbrc.1993.1458; MUNDER PG, 1990, CHEM IMMUNOL, V49, P206; Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0; Nieto-Miguel T, 2006, J BIOL CHEM, V281, P14833, DOI 10.1074/jbc.M511251200; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Pike LJ, 2002, BIOCHEMISTRY-US, V41, P2075, DOI 10.1021/bi0156557; POST JA, 1988, FEBS LETT, V240, P78, DOI 10.1016/0014-5793(88)80343-0; Quesada E, 2004, J MED CHEM, V47, P5333, DOI 10.1021/jm049808a; Spandl J, 2009, TRAFFIC, V10, P1579, DOI 10.1111/j.1600-0854.2009.00980.x; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Thai TP, 2001, HUM MOL GENET, V10, P127, DOI 10.1093/hmg/10.2.127; Thiele C, 2008, CURR OPIN CELL BIOL, V20, P378, DOI 10.1016/j.ceb.2008.05.009; THUMSER AEA, 1994, BIOCHEM J, V301, P801, DOI 10.1042/bj3010801; Tokumura A, 1997, CHEM PHYS LIPIDS, V86, P75, DOI 10.1016/S0009-3084(97)02664-9; Torrecillas A, 2006, INT J PHARMACEUT, V318, P28, DOI 10.1016/j.ijpharm.2006.03.008; van Blitterswijk WJ, 2008, CURR PHARM DESIGN, V14, P2061, DOI 10.2174/138161208785294636; VANBLITTERSWIJK WJ, 1987, LIPIDS, V22, P820, DOI 10.1007/BF02535537; Vink SR, 2007, CANCER TREAT REV, V33, P191, DOI 10.1016/j.ctrv.2006.12.001; VOGLER WR, 1985, EXP HEMATOL, V13, P629; WIEDER T, 1995, LIPIDS, V30, P389, DOI 10.1007/BF02536296; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; Zerp SF, 2008, ANTI-CANCER DRUG, V19, P65, DOI 10.1097/CAD.0b013e3282f16d36; ZOELLER RA, 1995, J LIPID RES, V36, P1866	49	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31342	10.1371/journal.pone.0031342	http://dx.doi.org/10.1371/journal.pone.0031342			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348073	Green Published, gold, Green Submitted			2022-12-25	WOS:000302737400016
J	Todaro, MA; Dal Zotto, M; Jondelius, U; Hochberg, R; Hummon, WD; Kanneby, T; Rocha, CEF				Todaro, M. Antonio; Dal Zotto, Matteo; Jondelius, Ulf; Hochberg, Rick; Hummon, William D.; Kanneby, Tobias; Rocha, Carlos E. F.			Gastrotricha: A Marine Sister for a Freshwater Puzzle	PLOS ONE			English	Article							INTERRELATIONSHIPS; MACRODASYIDA; PHYLOGENY; GENERA	Background: Within an evolutionary framework of Gastrotricha Marinellina flagellata and Redudasys fornerise bear special interest, as they are the only Macrodasyida that inhabit freshwater ecosystems. Notwithstanding, these rare animals are poorly known; found only once (Austria and Brazil), they are currently systematised as incertae sedis. Here we report on the rediscovery of Redudasys fornerise, provide an account on morphological novelties and present a hypothesis on its phylogenetic relationship based on molecular data. Methodology/Principal Findings: Specimens were surveyed using DIC microscopy and SEM, and used to obtain the 18 S rRNA gene sequence; molecular data was analyzed cladistically in conjunction with data from 42 additional species belonging to the near complete Macrodasyida taxonomic spectrum. Morphological analysis, while providing new information on taxonomically relevant traits (adhesive tubes, protonephridia and sensorial bristles), failed to detect elements of the male system, thus stressing the parthenogenetic nature of the Brazilian species. Phylogenetic analysis, carried out with ML, MP and Bayesian approaches, yielded topologies with strong nodal support and highly congruent with each other. Among the supported groups is the previously undocumented clade showing the alliance between Redudasys fornerise and Dactylopodola agadasys; other strongly sustained clades include the densely sampled families Thaumastodermatidae and Turbanellidae and most genera. Conclusions/Significance: A reconsideration of the morphological traits of Dactylopodola agadasys in light of the new information on Redudasys fornerise makes the alliance between these two taxa very likely. As a result, we create Anandrodasys gen. nov. to contain members of the previously described D. agadasys and erect Redudasyidae fam. nov. to reflect this novel relationship between Anandrodasys and Redudasys. From an ecological perspective, the derived position of Redudasys, which is deeply nested within the Macrodasyida clade, unequivocally demonstrates that invasion of freshwater by gastrotrichs has taken place at least twice, in contrast with the single event hypothesis recently put forward.	[Todaro, M. Antonio; Dal Zotto, Matteo] Univ Modena & Reggio Emilia, Dept Biol, Modena, Italy; [Jondelius, Ulf; Kanneby, Tobias] Swedish Museum Nat Hist, Dept Invertebrate Zool, S-10405 Stockholm, Sweden; [Hochberg, Rick] Univ Massachusetts Lowell, Dept Biol Sci, Lowell, MA USA; [Hummon, William D.] Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA; [Rocha, Carlos E. F.] Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil	Universita di Modena e Reggio Emilia; Swedish Museum of Natural History; University of Massachusetts System; University of Massachusetts Lowell; University System of Ohio; Ohio University; Universidade de Sao Paulo	Todaro, MA (corresponding author), Univ Modena & Reggio Emilia, Dept Biol, Modena, Italy.	antonio.todaro@unimore.it	Jondelius, Ulf/AAF-7943-2020; Todaro, M. Antonio/H-1311-2013	Jondelius, Ulf/0000-0003-2847-2192; Todaro, M. Antonio/0000-0002-6353-7281; Kanneby, Tobias/0000-0001-7151-5915; Dal Zotto, Matteo/0000-0003-1386-7626	University of Sao Paulo [2007.1.466.41.5]; Italian MIUR; Swedish Taxonomy Initiative; US-National Science Foundation [n. DEB 0918499]	University of Sao Paulo; Italian MIUR(Ministry of Education, Universities and Research (MIUR)); Swedish Taxonomy Initiative; US-National Science Foundation(National Science Foundation (NSF))	Collecting of Redudasys fornerise was done during a visit of MAT sponsored by University of Sao Paulo - Graduate Programs, grant no. 2007.1.466.41.5 (CEFR, PI). This study benefited from an Italian MIUR grants to MAT (PRIN-2007 "Approccio integrato all'identificazione dei Gastrotrichi marini"), and grants from the Swedish Taxonomy Initiative to UJ and the US-National Science Foundation (n. DEB 0918499) to RH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dal Zotto Matteo, 2010, Meiofauna Marina, V18, P41; Garraffoni ARS, 2010, ZOOKEYS, P1, DOI 10.3897/zookeys.60.495; Giribet G, 2004, CLADISTICS, V20, P1, DOI 10.1111/j.1096-0031.2004.00004.x; Hochberg Rick, 2003, Meiofauna Marina, V12, P37; Hochberg Rick, 2008, Meiofauna Marina, V16, P101; Hummon WD, 2010, GLOBAL DATABASE MARI; Hummon WD, 2010, ZOOTAXA, P1; Hummon WD, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.94.794; Kanneby T, 2009, ZOOTAXA, P26, DOI 10.11646/zootaxa.2278.1.2; Kieneke A, 2008, ZOOL SCR, V37, P429, DOI 10.1111/j.1463-6409.2008.00334.x; KISIELEWSKI J, 1987, HYDROBIOLOGIA, V153, P23, DOI 10.1007/BF00005502; Nylander J. A. A., 2004, MRMODELTEST V2; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Petrov NB, 2007, MOL BIOL+, V41, P445, DOI 10.1134/S0026893307030107; Plazzi F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-209; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; RUTTNER-KOLISKO AGNES, 1955, OESTERREICH ZOOL ZEITSCHR, V6, P55; Sorensen MV, 2006, CLADISTICS, V22, P32, DOI 10.1111/j.1096-0031.2006.00085.x; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Todaro MA, 2006, ZOOL SCR, V35, P251, DOI 10.1111/j.1463-6409.2006.00228.x; Todaro MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017892; Todaro M. Antonio, 2008, Meiofauna Marina, V16, P3; Todaro MA, 2003, ZOOL ANZ, V242, P145, DOI 10.1078/0044-5231-00093	24	40	43	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31740	10.1371/journal.pone.0031740	http://dx.doi.org/10.1371/journal.pone.0031740			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348127	gold, Green Published			2022-12-25	WOS:000302737400047
J	Edgar, JL; Paul, ES; Harris, L; Penturn, S; Nicol, CJ				Edgar, Joanne L.; Paul, Elizabeth S.; Harris, Lauren; Penturn, Sarah; Nicol, Christine J.			No Evidence for Emotional Empathy in Chickens Observing Familiar Adult Conspecifics	PLOS ONE			English	Article							STRESS; SYSTEM; PAIN	The capacity of animals to empathise is of high potential relevance to the welfare of group-housed domestic animals. Emotional empathy is a multifaceted and multilayered phenomenon which ranges from relatively simple processes such as emotional matching behaviour to more complex processes involving interaction between emotional and cognitive perspective taking systems. Our previous research has demonstrated that hens show clear behavioural and physiological responses to the mild distress of their chicks. To investigate whether this capacity exists outside the mother/offspring bond, we conducted a similar experiment in which domestic hens were exposed to the mild distress of unrelated, but familiar adult conspecifics. Each observer hen was exposed to two replicates of four conditions, in counterbalanced order; control (C); control with noise of air puff (CN); air puff to conspecific hen (APC); air puff to observer hen (APH). During each test, the observer hens' behaviour and physiology were measured throughout a 10 min pre-treatment and a 10 min treatment period. Despite showing signs of distress in response to an aversive stimulus directed at themselves (APH), and using methodology sufficiently sensitive to detect empathy-like responses previously, observer hens showed no behavioural or physiological responses to the mild distress of a familiar adult conspecific. The lack of behavioural and physiological response indicates that hens show no basis for emotional empathy in this context.	[Edgar, Joanne L.; Paul, Elizabeth S.; Harris, Lauren; Penturn, Sarah; Nicol, Christine J.] Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England	University of Bristol	Edgar, JL (corresponding author), Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England.	j.edgar@bris.ac.uk	Nicol, Christine J/B-4841-2011	Nicol, Christine J/0000-0001-6734-2177; Edgar, Joanne/0000-0002-7729-1999	BBSRC Animal Welfare Initiative; Biotechnology and Biological Sciences Research Council [BB/C518949/1] Funding Source: researchfish	BBSRC Animal Welfare Initiative(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by the BBSRC Animal Welfare Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Busnardo C, 2010, AUTON NEUROSCI-BASIC, V158, P51, DOI 10.1016/j.autneu.2010.06.003; Campler M, 2009, BEHAV PROCESS, V81, P39, DOI 10.1016/j.beproc.2008.12.018; COLLIAS N, 1953, BEHAVIOUR, V5, P175, DOI 10.1163/156853953X00104; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Edgar JL, 2011, P ROY SOC B-BIOL SCI, V278, P3129, DOI 10.1098/rspb.2010.2701; Edgar JL, APPL ANIM B IN PRESS; Eisenberg N., 1986, ALTRUISTIC COGNITION; Jeon D, 2010, NAT NEUROSCI, V13, P482, DOI 10.1038/nn.2504; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; Lowe JC, 2007, COMPUT ELECTRON AGR, V57, P74, DOI 10.1016/j.compag.2007.02.003; Lowe TE, 2005, ANIM WELFARE, V14, P35; Nicol CJ, 2009, ANIM BEHAV, V78, P413, DOI 10.1016/j.anbehav.2009.05.016; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Preston SD, 2007, SOC NEUROSCI-UK, V2, P254, DOI 10.1080/17470910701376902; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Singer T, 2006, NEUROSCI BIOBEHAV R, V30, P855, DOI 10.1016/j.neubiorev.2006.06.011	16	22	24	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31542	10.1371/journal.pone.0031542	http://dx.doi.org/10.1371/journal.pone.0031542			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348100	Green Submitted, Green Published, gold			2022-12-25	WOS:000302733900051
J	Yamagata, K; Iwamoto, D; Terashita, Y; Li, C; Wakayama, S; Hayashi-Takanaka, Y; Kimura, H; Saeki, K; Wakayama, T				Yamagata, Kazuo; Iwamoto, Daisaku; Terashita, Yukari; Li, Chong; Wakayama, Sayaka; Hayashi-Takanaka, Yoko; Kimura, Hiroshi; Saeki, Kazuhiro; Wakayama, Teruhiko			Fluorescence Cell Imaging and Manipulation Using Conventional Halogen Lamp Microscopy	PLOS ONE			English	Article							FULL-TERM DEVELOPMENT; MOUSE OOCYTES; MAMMALIAN OOCYTES; IN-VITRO; IMMUNOFLUORESCENCE; FERTILIZATION; ACTIVATION; SPINDLE; EMBRYOS; NUCLEI	Technologies for vitally labeling cells with fluorescent dyes have advanced remarkably. However, to excite fluorescent dyes currently requires powerful illumination, which can cause phototoxic damage to the cells and increases the cost of microscopy. We have developed a filter system to excite fluorescent dyes using a conventional transmission microscope equipped with a halogen lamp. This method allows us to observe previously invisible cell organelles, such as the metaphase spindle of oocytes, without causing phototoxicity. Cells remain healthy even after intensive manipulation under fluorescence observation, such as during bovine, porcine and mouse somatic cell cloning using nuclear transfer. This method does not require expensive epifluorescence equipment and so could help to reduce the science gap between developed and developing countries.	[Yamagata, Kazuo; Terashita, Yukari; Li, Chong; Wakayama, Sayaka; Wakayama, Teruhiko] RIKEN Ctr Dev Biol, Kobe, Hyogo, Japan; [Yamagata, Kazuo] Osaka Univ, Res Inst Microbial Res, Suita, Osaka, Japan; [Iwamoto, Daisaku; Saeki, Kazuhiro] Kinki Univ, Dept Genet Engn, Wakayama, Japan; [Terashita, Yukari] Tohoku Univ, Grad Sch Agr Sci, Lab Anim Reprod, Sendai, Miyagi 980, Japan; [Hayashi-Takanaka, Yoko; Kimura, Hiroshi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan	RIKEN; Osaka University; Kindai University (Kinki University); Tohoku University; Osaka University	Yamagata, K (corresponding author), RIKEN Ctr Dev Biol, Kobe, Hyogo, Japan.	teru@cdb.riken.jp	Hayashi, Yoko/GPT-4159-2022; Kimura, Hiroshi/B-9524-2015	Kimura, Hiroshi/0000-0003-0854-083X; HAYASHI, Yoko/0000-0002-0556-6738	Scientific Research in Priority Areas [15080211]; Grants-in-Aid for Scientific Research [23248048] Funding Source: KAKEN	Scientific Research in Priority Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Financial support for this research was provided by Scientific Research in Priority Areas (15080211) to T. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Hayashi-Takanaka Y, 2011, NUCLEIC ACIDS RES, V39, P6475, DOI 10.1093/nar/gkr343; Hayashi-Takanaka Y, 2009, J CELL BIOL, V187, P781, DOI 10.1083/jcb.200904137; HEIMER GV, 1972, J CLIN PATHOL, V25, P88, DOI 10.1136/jcp.25.1.88; Hoshino Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004142; Kanatsu-Shinohara M, 2004, BIOL REPROD, V70, P70, DOI 10.1095/biolreprod.103.020867; KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709; Kishigami S, 2007, J REPROD DEVELOP, V53, P1207, DOI 10.1262/jrd.19067; LIDWELL OM, 1967, J CLIN PATHOL, V20, P214, DOI 10.1136/jcp.20.2.214; Liu L, 2000, NAT BIOTECHNOL, V18, P223, DOI 10.1038/72692; Ross PJ, 2006, BIOTECHNIQUES, V41, P741, DOI 10.2144/000112310; Silva CP, 1999, FERTIL STERIL, V71, P719, DOI 10.1016/S0015-0282(98)00530-5; Terasaki M., 1995, P327; Terashita Y, 2011, J REPROD DEVELOP, V57, P564, DOI 10.1262/jrd.11-015H; Van Thuan N, 2010, J REPROD DEVELOP, V56, P20, DOI 10.1262/jrd.09-221A; Wakayama S, 2007, CURR BIOL, V17, pR120, DOI 10.1016/j.cub.2006.12.020; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Westhusin ME, 1996, THERIOGENOLOGY, V46, P243, DOI 10.1016/0093-691X(96)00181-1; Yamagata K, 2009, J REPROD DEVELOP, V55, P343, DOI 10.1262/jrd.20166	18	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31638	10.1371/journal.pone.0031638	http://dx.doi.org/10.1371/journal.pone.0031638			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347500	gold, Green Published, Green Submitted			2022-12-25	WOS:000302730100080
J	Maulucci, G; De Spirito, M; Arcovito, G; Papi, M				Maulucci, Giuseppe; De Spirito, Marco; Arcovito, Giuseppe; Papi, Massimiliano			The Thermal Structural Transition of Alpha-Crystallin Modulates Subunit Interactions and Increases Protein Solubility	PLOS ONE			English	Article							CHAPERONE-LIKE ACTIVITY; QUATERNARY STRUCTURE; AGGREGATION; STABILITY	Background: Alpha crystallin is an oligomer composed of two types of subunits, alpha-A and alpha-B crystallin, and is the major constituent of human lens. The temperature induced condensation of alpha-crystallin, the main cause for eye lens opacification (cataract), is a two step-process, a nucleation followed by an aggregation phase, and a protective effect towards the aggregation is exhibited over the alpha crystallin phase transition temperature (Tc = 318.16 K). Methods/Results: To investigate if a modulation of the subunit interactions over Tc could trigger the protective mechanism towards the aggregation, we followed, by using simultaneously static and dynamic light scattering, the temperature induced condensation of alpha-crystallin. By developing a mathematical model able to uncouple the nucleation and aggregation processes, we find a previously unobserved transition in the nucleation rate constant. Its temperature dependence allows to determine fundamental structural parameters, the chemical potential (Delta mu) and the interfacial tension (gamma) of the aggregating phase, that characterize subunit interactions. Conclusions/General Significance: The decrease of both Delta mu and gamma at Tc, and a relative increase in solubility, reveal a significative decrease in the strenght of alpha-crystallin subunits interactions, which protects from supramolecolar condensation in hypertermic conditions. On the whole, we suggest a general approach able to understand the structural and kinetic mechanisms involved in aggregation-related diseases and in drugs development and testing.	[Maulucci, Giuseppe; De Spirito, Marco; Arcovito, Giuseppe; Papi, Massimiliano] Univ Cattolica Sacro Cuore, Ist Fis, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Maulucci, G (corresponding author), Univ Cattolica Sacro Cuore, Ist Fis, Rome, Italy.	m.despirito@rm.unicatt.it	Papi, Massimiliano/AAC-3657-2022; Maulucci, Giuseppe/C-7400-2009; De Spirito, Marco/C-5386-2008; Papi, Massimiliano/B-3168-2012; De Spirito, Marco/U-3817-2019	Papi, Massimiliano/0000-0002-0029-1309; Maulucci, Giuseppe/0000-0002-2154-319X; De Spirito, Marco/0000-0003-4260-5107; De Spirito, Marco/0000-0003-4260-5107				Bassi FA, 1995, BIOPHYS J, V69, P2720, DOI 10.1016/S0006-3495(95)80143-8; BERNE B. J., 1976, DYNAMIC LIGHT SCATTE; BIOSCA JA, 1983, FEBS LETT, V153, P217, DOI 10.1016/0014-5793(83)80151-3; CHEN SH, 1986, PHYS REV LETT, V57, P2583, DOI 10.1103/PhysRevLett.57.2583; Clark JI, 2000, CURR OPIN STRUC BIOL, V10, P52, DOI 10.1016/S0959-440X(99)00048-2; de Hoog EHA, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.021407; Debenedetti P.G., 1996, METASTABLE LIQUIDS C; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; Doss-Pepe EW, 1998, EXP EYE RES, V67, P657, DOI 10.1006/exer.1998.0561; Eaton W A, 1990, Adv Protein Chem, V40, P63, DOI 10.1016/S0065-3233(08)60287-9; Garland DL, 1996, EXP EYE RES, V62, P285, DOI 10.1006/exer.1996.0034; GUPTASARMA P, 1992, BIOCHEMISTRY-US, V31, P4296, DOI 10.1021/bi00132a021; Horwitz J, 2004, EXP EYE RES, V79, P817, DOI 10.1016/j.exer.2004.05.007; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; JEDZINIAK JA, 1972, INVEST OPHTH VISUAL, V11, P905; KOPPEL DE, 1972, J CHEM PHYS, V57, P4814, DOI 10.1063/1.1678153; KRAMPS HA, 1975, EUR J BIOCHEM, V50, P503, DOI 10.1111/j.1432-1033.1975.tb09889.x; Kusumoto Y, 1998, P NATL ACAD SCI USA, V95, P12277, DOI 10.1073/pnas.95.21.12277; Lasaga AC, 1998, KINETIC THEORY; Lattuada M, 2003, J COLLOID INTERF SCI, V268, P96, DOI 10.1016/j.jcis.2003.07.028; LUTHRA M, 1993, J BIOL CHEM, V268, P18119; Maulucci G, 2005, BIOPHYS J, V88, P3545, DOI 10.1529/biophysj.104.048876; Maulucci G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018906; MIESBAUER LR, 1994, J BIOL CHEM, V269, P12494; Milton K, 1969, SCATTERING LIGHT OTH SCATTERING LIGHT OTH, P414; Papi M, 2010, EUR BIOPHYS J BIOPHY, V39, P1597, DOI 10.1007/s00249-010-0617-8; Parasassi T, 2008, FASEB J, V22, P2350, DOI 10.1096/fj.07-097774; Putilina T, 2003, J BIOL CHEM, V278, P13747, DOI 10.1074/jbc.M208157200; Raman B, 1997, J BIOL CHEM, V272, P23559, DOI 10.1074/jbc.272.38.23559; RAMAN B, 1995, FEBS LETT, V365, P133, DOI 10.1016/0014-5793(95)00440-K; RAMAN B, 1994, J BIOL CHEM, V269, P27264; Ramkrishna B, 2000, POPULATION BALANCE; SANTINI SA, 1992, BIOCHEM J, V287, P107, DOI 10.1042/bj2870107; Seinfeld J. H., 1998, ATMOSPHERIC CHEM PHY; THORN M, 1994, PHYS REV LETT, V72, P3622, DOI 10.1103/PhysRevLett.72.3622; Tirado-Miranda M, 2003, EUR BIOPHYS J BIOPHY, V32, P128, DOI 10.1007/s00249-002-0275-6; WALSH MT, 1991, J BIOL CHEM, V266, P20079; WEITZ DA, 1986, PHYS REV LETT, V57, P2037, DOI 10.1103/PhysRevLett.57.2037; XIA JZ, 1994, BIOPHYS J, V66, P861, DOI 10.1016/S0006-3495(94)80862-8; ZHU PW, 1994, PHYS REV E, V50, P1360, DOI 10.1103/PhysRevE.50.1360	40	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e30705	10.1371/journal.pone.0030705	http://dx.doi.org/10.1371/journal.pone.0030705			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347398	Green Submitted, Green Published, gold			2022-12-25	WOS:000302180600014
J	Amorocho, DF; Abreu-Grobois, FA; Dutton, PH; Reina, RD				Amorocho, Diego F.; Alberto Abreu-Grobois, F.; Dutton, Peter H.; Reina, Richard D.			Multiple Distant Origins for Green Sea Turtles Aggregating off Gorgona Island in the Colombian Eastern Pacific	PLOS ONE			English	Article							CHELONIA-MYDAS-AGASSIZII; MITOCHONDRIAL-DNA; CONTROL REGION; POPULATION-STRUCTURE; MARINE TURTLES; NATIONAL-PARK; GENETICS; PHYLOGEOGRAPHY; STRATEGIES; DISPERSAL	Mitochondrial DNA analyses have been useful for resolving maternal lineages and migratory behavior to foraging grounds (FG) in sea turtles. However, little is known about source rookeries and haplotype composition of foraging green turtle aggregations in the southeastern Pacific. We used mitochondrial DNA control region sequences to identify the haplotype composition of 55 green turtles, Chelonia mydas, captured in foraging grounds of Gorgona National Park in the Colombian Pacific. Amplified fragments of the control region (457 bp) revealed the presence of seven haplotypes, with haplotype (h) and nucleotide (pi) diversities of h = 0.300 +/- 0.080 and pi = 0.009 +/- 0.005 respectively. The most common haplotype was CMP4 observed in 83% of individuals, followed by CMP22 (5%). The genetic composition of the Gorgona foraging population primarily comprised haplotypes that have been found at eastern Pacific rookeries including Mexico and the Galapagos, as well as haplotypes of unknown stock origin that likely originated from more distant western Pacific rookeries. Mixed stock analysis suggests that the Gorgona FG population is comprised mostly of animals from the Galapagos rookery (80%). Lagrangian drifter data showed that movement of turtles along the eastern Pacific coast and eastward from distant western and central Pacific sites was possible through passive drift. Our results highlight the importance of this protected area for conservation management of green turtles recruited from distant sites along the eastern Pacific Ocean.	[Amorocho, Diego F.; Reina, Richard D.] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Amorocho, Diego F.] Res Ctr Environm Management & Dev, Cali, Colombia; [Alberto Abreu-Grobois, F.] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Unidad Acad Mazatlan, Mazatlan, Sinaloa, Mexico; [Dutton, Peter H.] NOAA, Protected Resources Div, SW Fisheries Sci Ctr, La Jolla, CA USA	Monash University; Universidad Nacional Autonoma de Mexico; National Oceanic Atmospheric Admin (NOAA) - USA	Amorocho, DF (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic, Australia.	richard.reina@monash.edu	Grobois, Alberto Abreu/A-3560-2017; Reina, Richard/AAC-7017-2019	Grobois, Alberto Abreu/0000-0002-7350-757X; 	United States National Fish and Wildlife Foundation; Chelonian Research Foundation; Rufford Foundation; Monash University	United States National Fish and Wildlife Foundation; Chelonian Research Foundation; Rufford Foundation; Monash University(Monash University)	Funding was received from the following: United States National Fish and Wildlife Foundation funded fieldwork and analysis costs; the Chelonian Research Foundation funded fieldwork and analysis costs; the Rufford Foundation funded fieldwork, administrative and analysis costs; Monash University funded travel and analysis costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorocho DF, 2001, CONSERVACION TORTUGA; Amorocho DF, 2001, GORGONA MARINA CONTR, P141; Amorocho DF, 1992, CONTRIBUCION CONOCIM, P155; Amorocho Diego F., 2007, Endangered Species Research, V3, P43, DOI 10.3354/esr003043; Amorocho DF, 2008, J EXP MAR BIOL ECOL, V360, P117, DOI 10.1016/j.jembe.2008.04.009; Balazs George H., 1999, P101; Balazs George H., 2006, Atoll Research Bulletin, P147; Baquero Gallegos A, 2008, S TORT MAR PAC OR LI, P116; Bass AL, 1998, COPEIA, P1064; Bass AL, 2000, HERPETOLOGICA, V56, P357; Bass AL, 2006, J HERED, V97, P346, DOI 10.1093/jhered/esl004; Bjorndal KA, 2005, MAR BIOL, V147, P1449, DOI 10.1007/s00227-005-0045-y; Bolker BM, 2007, MOL ECOL, V16, P685, DOI 10.1111/j.1365-294X.2006.03161.x; Bourjea J, 2007, MOL ECOL, V16, P175, DOI 10.1111/j.1365-294X.2006.03122.x; Bowen BW, 2007, MOL ECOL, V16, P4886, DOI 10.1111/j.1365-294X.2007.03542.x; Bowen BW, 2007, MOL ECOL, V16, P49, DOI 10.1111/j.1365-294X.2006.03096.x; Bowen B. W., 1995, CONSERV GENET, P190; Bowen Brian W., 1997, P29; BOWEN BW, 1992, EVOLUTION, V46, P865, DOI 10.1111/j.1558-5646.1992.tb00605.x; Bowen BW, 2000, MARINE TURTLE NEWSLE, P20; Broderick AC, 2007, P ROY SOC B-BIOL SCI, V274, P1533, DOI 10.1098/rspb.2007.0211; Chassin-Noria O, 2004, GENETICA, V121, P195, DOI 10.1023/B:GENE.0000040394.47843.e4; Davenport J, 1997, J THERM BIOL, V22, P479, DOI 10.1016/S0306-4565(97)00066-1; Dethmers KEM, 2006, MOL ECOL, V15, P3931, DOI 10.1111/j.1365-294X.2006.03070.x; Dutton Peter, 1995, Marine Turtle Newsletter, V69, P9; Dutton PH, 2008, OCEAN DEV INT LAW, V39, P200, DOI 10.1080/00908320802013685; Dutton PH, 2009, MOL ECOL RESOUR, V9, P354, DOI 10.1111/j.1755-0998.2008.02443.x; Dutton Peter H., 2008, Endangered Species Research, V5, P37, DOI 10.3354/esr00101; Dutton PH, 2007, P 22 ANN S SEA TURTL; Dutton PH, 1994, P 14 ANN S SEA TURTL; Eguchi T, 2010, MAR BIOL, V157, P1869, DOI 10.1007/s00227-010-1458-9; Encalada SE, 1996, MOL ECOL, V5, P473; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FitzSimmons NN, 1997, P NATL ACAD SCI USA, V94, P8912, DOI 10.1073/pnas.94.16.8912; Hansen L, 2007, P 24 ANN S SEA TURTL; HIRTH HF, 1997, SYNOPSIS BIOL DATA G; Juarez-Ceron JA, 2002, P 22 ANN S SEA TURTL, P70; Kessler WS, 2006, PROG OCEANOGR, V69, P181, DOI 10.1016/j.pocean.2006.03.009; Koch V, 2007, MAR BIOL, V153, P35, DOI 10.1007/s00227-007-0782-1; LAHANAS PN, 1994, GENETICA, V94, P57, DOI 10.1007/BF01429220; Lopez-Castro Melania C., 2010, Endangered Species Research, V11, P35, DOI 10.3354/esr00264; Luke K, 2004, MAR BIOL, V144, P799, DOI 10.1007/s00227-003-1241-2; Luschi P, 2003, OIKOS, V103, P293, DOI 10.1034/j.1600-0706.2003.12123.x; Meylan AB., 1982, BIOL CONSERVATION SE, P91; Monzon-Arguello C, 2010, J BIOGEOGR, V37, P1752, DOI 10.1111/j.1365-2699.2010.02326.x; Musick John A., 1997, P137; Naro-Maciel E, 2007, J HERED, V98, P29, DOI 10.1093/jhered/esl050; Nei M, 1987, MOL EVOLUTIONARY GEN; Nishizawa H, 2010, ZOOL SCI, V27, P14, DOI 10.2108/zsj.27.14; NORMAN JA, 1994, MOL ECOL, V3, P363, DOI 10.1111/j.1365-294X.1994.tb00076.x; Pritchard Peter C.H., 1999, P21; Roden SE, 2009, MOL ECOL RESOUR, V9, P1055, DOI 10.1111/j.1755-0998.2009.02573.x; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Seminoff JA, 2007, 130 NAT MAR FISH SER; Seminoff Jeffrey A., 2008, Endangered Species Research, V4, P57, DOI 10.3354/esr00066; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Velez-Zuazo X, 2008, MOL ECOL, V17, P839, DOI 10.1111/j.1365-294X.2007.03635.x; Wallace BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015465; Zarate P, EVALUACION AREAS ALI; Zarate P, 2007, P 24 ANN S SEA TURTL; Zarate PM, 2006, 26 ANN S SEA TURTL B	65	42	46	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e31486	10.1371/journal.pone.0031486	http://dx.doi.org/10.1371/journal.pone.0031486			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319635	Green Submitted, gold, Green Published			2022-12-25	WOS:000301979000030
J	Su, PH; Lin, YW; Huang, RL; Liao, YP; Lee, HY; Wang, HC; Chao, TK; Chen, CK; Chan, MWY; Chu, TY; Yu, MH; Lai, HC				Su, P-H; Lin, Y-W; Huang, R-L; Liao, Y-P; Lee, H-Y; Wang, H-C; Chao, T-K; Chen, C-K; Chan, M. W. Y.; Chu, T-Y; Yu, M-H; Lai, H-C			Epigenetic silencing of PTPRR activates MAPK signaling, promotes metastasis and serves as a biomarker of invasive cervical cancer	ONCOGENE			English	Article						protein tyrosine phosphatase receptor type R; DNA methyltransferase; mitogen-activated protein kinase; metastasis; methylation; cervical cancer	PROTEIN-TYROSINE PHOSPHATASES; TO-MESENCHYMAL TRANSITION; RISK HUMAN-PAPILLOMAVIRUS; DNA METHYLATION MARKERS; EPITHELIAL-CELLS; E-CADHERIN; INTRAEPITHELIAL NEOPLASIA; INDUCED CARCINOGENESIS; ONCOGENE EXPRESSION; MOTOR COORDINATION	Epigenetic modifications are a driving force in carcinogenesis. However, their role in cancer metastasis remains poorly understood. The present study investigated the role of DNA methylation in the cervical cancer metastasis. Here, we report evidence of the overexpression of DNA methyltransferases 3B (DNMT3B) in invasive cervical cancer and of the inhibition of metastasis by DNMT3B interference. Using methyl-DNA immunoprecipitation coupled with microarray analysis, we found that the protein tyrosine phosphatase receptor type R (PTPRR) was silenced through DNMT3B-mediated methylation in the cervical cancer. PTPRR inhibited p44/42 MAPK signaling, the expression of the transcription factor AP1, human papillomavirus (HPV) oncogenes E6/E7 and DNMTs. The methylation status of PTPRR increased in cervical scrapings (n = 358) in accordance with disease severity, especially in invasive cancer. Methylation of the PTPRR promoter has an important role in the metastasis and may be a biomarker of invasive cervical cancer. Oncogene (2013) 32, 15-26; doi:10.1038/onc.2012.29; published online 13 February 2012	[Huang, R-L; Lee, H-Y; Wang, H-C; Yu, M-H; Lai, H-C] Natl Def Med Ctr, Triserv Gen Hosp, Dept Obstet & Gynecol, Taipei City 114, Taiwan; [Su, P-H; Lai, H-C] Natl Def Med Ctr, Lab Epigenet & Canc Stem Cells, Taipei City 114, Taiwan; [Lin, Y-W] Natl Def Med Ctr, Dept Microbiol & Immunol, Taipei City 114, Taiwan; [Liao, Y-P; Chen, C-K; Lai, H-C] Natl Def Med Ctr, Grad Inst Life Sci, Taipei City 114, Taiwan; [Chao, T-K] Triserv Gen Hosp, Dept Pathol, Taipei, Taiwan; [Chan, M. W. Y.] Natl Chung Cheng Univ, Dept Life Sci, Min Hsiung, Chia Yi, Taiwan; [Chu, T-Y] Tzu Chi Univ, Dept Obstet & Gynecol, Hualien, Taiwan; [Su, P-H; Lai, H-C] Natl Def Med Ctr, Grad Inst Med Sci, Taipei City 114, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Chung Cheng University; Tzu Chi University; National Defense Medical Center	Lai, HC (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Obstet & Gynecol, 5F,325,Sec 2,Cheng Gong Rd, Taipei City 114, Taiwan.	hclai@ndmctsgh.edu.tw	Chan, Michael/F-9615-2018	Chan, Michael/0000-0003-1431-322X; Chan, Michael/0000-0003-0314-2437; Chu, Tang-Yuan/0000-0003-2717-2681; Huang, Rui Lan/0000-0001-6458-4672	National Science Council, Taiwan, ROC [NSC98-2314-B-016-030-MY3]; Tri-Service General Hospital [TSGH-C100-010-014-S01, TSGH-C100-010-014-S02]; Teh-Tzer Study Group for Human Medical Research Foundation	National Science Council, Taiwan, ROC(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital; Teh-Tzer Study Group for Human Medical Research Foundation	This work was supported by Grant NSC98-2314-B-016-030-MY3 from the National Science Council, Taiwan, ROC (to H-CL); Grant TSGH-C100-010-014-S01 (to M-HY) and TSGH-C100-010-014-S02 (H-CL) from the Tri-Service General Hospital and Teh-Tzer Study Group for Human Medical Research Foundation (to H-CL).	Ahluwalia A, 2001, GYNECOL ONCOL, V82, P299, DOI 10.1006/gyno.2001.6284; Amara K, 2010, CANCER SCI, V101, P1722, DOI 10.1111/j.1349-7006.2010.01569.x; Berger JC, 2005, CANCER BIOL THER, V4, P805, DOI 10.4161/cbt.4.8.1865; Blanco-Aparicio C, 1999, J CELL BIOL, V147, P1129, DOI 10.1083/jcb.147.6.1129; Branca M, 2004, AM J CLIN PATHOL, V122, P902, DOI 10.1309/VQXFT880JXC7QD2W; Burgers WA, 2007, ONCOGENE, V26, P1650, DOI 10.1038/sj.onc.1209950; Buschbeck M, 2002, J BIOL CHEM, V277, P29503, DOI 10.1074/jbc.M202149200; BUTZ K, 1993, J VIROL, V67, P6476, DOI 10.1128/JVI.67.11.6476-6486.1993; Caberg JHD, 2008, CARCINOGENESIS, V29, P1441, DOI 10.1093/carcin/bgn145; Chen HM, 2009, CANCER RES, V69, P9228, DOI 10.1158/0008-5472.CAN-09-1950; Chirivi RGS, 2007, J NEUROCHEM, V101, P829, DOI 10.1111/j.1471-4159.2006.04398.x; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Chung MT, 2009, GYNECOL ONCOL, V112, P646, DOI 10.1016/j.ygyno.2008.10.026; Chung MT, 2009, GYNECOL ONCOL, V112, P301, DOI 10.1016/j.ygyno.2008.10.004; de Wilde J, 2008, CELL ONCOL, V30, P77; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fujisawa T, 2011, INT J CANC; Girault I, 2003, CLIN CANCER RES, V9, P4415; Gu W, 2011, CANCER GENE THER, V18, P897, DOI 10.1038/cgt.2011.58; Hellner K, 2009, VIROLOGY, V391, P57, DOI 10.1016/j.virol.2009.05.036; Hickson JA, 2006, CANCER RES, V66, P2264, DOI 10.1158/0008-5472.CAN-05-3676; Horiguchi K, 2009, J BIOL CHEM, V284, P245, DOI 10.1074/jbc.M804777200; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jin BL, 2009, CANCER RES, V69, P7412, DOI 10.1158/0008-5472.CAN-09-0116; Jones PA, 2009, NAT REV GENET, V10, P805, DOI 10.1038/nrg2651; Kikuchi K, 1996, VIRUS GENES, V13, P45, DOI 10.1007/BF00576977; Kwon O, 2010, CARCINOGENESIS; Kyo S, 1997, J GEN VIROL, V78, P401, DOI 10.1099/0022-1317-78-2-401; Lai HC, 2010, CANCER; Lai HC, 2008, INT J CANCER, V123, P161, DOI 10.1002/ijc.23519; Laurson J, 2010, CARCINOGENESIS, V31, P918, DOI 10.1093/carcin/bgq027; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Lemieux E, 2009, INT J CANCER, V125, P1575, DOI 10.1002/ijc.24485; Lichtig H, 2010, VIROLOGY, V396, P47, DOI 10.1016/j.virol.2009.10.011; Lin YW, 2009, J CANCER RES CLIN, V135, P1665, DOI 10.1007/s00432-009-0613-5; Liu CY, 2009, J PATHOL, V219, P222, DOI 10.1002/path.2589; Menigatti M, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-124; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Motiwala T, 2004, P NATL ACAD SCI USA, V101, P13844, DOI 10.1073/pnas.0405451101; Narisawa-Saito M, 2007, CANCER SCI, V98, P1505, DOI 10.1111/j.1349-7006.2007.00546.x; Nephew KP, 2009, GYNECOL ONCOL, V112, P291, DOI 10.1016/j.ygyno.2008.12.016; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Noordman Yvet E, 2006, J Mol Signal, V1, P4, DOI 10.1186/1750-2187-1-4; Nussenzweig MC, 2004, NAT MED, V10, P1304, DOI 10.1038/nm1204-1304; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; OSTOR AG, 1993, INT J GYNECOL PATHOL, V12, P186; Paschos K, 2010, TRENDS MICROBIOL, V18, P439, DOI 10.1016/j.tim.2010.07.003; Prusty BK, 2005, INT J CANCER, V113, P951, DOI 10.1002/ijc.20668; Pulido R, 1998, EMBO J, V17, P7337, DOI 10.1093/emboj/17.24.7337; Rhee I, 2000, NATURE, V404, P1003, DOI 10.1038/35010000; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Rodenhiser DI, 2009, CLIN EXP METASTAS, V26, P5, DOI 10.1007/s10585-008-9166-2; Rodriguez-Sastre MA, 2005, GYNECOL ONCOL, V97, P330, DOI 10.1016/j.ygyno.2004.12.062; Sankpal NV, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3070; Schmitt I, 2009, CEREBELLUM, V8, P71, DOI 10.1007/s12311-009-0118-4; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Shi HD, 2003, CANCER RES, V63, P2164; Sova P, 2006, CANCER EPIDEM BIOMAR, V15, P114, DOI 10.1158/1055-9965.EPI-05-0323; Strippoli R, 2008, DIS MODEL MECH, V1, P264, DOI 10.1242/dmm.001321; Szalmas A, 2009, SEMIN CANCER BIOL, V19, P144, DOI 10.1016/j.semcancer.2009.02.011; Talora C, 2002, GENE DEV, V16, P2252, DOI 10.1101/gad.988902; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Veeck J, 2010, J MAMMARY GLAND BIOL, V15, P5, DOI 10.1007/s10911-010-9165-1; Veeriah S, 2009, P NATL ACAD SCI USA, V106, P9435, DOI 10.1073/pnas.0900571106; Wang SS, 2008, CANCER RES, V68, P2489, DOI 10.1158/0008-5472.CAN-07-3194; Weng YI, 2009, METHODS MOL BIOL, V590, P165, DOI 10.1007/978-1-60327-378-7_10; Wentzensen N, 2009, GYNECOL ONCOL, V112, P293, DOI 10.1016/j.ygyno.2008.10.012; WHO/ICO, 2010, HUM PAP REL CANC WOR; Wilting S, 2006, J PATHOL, V209, P220, DOI 10.1002/path.1966; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050; Yaqinuddin A, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-13; zur Hausen H, 2001, JNCI-J NATL CANCER I, V93, P252	74	49	50	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2013	32	1					15	26		10.1038/onc.2012.29	http://dx.doi.org/10.1038/onc.2012.29			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	063VG	22330137				2022-12-25	WOS:000313029500002
J	Cork, SM; Kaur, B; Devi, NS; Cooper, L; Saltz, JH; Sandberg, EM; Kaluz, S; Van Meir, EG				Cork, S. M.; Kaur, B.; Devi, N. S.; Cooper, L.; Saltz, J. H.; Sandberg, E. M.; Kaluz, S.; Van Meir, E. G.			A proprotein convertase/MMP-14 proteolytic cascade releases a novel 40 kDa vasculostatin from tumor suppressor BAI1	ONCOGENE			English	Article						angiogenesis; cancer; brain; glioma	BRAIN-SPECIFIC ANGIOGENESIS; IN-VIVO ANGIOGENESIS; COLORECTAL-CANCER; TYPE-1 REPEATS; P53 EXPRESSION; CELL-ADHESION; INHIBITOR-1; PROTEIN; FURIN; GENE	Brain-specific angiogenesis inhibitor 1 (BAI1), an orphan G protein-coupled receptor-type seven transmembrane protein, was recently found mutated or silenced in multiple human cancers and can interfere with tumor growth when overexpressed. Yet, little is known about its regulation and the molecular mechanisms through which this novel tumor suppressor exerts its anticancer effects. Here, we demonstrate that the N terminus of BAI1 is cleaved extracellularly to generate a truncated receptor and a 40-kDa fragment (Vasculostatin-40) that inhibits angiogenesis. We demonstrate that this novel proteolytic processing event depends on a two-step cascade of protease activation: proprotein convertases, primarily furin, activate latent matrix metalloproteinase-14, which then directly cleaves BAI1 to release the bioactive fragment. These findings significantly augment our knowledge of BAI1 by showing a novel post-translational mechanism regulating BAI1 activity through cancer-associated proteases, have important implications for BAI1 function and regulation, and present novel opportunities for therapy of cancer and other vascular diseases. Oncogene (2012) 31, 5144-5152; doi:10.1038/onc.2012.1; published online 13 February 2012	[Saltz, J. H.; Kaluz, S.; Van Meir, E. G.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Cork, S. M.; Kaur, B.; Devi, N. S.; Sandberg, E. M.; Kaluz, S.; Van Meir, E. G.] Emory Univ, Sch Med, Dept Neurosurg, Lab Mol Neurooncol, Atlanta, GA 30322 USA; [Cooper, L.; Saltz, J. H.] Emory Univ, Ctr Comprehens Informat, Atlanta, GA 30322 USA; [Van Meir, E. G.] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University	Van Meir, EG (corresponding author), Emory Univ, Winship Canc Inst, 1365C Clifton Rd NE,Room C5078, Atlanta, GA 30322 USA.	evanmei@emory.edu	kaur, Balveen/E-3355-2011	Van Meir, Erwin G./0000-0003-2444-7707; Kaluz, Stefan/0000-0002-6273-3766	US National Institutes of Health [R01 CA86335, 29XS193]; Winship Cancer Institute [P30 CA138292]; Emory Neurosciences Initiative; NATIONAL CANCER INSTITUTE [P30CA138292, R01CA086335, R01CA150153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064607, P30NS045758] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Winship Cancer Institute; Emory Neurosciences Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Paper contributions. SMC performed Vstat40 characterization, angiogenesis, cleavage site detection and furin/MMP-14 protease identification experiments, and SMC and EGVM wrote the manuscript. NSD, BK, EMS and SK performed Vstat40 and protease identification experiments. LC and JHS performed the survival analysis. Experiments were conceived of and planned by the respective authors under the direction of EGVM. We appreciate the helpful advice and assistance of all members of the Laboratory of Molecular Neuro-Oncology. SMC was in the Emory graduate program in Neuroscience and acknowledges project guidance by her thesis committee (Drs Randy Hall, Robert McKeon, Paula Vertino and Wei Zhou). We thank Dr C Dubois (Universitede Sherbrooke) for the kind gift of LoVo cells. The US National Institutes of Health (R01 CA86335 to EGVM and contract 29XS193 to JHS), P30 CA138292 (to the Winship Cancer Institute) and the Emory Neurosciences Initiative (to EGVM) contributed to the funding of this research.	Bassi DE, 2001, MOL CARCINOGEN, V31, P224, DOI 10.1002/mc.1057; BECKSICKINGER AG, 1992, EUR J BIOCHEM, V206, P957, DOI 10.1111/j.1432-1033.1992.tb17006.x; Belkin AM, 2001, J BIOL CHEM, V276, P18415, DOI 10.1074/jbc.M010135200; Bjarnadottir TK, 2004, GENOMICS, V84, P23, DOI 10.1016/j.ygeno.2003.12.004; Cao J, 2005, J BIOL CHEM, V280, P10974, DOI 10.1074/jbc.M412370200; Cork SM, 2011, J MOL MED, V89, P743, DOI 10.1007/s00109-011-0759-x; Dawson DW, 1997, J CELL BIOL, V138, P707, DOI 10.1083/jcb.138.3.707; de Fraipont F, 2001, TRENDS MOL MED, V7, P401, DOI 10.1016/S1471-4914(01)02102-5; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Duda DG, 2002, BRIT J CANCER, V86, P490, DOI 10.1038/sj.bjc.6600067; Fillmore HL, 2001, J NEURO-ONCOL, V53, P187, DOI 10.1023/A:1012213604731; Fukushima Y, 1998, INT J ONCOL, V13, P967; Guedez L, 2003, AM J PATHOL, V162, P1431, DOI 10.1016/S0002-9440(10)64276-9; Gupta K, 1999, Angiogenesis, V3, P147, DOI 10.1023/A:1009018702832; Hardcastle J, 2010, MOL THER, V18, P285, DOI 10.1038/mt.2009.232; Hatanaka H, 2000, INT J MOL MED, V5, P181; Hotary KB, 2002, J EXP MED, V195, P295, DOI 10.1084/jem.20010815; Hsiao CC, 2009, FEBS LETT, V583, P3285, DOI 10.1016/j.febslet.2009.09.001; Ishii N, 1999, BRAIN PATHOL, V9, P469, DOI 10.1111/j.1750-3639.1999.tb00536.x; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; Jin ZH, 2007, HUM MOL GENET, V16, P1972, DOI 10.1093/hmg/ddm144; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kaur B, 2005, ONCOGENE, V24, P3632, DOI 10.1038/sj.onc.1208317; Kaur B, 2003, AM J PATHOL, V162, P19, DOI 10.1016/S0002-9440(10)63794-7; Kaur B, 2009, CANCER RES, V69, P1212, DOI 10.1158/0008-5472.CAN-08-1166; Klenotic PA, 2010, AM J PATHOL, V176, P2039, DOI 10.2353/ajpath.2010.090782; Krasnoperov V, 2002, J BIOL CHEM, V277, P46518, DOI 10.1074/jbc.M206415200; Kudo S, 2007, ONCOL REP, V18, P785; Lin HH, 2004, J BIOL CHEM, V279, P31823, DOI 10.1074/jbc.M402974200; Mercapide J, 2002, CLIN CANCER RES, V8, P1740; Nam DH, 2004, ONCOL REP, V11, P863; Nicholson AC, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-11; Nishimori H, 1997, ONCOGENE, V15, P2145, DOI 10.1038/sj.onc.1201542; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Sato H, 1996, FEBS LETT, V393, P101, DOI 10.1016/0014-5793(96)00861-7; TAKAHASHI S, 1995, J BIOL CHEM, V270, P26565, DOI 10.1074/jbc.270.44.26565; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; VAN MEIR EG, 1994, NAT GENET, V8, P171, DOI 10.1038/ng1094-171; Yee KO, 2004, AM J PATHOL, V165, P541, DOI 10.1016/S0002-9440(10)63319-6; Yoon KC, 2005, GENE THER, V12, P617, DOI 10.1038/sj.gt.3302442; Yoshida Y, 1999, INT J ONCOL, V15, P1221; Zhang XF, 2007, MICROVASC RES, V74, P90, DOI 10.1016/j.mvr.2007.04.007; Zhu D, 2011, CANCER RES, V71, P5859, DOI 10.1158/0008-5472.CAN-11-1157	46	56	57	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	DEC	2012	31	50					5144	5152		10.1038/onc.2012.1	http://dx.doi.org/10.1038/onc.2012.1			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	055WY	22330140	Green Accepted			2022-12-25	WOS:000312449800003
J	Bongiovanni, A; Romancino, DP; Campos, Y; Paterniti, G; Qiu, XH; Moshiach, S; Di Felice, V; Vergani, N; Ustek, D; d'Azzo, A				Bongiovanni, Antonella; Romancino, Daniele P.; Campos, Yvan; Paterniti, Gaetano; Qiu, Xiaohui; Moshiach, Simon; Di Felice, Valentina; Vergani, Naja; Ustek, Duran; d'Azzo, Alessandra			Alix Protein Is Substrate of Ozz-E3 Ligase and Modulates Actin Remodeling in Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR DOWN-REGULATION; UBIQUITIN LIGASE; CORTICAL ACTIN; CELL-MIGRATION; HIV-1 RELEASE; ESCRT; DYNAMICS; CYTOSKELETON; CYTOKINESIS; ENDOCYTOSIS	Alix/AIP1 is a multifunctional adaptor protein that participates in basic cellular processes, including membrane trafficking and actin cytoskeleton assembly, by binding selectively to a variety of partner proteins. However, the mechanisms regulating Alix turnover, subcellular distribution, and function in muscle cells are unknown. We now report that Alix is expressed in skeletal muscle throughout myogenic differentiation. In myotubes, a specific pool of Alix colocalizes with Ozz, the substrate-binding component of the muscle-specific ubiquitin ligase complex Ozz-E3. We found that interaction of the two endogenous proteins in the differentiated muscle fibers changes Alix conformation and promotes its ubiquitination. This in turn regulates the levels of the protein in specific subcompartments, in particular the one containing the actin polymerization factor cortactin. In Ozz(-/-) myotubes, the levels of filamentous (F)-actin is perturbed, and Alix accumulates in large puncta positive for cortactin. In line with this observation, we show that the knockdown of Alix expression in C2C12 muscle cells affects the amount and distribution of F-actin, which consequently leads to changes in cell morphology, impaired formation of sarcolemmal protrusions, and defective cell motility. These findings suggest that the Ozz-E3 ligase regulates Alix at sites where the actin cytoskeleton undergoes remodeling.	[Bongiovanni, Antonella; Romancino, Daniele P.; Paterniti, Gaetano] CNR, Inst Biomed & Mol Immunol, I-90146 Palermo, Italy; [Campos, Yvan; Qiu, Xiaohui; Moshiach, Simon; Vergani, Naja; Ustek, Duran; d'Azzo, Alessandra] St Jude Childrens Res Hosp, Dept Genet, Memphis, TN 38105 USA; [Di Felice, Valentina] Univ Palermo, Dept Expt Biomed & Clin Neurosci, I-90127 Palermo, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR); St Jude Children's Research Hospital; University of Palermo	Bongiovanni, A (corresponding author), CNR, Inst Biomed & Mol Immunol, Via Ugo La Malfa 153, I-90146 Palermo, Italy.	bongiovanni@ibim.cnr.it; sandra.dazzo@stjude.org	Romancino, Daniele/C-3031-2015; Ustek, Duran/C-3484-2009; Di Felice, Valentina/AAG-3740-2021; Di Felice, Valentina/A-4457-2009; Bongiovanni, Antonella/AAX-5051-2020	Ustek, Duran/0000-0002-0060-2859; Di Felice, Valentina/0000-0002-4132-1260; Di Felice, Valentina/0000-0002-4132-1260; Bongiovanni, Antonella/0000-0002-0307-4043; Romancino, Daniele/0000-0003-2041-0122	National Institutes of Health from USPHS [AR049867, CA021765]; National Institutes of Health from NCI; Assisi Foundation of Memphis; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049867] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Assisi Foundation of Memphis; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR049867 and CA021765 from USPHS and NCI (to A. d'A.). This work was also supported by the Assisi Foundation of Memphis and the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital (to A. d'A.).	Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Cabezas A, 2005, J CELL SCI, V118, P2625, DOI 10.1242/jcs.02382; Campos Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009866; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; CONDEELIS J, 1993, ANNU REV CELL BIOL, V9, P411, DOI 10.1146/annurev.cb.09.110193.002211; Cory GOC, 2007, CURR BIOL, V17, pR455, DOI 10.1016/j.cub.2007.04.015; Di Felice V, 2007, BIOL CELL, V99, P689, DOI 10.1042/BC20070043; Di Felice V, 2009, J CELL PHYSIOL, V221, P729, DOI 10.1002/jcp.21912; Dunn G. A., 1980, BSCB S, V3, P409; Fisher RD, 2007, CELL, V128, P841, DOI 10.1016/j.cell.2007.01.035; Grinnell F, 1978, Int Rev Cytol, V53, P65; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kim JW, 2005, DEV CELL, V8, P937, DOI 10.1016/j.devcel.2005.04.001; Lynch DK, 2003, J BIOL CHEM, V278, P21805, DOI 10.1074/jbc.M211407200; Marquette ML, 2008, IN VITRO CELL DEV-AN, V44, P105, DOI 10.1007/s11626-007-9078-5; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Missotten M, 1999, CELL DEATH DIFFER, V6, P124, DOI 10.1038/sj.cdd.4400456; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Nastasi T, 2004, DEV CELL, V6, P269, DOI 10.1016/S1534-5807(04)00020-6; Nikko E, 2007, EUKARYOT CELL, V6, P1266, DOI 10.1128/EC.00024-07; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Odorizzi G, 2006, J CELL SCI, V119, P3025, DOI 10.1242/jcs.03072; ORDAHL CP, 1992, DEVELOPMENT, V114, P339; Orth JD, 2006, CANCER RES, V66, P3603, DOI 10.1158/0008-5472.CAN-05-2916; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Pan S, 2006, J BIOL CHEM, V281, P34640, DOI 10.1074/jbc.M602263200; Persons DA, 1999, BLOOD, V93, P488, DOI 10.1182/blood.V93.2.488.402k17_488_499; Pires R, 2009, STRUCTURE, V17, P843, DOI 10.1016/j.str.2009.04.007; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; Richter C, 2007, EMBO J, V26, P2454, DOI 10.1038/sj.emboj.7601692; Schmidt MHH, 2004, MOL CELL BIOL, V24, P8981, DOI 10.1128/MCB.24.20.8981-8993.2004; Sette P, 2010, J VIROL, V84, P8181, DOI 10.1128/JVI.00634-10; Somogyi K, 2004, MECH DEVELOP, V121, P57, DOI 10.1016/j.mod.2003.10.003; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Vito P, 1999, J BIOL CHEM, V274, P1533, DOI 10.1074/jbc.274.3.1533; Votteler J, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-12; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Welch MD, 1997, CURR OPIN CELL BIOL, V9, P54, DOI 10.1016/S0955-0674(97)80152-4; Zhai QT, 2011, J VIROL, V85, P9222, DOI 10.1128/JVI.02653-10; Zhou X, 2008, BIOCHEM J, V414, P215, DOI 10.1042/BJ20080642	43	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12159	12171		10.1074/jbc.M111.297036	http://dx.doi.org/10.1074/jbc.M111.297036			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334701	Green Published, hybrid			2022-12-25	WOS:000302782200058
J	Shi, JH; Zheng, B; Chen, S; Ma, GY; Wen, JK				Shi, Jian-hong; Zheng, Bin; Chen, Si; Ma, Guo-yan; Wen, Jin-kun			Retinoic Acid Receptor alpha Mediates All-trans-retinoic Acid-induced Klf4 Gene Expression by Regulating Klf4 Promoter Activity in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTOR; GROWTH-INHIBITION; HDAC2 PHOSPHORYLATION; INDUCED ACTIVATION; INTERFERON-GAMMA; BINDING PROTEIN; CAROTID-ARTERY; RAR-ALPHA; TRANSCRIPTION; FACTOR-4	The transcription factor Kruppel-like factor 4 (KLF4) plays a critical role in vascular smooth muscle cell (VSMC) differentiation induced by all-trans-retinoic acid (ATRA). Although it has been demonstrated that ATRA stimulation augments both KLF4 protein and mRNA levels in VSMCs, the molecular mechanisms by which ATRA regulates Klf4 transcription are unknown. In this study, we examined the roles of ATRA-selective nuclear retinoic acid receptors (RARs) in the transcriptional regulation of Klf4. The introduction of small interfering RNA and an RAR antagonist demonstrated that RAR alpha, but not RAR beta or RAR gamma, mediated ATRA-induced Klf4 expression. A luciferase assay for the Klf4 promoter showed that three GC boxes in the proximal Klf4 promoter were indispensible for ATRA-induced Klf4 transcription and that RAR alpha enhanced Klf4 promoter activity in a GC box-dependent manner. Furthermore, chromatin immunoprecipitation and oligonucleotide pulldown assays demonstrated that the transcription factors KLF4, Sp1, and YB1 directly bound to the GC boxes of the proximal Klf4 promoter. Upon RAR alpha agonist stimulation, RAR alpha was recruited to the Klf4 promoter through its interaction with KLF4, Sp1, and YB1 to form a transcriptional activation complex on the three GC boxes of the Klf4 promoter. These results suggest that RAR alpha serves as an essential co-activator for ATRA signaling and that the recruitment of RAR alpha to the KLF4-Sp1-YB1 complex, which leads to Klf4 expression in VSMCs, is independent of a retinoic acid response element.	[Shi, Jian-hong; Zheng, Bin; Chen, Si; Ma, Guo-yan; Wen, Jin-kun] Hebei Med Univ, Dept Biochem & Mol Biol, Key Lab Neurobiol & Vasc Biol, China Adm Educ, Shijiazhuang 050017, Peoples R China; [Shi, Jian-hong] Hebei Univ, Basic Med Sch, Baoding 071000, Peoples R China	Hebei Medical University; Hebei University	Wen, JK (corresponding author), Hebei Med Univ, Dept Biochem & Mol Biol, Key Lab Neurobiol & Vasc Biol, China Adm Educ, 361 Zhongshan E Rd, Shijiazhuang 050017, Peoples R China.	wjk@hebmu.edu.cn	Shi, Jian-hong/AAF-6078-2019; Shi, Jian-hong/AAP-5703-2021	Shi, Jian-hong/0000-0003-2232-1000; Wen, Jinkun/0000-0002-8453-4549	National Natural Science Foundation of China [30971457, 90919035, 30871272, 31071003]; National Basic Research Program of China [2012CB518601]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work is supported by National Natural Science Foundation of China Grants 30971457, 90919035, 30871272, and 31071003 and National Basic Research Program of China Grant 2012CB518601.	Axel DI, 2001, CARDIOVASC RES, V49, P851, DOI 10.1016/S0008-6363(00)00312-6; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Charoensit P, 2010, CANCER GENE THER, V17, P512, DOI 10.1038/cgt.2010.12; Chen ZY, 2000, FEBS LETT, V477, P67, DOI 10.1016/S0014-5793(00)01764-6; Chen ZY, 2005, CANCER RES, V65, P10394, DOI 10.1158/0008-5472.CAN-05-2059; Chen ZY, 2004, J NUTR, V134, P792, DOI 10.1093/jn/134.4.792; Cullingford TE, 2008, BBA-MOL CELL RES, V1783, P1229, DOI 10.1016/j.bbamcr.2008.03.007; Dang DT, 2002, NUCLEIC ACIDS RES, V30, P2736, DOI 10.1093/nar/gkf400; Deaton RA, 2009, AM J PHYSIOL-HEART C, V296, pH1027, DOI 10.1152/ajpheart.01230.2008; En-Nia A, 2005, J BIOL CHEM, V280, P7702, DOI 10.1074/jbc.M413353200; Evans PM, 2008, ACTA BIOCH BIOPH SIN, V40, P554, DOI 10.1111/j.1745-7270.2008.00439.x; Garvey SM, 2010, J PHARMACOL EXP THER, V333, P34, DOI 10.1124/jpet.109.163949; Ghaleb AM, 2008, CURR COLORECT CANC R, V4, P59, DOI 10.1007/s11888-008-0011-4; Han M, 2006, AM J PHYSIOL-CELL PH, V291, pC50, DOI 10.1152/ajpcell.00524.2005; Han M, 2009, FEBS J, V276, P1720, DOI 10.1111/j.1742-4658.2009.06902.x; Herdeg C, 2003, CARDIOVASC RES, V57, P544, DOI 10.1016/S0008-6363(02)00709-5; Jurchott K, 2003, J BIOL CHEM, V278, P27988, DOI 10.1074/jbc.M212966200; Krohn R, 2007, CIRCULATION, V116, P1812, DOI 10.1161/CIRCULATIONAHA.107.708016; Kumar P, 2010, J BIOL CHEM, V285, P37521, DOI 10.1074/jbc.M110.132795; Li HX, 2010, J BIOL CHEM, V285, P17846, DOI 10.1074/jbc.M109.076992; Liu SA, 2008, MOL CANCER RES, V6, P306, DOI 10.1158/1541-7786.MCR-07-0159; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Loudig O, 2000, MOL ENDOCRINOL, V14, P1483, DOI 10.1210/me.14.9.1483; Mahatan CS, 1999, NUCLEIC ACIDS RES, V27, P4562, DOI 10.1093/nar/27.23.4562; Makkonen KM, 2009, J BIOL CHEM, V284, P18270, DOI 10.1074/jbc.M109.012492; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; Meng F, 2009, BIOCHEM BIOPH RES CO, V387, P13, DOI 10.1016/j.bbrc.2009.05.112; Miano JM, 1996, CIRCULATION, V93, P1886, DOI 10.1161/01.CIR.93.10.1886; Miano JM, 1998, CIRCULATION, V98, P1219, DOI 10.1161/01.CIR.98.12.1219; Nemer M, 2007, CELL CYCLE, V6, P117, DOI 10.4161/cc.6.2.3718; Sengupta S, 2011, ONCOGENE, V30, P482, DOI 10.1038/onc.2010.435; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Si JT, 2002, BLOOD, V100, P4401, DOI 10.1182/blood-2001-12-0374; TING JPY, 1994, J EXP MED, V179, P1605, DOI 10.1084/jem.179.5.1605; Wang C, 2008, J BIOCHEM, V144, P313, DOI 10.1093/jb/mvn068; Wiegman PJ, 2000, ARTERIOSCL THROM VAS, V20, P89, DOI 10.1161/01.ATV.20.1.89; Wu JB, 2009, J BIOL CHEM, V284, P16723, DOI 10.1074/jbc.M901779200; Yu K, 2011, CARDIOVASC RES, V90, P464, DOI 10.1093/cvr/cvr017; Zhang R, 2010, ACTA PHARMACOL SIN, V31, P1293, DOI 10.1038/aps.2010.96; Zhang XH, 2009, FEBS LETT, V583, P1231, DOI 10.1016/j.febslet.2009.03.016; Zheng B, 2011, CELL RES, V21, P1487, DOI 10.1038/cr.2011.34; Zheng B, 2010, IUBMB LIFE, V62, P132, DOI 10.1002/iub.298; Zheng B, 2009, J BIOL CHEM, V284, P22773, DOI 10.1074/jbc.M109.026989	45	36	42	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10799	10811		10.1074/jbc.M111.321836	http://dx.doi.org/10.1074/jbc.M111.321836			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22337869	Green Published, hybrid			2022-12-25	WOS:000302780100009
J	Bentink, S; Haibe-Kains, B; Risch, T; Fan, JB; Hirsch, MS; Holton, K; Rubio, R; April, C; Chen, J; Wickham-Garcia, E; Liu, J; Culhane, A; Drapkin, R; Quackenbush, J; Matulonis, UA				Bentink, Stefan; Haibe-Kains, Benjamin; Risch, Thomas; Fan, Jian-Bing; Hirsch, Michelle S.; Holton, Kristina; Rubio, Renee; April, Craig; Chen, Jing; Wickham-Garcia, Eliza; Liu, Joyce; Culhane, Aedin; Drapkin, Ronny; Quackenbush, John; Matulonis, Ursula A.			Angiogenic mRNA and microRNA Gene Expression Signature Predicts a Novel Subtype of Serous Ovarian Cancer	PLOS ONE			English	Article							STAGE-III; PHASE-II; SURVIVAL; PACLITAXEL; BEVACIZUMAB; VALIDATION; CISPLATIN; PROFILE; TRIAL	Ovarian cancer is the fifth leading cause of cancer death for women in the U.S. and the seventh most fatal worldwide. Although ovarian cancer is notable for its initial sensitivity to platinum-based therapies, the vast majority of patients eventually develop recurrent cancer and succumb to increasingly platinum-resistant disease. Modern, targeted cancer drugs intervene in cell signaling, and identifying key disease mechanisms and pathways would greatly advance our treatment abilities. In order to shed light on the molecular diversity of ovarian cancer, we performed comprehensive transcriptional profiling on 129 advanced stage, high grade serous ovarian cancers. We implemented a, re-sampling based version of the ISIS class discovery algorithm (rISIS: robust ISIS) and applied it to the entire set of ovarian cancer transcriptional profiles. rISIS identified a previously undescribed patient stratification, further supported by micro-RNA expression profiles, and gene set enrichment analysis found strong biological support for the stratification by extracellular matrix, cell adhesion, and angiogenesis genes. The corresponding "angiogenesis signature'' was validated in ten published independent ovarian cancer gene expression datasets and is significantly associated with overall survival. The subtypes we have defined are of potential translational interest as they may be relevant for identifying patients who may benefit from the addition of anti-angiogenic therapies that are now being tested in clinical trials.	[Bentink, Stefan; Haibe-Kains, Benjamin; Risch, Thomas; Holton, Kristina; Rubio, Renee; Culhane, Aedin; Quackenbush, John] Dana Farber Canc Inst, Dept Biostatist & Computat Biol, Boston, MA 02115 USA; [Liu, Joyce; Quackenbush, John] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Fan, Jian-Bing; April, Craig; Chen, Jing; Wickham-Garcia, Eliza] Illumina Inc, San Diego, CA USA; [Hirsch, Michelle S.; Drapkin, Ronny] Brigham & Womens Hosp, Dept Pathol, Div Womans & Perinatal Pathol, Boston, MA 02115 USA; [Drapkin, Ronny; Matulonis, Ursula A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Bentink, Stefan; Haibe-Kains, Benjamin; Culhane, Aedin; Quackenbush, John] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Hirsch, Michelle S.; Liu, Joyce; Drapkin, Ronny; Matulonis, Ursula A.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Illumina; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Bentink, S (corresponding author), Dana Farber Canc Inst, Dept Biostatist & Computat Biol, Boston, MA 02115 USA.	johnq@jimmy.harvard.edu	Culhane, Aedin/AAG-8490-2019; Haibe-Kains, Benjamin/D-3702-2011; Drapkin, Ronny/E-9944-2016	Culhane, Aedin/0000-0002-1395-9734; Haibe-Kains, Benjamin/0000-0002-7684-0079; Drapkin, Ronny/0000-0002-6912-6977; Quackenbush, John/0000-0002-2702-5879	Dana-Farber/Harvard Cancer Center; Claudia Adams Barr Foundation; Kittredge Foundation; Dana-Farber Cancer Institute; National Cancer Institute [3P50 CA105009-05S1]; NATIONAL CANCER INSTITUTE [P50CA105009] Funding Source: NIH RePORTER	Dana-Farber/Harvard Cancer Center; Claudia Adams Barr Foundation; Kittredge Foundation; Dana-Farber Cancer Institute; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Dana-Farber/Harvard Cancer Center Women's Cancer Program, the Claudia Adams Barr Foundation, the Kittredge Foundation, and the Dana-Farber Cancer Institute High Tech Fund. Additional support was provided by a grant from the National Cancer Institute (3P50 CA105009-05S1). The DASL assays were provided by Illumina, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajanian C, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.18_suppl.lba5007; April C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008162; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berchuck A, 2005, CLIN CANCER RES, V11, P3686, DOI 10.1158/1078-0432.CCR-04-2398; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; Burger RA, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.18_suppl.lba1; Burger RA, 2007, J CLIN ONCOL, V25, P5165, DOI 10.1200/JCO.2007.11.5345; Cannistra SA, 2007, J CLIN ONCOL, V25, P5180, DOI 10.1200/JCO.2007.12.0782; Chen J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn387; Clauss A, 2010, NEOPLASIA, V12, P161, DOI 10.1593/neo.91542; Crijns APG, 2009, PLOS MED, V6, P181, DOI 10.1371/journal.pmed.1000024; Culhane AC, 2010, NUCLEIC ACIDS RES, V38, pD716, DOI 10.1093/nar/gkp1015; De Smet F, 2006, INT J GYNECOL CANCER, V16, P147, DOI 10.1111/j.1525-1438.2006.00321.x; Denkert C, 2009, J PATHOL, V218, P273, DOI 10.1002/path.2547; Dressman HK, 2007, J CLIN ONCOL, V25, P517, DOI 10.1200/JCO.2006.06.3743; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Haibe-Kains B, 2011, 3 GENE MODEL R UNPUB; Hartmann LC, 2005, CLIN CANCER RES, V11, P2149, DOI 10.1158/1078-0432.CCR-04-1673; Jazaeri AA, 2005, CLIN CANCER RES, V11, P6300, DOI 10.1158/1078-0432.CCR-04-2682; Kapp AV, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-231; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Liu JF, 2009, GYNECOL ONCOL, V115, P401, DOI 10.1016/j.ygyno.2009.08.023; Matulonis UA, 2009, J CLIN ONCOL, V27, P5601, DOI 10.1200/JCO.2009.23.2777; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; Mok SC, 2009, CANCER CELL, V16, P521, DOI 10.1016/j.ccr.2009.10.018; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Perren T, 2010, ANN ONCOL, V21, P2; Ruschhaupt M, 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1078; Spentzos D, 2004, J CLIN ONCOL, V22, P4700, DOI 10.1200/JCO.2004.04.070; Spentzos D, 2005, J CLIN ONCOL, V23, P7911, DOI 10.1200/JCO.2005.02.9363; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; von Heydebreck A, 2001, Bioinformatics, V17 Suppl 1, pS107; Wong KK, 2001, BIOTECHNIQUES, V30, P670, DOI 10.2144/01303dd05; Yoshihara K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009615; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105	36	79	80	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e30269	10.1371/journal.pone.0030269	http://dx.doi.org/10.1371/journal.pone.0030269			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348002	Green Submitted, gold, Green Published			2022-12-25	WOS:000302733900005
J	Gallegos, KM; Conrady, DG; Karve, SS; Gunasekera, TS; Herr, AB; Weiss, AA				Gallegos, Karen M.; Conrady, Deborah G.; Karve, Sayali S.; Gunasekera, Thusitha S.; Herr, Andrew B.; Weiss, Alison A.			Shiga Toxin Binding to Glycolipids and Glycans	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; SURFACE-PLASMON RESONANCE; ESCHERICHIA-COLI O157-H7; GLOBOTRIAOSYL CERAMIDE; B-SUBUNIT; ENDOTHELIAL-CELLS; RECEPTOR FUNCTION; HYBRID TOXINS; LIPID RAFTS; IN-VIVO	Background: Immunologically distinct forms of Shiga toxin (Stx1 and Stx2) display different potencies and disease outcomes, likely due to differences in host cell binding. The glycolipid globotriaosylceramide (Gb3) has been reported to be the receptor for both toxins. While there is considerable data to suggest that Gb3 can bind Stx1, binding of Stx2 to Gb3 is variable. Methodology: We used isothermal titration calorimetry (ITC) and enzyme-linked immunosorbent assay (ELISA) to examine binding of Stx1 and Stx2 to various glycans, glycosphingolipids, and glycosphingolipid mixtures in the presence or absence of membrane components, phosphatidylcholine, and cholesterol. We have also assessed the ability of glycolipids mixtures to neutralize Stx-mediated inhibition of protein synthesis in Vero kidney cells. Results: By ITC, Stx1 bound both Pk (the trisaccharide on Gb3) and P (the tetrasaccharide on globotetraosylceramide, Gb4), while Stx2 did not bind to either glycan. Binding to neutral glycolipids individually and in combination was assessed by ELISA. Stx1 bound to glycolipids Gb3 and Gb4, and Gb3 mixed with other neural glycolipids, while Stx2 only bound to Gb3 mixtures. In the presence of phosphatidylcholine and cholesterol, both Stx1 and Stx2 bound well to Gb3 or Gb4 alone or mixed with other neutral glycolipids. Pre-incubation with Gb3 in the presence of phosphatidylcholine and cholesterol neutralized Stx1, but not Stx2 toxicity to Vero cells. Conclusions: Stx1 binds primarily to the glycan, but Stx2 binding is influenced by residues in the ceramide portion of Gb3 and the lipid environment. Nanomolar affinities were obtained for both toxins to immobilized glycolipids mixtures, while the effective dose for 50% inhibition (ED50) of protein synthesis was about 10(-11) M. The failure of preincubation with Gb3 to protect cells from Stx2 suggests that in addition to glycolipid expression, other cellular components contribute to toxin potency.	[Gallegos, Karen M.; Conrady, Deborah G.; Karve, Sayali S.; Gunasekera, Thusitha S.; Herr, Andrew B.; Weiss, Alison A.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Gallegos, KM (corresponding author), Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45221 USA.	alison.weiss@uc.edu	Herr, Andrew/R-3049-2019	Herr, Andrew/0000-0002-3598-3399; Weiss, Alison/0000-0002-4726-8376	National Institutes OF Health [R01 AI 064893, U01 AI 075498]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI075498, R01AI064893] Funding Source: NIH RePORTER	National Institutes OF Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes OF Health Grants R01 AI 064893 and U01 AI 075498. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong GD, 2006, J INFECT DIS, V193, P1120, DOI 10.1086/501472; BASTA M, 1989, J CLIN MICROBIOL, V27, P1617, DOI 10.1128/JCM.27.7.1617-1622.1989; Binnington B, 2002, NEUROCHEM RES, V27, P807, DOI 10.1023/A:1020261125008; Bitzan M, 2009, KIDNEY INT, V75, pS62, DOI 10.1038/ki.2008.624; BOULANGER J, 1990, J CLIN MICROBIOL, V28, P2830, DOI 10.1128/JCM.28.12.2830-2833.1990; BOYD B, 1994, EUR J BIOCHEM, V223, P873, DOI 10.1111/j.1432-1033.1994.tb19064.x; CDC, 2005, ENT ESCH COL; Conrady DG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015153; Cummings MD, 1998, BIOCHEMISTRY-US, V37, P1789, DOI 10.1021/bi971807f; DEGRANDIS S, 1989, J BIOL CHEM, V264, P12520; DONOHUEROLFE A, 1991, REV INFECT DIS, V13, pS293; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Flagler MJ, 2010, BIOCHEMISTRY-US, V49, P1649, DOI 10.1021/bi902084y; Flagler MJ, 2010, DETERMINATION MOL BA, P242; Fuller CA, 2011, INFECT IMMUN, V79, P1329, DOI 10.1128/IAI.01182-10; Hammache D, 1998, J BIOL CHEM, V273, P7967, DOI 10.1074/jbc.273.14.7967; HEAD SC, 1991, J BIOL CHEM, V266, P3617; Heinrich L, 2010, J IMMUNOL METHODS, V352, P13, DOI 10.1016/j.jim.2009.10.002; Huang J, 2010, BLOOD, V116, P3653, DOI 10.1182/blood-2010-02-271957; Hughes AK, 2000, KIDNEY INT, V57, P2350, DOI 10.1046/j.1523-1755.2000.00095.x; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Kale RR, 2008, ANGEW CHEM INT EDIT, V47, P1265, DOI 10.1002/anie.200703680; Katagiri YU, 1999, J BIOL CHEM, V274, P35278, DOI 10.1074/jbc.274.49.35278; Khan F, 2009, KIDNEY INT, V75, P1209, DOI 10.1038/ki.2009.7; Kim Y-H, 1996, KOREAN J VET PUBLIC, V20, P55; Kitova EN, 2007, GLYCOBIOLOGY, V17, P1127, DOI 10.1093/glycob/cwm081; KOZLOV YV, 1988, GENE, V67, P213, DOI 10.1016/0378-1119(88)90398-8; Kulkarni AA, 2010, MED RES REV, V30, P327, DOI 10.1002/med.20196; Lewallen DM, 2009, CHEMBIOCHEM, V10, P1486, DOI 10.1002/cbic.200900211; Ling H, 1998, BIOCHEMISTRY-US, V37, P1777, DOI 10.1021/bi971806n; Ling H, 2000, STRUCTURE, V8, P253, DOI 10.1016/S0969-2126(00)00103-9; Lingwood CA, 2010, FEBS LETT, V584, P1879, DOI 10.1016/j.febslet.2009.11.089; Lingwood CA, 1996, TRENDS MICROBIOL, V4, P147, DOI 10.1016/0966-842X(96)10017-2; Lingwood D, 2011, NAT CHEM BIOL, V7, P260, DOI 10.1038/nchembio.551; Liu F, 2011, BLOOD, V118, P3392, DOI 10.1182/blood-2011-06-363648; Mahfoud R, 2010, J BIOL CHEM, V285, P36049, DOI 10.1074/jbc.M110.110189; McGannon CM, 2010, ANTIMICROB AGENTS CH, V54, P3790, DOI 10.1128/AAC.01783-09; Millen SH, 2010, BIOCHEMISTRY-US, V49, P5954, DOI 10.1021/bi100474z; Miura Y, 2002, ANAL BIOCHEM, V310, P27, DOI 10.1016/S0003-2697(02)00318-4; Nakajima H, 2001, J BIOL CHEM, V276, P42915, DOI 10.1074/jbc.M106015200; NORTON WT, 1975, J NEUROSCI RES, V1, P57, DOI 10.1002/jnr.490010106; OBRIG TG, 1987, BIOCHEM J, V244, P287, DOI 10.1042/bj2440287; Ogawa-Goto K, 1998, NEUROCHEM RES, V23, P305, DOI 10.1023/A:1022497114813; Okuda T, 2006, J BIOL CHEM, V281, P10230, DOI 10.1074/jbc.M600057200; Palermo MS, 2009, EXPERT REV ANTI-INFE, V7, P697, DOI [10.1586/eri.09.49, 10.1586/ERI.09.49]; PELLIZZARI A, 1992, BIOCHEMISTRY-US, V31, P1363, DOI 10.1021/bi00120a011; Rinaldi S, 2009, GLYCOBIOLOGY, V19, P789, DOI 10.1093/glycob/cwp049; Risselada HJ, 2008, P NATL ACAD SCI USA, V105, P17367, DOI 10.1073/pnas.0807527105; Rutjes NWP, 2002, KIDNEY INT, V62, P832, DOI 10.1046/j.1523-1755.2002.00502.x; Scheiring J, 2008, PEDIATR NEPHROL, V23, P1749, DOI 10.1007/s00467-008-0935-6; Shimizu T, 2007, MICROB PATHOGENESIS, V43, P88, DOI 10.1016/j.micpath.2007.04.003; Shin IS, 2009, BMB REP, V42, P310, DOI 10.5483/BMBRep.2009.42.5.310; STHILAIRE PM, 1994, BIOCHEMISTRY-US, V33, P14452, DOI 10.1021/bi00252a011; Takenaga M, 2000, J Infect Chemother, V6, P21, DOI 10.1007/s101560050044; TESH VL, 1991, MOL MICROBIOL, V5, P1817, DOI 10.1111/j.1365-2958.1991.tb00805.x; TESH VL, 1993, INFECT IMMUN, V61, P3392, DOI 10.1128/IAI.61.8.3392-3402.1993; WADDELL T, 1988, BIOCHEM BIOPH RES CO, V152, P674, DOI 10.1016/S0006-291X(88)80091-3; WEINSTEIN DL, 1989, INFECT IMMUN, V57, P3743, DOI 10.1128/IAI.57.12.3743-3750.1989; Wen SX, 2006, VACCINE, V24, P1142, DOI 10.1016/j.vaccine.2005.08.094; Whyte DA, 2008, PEDIATR REV, V29, P335, DOI 10.1542/pir.29-10-335; Yahi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009079; Zumbrun SD, 2010, INFECT IMMUN, V78, P4488, DOI 10.1128/IAI.00620-10	62	64	66	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e30368	10.1371/journal.pone.0030368	http://dx.doi.org/10.1371/journal.pone.0030368			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348006	Green Submitted, Green Published, gold			2022-12-25	WOS:000302733900007
J	Stokke, C; Flatten, I; Skarstad, K				Stokke, Caroline; Flatten, Ingvild; Skarstad, Kirsten			An Easy-To-Use Simulation Program Demonstrates Variations in Bacterial Cell Cycle Parameters Depending on Medium and Temperature	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; CHROMOSOME-REPLICATION; DIVISION CYCLE; DNA-REPLICATION; FLOW-CYTOMETRY; B-R; INITIATION; PROTEIN; B/R; DISTRIBUTIONS	Many studies are performed on chromosome replication and segregation in Escherichia coli and other bacteria capable of complex replication with C phases spanning several generations. For such investigations an understanding of the replication patterns, including copy numbers of origins and replication forks, is crucial for correct interpretation of the results. Flow cytometry is an important tool for generation of experimental DNA distributions of cell populations. Here, a Visual Basic based simulation program was written for the computation of theoretical DNA distributions for different choices of cell cycle parameters (C and D phase durations, doubling time etc). These cell cycle parameters can be iterated until the best fit between the experimental and theoretical DNA histograms is obtained. The Excel file containing the simulation software is attached as supporting information. Cultures of Escherichia coli were grown at twelve different media and temperature conditions, with following measurements by flow cytometry and simulation of the DNA distributions. A good fit was found for each growth condition by use of our simulation program. The resulting cell cycle parameters displayed clear inter-media differences in replication patterns, but indicated a high degree of temperature independence for each medium. The exception was the poorest medium (acetate), where the cells grew with overlapping replication cycles at 42 degrees C, but without at the lower temperatures. We have developed an easy-to-use tool for determination of bacteria's cell cycle parameters, and consequently the cells' chromosome configurations. The procedure only requires DNA distribution measurements by flow cytometry. Use of this simulation program for E. coli cultures shows that even cells growing quite slowly can have overlapping replication cycles. It is therefore always important not only to assume cells' replication patterns, but to actually determine the cell cycle parameters when changing growth conditions.	[Stokke, Caroline; Flatten, Ingvild; Skarstad, Kirsten] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Cell Biol, Oslo, Norway	University of Oslo	Stokke, C (corresponding author), Oslo Univ Hosp, Intervent Ctr, Oslo, Norway.	Kirsten.Skarstad@rr-research.no		Flatten, Ingvild/0000-0002-4213-1135	Norwegian Research Council	Norwegian Research Council(Research Council of NorwayEuropean Commission)	The work was supported by the Norwegian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 2008, GENES CELLS, V13, P181, DOI 10.1111/j.1365-2443.2007.01157.x; ALLMAN R, 1991, J BACTERIOL, V173, P7970, DOI 10.1128/jb.173.24.7970-7974.1991; Atlung T, 1999, J BACTERIOL, V181, P5557, DOI 10.1128/JB.181.18.5557-5562.1999; ATLUNG T, 1993, J BACTERIOL, V175, P6537, DOI 10.1128/jb.175.20.6537-6545.1993; Bipatnath M, 1998, J BACTERIOL, V180, P265, DOI 10.1128/JB.180.2.265-273.1998; BOYE E, 1991, RES MICROBIOL, V142, P131, DOI 10.1016/0923-2508(91)90020-B; CLARK DJ, 1967, J MOL BIOL, V23, P99, DOI 10.1016/S0022-2836(67)80070-6; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; Fossum S, 2007, EMBO J, V26, P4514, DOI 10.1038/sj.emboj.7601871; Gilbert DM, 2001, SCIENCE, V294, P96, DOI 10.1126/science.1061724; HELMSTETTER CE, 1976, J MOL BIOL, V102, P477, DOI 10.1016/0022-2836(76)90329-6; Hiraga S, 1998, MOL CELL, V1, P381, DOI 10.1016/S1097-2765(00)80038-6; Janniere L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000447; JENSEN KF, 1993, J BACTERIOL, V175, P3401, DOI 10.1128/jb.175.11.3401-3407.1993; KUBITSCHEK HE, 1978, J BACTERIOL, V136, P179, DOI 10.1128/JB.136.1.179-190.1978; Michelsen O, 2003, MICROBIOL-SGM, V149, P1001, DOI 10.1099/mic.0.26058-0; Molina F, 2004, MOL MICROBIOL, V52, P1597, DOI 10.1111/j.1365-2958.2004.04097.x; Morigen, 2009, GENES CELLS, V14, P643, DOI 10.1111/j.1365-2443.2009.01298.x; Odsbu I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007617; Reyes-Lamothe R, 2008, CELL, V133, P90, DOI 10.1016/j.cell.2008.01.044; SKARSTAD K, 1985, J BACTERIOL, V163, P661, DOI 10.1128/JB.163.2.661-668.1985; SKARSTAD K, 1986, EMBO J, V5, P1711, DOI 10.1002/j.1460-2075.1986.tb04415.x; Steen HB, 2001, CURR PROTOC CYTOM, P11; Stokke C, 2011, MICROBIOL-SGM, V157, P695, DOI 10.1099/mic.0.045112-0; SUEOKA N, 1965, GENETICS, V52, P747; WOLDRINGH CL, 1977, J BACTERIOL, V131, P270, DOI 10.1128/JB.131.1.270-279.1977; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Woodfine K, 2004, HUM MOL GENET, V13, P191, DOI 10.1093/hmg/ddh016	28	36	37	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e30981	10.1371/journal.pone.0030981	http://dx.doi.org/10.1371/journal.pone.0030981			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348034	gold, Green Published, Green Submitted			2022-12-25	WOS:000302733900018
J	Mafra, V; Kubo, KS; Alves-Ferreira, M; Ribeiro-Alves, M; Stuart, RM; Boava, LP; Rodrigues, CM; Machado, MA				Mafra, Valeria; Kubo, Karen S.; Alves-Ferreira, Marcio; Ribeiro-Alves, Marcelo; Stuart, Rodrigo M.; Boava, Leonardo P.; Rodrigues, Carolina M.; Machado, Marcos A.			Reference Genes for Accurate Transcript Normalization in Citrus Genotypes under Different Experimental Conditions	PLOS ONE			English	Article							TIME RT-PCR; POLYMERASE-CHAIN-REACTION; SINENSIS L. OSBECK; INTERNAL CONTROL; FUNCTIONAL-CHARACTERIZATION; REAL; EXPRESSION; SELECTION; VALIDATION; ORANGE	Real-time reverse transcription PCR (RT-qPCR) has emerged as an accurate and widely used technique for expression profiling of selected genes. However, obtaining reliable measurements depends on the selection of appropriate reference genes for gene expression normalization. The aim of this work was to assess the expression stability of 15 candidate genes to determine which set of reference genes is best suited for transcript normalization in citrus in different tissues and organs and leaves challenged with five pathogens (Alternaria alternata, Phytophthora parasitica, Xylella fastidiosa and Candidatus Liberibacter asiaticus). We tested traditional genes used for transcript normalization in citrus and orthologs of Arabidopsis thaliana genes described as superior reference genes based on transcriptome data. geNorm and NormFinder algorithms were used to find the best reference genes to normalize all samples and conditions tested. Additionally, each biotic stress was individually analyzed by geNorm. In general, FBOX (encoding a member of the F-box family) and GAPC2 (GAPDH) was the most stable candidate gene set assessed under the different conditions and subsets tested, while CYP (cyclophilin), TUB (tubulin) and CtP (cathepsin) were the least stably expressed genes found. Validation of the best suitable reference genes for normalizing the expression level of the WRKY70 transcription factor in leaves infected with Candidatus Liberibacter asiaticus showed that arbitrary use of reference genes without previous testing could lead to misinterpretation of data. Our results revealed FBOX, SAND (a SAND family protein), GAPC2 and UPL7 (ubiquitin protein ligase 7) to be superior reference genes, and we recommend their use in studies of gene expression in citrus species and relatives. This work constitutes the first systematic analysis for the selection of superior reference genes for transcript normalization in different citrus organs and under biotic stress.	[Mafra, Valeria; Kubo, Karen S.; Stuart, Rodrigo M.; Boava, Leonardo P.; Rodrigues, Carolina M.; Machado, Marcos A.] Ctr Citricultura Sylvio Moreira, Lab Biotecnol, Cordeiropolis, SP, Brazil; [Mafra, Valeria; Kubo, Karen S.; Stuart, Rodrigo M.] Univ Estadual Campinas, Inst Biol, Campinas, SP, Brazil; [Alves-Ferreira, Marcio] Univ Fed Rio de Janeiro, Lab Genet Mol Vegetal, Dept Genet, Inst Biol, Rio De Janeiro, Brazil; [Ribeiro-Alves, Marcelo] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Mafra, V (corresponding author), Ctr Citricultura Sylvio Moreira, Lab Biotecnol, Cordeiropolis, SP, Brazil.	marcos@centrodecitricultura.br	Machado, Marcos/G-3582-2012; Alves-Ferreira, Marcio/C-5849-2009; Citros, Inct/I-2442-2013	Machado, Marcos/0000-0001-9780-3990; Alves-Ferreira, Marcio/0000-0002-6107-3700; Ribeiro-Alves, Marcelo/0000-0002-8663-3364	Instituto Nacional de Ciencia e Tecnologia de Genomica para Melhoramento de Citros	Instituto Nacional de Ciencia e Tecnologia de Genomica para Melhoramento de Citros	This work is part of Valeria Mafra's Ph.D. thesis in the Department of Genetics and Evolution, State University of Campinas, Brazil, and was supported by Instituto Nacional de Ciencia e Tecnologia de Genomica para Melhoramento de Citros. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht U, 2008, PLANT SCI, V175, P291, DOI 10.1016/j.plantsci.2008.05.001; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Boava LP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-39; Boava Leonardo P, 2010, BMC Res Notes, V3, P43, DOI 10.1186/1756-0500-3-43; Carvalho K, 2010, ANAL BIOCHEM, V402, P197, DOI 10.1016/j.ab.2010.03.038; Cernadas RA, 2008, MOL PLANT PATHOL, V9, P609, DOI 10.1111/J.1364-3703.2008.00486.X; Chai LJ, 2011, MOL BIOL REP, V38, P1, DOI 10.1007/s11033-010-0070-x; Cottage A, 2004, CELL MOL BIOL LETT, V9, P739; Cruz F, 2009, MOL BREEDING, V23, P607, DOI 10.1007/s11032-009-9259-x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Demidenko NV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019434; Endo T, 2006, SCI HORTIC-AMSTERDAM, V109, P315, DOI 10.1016/j.scienta.2006.06.008; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Fan J, 2010, PLANT PATHOL, V59, P1037, DOI 10.1111/j.1365-3059.2010.02328.x; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Huerta L, 2008, PLANT CELL ENVIRON, V31, P1620, DOI 10.1111/j.1365-3040.2008.01870.x; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Iglesias Domingo J., 2007, Braz. J. Plant Physiol., V19, P333, DOI 10.1590/S1677-04202007000400006; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Kraft E, 2005, PLANT PHYSIOL, V139, P1597, DOI 10.1104/pp.105.067983; Li QF, 2010, PLANT MOL BIOL REP, V28, P49, DOI 10.1007/s11105-009-0124-1; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Lilly ST, 2011, MOL PLANT MICROBE IN, V24, P294, DOI 10.1094/MPMI-10-10-0236; Liu Q, 2007, J EXP BOT, V58, P4161, DOI 10.1093/jxb/erm273; Liu Q, 2009, J EXP BOT, V60, P801, DOI 10.1093/jxb/ern329; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Matta BP, 2011, DEV GENES EVOL, V221, P49, DOI 10.1007/s00427-011-0356-6; Miao HX, 2011, PLANT SCI, V180, P358, DOI 10.1016/j.plantsci.2010.10.012; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Nishikawa F, 2009, TREE PHYSIOL, V29, P921, DOI 10.1093/treephys/tpp021; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Poteryaev D, 2005, BIOCHEM SOC T, V33, P606, DOI 10.1042/BST0330606; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Sharifi-Sirchi GR, 2011, AFR J BIOTECHNOL, V10, P3818; Silveira ED, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-84; Talon Manuel, 2008, Int J Plant Genomics, V2008, P528361, DOI 10.1155/2008/528361; Tan FC, 2007, PHYSIOL PLANTARUM, V131, P481, DOI 10.1111/j.1399-3054.2007.00971.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vierstra RD, 2003, TRENDS PLANT SCI, V8, P135, DOI 10.1016/S1360-1385(03)00014-1; Volkov RA, 2003, J EXP BOT, V54, P2343, DOI 10.1093/jxb/erg244; Wan HJ, 2010, ANAL BIOCHEM, V399, P257, DOI 10.1016/j.ab.2009.12.008; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yan J., 2011, MOL BIOL REP, V38, P1; Zheng TG, 2011, BIOL PLANTARUM, V55, P431, DOI 10.1007/s10535-011-0107-6	51	235	267	4	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31263	10.1371/journal.pone.0031263	http://dx.doi.org/10.1371/journal.pone.0031263			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347455	Green Submitted, Green Published, gold			2022-12-25	WOS:000302730200016
J	Sun, EC; Zhao, J; Liu, NH; Yang, T; Xu, QY; Qin, YL; Bu, ZG; Yang, YH; Lunt, RA; Wang, LF; Wu, DL				Sun, Encheng; Zhao, Jing; Liu, Nihong; Yang, Tao; Xu, Qingyuan; Qin, Yongli; Bu, Zhigao; Yang, Yinhui; Lunt, Ross A.; Wang, Linfa; Wu, Donglai			Comprehensive Mapping of Common Immunodominant Epitopes in the West Nile Virus Nonstructural Protein 1 Recognized by Avian Antibody Responses	PLOS ONE			English	Article							JAPANESE ENCEPHALITIS-VIRUS; LINKED-IMMUNOSORBENT-ASSAY; NEW-YORK-CITY; NS1 PROTEIN; EXPERIMENTAL-INFECTION; MONOCLONAL-ANTIBODIES; FLAVIVIRUS INFECTION; PROTECTIVE IMMUNITY; PEPTIDE LIBRARY; DOMESTIC GEESE	West Nile virus (WNV) is a mosquito-borne flavivirus that primarily infects birds but occasionally infects humans and horses. Certain species of birds, including crows, house sparrows, geese, blue jays and ravens, are considered highly susceptible hosts to WNV. The nonstructural protein 1 (NS1) of WNV can elicit protective immune responses, including NS1-reactive antibodies, during infection of animals. The antigenicity of NS1 suggests that NS1-reactive antibodies could provide a basis for serological diagnostic reagents. To further define serological reagents for diagnostic use, the antigenic sites in NS1 that are targeted by host immune responses need to be identified and the potential diagnostic value of individual antigenic sites also needs to be defined. The present study describes comprehensive mapping of common immunodominant linear B-cell epitopes in the WNV NS1 using avian WNV NS1 antisera. We screened antisera from chickens, ducks and geese immunized with purified NS1 for reactivity against 35 partially overlapping peptides covering the entire WNV NS1. This study identified twelve, nine and six peptide epitopes recognized by chicken, duck and goose antibody responses, respectively. Three epitopes (NS1-3, 14 and 24) were recognized by antibodies elicited by immunization in all three avian species tested. We also found that NS1-3 and 24 were WNV-specific epitopes, whereas the NS1-14 epitope was conserved among the Japanese encephalitis virus (JEV) serocomplex viruses based on the reactivity of avian WNV NS1 antisera against polypeptides derived from the NS1 sequences of viruses of the JEV serocomplex. Further analysis showed that the three common polypeptide epitopes were not recognized by antibodies in Avian Influenza Virus (AIV), Newcastle Disease Virus (NDV), Duck Plague Virus (DPV) and Goose Parvovirus (GPV) antisera. The knowledge and reagents generated in this study have potential applications in differential diagnostic approaches and subunit vaccines development for WNV and other viruses of the JEV serocomplex.	[Sun, Encheng; Zhao, Jing; Liu, Nihong; Yang, Tao; Xu, Qingyuan; Qin, Yongli; Bu, Zhigao; Wu, Donglai] Chinese Acad Agr Sci, Key Lab Vet Publ Hlth, State Key Lab Vet Biotechnol, Harbin Vet Res Inst,Minist Agr, Harbin, Peoples R China; [Sun, Encheng; Zhao, Jing; Qin, Yongli] Chinese Acad Agr Sci, Grad Sch, Beijing 100193, Peoples R China; [Yang, Yinhui] Beijing Inst Microbiol & Epidemiol, Beijing, Peoples R China; [Lunt, Ross A.; Wang, Linfa] CSIRO Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic, Australia	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Graduate School, CAAS; Beijing Institute of Microbiology & Epidemiology; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Sun, EC (corresponding author), Chinese Acad Agr Sci, Key Lab Vet Publ Hlth, State Key Lab Vet Biotechnol, Harbin Vet Res Inst,Minist Agr, Harbin, Peoples R China.	dlwu@hvri.ac.cn	wang, lin/GSE-3040-2022; Lunt, Ross A/I-4941-2013	Lunt, Ross A/0000-0002-9630-8493	National High-Tech Research and Development Program of China [2011AA10A212]; Heilongjiang Natural Science Foundation of China [ZJN-0602-01]; State Key Laboratory of Veterinary Biotechnology [SKLVBP201018]	National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Heilongjiang Natural Science Foundation of China(Natural Science Foundation of Heilongjiang Province); State Key Laboratory of Veterinary Biotechnology	This study was supported by National High-Tech Research and Development Program of China (No. 2011AA10A212), Heilongjiang Natural Science Foundation of China (No. ZJN-0602-01) and grants from State Key Laboratory of Veterinary Biotechnology (SKLVBP201018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim JH, 2010, J VIROL METHODS, V167, P186, DOI 10.1016/j.jviromet.2010.04.003; Bernard KA, 2001, EMERG INFECT DIS, V7, P679; CARDOSA MJ, 1986, J VIROL, V57, P952, DOI 10.1128/JVI.57.3.952-959.1986; Centers for Disease Control and Prevention, 2011, W NIL VIR HUM INF US; Chung KM, 2006, J VIROL, V80, P1340, DOI 10.1128/JVI.80.3.1340-1351.2006; Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103; Eidson M, 2001, EMERG INFECT DIS, V7, P631, DOI 10.3201/eid0704.010405; Eidson M, 2001, EMERG INFECT DIS, V7, P615; Garmendia AE, 2001, MICROBES INFECT, V3, P223, DOI 10.1016/S1286-4579(01)01374-0; HENCHAL EA, 1988, J GEN VIROL, V69, P2101, DOI 10.1099/0022-1317-69-8-2101; Julian KG, 2002, VECTOR-BORNE ZOONOT, V2, P145, DOI 10.1089/15303660260613710; Kitai Y, 2007, CLIN VACCINE IMMUNOL, V14, P1024, DOI 10.1128/CVI.00051-07; Kitai Y, 2011, VECTOR-BORNE ZOONOT, V11, P1093, DOI 10.1089/vbz.2010.0094; Kitai Y, 2011, J VIROL METHODS, V171, P123, DOI 10.1016/j.jviromet.2010.10.012; Kitai Y, 2010, CLIN VACCINE IMMUNOL, V17, P875, DOI 10.1128/CVI.00217-09; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Komar N, 2002, EMERG INFECT DIS, V8, P741, DOI 10.3201/eid0807.020157; Komar N, 2001, EMERG INFECT DIS, V7, P621; Komar N, 2001, VECTOR-BORNE ZOONOT, V1, P191, DOI 10.1089/153036601753552558; Koraka P, 2002, MICROBES INFECT, V4, P1209, DOI 10.1016/S1286-4579(02)01647-7; Kramer LD, 2001, ANN NY ACAD SCI, V951, P84; Kuno G, 2001, REV MED VIROL, V11, P165, DOI 10.1002/rmv.314; Langevin SA, 2001, EMERG INFECT DIS, V7, P726, DOI 10.3201/eid0704.010422; Langevin SA, 2011, J GEN VIROL, V92, P2810, DOI 10.1099/vir.0.035535-0; Lee TH, 2012, J GEN VIROL, V93, P20, DOI 10.1099/vir.0.036640-0; Lin CW, 2008, BIOTECHNOL LETT, V30, P205, DOI 10.1007/s10529-007-9529-9; Lin YL, 1998, J VIROL, V72, P191, DOI 10.1128/JVI.72.1.191-200.1998; Lindenbach BD, 1997, J VIROL, V71, P9608, DOI 10.1128/JVI.71.12.9608-9617.1997; LVOV DK, 1975, MED BIOL, V53, P325; Malkinson M, 2001, ANN NY ACAD SCI, V951, P255; Mehlhop E, 2007, CELL HOST MICROBE, V2, P417, DOI 10.1016/j.chom.2007.09.015; *OFF INT EP, 1999, DIS INFORMATION, V12, P166; Office International des Epizooties, 2000, DIS INF, V13, P150; Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240; Panella NA, 2001, EMERG INFECT DIS, V7, P754; PEIRIS JSM, 1981, NATURE, V289, P189, DOI 10.1038/289189a0; Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002; Sardelis MR, 2001, EMERG INFECT DIS, V7, P1018, DOI 10.3201/eid0706.010617; SCHLESINGER JJ, 1993, VIROLOGY, V192, P132, DOI 10.1006/viro.1993.1015; SCHLESINGER JJ, 1985, J IMMUNOL, V135, P2805; SEMENOV B F, 1973, Vestnik Akademii Meditsinskikh Nauk SSSR, V28, P79; Senne DA, 2000, AVIAN DIS, V44, P642, DOI 10.2307/1593105; Shi PY, 2003, EXPERT REV MOL DIAGN, V3, P733, DOI 10.1586/14737159.3.6.733; Steele KE, 2000, VET PATHOL, V37, P208, DOI 10.1354/vp.37-3-208; Sun EC, 2012, J GEN VIROL, V93, P50, DOI 10.1099/vir.0.034900-0; Sun EC, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-160; Sun EC, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-100; Swayne DE, 2001, EMERG INFECT DIS, V7, P751; Swayne DE, 2000, AVIAN DIS, V44, P932, DOI 10.2307/1593067; TAYLOR RM, 1956, AM J TROP MED HYG, V5, P579, DOI 10.4269/ajtmh.1956.5.579; Turell MJ, 2000, AM J TROP MED HYG, V62, P413, DOI 10.4269/ajtmh.2000.62.413; Weissenbock H, 2002, EMERG INFECT DIS, V8, P652, DOI 10.3201/eid0807.020094; Williams DT, 2001, AM J TROP MED HYG, V65, P379, DOI 10.4269/ajtmh.2001.65.379; WORK TH, 1955, AM J TROP MED HYG, V4, P872, DOI 10.4269/ajtmh.1955.4.872; Xu GY, 2004, VACCINE, V22, P1846, DOI 10.1016/j.vaccine.2003.09.015; 1999, MMWR MORB MORTAL WKL, V48, P845	56	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31434	10.1371/journal.pone.0031434	http://dx.doi.org/10.1371/journal.pone.0031434			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347477	gold, Green Published, Green Submitted			2022-12-25	WOS:000302730200022
J	Walker, KAD; Morgan, C; Doak, SH; Dunstan, PR				Walker, Kelly-Ann D.; Morgan, Claire; Doak, Shareen H.; Dunstan, Peter R.			Quantum Dots for Multiplexed Detection and Characterisation of Prostate Cancer Cells Using a Scanning Near-Field Optical Microscope	PLOS ONE			English	Article							REFLECTION FLUORESCENCE MICROSCOPY; E-CADHERIN EXPRESSION; ZONULA OCCLUDENS-1; MECHANISMS; INVASION; METASTASIS; LINES; BONE	In this study scanning near-field optical microscopy (SNOM) has been utilised in conjunction with quantum dot labelling to interrogate the biomolecular composition of cell membranes. The technique overcomes the limits of optical diffraction found in standard fluorescence microscopy and also yields vital topographic information. The technique has been applied to investigate cell-cell adhesion in human epithelial cells. This has been realised through immunofluorescence labelling of the cell-cell adhesion protein E-cadherin. Moreover, a dual labelling protocol has been optimised to facilitate a comparative study of the adhesion mechanisms and the effect of aberrant adhesion protein expression in both healthy and cancerous epithelial cells. This study reports clear differences in the morphology and phenotype of healthy and cancerous cells. In healthy prostate epithelial cells (PNT2), E-cadherin was predominantly located around the cell periphery and within filopodial extensions. The presence of E-cadherin appeared to be enhanced when cell-cell contact was established. In contrast, examination of metastatic prostate adenocarcinoma cells (PC-3) revealed no E-cadherin labelling around the periphery of the cells. This lack of functional E-cadherin in PC-3 cells coincided with a markedly different morphology and PC-3 cells were not found to form close cell-cell associations with their neighbours. We have demonstrated that with a fully optimised sample preparation methodology, multiplexed quantum dot labelling in conjunction with SNOM imaging can be successfully applied to interrogate biomolecular localisation within delicate cellular membranes.	[Walker, Kelly-Ann D.] Swansea Univ, Coll Engn, Multidisciplinary Nanotechnol Ctr, Swansea, W Glam, Wales; [Morgan, Claire; Doak, Shareen H.] Swansea Univ, Coll Med, Inst Life Sci, Swansea, W Glam, Wales; [Dunstan, Peter R.] Swansea Univ, Coll Sci, Multidisciplinary Nanotechnol Ctr, Dept Phys, Swansea, W Glam, Wales	Swansea University; Swansea University; Swansea University	Walker, KAD (corresponding author), Swansea Univ, Coll Engn, Multidisciplinary Nanotechnol Ctr, Singleton Pk, Swansea, W Glam, Wales.	k.d.walker@swansea.ac.uk	Dunstan, Peter/HII-2875-2022	Doak, Shareen/0000-0002-6753-1987; Dunstan, Peter/0000-0002-4337-4307; Morgan, Claire/0000-0002-3969-0710	EPSRC; St David's Medical Foundation; Prostate UK [G2009/27]; RCUK	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); St David's Medical Foundation; Prostate UK; RCUK(UK Research & Innovation (UKRI))	HEFCW are acknowledged for equipment investment (www.hefcw.ac.uk). EPSRC are acknowledged for providing PhD research student funding (www.EPSRC.ac.uk). Thanks to St David's Medical Foundation & Prostate UK (grant number: G2009/27) for supporting aspects of this work (www.prostateaction.org.uk). SH Doak is supported by an RCUK Academic Fellowship (www.rcuk.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Baylis RM, 2007, ULTRAMICROSCOPY, V107, P308, DOI 10.1016/j.ultramic.2006.08.005; Bryden AAG, 1999, BJU INT, V84, P1032; Chunthapong J, 2004, J CELL BIOCHEM, V91, P649, DOI 10.1002/jcb.20032; Clarke NW, 2009, ASIAN J ANDROL, V11, P57, DOI 10.1038/aja.2008.29; Davies G, 2000, J UROLOGY, V163, P985, DOI 10.1016/S0022-5347(05)67869-X; Galbraith CG, 2011, J CELL SCI, V124, P1607, DOI 10.1242/jcs.080085; Gottardi CJ, 1996, P NATL ACAD SCI USA, V93, P10779, DOI 10.1073/pnas.93.20.10779; Hofer M, 2010, ULTRAMICROSCOPY, V110, P605, DOI 10.1016/j.ultramic.2010.02.019; Jin JK, 2011, INT J CANCER, V128, P2545, DOI 10.1002/ijc.26024; Kumper S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011801; Lang SH, 2002, PROSTATE, V52, P253, DOI 10.1002/pros.10088; Lang SH, 2001, BRIT J CANCER, V85, P590, DOI 10.1054/bjoc.2001.1967; Mao QQ, 2010, CANCER INVEST, V28, P1013, DOI 10.3109/07357900802620844; Mattheyses AL, 2010, J CELL SCI, V123, P3621, DOI 10.1242/jcs.056218; MORTON RA, 1993, CANCER RES, V53, P3585; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Polette M, 2005, CANCER RES, V65, P7691, DOI 10.1158/0008-5472.CAN-04-4230; Richmond PJM, 1997, CANCER RES, V57, P3189; Saha B, 2008, PROSTATE, V68, P78, DOI 10.1002/pros.20670; UMBAS R, 1994, CANCER RES, V54, P3929; Walker KAD, 2011, ULTRAMICROSCOPY, V111, P1200, DOI 10.1016/j.ultramic.2011.01.008; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Yilmaz M, 2010, MOL CANCER RES, V8, P629, DOI 10.1158/1541-7786.MCR-10-0139; Zhong LY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005945; Zhou Q, 2009, MOL CANCER THER, V8, P1684, DOI 10.1158/1535-7163.MCT-09-0191	26	12	12	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31592	10.1371/journal.pone.0031592	http://dx.doi.org/10.1371/journal.pone.0031592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347497	gold, Green Submitted, Green Published			2022-12-25	WOS:000302730200027
J	Lembo, A; Di Cunto, F; Provero, P				Lembo, Antonio; Di Cunto, Ferdinando; Provero, Paolo			Shortening of 3 ' UTRs Correlates with Poor Prognosis in Breast and Lung Cancer	PLOS ONE			English	Article							3' UNTRANSLATED REGIONS; MESSENGER-RNA POLYADENYLATION; ALTERNATIVE POLYADENYLATION; AURORA-A; BASAL-LIKE; EXPRESSION; CELLS; GENE; METASTASIS; SURVIVAL	A major part of the post-transcriptional regulation of gene expression is affected by trans-acting elements, such as microRNAs, binding the 3' untraslated region (UTR) of their target mRNAs. Proliferating cells partly escape this type of negative regulation by expressing shorter 3' UTRs, depleted of microRNA binding sites, compared to non-proliferating cells. Using large-scale gene expression datasets, we show that a similar phenomenon takes place in breast and lung cancer: tumors expressing shorter 3' UTRs tend to be more aggressive and to result in shorter patient survival. Moreover, we show that a gene expression signature based only on the expression ratio of alternative 3' UTRs is a strong predictor of survival in both tumors. Genes undergoing 3 ' UTR shortening in aggressive tumors of the two tissues significantly overlap, and several of them are known to be involved in tumor progression. However the pattern of 3' UTR shortening in aggressive tumors in vivo is clearly distinct from analogous patterns involved in proliferation and transformation.	[Lembo, Antonio] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy; Univ Turin, Ctr Mol Biotechnol, Turin, Italy	University of Turin; University of Turin	Lembo, A (corresponding author), Univ Turin, Dept Genet Biol & Biochem, Turin, Italy.	paolo.provero@unito.it	Provero, Paolo/AAC-1930-2019; Di Cunto, Ferdinando/K-5575-2016	di cunto, ferdinando/0000-0001-9367-6357	Italian Association for Cancer Research [IG-9408]	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	PP and AL are supported by the Italian Association for Cancer Research under grant IG-9408. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbano R, 2010, INT J CANC; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bradshaw AD, 2003, P NATL ACAD SCI USA, V100, P6045, DOI 10.1073/pnas.1030790100; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cappelli E, 2011, EXP CELL RES, V317, P1203, DOI 10.1016/j.yexcr.2011.01.021; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Dodson H, 2004, EMBO J, V23, P3864, DOI 10.1038/sj.emboj.7600393; Dutertre S, 2002, ONCOGENE, V21, P6175, DOI 10.1038/sj.onc.1205775; Elsheikh SE, 2008, BRIT J CANCER, V99, P327, DOI 10.1038/sj.bjc.6604463; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fu YG, 2011, GENOME RES, V21, P741, DOI 10.1101/gr.115295.110; Gautier L, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-111; Grande-Garcia A, 2008, EUR J CELL BIOL, V87, P641, DOI 10.1016/j.ejcb.2008.02.001; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ji Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008419; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Kais Z, 2011, MOL CANC RES; Kao KJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-143; Kastl L, 2012, BREAST CANCER RES TR, V131, P445, DOI 10.1007/s10549-011-1424-3; Ko JC, 2009, LUNG CANCER, V65, P290, DOI 10.1016/j.lungcan.2008.12.008; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Laurent C, 2011, CANCER RES, V71, P666, DOI 10.1158/0008-5472.CAN-10-0605; Le Scodan R, 2010, INT J RADIAT ONCOL, V78, P328, DOI 10.1016/j.ijrobp.2009.07.1735; Lee JY, 2007, NUCLEIC ACIDS RES, V35, pD165, DOI 10.1093/nar/gkl870; Lin HX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015797; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176; Nagai MA, 2011, BREAST CANCER RES TR, V126, P1, DOI 10.1007/s10549-010-0867-2; Nie F, 2010, INT J ONCOL, V37, P1261, DOI 10.3892/ijo_00000777; Ogawa E, 2008, ANN SURG ONCOL, V15, P547, DOI 10.1245/s10434-007-9653-8; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Pogribny IP, 2010, INT J CANCER, V127, P1785, DOI 10.1002/ijc.25191; Reddy SDN, 2008, CANCER RES, V68, P8195, DOI 10.1158/0008-5472.CAN-08-2103; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Sankaran S, 2007, CANCER RES, V67, P11186, DOI 10.1158/0008-5472.CAN-07-2578; Savage K, 2008, BREAST CANCER RES TR, V110, P245, DOI 10.1007/s10549-007-9718-1; Schneider G, 2010, BBA-MOL CELL RES, V1803, P1308, DOI 10.1016/j.bbamcr.2010.07.003; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Shevde LA, 2010, J CELL MOL MED, V14, P1693, DOI 10.1111/j.1582-4934.2009.00821.x; Shi M, 2010, CANCER METAST REV, V29, P785, DOI 10.1007/s10555-010-9265-9; Shi XB, 2008, CELL CYCLE, V7, P1529, DOI 10.4161/cc.7.11.5977; Singh P, 2009, CANCER RES, V69, P9422, DOI 10.1158/0008-5472.CAN-09-2236; Soderlund K, 2007, RADIOTHER ONCOL, V84, P242, DOI 10.1016/j.radonc.2007.06.012; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Suzuki M, 2005, BRIT J CANCER, V92, P942, DOI 10.1038/sj.bjc.6602376; Thomsen S, 2010, DEVELOPMENT, V137, P2951, DOI 10.1242/dev.047324; Toziu-Kara S, 2007, J MOL ENDOCRINOL, V39, P305, DOI 10.1677/JME-07-0001; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; Wang JS, 2008, MOL CANCER RES, V6, P372, DOI 10.1158/1541-7786.MCR-07-0162; Wang LH, 2010, CANCER RES, V70, P9118, DOI 10.1158/0008-5472.CAN-10-1246; Wang NJ, 2010, WORLD J SURG, V34, P2545, DOI 10.1007/s00268-010-0690-2; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Wiestner A, 2007, BLOOD, V109, P4599, DOI 10.1182/blood-2006-08-039859; Xu XE, 2010, PROTEOMICS, V10, P1374, DOI 10.1002/pmic.200900380; Yang XM, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.050237; Zhang HB, 2005, NUCLEIC ACIDS RES, V33, pD116, DOI 10.1093/nar/gki055; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100; Zhu CQ, 2010, J CLIN ONCOL, V28, P4417, DOI 10.1200/JCO.2009.26.4325	69	73	76	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31129	10.1371/journal.pone.0031129	http://dx.doi.org/10.1371/journal.pone.0031129			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347440	Green Published, gold, Green Submitted			2022-12-25	WOS:000302730100044
J	Rabuffetti, M; Farina, E; Alberoni, M; Pellegatta, D; Appollonio, I; Affanni, P; Forni, M; Ferrarin, M				Rabuffetti, Marco; Farina, Elisabetta; Alberoni, Margherita; Pellegatta, Daniele; Appollonio, Ildebrando; Affanni, Paola; Forni, Marco; Ferrarin, Maurizio			Spatio-Temporal Features of Visual Exploration in Unilaterally Brain-Damaged Subjects with or without Neglect: Results from a Touchscreen Test	PLOS ONE			English	Article							RIGHT-HEMISPHERE STROKE; SPATIAL WORKING-MEMORY; MINI-MENTAL-STATE; VISUOSPATIAL NEGLECT; HEMISPATIAL NEGLECT; REACTION-TIME; CANCELLATION; ATTENTION; SEARCH; SPACE	Cognitive assessment in a clinical setting is generally made by pencil-and-paper tests, while computer-based tests enable the measurement and the extraction of additional performance indexes. Previous studies have demonstrated that in a research context exploration deficits occur also in patients without evidence of unilateral neglect at pencil-and-paper tests. The objective of this study is to apply a touchscreen-based cancellation test, feasible also in a clinical context, to large groups of control subjects and unilaterally brain-damaged patients, with and without unilateral spatial neglect (USN), in order to assess disturbances of the exploratory skills. A computerized cancellation test on a touchscreen interface was used for assessing the performance of 119 neurologically unimpaired control subjects and 193 patients with unilateral right or left hemispheric brain damage, either with or without USN. A set of performance indexes were defined including Latency, Proximity, Crossings and their spatial lateral gradients, and Preferred Search Direction. Classic outcome scores were computed as well. Results show statistically significant differences among groups (assumed p<0.05). Right-brain-damaged patients with USN were significantly slower (median latency per detected item was 1.18 s) and less efficient (about 13 search-path crossings) in the search than controls (median latency 0.64 s; about 3 crossings). Their preferred search direction (53.6% downward, 36.7% leftward) was different from the one in control patients (88.2% downward, 2.1% leftward). Right-brain-damaged patients without USN showed a significantly abnormal behavior (median latency 0.84 s, about 5 crossings, 83.3% downward and 9.1% leftward direction) situated half way between controls and right-brain-damaged patients with USN. Left-brain-damaged patients without USN were significantly slower and less efficient than controls (latency 1.19 s, about 7 crossings), preserving a normal preferred search direction (93.7% downward). Therefore, the proposed touchscreen-based assessment had evidenced disorders in spatial exploration also in patients without clinically diagnosed USN.	[Rabuffetti, Marco; Farina, Elisabetta; Alberoni, Margherita; Pellegatta, Daniele; Affanni, Paola; Forni, Marco; Ferrarin, Maurizio] Fdn Don Carlo Gnocchi ONLUS, Ancona, Italy; [Appollonio, Ildebrando] Osped San Gerardo, Neurol Clin, Monza, Italy; [Appollonio, Ildebrando] Univ Milano Bicocca, Dipartimento Neurosci, Milan, Italy	IRCCS Fondazione Don Carlo Gnocchi Onlus; San Gerardo Hospital; University of Milano-Bicocca	Rabuffetti, M (corresponding author), Fdn Don Carlo Gnocchi ONLUS, Ancona, Italy.	mrabuffetti@dongnocchi.it	Ferrarin, Maurizio/I-3230-2012; Appollonio, Ildebrando/U-7384-2019	Ferrarin, Maurizio/0000-0002-7797-2399; APPOLLONIO, ILDEBRANDO/0000-0003-4717-6479; Rabuffetti, Marco/0000-0003-1638-7978	Italian Ministery of Health	Italian Ministery of Health(Ministry of Health, Italy)	The study was partially funded by Governative Agencies ("Ricerca Finalizzata-2001-146" and Ricerca Corrente funds by Italian Ministery of Health). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adair JC, 2008, ANN NY ACAD SCI, V1142, P21, DOI 10.1196/annals.1444.008; ALBERT ML, 1973, NEUROLOGY, V23, P658, DOI 10.1212/WNL.23.6.658; Azouvi P, 2002, J NEUROL NEUROSUR PS, V73, P160, DOI 10.1136/jnnp.73.2.160; Barrett AM, 2006, J COGNITIVE NEUROSCI, V18, P1223, DOI 10.1162/jocn.2006.18.7.1223; Behrmann M, 1997, NEUROPSYCHOLOGIA, V35, P1445, DOI 10.1016/S0028-3932(97)00058-4; Behrmann M, 1998, CONSCIOUS COGN, V7, P381, DOI 10.1006/ccog.1998.0363; Berti A, 2002, NEUROPSYCHOLOGY, V16, P390, DOI 10.1037//0894-4105.16.3.390; Bisiach E., 2000, HDB NEUROPSYCHOLOGY, P459; Blangero A, 2010, CORTEX, V46, P77, DOI 10.1016/j.cortex.2009.02.015; Butler BC, 2004, NEUROPSYCHOLOGIA, V42, P346, DOI 10.1016/j.neuropsychologia.2003.08.008; Castellan NJ, 1988, NONPARAMETRIC STAT B; Cherney Leora Reiff, 2004, Top Stroke Rehabil, V11, P22; Deouell LY, 2005, J INT NEUROPSYCH SOC, V11, P697, DOI 10.1017/S13556177050824; Diller L., 1977, HEMIINATTENTION HEMI, P62; Donnelly N, 1999, BEHAV RES METH INS C, V31, P668, DOI 10.3758/BF03200743; Eglin M, 1994, NEUROPSYCHOLOGY, V4, P451; Eramudugolla R, 2009, NEUROCASE, V15, P24, DOI 10.1080/13554790802570472; Erez ABH, 2009, NEUROPSYCHOL REHABIL, V19, P677, DOI 10.1080/09602010802711160; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; Guest RM, 2002, PATTERN ANAL APPL, V5, P261, DOI 10.1007/s100440200023; HALLIGAN PW, 1992, J NEUROL NEUROSUR PS, V55, P1060, DOI 10.1136/jnnp.55.11.1060; Heilman K, 2003, CLIN NEUROPSYCHOLOGY, P296, DOI DOI 10.1016/J.NEUR0PSYCHOLOGIA.2011.09.030; Hillstrom AP, 2004, CORTEX, V40, P433, DOI 10.1016/S0010-9452(08)70137-0; Husain M, 2001, BRAIN, V124, P941, DOI 10.1093/brain/124.5.941; Husain M, 2000, BRAIN, V123, P1643, DOI 10.1093/brain/123.8.1643; Husain Masud, 2008, Handb Clin Neurol, V88, P359, DOI 10.1016/S0072-9752(07)88018-3; Karnath HO, 1998, BRAIN, V121, P2357, DOI 10.1093/brain/121.12.2357; Kinsbourne M., 1987, NEUROPHYSIOLOGICAL N, P69, DOI DOI 10.1016/S0166-4115(08)61709-4; Kinsbourne M., 1993, UNILATERAL NEGLECT C, P63, DOI 10.4324/9780203765258; Konczak J, 1999, EXP BRAIN RES, V128, P219, DOI 10.1007/s002210050840; LADAVAS E, 1990, CORTEX, V26, P307, DOI 10.1016/S0010-9452(13)80083-4; Lafosse C, 2003, J CLIN EXP NEUROPSYC, V25, P308, DOI 10.1076/jcen.25.3.308.13807; Lanyon LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011128; Larose D.T., 2006, DATA MINING METHODS; Liang Y, 2007, PATTERN ANAL APPL, V10, P361, DOI 10.1007/s10044-007-0074-x; Malhotra P, 2005, BRAIN, V128, P424, DOI 10.1093/brain/awh372; Manly T, 2009, NEUROPSYCHOLOGY, V23, P519, DOI 10.1037/a0015413; Mapstone M, 2003, NEUROPSYCHOLOGIA, V41, P1396, DOI 10.1016/S0028-3932(03)00043-5; Mark VW, 2004, NEUROLOGY, V63, P78, DOI 10.1212/01.WNL.0000131947.08670.D4; MASSIRONI M, 1988, NEUROPSYCHOLOGIA, V26, P161, DOI 10.1016/0028-3932(88)90039-5; MATTINGLEY JB, 1994, J NEUROL NEUROSUR PS, V57, P597, DOI 10.1136/jnnp.57.5.597; MEASSO G, 1993, DEV NEUROPSYCHOL, V9, P77, DOI 10.1080/87565649109540545; Muri RM, 2009, PSYCHOL RES-PSYCH FO, V73, P147, DOI 10.1007/s00426-008-0204-0; Parton A, 2006, NEUROREPORT, V17, P833, DOI 10.1097/01.wnr.0000220130.86349.a7; Pignatti R, 2005, J CLIN EXP NEUROPSYC, V27, P436, DOI 10.1080/13803390490520427; Potter J, 2000, CLIN REHABIL, V14, P441, DOI 10.1191/0269215500cr344oa; Ptak R, 2006, BRAIN RES, V1092, P190, DOI 10.1016/j.brainres.2006.03.069; Rabuffetti M, 2002, MED BIOL ENG COMPUT, V40, P675, DOI 10.1007/BF02345306; Samuelsson H, 2002, J INT NEUROPSYCH SOC, V8, P382, DOI 10.1017/S1355617702813194; Sarri M, 2009, NEUROPSYCHOLOGIA, V47, P91, DOI 10.1016/j.neuropsychologia.2008.08.020; Schendel KL, 2002, J CLIN EXP NEUROPSYC, V24, P941, DOI 10.1076/jcen.24.7.941.8390; Shimodozono M, 2006, NEUROPSYCHOLOGIA, V44, P1752, DOI 10.1016/j.neuropsychologia.2006.03.012; Sunderland A, 2000, STROKE, V31, P430, DOI 10.1161/01.STR.31.2.430; Vallar G., 1994, Archivio di Psicologia Neurologia e Psichiatria, V55, P827; VALLAR G, 1986, NEUROPSYCHOLOGIA, V24, P609, DOI 10.1016/0028-3932(86)90001-1; WEINTRAUB S, 1988, J NEUROL NEUROSUR PS, V51, P1481, DOI 10.1136/jnnp.51.12.1481; Wilson B. A., 1987, BEHAV INATTENTION TE; Woods AJ, 2007, J CLIN EXP NEUROPSYC, V29, P719, DOI 10.1080/13825580600954264; ZOCCOLOTTI P, 1989, INT J NEUROSCI, V47, P209, DOI 10.3109/00207458908987435	60	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31511	10.1371/journal.pone.0031511	http://dx.doi.org/10.1371/journal.pone.0031511			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347489	Green Submitted, Green Published, gold			2022-12-25	WOS:000302730100077
J	Raju, I; Oonthonpan, L; Abraham, EC				Raju, Ilangovan; Oonthonpan, Lalita; Abraham, Edathara C.			Mutations in Human alpha A-Crystallin/sHSP Affect Subunit Exchange Interaction with alpha B-Crystallin	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; MOLECULAR CHAPERONE; CATARACT; GENE; LENS; CRYAA; CHAIN; IDENTIFICATION; AGGREGATION; MUTANT	Background: Mutation in alpha A-crystallin contributes to the development of congenital cataract in humans. Heterooligomerization of alpha A-crystallin and alpha B-crystallin is essential for maintaining transparency in the eye lens. The effect of congenital cataract causing mutants of alpha A-crystallin on subunit exchange and interaction with alpha B-crystallin is unknown. In the present study, interaction of the mutants of alpha A-crystallin with alpha B-crystallin was studied both in vitro and in situ by the fluorescence resonance energy transfer (FRET) technique. Methodology/Principal Findings: In vitro FRET technique was used to demonstrate the rates of subunit exchange of alpha B-wt with the following alpha A-crystallin mutants: R12C, R21L, R21W, R49C, R54C, and R116C. The subunit exchange rates (k values) of R21W and R116C with alpha B-wt decreased drastically as compared to alpha A-wt interacting with alpha B-wt. Moderately decreased k values were seen with R12C, R49C and R54C while R21L showed nearly normal k value. The interaction of alpha A-mutants with alpha B-wt was also assessed by in situ FRET. YFP-tagged alpha A mutants were co-expressed with CFP-tagged alpha B-wt in HeLa cells and the spectral signals were captured with a confocal microscope before and after acceptor laser photobleaching. The interaction of R21W and R116C with alpha B-wt was decreased nearly 50% as compared to alpha A-wt while the rest of the mutants showed slightly decreased interaction. Thus, there is good agreement between the in vitro and in situ FRET data. Conclusions/Significance: Structural changes occurring in these mutants, as reported earlier, could be the underlying cause for the decreased interaction with alpha B may contribute to development of congenital cataract.	[Raju, Ilangovan; Oonthonpan, Lalita; Abraham, Edathara C.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Raju, I (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	ecabraham@uams.edu		Oonthonpan, Lalita/0000-0001-9425-8448	National Institutes of Health [EY011352-15]; NATIONAL EYE INSTITUTE [R01EY011352] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by National Institutes of Health, grant number: EY011352-15. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andley UP, 1996, J BIOL CHEM, V271, P31973, DOI 10.1074/jbc.271.50.31973; Augusteyn RC, 1998, INT J BIOL MACROMOL, V22, P253, DOI 10.1016/S0141-8130(98)00023-3; Bera S, 2002, BIOCHEMISTRY-US, V41, P297, DOI 10.1021/bi011010v; Bova MP, 1997, J BIOL CHEM, V272, P29511, DOI 10.1074/jbc.272.47.29511; Brady JP, 1997, P NATL ACAD SCI USA, V94, P884, DOI 10.1073/pnas.94.3.884; CARVER JA, 1992, FEBS LETT, V311, P143, DOI 10.1016/0014-5793(92)81386-Z; DEJONG WW, 1975, FEBS LETT, V58, P310, DOI 10.1016/0014-5793(75)80286-9; Devi RR, 2008, MOL VIS, V14, P1157; DUBIN RA, 1990, GENOMICS, V7, P594, DOI 10.1016/0888-7543(90)90204-8; FORSTER T, 1959, DISCUSS FARADAY SOC, P7; Graw J, 2006, GRAEF ARCH CLIN EXP, V244, P912, DOI 10.1007/s00417-005-0234-x; Gupta R, 2004, J BIOL CHEM, V279, P44258, DOI 10.1074/jbc.M405648200; Hansen L, 2007, INVEST OPHTH VIS SCI, V48, P3937, DOI 10.1167/iovs.07-0013; HERMAN B, 1989, METHOD CELL BIOL, V30, P219; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Jovin TM, 1989, CELL STRUCT FUNCT, P117; Kallur LS, 2008, MOL CELL BIOCHEM, V308, P85, DOI 10.1007/s11010-007-9615-2; Kore R, 2011, MOL CELL BI IN PRESS; Lindner RA, 2001, BIOCHEM J, V354, P79, DOI 10.1042/0264-6021:3540079; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Mackay DS, 2003, EUR J HUM GENET, V11, P784, DOI 10.1038/sj.ejhg.5201046; Raju I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028085; Raju I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019876; Rao PV, 1995, BBA-GEN SUBJECTS, V1245, P439, DOI 10.1016/0304-4165(95)00125-5; Santhiya S, 2006, MOL VIS, V12, P768; Singh D, 2007, J MOL BIOL, V373, P1293, DOI 10.1016/j.jmb.2007.08.062; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; VANDEROU.FJ, 1974, EUR J BIOCHEM, V49, P157; VANDEROU.FJ, 1973, EUR J BIOCHEM, V39, P207; WANG KY, 1994, J BIOL CHEM, V269, P13601; Xia XH, 2006, INVEST OPHTH VIS SCI, V47, P3004	32	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31421	10.1371/journal.pone.0031421	http://dx.doi.org/10.1371/journal.pone.0031421			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347476	gold, Green Published, Green Submitted			2022-12-25	WOS:000302730100070
J	Rossi, A; Coccia, M; Trotta, E; Angelini, M; Santoro, MG				Rossi, Antonio; Coccia, Marta; Trotta, Edoardo; Angelini, Mara; Santoro, M. Gabriella			Regulation of Cyclooxygenase-2 Expression by Heat: A Novel Aspect of Heat Shock Factor 1 Function in Human Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; NUCLEAR-FACTOR; KAPPA-B; GENE-TRANSCRIPTION; STRESS-RESPONSE; UP-REGULATION; FACTOR-I; FEVER; PROSTAGLANDINS; TEMPERATURE	The heat-shock response, a fundamental defense mechanism against proteotoxic stress, is regulated by a family of heat-shock transcription factors (HSF). In humans HSF1 is considered the central regulator of heat-induced transcriptional responses. The main targets for HSF1 are specific promoter elements (HSE) located upstream of heat-shock genes encoding cytoprotective heat-shock proteins (HSP) with chaperone function. In addition to its cytoprotective function, HSF1 was recently hypothesized to play a more complex role, regulating the expression of non-HSP genes; however, the non-canonical role of HSF1 is still poorly understood. Herein we report that heat-stress promotes the expression of cyclooxygenase-2 (COX-2), a key regulator of inflammation controlling prostanoid and thromboxane synthesis, resulting in the production of high levels of prostaglandin-E-2 in human cells. We show that heat-induced COX-2 expression is regulated at the transcriptional level via HSF1-mediated signaling and identify, by in-vitro reporter gene activity assay and deletion-mutant constructs analysis, the COX-2 heat-responsive promoter region and a new distal cis-acting HSE located at position - 2495 from the transcription start site. As shown by ChIP analysis, HSF1 is recruited to the COX-2 promoter rapidly after heat treatment; by using shRNA-mediated HSF1 suppression and HSE-deletion from the COX-2 promoter, we demonstrate that HSF1 plays a central role in the transcriptional control of COX-2 by heat. Finally, COX-2 transcription is also induced at febrile temperatures in endothelial cells, suggesting that HSF1-dependent COX-2 expression could contribute to increasing blood prostaglandin levels during fever. The results identify COX-2 as a human non-classical heat-responsive gene, unveiling a new aspect of HSF1 function.	[Rossi, Antonio; Coccia, Marta; Trotta, Edoardo; Santoro, M. Gabriella] CNR, Inst Translat Pharmacol, Rome, Italy; [Coccia, Marta; Angelini, Mara; Santoro, M. Gabriella] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR); University of Rome Tor Vergata	Rossi, A (corresponding author), CNR, Inst Translat Pharmacol, Rome, Italy.	santoro@bio.uniroma2.it	Trotta, Edoardo/AAW-4697-2020	Trotta, Edoardo/0000-0002-1417-9238; Santoro, Maria Gabriella/0000-0003-1432-4949; ROSSI, ANTONIO/0000-0003-0383-3828	Italian Ministry of Health; ISS [7OCF/7, ACC12]; EU-EICOSANOX	Italian Ministry of Health(Ministry of Health, Italy); ISS; EU-EICOSANOX	This work was supported by grants from the Italian Ministry of Health, ISS projects 'Ricerca Oncologica' [N. 7OCF/7] and 'Alleanza contro il Cancro' [N. ACC12], and the EU-EICOSANOX project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAVAYA K, 1991, GENE DEV, V5, P2117, DOI 10.1101/gad.5.11.2117; Anckar J, 2007, ADV EXP MED BIOL, V594, P78; Arnaud C, 2003, CARDIOVASC RES, V58, P582, DOI 10.1016/S0008-6363(03)00295-5; Blatteis CM, 2005, PROSTAG OTH LIPID M, V76, P1, DOI 10.1016/j.prostaglandins.2005.01.001; CALDERWOOD SK, 1989, J CELL PHYSIOL, V141, P325, DOI 10.1002/jcp.1041410214; Caughey GE, 2001, J BIOL CHEM, V276, P37839; Chen Q, 2006, NAT IMMUNOL, V7, P1299, DOI 10.1038/ni1406; de Gregorio R, 2001, J BIOL CHEM, V276, P27003, DOI 10.1074/jbc.M100885200; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Egan K., 2006, V176, P189; Evers LH, 2010, EXP DERMATOL, V19, P777, DOI 10.1111/j.1600-0625.2010.01105.x; Fujimoto M, 2010, FEBS J, V277, P4112, DOI 10.1111/j.1742-4658.2010.07827.x; Gothard LQ, 2003, J BIOL CHEM, V278, P9322, DOI 10.1074/jbc.M209412200; Guertin MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001114; Hasday JD, 2000, CELL STRESS CHAPERON, V5, P471, DOI 10.1379/1466-1268(2000)005<0471:FATHSR>2.0.CO;2; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hill JM, 2001, VIRUS GENES, V23, P273, DOI 10.1023/A:1012517221937; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; Inouye S, 2007, J BIOL CHEM, V282, P33210, DOI 10.1074/jbc.M704471200; Jaattela M, 1999, ANN MED, V31, P261, DOI 10.3109/07853899908995889; Jia DW, 2010, EXPERT REV MED DEVIC, V7, P407, DOI [10.1586/erd.10.13, 10.1586/ERD.10.13]; Kang YJ, 2007, PROG LIPID RES, V46, P108, DOI 10.1016/j.plipres.2007.01.001; Kline MP, 1997, MOL CELL BIOL, V17, P2107, DOI 10.1128/MCB.17.4.2107; Lu YB, 2005, J IMMUNOL, V175, P5423, DOI 10.4049/jimmunol.175.8.5423; Maity TK, 2011, CYTOKINE, V54, P61, DOI 10.1016/j.cyto.2010.12.017; Marnett LJ, 2000, CURR OPIN CHEM BIOL, V4, P545, DOI 10.1016/S1367-5931(00)00130-7; Mbonye UR, 2006, J BIOL CHEM, V281, P35770, DOI 10.1074/jbc.M608281200; Mbonye UR, 2009, BMB REP, V42, P552, DOI 10.5483/BMBRep.2009.42.9.552; Morimoto RI, 1998, NAT BIOTECHNOL, V16, P833, DOI 10.1038/nbt0998-833; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; MOSSER DD, 1988, MOL CELL BIOL, V8, P4736, DOI 10.1128/MCB.8.11.4736; Murapa P, 2007, J IMMUNOL, V179, P8305, DOI 10.4049/jimmunol.179.12.8305; Pang LH, 2003, J IMMUNOL, V170, P1043, DOI 10.4049/jimmunol.170.2.1043; Parfenova H, 2001, AM J PHYSIOL-CELL PH, V281, pC166, DOI 10.1152/ajpcell.2001.281.1.C166; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Rao Wei, 2010, Critical Reviews in Biomedical Engineering, V38, P101, DOI 10.1615/CritRevBiomedEng.v38.i1.80; Ray S, 2004, J BIOL CHEM, V279, P35604, DOI 10.1074/jbc.M401851200; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Robertson AG, 2008, GENOME RES, V18, P1906, DOI 10.1101/gr.078519.108; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Rossi A, 1997, P NATL ACAD SCI USA, V94, P746, DOI 10.1073/pnas.94.2.746; Rossi A, 2010, J BIOL CHEM, V285, P13607, DOI 10.1074/jbc.M109.082693; Sakurai H, 2010, FEBS J, V277, P4140, DOI 10.1111/j.1742-4658.2010.07829.x; Sandqvist A, 2009, MOL BIOL CELL, V20, P1340, DOI 10.1091/mbc.E08-08-0864; Sawaoka H, 2003, J BIOL CHEM, V278, P13928, DOI 10.1074/jbc.M300016200; Shin YK, 2005, CANCER RES, V65, P9501, DOI 10.1158/0008-5472.CAN-05-0220; Singh IS, 2000, J BIOL CHEM, V275, P9841, DOI 10.1074/jbc.275.13.9841; Singh IS, 2008, AM J RESP CELL MOL, V39, P235, DOI 10.1165/rcmb.2007-0294OC; Tanabe T, 2002, PROSTAG OTH LIPID M, V68-9, P95, DOI 10.1016/S0090-6980(02)00024-2; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Xie Y, 2002, J BIOL CHEM, V277, P11802, DOI 10.1074/jbc.M109296200; Zhao YH, 2009, ONCOGENE, V28, P3689, DOI 10.1038/onc.2009.229	55	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31304	10.1371/journal.pone.0031304	http://dx.doi.org/10.1371/journal.pone.0031304			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347460	gold, Green Published, Green Submitted			2022-12-25	WOS:000302730100059
J	Newman, SH; Hill, NJ; Spragens, KA; Janies, D; Voronkin, IO; Prosser, DJ; Yan, BP; Lei, FM; Batbayar, N; Natsagdorj, T; Bishop, CM; Butler, PJ; Wikelski, M; Balachandran, S; Mundkur, T; Douglas, DC; Takekawa, JY				Newman, Scott H.; Hill, Nichola J.; Spragens, Kyle A.; Janies, Daniel; Voronkin, Igor O.; Prosser, Diann J.; Yan, Baoping; Lei, Fumin; Batbayar, Nyambayar; Natsagdorj, Tseveenmyadag; Bishop, Charles M.; Butler, Patrick J.; Wikelski, Martin; Balachandran, Sivananinthaperumal; Mundkur, Taej; Douglas, David C.; Takekawa, John Y.			Eco-Virological Approach for Assessing the Role of Wild Birds in the Spread of Avian Influenza H5N1 along the Central Asian Flyway	PLOS ONE			English	Article							DOMESTIC DUCKS; MIGRATORY WATERFOWL; VIRUS-INFECTION; CHINA; OUTBREAKS; POULTRY; PERSISTENCE; EVOLUTION; DYNAMICS; REVEALS	A unique pattern of highly pathogenic avian influenza (HPAI) H5N1 outbreaks has emerged along the Central Asia Flyway, where infection of wild birds has been reported with steady frequency since 2005. We assessed the potential for two hosts of HPAI H5N1, the bar-headed goose (Anser indicus) and ruddy shelduck (Tadorna tadorna), to act as agents for virus dispersal along this 'thoroughfare'. We used an eco-virological approach to compare the migration of 141 birds marked with GPS satellite transmitters during 2005-2010 with: 1) the spatio-temporal patterns of poultry and wild bird outbreaks of HPAI H5N1, and 2) the trajectory of the virus in the outbreak region based on phylogeographic mapping. We found that biweekly utilization distributions (UDs) for 19.2% of bar-headed geese and 46.2% of ruddy shelduck were significantly associated with outbreaks. Ruddy shelduck showed highest correlation with poultry outbreaks owing to their wintering distribution in South Asia, where there is considerable opportunity for HPAI H5N1 spillover from poultry. Both species showed correlation with wild bird outbreaks during the spring migration, suggesting they may be involved in the northward movement of the virus. However, phylogeographic mapping of HPAI H5N1 clades 2.2 and 2.3 did not support dissemination of the virus in a northern direction along the migration corridor. In particular, two subclades (2.2.1 and 2.3.2) moved in a strictly southern direction in contrast to our spatio-temporal analysis of bird migration. Our attempt to reconcile the disciplines of wild bird ecology and HPAI H5N1 virology highlights prospects offered by both approaches as well as their limitations.	[Newman, Scott H.] Food & Agr Org United Nations, EMPRES Wildlife Unit, Ctr Transboundary Anim Dis, Anim Prod & Hlth Div, Rome, Italy; [Hill, Nichola J.; Spragens, Kyle A.; Takekawa, John Y.] US Geol Survey, Western Ecol Res Ctr, San Francisco Bay Estuary Field Stn, Vallejo, CA USA; [Hill, Nichola J.] Univ Calif Davis, Sch Vet Med, Wildlife Hlth Ctr, Davis, CA 95616 USA; [Janies, Daniel; Voronkin, Igor O.] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Prosser, Diann J.] US Geol Survey, Patuxent Wildlife Res Ctr, Beltsville Lab, Beltsville, MD USA; [Yan, Baoping] Chinese Acad Sci, Comp Network Informat Ctr, Beijing, Peoples R China; [Lei, Fumin] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China; [Batbayar, Nyambayar] Wildlife Sci & Conservat Ctr, Bayanzurkh Dist Ulaanbaa, Mongolia; [Natsagdorj, Tseveenmyadag] Mongolian Acad Sci, Ornithol Lab, Inst Biol, Ulaanbaatar, Mongolia; [Bishop, Charles M.] Bangor Univ, Sch Biol Sci, Brambell Labs, Bangor, Gwynedd, Wales; [Butler, Patrick J.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Wikelski, Martin] Max Planck Inst Ornithol, Radolfzell am Bodensee, Germany; [Balachandran, Sivananinthaperumal] Bombay Nat Hist Soc, Bombay, Maharashtra, India; [Mundkur, Taej] Wetlands Int, NL-6700 AL Wageningen, Netherlands; [Douglas, David C.] US Geol Survey, Alaska Sci Ctr, Juneau, AK USA	Food & Agriculture Organization of the United Nations (FAO); United States Department of the Interior; United States Geological Survey; University of California System; University of California Davis; University System of Ohio; Ohio State University; United States Department of the Interior; United States Geological Survey; Chinese Academy of Sciences; Computer Network Information Center, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Mongolian Academy of Sciences; Bangor University; University of Birmingham; Max Planck Society; United States Department of the Interior; United States Geological Survey	Newman, SH (corresponding author), Food & Agr Org United Nations, EMPRES Wildlife Unit, Ctr Transboundary Anim Dis, Anim Prod & Hlth Div, Rome, Italy.	john_takekawa@usgs.gov	Batbayar, Nyambayar/N-3761-2019; Douglas, David C./AAU-1087-2021; Batbayar, Nyambayar/N-7066-2015; Hill, Nichola/G-4003-2011	Batbayar, Nyambayar/0000-0002-9138-9626; Douglas, David C./0000-0003-0186-1104; Batbayar, Nyambayar/0000-0002-9138-9626; Prosser, Diann/0000-0002-5251-1799; /0000-0003-3213-6693	Food and Agriculture Organization of the United Nations through the EMPRES Wildlife Unit; United States Geological Survey (Western Ecological Research Center); United States Geological Survey (Patuxent Wildlife Research Center); United States Geological Survey (Alaska Science Center); National Science Foundation [0713027]; Biotechnology and Biological Science Research Council of the United Kingdom; Chinese Academy of Sciences [2007FY210700, INFO-115-D02, KSCX2-YW-N-063, 2005CB523007]; BBSRC [BB/F015615/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F015615/1] Funding Source: researchfish	Food and Agriculture Organization of the United Nations through the EMPRES Wildlife Unit; United States Geological Survey (Western Ecological Research Center); United States Geological Survey (Patuxent Wildlife Research Center)(United States Geological Survey); United States Geological Survey (Alaska Science Center)(United States Geological Survey); National Science Foundation(National Science Foundation (NSF)); Biotechnology and Biological Science Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Chinese Academy of Sciences(Chinese Academy of Sciences); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Food and Agriculture Organization of the United Nations through the EMPRES Wildlife Unit, the United States Geological Survey (Western Ecological Research Center, Patuxent Wildlife Research Center, Alaska Science Center, and Wild Bird Avian Influenza Program), the National Science Foundation Small Grants for Exploratory Research (No. 0713027), and the Biotechnology and Biological Science Research Council of the United Kingdom and the Chinese Academy of Sciences (No. 2007FY210700, INFO-115-D02, KSCX2-YW-N-063 and 2005CB523007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barua A, 1997, WORLD POULTRY SCI J, V53, P387, DOI 10.1079/WPS19970031; Bin Muzaffar S, 2010, WATERBIRDS, V33, P219, DOI 10.1675/063.033.s116; Bishop MA, 2007, CHINA CRANE NEWS, V11, P24; Bishop Mary A., 1997, Wildfowl, V48, P118; Biswas PK, 2008, EMERG INFECT DIS, V14, P1909, DOI 10.3201/eid1412.071567; Brown IH, 2010, AVIAN DIS, V54, P187, DOI 10.1637/8949-053109-Reg.1; Brown JD, 2008, EMERG INFECT DIS, V14, P136, DOI 10.3201/eid1401.070740; Brown JD, 2006, EMERG INFECT DIS, V12, P1663, DOI 10.3201/eid1211.060652; Butler D, 2006, NATURE, V441, P263, DOI 10.1038/441263a; Chakrabarti AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007846; Chen HL, 2006, J VIROL, V80, P5976, DOI 10.1128/JVI.00110-06; Cui P, 2011, VECTOR-BORNE ZOONOT, V11, P567, DOI 10.1089/vbz.2009.0240; FAO, 2010, EMPRES I GLOB AN HLT; Feare CJ, 2010, J WILDLIFE DIS, V46, P1340, DOI 10.7589/0090-3558-46.4.1340; Gaidet N, 2010, J APPL ECOL, V47, P1147, DOI 10.1111/j.1365-2664.2010.01845.x; Galvin KA, 2009, ANNU REV ANTHROPOL, V38, P185, DOI 10.1146/annurev-anthro-091908-164442; Gauthier-Clerc M, 2007, IBIS, V149, P202, DOI 10.1111/j.1474-919X.2007.00699.x; Gilbert M, 2006, EMERG INFECT DIS, V12, P227, DOI 10.3201/eid1202.050640; Gilbert M, 2007, AGR ECOSYST ENVIRON, V119, P409, DOI 10.1016/j.agee.2006.09.001; Gilbert M, 2006, EMERG INFECT DIS, V12, P1650, DOI 10.3201/eid1211.060223; Gilbert M, 2010, ECOHEALTH, V7, P448, DOI 10.1007/s10393-010-0672-8; Goloboff P, 2008, CLADISTICS, V24, P91; Gopal B, 1994, WETLANDS SHALLOW CON, P457; Hogerwerf L, 2010, ECOHEALTH, V7, P213, DOI 10.1007/s10393-010-0324-z; Hooge PN, 1997, ANIMAL MOVEMENT EXTE; Hovmoller R, 2010, CLADISTICS, V26, P1, DOI 10.1111/j.1096-0031.2009.00297.x; Hoye BJ, 2011, OIKOS, V120, P748, DOI 10.1111/j.1600-0706.2010.18961.x; Hulse-Post DJ, 2005, P NATL ACAD SCI USA, V102, P10682, DOI 10.1073/pnas.0504662102; Iverson SA, IBIS IN PRESS; Janies D, 2007, SYST BIOL, V56, P321, DOI 10.1080/10635150701266848; Javed Salim, 2000, Global Environmental Research, V4, P195; Kamal RP, 2007, ARCH VIROL, V152, P1637, DOI 10.1007/s00705-007-1002-5; Keating KA, 2009, ECOLOGY, V90, P1971, DOI 10.1890/08-1131.1; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Kou Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006926; Kwon YK, 2010, VET PATHOL, V47, P495, DOI 10.1177/0300985809359602; Lebarbenchon C, 2010, EMERG INFECT DIS, V16, P1057, DOI 10.3201/eid1607.090389; Lei FM, 2007, AVIAN DIS, V51, P568, DOI 10.1637/0005-2086(2007)51[568:COHIVI]2.0.CO;2; Li KB, 2003, BIOINFORMATICS, V19, P1585, DOI 10.1093/bioinformatics/btg192; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Li YB, 2010, J VIROL, V84, P8389, DOI 10.1128/JVI.00413-10; Liang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013575; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Liu Y, 2004, INT J REMOTE SENS, V25, P4177, DOI 10.1080/01431160410001680419; Lvov D. K., 2006, Voprosy Virusologii, V51, P11; Middleton B, 1989, THESIS IOWA STATE U; Mishra AC, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-26; Miyabayashi Y, 1999, ATLAS KEY SITES ANAT; Newman SH, 2010, FAO EMPRES WILDLIFE; ODUM EP, 1960, AM J CLIN NUTR, V8, P621, DOI 10.1093/ajcn/8.5.621; Ottaviani D, 2010, ECOHEALTH, V7, P226, DOI 10.1007/s10393-010-0316-z; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Prosser DJ, 2009, IBIS, V151, P568, DOI 10.1111/j.1474-919X.2009.00932.x; Sakoda Y, 2010, VIROLOGY, V406, P88, DOI 10.1016/j.virol.2010.07.007; Sharshov K, 2010, EMERG INFECT DIS, V16, P349, DOI 10.3201/eid1602.090974; Si YL, 2009, GEOSPATIAL HEALTH, V4, P65, DOI 10.4081/gh.2009.211; SLATKIN M, 1989, GENETICS, V123, P603; Smith GJD, 2009, EMERG INFECT DIS, V15, P402, DOI 10.3201/eid1503.081190; Songserm T, 2006, EMERG INFECT DIS, V12, P575, DOI 10.3201/eid1204.051614; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sturm-Ramirez KM, 2005, J VIROL, V79, P11269, DOI 10.1128/JVI.79.17.11269-11279.2005; U.S. Geological Survey, 2010, SAT TRACK MIGR BIRDS; Van Borm S, 2005, EMERG INFECT DIS, V11, P702, DOI 10.3201/eid1105.050211; Vijayan VS, 1988, KEOLADEO NATL PARK E; Wallace R, 2009, AVIAN INFLUENZA FARM, P141; Wallace RG, 2007, P NATL ACAD SCI USA, V104, P4473, DOI 10.1073/pnas.0700435104; Webster RG, 2007, AVIAN DIS, V51, P269, DOI 10.1637/7641-050206R.1; WHO, 2010, CUM NUMB CONF HUM CA; Xiao XM, 2007, J WILDLIFE DIS, V43, pS40; Zhang FY, 1997, BIRD MIGRATION RES C; Zhang ZJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015314; Zhou JY, 2009, J VIROL, V83, P8957, DOI 10.1128/JVI.00793-09	73	57	59	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e30636	10.1371/journal.pone.0030636	http://dx.doi.org/10.1371/journal.pone.0030636			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347393	Green Published, Green Submitted, gold			2022-12-25	WOS:000302180600013
J	Song, M; Xiong, JX; Wang, YY; Tang, J; Zhang, B; Bai, Y				Song, Min; Xiong, Jia-xiang; Wang, Yan-yan; Tang, Jun; Zhang, Bo; Bai, Yun			VIP Enhances Phagocytosis of Fibrillar Beta-Amyloid by Microglia and Attenuates Amyloid Deposition in the Brain of APP/PS1 Mice	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; NITRIC-OXIDE SYNTHASE; ALZHEIMER-DISEASE; TNF-ALPHA; POLYPEPTIDE; RAT; STIMULATION; INFLAMMATION; MACROPHAGES; ACTIVATION	Vasoactive intestinal peptide (VIP) is a multifunctional neuropeptide with demonstrated immunosuppressive and neuroprotective activities. It has been shown to inhibit Amyloid beta (A beta)-induced neurodegeneration by indirectly suppressing the production and release of a variety of inflammatory and neurotoxic factors by activated microglia. We demonstrated that VIP markedly increased microglial phagocytosis of fibrillar A beta 42 and that this enhanced phagocytotic activity depended on activation of the Protein kinase C (PKC) signaling pathway. In addition, VIP suppressed the release of tumor necrosis factor alpha (TNF-alpha) and nitric oxide(NO) from microglia activated by combined treatment with fibrillar A beta 42 and low dose interferon-gamma (IFN-gamma). We utilized an adenovirus-mediated gene delivery method to overexpress VIP constitutively in the hippocampus of APPswPS1 transgenic mice. The A beta load was significantly reduced in the hippocampus of this animal model of Alzheimer's disease, possibly due to the accumulation and activation of cd11b-immunoactive microglial cells. The modulation of microglial activation, phagocytosis, and secretion by VIP is a promising therapeutic option for the treatment of Alzheimer's disease(AD).	[Song, Min; Wang, Yan-yan; Tang, Jun; Zhang, Bo; Bai, Yun] Third Mil Med Univ, Dept Med Genet, Chongqing, Peoples R China; [Xiong, Jia-xiang] Third Mil Med Univ, Dept Med Physiol, Chongqing, Peoples R China	Army Medical University; Army Medical University	Song, M (corresponding author), Third Mil Med Univ, Dept Med Genet, Chongqing, Peoples R China.	baiyungene@gmail.com			National Natural Science Foundation of China [81000147, 30228018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (NO. 81000147, NO. 30228018) and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAI H, 1984, NEUROSCI LETT, V52, P73, DOI 10.1016/0304-3940(84)90353-7; Bedoui S, 2003, J IMMUNOL, V171, P3451, DOI 10.4049/jimmunol.171.7.3451; Choucair-Jaafar N, 2011, FUND CLIN PHARMACOL, V25, P115, DOI 10.1111/j.1472-8206.2010.00811.x; Combs CK, 2001, J NEUROSCI, V21, P1179; DELAFUENTE M, 1993, REGUL PEPTIDES, V48, P345, DOI 10.1016/0167-0115(93)90163-3; Delgado M, 2003, FASEB J, V17, P944, DOI 10.1096/fj.02-0799fje; Delgado M, 2002, GLIA, V39, P148, DOI 10.1002/glia.10098; Delgado M, 2004, PHARMACOL REV, V56, P249, DOI 10.1124/pr.56.2.7; Delgado M, 2008, GLIA, V56, P1091, DOI 10.1002/glia.20681; DiCarlo G, 2001, NEUROBIOL AGING, V22, P1007, DOI 10.1016/S0197-4580(01)00292-5; El Zein N, 2008, J LEUKOCYTE BIOL, V83, P972, DOI 10.1189/jlb.0507327; FARMERY SM, 1984, NEUROPHARMACOLOGY, V23, P101, DOI 10.1016/0028-3908(84)90224-7; GLOWA JR, 1992, BRAIN RES, V570, P49, DOI 10.1016/0006-8993(92)90562-N; Gonzalez-Rey Elena, 2005, Curr Opin Investig Drugs, V6, P1116; Gozes I, 1996, P NATL ACAD SCI USA, V93, P427, DOI 10.1073/pnas.93.1.427; GOZES I, 1993, J MOL NEUROSCI, V4, P185, DOI 10.1007/BF02782501; Grimm MC, 2003, J IMMUNOL, V171, P4990, DOI 10.4049/jimmunol.171.10.4990; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Heneka MT, 1998, J NEUROCHEM, V71, P88; Joo KM, 2004, J COMP NEUROL, V476, P388, DOI 10.1002/cne.20231; Krishnadas A, 2003, CURR PHARM DESIGN, V9, P1005, DOI 10.2174/1381612033455206; Liu J, 2000, IMMUNOLOGY, V101, P61, DOI 10.1046/j.1365-2567.2000.00082.x; Lodde BM, 2004, BIOCHEM BIOPH RES CO, V319, P189, DOI 10.1016/j.bbrc.2004.04.171; LOREN I, 1979, NEUROSCIENCE, V4, P1953, DOI 10.1016/0306-4522(79)90068-X; Mandrekar-Colucci S, 2010, CNS NEUROL DISORD-DR, V9, P156, DOI 10.2174/187152710791012071; Martinez C, 2002, P NATL ACAD SCI USA, V99, P1053, DOI 10.1073/pnas.012367999; Monsonego A, 2003, SCIENCE, V302, P834, DOI 10.1126/science.1088469; MUHVIC D, 1992, ANN NY ACAD SCI, V650, P170; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Reinke E, 2006, IMMUNOL LETT, V104, P102, DOI 10.1016/j.imlet.2005.11.009; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Tan J, 1999, SCIENCE, V286, P2352, DOI 10.1126/science.286.5448.2352; Weldon DT, 1998, J NEUROSCI, V18, P2161; Wu RQ, 2003, REGUL PEPTIDES, V112, P19, DOI 10.1016/S0167-0115(03)00018-1; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; ZHOU JN, 1995, NEUROBIOL AGING, V16, P571, DOI 10.1016/0197-4580(95)00043-E; Zhu YN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002135	38	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e29790	10.1371/journal.pone.0029790	http://dx.doi.org/10.1371/journal.pone.0029790			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328918	Green Published, Green Submitted, gold			2022-12-25	WOS:000302179300004
J	Raffaello, T; Kerio, S; Asiegbu, FO				Raffaello, Tommaso; Kerio, Susanna; Asiegbu, Fred O.			Role of the HaHOG1 MAP Kinase in Response of the Conifer Root and But Rot Pathogen (Heterobasidion annosum) to Osmotic and Oxidative Stress	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SIGNAL-TRANSDUCTION; HOG PATHWAY; YEAST; GENE; EXPRESSION; ENCODES; GROWTH; DIFFERENTIATION; RESISTANCE	The basidiomycete Heterobasidion annosum (Fr.) Bref. s.l. is a filamentous white rot fungus, considered to be the most economically important pathogen of conifer trees. Despite the severity of the tree infection, very little is known about the molecular and biochemical aspects related to adaptation to abiotic stresses. In this study, the osmotic and oxidative tolerance as well as the role of the HaHOG1 Mitogen Activated Protein Kinase (MAPK) gene were investigated. The transcript levels of the yeast orthologues GPD1, HSP78, STL1, GRE2 and the ATPase pumps ENA1, PMR1, PMC1 known to have an important role in osmotolerance were also quantified under salt osmotic conditions. The HaHOG1 gene was used for a heterologous expression and functional study in the Saccharomyces cerevisiae Delta hog1 strain. Moreover, the phosphorylation level of HaHog1p was studied under salt osmotic and oxidative stress. The result showed that H. annosum displayed a decreased growth when exposed to an increased concentration of osmotic and oxidative stressors. GPD1, HSP78, STL1 and GRE2 showed an induction already at 10 min after exposure to salt stress. Among the ATPase pumps studied, PMC1 was highly induced when the fungus was exposed to 0.2 M CaCl2 for 60 min. The heterologous expression of the HaHOG1 sequence in yeast confirmed that the gene is able to restore the osmotolerance and oxidative tolerance in the S. cerevisiae hog1 Delta mutant strain. The HaHog1p was strongly phosphorylated in the presence of NaCl, KCl, H2O2 but not in the presence of CaCl2 and MgCl2. The GFP-HaHog1p fusion protein accumulated in the nuclei of the S. cerevisiae hog1 Delta cells when exposed to high osmotic conditions but not under oxidative stress. These results provide the first insights about the response of H. annosum to osmotic and oxidative stress and elucidate the role of the HaHOG1 gene in such conditions.	[Raffaello, Tommaso; Kerio, Susanna; Asiegbu, Fred O.] Univ Helsinki, Dept Forest Sci, Helsinki, Finland; [Raffaello, Tommaso; Asiegbu, Fred O.] Viikki Grad Sch Mol Biosci VGSB, Helsinki, Finland	University of Helsinki	Raffaello, T (corresponding author), Univ Helsinki, Dept Forest Sci, Helsinki, Finland.	tommaso.raffaello@helsinki.fi		Raffaello, Tommaso/0000-0002-4074-0682; Kerio, Susanna/0000-0002-1637-5451; Asiegbu, Fred O/0000-0003-0223-7194	Helsinki University [490025]; Academy of Finland [131660]; Viikki Graduate School in Molecular Biosciences (VGSB)	Helsinki University; Academy of Finland(Academy of Finland); Viikki Graduate School in Molecular Biosciences (VGSB)	This work was supported by Helsinki University Research grant (490025) to FOA, the Academy of Finland grant (131660) and Viikki Graduate School in Molecular Biosciences (VGSB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam AL, 2008, J BASIC MICROB, V48, P151, DOI 10.1002/jobm.200700403; ALBERTYN J, 1994, MOL CELL BIOL, V14, P4135, DOI 10.1128/MCB.14.6.4135; Alonso-Monge R, 2003, EUKARYOT CELL, V2, P351, DOI 10.1128/EC.2.2.351-361.2003; ANTEBI A, 1992, MOL BIOL CELL, V3, P633, DOI 10.1091/mbc.3.6.633; Asiegbu FO, 2005, MOL PLANT PATHOL, V6, P395, DOI 10.1111/J.1364-3703.2005.00295.X; Bahn YS, 2005, MOL BIOL CELL, V16, P2285, DOI 10.1091/mbc.E04-11-0987; Benito B, 2002, MICROBIOL-SGM, V148, P933, DOI 10.1099/00221287-148-4-933; Benito B, 2009, EUKARYOT CELL, V8, P821, DOI 10.1128/EC.00252-08; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bilsland E, 2004, MOL MICROBIOL, V53, P1743, DOI 10.1111/j.1365-2958.2004.04238.x; Bilsland-Marchesan E, 2003, YEAST, V20, pS203; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Chen CN, 2003, YEAST, V20, P545, DOI 10.1002/yea.979; Dixon KP, 1999, PLANT CELL, V11, P2045, DOI 10.1105/tpc.11.10.2045; Eaton CJ, 2008, CURR GENET, V53, P163, DOI 10.1007/s00294-007-0174-6; Ferreira C, 2005, MOL BIOL CELL, V16, P2068, DOI 10.1091/mbc.E04-10-0884; Hernandez-Lopez MJ, 2006, EUKARYOT CELL, V5, P1410, DOI 10.1128/EC.00068-06; Igbaria A, 2008, MOL PLANT MICROBE IN, V21, P769, DOI 10.1094/MPMI-21-6-0769; Jin Y, 2005, P NATL ACAD SCI USA, V102, P18992, DOI 10.1073/pnas.0509653102; JONES AS, 1953, BIOCHIM BIOPHYS ACTA, V10, P607, DOI 10.1016/0006-3002(53)90304-7; Kawasaki L, 2002, MOL MICROBIOL, V45, P1153, DOI 10.1046/j.1365-2958.2002.03087.x; Kayingo G, 2009, MICROBIOL-SGM, V155, P1547, DOI 10.1099/mic.0.023457-0; Korhonen K, 1998, HETEROBASIDION ANNOSUM: BIOLOGY, ECOLOGY, IMPACT AND CONTROL, P43; Lee SJ, 2002, FEMS MICROBIOL LETT, V209, P9, DOI 10.1016/S0378-1097(01)00491-8; LEONHARDT SA, 1993, MOL CELL BIOL, V13, P6304, DOI 10.1128/MCB.13.10.6304; Lin CH, 2010, FUNGAL GENET BIOL, V47, P818, DOI 10.1016/j.fgb.2010.06.009; Marchi V, 1999, FEBS LETT, V454, P181, DOI 10.1016/S0014-5793(99)00803-0; Miura T, 2006, EXTREMOPHILES, V10, P279, DOI 10.1007/s00792-005-0496-6; Niemela T, 1998, HETEROBASIDION ANNOSUM: BIOLOGY, ECOLOGY, IMPACT AND CONTROL, P27; Nikolaou E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-44; Oliva J, 2011, FOREST ECOL MANAG, V262, P1378, DOI 10.1016/j.foreco.2011.06.033; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinson-Gadais L, 2008, MYCOPATHOLOGIA, V165, P51, DOI 10.1007/s11046-007-9076-x; Posas F, 2000, J BIOL CHEM, V275, P17249, DOI 10.1074/jbc.M910016199; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Qian JC, 2011, BIOTECHNOL LETT, V33, P571, DOI 10.1007/s10529-010-0458-7; Reiser V, 1999, MOL BIOL CELL, V10, P1147, DOI 10.1091/mbc.10.4.1147; Rodaki A, 2009, MOL BIOL CELL, V20, P4845, DOI 10.1091/mbc.E09-01-0002; Segmuller N, 2007, EUKARYOT CELL, V6, P211, DOI 10.1128/EC.00153-06; Silverman-Gavrila LB, 2001, EUR J CELL BIOL, V80, P379, DOI 10.1078/0171-9335-00175; Smith DA, 2010, FEMS MICROBIOL LETT, V306, P1, DOI 10.1111/j.1574-6968.2010.01937.x; Takatsume Y, 2010, BIOCHEM J, V427, P275, DOI 10.1042/BJ20091334; Vasiliauskas R, 1998, CAN J FOREST RES, V28, P961, DOI 10.1139/cjfr-28-7-961; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Zhang Y, 2002, APPL ENVIRON MICROB, V68, P532, DOI 10.1128/AEM.68.2.532-538.2002	45	10	10	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e31186	10.1371/journal.pone.0031186	http://dx.doi.org/10.1371/journal.pone.0031186			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22319614	Green Submitted, Green Published, gold			2022-12-25	WOS:000301977500030
J	Gulzar, ZG; McKenney, JK; Brooks, JD				Gulzar, Z. G.; McKenney, J. K.; Brooks, J. D.			Increased expression of NuSAP in recurrent prostate cancer is mediated by E2F1	ONCOGENE			English	Article						prostate cancer; gene-expression profiling; NuSAP; E2F1; recurrence	GENE-EXPRESSION; PROGNOSTIC BIOMARKERS; BINDING PROTEIN-3; BREAST-CANCER; PROLIFERATION; SURVIVAL; REVEALS; OVEREXPRESSION; IDENTIFICATION; PROGRESSION	Increasing evidence suggests that prostate cancer is overdiagnosed and overtreated, and prognostic biomarkers would aid in treatment selection. To define prognostic biomarkers for aggressive prostate cancer, we carried out gene-expression profiling of 98 prostate tumors and 52 benign adjacent prostate tissue samples with detailed clinical annotation. We identified 28 transcripts significantly associated with recurrence after radical prostatectomy including NuSAP, a protein that binds DNA to the mitotic spindle. Elevated NuSAP transcript levels were associated with poor outcome in two independent prostate cancer gene-expression datasets. To characterize the role and regulation of NuSAP in prostate cancer, we studied the expression of NuSAP in the LNCaP and PC3 human prostate cancer cell lines. Posttranscriptional silencing of the NuSAP gene severely hampered the ability of PC3 to invade and proliferate in vitro. The promoter region of the NuSAP gene contains two CCAAT boxes and binding sites for E2F. Transient transfection of an E2F1 cDNA and 431 bp of the NuSAP promoter demonstrated E2F1 as an important regulator of expression. Deletion of the E2F-binding site at nucleotide -246 negated the effects of E2F1 on NuSAP expression. Electrophoretic mobility shift assays demonstrated that nuclear extracts of cells overexpressing E2F1 bound directly to the E2F-binding site in the NuSAP promoter region. Finally, immunohistochemistry showed a strong correlation between E2F1 and NuSAP expression in human prostate cancer samples. NuSAP is a novel biomarker for prostate cancer recurrence after surgery and its overexpression appears to be driven in part by E2F1 activation. Oncogene (2013) 32, 70-77; doi:10.1038/onc.2012.27; published online 20 February 2012	[Gulzar, Z. G.; Brooks, J. D.] Stanford Univ, Dept Urol, Sch Med, Stanford, CA 94305 USA; [McKenney, J. K.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Brooks, JD (corresponding author), Stanford Univ, Dept Urol, Sch Med, Room S287,300 Pasteur Dr, Stanford, CA 94305 USA.	jdbrooks@stanford.edu			NIH [CA112016, CA111782, CA130472]; Department of Defense [W81XWH-11-1-0447]; NATIONAL CANCER INSTITUTE [R01CA112016, R01CA111782, F32CA130472] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded by the NIH (CA112016, CA111782 and CA130472 to JDB) and the Department of Defense (W81XWH-11-1-0447 to JDB).	Abraham JE, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2629; Adamo B, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2852; Amemiya H, 2010, INVEST CLIN, V51, P369; Aune G, 2011, GYNECOL ONCOL, V121, P402, DOI 10.1016/j.ygyno.2010.12.355; Bogunovic D, 2009, P NATL ACAD SCI USA, V106, P20429, DOI 10.1073/pnas.0905139106; Bryant RJ, 2007, PROSTATE, V67, P547, DOI 10.1002/pros.20550; Chan JM, 2002, J NATL CANCER I, V94, P1099; Chotteau-Lelievre A, 2004, CLIN CANCER RES, V10, P7297, DOI 10.1158/1078-0432.CCR-04-0593; Davis JN, 2006, CANCER RES, V66, P11897, DOI 10.1158/0008-5472.CAN-06-2497; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Engers R, 2007, ENDOCR-RELAT CANCER, V14, P245, DOI 10.1677/ERC-06-0036; Freedland SJ, 2005, JAMA-J AM MED ASSOC, V294, P433, DOI 10.1001/jama.294.4.433; Fujiwara T, 2006, BRIT J HAEMATOL, V135, P583, DOI 10.1111/j.1365-2141.2006.06340.x; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Gorter A, 2010, MODERN PATHOL, V23, P1605, DOI 10.1038/modpathol.2010.154; Helfenstein A, 2004, AM J CLIN PATHOL, V122, P912, DOI 10.1309/G638TKNNG2CJUXWL; Hussain S, 2009, J CELL BIOL, V186, P27, DOI 10.1083/jcb.200810180; Iyer J, 2011, CELL SIGNAL, V23, P991, DOI 10.1016/j.cellsig.2010.11.006; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kim YH, 2009, METHODS MOL BIOL, V556, P21, DOI 10.1007/978-1-60327-192-9_3; Kosari F, 2008, CLIN CANCER RES, V14, P1734, DOI 10.1158/1078-0432.CCR-07-1494; Lammers L A, 2010, Br J Cancer, V103, P765, DOI 10.1038/sj.bjc.6605800; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lapointe J, 2007, CANCER RES, V67, P8504, DOI 10.1158/0008-5472.CAN-07-0673; LaTulippe E, 2002, CANCER RES, V62, P4499; Luo J, 2001, CANCER RES, V61, P4683; Luo JH, 2002, MOL CARCINOGEN, V33, P25, DOI 10.1002/mc.10018; Malhotra S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020293; Miyata Y, 2004, UROLOGY, V63, P1184, DOI 10.1016/j.urology.2004.02.015; Monge M, 2009, CARCINOGENESIS, V30, P1288, DOI 10.1093/carcin/bgp119; Murphy AJ, 2007, CANCER RES, V67, P2893, DOI 10.1158/0008-5472.CAN-06-2962; Mustjoki S, 2009, HAEMATOL-HEMATOL J, V94, P1469, DOI 10.3324/haematol.2009.008094; Pflueger D, 2011, GENOME RES, V21, P56, DOI 10.1101/gr.110684.110; Rodriguez-Enriquez S, 2011, J CELL BIOCHEM, V112, P2703, DOI 10.1002/jcb.23224; Roobol MJ, 2009, EUR UROL, V56, P584, DOI 10.1016/j.eururo.2009.07.018; Schrader C, 2005, BRIT J CANCER, V93, P939, DOI 10.1038/sj.bjc.6602795; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Setoguchi T, 2011, CANCER SCI, V102, P883, DOI 10.1111/j.1349-7006.2011.01872.x; Sharma A, 2010, J CLIN INVEST, V120, P4478, DOI 10.1172/JCI44239; Sherlock G, 2001, NUCLEIC ACIDS RES, V29, P152, DOI 10.1093/nar/29.1.152; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Vanden Bosch A, 2010, J CELL SCI, V123, P3244, DOI 10.1242/jcs.063875; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; von Euler H, 2011, VET COMP ONCOL, V9, P1, DOI 10.1111/j.1476-5829.2010.00238.x; Wadia PP, 2010, BLOOD, V115, P2077, DOI 10.1182/blood-2009-03-211375; Welsh JB, 2001, CANCER RES, V61, P5974; Wong N, 2009, INT J CANCER, V124, P644, DOI 10.1002/ijc.23968; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498; Yuan RH, 2007, CLIN CANCER RES, V13, P5368, DOI 10.1158/1078-0432.CCR-07-1113	51	75	80	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2013	32	1					70	77		10.1038/onc.2012.27	http://dx.doi.org/10.1038/onc.2012.27			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	063VG	22349817	Green Accepted			2022-12-25	WOS:000313029500007
J	Sanchez, M; Picard, N; Sauve, K; Tremblay, A				Sanchez, M.; Picard, N.; Sauve, K.; Tremblay, A.			Coordinate regulation of estrogen receptor beta degradation by Mdm2 and CREB-binding protein in response to growth signals	ONCOGENE			English	Article						ErbB2/Her-2/Neu; ErbB3; PI3-K/Akt pathway; 26S proteasome-ubiquitin system; CBP/p300; breast cancer	BREAST-CANCER CELLS; PHOSPHORYLATION; ACTIVATION; ALPHA; PATHWAY; KINASE; PROTEASOME; COACTIVATOR; GAMMA; CBP	The biological actions of estrogen are mediated via estrogen receptors ER alpha and ER beta. Yet, other cellular signaling events that also impact ER functions have an important role in breast carcinogenesis. Here, we show that activation of ErbB2/ErbB3 tyrosine kinase receptors with growth factor heregulin-beta prompts ER beta degradation by the 26S proteasome, a mechanism that requires the coactivator cAMP response element-binding (CREB)-binding protein (CBP). We found that CBP promotes ER beta ubiquitination and degradation through enhancement of the PI3-K/Akt pathway by heregulin-beta, an effect potentiated by a negatively charged hinge region of ER beta. Activated Akt triggered the recruitment of E3 ubiquitin ligase Mdm2 to ER beta, which was further stabilized by CBP, resulting in ER beta poly-ubiquitination. Mutation of CBP Thr-1872 or Mdm2 Ser-186/188 Akt sites resulted in a dissociation of the ER beta-CBP-Mdm2 complex and reduced ER beta turnover. We found that the decrease in ER beta induced by heregulin-beta was associated with reduced target gene promoter occupancy and enhanced proliferation of breast cancer cells. However, knockdown of Mdm2 restored endogenous ER beta levels resulting in reduction of breast cancer cell growth. These studies identify a tripartite Akt-regulated phosphorylation mechanism that functions to hamper normal ER beta activity and turnover through the concerted actions of CBP and Mdm2 in response to growth factor signaling pathways in breast cancer cells. Oncogene (2013) 32, 117-126; doi:10.1038/onc.2012.19; published online 20 February 2012	[Sanchez, M.; Picard, N.; Sauve, K.; Tremblay, A.] Univ Montreal, Ste Justine Hosp Res Ctr, Dept Biochem, Montreal, PQ H3T 1C5, Canada; [Tremblay, A.] Univ Montreal, Dept Obstet & Gynecol, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	Tremblay, A (corresponding author), Univ Montreal, Ste Justine Hosp Res Ctr, Dept Biochem, 3175 Cote Ste Catherine, Montreal, PQ H3T 1C5, Canada.	andre.tremblay.1@umontreal.ca			FHSJ (Fondation de l'Hopital Ste-Justine); FRSQ (Fonds de la Recherche en Sante du Quebec); GRUM (Groupe de Recherche sur le Medicament de l'Universite de Montreal); CIHR (Canadian Institutes of Health Research); NSERC (Natural Sciences and Engineering Research Council of Canada); Cancer Research Society Inc.; Canadian Foundation for Innovation; FHSJ	FHSJ (Fondation de l'Hopital Ste-Justine); FRSQ (Fonds de la Recherche en Sante du Quebec)(Fonds de la Recherche en Sante du Quebec); GRUM (Groupe de Recherche sur le Medicament de l'Universite de Montreal); CIHR (Canadian Institutes of Health Research)(Canadian Institutes of Health Research (CIHR)); NSERC (Natural Sciences and Engineering Research Council of Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Cancer Research Society Inc.; Canadian Foundation for Innovation(Canada Foundation for Innovation); FHSJ	We thank members of the laboratory for critical reading and useful comments. MS is supported by a doctoral award from the FHSJ (Fondation de l'Hopital Ste-Justine), NP by the FRSQ (Fonds de la Recherche en Sante du Quebec) and the FHSJ, and KS by the GRUM (Groupe de Recherche sur le Medicament de l'Universite de Montreal), the FHSJ and the CIHR (Canadian Institutes of Health Research). AT is a New Investigator of the CIHR. This work was supported by grants from the CIHR, the NSERC (Natural Sciences and Engineering Research Council of Canada), the Cancer Research Society Inc. and the Canadian Foundation for Innovation.	Ariazi EA, 2002, CANCER RES, V62, P6510; Arpino G, 2008, ENDOCR REV, V29, P217, DOI 10.1210/er.2006-0045; Avallone R, 2006, MOL ENDOCRINOL, V20, P3165, DOI 10.1210/me.2006-0146; Berry NB, 2008, MOL ENDOCRINOL, V22, P1535, DOI 10.1210/me.2007-0449; Brekman A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2804; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; Demers A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007728; Feng JH, 2004, J BIOL CHEM, V279, P35510, DOI 10.1074/jbc.M404936200; Goodman RH, 2000, GENE DEV, V14, P1553; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Jordan VC, 2007, J CLIN ONCOL, V25, P5815, DOI 10.1200/JCO.2007.11.3886; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kim K, 2011, J MOL ENDOCRINOL, V46, P67, DOI 10.1677/JME-10-0110; Lazennec G, 2006, CANCER LETT, V231, P151, DOI 10.1016/j.canlet.2005.01.021; Lazennec G, 2001, ENDOCRINOLOGY, V142, P4120, DOI 10.1210/en.142.9.4120; Leygue E, 1998, CANCER RES, V58, P3197; Lindberg K, 2010, J CELL PHYSIOL, V222, P156, DOI 10.1002/jcp.21932; Loda M, 2010, CANCER CELL, V17, P311, DOI 10.1016/j.ccr.2010.03.013; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Ma YX, 2010, MOL ENDOCRINOL, V24, P76, DOI 10.1210/me.2009-0218; Marine JC, 2010, CELL DEATH DIFFER, V17, P93, DOI 10.1038/cdd.2009.68; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Meek DW, 2010, SEMIN CANCER BIOL, V20, P19, DOI 10.1016/j.semcancer.2009.10.005; Nair HB, 2011, STEROIDS, V76, P792, DOI 10.1016/j.steroids.2011.02.038; Nawaz Z, 1999, P NATL ACAD SCI USA, V96, P1858, DOI 10.1073/pnas.96.5.1858; Nawaz Z, 1999, MOL CELL BIOL, V19, P1182; Picard N, 2008, MOL ENDOCRINOL, V22, P317, DOI 10.1210/me.2007-0281; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Roger P, 2008, ADV EXP MED BIOL, V617, P139, DOI 10.1007/978-0-387-69080-3_13; Sakamoto G, 2009, BREAST CANCER-TOKYO, V16, P281, DOI 10.1007/s12282-009-0110-3; SANCHEZ M, 2005, MOL GENET CANC, V5, P149; Sanchez M, 2007, J BIOL CHEM, V282, P4830, DOI 10.1074/jbc.M607908200; Sanchez M, 2010, TRENDS ENDOCRIN MET, V21, P104, DOI 10.1016/j.tem.2009.09.007; Sauve K, 2009, CANCER RES, V69, P5793, DOI 10.1158/0008-5472.CAN-08-4924; Shao WL, 2004, P NATL ACAD SCI USA, V101, P11599, DOI 10.1073/pnas.0402997101; Shi DD, 2009, P NATL ACAD SCI USA, V106, P16275, DOI 10.1073/pnas.0904305106; St-Laurent V, 2005, J STEROID BIOCHEM, V94, P23, DOI 10.1016/j.jsbmb.2005.02.001; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; Treeck O, 2010, BREAST CANCER RES TR, V120, P557, DOI 10.1007/s10549-009-0413-2; Tremblay A, 1999, MOL CELL, V3, P513, DOI 10.1016/S1097-2765(00)80479-7; Tremblay A, 2001, J STEROID BIOCHEM, V77, P19, DOI 10.1016/S0960-0760(01)00031-0; Weigel NL, 2007, MOL ENDOCRINOL, V21, P2311, DOI 10.1210/me.2007-0101	44	22	22	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN	2013	32	1					117	126		10.1038/onc.2012.19	http://dx.doi.org/10.1038/onc.2012.19			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	063VG	22349818				2022-12-25	WOS:000313029500012
J	Dolmer, K; Gettins, PGW				Dolmer, Klavs; Gettins, Peter G. W.			How the Serpin alpha(1)-Proteinase Inhibitor Folds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; REACTIVE CENTER LOOP; ALPHA(1)-ANTITRYPSIN DEFICIENCY; PROTEINASE INHIBITION; MOLECULAR-BASIS; BETA-SHEET; MECHANISM; COMPLEX; POLYMERIZATION; INSERTION	Serpins are remarkable and unique proteins in being able to spontaneously fold into a metastable conformation without the aid of a chaperone or prodomain. This metastable conformation is essential for inhibition of proteinases, so that massive serpin conformational change, driven by the favorable energetics of relaxation of the metastable conformation to the more stable one, can kinetically trap the proteinase-serpin acylenzyme intermediate. Failure to direct folding to the metastable conformation would lead to inactive, latent serpin. How serpins fold into such a metastable state is unknown. Using the ability of component peptides from the serpin alpha 1PI to associate, we have now elucidated the pathway by which this serpin efficiently folds into its metastable state. In addition we have established the likely structure of the polymerogenic intermediate of the Z variant of alpha 1PI.	[Dolmer, Klavs; Gettins, Peter G. W.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gettins, PGW (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, M-C 669,900 S Ashland, Chicago, IL 60607 USA.	pgettins@uic.edu	Dolmer, Klavs/G-5512-2012	Dolmer, Klavs/0000-0001-7359-360X				CREIGHTON TE, 1992, NATURE, V356, P194, DOI 10.1038/356194a0; Dementiev A, 2003, J BIOL CHEM, V278, P37881, DOI 10.1074/jbc.M305195200; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; Elliott PR, 1998, J MOL BIOL, V275, P419, DOI 10.1006/jmbi.1997.1458; Gettins PGW, 2002, FEBS LETT, V523, P2, DOI 10.1016/S0014-5793(02)02924-1; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Kaslik G, 1997, BIOCHEMISTRY-US, V36, P5455, DOI 10.1021/bi962931m; Knaupp AS, 2011, J MOL BIOL, V413, P888, DOI 10.1016/j.jmb.2011.09.013; Krishnan B, 2011, NAT STRUCT MOL BIOL, V18, P222, DOI 10.1038/nsmb.1976; LAWRENCE DA, 1994, BIOCHEMISTRY-US, V33, P3643, DOI 10.1021/bi00178a022; Lee KN, 1996, NAT STRUCT BIOL, V3, P497, DOI 10.1038/nsb0696-497; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; LOMAS DA, 1995, J BIOL CHEM, V270, P5282, DOI 10.1074/jbc.270.10.5282; Mahadeva R, 1998, THORAX, V53, P501, DOI 10.1136/thx.53.6.501; MOTTONEN J, 1992, NATURE, V355, P270, DOI 10.1038/355270a0; OGUSHI F, 1987, J CLIN INVEST, V80, P1366, DOI 10.1172/JCI113214; Onda M, 2008, J BIOL CHEM, V283, P17568, DOI 10.1074/jbc.M709262200; Peterson FC, 2000, BIOCHEMISTRY-US, V39, P11884, DOI 10.1021/bi001152+; SHORE JD, 1995, J BIOL CHEM, V270, P5395, DOI 10.1074/jbc.270.10.5395; STEIN PE, 1995, NAT STRUCT BIOL, V2, P96, DOI 10.1038/nsb0295-96; Stratikos E, 1999, P NATL ACAD SCI USA, V96, P4808, DOI 10.1073/pnas.96.9.4808; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Yamasaki M, 2011, EMBO REP, V12, P1011, DOI 10.1038/embor.2011.171; YU MH, 1995, NAT STRUCT BIOL, V2, P363, DOI 10.1038/nsb0595-363	25	24	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12425	12432		10.1074/jbc.M111.315465	http://dx.doi.org/10.1074/jbc.M111.315465			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334651	hybrid, Green Published			2022-12-25	WOS:000302782200082
J	Vyas, P; Brown, DT				Vyas, Payal; Brown, David T.			N- and C-terminal Domains Determine Differential Nucleosomal Binding Geometry and Affinity of Linker Histone Isotypes H1(0) and H1c	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-STRUCTURE; GLOBULAR DOMAIN; SECONDARY STRUCTURE; INTERACTION SURFACE; CRYSTAL-STRUCTURE; SOMATIC SUBTYPES; HIGH-MOBILITY; IN-VIVO; DNA; PHOSPHORYLATION	Eukaryotic linker or H1 histones modulate DNA compaction and gene expression in vivo. In mammals, these proteins exist as multiple isotypes with distinct properties, suggesting a functional significance to the heterogeneity. Linker histones typically have a tripartite structure composed of a conserved central globular domain flanked by a highly variable short N-terminal domain and a longer highly basic C-terminal domain. We hypothesized that the variable terminal domains of individual subtypes contribute to their functional heterogeneity by influencing chromatin binding interactions. We developed a novel dual color fluorescence recovery after photobleaching assay system in which two H1 proteins fused to spectrally separable fluorescent proteins can be co-expressed and their independent binding kinetics simultaneously monitored in a single cell. This approach was combined with domain swap and point mutagenesis to determine the roles of the terminal domains in the differential binding characteristics of the linker histone isotypes, mouse H1(0) and H1c. Exchanging the N-terminal domains between H1(0) and H1c changed their overall binding affinity to that of the other variant. In contrast, switching the C-terminal domains altered the chromatin interaction surface of the globular domain. These results indicate that linker histone subtypes bind to chromatin in an intrinsically specific manner and that the highly variable terminal domains contribute to differences between subtypes. The methods developed in this study will have broad applications in studying dynamic properties of additional histone subtypes and other mobile proteins.	[Vyas, Payal; Brown, David T.] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center	Brown, DT (corresponding author), Univ Mississippi, Med Ctr, Dept Biochem, 2500 N State St, Jackson, MS 39216 USA.	dbrown@umc.edu			Mississippi Idea Networks of Biomedical Research Excellence; National Center for Research Resources [5P20RR016476-11]; NIGMS from the National Institutes of Health [8 P20 GM103476-11]; National Science Foundation [MCB0235800]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476] Funding Source: NIH RePORTER	Mississippi Idea Networks of Biomedical Research Excellence; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS from the National Institutes of Health; National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Mississippi Idea Networks of Biomedical Research Excellence funded by grants from the National Center for Research Resources (5P20RR016476-11) and NIGMS (8 P20 GM103476-11) from the National Institutes of Health. This work was also supported by Grant MCB0235800 from the National Science Foundation (to D. T. B.).	Alami R, 2003, P NATL ACAD SCI USA, V100, P5920, DOI 10.1073/pnas.0736105100; ALLAN J, 1986, J MOL BIOL, V187, P591, DOI 10.1016/0022-2836(86)90337-2; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; Bhan S, 2008, GENE, V414, P10, DOI 10.1016/j.gene.2008.01.025; Bharath MMS, 2003, NUCLEIC ACIDS RES, V31, P4264, DOI 10.1093/nar/gkg481; Bharath MMS, 2002, BIOCHEMISTRY-US, V41, P7617, DOI 10.1021/bi025773+; BOHM L, 1985, FEBS LETT, V193, P1, DOI 10.1016/0014-5793(85)80067-3; Brown DT, 2006, NAT STRUCT MOL BIOL, V13, P250, DOI 10.1038/nsmb1050; Brown DT, 2003, BIOCHEM CELL BIOL, V81, P221, DOI 10.1139/o03-049; Brown DT, 1996, NUCLEIC ACIDS RES, V24, P486, DOI 10.1093/nar/24.3.486; Carruthers LM, 1998, BIOCHEMISTRY-US, V37, P14776, DOI 10.1021/bi981684e; Catez F, 2006, NAT STRUCT MOL BIOL, V13, P305, DOI 10.1038/nsmb1077; Catez F, 2004, MOL CELL BIOL, V24, P4321, DOI 10.1128/MCB.24.10.4321-4328.2004; CERF C, 1994, BIOCHEMISTRY-US, V33, P11079, DOI 10.1021/bi00203a004; Clausell J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007243; Daujat S, 2005, J BIOL CHEM, V280, P38090, DOI 10.1074/jbc.C500229200; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Gabrilovich DI, 2002, J LEUKOCYTE BIOL, V72, P285; Garcia BA, 2004, J PROTEOME RES, V3, P1219, DOI 10.1021/pr0498887; George EM, 2010, J BIOL CHEM, V285, P20891, DOI 10.1074/jbc.M110.108639; Hansen JC, 2010, J CELL PHYSIOL, V224, P289, DOI 10.1002/jcp.22150; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; HARTMAN PG, 1977, EUR J BIOCHEM, V77, P45, DOI 10.1111/j.1432-1033.1977.tb11639.x; Izzo A, 2008, BIOL CHEM, V389, P333, DOI 10.1515/BC.2008.037; Konishi A, 2003, CELL, V114, P673, DOI 10.1016/S0092-8674(03)00719-0; Lee H, 2004, SCIENCE, V304, P1675, DOI 10.1126/science.1098096; Lever MA, 2000, NATURE, V408, P873, DOI 10.1038/35048603; Luger K, 2005, CURR OPIN STRUC BIOL, V15, P188, DOI 10.1016/j.sbi.2005.03.006; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Mueller F, 2008, BIOPHYS J, V94, P3323, DOI 10.1529/biophysj.107.123182; Mueller F, 2010, CURR OPIN CELL BIOL, V22, P403, DOI 10.1016/j.ceb.2010.03.002; Orrego M, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-22; Parseghian MH, 2001, BIOCHEM CELL BIOL, V79, P289; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Raghuram N, 2010, BIOCHEMISTRY-US, V49, P4420, DOI 10.1021/bi100296z; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; Robinson PJJ, 2006, CURR OPIN STRUC BIOL, V16, P336, DOI 10.1016/j.sbi.2006.05.007; Roque A, 2005, J BIOL CHEM, V280, P32141, DOI 10.1074/jbc.M505636200; Roque A, 2008, NUCLEIC ACIDS RES, V36, P4719, DOI 10.1093/nar/gkn440; Sancho M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000227; SIMPSON RT, 1978, BIOCHEMISTRY-US, V17, P5524, DOI 10.1021/bi00618a030; Stasevich TJ, 2010, EMBO J, V29, P1225, DOI 10.1038/emboj.2010.24; Th'ng JPH, 2005, J BIOL CHEM, V280, P27809, DOI 10.1074/jbc.M501627200; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; van Holde KE., 1989, SPRINGER SERIES MOL; Vila R, 2002, PROTEIN SCI, V11, P214, DOI 10.1110/ps.29602; Vila R, 2001, J BIOL CHEM, V276, P46429, DOI 10.1074/jbc.M106952200; Wisniewski JR, 2007, MOL CELL PROTEOMICS, V6, P72, DOI 10.1074/mcp.M600255-MCP200; Woodcock CL, 2006, CURR OPIN STRUC BIOL, V16, P213, DOI 10.1016/j.sbi.2006.02.005; Yellajoshyula D, 2006, P NATL ACAD SCI USA, V103, P18568, DOI 10.1073/pnas.0606478103; Zhou YB, 1998, NATURE, V395, P402, DOI 10.1038/26521	55	41	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11778	11787		10.1074/jbc.M111.312819	http://dx.doi.org/10.1074/jbc.M111.312819			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334665	hybrid, Green Published			2022-12-25	WOS:000302782200017
J	van Straaten, KE; Routier, FH; Sanders, DAR				van Straaten, Karin E.; Routier, Francoise H.; Sanders, David A. R.			Structural Insight into the Unique Substrate Binding Mechanism and Flavin Redox State of UDP-galactopyranose Mutase from Aspergillus fumigatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; OXIDIZED STATE; GALACTOFURANOSE; PROTEIN; IDENTIFICATION; BIOSYNTHESIS; MUTAGENESIS; VALIDATION; VIRULENCE	UDP-galactopyranose mutase (UGM) is a flavin-containing enzyme that catalyzes the reversible conversion of UDP-galactopyranose (UDP-Galp) to UDP-galactofuranose (UDP-Galf). As in prokaryotic UGMs, the flavin needs to be reduced for the enzyme to be active. Here we present the first eukaryotic UGM structures from Aspergillus fumigatus (AfUGM). The structures are of UGM alone, with the substrate UDP-Galp and with the inhibitor UDP. Additionally, we report the structures of AfUGM bound to substrate with oxidized and reduced flavin. These structures provide insight into substrate recognition and structural changes observed upon substrate binding involving the mobile loops and the critical arginine residues Arg-182 and Arg-327. Comparison with prokaryotic UGM reveals that despite low sequence identity with known prokaryotic UGMs the overall fold is largely conserved. Structural differences between prokaryotic UGM and AfUGM result from inserts in AfUGM. A notable difference from prokaryotic UGMs is that AfUGM contains a third flexible loop (loop III) above the si-face of the isoalloxazine ring that changes position depending on the redox state of the flavin cofactor. This loop flipping has not been observed in prokaryotic UGMs. In addition we have determined the crystals structures and steady-state kinetic constants of the reaction catalyzed by mutants R182K, R327K, R182A, and R327A. These results support our hypothesis that Arg-182 and Arg-327 play important roles in stabilizing the position of the diphosphates of the nucleotide sugar and help to facilitate the positioning of the galactose moiety for catalysis.	[van Straaten, Karin E.; Sanders, David A. R.] Univ Saskatchewan, Dept Chem, Saskatoon, SK S7N 5C9, Canada; [Routier, Francoise H.] Hannover Med Sch, D-30625 Hannover, Germany	University of Saskatchewan; Hannover Medical School	Sanders, DAR (corresponding author), 110 Sci Pl, Saskatoon, SK S7N 5C9, Canada.	david.sanders@usask.ca	Sanders, David A.R./I-5668-2016; Routier, Francoise/O-1611-2019	Routier, Francoise/0000-0002-7163-0590	Natural Science and Engineering Research Council of Canada (NSERC); Canadian Institutes of Health Research; Saskatchewan Health Research Foundation; NSERC; National Research Council of Canada; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Saskatchewan Health Research Foundation; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council of Canada; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	This work was supported in part by grants from Natural Science and Engineering Research Council of Canada (NSERC) and Canadian Institutes of Health Research-Regional Partnership Program (to D. A. R. S.).; We thank the Saskatchewan Health Research Foundation for funding the Molecular Design Research Group of the University of Saskatchewan, Dr. David Palmer (University of Saskatchewan) for many helpful discussions and shared equipment, and Dr. Sean Dalrymple for helpful discussions during manuscript preparation. We thank the staff of macromolecular beam line 08ID-1, Canadian Light Source (CLS), Saskatoon, Saskatchewan, Canada, for their technical assistance during data collection. The structural studies described in this paper were performed at the CLS, which is supported by NSERC, the National Research Council of Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bakker H, 2005, BIOL CHEM, V386, P657, DOI 10.1515/BC.2005.076; Beis K, 2005, J MOL BIOL, V348, P971, DOI 10.1016/j.jmb.2005.02.057; Beverley SM, 2005, EUKARYOT CELL, V4, P1147, DOI 10.1128/EC.4.6.1147-1154.2005; Bruns CM, 1999, J MOL BIOL, V288, P427, DOI 10.1006/jmbi.1999.2697; Chad JM, 2007, BIOCHEMISTRY-US, V46, P6723, DOI 10.1021/bi7002795; D'Arcy A, 2004, METHODS, V34, P323, DOI 10.1016/j.ymeth.2004.03.023; Damveld RA, 2008, GENETICS, V178, P873, DOI 10.1534/genetics.107.073148; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; El-Ganiny AM, 2008, FUNGAL GENET BIOL, V45, P1533, DOI 10.1016/j.fgb.2008.09.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fodje M. N., 2010, P PCAPAC 2010 OCT 5; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gruber TD, 2009, BIOCHEMISTRY-US, V48, P9171, DOI 10.1021/bi901437v; Gruber TD, 2009, J MOL BIOL, V391, P327, DOI 10.1016/j.jmb.2009.05.081; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Keegan RM, 2007, ACTA CRYSTALLOGR D, V63, P447, DOI 10.1107/S0907444907002661; Kleczka B, 2004, GLYCOBIOLOGY, V14, P1119; Kleczka B, 2007, J BIOL CHEM, V282, P10498, DOI 10.1074/jbc.M700023200; Koplin R, 1997, J BIOL CHEM, V272, P4121, DOI 10.1074/jbc.272.7.4121; Lamarre C, 2009, CELL MICROBIOL, V11, P1612, DOI 10.1111/j.1462-5822.2009.01352.x; Nassau PM, 1996, J BACTERIOL, V178, P1047, DOI 10.1128/jb.178.4.1047-1052.1996; Novelli JF, 2009, DEV BIOL, V335, P340, DOI 10.1016/j.ydbio.2009.09.010; Oppenheimer M, 2011, BIOCHEM BIOPH RES CO, V407, P552, DOI 10.1016/j.bbrc.2011.03.057; Oppenheimer M, 2010, ARCH BIOCHEM BIOPHYS, V502, P31, DOI 10.1016/j.abb.2010.06.035; Pan F, 2001, J BACTERIOL, V183, P3991, DOI 10.1128/JB.183.13.3991-3998.2001; Partha SK, 2009, J MOL BIOL, V394, P864, DOI 10.1016/j.jmb.2009.10.013; Pedersen LL, 2003, CELL MOL LIFE SCI, V60, P259, DOI 10.1007/s000180300021; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Richards MR, 2009, CHEMBIOCHEM, V10, P1920, DOI 10.1002/cbic.200900208; Sanders DAR, 2001, NAT STRUCT BIOL, V8, P858, DOI 10.1038/nsb1001-858; Schmalhorst PS, 2008, EUKARYOT CELL, V7, P1268, DOI 10.1128/EC.00109-08; Tefsen B, 2012, GLYCOBIOLOGY, V22, P456, DOI 10.1093/glycob/cwr144; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Van Straaten K. E., 2012, ACTA CRYS F IN PRESS; Weston A, 1998, TUBERCLE LUNG DIS, V78, P123, DOI 10.1016/S0962-8479(98)80005-1; Yao XH, 2009, PROTEINS, V74, P972, DOI 10.1002/prot.22206; Yuan Y, 2008, J AM CHEM SOC, V130, P3157, DOI 10.1021/ja7104152; Zhang QB, 2000, J AM CHEM SOC, V122, P9065, DOI 10.1021/ja001333z	40	24	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10780	10790		10.1074/jbc.M111.322974	http://dx.doi.org/10.1074/jbc.M111.322974			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334662	hybrid, Green Published			2022-12-25	WOS:000302780100007
J	Wang, XH; Li, JP; Kuo, HK; Chiu, LL; Dement, GA; Lan, JL; Chen, DY; Yang, CY; Hu, HB; Tan, TH				Wang, Xiaohong; Li, Ju-Pi; Kuo, Hui-Kai; Chiu, Li-Li; Dement, Gregory A.; Lan, Joung-Liang; Chen, Der-Yuan; Yang, Chia-Yu; Hu, Hongbo; Tan, Tse-Hua			Down-regulation of B Cell Receptor Signaling by Hematopoietic Progenitor Kinase 1 (HPK1)-mediated Phosphorylation and Ubiquitination of Activated B Cell Linker Protein (BLNK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; CASPASE-MEDIATED CLEAVAGE; KAPPA-B; T-CELLS; HEMATOPOIETIC-PROGENITOR-KINASE-1 HPK1; PSORIATIC-ARTHRITIS; PATHWAY; ADAPTER; EXPRESSION; AUTOIMMUNITY	Background: HPK1 is a hematopoiesis-specific Ste20-like serine/threonine kinase that suppresses immune responses and autoimmunity. Results: HPK1 knock-out B cells show loss of Thr-152 phosphorylation, 14-3-3 binding, and Lys-37/38/42-ubiquitination of BLNK. Conclusion: HPK1 attenuates BCR signaling via inducing phosphorylation and ubiquitination of BLNK. Significance: This is the first report of BLNK ubiquitination that is initiated by HPK1-induced phosphorylation.	[Wang, Xiaohong; Dement, Gregory A.; Hu, Hongbo; Tan, Tse-Hua] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Li, Ju-Pi; Kuo, Hui-Kai; Yang, Chia-Yu] Natl Hlth Res Inst, Immunol Res Ctr, Zhunan 35053, Taiwan; [Chiu, Li-Li; Lan, Joung-Liang; Chen, Der-Yuan] Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taichung 40705, Taiwan; [Lan, Joung-Liang; Chen, Der-Yuan] Natl Yang Ming Univ, Fac Med, Taipei 11221, Taiwan	Baylor College of Medicine; National Health Research Institutes - Taiwan; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University	Tan, TH (corresponding author), Natl Hlth Res Inst, Immunol Res Ctr, 35 Keyan Rd, Zhunan Town 35053, Miaoli County, Taiwan.	ttan@bcm.edu	Li, Ju-Pi/AAS-8866-2021; Tan, Tse-Hua/E-3983-2010; Tan, Tse-Hua/ABD-7080-2021; Hu, Hongbo/J-8059-2016	Li, Ju-Pi/0000-0003-3406-4865; Tan, Tse-Hua/0000-0003-4969-3170; Tan, Tse-Hua/0000-0003-4969-3170; Hu, Hongbo/0000-0002-8177-7641	National Institutes of Health [R01-AI066895, K12 GM84897, T32AI007495]; National Health Research Institutes, Taiwan [98A1-IMPP01-014]; Taichung Veterans General Hospital, Taiwan [TCVGH-NHRI01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066895, T32AI007495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM084897] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); Taichung Veterans General Hospital, Taiwan; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AI066895 (to T.-H.T.) and K12 GM84897 and T32AI007495 (to G. A. D.). This work was also supported by National Health Research Institutes, Taiwan, Grant 98A1-IMPP01-014 (to T.- H. T.) and Taichung Veterans General Hospital, Taiwan, Grant TCVGH-NHRI01 (to J.-L. L.).	Arnold R, 2001, J BIOL CHEM, V276, P14675, DOI 10.1074/jbc.M008343200; Batliwalla FM, 2005, MOL MED, V11, P21, DOI 10.2119/2006-00003.Gulko; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Brenner D, 2009, P NATL ACAD SCI USA, V106, P14508, DOI 10.1073/pnas.0900457106; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Bunnell SC, 2000, J BIOL CHEM, V275, P2219, DOI 10.1074/jbc.275.3.2219; Chen Y. R., 1999, GENE THER MOL BIOL, V4, P83; Chen YR, 1999, ONCOGENE, V18, P7370, DOI 10.1038/sj.onc.1203116; Chiu CW, 2002, EMBO J, V21, P6461, DOI 10.1093/emboj/cdf658; Chuang HC, 2011, NAT IMMUNOL, V12, P1113, DOI 10.1038/ni.2121; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Di Bartolo V, 2007, J EXP MED, V204, P681, DOI 10.1084/jem.20062066; Diener K, 1997, P NATL ACAD SCI USA, V94, P9687, DOI 10.1073/pnas.94.18.9687; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Hu MCT, 1999, ONCOGENE, V18, P5514, DOI 10.1038/sj.onc.1202740; Hu MCT, 1996, GENE DEV, V10, P2251, DOI 10.1101/gad.10.18.2251; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; Jang IK, 2009, IMMUNOL REV, V232, P150, DOI 10.1111/j.1600-065X.2009.00842.x; Koretzky GA, 2006, NAT REV IMMUNOL, V6, P67, DOI 10.1038/nri1750; Kosugi A, 2001, IMMUNOL LETT, V76, P133, DOI 10.1016/S0165-2478(01)00174-2; Ling P, 1999, MOL CELL BIOL, V19, P1359; Liou J, 2000, IMMUNITY, V12, P399, DOI 10.1016/S1074-7613(00)80192-2; Liu YC, 1996, J BIOL CHEM, V271, P14591, DOI 10.1074/jbc.271.24.14591; Ma WB, 2001, ONCOGENE, V20, P1703, DOI 10.1038/sj.onc.1204224; Obsilova V, 2008, PHYSIOL RES, V57, pS11, DOI 10.33549/physiolres.931598; Shui JW, 2007, NAT IMMUNOL, V8, P84, DOI 10.1038/ni1416; Stoeckman AK, 2006, GENES IMMUN, V7, P583, DOI 10.1038/sj.gene.6364334; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Townsend MJ, 2010, IMMUNOL REV, V237, P264, DOI 10.1111/j.1600-065X.2010.00945.x; Tsuji S, 2001, J EXP MED, V194, P529, DOI 10.1084/jem.194.4.529; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yanaba K, 2008, IMMUNOL REV, V223, P284, DOI 10.1111/j.1600-065X.2008.00646.x; Yao ZB, 1999, J BIOL CHEM, V274, P2118, DOI 10.1074/jbc.274.4.2118; Zhang Q, 2011, J AUTOIMMUN, V37, P180, DOI 10.1016/j.jaut.2011.09.006	34	32	45	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11037	11048		10.1074/jbc.M111.310946	http://dx.doi.org/10.1074/jbc.M111.310946			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334673	hybrid, Green Published			2022-12-25	WOS:000302780100032
J	Karle, AC; Oostingh, GJ; Mutschlechner, S; Ferreira, F; Lackner, P; Bohle, B; Fischer, GF; Vogt, AB; Duschl, A				Karle, Anette C.; Oostingh, Gertie J.; Mutschlechner, Sonja; Ferreira, Fatima; Lackner, Peter; Bohle, Barbara; Fischer, Gottfried F.; Vogt, Anne B.; Duschl, Albert			Nitration of the Pollen Allergen Bet v 1.0101 Enhances the Presentation of Bet v 1-Derived Peptides by HLA-DR on Human Dendritic Cells	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; PROTEIN NITRATION; POSTTRANSLATIONAL MODIFICATION; SCAVENGER RECEPTORS; CHILDHOOD ASTHMA; AIR-POLLUTANTS; SELF-PROTEINS; CUTTING EDGE; B-CELL; ANTIGEN	Nitration of pollen derived allergens can occur by NO2 and ozone in polluted air and it has already been shown that nitrated major birch (Betula verrucosa) pollen allergen Bet v 1.0101 (Bet v 1) exhibits an increased potency to trigger an immune response. However, the mechanisms by which nitration might contribute to the induction of allergy are still unknown. In this study, we assessed the effect of chemically induced nitration of Bet v 1 on the generation of HLA-DR associated peptides. Human dendritic cells were loaded with unmodified Bet v 1 or nitrated Bet v 1, and the naturally processed HLA-DR associated peptides were subsequently identified by liquid chromatography-mass spectrometry. Nitration of Bet v 1 resulted in enhanced presentation of allergen-derived HLA-DR-associated peptides. Both the copy number of Bet v 1 derived peptides as well as the number of nested clusters was increased. Our study shows that nitration of Bet v 1 alters antigen processing and presentation via HLA-DR, by enhancing both the quality and the quantity of the Bet v 1-specific peptide repertoire. These findings indicate that air pollution can contribute to allergic diseases and might also shed light on the analogous events concerning the nitration of self-proteins.	[Karle, Anette C.; Vogt, Anne B.] F Hoffmann La Roche Ltd, Non Clin Drug Safety, Immunosafety, Basel, Switzerland; [Ferreira, Fatima] Salzburg Univ, Dept Mol Biol, Christian Doppler Lab Allergy Diag & Therapy, A-5020 Salzburg, Austria; [Mutschlechner, Sonja; Bohle, Barbara] Med Univ Vienna, Ctr Physiol Pathophysiol & Immunol, Dept Pathophysiol, Christian Doppler Lab Immunomodulat, Vienna, Austria; [Fischer, Gottfried F.] Univ Clin Blood Grp Serol & Transfus Med, Clin Dept Blood Grp Serol, Vienna, Austria	Roche Holding; Salzburg University; Medical University of Vienna	Karle, AC (corresponding author), Novartis Pharma AG, Basel, Switzerland.	anne.vogt@roche.com	Ferreira, Fatima/AAB-4321-2019; Ferreira, Fatima/E-4889-2011; Duschl, Albert/E-5872-2011; Oostingh, Gertie Janneke/HHC-1098-2022; Lackner, Peter/L-2900-2015	Ferreira, Fatima/0000-0003-0989-2335; Ferreira, Fatima/0000-0003-0989-2335; Duschl, Albert/0000-0002-7034-9860; Lackner, Peter/0000-0003-4681-6307; Bohle, Barbara/0000-0002-5105-7985; Oostingh, Gertie Janneke/0000-0001-5083-217X	Osterreichische Nationalbank [P10150]; Christian Doppler Laboratory for Allergy Diagnosis and Therapy; Christian Doppler Laboratory for Immunomodulation, Austria; University of Salzburg; Biomay AG, Vienna, Austria	Osterreichische Nationalbank; Christian Doppler Laboratory for Allergy Diagnosis and Therapy; Christian Doppler Laboratory for Immunomodulation, Austria; University of Salzburg; Biomay AG, Vienna, Austria	P10150 of the Osterreichische Nationalbank, the Christian Doppler Laboratory for Allergy Diagnosis and Therapy and the Christian Doppler Laboratory for Immunomodulation, Austria to F.F. A.D. and F.F. were supported by the priority program "BioScience and Health'' of the University of Salzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Barbara Bohle and Fatima Ferreira are supported by Biomay AG, Vienna, Austria. Anne Vogt is an employee of F. Hoffmann-La Roche Ltd. Anette Karle was an employee of F. Hoffmann-La Roche Ltd when she performed the experiments outlined in the present manuscript. The other authors declare no conflict of interest. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abraham R, 1997, J IMMUNOL, V158, P4029; BECKMANN JS, 1994, BIOL CHEM H-S, V375, P81, DOI 10.1515/bchm3.1994.375.2.81; Birnboim HC, 2003, J IMMUNOL, V171, P528, DOI 10.4049/jimmunol.171.2.528; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; Cross AH, 1998, J NEUROIMMUNOL, V88, P45, DOI 10.1016/S0165-5728(98)00078-2; Doyle HA, 2001, TRENDS IMMUNOL, V22, P443, DOI 10.1016/S1471-4906(01)01976-7; Engelhard VH, 2006, CURR OPIN IMMUNOL, V18, P92, DOI 10.1016/j.coi.2005.11.015; FATENEJAD S, 1993, P NATL ACAD SCI USA, V90, P12010, DOI 10.1073/pnas.90.24.12010; FISCHER GF, 1995, VOX SANG, V69, P328, DOI 10.1111/j.1423-0410.1995.tb00368.x; Franze T, 2005, ENVIRON SCI TECHNOL, V39, P1673, DOI 10.1021/es0488737; Franze T, 2003, ANALYST, V128, P824, DOI 10.1039/b303132b; Gauderman WJ, 2005, EPIDEMIOLOGY, V16, P737, DOI 10.1097/01.ede.0000181308.51440.75; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Girbal-Neuhauser E, 1999, J IMMUNOL, V162, P585; Good PF, 1998, J NEUROPATH EXP NEUR, V57, P338, DOI 10.1097/00005072-199804000-00006; GORGA JC, 1987, J BIOL CHEM, V262, P16087; Griffiths HR, 2006, FREE RADICAL BIO MED, V40, P488, DOI 10.1016/j.freeradbiomed.2005.08.039; Gruijthuijsen YK, 2006, INT ARCH ALLERGY IMM, V141, P265, DOI 10.1159/000095296; Gyorgy B, 2006, INT J BIOCHEM CELL B, V38, P1662, DOI 10.1016/j.biocel.2006.03.008; Hill JA, 2003, J IMMUNOL, V171, P538, DOI 10.4049/jimmunol.171.2.538; Jahn-Schmid B, 2010, J ALLERGY CLIN IMMUN, V126, P1068, DOI 10.1016/j.jaci.2010.05.038; Kropshofer H, 1996, EMBO J, V15, P6144, DOI 10.1002/j.1460-2075.1996.tb01002.x; Lee YL, 2003, EUR RESPIR J, V21, P964, DOI 10.1183/09031936.03.00094602; Liu ZX, 2011, MOL BIOSYST, V7, P1197, DOI 10.1039/c0mb00279h; Mamula MJ, 1999, J BIOL CHEM, V274, P22321, DOI 10.1074/jbc.274.32.22321; McConnell R, 2006, ENVIRON HEALTH PERSP, V114, P766, DOI 10.1289/ehp.8594; Moss CX, 2005, J BIOL CHEM, V280, P18498, DOI 10.1074/jbc.M501241200; Mutschlechner S, 2010, J ALLERGY CLIN IMMUN, V125, P711, DOI 10.1016/j.jaci.2009.10.052; Ohmori H, 2005, AUTOIMMUN REV, V4, P224, DOI 10.1016/j.autrev.2004.11.011; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qiao SW, 2005, J IMMUNOL, V175, P254, DOI 10.4049/jimmunol.175.1.254; Ring J, 2001, ANN ALLERG ASTHMA IM, V87, P2, DOI 10.1016/S1081-1206(10)62332-0; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Sarnat JA, 2007, CURR OPIN PULM MED, V13, P63, DOI 10.1097/MCP.0b013e3280117d25; Singh N, 1998, J IMMUNOL, V160, P4869; Smith MA, 1997, J NEUROSCI, V17, P2653; Souza JM, 1999, ARCH BIOCHEM BIOPHYS, V371, P169, DOI 10.1006/abbi.1999.1480; Souza JM, 2000, ARCH BIOCHEM BIOPHYS, V380, P360, DOI 10.1006/abbi.2000.1940; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Untersmayr E, 2011, PLOS ONE, V5; vanderVeen RC, 1997, J NEUROIMMUNOL, V77, P1, DOI 10.1016/S0165-5728(97)00013-1; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; Wallberg M, 2007, EUR J IMMUNOL, V37, P1986, DOI 10.1002/eji.200636912	43	48	49	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31483	10.1371/journal.pone.0031483	http://dx.doi.org/10.1371/journal.pone.0031483			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348091	Green Published, gold, Green Submitted			2022-12-25	WOS:000302737400025
J	Fritz, HM; Buchholz, KR; Chen, XC; Durbin-Johnson, B; Rocke, DM; Conrad, PA; Boothroyd, JC				Fritz, Heather M.; Buchholz, Kerry R.; Chen, Xiucui; Durbin-Johnson, Blythe; Rocke, David M.; Conrad, Patricia A.; Boothroyd, John C.			Transcriptomic Analysis of Toxoplasma Development Reveals Many Novel Functions and Structures Specific to Sporozoites and Oocysts	PLOS ONE			English	Article							SURFACE-ANTIGEN; PARASITOPHOROUS VACUOLE; GONDII OOCYSTS; WATERBORNE TOXOPLASMOSIS; DIFFERENTIATION MUTANTS; PARASITE; PROTEIN; IDENTIFICATION; GENES; STAGE	Sexual reproduction of Toxoplasma gondii occurs exclusively within enterocytes of the definitive felid host. The resulting immature oocysts are excreted into the environment during defecation, where in the days following, they undergo a complex developmental process. Within each oocyst, this culminates in the generation of two sporocysts, each containing 4 sporozoites. A single felid host is capable of shedding millions of oocysts, which can survive for years in the environment, are resistant to most methods of microbial inactivation during water-treatment and are capable of producing infection in warm-blooded hosts at doses as low as 1-10 ingested oocysts. Despite its extremely interesting developmental biology and crucial role in initiating an infection, almost nothing is known about the oocyst stage beyond morphological descriptions. Here, we present a complete transcriptomic analysis of the oocyst from beginning to end of its development. In addition, and to identify genes whose expression is unique to this developmental form, we compared the transcriptomes of developing oocysts with those of in vitro-derived tachyzoites and in vivo-derived bradyzoites. Our results reveal many genes whose expression is specifically up-or down-regulated in different developmental stages, including many genes that are likely critical to oocyst development, wall formation, resistance to environmental destruction and sporozoite infectivity. Of special note is the up-regulation of genes that appear "off'' in tachyzoites and bradyzoites but that encode homologues of proteins known to serve key functions in those asexual stages, including a novel pairing of sporozoite-specific paralogues of AMA1 and RON2, two proteins that have recently been shown to form a crucial bridge during tachyzoite invasion of host cells. This work provides the first in-depth insight into the development and functioning of one of the most important but least studied stages in the Toxoplasma life cycle.	[Fritz, Heather M.; Conrad, Patricia A.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Buchholz, Kerry R.; Boothroyd, John C.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Chen, Xiucui; Durbin-Johnson, Blythe; Rocke, David M.] Univ Calif Davis, Sch Med, Div Biostat, Davis, CA 95616 USA	University of California System; University of California Davis; Stanford University; University of California System; University of California Davis	Fritz, HM (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.	paconrad@ucdavis.edu; john.boothroyd@stanford.edu	Rocke, David M/I-7044-2013	Rocke, David M/0000-0002-3958-7318; Buchholz, Kerry/0000-0001-9419-0076; Boothroyd, John C./0000-0001-9719-745X	National Institutes of Health (NIH) [AI41014, AI21423, RR07038, T32 AI7328]; Eukaryotic Pathogens - Driving Biological Projects grant; UC Davis Center for Food Animal Health; NSF-EID [1065990]; NIH from National Center for Research Resources [KO1RR031487]; American Cancer Society [119025-PF-10-165-01-MPC]; NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR007038, K01RR031487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007328, R01AI041014, R37AI021423, R01AI021423] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD010917] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eukaryotic Pathogens - Driving Biological Projects grant; UC Davis Center for Food Animal Health; NSF-EID; NIH from National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Cancer Society(American Cancer Society); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (NIH) grants AI41014, AI21423 and a Eukaryotic Pathogens - Driving Biological Projects grant. Oocyst production was funded by UC Davis Center for Food Animal Health grant and NSF-EID grant # 1065990. HMF was supported by NIH T32 grant # RR07038 and NIH KO1 Award Number KO1RR031487 from the National Center for Research Resources. KB was supported by NIH training grant T32 AI7328 and a grant from the American Cancer Society Award # 119025-PF-10-165-01-MPC. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSEN MS, 1995, J PARASITOL, V81, P107, DOI 10.2307/3284017; Ahn Hye-Jin, 2006, Korean Journal of Parasitology, V44, P303, DOI 10.3347/kjp.2006.44.4.303; Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; Aramini JJ, 1999, EPIDEMIOL INFECT, V122, P305, DOI 10.1017/S0950268899002113; Bahia-Oliveira LMG, 2003, EMERG INFECT DIS, V9, P55; Bahl A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-603; BECKERS CJM, 1994, J CELL BIOL, V127, P947, DOI 10.1083/jcb.127.4.947; BOHNE W, 1995, MOL MICROBIOL, V16, P1221, DOI 10.1111/j.1365-2958.1995.tb02344.x; Boothroyd JC, 2008, NAT REV MICROBIOL, V6, P79, DOI 10.1038/nrmicro1800; Buchholz KR, 2011, EUKARYOT CELL, V10, P1637, DOI 10.1128/EC.05182-11; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Carruthers Vern B., 2008, V47, P33; Carruthers VB, 2007, CURR OPIN MICROBIOL, V10, P82; Carter V, 2008, MOL MICROBIOL, V68, P1560, DOI 10.1111/j.1365-2958.2008.06254.x; Cerutti A, 2011, ANNU REV IMMUNOL, V29, P273, DOI 10.1146/annurev-immunol-031210-101317; Claudianos C, 2002, MOL MICROBIOL, V45, P1473, DOI 10.1046/j.1365-2958.2002.03118.x; Cleary MD, 2002, EUKARYOT CELL, V1, P329, DOI 10.1128/EC.1.3.329-340.2002; Dabritz HA, 2010, ZOONOSES PUBLIC HLTH, V57, P34, DOI 10.1111/j.1863-2378.2009.01273.x; Dabritz HA, 2007, JAVMA-J AM VET MED A, V231, P1676, DOI 10.2460/javma.231.11.1676; de Moura L, 2006, EMERG INFECT DIS, V12, P326, DOI 10.3201/eid1202.041115; DUBEY JP, 1972, J PROTOZOOL, V19, P155, DOI 10.1111/j.1550-7408.1972.tb03431.x; Dumetre A, 2004, J MICROBIOL METH, V56, P427, DOI 10.1016/j.mimet.2003.11.020; Dumetre A, 2003, FEMS MICROBIOL REV, V27, P651, DOI 10.1016/S0168-6445(03)00071-8; Durbin B, 2003, BIOINFORMATICS, V19, P1360, DOI 10.1093/bioinformatics/btg178; Durbin B P, 2002, Bioinformatics, V18 Suppl 1, pS105; Dzierszinski F, 2001, J MOL BIOL, V309, P1017, DOI 10.1006/jmbi.2001.4730; Dzierszinski F, 2000, MOL MICROBIOL, V37, P574, DOI 10.1046/j.1365-2958.2000.02014.x; Elmore SA, 2010, TRENDS PARASITOL, V26, P190, DOI 10.1016/j.pt.2010.01.009; Ferguson DJP, 2002, INT J PARASITOL, V32, P1399, DOI 10.1016/S0020-7519(02)00129-7; FRENKEL JK, 1990, J AM VET MED ASSOC, V196, P240; Friesen J, 2008, MOL BIOCHEM PARASIT, V157, P228, DOI 10.1016/j.molbiopara.2007.10.005; Fritz H, 2012, J MICROBIOL METH, V88, P47, DOI 10.1016/j.mimet.2011.10.010; Fritz HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029955; Gail M, 2001, MOL GENET GENOMICS, V265, P905, DOI 10.1007/s004380100487; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Guerardel Y, 2005, MICROBES INFECT, V7, P41, DOI 10.1016/j.micinf.2004.09.007; He XL, 2002, NAT STRUCT BIOL, V9, P606, DOI 10.1038/nsb819; Hill D, 2011, J PARASITOL, V97, P328, DOI 10.1645/GE-2782.1; Hill Dolores E., 2005, Animal Health Research Reviews, V6, P41, DOI 10.1079/AHR2005100; Huber W., 2003, STAT APPL GENET MOL, V2, pARTICL, DOI [10.2202/1544-6115.1008, DOI 10.2202/1544-6115.1008]; HUSKINSONMARK J, 1991, J INFECT DIS, V164, P170, DOI 10.1093/infdis/164.1.170; Innes EA, 2010, ZOONOSES PUBLIC HLTH, V57, P1, DOI 10.1111/j.1863-2378.2009.01276.x; Isaac-Renton J, 1998, APPL ENVIRON MICROB, V64, P2278; Jones J, 2003, AM FAM PHYSICIAN, V67, P2131; Jung C, 2004, INT J PARASITOL, V34, P285, DOI 10.1016/j.ijpara.2003.12.004; KASPER LH, 1993, RES IMMUNOL, V144, P45, DOI 10.1016/S0923-2494(05)80097-5; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kibe MK, 2005, NUCLEIC ACIDS RES, V33, P1722, DOI 10.1093/nar/gki314; Kim JY, 2008, KOREAN J PARASITOL, V46, P209, DOI 10.3347/kjp.2008.46.4.209; Kim SK, 2007, INFECT IMMUN, V75, P1626, DOI 10.1128/IAI.01862-06; Kim SK, 2005, J IMMUNOL, V174, P8038, DOI 10.4049/jimmunol.174.12.8038; Kwok LY, 2004, MOL MICROBIOL, V51, P47, DOI 10.1046/j.1365-2958.2003.03823.x; Lamarque M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001276; Lekutis C, 2001, INT J PARASITOL, V31, P1285, DOI 10.1016/S0020-7519(01)00261-2; Lindsay DS, 2009, J PARASITOL, V95, P1019, DOI 10.1645/GE-1919.1; Mai K, 2011, INT J PARASITOL, V41, P1157, DOI 10.1016/j.ijpara.2011.07.001; Manger ID, 1998, INFECT IMMUN, V66, P1632, DOI 10.1128/IAI.66.4.1632-1637.1998; Manger ID, 1998, INFECT IMMUN, V66, P2237, DOI 10.1128/IAI.66.5.2237-2244.1998; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; Matrajt M, 2002, MOL MICROBIOL, V44, P735, DOI 10.1046/j.1365-2958.2002.02904.x; Mercier C, 2005, INT J PARASITOL, V35, P829, DOI 10.1016/j.ijpara.2005.03.011; MINEO JR, 1994, EXP PARASITOL, V79, P11, DOI 10.1006/expr.1994.1054; Munoz-Zanzi CA, 2010, EMERG INFECT DIS, V16, P1591, DOI 10.3201/eid1610.091674; Pleass RJ, 2001, J BIOL CHEM, V276, P8197, DOI 10.1074/jbc.M009396200; Possenti A, 2010, INT J PARASITOL, V40, P1639, DOI 10.1016/j.ijpara.2010.06.009; R Development Core Team, 2009, R FDN STAT COMP; Rachinel N, 2004, J IMMUNOL, V173, P2725, DOI 10.4049/jimmunol.173.4.2725; Radke JR, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-26; Radke JR, 2004, MOL MICROBIOL, V52, P93, DOI 10.1111/j.1365-2958.2003.03967.x; Reese ML, 2011, P NATL ACAD SCI USA, V108, P9625, DOI 10.1073/pnas.1015980108; Rocke DLG, LMGENE LMGENE SOFTWA; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Saeij JPJ, 2008, INFECT IMMUN, V76, P2402, DOI 10.1128/IAI.01494-07; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; SEOL W, 1992, BIOCHEMISTRY-US, V31, P3550, DOI 10.1021/bi00128a032; Singh U, 2002, MOL MICROBIOL, V44, P721, DOI 10.1046/j.1365-2958.2002.02903.x; Speer CA, 1998, J PARASITOL, V84, P505, DOI 10.2307/3284713; Speer CA, 1995, MOL BIOCHEM PARASIT, V75, P75, DOI 10.1016/0166-6851(95)02515-4; SULZER AJ, 1986, AM J TROP MED HYG, V35, P290, DOI 10.4269/ajtmh.1986.35.290; Templeton TJ, 2004, INFECT IMMUN, V72, P980, DOI 10.1128/IAI.72.2.980-987.2004; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Tilley M, 1997, INFECT IMMUN, V65, P4598, DOI 10.1128/IAI.65.11.4598-4605.1997; TOMAVO S, 1991, INFECT IMMUN, V59, P3750, DOI 10.1128/IAI.59.10.3750-3753.1991; Tonkin ML, 2011, SCIENCE, V333, P463, DOI 10.1126/science.1204988; Trexler M, 2000, EUR J BIOCHEM, V267, P5751, DOI 10.1046/j.1432-1327.2000.01641.x; Tyler JS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001282; Woof JM, 2002, BIOCHEM SOC T, V30, P491, DOI 10.1042/bst0300491; Yang SM, 1997, GENE, V184, P1, DOI 10.1016/S0378-1119(96)00566-5	89	108	114	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e29998	10.1371/journal.pone.0029998	http://dx.doi.org/10.1371/journal.pone.0029998			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22347997	gold, Green Published, Green Submitted			2022-12-25	WOS:000302733900003
J	Sasson, SC; Zaunders, JJ; Seddiki, N; Bailey, M; McBride, K; Koelsch, KK; Merlin, KM; Smith, DE; Cooper, DA; Kelleher, AD				Sasson, Sarah C.; Zaunders, John J.; Seddiki, Nabila; Bailey, Michelle; McBride, Kristin; Koelsch, Kersten K.; Merlin, Kate M.; Smith, Don E.; Cooper, David A.; Kelleher, Anthony D.			Progressive Activation of CD127+1322-Recent Thymic Emigrants into Terminally Differentiated CD127-132+T-Cells in HIV-1 Infection	PLOS ONE			English	Article							INTERLEUKIN-7 RECEPTOR EXPRESSION; CD8 T-CELLS; CD127 EXPRESSION; IL-7; EXPANSION; LYMPHOCYTES; PROLIFERATION; DYSFUNCTION; APOPTOSIS; CYTOKINES	Aim: HIV infection is associated with distortion of T-cell homeostasis and the IL-7/IL7R axis. Progressive infection results in loss of CD127+132- and gains in CD127-132+ CD4+ and CD8+ T-cells. We investigated the correlates of loss of CD127 from the T-cell surface to understand mechanisms underlying this homeostatic dysregulation. Methods: Peripheral and cord blood mononuclear cells (PBMCs; CBMC) from healthy volunteers and PBMC from patients with HIV infection were studied. CD127+132-, CD127+132+ and CD127-132+ T-cells were phenotyped by activation, differentiation, proliferation and survival markers. Cellular HIV-DNA content and signal-joint T-cell receptor excision circles (sjTRECs) were measured. Results: CD127+132- T-cells were enriched for naive cells while CD127-132+ T-cells were enriched for activated/terminally differentiated T-cells in CD4+ and CD8+ subsets in health and HIV infection. HIV was associated with increased proportions of activated/terminally differentiated CD127-132+ T-cells. In contrast to CD127+132- T-cells, CD127-132+ T-cells were Ki-67+Bcl-2(low) and contained increased levels of HIV-DNA. Naive CD127+132- T-cells contained a higher proportion of sjTRECs. Conclusion: The loss of CD127 from the T-cell surface in HIV infection is driven by activation of CD127+132- recent thymic emigrants into CD127-132+ activated/terminally differentiated cells. This process likely results in an irreversible loss of CD127 and permanent distortion of T-cell homeostasis. low	[Sasson, Sarah C.; Seddiki, Nabila; Bailey, Michelle; McBride, Kristin; Smith, Don E.; Cooper, David A.; Kelleher, Anthony D.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Sasson, Sarah C.; Zaunders, John J.; Seddiki, Nabila; Bailey, Michelle; McBride, Kristin; Koelsch, Kersten K.; Merlin, Kate M.; Cooper, David A.; Kelleher, Anthony D.] St Vincent Hosp, Ctr Appl Med Res, HIV Immunopthol Res Lab, Sydney, NSW, Australia	University of New South Wales Sydney; Kirby Institute; St Vincents Hospital Sydney	Sasson, SC (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW, Australia.	s.sasson@amr.org.au	Zaunders, John/J-6553-2012	Zaunders, John/0000-0002-5912-5989; Sasson, Sarah/0000-0002-5329-9072; Seddiki, Nabila/0000-0002-0379-8527	Australian Government Department of Health and Ageing; National Health and Medical Research Council; Bristol-Myers Squibb; Glaxo- SmithKline; Agouron; Abbott Australasia; Gilead Sciences; Boehringer Ingelheim; Merck Sharp Dohme; Roche Products	Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Bristol-Myers Squibb(Bristol-Myers Squibb); Glaxo- SmithKline(GlaxoSmithKline); Agouron; Abbott Australasia(Abbott Laboratories); Gilead Sciences(Gilead Sciences); Boehringer Ingelheim(Boehringer Ingelheim); Merck Sharp Dohme(Merck & Company); Roche Products	This study was funded from the following sources: the Australian Government Department of Health and Ageing; the National Health and Medical Research Council via Project and program grants, a Dora Lush (Biomedical) PhD Scholarship (SCS) and a Practitioner Fellowship (ADK). The views expressed in this publication do not necessarily represent the position of the Australian Government. The Kirby Institute is affiliated with the Faculty of Medicine, University of New South Wales. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; D.S. has received conference travel support, lectureship honoraria, or research grants from Bristol-Myers Squibb, Glaxo- SmithKline, Agouron, Abbott Australasia, Gilead Sciences, Boehringer Ingelheim, Merck Sharp & Dohme, and Roche Products; he does not own shares in any of these companies. All other authors: no conflicts declared. This does not alter the authors' adherence to all the PLOS One policies on sharing data and materials.	Alves NL, 2008, J IMMUNOL, V180, P5201, DOI 10.4049/jimmunol.180.8.5201; Bolotin E, 1999, BONE MARROW TRANSPL, V23, P783, DOI 10.1038/sj.bmt.1701655; CARINI C, 1994, EUR J IMMUNOL, V24, P2927, DOI 10.1002/eji.1830241202; Colle JH, 2006, JAIDS-J ACQ IMM DEF, V42, P277, DOI 10.1097/01.qai.0000214823.11034.4e; Faller E, 2009, INT IMMUNOL, V21, P203, DOI 10.1093/intimm/dxn140; Faller EM, 2006, JAIDS-J ACQ IMM DEF, V43, P257, DOI 10.1097/01.qai.0000230319.78288.f4; French Martyn, 2002, HIV Clin Trials, V3, P177; Fry TJ, 2001, BLOOD, V97, P2983, DOI 10.1182/blood.V97.10.2983; Fuller MJ, 2005, J IMMUNOL, V174, P5926, DOI 10.4049/jimmunol.174.10.5926; Hazenberg MD, 2000, NAT MED, V6, P1036, DOI 10.1038/79549; Henriques CM, 2010, BLOOD, V115, P3269, DOI 10.1182/blood-2009-10-246876; Jiang Q, 2004, CELL SIGNAL, V16, P281, DOI 10.1016/S0898-6568(03)00138-4; Lang KS, 2005, EUR J IMMUNOL, V35, P738, DOI 10.1002/eji.200425828; Levy Y, 2009, J CLIN INVEST, V119, P997, DOI 10.1172/JCI38052; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; MacPherson PA, 2001, J ACQ IMMUN DEF SYND, V28, P454, DOI 10.1097/00042560-200112150-00008; Mussini C, 2002, AIDS, V16, P1609, DOI 10.1097/00002030-200208160-00006; Napolitano LA, 2001, NAT MED, V7, P73, DOI 10.1038/83381; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Radziewicz H, 2007, J VIROL, V81, P2545, DOI 10.1128/JVI.02021-06; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Rosenberg SA, 2006, J IMMUNOTHER, V29, P313, DOI 10.1097/01.cji.0000210386.55951.c2; Sasson SC, 2006, J INFECT DIS, V193, P505, DOI 10.1086/499309; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Seddon BaZ R, 2002, J IMMUNOL, P3752; Sereti I, 2009, BLOOD, V113, P6304, DOI 10.1182/blood-2008-10-186601; Smith DE, 2003, AIDS RES HUM RETROV, V19, P189, DOI 10.1089/088922203763315696; Soares MVD, 1998, J IMMUNOL, V161, P5909; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; Suzuki Kazuo, 2005, J RNAi Gene Silencing, V1, P66; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Vingerhoets J, 1998, IMMUNOL LETT, V61, P53, DOI 10.1016/S0165-2478(97)00162-4; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Vranjkovic A, 2007, INT IMMUNOL, V19, P1329, DOI 10.1093/intimm/dxm102; Webb LMC, 1999, IMMUNOLOGY, V98, P400, DOI 10.1046/j.1365-2567.1999.00906.x; Zaunders JJ, 2003, J INFECT DIS, V187, P1735, DOI 10.1086/375030; Zaunders JJ, 2003, BLOOD; Zhang SY, 2009, EUR J IMMUNOL, V39, P1425, DOI 10.1002/eji.200839059	39	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31148	10.1371/journal.pone.0031148	http://dx.doi.org/10.1371/journal.pone.0031148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348045	Green Published, Green Submitted, gold			2022-12-25	WOS:000302733900025
J	Nokia, MS; Sisti, HM; Choksi, MR; Shors, TJ				Nokia, Miriam S.; Sisti, Helene M.; Choksi, Monica R.; Shors, Tracey J.			Learning to Learn: Theta Oscillations Predict New Learning, which Enhances Related Learning and Neurogenesis	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; TRACE MEMORIES; DENTATE GYRUS; NEURONS; NAVIGATION; INCREASES; SURVIVAL; CELLS; RAT; ACQUISITION	Animals in the natural world continuously encounter learning experiences of varying degrees of novelty. New neurons in the hippocampus are especially responsive to learning associations between novel events and more cells survive if a novel and challenging task is learned. One might wonder whether new neurons would be rescued from death upon each new learning experience or whether there is an internal control system that limits the number of cells that are retained as a function of learning. In this experiment, it was hypothesized that learning a task that was similar in content to one already learned previously would not increase cell survival. We further hypothesized that in situations in which the cells are rescued hippocampal theta oscillations (3-12 Hz) would be involved and perhaps necessary for increasing cell survival. Both hypotheses were disproved. Adult male Sprague-Dawley rats were trained on two similar hippocampus-dependent tasks, trace and very-long delay eyeblink conditioning, while recording hippocampal local-field potentials. Cells that were generated after training on the first task were labeled with bromodeoxyuridine and quantified after training on both tasks had ceased. Spontaneous theta activity predicted performance on the first task and the conditioned stimulus induced a theta-band response early in learning the first task. As expected, performance on the first task correlated with performance on the second task. However, theta activity did not increase during training on the second task, even though more cells were present in animals that had learned. Therefore, as long as learning occurs, relatively small changes in the environment are sufficient to increase the number of surviving neurons in the adult hippocampus and they can do so in the absence of an increase in theta activity. In conclusion, these data argue against an upper limit on the number of neurons that can be rescued from death by learning.	[Nokia, Miriam S.; Sisti, Helene M.; Choksi, Monica R.; Shors, Tracey J.] Rutgers State Univ, Dept Psychol, Ctr Collaborat Neurosci, Piscataway, NJ USA	Rutgers State University New Brunswick	Nokia, MS (corresponding author), Univ Jyvaskyla, Dept Psychol, Jyvaskyla, Finland.	miriam.nokia@jyu.fi	Nokia, Miriam/AAL-7599-2021	Nokia, Miriam/0000-0003-2222-6118	National Institutes of Health [MH-59970, ARRA-3R01MH059970-10S1]; National Science Foundation [IOB-0444364, IOS-0914386]; Academy of Finland; Emil Aaltonen Foundation; Jenny and Antti Wihuri Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Academy of Finland(Academy of Finland); Emil Aaltonen Foundation; Jenny and Antti Wihuri Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health (grant nos. MH-59970 and ARRA-3R01MH059970-10S1) and the National Science Foundation (grant nos. IOB-0444364 and IOS-0914386) to TJS. This work was also supported by grants from the Academy of Finland, Emil Aaltonen Foundation and Jenny and Antti Wihuri Foundation to MSN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2010, TRENDS COGN SCI, V14, P325, DOI 10.1016/j.tics.2010.04.003; Anderson ML, 2011, EUR J NEUROSCI, V33, P175, DOI 10.1111/j.1460-9568.2010.07486.x; Asaka Y, 2005, P NATL ACAD SCI USA, V102, P13284, DOI 10.1073/pnas.0506515102; Beylin AV, 2001, NEUROBIOL LEARN MEM, V76, P447, DOI 10.1006/nlme.2001.4039; Bizon JL, 2003, EUR J NEUROSCI, V18, P215, DOI 10.1046/j.1460-9568.2003.02733.x; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Curlik DM, 2011, J COGNITIVE NEUROSCI, V23, P2159, DOI 10.1162/jocn.2010.21597; Dalla C, 2009, P NATL ACAD SCI USA, V106, P2927, DOI 10.1073/pnas.0809650106; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Fell J, 2011, J NEUROSCI, V31, P5392, DOI 10.1523/JNEUROSCI.3668-10.2011; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Griffin AL, 2004, BEHAV NEUROSCI, V118, P403, DOI 10.1037/0735-7044.118.2.403; Guderian S, 2009, P NATL ACAD SCI USA, V106, P5365, DOI 10.1073/pnas.0900289106; Hodes GE, 2009, NEUROSCIENCE, V163, P609, DOI 10.1016/j.neuroscience.2009.06.057; Hoffmann LC, 2009, P NATL ACAD SCI USA, V106, P21371, DOI 10.1073/pnas.0908403106; Itskov V, 2011, J NEUROSCI, V31, P2828, DOI 10.1523/JNEUROSCI.3773-10.2011; Jirenhed DA, 2011, CEREBELLUM, V10, P523, DOI 10.1007/s12311-011-0264-3; KRAMIS R, 1975, EXP NEUROL, V49, P58, DOI 10.1016/0014-4886(75)90195-8; Kuo AG, 2006, LEARN MEMORY, V13, P201, DOI 10.1101/lm.98406; Leuner B, 2007, HIPPOCAMPUS, V17, P434, DOI 10.1002/hipo.20278; Leuner B, 2006, J NEUROSCI, V26, P13437, DOI 10.1523/JNEUROSCI.2781-06.2006; Leuner B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011597; Lisman J, 2010, CURR BIOL, V20, pR490, DOI 10.1016/j.cub.2010.04.011; Maguire EA, 2003, HIPPOCAMPUS, V13, P250, DOI 10.1002/hipo.10087; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Nokia MS, 2010, J NEUROSCI, V30, P11486, DOI 10.1523/JNEUROSCI.2165-10.2010; Nokia MS, 2010, HIPPOCAMPUS, V20, P457, DOI 10.1002/hipo.20696; Nokia MS, 2009, BEHAV NEUROSCI, V123, P631, DOI 10.1037/a0015334; Paxinos WC, 1998, RAT BRAIN STEREOTAXI, P256; PROKASY WF, 1984, PSYCHOPHYSIOLOGY, V21, P1, DOI 10.1111/j.1469-8986.1984.tb02309.x; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Shors TJ, 2011, BEHAV BRAIN IN PRESS; Shors TJ, 2008, CELL STEM CELL, V3, P253, DOI 10.1016/j.stem.2008.08.010; Sisti HM, 2007, LEARN MEMORY, V14, P368, DOI 10.1101/lm.488707; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; Urcelay GP, 2010, ANIM COGN, V13, P21, DOI 10.1007/s10071-009-0295-z; Waddell J, 2008, EUR J NEUROSCI, V27, P3020, DOI 10.1111/j.1460-9568.2008.06222.x; Waddell J, 2011, NEUROBIOL LEARN MEM, V95, P159, DOI 10.1016/j.nlm.2010.09.012; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Wikgren J, 2010, NEUROSCIENCE, V165, P1538, DOI 10.1016/j.neuroscience.2009.11.044	43	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e31375	10.1371/journal.pone.0031375	http://dx.doi.org/10.1371/journal.pone.0031375			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	924ZX	22348078	Green Published, gold, Green Submitted			2022-12-25	WOS:000302730900026
J	Johnson, RC; Weber, PK; Wikert, JD; Workman, ML; MacFarlane, RB; Grove, MJ; Schmitt, AK				Johnson, Rachel C.; Weber, Peter K.; Wikert, John D.; Workman, Michelle L.; MacFarlane, R. Bruce; Grove, Marty J.; Schmitt, Axel K.			Managed Metapopulations: Do Salmon Hatchery 'Sources' Lead to In-River 'Sinks' in Conservation?	PLOS ONE			English	Article							ONCORHYNCHUS-TSHAWYTSCHA; ANADROMOUS SALMONIDS; SOCKEYE-SALMON; CHINOOK SALMON; WILD; OTOLITHS; SULFUR; FITNESS; TROUT; POPULATIONS	Maintaining viable populations of salmon in the wild is a primary goal for many conservation and recovery programs. The frequency and extent of connectivity among natal sources defines the demographic and genetic boundaries of a population. Yet, the role that immigration of hatchery-produced adults may play in altering population dynamics and fitness of natural populations remains largely unquantified. Quantifying, whether natural populations are self-sustaining, functions as sources (population growth rate in the absence of dispersal, lambda>1), or as sinks (lambda<1) can be obscured by an inability to identify immigrants. In this study we use a new isotopic approach to demonstrate that a natural spawning population of Chinook salmon, (Oncorhynchus tshawytscha) considered relatively healthy, represents a sink population when the contribution of hatchery immigrants is taken into consideration. We retrieved sulfur isotopes (S-34/S-32, referred to as delta S-34) in adult Chinook salmon otoliths (ear bones) that were deposited during their early life history as juveniles to determine whether individuals were produced in hatcheries or naturally in rivers. Our results show that only 10.3% (CI = 5.5 to 18.1%) of adults spawning in the river had otolith delta S-34 values less than 8.5%, which is characteristic of naturally produced salmon. When considering the total return to the watershed (total fish in river and hatchery), we estimate that 90.7 to 99.3% (CI) of returning adults were produced in a hatchery (best estimate = 95.9%). When population growth rate of the natural population was modeled to account for the contribution of previously unidentified hatchery immigrants, we found that hatchery-produced fish caused the false appearance of positive population growth. These findings highlight the potential dangers in ignoring source-sink dynamics in recovering natural populations, and question the extent to which declines in natural salmon populations are undetected by monitoring programs.	[Johnson, Rachel C.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; [Weber, Peter K.] Lawrence Livermore Natl Lab, Div Chem Sci, Livermore, CA USA; [Wikert, John D.] US Fish & Wildlife Serv, Anadromous Fish Restorat Program, Stockton, CA USA; [Workman, Michelle L.] E Bay Municipal Util Dist, Lodi, CA USA; [MacFarlane, R. Bruce] Natl Marine Fisheries Serv, SW Fisheries Sci Ctr, Santa Cruz, CA USA; [Grove, Marty J.; Schmitt, Axel K.] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90024 USA	University of California System; University of California Santa Cruz; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of the Interior; US Fish & Wildlife Service; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Los Angeles	Johnson, RC (corresponding author), US Bur Reclamat, Bay Delta Off, Sacramento, CA 95825 USA.	rbarnettjohnson@usbr.gov	Weber, Peter Kilian/AAP-9517-2020	Weber, Peter Kilian/0000-0001-6022-6050; Schmitt, Axel/0000-0002-9029-4211	U.S. Fish and Wildlife Service; Division of Earth Sciences, National Science Foundation	U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Division of Earth Sciences, National Science Foundation(National Science Foundation (NSF))	RBJ, PW, and RBM gratefully acknowledge the U.S. Fish and Wildlife Service's Anadromous Fish Restoration Program for awarding the grant that funded this project. The ion microprobe facility at UCLA is partly supported by a grant from the Instrumentation and Facilities Program, Division of Earth Sciences, National Science Foundation. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Araki H, 2007, CONSERV BIOL, V21, P181, DOI 10.1111/j.1523-1739.2006.00564.x; BACHMAN RA, 1984, T AM FISH SOC, V113, P1, DOI 10.1577/1548-8659(1984)113&lt;1:FBOFWA&gt;2.0.CO;2; Barnett-Johnson R, 2005, CAN J FISH AQUAT SCI, V62, P2425, DOI 10.1139/F05-194; Barnett-Johnson R, 2007, CANADIAN J FISHERIES, V318, P100; Barnett-Johnson R, 2008, LIMNOL OCEANOGR, V53, P1633, DOI 10.4319/lo.2008.53.4.1633; Barnett-Johnson R, 2007, CAN J FISH AQUAT SCI, V64, P1683, DOI 10.1139/F07-129; Blanchet S, 2008, BIOL CONSERV, V141, P1989, DOI 10.1016/j.biocon.2008.05.014; Brawn JD, 1996, ECOLOGY, V77, P3, DOI 10.2307/2265649; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Campana SE, 2001, CAN J FISH AQUAT SCI, V58, P30, DOI 10.1139/f00-177; Carlson SM, 2008, EVOL APPL, V1, P222, DOI 10.1111/j.1752-4571.2008.00025.x; Carr M. H., 2003, ECOLOGICAL APPL, V13, P90; Chilcote MW, 2011, CAN J FISH AQUAT SCI, V68, P511, DOI 10.1139/F10-168; Cooper AB, 1999, FISH B-NOAA, V97, P213; Ding T, 2001, GEOCHIM COSMOCHIM AC, V65, P2433, DOI 10.1016/S0016-7037(01)00611-1; Dunham JB, 1999, ECOL APPL, V9, P642, DOI 10.2307/2641151; FISHER FW, 1994, CONSERV BIOL, V8, P870, DOI 10.1046/j.1523-1739.1994.08030863-5.x; Ford MJ, 2002, CONSERV BIOL, V16, P815, DOI 10.1046/j.1523-1739.2002.00257.x; Fry B, 2011, LIMNOL OCEANOGR, V56, P1563, DOI 10.4319/lo.2011.56.5.1563; Gilpin M.E., 1991, METAPOPULATION DYNAM; Godbout L, 2010, ENVIRON BIOL FISH, V89, P521, DOI 10.1007/s10641-010-9689-7; Gowan C, 1996, ECOL APPL, V6, P931, DOI 10.2307/2269496; Hanski Ilkka, 1997, P5, DOI 10.1016/B978-012323445-2/50003-1; Hendry AP, 2000, SCIENCE, V290, P516, DOI 10.1126/science.290.5491.516; HESSLEIN RH, 1993, CAN J FISH AQUAT SCI, V50, P2071, DOI 10.1139/f93-230; Hill MF, 2002, AM NAT, V160, P389, DOI 10.1086/341526; Ingram BL, 1999, GEOLOGY, V27, P851; Kennedy BP, 1997, NATURE, V387, P766, DOI 10.1038/42835; Kostow KE, 2004, CAN J FISH AQUAT SCI, V61, P577, DOI [10.1139/f04-019, 10.1139/F04-019]; Krouse H. R., 1991, Stable isotopes: natural and anthropogenic sulphur in the environment., P267; Laplace PS., 1820, THEORIE ANAL PROBABI; Levin PS, 2001, P ROY SOC B-BIOL SCI, V268, P1153, DOI 10.1098/rspb.2001.1634; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Lewis JR, 2006, J USABILITY STUD, V1, P136; Lichatocwich J, 1999, SALMON RIVERS; Lindley ST, 2007, SAN FRANCISCO ESTUAR, V5, P26; Mann CC, 2000, SCIENCE, V52, P119; McClure MM, 2003, ECOL APPL, V13, P964, DOI 10.1890/1051-0761(2003)13[964:ALMSAA]2.0.CO;2; McGinnity P, 2003, P ROY SOC B-BIOL SCI, V270, P2443, DOI 10.1098/rspb.2003.2520; Merz JE, 2004, N AM J FISH MANAGE, V24, P397, DOI 10.1577/M03-038.1; Merz JE, 2006, ECOL APPL, V16, P999, DOI 10.1890/1051-0761(2006)016[0999:SWAWMN]2.0.CO;2; MOYLE PB, 1994, CONSERV BIOL, V8, P869, DOI 10.1046/j.1523-1739.1994.08030863-4.x; NEHLSEN W, 1991, FISHERIES, V16, P4, DOI 10.1577/1548-8446(1991)016&lt;0004:PSATCS&gt;2.0.CO;2; Nriagu J.O., 1991, STABLE ISOTOPES NATU, P177; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Rhodes Justin S., 1999, North American Journal of Fisheries Management, V19, P670, DOI 10.1577/1548-8675(1999)019&lt;0670:CPOGSH&gt;2.0.CO;2; Ruggerone GT, 2010, MAR COAST FISH, V2, P306, DOI 10.1577/C09-054.1; Schtickzelle N, 2007, FISH FISH, V8, P297, DOI 10.1111/j.1467-2979.2007.00256.x; Snyder NFR, 1996, CONSERV BIOL, V10, P338, DOI 10.1046/j.1523-1739.1996.10020338.x; TAYLOR EB, 1991, AQUACULTURE, V98, P185, DOI 10.1016/0044-8486(91)90383-I; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; Walther BD, 2006, MAR ECOL PROG SER, V311, P125, DOI 10.3354/meps311125; Weber ED, 2003, CAN J FISH AQUAT SCI, V60, P1018, DOI 10.1139/F03-087; Weber PK, 2002, CAN J FISH AQUAT SCI, V59, P587, DOI [10.1139/f02-038, 10.1139/F02-038]; WIENS JA, 1996, METAPOPULATIONS WILD; Williams J.G, 2006, SAN FRANC ESTUARY WA, V4, P3, DOI [10.15447/sfews.2006v4iss3art2, DOI 10.15447/SFEWS.2006V4ISS3ART2]	58	23	23	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e28880	10.1371/journal.pone.0028880	http://dx.doi.org/10.1371/journal.pone.0028880			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347362	Green Submitted, Green Published, gold			2022-12-25	WOS:000302730100003
J	Li, L; Xu, ZF; Zhou, Y; Sun, LL; Liu, ZD; Chen, HC; Zhou, R				Li, Lu; Xu, Zhuofei; Zhou, Yang; Sun, Lili; Liu, Ziduo; Chen, Huanchun; Zhou, Rui			Global Effects of Catecholamines on Actinobacillus pleuropneumoniae Gene Expression	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; BIOFILM FORMATION; MICROBIAL ENDOCRINOLOGY; INFECTIOUS-DISEASE; RTX-TOXINS; YERSINIA-ENTEROCOLITICA; PERIODONTAL BACTERIA; SALMONELLA-ENTERICA; UREASE ACTIVITY; INDUCED GROWTH	Bacteria can use mammalian hormones to modulate pathogenic processes that play essential roles in disease development. Actinobacillus pleuropneumoniae is an important porcine respiratory pathogen causing great economic losses in the pig industry globally. Stress is known to contribute to the outcome of A. pleuropneumoniae infection. To test whether A. pleuropneumoniae could respond to stress hormone catecholamines, gene expression profiles after epinephrine (Epi) and norepinephrine (NE) treatment were compared with those from untreated bacteria. The microarray results showed that 158 and 105 genes were differentially expressed in the presence of Epi and NE, respectively. These genes were assigned to various functional categories including many virulence factors. Only 18 genes were regulated by both hormones. These genes included apxIA (the ApxI toxin structural gene), pgaB (involved in biofilm formation), APL_0443 (an autotransporter adhesin) and genes encoding potential hormone receptors such as tyrP2, the ygiY-ygiX (qseC-qseB) operon and narQ-narP (involved in nitrate metabolism). Further investigations demonstrated that cytotoxic activity was enhanced by Epi but repressed by NE in accordance with apxIA gene expression changes. Biofilm formation was not affected by either of the two hormones despite pgaB expression being affected. Adhesion to host cells was induced by NE but not by Epi, suggesting that the hormones affect other putative adhesins in addition to APL_0443. This study revealed that A. pleuropneumoniae gene expression, including those encoding virulence factors, was altered in response to both catecholamines. The differential regulation of A. pleuropneumoniae gene expression by the two hormones suggests that this pathogen may have multiple responsive systems for the two catecholamines.	[Li, Lu; Xu, Zhuofei; Zhou, Yang; Sun, Lili; Liu, Ziduo; Chen, Huanchun; Zhou, Rui] Huazhong Agr Univ, Div Anim Infect Dis, State Key Lab Agr Microbiol, Coll Vet Med, Wuhan, Peoples R China	Huazhong Agricultural University	Zhou, R (corresponding author), Huazhong Agr Univ, Div Anim Infect Dis, State Key Lab Agr Microbiol, Coll Vet Med, Wuhan, Peoples R China.	rzhou@mail.hzau.edu.cn	Zhou, Yang/GSE-6288-2022		National Natural Science Foundation of China [31070113]; National Basic Research Program of China (973 Program) [2012CB518802]; Special Fund for Agro-scientific Research in the Public Interest [200903036-05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Special Fund for Agro-scientific Research in the Public Interest	This work was supported by the National Natural Science Foundation of China (31070113), National Basic Research Program of China (973 Program, 2012CB518802) and Special Fund for Agro-scientific Research in the Public Interest (200903036-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abul-Milh M, 1999, INFECT IMMUN, V67, P4983, DOI 10.1128/IAI.67.10.4983-4987.1999; Anderson MT, 2008, J BACTERIOL, V190, P3940, DOI 10.1128/JB.00086-08; Auger E, 2009, INFECT IMMUN, V77, P1426, DOI 10.1128/IAI.00297-08; Baltes N, 2004, INFECT IMMUN, V72, P6711, DOI 10.1128/IAI.72.11.6711-6716.2004; Baltes N, 2001, INFECT IMMUN, V69, P472, DOI 10.1128/IAI.69.1.472-478.2001; Bansal T, 2007, INFECT IMMUN, V75, P4597, DOI 10.1128/IAI.00630-07; BELANGER M, 1994, INFECT IMMUN, V62, P868; BELANGER M, 1990, INFECT IMMUN, V58, P3523; Boekema BKHL, 2004, INFECT IMMUN, V72, P691, DOI 10.1128/IAI.72.2.691-700.2004; Bosse JT, 2010, J BACTERIOL, V192, P2414, DOI 10.1128/JB.01513-09; Bosse JT, 1997, INFECT IMMUN, V65, P4389; Bosse JT, 2002, MICROBES INFECT, V4, P225, DOI 10.1016/S1286-4579(01)01534-9; Bosse JT, 2000, CAN J VET RES, V64, P145; Boyce JD, 2002, INFECT IMMUN, V70, P6871, DOI 10.1128/IAI.70.12.6871-6879.2002; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; Brown SW, 2003, J NEUROIMMUNOL, V135, P47, DOI 10.1016/S0165-5728(02)00435-6; Buettner FFR, 2008, INFECT IMMUN, V76, P2284, DOI 10.1128/IAI.01540-07; Buettner FFR, 2008, VET MICROBIOL, V127, P106, DOI 10.1016/j.vetmic.2007.08.005; Burton CL, 2002, INFECT IMMUN, V70, P5913, DOI 10.1128/IAI.70.11.5913-5923.2002; Chen CS, 2006, EUR J PHARMACOL, V539, P116, DOI 10.1016/j.ejphar.2006.03.081; Chiers K, 2010, VET RES, V41, DOI 10.1051/vetres/2010037; Clarke MB, 2006, P NATL ACAD SCI USA, V103, P10420, DOI 10.1073/pnas.0604343103; CURTIS SE, 1976, AM J VET RES, V37, P299; Dalai B, 2009, MICROB PATHOGENESIS, V46, P128, DOI 10.1016/j.micpath.2008.11.005; Deslandes V, BMC GENOMICS, V11, P98; Deslandes V, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-72; Diez A, 2000, MOL MICROBIOL, V36, P1494, DOI 10.1046/j.1365-2958.2000.01979.x; Domka J, 2006, APPL ENVIRON MICROB, V72, P2449, DOI 10.1128/AEM.72.4.2449-2459.2006; Everest P, 2007, GUT, V56, P1037, DOI 10.1136/gut.2006.117150; Flierl MA, 2007, NATURE, V449, P721, DOI 10.1038/nature06185; Freestone PPE, 2000, J BACTERIOL, V182, P6091, DOI 10.1128/JB.182.21.6091-6098.2000; Freestone PPE, 2008, TRENDS MICROBIOL, V16, P55, DOI 10.1016/j.tim.2007.11.005; Freestone PPE, 2007, FEMS MICROBIOL LETT, V269, P221, DOI 10.1111/j.1574-6968.2006.00619.x; Freestone PPE, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-8; FREY J, 1995, TRENDS MICROBIOL, V3, P257, DOI 10.1016/S0966-842X(00)88939-8; FREY J, 1993, J GEN MICROBIOL, V139, P1723, DOI 10.1099/00221287-139-8-1723; GRUCHOW HW, 1979, J HUM STRESS, V5, P11, DOI 10.1080/0097840X.1979.9934523; Hendrickson BA, 1999, INFECT IMMUN, V67, P745, DOI 10.1128/IAI.67.2.745-753.1999; Horn G, 2007, CELL MOL LIFE SCI, V64, P1457, DOI 10.1007/s00018-007-6388-4; Hughes DT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000553; Jacobsen I, 2005, INFECT IMMUN, V73, P226, DOI 10.1128/IAI.73.1.226-234.2005; Jacques M, 2004, CAN J VET RES, V68, P81; Jarma E, 2004, MICROB PATHOGENESIS, V36, P197, DOI 10.1016/j.micpath.2003.11.005; KAMP EM, 1991, INFECT IMMUN, V59, P3079, DOI 10.1128/IAI.59.9.3079-3085.1991; Kaplan JB, 2004, J BACTERIOL, V186, P8213, DOI 10.1128/JB.186.24.8213-8220.2004; Kaplan JB, 2005, VET MICROBIOL, V108, P89, DOI 10.1016/j.vetmic.2005.02.011; KELLEY KW, 1980, ANN RECH VET, V11, P445; Kihara A, 1998, J MOL BIOL, V279, P175, DOI 10.1006/jmbi.1998.1781; LEDIVIDICH J, 1991, BIOL NEONATE, V59, P268, DOI 10.1159/000243360; Li L, MICROB PATHOG; Li L, 2008, MICROB PATHOGENESIS, V45, P192, DOI 10.1016/j.micpath.2008.05.008; Lone AG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006139; Lyte M, 1996, FEMS MICROBIOL LETT, V139, P155, DOI 10.1016/0378-1097(96)00135-8; Lyte M, 1997, BIOCHEM BIOPH RES CO, V232, P682, DOI 10.1006/bbrc.1997.6356; Lyte M, 2004, TRENDS MICROBIOL, V12, P14, DOI 10.1016/j.tim.2003.11.004; LYTE M, 1993, J ENDOCRINOL, V137, P343, DOI 10.1677/joe.0.1370343; Negrete-Abascal E, 1998, CAN J VET RES, V62, P183; NEGRETEABASCAL E, 1994, CAN J VET RES, V58, P83; Oneal MJ, 2008, MICROBIOL-SGM, V154, P2581, DOI 10.1099/mic.0.2008/020230-0; PARADIS SE, 1994, INFECT IMMUN, V62, P3311, DOI 10.1128/IAI.62.8.3311-3319.1994; PETERSON PK, 1991, REV INFECT DIS, V13, P710; Ramjeet M, 2005, J BIOL CHEM, V280, P39104, DOI 10.1074/jbc.M502852200; Ramjeet M, 2008, MOL MICROBIOL, V70, P221, DOI 10.1111/j.1365-2958.2008.06409.x; Reading NC, 2009, P NATL ACAD SCI USA, V106, P5889, DOI 10.1073/pnas.0811409106; Roberts A, 2005, ORAL MICROBIOL IMMUN, V20, P147, DOI 10.1111/j.1399-302X.2004.00196.x; Roberts A, 2002, ORAL MICROBIOL IMMUN, V17, P296, DOI 10.1034/j.1399-302X.2002.170506.x; Salak-Johnson JL, 2007, J ANIM SCI, V85, pE81, DOI 10.2527/jas.2006-538; Sandrini SM, 2010, J BACTERIOL, V192, P587, DOI 10.1128/JB.01028-09; Smoot LM, 2001, P NATL ACAD SCI USA, V98, P10416, DOI 10.1073/pnas.191267598; Sperandio V, 2003, P NATL ACAD SCI USA, V100, P8951, DOI 10.1073/pnas.1537100100; Stevenson A, 2003, VET MICROBIOL, V92, P121, DOI 10.1016/S0378-1135(02)00351-6; Stewart V, 2003, MOL MICROBIOL, V50, P1391, DOI 10.1046/j.1365-2958.2003.03776.x; Tegetmeyer HE, 2009, VET MICROBIOL, V137, P392, DOI 10.1016/j.vetmic.2009.01.026; Thanabalu T, 1998, EMBO J, V17, P6487, DOI 10.1093/emboj/17.22.6487; Vendeville A, 2005, NAT REV MICROBIOL, V3, P383, DOI 10.1038/nrmicro1146; Vlisidou I, 2004, INFECT IMMUN, V72, P5446, DOI 10.1128/IAI.72.9.5446-5451.2004; Voigt W, 2006, J CLIN MICROBIOL, V44, P2247, DOI 10.1128/JCM.00330-05; Walters M, 2006, J BACTERIOL, V188, P5668, DOI 10.1128/JB.00648-06; Whitehead RN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-35; Wojtarowicz Aleksandra, 2003, Folia Morphol (Warsz), V62, P215; Xu ZF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001450; YOUNG JB, 1998, WILLIAMS TXB ENDOCRI, P665	82	34	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31121	10.1371/journal.pone.0031121	http://dx.doi.org/10.1371/journal.pone.0031121			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347439	Green Published, Green Submitted, gold			2022-12-25	WOS:000302730100043
J	Jin, M; Lang, J; Shen, ZQ; Chen, ZL; Qiu, ZG; Wang, XW; Li, JW				Jin, Min; Lang, Jing; Shen, Zhi-Qiang; Chen, Zhao-Li; Qiu, Zhi-Gang; Wang, Xin-Wei; Li, Jun-Wen			A Rapid Subtractive Immunization Method to Prepare Discriminatory Monoclonal Antibodies for Food E. coli O157:H7 Contamination	PLOS ONE			English	Article							IMMUNOGOLD FILTRATION ASSAY; ESCHERICHIA-COLI; GENERATION; PROTEINS; ANTIGENS; TOLERIZATION; EPITOPES; STRATEGY; AFFINITY; SURFACE	To detect food E. coli O157:H7 contamination rapidly and accurately, it is essential to prepare high specific monoclonal antibodies (mAbs) against the pathogen. Cyclophosphamide (Cy)-mediated subtractive immunization strategy was performed in mice to generate mAbs that react with E. coli O157:H7, but not with other affiliated bacteria. Specificity of 19 mAbs was evaluated by ELISA and/or dot-immunogold filtration assay (DIGFA). Immunogloubin typing, affinity and binding antigens of 5 selected mAbs were also analysed. MAbs 1D8, 4A7, 5A2 were found to have high reactivity with E. coli O157:H7 and no cross-reactivity with 80 other strains of bacteria including Salmonella sp., Shigella sp., Proteus sp., Yersinia enterocolitica, Staphylococcus aureus, Klebsiella pneumoniae, Citrobacter freundii and other non-E. coli O157:H7 enteric bacteria. Their ascetic titers reached 1:10(6) with E. coli O157:H7 and affinity constants ranged from 1.57x10(10) to 2.79x10(10) L/mol. The antigens recognized by them were different localized proteins. Furthermore, immune-colloidal gold probe coated with mAb 5A2 could specifically distinguish minced beef contaminated by E. coli O157:H7 from 84 other bacterial contaminations. The Cy-mediated subtractive immunization procedure coupled with hybridoma technology is a rapid and efficient approach to prepare discriminatory mAbs for detection of E. coli O157:H7 contamination in food.	[Jin, Min; Lang, Jing; Shen, Zhi-Qiang; Chen, Zhao-Li; Qiu, Zhi-Gang; Wang, Xin-Wei; Li, Jun-Wen] Inst Hlth & Environm Med, Dept Environm & Hlth, Key Lab Risk Assessment & Control Environm & Food, Tianjin, Peoples R China		Jin, M (corresponding author), Inst Hlth & Environm Med, Dept Environm & Hlth, Key Lab Risk Assessment & Control Environm & Food, Tianjin, Peoples R China.	junwen9999@hotmail.com		Qiu, Zhigang/0000-0003-1199-3397	National High Technology Research and Development Program of China [2009AA06Z404, 2009AA03Z332]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This research was supported by the National High Technology Research and Development Program of China (2009AA06Z404, 2009AA03Z332). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEATTY JD, 1987, J IMMUNOL METHODS, V100, P173, DOI 10.1016/0022-1759(87)90187-6; Fukushima H, 2007, APPL ENVIRON MICROB, V73, P92, DOI 10.1128/AEM.01772-06; Han FC, 2000, WORLD J GASTROENTERO, V6, P400; Holbrook FL, 2002, IMMUNOL CELL BIOL, V80, P319, DOI 10.1046/j.1440-1711.2002.01095.x; Hooper JD, 2003, ONCOGENE, V22, P1783, DOI 10.1038/sj.onc.1206220; Joshi SA, 2003, REPRODUCTION, V125, P495, DOI 10.1530/reprod/125.4.495; Krueger P, 2001, J IMMUNOTHER, V24, P334, DOI 10.1097/00002371-200107000-00009; LANE RD, 1986, METHOD ENZYMOL, V121, P183; Lefebvre DJ, 2008, J GEN VIROL, V89, P177, DOI 10.1099/vir.0.83280-0; LOOMANS EEMG, 1995, J IMMUNOL METHODS, V184, P207, DOI 10.1016/0022-1759(95)00089-S; Luciani M., 2006, Veterinaria Italiana, V42, P173; Luciani M, 2006, Vet Ital, V42, P183; MCKINNEY MM, 1987, J IMMUNOL METHODS, V96, P271, DOI 10.1016/0022-1759(87)90324-3; Mernaugh RL, 2005, J IMMUNOL METHODS, V306, P115, DOI 10.1016/j.jim.2005.08.006; Navarro A, 2007, J MED MICROBIOL, V56, P1447, DOI 10.1099/jmm.0.47201-0; Ning YS, 2006, PROTEOMICS, V6, P438, DOI 10.1002/pmic.200500327; OU SK, 1991, J IMMUNOL METHODS, V145, P111, DOI 10.1016/0022-1759(91)90316-8; Park CH, 1998, J CLIN MICROBIOL, V36, P1408, DOI 10.1128/JCM.36.5.1408-1409.1998; Rasmussen N, 2009, J PROTEOME RES, V8, P5048, DOI 10.1021/pr9004635; Sakakibara K, 2005, GENES CELLS, V10, P345, DOI 10.1111/j.1365-2443.2005.00838.x; Sleister HM, 2002, J IMMUNOL METHODS, V261, P213, DOI 10.1016/S0022-1759(01)00567-1; Sleister HM, 2001, J IMMUNOL METHODS, V252, P121, DOI 10.1016/S0022-1759(01)00346-5; Sowers EG, 1996, J CLIN MICROBIOL, V34, P1286, DOI 10.1128/JCM.34.5.1286-1289.1996; Villavedra M, 2007, J FISH DIS, V30, P191, DOI 10.1111/j.1365-2761.2007.00800.x; Wang XJ, 2006, J VIROL METHODS, V132, P212, DOI 10.1016/j.jviromet.2005.09.012; Watanabe Y, 1999, EMERG INFECT DIS, V5, P424, DOI 10.3201/eid0503.990313; Westerman RB, 1997, J CLIN MICROBIOL, V35, P679, DOI 10.1128/JCM.35.3.679-684.1997; Xin ZT, 2004, J IMMUNOL METHODS, V293, P13, DOI 10.1016/j.jim.2004.06.006; Yang LJ, 2002, WORLD J GASTROENTERO, V8, P808, DOI 10.3748/wjg.v8.i5.808	29	15	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31352	10.1371/journal.pone.0031352	http://dx.doi.org/10.1371/journal.pone.0031352			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347466	Green Submitted, Green Published, gold			2022-12-25	WOS:000302180600035
J	Ueno, T; Tomita, J; Kume, S; Kume, K				Ueno, Taro; Tomita, Jun; Kume, Shoen; Kume, Kazuhiko			Dopamine Modulates Metabolic Rate and Temperature Sensitivity in Drosophila melanogaster	PLOS ONE			English	Article							CIRCADIAN CLOCK; MUSHROOM BODIES; TARGETED EXPRESSION; GENE-EXPRESSION; SLEEP; PREFERENCE; BEHAVIOR; RECEPTOR; NEURONS; THERMOTAXIS	Homeothermal animals, such as mammals, maintain their body temperature by heat generation and heat dissipation, while poikilothermal animals, such as insects, accomplish it by relocating to an environment of their favored temperature. Catecholamines are known to regulate thermogenesis and metabolic rate in mammals, but their roles in other animals are poorly understood. The fruit fly, Drosophila melanogaster, has been used as a model system for the genetic studies of temperature preference behavior. Here, we demonstrate that metabolic rate and temperature sensitivity of some temperature sensitive behaviors are regulated by dopamine in Drosophila. Temperature-sensitive molecules like dTrpA1 and shi(ts) induce temperature-dependent behavioral changes, and the temperature at which the changes are induced were lowered in the dopamine transporter-defective mutant, fumin. The mutant also displays a preference for lower temperatures. This thermophobic phenotype was rescued by the genetic recovery of the dopamine transporter in dopamine neurons. Flies fed with a dopamine biosynthesis inhibitor (3-iodo-L-tyrosine), which diminishes dopamine signaling, exhibited preference for a higher temperature. Furthermore, we found that the metabolic rate is up-regulated in the fumin mutant. Taken together, dopamine has functions in the temperature sensitivity of behavioral changes and metabolic rate regulation in Drosophila, as well as its previously reported functions in arousal/sleep regulation.	[Ueno, Taro; Tomita, Jun; Kume, Shoen; Kume, Kazuhiko] Kumamoto Univ, Inst Embryol & Genet, Dept Stem Cell Biol, Kumamoto, Japan; [Kume, Shoen] Kumamoto Univ, Global COE program, Kumamoto, Japan	Kumamoto University; Kumamoto University	Ueno, T (corresponding author), Kumamoto Univ, Inst Embryol & Genet, Dept Stem Cell Biol, Kumamoto, Japan.	kkume@kumamoto-u.ac.jp	Ueno, Taro/AAN-7260-2021; Kume, Shoen/M-4356-2016	Ueno, Taro/0000-0003-3697-4301; Kume, Shoen/0000-0002-4292-205X; Kume, Kazuhiko/0000-0003-4232-1657	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [17024049]; Japanese Society for the Promotion of Science (JSPS) [15300108, 17300105, 22300132]; 21st Century Center of Excellence (COE); Global COE from MEXT	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 21st Century Center of Excellence (COE)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE from MEXT	This work was supported by a grant-in-aid (17024049) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and a grant-in-aid (15300108, 17300105, 22300132 to KK) from the Japanese Society for the Promotion of Science (JSPS); a 21st Century Center of Excellence (COE) grant; and a Global COE grant from MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Angilletta MJ, 2002, J THERM BIOL, V27, P249, DOI 10.1016/S0306-4565(01)00094-8; Bale JS, 2002, PHILOS T R SOC B, V357, P849, DOI 10.1098/rstb.2002.1074; Bang S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001346; Billes SK, 2008, NEUROPSYCHOPHARMACOL, V33, P1287, DOI 10.1038/sj.npp.1301526; BRAND AH, 1993, DEVELOPMENT, V118, P401; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dillon ME, 2009, J THERM BIOL, V34, P109, DOI 10.1016/j.jtherbio.2008.11.007; Gallio M, 2011, CELL, V144, P614, DOI 10.1016/j.cell.2011.01.028; Gervasi N, 2010, NEURON, V65, P516, DOI 10.1016/j.neuron.2010.01.014; Glanville EJ, 2006, J EXP BIOL, V209, P4869, DOI 10.1242/jeb.02585; Glaser FT, 2005, CURR BIOL, V15, P1352, DOI 10.1016/j.cub.2005.06.056; Goto SG, 1998, J INSECT PHYSIOL, V44, P1233, DOI 10.1016/S0022-1910(98)00101-2; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; HEINRICH B, 1979, SCIENCE, V205, P1269, DOI 10.1126/science.205.4412.1269; Heinrich B., 1993, HOT BLOODED INSECTS; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hong ST, 2008, NATURE, V454, P771, DOI 10.1038/nature07090; Hong ST, 2006, J NEUROSCI, V26, P7245, DOI 10.1523/JNEUROSCI.5426-05.2006; Hyun S, 2005, NEURON, V48, P267, DOI 10.1016/j.neuron.2005.08.025; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Kong EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009954; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Kume K., 2006, SLEEP BIOL RHYTHMS, V4, P263, DOI DOI 10.1111/J.1479-8425.2006.00225.X; Lee Y, 2005, NAT GENET, V37, P305, DOI 10.1038/ng1513; Majercak J, 1999, NEURON, V24, P219, DOI 10.1016/S0896-6273(00)80834-X; Makos MA, 2009, ANAL CHEM, V81, P1848, DOI 10.1021/ac802297b; Mao ZM, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.005.2009; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Neckameyer WS, 1996, DEV BIOL, V176, P209, DOI 10.1006/dbio.1996.0128; Peabody NC, 2009, J NEUROSCI, V29, P3343, DOI 10.1523/JNEUROSCI.4241-08.2009; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Porzgen P, 2001, MOL PHARMACOL, V59, P83; Pulver SR, 2009, J NEUROPHYSIOL, V101, P3075, DOI 10.1152/jn.00071.2009; R Development Core Team, 2009, R FDN STAT COMP; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Sehadova H, 2009, NEURON, V64, P251, DOI 10.1016/j.neuron.2009.08.026; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Takeuchi K, 2009, SCIENCE, V323, P1740, DOI 10.1126/science.1165712; Thomas SA, 1997, NATURE, V387, P94, DOI 10.1038/387094a0; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Van Voorhies WA, 2004, J APPL PHYSIOL, V97, P1915, DOI 10.1152/japplphysiol.00505.2004; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006; YEH E, 1995, P NATL ACAD SCI USA, V92, P7036, DOI 10.1073/pnas.92.15.7036; Zars T, 2001, J COMP PHYSIOL A, V187, P235, DOI 10.1007/s003590100194; Zhang K, 2007, SCIENCE, V316, P1901, DOI 10.1126/science.1137357	50	34	37	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31513	10.1371/journal.pone.0031513	http://dx.doi.org/10.1371/journal.pone.0031513			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347491	Green Submitted, Green Published, gold			2022-12-25	WOS:000302180600041
J	Moon, JJ; Suh, H; Polhemus, ME; Ockenhouse, CF; Yadava, A; Irvine, DJ				Moon, James J.; Suh, Heikyung; Polhemus, Mark E.; Ockenhouse, Christian F.; Yadava, Anjali; Irvine, Darrell J.			Antigen-Displaying Lipid-Enveloped PLGA Nanoparticles as Delivery Agents for a Plasmodium vivax Malaria Vaccine	PLOS ONE			English	Article							IMMUNE-RESPONSES; ANTIBODY-RESPONSES; EPITOPE DENSITY; IMMUNOGENICITY; IMMUNIZATION	The parasite Plasmodium vivax is the most frequent cause of malaria outside of sub-Saharan Africa, but efforts to develop viable vaccines against P. vivax so far have been inadequate. We recently developed pathogen-mimicking polymeric vaccine nanoparticles composed of the FDA-approved biodegradable polymer poly(lactide-co-glycolide) acid (PLGA) "enveloped'' by a lipid membrane. In this study, we sought to determine whether this vaccine delivery platform could be applied to enhance the immune response against P. vivax sporozoites. A candidate malaria antigen, VMP001, was conjugated to the lipid membrane of the particles, and an immunostimulatory molecule, monophosphoryl lipid A (MPLA), was incorporated into the lipid membranes, creating pathogen-mimicking nanoparticle vaccines (VMP001-NPs). Vaccination with VMP001-NPs promoted germinal center formation and elicited durable antigen-specific antibodies with significantly higher titers and more balanced Th1/Th2 responses in vivo, compared with vaccines composed of soluble protein mixed with MPLA. Antibodies raised by NP vaccinations also exhibited enhanced avidity and affinity toward the domains within the circumsporozoite protein implicated in protection and were able to agglutinate live P. vivax sporozoites. These results demonstrate that these VMP001-NPs are promising vaccines candidates that may elicit protective immunity against P. vivax sporozoites.	[Moon, James J.; Suh, Heikyung; Irvine, Darrell J.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Moon, James J.; Suh, Heikyung; Irvine, Darrell J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Polhemus, Mark E.; Ockenhouse, Christian F.; Yadava, Anjali] Walter Reed Army Inst Res, Div Malaria Vaccine Dev, Silver Spring, MD USA; [Irvine, Darrell J.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Irvine, Darrell J.] Ragon Inst MGH MIT & Harvard, Boston, MA USA; [Suh, Heikyung; Irvine, Darrell J.] Howard Hughes Med Inst, Chevy Chase, MD USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Howard Hughes Medical Institute	Moon, JJ (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.	djirvine@mit.edu	Moon, James J/ABE-4429-2021	Moon, James J/0000-0003-2238-2372	Ragon Institute of MGH, MIT, and Harvard; Department of Defense [W911NF-07-D-0004]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354] Funding Source: NIH RePORTER	Ragon Institute of MGH, MIT, and Harvard; Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Ragon Institute of MGH, MIT, and Harvard, and the Department of Defense (contract W911NF-07-D-0004). DJI is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataman-Onal Y, 2006, J CONTROL RELEASE, V112, P175, DOI 10.1016/j.jconrel.2006.02.006; Ballou WR, 2009, PARASITE IMMUNOL, V31, P492, DOI 10.1111/j.1365-3024.2009.01143.x; Bell BA, 2009, VACCINE, V27, P1448, DOI 10.1016/j.vaccine.2008.12.027; Bershteyn A, 2011, J CONTROL R IN PRESS; Bershteyn A, 2008, SOFT MATTER, V4, P1787, DOI 10.1039/b804933e; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; CHAROENVIT Y, 1991, SCIENCE, V251, P668, DOI 10.1126/science.1704150; Cui ZR, 2004, VACCINE, V22, P2631, DOI 10.1016/j.vaccine.2003.12.013; Demento SL, 2010, J IMMUNOL, V185, P2989, DOI 10.4049/jimmunol.1000768; Demento SL, 2009, VACCINE, V27, P3013, DOI 10.1016/j.vaccine.2009.03.034; Fifis T, 2004, J IMMUNOL, V173, P3148, DOI 10.4049/jimmunol.173.5.3148; Jegerlehner A, 2002, EUR J IMMUNOL, V32, P3305, DOI 10.1002/1521-4141(200211)32:11<3305::AID-IMMU3305>3.0.CO;2-J; Jewell CM, 2011, P NATL ACAD SCI US; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; JONES TR, 1992, AM J TROP MED HYG, V47, P837, DOI 10.4269/ajtmh.1992.47.837; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Kazzaz J, 2006, J CONTROL RELEASE, V110, P566, DOI 10.1016/j.jconrel.2005.10.010; KOVACSOVICSBANKOWSKI M, 1993, P NATL ACAD SCI USA, V90, P4942, DOI 10.1073/pnas.90.11.4942; Liu HP, 2011, ANGEW CHEM INT EDIT, V50, P7052, DOI 10.1002/anie.201101266; Liu WL, 2005, EUR J IMMUNOL, V35, P505, DOI 10.1002/eji.200425749; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; Moon JJ, 2012, P NATL ACAD SCI USA, V109, P1080, DOI 10.1073/pnas.1112648109; Moon JJ, 2011, NAT MATER, V10, P243, DOI 10.1038/NMAT2960; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; Nutt SL, 2011, NAT IMMUNOL, V12, P472, DOI 10.1038/ni.2019; Otten G, 2003, J VIROL, V77, P6087, DOI 10.1128/JVI.77.10.6087-6092.2003; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332; Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106; Udhayakumar V, 1998, VACCINE, V16, P982, DOI 10.1016/S0264-410X(97)00290-9; Vanderberg JP, 2004, INT J PARASITOL, V34, P991, DOI 10.1016/j.ijpara.2004.05.005; Vogel G, 2010, SCIENCE, V329, P618, DOI 10.1126/science.329.5992.618; Yadava A, 2007, INFECT IMMUN, V75, P1177, DOI 10.1128/IAI.01667-06; Yue Y, 2009, VIROLOGY, V386, P438, DOI 10.1016/j.virol.2009.01.029; Zhang XQ, 2007, J PHARM SCI-US, V96, P3283, DOI 10.1002/jps.20978	35	102	106	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e31472	10.1371/journal.pone.0031472	http://dx.doi.org/10.1371/journal.pone.0031472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328935	Green Published, gold, Green Submitted			2022-12-25	WOS:000302179300021
J	Parthasarathy, S; Fitzgerald, M; Goodwin, JL; Unruh, M; Guerra, S; Quan, SF				Parthasarathy, Sairam; Fitzgerald, MaryPat; Goodwin, James L.; Unruh, Mark; Guerra, Stefano; Quan, Stuart F.			Nocturia, Sleep-Disordered Breathing, and Cardiovascular Morbidity in a Community-Based Cohort	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; POSITIVE AIRWAY PRESSURE; RISK-FACTOR; NATRIURETIC-PEPTIDE; APNEA-HYPOPNEA; OLDER-ADULTS; BACH SURVEY; MORTALITY; HEALTH; WOMEN	Background: Nocturia has been independently associated with cardiovascular morbidity and all-cause mortality, but such studies did not adjust for sleep-disordered breathing (SDB), which may have mediated such a relationship. Our aims were to determine whether an association between nocturia and cardiovascular morbidity exists that is independent of SDB. We also determined whether nocturia is independently associated with SDB. Methodology/Principal Findings: In order to accomplish these aims we performed a cross-sectional analysis of the Sleep Heart Health Study that contained information regarding SDB, nocturia, and cardiovascular morbidity in a middle-age to elderly community-based population. In 6342 participants (age 63 +/- 11 [SD] years, 53% women), after adjusting for known confounders such as age, body mass index, diuretic use, diabetes mellitus, alpha-blocker use, nocturia was independently associated with SDB (measured as Apnea Hypopnea index >15 per hour; OR 1.3; 95%CI, 1.2-1.5). After adjusting for SDB and other known confounders, nocturia was independently associated with prevalent hypertension (OR 1.23; 95%CI 1.08-140; P = 0.002), cardiovascular disease (OR 1.26; 95%CI 1.05-1.52; P = 0.02) and stroke (OR 1.62; 95%CI 1.14-2.30; P = 0.007). Moreover, nocturia was also associated with adverse objective alterations of sleep as measured by polysomnography and self-reported excessive daytime sleepiness (P<0.05). Conclusions/Significance: Nocturia is independently associated with sleep-disordered breathing. After adjusting for SDB, there remained an association between nocturia and cardiovascular morbidity. Such results support screening for SDB in patients with nocturia, but the mechanisms underlying the relationship between nocturia and cardiovascular morbidity requires further study. MeSH terms: Nocturia, sleep-disordered breathing, obstructive sleep apnea, sleep apnea, polysomnography, hypertension.	[Parthasarathy, Sairam; Quan, Stuart F.] Univ Arizona, Dept Med, Tucson, AZ 85719 USA; [Parthasarathy, Sairam; Goodwin, James L.; Guerra, Stefano; Quan, Stuart F.] Univ Arizona, Arizona Resp Ctr, Tucson, AZ USA; [Fitzgerald, MaryPat] Hines Vet Affairs Hosp, Dept Surg, Hines, IL USA; [Unruh, Mark] Univ Pittsburgh, Dept Med, Renal Electrolyte Div, Pittsburgh, PA USA; [Guerra, Stefano] Consorcio Invest Biomed Epidemiol & Salud Publ CI, Ctr Res Environm Epidemiol, Inst Municipal Invest Med, Barcelona, Spain; [Quan, Stuart F.] Harvard Univ, Sch Med, Div Sleep Med, Boston, MA USA	University of Arizona; University of Arizona; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Harvard University; Harvard Medical School	Parthasarathy, S (corresponding author), Univ Arizona, Dept Med, Tucson, AZ 85719 USA.	spartha@arc.arizona.edu	Parthasarathy, Sairam/L-1612-2013; Quan, Stuart/J-5026-2019	Quan, Stuart/0000-0002-9474-7679	National Institutes of Health (National Heart, Lung and Blood Institute [NHLBI]); University of Washington [U01HL53940]; Boston University [U01HL53941]; University of Arizona [U01HL53938]; University of California, Davis [U01HL53916]; University of Minnesota [U01HL53934]; New York University [U01HL53931]; Johns Hopkins University [U01HL53937, U01HL64360]; Case Western Reserve University [U01HL63463]; Missouri Breaks Research [U01HL63429]; National Heart, Lung and Blood Institute;  [1R01HL095748];  [5R01DK077785];  [DK075967-03]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL053940, U01HL053938, U01HL064360, U01HL053934, U01HL053916, U01HL053941, U01HL053937, U01HL053931, R01HL095748, U01HL063429, U01HL063463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077785, K24DK075967] Funding Source: NIH RePORTER	National Institutes of Health (National Heart, Lung and Blood Institute [NHLBI])(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Washington(University of Washington); Boston University; University of Arizona; University of California, Davis(University of California System); University of Minnesota(University of Minnesota System); New York University; Johns Hopkins University(Johns Hopkins University); Case Western Reserve University; Missouri Breaks Research; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was funded by the National Institutes of Health (National Heart, Lung and Blood Institute [NHLBI]). The sponsor was involved in oversight of human subject safety through an independent Data Safety Monitoring Board (DSMB), and had non-voting representation in the steering committee that approved this manuscript submission. This work was supported by National Heart, Lung and Blood Institute cooperative agreements U01HL53940 (University of Washington), U01HL53941 (Boston University), U01HL53938 (University of Arizona), U01HL53916 (University of California, Davis), U01HL53934 (University of Minnesota), U01HL53931 (New York University), U01HL53937 and U01HL64360 (Johns Hopkins University), U01HL63463 (Case Western Reserve University), U01HL63429 (Missouri Breaks Research). Investigators were funded through the following grants during the data analysis and manuscript preparation 1R01HL095748 (S.P), 5R01DK077785 (M.U.), DK075967-03 (M.F). This is not an industry-funded study. SP, MF, JLG, MU, SG, and SFQ have no relevant financial interest in this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, AM J EPIDEMIOL, V129, P687; Asplund R, 1999, BJU INT, V84, P297; Ayas NT, 2003, ARCH INTERN MED, V163, P205, DOI 10.1001/archinte.163.2.205; Bing MH, 2008, BJU INT, V102, P808, DOI 10.1111/j.1464-410X.2008.07813.x; Bursztyn M, 2006, AM J CARDIOL, V98, P1311, DOI 10.1016/j.amjcard.2006.06.024; Chasens ER, 2002, DIABETES EDUCATOR, V28, P424, DOI 10.1177/014572170202800312; DAWBER TR, 1963, ANN NY ACAD SCI, V107, P539, DOI 10.1111/j.1749-6632.1963.tb13299.x; de Lemos JA, 2003, LANCET, V362, P316, DOI 10.1016/S0140-6736(03)13976-1; FitzGerald MP, 2007, J UROLOGY, V177, P1385, DOI 10.1016/j.juro.2006.11.057; FitzGerald MP, 2006, AM J OBSTET GYNECOL, V194, P1399, DOI 10.1016/j.ajog.2006.01.048; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Friedman O, 2010, HYPERTENSION, V56, P1077, DOI 10.1161/HYPERTENSIONAHA.110.154427; Gooneratne NS, 2011, SLEEP, V34, P435, DOI 10.1093/sleep/34.4.435; Guilleminault C, 2004, J PSYCHOSOM RES, V56, P511, DOI 10.1016/S0022-3999(04)00021-2; Hajduk IA, 2003, SLEEP, V26, P61; Hsieh CH, 2008, AUST NZ J OBSTET GYN, V48, P312, DOI 10.1111/j.1479-828X.2008.00870.x; Johnson TM, 2005, J AM GERIATR SOC, V53, P1011, DOI 10.1111/j.1532-5415.2005.53321.x; Kiely JL, 1999, EUR RESPIR J, V13, P1086, DOI 10.1034/j.1399-3003.1999.13e24.x; Kragelund C, 2005, NEW ENGL J MED, V352, P666, DOI 10.1056/NEJMoa042330; Kramer NR, 1998, CHEST, V114, P634, DOI 10.1378/chest.114.2.634; Kupelian V, 2009, J UROLOGY, V181, P694, DOI 10.1016/j.juro.2008.10.039; Kupelian V, 2011, J UROLOGY, V185, P571, DOI 10.1016/j.juro.2010.09.108; LEBOWITZ MD, 1975, AM J EPIDEMIOL, V102, P137, DOI 10.1093/oxfordjournals.aje.a112141; LEE ET, 1990, AM J EPIDEMIOL, V132, P1141, DOI 10.1093/oxfordjournals.aje.a115757; Leung RST, 2001, AM J RESP CRIT CARE, V164, P2147, DOI 10.1164/ajrccm.164.12.2107045; Margel D, 2006, UROLOGY, V67, P974, DOI 10.1016/j.urology.2005.11.054; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Marshall NS, 2008, SLEEP, V31, P1079; Mullington JM, 2009, PROG CARDIOVASC DIS, V51, P294, DOI 10.1016/j.pcad.2008.10.003; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; O'Connor GT, 2009, AM J RESP CRIT CARE, V179, P1159, DOI 10.1164/rccm.200712-1809OC; Pressman MR, 1996, ARCH INTERN MED, V156, P545, DOI 10.1001/archinte.156.5.545; Punjabi NM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000132; Quan SF, 1997, SLEEP, V20, P1077; Rechtschaffen A, 1968, NIH PUBLICATION, V204; Redline S, 1998, SLEEP, V21, P759; Romero E, 2009, SLEEP BREATH; STEWART RB, 1992, J AM GERIATR SOC, V40, P1217, DOI 10.1111/j.1532-5415.1992.tb03645.x; Van Kerrebroeck P, 2002, BJU INT, V90, P11, DOI 10.1046/j.1464-410X.90.s3.3.x; Vassalle C, 2007, CLIN CHEM, V53, P1886, DOI 10.1373/clinchem.2007.088302; Yoshimura K, 2004, INT J UROL, V11, P282, DOI 10.1111/j.1442-2042.2004.00791.x; Young T, 2008, SLEEP, V31, P1071; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064	43	65	66	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e30969	10.1371/journal.pone.0030969	http://dx.doi.org/10.1371/journal.pone.0030969			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328924	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000302179300010
J	Tourtas, T; Birke, MT; Kruse, FE; Welge-Lussen, UC; Birke, K				Tourtas, Theofilos; Birke, Marco T.; Kruse, Friedrich E.; Welge-Luessen, Ulrich-Christoph; Birke, Kerstin			Preventive Effects of Omega-3 and Omega-6 Fatty Acids on Peroxide Mediated Oxidative Stress Responses in Primary Human Trabecular Meshwork Cells	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; OUTFLOW PATHWAY; AQUEOUS-HUMOR; DISEASE; OMEGA-3-FATTY-ACIDS; SENESCENCE; PROTECTION; MARKERS; RETINA; HEALTH	Pathologic processes in glaucoma include increased apoptosis, accumulation of extracellular material in the trabecular meshwork and optic nerve, condensations of the cytoskeleton and precocious cellular senescence. Oxidative stress was shown to generate these alterations in primary ocular cells. Fatty acids omega-3 and -6 are alleged to constitute a prophylaxis against these deleterious effects. Here, we tested actual preventive effects omega-3 and -6 against peroxide induced stress responses in primary human trabecular meshwork cells. Changes of mitochondrial activity, proliferation, heat shock proteins, extracellular matrix components, and inflammatory markers were evaluated. Alterations of the cytoskeleton were evaluated by phalloidin labeling. Here we report a repressive effect of omega-6 on metabolic activity and proliferation, which was not detected for omega-3. Both agents were able to prevent the anti-proliferative effect of H2O2, but only omega-3 prevented metabolic repression. Expression of heat shock protein 27 was unaltered by both fatty acids, whereas heat shock protein 90 was significantly induced by both. Omega-6 increased fibronectin and connective tissue growth factor synthesis, as well as the amount of secreted fibronectin. Omega-3, instead, induced plasminogen activator inhibitor 1 synthesis. H2O2 further increased fibronectin production in omega-6 supplemented cells, which was not the case in omega-3 treated cells. H2O2 stimulation of plasminogen activator inhibitor 1 and connective tissue growth factor was repressed by both fatty acids. Both fatty acids appeared to abolish H2O2 mediated stimulation of nuclear factor kappa B and IL-6, but not IL-1 alpha and IL-8. H2O2 induced formation of cross-linked actin networks and stress fibers, which was reduced by preemptive application of omega-3. Omega-6, in contrast, had no protective effect on that, and even seemed to promote condensation. Based on the observed side effects of omega-6, omega-3 appears to be the more beneficial fatty acid in respect of prophylactic intake for prevention of a glaucomatous disease.	[Tourtas, Theofilos; Birke, Marco T.; Kruse, Friedrich E.; Welge-Luessen, Ulrich-Christoph; Birke, Kerstin] Univ Hosp Erlangen, Dept Ophthalmol, Erlangen, Germany	University of Erlangen Nuremberg	Tourtas, T (corresponding author), Univ Hosp Erlangen, Dept Ophthalmol, Erlangen, Germany.	kerstin.birke@uk-erlangen.de		Tourtas, Theofilos/0000-0002-3465-9837				Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P2533, DOI 10.1167/iovs.05-1639; Bougnoux P, 2006, CANCER EPIDEM BIOMAR, V15, P416, DOI 10.1158/1055-9965.EPI-05-0546; Calder PC, 2001, LIPIDS, V36, P1007, DOI 10.1007/s11745-001-0812-7; Chilton FH, 2011, PHYSL BEHAV; Clark A F, 1995, J Glaucoma, V4, P183; Clark AF, 2005, CELL MOTIL CYTOSKEL, V60, P83, DOI 10.1002/cm.20049; CLARK AF, 1994, INVEST OPHTH VIS SCI, V35, P281; Den Ruijter HM, 2007, CARDIOVASC RES, V73, P316, DOI 10.1016/j.cardiores.2006.06.014; Dumont P, 2000, FREE RADICAL BIO MED, V28, P361, DOI 10.1016/S0891-5849(99)00249-X; Ebrahimi M, 2010, MOL VIS, V16, P1680; Ferreira SM, 2004, AM J OPHTHALMOL, V137, P62, DOI 10.1016/S0002-9394(03)00788-8; Filla MS, 2009, INVEST OPHTH VIS SCI, V50, P5723, DOI 10.1167/iovs.08-3215; Fuchshofer R, 2007, INVEST OPHTH VIS SCI, V48, P715, DOI 10.1167/iovs.06-0226; Gabelt BT, 2005, PROG RETIN EYE RES, V24, P612, DOI 10.1016/j.preteyeres.2004.10.003; Galimberti Daniela, 2011, Front Biosci (Schol Ed), V3, P252, DOI 10.2741/s149; Ghanem AA, 2010, CURR EYE RES, V35, P295, DOI 10.3109/02713680903548970; Hallahan B, 2005, BRIT J PSYCHIAT, V186, P275, DOI 10.1192/bjp.186.4.275; He Y, 2008, INVEST OPHTH VIS SCI, V49, P1447, DOI 10.1167/iovs.07-1361; He Y, 2009, MOL VIS, V15, P815; ISHIKAWA H, 1977, COMP BIOCHEM PHYS B, V58, P1, DOI 10.1016/0305-0491(77)90116-X; Izzotti A, 2006, MUTAT RES-REV MUTAT, V612, P105, DOI 10.1016/j.mrrev.2005.11.001; Izzotti A, 2003, AM J MED, V114, P638, DOI 10.1016/S0002-9343(03)00114-1; Joachim S, 2011, INVEST OPHTHALMOL VI; Kang JH, 2003, AM J EPIDEMIOL, V158, P337, DOI 10.1093/aje/kwg167; Lanneau D, 2010, THESCIENTIFICWORLDJO, V10, P1543, DOI 10.1100/tsw.2010.152; Li GR, 2007, MOL VIS, V13, P2282; Lin YZ, 2010, INVEST OPHTH VIS SCI, V51, P6483, DOI 10.1167/iovs.10-5410; Liton PB, 2009, EXP EYE RES, V88, P724, DOI 10.1016/j.exer.2008.11.002; Liton PB, 2005, EXP GERONTOL, V40, P745, DOI 10.1016/j.exger.2005.06.005; Lou YR, 2011, CARCINOGENESIS; Lutjen-Drecoll E, 2005, EXP EYE RES, V81, P1, DOI 10.1016/j.exer.2005.02.008; Pache M, 2006, SURV OPHTHALMOL, V51, P179, DOI 10.1016/j.survophthal.2006.02.008; Roman AS, 2006, AM J OBSTET GYNECOL, V195, P1693, DOI 10.1016/j.ajog.2006.04.009; Sacca SC, 2005, ARCH OPHTHALMOL-CHIC, V123, P458, DOI 10.1001/archopht.123.4.458; Sacca SC, 2007, EXP EYE RES, V84, P389, DOI 10.1016/j.exer.2006.10.008; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; Simopoulos AP, 2011, MOL NEUROBIOL; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Tanwar M, 2010, MOL VIS, V16, P518; Temple MD, 2005, TRENDS CELL BIOL, V15, P319, DOI 10.1016/j.tcb.2005.04.003; Terman A, 2006, ANTIOXID REDOX SIGN, V8, P197, DOI 10.1089/ars.2006.8.197; Tezel G, 2007, INVEST OPHTH VIS SCI, V48, P1201, DOI 10.1167/iovs.06-0737; Walgren JL, 2004, METABOLISM, V53, P165, DOI 10.1016/j.metabol.2003.09.008; Wall R, 2010, NUTR REV, V68, P280, DOI 10.1111/j.1753-4887.2010.00287.x; Welge-Lussen U, 2010, KLIN MONATSBL AUGENH, V227, P99, DOI 10.1055/s-0029-1245171; WILSON K, 1993, CURR EYE RES, V12, P783, DOI 10.3109/02713689309020383; Wordinger RJ, 1999, PROG RETIN EYE RES, V18, P629, DOI 10.1016/S1350-9462(98)00035-4; Yoshida Y, 2004, J BIOL CHEM, V279, P1768, DOI 10.1074/jbc.M311498200; Yu AL, 2008, INVEST OPHTH VIS SCI, V49, P4872, DOI 10.1167/iovs.07-0984; Zanon-Moreno V, 2009, EUR J OPHTHALMOL, V19, P565, DOI 10.1177/112067210901900408; Zhou LL, 1999, J CELL PHYSIOL, V180, P182, DOI 10.1002/(SICI)1097-4652(199908)180:2<182::AID-JCP6>3.0.CO;2-X	51	23	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31340	10.1371/journal.pone.0031340	http://dx.doi.org/10.1371/journal.pone.0031340			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319624	gold, Green Published			2022-12-25	WOS:000302178400036
J	Wangpraseurt, D; Weber, M; Roy, H; Polerecky, L; de Beer, D; Suharsono; Nugues, MM				Wangpraseurt, Daniel; Weber, Miriam; Roy, Hans; Polerecky, Lubos; de Beer, Dirk; Suharsono; Nugues, Maggy M.			In Situ Oxygen Dynamics in Coral-Algal Interactions	PLOS ONE			English	Article							DIFFUSIVE BOUNDARY-LAYERS; CARIBBEAN CORAL; PHASE-SHIFTS; GORGONIAN CORALS; WATER VELOCITY; CLIMATE-CHANGE; SOFT CORALS; TURF ALGAE; BROWN ALGA; REEFS	Background: Coral reefs degrade globally at an alarming rate, with benthic algae often replacing corals. However, the extent to which benthic algae contribute to coral mortality, and the potential mechanisms involved, remain disputed. Recent laboratory studies suggested that algae kill corals by inducing hypoxia on the coral surface, through stimulated microbial respiration. Methods/Findings: We examined the main premise of this hypothesis by measuring in situ oxygen microenvironments at the contact interface between the massive coral Porites spp. and turf algae, and between Porites spp. and crustose coralline algae (CCA). Oxygen levels at the interface were similar to healthy coral tissue and ranged between 300-400 mu M during the day. At night, the interface was hypoxic (similar to 70 mu M) in coral-turf interactions and close to anoxic (similar to 2 mu M) in coral-CCA interactions, but these values were not significantly different from healthy tissue. The diffusive boundary layer (DBL) was about three times thicker at the interface than above healthy tissue, due to a depression in the local topography. A numerical model, developed to analyze the oxygen profiles above the irregular interface, revealed strongly reduced net photosynthesis and dark respiration rates at the coral-algal interface compared to unaffected tissue during the day and at night, respectively. Conclusions/Significance: Our results showed that hypoxia was not a consistent feature in the microenvironment of the coral-algal interface under in situ conditions. Therefore, hypoxia alone is unlikely to be the cause of coral mortality. Due to the modified topography, the interaction zone is distinguished by a thicker diffusive boundary layer, which limits the local metabolic activity and likely promotes accumulation of potentially harmful metabolic products (e.g., allelochemicals and protons). Our study highlights the importance of mass transfer phenomena and the need for direct in situ measurements of microenvironmental conditions in studies on coral stress.	[Wangpraseurt, Daniel; Nugues, Maggy M.] Leibniz Ctr Trop Marine Ecol, Dept Ecol, Coral Reef Ecol Grp CORE, Bremen, Germany; [Wangpraseurt, Daniel; Weber, Miriam; Polerecky, Lubos; de Beer, Dirk] Max Planck Inst Marine Microbiol, Bremen, Germany; [Roy, Hans] HYDRA Inst Marine Sci, Elba Field Stn, Campo Nellelba, Italy; [Roy, Hans] Aarhus Univ, Dept Biol Sci, Ctr Geomicrobiol, Aarhus, Denmark; [Suharsono] Indonesian Inst Sci, Res Ctr Oceanog, Jakarta, Indonesia	Leibniz Zentrum fur Marine Tropenforschung (ZMT); Max Planck Society; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); Aarhus University; Indonesian Institute of Sciences	Wangpraseurt, D (corresponding author), Univ Technol Sydney, Sch Environm, Sydney, NSW 2007, Australia.	daniel.wangpraseurt@student.uts.edu.au	Nugues, Maggy M/O-4314-2015; de Beer, Dirk/L-4840-2013; Polerecky, Lubos/E-1134-2014; Røy, Hans/G-3842-2010	Nugues, Maggy M/0000-0002-1399-9787; de Beer, Dirk/0000-0001-5274-1781; Polerecky, Lubos/0000-0003-4425-585X; Røy, Hans/0000-0002-6477-3091; Wangpraseurt, Daniel/0000-0003-4834-8981	Leibniz Center for Tropical Marine Ecology; Max Planck Institute for Marine Microbiology; German Academic Exchange Service (DAAD)	Leibniz Center for Tropical Marine Ecology; Max Planck Institute for Marine Microbiology; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This research was funded by the Leibniz Center for Tropical Marine Ecology and the Max Planck Institute for Marine Microbiology. Dr. Wangpraseurt was supported by a scholarship from the German Academic Exchange Service (DAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Horani FA, 2005, CORAL REEFS, V24, P173, DOI 10.1007/s00338-004-0461-3; ATKINSON MJ, 1992, LIMNOL OCEANOGR, V37, P273, DOI 10.4319/lo.1992.37.2.0273; Barott K, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008043, 10.1371/journal.pone.0010950]; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; de Beer D, 2000, MAR ECOL PROG SER, V194, P75, DOI 10.3354/meps194075; de Voogd NJ, 2009, MAR ECOL PROG SER, V396, P169, DOI 10.3354/meps08349; DENYS R, 1991, MAR BIOL, V108, P315, DOI 10.1007/BF01344346; Diaz-Pulido G, 2011, ECOL LETT, V14, P156, DOI 10.1111/j.1461-0248.2010.01565.x; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; GARCIA HE, 1992, LIMNOL OCEANOGR, V37, P1307, DOI 10.4319/lo.1992.37.6.1307; Gardella DJ, 1999, MAR BIOL, V135, P289, DOI 10.1007/s002270050626; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; HUTCHINGS PA, 1986, CORAL REEFS, V4, P239, DOI 10.1007/BF00298083; Jensen PR, 1996, MAR BIOL, V125, P411, DOI 10.1007/BF00346321; Jompa J, 2003, MAR ECOL PROG SER, V258, P87, DOI 10.3354/meps258087; Jompa J, 2003, MAR ECOL PROG SER, V258, P79, DOI 10.3354/meps258079; Jompa J, 2002, LIMNOL OCEANOGR, V47, P527, DOI 10.4319/lo.2002.47.2.0527; JORGENSEN BB, 1990, LIMNOL OCEANOGR, V35, P1343, DOI 10.4319/lo.1990.35.6.1343; JORGENSEN BB, 1985, LIMNOL OCEANOGR, V30, P111, DOI 10.4319/lo.1985.30.1.0111; Kim K, 2000, MAR BIOL, V137, P393, DOI 10.1007/s002270000333; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; LABARRE SC, 1986, MAR ECOL PROG SER, V28, P147, DOI 10.3354/meps028147; Larkum AWD, 2003, MAR BIOL, V142, P1073, DOI 10.1007/s00227-003-1022-y; Ledlie MH, 2007, CORAL REEFS, V26, P641, DOI 10.1007/s00338-007-0230-1; LI YH, 1974, GEOCHIM COSMOCHIM AC, V38, P703; Littler MM, 1997, CORAL REEFS, V16, P168; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; Morrow KM, 2011, CORAL REEFS, V30, P309, DOI 10.1007/s00338-011-0747-1; Nugues MM, 2009, CORAL REEFS, V28, P507, DOI 10.1007/s00338-009-0468-x; Nugues MM, 2006, MAR ECOL PROG SER, V315, P75, DOI 10.3354/meps315075; Nugues MM, 2003, CORAL REEFS, V22, P507, DOI 10.1007/s00338-003-0338-x; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; Quan-Young LI, 2006, LIMNOL OCEANOGR, V51, P1159, DOI 10.4319/lo.2006.51.2.1159; Rasher DB, 2010, P NATL ACAD SCI USA, V107, P9683, DOI 10.1073/pnas.0912095107; Renema W, 2006, CORAL REEFS, V25, P351, DOI 10.1007/s00338-006-0119-4; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; River GF, 2001, J EXP MAR BIOL ECOL, V261, P159, DOI 10.1016/S0022-0981(01)00266-0; Roy H, 2002, LIMNOL OCEANOGR, V47, P837, DOI 10.4319/lo.2002.47.3.0837; Sammarco P.W., 1983, Coral Reefs, V1, P173, DOI 10.1007/BF00571194; SHASHAR N, 1993, BIOL BULL, V185, P455, DOI 10.2307/1542485; SLATTERY M, 1995, J EXP MAR BIOL ECOL, V190, P61, DOI 10.1016/0022-0981(95)00032-M; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; STENECK RS, 1994, OIKOS, V69, P476, DOI 10.2307/3545860; Thomas FIM, 1997, LIMNOL OCEANOGR, V42, P81, DOI 10.4319/lo.1997.42.1.0081; Titlyanov EA, 2007, J EXP MAR BIOL ECOL, V342, P282, DOI 10.1016/j.jembe.2006.11.007; Vermeij MJA, 2011, MAR ECOL PROG SER, V422, P1, DOI 10.3354/meps08964; Vermeij MJA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014312; Vu I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004514; Weber M, 2009, THESIS U BREMEN GERM; Weber M, 2007, ENVIRON SCI TECHNOL, V41, P6210, DOI 10.1021/es070200b; Wilsanand V, 1999, MICROBIOS, V99, P137	55	54	54	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e31192	10.1371/journal.pone.0031192	http://dx.doi.org/10.1371/journal.pone.0031192			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319615	Green Published, gold, Green Submitted			2022-12-25	WOS:000301979000026
J	Feng, C; Li, YF; Yau, YH; Lee, HS; Tang, XY; Xue, ZH; Zhou, YC; Lim, WM; Cornvik, TC; Ruedl, C; Shochat, SG; Tan, SM				Feng, Chen; Li, Yan-Feng; Yau, Yin-Hoe; Lee, Hui-Shan; Tang, Xiao-Yan; Xue, Zhi-Hong; Zhou, Yi-Chao; Lim, Wei-Min; Cornvik, Tobias C.; Ruedl, Christiane; Shochat, Susana G.; Tan, Suet-Mien			Kindlin-3 Mediates Integrin alpha L beta 2 Outside-in Signaling, and It Interacts with Scaffold Protein Receptor for Activated-C Kinase 1 (RACK1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION DEFICIENCY-III; CELL-MIGRATION; LEUKOCYTE ADHESION; BETA-SUBUNIT; MONOCLONAL-ANTIBODY; BINDING-PROTEIN; TALIN; DOMAIN; COACTIVATOR; MECHANISMS	Integrins are heterodimeric type I membrane cell adhesion molecules that are involved in many biological processes. Integrins are bidirectional signal transducers because their cytoplasmic tails are docking sites for cytoskeletal and signaling molecules. Kindlins are cytoplasmic molecules that mediate inside-out signaling and activation of the integrins. The three kindlin paralogs in humans are kindlin-1, -2, and -3. Each of these contains a 4.1-ezrin-radixin-moesin (FERM) domain and a pleckstrin homology domain. Kindlin-3 is expressed in platelets, hematopoietic cells, and endothelial cells. Here we show that kindlin-3 is involved in integrin alpha L beta 2 outside-in signaling. It also promotes micro-clustering of integrin alpha L beta 2. We provide evidence that kindlin-3 interacts with the receptor for activated-C kinase 1 (RACK1), a scaffold protein that folds into a seven-blade propeller. This interaction involves the pleckstrin homology domain of kindlin-3 and blades 5-7 of RACK1. Using the SKW3 human T lymphoma cells, we show that integrin alpha L beta 2 engagement by its ligand ICAM-1 promotes the association of kindlin-3 with RACK1. We also show that kindlin-3 co-localizes with RACK1 in polarized SKW3 cells and human T lymphoblasts. Our findings suggest that kindlin-3 plays an important role in integrin alpha L beta 2 outside-in signaling.	[Feng, Chen; Li, Yan-Feng; Yau, Yin-Hoe; Lee, Hui-Shan; Tang, Xiao-Yan; Xue, Zhi-Hong; Zhou, Yi-Chao; Lim, Wei-Min; Cornvik, Tobias C.; Ruedl, Christiane; Shochat, Susana G.; Tan, Suet-Mien] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tan, SM (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	smtan@ntu.edu.sg	Xue, Zhihong/T-8848-2019; li, yan/GTI-4638-2022; Hoe, YAU Yin/A-2817-2011; Ruedl, christiane/A-2219-2011; Tan, Suet/A-2224-2011	Hoe, YAU Yin/0000-0001-8136-2393; Ruedl, christiane/0000-0002-5599-6541; Tan, Suet-Mien/0000-0003-2371-8739	Nanyang Technological University AcRF [RG34/08]; Singapore A*STAR Biomedical Research Council [10/1/22/19/654]	Nanyang Technological University AcRF(Nanyang Technological University); Singapore A*STAR Biomedical Research Council(Agency for Science Technology & Research (A*STAR))	This work was supported by Nanyang Technological University AcRF Grant RG34/08 and by Singapore A*STAR Biomedical Research Council Grant 10/1/22/19/654.	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Bialkowska K, 2010, J BIOL CHEM, V285, P18640, DOI 10.1074/jbc.M109.085746; Buensuceso CS, 2005, J BIOL CHEM, V280, P644, DOI 10.1074/jbc.M410229200; Buensuceso CS, 2001, J CELL SCI, V114, P1691; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Chang BY, 1998, MOL CELL BIOL, V18, P3245, DOI 10.1128/MCB.18.6.3245; Chen SH, 2008, MOL BIOL CELL, V19, P3909, DOI 10.1091/mbc.E08-04-0433; Cheng M, 2007, J BIOL CHEM, V282, P18225, DOI 10.1074/jbc.M701386200; Cluzel C, 2005, J CELL BIOL, V171, P383, DOI 10.1083/jcb.200503017; COLLER BS, 1983, J CLIN INVEST, V72, P325, DOI 10.1172/JCI110973; Cox EA, 2003, MOL BIOL CELL, V14, P658, DOI 10.1091/mbc.E02-03-0142; Critchley DR, 2008, J CELL SCI, V121, P1345, DOI 10.1242/jcs.018085; Csukai M, 1997, J BIOL CHEM, V272, P29200, DOI 10.1074/jbc.272.46.29200; Das M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026355; de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8; Doan AT, 2007, EXP CELL RES, V313, P2667, DOI 10.1016/j.yexcr.2007.05.013; DUSTIN ML, 1986, J IMMUNOL, V137, P245; Feigelson SW, 2011, BLOOD, V117, P7042, DOI 10.1182/blood-2010-12-322859; GIAEVER I, 1993, NATURE, V366, P591, DOI 10.1038/366591a0; Goult BT, 2009, J MOL BIOL, V394, P944, DOI 10.1016/j.jmb.2009.09.061; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Has C, 2009, AM J PATHOL, V175, P1442, DOI 10.2353/ajpath.2009.090203; He YH, 2011, J INVEST DERMATOL, V131, P245, DOI 10.1038/jid.2010.273; HILDRETH JEK, 1983, EUR J IMMUNOL, V13, P202, DOI 10.1002/eji.1830130305; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ithychanda SS, 2009, J BIOL CHEM, V284, P4713, DOI 10.1074/jbc.M807719200; Jung GY, 2011, J CELL BIOCHEM, V112, P2541, DOI 10.1002/jcb.23178; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; Kuijpers TW, 2009, BLOOD, V113, P4740, DOI 10.1182/blood-2008-10-182154; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Luo BH, 2004, J BIOL CHEM, V279, P10215, DOI 10.1074/jbc.M312732200; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; Manevich-Mendelson E, 2009, BLOOD, V114, P2344, DOI 10.1182/blood-2009-04-218636; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; McDowall A, 2010, BLOOD, V115, P4834, DOI 10.1182/blood-2009-08-238709; Meves A, 2009, TRENDS CELL BIOL, V19, P504, DOI 10.1016/j.tcb.2009.07.006; Mochly-Rosen D, 1998, FASEB J, V12, P35; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Morin NA, 2008, J EXP MED, V205, P195, DOI 10.1084/jem.20071543; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Pluskota E, 2011, BLOOD, V117, P4978, DOI 10.1182/blood-2010-11-321182; Qu H, 2011, J CELL SCI, V124, P879, DOI 10.1242/jcs.076976; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Rajamanonmani R, 2009, J GEN VIROL, V90, P799, DOI 10.1099/vir.0.006874-0; Rodriguez MM, 1999, BIOCHEMISTRY-US, V38, P13787, DOI 10.1021/bi991055k; Saltel F, 2009, J CELL BIOL, V187, P715, DOI 10.1083/jcb.200908134; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shen ZL, 2012, AM J SURG, V203, P222, DOI 10.1016/j.amjsurg.2011.06.050; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; Streuli CH, 2009, J CELL SCI, V122, P171, DOI 10.1242/jcs.018945; Svensson L, 2009, NAT MED, V15, P306, DOI 10.1038/nm.1931; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tan SM, 2001, FEBS LETT, V505, P27, DOI 10.1016/S0014-5793(01)02778-8; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; Vararattanavech A, 2008, BIOCHEM J, V410, P495, DOI 10.1042/BJ20071218; Vararattanavech A, 2009, J BIOL CHEM, V284, P3239, DOI 10.1074/jbc.M802782200	68	55	55	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10714	10726		10.1074/jbc.M111.299594	http://dx.doi.org/10.1074/jbc.M111.299594			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334666	hybrid, Green Published			2022-12-25	WOS:000302780100001
J	Sanchez, EJ; Lewis, KM; Danna, BR; Kang, C				Sanchez, Emiliano J.; Lewis, Kevin M.; Danna, Benjamin R.; Kang, ChulHee			High-capacity Ca2+ Binding of Human Skeletal Calsequestrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-RELEASE CHANNEL; CARDIAC CALSEQUESTRIN; SARCOPLASMIC-RETICULUM; MUSCLE; PHOSPHORYLATION; MECHANISM; JUNCTIN; DOMAIN; STORE; ROLES	Calsequestrin, the major calcium storage protein in both cardiac and skeletal muscle, binds large amounts of Ca2+ in the sarcoplasmic reticulum and releases them during muscle contraction. For the first time, the crystal structures of Ca2+ complexes for both human (hCASQ1) and rabbit (rCASQ1) skeletal calsequestrin were determined, clearly defining their Ca2+ sequestration capabilities through resolution of high- and low-affinity Ca2+-binding sites. rCASQ1 crystallized in low CaCl2 buffer reveals three high-affinity Ca2+ sites with trigonal bipyramidal, octahedral, and pentagonal bipyramidal coordination geometries, along with three low-affinity Ca2+ sites. hCASQ1 crystallized in high CaCl2 shows 15 Ca2+ ions, including the six Ca2+ ions in rCASQ1. Most of the low-affinity sites, some of which are mu-carboxylate-bridged, are established by the rotation of dimer interfaces, indicating cooperative Ca2+ binding that is consistent with our atomic absorption spectroscopic data. On the basis of these findings, we propose a mechanism for the observed in vitro and in vivo dynamic high-capacity and low-affinity Ca2+-binding activity of calsequestrin.	[Sanchez, Emiliano J.; Danna, Benjamin R.; Kang, ChulHee] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Lewis, Kevin M.; Kang, ChulHee] Washington State Univ, Dept Chem, Pullman, WA 99164 USA	Washington State University; Washington State University	Kang, C (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	chkang@wsu.edu		Kang, ChulHee/0000-0002-0693-7860; Lewis, Kevin/0000-0003-3403-9520	American Heart Association [850084Z]; National Science Foundations [MCB 1021148, DBI 0959778]; M. J. Murdock Charitable Trust	American Heart Association(American Heart Association); National Science Foundations(National Science Foundation (NSF)); M. J. Murdock Charitable Trust	This work was supported by American Heart Association Grant 850084Z, National Science Foundations Grants MCB 1021148 and DBI 0959778, and the M. J. Murdock Charitable Trust.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Beard NA, 2004, PROG BIOPHYS MOL BIO, V85, P33, DOI 10.1016/j.pbiomolbio.2003.07.001; Dainese M, 2009, FASEB J, V23, P1710, DOI 10.1096/fj.08-121335; Dulhunty A, 2009, J PHYSIOL-LONDON, V587, P3135, DOI 10.1113/jphysiol.2009.171959; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FINN BE, 1995, NAT STRUCT BIOL, V2, P777, DOI 10.1038/nsb0995-777; FRANZINIARMSTRONG C, 1987, J CELL BIOL, V105, P49, DOI 10.1083/jcb.105.1.49; Gyorke S, 2009, J PHYSIOL-LONDON, V587, P3091, DOI 10.1113/jphysiol.2009.172049; HARDMAN KD, 1982, J MOL BIOL, V157, P69, DOI 10.1016/0022-2836(82)90513-7; Kang CH, 2010, EUR J PHARMACOL, V646, P12, DOI 10.1016/j.ejphar.2010.08.001; Kim E, 2007, J MOL BIOL, V373, P1047, DOI 10.1016/j.jmb.2007.08.055; Knollmann BC, 2009, J PHYSIOL-LONDON, V587, P3081, DOI 10.1113/jphysiol.2009.172098; Lee KW, 2012, J BIOL CHEM, V287, P1679, DOI 10.1074/jbc.M111.254045; MacLennan DH, 2009, J PHYSIOL-LONDON, V587, P3113, DOI 10.1113/jphysiol.2009.172155; MacLennan DH, 1998, NAT STRUCT BIOL, V5, P409, DOI 10.1038/nsb0698-409; Meissner G, 2009, J PHYSIOL-LONDON, V587, P3089, DOI 10.1113/jphysiol.2009.171835; Nori A, 2000, EXP CELL RES, V260, P40, DOI 10.1006/excr.2000.4989; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park HJ, 2003, J BIOL CHEM, V278, P16176, DOI 10.1074/jbc.M300120200; Park HJ, 2004, J BIOL CHEM, V279, P18026, DOI 10.1074/jbc.M311553200; Protasi F, 2009, J PHYSIOL-LONDON, V587, P3095, DOI 10.1113/jphysiol.2009.171967; Royer L, 2009, J PHYSIOL-LONDON, V587, P3101, DOI 10.1113/jphysiol.2009.171934; Sanchez EJ, 2012, J BIOL CHEM, V287, P3042, DOI 10.1074/jbc.M111.326363; Sanchez EJ, 2011, MOL CELL BIOCHEM, V353, P195, DOI 10.1007/s11010-011-0787-4; SORIANOGARCIA M, 1992, BIOCHEMISTRY-US, V31, P2554, DOI 10.1021/bi00124a016; Terentyev D, 2006, CIRC RES, V98, P1151, DOI 10.1161/01.RES.0000220647.93982.08; Wang SR, 1998, NAT STRUCT BIOL, V5, P476, DOI 10.1038/nsb0698-476	27	45	48	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11592	11601		10.1074/jbc.M111.335075	http://dx.doi.org/10.1074/jbc.M111.335075			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22337878	Green Published, hybrid			2022-12-25	WOS:000302780100086
J	Horgan, CP; Hanscom, SR; Kelly, EE; McCaffrey, MW				Horgan, Conor P.; Hanscom, Sara R.; Kelly, Eoin E.; McCaffrey, Mary W.			Tumor Susceptibility Gene 101 (TSG101) Is a Novel Binding-Partner for the Class II Rab11-FIPs	PLOS ONE			English	Article							RAB COUPLING PROTEIN; ESCRT MACHINERY; CLEAVAGE FURROW; CYTOKINESIS; COMPLEX; COMPARTMENT; MIDBODY; GTPASES; DIFFERENTIATION; PROLIFERATION	The Rab11-FIPs (Rab11-family interacting proteins; henceforth, FIPs) are a family of Rab11a/Rab11b/Rab25 GTPase effector proteins implicated in an assortment of intracellular trafficking processes. Through proteomic screening, we have identified TSG101 (tumor susceptibility gene 101), a component of the ESCRT-I (endosomal sorting complex required for transport) complex, as a novel FIP4-binding protein, which we find can also bind FIP3. We show that alpha-helical coiled-coil regions of both TSG101 and FIP4 mediate the interaction with the cognate protein, and that point mutations in the coiled-coil regions of both TSG101 and FIP4 abrogate the interaction. We find that expression of TSG101 and FIP4 mutants cause cytokinesis defects, but that the TSG101-FIP4 interaction is not required for localisation of TSG101 to the midbody/Flemming body during abscission. Together, these data suggest functional overlap between Rab11-controlled processes and components of the ESCRT pathway.	[Horgan, Conor P.; Hanscom, Sara R.; Kelly, Eoin E.; McCaffrey, Mary W.] Natl Univ Ireland Univ Coll Cork, BioSci Inst, Dept Biochem, Mol Cell Biol Lab, Cork, Ireland	University College Cork	Horgan, CP (corresponding author), Natl Univ Ireland Univ Coll Cork, BioSci Inst, Dept Biochem, Mol Cell Biol Lab, Cork, Ireland.	m.mccaffrey@ucc.ie			Science Foundation Ireland (SFI);  [08/RFP/NSC 1499];  [05/IN.3/B859, 09/IN.1/B2629]	Science Foundation Ireland (SFI)(Science Foundation Ireland); ; 	This work was supported by Science Foundation Ireland (SFI) Research Frontiers Programme (RFP) and Principal Investigator grants (08/RFP/NSC 1499 and 05/IN.3/B859, 09/IN.1/B2629). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; Bodon G, 2011, J BIOL CHEM; Bruce EA, 2010, J VIROL, V84, P5848, DOI 10.1128/JVI.00307-10; Caballe A, 2011, TRAFFIC, V12, P1318, DOI 10.1111/j.1600-0854.2011.01244.x; Carlton JG, 2008, P NATL ACAD SCI USA, V105, P10541, DOI 10.1073/pnas.0802008105; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Elia N, 2011, P NATL ACAD SCI USA, V108, P4846, DOI 10.1073/pnas.1102714108; Fielding AB, 2005, EMBO J, V24, P3389, DOI 10.1038/sj.emboj.7600803; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Horgan CP, 2007, TRAFFIC, V8, P414, DOI 10.1111/j.1600-0854.2007.00543.x; Horgan Conor P, 2012, Front Biosci (Schol Ed), V4, P547; Horgan CP, 2011, BIOCHEM SOC T, V39, P1202, DOI 10.1042/BST0391202; Horgan CP, 2011, CELL BIOL INT, V35, P171, DOI 10.1042/CBI20100284; Horgan CP, 2010, BIOCHEM BIOPH RES CO, V394, P387, DOI 10.1016/j.bbrc.2010.03.028; Horgan CP, 2010, J CELL SCI, V123, P181, DOI 10.1242/jcs.052670; Horgan CP, 2009, BIOCHEM SOC T, V37, P1032, DOI 10.1042/BST0371032; Horgan CP, 2005, METHOD ENZYMOL, V403, P499, DOI 10.1016/S0076-6879(05)03044-2; Horgan CP, 2004, BIOCHEM BIOPH RES CO, V319, P83, DOI 10.1016/j.bbrc.2004.04.157; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Kelly EE, 2010, BIOL CELL, V102, P51, DOI 10.1042/BC20090068; Krzyzaniak MA, 2009, TRAFFIC, V10, P1439, DOI 10.1111/j.1600-0854.2009.00967.x; Lee HH, 2008, SCIENCE, V322, P576, DOI 10.1126/science.1162042; Lindsay AJ, 2004, FEBS LETT, V571, P86, DOI 10.1016/j.febslet.2004.06.068; Lindsay AJ, 2002, J BIOL CHEM, V277, P12190, DOI 10.1074/jbc.M108665200; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Muto A, 2006, DEV BIOL, V292, P90, DOI 10.1016/j.ydbio.2005.12.050; Muto A, 2007, DEV DYNAM, V236, P214, DOI 10.1002/dvdy.21009; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Schonteich E, 2007, EUR J CELL BIOL, V86, P417, DOI 10.1016/j.ejcb.2007.05.004; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Takahashi S, 2011, GENES CELLS, V16, P938, DOI 10.1111/j.1365-2443.2011.01538.x; Wallace DM, 2002, BIOCHEM BIOPH RES CO, V292, P909, DOI 10.1006/bbrc.2002.6736; Wallace DME, 2002, BIOCHEM BIOPH RES CO, V299, P770, DOI 10.1016/S0006-291X(02)02720-1; Weiss ER, 2011, J MOL BIOL, V410, P525, DOI 10.1016/j.jmb.2011.04.055; Wilcke M, 2000, J CELL BIOL, V151, P1207, DOI 10.1083/jcb.151.6.1207; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wilson GM, 2005, MOL BIOL CELL, V16, P849, DOI 10.1091/mbc.e04-10-0927; Wollert T, 2009, J CELL SCI, V122, P2163, DOI 10.1242/jcs.029884; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Yasuda Jiro, 2005, Uirusu, V55, P281, DOI 10.2222/jsv.55.281	44	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e32030	10.1371/journal.pone.0032030	http://dx.doi.org/10.1371/journal.pone.0032030			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348143	gold, Green Submitted, Green Published			2022-12-25	WOS:000302737400060
J	Jimenez-Lopez, JC; Morales, S; Castro, AJ; Volkmann, D; Rodriguez-Garcia, MI; Alche, JD				Jimenez-Lopez, Jose C.; Morales, Sonia; Castro, Antonio J.; Volkmann, Dieter; Rodriguez-Garcia, Maria I.; de D. Alche, Juan			Characterization of Profilin Polymorphism in Pollen with a Focus on Multifunctionality	PLOS ONE			English	Article							ACTIN-BINDING PROTEIN; GENE FAMILY; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; IMMUNOLOGICAL CHARACTERIZATION; FUNCTIONAL-CHARACTERIZATION; PHOSPHOINOSITIDE 3-KINASE; MULTIGENE FAMILY; PLANT PROFILIN; MAJOR ALLERGEN; CDNA CLONING	Profilin, a multigene family involved in actin dynamics, is a multiple partners-interacting protein, as regard of the presence of at least of three binding domains encompassing actin, phosphoinositide lipids, and poly-L-proline interacting patches. In addition, pollen profilins are important allergens in several species like Olea europaea L. (Ole e 2), Betula pendula (Bet v 2), Phleum pratense (Phl p 12), Zea mays (Zea m 12) and Corylus avellana (Cor a 2). In spite of the biological and clinical importance of these molecules, variability in pollen profilin sequences has been poorly pointed out up until now. In this work, a relatively high number of pollen profilin sequences have been cloned, with the aim of carrying out an extensive characterization of their polymorphism among 24 olive cultivars and the above mentioned plant species. Our results indicate a high level of variability in the sequences analyzed. Quantitative intra-specific/varietal polymorphism was higher in comparison to inter-specific/cultivars comparisons. Multi-optional posttranslational modifications, e.g. phosphorylation sites, physicochemical properties, and partners-interacting functional residues have been shown to be affected by profilin polymorphism. As a result of this variability, profilins yielded a clear taxonomic separation between the five plant species. Profilin family multifunctionality might be inferred by natural variation through profilin isovariants generated among olive germplasm, as a result of polymorphism. The high variability might result in both differential profilin properties and differences in the regulation of the interaction with natural partners, affecting the mechanisms underlying the transmission of signals throughout signaling pathways in response to different stress environments. Moreover, elucidating the effect of profilin polymorphism in adaptive responses like actin dynamics, and cellular behavior, represents an exciting research goal for the future.	[Jimenez-Lopez, Jose C.; Morales, Sonia; Castro, Antonio J.; Rodriguez-Garcia, Maria I.; de D. Alche, Juan] High Council Sci Res, Estac Expt Zaidin, Dept Biochem Cell & Mol Biol Plants, Granada, Spain; [Volkmann, Dieter] Univ Bonn, Dept Plant Cell Biol, Inst Cellular & Mol Bot, Bonn, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); University of Bonn	Jimenez-Lopez, JC (corresponding author), High Council Sci Res, Estac Expt Zaidin, Dept Biochem Cell & Mol Biol Plants, Granada, Spain.	juandedios.alche@eez.csic.es	Rodriguez-Garcia, Maria/K-5833-2014; Castro, Antonio J/K-8091-2014; De Dios Alche, Juan/K-6079-2014; Jimenez-Lopez, Jose C./H-5896-2011	Rodriguez-Garcia, Maria/0000-0002-7664-3235; Castro, Antonio J/0000-0001-6664-8158; De Dios Alche, Juan/0000-0002-7547-6025; Jimenez-Lopez, Jose C./0000-0002-1470-360X	European Regional Development Fund [MCINN BFU 2004-00601/BFI, BFU 2008-00629, BFU2011-2277]; CICE (Junta de Andalucia) [P2010-CVI15767, P2010-AGR6274, P2011-CVI-7487]; coordinated project Spain/Germany [MEC HA2004-0094]; Spanish CSIC	European Regional Development Fund(European Commission); CICE (Junta de Andalucia)(Junta de Andalucia); coordinated project Spain/Germany; Spanish CSIC	This study was supported by the following European Regional Development Fund co-financed grants: MCINN BFU 2004-00601/BFI, BFU 2008-00629, BFU2011-22779, CICE (Junta de Andalucia) P2010-CVI15767, P2010-AGR6274 and P2011-CVI-7487, and by the coordinated project Spain/Germany MEC HA2004-0094. The funders had no role in the study, design or decision to publish.; JCJL and SM thank Spanish CSIC for their respective I3P-CSIC grants. The authors also want to thank Concepcion Martinez for her excellent technical assistance. The authors want to deeply thank the sources of pollen collections in Spain: 1) World olive germplasm bank, CIFA "Alameda del Obispo'' (Junta de Andalucia), Cordoba; 2) Estacion Experimental del Zaidin (CSIC), Granada; 3) Olive Culture Museum, Baeza, Jaen; 4) CIFA "Venta del Llano'', Jaen; and in Germany: The Botanic Garden (Bonn).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aparicio-Fabre R, 2006, PLANT J, V47, P491, DOI 10.1111/j.1365-313X.2006.02787.x; Asturias JA, 1997, J ALLERGY CLIN IMMUN, V100, P365, DOI 10.1016/S0091-6749(97)70250-1; Asturias JA, 2004, J INVEST ALLERG CLIN, V14, P43; Asturias JA, 1997, CLIN EXP ALLERGY, V27, P1307, DOI 10.1111/j.1365-2222.1997.tb01176.x; Baluska F, 2002, TRENDS CELL BIOL, V12, P14, DOI 10.1016/S0962-8924(01)02208-5; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BINDER M, 1995, EUR J BIOCHEM, V233, P976, DOI 10.1111/j.1432-1033.1995.976_3.x; BLASCO R, 1991, J VIROL, V65, P4598, DOI 10.1128/JVI.65.9.4598-4608.1991; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Butler-Cole C, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-76; Chalkia D, 2008, MOL BIOL EVOL, V25, P2717, DOI 10.1093/molbev/msn215; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Deeks MJ, 2002, TRENDS PLANT SCI, V7, P492, DOI 10.1016/S1360-1385(02)02341-5; Di Nardo A, 2000, J CELL SCI, V113, P3795; FEDOROV AA, 1994, P NATL ACAD SCI USA, V91, P8636, DOI 10.1073/pnas.91.18.8636; Fischer S, 1996, J ALLERGY CLIN IMMUN, V98, P189, DOI 10.1016/S0091-6749(96)70242-7; Games P. A., 1976, J EDUCATIONAL STATIS, V1, P113, DOI [10.3102/10769986001002113, DOI 10.2307/1164979]; Gao ZS, 2005, THEOR APPL GENET, V111, P1087, DOI 10.1007/s00122-005-0034-z; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gibbon BC, 1998, PLANT CELL, V10, P981, DOI 10.1105/tpc.10.6.981; GIEHL K, 1994, EUR J BIOCHEM, V226, P681, DOI 10.1111/j.1432-1033.1994.tb20096.x; Guillen G, 1999, PLANT J, V19, P497, DOI 10.1046/j.1365-313X.1999.00542.x; GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HAUGWITZ M, 1991, J CELL SCI, V100, P481; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hess MW, 1997, SEX PLANT REPROD, V10, P283, DOI 10.1007/s004970050099; HONORE B, 1993, FEBS LETT, V330, P151, DOI 10.1016/0014-5793(93)80262-S; Huang SR, 1996, PLANT PHYSIOL, V111, P115, DOI 10.1104/pp.111.1.115; Jeong YM, 2006, PLANT PHYSIOL, V140, P196, DOI 10.1104/pp.105.071316; Jockusch BM, 2007, REV PHYSIOL BIOCH P, V159, P131, DOI 10.1007/112_2007_704; JOCKUSCH BM, 1974, EXP CELL RES, V89, P241, DOI 10.1016/0014-4827(74)90787-3; Kandasamy MK, 2002, CELL MOTIL CYTOSKEL, V52, P22, DOI 10.1002/cm.10029; Kandasamy MK, 2007, PLANT CELL, V19, P3111, DOI 10.1105/tpc.107.052621; Karlsson R, 2007, MOL BIOL INTELL UNIT, P29, DOI 10.1007/978-0-387-46407-7_3; Kovar DR, 2000, PLANT CELL, V12, P583, DOI 10.1105/tpc.12.4.583; Kovar DR, 2001, BIOCHEM J, V358, P49, DOI 10.1042/0264-6021:3580049; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lambrechts A, 1997, EMBO J, V16, P484, DOI 10.1093/emboj/16.3.484; Lambrechts A, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-12; LARSSON H, 1988, BIOCHIM BIOPHYS ACTA, V953, P95, DOI 10.1016/0167-4838(88)90013-1; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; Levene H., 1960, CONTRIBUTIONS PROBAB, P278, DOI DOI 10.1137/1003016; Limmongkon A, 2004, BIOCHEM BIOPH RES CO, V324, P382, DOI 10.1016/j.bbrc.2004.09.071; Lu PJ, 1996, BIOCHEMISTRY-US, V35, P14027, DOI 10.1021/bi961878z; Luan S, 2003, ANNU REV PLANT BIOL, V54, P63, DOI 10.1146/annurev.arplant.54.031902.134743; MACHESKY LM, 1994, BIOCHEMISTRY-US, V33, P10815, DOI 10.1021/bi00201a032; Mahoney NM, 1997, NAT STRUCT BIOL, V4, P953, DOI 10.1038/nsb1197-953; MAZZOTTI G, 1995, J HISTOCHEM CYTOCHEM, V43, P181, DOI 10.1177/43.2.7822774; McDowell JM, 1996, GENETICS, V142, P587; MCLEAN BG, 1990, PLANT CELL, V2, P335, DOI 10.1105/tpc.2.4.335; MCLEAN BG, 1990, CELL MOTIL CYTOSKEL, V17, P276; MEAGHER RB, 1990, CELL MOTIL CYTOSKEL, V16, P164, DOI 10.1002/cm.970160303; MEHTA CR, 1983, J AM STAT ASSOC, V78, P427, DOI 10.2307/2288652; MITTERMANN I, 1995, PLANT MOL BIOL, V27, P137, DOI 10.1007/BF00019185; Pierce J.R., 1980, INTRO INFORM THEORY; Polet D, 2006, CELL MOTIL CYTOSKEL, V63, P14, DOI 10.1002/cm.20102; POLLARD TD, 1991, CELL MOTIL CYTOSKEL, V20, P169, DOI 10.1002/cm.970200209; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Radauer C, 2006, CLIN EXP ALLERGY, V36, P920, DOI 10.1111/j.1365-2222.2006.02521.x; Rallo L., 2005, VARIEDADES OLIVO ESP; Ren HY, 2007, PROTOPLASMA, V230, P171, DOI 10.1007/s00709-006-0231-x; Rihs HP, 1999, J ALLERGY CLIN IMMUN, V104, P1293, DOI 10.1016/S0091-6749(99)70027-8; RIHS HP, 1994, INT ARCH ALLERGY IMM, V105, P190, DOI 10.1159/000236824; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sathish K, 2004, CELL SIGNAL, V16, P589, DOI 10.1016/j.cellsig.2003.10.001; Schluter K, 1998, J CELL SCI, V111, P3261; Schluter K, 1997, BBA-MOL CELL RES, V1359, P97, DOI 10.1016/S0167-4889(97)00100-6; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Skare P, 2002, FEBS LETT, V522, P119, DOI 10.1016/S0014-5793(02)02913-7; Snowman BN, 2002, PLANT CELL, V14, P2613, DOI 10.1105/tpc.002998; SOHN RH, 1994, BIOESSAYS, V16, P465, DOI 10.1002/bies.950160705; Staiger CJ, 2006, CURR OPIN PLANT BIOL, V9, P554, DOI 10.1016/j.pbi.2006.09.013; Staiger CJ, 2000, ANNU REV PLANT PHYS, V51, P257, DOI 10.1146/annurev.arplant.51.1.257; STAIGER CJ, 1993, PLANT J, V4, P631, DOI 10.1046/j.1365-313X.1993.04040631.x; Staiger CJ, 1997, TRENDS PLANT SCI, V2, P275, DOI 10.1016/S1360-1385(97)86350-9; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thorn KS, 1997, STRUCTURE, V5, P19, DOI 10.1016/S0969-2126(97)00163-9; VALENTA R, 1993, J BIOL CHEM, V268, P22777; Vantard M, 2002, CURR OPIN PLANT BIOL, V5, P502, DOI 10.1016/S1369-5266(02)00300-X; Vemuri B, 2001, CELL SIGNAL, V13, P433, DOI 10.1016/S0898-6568(01)00164-4; Vidali L, 1997, CELL MOTIL CYTOSKEL, V36, P323, DOI 10.1002/(SICI)1097-0169(1997)36:4<323::AID-CM3>3.0.CO;2-6; Volkmann D, 1999, MICROSC RES TECHNIQ, V47, P135, DOI 10.1002/(SICI)1097-0029(19991015)47:2<135::AID-JEMT6>3.0.CO;2-1; von Braun SS, 2008, PLANTA, V227, P1151, DOI 10.1007/s00425-007-0688-7; von Witsch M, 1998, EUR J CELL BIOL, V77, P303, DOI 10.1016/S0171-9335(98)80089-7; Wang HY, 2005, PLANTA, V222, P594, DOI 10.1007/s00425-005-0005-2; Wilkies DE, 2003, J EUKARYOT MICROBIOL, V50, P252, DOI 10.1111/j.1550-7408.2003.tb00130.x; Witke W, 2001, P NATL ACAD SCI USA, V98, P3832, DOI 10.1073/pnas.051515498; Wopfner N, 2002, BIOL CHEM, V383, P1779, DOI 10.1515/BC.2002.199	99	25	136	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e30878	10.1371/journal.pone.0030878	http://dx.doi.org/10.1371/journal.pone.0030878			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348028	Green Published, Green Submitted, gold			2022-12-25	WOS:000302737400006
J	Julg, B; Poole, D; Ghebremichael, M; Castilla, C; Altfeld, M; Sunpath, H; Murphy, RA; Walker, BD				Julg, Boris; Poole, Danielle; Ghebremichael, Musie; Castilla, Carmen; Altfeld, Marcus; Sunpath, Henry; Murphy, Richard A.; Walker, Bruce D.			Factors Predicting Discordant Virological and Immunological Responses to Antiretroviral Therapy in HIV-1 Clade C Infected Zulu/Xhosa in South Africa	PLOS ONE			English	Article							CD4 CELL COUNT; 1-INFECTED PATIENTS; RECOVERY; COHORT; SUPPRESSION; INDIVIDUALS; COMMUNITY; OUTCOMES; SEX	Factors predicting suboptimal CD4 cell recovery have been studied in HIV clade-B infected US and European populations. It is, however, uncertain to what extent these results are applicable to HIV clade-C infected African populations. Multivariate analysis using logistic regression and longitudinal analyses using mixed models were employed to assess the impact of age, gender, baseline CD4 cell count, hemoglobin, body mass index (BMI), tuberculosis and other opportunistic co-infections, and frequencies of regimen change on CD4 cell recovery at 12 and 30 months and on overtime change in CD4 cells among 442 virologically suppressed South Africans. Despite adequate virological response 37% (95% CI:32%-42%) and 83% (95% CI:79%-86%) of patients on antiretroviral therapy failed to restore CD4 cell counts >= 200 cells/mm(3) after 12 and >= 500 cells/mm(3) after 30 months, respectively, in this South African cohort. Critical risk factors for inadequate recovery were older age (p = 0.001) and nadir CD4 cell count at ART initiation (p < 0.0001), while concurrent TB co-infection, BMI, baseline hemoglobin, gender and antiretroviral regimen were not significant risk factors. These data suggest that greater efforts are needed to identify and treat HAART-eligible patients prior to severe CD4 cell decline or achievement of advanced age.	[Julg, Boris; Poole, Danielle; Ghebremichael, Musie; Altfeld, Marcus; Walker, Bruce D.] MIT, Ragon Inst MGH, Boston, MA USA; [Julg, Boris; Poole, Danielle; Altfeld, Marcus; Walker, Bruce D.] Univ KwaZulu Natal, HIV Pathogenesis Programme, Doris Duke Med Res Inst, Durban, South Africa; [Julg, Boris; Poole, Danielle; Altfeld, Marcus; Walker, Bruce D.] Univ KwaZulu Natal, KwaZulu Natal Res Inst TB & HIV, Durban, South Africa; [Ghebremichael, Musie] Harvard Univ, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Ghebremichael, Musie] Dana Farber Canc Inst, Boston, MA 02115 USA; [Castilla, Carmen] Univ Med & Dent New Jersey, Newark, NJ 07103 USA; [Sunpath, Henry] McCord Hosp, Durban, South Africa; [Murphy, Richard A.] Doctors Borders, Operat Support Unit, New York, NY USA; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Kwazulu Natal; University of Kwazulu Natal; Harvard University; Harvard University; Dana-Farber Cancer Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Howard Hughes Medical Institute	Julg, B (corresponding author), MIT, Ragon Inst MGH, Boston, MA USA.	bjulg@partners.org	Juelg, Boris/ABA-1955-2020; Altfeld, Marcus/AAE-7306-2019	Juelg, Boris/0000-0002-4687-9626; Altfeld, Marcus/0000-0001-5972-2997; Murphy, Richard/0000-0003-2249-7452	Mark and Lisa Schwartz Foundation; Doris Duke Distinguished Clinical Scientist Award; Howard Hughes Medical Institute; National Institutes of Health [AI30914]; Ragon Institute of MGH, MIT and Harvard; McCord Hospital; CDC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030914, R37AI067073, P30AI060354] Funding Source: NIH RePORTER	Mark and Lisa Schwartz Foundation; Doris Duke Distinguished Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ragon Institute of MGH, MIT and Harvard; McCord Hospital; CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support was provided by the Ragon Institute of MGH, MIT and Harvard, the Mark and Lisa Schwartz Foundation, a Doris Duke Distinguished Clinical Scientist Award to MA, and The Howard Hughes Medical Institute (to BDW). Further support was provided by National Institutes of Health grant AI30914 to BDW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank Roma Maharaj, Ansuri Singh and Fiona Samed from Sinikithemba ARV clinic at McCord hospital for their assistance in the collection of data; we wish to furthermore thank Claire Kerry and the management of McCord Hospital for support of this study. The Sinikithemba ARV clinic at Mc Cord hospital is a PEPFAR and CDC funded programme.	Barnighausen T, 2008, AIDS, V22, P139, DOI 10.1097/QAD.0b013e3282f2ef43; Battegay M, 2006, LANCET INFECT DIS, V6, P280, DOI 10.1016/S1473-3099(06)70463-7; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Chene G, 2003, LANCET, V362, P679, DOI 10.1016/S0140-6736(03)14229-8; Collazos J, 2007, AIDS, V21, P835, DOI 10.1097/QAD.0b013e3280b0774a; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Florence E, 2003, HIV Med, V4, P255, DOI 10.1046/j.1468-1293.2003.00156.x; Gutierrez F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000089; Hughes MD, 1998, AIDS, V12, P1823, DOI 10.1097/00002030-199814000-00014; Hunt PW, 2003, AIDS, V17, P1907, DOI 10.1097/00002030-200309050-00009; Kaufmann GR, 2003, ARCH INTERN MED, V163, P2187, DOI 10.1001/archinte.163.18.2187; Kaufmann GR, 2005, CLIN INFECT DIS, V41, P361, DOI 10.1086/431484; Khanna N, 2008, CLIN INFECT DIS, V47, P1093, DOI 10.1086/592113; Lawn SD, 2009, AIDS, V23, P335, DOI 10.1097/QAD.0b013e328321823f; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Nglazi MD, 2011, JAIDS-J ACQ IMM DEF, V56, pE1, DOI 10.1097/QAI.0b013e3181ff0bdc; Nies-Kraske E, 2009, J INFECT DIS, V199, P1648, DOI 10.1086/598980; Patterson K, 2007, HIV MED, V8, P406, DOI 10.1111/j.1468-1293.2007.00485.x; Sanne IM, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-38; Wanchu A, 2010, INDIAN J PATHOL MICR, V53, P745, DOI 10.4103/0377-4929.72070	22	15	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31161	10.1371/journal.pone.0031161	http://dx.doi.org/10.1371/journal.pone.0031161			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348047	Green Published, gold, Green Submitted			2022-12-25	WOS:000302737400011
J	Lavoie, PM; Ladd, M; Hirschfeld, AF; Huusko, J; Mahlman, M; Speert, DP; Hallman, M; Lacaze-Masmonteil, T; Turvey, SE				Lavoie, Pascal M.; Ladd, Mihoko; Hirschfeld, Aaron F.; Huusko, Johanna; Mahlman, Mari; Speert, David P.; Hallman, Mikko; Lacaze-Masmonteil, Thierry; Turvey, Stuart E.			Influence of Common Non-Synonymous Toll-like Receptor 4 Polymorphisms on Bronchopulmonary Dysplasia and Prematurity in Human Infants	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; HIGH-RISK INFANTS; ASP299GLY POLYMORPHISM; LUNG HYPERPERMEABILITY; GENETIC SUSCEPTIBILITY; TLR4 POLYMORPHISMS; IMMUNE GLOBULIN; YOUNG-CHILDREN; NITRIC-OXIDE; INFECTION	Bronchopulmonary dysplasia (BPD) is a common chronic lung disease and major risk factor for severe respiratory syncytial virus (RSV) infection among preterm infants. The Toll-like receptor 4 (TLR4) is involved in oxidative injury responses in the lungs. Two non-synonymous single nucleotide polymorphisms in the TLR4 gene have been associated with RSV infection in children. However, it is unclear to what extent this association is confounded by BPD or prematurity. In this study, we analyzed two population-based cohorts of preterm infants at risk for BPD as well as ethnicity-matched infants born at term, to test whether the TLR4 polymorphisms Asp299Gly (rs4986790) and Thr399Ile (rs4986791) are independently associated with BPD or premature birth. In a Canadian cohort (n = 269) composed of a majority of Caucasian preterm infants (BPD incidence of 38%), the TLR4-299 heterozygous genotype was significantly under-represented in infants without BPD (1.6% of infants versus 12% in infants with severe BPD) after adjusting for twins, ethnicity, gestational age, birth weight and gender (p = 0.014). This association was not replicated in a Finnish cohort (n = 434) of premature singletons or first-born siblings of Caucasian descent, although the incidence of BPD was substantially lower in this latter population (15%). We did not detect a significant association (>2-fold) between TLR4 genotypes and prematurity (p>0.05). We conclude that these TLR4 genotypes may have, at best, a modest influence on BPD severity in some populations of high-risk preterm infants. Further studies are warranted to clarify how clinical heterogeneity may impact genetic susceptibility to BPD.	[Lavoie, Pascal M.; Ladd, Mihoko; Hirschfeld, Aaron F.; Speert, David P.; Turvey, Stuart E.] Child & Family Res Inst British Columbia, Vancouver, BC, Canada; [Lavoie, Pascal M.] Univ British Columbia, Dept Pediat, Div Neonatol, Vancouver, BC V6T 1W5, Canada; [Speert, David P.; Turvey, Stuart E.] Univ British Columbia, Dept Pediat, Div Infect & Immunol Dis, Vancouver, BC V6T 1W5, Canada; [Huusko, Johanna; Mahlman, Mari; Hallman, Mikko] Oulu Univ, Cent Hosp, SF-90220 Oulu, Finland; [Huusko, Johanna; Mahlman, Mari; Hallman, Mikko] Univ Oulu, Dept Pediat, SF-90100 Oulu, Finland; [Lacaze-Masmonteil, Thierry] Univ Ottawa, Childrens Hosp Eastern Ontario, Ottawa, ON K1N 6N5, Canada	Child & Family Research Institute; University of British Columbia; University of British Columbia; University of Oulu; University of Oulu; University of Ottawa; Children's Hospital of Eastern Ontario	Lavoie, PM (corresponding author), Child & Family Res Inst British Columbia, Vancouver, BC, Canada.	plavoie@cw.bc.ca	Hallman, Niilo/AHD-9810-2022; Huusko, Johanna M/H-9448-2019; Turvey, Stuart/HGV-1191-2022	Lavoie, Pascal/0000-0002-2205-0362; Turvey, Stuart/0000-0003-1599-1065	British Columbia Lung Association; Canadian Institutes of Health Research; Finnish Academy; Sigrid Juselius Foundation; Canadian Child Health Clinician-Scientist Program; Michael Smith Foundation for Health Research	British Columbia Lung Association; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Finnish Academy(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Canadian Child Health Clinician-Scientist Program; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This study was funded by the British Columbia Lung Association (to PML), the Canadian Institutes of Health Research (to DPS), the Finnish Academy and the Sigrid Juselius Foundation (to MH). PML and SET acknowledge support from Canadian Child Health Clinician-Scientist Program and the Michael Smith Foundation for Health Research. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambalavanan N, 2011, PEDIATRICS, V127, pE106, DOI 10.1542/peds.2010-0648; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Armstrong L, 2004, AM J RESP CELL MOL, V31, P241, DOI 10.1165/rcmb.2004-0078OC; Awomoyi AA, 2007, J IMMUNOL, V179, P3171, DOI 10.4049/jimmunol.179.5.3171; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; Bhandari V, 2006, PEDIATRICS, V117, P1901, DOI 10.1542/peds.2005-1414; Boyce TG, 2000, J PEDIATR-US, V137, P865, DOI 10.1067/mpd.2000.110531; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Connor E, 1997, PEDIATRICS, V99, P93; Douville RN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012087; Goetghebuer T, 2004, PEDIATR PULM, V38, P321, DOI 10.1002/ppul.20069; GROOTHUIS JR, 1993, NEW ENGL J MED, V329, P1524, DOI 10.1056/NEJM199311183292102; Haynes LM, 2001, J VIROL, V75, P10730, DOI 10.1128/JVI.75.22.10730-10737.2001; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kamal-Bahl S, 2002, ARCH PEDIAT ADOL MED, V156, P1034, DOI 10.1001/archpedi.156.10.1034; Kleeberger SR, 2000, AM J RESP CELL MOL, V22, P620, DOI 10.1165/ajrcmb.22.5.3912; Kleeberger SR, 2001, AM J PHYSIOL-LUNG C, V280, pL326, DOI 10.1152/ajplung.2001.280.2.L326; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Lavoie PM, 2008, PEDIATRICS, V122, P479, DOI 10.1542/peds.2007-2313; Lavoie PM, 2010, CURR OPIN PEDIATR, V22, P134, DOI 10.1097/MOP.0b013e328336eb85; Lofgren J, 2010, PEDIATR PULM, V45, P687, DOI 10.1002/ppul.21248; Lorenz E, 2002, PEDIATR RES, V52, P373, DOI 10.1203/01.PDR.0000025342.83436.53; Mercier JC, 2010, LANCET, V376, P346, DOI 10.1016/S0140-6736(10)60664-2; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Paulus SC, 2007, CLIN IMMUNOL, V123, P252, DOI 10.1016/j.clim.2007.03.003; Puthothu B, 2006, DIS MARKERS, V22, P303, DOI 10.1155/2006/865890; Qureshi ST, 2006, J IMMUNOL, V176, P4950, DOI 10.4049/jimmunol.176.8.4950; Rallabhandi P, 2006, J IMMUNOL, V177, P322, DOI 10.4049/jimmunol.177.1.322; Redline RW, 2003, PEDIATR DEVEL PATHOL, V6, P435, DOI 10.1007/s10024-003-7070-y; Rey G, 2008, MOL HUM REPROD, V14, P555, DOI 10.1093/molehr/gan049; Schanzer DL, 2006, PEDIATR INFECT DIS J, V25, P795, DOI 10.1097/01.inf.0000232632.86800.8c; Tal G, 2004, J INFECT DIS, V189, P2057, DOI 10.1086/420830; Tulic MK, 2007, J IMMUNOL, V179, P132, DOI 10.4049/jimmunol.179.1.132; Zhang XC, 2005, J IMMUNOL, V175, P4834, DOI 10.4049/jimmunol.175.8.4834	34	16	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31351	10.1371/journal.pone.0031351	http://dx.doi.org/10.1371/journal.pone.0031351			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348075	gold, Green Submitted, Green Published			2022-12-25	WOS:000302737400017
J	Lundwall, RA; Guo, DC; Dannemiller, JL				Lundwall, Rebecca A.; Guo, Dong-Chuan; Dannemiller, James L.			Exogenous Visual Orienting Is Associated with Specific Neurotransmitter Genetic Markers: A Population-Based Genetic Association Study	PLOS ONE			English	Article							DOPAMINE-BETA-HYDROXYLASE; APOLIPOPROTEIN-E; VISUOSPATIAL ATTENTION; STRATIFICATION; POLYMORPHISMS; GENOTYPE; ADHD; BIAS; HERITABILITY; THREAT	Background: Currently, there is a sense that the spatial orienting of attention is related to genotypic variations in cholinergic genes but not to variations in dopaminergic genes. However, reexamination of associations with both cholinergic and dopaminergic genes is warranted because previous studies used endogenous rather than exogenous cues and costs and benefits were not analyzed separately. Examining costs (increases in response time following an invalid pre-cue) and benefits (decreases in response time following a valid pre-cue) separately could be important if dopaminergic genes (implicated in disorders such as attention deficit disorder) independently influence the different processes of orienting (e.g., disengage, move, engage). Methodology/Principal Findings: We tested normal subjects (N = 161) between 18 and 61 years. Participants completed a computer task in which pre-cues preceded the presence of a target. Subjects responded (with a key press) to the location of the target (right versus left of fixation). The cues could be valid (i.e., appear where the target would appear) or invalid (appear contralateral to where the target would appear). DNA sequencing assays were performed on buccal cells to genotype known genetic markers and these were examined for association with task scores. Here we show significant associations between visual orienting and genetic markers (on COMT, DAT1, and APOE; R(2)s from 4% to 9%). Conclusions/Significance: One measure in particular - the response time cost of a single dim, invalid cue - was associated with dopaminergic markers on COMT and DAT1. Additionally, variations of APOE genotypes based on the epsilon 2/epsilon 3/epsilon 4 alleles were also associated with response time differences produced by simultaneous cues with unequal luminances. We conclude that individual differences in visual orienting are related to several dopaminergic markers as well as to a cholinergic marker. These results challenge the view that orienting is not associated with genotypic variation in dopaminergic genes.	[Lundwall, Rebecca A.; Dannemiller, James L.] Rice Univ, Dept Psychol, Houston, TX 77251 USA; [Guo, Dong-Chuan] Univ Texas Hlth Sci Ctr, Dept Internal Med, Houston, TX USA	Rice University; University of Texas System; University of Texas Health Science Center Houston	Lundwall, RA (corresponding author), Rice Univ, Dept Psychol, Houston, TX 77251 USA.	beckylundwall@rice.edu	Lundwall, Rebecca/K-2506-2013	Lundwall, Rebecca/0000-0003-4036-9091	Rice Graduate Student Research Fellowship; Center for Clinical and Translational Science [UL1 RR024148]; Lynette S. Autrey Research grant; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER	Rice Graduate Student Research Fellowship; Center for Clinical and Translational Science; Lynette S. Autrey Research grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by a Rice Graduate Student Research Fellowship to RAL, a grant from the Center for Clinical and Translational Science: (UL1 RR024148) to DCG, and a Lynette S. Autrey Research grant to JLD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnsten AFT, 2009, CNS DRUGS, V23, P33, DOI 10.2165/00023210-200923000-00005; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Bellgrove MA, 2007, MOL PSYCHIATR, V12, P786, DOI 10.1038/sj.mp.4002022; Blasi G, 2005, J NEUROSCI, V25, P5038, DOI 10.1523/JNEUROSCI.0476-05.2005; Brookes KJ, 2007, AM J MED GENET B, V144B, P1070, DOI 10.1002/ajmg.b.30572; Caporaso NE, 2002, CANCER EPIDEM BIOMAR, V11, P1544; Cubells JF, 1997, AM J MED GENET, V74, P374, DOI 10.1002/(SICI)1096-8628(19970725)74:4<374::AID-AJMG7>3.0.CO;2-P; Espeseth T, 2006, COGN AFFECT BEHAV NE, V6, P31, DOI 10.3758/CABN.6.1.31; Fan J, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-14; Fossella J, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-14; Gabay S, 2010, PSYCHON B REV, V17, P47, DOI 10.3758/PBR.17.1.47; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; GIROS B, 1992, MOL PHARMACOL, V42, P383; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Green AE, 2008, NAT REV NEUROSCI, V9, P710, DOI 10.1038/nrn2461; Greenwood PM, 2000, P NATL ACAD SCI USA, V97, P11661, DOI 10.1073/pnas.97.21.11661; Hegele RA, 2002, ARTERIOSCL THROM VAS, V22, P1058, DOI 10.1161/01.ATV.0000026801.56080.14; Hill A.B., 1971, PRINCIPLES MED STAT; Hubacek JA, 2008, EUR J HUM GENET, V16, P135, DOI 10.1038/sj.ejhg.5201941; Hutchison KE, 2004, PSYCHOL BULL, V130, P66, DOI 10.1037/0033-2909.130.1.66; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kean M, 2003, BRIT J PSYCHOL, V94, P373, DOI 10.1348/000712603767876280; Khlat M, 2004, CANCER EPIDEM BIOMAR, V13, P1660; Kim CH, 2002, AM J MED GENET, V108, P140, DOI 10.1002/ajmg.10196; Kirley A, 2002, NEUROPSYCHOPHARMACOL, V27, P607; Kopeckova M, 2006, FOLIA BIOL-PRAGUE, V52, P194; Landry R, 2004, J CHILD PSYCHOL PSYC, V45, P1115, DOI 10.1111/j.1469-7610.2004.00304.x; Long AD, 1999, GENOME RES, V9, P720; Lowe N, 2004, AM J MED GENET B, V131B, P33, DOI 10.1002/ajmg.b.30071; LUCE RD, 1972, PSYCHOL REV, V79, P14, DOI 10.1037/h0031867; NISSEN MJ, 1977, PERCEPT PSYCHOPHYS, V22, P338, DOI 10.3758/BF03199699; Oie M, 1998, SCHIZOPHR RES, V34, P195, DOI 10.1016/S0920-9964(98)00092-9; Parasuraman R, 2005, PSYCHOL SCI, V16, P200, DOI 10.1111/j.0956-7976.2005.00804.x; Parasuraman R, 2002, NEUROPSYCHOLOGY, V16, P254, DOI 10.1037//0894-4105.16.2.254; PARASURAMAN R, 1992, BRAIN, V115, P711, DOI 10.1093/brain/115.3.711; Penn HE, 2006, CHILD NEUROPSYCHOL, V12, P57, DOI 10.1080/09297040500253546; Poirier J, 1996, J PSYCHIATR NEUROSCI, V21, P128; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1984, J NEUROSCI, V4, P1863; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Rastelli F, 2008, EXP BRAIN RES, V187, P439, DOI 10.1007/s00221-008-1316-x; Rihet P, 2002, PSYCHOPHARMACOLOGY, V163, P62, DOI 10.1007/s00213-002-1127-x; Rommelse NNJ, 2008, AM J MED GENET B, V147B, P1536, DOI 10.1002/ajmg.b.30848; Sarter M, 1999, ANN NY ACAD SCI, V877, P368, DOI 10.1111/j.1749-6632.1999.tb09277.x; SOKOLOV EN, 1963, ANNU REV PHYSIOL, V25, P545, DOI 10.1146/annurev.ph.25.030163.002553; Starr JM, 2007, NEUROSCI LETT, V421, P57, DOI 10.1016/j.neulet.2007.05.023; Swanson J, 2001, CLIN NEUROSCI RES, V1, P207, DOI 10.1016/S1566-2772(01)00007-X; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P513; Wang YT, 2006, CANCER EPIDEM BIOMAR, V15, P124, DOI 10.1158/1055-9965.EPI-05-0304; Waszak F, 2010, DEV PSYCHOL, V46, P337, DOI 10.1037/a0018541; Wright RD, 1995, CAN J EXP PSYCHOL, V49, P540, DOI 10.1037/1196-1961.49.4.540; Zhang DQ, 2007, J NEUROSCI, V27, P692, DOI 10.1523/JNEUROSCI.4478-06.2007; Zhao YQ, 2001, NEUROREPORT, V12, P2939, DOI 10.1097/00001756-200109170-00037	53	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e30731	10.1371/journal.pone.0030731	http://dx.doi.org/10.1371/journal.pone.0030731			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	925CF	22348020	gold, Green Published, Green Submitted			2022-12-25	WOS:000302737400004
J	Madaro, L; Pelle, A; Nicoletti, C; Crupi, A; Marrocco, V; Bossi, G; Soddu, S; Bouche, M				Madaro, Luca; Pelle, Andrea; Nicoletti, Carmine; Crupi, Annunziata; Marrocco, Valeria; Bossi, Gianluca; Soddu, Silvia; Bouche, Marina			PKC Theta Ablation Improves Healing in a Mouse Model of Muscular Dystrophy	PLOS ONE			English	Article							SKELETAL-MUSCLE FIBERS; MDX MICE; GENE-EXPRESSION; INSULIN-RESISTANCE; T-LYMPHOCYTES; ACTIVATION; PATHWAY; CELLS; DEGENERATION; INHIBITION	Inflammation is a key pathological characteristic of dystrophic muscle lesion formation, limiting muscle regeneration and resulting in fibrotic and fatty tissue replacement of muscle, which exacerbates the wasting process in dystrophic muscles. Limiting immune response is thus one of the therapeutic options to improve healing, as well as to improve the efficacy of gene- or cell-mediated strategies to restore dystrophin expression. Protein kinase C theta (PKC theta) is a member of the PKCs family highly expressed in both immune cells and skeletal muscle; given its crucial role in adaptive, but also innate, immunity, it is being proposed as a valuable pharmacological target for immune disorders. In our study we asked whether targeting PKC theta could represent a valuable approach to efficiently prevent inflammatory response and disease progression in a mouse model of muscular dystrophy. We generated the bi-genetic mouse model mdx/theta(-/-), where PKC theta expression is lacking in mdx mice, the mouse model of Duchenne muscular dystrophy. We found that muscle wasting in mdx/theta(-/-) mice was greatly prevented, while muscle regeneration, maintenance and performance was significantly improved, as compared to mdx mice. This phenotype was associated to reduction in inflammatory infiltrate, pro-inflammatory gene expression and pro-fibrotic markers activity, as compared to mdx mice. Moreover, BM transplantation experiments demonstrated that the phenotype observed was primarily dependent on lack of PKC theta expression in hematopoietic cells. These results demonstrate a hitherto unrecognized role of immune-cell intrinsic PKC theta activity in the development of DMD. Although the immune cell population(s) involved remain unidentified, our findings reveal that PKC theta can be proposed as a new pharmacological target to counteract the disease, as well as to improve the efficacy of gene- or cell- therapy approaches.	[Madaro, Luca; Pelle, Andrea; Nicoletti, Carmine; Crupi, Annunziata; Marrocco, Valeria; Bouche, Marina] Sapienza Univ, DAHFMO, Unit Histol, Rome, Italy; [Madaro, Luca; Pelle, Andrea; Nicoletti, Carmine; Crupi, Annunziata; Marrocco, Valeria; Bouche, Marina] Sapienza Univ, DAHFMO, IIM, Rome, Italy; [Bossi, Gianluca; Soddu, Silvia] Regina Elena Inst Canc Res, Dept Expt Oncol, Rome, Italy	Sapienza University Rome; Sapienza University Rome; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Madaro, L (corresponding author), Sapienza Univ, DAHFMO, Unit Histol, Rome, Italy.	marina.bouche@uniroma1.it	Bossi, Gianluca/B-9394-2017; Soddu, Silvia/K-2467-2018; Madaro, Luca/ABE-4683-2021; Bossi, Gianluca/G-8375-2016; Madaro, Luca/K-4629-2016; Bossi, Gianluca/ABH-6846-2020; Soddu, Silvia/ABH-6774-2020; Sampaolesi, Maurilio/H-6509-2013	Bossi, Gianluca/0000-0002-2947-1063; Soddu, Silvia/0000-0001-8526-0044; Madaro, Luca/0000-0003-0839-5724; Bossi, Gianluca/0000-0002-2947-1063; Madaro, Luca/0000-0003-0839-5724; Bossi, Gianluca/0000-0002-2947-1063; Soddu, Silvia/0000-0001-8526-0044; NICOLETTI, Carmine/0000-0001-5896-2040; Bouche, Marina/0000-0002-0938-5360; Sampaolesi, Maurilio/0000-0002-2422-3757; Crupi, Annunziata/0000-0002-5582-0749	Italian Ministry for University and Research; Sapienza University of Rome; French Association against Myopathies; Italian Space Agency; Duchenne Parent Project, Netherland, Fellowship	Italian Ministry for University and Research(Ministry of Education, Universities and Research (MIUR)); Sapienza University of Rome; French Association against Myopathies; Italian Space Agency(Agenzia Spaziale Italiana (ASI)); Duchenne Parent Project, Netherland, Fellowship	This work was supported by the Italian Ministry for University and Research, by the Sapienza University of Rome, by the French Association against Myopathies and by the Italian Space Agency. Dr. Madaro is recipient of a Duchenne Parent Project, Netherland, Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Baier G, 2003, IMMUNOL REV, V192, P64, DOI 10.1034/j.1600-065X.2003.00018.x; Baier G, 2009, CURR OPIN CELL BIOL, V21, P262, DOI 10.1016/j.ceb.2008.12.008; Balaban B, 2005, AM J PHYS MED REHAB, V84, P843, DOI 10.1097/01.phm.0000184156.98671.d0; Boschelli DH, 2009, CURR TOP MED CHEM, V9, P640, DOI 10.2174/156802609789007372; Consalvi S, 2011, MOL MED; Cooles FA, 2011, CURR OPIN RHEUMATOL; D'Andrea M, 2006, J CELL PHYSIOL, V207, P379, DOI 10.1002/jcp.20585; Eghtesad S, 2011, MOL MED; Ekmark M, 2003, J PHYSIOL-LONDON, V548, P259, DOI 10.1113/jphysiol.2002.036228; Evans NP, 2009, PM&R, V1, P755, DOI 10.1016/j.pmrj.2009.04.010; Evans NP, 2009, AM J PHYS MED REHAB, V88, P502, DOI 10.1097/PHM.0b013e3181a5a24f; Gao ZG, 2007, AM J PHYSIOL-ENDOC M, V292, pE84, DOI 10.1152/ajpendo.00178.2006; Goyenvalle A, 2010, MOL THER, V18, P198, DOI 10.1038/mt.2009.248; Hodgetts S, 2006, NEUROMUSCULAR DISORD, V16, P591, DOI 10.1016/j.nmd.2006.06.011; Iwata Y, 2009, HUM MOL GENET, V18, P824, DOI 10.1093/hmg/ddn408; Keeling RM, 2007, MUSCLE NERVE, V35, P43, DOI 10.1002/mus.20646; Kumar A, 2004, FASEB J, V18, P102, DOI 10.1096/fj.03-0453com; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; Kumar A, 2010, AM J PATHOL, V177, P248, DOI 10.2353/ajpath.2010.091176; Kwon Myung-Ja, 2010, Endocrine Metabolic & Immune Disorders-Drug Targets, V10, P367; Madaro L, 2011, MOL BIOL CELL, V22, P1409, DOI 10.1091/mbc.E10-10-0821; Mendell JR, 2010, NEW ENGL J MED, V363, P1429, DOI 10.1056/NEJMoa1000228; Messina G, 2010, CELL, V140, P554, DOI 10.1016/j.cell.2010.01.027; Messina S, 2006, EXP NEUROL, V198, P234, DOI 10.1016/j.expneurol.2005.11.021; Messina S, 2009, EXP NEUROL, V220, P349, DOI 10.1016/j.expneurol.2009.09.015; Odom GL, 2011, MOL THER, V19, P36, DOI 10.1038/mt.2010.205; Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039; Serra C, 2003, J CELL PHYSIOL, V196, P89, DOI 10.1002/jcp.10278; Siu PM, 2004, J APPL PHYSIOL, V97, P277, DOI 10.1152/japplphysiol.00534.2004; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Sutcliffe EL, 2011, MOL CELL, V41, P704, DOI 10.1016/j.molcel.2011.02.030; Tang Y, 2010, GENE THER, V17, P1476, DOI 10.1038/gt.2010.110; Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373; Tokugawa S, 2009, NEUROPATHOLOGY, V29, P211, DOI 10.1111/j.1440-1789.2008.00967.x; Vidal B, 2008, GENE DEV, V22, P1747, DOI 10.1101/gad.465908; Zanin-Zhorov A, 2010, SCIENCE, V328, P372, DOI 10.1126/science.1186068	37	34	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31515	10.1371/journal.pone.0031515	http://dx.doi.org/10.1371/journal.pone.0031515			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348094	gold, Green Published, Green Submitted			2022-12-25	WOS:000302737400026
J	Ohuchi, H; Yamashita, T; Tomonari, S; Fujita-Yanagibayashi, S; Sakai, K; Noji, S; Shichida, Y				Ohuchi, Hideyo; Yamashita, Takahiro; Tomonari, Sayuri; Fujita-Yanagibayashi, Sari; Sakai, Kazumi; Noji, Sumihare; Shichida, Yoshinori			A Non-Mammalian Type Opsin 5 Functions Dually in the Photoreceptive and Non-Photoreceptive Organs of Birds	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; MAMMALIAN NEURAL TISSUE; JAPANESE-QUAIL; CHICKEN RETINA; ARGININE-VASOTOCIN; ADRENAL-GLAND; AVIAN BRAIN; EXPRESSION; RHODOPSIN; NEURONS	A mammalian type opsin 5 (neuropsin) is a recently identified ultraviolet (UV)-sensitive pigment of the retina and other photosensitive organs in birds. Two other opsin 5-related molecules have been found in the genomes of non-mammalian vertebrates. However, their functions have not been examined as yet. Here, we identify the molecular properties of a second avian opsin 5, cOpn5L2 (chicken opsin 5-like 2), and its localization in the post-hatch chicken. Spectrophotometric analysis and radionucleotide-binding assay have revealed that cOpn5L2 is a UV-sensitive bistable pigment that couples with the Gi subtype of guanine nucleotide-binding protein (G protein). As a bistable pigment, it also shows the direct binding ability to agonist all-trans-retinal to activate G protein. The absorption maxima of UV-light-absorbing and visible light-absorbing forms were 350 and 521 nm, respectively. Expression analysis showed relatively high expression of cOpn5L2 mRNA in the adrenal gland, which is not photoreceptive but an endocrine organ, while lower expression was found in the brain and retina. At the protein level, cOpn5L2 immunoreactive cells were present in the chromaffin cells of the adrenal gland. In the brain, cOpn5L2 immunoreactive cells were found in the paraventricular and supraoptic nuclei of the anterior hypothalamus, known for photoreceptive deep brain areas. In the retina, cOpn5L2 protein was localized to subsets of cells in the ganglion cell layer and the inner nuclear layer. These results suggest that the non-mammalian type opsin 5 (Opn5L2) functions as a second UV sensor in the photoreceptive organs, while it might function as chemosensor using its direct binding ability to agonist all-trans-retinal in non-photoreceptive organs such as the adrenal gland of birds.	[Ohuchi, Hideyo; Tomonari, Sayuri; Noji, Sumihare] Univ Tokushima, Inst Sci & Technol, Grad Sch, Dept Life Syst, Tokushima 770, Japan; [Yamashita, Takahiro; Fujita-Yanagibayashi, Sari; Sakai, Kazumi; Shichida, Yoshinori] Kyoto Univ, Dept Biophys, Grad Sch Sci, Kyoto, Japan	Tokushima University; Kyoto University	Ohuchi, H (corresponding author), Univ Tokushima, Inst Sci & Technol, Grad Sch, Dept Life Syst, Tokushima 770, Japan.	hohuchi@bio.tokushima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [A06]; MEXT, Japan [22657057]; Takeda Science Foundation;  [20227002];  [21026019];  [23770074]	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); ; ; 	This work was supported in part by Grants-in-Aid for Scientific Research (grant numbers, 20227002, 21026019, 23770074) and the Global Center of Excellence Program (A06) "Formation of a Strategic Base for Biodiversity and Evolutionary Research: From Genome to Ecosystem" of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan to TY, YS, and by a Grant-in-Aid for Challenging Exploratory Research of MEXT, Japan to HO, SN (22657057), and Takeda Science Foundation to TY (http://www.takeda-sci.or.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 1996, J BIOL CHEM, V271, P25406, DOI 10.1074/jbc.271.41.25406; Ball GF, 2008, PHILOS T R SOC B, V363, P231, DOI 10.1098/rstb.2007.2137; Bumsted-O'Brien KM, 2007, J COMP NEUROL, V505, P58, DOI 10.1002/cne.21458; Chaturvedi CM, 2000, GEN COMP ENDOCR, V117, P129, DOI 10.1006/gcen.1999.7400; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; COHEN GB, 1993, BIOCHEMISTRY-US, V32, P6111, DOI 10.1021/bi00074a024; D'Hondt E, 2000, BRAIN RES, V856, P55, DOI 10.1016/S0006-8993(99)02271-4; ERANKO O, 1957, NATURE, V179, P417, DOI 10.1038/179417b0; FARNER DS, 1980, ANNU REV PHYSIOL, V42, P457, DOI 10.1146/annurev.ph.42.030180.002325; Fernald RD, 2006, SCIENCE, V313, P1914, DOI 10.1126/science.1127889; Flanagan CA, 2005, MOL PHARMACOL, V68, P1, DOI 10.1124/mol.105.014183; FOSTER RG, 1988, CELL TISSUE RES, V253, P327, DOI 10.1007/BF00222289; FRANKE RR, 1992, J BIOL CHEM, V267, P14767; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Halford S, 2009, CURR BIOL, V19, P1396, DOI 10.1016/j.cub.2009.06.066; Jaliffa CO, 2001, BRAIN RES, V912, P195, DOI 10.1016/S0006-8993(01)02736-6; Jurkevich A, 2003, DOMEST ANIM ENDOCRIN, V25, P93, DOI 10.1016/S0739-7240(03)00048-1; KAZULA A, 1993, VISUAL NEUROSCI, V10, P621, DOI 10.1017/S0952523800005320; Kober AKMH, 2010, POULTRY SCI, V89, P1709, DOI 10.3382/ps.2009-00588; KUENZEL WJ, 1993, POULTRY SCI, V72, P959, DOI 10.3382/ps.0720959; LAMB TD, 1995, VISION RES, V35, P3083, DOI 10.1016/0042-6989(95)00114-F; LEE E, 1994, METHOD ENZYMOL, V237, P146; MILLAR T, 1985, NEUROSCI LETT, V61, P311, DOI 10.1016/0304-3940(85)90482-3; Nakane Y, 2010, P NATL ACAD SCI USA, V107, P15264, DOI 10.1073/pnas.1006393107; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; Sanchez-Guardado LO, 2011, DEV DYNAM, V240, P1475, DOI 10.1002/dvdy.22621; Panzica GC, 2001, BRAIN RES REV, V37, P178, DOI 10.1016/S0165-0173(01)00118-7; Prakobsaeng N, 2011, GEN COMP ENDOCR, V171, P189, DOI 10.1016/j.ygcen.2011.01.007; Puelles L., 2007, CHICK BRAIN STEREOTA, V1st; de Lima LHRG, 2011, CHRONOBIOL INT, V28, P89, DOI 10.3109/07420528.2010.540685; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; SANNA PP, 1992, NEUROSCIENCE, V47, P745, DOI 10.1016/0306-4522(92)90182-2; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shen WL, 2011, SCIENCE, V331, P1333, DOI 10.1126/science.1198904; Shichida Y, 2009, PHILOS T R SOC B, V364, P2881, DOI 10.1098/rstb.2009.0051; Singh S, 2006, COMP BIOCHEM PHYS A, V143, P202, DOI 10.1016/j.cbpa.2005.11.022; Stanke JJ, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-13; Tarttelin EE, 2003, FEBS LETT, V554, P410, DOI 10.1016/S0014-5793(03)01212-2; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Tomonari S, 2008, DEV DYNAM, V237, P1910, DOI 10.1002/dvdy.21611; Tsutsui K, 2007, BIOCHEMISTRY-US, V46, P6437, DOI 10.1021/bi7003763; VANGILS J, 1993, J COMP NEUROL, V334, P304, DOI 10.1002/cne.903340211; Vigh B, 2004, HISTOL HISTOPATHOL, V19, P607, DOI 10.14670/HH-19.607; Yamashita T, 2000, J BIOL CHEM, V275, P34272, DOI 10.1074/jbc.M002954200; Yamashita T, 2010, P NATL ACAD SCI USA, V107, P22084, DOI 10.1073/pnas.1012498107	47	30	31	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31534	10.1371/journal.pone.0031534	http://dx.doi.org/10.1371/journal.pone.0031534			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348098	Green Published, Green Submitted, gold			2022-12-25	WOS:000302737400030
J	Otsuka, N; Han, HJ; Toyoizumi-Ajisaka, H; Nakamura, Y; Arakawa, Y; Shibayama, K; Kamachi, K				Otsuka, Nao; Han, Hyun-Ja; Toyoizumi-Ajisaka, Hiromi; Nakamura, Yukitsugu; Arakawa, Yoshichika; Shibayama, Keigo; Kamachi, Kazunari			Prevalence and Genetic Characterization of Pertactin-Deficient Bordetella pertussis in Japan	PLOS ONE			English	Article							VIRULENCE FACTORS; CONTROLLED-TRIAL; ANTIGENIC VARIATION; ANTIBODIES; SECRETION; VACCINES; STRAINS; TOXIN; PARAPERTUSSIS; POLYMORPHISM	The adhesin pertactin (Prn) is one of the major virulence factors of Bordetella pertussis, the etiological agent of whooping cough. However, a significant prevalence of Prn-deficient (Prn(-)) B. pertussis was observed in Japan. The Prn(-) isolate was first discovered in 1997, and 33 (27%) Prn(-) isolates were identified among 121 B. pertussis isolates collected from 1990 to 2009. Sequence analysis revealed that all the Prn(-) isolates harbor exclusively the vaccine-type prn1 allele and that loss of Prn expression is caused by 2 different mutations: an 84-bp deletion of the prn signal sequence (prn1 Delta SS, n = 24) and an IS481 insertion in prn1 (prn1::IS481, n = 9). The frequency of Prn(-) isolates, notably those harboring prn1 Delta SS, significantly increased since the early 2000s, and Prn(-) isolates were subsequently found nationwide. Multilocus variable-number tandem repeat analysis (MLVA) revealed that 24 (73%) of 33 Prn(-) isolates belong to MLVA-186, and 6 and 3 Prn(-) isolates belong to MLVA-194 and MLVA-226, respectively. The 3 MLVA types are phylogenetically closely related, suggesting that the 2 Prn(-) clinical strains (harboring prn1 Delta SS and prn1::IS481) have clonally expanded in Japan. Growth competition assays in vitro also demonstrated that Prn(-) isolates have a higher growth potential than the Prn(+) back-mutants from which they were derived. Our observations suggested that human host factors (genetic factors and immune status) that select for Prn(-) strains have arisen and that Prn expression is not essential for fitness under these conditions.	[Otsuka, Nao; Han, Hyun-Ja; Toyoizumi-Ajisaka, Hiromi; Nakamura, Yukitsugu; Arakawa, Yoshichika; Shibayama, Keigo; Kamachi, Kazunari] Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan	National Institute of Infectious Diseases (NIID)	Otsuka, N (corresponding author), Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan.	kamachi@nih.go.jp	Arakawa, Yoshichika/P-5997-2015	Kamachi, Kazunari/0000-0001-5259-1744	Ministry of Health, Labor and Welfare of Japan [09158691, 09158699]	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This research was supported by grants for Research on Emerging and Re-emerging Infectious Diseases (09158691 and 09158699) from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOYAMA T, 1986, J CLIN MICROBIOL, V23, P1046, DOI 10.1128/JCM.23.6.1046-1048.1986; Bassinet L, 2000, INFECT IMMUN, V68, P1934, DOI 10.1128/IAI.68.4.1934-1941.2000; Bouchez V, 2011, CLIN MICROBIOL INFEC, V17, P675, DOI 10.1111/j.1469-0691.2010.03303.x; Bouchez V, 2009, VACCINE, V27, P6034, DOI 10.1016/j.vaccine.2009.07.074; Bouchez V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002437; Caro V, 2006, MICROBES INFECT, V8, P2228, DOI 10.1016/j.micinf.2006.04.014; Cassiday P, 2000, J INFECT DIS, V182, P1402, DOI 10.1086/315881; Cherry JD, 1997, PEDIATR INFECT DIS J, V16, pS90, DOI 10.1097/00006454-199704001-00004; Doulatov S, 2004, NATURE, V431, P476, DOI 10.1038/nature02833; Greco D, 1996, NEW ENGL J MED, V334, P341, DOI 10.1056/NEJM199602083340601; Gustafsson L, 1996, NEW ENGL J MED, V334, P349, DOI 10.1056/NEJM199602083340602; Han HJ, 2008, VACCINE, V26, P1530, DOI 10.1016/j.vaccine.2008.01.020; Han HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017797; Heikkinen E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000904; Hellwig SMM, 2003, J INFECT DIS, V188, P738, DOI 10.1086/377283; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; Hewlett EL, 2005, NEW ENGL J MED, V352, P1215, DOI 10.1056/NEJMcp041025; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; Inatsuka CS, 2010, INFECT IMMUN, V78, P2901, DOI 10.1128/IAI.00188-10; Junker M, 2006, P NATL ACAD SCI USA, V103, P4918, DOI 10.1073/pnas.0507923103; Kallonen T, 2009, EXPERT REV VACCINES, V8, P863, DOI [10.1586/erv.09.46, 10.1586/ERV.09.46]; Kodama A, 2004, J CLIN MICROBIOL, V42, P5453, DOI 10.1128/JCM.42.12.5453-5457.2004; Kurniawan J, 2010, EMERG INFECT DIS, V16, P297, DOI 10.3201/eid1602.081707; LEININGER E, 1992, INFECT IMMUN, V60, P2380, DOI 10.1128/IAI.60.6.2380-2385.1992; LEININGER E, 1991, P NATL ACAD SCI USA, V88, P345, DOI 10.1073/pnas.88.2.345; Litt DJ, 2009, J CLIN MICROBIOL, V47, P680, DOI 10.1128/JCM.01838-08; Mastrantonio P, 1999, MICROBIOL-UK, V145, P2069, DOI 10.1099/13500872-145-8-2069; Miller JL, 2008, PLOS BIOL, V6, P1195, DOI 10.1371/journal.pbio.0060131; Mooi FR, 1998, INFECT IMMUN, V66, P670, DOI 10.1128/IAI.66.2.670-675.1998; Mooi FR, 2000, EUR J CLIN MICROBIOL, V19, P174, DOI 10.1007/s100960050455; Mooi FR, 2010, INFECT GENET EVOL, V10, P36, DOI 10.1016/j.meegid.2009.10.007; Mooi FR, 2009, EMERG INFECT DIS, V15, P1206, DOI 10.3201/eid1508.081511; Nicholson TL, 2009, INFECT IMMUN, V77, P2136, DOI 10.1128/IAI.01379-08; Okada K, 2010, VACCINE, V28, P7626, DOI 10.1016/j.vaccine.2010.09.050; Olin P, 1997, LANCET, V350, P1569, DOI 10.1016/S0140-6736(97)06508-2; Pradel E, 2000, INFECT IMMUN, V68, P1919, DOI 10.1128/IAI.68.4.1919-1927.2000; ROBERTS M, 1991, MOL MICROBIOL, V5, P1393, DOI 10.1111/j.1365-2958.1991.tb00786.x; Schouls LM, 2004, J BACTERIOL, V186, P5496, DOI 10.1128/JB.186.16.5496-5505.2004; Sekiya K, 2001, P NATL ACAD SCI USA, V98, P11638, DOI 10.1073/pnas.191378598; Stefanelli P, 2009, NEW MICROBIOL, V32, P159; Stibitz S, 1998, J BACTERIOL, V180, P4963, DOI 10.1128/JB.180.18.4963-4966.1998; Storsaeter J, 1998, VACCINE, V16, P1907, DOI 10.1016/S0264-410X(98)00227-8; van den Berg BM, 1999, INFECT IMMUN, V67, P1050, DOI 10.1128/IAI.67.3.1050-1055.1999; van Gent M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018014; von Konig CHW, 2002, LANCET INFECT DIS, V2, P744, DOI 10.1016/S1473-3099(02)00452-8	46	108	112	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31985	10.1371/journal.pone.0031985	http://dx.doi.org/10.1371/journal.pone.0031985			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348138	Green Published, gold, Green Submitted			2022-12-25	WOS:000302737400057
J	Caesar, I; Jonson, M; Nilsson, KPR; Thor, S; Hammarstrom, P				Caesar, Ina; Jonson, Maria; Nilsson, K. Peter R.; Thor, Stefan; Hammarstrom, Per			Curcumin Promotes A-beta Fibrillation and Reduces Neurotoxicity in Transgenic Drosophila	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; IN-VIVO; AMYLOID PATHOLOGY; OXIDATIVE DAMAGE; INDUCED TOXICITY; PC12 CELLS; MODEL; DERIVATIVES; INHIBITORS; FIBRILS	The pathology of Alzheimer's disease (AD) is characterized by the presence of extracellular deposits of misfolded and aggregated amyloid-beta (A beta) peptide and intraneuronal accumulation of tangles comprised of hyperphosphorylated Tau protein. For several years, the natural compound curcumin has been proposed to be a candidate for enhanced clearance of toxic A beta amyloid. In this study we have studied the potency of feeding curcumin as a drug candidate to alleviate A beta toxicity in transgenic Drosophila. The longevity as well as the locomotor activity of five different AD model genotypes, measured relative to a control line, showed up to 75% improved lifespan and activity for curcumin fed flies. In contrast to the majority of studies of curcumin effects on amyloid we did not observe any decrease in the amount of A beta deposition following curcumin treatment. Conformation-dependent spectra from p-FTAA, a luminescent conjugated oligothiophene bound to A beta deposits in different Drosophila genotypes over time, indicated accelerated pre-fibrillar to fibril conversion of A beta(1-42) in curcumin treated flies. This finding was supported by in vitro fibrillation assays of recombinant A beta(1-42). Our study shows that curcumin promotes amyloid fibril conversion by reducing the pre-fibrillar/oligomeric species of A beta, resulting in a reduced neurotoxicity in Drosophila.	[Caesar, Ina; Jonson, Maria; Nilsson, K. Peter R.; Hammarstrom, Per] Linkoping Univ, Dept Chem, IFM, S-58183 Linkoping, Sweden; [Thor, Stefan] Linkoping Univ, Dept Clin & Expt Med, IKE, S-58183 Linkoping, Sweden	Linkoping University; Linkoping University	Caesar, I (corresponding author), Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA.	perha@ifm.liu.se	Thor, Stefan/Y-5804-2019	Thor, Stefan/0000-0001-5095-541X; Hammarstrom, Per/0000-0001-5827-3587	Knut and Alice Wallenberg foundation; Swedish Foundation for Strategic Research; Hjarnfonden; Swedish Research Council; Gustaf V. foundation; European Union	Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Hjarnfonden; Swedish Research Council(Swedish Research CouncilEuropean Commission); Gustaf V. foundation; European Union(European Commission)	This work was supported by The Knut and Alice Wallenberg foundation (ST, PH, KPRN), a generous gift from Alice and Georg Olsson (PH and KPRN), the Swedish Foundation for Strategic Research (ST, PH and KPRN), ""Hjarnfonden"" (ST), the Swedish Research Council (ST and PH), the Gustaf V. foundation (ST), and the European Union FP-7 Health project LUPAS (PH and KPRN). PH and ST are Swedish Royal Academy of Science Research Fellows sponsored by a grant from the Knut and Alice Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavez S, 2011, NATURE, V472, P226, DOI 10.1038/nature09873; Anand P, 2008, BIOCHEM PHARMACOL, V76, P1590, DOI 10.1016/j.bcp.2008.08.008; Aslund A, 2009, ACS CHEM BIOL, V4, P673, DOI 10.1021/cb900112v; Begum AN, 2008, J PHARMACOL EXP THER, V326, P196, DOI 10.1124/jpet.108.137455; Berg I, 2010, NAT PROTOC, V5, P935, DOI 10.1038/nprot.2010.41; Berg I, 2009, NEURODEGENER DIS, V6, P127, DOI 10.1159/000213761; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brorsson AC, 2010, BIOPHYS J, V98, P1677, DOI 10.1016/j.bpj.2009.12.4320; Byeon SR, 2007, BIOORG MED CHEM LETT, V17, P1466, DOI 10.1016/j.bmcl.2006.10.090; Byun JH, 2008, BIOORG MED CHEM LETT, V18, P5591, DOI 10.1016/j.bmcl.2008.08.111; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; Dias-Santagata D, 2007, J CLIN INVEST, V117, P236, DOI 10.1172/JCI28769; Garcia-Alloza M, 2007, J NEUROCHEM, V102, P1095, DOI 10.1111/j.1471-4159.2007.04613.x; Hamaguchi T, 2009, AM J PATHOL, V175, P2557, DOI 10.2353/ajpath.2009.090417; Hammarstrom P, 2010, BIOCHEMISTRY-US, V49, P6838, DOI 10.1021/bi100922r; HAY BA, 1994, DEVELOPMENT, V120, P2121; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Jurenka JS, 2009, ALTERN MED REV, V14, P141; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Lin RZ, 2008, NEUROSCI LETT, V440, P344, DOI 10.1016/j.neulet.2008.05.070; Lord A, 2011, AM J PATHOL, V178, P2286, DOI 10.1016/j.ajpath.2011.01.052; Luheshi LM, 2007, PLOS BIOL, V5, P2493, DOI 10.1371/journal.pbio.0050290; Luheshi LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000334; Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009; Minniti AN, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-2; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Nerelius C, 2009, P NATL ACAD SCI USA, V106, P9191, DOI 10.1073/pnas.0810364106; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Nilsson KPR, 2007, ACS CHEM BIOL, V2, P553, DOI 10.1021/cb700116u; Ono K, 2004, J NEUROSCI RES, V75, P742, DOI 10.1002/jnr.20025; Park SY, 2008, FOOD CHEM TOXICOL, V46, P2881, DOI 10.1016/j.fct.2008.05.030; Philipson O, 2009, NEUROBIOL AGING, V30, P1393, DOI 10.1016/j.neurobiolaging.2007.11.022; Qin XY, 2009, NEUROSCI LETT, V463, P158, DOI 10.1016/j.neulet.2009.07.047; Ran CZ, 2009, J AM CHEM SOC, V131, P15257, DOI 10.1021/ja9047043; Reinke AA, 2007, CHEM BIOL DRUG DES, V70, P206, DOI 10.1111/j.1747-0285.2007.00557.x; Ringman John M., 2005, Current Alzheimer Research, V2, P131, DOI 10.2174/1567205053585882; Rival T, 2009, EUR J NEUROSCI, V29, P1335, DOI 10.1111/j.1460-9568.2009.06701.x; Ryu EK, 2006, J MED CHEM, V49, P6111, DOI 10.1021/jm0607193; Sigurdson CJ, 2007, NAT METHODS, V4, P1023, DOI 10.1038/nmeth1131; Wang YJ, 2009, NEUROTOX RES, V15, P3, DOI 10.1007/s12640-009-9000-x; Wang YJ, 1997, J PHARMACEUT BIOMED, V15, P1867, DOI 10.1016/S0731-7085(96)02024-9; Wetzel R, 2007, BIOCHEMISTRY-US, V46, P1, DOI 10.1021/bi0620959; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Young MW, 2000, SCI AM, V282, P64, DOI 10.1038/scientificamerican0300-64	49	102	108	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31424	10.1371/journal.pone.0031424	http://dx.doi.org/10.1371/journal.pone.0031424			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348084	Green Submitted, Green Published, gold			2022-12-25	WOS:000302733900047
J	Wang, N; Khan, W; Smith, DL				Wang, Nan; Khan, Wajahatullah; Smith, Donald L.			Changes in Soybean Global Gene Expression after Application of Lipo-Chitooligosaccharide from Bradyrhizobium japonicum under Sub-Optimal Temperature	PLOS ONE			English	Article							SYMBIOTIC NITROGEN-FIXATION; NAC TRANSCRIPTION FACTORS; NOD-FACTOR; RAPID ALKALINIZATION; MEDICAGO-TRUNCATULA; FUNCTIONAL-ANALYSIS; MODEL LEGUME; EARLY GROWTH; PLANT; ROOT	Lipo-chitooligosaccharides (LCOs), signal compounds produced by N-2-fixing rhizobacteria after isoflavone induction, initiate nodule formation in host legumes. Given LCOs' structural similarity to pathogen-response-eliciting chitin oligomers, foliar application of LCOs was tested for ability to induce stress-related genes under optimal growth conditions. In order to study the effects of LCO foliar spray under stressed conditions, soybean (Glycine max) seedlings grown at optimal temperature were transferred to sub-optimal temperature. After a 5-day acclimation period, the first trifoliate leaves were sprayed with 10(-7) M LCO (NodBj-V (C-18:1, MeFuc)) purified from genistein-induced Bradyrhizobium japonicum culture, and harvested at 0 and 48 h following treatment. Microarray analysis was performed using Affymetrix GeneChip (R) Soybean Genome Arrays. Compared to the control at 48 h after LCO treatment, a total of 147 genes were differentially expressed as a result of LCO treatment, including a number of stress-related genes and transcription factors. In addition, during the 48 h time period following foliar spray application, over a thousand genes exhibited differential expression, including hundreds of those specific to the LCO-treated plants. Our results indicated that the dynamic soybean foliar transcriptome was highly responsive to LCO treatment. Quantitative real-time PCR (qPCR) validated the microarray data.	[Wang, Nan; Smith, Donald L.] McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada; [Khan, Wajahatullah] King Saud Univ, Coll Sci, Dept Biochem, Genome Res Chair Unit, Riyadh 11451, Saudi Arabia	McGill University; King Saud University	Wang, N (corresponding author), McGill Univ, Dept Plant Sci, Ste Anne De Bellevue, PQ, Canada.	Donald.Smith@McGill.Ca	Khan, Wajahatullah/J-9574-2012		Canadian Natural Sciences and Engineering Research Council of Canada (NSERC) through the Green Crop Network	Canadian Natural Sciences and Engineering Research Council of Canada (NSERC) through the Green Crop Network(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this research was provided by the Canadian Natural Sciences and Engineering Research Council of Canada (NSERC) for support through the Green Crop Network and a Discovery grant, both held by D. Smith. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBAGLI O, 1995, CELL GROWTH DIFFER, V6, P1193; Almaraz JJ, 2007, J PLANT PHYSIOL, V164, P1391, DOI 10.1016/j.jplph.2006.12.007; Asamizu E, 2005, MOL PLANT MICROBE IN, V18, P487, DOI 10.1094/MPMI-18-0487; Atti S, 2005, IRRIG DRAIN, V54, P15, DOI 10.1002/ird.153; Bae EK, 2006, TREE PHYSIOL, V26, P1405, DOI 10.1093/treephys/26.11.1405; Ben-Yaakov E, 2006, ISR J PLANT SCI, V54, P129, DOI 10.1560/IJPS_54_2_129; Benning Christoph, 2008, V27, P185; Blazejczyk M., 2007, FLEXARRAY STAT DATA; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boudichevskaia A, 2009, PLANT BREEDING, V128, P84, DOI 10.1111/j.1439-0523.2008.01537.x; Brechenimacher L, 2008, MOL PLANT MICROBE IN, V21, P631, DOI 10.1094/MPMI-21-5-0631; Chen H, 2009, CROP SCI, V49, P224, DOI 10.2135/cropsci2007.09.0536; Chinnusamy V, 2006, PHYSIOL PLANTARUM, V126, P52, DOI 10.1111/j.1399-3054.2006.00596.x; Colebatch G, 2004, PLANT J, V39, P487, DOI 10.1111/j.1365-313X.2004.02150.x; Colebatch G, 2002, MOL PLANT MICROBE IN, V15, P411, DOI 10.1094/MPMI.2002.15.5.411; CURRIER WW, 1976, PLANT PHYSIOL, V57, P820, DOI 10.1104/pp.57.5.820; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; D'Haeze W, 2002, GLYCOBIOLOGY, V12, p79R, DOI 10.1093/glycob/12.6.79R; Denarie J, 1996, ANNU REV BIOCHEM, V65, P503, DOI 10.1146/annurev.bi.65.070196.002443; Dordas C, 2003, ANN BOT-LONDON, V91, P173, DOI 10.1093/aob/mcf115; Duzan HM, 2005, PLANT PHYSIOL BIOCH, V43, P1022, DOI 10.1016/j.plaphy.2005.08.004; Dyachok JV, 2002, PLANT PHYSIOL, V128, P523, DOI 10.1104/pp.010547; Edwards R, 2000, TRENDS PLANT SCI, V5, P193, DOI 10.1016/S1360-1385(00)01601-0; El Yahyaoui F, 2004, PLANT PHYSIOL, V136, P3159, DOI 10.1104/pp.104.043612; Fang YW, 1998, PLANT PHYSIOL, V116, P53, DOI 10.1104/pp.116.1.53; FEHR WR, 1971, CROP SCI, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Felle HH, 1996, PLANT J, V10, P295, DOI 10.1046/j.1365-313X.1996.10020295.x; FIRMIN JL, 1986, NATURE, V324, P90, DOI 10.1038/324090a0; Fujiwara M, 2000, FEBS LETT, V481, P47, DOI 10.1016/S0014-5793(00)01965-7; Fukayama H, 2006, PLANT J, V47, P258, DOI 10.1111/j.1365-313X.2006.02779.x; Gage DJ, 2004, MICROBIOL MOL BIOL R, V68, P280, DOI 10.1128/MMBR.68.2.280-300.2004; Gamas P, 1998, MOL PLANT MICROBE IN, V11, P393, DOI 10.1094/MPMI.1998.11.5.393; Garcia-Maurino S, 2003, PLANTA, V216, P648, DOI 10.1007/s00425-002-0893-3; GRANT D, 2002, SOYBASE USDA ARS SOY; Hagiwara-Komoda Y, 2008, VIROLOGY, V376, P132, DOI 10.1016/j.virol.2008.03.020; Haruta M, 2003, PLANT PHYSIOL, V131, P814, DOI 10.1104/pp.014597; Hegedus D, 2003, PLANT MOL BIOL, V53, P383, DOI 10.1023/B:PLAN.0000006944.61384.11; Helliwell CA, 2001, PLANT CELL, V13, P2115, DOI 10.1105/tpc.13.9.2115; Hirsch Sibylle, 2009, P71, DOI 10.1007/978-3-540-89228-1_4; HOAGLAND D. R., 1938, Annual Report of the Smithsonian Institution, P461; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kamst E, 1998, Subcell Biochem, V29, P29; Kasprzewska A, 2003, CELL MOL BIOL LETT, V8, P809; Kawasaki Ernest S, 2006, J Biomol Tech, V17, P200; Khan W, 2008, J PLANT PHYSIOL, V165, P1342, DOI 10.1016/j.jplph.2007.11.001; Khan W, 2011, PLANT GROWTH REGUL, V63, P243, DOI 10.1007/s10725-010-9521-6; Kouchi H, 2004, DNA RES, V11, P263, DOI 10.1093/dnares/11.4.263; KUAN J, 1993, CRIT REV BIOCHEM MOL, V28, P209, DOI 10.3109/10409239309086795; KUCHITSU K, 1993, PROTOPLASMA, V174, P79, DOI 10.1007/BF01404046; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lee H, 2002, EMBO J, V21, P2692, DOI 10.1093/emboj/21.11.2692; Lindsay J, 2007, THESIS MCGILL U; Matile P, 1999, ANNU REV PLANT PHYS, V50, P67, DOI 10.1146/annurev.arplant.50.1.67; Miransari M, 2006, COMMUN SOIL SCI PLAN, V37, P1103, DOI 10.1080/00103620600586391; Miron M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-333; Mishra NS, 2006, ARCH BIOCHEM BIOPHYS, V452, P55, DOI 10.1016/j.abb.2006.05.001; Mitra RM, 2004, P NATL ACAD SCI USA, V101, P10217, DOI 10.1073/pnas.0402186101; Mitsuda N, 2005, PLANT CELL, V17, P2993, DOI 10.1105/tpc.105.036004; Moriyama Y, 2008, XENOBIOTICA, V38, P1107, DOI [10.1080/00498250701883753, 10.1080/00498250701883753 ]; Moura DS, 2006, HANDBOOK OF BIOLOGICALLY ACTIVE PEPTIDES, P33, DOI 10.1016/B978-012369442-3/50010-6; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Olah B, 2005, PLANT J, V44, P195, DOI 10.1111/j.1365-313X.2005.02522.x; Olczak M, 2003, ACTA BIOCHIM POL, V50, P1245; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Passardi F, 2004, TRENDS PLANT SCI, V9, P534, DOI 10.1016/j.tplants.2004.09.002; Patten CL, 2004, MOL GENET GENOMICS, V272, P580, DOI 10.1007/s00438-004-1089-2; Pearce G, 2010, PEPTIDES, V31, P1973, DOI 10.1016/j.peptides.2010.08.012; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Picault N, 2004, TRENDS PLANT SCI, V9, P138, DOI 10.1016/j.tplants.2004.01.007; PREVOST D, 1987, FEMS MICROBIOL ECOL, V45, P205, DOI 10.1016/0378-1097(87)90053-X; Prithiviraj B, 2003, PLANTA, V216, P437, DOI 10.1007/s00425-002-0928-9; RAINA S, 1995, EMBO J, V14, P1043, DOI 10.1002/j.1460-2075.1995.tb07085.x; Ramu SK, 2002, MOL PLANT MICROBE IN, V15, P522, DOI 10.1094/MPMI.2002.15.6.522; Rozen S, 2000, Methods Mol Biol, V132, P365; Sakai T, 2000, PLANT CELL, V12, P225, DOI 10.1105/tpc.12.2.225; SCHMIDT J, 1993, PLANT J, V4, P651, DOI 10.1046/j.1365-313X.1993.04040651.x; Schweighofer A, 2004, TRENDS PLANT SCI, V9, P236, DOI 10.1016/j.tplants.2004.03.007; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; Shin Y, 2005, DEV DYNAM, V232, P432, DOI 10.1002/dvdy.20229; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Souleimanov A, 2002, J EXP BOT, V53, P1929, DOI 10.1093/jxb/erf034; Sperling P, 2003, BBA-MOL CELL BIOL L, V1632, P1, DOI 10.1016/S1388-1981(03)00033-7; Takken FLW, 2006, CURR OPIN PLANT BIOL, V9, P383, DOI 10.1016/j.pbi.2006.05.009; TIMPTE C, 1995, PLANT J, V8, P561, DOI 10.1046/j.1365-313X.1995.8040561.x; van der Rest B, 2004, BIOCHEM J, V379, P601, DOI 10.1042/BJ20031489; van der Rest B, 2002, PLANT PHYSIOL, V130, P244, DOI 10.1104/pp.003392; Vidaurre DP, 2007, DEVELOPMENT, V134, P2561, DOI 10.1242/dev.006759; Wierzbicki AT, 2005, GENETICS, V169, P997, DOI 10.1534/genetics.104.031997; Yauk CL, 2007, ENVIRON MOL MUTAGEN, V48, P380, DOI 10.1002/em.20290; Yu B, 2002, P NATL ACAD SCI USA, V99, P5732, DOI 10.1073/pnas.082696499; ZHANG F, 1994, J EXP BOT, V45, P1467, DOI 10.1093/jxb/45.10.1467; Zhang SQ, 2001, TRENDS PLANT SCI, V6, P520, DOI 10.1016/S1360-1385(01)02103-3; ZHANG XQ, 1995, PLANT PHYSIOL, V108, P1561, DOI 10.1104/pp.108.4.1561	95	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31571	10.1371/journal.pone.0031571	http://dx.doi.org/10.1371/journal.pone.0031571			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348109	Green Published, Green Submitted, gold			2022-12-25	WOS:000302733900055
J	Schwilk, DW; Keeley, JE				Schwilk, Dylan W.; Keeley, Jon E.			A Plant Distribution Shift: Temperature, Drought or Past Disturbance?	PLOS ONE			English	Article							CLIMATE-CHANGE; FIRE HISTORY; CEANOTHUS; MOUNTAINS	Simple models of plant response to warming climates predict vegetation moving to cooler and/or wetter locations: in mountainous regions shifting upslope. However, species-specific responses to climate change are likely to be much more complex. We re-examined a recently reported vegetation shift in the Santa Rosa Mountains, California, to better understand the mechanisms behind the reported shift of a plant distribution upslope. We focused on five elevational zones near the center of the gradient that captured many of the reported shifts and which are dominated by fire-prone chaparral. Using growth rings, we determined that a major assumption of the previous work was wrong: past fire histories differed among elevations. To examine the potential effect that this difference might have on the reported upward shift, we focused on one species, Ceanothus greggii: a shrub that only recruits post-fire from a soil stored seedbank. For five elevations used in the prior study, we calculated time series of past per-capita mortality rates by counting growth rings on live and dead individuals. We tested three alternative hypotheses explaining the past patterns of mortality: 1) mortality increased over time consistent with climate warming, 2) mortality was correlated with drought indices, and 3) mortality peaked 40-50 years post fire at each site, consistent with self-thinning. We found that the sites were different ages since the last fire, and that the reported increase in the mean elevation of C. greggii was due to higher recent mortality at the lower elevations, which were younger sites. The time-series pattern of mortality was best explained by the self-thinning hypothesis and poorly explained by gradual warming or drought. At least for this species, the reported distribution shift appears to be an artifact of disturbance history and is not evidence of a climate warming effect.	[Schwilk, Dylan W.] Texas Tech Univ, Lubbock, TX 79409 USA; [Keeley, Jon E.] Western Ecol Res Ctr, Sequoia Kings Canyon Field Stn, US Geol Survey, Three Rivers, CA USA; [Keeley, Jon E.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA	Texas Tech University System; Texas Tech University; United States Department of the Interior; United States Geological Survey; University of California System; University of California Los Angeles	Schwilk, DW (corresponding author), Texas Tech Univ, Lubbock, TX 79409 USA.	dylan.schwilk@ttu.edu			USGS	USGS(United States Geological Survey)	This project was mostly unfunded; however, the field crew during the 2009 field work was partly funded by the USGS Multi-Hazards Demonstration Project funding to Jon Keeley. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	AGEE JK, 1991, NORTHWEST SCI, V65, P188; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Breshears DD, 2008, P NATL ACAD SCI USA, V105, P11591, DOI 10.1073/pnas.0806579105; Cairns DM, 2004, J ECOL, V92, P1019, DOI 10.1111/j.1365-2745.2004.00945.x; Cannone N, 2007, FRONT ECOL ENVIRON, V5, P360, DOI 10.1890/1540-9295(2007)5[360:UIOCCO]2.0.CO;2; CHAMBERLIN TC, 1965, SCIENCE, V148, P754, DOI 10.1126/science.148.3671.754; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Coale TH, 2011, ECOLOGY, V92, P1020, DOI 10.1890/i0012-9658-92-5-1020; Collett D, 2002, MODELLING BINARY DAT; Crimmins SM, 2011, SCIENCE, V331, P324, DOI 10.1126/science.1199040; Ewers FW, 2003, OECOLOGIA, V136, P213, DOI 10.1007/s00442-003-1273-9; Halloy SRP, 2003, ARCT ANTARCT ALP RES, V35, P248, DOI 10.1657/1523-0430(2003)035[0248:CEOAPB]2.0.CO;2; Keeley J. E., 1993, Madrono, V40, P1; Keeley J.E., 2000, N AM TERRESTRIAL VEG, P203; KEELEY JE, 1992, J VEG SCI, V3, P79, DOI 10.2307/3236001; KEELEY JE, 1991, BOT REV, V57, P81, DOI 10.1007/BF02858766; Keeley JE, 2008, ECOL APPL, V18, P1530, DOI 10.1890/07-0836.1; Kelly A, 2007, THESIS CALIFORNIA ST; Kelly AE, 2008, P NATL ACAD SCI USA, V105, P11823, DOI 10.1073/pnas.0802891105; Palmer W.C., 1965, 45 US DEP COMM WEATH, V30; Pinheiro J, 2000, MIXED EFFECTS MODELS; PINHEIRO JC, 2011, NLME LINEAR NONLINEA, V3, P1, DOI DOI 10.1371/J0URNAL.P0NE.0018860; PLATT JR, 1964, SCIENCE, V146, P347, DOI 10.1126/science.146.3642.347; R Core Team, 2021, R LANG ENV STAT COMP; SCHLESINGER WH, 1978, ECOLOGY, V59, P1256, DOI 10.2307/1938239; STEPHENSON JR, 1999, GTRPSW172 USDA FOR S; Stephenson NL, 2011, SCIENCE, V334, DOI 10.1126/science.1205740; Veblen TT, 2000, ECOL APPL, V10, P1178, DOI 10.1890/1051-0761(2000)010[1178:CAHIOF]2.0.CO;2; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Wiens JA, 2009, P NATL ACAD SCI USA, V106, P19729, DOI 10.1073/pnas.0901639106; Wolf A, 2011, SCIENCE, V334, DOI 10.1126/science.1204607; Zabriskie J, 1977, PLANTS DEEP CANYON C; ZAMMIT CA, 1993, J ECOL, V81, P499, DOI 10.2307/2261528	33	23	23	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e31173	10.1371/journal.pone.0031173	http://dx.doi.org/10.1371/journal.pone.0031173			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348051	Green Published, gold, Green Submitted			2022-12-25	WOS:000302730900021
J	Boudreau, LH; Maillet, J; LeBlanc, LM; Jean-Francois, J; Touaibia, M; Flamand, N; Surette, ME				Boudreau, Luc H.; Maillet, Jacques; LeBlanc, Luc M.; Jean-Francois, Jacques; Touaibia, Mohamed; Flamand, Nicolas; Surette, Marc E.			Caffeic Acid Phenethyl Ester and Its Amide Analogue Are Potent Inhibitors of Leukotriene Biosynthesis in Human Polymorphonuclear Leukocytes	PLOS ONE			English	Article							ARACHIDONIC-ACID; HUMAN NEUTROPHILS; 5-LIPOXYGENASE INHIBITOR; ADENOSINE; CAPE; RELEASE; B-4; TRANSLOCATION; METABOLITES; DERIVATIVES	Background: 5-lipoxygenase (5-LO) catalyses the transformation of arachidonic acid (AA) into leukotrienes (LTs), which are important lipid mediators of inflammation. LTs have been directly implicated in inflammatory diseases like asthma, atherosclerosis and rheumatoid arthritis; therefore inhibition of LT biosynthesis is a strategy for the treatment of these chronic diseases. Methodology/Principal Findings: Analogues of caffeic acid, including the naturally-occurring caffeic acid phenethyl ester (CAPE), were synthesized and evaluated for their capacity to inhibit 5-LO and LTs biosynthesis in human polymorphonuclear leukocytes (PMNL) and whole blood. Anti-free radical and anti-oxidant activities of the compounds were also measured. Caffeic acid did not inhibit 5-LO activity or LT biosynthesis at concentrations up to 10 mu M. CAPE inhibited 5-LO activity (IC50 0.13 mu M, 95% CI 0.08-0.23 mu M) more effectively than the clinically-approved 5-LO inhibitor zileuton (IC50 3.5 mu M, 95% CI 2.3-5.4 mu M). CAPE was also more effective than zileuton for the inhibition of LT biosynthesis in PMNL but the compounds were equipotent in whole blood. The activity of the amide analogue of CAPE was similar to that of zileuton. Inhibition of LT biosynthesis by CAPE was the result of the inhibition of 5-LO and of AA release. Caffeic acid, CAPE and its amide analog were free radical scavengers and antioxidants with IC50 values in the low mu M range; however, the phenethyl moiety of CAPE was required for effective inhibition of 5-LO and LT biosynthesis. Conclusions: CAPE is a potent LT biosynthesis inhibitor that blocks 5-LO activity and AA release. The CAPE structure can be used as a framework for the rational design of stable and potent inhibitors of LT biosynthesis.	[Boudreau, Luc H.; Maillet, Jacques; LeBlanc, Luc M.; Jean-Francois, Jacques; Touaibia, Mohamed; Surette, Marc E.] Univ Moncton, Dept Chim & Biochim, Moncton, NB E1A 3E9, Canada; [Boudreau, Luc H.; Flamand, Nicolas] Univ Laval, Fac Med, Dept Med, IUCPQ,Ctr Rech, Quebec City, PQ G1K 7P4, Canada	University of Moncton; Laval University	Boudreau, LH (corresponding author), Univ Moncton, Dept Chim & Biochim, Moncton, NB E1A 3E9, Canada.	marc.surette@umoncton.ca	Surette, Marc/AAW-1078-2021; Flamand, Nicolas/H-5823-2019	Flamand, Nicolas/0000-0001-5944-7200; Boudreau, Luc H/0000-0002-3674-5026; LeBlanc, Luc/0000-0003-2944-2737	Heart and Stroke Foundation of Canada; New Brunswick Health Research Foundation; Canada Research Chairs Program; Fonds de la recherche en sante du Quebec; Canadian Arthritis Network	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); New Brunswick Health Research Foundation; Canada Research Chairs Program(Canada Research Chairs); Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); Canadian Arthritis Network	This work was supported by grants from the Heart and Stroke Foundation of Canada (to M. E. S.) and the New Brunswick Health Research Foundation (to M. T. and M. E. S.). M. E. S. is supported by the Canada Research Chairs Program. N.F. is the recipient of a scholarship award from the Fonds de la recherche en sante du Quebec. L. H. B. is the recipient of a graduate student award from the Canadian Arthritis Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger W, 2007, INT J CLIN PRACT, V61, P663, DOI 10.1111/j.1742-1241.2007.01320.x; BORGEAT P, 1990, METHOD ENZYMOL, V187, P98; Boudreau LH, 2011, FASEB J, V25, P1097, DOI 10.1096/fj.10-173856; Boudreau LH, 2009, NEW J CHEM, V33, P1932, DOI 10.1039/b907878a; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Bruckner R, 2002, ADV ORGANIC CHEM REA, P238; CHAMULITRAT W, 1992, J BIOL CHEM, V267, P9574; Chen M, 2006, J EXP MED, V203, P837, DOI 10.1084/jem.20052371; Chen YY, 2009, CELL CYCLE, V8, P3488, DOI 10.4161/cc.8.21.9852; Chouinard F, 2011, J IMMUNOL, V186, P3188, DOI 10.4049/jimmunol.1002853; CRONSTEIN BN, 1994, J APPL PHYSIOL, V76, P5, DOI 10.1152/jappl.1994.76.1.5; Doiron J, 2009, BIOORG MED CHEM LETT, V19, P1118, DOI 10.1016/j.bmcl.2008.12.108; Flamand N, 2006, J BIOL CHEM, V281, P129, DOI 10.1074/jbc.M506513200; Flamand N, 2004, BRIT J PHARMACOL, V141, P552, DOI 10.1038/sj.bjp.0705654; Flamand N, 2002, MOL PHARMACOL, V62, P250, DOI 10.1124/mol.62.2.250; FONTEH AN, 1993, J IMMUNOL, V151, P339; Garcia-Marcos L, 2003, DRUG SAFETY, V26, P483, DOI 10.2165/00002018-200326070-00004; Gilbert NC, 2011, SCIENCE, V331, P217, DOI 10.1126/science.1197203; Gokalp O, 2006, MOL CELL BIOCHEM, V290, P55, DOI 10.1007/s11010-006-9157-z; Gupta S, 2001, CANCER-AM CANCER SOC, V91, P737, DOI 10.1002/1097-0142(20010215)91:4<737::AID-CNCR1059>3.0.CO;2-F; HAM EA, 1983, P NATL ACAD SCI-BIOL, V80, P4349, DOI 10.1073/pnas.80.14.4349; HATANO T, 1989, CHEM PHARM BULL, V37, P2016; Krump E, 1997, J EXP MED, V186, P1401, DOI 10.1084/jem.186.8.1401; Kunishima M, 1999, TETRAHEDRON, V55, P13159, DOI 10.1016/S0040-4020(99)00809-1; Leff JA, 1998, NEW ENGL J MED, V339, P147, DOI 10.1056/NEJM199807163390302; Liegeois C, 2000, J AGR FOOD CHEM, V48, P1129, DOI 10.1021/jf9911242; Lin CF, 2005, CHEM PHARM BULL, V53, P1402, DOI 10.1248/cpb.53.1402; Liu MC, 1996, J ALLERGY CLIN IMMUN, V98, P859, DOI 10.1016/S0091-6749(96)80002-9; Mahapatra T, 2005, J CHEM RES, P629; Mehrabian M, 2002, CIRC RES, V91, P120, DOI 10.1161/01.RES.0000028008.99774.7F; Michaluart P, 1999, CANCER RES, V59, P2347; Mirzoeva OK, 1996, PROSTAG LEUKOTR ESS, V55, P441, DOI 10.1016/S0952-3278(96)90129-5; Parlakpinar H, 2005, TOXICOLOGY, V207, P169, DOI 10.1016/j.tox.2004.08.024; Pergola C, 2010, EXPERT OPIN THER PAT, V20, P355, DOI 10.1517/13543771003602012; Radmark O, 2002, PROSTAG OTH LIPID M, V68-9, P211, DOI 10.1016/S0090-6980(02)00032-1; Rajan P, 2001, BIOORG MED CHEM LETT, V11, P215, DOI 10.1016/S0960-894X(00)00630-2; Rossi A, 2010, BRIT J PHARMACOL, V161, P555, DOI 10.1111/j.1476-5381.2010.00930.x; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Son S, 2001, CHEM PHARM BULL, V49, P236, DOI 10.1248/cpb.49.236; SUDINA GF, 1993, FEBS LETT, V329, P21, DOI 10.1016/0014-5793(93)80184-V; SURETTE ME, 1994, ANAL BIOCHEM, V216, P392, DOI 10.1006/abio.1994.1057; Surette ME, 1998, FASEB J, V12, P1521, DOI 10.1096/fasebj.12.14.1521; Surette ME, 2003, CLIN THER, V25, P948, DOI 10.1016/S0149-2918(03)80116-9; Surette ME, 1996, BIOCHEMISTRY-US, V35, P9187, DOI 10.1021/bi9530245; Surette ME, 1999, MOL PHARMACOL, V56, P1055, DOI 10.1124/mol.56.5.1055; Thibault N, 2002, J LEUKOCYTE BIOL, V71, P367; WALSH CE, 1981, J BIOL CHEM, V256, P7228; Wang XY, 2006, BIOORGAN MED CHEM, V14, P4879, DOI 10.1016/j.bmc.2006.03.015	49	54	57	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31833	10.1371/journal.pone.0031833	http://dx.doi.org/10.1371/journal.pone.0031833			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347509	Green Submitted, Green Published, gold			2022-12-25	WOS:000302730200037
J	Outinen, TK; Kuparinen, T; Jylhava, J; Leppanen, S; Mustonen, J; Makela, S; Porsti, I; Syrjanen, J; Vaheri, A; Hurme, M				Outinen, Tuula K.; Kuparinen, Taru; Jylhava, Juulia; Leppanen, Sonja; Mustonen, Jukka; Makela, Satu; Porsti, Ilkka; Syrjanen, Jaana; Vaheri, Antti; Hurme, Mikko			Plasma Cell-Free DNA Levels Are Elevated in Acute Puumala Hantavirus Infection	PLOS ONE			English	Article							INDUCED NEPHROPATHIA-EPIDEMICA; C-REACTIVE PROTEIN; VERO E6 CELLS; PROGNOSTIC MARKER; CLINICAL CORRELATIONS; RADIOLOGICAL FINDINGS; COLORECTAL-CANCER; HEMORRHAGIC-FEVER; VIRUS-INFECTION; RENAL SYNDROME	Introduction: Puumala hantavirus (PUUV) causes a hemorrhagic fever with renal syndrome called nephropathia epidemica (NE). The aim of the present study was to evaluate plasma cell-free DNA (cf-DNA) levels and urinary cf-DNA excretion in acute NE as well as their associations with the severity of the disease. Methods: Total plasma cf-DNA was quantified directly in plasma of 61 patients and urine of 20 patients with acute NE. We also carried out a qualitative high-sensitivity lab-on-a-chip DNA assay in 20 patients to elucidate the appearance of cf-DNA in plasma and urine. Results: The maximum plasma cf-DNA values taken during acute NE were significantly higher than the control values taken after the hospitalization period (median 1.33 mu g/ml, range 0.94-3.29 mu g/ml vs. median 0.77 mu g/ml, range 0.55-0.99 mu g/ml, P < 0.001). The maximum plasma cf-DNA levels correlated positively with maximum blood leukocyte count (r = 0.388, P = 0.002) and the length of hospital stay (r = 0.376, P = 0.003), and inversely with minimum blood platelet count (r = -0.297, P = 0.020). Qualitative analysis of plasma cf-DNA revealed that in most of the patients cf-DNA displayed a low-molecular weight appearance, corresponding to the size of apoptotic DNA (150-200 bp). The visually graded maximum cf-DNA band intensity correlated positively with the maximum quantity of total plasma cf-DNA (r = 0.513, P = 0.021). Maximum urinary excretion of cf-DNA in turn was not markedly increased during the acute phase of NE and did not correlate with any of the variables reflecting severity of the disease or with the maximum plasma cf-DNA level. Conclusions: The plasma levels of cf-DNA are elevated during acute PUUV infection and correlate with the apoptotic cf-DNA-band intensity. The plasma cf-DNA concentration correlates with some variables reflecting the severity of the disease. The urinary excretion of cf-DNA does not reflect the degree of inflammation in the kidney.	[Outinen, Tuula K.; Mustonen, Jukka; Makela, Satu; Porsti, Ilkka; Syrjanen, Jaana] Tampere Univ Hosp, Dept Internal Med, Tampere, Finland; [Kuparinen, Taru; Jylhava, Juulia; Leppanen, Sonja; Mustonen, Jukka; Makela, Satu; Porsti, Ilkka; Syrjanen, Jaana; Hurme, Mikko] Univ Tampere, Sch Med, Tampere, Finland; [Vaheri, Antti] Univ Helsinki, Haartman Inst, Infect Biol Res Program, Dept Virol, Helsinki, Finland; [Hurme, Mikko] Fimlab Labs, Tampere, Finland	Tampere University; Tampere University Hospital; Tampere University; University of Helsinki	Outinen, TK (corresponding author), Tampere Univ Hosp, Dept Internal Med, Tampere, Finland.	Tuula.Outinen@uta.fi	Vaheri, Antti/AAV-1523-2020	Outinen, Tuula/0000-0002-2773-4077; Makela, Satu/0000-0001-6967-2401; Hurme, Mikko/0000-0002-8614-1044; Jylhava, Juulia/0000-0003-0250-4491; Syrjanen, Jaana/0000-0002-7335-573X	Tampere 15 University Hospital; European Commission [QLK2-CT-2002-01358]; Finnish Kidney Foundation	Tampere 15 University Hospital; European Commission(European CommissionEuropean Commission Joint Research Centre); Finnish Kidney Foundation	This study was financially supported by the Competitive Research Funding of the Tampere 15 University Hospital, the European Commission Project "Diagnosis and control of rodent-borne viral 16 zoonoses in Europe'' (QLK2-CT-2002-01358) and Finnish Kidney Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonatos D, 2006, ANN NY ACAD SCI, V1075, P278, DOI 10.1196/annals.1368.037; Bhargava A, 2010, VIRUS RES, V153, P143, DOI 10.1016/j.virusres.2010.07.023; Botezatu I, 2000, CLIN CHEM, V46, P1078; Bottazzi B, 2009, IMMUNOL REV, V227, P9, DOI 10.1111/j.1600-065X.2008.00719.x; BRUMMERKORVENKONTIO M, 1980, J INFECT DIS, V141, P131, DOI 10.1093/infdis/141.2.131; Butt AN, 2008, ANN NY ACAD SCI, V1137, P236, DOI 10.1196/annals.1448.002; COSGRIFF TM, 1991, REV INFECT DIS, V13, P97; Courouble P, 2001, Eur J Emerg Med, V8, P17, DOI 10.1097/00063110-200103000-00004; Moreira VG, 2010, ANN CLIN BIOCHEM, V47, P253, DOI 10.1258/acb.2010.009173; Moreira VG, 2009, CLIN BIOCHEM, V42, P729, DOI 10.1016/j.clinbiochem.2008.12.021; Hung ECW, 2009, CLIN CHEM, V55, P715, DOI 10.1373/clinchem.2008.113530; Huttunen R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021700; Jahr S, 2001, CANCER RES, V61, P1659; Jylhava J, 2011, MECH AGEING DEV, V132, P20, DOI 10.1016/j.mad.2010.11.001; Kanerva M, 1998, REV MED VIROL, V8, P67, DOI 10.1002/(SICI)1099-1654(199804/06)8:2&lt;67::AID-RMV217&gt;3.0.CO;2-U; Kanerva M, 1996, CLIN NEPHROL, V46, P369; Klingstrom J, 2006, J VIROL, V80, P8279, DOI 10.1128/JVI.00742-06; Koide K, 2005, PRENATAL DIAG, V25, P604, DOI 10.1002/pd.1213; LAHDEVIRTA J, 1971, ANN CLIN RES, V3, P1; Laich A, 2002, CLIN CHEM, V48, P579; Laine O, 2011, BLOOD COAGUL FIBRIN, V22, P468, DOI 10.1097/MBC.0b013e328346a420; Laine O, 2010, THROMB RES, V126, P154, DOI 10.1016/j.thromres.2010.05.025; Li XD, 2005, VIROLOGY, V333, P180, DOI 10.1016/j.virol.2005.01.002; Li XD, 2004, J GEN VIROL, V85, P3261, DOI 10.1099/vir.0.80243-0; Linderholm M, 1996, J INFECT DIS, V173, P38, DOI 10.1093/infdis/173.1.38; Lo YMD, 2000, CLIN CHEM, V46, P319; Makary P, 2010, EPIDEMIOL INFECT, V138, P1484, DOI 10.1017/S0950268810000087; Makela S, 2004, AM J KIDNEY DIS, V43, P809, DOI 10.1053/j.ajkd.2003.12.044; Makela S, 2009, SCAND J INFECT DIS, V41, P57, DOI 10.1080/00365540802502629; Margraf S, 2008, SHOCK, V30, P352, DOI 10.1097/SHK.0b013e31816a6bb1; Mori M, 1999, J INFECT DIS, V179, P295, DOI 10.1086/314597; Mosca M, 2009, CLIN RHEUMATOL, V28, P1437, DOI 10.1007/s10067-009-1245-5; MUSTONEN J, 1994, SCAND J INFECT DIS, V26, P7, DOI 10.3109/00365549409008583; Mustonen J, 1996, KIDNEY INT, V49, P217, DOI 10.1038/ki.1996.29; Outinen TK, 2011, EUR J CLIN MICROBIOL; Outinen TK, 2011, J MED VIROL, V83, P731, DOI 10.1002/jmv.22018; Outinen TK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-132; Paakkala A, 2007, ACTA RADIOL, V48, P345, DOI 10.1080/02841850701199629; Paakkala A, 2008, SCAND J INFECT DIS, V40, P254, DOI 10.1080/00365540701633012; Rainer TH, 2003, CLIN CHEM, V49, P562, DOI 10.1373/49.4.562; Rhodes A, 2006, CRIT CARE, V10, DOI 10.1186/cc4894; Sane J, 2011, ANN MED; Saukkonen K, 2008, CLIN CHEM, V54, P1000, DOI 10.1373/clinchem.2007.101030; Schrocksnadel K, 2006, CLIN CHIM ACTA, V364, P82, DOI 10.1016/j.cca.2005.06.013; Su YH, 2004, J MOL DIAGN, V6, P101, DOI 10.1016/S1525-1578(10)60497-7; Su Ying-Hsiu, 2005, Cancer Biomarkers, V1, P177; Temonen M, 1996, CLIN IMMUNOL IMMUNOP, V78, P47, DOI 10.1006/clin.1996.0007; TEMONEN M, 1993, J GEN VIROL, V74, P515, DOI 10.1099/0022-1317-74-3-515; Vapalahti O, 2003, LANCET INFECT DIS, V3, P653, DOI 10.1016/S1473-3099(03)00774-6; Vapalahti O, 1996, J CLIN MICROBIOL, V34, P119, DOI 10.1128/JCM.34.1.119-125.1996; YANAGIHARA R, 1985, J VIROL, V55, P34, DOI 10.1128/JVI.55.1.34-38.1985; Zeerleder S, 2003, CRIT CARE MED, V31, P1947, DOI 10.1097/01.CCM.0000074719.40109.95; Zhong XY, 2007, ANN HEMATOL, V86, P139, DOI 10.1007/s00277-006-0182-5; Zhong XY, 2007, CLIN CHEM, V53, P1609, DOI 10.1373/clinchem.2006.084509	54	28	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31455	10.1371/journal.pone.0031455	http://dx.doi.org/10.1371/journal.pone.0031455			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347483	Green Published, gold, Green Submitted			2022-12-25	WOS:000302180600039
J	Uras, IZ; List, T; Nijman, SMB				Uras, Iris Z.; List, Thomas; Nijman, Sebastian M. B.			Ubiquitin-Specific Protease 4 Inhibits Mono-Ubiquitination of the Master Growth Factor Signaling Kinase PDK1	PLOS ONE			English	Article							NUCLEAR TRANSLOCATION; IN-VIVO; UBIQUITYLATION; ACTIVATION; SYSTEM; DOMAIN; USP4; P53; PHOSPHORYLATION; IDENTIFICATION	Background: Phosphorylation by the phospho-inositide-dependent kinase 1 (PDK1) is essential for many growth factor-activated kinases and thus plays a critical role in various processes such as cell proliferation and metabolism. However, the mechanisms that control PDK1 have not been fully explored and this is of great importance as interfering with PDK1 signaling may be useful to treat diseases, including cancer and diabetes. Methodology/Principal Findings: In human cells, few mono-ubiquitinated proteins have been described but in all cases this post-translational modification has a key regulatory function. Unexpectedly, we find that PDK1 is mono-ubiquitinated in a variety of human cell lines, indicating that PDK1 ubiquitination is a common and regulated process. Ubiquitination occurs in the kinase domain of PDK1 yet is independent of its kinase activity. By screening a library of ubiquitin proteases, we further identify the Ubiquitin-Specific Protease 4 (USP4) as an enzyme that removes ubiquitin from PDK1 in vivo and in vitro and co-localizes with PDK1 at the plasma membrane when the two proteins are overexpressed, indicating direct deubiquitination. Conclusions: The regulated mono-ubiquitination of PDK1 provides an unanticipated layer of complexity in this central signaling network and offers potential novel avenues for drug discovery.	[Uras, Iris Z.; List, Thomas; Nijman, Sebastian M. B.] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences	Uras, IZ (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria.	snijman@cemm.oeaw.ac.at	Uras, Iris/AAH-2221-2021	Uras, Iris/0000-0002-2434-2756; Nijman, Sebastian/0000-0003-0464-6661	WWTF [LS09-009]	WWTF	IZU has been funded by the Vienna Science and Technology Fund (WWTF) through project LS09-009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar RC, 2003, CURR OPIN CELL BIOL, V15, P184, DOI 10.1016/S0955-0674(03)00010-3; Baker RT, 1999, GENOMICS, V59, P264, DOI 10.1006/geno.1999.5879; Bayascas JR, 2008, MOL CELL BIOL, V28, P3258, DOI 10.1128/MCB.02032-07; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Chan WM, 2006, MOL CANCER RES, V4, P15, DOI 10.1158/1541-7786.MCR-05-0097; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Cohen P, 2010, CELL, V143, P686, DOI 10.1016/j.cell.2010.11.016; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fan YH, 2011, CELL DEATH DIFFER; Filippa N, 2000, MOL CELL BIOL, V20, P5712, DOI 10.1128/MCB.20.15.5712-5721.2000; Giasson BI, 2003, CELL, V114, P1, DOI 10.1016/S0092-8674(03)00509-9; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Huang TT, 2006, NAT REV MOL CELL BIO, V7, P323, DOI 10.1038/nrm1908; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; Komander D, 2004, EMBO J, V23, P3918, DOI 10.1038/sj.emboj.7600379; Lawlor MA, 2001, J CELL SCI, V114, P2903; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lim MA, 2003, P NATL ACAD SCI USA, V100, P14006, DOI 10.1073/pnas.2335486100; Lopez-Otin C, 2010, NAT REV CANCER, V10, P278, DOI 10.1038/nrc2823; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; McManus EJ, 2004, EMBO J, V23, P2071, DOI 10.1038/sj.emboj.7600218; Milojevic T, 2006, MOL PHARMACOL, V69, P1083, DOI 10.1124/mol.105.015818; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Scheid MP, 2005, MOL CELL BIOL, V25, P2347, DOI 10.1128/MCB.25.6.2347-2363.2005; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Zhang XN, 2011, EMBO J, V30, P2177, DOI 10.1038/emboj.2011.125; Zhao B, 2009, J CELL MOL MED, V13, P1886, DOI 10.1111/j.1582-4934.2009.00682.x	46	19	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31003	10.1371/journal.pone.0031003	http://dx.doi.org/10.1371/journal.pone.0031003			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347420	Green Published, gold, Green Submitted			2022-12-25	WOS:000302180600022
J	Guo, J; Kim, D; Gao, J; Kurtyka, C; Chen, H; Yu, C; Wu, D; Mittal, A; Beg, AA; Chellappan, SP; Haura, EB; Cheng, JQ				Guo, J.; Kim, D.; Gao, J.; Kurtyka, C.; Chen, H.; Yu, C.; Wu, D.; Mittal, A.; Beg, A. A.; Chellappan, S. P.; Haura, E. B.; Cheng, J. Q.			IKBKE is induced by STAT3 and tobacco carcinogen and determines chemosensitivity in non-small cell lung cancer	ONCOGENE			English	Article						IKBKE; STAT3; tobacco carcinogen; chemosensitivity; lung cancer	B KINASE-EPSILON; PULMONARY NEUROENDOCRINE CELLS; TUMOR-SUPPRESSOR CYLD; IKK-EPSILON; BREAST-CANCER; NICOTINIC RECEPTOR; EPITHELIAL-CELLS; GENE-EXPRESSION; SRC ONCOPROTEIN; IN-VIVO	Serine/threonine kinase IKBKE is a newly identified oncogene; however, its regulation remains elusive. Here, we provide evidence that IKBKE is a downstream target of signal transducer and activator of transcription 3 (STAT3) and that tobacco components induce IKBKE expression through STAT3. Ectopic expression of constitutively active STAT3 increased IKBKE mRNA and protein levels, whereas inhibition of STAT3 reduced IKBKE expression. Furthermore, expression levels of IKBKE are significantly associated with STAT3 activation and tobacco use history in non-small cell lung cancer (NSCLC) patients examined. In addition, we show induction of IKBKE by two components of cigarette smoke, nicotine and nicotine-derived nitrosamine ketone (NNK). Upon exposure to nicotine or NNK, cells express high levels of IKBKE protein and mRNA, which are largely abrogated by inhibition of STAT3. Characterization of the IKBKE promoter revealed two STAT3-response elements. The IKBKE promoter directly bound to STAT3 and responded to nicotine and NNK stimulation. Notably, enforcing expression of IKBKE induces chemoresistance, whereas knockdown of IKBKE not only sensitizes NSCLC cells to chemotherapy but also abrogates STAT3- and nicotine-induced cell survival. These data indicate for the first time that IKBKE is a direct target of STAT3 and is induced by tobacco carcinogens through STAT3 pathway. In addition, our study also suggests that IKBKE is an important therapeutic target and could have a pivotal role in tobacco-associated lung carcinogenesis. Oncogene (2013) 32, 151-159; doi:10.1038/onc.2012.39; published online 13 February 2012	[Guo, J.; Kim, D.; Gao, J.; Kurtyka, C.; Chen, H.; Yu, C.; Wu, D.; Mittal, A.; Cheng, J. Q.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Mol Oncol, Tampa, FL 33682 USA; [Beg, A. A.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Immunol, Tampa, FL 33682 USA; [Chellappan, S. P.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Tumor Biol, Tampa, FL 33682 USA; [Haura, E. B.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Thorac Oncol, Tampa, FL 33682 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Cheng, JQ (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, 12902 Magnolia Dr,SRB3, Tampa, FL 33612 USA.	jin.cheng@moffitt.org	Chen, Huihua/D-9162-2019	Chen, Huihua/0000-0002-5045-6845; Wu, Danwei/0000-0003-3411-0382	NCI [CA137041, P50 CA119997]; James and Esther King Biomedical Research Program [1KG02, 1KD04, 1KN08]; NATIONAL CANCER INSTITUTE [R01CA137041, P30CA076292, P50CA119997, R01CA160455] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); James and Esther King Biomedical Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Tissue Procurement, DNA Sequence and Image Core Facilities at H Lee Moffitt Cancer Center for providing cancer specimens, sequencing and cell apoptosis analysis as well as Fumi Kinose for helping provide lung cancer cell lines from the Moffitt lung cancer cell line core. This work was supported by NCI Grants CA137041 (JQC) and P50 CA119997 (EBH) and James and Esther King Biomedical Research Program 1KG02 (JQC), 1KD04 (JG) and 1KN08 (DK).	Adli M, 2006, J BIOL CHEM, V281, P26976, DOI 10.1074/jbc.M603133200; Arredondo J, 2006, FASEB J, V20, P2093, DOI 10.1096/fj.06-6191com; Barre B, 2005, J BIOL CHEM, V280, P15673, DOI 10.1074/jbc.M413203200; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Chang KT, 2005, AM J PHYSIOL-LUNG C, V289, pL446, DOI 10.1152/ajplung.00089.2005; Chen RJ, 2008, TOXICOL SCI, V104, P283, DOI 10.1093/toxsci/kfn086; Chen RJ, 2010, TOXICOL SCI, V115, P118, DOI 10.1093/toxsci/kfq028; Cheng AN, 2011, AM J CLIN PATHOL, V136, P60, DOI 10.1309/AJCP2JJGYNIUAS2V; Dasgupta P, 2006, CELL CYCLE, V5, P2324, DOI 10.4161/cc.5.20.3366; Eddy SF, 2005, CANCER RES, V65, P11375, DOI 10.1158/0008-5472.CAN-05-1602; Epling-Burnette PK, 2001, J CLIN INVEST, V107, P351, DOI 10.1172/JCI9940; Fan J, 2007, EJSO-EUR J SURG ONC, V33, P639, DOI 10.1016/j.ejso.2007.02.001; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Guo JP, 2011, J BIOL CHEM, V286, P37389, DOI 10.1074/jbc.M111.287433; Guo JP, 2010, J BIOL CHEM, V285, P3676, DOI 10.1074/jbc.M109.078212; Guo JP, 2009, AM J PATHOL, V175, P324, DOI 10.2353/ajpath.2009.080767; Harris J, 2006, J IMMUNOL, V177, P2527, DOI 10.4049/jimmunol.177.4.2527; Haura EB, 2005, CLIN CANCER RES, V11, P8288, DOI 10.1158/1078-0432.CCR-05-0827; Hosur V, 2011, MOL PHARMACOL, V79, P167, DOI 10.1124/mol.110.066381; Hutti JE, 2009, MOL CELL, V34, P461, DOI 10.1016/j.molcel.2009.04.031; Jull BA, 2001, J CANCER RES CLIN, V127, P707; Keen JC, 2006, IMMUNOLOGY, V117, P29, DOI 10.1111/j.1365-2567.2005.02260.x; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Liu XD, 2007, BIOCHEM BIOPH RES CO, V353, P121, DOI 10.1016/j.bbrc.2006.11.147; Liu Y, 2010, ANTI-CANCER AGENT ME, V10, P512, DOI 10.2174/187152010793498636; Mai HQ, 2003, J BIOL CHEM, V278, P1886, DOI 10.1074/jbc.M209044200; Mattioli I, 2006, J BIOL CHEM, V281, P6175, DOI 10.1074/jbc.M508045200; Memmott RM, 2010, CLIN CANCER RES, V16, P4, DOI 10.1158/1078-0432.CCR-09-0234; Nadiminty N, 2006, P NATL ACAD SCI USA, V103, P7264, DOI 10.1073/pnas.0509808103; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; Peters RT, 2000, MOL CELL, V5, P513, DOI 10.1016/S1097-2765(00)80445-1; Schuller HM, 2003, ANAT REC PART A, V270A, P51, DOI 10.1002/ar.a.10019; Shimada T, 1999, INT IMMUNOL, V11, P1357, DOI 10.1093/intimm/11.8.1357; Sierra J, 2003, MOL CELL BIOL, V23, P3339, DOI 10.1128/MCB.23.9.3339-3351.2003; Sinibaldi D, 2000, ONCOGENE, V19, P5419, DOI 10.1038/sj.onc.1203947; Song LX, 2003, ONCOGENE, V22, P4150, DOI 10.1038/sj.onc.1206479; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Tsurutani J, 2005, CARCINOGENESIS, V26, P1182, DOI 10.1093/carcin/bgi072; Vignais ML, 1996, MOL CELL BIOL, V16, P1759; Wang NZ, 2005, GENE, V353, P118, DOI 10.1016/j.gene.2005.04.013; Wen X, 1999, J BIOL CHEM, V274, P38204, DOI 10.1074/jbc.274.53.38204; West KA, 2004, CANCER RES, V64, P446, DOI 10.1158/0008-5472.CAN-03-3241; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Xie XD, 2011, P NATL ACAD SCI USA, V108, P6474, DOI 10.1073/pnas.1016132108; Yoshida H, 2005, J BIOL CHEM, V280, P41111, DOI 10.1074/jbc.M509526200; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	50	57	62	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN 10	2013	32	2					151	159		10.1038/onc.2012.39	http://dx.doi.org/10.1038/onc.2012.39			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	078CK	22330135	Green Accepted			2022-12-25	WOS:000314075500003
J	Zhang, S; Chen, H; Zhao, X; Cao, J; Tong, J; Lu, J; Wu, W; Shen, H; Wei, Q; Lu, D				Zhang, S.; Chen, H.; Zhao, X.; Cao, J.; Tong, J.; Lu, J.; Wu, W.; Shen, H.; Wei, Q.; Lu, D.			REV3L 3 ' UTR 460 T > C polymorphism in microRNA target sites contributes to lung cancer susceptibility	ONCOGENE			English	Article						genetic polymorphism; REV3L; lung cancer; microRNA	DNA-POLYMERASE-ZETA; CATALYTIC SUBUNIT; GENETIC-VARIANTS; BINDING-SITE; RISK; DISRUPTION; CHINESE; LEADS	REV3Lp, the catalytic subunit of DNA polymerase zeta, is the major participant in translesion DNA synthesis. Recent evidence suggests that REV3L has an important role in the maintenance of genome stability despite its mutagenic characteristics. Such a function makes it a cancer susceptibility candidate gene. To investigate association between REV3L polymorphisms and lung cancer risk in a Chinese population, we first genotyped 15 common polymorphisms of the REV3L gene and found that three single nucleotide polymorphisms (rs465646, rs459809 and rs1002481) were significantly associated with lung cancer risk. One of the strongest associations observed was for the 3'-terminal untranslated region (3'UTR) 460 T>C polymorphism (rs465646) (adjusted odds ratio (OR) = 0.69 for TC/CC; P = 0.007, compared with TT). Similar results were obtained in a subsequent replication study (adjusted OR = 0.72; P = 0.016). Combined data from the two studies of 1072 lung cancer patients and 1064 cancer-free controls generated an even stronger association (adjusted OR = 0.71; P = 3.04 x 10(-4)). This 3'UTR 460 T>C variant was predicted to modulate the binding of several micro RNAs. Surface plasmon resonance analysis and luciferase assays showed that the T allele demonstrated a stronger binding affinity for miR-25 and miR-32, resulting in significantly weaker reporter expression levels. Additional experiments revealed that miR-25/32 could downregulate endogenous REV3L. Furthermore, the tumor-suppressing role of REV3L was confirmed by the foci formation assay. These results support our hypothesis that the REV3L rs465646 variant modifies lung cancer susceptibility in Chinese Han population by affecting miRNA-mediated gene regulation. Oncogene (2013) 32, 242-250; doi:10.1038/onc.2012.32; published online 20 February 2012	[Zhang, S.; Chen, H.; Zhao, X.; Lu, J.; Wu, W.; Lu, D.] Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zhang, S.; Chen, H.; Zhao, X.; Lu, J.; Wu, W.; Lu, D.] Fudan Univ, Sch Life Sci, Inst Genet, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Zhang, S.; Cao, J.; Tong, J.] Soochow Univ, Coll Med, Sch Radiat Med & Protect, Suzhou, Peoples R China; [Shen, H.] Nanjing Med Univ, Ctr Canc, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Wei, Q.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	Fudan University; Fudan University; Soochow University - China; Nanjing Medical University; University of Texas System; UTMD Anderson Cancer Center	Lu, D (corresponding author), Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, 220 Handan Rd, Shanghai 200433, Peoples R China.	drlu@fudan.edu.cn	wu, wenting/Q-4979-2016	wu, wenting/0000-0003-0982-771X	Shanghai Science and Technology Research Program [09JC1402200, 10410709100]; Natural Science Foundation of China [30800622, 81001114, 81020108028]; Scientific Research Foundation for the Returned Overseas Chinese Scholars (State Education Ministry); Ministry of Education of China; Shanghai Key Subject Project for Public Health [08GWZX0301]	Shanghai Science and Technology Research Program; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars (State Education Ministry)(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Ministry of Education of China(Ministry of Education, China); Shanghai Key Subject Project for Public Health	This work was partially supported by the Shanghai Science and Technology Research Program (Grants 09JC1402200 and 10410709100), the Natural Science Foundation of China (Grants 30800622, 81001114 and 81020108028), the Scientific Research Foundation for the Returned Overseas Chinese Scholars (State Education Ministry), the Doctoral Fund of the Ministry of Education of China and the Shanghai Key Subject Project for Public Health (Grant 08GWZX0301).	Bemark M, 2000, CURR BIOL, V10, P1213, DOI 10.1016/S0960-9822(00)00724-7; Brondello JM, 2008, ONCOGENE, V27, P6093, DOI 10.1038/onc.2008.212; Chen D, 2008, CARCINOGENESIS, V29, P342, DOI 10.1093/carcin/bgm285; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; DATTA A, 1995, SCIENCE, V268, P1616, DOI 10.1126/science.7777859; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Esposito G, 2000, CURR BIOL, V10, P1221, DOI 10.1016/S0960-9822(00)00726-0; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Gan GN, 2008, CELL RES, V18, P174, DOI 10.1038/cr.2007.117; Gibbs PEM, 1998, P NATL ACAD SCI USA, V95, P6876, DOI 10.1073/pnas.95.12.6876; Hoeijmakers JHJ, 2007, MECH AGEING DEV, V128, P460, DOI 10.1016/j.mad.2007.05.002; Hu ZB, 2007, HUM MUTAT, V28, P431, DOI 10.1002/humu.20462; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Kajiwara K, 1996, BIOCHEM BIOPH RES CO, V219, P795, DOI 10.1006/bbrc.1996.0313; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Krieg AJ, 2006, MOL CELL BIOL, V26, P7030, DOI 10.1128/MCB.00322-06; Lawrence CW, 2001, PHILOS T R SOC B, V356, P41, DOI 10.1098/rstb.2000.0001; Lehmann AR, 2005, FEBS LETT, V579, P873, DOI 10.1016/j.febslet.2004.11.029; LEMONTT JF, 1972, MOL GEN GENET, V119, P27, DOI 10.1007/BF00270441; Lin WS, 1999, MUTAT RES-DNA REPAIR, V433, P89, DOI 10.1016/S0921-8777(98)00065-2; Lu J, 2009, FASEB J, V23, P3459, DOI 10.1096/fj.09-136549; Matsuda T, 2000, NATURE, V404, P1011, DOI 10.1038/35010014; Mishra PJ, 2007, P NATL ACAD SCI USA, V104, P13513, DOI 10.1073/pnas.0706217104; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; Nojima K, 2005, CANCER RES, V65, P11704, DOI 10.1158/0008-5472.CAN-05-1214; Pan QR, 2005, CANCER LETT, V217, P139, DOI 10.1016/j.canlet.2004.07.021; Rockwell S, 2001, Novartis Found Symp, V240, P133; Rockwell S, 2001, NOVART FDN SYMP, V240, P142; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Sonoda E, 2003, EMBO J, V22, P3188, DOI 10.1093/emboj/cdg308; Vatolin S, 2006, J MOL BIOL, V358, P983, DOI 10.1016/j.jmb.2006.02.063; Venkatesan RN, 2006, DNA REPAIR, V5, P294, DOI 10.1016/j.dnarep.2005.10.012; Wang G, 2008, AM J HUM GENET, V82, P283, DOI 10.1016/j.ajhg.2007.09.021; Wang HB, 2009, NEURO-ONCOLOGY, V11, P790, DOI 10.1215/15228517-2009-015; Wang QZ, 2009, CURR CANCER DRUG TAR, V9, P572, DOI 10.2174/156800909788486731; Wittschieben JP, 2006, CANCER RES, V66, P134, DOI 10.1158/0008-5472.CAN-05-2982; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480; Zhang YB, 2000, MOL CELL BIOL, V20, P7099, DOI 10.1128/MCB.20.19.7099-7108.2000; Zhu F, 2003, WORLD J GASTROENTERO, V9, P888	40	44	48	0	23	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 10	2013	32	2					242	250		10.1038/onc.2012.32	http://dx.doi.org/10.1038/onc.2012.32			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	078CK	22349819				2022-12-25	WOS:000314075500012
J	Kashima, L; Idogawa, M; Mita, H; Shitashige, M; Yamada, T; Ogi, K; Suzuki, H; Toyota, M; Ariga, H; Sasaki, Y; Tokino, T				Kashima, Lisa; Idogawa, Masashi; Mita, Hiroaki; Shitashige, Miki; Yamada, Tesshi; Ogi, Kazuhiro; Suzuki, Hiromu; Toyota, Minoru; Ariga, Hiroyoshi; Sasaki, Yasushi; Tokino, Takashi			CHFR Protein Regulates Mitotic Checkpoint by Targeting PARP-1 Protein for Ubiquitination and Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(ADP-RIBOSE) POLYMERASE-1; EPIGENETIC INACTIVATION; MICROTUBULE INHIBITORS; COLORECTAL-CANCER; BETA-CATENIN; CELL-CYCLE; GENE; EXPRESSION; DNA; INSTABILITY	The mitotic checkpoint gene CHFR (checkpoint with fork-head-associated (FHA) and RING finger domains) is silenced by promoter hypermethylation or mutated in various human cancers, suggesting that CHFR is an important tumor suppressor. Recent studies have reported that CHFR functions as an E3 ubiquitin ligase, resulting in the degradation of target proteins. To better understand how CHFR suppresses cell cycle progression and tumorigenesis, we sought to identify CHFR-interacting proteins using affinity purification combined with mass spectrometry. Here we show poly(ADP-ribose) polymerase 1 (PARP-1) to be a novel CHFR-interacting protein. In CHFR-expressing cells, mitotic stress induced the autoPARylation of PARP-1, resulting in an enhanced interaction between CHFR and PARP-1 and an increase in the polyubiquitination/degradation of PARP-1. The decrease in PARP-1 protein levels promoted cell cycle arrest at prophase, supporting that the cells expressing CHFR were resistant to microtubule inhibitors. In contrast, in CHFR-silenced cells, polyubiquitination was not induced in response to mitotic stress. Thus, PARP-1 protein levels did not decrease, and cells progressed into mitosis under mitotic stress, suggesting that CHFR-silenced cancer cells were sensitized to microtubule inhibitors. Furthermore, we found that cells from Chfr knockout mice and CHFR-silenced primary gastric cancer tissues expressed higher levels of PARP-1 protein, strongly supporting our data that the interaction between CHFR and PARP-1 plays an important role in cell cycle regulation and cancer therapeutic strategies. On the basis of our studies, we demonstrate a significant advantage for use of combinational chemotherapy with PARP inhibitors for cancer cells resistant to microtubule inhibitors.	[Tokino, Takashi] Sapporo Med Univ, Dept Med Genome Sci, Res Inst Frontier Med, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Shitashige, Miki; Yamada, Tesshi] Natl Inst Canc Res, Div Chemotherapy, Tokyo 1040045, Japan; [Shitashige, Miki; Yamada, Tesshi] Natl Inst Canc Res, Canc Prote Project, Tokyo 1040045, Japan; [Suzuki, Hiromu; Toyota, Minoru] Sapporo Med Univ, Dept Mol Biol, Sapporo, Hokkaido 0608556, Japan; [Kashima, Lisa; Ariga, Hiroyoshi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan	Sapporo Medical University; National Cancer Center - Japan; National Cancer Center - Japan; Sapporo Medical University; Hokkaido University	Tokino, T (corresponding author), Sapporo Med Univ, Dept Med Genome Sci, Res Inst Frontier Med, Chuo Ku, S-1,W-17, Sapporo, Hokkaido 0608556, Japan.	tokino@sapmed.ac.jp	Idogawa, Masashi/B-5208-2008; Ariga, Hiroyoshi/B-5895-2013; Tokino, Takashi/AAI-9887-2021; Sasaki, Yasushi/AAA-3079-2019	Idogawa, Masashi/0000-0002-8507-1726; Ariga, Hiroyoshi/0000-0001-7384-2143; Sasaki, Yasushi/0000-0002-3500-8059	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Kanzawa Medical Research Foundation; Grants-in-Aid for Scientific Research [21390014] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kanzawa Medical Research Foundation(Kanzawa Medical Research Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. T.) and the Kanzawa Medical Research Foundation (to L. K.).	Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; Annunziata CM, 2010, CLIN CANCER RES, V16, P4517, DOI 10.1158/1078-0432.CCR-10-0526; Bieche I, 1996, CLIN CANCER RES, V2, P1163; Bothos J, 2003, ONCOGENE, V22, P7101, DOI 10.1038/sj.onc.1206831; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Chang P, 2004, NATURE, V432, P645, DOI 10.1038/nature03061; Chaturvedi P, 2002, CANCER RES, V62, P1797; Idogawa M, 2005, GASTROENTEROLOGY, V128, P1919, DOI 10.1053/j.gastro.2005.03.007; Idogawa M, 2007, CANCER RES, V67, P911, DOI 10.1158/0008-5472.CAN-06-2360; Igarashi S, 2010, CLIN CANCER RES, V16, P5114, DOI 10.1158/1078-0432.CCR-10-0581; Kang DM, 2002, J CELL BIOL, V156, P249, DOI 10.1083/jcb.200108016; Kashima L, 2009, ONCOGENE, V28, P2643, DOI 10.1038/onc.2009.123; Kawasaki T, 2008, MODERN PATHOL, V21, P245, DOI 10.1038/modpathol.3800982; Martin N, 2009, EMBO J, V28, P3534, DOI 10.1038/emboj.2009.279; Miwa M, 2007, CANCER SCI, V98, P1528, DOI 10.1111/j.1349-7006.2007.00567.x; Ogi K, 2005, CANCER BIOL THER, V4, P773, DOI 10.4161/cbt.4.7.1896; Privette LM, 2008, TRANSL ONCOL, V1, P57, DOI 10.1593/tlo.08109; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Satoh A, 2003, CANCER RES, V63, P8606; Saxena A, 2002, J BIOL CHEM, V277, P26921, DOI 10.1074/jbc.M200620200; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Scolnick DM, 2000, NATURE, V406, P430, DOI 10.1038/35019108; Shimizu S, 2004, ONCOL REP, V12, P821; Soldatenkov VA, 1999, ONCOGENE, V18, P3954, DOI 10.1038/sj.onc.1202778; Suzuki H, 2000, CANCER RES, V60, P4353; TANUMA S, 1982, J BIOL CHEM, V257, P6565; Tentori L, 2010, CURR CANCER DRUG TAR, V10, P368, DOI 10.2174/156800910791208571; TOMODA T, 1991, AM J HEMATOL, V37, P223, DOI 10.1002/ajh.2830370402; Toyota M, 2003, P NATL ACAD SCI USA, V100, P7818, DOI 10.1073/pnas.1337066100; Wang T, 2008, J CELL BIOCHEM, V104, P318, DOI 10.1002/jcb.21624; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Wesierska-Gadek J, 2004, CANCER RES, V64, P4487, DOI 10.1158/0008-5472.CAN-03-3410; Yu XC, 2005, NAT GENET, V37, P401, DOI 10.1038/ng1538	33	70	74	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12975	12984		10.1074/jbc.M111.321828	http://dx.doi.org/10.1074/jbc.M111.321828			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22337872	Green Published, hybrid			2022-12-25	WOS:000302903700036
J	Konsavage, WM; Kyler, SL; Rennoll, SA; Jin, G; Yochum, GS				Konsavage, Wesley M., Jr.; Kyler, Sydney L.; Rennoll, Sherri A.; Jin, Ge; Yochum, Gregory S.			Wnt/beta-Catenin Signaling Regulates Yes-associated Protein (YAP) Gene Expression in Colorectal Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGAN SIZE CONTROL; HIPPO PATHWAY; TRANSCRIPTIONAL COACTIVATOR; CHROMATIN OCCUPANCY; PROMOTES APOPTOSIS; CONTACT INHIBITION; TUMOR-SUPPRESSOR; ALPHA-CATENIN; EFFECTOR YAP; WNT PATHWAY	Mutations in the Wnt/beta-catenin pathway occur in most colorectal cancers (CRCs), and these mutations lead to increased nuclear accumulation of the beta-catenin transcriptional co-activator. In the nucleus, beta-catenin associates with TCF/LEF sequence specific transcription factors to activate target gene expression. The Hippo pathway restricts cellular growth by preventing nuclear accumulation of the Yes-associated protein (YAP) transcriptional co-activator. YAP expression is elevated in CRCs suggesting that, like Wnt/beta-catenin signaling, the Hippo pathway may contribute to colorectal carcinogenesis. Regulation of YAP at the post-translational level has been well studied but the transcription factors that control YAP gene expression are unknown. Here we demonstrate that beta-catenin/TCF4 complexes bind a DNA enhancer element within the first intron of the YAP gene to drive YAP expression in CRC cells. As such, reducing beta-catenin expression in CRC cells using shRNAs leads to decreased YAP mRNA and protein levels. YAP is abundantly expressed in the cytoplasm and nuclei of several established human colon cancer cell lines and this localization pattern is insensitive to plating density. Finally, we show that YAP expression is elevated in the majority of a panel of primary human colorectal tumors compared with its expression in uninvolved colonic mucosa, and that YAP and beta-catenin localize to the nuclear compartment of tumor cells. Together, these results implicate YAP as an oncogene whose expression is driven by aberrant Wnt/beta-catenin signaling in human CRC cells.	[Konsavage, Wesley M., Jr.; Kyler, Sydney L.; Rennoll, Sherri A.; Jin, Ge; Yochum, Gregory S.] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Yochum, GS (corresponding author), Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Room C5757,500 Univ Dr, Hershey, PA 17033 USA.	gsy3@psu.edu	Raup-Konsavage, Wesley/ABB-1910-2020	Raup-Konsavage, Wesley/0000-0001-9413-9852	National Institutes of Health [R01DK080805]; Pennsylvania State University College of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080805] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania State University College of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK080805 (to G. S. Y.) and institutional funds provided by the Pennsylvania State University College of Medicine.	Anderson CB, 2002, P NATL ACAD SCI USA, V99, P8683, DOI 10.1073/pnas.122235399; Archbold HC, 2012, ACTA PHYSIOL, V204, P74, DOI 10.1111/j.1748-1716.2011.02293.x; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Bottomly D, 2010, NUCLEIC ACIDS RES, V38, P5735, DOI 10.1093/nar/gkq363; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; da Costa LT, 1999, ONCOGENE, V18, P5010, DOI 10.1038/sj.onc.1202872; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Hall CA, 2010, CANCER RES, V70, P8517, DOI 10.1158/0008-5472.CAN-10-1242; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Hergovich A, 2010, DEV CELL, V18, P508, DOI 10.1016/j.devcel.2010.04.003; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Liu AM, 2010, BIOCHEM BIOPH RES CO, V394, P623, DOI 10.1016/j.bbrc.2010.03.036; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Rizvi AZ, 2005, STEM CELLS, V23, P150, DOI 10.1634/stemcells.2004-0096; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Silvis MR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001823; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Yochum GS, 2007, P NATL ACAD SCI USA, V104, P3324, DOI 10.1073/pnas.0611576104; Yochum GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018966; Yochum GS, 2010, P NATL ACAD SCI USA, V107, P145, DOI 10.1073/pnas.0912294107; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhang X, 2011, ONCOGENE, V30, P2810, DOI 10.1038/onc.2011.8; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108	42	203	206	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11730	11739		10.1074/jbc.M111.327767	http://dx.doi.org/10.1074/jbc.M111.327767			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22337891	Green Published, hybrid			2022-12-25	WOS:000302782200012
J	Zhang, JX; Yang, X; Wang, Z; Zhou, H; Xie, XQ; Shen, YQ; Long, JF				Zhang, Jinxiu; Yang, Xue; Wang, Zheng; Zhou, Hao; Xie, Xingqiao; Shen, Yuequan; Long, Jiafu			Structure of an L27 Domain Heterotrimer from Cell Polarity Complex Patj/Pals1/Mals2 Reveals Mutually Independent L27 Domain Assembly Mode	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA STARDUST; PROTEIN; CRUMBS; ASSOCIATION; INTERACTS; HOMOLOGS; ADHESION; FAMILY; PHENIX	Background: Tandem L27 domains are important for multidomain proteins to assemble into supramolecular complexes for cell polarity regulation. Results: Tandem L27 domain-mediated tripartite Patj/Pals1/Mals2 and DLG1 CASK/Mals2 complexes form in a mutually independent assembly mode. Conclusion: The mutually independent assembly mode may be a novel mechanism for tandem L27 domain-mediated, tripartite complex formation. Significance: These findings reveal the distinct mechanism of tandem L27 domain-mediated assembly of obligate supramolecular complexes.	[Zhang, Jinxiu; Yang, Xue; Wang, Zheng; Zhou, Hao; Xie, Xingqiao; Shen, Yuequan; Long, Jiafu] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Zhang, Jinxiu; Yang, Xue; Wang, Zheng; Zhou, Hao; Xie, Xingqiao; Shen, Yuequan; Long, Jiafu] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Shen, YQ (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, 94 Weijin Rd, Tianjin 300071, Peoples R China.	yuequan74@yahoo.com; jflong@nankai.edu.cn	Zhou, Hao/G-9693-2019; Shen, Yuequan/C-8950-2013; Long, Jiafu/B-7420-2012	Zhou, Hao/0000-0001-6813-648X; Shen, Yuequan/0000-0002-3775-0900; Long, Jiafu/0000-0002-6625-0147	973 Program [2009CB825504]; Natural Science Foundation of China (NSFC) [31140029, 31100527, 31170684]; Fundamental Research Funds for the Central Universities [65011621, 65020241]	973 Program(National Basic Research Program of China); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was funded by the 973 Program (Grant 2009CB825504), the Natural Science Foundation of China (NSFC) (Grants 31140029, 31100527, and 31170684), and the Fundamental Research Funds for the Central Universities (Grants 65011621 and 65020241).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bachmann A, 2001, NATURE, V414, P638, DOI 10.1038/414638a; Bohl J, 2007, J BIOL CHEM, V282, P9392, DOI 10.1074/jbc.M610002200; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Doerks T, 2000, TRENDS BIOCHEM SCI, V25, P317, DOI 10.1016/S0968-0004(00)01599-1; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng W, 2005, P NATL ACAD SCI USA, V102, P6861, DOI 10.1073/pnas.0409346102; Feng W, 2004, NAT STRUCT MOL BIOL, V11, P475, DOI 10.1038/nsmb751; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Harris BZ, 2002, J BIOL CHEM, V277, P34902, DOI 10.1074/jbc.M205856200; Hong Y, 2001, NATURE, V414, P634, DOI 10.1038/414634a; Jo K, 1999, J NEUROSCI, V19, P4189, DOI 10.1523/jneurosci.19-11-04189.1999; Kamberov E, 2000, J BIOL CHEM, V275, P11425, DOI 10.1074/jbc.275.15.11425; Karnak D, 2002, J BIOL CHEM, V277, P46730, DOI 10.1074/jbc.M208781200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lee S, 2002, MOL CELL BIOL, V22, P1778, DOI 10.1128/MCB.22.6.1778-1791.2002; Lemmers C, 2002, J BIOL CHEM, V277, P25408, DOI 10.1074/jbc.M202196200; Li YH, 2004, EMBO J, V23, P2723, DOI 10.1038/sj.emboj.7600294; Macara AG, 2004, CURR BIOL, V14, pR160, DOI 10.1016/j.cub.2004.01.048; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Olsen O, 2007, J CELL BIOL, V179, P151, DOI 10.1083/jcb.200702054; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Petrosky KY, 2005, J BIOL CHEM, V280, P38528, DOI 10.1074/jbc.M506536200; Roh MH, 2002, J CELL BIOL, V157, P161, DOI 10.1083/jcb.200109010; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Srinivasan K, 2008, DEVELOPMENT, V135, P1781, DOI 10.1242/dev.013847; Straight SW, 2006, J BIOL CHEM, V281, P37738, DOI 10.1074/jbc.M607059200; Yang X, 2010, FASEB J, V24, P4806, DOI 10.1096/fj.10-163857; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	35	12	14	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11132	11140		10.1074/jbc.M111.321216	http://dx.doi.org/10.1074/jbc.M111.321216			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22337881	Green Published, hybrid			2022-12-25	WOS:000302780100041
J	Hoy, B; Geppert, T; Boehm, M; Reisen, F; Plattner, P; Gadermaier, G; Sewald, N; Ferreira, F; Briza, P; Schneider, G; Backert, S; Wessler, S				Hoy, Benjamin; Geppert, Tim; Boehm, Manja; Reisen, Felix; Plattner, Patrick; Gadermaier, Gabriele; Sewald, Norbert; Ferreira, Fatima; Briza, Peter; Schneider, Gisbert; Backert, Steffen; Wessler, Silja			Distinct Roles of Secreted HtrA Proteases from Gram-negative Pathogens in Cleaving the Junctional Protein and Tumor Suppressor E-cadherin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICOBACTER-PYLORI; SHIGELLA-FLEXNERI; EPITHELIAL-CELLS; NATURAL SUBSTRATE; STRESS-RESPONSE; DEGP PROTEASE; EXPRESSION; MONOLAYERS; CHAPERONE; ADHESION	The periplasmic chaperone and serine protease HtrA is important for bacterial stress responses and protein quality control. Recently, we discovered that HtrA from Helicobacter pylori is secreted and cleaves E-cadherin to disrupt the epithelial barrier, but it remained unknown whether this maybe a general virulence mechanism. Here, we show that important other pathogens including enteropathogenic Escherichia coli, Shigella flexneri, and Campylobacter jejuni, but not Neisseria gonorrhoeae, cleaved E-cadherin on host cells. HtrA deletion in C. jejuni led to severe defects in E-cadherin cleavage, loss of cell adherence, paracellular transmigration, and basolateral invasion. Computational modeling of HtrAs revealed a conserved pocket in the active center exhibiting pronounced proteolytic activity. Differential E-cadherin cleavage was determined by an alanine-to-glutamine exchange in the active center of neisserial HtrA. These data suggest that HtrA-mediated E-cadherin cleavage is a prevalent pathogenic mechanism of multiple Gram-negative bacteria representing an attractive novel target for therapeutic intervention to combat bacterial infections.	[Hoy, Benjamin; Wessler, Silja] Salzburg Univ, Div Microbiol, A-5020 Salzburg, Austria; [Gadermaier, Gabriele; Ferreira, Fatima; Briza, Peter] Salzburg Univ, Christian Doppler Lab Allergy Diag & Therapy, A-5020 Salzburg, Austria; [Geppert, Tim; Reisen, Felix; Schneider, Gisbert] ETH, Dept Chem & Appl Biosci, CH-8092 Zurich, Switzerland; [Boehm, Manja; Backert, Steffen] Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin 4, Ireland; [Plattner, Patrick; Sewald, Norbert] Univ Bielefeld, Dept Chem Organ & Bioorgan Chem, D-33501 Bielefeld, Germany	Salzburg University; Salzburg University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University College Dublin; University of Bielefeld	Wessler, S (corresponding author), Salzburg Univ, Div Microbiol, A-5020 Salzburg, Austria.	silja.wessler@sbg.ac.at	Briza, Peter/D-7309-2012; Wessler, Silja/C-6309-2015; Sewald, Norbert/A-2541-2012; Gadermaier, Gabriele/L-5997-2015; Ferreira, Fatima/AAB-4321-2019; Ferreira, Fatima/E-4889-2011	Briza, Peter/0000-0002-4941-6782; Wessler, Silja/0000-0001-7011-6162; Sewald, Norbert/0000-0002-0309-2655; Gadermaier, Gabriele/0000-0002-4886-417X; Ferreira, Fatima/0000-0003-0989-2335; Ferreira, Fatima/0000-0003-0989-2335; Schneider, Gisbert/0000-0001-6706-1084	Paul-Ehrlich Institute; Science Foundation Ireland [UCD 09/IN.1/B2609]; Austrian Science Fund (FWF) [P 24074] Funding Source: researchfish	Paul-Ehrlich Institute; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants from the Paul-Ehrlich Institute (to B. H. trol has been also linked to bacterial pathogenicity (10), but the and S. W.) and by Science Foundation Ireland Grant UCD 09/IN.1/B2609 (to S. B.).	Anderton JM, 2007, MICROB PATHOGENESIS, V42, P225, DOI 10.1016/j.micpath.2007.02.003; Balkovetz DF, 2003, MICROBES INFECT, V5, P613, DOI 10.1016/S1286-4579(03)00089-3; Bodelon G, 2009, J BACTERIOL, V191, P5169, DOI 10.1128/JB.00458-09; Brondsted L, 2005, APPL ENVIRON MICROB, V71, P3205, DOI 10.1128/AEM.71.6.3205-3212.2005; CAVARD D, 1989, J BACTERIOL, V171, P6316, DOI 10.1128/jb.171.11.6316-6322.1989; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Hoy B, 2010, EMBO REP, V11, P798, DOI 10.1038/embor.2010.114; Ingmer H, 2009, RES MICROBIOL, V160, P704, DOI 10.1016/j.resmic.2009.08.017; Jones CH, 2002, J BACTERIOL, V184, P5762, DOI 10.1128/JB.184.20.5762-5771.2002; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Lower M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017986; Lower M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003510; Malladi V, 2004, MICROBES INFECT, V6, P38, DOI 10.1016/j.micinf.2003.09.022; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Niessen CM, 2008, BBA-BIOMEMBRANES, V1778, P562, DOI 10.1016/j.bbamem.2007.12.015; Noe V, 2001, J CELL SCI, V114, P111; Purdy GE, 2002, INFECT IMMUN, V70, P6355, DOI 10.1128/IAI.70.11.6355-6364.2002; Reisen F, 2010, J PROTEOME RES, V9, P6498, DOI 10.1021/pr100719n; SANSONETTI PJ, 1994, CELL, V76, P829, DOI 10.1016/0092-8674(94)90358-1; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; VASSELON T, 1992, INFECT IMMUN, V60, P1031, DOI 10.1128/IAI.60.3.1031-1040.1992; Vogt SL, 2010, MOL MICROBIOL, V76, P1095, DOI 10.1111/j.1365-2958.2010.07145.x; Volokhina EB, 2011, J BACTERIOL, V193, P1612, DOI 10.1128/JB.00532-10; Wang J, 1998, MOL MICROBIOL, V30, P657, DOI 10.1046/j.1365-2958.1998.01102.x; Weisel M, 2007, CHEM CENT J, V1, DOI 10.1186/1752-153X-1-7; Wroblewski LE, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-29; Wu X, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-87	28	116	120	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10115	10120		10.1074/jbc.C111.333419	http://dx.doi.org/10.1074/jbc.C111.333419			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22337879	Green Published, hybrid			2022-12-25	WOS:000302167200043
J	Tanaka, T; Padavattan, S; Kumarevel, T				Tanaka, Tomoyuki; Padavattan, Sivaraman; Kumarevel, Thirumananseri			Crystal Structure of Archaeal Chromatin Protein Alba2-Double-stranded DNA Complex from Aeropyrum pernix K1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; SIR2; ALBA; MECHANISM; SSH10B	All thermophilic and hyperthermophilic archaea encode homologs of dimeric Alba (Sac10b) proteins that bind cooperatively at high density to DNA. Here, we report the 2.0 angstrom resolution crystal structure of an Alba2 (Ape10b2)-dsDNA complex from Aeropyrum pernix K1. A rectangular tube-like structure encompassing duplex DNA reveals the positively charged residues in the monomer-monomer interface of each dimer packing on either side of the bound dsDNA in successive minor grooves. The extended hairpin loop connecting strands beta 3 and beta 4 undergoes significant conformational changes upon DNA binding to accommodate the other Alba2 dimer during oligomerization. Mutational analysis of key interacting residues confirmed the specificity of Alba2-dsDNA interactions.	[Tanaka, Tomoyuki; Padavattan, Sivaraman; Kumarevel, Thirumananseri] RIKEN SPring 8 Ctr, Harima Inst, Sayo, Hyogo 6795148, Japan	RIKEN	Kumarevel, T (corresponding author), RIKEN SPring 8 Ctr, Harima Inst, 1-1-1 Kouto, Sayo, Hyogo 6795148, Japan.	tskvel@spring8.or.jp	Kumarevel, Thirumananseri/C-6275-2012	Kumarevel, Thirumananseri/0000-0001-9326-6585; Padavattan, Sivaraman/0000-0002-1732-5421	RIKEN SPring-8 Center	RIKEN SPring-8 Center	This research work was supported by the "Program for RIKEN SPring-8 Center projects to meet society's needs."	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bell SD, 2002, SCIENCE, V296, P148, DOI 10.1126/science.1070506; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cui Q, 2003, J BIOL CHEM, V278, P51015, DOI 10.1074/jbc.M308510200; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forbes AJ, 2004, P NATL ACAD SCI USA, V101, P2678, DOI 10.1073/pnas.0306575101; Georges AB, 2010, FASEB J, V24, P346, DOI 10.1096/fj.09-142117; Guo R, 2003, MOL MICROBIOL, V50, P1605, DOI 10.1046/j.1365-2958.2003.03793.x; Jelinska C, 2005, STRUCTURE, V13, P963, DOI 10.1016/j.str.2005.04.016; Jelinska C, 2010, BIOCHEM J, V427, P49, DOI 10.1042/BJ20091841; KEELING PJ, 1995, P NATL ACAD SCI USA, V92, P5761, DOI 10.1073/pnas.92.13.5761; Kumarevel T, 2008, PROTEINS, V71, P1156, DOI 10.1002/prot.21807; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; LURZ R, 1986, EMBO J, V5, P3715, DOI 10.1002/j.1460-2075.1986.tb04705.x; Marc F, 2002, J BIOL CHEM, V277, P30879, DOI 10.1074/jbc.M203674200; Marsh VL, 2005, J BIOL CHEM, V280, P21122, DOI 10.1074/jbc.M501280200; MCPHERSON A, 1990, EUR J BIOCHEM, V189, P1, DOI 10.1111/j.1432-1033.1990.tb15454.x; Oldfield TJ, 2001, ACTA CRYSTALLOGR D, V57, P82, DOI 10.1107/S0907444900014098; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Robinson H, 1998, NATURE, V392, P202, DOI 10.1038/32455; Sandman K, 2005, CURR OPIN MICROBIOL, V8, P656, DOI 10.1016/j.mib.2005.10.007; Wang GG, 2003, PROTEIN SCI, V12, P2815, DOI 10.1110/ps.03325103; Wardleworth BN, 2002, EMBO J, V21, P4654, DOI 10.1093/emboj/cdf465; White MF, 2002, TRENDS GENET, V18, P621, DOI 10.1016/S0168-9525(02)02808-1; Xue H, 2000, J BACTERIOL, V182, P3929, DOI 10.1128/JB.182.14.3929-3933.2000; Zhao KH, 2003, J BIOL CHEM, V278, P26071, DOI 10.1074/jbc.M303666200	28	24	25	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10394	10402		10.1074/jbc.M112.343210	http://dx.doi.org/10.1074/jbc.M112.343210			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22334696	hybrid, Green Published			2022-12-25	WOS:000302167200066
J	Chen, X; Lepier, A; Berninger, B; Tolkovsky, AM; Herbert, J				Chen, Xia; Lepier, Alexandra; Berninger, Benedikt; Tolkovsky, Aviva M.; Herbert, Joe			Cultured Subventricular Zone Progenitor Cells Transduced with Neurogenin-2 Become Mature Glutamatergic Neurons and Integrate into the Dentate Gyrus	PLOS ONE			English	Article							PRONEURAL GENES; ADULT; DIFFERENTIATION; GENERATION; SURVIVAL; IDENTITY	We have previously shown that transplantation of immature DCX+/NeuN+/Prox1+ neurons (found in the neonatal DG), but not undifferentiated neuronal progenitor cells (NPCs) from ventral subventricular zone (SVZ), results in neuronal maturation in vivo within the dentate niche. Here we investigated whether we could enhance the integration of SVZ NPCs by forced expression of the proneural gene Neurogenin 2 (NEUROG2). NPCs cultured from neonatal GFP-transgenic rat SVZ for 7 days in a non-differentiating medium were transduced with a retrovirus encoding NEUROG2 and DsRed or the DsRed reporter gene alone (control). By 3 days post-transduction, the NEUROG2-transduced cells maintained in culture contained mostly immature neurons (91% DCX+; 76% NeuN+), whereas the control virus-transduced cells remained largely undifferentiated (30% DCX+; <1% NeuN+). At 6 weeks following transplantation into the DG of adult male rats, there were no neurons among the transplanted cells treated with the control virus but the majority of the NEUROG2-transduced DsRed+ SVZ cells became mature neurons (92% NeuN+; DCX-negative). Although the NEUROG2-transduced SVZ cells did not express the dentate granule neuron marker Prox1, most of the NEUROG2-transduced SVZ cells (78%) expressed the glutamatergic marker Tbr1, suggesting the acquisition of a glutamatergic phenotype. Moreover, some neurons extended dendrites into the molecular layer, grew axons containing Ankyrin G+ axonal initial segments, and projected into the CA3 region, thus resembling mature DG granule neurons. A proportion of NEUROG2 transduced cells also expressed c-Fos and P-CREB, two markers of neuronal activation. We conclude that NEUROG2-transduction is sufficient to promote neuronal maturation and integration of transplanted NPCs from SVZ into the DG.	[Chen, Xia; Tolkovsky, Aviva M.; Herbert, Joe] Univ Cambridge, Cambridge Ctr Brain Repair, Dept Clin Neurosci, Cambridge, England; [Lepier, Alexandra; Berninger, Benedikt] Univ Munich, Inst Physiol, Dept Physiol Genom, D-8000 Munich, Germany; [Lepier, Alexandra; Berninger, Benedikt] Natl Res Ctr Environm & Hlth, Inst Stem Cell Res, Helmholtz Zentrum Munchen, Munich, Germany	University of Cambridge; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Chen, X (corresponding author), Univ Cambridge, Cambridge Ctr Brain Repair, Dept Clin Neurosci, Cambridge, England.	amt@mole.bio.cam.ac.uk; jh24@cam.ac.uk	Herbert, Joe/K-5877-2013; Berninger, Benedikt/H-4098-2019	Berninger, Benedikt/0000-0003-2652-2782	John and Lucille van Geest Foundation; Wellcome Trust; Bundesministerium fur Bildung und Forschung	John and Lucille van Geest Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by a studentship from the John and Lucille van Geest Foundation (XC) and a grant from the Wellcome Trust (JH). Work at LMU Munich was supported by a grant from the Bundesministerium fur Bildung und Forschung "Integration of stem cell derived neurons" (BB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Berninger B, 2007, EUR J NEUROSCI, V25, P2581, DOI 10.1111/j.1460-9568.2007.05509.x; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Brill MS, 2009, NAT NEUROSCI, V12, P1524, DOI 10.1038/nn.2416; Britz O, 2006, CEREB CORTEX, V16, pI138, DOI 10.1093/cercor/bhj168; Chen X, 2011, PLOS ONE, P6; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; Fode C, 2000, GENE DEV, V14, P67; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Galeeva A, 2007, NEUROSCIENCE, V146, P604, DOI 10.1016/j.neuroscience.2007.02.002; Galichet C, 2008, DEVELOPMENT, V135, P2031, DOI 10.1242/dev.015115; Heinrich C, 2006, J NEUROSCI, V26, P4701, DOI 10.1523/JNEUROSCI.5516-05.2006; Heinrich C, 2011, NAT PROTOC, V6, P214, DOI 10.1038/nprot.2010.188; Heinrich C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000373; Herrera DG, 1999, ANN NEUROL, V46, P867, DOI 10.1002/1531-8249(199912)46:6<867::AID-ANA9>3.0.CO;2-Z; Kaltezioti V, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000565; Karalay O, 2011, P NATL ACAD SCI USA, V108, P5807, DOI 10.1073/pnas.1013456108; Liu JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017562; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Milosevic A, 2008, MOL CELL NEUROSCI, V39, P324, DOI 10.1016/j.mcn.2008.07.015; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Ormerod BK, 2008, PHILOS T R SOC B, V363, P153, DOI 10.1098/rstb.2006.2018; Pinnock S., 2011, PLOS ONE, V5; Raedt R, 2009, EPILEPSY RES, V87, P148, DOI 10.1016/j.eplepsyres.2009.08.009; Sekiguchi M, 2009, NEUROSCI LETT, V452, P232, DOI 10.1016/j.neulet.2009.01.074; Shetty AK, 2008, J NEUROSCI RES, V86, P3062, DOI 10.1002/jnr.21764; Sinclair SR, 1999, EUR J NEUROSCI, V11, P4341, DOI 10.1046/j.1460-9568.1999.00867.x; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Winpenny E, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-12; Winpenny E, 2010, CELL CYCLE, V9, P2259, DOI 10.4161/cc.9.12.12018; Yan RT, 2001, P NATL ACAD SCI USA, V98, P15014, DOI 10.1073/pnas.261455698; Yi SH, 2008, MOL THER, V16, P1873, DOI 10.1038/mt.2008.189	36	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31547	10.1371/journal.pone.0031547	http://dx.doi.org/10.1371/journal.pone.0031547			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348101	Green Submitted, Green Published, gold			2022-12-25	WOS:000302737400032
J	Lyke, KE; Dabo, A; Arama, C; Daou, M; Diarra, I; Wang, A; Plowe, CV; Doumbo, OK; Sztein, MB				Lyke, Kirsten E.; Dabo, Abdoulaye; Arama, Charles; Daou, Modibo; Diarra, Issa; Wang, Amy; Plowe, Christopher V.; Doumbo, Ogobara K.; Sztein, Marcelo B.			Reduced T Regulatory Cell Response during Acute Plasmodium falciparum Infection in Malian Children Co-Infected with Schistosoma haematobium	PLOS ONE			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; HUMAN PERIPHERAL-BLOOD; STAGE MALARIA VACCINE; GROWTH-FACTOR-BETA; IMMUNE-RESPONSES; INFLAMMATORY MARKERS; HELMINTH INFECTIONS; CYTOKINE PRODUCTION; MEDIATED-IMMUNITY; CEREBRAL MALARIA	Background: Regulatory T cells (Tregs) suppress host immune responses and participate in immune homeostasis. In co-infection, secondary parasite infections may disrupt the immunologic responses induced by a pre-existing parasitic infection. We previously demonstrated that schistosomiasis-positive (SP) Malian children, aged 4-8 years, are protected against the acquisition of malaria compared to matched schistosomiasis-negative (SN) children. Methods and Findings: To determine if Tregs contribute to this protection, we performed immunologic and Treg depletion in vitro studies using PBMC acquired from children with and without S. haematobium infection followed longitudinally for the acquisition of malaria. Levels of Tregs were lower in children with dual infections compared to children with malaria alone (0.49 versus 1.37%, respectively, P = 0.004) but were similar months later, during a period with negligible malaria transmission. The increased levels of Tregs in SN subjects were associated with suppressed serum Th1 cytokine levels, as well as elevated parasitemia compared to co-infected counterparts. Conclusions: These results suggest that lower levels of Tregs in helminth-infected children correlate with altered circulating cytokine and parasitologic results which may play a partial role in mediating protection against falciparum malaria.	[Lyke, Kirsten E.; Wang, Amy; Plowe, Christopher V.; Sztein, Marcelo B.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Dabo, Abdoulaye; Daou, Modibo; Diarra, Issa; Doumbo, Ogobara K.] Univ Bamako, Malaria Res & Training Ctr, Bamako, Mali; [Arama, Charles] Univ Stockholm, Dept Immunol, S-10691 Stockholm, Sweden; [Plowe, Christopher V.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	University System of Maryland; University of Maryland Baltimore; University of Bamako; Stockholm University; Howard Hughes Medical Institute; Johns Hopkins University	Lyke, KE (corresponding author), Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.	KLyke@medicine.umaryland.edu			National Institute of Allergy and Infectious Diseases (NIAID/NIH) [AI49203, R-01 (AI067954)]; Doris Duke Clinical Development Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI049203, R01AI067954] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Doris Duke Clinical Development Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The clinical portion of the study was funded by a K23 award from the National Institute of Allergy and Infectious Diseases (NIAID/NIH) (AI49203). Immunologic assays were funded in part by a Doris Duke Clinical Development Award as well as an R-01 (AI067954) from NIAID/NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angov E, 2003, MOL BIOCHEM PARASIT, V128, P195, DOI 10.1016/S0166-6851(03)00077-X; Araujo MI, 2006, CHEM IMMUNOL ALLERGY, V90, P29, DOI 10.1159/000088879; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Baumgart M, 2006, J IMMUNOL, V176, P5374, DOI 10.4049/jimmunol.176.9.5374; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Briand V, 2005, AM J TROP MED HYG, V72, P702, DOI 10.4269/ajtmh.2005.72.702; CORACHAN M, 1992, AM J TROP MED HYG, V47, P6, DOI 10.4269/ajtmh.1992.47.6; Coulibaly D, 2002, AM J TROP MED HYG, V67, P604; DECLERCQ D, 1994, T ROY SOC TROP MED H, V88, P653, DOI 10.1016/0035-9203(94)90212-7; Diallo TO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012764; Diallo TO, 2004, PARASITE IMMUNOL, V26, P365, DOI 10.1111/j.0141-9838.2004.00719.x; Dutta S, 2002, INFECT IMMUN, V70, P3101, DOI 10.1128/IAI.70.6.3101-3110.2002; Finney OC, 2010, EUR J IMMUNOL, V40, P47, DOI 10.1002/eji.200939708; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gillan V, 2005, INFECT IMMUN, V73, P4034, DOI 10.1128/IAI.73.7.4034-4042.2005; GRZYCH JM, 1991, J IMMUNOL, V146, P1322; Hesse M, 2004, J IMMUNOL, V172, P3157, DOI 10.4049/jimmunol.172.5.3157; Hisaeda H, 2004, NAT MED, V10, P29, DOI 10.1038/nm975; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Ji JX, 2005, J IMMUNOL, V174, P7147, DOI 10.4049/jimmunol.174.11.7147; Long TTA, 2003, INT J PARASITOL, V33, P175, DOI 10.1016/S0020-7519(02)00261-8; Lyke KE, 2005, AM J TROP MED HYG, V73, P1124, DOI 10.4269/ajtmh.2005.73.1124; Lyke KE, 2005, INFECT IMMUN, V73, P5799, DOI 10.1128/IAI.73.9.5799-5808.2005; Lyke KE, 2004, INFECT IMMUN, V72, P5630, DOI 10.1128/IAI.72.10.5630-5637.2004; Lyke KE, 2006, INFECT IMMUN, V74, P5718, DOI 10.1128/IAI.01822-05; Lyke KE, 2009, VACCINE, V27, P2171, DOI 10.1016/j.vaccine.2009.01.097; Mills KHG, 2004, NAT REV IMMUNOL, V4, P841, DOI 10.1038/nri1485; Minigo G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000402; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Mouk EMO, 2009, AM J TROP MED HYG, V80, P475, DOI 10.4269/ajtmh.2009.80.475; Nacher M, 2000, PARASITE IMMUNOL, V22, P107, DOI 10.1046/j.1365-3024.2000.00284.x; Nacher M, 2001, AM J TROP MED HYG, V65, P834, DOI 10.4269/ajtmh.2001.65.834; Nacher M, 2002, J PARASITOL, V88, P55, DOI 10.1645/0022-3395(2002)088[0055:IHIAAW]2.0.CO;2; Nausch N, 2011, PLOS ONE, V6; Nie CQ, 2007, INFECT IMMUN, V75, P2275, DOI 10.1128/IAI.01783-06; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; Omer FM, 2003, J IMMUNOL, V171, P5430, DOI 10.4049/jimmunol.171.10.5430; Park HB, 2004, INT IMMUNOL, V16, P1203, DOI 10.1093/intimm/dxh123; PEARCE EJ, 1991, J EXP MED, V173, P159, DOI 10.1084/jem.173.1.159; Remoue F, 2003, T ROY SOC TROP MED H, V97, P361, DOI 10.1016/S0035-9203(03)90170-2; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Salerno-Goncalves R, 2010, CLIN VACCINE IMMUNOL, V17, P1305, DOI 10.1128/CVI.00234-10; Satoguina J, 2002, MICROBES INFECT, V4, P1291, DOI 10.1016/S1286-4579(02)00014-X; Scholzen A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000543; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Singh B, 2001, IMMUNOL REV, V182, P190, DOI 10.1034/j.1600-065X.2001.1820115.x; Sokhna C, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-43; Spiegel A, 2003, T ROY SOC TROP MED H, V97, P198, DOI 10.1016/S0035-9203(03)90117-9; Tacket CO, 2000, INFECT IMMUN, V68, P1196, DOI 10.1128/IAI.68.3.1196-1201.2000; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115; Torcia MG, 2008, P NATL ACAD SCI USA, V105, P646, DOI 10.1073/pnas.0709969105; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006; Walther M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000364; Wammes LJ, 2010, EUR J IMMUNOL, V40, P437, DOI 10.1002/eji.200939699; Wan YY, 2007, IMMUNOL REV, V220, P199, DOI 10.1111/j.1600-065X.2007.00565.x; Watanabe K, 2007, AM J TROP MED HYG, V77, P676, DOI 10.4269/ajtmh.2007.77.676	59	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31647	10.1371/journal.pone.0031647	http://dx.doi.org/10.1371/journal.pone.0031647			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348117	gold, Green Published, Green Submitted			2022-12-25	WOS:000302737400039
J	Abush, H; Akirav, I				Abush, Hila; Akirav, Irit			Short- and Long-Term Cognitive Effects of Chronic Cannabinoids Administration in Late-Adolescence Rats	PLOS ONE			English	Article							OBJECT RECOGNITION MEMORY; MEDIAL PREFRONTAL CORTEX; SPATIAL WORKING-MEMORY; RECEPTOR KNOCKOUT MICE; PITUITARY-ADRENAL AXIS; PATHWAY IN-VIVO; ADULT RATS; NUCLEUS-ACCUMBENS; CB1 RECEPTOR; PARIETAL CORTEX	The use of cannabis can impair cognitive function, especially short-term memory. A controversial question is whether long-term cannabis use during the late-adolescence period can cause irreversible deficits in higher brain function that persist after drug use stops. In order to examine the short-and long-term effects of chronic exposure to cannabinoids, rats were administered chronic i.p. treatment with the CB1/CB2 receptor agonist WIN55,212-2 (WIN; 1.2 mg/kg) for two weeks during the late adolescence period (post-natal days 45-60) and tested for behavioral and electrophysiological measures of cognitive performance 24 hrs, 10 and 30 days after the last drug injection. The impairing effects of chronic WIN on short-term memory in the water maze and the object recognition tasks as well as long-term potentiation (LTP) in the ventral subiculum (vSub)-nucleus accumbens (NAc) pathway were temporary as they lasted only 24 h or 10 d after withdrawal. However, chronic WIN significantly impaired hippocampal dependent short-term memory measured in the object location task 24 hrs, 10, 30, and 75 days after the last drug injection. Our findings suggest that some forms of hippocampal-dependent short-term memory are sensitive to chronic cannabinoid administration but other cognitive impairments are temporary and probably result from a residue of cannabinoids in the brain or acute withdrawal effects from cannabinoids. Understanding the effects of cannabinoids on cognitive function may provide us with tools to overcome these impairments and for cannabinoids to be more favorably considered for clinical use.	[Abush, Hila; Akirav, Irit] Univ Haifa, Dept Psychol, IL-31999 Haifa, Israel	University of Haifa	Abush, H (corresponding author), Univ Haifa, Dept Psychol, IL-31999 Haifa, Israel.	irit.akirav@gmail.com						Abush H, 2010, HIPPOCAMPUS, V20, P1126, DOI 10.1002/hipo.20711; Aggleton JP, 2004, NEUROSCI BIOBEHAV R, V28, P611, DOI 10.1016/j.neubiorev.2004.08.007; Akirav I, 2001, EUR J NEUROSCI, V14, P719, DOI 10.1046/j.0953-816x.2001.01687.x; Akirav I, 2006, CEREB CORTEX, V16, P1759, DOI 10.1093/cercor/bhj114; Barna I, 2004, LIFE SCI, V75, P2959, DOI 10.1016/j.lfs.2004.06.006; BELUE RC, 1995, NEUROTOXICOL TERATOL, V17, P25, DOI 10.1016/0892-0362(94)00053-G; Brusberg M, 2009, J NEUROSCI, V29, P1554, DOI 10.1523/JNEUROSCI.5166-08.2009; Castellano C, 2003, CNS NEUROL DISORD-DR, V2, P389, DOI 10.2174/1568007033482670; COLLINS DR, 1994, EUR J PHARMACOL, V259, pR7, DOI 10.1016/0014-2999(94)90666-1; Croxford JL, 2003, J CLIN INVEST, V111, P1231, DOI 10.1172/JCI200317652; Da Silva GE, 2002, PROG NEURO-PSYCHOPH, V26, P321, DOI 10.1016/S0278-5846(01)00275-5; DeCoteau WE, 1998, BEHAV NEUROSCI, V112, P68, DOI 10.1037/0735-7044.112.1.68; DEFONSECA FR, 1993, NEUROREPORT, V4, P135, DOI 10.1097/00001756-199302000-00005; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Chiara G, 2004, NEUROPHARMACOLOGY, V47, P227, DOI 10.1016/j.neuropharm.2004.06.032; Dong Z, 2007, NEUROSCIENCE, V144, P845, DOI 10.1016/j.neuroscience.2006.10.018; Egertova M, 2000, J COMP NEUROL, V422, P159, DOI 10.1002/(SICI)1096-9861(20000626)422:2<159::AID-CNE1>3.0.CO;2-1; Ehrenreich H, 1999, PSYCHOPHARMACOLOGY, V142, P295, DOI 10.1007/s002130050892; Ennaceur A, 1997, EXP BRAIN RES, V113, P509, DOI 10.1007/PL00005603; Ferrari F, 1999, PHARMACOL BIOCHEM BE, V64, P555, DOI 10.1016/S0091-3057(99)00106-9; Floresco SB, 1997, J NEUROSCI, V17, P1880; FRIDE E, 1995, BRAIN RES, V697, P83, DOI 10.1016/0006-8993(95)00790-W; Fride E, 1996, DEV BRAIN RES, V95, P131, DOI 10.1016/0165-3806(96)00087-9; Fride E, 1996, PSYCHONEUROENDOCRINO, V21, P157, DOI 10.1016/0306-4530(95)00039-9; Ganon-Elazar E, 2009, J NEUROSCI, V29, P11078, DOI 10.1523/JNEUROSCI.1223-09.2009; Garcia R, 1997, NEUROSCI LETT, V233, P41, DOI 10.1016/S0304-3940(97)00621-6; Gardner EL, 1998, NEUROBIOL DIS, V5, P502, DOI 10.1006/nbdi.1998.0219; Goldbart A, 2003, NEUROSCIENCE, V122, P585, DOI 10.1016/j.neuroscience.2003.08.054; Gonzalez S, 2005, PHARMACOL BIOCHEM BE, V81, P300, DOI 10.1016/j.pbb.2005.01.028; Goodman T, 2010, NEUROSCIENCE, V171, P769, DOI 10.1016/j.neuroscience.2010.09.047; Goodrich-Hunsaker NJ, 2008, NEUROBIOL LEARN MEM, V90, P389, DOI 10.1016/j.nlm.2008.05.002; Gorzalka BB, 2008, NEUROSCI BIOBEHAV R, V32, P1152, DOI 10.1016/j.neubiorev.2008.03.004; Hampson RE, 2003, HIPPOCAMPUS, V13, P543, DOI 10.1002/hipo.10081; Hanlon EC, 2004, PSYCHOPHARMACOLOGY, V172, P241, DOI 10.1007/s00213-003-1654-0; Harloe JP, 2008, LEARN MEMORY, V15, P806, DOI 10.1101/lm.1113008; Harvey MA, 2007, DRUG ALCOHOL REV, V26, P309, DOI 10.1080/09595230701247772; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; Hill MN, 2010, PROG NEURO-PSYCHOPH, V34, P791, DOI 10.1016/j.pnpbp.2009.11.001; Hill MN, 2010, P NATL ACAD SCI USA, V107, P9406, DOI 10.1073/pnas.0914661107; Hill MN, 2004, EUR J NEUROSCI, V20, P859, DOI 10.1111/j.1460-9568.2004.03522.x; Hofmann ME, 2011, J PHYSIOL-LONDON, V589, P3801, DOI 10.1113/jphysiol.2011.211482; Holter SM, 2005, EUR J PHARMACOL, V510, P69, DOI 10.1016/j.ejphar.2005.01.008; Iversen L, 2005, CURR OPIN PHARMACOL, V5, P69, DOI 10.1016/j.coph.2004.08.010; Jacobsen LK, 2004, ANN NY ACAD SCI, V1021, P384, DOI 10.1196/annals.1308.053; Jager G, 2006, PSYCHOPHARMACOLOGY, V185, P358, DOI 10.1007/s00213-005-0298-7; Jager Gerry, 2008, Curr Drug Abuse Rev, V1, P114; JOHANSSON E, 1989, EUR J CLIN PHARMACOL, V37, P273, DOI 10.1007/BF00679783; Kanayama G, 2004, PSYCHOPHARMACOLOGY, V176, P239, DOI 10.1007/s00213-004-1885-8; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Koob GF, 1998, ALCOHOL CLIN EXP RES, V22, P3, DOI 10.1097/00000374-199802000-00001; Lutz B, 2009, CURR OPIN PHARMACOL, V9, P46, DOI 10.1016/j.coph.2008.12.001; Mackie K, 2005, HANDB EXP PHARMACOL, V168, P299; Maroun M, 2003, J NEUROSCI, V23, P4406; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; Mato S, 2004, NAT NEUROSCI, V7, P585, DOI 10.1038/nn1251; Moore NLT, 2010, J PHARMACOL EXP THER, V335, P294, DOI 10.1124/jpet.110.169359; Morris RGM, 2006, NEURON, V50, P479, DOI 10.1016/j.neuron.2006.04.012; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Niyuhire F, 2007, PSYCHOPHARMACOLOGY, V191, P223, DOI 10.1007/s00213-006-0650-6; NOWICKY AV, 1987, BRAIN RES BULL, V19, P663, DOI 10.1016/0361-9230(87)90052-9; O'Shea M, 2004, J PSYCHOPHARMACOL, V18, P502, DOI 10.1177/0269881104047277; O'Shea M, 2006, J PSYCHOPHARMACOL, V20, P611, DOI 10.1177/0269881106065188; Patel S, 2004, ENDOCRINOLOGY, V145, P5431, DOI 10.1210/en.2004-0638; Patel S, 2008, EUR J NEUROSCI, V27, P2821, DOI 10.1111/j.1460-9568.2008.06266.x; Pistis M, 2002, EUR J NEUROSCI, V15, P1795, DOI 10.1046/j.1460-9568.2002.02019.x; Pope HG, 1996, JAMA-J AM MED ASSOC, V275, P521, DOI 10.1001/jama.275.7.521; Pope HG, 2003, DRUG ALCOHOL DEPEN, V69, P303, DOI 10.1016/S0376-8716(02)00334-4; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Quinn HR, 2008, NEUROPSYCHOPHARMACOL, V33, P1113, DOI 10.1038/sj.npp.1301475; Ranganathan M, 2006, PSYCHOPHARMACOLOGY, V188, P425, DOI 10.1007/s00213-006-0508-y; Riedel G, 2005, HANDB EXP PHARMACOL, V168, P445; Rossato JI, 2006, LEARN MEMORY, V13, P431, DOI 10.1101/lm.315206; Rubino T, 2008, NEUROPSYCHOPHARMACOL, V33, P2760, DOI 10.1038/sj.npp.1301664; SAVE E, 1992, BEHAV NEUROSCI, V106, P447, DOI 10.1037/0735-7044.106.3.447; Schneider M, 2005, BEHAV PHARMACOL, V16, P447, DOI 10.1097/00008877-200509000-00018; Schneider M, 2003, NEUROPSYCHOPHARMACOL, V28, P1760, DOI 10.1038/sj.npp.1300225; Schneider M, 2008, ADDICT BIOL, V13, P345, DOI 10.1111/j.1369-1600.2008.00117.x; Schneider M, 2007, EUR NEUROPSYCHOPHARM, V17, P180, DOI 10.1016/j.euroneuro.2006.03.009; Schotanus SM, 2008, J NEUROCHEM, V106, P1758, DOI 10.1111/j.1471-4159.2008.05512.x; SEAMANS JK, 1994, BEHAV NEUROSCI, V108, P456, DOI 10.1037/0735-7044.108.3.456; Segev A, 2011, PLOS ONE IN PRESS; Segev A, 2011, LEARN MEMORY, V18, P254, DOI 10.1101/lm.2110511; Sim-Selley LJ, 2006, MOL PHARMACOL, V70, P986, DOI 10.1124/mol.105.019612; Sim-Selley LJ, 2002, J PHARMACOL EXP THER, V303, P36, DOI 10.1124/jpet.102.035618; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; STIGLICK A, 1985, PSYCHOPHARMACOLOGY, V85, P436, DOI 10.1007/BF00429660; TERRANOVA JP, 1995, N-S ARCH PHARMACOL, V352, P576, DOI 10.1007/BF00169393; Valverde O, 2005, HANDB EXP PHARMACOL, V168, P117; VANEDEN CG, 1990, PROG BRAIN RES, V85, P169; Warburton EC, 2010, NEUROPSYCHOLOGIA, V48, P2262, DOI 10.1016/j.neuropsychologia.2009.12.022; Wise LE, 2011, PSYCHOPHARMACOL 0511; Wise R, 2002, BIOL PSYCHIAT, P509; Wise RA, 1996, CURR OPIN NEUROBIOL, V6, P243, DOI 10.1016/S0959-4388(96)80079-1; WOLFER DP, 1995, HIPPOCAMPUS, V5, P329, DOI 10.1002/hipo.450050406; Zhang Q, 2002, DRUG METAB DISPOS, V30, P1077, DOI 10.1124/dmd.30.10.1077	98	63	63	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e31731	10.1371/journal.pone.0031731	http://dx.doi.org/10.1371/journal.pone.0031731			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348124	Green Published, gold, Green Submitted			2022-12-25	WOS:000302733900061
J	Kuo, TC; Wang, CH; Lin, HC; Lin, YH; Lin, M; Lin, CM; Kuo, HS				Kuo, Tai-Chih; Wang, Chung-Ho; Lin, Hsiu-Chen; Lin, Yuan-Hau; Lin, Matthew; Lin, Chun-Mao; Kuo, Hsien-Shou			Assessment of Renal Function by the Stable Oxygen and Hydrogen Isotopes in Human Blood Plasma	PLOS ONE			English	Article							SERUM CREATININE; DEUTERIUM-OXIDE; WATER CHANNELS; NATURAL-WATERS; RATIOS; HAIR; AQUAPORIN-1; VASOPRESSIN; KIDNEY; RATS	Water (H2O) is the most abundant and important molecule of life. Natural water contains small amount of heavy isotopes. Previously, few animal model studies have shown that the isotopic composition of body water could play important roles in physiology and pathophysiology. Here we study the stable isotopic ratios of hydrogen (delta H-2) and oxygen (delta O-18) in human blood plasma. The stable isotopic ratio is defined and determined by delta(sample) = [(R-sample/R-STD)-1] * 1000, where R is the molar ratio of rare to abundant, for example, O-18/O-16. We observe that the delta H-2 and the delta O-18 in human blood plasma are associated with the human renal functions. The water isotope ratios of the delta H-2 and delta O-18 in human blood plasma of the control subjects are comparable to those of the diabetes subjects (with healthy kidney), but are statistically higher than those of the end stage renal disease subjects (p<0.001 for both ANOVA and Student's t-test). In addition, our data indicate the existence of the biological homeostasis of water isotopes in all subjects, except the end stage renal disease subjects under the haemodialysis treatment. Furthermore, the unexpected water contents (delta H-2 and delta O-18) in blood plasma of body water may shed light on a novel assessment of renal functions.	[Kuo, Tai-Chih; Lin, Hsiu-Chen; Lin, Chun-Mao; Kuo, Hsien-Shou] Taipei Med Univ, Coll Med, Taipei, Taiwan; [Wang, Chung-Ho] Acad Sinica, Inst Earth Sci, Taipei 115, Taiwan; [Lin, Hsiu-Chen] Taipei Med Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Lin, Yuan-Hau] FU CHEN Hosp, Taipei, Taiwan; [Lin, Matthew] Garfield Med Ctr, Monterey Pk, CA USA	Taipei Medical University; Academia Sinica - Taiwan; Taipei Medical University; Taipei Medical University Hospital	Kuo, TC (corresponding author), Taipei Med Univ, Coll Med, Taipei, Taiwan.	hsiensaw@tmu.edu.tw		Wang, Chung-Ho/0000-0003-2014-6747; Lin, Hsiu-Chen/0000-0003-1076-1121; Lin, Chun-Mao/0000-0002-8366-4026				ARGENT NB, 1990, CLIN CHIM ACTA, V190, P185, DOI 10.1016/0009-8981(90)90172-O; BAERTSCHI P, 1976, EARTH PLANET SC LETT, V31, P341, DOI 10.1016/0012-821X(76)90115-1; Beitz E, 2006, P NATL ACAD SCI USA, V103, P269, DOI 10.1073/pnas.0507225103; Borgnia M, 1999, ANNU REV BIOCHEM, V68, P425, DOI 10.1146/annurev.biochem.68.1.425; Bowen G. J., 2008, ONLINE ISOTOPES PREC; Bowen GJ, 2009, AM J PHYS ANTHROPOL, V139, P494, DOI 10.1002/ajpa.21008; Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; Bowen GJ, 2002, GEOLOGY, V30, P315, DOI 10.1130/0091-7613(2002)030<0315:SDOOIM>2.0.CO;2; Branten AJW, 2005, NEPHROL DIAL TRANSPL, V20, P707, DOI 10.1093/ndt/gfh719; BRENNINKMEIJER CAM, 1987, CHEM GEOL, V66, P21, DOI 10.1016/0168-9622(87)90024-8; Cazacu M, 2001, DEUTERIUM VARIATION; Chakrabarti G, 1999, BIOCHEMISTRY-US, V38, P3067, DOI 10.1021/bi982461r; Chaplin M, 2011, WATER MOL LIQUID WAT; Chesson LA, 2010, FOOD CHEM, V119, P1250, DOI 10.1016/j.foodchem.2009.07.046; COLEMAN ML, 1982, ANAL CHEM, V54, P993, DOI 10.1021/ac00243a035; Combet S, 2008, AM J PHYSIOL-RENAL, V294, pF1408, DOI 10.1152/ajprenal.00437.2007; CRAIG H, 1961, SCIENCE, V133, P1702, DOI 10.1126/science.133.3465.1702; De Wit JC., 1980, GEOSTANDARD NEWSLETT, V4, P33, DOI [DOI 10.1111/J.1751-908X.1980.TB00270.X, 10.1111/j.1751-908X.1980.tb00270.x]; Dufner D, 2003, CURR OPIN CLIN NUTR, V6, P511, DOI 10.1097/00075197-200309000-00004; Ehleringer JR, 2008, P NATL ACAD SCI USA, V105, P2788, DOI 10.1073/pnas.0712228105; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; EPSTEIN S, 1953, GEOCHIM COSMOCHIM AC, V4, P213, DOI 10.1016/0016-7037(53)90051-9; GONFIANTINI R, 1978, NATURE, V271, P534, DOI 10.1038/271534a0; HAGEMANN R, 1970, TELLUS, V22, P712, DOI 10.1111/j.2153-3490.1970.tb00540.x; Hobson KA, 1999, P NATL ACAD SCI USA, V96, P8003, DOI 10.1073/pnas.96.14.8003; Junge W, 2004, CLIN CHIM ACTA, V344, P137, DOI 10.1016/j.cccn.2004.02.007; KATZ JJ, 1957, JNCI-J NATL CANCER I, V18, P641; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Konings CJAM, 2002, PERITON DIALYSIS INT, V22, P683; Kushner DJ, 1999, CAN J PHYSIOL PHARM, V77, P79, DOI 10.1139/cjpp-77-2-79; Lambert CP, 1999, EXP PHYSIOL, V84, P391, DOI 10.1017/S0958067099018266; Lloyd S., 2003, IEEE T INFORM THEORY, V28, P129; Mamonov AB, 2007, J GEN PHYSIOL, V130, P111, DOI 10.1085/jgp.200709810; NIELSEN S, 1993, AM J PHYSIOL, V265, pF204, DOI 10.1152/ajprenal.1993.265.2.F204; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; NIELSEN S, 1993, J CELL BIOL, V120, P371, DOI 10.1083/jcb.120.2.371; O'Grady SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011699; Panda D, 2000, BIOCHEMISTRY-US, V39, P5075, DOI 10.1021/bi992217f; Peng TR, 2010, EARTH PLANET SC LETT, V289, P357, DOI 10.1016/j.epsl.2009.11.024; PERRONE RD, 1992, CLIN CHEM, V38, P1933; Shankar A, 2010, VASC HEALTH RISK MAN, V6, P619; Sharp ZD, 2003, J ARCHAEOL SCI, V30, P1709, DOI 10.1016/S0305-4403(03)00071-2; SOMLYAI G, 1993, FEBS LETT, V317, P1, DOI 10.1016/0014-5793(93)81479-J; STANSELL MJ, 1968, CLIN CHEM, V14, P1112; Terris J, 1996, AM J PHYSIOL-RENAL, V271, pF414, DOI 10.1152/ajprenal.1996.271.2.F414; THOMSON JF, 1958, P SOC EXP BIOL MED, V97, P758, DOI 10.3181/00379727-97-23871; TSE RS, 1980, ANAL CHEM, V52, P2445, DOI 10.1021/ac50064a053; VASDEV S, 1991, HYPERTENSION, V18, P550, DOI 10.1161/01.HYP.18.4.550; Wang C.H., 2001, W PACIFIC EARTH SCI, V1, P429	49	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e32137	10.1371/journal.pone.0032137	http://dx.doi.org/10.1371/journal.pone.0032137			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22348150	Green Published, Green Submitted, gold			2022-12-25	WOS:000302733900067
J	Mi, QS; Weiland, M; Qi, RQ; Gao, XH; Poisson, LM; Zhou, L				Mi, Qing-Sheng; Weiland, Matthew; Qi, Rui-Qun; Gao, Xing-Hua; Poisson, Laila M.; Zhou, Li			Identification of Mouse Serum miRNA Endogenous References by Global Gene Expression Profiles	PLOS ONE			English	Article							CIRCULATING MICRORNAS; PLASMA MICRORNAS; BIOMARKERS; CANCER; NORMALIZATION; MIRBASE; TARGETS; DICER; DNA	MicroRNAs (miRNAs) are recently discovered small non-coding RNAs and can serve as serum biomarkers for disease diagnosis and prognoses. Lack of reliable serum miRNA endogenous references for normalization in miRNA gene expression makes single miRNA assays inaccurate. Using TaqMan (R) real-time PCR miRNA arrays with a global gene expression normalization strategy, we have analyzed serum miRNA expression profiles of 20 female mice of NOD/ShiLtJ (n = 8), NOR/LtJ (n = 6), and C57BL/6J (n = 6) at different ages and disease conditions. We identified five miRNAs, miR-146a, miR-16, miR-195, miR-30e and miR-744, to be stably expressed in all strains, which could serve as mouse serum miRNA endogenous references for single assay experiments.	[Mi, Qing-Sheng; Weiland, Matthew; Qi, Rui-Qun; Zhou, Li] Henry Ford Hlth Syst, Henry Ford Immunol Program, Detroit, MI 48202 USA; [Mi, Qing-Sheng; Weiland, Matthew; Qi, Rui-Qun; Zhou, Li] Henry Ford Hlth Syst, Dept Dermatol, Detroit, MI USA; [Mi, Qing-Sheng; Zhou, Li] Henry Ford Hlth Syst, Dept Internal Med, Detroit, MI USA; [Qi, Rui-Qun; Gao, Xing-Hua] China Med Univ, Hosp 1, Dept Dermatol, Shenyang, Peoples R China; [Poisson, Laila M.] Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; China Medical University; Henry Ford Health System; Henry Ford Hospital	Mi, QS (corresponding author), Henry Ford Hlth Syst, Henry Ford Immunol Program, Detroit, MI 48202 USA.	qmi1@hfhs.org; lzhou1@hfhs.org			Henry Ford Health System [T71016, T71017]; Henry Ford Stubnitz [J80005]; Melanoma Research Alliance; Changjiang Scholars; Innovative Research Teams in Universities; Ministry of Education, China [IRT0760]; Shahani Foundation	Henry Ford Health System; Henry Ford Stubnitz; Melanoma Research Alliance; Changjiang Scholars(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Innovative Research Teams in Universities; Ministry of Education, China(Ministry of Education, China); Shahani Foundation	This work was supported in part by a grant from Henry Ford Health System Start-up Grant for the Immunology Program (T71016 and T71017), Henry Ford Stubnitz Grant (J80005), Melanoma Research Alliance, and Changjiang Scholars and Innovative Research Teams in Universities, Ministry of Education, China (IRT0760), and the Shahani Foundation. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BURKI E, 1948, OPHTHALMOLOGICA, V115, P241; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen CZ, 2005, SEMIN IMMUNOL, V17, P155, DOI 10.1016/j.smim.2005.01.001; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Cui WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022988; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Ji X, 2009, CLIN CHEM, V55, P1944, DOI 10.1373/clinchem.2009.125310; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; LEON SA, 1977, CANCER RES, V37, P646; Li GM, 2008, CELL RES, V18, P1, DOI 10.1038/cr.2008.9; Lossos IS, 2003, LEUKEMIA, V17, P789, DOI 10.1038/sj.leu.2402880; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; STROUN M, 1989, ONCOLOGY, V46, P318; Tong YK, 2006, CLIN CHIM ACTA, V363, P187, DOI 10.1016/j.cccn.2005.05.048; Tsujiura M, 2010, BRIT J CANCER, V102, P1174, DOI 10.1038/sj.bjc.6605608; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vasilescu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007405; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wittmann J, 2010, BBA-REV CANCER, V1806, P200, DOI 10.1016/j.bbcan.2010.07.002; Zhou L, 2009, P NATL ACAD SCI USA, V106, P10266, DOI 10.1073/pnas.0811119106; Zhou L, 2009, INT IMMUNOPHARMACOL, V9, P524, DOI 10.1016/j.intimp.2009.01.017	36	33	33	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2012	7	2							e31278	10.1371/journal.pone.0031278	http://dx.doi.org/10.1371/journal.pone.0031278			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZX	22348064	gold, Green Published, Green Submitted			2022-12-25	WOS:000302730900024
J	Genius, J; Geiger, J; Bender, A; Moller, HJ; Klopstock, T; Rujescu, D				Genius, Just; Geiger, Johanna; Bender, Andreas; Moeller, Hans-Juergen; Klopstock, Thomas; Rujescu, Dan			Creatine Protects against Excitoxicity in an In Vitro Model of Neurodegeneration	PLOS ONE			English	Article							NMR MAGNETIZATION-TRANSFER; ENERGY-METABOLISM; RAT-BRAIN; GLUTAMATE METABOLISM; ORAL SUPPLEMENTATION; HUNTINGTONS-DISEASE; KINASE; GENERATION; NEURONS; CYCLOCREATINE	Creatine has been shown to be neuroprotective in aging, neurodegenerative conditions and brain injury. As a common molecular background, oxidative stress and disturbed cellular energy homeostasis are key aspects in these conditions. Moreover, in a recent report we could demonstrate a life-enhancing and health-promoting potential of creatine in rodents, mainly due to its neuroprotective action. In order to investigate the underlying pharmacology mediating these mainly neuroprotective properties of creatine, cultured primary embryonal hippocampal and cortical cells were challenged with glutamate or H2O2. In good agreement with our in vivo data, creatine mediated a direct effect on the bioenergetic balance, leading to an enhanced cellular energy charge, thereby acting as a neuroprotectant. Moreover, creatine effectively antagonized the H2O2-induced ATP depletion and the excitotoxic response towards glutamate, while not directly acting as an antioxidant. Additionally, creatine mediated a direct inhibitory action on the NMDA receptor-mediated calcium response, which initiates the excitotoxic cascade. Even excessive concentrations of creatine had no neurotoxic effects, so that high-dose creatine supplementation as a health-promoting agent in specific pathological situations or as a primary prophylactic compound in risk populations seems feasible. In conclusion, we were able to demonstrate that the protective potential of creatine was primarily mediated by its impact on cellular energy metabolism and NMDA receptor function, along with reduced glutamate spillover, oxidative stress and subsequent excitotoxicity.	[Genius, Just; Geiger, Johanna; Moeller, Hans-Juergen; Rujescu, Dan] Univ Munich, Dept Psychiat, D-8000 Munich, Germany; [Bender, Andreas; Klopstock, Thomas] Univ Munich, Dept Neurol, D-8000 Munich, Germany	University of Munich; University of Munich	Genius, J (corresponding author), Univ Munich, Dept Psychiat, D-8000 Munich, Germany.	dan.rujescu@med.uni-muenchen.de	Rujescu, Dan/GRS-3875-2022	Bender, Andreas/0000-0002-6328-7104; Genius, Just/0000-0003-3270-3491				Adcock KH, 2002, DEV NEUROSCI-BASEL, V24, P382, DOI 10.1159/000069043; Ames A, 2000, BRAIN RES REV, V34, P42, DOI 10.1016/S0165-0173(00)00038-2; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Beal MF, 1998, BBA-BIOENERGETICS, V1366, P211, DOI 10.1124/jpet.112.192138; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; Bender A, 2008, NEUROBIOL AGING, V29, P1404, DOI 10.1016/j.neurobiolaging.2007.03.001; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Blagosklonny MV, 2011, AGING-US, V3, P685, DOI 10.18632/aging.100352; Bordelon YM, 1997, J NEUROCHEM, V69, P1629; Brewer GJ, 2000, J NEUROCHEM, V74, P1968, DOI 10.1046/j.1471-4159.2000.0741968.x; Budd SL, 1997, FEBS LETT, V415, P21, DOI 10.1016/S0014-5793(97)01088-0; Chen LL, 1995, J COMP NEUROL, V363, P389, DOI 10.1002/cne.903630305; CORBETT RJT, 1994, J CEREBR BLOOD F MET, V14, P1070, DOI 10.1038/jcbfm.1994.140; Dechent P, 1999, AM J PHYSIOL-REG I, V277, pR698, DOI 10.1152/ajpregu.1999.277.3.R698; DUNANT Y, 1988, J NEUROCHEM, V50, P431, DOI 10.1111/j.1471-4159.1988.tb02930.x; ERECINSKA M, 1988, J NEUROCHEM, V51, P892, DOI 10.1111/j.1471-4159.1988.tb01826.x; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guerrero ML, 1997, AM J PHYSIOL-CELL PH, V272, pC697, DOI 10.1152/ajpcell.1997.272.2.C697; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; HEMMER W, 1993, DEV NEUROSCI-BASEL, V15, P249, DOI 10.1159/000111342; Ide T, 2010, CELL CYCLE, V9, P1706, DOI 10.4161/cc.9.9.11473; Ipsiroglu OS, 2001, LIFE SCI, V69, P1805, DOI 10.1016/S0024-3205(01)01268-1; Juravleva E, 2005, J NEUROSCI RES, V79, P224, DOI 10.1002/jnr.20291; KANNER BI, 1987, CRIT REV BIOCHEM MOL, V22, P1, DOI 10.3109/10409238709082546; Klivenyi P, 1999, NAT MED, V5, P347, DOI 10.1038/6568; Lawler JM, 2002, BIOCHEM BIOPH RES CO, V290, P47, DOI 10.1006/bbrc.2001.6164; Lin YS, 2011, AGING-US, V3, P657, DOI 10.18632/aging.100338; Matthews RT, 1998, J NEUROSCI, V18, P156; MILLER EE, 1993, P NATL ACAD SCI USA, V90, P3304, DOI 10.1073/pnas.90.8.3304; MITANI A, 1994, J NEUROCHEM, V62, P626; NORWOOD WI, 1983, AM J PHYSIOL, V244, pC205, DOI 10.1152/ajpcell.1983.244.3.C205; Rothman DL, 1999, PHILOS T R SOC B, V354, P1165, DOI 10.1098/rstb.1999.0472; SAUTER A, 1993, J BIOL CHEM, V268, P13166; Stout AK, 1998, NAT NEUROSCI, V1, P366, DOI 10.1038/1577; Trotti D, 1998, TRENDS PHARMACOL SCI, V19, P328, DOI 10.1016/S0165-6147(98)01230-9; TSUJI K, 1995, J NEUROCHEM, V65, P1816; Weber JD, 1997, J BIOL CHEM, V272, P32966, DOI 10.1074/jbc.272.52.32966; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; YUDKOFF M, 1993, DEV NEUROSCI-BASEL, V15, P343, DOI 10.1159/000111354; ZELEZNIKAR RJ, 1991, J BIOL CHEM, V266, P15110	40	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30554	10.1371/journal.pone.0030554	http://dx.doi.org/10.1371/journal.pone.0030554			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347384	gold, Green Published, Green Submitted			2022-12-25	WOS:000302730100016
J	Rai, AK; Thakur, CP; Singh, A; Seth, T; Srivastava, SK; Singh, P; Mitra, DK				Rai, Ambak K.; Thakur, Chandreshwar P.; Singh, Amar; Seth, Tulika; Srivastava, Sandeep K.; Singh, Pushpendra; Mitra, Dipendra K.			Regulatory T Cells Suppress T Cell Activation at the Pathologic Site of Human Visceral Leishmaniasis	PLOS ONE			English	Article							IL-10; INFECTION; ANTIMONY; IMMUNOSUPPRESSION; ACCUMULATION; RESISTANCE; IMMUNITY; DONOVANI; INDIA	Suppression of T cell response is thought to be involved in the pathogenesis of visceral leishmaniasis (VL). Regulatory T cell (Treg) mediated immune-suppression is reported in animal models of Leishmania infection. However, their precise role among human patients still requires pathologic validation. The present study is aimed at understanding the frequency dynamics and function of Treg cells in the blood and bone marrow (BM) of VL patients. The study included 42 parasitologically confirmed patients, 17 healthy contact and 9 normal bone marrow specimens (NBM). We show i) the selective accumulation of Treg cells at one of the disease inflicted site(s), the BM, ii) their in vitro expansion in response to LD antigen and iii) persistence after successful chemotherapy. Results indicate that the Treg cells isolated from BM produces IL-10 and may inhibit T cell activation in IL-10 dependent manner. Moreover, we observed significantly higher levels of IL-10 among drug unresponsive patients, suggesting their critical role in suppression of immunity among VL patients. Our results suggest that IL-10 plays an important role in suppression of host immunity in human VL and possibly determines the efficacy of chemotherapy.	[Rai, Ambak K.; Singh, Amar; Srivastava, Sandeep K.; Singh, Pushpendra; Mitra, Dipendra K.] All India Inst Med Sci, Cellular Immunol Div, Dept TII, New Delhi, India; [Thakur, Chandreshwar P.] Balaji Utthan Sansthan, Patna, Bihar, India; [Seth, Tulika] All India Inst Med Sci, Dept Hematol, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Rai, AK (corresponding author), All India Inst Med Sci, Cellular Immunol Div, Dept TII, New Delhi, India.	salilmitra1@yahoo.com	Rai, Ambak/ABI-3831-2020; Singh, Pushpendra/T-4248-2018; srivastava, sandeep/ABH-3565-2022	Singh, Pushpendra/0000-0002-7277-115X; srivastava, sandeep/0000-0002-9965-2257; SRIVASTAVA, SANDEEP/0000-0003-4484-0223; Rai, Ambak/0000-0002-6564-6342	Department of Biotechnology (Government of India) [BT/PR6737/Med/14/871/2005]; Council of Scientific and Industrial Research (CSIR), Government of India	Department of Biotechnology (Government of India)(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	The authors acknowledge the Department of Biotechnology (Government of India) for funding the work (Grant No.: BT/PR6737/Med/14/871/2005). The authors also thank Council of Scientific and Industrial Research (CSIR), Government of India for providing fellowships to Dr. Ambak K. Rai. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar AN, 2003, IMMUNOLOGY, V109, P319, DOI 10.1046/j.1365-2567.2003.01678.x; Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; Ashutosh, 2007, J MED MICROBIOL, V56, P143, DOI 10.1099/jmm.0.46841-0; Awasthi A, 2004, INDIAN J MED RES, V119, P238; Biedermann T, 2001, NAT IMMUNOL, V2, P1054, DOI 10.1038/ni725; Bray PG, 2003, TRENDS PARASITOL, V19, P232, DOI 10.1016/S1471-4922(03)00069-2; Caldas A, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-113; CARVALHO EM, 1989, J CLIN INVEST, V83, P860, DOI 10.1172/JCI113969; CHULAY JD, 1983, AM J TROP MED HYG, V32, P475, DOI 10.4269/ajtmh.1983.32.475; Goto H, 2004, BRAZ J MED BIOL RES, V37, P615, DOI 10.1590/S0100-879X2004000400020; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Joshi B, 2006, MOL CELL BIOCHEM, V287, P157, DOI 10.1007/s11010-006-9132-8; Kane MM, 2001, J IMMUNOL, V166, P1141, DOI 10.4049/jimmunol.166.2.1141; Maurya R, 2010, PARASITE IMMUNOL, V32, P479, DOI 10.1111/j.1365-3024.2010.01219.x; Mendez S, 2004, J EXP MED, V200, P201, DOI 10.1084/jem.20040298; Murray HW, 2002, INFECT IMMUN, V70, P6284, DOI 10.1128/IAI.70.11.6284-6293.2002; Nylen S, 2007, J EXP MED, V204, P805, DOI 10.1084/jem.20061141; Saha S, 2007, J IMMUNOL, V179, P5592, DOI 10.4049/jimmunol.179.8.5592; Sharma PK, 2009, AM J RESP CRIT CARE, V179, P1061, DOI 10.1164/rccm.200804-529OC; Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056; Sundar S, 1997, J INFECT DIS, V176, P1117, DOI 10.1086/516526; Sundar S, 2006, INDIAN J MED RES, V123, P345; Thakur CP, 2004, INDIAN J MED RES, V120, P166; Thakur CP, 2003, T ROY SOC TROP MED H, V97, P409, DOI 10.1016/S0035-9203(03)90071-X; Wilson ME, 2005, MICROB PATHOGENESIS, V38, P147, DOI 10.1016/j.micpath.2004.11.002; Zou LH, 2004, CANCER RES, V64, P8451, DOI 10.1158/0008-5472.CAN-04-1987	26	57	58	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31551	10.1371/journal.pone.0031551	http://dx.doi.org/10.1371/journal.pone.0031551			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347492	Green Submitted, Green Published, gold			2022-12-25	WOS:000302730100079
J	Togashi, Y; Soda, M; Sakata, S; Sugawara, E; Hatano, S; Asaka, R; Nakajima, T; Mano, H; Takeuchi, K				Togashi, Yuki; Soda, Manabu; Sakata, Seiji; Sugawara, Emiko; Hatano, Satoko; Asaka, Reimi; Nakajima, Takashi; Mano, Hiroyuki; Takeuchi, Kengo			KLC1-ALK: A Novel Fusion in Lung Cancer Identified Using a Formalin-Fixed Paraffin-Embedded Tissue Only	PLOS ONE			English	Article							LARGE-CELL LYMPHOMA; KINASE GENE; ALK KINASE; CRIZOTINIB; IMMUNOHISTOCHEMISTRY; EXPRESSION; TPM3-ALK; PROTEINS; PARTNER	The promising results of anaplastic lymphoma kinase (ALK) inhibitors have changed the significance of ALK fusions in several types of cancer. These fusions are no longer mere research targets or diagnostic markers, but they are now directly linked to the therapeutic benefit of patients. However, most available tumor tissues in clinical settings are formalin-fixed and paraffin-embedded (FFPE), and this significantly limits detailed genetic studies in many clinical cases. Although recent technical improvements have allowed the analysis of some known mutations in FFPE tissues, identifying unknown fusion genes by using only FFPE tissues remains difficult. We developed a 59-rapid amplification of cDNA ends-based system optimized for FFPE tissues and evaluated this system on a lung cancer tissue with ALK rearrangement and without the 2 known ALK fusions EML4-ALK and KIF5B-ALK. With this system, we successfully identified a novel ALK fusion, KLC1-ALK. The result was confirmed by reverse transcription-polymerase chain reaction and fluorescence in situ hybridization. Then, we synthesized the putative full-length cDNA of KLC1-ALK and demonstrated the transforming potential of the fusion kinase with assays using mouse 3T3 cells. To the best of our knowledge, KLC1-ALK is the first novel oncogenic fusion identified using only FFPE tissues. This finding will broaden the potential value of archival FFPE tissues and provide further biological and clinical insights into ALK-positive lung cancer.	[Togashi, Yuki; Sakata, Seiji; Sugawara, Emiko; Hatano, Satoko; Asaka, Reimi; Takeuchi, Kengo] Japanese Fdn Canc Res, Inst Canc, Pathol Project Mol Targets, Tokyo 170, Japan; [Togashi, Yuki; Hatano, Satoko; Asaka, Reimi; Takeuchi, Kengo] Japanese Fdn Canc Res, Inst Canc, Div Pathol, Tokyo 170, Japan; [Soda, Manabu; Mano, Hiroyuki] Jichi Med Univ, Div Funct Genom, Shimotsuke, Tochigi, Japan; [Sugawara, Emiko] Tokyo Med & Dent Univ, Grad Sch, Dept Comprehens Pathol, Tokyo, Japan; [Nakajima, Takashi] Shizuoka Canc Ctr, Div Diagnost Pathol, Nagaizumi, Shizuoka, Japan; [Mano, Hiroyuki] Univ Tokyo, Grad Sch Med, Dept Med Genom, Tokyo, Japan	Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Jichi Medical University; Tokyo Medical & Dental University (TMDU); Shizuoka Cancer Center; University of Tokyo	Togashi, Y (corresponding author), Japanese Fdn Canc Res, Inst Canc, Pathol Project Mol Targets, Tokyo 170, Japan.	kentakeuchi-tky@umin.net	Takeuchi, Kengo/C-3614-2008	Takeuchi, Kengo/0000-0002-1599-5800	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; Ministry of Health, Labor, and Welfare of Japan; Vehicle Racing Commemorative Foundation of Japan; Princess Takamatsu Cancer Research Fund; Uehara Memorial Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Vehicle Racing Commemorative Foundation of Japan; Princess Takamatsu Cancer Research Fund; Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan as well as by grants from the Japan Society for the Promotion of Science; the Ministry of Health, Labor, and Welfare of Japan; the Vehicle Racing Commemorative Foundation of Japan; the Princess Takamatsu Cancer Research Fund; and the Uehara Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bridge JA, 2001, AM J PATHOL, V159, P411, DOI 10.1016/S0002-9440(10)61711-7; Butrynski JE, 2010, NEW ENGL J MED, V363, P1727, DOI 10.1056/NEJMoa1007056; Choi YL, 2008, CANCER RES, V68, P4971, DOI 10.1158/0008-5472.CAN-07-6158; Colleoni GWB, 2000, AM J PATHOL, V156, P781, DOI 10.1016/S0002-9440(10)64945-0; Cools J, 2002, GENE CHROMOSOME CANC, V34, P354, DOI 10.1002/gcc.10033; Debelenko LV, 2011, MODERN PATHOL, V24, P430, DOI 10.1038/modpathol.2010.213; Debiec-Rychter M, 2003, GENE CHROMOSOME CANC, V38, P187, DOI 10.1002/gcc.10267; Delsol G, 1997, BLOOD, V89, P1483, DOI 10.1182/blood.V89.5.1483.1483_1483_1490; Du XL, 2007, J MOL MED, V85, P863, DOI 10.1007/s00109-007-0159-4; Gambacorti-Passerini C, 2011, NEW ENGL J MED, V364, P775, DOI 10.1056/NEJMc1013224; Gascoyne RD, 2003, BLOOD, V102, P2568, DOI 10.1182/blood-2003-03-0786; Hernandez L, 1999, BLOOD, V94, P3265; Houtman SH, 2007, NEUROSCIENCE, V144, P1373, DOI 10.1016/j.neuroscience.2006.11.015; Jazii FR, 2006, WORLD J GASTROENTERO, V12, P7104, DOI 10.3748/wjg.v12.i44.7104; Kijima T, 2011, CANCER SCI, V102, P1602, DOI 10.1111/j.1349-7006.2011.01970.x; Kimura H, 2011, LUNG CANC; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lamant L, 2003, GENE CHROMOSOME CANC, V37, P427, DOI 10.1002/gcc.10232; Lamant L, 1999, BLOOD, V93, P3088; Lawrence B, 2000, AM J PATHOL, V157, P377, DOI 10.1016/S0002-9440(10)64550-6; Lin E, 2009, MOL CANCER RES, V7, P1466, DOI 10.1158/1541-7786.MCR-08-0522; Ma ZG, 2003, GENE CHROMOSOME CANC, V37, P98, DOI 10.1002/gcc.10177; Martelli MP, 2009, AM J PATHOL, V174, P661, DOI 10.2353/ajpath.2009.080755; Meech SJ, 2001, BLOOD, V98, P1209, DOI 10.1182/blood.V98.4.1209; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Nakajima T, 2010, J THORAC ONCOL, V5, P2041, DOI 10.1097/JTO.0b013e3181f77b58; Onishi M, 1996, EXP HEMATOL, V24, P324; Panagopoulos I, 2006, INT J CANCER, V118, P1181, DOI 10.1002/ijc.21490; Rahman A, 1999, J CELL BIOL, V146, P1277, DOI 10.1083/jcb.146.6.1277; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Sablin EP, 2000, CURR OPIN CELL BIOL, V12, P35, DOI 10.1016/S0955-0674(99)00054-X; SHIOTA M, 1994, ONCOGENE, V9, P1567; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Stenoien DL, 1997, MOL BIOL CELL, V8, P675, DOI 10.1091/mbc.8.4.675; Sugawara E, CANCER IN PRESS; Takeuchi K, 2010, HAEMATOLOGICA; Takeuchi K, 2008, CLIN CANCER RES, V14, P6618, DOI 10.1158/1078-0432.CCR-08-1018; Takeuchi K, 2011, CLIN CANCER RES, V17, P3341, DOI 10.1158/1078-0432.CCR-11-0063; Takeuchi K, 2009, CLIN CANCER RES, V15, P3143, DOI 10.1158/1078-0432.CCR-08-3248; Tort F, 2001, LAB INVEST, V81, P419, DOI 10.1038/labinvest.3780249; Touriol C, 2000, BLOOD, V95, P3204, DOI 10.1182/blood.V95.10.3204.010k04_3204_3207; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Van Roosbroeck K, 2010, HAEMATOL-HEMATOL J, V95, P509, DOI 10.3324/haematol.2009.014761; Yamamoto M, CANC SCI IN PRESS	44	183	191	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31323	10.1371/journal.pone.0031323	http://dx.doi.org/10.1371/journal.pone.0031323			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347464	gold, Green Published, Green Submitted			2022-12-25	WOS:000302730100061
J	Yu, Y; Fay, NC; Smoligovets, AA; Wu, HJ; Groves, JT				Yu, Yan; Fay, Nicole C.; Smoligovets, Alexander A.; Wu, Hung-Jen; Groves, Jay T.			Myosin IIA Modulates T Cell Receptor Transport and CasL Phosphorylation during Early Immunological Synapse Formation	PLOS ONE			English	Article							SUBSTRATE-RELATED PROTEIN; TYROSINE PHOSPHORYLATION; PROTEASOMAL DEGRADATION; ANTIGEN RECEPTOR; ACTIN; CRK; FORCE; TCR; MICROCLUSTERS; MECHANISMS	Activation of T cell receptor (TCR) by antigens occurs in concert with an elaborate multi-scale spatial reorganization of proteins at the immunological synapse, the junction between a T cell and an antigen-presenting cell (APC). The directed movement of molecules, which intrinsically requires physical forces, is known to modulate biochemical signaling. It remains unclear, however, if mechanical forces exert any direct influence on the signaling cascades. We use T cells from AND transgenic mice expressing TCRs specific to the moth cytochrome c 88-103 peptide, and replace the APC with a synthetic supported lipid membrane. Through a series of high spatiotemporal molecular tracking studies in live T cells, we demonstrate that the molecular motor, non-muscle myosin IIA, transiently drives TCR transport during the first one to two minutes of immunological synapse formation. Myosin inhibition reduces calcium influx and colocalization of active ZAP-70 (zeta-chain associated protein kinase 70) with TCR, revealing an influence on signaling activity. More tellingly, its inhibition also significantly reduces phosphorylation of the mechanosensing protein CasL (Crk-associated substrate the lymphocyte type), raising the possibility of a direct mechanical mechanism of signal modulation involving CasL.	[Yu, Yan; Fay, Nicole C.; Smoligovets, Alexander A.; Wu, Hung-Jen; Groves, Jay T.] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem, Berkeley, CA 94720 USA; [Fay, Nicole C.; Smoligovets, Alexander A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Yu, Yan; Fay, Nicole C.; Smoligovets, Alexander A.; Wu, Hung-Jen; Groves, Jay T.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Groves, Jay T.] Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; National University of Singapore	Yu, Y (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem, Berkeley, CA 94720 USA.	jtgroves@lbl.gov	Yu, Yan/A-3919-2015; Yu, Yan/A-3919-2015; Wu, Hung-Jen/H-3769-2016	Yu, Yan/0000-0001-6496-5045; Yu, Yan/0000-0002-6482-5672; Wu, Hung-Jen/0000-0003-3082-7431	Office of Science, Office of Basic Energy Sciences, the Materials Sciences and Engineering Division and the Chemical Sciences, Geosciences, and Biosciences Division under the U.S. Department of Energy (DOE) [DE-AC02-05CH11231]; National Science Foundation (NSF); Office of Science, Office of Basic Energy Sciences, Scientific User Facilities Division, of the U.S. DOE [DE-AC02-05CH11231]; U.S. Department of Defense [BC102681]; U.S. Department of Defense under U.S. Army Medical Research Acquisition Activity [W81XWH-11-1-0256]; National Cancer Institute (NCI) [U54 CA143836]; NATIONAL CANCER INSTITUTE [U54CA143836] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences, the Materials Sciences and Engineering Division and the Chemical Sciences, Geosciences, and Biosciences Division under the U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); National Science Foundation (NSF)(National Science Foundation (NSF)); Office of Science, Office of Basic Energy Sciences, Scientific User Facilities Division, of the U.S. DOE(United States Department of Energy (DOE)); U.S. Department of Defense(United States Department of Defense); U.S. Department of Defense under U.S. Army Medical Research Acquisition Activity; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	YY, AAS, and H-JW were supported by the Director, Office of Science, Office of Basic Energy Sciences, the Materials Sciences and Engineering Division and the Chemical Sciences, Geosciences, and Biosciences Division under the U. S. Department of Energy (DOE) contract No. DE-AC02-05CH11231. NCF was supported by a Graduate Fellowship from the National Science Foundation (NSF). Patterned substrate fabrication was performed, in part, at the Molecular Foundry, Lawrence Berkeley National Laboratory (LBNL), and was supported by the Office of Science, Office of Basic Energy Sciences, Scientific User Facilities Division, of the U.S. DOE under contract No. DE-AC02-05CH11231. Support for mechanosignaling aspects of this work was provided by the U.S. Department of Defense DA Congressionally Directed Medical Research Program Idea Award BC102681 under U.S. Army Medical Research Acquisition Activity No. W81XWH-11-1-0256 and by Award U54 CA143836 from the National Cancer Institute (NCI). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NCI or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander NR, 2008, CURR BIOL, V18, P1295, DOI 10.1016/j.cub.2008.07.090; Aratyn-Schaus Y, 2010, CURR BIOL, V20, P1145, DOI 10.1016/j.cub.2010.05.049; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; DeMond AL, 2008, BIOPHYS J, V94, P3286, DOI 10.1529/biophysj.107.119099; Doh J, 2006, P NATL ACAD SCI USA, V103, P5700, DOI 10.1073/pnas.0509404103; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Gelkop S, 2001, J BIOL CHEM, V276, P36174, DOI 10.1074/jbc.M100731200; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Grecco HE, 2011, CELL, V144, P897, DOI 10.1016/j.cell.2011.01.029; Groves JT, 2008, ANNU REV BIOMED ENG, V10, P311, DOI 10.1146/annurev.bioeng.10.061807.160431; Groves JT, 2010, NAT STRUCT MOL BIOL, V17, P659, DOI 10.1038/nsmb.1844; Groves JT, 1997, SCIENCE, V275, P651, DOI 10.1126/science.275.5300.651; Hartman NC, 2009, P NATL ACAD SCI USA, V106, P12729, DOI 10.1073/pnas.0902621106; Hashimoto-Tane A, 2011, IMMUNITY, V34, P919, DOI 10.1016/j.immuni.2011.05.012; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Husson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019680; Ilani T, 2009, NAT IMMUNOL, V10, P531, DOI 10.1038/ni.1723; Ingber DE, 2003, ANN MED, V35, P564, DOI 10.1080/07853890310016333; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Jacobelli J, 2004, NAT IMMUNOL, V5, P531, DOI 10.1038/ni1065; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; Kanda H, 1999, IMMUNOLOGY, V97, P56; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Kim ST, 2009, J BIOL CHEM, V284, P31028, DOI 10.1074/jbc.M109.052712; Kovacs M, 2007, P NATL ACAD SCI USA, V104, P9994, DOI 10.1073/pnas.0701181104; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Li YC, 2010, J IMMUNOL, V184, P5959, DOI 10.4049/jimmunol.0900775; Liu XH, 2000, EMBO J, V19, P6759, DOI 10.1093/emboj/19.24.6759; Loose M, 2008, SCIENCE, V320, P789, DOI 10.1126/science.1154413; Manza BN, 2011, P NATL ACAD SCI USA, V108, P9089, DOI 10.1073/pnas.1018771108; Minegishi M, 1996, J EXP MED, V184, P1365, DOI 10.1084/jem.184.4.1365; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Nye JA, 2008, LANGMUIR, V24, P4145, DOI 10.1021/la703788h; Ohashi Y, 1999, J IMMUNOL, V163, P3727; Ohashi Y, 1998, J BIOL CHEM, V273, P6446, DOI 10.1074/jbc.273.11.6446; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Reedquist KA, 1996, J BIOL CHEM, V271, P8435, DOI 10.1074/jbc.271.14.8435; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P584, DOI 10.1021/bi0483357; Salaita K, 2010, SCIENCE, V327, P1380, DOI 10.1126/science.1181729; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606; Smith AW, 2011, J PHYS CHEM A, V115, P3867, DOI 10.1021/jp108295s; Smoligovets AA, 2011, J CELL SCI IN PRESS; Takacs B, 2010, P NATL ACAD SCI USA, V107, P6799, DOI 10.1073/pnas.0907585107; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wei QZ, 2000, MOL BIOL CELL, V11, P3617, DOI 10.1091/mbc.11.10.3617; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Yu CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011878; Zheng MZ, 2006, J CELL SCI, V119, P96, DOI 10.1242/jcs.02712	63	50	50	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30704	10.1371/journal.pone.0030704	http://dx.doi.org/10.1371/journal.pone.0030704			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347397	gold, Green Published, Green Submitted			2022-12-25	WOS:000302730100022
J	Elman, I; Becerra, L; Tschibelu, E; Yamamoto, R; George, E; Borsook, D				Elman, Igor; Becerra, Lino; Tschibelu, Evelyne; Yamamoto, Rinah; George, Edward; Borsook, David			Yohimbine-Induced Amygdala Activation in Pathological Gamblers: A Pilot Study	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; AUTONOMIC AROUSAL; M-CHLOROPHENYLPIPERAZINE; BRAIN ACTIVATION; NERVOUS-SYSTEM; HEART-RATE; STRESS; COCAINE; SEEKING; ALCOHOLICS	Rationale and Objectives: There is evidence that drug addiction is associated with increased physiological and psychological responses to stress. In this pilot functional magnetic resonance imaging (fMRI) study we assessed whether a prototype behavioral addiction, pathological gambling (PG), is likewise associated with an enhanced response to stress. Methods: We induced stress by injecting yohimbine (0.2-0.3 mg/kg, IV), an alpha-2 adrenoceptor antagonist that elicits stress-like physiological and psychological effects in humans and in laboratory animals, to four subjects with PG and to five non-gamblers mentally healthy control subjects. Their fMRI brain responses were assessed along with subjective stress and gambling urges ratings. Results: Voxelwise analyses of data sets from individual subjects, utilizing generalized linear model approach, revealed significant left amygdala activation in response to yohimbine across all PG subjects. This amygdala effect was not observed in the five control individuals. Yohimbine elicited subjective stress ratings in both groups with greater (albeit not statically significantly) average response in the PG subjects. On the other hand, yohimbine did not induce urges to gamble. Conclusions: The present data support the hypothesis of brain sensitization to pharmacologically-induced stress in PG.	[Elman, Igor] Harvard Univ, Sch Med, Cambridge Hlth Alliance, Bedford Vet Adm Med Ctr, Somerville, MA USA; [Elman, Igor] Harvard Univ, Sch Med, Cambridge Hlth Alliance, Dept Psychiat, Somerville, MA USA; [Becerra, Lino; Tschibelu, Evelyne; Yamamoto, Rinah; George, Edward; Borsook, David] Harvard Univ, Sch Med, Belmont, MA 02178 USA; [Becerra, Lino; George, Edward; Borsook, David] McLean Hosp, PAIN Grp, Belmont, MA 02178 USA; [Tschibelu, Evelyne; Yamamoto, Rinah] McLean Hosp, Clin Psychopathol Lab, Belmont, MA 02178 USA	Harvard University; Cambridge Health Alliance; Harvard University; Cambridge Health Alliance; Harvard University; Harvard University; McLean Hospital; Harvard University; McLean Hospital	Elman, I (corresponding author), Harvard Univ, Sch Med, Cambridge Hlth Alliance, Bedford Vet Adm Med Ctr, Somerville, MA USA.	ielman@cha.harvard.edu	Elman, Igor/O-2884-2017	Elman, Igor/0000-0002-1345-2677	National Institute on Drug Abuse [DA017959]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017959] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Grant DA017959 from the National Institute on Drug Abuse, awarded to Dr. Igor Elman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Angrist B M, 1970, Biol Psychiatry, V2, P95; ANTELMAN SM, 1980, SCIENCE, V207, P329, DOI 10.1126/science.7188649; Baas D, 2004, BRAIN RES REV, V45, P96, DOI 10.1016/j.brainresrev.2004.02.004; Becerra L, 2006, ANESTH ANALG, V103, P208, DOI 10.1213/01.ane.0000221457.71536.e0; Belujon P, 2011, ANN NY ACAD SCI, V1216, P114, DOI 10.1111/j.1749-6632.2010.05896.x; Bergh C, 1997, PSYCHOL MED, V27, P473, DOI 10.1017/S0033291796003789; Biddle D, 2005, J TRAUMA STRESS, V18, P759, DOI 10.1002/jts.20084; Bremner JD, 1996, SYNAPSE, V23, P39, DOI 10.1002/(SICI)1098-2396(199605)23:1<39::AID-SYN5>3.3.CO;2-Y; Bremner JD, 1996, SYNAPSE, V23, P28, DOI 10.1002/(SICI)1098-2396(199605)23:1<28::AID-SYN4>3.0.CO;2-J; Chamberlain SR, 2007, CURR OPIN PSYCHIATR, V20, P255, DOI 10.1097/yco.0b013e3280ba4989; Cippitelli A, 2010, PSYCHOPHARMACOLOGY, V208, P417, DOI 10.1007/s00213-009-1741-y; Crockford DN, 2005, BIOL PSYCHIAT, V58, P787, DOI 10.1016/j.biopsych.2005.04.037; Cunningham-Williams RM, 2005, J PSYCHIATR RES, V39, P377, DOI 10.1016/j.jpsychires.2004.09.002; Daughters SB, 2005, J GAMBL STUD, V21, P363, DOI 10.1007/s10899-005-5554-6; de Castro V, 2007, ADDICT BEHAV, V32, P1555, DOI 10.1016/j.addbeh.2006.11.014; DeCaria CM, 1996, J CLIN PSYCHIAT, V57, P80; Egli RE, 2005, NEUROPSYCHOPHARMACOL, V30, P657, DOI 10.1038/sj.npp.1300639; Elman I, 2010, AM J ADDICTION, V19, P332, DOI 10.1111/j.1521-0391.2010.00055.x; Everitt BS, 1999, HUM BRAIN MAPP, V7, P1; First M. B., 2002, USERS GUIDE SCID 1 S; Folstein M, 2010, NUTR REV, V68, pS70, DOI 10.1111/j.1753-4887.2010.00351.x; Ghitza UE, 2006, NEUROPSYCHOPHARMACOL, V31, P2188, DOI 10.1038/sj.npp.1300964; Goeders NE, 2003, EUR NEUROPSYCHOPHARM, V13, P435, DOI 10.1016/j.euroneuro.2003.08.004; Goodman A, 2008, BIOCHEM PHARMACOL, V75, P266, DOI 10.1016/j.bcp.2007.07.030; Goudriaan AE, 2004, NEUROSCI BIOBEHAV R, V28, P123, DOI 10.1016/j.neubiorev.2004.03.001; Goudriaan AE, 2010, ADDICT BIOL, V15, P491, DOI 10.1111/j.1369-1600.2010.00242.x; Grinols EL., 2004, GAMBLING AM COSTS BE; GUTHRIE SK, 1990, EUR J CLIN PHARMACOL, V39, P409, DOI 10.1007/BF00315421; GUTHRIE SK, 1993, BIOL PSYCHIAT, V34, P558, DOI 10.1016/0006-3223(93)90199-N; HEDNER T, 1992, EUR J CLIN PHARMACOL, V43, P651, DOI 10.1007/BF02284967; Heilig M, 2007, TRENDS NEUROSCI, V30, P399, DOI 10.1016/j.tins.2007.06.006; Hollander E, 2005, WORLD J BIOL PSYCHIA, V6, P113, DOI 10.1080/15622970510029768; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; Krueger THC, 2005, NEUROPSYCHOBIOLOGY, V52, P206, DOI 10.1159/000089004; Krystal JH, 1997, PSYCHOPHARMACOLOGY, V131, P207, DOI 10.1007/s002130050285; Krystal JH, 1996, AM J PSYCHIAT, V153, P83; Langleben DD, 2008, AM J PSYCHIAT, V165, P390, DOI 10.1176/appi.ajp.2007.07010070; Lee B, 2004, NEUROPSYCHOPHARMACOL, V29, P686, DOI 10.1038/sj.npp.1300391; LESIEUR HR, 1987, AM J PSYCHIAT, V144, P1184; Meyer G, 2000, BIOL PSYCHIAT, V48, P948, DOI 10.1016/S0006-3223(00)00888-X; Meyer G, 2004, PSYCHONEUROENDOCRINO, V29, P1272, DOI 10.1016/j.psyneuen.2004.03.005; Moodie C, 2005, ADDICTION, V100, P51, DOI 10.1111/j.1360-0443.2005.00942.x; Neumeister A, 2005, PHARMACOGENET GENOM, V15, P143, DOI 10.1097/01213011-200503000-00002; Pendse G, 2009, NEUROIMAGE, V47, P231, DOI 10.1016/j.neuroimage.2009.02.035; POST RM, 1982, J NERV MENT DIS, V170, P717, DOI 10.1097/00005053-198212000-00002; Potenza MN, 2008, PHILOS T R SOC B, V363, P3181, DOI 10.1098/rstb.2008.0100; Potenza MN, 2002, J GEN INTERN MED, V17, P721, DOI 10.1046/j.1525-1497.2002.10812.x; Potenza MN, 2001, JAMA-J AM MED ASSOC, V286, P141, DOI 10.1001/jama.286.2.141; Rasmusson AM, 2000, BIOL PSYCHIAT, V47, P526, DOI 10.1016/S0006-3223(99)00185-7; Ritchey M, 2011, NEUROPSYCHOLOGIA, V49, P640, DOI 10.1016/j.neuropsychologia.2010.09.009; Roalf DR, 2009, NEUROBIOL AGING; Rohan M, 2001, P INT SOC MAGN RESO, V9, P1237; ROY A, 1988, ARCH GEN PSYCHIAT, V45, P369; SATEL SL, 1991, AM J PSYCHIAT, V148, P495; SEYMOUR GE, 1976, J PSYCHOSOM RES, V20, P469, DOI 10.1016/0022-3999(76)90011-8; Shaffer HJ, 1997, PATHOLOGICAL PROBLEM, p[67, 104]; Shalev U, 2010, BRAIN RES, V1314, P15, DOI 10.1016/j.brainres.2009.07.028; SHARPE L, 1995, ADDICTION, V90, P1529, DOI 10.1111/j.1360-0443.1995.tb02815.x; Sharpe L, 2004, J GAMBL STUD, V20, P95, DOI 10.1023/B:JOGS.0000016706.96540.43; Shepard JD, 2000, BRAIN RES, V861, P288, DOI 10.1016/S0006-8993(00)02019-9; Shepard JD, 2003, BRAIN RES, V963, P203, DOI 10.1016/S0006-8993(02)03978-1; Sinha R, 2001, PSYCHOPHARMACOLOGY, V158, P343, DOI 10.1007/s002130100917; Sinha R, 2011, ARCH GEN PSYCHIAT; Sodano R, 2010, J GAMBL STUD, V26, P53, DOI 10.1007/s10899-009-9146-8; SORG BA, 1991, BRAIN RES, V559, P29, DOI 10.1016/0006-8993(91)90283-2; Southwick SM, 1997, ARCH GEN PSYCHIAT, V54, P749; Southwick SM, 1999, BIOL PSYCHIAT, V46, P1192, DOI 10.1016/S0006-3223(99)00219-X; Stine SM, 2002, BIOL PSYCHIAT, V51, P642, DOI 10.1016/S0006-3223(01)01292-6; Stine SM, 2001, PSYCHOPHARMACOLOGY, V154, P274, DOI 10.1007/s002130000644; Strakowski SM, 1996, BIOL PSYCHIAT, V40, P872, DOI 10.1016/0006-3223(95)00497-1; Tamminga CA, 2006, AM J PSYCHIAT, V163, P180, DOI 10.1176/appi.ajp.163.2.180; Tavares H, 2005, ALCOHOL CLIN EXP RES, V29, P1427, DOI 10.1097/01.alc.0000175071.22872.98; Umhau JC, 2011, NEUROPSYCHOPHARMACOL, V36, P1178, DOI 10.1038/npp.2010.253; Weinstock J, 2006, AM J ADDICTION, V15, P144, DOI 10.1080/10550490500528449; Yamamoto RT, 2007, SUBST ABUSE TREAT PR, V2, DOI 10.1186/1747-597X-2-30; YEHUDA R, 1993, BIOL PSYCHIAT, V33, P479, DOI 10.1016/0006-3223(93)90001-T	78	20	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e31118	10.1371/journal.pone.0031118	http://dx.doi.org/10.1371/journal.pone.0031118			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319607	Green Submitted, Green Published, gold			2022-12-25	WOS:000301979000020
J	Yoshikawa, S; Kukimoto-Niino, M; Parker, L; Handa, N; Terada, T; Fujimoto, T; Terazawa, Y; Wakiyama, M; Sato, M; Sano, S; Kobayashi, T; Tanaka, T; Chen, L; Liu, ZJ; Wang, BC; Shirouzu, M; Kawa, S; Semba, K; Yamamoto, T; Yokoyama, S				Yoshikawa, S.; Kukimoto-Niino, M.; Parker, L.; Handa, N.; Terada, T.; Fujimoto, T.; Terazawa, Y.; Wakiyama, M.; Sato, M.; Sano, S.; Kobayashi, T.; Tanaka, T.; Chen, L.; Liu, Z-J; Wang, B-C; Shirouzu, M.; Kawa, S.; Semba, K.; Yamamoto, T.; Yokoyama, S.			Structural basis for the altered drug sensitivities of non-small cell lung cancer-associated mutants of human epidermal growth factor receptor	ONCOGENE			English	Article						EGFR; T790M; gefitinib; tyrosine kinase inhibitor; NSCLC; drug resistance	EGFR KINASE INHIBITORS; DIFFRACTION DATA; MUTATIONS; GEFITINIB; ACTIVATION; RESISTANT; TRANSFORMATION; REFINEMENT; MECHANISM; SOFTWARE	The epidermal growth factor receptor (EGFR) has an essential role in multiple signaling pathways, including cell proliferation and migration, through extracellular ligand binding and subsequent activation of its intracellular tyrosine kinase (TK) domain. The non-small cell lung cancer (NSCLC)-associated EGFR mutants, L858R and G719S, are constitutively active and oncogenic. They display sensitivity to TK inhibitors, including gefitinib and erlotinib. In contrast, the secondary mutation of the gatekeeper residue, T790M, reportedly confers inhibitor resistance on the oncogenic EGFR mutants. In this study, our biochemical analyses revealed that the introduction of the T790M mutation confers gefitinib resistance on the G719S mutant. The G719S/T790M double mutant has enhanced activity and retains high gefitinib-binding affinity. The T790M mutation increases the ATP affinity of the G719S mutant, explaining the acquired drug resistance of the double mutant. Structural analyses of the G719S/T790M double mutant, as well as the wild type and the G719S and L858R mutants, revealed that the T790M mutation stabilizes the hydrophobic spine of the active EGFR-TK conformation. The Met790 side chain of the G719S/T790M double mutant, in the apo form and gefitinib- and AMPPNP-bound forms, adopts different conformations that explain the accommodation of these ligands. In the L858R mutant structure, the active-site cleft is expanded by the repositioning of Phe723 within the P-loop. Notably, the introduction of the F723A mutation greatly enhanced the gefitinib sensitivity of the wild-type EGFR in vivo, supporting our hypothesis that the expansion of the active-site cleft results in enhanced gefitinib sensitivity. Taken together, our results provide a structural basis for the altered drug sensitivities caused by distinct NSCLC-associated EGFR mutations. Oncogene (2013) 32, 27-38; doi:10.1038/onc.2012.21; published online 20 February 2012	[Yoshikawa, S.; Kukimoto-Niino, M.; Parker, L.; Handa, N.; Terada, T.; Fujimoto, T.; Terazawa, Y.; Wakiyama, M.; Shirouzu, M.; Yokoyama, S.] Yokohama Inst, RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Yamamoto, T.] Univ Tokyo, Inst Med Sci, Div Oncol, Minato Ku, Tokyo 1088639, Japan; [Sato, M.; Sano, S.; Kobayashi, T.; Tanaka, T.] Japan Aerosp Explorat Agcy, Ibaraki, Japan; [Chen, L.; Liu, Z-J; Wang, B-C] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Semba, K.] Waseda Univ, Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Tokyo, Japan; [Yamamoto, T.] Okinawa Inst Sci & Technol, Cell Signal Unit, Okinawa, Japan; [Yokoyama, S.] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 113, Japan	RIKEN; University of Tokyo; Japan Aerospace Exploration Agency (JAXA); University System of Georgia; University of Georgia; Waseda University; Okinawa Institute of Science & Technology Graduate University; University of Tokyo	Yokoyama, S (corresponding author), Yokohama Inst, RIKEN Syst & Struct Biol Ctr, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	tyamamot@ims.u-tokyo.ac.jp; yokoyama@biochem.s.u-tokyo.ac.jp	Yokoyama, Shigeyuki/N-6911-2015; Kukimoto-Niino, Mutsuko/C-6704-2017; Wakiyama, Motoaki/N-6928-2015; Shirouzu, Mikako/A-6521-2016; Liu, Zhi-Jie/A-3946-2012	Yokoyama, Shigeyuki/0000-0003-3133-7338; Kukimoto-Niino, Mutsuko/0000-0002-4178-1611; Wakiyama, Motoaki/0000-0002-8029-4795; Liu, Zhi-Jie/0000-0001-7279-2893; Sano, Satoshi/0000-0001-5909-7474	US Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; High-quality Protein Crystal Growth Experiment Project in JEM; RIKEN Structural Genomics/Proteomics Initiative; National Project on Protein Structural and Functional Analyses; Targeted Proteins Research Program (TPRP); Ministry of Education, Culture, Sports, Science and Technology of Japan; Japanese Society for the Promotion of Science Fellowship (LJP)	US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); High-quality Protein Crystal Growth Experiment Project in JEM; RIKEN Structural Genomics/Proteomics Initiative; National Project on Protein Structural and Functional Analyses(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Targeted Proteins Research Program (TPRP)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for the Promotion of Science Fellowship (LJP)	We thank C Takemoto, T Kaminishi, M Kawazoe, Y Fujii and S Kishishita for assisting with the data collection; Y Ishizuka-Katsura, R Akasaka, M Yamaguchi-Hirafuji, T Uchikubo-Kamo, A Urushibata and N Maoka for technical assistance; S Kusano for helpful assistance; and K Murayama for helpful advice. We also thank the beamline staffs of the X06SA (SLS), BL-5A (PF), BL41XU (SPring-8) and BL26B2 (SPring-8) beamlines. Portions of the data were collected at the Southeast Regional Collaborative Access Team (SER-CAT) 22-ID beamline at the Advanced Photon Source, Argonne National Laboratory. Supporting institutions may be found at http://www.ser.anl.gov/. Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. W-31-109-Eng-38. This study was supported in part by the 'High-quality Protein Crystal Growth Experiment Project in JEM' promoted by the Japan Aerospace Exploration Agency. The Russian Spacecraft 'Progress' and 'Soyuz', provided by the Russian Federal Space Agency, were used for space transportation. A portion of the crystallization technology for the counter-diffusion method was developed by European Space Agency and University of Granada. This work was supported by the RIKEN Structural Genomics/Proteomics Initiative, the National Project on Protein Structural and Functional Analyses, the Targeted Proteins Research Program (TPRP), the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by a Japanese Society for the Promotion of Science Fellowship (LJP).	Arteaga CL, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.35642; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carmi C, 2010, J MED CHEM, V53, P2038, DOI 10.1021/jm901558p; Cha MY, 2012, INT J CANCER, V130, P2445, DOI 10.1002/ijc.26276; Cha MY, 2009, J MED CHEM, V52, P6880, DOI 10.1021/jm901146p; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano WL, 2005, PYMOL V 0 98; Dixit A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007485; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engelman JA, 2007, CANCER RES, V67, P11924, DOI 10.1158/0008-5472.CAN-07-1885; GARCIARUIZ JM, 1994, ACTA CRYSTALLOGR D, V50, P484, DOI 10.1107/S0907444993014350; Gilmer TM, 2008, CANCER RES, V68, P571, DOI 10.1158/0008-5472.CAN-07-2404; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Jiang JR, 2005, CANCER RES, V65, P8968, DOI 10.1158/0008-5472.CAN-05-1829; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kobayashi N, 2012, LUNG CANCER, V75, P161, DOI 10.1016/j.lungcan.2011.04.022; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; LESLIE AG, 1992, JOINT CCP4 ESF EAMCB, V26; Li D, 2008, ONCOGENE, V27, P4702, DOI 10.1038/onc.2008.109; Liu Y, 1998, BIOORGAN MED CHEM, V6, P1219, DOI 10.1016/S0968-0896(98)00099-6; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mukohara T, 2005, JNCI-J NATL CANCER I, V97, P1185, DOI 10.1093/jnci/dji238; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Rouge TD, 2007, CANCER RES, V67, P6253, DOI 10.1158/0008-5472.CAN-07-0538; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Suzuki T, 2002, GENE DEV, V16, P1356, DOI 10.1101/gad.962802; Taube E, 2012, INT J CANCER, V131, P970, DOI 10.1002/ijc.26461; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wakeling AE, 2002, CANCER RES, V62, P5749; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Wu CH, 2010, J MED CHEM, V53, P7316, DOI 10.1021/jm100607r; Yao M, 2006, ACTA CRYSTALLOGR D, V62, P189, DOI 10.1107/S0907444905038965; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhou WJ, 2011, BIOORG MED CHEM LETT, V21, P638, DOI 10.1016/j.bmcl.2010.12.036; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	48	88	91	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2013	32	1					27	38		10.1038/onc.2012.21	http://dx.doi.org/10.1038/onc.2012.21			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	063VG	22349823				2022-12-25	WOS:000313029500003
J	Radic, Z; Sit, RK; Kovarik, Z; Berend, S; Garcia, E; Zhang, LM; Amitai, G; Green, C; Radic, B; Fokin, VV; Sharpless, KB; Taylor, P				Radic, Zoran; Sit, Rakesh K.; Kovarik, Zrinka; Berend, Suzana; Garcia, Edzna; Zhang, Limin; Amitai, Gabriel; Green, Carol; Radic, Bozica; Fokin, Valery V.; Sharpless, K. Barry; Taylor, Palmer			Refinement of Structural Leads for Centrally Acting Oxime Reactivators of Phosphylated Cholinesterases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLICK CHEMISTRY; IN-SITU; ACETYLCHOLINESTERASE; ORGANOPHOSPHATES; RESIDUES; BINDING; BRAIN; SOMAN; BLOOD	We present a systematic structural optimization of uncharged but ionizable N-substituted 2-hydroxyiminoacetamido alkylamine reactivators of phosphylated human acetylcholinesterase (hAChE) intended to catalyze the hydrolysis of organophosphate (OP)-inhibited hAChE in the CNS. Starting with the initial lead oxime RS41A identified in our earlier study and extending to the azepine analog RS194B, reactivation rates for OP-hAChE conjugates formed by sarin, cyclosarin, VX, paraoxon, and tabun are enhanced severalfold in vitro. To analyze the mechanism of intrinsic reactivation of the OP-AChE conjugate and penetration of the blood-brain barrier, the pH dependence of the oxime and amine ionizing groups of the compounds and their nucleophilic potential were examined by UV-visible spectroscopy, H-1 NMR, and oximolysis rates for acetylthiocholine and phosphoester hydrolysis. Oximolysis rates were compared in solution and on AChE conjugates and analyzed in terms of the ionization states for reactivation of the OP-conjugated AChE. In addition, toxicity and pharmacokinetic studies in mice show significantly improved CNS penetration and retention for RS194B when compared with RS41A. The enhanced intrinsic reactivity against the OP-AChE target combined with favorable pharmacokinetic properties resulted in great improvement of antidotal properties of RS194B compared with RS41A and the standard peripherally active oxime, 2-pyridinealdoxime methiodide. Improvement was particularly noticeable when pretreatment of mice with RS194B before OP exposure was combined with RS194B reactivation therapy after the OP insult.	[Radic, Zoran; Garcia, Edzna; Zhang, Limin; Taylor, Palmer] UCSD, SSPPS, La Jolla, CA 92093 USA; [Sit, Rakesh K.; Fokin, Valery V.; Sharpless, K. Barry] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Kovarik, Zrinka; Berend, Suzana; Radic, Bozica] Inst Med Res & Occupat Hlth, HR-10001 Zagreb, Croatia; [Amitai, Gabriel] Israel Inst Biol Res, Dept Pharmacol, IL-74100 Ness Ziona, Israel; [Green, Carol] SRI Int, Menlo Pk, CA 94025 USA	University of California System; University of California San Diego; Scripps Research Institute; Institute for Medical Research & Occupational Health (IMROH); SRI International	Taylor, P (corresponding author), UCSD, SSPPS, 9500 Gilman Dr, La Jolla, CA 92093 USA.	pwtaylor@ucsd.edu	RADIC, ZORAN/P-7924-2017		CounterACT Program; National Institutes of Health Office of the Director; National Institutes of Health from NINDS [U01 NS058046]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS058046] Funding Source: NIH RePORTER	CounterACT Program; National Institutes of Health Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health from NINDS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by the CounterACT Program, National Institutes of Health Office of the Director, and National Institutes of Health Grant U01 NS058046 from NINDS.	Aldridge W. N., 1972, ENZYME INHIBITORS SU; Amitai G, 2007, TOXICOLOGY, V233, P187, DOI 10.1016/j.tox.2006.09.020; ASHANI Y, 1995, J BIOL CHEM, V270, P6370, DOI 10.1074/jbc.270.11.6370; Berend S, 2010, J ENZYM INHIB MED CH, V25, P531, DOI 10.3109/14756360903357593; Calic M, 2006, TOXICOLOGY, V219, P85, DOI 10.1016/j.tox.2005.11.003; Cochran R, 2011, J BIOL CHEM, V286, P29718, DOI 10.1074/jbc.M111.264739; Cook P. F., 2007, ENZYME KINETICS MECH, P225; de Koning MC, 2011, TOXICOL LETT, V206, P54, DOI 10.1016/j.toxlet.2011.04.004; Demar JC, 2010, CHEM-BIOL INTERACT, V187, P191, DOI 10.1016/j.cbi.2010.02.015; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Garcia GE, 2010, CHEM-BIOL INTERACT, V187, P199, DOI 10.1016/j.cbi.2010.02.033; HAREL M, 1993, P NATL ACAD SCI USA, V90, P9031, DOI 10.1073/pnas.90.19.9031; Kalisiak J, 2011, J MED CHEM, V54, P3319, DOI 10.1021/jm200054r; Kovarik Z, 2004, BIOCHEMISTRY-US, V43, P3222, DOI 10.1021/bi036191a; Krasinski A, 2005, J AM CHEM SOC, V127, P6686, DOI 10.1021/ja043031t; Lewis WG, 2002, ANGEW CHEM INT EDIT, V41, P1053, DOI 10.1002/1521-3773(20020315)41:6<1053::AID-ANIE1053>3.0.CO;2-4; LITTLE PJ, 1988, DRUG METAB DISPOS, V16, P515; Malany S, 2000, J AM CHEM SOC, V122, P2981, DOI 10.1021/ja9933590; Mercey G, 2011, CHEM COMMUN, V47, P5295, DOI 10.1039/c1cc10787a; Radic Z, 2006, TOXICOLOGY ORGANOPHO, P161; Shih TM, 2010, CHEM-BIOL INTERACT, V187, P207, DOI 10.1016/j.cbi.2010.03.006; Silman I, 2008, CHEM-BIOL INTERACT, V175, P3, DOI 10.1016/j.cbi.2008.05.035; Sit RK, 2011, J BIOL CHEM, V286, P19422, DOI 10.1074/jbc.M111.230656; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; THOMPSON WR, 1947, BACTERIOL REV, V11, P115, DOI 10.1128/MMBR.11.2.115-145.1947; WEIL CS, 1952, BIOMETRICS, V8, P249, DOI 10.2307/3001557; Wilson I. B., 1971, DRUG DESIGN, VII, P213; WILSON IB, 1950, J BIOL CHEM, V185, P479	28	87	90	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11798	11809		10.1074/jbc.M111.333732	http://dx.doi.org/10.1074/jbc.M111.333732			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22343626	Green Published, hybrid			2022-12-25	WOS:000302782200019
J	Almeida, AS; Queiroga, CSF; Sousa, MFQ; Alves, PM; Vieira, HLA				Almeida, Ana S.; Queiroga, Claudia S. F.; Sousa, Marcos F. Q.; Alves, Paula M.; Vieira, Helena L. A.			Carbon Monoxide Modulates Apoptosis by Reinforcing Oxidative Metabolism in Astrocytes ROLE OF Bcl-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; MITOCHONDRIAL RESPIRATORY-CHAIN; HEME OXYGENASE-1; THERAPEUTIC APPLICATIONS; CEREBRAL-ISCHEMIA; BRAIN; CELLS; BCL-2; RAT; BIOGENESIS	Modulation of cerebral cell metabolism for improving the outcome of hypoxia-ischemia and reperfusion is a strategy yet to be explored. Because carbon monoxide (CO) is known to prevent cerebral cell death; herein the role of CO in the modulation of astrocytic metabolism, in particular, at the level of mitochondria was investigated. Low concentrations of CO partially inhibited oxidative stress-induced apoptosis in astrocytes, by preventing caspase-3 activation, mitochondrial potential depolarization, and plasmatic membrane permeability. CO exposure enhanced intracellular ATP generation, which was accompanied by an increase on specific oxygen consumption, a decrease on lactate production, and a reduction of glucose use, indicating an improvement of oxidative phosphorylation. Accordingly, CO increased cytochrome c oxidase (COX) enzymatic specific activity and stimulated mitochondrial biogenesis. In astrocytes, COX interacts with Bcl-2, which was verified by immunoprecipitation; this interaction is superior after 24 h of CO treatment. Furthermore, CO enhanced Bcl-2 expression in astrocytes. By silencing Bcl-2 expression with siRNA transfection, CO effects in astrocytes were prevented, namely: (i) inhibition of apoptosis, (ii) increase on ATP generation, (iii) stimulation of COX activity, and (iv) mitochondrial biogenesis. Thus, Bcl-2 expression is crucial for CO modulation of oxidative metabolism and for conferring cytoprotection. In conclusion, CO protects astrocytes against oxidative stress-induced apoptosis by improving metabolism functioning, particularly mitochondrial oxidative phosphorylation.	[Almeida, Ana S.; Queiroga, Claudia S. F.; Sousa, Marcos F. Q.; Alves, Paula M.; Vieira, Helena L. A.] Inst Biol Expt & Tecnol, P-2781901 Oeiras, Portugal; [Queiroga, Claudia S. F.; Alves, Paula M.; Vieira, Helena L. A.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2781901 Oeiras, Portugal; [Almeida, Ana S.; Queiroga, Claudia S. F.; Vieira, Helena L. A.] Univ Nova Lisboa, Fac Ciencias Med, Chron Dis Res Ctr, P-1169056 Lisbon, Portugal	Universidade Nova de Lisboa; Universidade Nova de Lisboa	Vieira, HLA (corresponding author), Edificio Lab Associado Oeiras, Biol Cytoprotect Lab, Chron Dis Res Ctr, Campus IGC,Rua Quinta Grande 6, P-2780156 Oeiras, Portugal.	helena.vieira@fcm.unl.pt	Alves, Paula M/C-1070-2008; Vieira, Helena/AAZ-9562-2021	Alves, Paula M/0000-0003-1445-3556; Queiroga, Claudia/0000-0002-3984-9576; Vieira, Helena/0000-0001-9415-3742; Almeida, Ana Sofia/0000-0001-7654-9049	Portuguese Fundacao para a Ciencia e Tecnologia [PTDC/SAU-NEU/098747/2008]; Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BPD/27125/2006, SFRH/BD/43387/2008]	Portuguese Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by Portuguese Fundacao para a Ciencia e Tecnologia Project PTDC/SAU-NEU/098747/2008 and by Fellowships SFRH/BPD/27125/2006 (to H. L. A. V.) and SFRH/BD/43387/2008 (to C. S. F. Q.) from Fundacao para a Ciencia e a Tecnologia, Portugal.	Ahlstrom K, 2009, ACTA ANAESTH SCAND, V53, P1036, DOI 10.1111/j.1399-6576.2009.01992.x; Alonso JR, 2003, PHARMACOL TOXICOL, V93, P142, DOI 10.1034/j.1600-0773.2003.930306.x; Atkinson B., 1987, BIOCH ENG FUNDAMENTA; Bannenberg GL, 2009, EXPERT OPIN THER PAT, V19, P663, DOI 10.1517/13543770902858824; Bilban M, 2008, J MOL MED, V86, P267, DOI 10.1007/s00109-007-0276-0; Chen ZX, 2007, CELL DEATH DIFFER, V14, P1617, DOI 10.1038/sj.cdd.4402165; Chen ZX, 2010, CELL DEATH DIFFER, V17, P408, DOI 10.1038/cdd.2009.132; Chin BY, 2007, P NATL ACAD SCI USA, V104, P5109, DOI 10.1073/pnas.0609611104; Chora AA, 2007, J CLIN INVEST, V117, P438, DOI 10.1172/JCI28844; D'Amico G, 2006, J CELL SCI, V119, P2291, DOI 10.1242/jcs.02914; Di Noia MA, 2006, J BIOL CHEM, V281, P15687, DOI 10.1074/jbc.M510595200; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Kristian T, 2000, J NEUROCHEM, V74, P1999, DOI 10.1046/j.1471-4159.2000.0741999.x; Lo Iacono L, 2011, FREE RADICAL BIO MED, V50, P1556, DOI 10.1016/j.freeradbiomed.2011.02.033; Maranga L, 2006, BIOTECHNOL BIOENG, V94, P139, DOI 10.1002/bit.20890; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Panahian N, 1999, J NEUROCHEM, V72, P1187; Queiroga CSF, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-10; Queiroga CSF, 2010, J BIOL CHEM, V285, P17077, DOI 10.1074/jbc.M109.065052; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Santos SS, 2005, J NEUROSCI RES, V79, P26, DOI 10.1002/jnr.20279; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; Soares MP, 2009, TRENDS MOL MED, V15, P50, DOI 10.1016/j.molmed.2008.12.004; Stein AB, 2005, J MOL CELL CARDIOL, V38, P127, DOI 10.1016/j.yjmcc.2004.10.006; Suliman HB, 2007, J CLIN INVEST, V117, P3730, DOI 10.1172/JCI32967; Suliman HB, 2007, J CELL SCI, V120, P299, DOI 10.1242/jcs.03318; Taille C, 2005, J BIOL CHEM, V280, P25350, DOI 10.1074/jbc.M503512200; Tsui TY, 2007, SHOCK, V27, P165, DOI 10.1097/01.shk.0000239781.71516.61; Tsui TY, 2005, BIOCHEM BIOPH RES CO, V336, P898, DOI 10.1016/j.bbrc.2005.08.187; Vannucci RC, 1998, J NEUROCHEM, V71, P1215; Vannucci SJ, 2004, J EXP BIOL, V207, P3149, DOI 10.1242/jeb.01064; Vieira HLA, 2008, J NEUROCHEM, V107, P375, DOI 10.1111/j.1471-4159.2008.05610.x; Wang B, 2011, STROKE, V42, P2605, DOI 10.1161/STROKEAHA.110.607101; Zeynalov E, 2009, NEUROTOX RES, V15, P133, DOI 10.1007/s12640-009-9014-4; Zhang XC, 2003, J BIOL CHEM, V278, P22061, DOI 10.1074/jbc.M301858200; Zimmermann A, 2007, AM J PHYSIOL-HEART C, V293, pH2501, DOI 10.1152/ajpheart.00354.2007; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com	40	78	78	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10761	10770		10.1074/jbc.M111.306738	http://dx.doi.org/10.1074/jbc.M111.306738			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334654	Green Published, hybrid			2022-12-25	WOS:000302780100005
J	Gubaev, A; Klostermeier, D				Gubaev, Airat; Klostermeier, Dagmar			Potassium Ions Are Required for Nucleotide-induced Closure of Gyrase N-gate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS DNA; ATP-OPERATED CLAMP; STRAND-PASSAGE; B-PROTEIN; TERMINAL FRAGMENT; 2-GATE MECHANISM; CLOSED CONFORMATION; CRYSTAL-STRUCTURE; TOPOISOMERASE-II; HYDROLYSIS	DNA gyrase catalyzes ATP-dependent negative supercoiling of DNA by a strand passage mechanism that requires coordinated opening and closing of three protein interfaces, the N-, DNA-, and C-gates. ATP binding to the GyrB subunits of gyrase causes dimerization and N-gate closure. The closure of the N-gate is a key step in the gyrase catalytic cycle, as it captures the DNA segment to be transported and poises gyrase toward strand passage. We show here that K+ ions are required for DNA supercoiling but are dispensable for ATP-independent DNA relaxation. Although DNA binding, distortion, wrapping, and DNA-induced narrowing of the N-gate occur in the absence of K+, nucleotide-induced N-gate closure depends on their presence. Our results provide evidence that K+ ions relay small conformational changes in the nucleotide-binding pocket to the formation of a tight dimer interface at the N-gate by connecting regions from both GyrB monomers and suggest an important role for K+ in synchronization of N-gate closure and DNA-gate opening.	[Gubaev, Airat; Klostermeier, Dagmar] Univ Munster, Inst Phys Chem, D-48149 Munster, Germany	University of Munster	Gubaev, A (corresponding author), Univ Munster, Inst Phys Chem, Corrensstr 30, D-48149 Munster, Germany.	airat.gubaev@uni-muenster.de			Swiss National Science Foundation (National Center of Competence in Research Nanoscale Sciences)	Swiss National Science Foundation (National Center of Competence in Research Nanoscale Sciences)	This work was supported by the Swiss National Science Foundation (National Center of Competence in Research Nanoscale Sciences).	ALI JA, 1993, BIOCHEMISTRY-US, V32, P2717, DOI 10.1021/bi00061a033; ALI JA, 1995, BIOCHEMISTRY-US, V34, P9801, DOI 10.1021/bi00030a018; BASHKIROV VI, 1991, GENETICA, V85, P3, DOI 10.1007/BF00056101; Bates AD, 2011, NUCLEIC ACIDS RES, V39, P6327, DOI 10.1093/nar/gkr258; Brino L, 2000, J BIOL CHEM, V275, P9468, DOI 10.1074/jbc.275.13.9468; Corbett KD, 2005, J MOL BIOL, V351, P545, DOI 10.1016/j.jmb.2005.06.029; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Fu GS, 2009, NUCLEIC ACIDS RES, V37, P5908, DOI 10.1093/nar/gkp586; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P3872, DOI 10.1073/pnas.73.11.3872; Gottler T, 2007, J MOL BIOL, V367, P1392, DOI 10.1016/j.jmb.2007.01.055; Gubaev A, 2011, P NATL ACAD SCI USA, V108, P14085, DOI 10.1073/pnas.1102100108; Gubaev A, 2009, P NATL ACAD SCI USA, V106, P13278, DOI 10.1073/pnas.0902493106; Hilbert M, 2011, NUCLEIC ACIDS RES, V39, P2260, DOI 10.1093/nar/gkq1127; Hu XJ, 2003, FEBS LETT, V544, P268, DOI 10.1016/S0014-5793(03)00519-2; Kampranis SC, 1999, P NATL ACAD SCI USA, V96, P8414, DOI 10.1073/pnas.96.15.8414; Kampranis SC, 1998, J BIOL CHEM, V273, P26305, DOI 10.1074/jbc.273.41.26305; Lanz MA, 2011, NUCLEIC ACIDS RES, V39, P9681, DOI 10.1093/nar/gkr680; LIU LF, 1978, P NATL ACAD SCI USA, V75, P2098, DOI 10.1073/pnas.75.5.2098; Machius M, 2001, P NATL ACAD SCI USA, V98, P11218, DOI 10.1073/pnas.201220098; Roca J, 1996, P NATL ACAD SCI USA, V93, P4057, DOI 10.1073/pnas.93.9.4057; Roca J, 2004, J BIOL CHEM, V279, P25783, DOI 10.1074/jbc.M402555200; ROCA J, 1994, CELL, V77, P609, DOI 10.1016/0092-8674(94)90222-4; Roca J, 2009, NUCLEIC ACIDS RES, V37, P721, DOI 10.1093/nar/gkn994; Sissi C, 2005, J MOL BIOL, V353, P1152, DOI 10.1016/j.jmb.2005.09.043; Theissen B, 2008, P NATL ACAD SCI USA, V105, P548, DOI 10.1073/pnas.0705488105; Tingey AP, 1996, NUCLEIC ACIDS RES, V24, P4868, DOI 10.1093/nar/24.24.4868; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0; Williams NL, 2001, J MOL BIOL, V306, P969, DOI 10.1006/jmbi.2001.4468; Williams NL, 1999, BIOCHEMISTRY-US, V38, P14157, DOI 10.1021/bi991478m; Williams NL, 1999, BIOCHEMISTRY-US, V38, P13502, DOI 10.1021/bi9912488	30	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10916	10921		10.1074/jbc.M111.308247	http://dx.doi.org/10.1074/jbc.M111.308247			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22343632	hybrid, Green Published			2022-12-25	WOS:000302780100020
J	Wang, RR; Li, Q; Helfer, CM; Jiao, J; You, JX				Wang, Ranran; Li, Qing; Helfer, Christine M.; Jiao, Jing; You, Jianxin			Bromodomain Protein Brd4 Associated with Acetylated Chromatin Is Important for Maintenance of Higher-order Chromatin Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOST MITOTIC CHROMOSOMES; P-TEFB; GENE-EXPRESSION; S-PHASE; TRANSCRIPTION; INTERACTS; FIBER; PROGRESSION; CELLS; RECOGNITION	Chromatin structure organization is crucial for regulating many fundamental cellular processes. However, the molecular mechanism that regulates the assembly of higher-order chromatin structure remains poorly understood. In this study, we demonstrate that Brd4 (bromodomain-containing protein 4) protein participates in the maintenance of the higher-order chromatin structure. Brd4, a member of the BET family of proteins, has been shown to play important roles in cellular growth control, cell cycle progression, and cancer development. We apply in situ single cell chromatin imaging and micrococcal nuclease (MNase) assay to show that Brd4 depletion leads to a large scale chromatin unfolding. Adominant-negative inhibitor encoding the double bromodomains (BDI/II) of Brd4 can competitively dissociate endogenous Brd4 from chromatin to trigger severely fragmented chromatin morphology. Mechanistic studies using Brd4 truncation mutants reveal that the Brd4 C-terminal domain is crucial for maintaining normal chromatin structure. Using bimolecular fluorescence complementation technology, we demonstrate that Brd4 molecules interact intermolecularly on chromatin and that replacing Brd4 molecules by BDI/II causes abnormal nucleosome aggregation and chromatin fragmentation. These studies establish a novel structural role of Brd4 in supporting the higher chromatin architecture.	[Wang, Ranran; Li, Qing; Helfer, Christine M.; Jiao, Jing; You, Jianxin] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	You, JX (corresponding author), 3610 Hamilton Walk, Philadelphia, PA 19104 USA.	jianyou@mail.med.upenn.edu		Wang, Ranran/0000-0002-7920-0704	National Institutes of Health from the NCI [R01CA148768, R01CA142723]; China Scholarship Council [2007-3079]; NATIONAL CANCER INSTITUTE [R01CA142723, R01CA148768] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA148768 and R01CA142723 from the NCI (to J. Y.) and a fellowship from the China Scholarship Council (2007-3079) (to Q. L.).	Bickmore WA, 2003, HUM MOL GENET, V12, pR207, DOI 10.1093/hmg/ddg260; Bisgrovet DA, 2007, P NATL ACAD SCI USA, V104, P13690, DOI 10.1073/pnas.0705053104; Crawford NPS, 2008, P NATL ACAD SCI USA, V105, P6380, DOI 10.1073/pnas.0710331105; Davis PK, 2003, CANCER BIOL THER, V2, P22; Dey A, 2000, MOL CELL BIOL, V20, P6537, DOI 10.1128/MCB.20.17.6537-6549.2000; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Farina A, 2004, MOL CELL BIOL, V24, P9059, DOI 10.1128/MCB.24.20.9059-9069.2004; Filetici P, 2001, FRONT BIOSCI-LANDMRK, V6, pD866, DOI 10.2741/Filetici; French CA, 2001, AM J PATHOL, V159, P1987, DOI 10.1016/S0002-9440(10)63049-0; Gelato KA, 2008, BIOL CHEM, V389, P353, DOI 10.1515/BC.2008.048; Houzelstein D, 2002, MOL CELL BIOL, V22, P3794, DOI 10.1128/MCB.22.11.3794-3802.2002; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Leroy G, 2008, MOL CELL, V30, P51, DOI 10.1016/j.molcel.2008.01.018; Lin A, 2008, J VIROL, V82, P12009, DOI 10.1128/JVI.01680-08; Maruyama T, 2002, MOL CELL BIOL, V22, P6509, DOI 10.1128/MCB.22.18.6509-6520.2002; Mochizuki K, 2008, J BIOL CHEM, V283, P9040, DOI 10.1074/jbc.M707603200; Mohd-Sarip A, 2004, SCIENCE, V306, P1484, DOI 10.1126/science.1106767; Morales V, 2001, BIOCHIMIE, V83, P1029, DOI 10.1016/S0300-9084(01)01347-5; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakamura Y, 2007, J BIOL CHEM, V282, P4193, DOI 10.1074/jbc.M605971200; Nishiyama A, 2006, MOL BIOL CELL, V17, P814, DOI 10.1091/mbc.E05-08-0729; Ottinger M, 2006, J VIROL, V80, P10772, DOI 10.1128/JVI.00804-06; Pivot-Pajot C, 2003, MOL CELL BIOL, V23, P5354, DOI 10.1128/MCB.23.15.5354-5365.2003; Robinson PJJ, 2006, P NATL ACAD SCI USA, V103, P6506, DOI 10.1073/pnas.0601212103; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Tremethick DJ, 2007, CELL, V128, P651, DOI 10.1016/j.cell.2007.02.008; Wu SY, 2006, GENE DEV, V20, P2383, DOI 10.1101/gad.1448206; Yan JP, 2011, J BIOL CHEM, V286, P27663, DOI 10.1074/jbc.M111.246975; Yan JP, 2010, J VIROL, V84, P76, DOI 10.1128/JVI.01647-09; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; You J, 2004, CELL, V117, P349, DOI 10.1016/S0092-8674(04)00402-7; You JX, 2006, J VIROL, V80, P8909, DOI 10.1128/JVI.00502-06; You JX, 2009, MOL CELL BIOL, V29, P5094, DOI 10.1128/MCB.00299-09; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	39	90	107	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10738	10752		10.1074/jbc.M111.323493	http://dx.doi.org/10.1074/jbc.M111.323493			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334664	Green Published, hybrid			2022-12-25	WOS:000302780100003
J	Eftychi, C; Karagianni, N; Alexiou, M; Apostolaki, M; Kollias, G				Eftychi, Christina; Karagianni, Niki; Alexiou, Maria; Apostolaki, Maria; Kollias, George			Myeloid Takl Acts as a Negative Regulator of the LPS Response and Mediates Resistance to Endotoxemia	PLOS ONE			English	Article							NF-KAPPA-B; KINASE TAK1; IN-VIVO; IMMUNE-RESPONSES; STEM-CELLS; INNATE; BETA; APOPTOSIS; MICE; INFLAMMATION	TGF beta-activated kinase 1 (TAK1), a member of the mitogen-activated protein kinase kinase kinase (MAP3K) family, is considered a key intermediate in a multitude of innate immune signaling pathways. Yet, the specific role of TAK1 in the myeloid compartment during inflammatory challenges has not been revealed. To address this question, we generated myeloid-specific kinase-dead TAK1 mutant mice. TAK1 deficiency in macrophages results in impaired NF-kappa B and JNK activation upon stimulation with lipopolysaccharide (LPS). Moreover, TAK1-deficient macrophages and neutrophils show an enhanced inflammatory cytokine profile in response to LPS stimulation. Myeloid-specific TAK1 deficiency in mice leads to increased levels of circulating IL-1 beta, TNF and reduced IL-10 after LPS challenge and sensitizes them to LPS-induced endotoxemia. These results highlight an antiinflammatory role for myeloid TAK1, which is essential for balanced innate immune responses and host survival during endotoxemia.	[Eftychi, Christina; Karagianni, Niki; Alexiou, Maria; Apostolaki, Maria; Kollias, George] Biomed Sci Res Ctr Alexander Fleming, Inst Immunol, Vari, Greece	Alexander Fleming Biomedical Sciences Research Center	Eftychi, C (corresponding author), Biomed Sci Res Ctr Alexander Fleming, Inst Immunol, Vari, Greece.	g.kollias@fleming.gr	Kollias, George/A-7079-2012	Kollias, George/0000-0003-1867-3150	European Commission [Health-F2-2008-223404, Health-F2-2009-223151, HPRN-CT-2002-00255]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by European Commission grants, Masterswitch (Health-F2-2008-223404), INFLA(Information and Cancer Research in Europe)-CARE (Health-F2-2009-223151) and RTN (HPRN-CT-2002-00255) to GK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Bettermann K, 2010, CANCER CELL, V17, P481, DOI 10.1016/j.ccr.2010.03.021; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Courties G, 2010, BLOOD; DINARELLO CA, 1997, CHEST S, V112, P321, DOI DOI 10.1378/CHEST.112.6_SUPPLEMENT.321S; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Inokuchi S, 2010, P NATL ACAD SCI USA, V107, P844, DOI 10.1073/pnas.0909781107; Jadrich JL, 2006, DEVELOPMENT, V133, P1529, DOI 10.1242/dev.02333; Kajino-Sakamoto R, 2008, J IMMUNOL, V181, P1143, DOI 10.4049/jimmunol.181.2.1143; KONTGEN F, 1993, METHOD ENZYMOL, V225, P878; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Sarkar S, 2011, MOL CELL BIOL, V31, P602, DOI 10.1128/MCB.00835-10; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sato S, 2006, INT IMMUNOL, V18, P1405, DOI 10.1093/intimm/dxl082; Sayama K, 2006, J BIOL CHEM, V281, P22013, DOI 10.1074/jbc.M601065200; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Tang MH, 2008, J EXP MED, V205, P1611, DOI 10.1084/jem.20080297; Tzima S, 2009, J EXP MED, V206, P1167, DOI 10.1084/jem.20081582; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Ye M, 2003, IMMUNITY, V19, P689, DOI 10.1016/S1074-7613(03)00299-1	27	21	22	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31550	10.1371/journal.pone.0031550	http://dx.doi.org/10.1371/journal.pone.0031550			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348103	gold, Green Published			2022-12-25	WOS:000302737400034
J	Fogarty, ND; Vollmer, SV; Levitan, DR				Fogarty, Nicole D.; Vollmer, Steven V.; Levitan, Don R.			Weak Prezygotic Isolating Mechanisms in Threatened Caribbean Acropora Corals	PLOS ONE			English	Article							ANNULARIS SPECIES COMPLEX; REEF CORALS; REPRODUCTIVE ISOLATION; SCLERACTINIAN CORALS; GAMETE RECOGNITION; FERTILIZATION SUCCESS; CONSPECIFIC SPERM; GENETIC DIVERSITY; SPAWNING CORALS; SEA-URCHINS	The Caribbean corals, Acropora palmata and A. cervicornis, recently have undergone drastic declines primarily as a result of disease. Previous molecular studies have demonstrated that these species form a hybrid (A. prolifera) that varies in abundance throughout the range of the parental distribution. There is variable unidirectional introgression across loci and sites of A. palmata genes flowing into A. cervicornis. Here we examine the efficacy of prezygotic reproductive isolating mechanisms within these corals including spawning times and choice and no-choice fertilization crosses. We show that these species have subtly different mean but overlapping spawning times, suggesting that temporal isolation is likely not an effective barrier to hybridization. We found species-specific differences in gametic incompatibilities. Acropora palmata eggs were relatively resistant to hybridization, especially when conspecific sperm are available to outcompete heterospecific sperm. Acropora cervicornis eggs demonstrated no evidence for gametic incompatibility and no evidence of reduced viability after aging four hours. This asymmetry in compatibility matches previous genetic data on unidirectional introgression.	[Fogarty, Nicole D.; Levitan, Don R.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Vollmer, Steven V.] NE Univ, Ctr Marine Sci, Nahant, MA USA	State University System of Florida; Florida State University; Northeastern University	Fogarty, ND (corresponding author), Smithsonian Marine Stn, Ft Pierce, FL USA.	fogartyn@si.edu			Caribbean Coral Reef Ecosystems (CCRE) program [915]; Smithsonian Marine Science Network; PADI foundation; American Academy of Underwater Science; AWARE foundation; National Geographic Society [8230-07]; American Museum of Natural History; FSU; Marine Science Network; NSF [OCE-9911225]	Caribbean Coral Reef Ecosystems (CCRE) program; Smithsonian Marine Science Network(Smithsonian InstitutionSmithsonian Tennenbaum Marine Observatories Network); PADI foundation; American Academy of Underwater Science; AWARE foundation; National Geographic Society(National Geographic Society); American Museum of Natural History; FSU; Marine Science Network; NSF(National Science Foundation (NSF))	Funding was supplied by the Caribbean Coral Reef Ecosystems (CCRE) program (http://www.ccre.si.edu/) contribution #915, The Smithsonian Marine Science Network (http://www.sms.si.edu/), the PADI foundation (http://www.padifoundation.org/), the American Academy of Underwater Science (http://www.aaus.org), the Project AWARE foundation (http://www.projectaware.org/), the National Geographic Society (8230-07; http://www.nationalgeographic.com/), the Lerner-Gray Memorial Fund of the American Museum of Natural History (http://rggs.amnh.org/pages/academics_and_research/fellowship_and_grant_opportunities), and FSU's International dissertation, Bennison, Gramling, and Short Fellowships to N.D. Fogarty. The Marine Science Network supplied funding to S.V. Vollmer, and NSF OCE-9911225 and the National Geographic Society (8230-07) supplied funding to D.R. Levitan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acropora Biological Review Team, 2005, ATL ACR STAT REV DOC; Adey WH, 1977, 3 INT S FLA COR REEF; Anderson E., 1949, INTROGRESSIVE HYBRID; Arnold M.L., 2006, EVOLUTION GENETIC EX, P271; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Arnold ML, 2009, INT J MOL SCI, V10, P3836, DOI 10.3390/ijms10093836; ARNOLD ML, 1990, HEREDITY, V65, P297, DOI 10.1038/hdy.1990.99; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Babcock R, 1995, REPROD FERT DEVELOP, V7, P943, DOI 10.1071/RD9950943; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Baums IB, 2005, MAR ECOL PROG SER, V288, P115, DOI 10.3354/meps288115; Bruckner AW, 2002, P CAR ACR WORKSH SIL, P184; Budd AF, 1999, PALEOBIOLOGY, V25, P188, DOI 10.1017/S009483730002649X; BUDD AF, 1994, J PALEONTOL, V68, P951, DOI 10.1017/S0022336000026585; Cairns SD, 1982, STONY CORALS CNIDARI; Cortes J., 2003, LATIN AM CORAL REEFS; Coyne JA, 1998, PHILOS T ROY SOC B, V353, P287, DOI 10.1098/rstb.1998.0210; de Graaf M, 1999, B MAR SCI, V64, P189; Donnelly MJ, 2004, HEREDITY, V92, P61, DOI 10.1038/sj.hdy.6800377; DOWLING TE, 1992, CONSERV BIOL, V6, P355, DOI 10.1046/j.1523-1739.1992.06030355.x; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; Evans JP, 2005, EVOLUTION, V59, P106; Fogarty N.D., 2010, THESIS FLORIDA STATE; Fogarty ND, 2012, MAR ECO PRO IN PRESS; Fukami H, 2004, EVOLUTION, V58, P324, DOI 10.1111/j.0014-3820.2004.tb01648.x; [FWRI DTNP], 2010, 2006 ANN REP FISH WI, P35; Geyer LB, 2005, EVOLUTION, V59, P97; Gill FB, 1994, P 21 INT ORN C AUG 2; GOREAU TF, 1959, ECOLOGY, V40, P67, DOI 10.2307/1929924; Grant PR, 1981, PLANT SPECIATION; Green EP, 2000, BIOL CONSERV, V96, P347, DOI 10.1016/S0006-3207(00)00073-2; Harper FM, 2005, BIOL BULL-US, V209, P113, DOI 10.2307/3593129; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; Hatta M, 1999, MOL BIOL EVOL, V16, P1607, DOI 10.1093/oxfordjournals.molbev.a026073; Hemond EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008652; Hogarth WT, FED REG, V71, P26852; Howard DJ, 1999, ANNU REV ECOL SYST, V30, P109, DOI 10.1146/annurev.ecolsys.30.1.109; HUNT WG, 1973, HEREDITY, V31, P11; KEIM P, 1989, GENETICS, V123, P557; LANG J, 1998, STATUS CORAL REEFS N; Lepais O, 2009, MOL ECOL, V18, P2228, DOI 10.1111/j.1365-294X.2009.04137.x; Levin DA, 1996, CONSERV BIOL, V10, P10, DOI 10.1046/j.1523-1739.1996.10010010.x; Levitan DR, 2011, EVOLUTION, V65, P1254, DOI 10.1111/j.1558-5646.2011.01235.x; Levitan DR, 2010, EVOLUTION, V64, P785, DOI 10.1111/j.1558-5646.2009.00850.x; Levitan Don R., 2005, P47; Levitan DR, 2006, SCIENCE, V312, P267, DOI 10.1126/science.1122183; Levitan DR, 2004, EVOLUTION, V58, P308, DOI 10.1111/j.0014-3820.2004.tb01647.x; Levitan DR, 2002, EVOLUTION, V56, P1599, DOI 10.1111/j.0014-3820.2002.tb01472.x; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Martinsen GD, 2001, EVOLUTION, V55, P1325, DOI 10.1111/j.0014-3820.2001.tb00655.x; McNeill DF, 1997, GEOLOGY, V25, P891, DOI 10.1130/0091-7613(1997)025<0891:ELPFAO>2.3.CO;2; Mendelson TC, 2007, EVOLUTION, V61, P2596, DOI 10.1111/j.1558-5646.2007.00220.x; Miller DJ, 2003, MOL ECOL, V12, P805, DOI 10.1046/j.1365-294X.2003.01808.x; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.ecolsys.25.1.547; Pandolfi JM, 2006, ECOL LETT, V9, P818, DOI 10.1111/j.1461-0248.2006.00933.x; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Precht WF, 2002, CORAL REEFS, V21, P41, DOI 10.1007/s00338-001-0209-2; Rahman SM, 2004, COMP BIOCHEM PHYS A, V139, P469, DOI 10.1016/j.cbpb.2004.10.005; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Riginos C, 2006, MOL BIOL EVOL, V23, P1952, DOI 10.1093/molbev/msl062; Stebbins G. L., 1959, Proceedings of the American Philosophical Society, V103, P231; STEINER SCC, 1995, B MAR SCI, V56, P899; Styan CA, 2008, EVOLUTION, V62, P3041, DOI 10.1111/j.1558-5646.2008.00521.x; SZMANT AM, 1986, CORAL REEFS, V5, P43, DOI 10.1007/BF00302170; Thompson SL, 2010, MOL ECOL, V19, P132, DOI 10.1111/j.1365-294X.2009.04442.x; Van Oppen MJH, 2000, MOL ECOL, V9, P1363, DOI 10.1046/j.1365-294x.2000.01010.x; Van Oppen MJH, 2002, MOL ECOL, V11, P1363, DOI 10.1046/j.1365-294X.2002.01527.x; VANVEGHEL MLJ, 1993, B MAR SCI, V52, P1017; Vargas-Angel B, 2006, CORAL REEFS, V25, P110, DOI 10.1007/s00338-005-0070-9; VERON JEN, 1995, CORALS SPACE TIME BI; Vollmer SV, 2007, J HERED, V98, P40, DOI 10.1093/jhered/esl057; Vollmer SV, 2002, SCIENCE, V296, P2023, DOI 10.1126/science.1069524; Wallace C.C., 1999, STAGHORN CORALS WORL, DOI 10.1071/9780643101388; Williams DE, 2005, MAR ECOL PROG SER, V301, P119, DOI 10.3354/meps301119; Williams JH, 2001, HEREDITY, V87, P680, DOI 10.1046/j.1365-2540.2001.00968.x; Willis B. L., 1985, P 5 INT COR REEF C, V4, P343; Willis BL, 2006, ANNU REV ECOL EVOL S, V37, P489, DOI 10.1146/annurev.ecolsys.37.091305.110136; Willis BL, 1997, CORAL REEFS, V16, pS53, DOI 10.1007/s003380050242; Wolstenholme JK, 2004, MAR BIOL, V144, P567, DOI 10.1007/s00227-003-1209-2; Zlatarski Vassil N., 2010, Palaeoworld, V19, P333, DOI 10.1016/j.palwor.2010.09.012	82	55	57	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e30486	10.1371/journal.pone.0030486	http://dx.doi.org/10.1371/journal.pone.0030486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348010	Green Submitted, Green Published, gold			2022-12-25	WOS:000302737400001
J	Forcheron, F; Agay, D; Scherthan, H; Riccobono, D; Herodin, F; Meineke, V; Drouet, M				Forcheron, Fabien; Agay, Diane; Scherthan, Harry; Riccobono, Diane; Herodin, Francis; Meineke, Viktor; Drouet, Michel			Autologous Adipocyte Derived Stem Cells Favour Healing in a Minipig Model of Cutaneous Radiation Syndrome	PLOS ONE			English	Article							ACUTE SINGLE EXPOSURES; LINEAGE CELLS; WOUND REPAIR; SWINE SKIN; X-RAYS; DIFFERENTIATION; QUANTIFICATION; THERAPY; BURNS	Cutaneous radiation syndrome (CRS) is the delayed consequence of localized skin exposure to high doses of ionizing radiation. Here we examined for the first time in a large animal model the therapeutic potential of autologous adipose tissue-derived stroma cells (ASCs). For experiments, Gottingen minipigs were locally gamma irradiated using a Co-60 source at the dose of 50 Gy and grafted (n = 5) or not (n = 8). ASCs were cultured in MEM-alpha with 10% fetal calf serum and basic fibroblast growth factor (2 ng.mL(-1)) and post irradiation were intradermally injected on days 25, 46, 67 and finally between days 95 and 115 (50 x 10(6) ASCs each time) into the exposed area. All controls exhibited a clinical evolution with final necrosis (day 91). In grafted pigs an ultimate wound healing was observed in four out of five grafted animals (day 130 +/- 28). Immunohistological analysis of cytokeratin expression showed a complete epidermis recovery. Grafted ASCs accumulated at the dermis/subcutis barrier in which they attracted numerous immune cells, and even an increased vasculature in one pig. Globally this study suggests that local injection of ASCs may represent a useful strategy to mitigate CRS.	[Forcheron, Fabien; Agay, Diane; Riccobono, Diane; Herodin, Francis; Drouet, Michel] Inst Rech Biomed Armees Antenne La Tronche, La Tronche, France; [Scherthan, Harry; Meineke, Viktor] Inst Radiobiol Bundeswehr, Munich, Germany		Forcheron, F (corresponding author), Inst Rech Biomed Armees Antenne La Tronche, La Tronche, France.	micheldrouet@crssa.net			Direction Generale de l'Armement (Paris, France)	Direction Generale de l'Armement (Paris, France)	This work was supported by a grant from Direction Generale de l'Armement (Paris, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agay D, 2010, EXP HEMATOL, V38, P945, DOI 10.1016/j.exphem.2010.06.008; ARCHAMBEAU JO, 1984, RADIAT RES, V98, P37, DOI 10.2307/3576049; ARCHAMBEAU JO, 1979, RADIAT RES, V79, P298, DOI 10.2307/3575099; Bey E, 2010, WOUND REPAIR REGEN, V18, P50, DOI 10.1111/j.1524-475X.2009.00562.x; Boquest AC, 2007, STEM CELLS, V25, P852, DOI 10.1634/stemcells.2006-0428; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Drouet M, 2010, INT J RADIAT BIOL, V86, P636, DOI 10.3109/09553001003789604; Ebrahimian TG, 2009, ARTERIOSCL THROM VAS, V29, P503, DOI 10.1161/ATVBAHA.108.178962; Francois S, 2007, ANN HEMATOL, V86, P1, DOI 10.1007/s00277-006-0166-5; HOPEWELL JW, 1990, INT J RADIAT BIOL, V57, P751, DOI 10.1080/09553009014550911; Lefaix JL, 2005, NUCL RADIOLOGICAL BI, P87; Oike Y, 2003, P NATL ACAD SCI USA, V100, P9494, DOI 10.1073/pnas.1531901100; Papp A, 2006, PLAST RECONSTR SURG, V117, P889, DOI 10.1097/01.prs.0000197213.12989.03; Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Tarte K, 2010, BLOOD, V115, P1549, DOI 10.1182/blood-2009-05-219907; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Zuk PA, 2010, MOL BIOL CELL, V21, P1783, DOI 10.1091/mbc.E09-07-0589	18	61	71	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31694	10.1371/journal.pone.0031694	http://dx.doi.org/10.1371/journal.pone.0031694			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348120	Green Submitted, Green Published, gold			2022-12-25	WOS:000302737400042
J	Liu, WM; Ren, Y; Bossert, A; Wang, XW; Dayawansa, S; Tong, J; He, XS; Smith, DH; Gelbard, HA; Huang, JH				Liu, Weimin; Ren, Yi; Bossert, Adam; Wang, Xiaowei; Dayawansa, Samantha; Tong, Jing; He, Xiaoshen; Smith, Douglas H.; Gelbard, Harris A.; Huang, Jason H.			Allotransplanted Neurons Used to Repair Peripheral Nerve Injury Do Not Elicit Overt Immunogenicity	PLOS ONE			English	Article							SCHWANN-CELLS; INTERFERON-GAMMA; CLASS-I; REGENERATION; AXONS; MOTONEURONS; EXPRESSION; ALLOGRAFTS; INSIGHTS	A major problem hindering the development of autograft alternatives for repairing peripheral nerve injuries is immunogenicity. We have previously shown successful regeneration in transected rat sciatic nerves using conduits filled with allogeneic dorsal root ganglion (DRG) cells without any immunosuppression. In this study, we re-examined the immunogenicity of our DRG neuron implanted conduits as a potential strategy to overcome transplant rejection. A biodegradable NeuraGen (R) tube was infused with pure DRG neurons or Schwann cells cultured from a rat strain differing from the host rats and used to repair 8 mm gaps in the sciatic nerve. We observed enhanced regeneration with allogeneic cells compared to empty conduits 16 weeks post-surgery, but morphological analyses suggest recovery comparable to the healthy nerves was not achieved. The degree of regeneration was indistinguishable between DRG and Schwann cell allografts although immunogenicity assessments revealed substantially increased presence of Interferon gamma (IFN-gamma) in Schwann cell allografts compared to the DRG allografts by two weeks post-surgery. Macrophage infiltration of the regenerated nerve graft in the DRG group 16 weeks post-surgery was below the level of the empty conduit (0.56 fold change from NG; p<0.05) while the Schwann cell group revealed significantly higher counts (1.29 fold change from NG; p<0.001). Major histocompatibility complex I (MHC I) molecules were present in significantly increased levels in the DRG and Schwann cell allograft groups compared to the hollow NG conduit and the Sham healthy nerve. Our results confirmed previous studies that have reported Schwann cells as being immunogenic, likely due to MHC I expression. Nerve gap injuries are difficult to repair; our data suggest that DRG neurons are superior medium to implant inside conduit tubes due to reduced immunogenicity and represent a potential treatment strategy that could be preferable to the current gold standard of autologous nerve transplant.	[Liu, Weimin; Ren, Yi; Bossert, Adam; Wang, Xiaowei; Dayawansa, Samantha; Tong, Jing; Huang, Jason H.] Univ Rochester, Dept Neurosurg, Rochester, NY 14627 USA; [Liu, Weimin; Ren, Yi; Bossert, Adam; Wang, Xiaowei; Dayawansa, Samantha; Tong, Jing; Gelbard, Harris A.; Huang, Jason H.] Univ Rochester, Ctr Neural Dev & Dis, Rochester, NY USA; [Tong, Jing] Hebei Med Univ, Affiliated Hosp 4, Dept Neurosurg, Shijiazhuang, Hebei Province, Peoples R China; [He, Xiaoshen] Fourth Mil Univ, Xijing Hosp, Dept Neurosurg, Xian, Peoples R China; [Smith, Douglas H.] Univ Penn, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA; [Gelbard, Harris A.] Univ Rochester, Dept Neurol, Rochester, NY USA	University of Rochester; University of Rochester; Hebei Medical University; Air Force Military Medical University; University of Pennsylvania; Pennsylvania Medicine; University of Rochester	Liu, WM (corresponding author), Univ Rochester, Dept Neurosurg, Rochester, NY 14627 USA.	Jason_Huang@URMC.Rochester.edu	Huang, Jason H/J-4739-2019; Gelbard, Harris/M-9260-2019	Huang, Jason H/0000-0002-4426-0168; Gelbard, Harris/0000-0001-5095-7976	NIH [R01-NS067435]; SPAC from the University of Rochester Medical Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067435] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SPAC from the University of Rochester Medical Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by NIH grant R01-NS067435 and a SPAC grant from the University of Rochester Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain JR, 2000, MICROSURG, V20, P384, DOI 10.1002/1098-2752(2000)20:8<384::AID-MICR7>3.0.CO;2-W; Bhatheja K, 2006, INT J BIOCHEM CELL B, V38, P1995, DOI 10.1016/j.biocel.2006.05.007; Billiau A, 2009, CYTOKINE GROWTH F R, V20, P97, DOI 10.1016/j.cytogfr.2009.02.004; Bryan DJ, 2000, TISSUE ENG, V6, P129, DOI 10.1089/107632700320757; EVANS PJ, 1994, PROG NEUROBIOL, V43, P187, DOI 10.1016/0301-0082(94)90001-9; Ghaznavi AM, 2011, ANN PLAS SURG, V66, P273, DOI 10.1097/SAP.0b013e3181e6cff7; GUENARD V, 1992, J NEUROSCI, V12, P3310; GULATI AK, 1995, TRANSPLANTATION, V59, P1618, DOI 10.1097/00007890-199506150-00020; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; HARE GMT, 1993, TRANSPLANTATION, V56, P154, DOI 10.1097/00007890-199307000-00029; Hashimoto T, 2002, EXP BRAIN RES, V146, P356, DOI 10.1007/s00221-002-1173-y; Huang JH, 2009, TISSUE ENG PT A, V15, P1677, DOI 10.1089/ten.tea.2008.0294; Huang JH, 2004, SURG NEUROL, V61, P372, DOI 10.1016/j.surneu.2003.08.006; Joseph MS, 2011, J NEUROSCI RES, V89, P365, DOI 10.1002/jnr.22557; Kerschensteiner M, 2009, NEUROSCIENCE, V158, P1122, DOI 10.1016/j.neuroscience.2008.09.009; LEBEAU JM, 1988, J NEUROCYTOL, V17, P161, DOI 10.1007/BF01674203; Linda H, 1998, EXP NEUROL, V150, P282, DOI 10.1006/exnr.1997.6768; MILLESI H, 1972, J BONE JOINT SURG AM, VA 54, P727, DOI 10.2106/00004623-197254040-00004; Moalem G, 1999, FASEB J, V13, P1207, DOI 10.1096/fasebj.13.10.1207; Mosahebi A, 2002, EXP NEUROL, V173, P213, DOI 10.1006/exnr.2001.7846; NATHAN CF, 1983, J EXP MED, V158, P670, DOI 10.1084/jem.158.3.670; Neumann H, 1997, J EXP MED, V186, P2023, DOI 10.1084/jem.186.12.2023; Noble J, 1998, J TRAUMA, V45, P116, DOI 10.1097/00005373-199807000-00025; OLSSON T, 1989, J NEUROSCI, V9, P3870; Pattison JM, 1997, AM J MED SCI, V313, P257, DOI 10.1097/00000441-199705000-00002; Pedersen LE, 2011, IMMUNOGENETICS; Pfister BJ, 2006, J NEUROSCI METH, V153, P95, DOI 10.1016/j.jneumeth.2005.10.012; Rodriguez FJ, 2000, EXP NEUROL, V161, P571, DOI 10.1006/exnr.1999.7315; Thams S, 2009, J NEUROSCI, V29, P13503, DOI 10.1523/JNEUROSCI.0981-09.2009; VERT M, 1992, Clinical Materials, V10, P3, DOI 10.1016/0267-6605(92)90077-7; Wallquist W, 2005, J NEUROSCI, V25, P3692, DOI 10.1523/JNEUROSCI.5225-04.2005; Wu ZP, 2011, IMMUNOL LETT, V135, P118, DOI 10.1016/j.imlet.2010.10.011; Zanon RG, 2006, EXP NEUROL, V200, P521, DOI 10.1016/j.expneurol.2006.03.004	33	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31675	10.1371/journal.pone.0031675	http://dx.doi.org/10.1371/journal.pone.0031675			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347502	Green Published, Green Submitted, gold			2022-12-25	WOS:000302730200030
J	Beran, RKF; Sharma, R; Corsa, AC; Tian, Y; Golde, J; Lundgaard, G; Delaney, WE; Zhong, WD; Greenstein, AE				Beran, Rudolf K. F.; Sharma, Ruchi; Corsa, Amoreena C.; Tian, Yang; Golde, Justin; Lundgaard, Greta; Delaney, William E.; Zhong, Weidong; Greenstein, Andrew E.			Cellular Growth Kinetics Distinguish a Cyclophilin Inhibitor from an HSP90 Inhibitor as a Selective Inhibitor of Hepatitis C Virus	PLOS ONE			English	Article							HCV REPLICATION; POLYMERASE INHIBITOR; PROTEIN; COMBINATION; RNA; THERAPY; 17-AAG; CELLS	During antiviral drug discovery, it is critical to distinguish molecules that selectively interrupt viral replication from those that reduce virus replication by adversely affecting host cell viability. In this report we investigate the selectivity of inhibitors of the host chaperone proteins cyclophilin A (CypA) and heat-shock protein 90 (HSP90) which have each been reported to inhibit replication of hepatitis C virus (HCV). By comparing the toxicity of the HSP90 inhibitor, 17-(Allylamino)-17-demethoxygeldanamycin (17-AAG) to two known cytostatic compounds, colchicine and gemcitabine, we provide evidence that 17-AAG exerts its antiviral effects indirectly through slowing cell growth. In contrast, a cyclophilin inhibitor, cyclosporin A (CsA), exhibited selective antiviral activity without slowing cell proliferation. Furthermore, we observed that 17-AAG had little antiviral effect in a non-dividing cell-culture model of HCV replication, while CsA reduced HCV titer by more than two orders of magnitude in the same model. The assays we describe here are useful for discriminating selective antivirals from compounds that indirectly affect virus replication by reducing host cell viability or slowing cell growth.	[Beran, Rudolf K. F.; Sharma, Ruchi; Corsa, Amoreena C.; Tian, Yang; Golde, Justin; Lundgaard, Greta; Delaney, William E.; Zhong, Weidong; Greenstein, Andrew E.] Gilead Sci Inc, Dept Biol, Foster City, CA 94404 USA	Gilead Sciences	Beran, RKF (corresponding author), Gilead Sci Inc, Dept Biol, 353 Lakeside Dr, Foster City, CA 94404 USA.	andrew.greenstein@gilead.com		Greenstein, Andrew/0000-0002-1470-1970	Gilead Sciences	Gilead Sciences(Gilead Sciences)	No current external funding sources for this study. This study was funded exclusively through Gilead Sciences internal research funds.	ALLEN DW, 1962, BIOCHIM BIOPHYS ACTA, V55, P865; Chase G, 2008, VIROLOGY, V377, P431, DOI 10.1016/j.virol.2008.04.040; Cheng GF, 2011, ANTIMICROB AGENTS CH, V55, P2197, DOI 10.1128/AAC.01382-10; Flajolet M, 2000, GENE, V242, P369, DOI 10.1016/S0378-1119(99)00511-9; Fraser JS, 2009, NATURE, V462, P669, DOI 10.1038/nature08615; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Hu JM, 1996, P NATL ACAD SCI USA, V93, P1060, DOI 10.1073/pnas.93.3.1060; Hu JM, 1997, EMBO J, V16, P59, DOI 10.1093/emboj/16.1.59; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kneteman NM, 2009, HEPATOLOGY, V49, P745, DOI 10.1002/hep.22717; Le Pogam S, 2010, J INFECT DIS, V202, P1510, DOI 10.1086/656774; MALAWIST.SE, 1967, SCIENCE, V156, P521, DOI 10.1126/science.156.3774.521; MILAD M, 1995, MOL ENDOCRINOL, V9, P838, DOI 10.1210/me.9.7.838; Modi S, 2007, J CLIN ONCOL, V25, P5410, DOI 10.1200/JCO.2007.11.7960; Nakagawa S, 2007, BIOCHEM BIOPH RES CO, V353, P882, DOI 10.1016/j.bbrc.2006.12.117; Nelson HB, 2006, J VIROL, V80, P1181, DOI 10.1128/JVI.80.3.1181-1190.2006; Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367; Patel H, 2010, GUT, V58, P1644; Paulson MS, 2009, ANTIVIR RES, V83, P135, DOI 10.1016/j.antiviral.2009.04.003; Pietschmann T, 2001, J VIROL, V75, P1252, DOI 10.1128/JVI.75.3.1252-1264.2001; Pokrovskii MV, 2011, J VIROL, V85, P3978, DOI 10.1128/JVI.01760-10; Prodromou C, 2003, CURR CANCER DRUG TAR, V3, P301, DOI 10.2174/1568009033481877; Reichard O, 1997, HEPATOLOGY, V26, pS108, DOI 10.1002/hep.510260719; Robinson M, 2011, P NATL ACAD SCI USA, V108, P10290, DOI 10.1073/pnas.1101515108; Robinson M, 2010, ANTIMICROB AGENTS CH, V54, P3099, DOI 10.1128/AAC.00289-10; Rong LB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000544; Sainz B, 2006, J VIROL, V80, P10253, DOI 10.1128/JVI.01059-06; Sausville EA, 2003, CURR CANCER DRUG TAR, V3, P377, DOI 10.2174/1568009033481831; Smith DR, 2010, ANTIVIR RES, V87, P187, DOI 10.1016/j.antiviral.2010.04.015; Stuyver LJ, 2003, J VIROL, V77, P10689, DOI 10.1128/JVI.77.19.10689-10694.2003; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Ujino Saneyuki, 2010, Antiviral Chemistry & Chemotherapy, V20, P161, DOI 10.3851/IMP1479; Ujino S, 2009, J BIOL CHEM, V284, P6841, DOI 10.1074/jbc.M806452200; Yang F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001118	34	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30286	10.1371/journal.pone.0030286	http://dx.doi.org/10.1371/journal.pone.0030286			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347373	Green Submitted, gold, Green Published			2022-12-25	WOS:000302730100009
J	Liu, XL; Zhao, ZD; Xu, CF; Sun, L; Chen, JL; Zhang, LF; Liu, WJ				Liu, Xiaoling; Zhao, Zhendong; Xu, Chongfeng; Sun, Lei; Chen, Jilong; Zhang, Lianfeng; Liu, Wenjun			Cyclophilin A Restricts Influenza A Virus Replication through Degradation of the M1 Protein	PLOS ONE			English	Article							TIME RT-PCR; TRANSLATIONAL CONTROL; INITIATION-FACTOR; MESSENGER-RNA; HUMAN-CELLS; T-CELLS; INFECTION; UBIQUITIN; KINASE; HIV-1	Cyclophilin A (CypA) is a typical member of the cyclophilin family of peptidyl-prolyl isomerases and is involved in the replication of several viruses. Previous studies indicate that CypA interacts with influenza virus M1 protein and impairs the early stage of the viral replication. To further understand the molecular mechanism by which CypA impairs influenza virus replication, a 293T cell line depleted for endogenous CypA was established. The results indicated that CypA inhibited the initiation of virus replication. In addition, the infectivity of influenza virus increased in the absence of CypA. Further studies indicated that CypA had no effect on the stages of virus genome replication or transcription and also did not impair the nuclear export of the viral mRNA. However, CypA decreased the viral protein level. Additional studies indicated that CypA enhanced the degradation of M1 through the ubiquitin/proteasome-dependent pathway. Our results suggest that CypA restricts influenza virus replication through accelerating degradation of the M1 protein.	[Liu, Xiaoling; Zhao, Zhendong; Xu, Chongfeng; Sun, Lei; Chen, Jilong; Liu, Wenjun] Chinese Acad Sci, Ctr Mol Virol, CAS Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing, Peoples R China; [Zhao, Zhendong; Xu, Chongfeng; Chen, Jilong; Liu, Wenjun] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Liu, Wenjun] Chinese Acad Sci, China Japan Joint Lab Mol Immunol & Mol Microbiol, Inst Microbiol, Beijing, Peoples R China; [Zhang, Lianfeng] Chinese Acad Med Sci, Key Lab Human Dis Comparat Med, Minist Hlth, Inst Lab Anim Sci, Beijing 100730, Peoples R China; [Zhang, Lianfeng] Peking Union Med Coll, Comparat Med Ctr, Beijing 100021, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, XL (corresponding author), Chinese Acad Sci, Ctr Mol Virol, CAS Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing, Peoples R China.	liuwj@im.ac.cn	Liu, Xiaoling/HGD-3566-2022; Chen, Ji-Long/AAJ-2134-2021; SUN, LEI/B-3288-2018	Chen, Ji-Long/0000-0002-4274-0563; SUN, LEI/0000-0003-0141-2093	National Basic Research Program of China [2011CB504705, 2012CB518900]; National Natural Science Foundation of China [30972185, 81101253, 30901073]; Chinese Academy of Sciences [KSCX2-YW-N-054, KSCX2-YW-R-158]; National Key Technologies Research and Development Program of China [2010BAD04B01]; Beijing Municipal Natural Science Foundation [6102018]; Innovative Research Group of the National Natural Science Foundation of China [81021003]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Key Technologies Research and Development Program of China(National Key Technology R&D Program); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Innovative Research Group of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (www.973.gov.cn, Grant No. 2011CB504705, 2012CB518900), the National Natural Science Foundation of China (www.nsfc.gov.cn, Grant No. 30972185, 81101253, 30901073), the Chinese Academy of Sciences Innovation projects (www.cas.cn, Grant No. KSCX2-YW-N-054, KSCX2-YW-R-158), the National Key Technologies Research and Development Program of China (www.most.gov.cn, Grant No. 2010BAD04B01), and the Beijing Municipal Natural Science Foundation (www.bjkw.gov.cn, Grant No. 6102018). Wenjun Liu is the principal investigator of the Innovative Research Group of the National Natural Science Foundation of China (www.nsfc.gov.cn, Grant No. 81021003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerson B, 1998, J VIROL, V72, P303, DOI 10.1128/JVI.72.1.303-308.1998; Bose S, 2003, J GEN VIROL, V84, P1687, DOI 10.1099/vir.0.19074-0; Braaten D, 2001, EMBO J, V20, P1300, DOI 10.1093/emboj/20.6.1300; Brazin KN, 2002, P NATL ACAD SCI USA, V99, P1899, DOI 10.1073/pnas.042529199; Castro APV, 2003, J VIROL, V77, P9052, DOI 10.1128/JVI.77.16.9052-9068.2003; Chatterji U, 2006, J BIOL CHEM, V281, P37025, DOI 10.1074/jbc.M606066200; Colgan J, 2004, IMMUNITY, V21, P189, DOI 10.1016/j.immuni.2004.07.005; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Galat A, 2003, CURR TOP MED CHEM, V3, P1315, DOI 10.2174/1568026033451862; Garcia-Robles I, 2005, VIROLOGY, V332, P329, DOI 10.1016/j.virol.2004.09.036; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Jeong SJ, 2009, BIOCHEM BIOPH RES CO, V381, P294, DOI 10.1016/j.bbrc.2009.02.024; Kash JC, 2006, VIRUS RES, V119, P111, DOI 10.1016/j.virusres.2005.10.013; KATZE MG, 1986, MOL CELL BIOL, V6, P1741, DOI 10.1128/MCB.6.5.1741; Khor R, 2003, TRAFFIC, V4, P857, DOI 10.1046/j.1398-9219.2003.0140.x; KOESTLER TP, 1984, P NATL ACAD SCI-BIOL, V81, P4505, DOI 10.1073/pnas.81.14.4505; Lai JP, 2003, CLIN DIAGN LAB IMMUN, V10, P1123, DOI 10.1128/CDLI.10.6.1123-1128.2003; Li Y, 2009, J VIROL, V83, P10951, DOI 10.1128/JVI.00682-09; Liao TL, 2010, EMBO J, V29, P3879, DOI 10.1038/emboj.2010.250; Liu N, 2008, PROTEOMICS, V8, P1851, DOI 10.1002/pmic.200700757; Liu XL, 2009, CELL MICROBIOL, V11, P730, DOI 10.1111/j.1462-5822.2009.01286.x; LU Y, 1995, VIROLOGY, V214, P222, DOI 10.1006/viro.1995.9937; Luban J, 2007, J VIROL, V81, P1054, DOI 10.1128/JVI.01519-06; Min L, 2005, FRONT BIOSCI-LANDMRK, V10, P385, DOI 10.2741/1536; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reinhardt J, 2000, VET MICROBIOL, V74, P87, DOI 10.1016/S0378-1135(00)00169-3; Rold CJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000074; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Shaw ML, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000085; Tian XC, 2010, J VIROL, V84, P3373, DOI 10.1128/JVI.02555-09; Towers GJ, 2003, NAT MED, V9, P1138, DOI 10.1038/nm910; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; Wang YM, 2006, METHODS, V39, P356, DOI 10.1016/j.ymeth.2006.06.010; Watanabe K, 2006, FEBS LETT, V580, P5785, DOI 10.1016/j.febslet.2006.09.040; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Widjaja I, 2010, J VIROL, V84, P9625, DOI 10.1128/JVI.01048-10; Xu CF, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-372; Yang F, 2008, J VIROL, V82, P5269, DOI 10.1128/JVI.02614-07; Yin L, 1998, J VIROL, V72, P6430, DOI 10.1128/JVI.72.8.6430-6436.1998; Ylinen LMJ, 2009, J VIROL, V83, P2044, DOI 10.1128/JVI.01876-08; Zhirnov O. P., 1997, Molekulyarnaya Biologiya (Moscow), V31, P137	43	66	71	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31063	10.1371/journal.pone.0031063	http://dx.doi.org/10.1371/journal.pone.0031063			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347431	Green Published, Green Submitted, gold			2022-12-25	WOS:000302730100039
J	Wei, DT; Ren, CC; Chen, XY; Zhao, H				Wei, Dingtai; Ren, Chuancheng; Chen, Xiaoyuan; Zhao, Heng			The Chronic Protective Effects of Limb Remote Preconditioning and the Underlying Mechanisms Involved in Inflammatory Factors in Rat Stroke	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CEREBRAL-ISCHEMIA; FOCAL ISCHEMIA; MILD HYPOTHERMIA; BRAIN; TIM-3; REPERFUSION; EXPRESSION; DAMAGE; CARDIOPROTECTION	We recently demonstrated that limb remote preconditioning (LRP) protects against focal ischemia measured 2 days post-stroke. Here, we studied whether LRP provides long-term protection and improves neurological function. We also investigated whether LRP transmits its protective signaling via the afferent nerve pathways from the preconditioned limb to the ischemic brain and whether inflammatory factors are involved in LRP, including the novel galectin-9/Tim-3 inflammatory cell signaling pathway, which induces cell death in lymphocytes. LRP in the left hind femoral artery was performed immediately before stroke. LRP reduced brain injury size both at 2 days and 60 days post-stroke and improved behavioral outcomes for up to 2 months. The sensory nerve inhibitors capsaicin and hexamethonium, a ganglion blocker, abolished the protective effects of LRP. In addition, LRP inhibited edema formation and blood-brain barrier (BBB) permeability measured 2 days post-stroke. Western blot and immunostaining analysis showed that LRP inhibited protein expression of both galectin-9 and T-cell immunoglobulin domain and mucin domain 3 (Tim-3), which were increased after stroke. In addition, LRP decreased iNOS and nitrotyrosine protein expression after stroke. In conclusion, LRP executes long-term protective effects against stroke and may block brain injury by inhibiting activities of the galectin-9/Tim-3 pathway, iNOS, and nitrotyrosine.	[Wei, Dingtai; Ren, Chuancheng; Zhao, Heng] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Wei, Dingtai; Ren, Chuancheng; Zhao, Heng] Stanford Univ, Stroke Ctr, Stanford, CA 94305 USA; [Wei, Dingtai] Tianjin Med Univ, Dept Radiol, Gen Hosp, Tianjin, Peoples R China; [Wei, Dingtai] Fujian Med Univ, Dept Radiol, Ningde Hosp, Fuzhou, Fujian, Peoples R China; [Ren, Chuancheng] Fudan Univ, Shanghai Hosp 5, Shanghai 200433, Peoples R China; [Chen, Xiaoyuan] NIBIB, Lab Mol Imaging & Nanomed LOMIN, NIH, Bethesda, MD USA	Stanford University; Stanford University; Tianjin Medical University; Fujian Medical University; Fudan University; National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	Wei, DT (corresponding author), Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA.	hzhao@stanford.edu	Chen, Xiaoyuan/D-1860-2014	Chen, Xiaoyuan/0000-0002-9622-0870	NINDS [1R21NS057750-01A2, 1R01NS 064136-01]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS057750, R01NS064136] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by NINDS grants 1R21NS057750-01A2 (HZ) and 1R01NS 064136-01 (HZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Anderson AC, 2006, CURR OPIN IMMUNOL, V18, P665, DOI 10.1016/j.coi.2006.09.009; Brzozowski T, 2004, EUR J PHARMACOL, V499, P201, DOI 10.1016/j.ejphar.2004.07.072; Brzozowski T, 2004, J PHYSIOL PHARMACOL, V55, P165; Chapman CML, 2004, STROKE, V35, P1619, DOI 10.1161/01.STR.0000130857.19423.ad; Dave KR, 2006, NEUROSCI LETT, V404, P170, DOI 10.1016/j.neulet.2006.05.037; DIETRICH WD, 1993, J CEREBR BLOOD F MET, V13, P541, DOI 10.1038/jcbfm.1993.71; Dumas TC, 2001, TRENDS NEUROSCI, V24, P695, DOI 10.1016/S0166-2236(00)01956-1; Gao XW, 2008, J NEUROSCI RES, V86, P2505, DOI 10.1002/jnr.21703; Gao XW, 2008, J NEUROCHEM, V105, P943, DOI 10.1111/j.1471-4159.2008.05218.x; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Gidday JM, 1999, J CEREBR BLOOD F MET, V19, P331, DOI 10.1097/00004647-199903000-00011; Gielen AW, 2005, J NEUROIMMUNOL, V164, P93, DOI 10.1016/j.jneuroim.2005.04.004; Han HS, 2002, J NEUROSCI, V22, P3921, DOI 10.1523/JNEUROSCI.22-10-03921.2002; Hirabayashi H, 2000, BRAIN RES, V852, P319, DOI 10.1016/S0006-8993(99)02117-4; Hurn PD, 2007, J CEREBR BLOOD F MET, V27, P1798, DOI 10.1038/sj.jcbfm.9600482; Jensen HA, 2011, CIRCULATION, V123, P714, DOI 10.1161/CIRCULATIONAHA.110.986497; Karabiyikoglu M, 2003, J NEUROSURG, V98, P1271, DOI 10.3171/jns.2003.98.6.1271; Limbourg FP, 2002, J CLIN INVEST, V110, P1729, DOI 10.1172/JCI200215481; Malhotra S, 2011, BRAIN RES, V1386, P184, DOI 10.1016/j.brainres.2011.02.032; Martinez-Murillo R, 2007, NEUROSCI LETT, V415, P149, DOI 10.1016/j.neulet.2007.01.011; Nakae S, 2007, BLOOD, V110, P2565, DOI 10.1182/blood-2006-11-058800; Nanetti L, 2007, MOL CELL BIOCHEM, V303, P19, DOI 10.1007/s11010-007-9451-4; Perez-Pinzon MA, 2004, J BIOENERG BIOMEMBR, V36, P323, DOI 10.1023/B:JOBB.0000041762.47544.ff; PerezPinzon MA, 1997, J CEREBR BLOOD F MET, V17, P175, DOI 10.1097/00004647-199702000-00007; Polidori C, 2005, ENDOCRINOLOGY, V146, P3861, DOI 10.1210/en.2005-0397; Ren C, 2008, NEUROSCIENCE, V151, P1099, DOI 10.1016/j.neuroscience.2007.11.056; Ren CC, 2009, BRAIN RES, V1288, P88, DOI 10.1016/j.brainres.2009.07.029; Ren CC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003851; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Sander M, 2010, J APPL PHYSIOL, V108, P1691, DOI 10.1152/japplphysiol.91539.2008; Schoemaker RG, 2000, AM J PHYSIOL-HEART C, V278, pH1571, DOI 10.1152/ajpheart.2000.278.5.H1571; Su EW, 2008, CYTOKINE, V44, P9, DOI 10.1016/j.cyto.2008.06.013; Walsh SR, 2007, BRIT J ANAESTH, V99, P611, DOI 10.1093/bja/aem273; Walsh SR, 2010, VASC ENDOVASC SURG, V44, P434, DOI 10.1177/1538574410369709; Weinbrenner C, 2002, CARDIOVASC RES, V55, P590, DOI 10.1016/S0008-6363(02)00446-7; Wolfrum S, 2005, REGUL PEPTIDES, V127, P217, DOI 10.1016/j.regpep.2004.12.008; Wolfrum S, 2002, CARDIOVASC RES, V55, P583, DOI 10.1016/S0008-6363(02)00408-X; Zhao D, 2011, J CLIN IMMUNOL; Zhao H, 2005, J NEUROSCI, V25, P9794, DOI 10.1523/JNEUROSCI.3163-05.2005; Zhao H, 2003, J NEUROCHEM, V85, P1026, DOI 10.1046/j.1471-4159.2003.01756.x; Zhao H, 2006, J CEREBR BLOOD F MET, V26, P1114, DOI 10.1038/sj.jcbfm.9600348; Zhao Hong-Gang, 2004, Shengli Xuebao, V56, P407	43	73	80	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30892	10.1371/journal.pone.0030892	http://dx.doi.org/10.1371/journal.pone.0030892			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347410	Green Published, Green Submitted, gold			2022-12-25	WOS:000302730100029
J	Lenaerts, L; van Dam, W; Persoons, L; Naesens, L				Lenaerts, Liesbeth; van Dam, Wim; Persoons, Leentje; Naesens, Lieve			Interaction between Mouse Adenovirus Type 1 and Cell Surface Heparan Sulfate Proteoglycans	PLOS ONE			English	Article							FACTOR-X; GENE DELIVERY; BINDING SITE; FIBER SHAFT; HEXON; GLYCOSAMINOGLYCANS; INFECTION; ATTACHMENT; SEROTYPE-5; RECEPTORS	Application of human adenovirus type 5 (Ad5) derived vectors for cancer gene therapy has been limited by the poor cell surface expression, on some tumor cell types, of the primary Ad5 receptor, the coxsackie-adenovirus-receptor (CAR), as well as the accumulation of Ad5 in the liver following interaction with blood coagulation factor X (FX) and subsequent tethering the FX-Ad5 complex to heparan sulfate proteoglycan (HSPG) on liver cells. As an alternative vector, mouse adenovirus type 1 (MAV-1) is particularly attractive, since this non-human adenovirus displays pronounced endothelial cell tropism and does not use CAR as a cellular attachment receptor. We here demonstrate that MAV-1 uses cell surface heparan sulfate proteoglycans (HSPGs) as primary cellular attachment receptor. Direct binding of MAV-1 to heparan sulfate-coated plates proved to be markedly more efficient compared to that of Ad5. Experiments with modified heparins revealed that the interaction of MAV-1 to HSPGs depends on their N-sulfation and, to a lesser extent, 6-O-sulfation rate. Whereas the interaction between Ad5 and HSPGs was enhanced by FX, this was not the case for MAV-1. A slot blot assay demonstrated he ability of MAV-1 to directly interact with FX, although the amount of FX complexed to MAV-1 was much lower than observed for Ad5. Analysis of the binding of MAV-1 and Ad5 to the NCI-60 panel of different human tumor cell lines revealed the preference of MAV-1 for ovarian carcinoma cells. Together, the data presented here enlarge our insight into the HSPG receptor usage of MAV-1 and support the development of an MAV-1-derived gene vector for human cancer therapy.	[Lenaerts, Liesbeth; van Dam, Wim; Persoons, Leentje; Naesens, Lieve] Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium	KU Leuven	Lenaerts, L (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium.	lieve.naesens@rega.kuleuven.be	Naesens, Lieve MJ/V-8581-2017; Naesens, Lieve/V-8725-2019	Naesens, Lieve MJ/0000-0001-9742-9302; Naesens, Lieve/0000-0001-9742-9302	Flemish Fonds voor Wetenschappelijk Onderzoek [G.0267.04]; PDM-BOF [PDMK/08/187]; Centers of Excellence from the Katholieke Universiteit Leuven [EF/05/15]	Flemish Fonds voor Wetenschappelijk Onderzoek(FWO); PDM-BOF; Centers of Excellence from the Katholieke Universiteit Leuven	These investigations were supported by grants from the Flemish Fonds voor Wetenschappelijk Onderzoek (PhD Grant to Liesbeth Lenaerts and FWO project number G.0267.04), PDM-BOF (PDMK/08/187 grant to Liesbeth Lenaerts) and the Centers of Excellence from the Katholieke Universiteit Leuven (EF/05/15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba R, 2009, BLOOD, V114, P965, DOI 10.1182/blood-2009-03-208835; Alemany R, 2001, GENE THER, V8, P1347, DOI 10.1038/sj.gt.3301515; Bayo-Puxan N, 2006, J GEN VIROL, V87, P2487, DOI 10.1099/vir.0.81889-0; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bradshaw AC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001142; Charles PC, 1998, VIROLOGY, V245, P216, DOI 10.1006/viro.1998.9180; Chen Y, 2008, MOL CELLS, V26, P415; CrawfordMiksza L, 1996, J VIROL, V70, P1836, DOI 10.1128/JVI.70.3.1836-1844.1996; Dechecchi MC, 2000, VIROLOGY, V268, P382, DOI 10.1006/viro.1999.0171; Dechecchi MC, 2001, J VIROL, V75, P8772, DOI 10.1128/JVI.75.18.8772-8780.2001; Di Paolo NC, 2007, J VIROL, V81, P12249, DOI 10.1128/JVI.01584-07; Duffy MR, 2011, J VIROL, V85, P10914, DOI 10.1128/JVI.05382-11; Filmus J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-224; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gupta P, 1998, BLOOD, V92, P4641, DOI 10.1182/blood.V92.12.4641.424k10_4641_4651; Habuchi H, 2003, BIOCHEM J, V371, P131, DOI 10.1042/BJ20021259; Jonsson MI, 2009, J VIROL, V83, P3816, DOI 10.1128/JVI.02562-08; Kalyuzhniy O, 2008, P NATL ACAD SCI USA, V105, P5483, DOI 10.1073/pnas.0711757105; Kritz AB, 2007, MOL THER, V15, P741, DOI 10.1038/sj.mt.6300094; Laremore TN, 2009, CURR OPIN CHEM BIOL, V13, P633, DOI 10.1016/j.cbpa.2009.08.017; Lenaerts L, 2006, FEBS LETT, V580, P3937, DOI 10.1016/j.febslet.2006.06.027; Lenaerts L, 2005, ANTIMICROB AGENTS CH, V49, P4689, DOI 10.1128/AAC.49.11.4689-4699.2005; Lenaerts L, 2009, J GENE MED, V11, P119, DOI 10.1002/jgm.1283; Monteiro RQ, 2008, PROTEIN SCI, V17, P146, DOI 10.1110/ps.073016308; Nogami K, 2004, J BIOL CHEM, V279, P33104, DOI 10.1074/jbc.M405537200; Parker AL, 2006, BLOOD, V108, P2554, DOI 10.1182/blood-2006-04-008532; Raman S, 2009, J VIROL, V83, P2831, DOI 10.1128/JVI.02368-08; Rein Daniel T, 2006, Future Oncol, V2, P137, DOI 10.2217/14796694.2.1.137; Rezaie AR, 2000, TRENDS CARDIOVAS MED, V10, P333, DOI 10.1016/S1050-1738(01)00070-6; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; Smith T, 2002, MOL THER, V5, P770, DOI 10.1006/mthe.2002.0613; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Xie JS, 2006, J VIROL, V80, P11833, DOI 10.1128/JVI.00857-06; Yip GW, 2006, MOL CANCER THER, V5, P2139, DOI 10.1158/1535-7163.MCT-06-0082; Zaiss AK, 2011, J BIOL CHEM, V286, P24535, DOI 10.1074/jbc.M111.241562	35	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31454	10.1371/journal.pone.0031454	http://dx.doi.org/10.1371/journal.pone.0031454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347482	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000302180600038
J	Loeth, N; Assing, K; Madsen, HO; Vindelov, L; Buus, S; Stryhn, A				Loeth, Nina; Assing, Kristian; Madsen, Hans O.; Vindelov, Lars; Buus, Soren; Stryhn, Anette			Humoral and Cellular CMV Responses in Healthy Donors; Identification of a Frequent Population of CMV-Specific, CD4+T Cells in Seronegative Donors	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTES; HUMAN CYTOMEGALOVIRUS; ADOPTIVE TRANSFER; DENDRITIC CELLS; TRANSPLANT RECIPIENTS; CROSS-REACTIVITY; SEROLOGIC STATUS; BONE-MARROW; VIRUS; GENERATION	CMV status is an important risk factor in immune compromised patients. In hematopoeitic cell transplantations (HCT), both donor and recipient are tested routinely for CMV status by serological assays; however, one might argue that it might also be of relevance to examine CMV status by cellular (i.e., T lymphocyte) assays. Here, we have analyzed the CMV status of 100 healthy blood bank donors using both serology and cellular assays. About half (56%) were found to be CMV seropositive, and they all mounted strong CD8+ and/or moderate CD4+ T cell responses ex vivo against the immunodominant CMV protein, pp65. Of the 44 seronegative donors, only five (11%) mounted ex vivo T cell responses; surprisingly, 33 (75%) mounted strong CD4+ T cell responses after a brief in vitro peptide stimulation culture. This may have significant implications for the analysis and selection of HCT donors.	[Loeth, Nina; Buus, Soren; Stryhn, Anette] Univ Copenhagen, Fac Hlth Sci, Expt Immunol Lab, Copenhagen, Denmark; [Madsen, Hans O.] Copenhagen Univ Hosp, Rigshosp, Dept Clin Immunol, Tissue Typing Lab, Copenhagen, Denmark; [Vindelov, Lars] Copenhagen Univ Hosp, Rigshosp, Dept Hematol, Allogene Hematopoiet Cell Transplantat Lab, Copenhagen, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Loeth, N (corresponding author), Univ Copenhagen, Fac Hlth Sci, Expt Immunol Lab, Copenhagen, Denmark.	astryhn@sund.ku.dk	Madsen, Hans O/Q-2035-2015; Buus, Soren/F-5446-2010	Madsen, Hans O/0000-0001-5551-4787; Stryhn, Anette/0000-0002-4581-3553; Buus, Soren/0000-0001-8363-1999	Danish Cancer Society; Faculty of Health Sciences; Lundbeck Foundation [26375]; Research Council for Technology and Production; National Institutes of Health [HHSN 272 2009 00045C]	Danish Cancer Society(Danish Cancer Society); Faculty of Health Sciences(European Commission); Lundbeck Foundation(Lundbeckfonden); Research Council for Technology and Production; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was funded by the Danish Cancer Society, the Faculty of Health Sciences, the Lundbeck Foundation (26375), the Research Council for Technology and Production, and National Institutes of Health (HHSN 272 2009 00045C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almyroudis NG, 2007, TRANSPL INFECT DIS, V9, P286, DOI 10.1111/j.1399-3062.2007.00235.x; Boeckh M, 2004, BLOOD, V103, P2003, DOI 10.1182/blood-2003-10-3616; Boeckh M, 2003, BIOL BLOOD MARROW TR, V9, P543, DOI 10.1016/S1083-8791(03)00287-8; Boeckh M, 2003, BLOOD, V101, P407, DOI 10.1182/blood-2002-03-0993; Bonasio R, 2006, CURR OPIN IMMUNOL, V18, P503, DOI 10.1016/j.coi.2006.05.011; Boscardin SB, 2006, J EXP MED, V203, P599, DOI 10.1084/jem.20051639; Broers AEC, 2000, BLOOD, V95, P2240, DOI 10.1182/blood.V95.7.2240.007k08_2240_2245; Cobbold M, 2005, J EXP MED, V202, P379, DOI 10.1084/jem.20040613; Damle RG, 1998, ACTA VIROL, V42, P389; EDSON CM, 1985, J VIROL, V56, P333, DOI 10.1128/JVI.56.1.333-336.1985; Einsele H, 2002, BLOOD, V99, P3916, DOI 10.1182/blood.V99.11.3916; EMANUEL D, 1988, ANN INTERN MED, V109, P777, DOI 10.7326/0003-4819-109-10-777; Emery VC, 2001, J CLIN PATHOL, V54, P84, DOI 10.1136/jcp.54.2.84; Fonteneau JF, 2001, J IMMUNOL METHODS, V258, P111, DOI 10.1016/S0022-1759(01)00477-X; Gamadia LE, 2004, HUM IMMUNOL, V65, P486, DOI 10.1016/j.humimm.2004.02.020; Gandhi MK, 2004, LANCET INFECT DIS, V4, P725, DOI 10.1016/S1473-3099(04)01202-2; HO M, 1990, REV INFECT DIS, V12, pS701; Kern F, 2000, EUR J IMMUNOL, V30, P1676, DOI 10.1002/1521-4141(200006)30:6<1676::AID-IMMU1676>3.0.CO;2-V; Kern F, 2002, J INFECT DIS, V185, P1709, DOI 10.1086/340637; KIMURAKURODA J, 1986, J GEN VIROL, V67, P2663, DOI 10.1099/0022-1317-67-12-2663; KITAMURA K, 1986, VIROLOGY, V149, P74, DOI 10.1016/0042-6822(86)90088-7; Krause H, 1997, BONE MARROW TRANSPL, V19, P1111, DOI 10.1038/sj.bmt.1700801; La Rosa C, 2007, J INFECT DIS, V195, P633, DOI 10.1086/511307; Ljungman P, 2003, BLOOD, V102, P4255, DOI 10.1182/blood-2002-10-3263; Ljungman P, 2007, BEST PRACT RES CL HA, V20, P209, DOI 10.1016/j.beha.2006.09.003; Ljungman P, 2006, HAEMATOLOGICA, V91, P78; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Maecker HT, 2001, J IMMUNOL METHODS, V255, P27, DOI 10.1016/S0022-1759(01)00416-1; Moser JM, 2010, J IMMUNOL METHODS, V353, P8, DOI 10.1016/j.jim.2009.11.006; Ocadlikova D, 2010, NEOPLASMA, V57, P455, DOI 10.4149/neo_2010_05_455; Oelke M, 2000, CLIN CANCER RES, V6, P1997; Peggs KS, 2003, LANCET, V362, P1375, DOI 10.1016/S0140-6736(03)14634-X; RIDDELL SR, 1992, SCIENCE, V257, P238; Sester M, 2003, TRANSPLANTATION, V76, P1229, DOI 10.1097/01.TP.0000083894.61333.56; Sester M, 2001, TRANSPLANTATION, V71, P1287, DOI 10.1097/00007890-200105150-00018; Sinclair E, 2004, VIRAL IMMUNOL, V17, P445, DOI 10.1089/0882824041857049; Slezak SL, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-17; Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Tsai V, 1998, CRIT REV IMMUNOL, V18, P65, DOI 10.1615/CritRevImmunol.v18.i1-2.80; VAFAI A, 1990, VIRUS RES, V15, P163, DOI 10.1016/0168-1702(90)90006-W; Waldrop SL, 1997, J CLIN INVEST, V99, P1739, DOI 10.1172/JCI119338; WALTER EA, 1995, NEW ENGL J MED, V333, P1038, DOI 10.1056/NEJM199510193331603; Widmann T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003634; Zhou WD, 2009, BLOOD, V113, P6465, DOI 10.1182/blood-2009-02-203307	45	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31420	10.1371/journal.pone.0031420	http://dx.doi.org/10.1371/journal.pone.0031420			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347475	Green Published, Green Submitted, gold			2022-12-25	WOS:000302180600036
J	Garbuzova-Davis, S; Rodrigues, MCO; Mirtyl, S; Turner, S; Mitha, S; Sodhi, J; Suthakaran, S; Eve, DJ; Sanberg, CD; Kuzmin-Nichols, N; Sanberg, PR				Garbuzova-Davis, Svitlana; Rodrigues, Maria C. O.; Mirtyl, Santhia; Turner, Shanna; Mitha, Shazia; Sodhi, Jasmine; Suthakaran, Subatha; Eve, David J.; Sanberg, Cyndy D.; Kuzmin-Nichols, Nicole; Sanberg, Paul R.			Multiple Intravenous Administrations of Human Umbilical Cord Blood Cells Benefit in a Mouse Model of ALS	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; HEMATOPOIETIC STEM-CELLS; MARROW STROMAL CELLS; ADULT BONE-MARROW; MOTOR-NEURON LOSS; DISEASE PROGRESSION; SPINAL-CORD; TRANSGENIC MICE; BRAIN REPAIR; FAMILIAL ALS	Background: A promising therapeutic strategy for amyotrophic lateral sclerosis (ALS) is the use of cell-based therapies that can protect motor neurons and thereby retard disease progression. We recently showed that a single large dose (25x10(6) cells) of mononuclear cells from human umbilical cord blood (MNC hUCB) administered intravenously to pre-symptomatic G93A SOD1 mice is optimal in delaying disease progression and increasing lifespan. However, this single high cell dose is impractical for clinical use. The aim of the present pre-clinical translation study was therefore to evaluate the effects of multiple low dose systemic injections of MNC hUCB cell into G93A SOD1 mice at different disease stages. Methodology/Principal Findings: Mice received weekly intravenous injections of MNC hUCB or media. Symptomatic mice received 10(6) or 2.5x10(6) cells from 13 weeks of age. A third, pre-symptomatic, group received 10(6) cells from 9 weeks of age. Control groups were media-injected G93A and mice carrying the normal hSOD1 gene. Motor function tests and various assays determined cell effects. Administered cell distribution, motor neuron counts, and glial cell densities were analyzed in mouse spinal cords. Results showed that mice receiving 10(6) cells pre-symptomatically or 2.5x10(6) cells symptomatically significantly delayed functional deterioration, increased lifespan and had higher motor neuron counts than media mice. Astrocytes and microglia were significantly reduced in all cell-treated groups. Conclusions/Significance: These results demonstrate that multiple injections of MNC hUCB cells, even beginning at the symptomatic disease stage, could benefit disease outcomes by protecting motor neurons from inflammatory effectors. This multiple cell infusion approach may promote future clinical studies.	[Garbuzova-Davis, Svitlana; Rodrigues, Maria C. O.; Mirtyl, Santhia; Turner, Shanna; Mitha, Shazia; Sodhi, Jasmine; Suthakaran, Subatha; Eve, David J.; Sanberg, Paul R.] Univ S Florida, Coll Med, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA; [Garbuzova-Davis, Svitlana; Eve, David J.; Sanberg, Paul R.] Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Tampa, FL USA; [Garbuzova-Davis, Svitlana] Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL USA; [Garbuzova-Davis, Svitlana; Sanberg, Paul R.] Univ S Florida, Coll Med, Dept Pathol & Cell Biol, Tampa, FL USA; [Sanberg, Paul R.] Univ S Florida, Coll Med, Dept Psychiat, Tampa, FL USA; [Sanberg, Cyndy D.; Kuzmin-Nichols, Nicole] Saneron CCEL Therapeut Inc, Tampa, FL USA; [Rodrigues, Maria C. O.] Univ Sao Paulo, Ribeirao Preto Sch Med, Sao Paulo, Brazil	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Universidade de Sao Paulo	Garbuzova-Davis, S (corresponding author), Univ S Florida, Coll Med, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA.	sgarbuzo@health.usf.edu	Rodrigues, Maria Carolina Oliveira/A-2302-2012; Garbuzova-Davis, Svitlana/Q-3687-2019; Eve, David/I-6164-2012	Rodrigues, Maria Carolina Oliveira/0000-0003-0691-2222; Eve, David/0000-0003-1736-9755; Sanberg, Paul/0000-0001-9130-4592	Department of Neurosurgery and Brain Repair, at the University of South Florida (USF); Sao Paulo Research Foundation	Department of Neurosurgery and Brain Repair, at the University of South Florida (USF); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Department of Neurosurgery and Brain Repair, at the University of South Florida (USF). MCOR, received a fellowship from the Sao Paulo Research Foundation which supported her work at USF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alexander GM, 2004, MOL BRAIN RES, V130, P7, DOI 10.1016/j.molbrainres.2004.07.002; Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; Appel SH, 2008, NEUROLOGY, V71, P1326, DOI 10.1212/01.wnl.0000327668.43541.22; Appel S H, 2001, Curr Neurol Neurosci Rep, V1, P303, DOI 10.1007/s11910-001-0081-z; Bachstetter AD, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-22; Barbeito LH, BRAIN RES BRAIN RES, V47, P263; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Borlongan CV, 2004, STROKE, V35, P2385, DOI 10.1161/01.STR.0000141680.49960.d7; BROXMEYER HE, 1992, P NATL ACAD SCI USA, V89, P4109, DOI 10.1073/pnas.89.9.4109; BROXMEYER HE, 1989, P NATL ACAD SCI USA, V86, P3828, DOI 10.1073/pnas.86.10.3828; Bruijn LI, 2002, BIOTECHNIQUES, V32, P1112, DOI 10.2144/02325dd01; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen N, 2005, STEM CELLS, V23, P1560, DOI 10.1634/stemcells.2004-0284; Chen N, 2010, AGING DIS, V1, P173; Chen Ruifeng, 2000, Journal of Medicine (Westbury), V31, P21; Cho KJ, 1999, NEUROREPORT, V10, P3939, DOI 10.1097/00001756-199912160-00039; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Eglitis MA, 1999, NEUROREPORT, V10, P1289, DOI 10.1097/00001756-199904260-00025; Feeney SJ, 2001, MUSCLE NERVE, V24, P1510, DOI 10.1002/mus.1176; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219; Garbuzova-Davis S, 2003, J HEMATOTH STEM CELL, V12, P255, DOI 10.1089/152581603322022990; Garbuzova-Davis S, 2009, CELL TRANSPLANT, V18, P214; Garbuzova-Davis S, 2006, PROG BRAIN RES, V157, P207, DOI 10.1016/S0079-6123(06)57014-1; Garbuzova-Davis S, 2011, BRAIN RES, V1398, P113, DOI 10.1016/j.brainres.2011.04.049; Garbuzova-Davis S, 2009, EXP NEUROL, V216, P3, DOI 10.1016/j.expneurol.2008.11.004; Garbuzova-Davis S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002494; GIULIAN D, 1985, J CELL BIOL, V101, P2411, DOI 10.1083/jcb.101.6.2411; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Heiman-Patterson TD, 2005, J NEUROL SCI, V236, P1, DOI 10.1016/j.jns.2005.02.006; Hendrikx PJ, 1996, EXP HEMATOL, V24, P129; Henkel JS, 2009, J NEUROIMMUNE PHARM, V4, P389, DOI 10.1007/s11481-009-9171-5; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; Jozwiak S, 2010, CELL MED, V1, P71, DOI 10.3727/215517910X536618; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Levine JB, 1999, GLIA, V28, P215; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Mayani H, 1998, STEM CELLS, V16, P153, DOI 10.1002/stem.160153; Mazzini L, 2003, AMYOTROPH LATERAL SC, V4, P158, DOI 10.1080/14660820310014653; Mazzini L, 2008, J NEUROL SCI, V265, P78, DOI 10.1016/j.jns.2007.05.016; McGeer PL, 2002, MUSCLE NERVE, V26, P459, DOI 10.1002/mus.10191; Mitrecic D, 2010, CELL TRANSPLANT, V19, P537, DOI 10.3727/096368910X498269; NAKAHATA T, 1982, J CLIN INVEST, V70, P1324, DOI 10.1172/JCI110734; Nayar B, 2002, INT J GYNECOL OBSTET, V79, P31, DOI 10.1016/S0020-7292(02)00187-X; Nikolic WV, 2008, STEM CELLS DEV, V17, P423, DOI 10.1089/scd.2008.0018; Ohnishi S, 2009, BRAIN RES, V1296, P216, DOI 10.1016/j.brainres.2009.08.012; Philips T, 2011, LANCET NEUROL, V10, P253, DOI 10.1016/S1474-4422(11)70015-1; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rainsford E, 2002, BRIT J HAEMATOL, V116, P702, DOI 10.1046/j.0007-1048.2001.03321.x; Riley J, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E9; Rizvanov AA, 2008, NEUROCHEM INT, V53, P389, DOI 10.1016/j.neuint.2008.09.011; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sanberg P R, 2001, Clin Neurosurg, V48, P113; Sanberg PR, 2002, NEUROTOX RES, V4, P95, DOI 10.1080/10298420290015917; Sanberg PR, 2011, CELL TRANSPLANT, V20, P85, DOI 10.3727/096368910X532855; Sanberg PR, 2005, ANN NY ACAD SCI, V1049, P67, DOI 10.1196/annals.1334.008; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Sanchez-Ramos JR, 2001, EXP NEUROL, V171, P109, DOI 10.1006/exnr.2001.7748; Sanchez-Ramos JR, 2002, J NEUROSCI RES, V69, P880, DOI 10.1002/jnr.10337; Saporta S, 2003, J HEMATOTH STEM CELL, V12, P271, DOI 10.1089/152581603322023007; Souayah N, 2012, STEM CELL REV REP, V8, P224, DOI 10.1007/s12015-011-9281-3; Strong MJ, 2003, PHARMACOL THERAPEUT, V98, P379, DOI 10.1016/S0163-7258(03)00040-8; Suzuki M, 2008, TRENDS NEUROSCI, V31, P192, DOI 10.1016/j.tins.2008.01.006; Szilvassy SJ, 1999, BLOOD, V93, P1557, DOI 10.1182/blood.V93.5.1557; Teng YD, 2011, CURR NEUROPHARMACOL, V9, P574, DOI 10.2174/157015911798376299; Todaro AM, 2000, BLOOD PURIFICAT, V18, P144, DOI 10.1159/000014438; Van Den Bosch L, 2008, EXP NEUROL, V211, P1, DOI 10.1016/j.expneurol.2008.01.008; Vendrame M, 2005, STEM CELLS DEV, V14, P595, DOI 10.1089/scd.2005.14.595; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Willing AE, 2003, J NEUROSCI RES, V73, P296, DOI 10.1002/jnr.10659; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Zhao WH, 2010, GLIA, V58, P231, DOI 10.1002/glia.20919; ZOLA H, 1995, PEDIATR RES, V38, P397, DOI 10.1203/00006450-199509000-00021	76	39	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31254	10.1371/journal.pone.0031254	http://dx.doi.org/10.1371/journal.pone.0031254			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319620	Green Published, Green Submitted, gold			2022-12-25	WOS:000302178400033
J	Cottrell, EC; Holmes, MC; Livingstone, DE; Kenyon, CJ; Seckl, JR				Cottrell, Elizabeth C.; Holmes, Megan C.; Livingstone, Dawn E.; Kenyon, Christopher J.; Seckl, Jonathan R.			Reconciling the nutritional and glucocorticoid hypotheses of fetal programming	FASEB JOURNAL			English	Article						low-protein diet; 11 beta-hydroxysteroid dehydrogenase-2; hypothalamo-pituitary-adrenal axis	11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-2; BETA-HYDROXYSTEROID DEHYDROGENASE; MESSENGER-RIBONUCLEIC-ACID; CHORIOCARCINOMA JEG-3 CELLS; PITUITARY-ADRENAL AXIS; MATERNAL UNDERNUTRITION; PLACENTAL TROPHOBLAST; GROWTH-RETARDATION; ADULT DISEASE; BIRTH-WEIGHT	Fetal growth restriction associates with increased risk of adult cardiometabolic and neuropsychiatric disorders. Both maternal malnutrition [notably a low-protein (LP) diet] and stress/glucocorticoid exposure reduce fetal growth and cause persisting abnormalities (programming) in adult offspring. Deficiency of placental 11 beta-hydroxysteroid dehydrogenase-2 (11 beta-HSD2), which inactivates glucocorticoids, is reduced by an LP diet and has been proposed as a unifying mechanism. Here, we explored the importance of glucocorticoids and placental 11 beta-HSD2 in dietary programming. Pregnant mice were fed a control or isocaloric LP diet throughout gestation. The LP diet first elevated fetal glucocorticoid levels, then reduced placental growth, and finally decreased fetal weight near term by 17%. Whereas the LP diet reduced placental 11 beta-HSD2 activity near term by similar to 25%, consistent with previous reports, activity was increased between 20 and 40% at earlier ages, implying that glucocorticoid overexposure in LP fetuses occurs via 11 beta-HSD2-independent mechanisms. Consistent with this, heterozygous 11 beta-HSD2(+/-) crosses showed that although both LP and 11 beta-HSD2 deficiency reduced fetal growth, LP indeed acted independently of 11 beta-HSD2. Instead, the LP diet induced the fetal hypothalamic-pituitary-adrenal axis per se. Thus, maternal malnutrition and placental 11 beta-HSD2 deficiency act via distinct processes to retard fetal growth, both involving fetoplacental overexposure to glucocorticoids but from distinct sources.-Cottrell, E. C., Holmes, M. C., Livingstone, D. E., Keynon, C. J., Seckl, J. R. Reconciling the nutritional and glucocorticoid hypotheses of fetal programming. FASEB J. 26, 1866-1874 (2012). www.fasebj.org	[Cottrell, Elizabeth C.; Holmes, Megan C.; Livingstone, Dawn E.; Kenyon, Christopher J.; Seckl, Jonathan R.] Univ Edinburgh, Queens Med Res Inst, Endocrinol Unit, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh	Cottrell, EC (corresponding author), Univ Manchester, Fac Human & Med Sci, Manchester M13 9PT, Lancs, England.	elizabeth.cottrell@manchester.ac.uk	Seckl, Jonathan R/C-3555-2013	Cottrell, Elizabeth/0000-0002-0888-4707	Human Frontier Science Program [RGP0039/2006-C]	Human Frontier Science Program(Human Frontier Science Program)	The authors are grateful to Alan Borthwick and Laraine Wells for their technical support, and to Dr. Caitlin Wyrwoll and Professor Karen Chapman for expert advice. This study was supported in part by a Human Frontier Science Program grant (RGP0039/2006-C) to J.R.S. The authors declare no conflicts of interest.	Audette MC, 2010, PLACENTA, V31, P97, DOI 10.1016/j.placenta.2009.11.016; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; BAXTER RC, 1995, J CLIN ENDOCR METAB, V80, P2700, DOI 10.1210/jc.80.9.2700; Benediktsson R, 1997, CLIN ENDOCRINOL, V46, P161, DOI 10.1046/j.1365-2265.1997.1230939.x; Bertram C, 2001, ENDOCRINOLOGY, V142, P2841, DOI 10.1210/en.142.7.2841; Bhasin KKS, 2009, DIABETES, V58, P559, DOI 10.2337/db07-1530; Bloomfield FH, 2003, SCIENCE, V300, P606, DOI 10.1126/science.1080803; Bloomfield FH, 2003, ENDOCRINOLOGY, V144, P2933, DOI 10.1210/en.2003-0189; Carroll JA, 2001, DOMEST ANIM ENDOCRIN, V21, P97, DOI 10.1016/S0739-7240(01)00107-2; Chisaka H, 2005, J SOC GYNECOL INVEST, V12, P303, DOI 10.1016/j.jsgi.2005.02.003; Coan PM, 2008, J PHYSIOL-LONDON, V586, P4567, DOI 10.1113/jphysiol.2008.156133; Coan PM, 2010, J PHYSIOL-LONDON, V588, P527, DOI 10.1113/jphysiol.2009.181214; Condon J, 1997, MOL CELL ENDOCRINOL, V127, P121, DOI 10.1016/S0303-7207(97)04000-8; Constancia M, 2005, P NATL ACAD SCI USA, V102, P19219, DOI 10.1073/pnas.0504468103; Cottrell EC, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.019.2009; Dave-Sharma S, 1998, J CLIN ENDOCR METAB, V83, P2244, DOI 10.1210/jc.83.7.2244; Diederich S, 2002, J CLIN ENDOCR METAB, V87, P5695, DOI 10.1210/jc.2002-020970; EDWARDS CRW, 1993, LANCET, V341, P355, DOI 10.1016/0140-6736(93)90148-A; Edwards CRW, 1996, STEROIDS, V61, P263, DOI 10.1016/0039-128X(96)00033-5; Fowden AL, 2009, J PHYSIOL-LONDON, V587, P3459, DOI 10.1113/jphysiol.2009.173013; Gitau R, 1998, LANCET, V352, P707, DOI 10.1016/S0140-6736(05)60824-0; Harris HJ, 2001, ENDOCRINOLOGY, V142, P114, DOI 10.1210/en.142.1.114; Holmes MC, 2006, J NEUROSCI, V26, P3840, DOI 10.1523/JNEUROSCI.4464-05.2006; Langdown ML, 2001, MOL CELL ENDOCRINOL, V185, P109, DOI 10.1016/S0303-7207(01)00629-3; LangleyEvans SC, 1997, J HYPERTENS, V15, P537, DOI 10.1097/00004872-199715050-00010; LangleyEvans SC, 1996, PLACENTA, V17, P169, DOI 10.1016/S0143-4004(96)80010-5; Lesage J, 2001, ENDOCRINOLOGY, V142, P1692, DOI 10.1210/en.142.5.1692; Lindsay RS, 1996, DIABETOLOGIA, V39, P1299, DOI 10.1007/s001250050573; Ma XH, 2003, AM J OBSTET GYNECOL, V188, P13, DOI 10.1067/mob.2003.62; Mairesse J, 2007, AM J PHYSIOL-ENDOC M, V292, pE1526, DOI 10.1152/ajpendo.00574.2006; McInnes KJ, 2004, J BIOL CHEM, V279, P22908, DOI 10.1074/jbc.M402822200; MONTANO MM, 1993, J REPROD FERTIL, V99, P283; Murphy VE, 2002, J CLIN ENDOCR METAB, V87, P1660, DOI 10.1210/jc.87.4.1660; Nyirenda MJ, 1998, J CLIN INVEST, V101, P2174, DOI 10.1172/JCI1567; Roseboom TJ, 2011, PLACENTA, V32, P395, DOI 10.1016/j.placenta.2011.03.001; Sarkar S, 2001, AM J PHYSIOL-REG I, V281, pR1966, DOI 10.1152/ajpregu.2001.281.6.R1966; SECKL JR, 1990, J NEUROENDOCRINOL, V2, P911, DOI 10.1111/j.1365-2826.1990.tb00659.x; Sharma A, 2009, ENDOCRINOLOGY, V150, P4278, DOI 10.1210/en.2009-0479; Staud F, 2006, PLACENTA, V27, P171, DOI 10.1016/j.placenta.2005.01.001; Stein AD, 2004, INT J EPIDEMIOL, V33, P831, DOI 10.1093/ije/dyh083; STEWART PM, 1995, J CLIN ENDOCR METAB, V80, P885, DOI 10.1210/jc.80.3.885; Talge NM, 2007, J CHILD PSYCHOL PSYC, V48, P245, DOI 10.1111/j.1469-7610.2006.01714.x; Tremblay J, 1999, BIOL REPROD, V60, P541, DOI 10.1095/biolreprod60.3.541; Tzschoppe A, 2011, EUR J OBSTET GYN R B, V156, P50, DOI 10.1016/j.ejogrb.2011.01.008; van Beek JP, 2004, J CLIN ENDOCR METAB, V89, P5614, DOI 10.1210/jc.2004-0113; Welberg LAM, 2000, EUR J NEUROSCI, V12, P1047, DOI 10.1046/j.1460-9568.2000.00958.x; Whorwood CB, 2001, ENDOCRINOLOGY, V142, P2854, DOI 10.1210/en.142.7.2854; Wyrwoll CS, 2009, ENDOCRINOLOGY, V150, P1287, DOI 10.1210/en.2008-1100	49	78	78	0	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2012	26	5					1866	1874		10.1096/fj.12-203489	http://dx.doi.org/10.1096/fj.12-203489			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	937TD	22321728				2022-12-25	WOS:000303680800015
J	Manning, EP; Guinto, PJ; Tardiff, JC				Manning, Edward P.; Guinto, Pia J.; Tardiff, Jil C.			Correlation of Molecular and Functional Effects of Mutations in Cardiac Troponin T Linked to Familial Hypertrophic Cardiomyopathy AN INTEGRATIVE IN SILICO/IN VITRO APPROACH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIN FILAMENT; REGULATORY PROTEINS; TAIL DOMAIN; CALCIUM REGULATION; COILED-COILS; MUSCLE; CONTRACTION; BINDING; IDENTIFICATION; MYOFILAMENTS	Nearly 70% of all of the known cTnT mutations that cause familial hypertrophic cardiomyopathy fall within the TNT1 region that is critical to cTn-Tm binding. The high resolution structure of this domain has not been determined, and this lack of information has hindered structure-function analysis. In the current study, a coupled computational experimental approach was employed to correlate changes in cTnT dynamics to basic function using the regulated in vitro motility assay (R-IVM). An in silico approach to calculate forces in terms of a bending coordinate was used to precisely identify decreases in bending forces at residues 105 and 106 within the proposed cTnT "hinge" region. Significant functional changes were observed in multiple functional properties, including a decrease in the cooperativity of calcium activation, the calcium sensitivity of sliding speed, and maximum sliding speed. Correlation of the computational and experimental findings revealed an association between TNT1 flexibility and the cooperativity of thin filament calcium activation where an increase in flexibility led to a decrease in cooperativity. Further analysis of the primary sequence of the TNT1 region revealed a unique pattern of conserved charged TNT1 residues altered by the R92W and R92L mutations and may represent the underlying "structure" modulating this central functional domain. These data provide a framework for further integrated in silico/in vitro approaches that may be extended into a high-throughput predictive screen to overcome the current structural limitations in linking molecular phenotype to genotype in thin filament cardiomyopathies.	[Tardiff, Jil C.] Univ Arizona, Dept Med, Tucson, AZ 85724 USA; [Tardiff, Jil C.] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ 85724 USA; [Manning, Edward P.; Guinto, Pia J.] Albert Einstein Coll Med Bronx, Dept Physiol & Biophys, Bronx, NY 10461 USA	University of Arizona; University of Arizona; Yeshiva University; Albert Einstein College of Medicine	Tardiff, JC (corresponding author), Univ Arizona, Dept Med, 1656 E Mabel St,MRB 312,MS 245217, Tucson, AZ 85724 USA.	jtardiff@email.arizona.edu			National Institutes of Health [HL075619]; Predoctoral Training Grants [1F31HL085915-01]; American Heart Association [10PRE3610021]; Medical Scientist Training Grant [GM007288]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL085915, R01HL075619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Predoctoral Training Grants; American Heart Association(American Heart Association); Medical Scientist Training Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported in part by National Institutes of Health Grant HL075619 (to J. C. T.), and Predoctoral Training Grants 1F31HL085915-01 (to P. J. G.) and American Heart Association 10PRE3610021 (to E. P. M.), and Medical Scientist Training Grant GM007288.	Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chandra M, 1999, J MOL CELL CARDIOL, V31, P867, DOI 10.1006/jmcc.1999.0928; Chandra M, 2005, AM J PHYSIOL-HEART C, V289, pH2112, DOI 10.1152/ajpheart.00571.2005; Chandra M, 2001, AM J PHYSIOL-HEART C, V280, pH705, DOI 10.1152/ajpheart.2001.280.2.H705; Clarkson MW, 2004, BIOCHEMISTRY-US, V43, P12448, DOI 10.1021/bi0494424; Clemmens EW, 2005, J PHYSIOL-LONDON, V566, P737, DOI 10.1113/jphysiol.2005.084194; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Cuinto PJ, 2007, J THEOR COMPUT CHEM, V6, P413, DOI 10.1142/S0219633607003271; Ertz-Berger BR, 2005, P NATL ACAD SCI USA, V102, P18219, DOI 10.1073/pnas.0509181102; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Gordon AM, 1997, BIOPHYS J, V72, P1295, DOI 10.1016/S0006-3495(97)78776-9; Harada K, 2004, J BIOL CHEM, V279, P14488, DOI 10.1074/jbc.M309355200; Hinkle A, 1999, J BIOL CHEM, V274, P7157, DOI 10.1074/jbc.274.11.7157; Hinkle A, 2003, J BIOL CHEM, V278, P506, DOI 10.1074/jbc.M209194200; Homsher E, 2003, BIOPHYS J, V85, P1046, DOI 10.1016/S0006-3495(03)74543-3; Homsher E, 1996, BIOPHYS J, V70, P1881, DOI 10.1016/S0006-3495(96)79753-9; Homsher E, 2000, J PHYSIOL-LONDON, V524, P233, DOI 10.1111/j.1469-7793.2000.00233.x; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jin JP, 2008, CRIT REV EUKAR GENE, V18, P93, DOI 10.1615/CritRevEukarGeneExpr.v18.i2.10; Li XC, 2010, J MOL BIOL, V395, P327, DOI 10.1016/j.jmb.2009.10.060; Lim CC, 2008, BIOPHYS J, V94, P3577, DOI 10.1529/biophysj.107.112896; Murakami K, 2008, P NATL ACAD SCI USA, V105, P7200, DOI 10.1073/pnas.0801950105; Palm T, 2001, BIOPHYS J, V81, P2827, DOI 10.1016/S0006-3495(01)75924-3; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Sumandea MP, 2003, J BIOL CHEM, V278, P35135, DOI 10.1074/jbc.M306325200; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; Tobacman LS, 2002, J BIOL CHEM, V277, P27636, DOI 10.1074/jbc.M201768200; Voet D, 2004, BIOCHEMISTRY-US, P219	30	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14515	14523		10.1074/jbc.M111.257436	http://dx.doi.org/10.1074/jbc.M111.257436			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22334656	Green Published, hybrid			2022-12-25	WOS:000304003200018
J	Chen, G; Chen, SM; Wang, X; Ding, XF; Ding, J; Meng, LH				Chen, Guang; Chen, Si-Meng; Wang, Xiang; Ding, Xiao-Fei; Ding, Jian; Meng, Ling-Hua			Inhibition of Chemokine (CXC Motif) Ligand 12/Chemokine (CXC Motif) Receptor 4 Axis (CXCL12/CXCR4)-mediated Cell Migration by Targeting Mammalian Target of Rapamycin (mTOR) Pathway in Human Gastric Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE 3-KINASE; SIGNALING PATHWAY; GROWTH-FACTOR; CANCER CELLS; EXPRESSION; PROLIFERATION; ACTIVATION; MOTILITY; REORGANIZATION; CYTOSKELETON	CXCL12/CXCR4 plays an important role in metastasis of gastric carcinoma. Rapamycin has been reported to inhibit migration of gastric cancer cells. However, the role of mTOR pathway in CXCL12/CXCR4-mediated cell migration and the potential of drugs targeting PI3K/mTOR pathway remains unelucidated. We found that CXCL12 activated PI3K/Akt/mTOR pathway in MKN-45 cells. Stimulating CHO-K1 cells expressing pEGFP-C1-Grp1-PH fusion protein with CXCL12 resulted in generation of phosphatidylinositol ( 3,4,5)-triphosphate, which provided direct evidence of activating PI3K by CXCL12. Downregulation of p110 beta by siRNA but not p110 alpha blocked phosphorylation of Akt and S6K1 induced by CXCL12. Consistently, p110 beta-specific inhibitor blocked the CXCL12-activated PI3K/Akt/mTOR pathway. Moreover, CXCR4 immunoprecipitated by anti-p110 beta antibody increased after CXCL12 stimulation and G(i) protein inhibitor pertussis toxin abrogated CXCL12-induced activation of PI3K. Further studies demonstrated that inhibitors targeting the PI3K/mTOR pathway significantly blocked the chemotactic responses of MKN-45 cells triggered by CXCL12, which might be attributed primarily to inhibition of mTORC1 and related to prevention of F-actin reorganization as well as down-regulation of active RhoA, Rac1, and Cdc42. Furthermore, rapamycin inhibited the secretion of CXCL12 and the expression of CXCR4, which might form a positive feedback loop to further abolish upstream signaling leading to cell migration. Finally, we found cells expressing high levels of cxcl12 were sensitive to rapamycin in its activity inhibiting migration as well as proliferation. In summary, we found that the mTOR pathway played an important role in CXCL12/CXCR4-mediated cell migration and proposed that drugs targeting the mTOR pathway may be used for the therapy of metastatic gastric cancer expressing high levels of cxcl12.	[Chen, Guang; Chen, Si-Meng; Wang, Xiang; Ding, Jian; Meng, Ling-Hua] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai Inst Biol Sci, State Key Lab Drug Res,Div Antitumor Pharmacol, Shanghai 201203, Peoples R China; [Chen, Guang] Taizhou Coll, Sch Pharmaceut & Chem Engn, Taizhou 317000, Zhejiang, Peoples R China; [Ding, Xiao-Fei] Taizhou Coll, Sch Math & Informat Engn, Taizhou 317000, Zhejiang, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS; Taizhou University; Taizhou University	Ding, J (corresponding author), 555 Zu Chong Zhi Rd,Zhang Jiang Hitech Pk, Shanghai 201203, Peoples R China.	jding@mail.shcnc.ac.cn; lhmeng@mail.shcnc.ac.cn	meng, linghua/Y-8110-2019		National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" [2012ZX09301-001]; National Natural Science Foundation of China [81021062'81173079]; Chinese Academy of Sciences [KSCX2-EW-Q-3]; SA-SIBS	National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program"; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); SA-SIBS	* This work was supported in part by National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" 2012ZX09301-001, National Natural Science Foundation of China Grant 81021062'81173079, and Knowledge Innovation Program of Chinese Academy of Sciences Grant KSCX2-EW-Q-3.; <SUP>3</SUP> Supported by the SA-SIBS scholarship program. To whom correspondence may be addressed: 555 Zu Chong Zhi Rd., Zhang Jiang Hi-Tech Park, Pudong, Shanghai 201203, China. Tel. and Fax: 86-21-50806722; E-mail: lhmeng@mail.shcnc.ac.cn.	Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Barbero S, 2003, CANCER RES, V63, P1969; Baselga J, 2009, J CLIN ONCOL, V27, P2630, DOI 10.1200/JCO.2008.18.8391; Boku N, 2008, INT J CLIN ONCOL, V13, P483, DOI 10.1007/s10147-008-0847-2; Chen GA, 2010, J MOL MED, V88, P941, DOI 10.1007/s00109-010-0635-0; Chinni SR, 2006, PROSTATE, V66, P32, DOI 10.1002/pros.20318; Easton JB, 2006, ONCOGENE, V25, P6436, DOI 10.1038/sj.onc.1209886; Ehtesham M, 2009, CANCER LETT, V274, P305, DOI 10.1016/j.canlet.2008.09.034; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; Hashimoto I, 2008, EUR J CANCER, V44, P1022, DOI 10.1016/j.ejca.2008.02.043; Ishigami S, 2007, ANN SURG ONCOL, V14, P3154, DOI 10.1245/s10434-007-9521-6; Iwasa S, 2009, ANTICANCER RES, V29, P4751; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Leelawat K, 2007, WORLD J GASTROENTERO, V13, P1561, DOI 10.3748/wjg.v13.i10.1561; Li T, 2010, J PHARMACOL EXP THER, V334, P830, DOI 10.1124/jpet.110.167940; Liu L, 2008, ONCOGENE, V27, P4998, DOI 10.1038/onc.2008.137; Liu L, 2006, ONCOGENE, V25, P7029, DOI 10.1038/sj.onc.1209691; Liu L, 2010, J BIOL CHEM, V285, P38362, DOI 10.1074/jbc.M110.141168; Monterrubio M, 2009, BIOCHEM BIOPH RES CO, V388, P199, DOI 10.1016/j.bbrc.2009.07.153; Phillips RJ, 2005, J BIOL CHEM, V280, P22473, DOI 10.1074/jbc.M500963200; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Song N, 2009, CANCER RES, V69, P6057, DOI 10.1158/0008-5472.CAN-08-2007; Sotsios Y, 1999, J IMMUNOL, V163, P5954; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Wald O, 2011, J THORAC CARDIOV SUR, V141, P1503, DOI 10.1016/j.jtcvs.2010.11.056; Wu YM, 2009, J NEUROCHEM, V109, P1157, DOI 10.1111/j.1471-4159.2009.06043.x; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Zhao M, 2008, BREAST CANCER RES TR, V110, P211, DOI 10.1007/s10549-007-9712-7; Zhou HY, 2010, CRIT REV EUKAR GENE, V20, P1	31	72	78	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12132	12141		10.1074/jbc.M111.302299	http://dx.doi.org/10.1074/jbc.M111.302299			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22337890	Green Published, hybrid			2022-12-25	WOS:000302782200049
J	Song, XL; Thalacker, FW; Nilsen-Hamilton, M				Song, Xiaoling; Thalacker, Frederic W.; Nilsen-Hamilton, Marit			Synergistic and Multidimensional Regulation of Plasminogen Activator Inhibitor Type 1 Expression by Transforming Growth Factor Type beta and Epidermal Growth Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYMIC EPITHELIAL-CELLS; MESSENGER-RNA STABILITY; HUMAN ENDOTHELIAL-CELLS; TGF-BETA; FACTOR INCREASES; GENE-EXPRESSION; FACTOR-ALPHA; PAI-1; TRANSCRIPTION; PROTEIN	The major physiological inhibitor of plasminogen activator, type I plasminogen activator inhibitor (PAI-1), controls blood clotting and tissue remodeling events that involve cell migration. Transforming growth factor type beta (TGF beta) and epidermal growth factor (EGF) interact synergistically to increase PAI-1 mRNA and protein levels in human HepG2 and mink Mv1Lu cells. Other growth factors that activate tyrosine kinase receptors can substitute for EGF. EGF and TGF beta regulate PAI-1 by synergistically activating transcription, which is further amplified by a decrease in the rate of mRNA degradation, the latter being regulated only by EGF. The combined effect of transcriptional activation and mRNA stabilization results in a rapid 2-order of magnitude increase in the level of PAI-1. TGF beta also increases the sensitivity of the cells to EGF, thereby recruiting the cooperation of EGF at lower than normally effective concentrations. The contribution of EGF to the regulation of PAI-1 involves the MAPK pathway, and the synergistic interface with the TGF beta pathway is downstream of MEK1/2 and involves phosphorylation of neither ERK1/2 nor Smad2/3. Synergism requires the presence of both Smad and AP-1 recognition sites in the promoter. This work demonstrates the existence of a multidimensional cellular mechanism by which EGF and TGF beta are able to promote large and rapid changes in PAI-1 expression.	[Song, Xiaoling; Thalacker, Frederic W.; Nilsen-Hamilton, Marit] Iowa State & Ames Natl Labs, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA		Nilsen-Hamilton, M (corresponding author), Iowa State & Ames Natl Labs, Dept Biochem Biophys & Mol Biol, 3206 Mol Biol Bldg, Ames, IA 50011 USA.	marit@iastate.edu	Nilsen-Hamilton, Marit/V-2796-2019	Song, Xiaoling/0000-0002-0321-5379	National Institutes of Health [1-R01-GM33528]; United States Department of Energy, Office of Biological and Environmental Research, through the Ames Laboratory; United States Department of Energy [DE-AC02-07CH11358]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033528] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Biological and Environmental Research, through the Ames Laboratory(United States Department of Energy (DOE)); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1-R01-GM33528. This work was also supported by the United States Department of Energy, Office of Biological and Environmental Research, through the Ames Laboratory. The Ames Laboratory is operated for the United States Department of Energy by Iowa State University under Contract DE-AC02-07CH11358.	de Caestecker MP, 1998, GENE DEV, V12, P1587, DOI 10.1101/gad.12.11.1587; Dellas C, 2005, THROMB HAEMOSTASIS, V93, P631, DOI 10.1160/TH05-01-0033; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; Dufourny B, 2000, J ENDOCRINOL, V166, P329, DOI 10.1677/joe.0.1660329; Emmanuel C, 2002, CYTOKINE, V18, P237, DOI 10.1006/cyto.2002.1042; Fakhouri F, 2001, J AM SOC NEPHROL, V12, P2701, DOI 10.1681/ASN.V12122701; FERNANDEZPOL JA, 1989, J BIOL CHEM, V264, P4151; Freytag J, 2009, J ONCOL, V2009, DOI 10.1155/2009/963209; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; HAGGROTH L, 1986, THROMB RES, V42, P585, DOI 10.1016/0049-3848(86)90337-3; HOPKINS WE, 1991, THROMB HAEMOSTASIS, V66, P239; JINNO Y, 1988, NUCLEIC ACIDS RES, V16, P4957, DOI 10.1093/nar/16.11.4957; Johannessen LE, 1999, BIOCHEM J, V337, P599, DOI 10.1042/0264-6021:3370599; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; LANDIN K, 1991, THROMB HAEMOSTASIS, V65, P130; LE PT, 1991, J EXP MED, V174, P1147, DOI 10.1084/jem.174.5.1147; Lee PT, 2007, MOL BIOL CELL, V18, P5004, DOI 10.1091/mbc.E07-04-0384; LOSKUTOFF DJ, 1989, PROG HEMOST THROMB, V9, P87; Mbalaviele G, 2005, J CELL BIOCHEM, V94, P403, DOI 10.1002/jcb.20253; NAKABEPPU Y, 1991, CELL, V64, P751, DOI 10.1016/0092-8674(91)90504-R; NILSENHAMILTON M, 1982, CELL, V31, P237, DOI 10.1016/0092-8674(82)90423-8; Okada H, 1997, AM J PHYSIOL-RENAL, V273, pF563, DOI 10.1152/ajprenal.1997.273.4.F563; Paugh BS, 2008, FASEB J, V22, P455, DOI 10.1096/fj.07-8276com; Peiretti F, 1997, ARTERIOSCL THROM VAS, V17, P1550, DOI 10.1161/01.ATV.17.8.1550; RANGANATHAN G, 1990, J BIOL CHEM, V265, P3001; RHEINWALD JG, 1987, J CELL BIOL, V104, P263, DOI 10.1083/jcb.104.2.263; ROBERTS AB, 1985, P NATL ACAD SCI USA, V82, P119, DOI 10.1073/pnas.82.1.119; Saha Debabrata, 1999, Neoplasia (New York), V1, P508; Schluns KS, 1997, J IMMUNOL, V158, P2704; SCHNEIDER DJ, 1991, P NATL ACAD SCI USA, V88, P9959, DOI 10.1073/pnas.88.22.9959; SHAPIRO DJ, 1987, BIOESSAYS, V6, P221, DOI 10.1002/bies.950060507; Song JW, 2006, YONSEI MED J, V47, P201, DOI 10.3349/ymj.2006.47.2.201; SPRENGERS ED, 1987, BLOOD, V69, P381; Stern HM, 1997, DEVELOPMENT, V124, P3511; Stoll SW, 1999, BIOCHEM BIOPH RES CO, V265, P214, DOI 10.1006/bbrc.1999.1654; Stolz DB, 1997, J CELL PHYSIOL, V170, P57; THALACKER FW, 1992, BIOCHEM J, V287, P855, DOI 10.1042/bj2870855; THALACKER FW, 1987, J BIOL CHEM, V262, P2283; VANZONNEVELD AJ, 1988, P NATL ACAD SCI USA, V85, P5525; Verrecchia F, 2001, ONCOGENE, V20, P3332, DOI 10.1038/sj.onc.1204448; Watanabe A, 2001, CARDIOVASC RES, V51, P151, DOI 10.1016/S0008-6363(01)00274-7; Wilkins-Port CE, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/85208; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Xu Z, 2010, BLOOD, V115, P2038, DOI 10.1182/blood-2009-09-244962; Yang JW, 2002, J AM SOC NEPHROL, V13, P2464, DOI 10.1097/01.ASN.0000031827.16102.C1; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zhou S, 1998, MOL CELL, V2, P121, DOI 10.1016/S1097-2765(00)80120-3	48	5	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12520	12528		10.1074/jbc.M111.338079	http://dx.doi.org/10.1074/jbc.M111.338079			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334677	Green Published, hybrid			2022-12-25	WOS:000302782200091
J	Stocki, P; Wang, XN; Dickinson, AM				Stocki, Pawel; Wang, Xiao N.; Dickinson, Anne M.			Inducible Heat Shock Protein 70 Reduces T Cell Responses and Stimulatory Capacity of Monocyte-derived Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; TUMOR-NECROSIS-FACTOR; ANTIGEN PRESENTATION; EXTRACELLULAR HSP70; CROSS-PRESENTATION; BONE-MARROW; PATHWAY; CONTAMINATION; EXPRESSION; SIGNAL	Heat shock protein 70 (Hsp70) has gained a lot of attention in the past decade due to its potential immunoregulatory functions. Some of the described proinflammatory functions of Hsp70 became controversial as they were based on recombinant Hsp70 proteins specimens, which were later shown to be endotoxin-contaminated. In this study we used low endotoxin inducible Hsp70 (also known as Hsp72, HSPA1A), and we observed that after a 24-h incubation of monocyte-derived immature dendritic cells (mo-iDCs) with 20 mu g/ml of low endotoxin Hsp70, their ability to stimulate allogenic T cells was reduced. Interestingly, low endotoxin Hsp70 also significantly reduced T cell responses when they were simulated with either IL-2 or phytohemagglutinin, therefore showing that Hsp70 could alter T cell responses independently from its effect on mo-iDCs. We also reported a greater response of Hsp70 treatment when activated versus nonactivated T cells were used. This effect of Hsp70 was similar for all tested populations of T cells that included CD3(+), CD4(+), or CD8(+). Taken together, our observations strongly suggest that Hsp70 might dampen, rather than provoke, T cell-mediated inflammatory reactions in many clinical conditions where up-regulation of Hsp70 is observed.	[Stocki, Pawel; Wang, Xiao N.; Dickinson, Anne M.] Newcastle Univ, Inst Cellular Med, Dept Haematol Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Stocki, P (corresponding author), Univ Toronto, Dept Biochem, Med Sci Bldg,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	pawel.stocki@utoronto.ca			Leukaemia Research Fund, United Kingdom [04070]; Tyneside Leukaemia Research Fund, United Kingdom; European Commission "Trans-Net" [MRTN-CT-2004-512253]	Leukaemia Research Fund, United Kingdom; Tyneside Leukaemia Research Fund, United Kingdom; European Commission "Trans-Net"	This work was supported by Leukaemia Research Fund, United Kingdom, Grant 04070; a grant from the Tyneside Leukaemia Research Fund, United Kingdom; and European Commission "Trans-Net" Grant MRTN-CT-2004-512253.	Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Baba HA, 1997, TRANSPLANTATION, V64, P1035, DOI 10.1097/00007890-199710150-00016; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Bausinger H, 2002, EUR J IMMUNOL, V32, P3708, DOI 10.1002/1521-4141(200212)32:12<3708::AID-IMMU3708>3.0.CO;2-C; Bendz H, 2008, J BIOL CHEM, V283, P26477, DOI 10.1074/jbc.M803310200; Bendz H, 2007, J BIOL CHEM, V282, P31688, DOI 10.1074/jbc.M704129200; Binder RJ, 2000, J IMMUNOL, V165, P2582, DOI 10.4049/jimmunol.165.5.2582; Delneste Y, 2002, IMMUNITY, V17, P353, DOI 10.1016/S1074-7613(02)00388-6; Figueiredo C, 2009, BLOOD, V113, P3008, DOI 10.1182/blood-2008-06-162727; Gao BC, 2003, J BIOL CHEM, V278, P174, DOI 10.1074/jbc.M208742200; Hantschel M, 2000, CELL STRESS CHAPERON, V5, P438, DOI 10.1379/1466-1268(2000)005<0438:HPMEOP>2.0.CO;2; Henderson B, 2010, CELL STRESS CHAPERON, V15, P123, DOI 10.1007/s12192-009-0137-6; Jarvis M, 2003, TRANSPLANTATION, V76, P849, DOI 10.1097/01.TP.0000083556.73555.78; LI ZH, 1993, EMBO J, V12, P3143, DOI 10.1002/j.1460-2075.1993.tb05983.x; Ludwig D, 1999, DIGEST DIS SCI, V44, P1440, DOI 10.1023/A:1026616221950; Mambula SS, 2006, J IMMUNOL, V177, P7849, DOI 10.4049/jimmunol.177.11.7849; Motta A, 2007, IMMUNOLOGY, V121, P462, DOI 10.1111/j.1365-2567.2007.02564.x; MULTHOFF G, 1995, INT J CANCER, V61, P272, DOI 10.1002/ijc.2910610222; Njemini R, 2003, SCAND J IMMUNOL, V58, P664, DOI 10.1111/j.1365-3083.2003.01341.x; Panjwani NN, 2002, J IMMUNOL, V168, P2997, DOI 10.4049/jimmunol.168.6.2997; Pfister K, 2007, CANCER-AM CANCER SOC, V110, P926, DOI 10.1002/cncr.22864; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Stocki P, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.179630; Stocki P, 2010, CELL STRESS CHAPERON, V15, P729, DOI 10.1007/s12192-010-0184-z; Theriault JR, 2005, FEBS LETT, V579, P1951, DOI 10.1016/j.febslet.2005.02.046; Triantafilou K, 2001, NAT IMMUNOL, V2, P338, DOI 10.1038/86342; Triantafilou M, 2004, BIOCHEM SOC T, V32, P636, DOI 10.1042/BST0320636; UDONO H, 1993, J EXP MED, V178, P1391, DOI 10.1084/jem.178.4.1391; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; Ye ZY, 2007, J BIOL CHEM, V282, P4479, DOI 10.1074/jbc.M606802200; Zheng H., J BIOL CHEM, V285, P349	33	51	54	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12387	12394		10.1074/jbc.M111.307579	http://dx.doi.org/10.1074/jbc.M111.307579			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334699	Green Published, hybrid			2022-12-25	WOS:000302782200078
J	Antonopoulos, A; Demotte, N; Stroobant, V; Haslam, SM; van der Bruggen, P; Dell, A				Antonopoulos, Aristotelis; Demotte, Nathalie; Stroobant, Vincent; Haslam, Stuart M.; van der Bruggen, Pierre; Dell, Anne			Loss of Effector Function of Human Cytolytic T Lymphocytes Is Accompanied by Major Alterations in N- and O-Glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; ENDO-BETA-GALACTOSIDASE; ESCHERICHIA-FREUNDII; GLYCAN INTERACTIONS; CELL-RECEPTOR; HIGH-AFFINITY; CD8; ACTIVATION; BINDING; COMPLEX	Most human tumors are not eliminated by the immune system, and therapeutic vaccination shows poor results, a fact that can be explained at least partially by an immunosuppressive tumor microenvironment that is abundant in galectin-3. On cytolytic T lymphocyte (CTL) clones, maintained in culture by regular stimulation, recently activated CTLs present low effector functions. However, these functions are restored after a short treatment with LacNAc. The latter, which is in agreement with the glycoprotein-galectin lattice concept involving reduced motility, poses the question why galectin-3 ligands improve effector functions. We employed ultrasensitive MALDI-TOF-MS on resting and recently activated CTL clones combined with various glycosidase digestions and GC-MS linkage analyses. Our results showed that compared with the resting CTLs, the N-glycans of the recently activated CTLs consisted of (i) larger LacNAc oligomers of which a significant portion was longer than four-units and (ii) more multi-antennary structures. Interestingly, our results showed that the poly-LacNAc appeared to be equally distributed on all available N-glycan branches and not selectively enriched on a specific branch. The above structural alterations in the recently activated CTLs are expected to increase the galectin-3-LacNAc lattices and multivalent interactions and, therefore, reduce the motility of surface glycoproteins, such as the T-cell receptor. These findings suggest that the loss of effector functions on CTLs may be linked to reduced motility of surface glycoproteins. In addition, our results showed that recently activated CTLs had a reduced abundance of NeuAc alpha 2,6-linked N-glycans and an increased abundance of disialylated core 1 and monosialylated core 2 O-glycan structures.	[Antonopoulos, Aristotelis; Haslam, Stuart M.; Dell, Anne] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England; [Demotte, Nathalie; Stroobant, Vincent; van der Bruggen, Pierre] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Demotte, Nathalie; Stroobant, Vincent; van der Bruggen, Pierre] WELBIO, Ludwig Inst Canc Res, B-1200 Brussels, Belgium	Imperial College London; Universite Catholique Louvain; Ludwig Institute for Cancer Research; WELBIO	Dell, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, S Kensington Campus, London SW7 2AZ, England.	a.dell@imperial.ac.uk		Dell, Anne/0000-0003-1380-2347	Biotechnology and Biological Sciences Research Council [B19088, BBF0083091]; Fondation contre le Cancer (Belgium); Fonds de la Recherche Scientifique Medicale (Belgium)	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Fondation contre le Cancer (Belgium); Fonds de la Recherche Scientifique Medicale (Belgium)(Fonds de la Recherche Scientifique - FNRS)	This work was supported from Biotechnology and Biological Sciences Research Council Grants B19088 and BBF0083091 (to A. D. and S. M. H.). This work was also supported by grants from the Fondation contre le Cancer (Belgium) and Fonds de la Recherche Scientifique Medicale (Belgium) (to P. B.).	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Antonopoulos A, 2011, BIOCHEM SOC T, V39, P1334, DOI 10.1042/BST0391334; BARBER EK, 1989, P NATL ACAD SCI USA, V86, P3277, DOI 10.1073/pnas.86.9.3277; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Chen IJ, 2007, J BIOL CHEM, V282, P35361, DOI 10.1074/jbc.M706923200; CLEVERS H, 1988, ANNU REV IMMUNOL, V6, P629, DOI 10.1146/annurev.iy.06.040188.003213; Comelli EM, 2006, J IMMUNOL, V177, P2431, DOI 10.4049/jimmunol.177.4.2431; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; Dam TK, 2010, GLYCOBIOLOGY, V20, P1061, DOI 10.1093/glycob/cwq084; Daniels MA, 2001, IMMUNITY, V15, P1051, DOI 10.1016/S1074-7613(01)00252-7; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Demotte N, 2008, IMMUNITY, V28, P414, DOI 10.1016/j.immuni.2008.01.011; Demotte N, 2010, CANCER RES, V70, P7476, DOI 10.1158/0008-5472.CAN-10-0761; Earl LA, 2010, J BIOL CHEM, V285, P2242, DOI 10.1074/jbc.M109.066191; Friedl P, 2005, NAT REV IMMUNOL, V5, P532, DOI 10.1038/nri1647; FUKUDA MN, 1981, J BIOL CHEM, V256, P3900; Harlin H, 2006, CANCER IMMUNOL IMMUN, V55, P1185, DOI 10.1007/s00262-005-0118-2; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Irles C, 2003, NAT IMMUNOL, V4, P189, DOI 10.1038/ni877; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; Joo HG, 2001, J LEUKOCYTE BIOL, V69, P555; Kuball J, 2009, J EXP MED, V206, P463, DOI 10.1084/jem.20082487; Leppanen A, 2005, J BIOL CHEM, V280, P5549, DOI 10.1074/jbc.m412019200; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; LOBSANOV YD, 1993, J BIOL CHEM, V268, P27034; Merry AH, 2003, J BIOL CHEM, V278, P27119, DOI 10.1074/jbc.M213056200; Moody AM, 2003, J BIOL CHEM, V278, P7240, DOI 10.1074/jbc.M210468200; Moody AM, 2001, CELL, V107, P501, DOI 10.1016/S0092-8674(01)00577-3; NAKAGAWA H, 1980, J BIOL CHEM, V255, P5955; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Pace KE, 1999, J IMMUNOL, V163, P3801; PILLER F, 1988, J BIOL CHEM, V263, P15146; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; SATO T, 1993, BIOCHEMISTRY-US, V32, P12694, DOI 10.1021/bi00210a019; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Togayachi A, 2007, P NATL ACAD SCI USA, V104, P15829, DOI 10.1073/pnas.0707426104; VanderHove LE, 1997, CLIN EXP IMMUNOL, V109, P501, DOI 10.1046/j.1365-2249.1997.4771375.x; Wang SF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017621; Wieers Gregoire, 2011, Cancers (Basel), V3, P2904, DOI 10.3390/cancers3032904; Zippelius A, 2004, CANCER RES, V64, P2865, DOI 10.1158/0008-5472.CAN-03-3066	41	31	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11240	11251		10.1074/jbc.M111.320820	http://dx.doi.org/10.1074/jbc.M111.320820			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334653	Green Published, hybrid			2022-12-25	WOS:000302780100052
J	Linheiro, RS; Bergman, CM				Linheiro, Raquel S.; Bergman, Casey M.			Whole Genome Resequencing Reveals Natural Target Site Preferences of Transposable Elements in Drosophila melanogaster	PLOS ONE			English	Article							DNA; INSERTION; INTEGRATION; GENES; SEQUENCES; COMMON; SCREEN; FAMILY; HIV-1; RETROTRANSPOSON	Transposable elements are mobile DNA sequences that integrate into host genomes using diverse mechanisms with varying degrees of target site specificity. While the target site preferences of some engineered transposable elements are well studied, the natural target preferences of most transposable elements are poorly characterized. Using population genomic resequencing data from 166 strains of Drosophila melanogaster, we identified over 8,000 new insertion sites not present in the reference genome sequence that we used to decode the natural target preferences of 22 families of transposable element in this species. We found that terminal inverted repeat transposon and long terminal repeat retrotransposon families present clade-specific target site duplications and target site sequence motifs. Additionally, we found that the sequence motifs at transposable element target sites are always palindromes that extend beyond the target site duplication. Our results demonstrate the utility of population genomics data for high-throughput inference of transposable element targeting preferences in the wild and establish general rules for terminal inverted repeat transposon and long terminal repeat retrotransposon target site selection in eukaryotic genomes.	[Linheiro, Raquel S.; Bergman, Casey M.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Linheiro, RS (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	casey.bergman@manchester.ac.uk	Bergman, Casey/F-7854-2010	Bergman, Casey/0000-0002-5462-9854; Linheiro, Raquel/0000-0003-2659-0910	Fundacao para a Ciencia e a Tecnologia; Biotechnology and Biological Sciences Research Council [BB/E012868/1]; BBSRC [BB/E012868/1] Funding Source: UKRI	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Fundacao para a Ciencia e a Tecnologia fellowship (to Dr. Linheiro) and Biotechnology and Biological Sciences Research Council grant BB/E012868/1 (to Dr. Bergman). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GENOME COORDINATE SY; [Anonymous], DROSOPHILA GENETIC R; Beall EL, 1998, EMBO J, V17, P2122, DOI 10.1093/emboj/17.7.2122; BERNSTEIN M, 1995, GENETICS, V139, P631; Berry C, 2006, PLOS COMPUT BIOL, V2, P1450, DOI 10.1371/journal.pcbi.0020157; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Bowen NJ, 2001, GENOME RES, V11, P1527, DOI 10.1101/gr.164201; CHARLESWORTH B, 1989, ANNU REV GENET, V23, P251, DOI 10.1146/annurev.ge.23.120189.001343; COLLINS JJ, 1994, GENETICS, V137, P771; Craig N. L., 2002, MOBILE DNA, P3; Delelis O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000608; DUNSMUIR P, 1980, CELL, V21, P575, DOI 10.1016/0092-8674(80)90495-X; Eickbush TH, 2002, MOBILE DNA, P1111; Ellinghaus D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-18; ELLISON V, 1995, J BIOL CHEM, V270, P3320, DOI 10.1074/jbc.270.7.3320; FAWCETT DH, 1986, CELL, V47, P1007, DOI 10.1016/0092-8674(86)90815-9; Fiston-Lavier AS, 2010, NUCL ACIDS RES; Gawronski JD, 2009, P NATL ACAD SCI USA, V106, P16422, DOI 10.1073/pnas.0906627106; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Grandgenett DP, 2005, P NATL ACAD SCI USA, V102, P5903, DOI 10.1073/pnas.0502045102; Haren L, 1999, ANNU REV MICROBIOL, V53, P245, DOI 10.1146/annurev.micro.53.1.245; Holman AG, 2005, P NATL ACAD SCI USA, V102, P6103, DOI 10.1073/pnas.0501646102; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Kaminker JS, 2002, GENOME BIOL, V3, P0084, DOI DOI 10.1186/GB-2002-3-12-RFESEARCH84; Kapitonov VV, 2003, P NATL ACAD SCI USA, V100, P6569, DOI 10.1073/pnas.0732024100; Keng VW, 2009, NAT BIOTECHNOL, V27, P264, DOI 10.1038/nbt.1526; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kondrychyn I, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-418; Koudijs MJ, 2011, GENOME RES; Langridge GC, 2009, GENOME RES, V19, P2308, DOI 10.1101/gr.097097.109; Levy A, 2010, NUCLEIC ACIDS RES, V38, P1515, DOI 10.1093/nar/gkp1134; Liao GC, 2000, P NATL ACAD SCI USA, V97, P3347, DOI 10.1073/pnas.050017397; Linheiro RS, 2008, NUCLEIC ACIDS RES, V36, P6199, DOI 10.1093/nar/gkn563; Llorens C, 2011, NUCLEIC ACIDS RES, V39, pD70, DOI 10.1093/nar/gkq1061; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; MERRIMAN PJ, 1995, GENETICS, V141, P1425; Miyao A, 2003, PLANT CELL, V15, P1771, DOI 10.1105/tpc.012559; Moalic Y, 2006, J VIROL, V80, P10980, DOI 10.1128/JVI.00904-06; MORI I, 1988, P NATL ACAD SCI USA, V85, P861, DOI 10.1073/pnas.85.3.861; Nefedova LN, 2011, VIRUS GENES, V42, P297, DOI 10.1007/s11262-010-0566-4; O'Brochta DA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-108; OHARE K, 1983, CELL, V34, P25, DOI 10.1016/0092-8674(83)90133-2; Quesneville H, 2005, PLOS COMPUT BIOL, V1, P166, DOI 10.1371/journal.pcbi.0010022; Quinlan AR, 2010, GENOME RES, V20, P623, DOI 10.1101/gr.102970.109; Reiss D, 2003, MOL BIOL EVOL, V20, P869, DOI 10.1093/molbev/msg090; Richardson JM, 2009, CELL, V138, P1096, DOI 10.1016/j.cell.2009.07.012; Sackton TB, 2009, GENOME BIOL EVOL, V1, P449, DOI 10.1093/gbe/evp048; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Stewart C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002236; TUDOR M, 1992, MOL GEN GENET, V232, P126, DOI 10.1007/BF00299145; van Opijnen T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/nmeth.1377]; Vigdal TJ, 2002, J MOL BIOL, V323, P441, DOI 10.1016/S0022-2836(02)00991-9; Viggiano L, 1997, GENE, V197, P29, DOI 10.1016/S0378-1119(97)00217-5; Wang WC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-328; Whalen JH, 1998, MOL GEN GENET, V260, P401, DOI 10.1007/s004380050910; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Witherspoon DJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-410; Wu XL, 2005, J VIROL, V79, P5211, DOI 10.1128/JVI.79.8.5211-5214.2005; Zerjal T, 2009, PLANT MOL BIOL, V71, P99, DOI 10.1007/s11103-009-9511-0	61	75	77	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e30008	10.1371/journal.pone.0030008	http://dx.doi.org/10.1371/journal.pone.0030008			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347367	Green Published, Green Submitted, gold			2022-12-25	WOS:000302730200001
J	Rozas, D; Gullon, S; Mellado, RP				Rozas, Daniel; Gullon, Sonia; Mellado, Rafael P.			A Novel Two-Component System Involved in the Transition to Secondary Metabolism in Streptomyces coelicolor	PLOS ONE			English	Article							SUBTILIS FUNCTIONAL GENOMICS; BIOSYNTHETIC GENE-CLUSTER; PROTEINS; SEQUENCE; PROTEOME; MODEL; DEGU; SIPY	Background: Bacterial two-component signal transduction regulatory systems are the major set of signalling proteins frequently mediating responses to changes in the environment. They typically consist of a sensor, a membrane-associated histidine kinase and a cytoplasmic response regulator. The membrane-associated sensor detects the environmental signal or stress, whereas the cytoplasmic regulatory protein controls the cellular response usually by gene transcription modulation. Methodology/PrincipalFindings: The Streptomyces coelicolor two genes operon SCO5784-SCO5785 encodes a two-component system, where SCO5784 encodes a histidine-kinase sensor and SCO5785 encodes a response regulator protein. When the expression level of the regulator gene decreases, the antibiotic synthesis and sporulation is delayed temporarily in addition to some ribosomal genes became up regulated, whereas the propagation of the regulatory gene in high copy number results in the earlier synthesis of antibiotics and sporulation, as well as the down regulation of some ribosomal genes and, moreover, in the overproduction of several extracellular proteins. Therefore, this two-component system in S. coelicolor seems to influence various processes characterised by the transition from primary to secondary metabolism, as determined by proteomic and transcriptomic analyses. Conclusions/Significance: Propagation of SCO5785 in multicopy enhances the production of antibiotics as well as secretory proteins. In particular, the increase in the expression level of secretory protein encoding genes, either as an artefactual or real effect of the regulator, could be of potential usefulness when using Streptomyces strains as hosts for homologous or heterologous extracellular protein production.	[Rozas, Daniel; Gullon, Sonia; Mellado, Rafael P.] Ctr Nacl Biotecnol CSIC, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Rozas, D (corresponding author), Ctr Nacl Biotecnol CSIC, Madrid, Spain.	rpmellado@cnb.csic.es	Gullón, Sonia/P-7460-2018; Mellado, Rafael P/D-2680-2009	Rozas, Daniel/0000-0003-2418-0926	Spanish Ministry of Science and Innovation [BIO2003-03948, BIO2006-12762]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grants BIO2003-03948 and BIO2006-12762 from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Chater KF, 1998, MICROBIOL-UK, V144, P1465, DOI 10.1099/00221287-144-6-1465; Escutia MR, 2006, PROTEOMICS, V6, P4137, DOI 10.1002/pmic.200500927; Eymann C, 2002, J BACTERIOL, V184, P2500, DOI 10.1128/JB.184.9.2500-2520.2002; FERNANDEZMORENO MA, 1994, J BIOL CHEM, V269, P24854; GIBERT M, 1995, CRIT REV BIOTECHNOL, V15, P13, DOI 10.3109/07388559509150530; Gordon ND, 2008, J BACTERIOL, V190, P894, DOI 10.1128/JB.01759-07; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Hesketh A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r161; HOBBS G, 1989, APPL MICROBIOL BIOT, V31, P272; Hodgson DA, 2000, ADV MICROB PHYSIOL, V42, P47, DOI 10.1016/S0065-2911(00)42003-5; Hopwood D. A., 1985, GENETIC MANIPULATION; Hutchings MI, 2004, MICROBIOL-SGM, V150, P2795, DOI 10.1099/mic.0.27181-0; Hyyrylainen HL, 2005, APPL MICROBIOL BIOT, V67, P389, DOI 10.1007/s00253-005-1898-1; Ichinose K, 1998, CHEM BIOL, V5, P647, DOI 10.1016/S1074-5521(98)90292-7; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; KOJIMA S, 1990, PROTEIN ENG, V3, P527; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leroy B, 2010, PROTEOMICS, V10, P2281, DOI 10.1002/pmic.200900286; Lopez-Ferrer D, 2004, ANAL CHEM, V76, P6853, DOI 10.1021/ac049305c; Mader U, 2002, MOL GENET GENOMICS, V268, P455, DOI 10.1007/s00438-002-0774-2; MartinezCosta OH, 1996, J BIOL CHEM, V271, P10627, DOI 10.1074/jbc.271.18.10627; McArthur M, 2008, P NATL ACAD SCI USA, V105, P1020, DOI 10.1073/pnas.0710724105; Ogura M, 2001, NUCLEIC ACIDS RES, V29, P3804, DOI 10.1093/nar/29.18.3804; Paget MSB, 1999, MOL MICROBIOL, V33, P97, DOI 10.1046/j.1365-2958.1999.01452.x; Palacin A, 2002, J BACTERIOL, V184, P4875, DOI 10.1128/JB.184.17.4875-4880.2002; Pang XH, 2004, ANTIMICROB AGENTS CH, V48, P575, DOI 10.1128/AAC.48.2.575-588.2004; Paradela A, 2010, TALANTA, V80, P1496, DOI 10.1016/j.talanta.2009.06.083; Rabilloud T, 1998, ELECTROPHORESIS, V19, P758, DOI 10.1002/elps.1150190526; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sun JH, 2001, J BACTERIOL, V183, P3488, DOI 10.1128/JB.183.11.3488-3498.2001; Widdick DA, 2006, P NATL ACAD SCI USA, V103, P17927, DOI 10.1073/pnas.0607025103; Xu DL, 2010, APPL ENVIRON MICROB, V76, P7741, DOI 10.1128/AEM.00819-10	36	20	22	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31760	10.1371/journal.pone.0031760	http://dx.doi.org/10.1371/journal.pone.0031760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347508	Green Submitted, Green Published, gold			2022-12-25	WOS:000302730200036
J	Eixarch, E; Batalle, D; Illa, M; Munoz-Moreno, E; Arbat-Plana, A; Amat-Roldan, I; Figueras, F; Gratacos, E				Eixarch, Elisenda; Batalle, Dafnis; Illa, Miriam; Munoz-Moreno, Emma; Arbat-Plana, Ariadna; Amat-Roldan, Ivan; Figueras, Francesc; Gratacos, Eduard			Neonatal Neurobehavior and Diffusion MRI Changes in Brain Reorganization Due to Intrauterine Growth Restriction in a Rabbit Model	PLOS ONE			English	Article							WHITE-MATTER INJURY; AGE TERM FETUSES; PRETERM INFANTS; CEREBRAL-PALSY; HUMAN NEWBORN; RAT MODEL; FETAL; RETARDATION; PREMATURE; CHILDREN	Background: Intrauterine growth restriction (IUGR) affects 5-10% of all newborns and is associated with a high risk of abnormal neurodevelopment. The timing and patterns of brain reorganization underlying IUGR are poorly documented. We developed a rabbit model of IUGR allowing neonatal neurobehavioral assessment and high resolution brain diffusion magnetic resonance imaging (MRI). The aim of the study was to describe the pattern and functional correlates of fetal brain reorganization induced by IUGR. Methodology/Principal Findings: IUGR was induced in 10 New Zealand fetal rabbits by ligation of 40-50% of uteroplacental vessels in one horn at 25 days of gestation. Ten contralateral horn fetuses were used as controls. Cesarean section was performed at 30 days (term 31 days). At postnatal day +1, neonates were assessed by validated neurobehavioral tests including evaluation of tone, spontaneous locomotion, reflex motor activity, motor responses to olfactory stimuli, and coordination of suck and swallow. Subsequently, brains were collected and fixed and MRI was performed using a high resolution acquisition scheme. Global and regional (manual delineation and voxel based analysis) diffusion tensor imaging parameters were analyzed. IUGR was associated with significantly poorer neurobehavioral performance in most domains. Voxel based analysis revealed fractional anisotropy (FA) differences in multiple brain regions of gray and white matter, including frontal, insular, occipital and temporal cortex, hippocampus, putamen, thalamus, claustrum, medial septal nucleus, anterior commissure, internal capsule, fimbria of hippocampus, medial lemniscus and olfactory tract. Regional FA changes were correlated with poorer outcome in neurobehavioral tests. Conclusions: IUGR is associated with a complex pattern of brain reorganization already at birth, which may open opportunities for early intervention. Diffusion MRI can offer suitable imaging biomarkers to characterize and monitor brain reorganization due to fetal diseases.	[Eixarch, Elisenda; Batalle, Dafnis; Illa, Miriam; Munoz-Moreno, Emma; Arbat-Plana, Ariadna; Amat-Roldan, Ivan; Figueras, Francesc; Gratacos, Eduard] Hosp Clin Barcelona, ICGON, Dept Maternal Fetal Med, Barcelona, Spain; [Eixarch, Elisenda; Batalle, Dafnis; Illa, Miriam; Munoz-Moreno, Emma; Arbat-Plana, Ariadna; Amat-Roldan, Ivan; Figueras, Francesc; Gratacos, Eduard] Univ Barcelona, IDIBAPS, Barcelona, Spain; [Eixarch, Elisenda; Batalle, Dafnis; Illa, Miriam; Munoz-Moreno, Emma; Arbat-Plana, Ariadna; Amat-Roldan, Ivan; Figueras, Francesc; Gratacos, Eduard] CIBERER, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Eixarch, E (corresponding author), Hosp Clin Barcelona, ICGON, Dept Maternal Fetal Med, Barcelona, Spain.	egratacos@clinic.ub.es	Gratacos, Eduard/AAR-4939-2020; Muñoz-Moreno, Emma/A-2363-2016; Muñoz-Moreno, Emma/ABD-6424-2021; Batalle, Dafnis/C-1718-2013; Batalle, Dafnis/H-7531-2019	Gratacos, Eduard/0000-0002-7405-7224; Muñoz-Moreno, Emma/0000-0003-2104-7265; Muñoz-Moreno, Emma/0000-0003-2104-7265; Batalle, Dafnis/0000-0003-2097-979X; Batalle, Dafnis/0000-0003-2097-979X; Eixarch, Elisenda/0000-0001-7379-9608; Illa, Miriam/0000-0002-8366-830X; Arbat-Plana, Ariadna/0000-0003-0479-8323	Fondo the Investigacion Sanitaria (Spain) [PI/060347]; Obra Social La Caixa (Barcelona, Spain); Carlos III Institute of Health (Spain) [CM08/00105]; Hospital Clinic (Barcelona, Spain)	Fondo the Investigacion Sanitaria (Spain)(Instituto de Salud Carlos III); Obra Social La Caixa (Barcelona, Spain)(La Caixa Foundation); Carlos III Institute of Health (Spain)(Instituto de Salud Carlos III); Hospital Clinic (Barcelona, Spain)	This work was supported by Fondo the Investigacion Sanitaria (PI/060347) (Spain), Obra Social La Caixa (Barcelona, Spain); Rio Hortega grant from Carlos III Institute of Health (Spain) [CM08/00105 to E.E.] and Emili Letang fellowship by Hospital Clinic (Barcelona, Spain) [to M.I.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2010, NEURORADIOLOGY, V52, P699, DOI 10.1007/s00234-010-0716-3; Baschat AA, 2004, OBSTET GYNECOL SURV, V59, P617, DOI 10.1097/01.OGX.0000133943.54530.76; Bassan H, 2000, PEDIATR NEPHROL, V15, P192, DOI 10.1007/s004670000457; Bassan H, 2011, PEDIATR NEUROL, V44, P122, DOI 10.1016/j.pediatrneurol.2010.09.012; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Berman J I, 2011, AJNR Am J Neuroradiol, V32, pE21, DOI 10.3174/ajnr.A1975; D'Arceuil H, 2008, DEV NEUROSCI-BASEL, V30, P262, DOI 10.1159/000110503; Derrick M, 2004, J NEUROSCI, V24, P24, DOI 10.1523/JNEUROSCI.2816-03.2004; Derrick M, 2007, STROKE, V38, P731, DOI 10.1161/01.STR.0000251445.94697.64; Derrick M, 2009, INT J DEV NEUROSCI, V27, P549, DOI 10.1016/j.ijdevneu.2009.06.008; Dieni S, 2003, J NEUROBIOL, V55, P41, DOI 10.1002/neu.10194; Drobyshevsky A, 2007, J CEREBR BLOOD F MET, V27, P270, DOI 10.1038/sj.jcbfm.9600333; Drobyshevsky A, 2006, NEUROIMAGE, V32, P1106, DOI 10.1016/j.neuroimage.2006.06.002; Dubois J, 2008, BRAIN, V131, P2028, DOI 10.1093/brain/awn137; Eixarch E, 2011, PLACENTA, V32, P304, DOI 10.1016/j.placenta.2011.01.014; Eixarch E, 2009, FETAL DIAGN THER, V26, P203, DOI 10.1159/000264063; Eixarch E, 2008, ULTRASOUND OBST GYN, V32, P894, DOI 10.1002/uog.6249; Esteban FJ, 2010, NEUROIMAGE, V53, P1225, DOI 10.1016/j.neuroimage.2010.07.019; Feldman R, 2006, PEDIATRICS, V118, pE869, DOI 10.1542/peds.2005-2040; Figueras F, 2009, PEDIATRICS, V124, pE934, DOI 10.1542/peds.2008-3346; Geva R, 2006, BRAIN RES, V1117, P186, DOI 10.1016/j.brainres.2006.08.004; Geva R, 2006, PEDIATRICS, V118, P91, DOI 10.1542/peds.2005-2343; Huppi PS, 1998, PEDIATR RES, V44, P584; Jiang SZ, 2009, MAGN RESON MED, V62, P645, DOI 10.1002/mrm.22032; Jones DK, 2002, NEUROIMAGE, V17, P592, DOI 10.1006/nimg.2002.1148; Kasprian G, 2008, NEUROIMAGE, V43, P213, DOI 10.1016/j.neuroimage.2008.07.026; Kochunov P, 2010, NEUROBIOLOG IN PRESS; Lee JE, 2009, NEUROIMAGE, V44, P870, DOI 10.1016/j.neuroimage.2008.09.041; Leitner Y, 2007, J CHILD NEUROL, V22, P580, DOI 10.1177/0883073807302605; Lodygensky GA, 2008, PEDIATR RES, V63, P438, DOI 10.1203/PDR.0b013e318165c005; Lodygensky GA, 2008, INT J DEV NEUROSCI, V26, P13, DOI 10.1016/j.ijdevneu.2007.08.018; Mallard C, 2000, NEUROSCIENCE, V100, P327, DOI 10.1016/S0306-4522(00)00271-2; Mallard EC, 1998, PEDIATR RES, V43, P262, DOI 10.1203/00006450-199802000-00018; Mattes D, 2001, PROC SPIE, V4322, P1609, DOI 10.1117/12.431046; McCarton CM, 1996, PEDIATRICS, V98, P1167; Merino JG, 2010, NAT REV NEUROL, V6, P560, DOI 10.1038/nrneurol.2010.129; Miller KL, 2011, NEUROIMAGE, V57, P167, DOI 10.1016/j.neuroimage.2011.03.070; Miller SP, 2007, NEW ENGL J MED, V357, P1928, DOI 10.1056/NEJMoa067393; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Neil J, 2002, NMR BIOMED, V15, P543, DOI 10.1002/nbm.784; Neil JJ, 1998, RADIOLOGY, V209, P57, DOI 10.1148/radiology.209.1.9769812; NITSOS I, 1990, INT J DEV NEUROSCI, V8, P233, DOI 10.1016/0736-5748(90)90029-2; Olivier P, 2007, NEUROBIOL DIS, V26, P253, DOI 10.1016/j.nbd.2007.01.001; Padilla N, 2011, BRAIN RES, V1382, P98, DOI 10.1016/j.brainres.2011.01.032; Pallotto EK, 2006, CLIN OBSTET GYNECOL, V49, P257, DOI 10.1097/00003081-200606000-00008; Rees S, 2008, INT J DEV NEUROSCI, V26, P3, DOI 10.1016/j.ijdevneu.2007.08.020; Rees S, 2011, INT J DEV NEUROSCI, V29, P551, DOI 10.1016/j.ijdevneu.2011.04.004; Rivers CS, 2005, CEREBROVASC DIS, V19, P328, DOI 10.1159/000084691; ROYSTON P, 1993, STAT MED, V12, P181, DOI 10.1002/sim.4780120209; Saadani-Makki F, 2009, J CHILD NEUROL, V24, P1179, DOI 10.1177/0883073809338213; Saadani-Makki F, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.090; Sanz-Cortes M, 2010, ULTRASOUND OBST GYN, V36, P159, DOI 10.1002/uog.7724; Scherjon S, 2000, PEDIATRICS, V105, P385, DOI 10.1542/peds.105.2.385; Shedeed SA, 2011, PEDIATR CARDIOL, V32, P47, DOI 10.1007/s00246-010-9813-7; Sizonenko SPV, 2007, CEREB CORTEX, V17, P2609, DOI 10.1093/cercor/bhl168; Snook L, 2007, NEUROIMAGE, V34, P243, DOI 10.1016/j.neuroimage.2006.07.021; Sun SW, 2003, MAGN RESON MED, V50, P743, DOI 10.1002/mrm.10605; Tolcos M, 2011, EXP NEUROL, V232, P53, DOI 10.1016/j.expneurol.2011.08.002; Tolsa CB, 2004, PEDIATR RES, V56, P132, DOI 10.1203/01.PDR.0000128983.54614.7E; Toussaint N., 2007, P MICCAI 07 WORKSH I; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Tyszka JM, 2006, NEUROIMAGE, V29, P1058, DOI 10.1016/j.neuroimage.2005.08.037; Val-Laillet D, 2008, APPL ANIM BEHAV SCI, V111, P173, DOI 10.1016/j.applanim.2007.06.003; Van Camp N, 2009, NMR BIOMED, V22, P697, DOI 10.1002/nbm.1381; Vercauteren T, 2009, NEUROIMAGE, V45, pS61, DOI 10.1016/j.neuroimage.2008.10.040; Walker DM, 2008, ARCH DIS CHILD-FETAL, V93, pF322, DOI 10.1136/adc.2007.120485; Wang SL, 2008, STROKE, V39, P2348, DOI 10.1161/STROKEAHA.107.509927; Westin CF, 2002, MED IMAGE ANAL, V6, P93, DOI 10.1016/S1361-8415(02)00053-1; WIMBERGER DM, 1995, J COMPUT ASSIST TOMO, V19, P28, DOI 10.1097/00004728-199501000-00005; Zhan L, 2008, 13 ANN M ORG HUM BRA	70	64	65	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31497	10.1371/journal.pone.0031497	http://dx.doi.org/10.1371/journal.pone.0031497			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347486	Green Published, gold, Green Submitted			2022-12-25	WOS:000302730100075
J	Frazier-Wood, AC; Kabagambe, EK; Borecki, IB; Tiwari, HK; Ordovas, JM; Arnett, DK				Frazier-Wood, Alexis C.; Kabagambe, Edmond K.; Borecki, Ingrid B.; Tiwari, Hemant K.; Ordovas, Jose M.; Arnett, Donna K.			Preliminary Evidence for an Association between LRP-1 Genotype and Body Mass Index in Humans	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; CORONARY-ARTERY-DISEASE; LDL RECEPTOR; PLASMA-LIPOPROTEINS; CZECH POPULATION; PROTEIN; POLYMORPHISMS; MODULATION; EXPRESSION; OBESITY	Background/Aims: The LDL receptor-related protein-1 gene (LRP-1) has been associated with obesity in animal models, but no such association has yet been reported in humans. As data suggest this increase in fat mass may be mediated through a mechanism involving the clearance of plasma triglyceride-rich lipoproteins (TGRL), where the LRP interacts with apolipoprotein E (ApoE) on chylomicron remnants, we aimed to examine (1) whether there was an association between 3 single nucleotide polymorphisms (SNPs) on LRP-1 with body mass index (BMI) and (2) whether any association between LRP-1 SNPs and BMI could be modified by polymorphisms on the ApoE gene when comparing the wild type epsilon 3/epsilon 3 genotype against mutant ApoE allele (epsilon 2/epsilon 4) carriers. Methods/Results: We used data from 1,036 men and women (mean age +/- SD = 49 +/- 16 y) participating in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) Study. Mixed linear models, which controlled for age, sex, alcohol intake and smoking, as well as family pedigree and center of data collection were calculated. Models that used LRP-1 genotype as a predictor of BMI revealed that individuals who were homozygous for the minor allele at the LRP-1 I10701 locus had BMIs, on average, 1.03 kg/m(2) higher than major allele carriers (P = 0.03). In subsequent mixed linear models that included main effects of LRP-1 I10701 SNP and ApoE alleles, and an interaction term the two genotypes, there was no interaction detected between the LRP-1 I70701 genotype with either the ApoE epsilon 2 or epsilon 4 allele carriers (P>0.05). Conclusions: This has implications for starting to understand pathways from genotype to human BMI, which may operate through TGRL uptake at the LRP-1 receptor. This may pave the way for future research into individualized dietary interventions.	[Frazier-Wood, Alexis C.; Kabagambe, Edmond K.; Arnett, Donna K.] Univ Alabama, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; [Frazier-Wood, Alexis C.; Tiwari, Hemant K.] Univ Alabama, Sch Publ Hlth, Sect Stat Genet, Birmingham, AL 35294 USA; [Frazier-Wood, Alexis C.] Univ Alabama, Sch Publ Hlth, Off Energet, Birmingham, AL 35294 USA; [Kabagambe, Edmond K.; Arnett, Donna K.] Univ Alabama, Sch Publ Hlth, Nutr Obes Res Ctr, Birmingham, AL 35294 USA; [Borecki, Ingrid B.] Washington Univ, Sch Med, Dept Genet, Div Stat Genom, St Louis, MO 63110 USA; [Ordovas, Jose M.] Tufts Univ, Human Nutr Res Ctr Aging, Jean Mayer US Dept Agr, Nutr & Genom Lab, Boston, MA 02111 USA; [Ordovas, Jose M.] CNIC, Dept Epidemiol & Populat Genet, Madrid, Spain; [Ordovas, Jose M.] IMDEA Food, Madrid, Spain	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Washington University (WUSTL); Tufts University; United States Department of Agriculture (USDA); Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Frazier-Wood, AC (corresponding author), Univ Alabama, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA.	LekkiWood@Gmail.com	Wood, Lekki/B-8053-2010; Ordovas, Jose/B-8727-2013	Wood, Lekki/0000-0001-7616-2119; Ordovas, Jose/0000-0002-7581-5680; Kabagambe, Edmond/0000-0002-8993-3186	National Heart, Lung, and Blood Institute (NHLBI) [U01HL072524]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072524] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by National Heart, Lung, and Blood Institute (NHLBI) grant number U01HL072524. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benes P, 2002, HUM BIOL, V74, P129, DOI 10.1353/hub.2002.0001; Benes P, 2001, J MOL MED-JMM, V79, P116, DOI 10.1007/s001090100196; DALLONGEVILLE J, 1992, J LIPID RES, V33, P447; DANIEL TO, 1983, J BIOL CHEM, V258, P4606; HERZ J, 1990, J BIOL CHEM, V265, P21355; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; Kabagambe EK, 2009, ATHEROSCLEROSIS, V203, P633, DOI 10.1016/j.atherosclerosis.2008.08.005; KROON PA, 1984, BIOCHEM J, V223, P329, DOI 10.1042/bj2230329; Liu QA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000575; Mamo JCL, 2001, AM J PHYSIOL-ENDOC M, V281, pE626, DOI 10.1152/ajpendo.2001.281.3.E626; Masson O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007422; Peters BJ, 2011, ATHEROSCLEROSIS, V2011, P1879; Pocathikorn A, 2003, ATHEROSCLEROSIS, V168, P115, DOI 10.1016/S0021-9150(03)00087-X; Schreyer SA, 2002, AM J PHYSIOL-ENDOC M, V282, pE207, DOI 10.1152/ajpendo.2002.282.1.E207; Spilke J, 2005, J AGRON CROP SCI, V191, P47, DOI 10.1111/j.1439-037X.2004.00120.x; STEINMETZ A, 1989, ARTERIOSCLEROSIS, V9, P405, DOI 10.1161/01.ATV.9.3.405; Terrand J, 2009, J BIOL CHEM, V284, P381, DOI 10.1074/jbc.M806538200	17	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30732	10.1371/journal.pone.0030732	http://dx.doi.org/10.1371/journal.pone.0030732			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347399	Green Published, gold, Green Submitted			2022-12-25	WOS:000302730100023
J	Moumne, L; Campbell, K; Howland, D; Ouyang, YB; Bates, GP				Moumne, Lara; Campbell, Ken; Howland, David; Ouyang, Yingbin; Bates, Gillian P.			Genetic Knock-Down of Hdac3 Does Not Modify Disease-Related Phenotypes in a Mouse Model of Huntington's Disease	PLOS ONE			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; SUBEROYLANILIDE HYDROXAMIC ACID; HISTONE DEACETYLASE 3; MOTOR DEFICITS; MICE; R6/2; HD; AGGREGATION; INHIBITION; EXPRESSION	Huntington's disease (HD) is an autosomal dominant progressive neurodegenerative disorder caused by an expansion of a CAG/polyglutamine repeat for which there are no disease modifying treatments. In recent years, transcriptional dysregulation has emerged as a pathogenic process that appears early in disease progression and has been recapitulated across multiple HD models. Altered histone acetylation has been proposed to underlie this transcriptional dysregulation and histone deacetylase (HDAC) inhibitors, such as suberoylanilide hydroxamic acid (SAHA), have been shown to improve polyglutamine-dependent phenotypes in numerous HD models. However potent pan-HDAC inhibitors such as SAHA display toxic side-effects. To better understand the mechanism underlying this potential therapeutic benefit and to dissociate the beneficial and toxic effects of SAHA, we set out to identify the specific HDAC(s) involved in this process. For this purpose, we are exploring the effect of the genetic reduction of specific HDACs on HD-related phenotypes in the R6/2 mouse model of HD. The study presented here focuses on HDAC3, which, as a class I HDAC, is one of the preferred targets of SAHA and is directly involved in histone deacetylation. To evaluate a potential benefit of Hdac3 genetic reduction in R6/2, we generated a mouse carrying a critical deletion in the Hdac3 gene. We confirmed that the complete knock-out of Hdac3 is embryonic lethal. To test the effects of HDAC3 inhibition, we used Hdac3(+/-) heterozygotes to reduce nuclear HDAC3 levels in R6/2 mice. We found that Hdac3 knock-down does not ameliorate physiological or behavioural phenotypes and has no effect on molecular changes including dysregulated transcripts. We conclude that HDAC3 should not be considered as the major mediator of the beneficial effect induced by SAHA and other HDAC inhibitors in HD.	[Moumne, Lara; Bates, Gillian P.] Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England; [Campbell, Ken; Ouyang, Yingbin] Taconic, Cranbury, NJ USA; [Howland, David] CHDI Management CHDI Fdn, Princeton, NJ USA	University of London; King's College London	Moumne, L (corresponding author), Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England.	gillian.bates@kcl.ac.uk	Bates, Gillian/E-1146-2012	Bates, Gillian/0000-0002-4041-6305	CHDI Foundation	CHDI Foundation	This work was funded by CHDI Foundation, a privately-funded non-profit biomedical research organization exclusively dedicated to discovering and developing therapeutics that slow the progression of Huntington's disease. DH was involved in the design and generation of the Hdac3 KO mouse. With the exception of this, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Bardai FH, 2011, J NEUROSCI, V31, P1746, DOI 10.1523/JNEUROSCI.5704-10.2011; Bates EA, 2006, J NEUROSCI, V26, P2830, DOI 10.1523/JNEUROSCI.3344-05.2006; BATES G, 2002, HUNTINGTONS DIS; Benn CL, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-17; Benn CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005747; Bhaskara S, CANC CELL, V18, P436; Bobrowska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020696; Broide RS, 2007, J MOL NEUROSCI, V31, P47, DOI 10.1007/BF02686117; Carter RJ, 1999, J NEUROSCI, V19, P3248; Cha JHJ, 2007, PROG NEUROBIOL, V83, P228, DOI 10.1016/j.pneurobio.2007.03.004; Codd R, 2009, INT J BIOCHEM CELL B, V41, P736, DOI 10.1016/j.biocel.2008.05.026; Crook ZR, 2011, NEURON, V69, P423, DOI 10.1016/j.neuron.2010.12.035; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Gardian G, 2005, J BIOL CHEM, V280, P556, DOI 10.1074/jbc.M410210200; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Hockly E, 2006, NEUROBIOL DIS, V21, P228, DOI 10.1016/j.nbd.2005.07.007; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Hockly E, 2003, BRAIN RES BULL, V61, P469, DOI 10.1016/S0361-9230(03)00185-0; Ko J, 2001, BRAIN RES BULL, V56, P319, DOI 10.1016/S0361-9230(01)00599-8; Kuhn A, 2007, HUM MOL GENET, V16, P1845, DOI 10.1093/hmg/ddm133; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Lione LA, 1999, J NEUROSCI, V19, P10428; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; McQuown SC, 2011, J NEUROSCI, V31, P764, DOI 10.1523/JNEUROSCI.5052-10.2011; Mielcarek M, 2011, PLOS ONE IN PRESS; Moffitt H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008025; Montgomery RL, 2008, J CLIN INVEST, V118, P3588, DOI 10.1172/JCI35847; Pallos J, 2008, HUM MOL GENET, V17, P3767, DOI 10.1093/hmg/ddn273; Ryu H, 2003, P NATL ACAD SCI USA, V100, P4281, DOI 10.1073/pnas.0737363100; Sadri-Vakili G, 2007, HUM MOL GENET, V16, P1293, DOI 10.1093/hmg/ddm078; Salisbury CM, 2007, P NATL ACAD SCI USA, V104, P1171, DOI 10.1073/pnas.0608659104; Sathasivam K, 2001, HUM MOL GENET, V10, P2425, DOI 10.1093/hmg/10.21.2425; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Schuettengruber B, 2003, MOL CELL BIOL, V23, P6993, DOI 10.1128/MCB.23.19.6993-7004.2003; Soriano FX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021056; Stack EC, 2005, J COMP NEUROL, V490, P354, DOI 10.1002/cne.20680; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Thomas EA, 2008, P NATL ACAD SCI US; Woodman B, 2007, BRAIN RES BULL, V72, P83, DOI 10.1016/j.brainresbull.2006.11.004; Xu CP, 2009, CHEM BIOL, V16, P980, DOI 10.1016/j.chembiol.2009.07.010; Yang WM, 2002, J BIOL CHEM, V277, P9447, DOI 10.1074/jbc.M105993200; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346	49	46	47	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31080	10.1371/journal.pone.0031080	http://dx.doi.org/10.1371/journal.pone.0031080			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347433	Green Submitted, Green Published, gold			2022-12-25	WOS:000302730100041
J	Ren, LC; Wang, Y; Shi, ML; Wang, XN; Yang, Z; Zhao, ZH				Ren, Licheng; Wang, Yang; Shi, Minglei; Wang, Xiaoning; Yang, Zhong; Zhao, Zhihu			CTCF Mediates the Cell-Type Specific Spatial Organization of the Kcnq5 Locus and the Local Gene Regulation	PLOS ONE			English	Article							CHROMOSOME CONFORMATION; NUCLEAR-ORGANIZATION; HUMAN GENOME; CHROMATIN INTERACTIONS; EXPRESSION; CHANNELS; COHESIN	Chromatin loops play important roles in the dynamic spatial organization of genes in the nucleus. Growing evidence has revealed that the multivalent functional zinc finger protein CCCTC-binding factor (CTCF) is a master regulator of genome spatial organization, and mediates the ubiquitous chromatin loops within the genome. Using circular chromosome conformation capture (4C) methodology, we discovered that CTCF may be a master organizer in mediating the spatial organization of the kcnq5 gene locus. We characterized the cell-type specific spatial organization of the kcnq5 gene locus mediated by CTCF in detail using chromosome conformation capture (3C) and 3C-derived techniques. Cohesion also participated in mediating the organization of this locus. RNAi-mediated knockdown of CTCF sharply diminished the interaction frequencies between the chromatin loops of the kcnq5 gene locus and down-regulated local gene expression. Functional analysis showed that the interacting chromatin loops of the kcnq5 gene locus can repress the gene expression in a luciferase reporter assay. These interacting chromatin fragments were a series of repressing elements whose contacts were mediated by CTCF. Therefore, these findings suggested that the dynamical spatial organization of the kcnq5 locus regulates local gene expression.	[Ren, Licheng; Wang, Xiaoning; Yang, Zhong] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China; [Wang, Yang; Shi, Minglei; Zhao, Zhihu] Beijing Inst Biotechnol, Beijing, Peoples R China; [Wang, Xiaoning; Yang, Zhong] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Wang, Xiaoning; Yang, Zhong] Fudan Univ, Sch Life Sci, Dept Microbiol & Microbial Engn, Shanghai 200433, Peoples R China	East China University of Science & Technology; Fudan University; Fudan University	Ren, LC (corresponding author), Hainan Med Coll, Dept Biol, Haikou, Hainan, Peoples R China.	xnwang88@gmail.com; yangzzh@163.com; zhaozh@nic.bmi.ac.cn	yang, zhong/E-9993-2012		National Natural Science Foundation of China [30871374, 31071119, 31030026]; National Key Basis Research Program of China (973) [2009CB825602]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basis Research Program of China (973)	The project was supported by the National Natural Science Foundation of China (30871374, 31071119, 31030026), National Key Basis Research Program of China (973) (2009CB825602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Ekberg J, 2007, J BIOL CHEM, V282, P12135, DOI 10.1074/jbc.M609385200; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Fullwood MJ, 2009, J CELL BIOCHEM, V107, P30, DOI 10.1002/jcb.22116; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Gondor A, 2008, NAT PROTOC, V3, P303, DOI 10.1038/nprot.2007.540; Gondor A, 2009, NATURE, V461, P212, DOI 10.1038/nature08453; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hogan GJ, 2006, PLOS GENET, V2, P1433, DOI 10.1371/journal.pgen.0020158; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Hu H, 2007, J NEUROSCI, V27, P1853, DOI 10.1523/JNEUROSCI.4463-06.2007; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kumaran RI, 2008, CELL, V132, P929, DOI 10.1016/j.cell.2008.03.004; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Majumder P, 2008, J EXP MED, V205, P785, DOI 10.1084/jem.20071843; Majumder P, 2006, J BIOL CHEM, V281, P18435, DOI 10.1074/jbc.M601298200; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Ohlsson R, 2010, BIOESSAYS, V32, P37, DOI 10.1002/bies.200900118; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Simonis M, 2007, NAT METHODS, V4, P895, DOI 10.1038/NMETH1114; Splinter E, 2004, METHOD ENZYMOL, V375, P493; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Williams A, 2008, J EXP MED, V205, P747, DOI 10.1084/jem.20080066; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	35	12	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31416	10.1371/journal.pone.0031416	http://dx.doi.org/10.1371/journal.pone.0031416			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347474	Green Published, gold, Green Submitted			2022-12-25	WOS:000302730100069
J	Altorf-van der Kuill, W; Engberink, MF; Vedder, MM; Boer, JMA; Verschuren, WMM; Geleijnse, JM				Altorf-van der Kuill, Wieke; Engberink, Marielle F.; Vedder, Moniek M.; Boer, Jolanda M. A.; Verschuren, W. M. Monique; Geleijnse, Johanna M.			Sources of Dietary Protein in Relation to Blood Pressure in a General Dutch Population	PLOS ONE			English	Article							DISEASE RISK-FACTORS; MEN; HYPERTENSION; WOMEN; CANCER; TRIAL	Background: Little is known about the relation of different dietary protein types with blood pressure (BP). We examined whether intake of total, plant, animal, dairy, meat, and grain protein was related to BP in a cross sectional cohort of 20,820 Dutch adults, aged 20-65 y and not using antihypertensive medication. Design: Mean BP levels were calculated in quintiles of energy-adjusted protein with adjustment for age, sex, BMI, education, smoking, and intake of energy, alcohol, and other nutrients including protein from other sources. In addition, mean BP difference after substitution of 3 en% carbohydrates or MUFA with protein was calculated. Results: Total protein and animal protein were not associated with BP (p(trend)=0.62 and 0.71 respectively), both at the expense of carbohydrates and MUFA. Systolic BP was 1.8 mmHg lower (p(trend)<0.01) in the highest (>36 g/d) than in the lowest (, 27 g/d) quintile of plant protein. This inverse association was present both at the expense of carbohydrates and MUFA and more pronounced in individuals with untreated hypertension (-3.6 mmHg) than in those with normal (+0.1 mmHg) or prehypertensive BP (-0.3 mmHg; p(interaction)<0.01). Meat and grain protein were not related to BP. Dairy protein was directly associated with systolic BP (+1.6 mmHg, p(trend)<0.01), but not with diastolic BP (p(trend)=0.24). Conclusions: Total protein and animal protein were not associated with BP in this general untreated Dutch population. Plant protein may be beneficial to BP, especially in people with elevated BP. However, because high intake of plant protein may be a marker of a healthy diet and lifestyle in general, confirmation from randomized controlled trials is warranted.	[Altorf-van der Kuill, Wieke; Engberink, Marielle F.; Geleijnse, Johanna M.] Top Inst Food & Nutr, Wageningen, Netherlands; [Altorf-van der Kuill, Wieke; Engberink, Marielle F.; Vedder, Moniek M.; Geleijnse, Johanna M.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; [Altorf-van der Kuill, Wieke; Vedder, Moniek M.; Boer, Jolanda M. A.; Verschuren, W. M. Monique] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands	Top Institute Food & Nutrition; Wageningen University & Research; Netherlands National Institute for Public Health & the Environment	Altorf-van der Kuill, W (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.	Wieke.Altorf-vanderKuil@wur.nl	Geleijnse, Johanna Marianna M/B-5749-2012	Geleijnse, Johanna Marianna M/0000-0001-7638-0589	Ministry of Health, Welfare and Sport of the Netherlands; National Institute for Public Health and the Environment, Bilthoven, The Netherlands; European Union; Top Institute (TI) Food and Nutrition; Alpro Foundation, Belgium	Ministry of Health, Welfare and Sport of the Netherlands; National Institute for Public Health and the Environment, Bilthoven, The Netherlands(Netherlands Government); European Union(European Commission); Top Institute (TI) Food and Nutrition; Alpro Foundation, Belgium	The Monitoring Project on Risk Factors and Chronic Diseases in the Netherlands (MORGEN) Study was supported by the Ministry of Health, Welfare and Sport of the Netherlands, the National Institute for Public Health and the Environment, Bilthoven, The Netherlands and the Europe Against Cancer Program of the European Union. For the current analysis Wageningen University was supported by Top Institute (TI) Food and Nutrition, which is a public/private partnership that generates vision on scientific breakthroughs in food and nutrition, resulting in the development of innovative products and technologies. Partners are major Dutch Food companies and research organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: For the current analysis Wageningen University was supported by Top Institute (TI) Food and Nutrition. Johanna M. Geleijnse received an unrestricted grant from the Alpro Foundation, Belgium for an epidemiological analysis on fruit and vegetable intake in relation to cardiovascular diseases, which bears no relation to the present study. All other authors have no conflict of interest. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Alonso A, 2006, ARCH MED RES, V37, P778, DOI 10.1016/j.arcmed.2006.01.007; Altorf-van der Kuil W, 2010, J HYPERTENS, V28, P2394, DOI 10.1097/HJH.0b013e32833eff63; Altorf-van Der Kuil W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012102; Appel LJ, 2006, HYPERTENSION, V47, P296, DOI 10.1161/01.HYP.0000202568.01167.B6; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Appel LJ, 2005, JAMA-J AM MED ASSOC, V294, P2455, DOI 10.1001/jama.294.19.2455; Blokstra A, 2005, MONITORING RISK FACT; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Delbridge EA, 2009, AM J CLIN NUTR, V90, P1203, DOI 10.3945/ajcn.2008.27209; Elliott P, 2006, ARCH INTERN MED, V166, P79, DOI 10.1001/archinte.166.1.79; Halkjaer J, 2009, EUR J CLIN NUTR, V63, pS16, DOI 10.1038/ejcn.2009.73; He J, 2011, CIRCULATION, V124, P589, DOI 10.1161/CIRCULATIONAHA.110.009159; Hochstenbach-Waelen A, 2010, PHYSIOL BEHAV, V101, P237, DOI 10.1016/j.physbeh.2010.05.005; KESTIN M, 1989, AM J CLIN NUTR, V50, P280, DOI 10.1093/ajcn/50.2.280; Masala G, 2008, J HYPERTENS, V26, P2112, DOI 10.1097/HJH.0b013e32830ef75c; Muzio F, 2007, AM J CLIN NUTR, V86, P946, DOI 10.1093/ajcn/86.4.946; NEVO, 1996, DUTCH FOOD COMP TABL; Ocke MC, 1997, INT J EPIDEMIOLOGY, V26; PRESCOTT SL, 1988, CLIN SCI, V74, P665, DOI 10.1042/cs0740665; Savica V, 2010, ANNU REV NUTR, V30, P365, DOI 10.1146/annurev-nutr-010510-103954; Simpson SJ, 2003, APPETITE, V41, P123, DOI 10.1016/S0195-6663(03)00049-7; Stamler J, 1996, CIRCULATION, V94, P1629, DOI 10.1161/01.CIR.94.7.1629; Stamler J, 2002, HYPERTENSION, V39, P1000, DOI 10.1161/01.HYP.0000016178.80811.D9; Stamler J, 2009, CIRCULATION, V120, P221, DOI 10.1161/CIRCULATIONAHA.108.839241; Umesawa M, 2009, AM J CLIN NUTR, V90, P377, DOI 10.3945/ajcn.2008.27109; Wang YF, 2008, J HUM HYPERTENS, V22, P745, DOI 10.1038/jhh.2008.64; Whelton PK, 2002, JAMA-J AM MED ASSOC, V288, P1882, DOI 10.1001/jama.288.15.1882; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S	28	18	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e30582	10.1371/journal.pone.0030582	http://dx.doi.org/10.1371/journal.pone.0030582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347387	gold, Green Published			2022-12-25	WOS:000302180600011
J	Zwart, SR; Jessup, JM; Ji, JP; Smith, SM				Zwart, Sara R.; Jessup, J. Milburn; Ji, Jiuping; Smith, Scott M.			Saturation Diving Alters Folate Status and Biomarkers of DNA Damage and Repair	PLOS ONE			English	Article							RED-CELL MASS; NUTRITIONAL-STATUS; BODY IRON; BED REST; CANCER; DIVE; HUMANS; NEOCYTOLYSIS; GAMMA-H2AX; DISEASE	Exposure to oxygen-rich environments can lead to oxidative damage, increased body iron stores, and changes in status of some vitamins, including folate. Assessing the type of oxidative damage in these environments and determining its relationships with changes in folate status are important for defining nutrient requirements and designing countermeasures to mitigate these effects. Responses of humans to oxidative stressors were examined in participants undergoing a saturation dive in an environment with increased partial pressure of oxygen, a NASA Extreme Environment Mission Operations mission. Six participants completed a 13-d saturation dive in a habitat 19 m below the ocean surface near Key Largo, FL. Fasting blood samples were collected before, twice during, and twice after the dive and analyzed for biochemical markers of iron status, oxidative damage, and vitamin status. Body iron stores and ferritin increased during the dive (P < 0.001), with a concomitant decrease in RBC folate (P < 0.001) and superoxide dismutase activity (P < 0.001). Folate status was correlated with serum ferritin (Pearson r = -0.34, P < 0.05). Peripheral blood mononuclear cell poly(ADP-ribose) increased during the dive and the increase was significant by the end of the dive (P < 0.001); gamma-H2AX did not change during the mission. Together, the data provide evidence that when body iron stores were elevated in a hyperoxic environment, a DNA damage repair response occurred in peripheral blood mononuclear cells, but double-stranded DNA damage did not. In addition, folate status decreases quickly in this environment, and this study provides evidence that folate requirements may be greater when body iron stores and DNA damage repair responses are elevated.	[Zwart, Sara R.] Univ Space Res Assoc, Houston, TX USA; [Jessup, J. Milburn; Ji, Jiuping] Natl Canc Inst, Bethesda, MD USA; [Smith, Scott M.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA	Universities Space Research Association (USRA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Zwart, SR (corresponding author), Univ Space Res Assoc, Houston, TX USA.	sara.zwart-1@nasa.gov			NASA; NATIONAL CANCER INSTITUTE [ZIABC011199] Funding Source: NIH RePORTER	NASA(National Aeronautics & Space Administration (NASA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the NASA Human Research Program Human Health and Countermeasures Element. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfrey CP, 1996, J APPL PHYSIOL, V81, P98, DOI 10.1152/jappl.1996.81.1.98; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Cook JD, 2003, BLOOD, V101, P3359, DOI 10.1182/blood-2002-10-3071; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Djurhuus R, 2006, AVIAT SPACE ENVIR MD, V77, P597; GILMAN SC, 1982, AVIAT SPACE ENVIR MD, V53, P1014; Gliszczynska-Swiglo A, 2006, FOOD CHEM, V96, P131, DOI 10.1016/j.foodchem.2005.02.018; Gliszczynska-Swiglo A, 2007, FOOD CHEM, V101, P1480, DOI 10.1016/j.foodchem.2006.04.022; Gliszczynska-Swiglo A, 2007, J AGR FOOD CHEM, V55, P8237, DOI 10.1021/jf070986x; Henning BF, 2001, GERONTOLOGY, V47, P30, DOI 10.1159/000052767; Ho PI, 2002, J NEUROSCI RES, V70, P694, DOI 10.1002/jnr.10416; Juiping J, 2011, PLOS ONE, V6; Kinders RJ, 2010, CLIN CANCER RES, V16, P5447, DOI 10.1158/1078-0432.CCR-09-3076; Krog J, 2010, AVIAT SPACE ENVIR MD, V81, P467, DOI 10.3357/ASEM.2528.2010; MURRAY RD, 1977, AVIAT SPACE ENVIR MD, V48, P1012; Patro Birija S, 2006, Med Chem, V2, P407, DOI 10.2174/157340606777724059; Redon CE, 2010, CLIN CANCER RES, V16, P4532, DOI 10.1158/1078-0432.CCR-10-0523; Rice L, 2005, CELL PHYSIOL BIOCHEM, V15, P245, DOI 10.1159/000087234; Rice L, 2001, ANN INTERN MED, V134, P652, DOI 10.7326/0003-4819-134-8-200104170-00010; Smith SM, 2006, J NUTR, V136, P2534, DOI 10.1093/jn/136.10.2534; Smith SM, 2005, J NUTR, V135, P437, DOI 10.1093/jn/135.3.437; Smith SM, 2004, J NUTR, V134, P1765, DOI 10.1093/jn/134.7.1765; Solier S, 2009, CELL CYCLE, V8, P1853, DOI 10.4161/cc.8.12.8865; STEVENS RG, 1994, INT J CANCER, V56, P364, DOI 10.1002/ijc.2910560312; Suh JR, 2000, J BIOL CHEM, V275, P35646, DOI 10.1074/jbc.M005864200; Tang DL, 2011, ANTIOXID REDOX SIGN, V14, P1315, DOI 10.1089/ars.2010.3356; Toyokuni S, 2009, CANCER SCI, V100, P9, DOI 10.1111/j.1349-7006.2008.01001.x; Zacharski LR, 2008, JNCI-J NATL CANCER I, V100, P996, DOI 10.1093/jnci/djn209; Zwart SR, 2009, J APPL PHYSIOL, V107, P54, DOI 10.1152/japplphysiol.91136.2008; Zwart SR, 2009, AVIAT SPACE ENVIR MD, V80, pA15, DOI 10.3357/ASEM.BR07.2009; Zwart SR, 2009, J NUTR, V139, P90, DOI 10.3945/jn.108.097592	31	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31058	10.1371/journal.pone.0031058	http://dx.doi.org/10.1371/journal.pone.0031058			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347427	Green Published, Green Submitted, gold			2022-12-25	WOS:000302180600027
J	Ferrari, MCO; Manassa, RP; Dixson, DL; Munday, PL; McCormick, MI; Meekan, MG; Sih, A; Chivers, DP				Ferrari, Maud C. O.; Manassa, Rachel P.; Dixson, Danielle L.; Munday, Philip L.; McCormick, Mark I.; Meekan, Mark G.; Sih, Andrew; Chivers, Douglas P.			Effects of Ocean Acidification on Learning in Coral Reef Fishes	PLOS ONE			English	Article							CLIMATE-CHANGE; CARBONIC-ACID; PREDATOR; PREY; DISSOCIATION; ADAPTATION; MORTALITY; CONSTANTS; SEAWATER; ANIMALS	Ocean acidification has the potential to cause dramatic changes in marine ecosystems. Larval damselfish exposed to concentrations of CO2 predicted to occur in the mid- to late-century show maladaptive responses to predator cues. However, there is considerable variation both within and between species in CO2 effects, whereby some individuals are unaffected at particular CO2 concentrations while others show maladaptive responses to predator odour. Our goal was to test whether learning via chemical or visual information would be impaired by ocean acidification and ultimately, whether learning can mitigate the effects of ocean acidification by restoring the appropriate responses of prey to predators. Using two highly efficient and widespread mechanisms for predator learning, we compared the behaviour of pre-settlement damselfish Pomacentrus amboinensis that were exposed to 440 mu atm CO2 (current day levels) or 850 mu atm CO2, a concentration predicted to occur in the ocean before the end of this century. We found that, regardless of the method of learning, damselfish exposed to elevated CO2 failed to learn to respond appropriately to a common predator, the dottyback, Pseudochromis fuscus. To determine whether the lack of response was due to a failure in learning or rather a short-term shift in trade-offs preventing the fish from displaying overt antipredator responses, we conditioned 440 or 700 mu atm-CO2 fish to learn to recognize a dottyback as a predator using injured conspecific cues, as in Experiment 1. When tested one day post-conditioning, CO2 exposed fish failed to respond to predator odour. When tested 5 days post-conditioning, CO2 exposed fish still failed to show an antipredator response to the dottyback odour, despite the fact that both control and CO2-treated fish responded to a general risk cue (injured conspecific cues). These results indicate that exposure to CO2 may alter the cognitive ability of juvenile fish and render learning ineffective.	[Ferrari, Maud C. O.; Sih, Andrew] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Manassa, Rachel P.; Dixson, Danielle L.; Munday, Philip L.; McCormick, Mark I.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Manassa, Rachel P.; Dixson, Danielle L.; Munday, Philip L.; McCormick, Mark I.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Meekan, Mark G.] Australian Inst Marine Sci, UWA Ocean Sci Ctr MO96, Crawley, WA, Australia; [Chivers, Douglas P.] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada	University of California System; University of California Davis; James Cook University; James Cook University; Australian Institute of Marine Science; University of Western Australia; University of Saskatchewan	Ferrari, MCO (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Dept Biomed Sci, Saskatoon, SK S7N 0W0, Canada.	maud.ferrari@usask.ca	Manassa, Rachel/E-1232-2013; Dixson, Danielle L/B-9253-2018; Sih, Andrew/P-7985-2015; Munday, Philip L/F-5443-2011; McCormick, Mark I/J-8301-2014	Dixson, Danielle L/0000-0003-1493-1482; Sih, Andrew/0000-0001-6161-1663; Munday, Philip L/0000-0001-9725-2498; McCormick, Mark I/0000-0001-9289-1645; Meekan, Mark/0000-0002-3067-9427; Chivers, Douglas/0000-0002-9497-4329	Natural Sciences and Engineering Council of Canada; Australian Research Council; ARC Centre of Excellence for Coral Reef Studies; Australian Institute of Marine Science	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Australian Research Council(Australian Research Council); ARC Centre of Excellence for Coral Reef Studies(Australian Research Council); Australian Institute of Marine Science	This work was supported by funding to MCOF and DPC from the Natural Sciences and Engineering Council of Canada, to MIM, PLM, MCOF, and DPC from the Australian Research Council and the ARC Centre of Excellence for Coral Reef Studies, and to MGM from the Australian Institute of Marine Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2006, CORAL REEFS, V25, P19, DOI 10.1007/s00338-005-0044-y; Beck B. B., 1994, P265; Brown GE, 1996, ETHOLOGY, V102, P776; Brown Grant E., 2005, P34; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; CRIPPS IL, PLOS ONE IN PRESS; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Dixson DL, 2010, ECOL LETT, V13, P68, DOI 10.1111/j.1461-0248.2009.01400.x; DOHERTY PJ, 1987, B MAR SCI, V41, P423; Domenici P, BIOL LETT IN PRESS; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; DUGATKIN LA, 1992, AM NAT, V139, P1384, DOI 10.1086/285392; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Ferrari MCO, 2011, ECOL LETT, V14, P1143, DOI 10.1111/j.1461-0248.2011.01683.x; Ferrari MCO, 2011, GLOBAL CHANGE BIOL, V17, P2980, DOI 10.1111/j.1365-2486.2011.02439.x; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; Ferrari MCO, FUNCTIONAL IN PRESS; Galef BG, 2001, ANIM BEHAV, V61, P3, DOI 10.1006/anbe.2000.1557; Gattuso J.P., 2010, GUIDE BEST PRACTICES; Grieco F, 2002, SCIENCE, V296, P136, DOI 10.1126/science.1068287; Griffin AS, 2000, CONSERV BIOL, V14, P1317, DOI 10.1046/j.1523-1739.2000.99326.x; Griffin AS, 2004, LEARN BEHAV, V32, P131; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Holmes TH, 2010, MAR ECOL PROG SER, V399, P273, DOI 10.3354/meps08337; Holmes TH, 2009, OECOLOGIA, V159, P401, DOI 10.1007/s00442-008-1220-x; Ishimatsu A, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002564; Ishimatsu A, 2008, MAR ECOL PROG SER, V373, P295, DOI 10.3354/meps07823; KLEIMAN DG, 1989, BIOSCIENCE, V39, P152, DOI 10.2307/1311025; Kleypas J., 2006, IMPACTS OCEAN ACIDIF; Kroeker KJ, ECOLOGY LET IN PRESS; Leis JM, 2007, MAR ECOL PROG SER, V347, P185, DOI 10.3354/meps06977; McCormick MI, 2006, J FISH BIOL, V68, P969, DOI 10.1111/j.1095-8649.2006.00982.x; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; MEEKAN MG, 1993, MAR ECOL PROG SER, V93, P217, DOI 10.3354/meps093217; Meekan MG, 2001, MAR BIOL, V139, P373; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; Mitchell MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015764; Munday PL, 2008, FISH FISH, V9, P261, DOI 10.1111/j.1467-2979.2008.00281.x; Munday PL, 2010, P NATL ACAD SCI USA, V107, P12930, DOI 10.1073/pnas.1004519107; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; Nilsson GE, 2012, NATURE CLIMATE CHANG; Ohde S, 1999, B MAR SCI, V65, P559; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Panchuk K, 2008, GEOLOGY, V36, P315, DOI 10.1130/G24474A.1; Royal Society, 2005, OC AC DUE INCR ATM C; Shamberger KEF, 2011, MAR CHEM, V127, P64, DOI 10.1016/j.marchem.2011.08.003; Shettleworth SJ, 2001, ANIM BEHAV, V61, P277, DOI 10.1006/anbe.2000.1606; SIH A, EVOLUTIONAR IN PRESS; Sih A, INTEGRATIVE IN PRESS; SIMPSON S, BIOL LETT IN PRESS; Sokal RR, 1995, BIOMETRY; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Zachos JC, 2005, SCIENCE, V308, P1611, DOI 10.1126/science.1109004	54	100	103	2	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e31478	10.1371/journal.pone.0031478	http://dx.doi.org/10.1371/journal.pone.0031478			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328936	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000302179300022
J	Kao, CL; Chan, TC; Tsai, CH; Chu, KY; Chuang, SF; Lee, CC; Li, ZRT; Wu, KW; Chang, LY; Shen, YH; Huang, LM; Lee, PI; Yang, CL; Compans, R; Rouse, BT; King, CC				Kao, Chuan-Liang; Chan, Ta-Chien; Tsai, Chu-Han; Chu, Kuan-Ying; Chuang, Shu-Fang; Lee, Chang-Chun; Li, Zheng-Rong Tiger; Wu, Ko-Wen; Chang, Luan-Yin; Shen, Yea-Huei; Huang, Li-Min; Lee, Ping-Ing; Yang, ChingLai; Compans, Richard; Rouse, Barry T.; King, Chwan-Chuen			Emerged HA and NA Mutants of the Pandemic Influenza H1N1 Viruses with Increasing Epidemiological Significance in Taipei and Kaohsiung, Taiwan, 2009-10	PLOS ONE			English	Article							SWINE-ORIGIN 2009; VIRAL LOAD; ANTIGENIC SITES; A VIRUSES; HONG-KONG; HEMAGGLUTININ; EVOLUTION; REPLICATION; INFECTION; A(H1N1)	The 2009 influenza pandemic provided an opportunity to observe dynamic changes of the hemagglutinin (HA) and neuraminidase (NA) of pH1N1 strains that spread in two metropolitan areas - Taipei and Kaohsiung. We observed cumulative increases of amino acid substitutions of both HA and NA that were higher in the post-peak than in the pre-peak period of the epidemic. About 14.94% and 3.44% of 174 isolates had one and two amino acids changes, respective, in the four antigenic sites. One unique adaptive mutation of HA2 (E374K) was first detected three weeks before the epidemic peak. This mutation evolved through the epidemic, and finally emerged as the major circulated strain, with significantly higher frequency in the post-peak period than in the pre-peak (64.65% vs 9.28%, p<0.0001). E374K persisted until ten months post-nationwide vaccination without further antigenic changes (e. g. prior to the highest selective pressure). In public health measures, the epidemic peaked at seven weeks after oseltamivir treatment was initiated. The emerging E374K mutants spread before the first peak of school class suspension, extended their survival in high-density population areas before vaccination, dominated in the second wave of class suspension, and were fixed as herd immunity developed. The tempospatial spreading of E374K mutants was more concentrated during the post-peak (p = 0.000004) in seven districts with higher spatial clusters (p<0.001). This is the first study examining viral changes during the naive phase of a pandemic of influenza through integrated virological/serological/clinical surveillance, tempo-spatial analysis, and intervention policies. The vaccination increased the percentage of E374K mutants (22.86% vs 72.34%, p<0.001) and significantly elevated the frequency of mutations in Sa antigenic site (2.36% vs 23.40%, p<0.001). Future pre-vaccination public health efforts should monitor amino acids of HA and NA of pandemic influenza viruses isolated at exponential and peak phases in areas with high cluster cases.	[Kao, Chuan-Liang; Chan, Ta-Chien; Chu, Kuan-Ying; Chuang, Shu-Fang; Lee, Chang-Chun; Li, Zheng-Rong Tiger; King, Chwan-Chuen] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Kao, Chuan-Liang; Tsai, Chu-Han; Chuang, Shu-Fang] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Kao, Chuan-Liang] NTU Hosp, Dept Lab Med, Taipei, Taiwan; [Chang, Luan-Yin; Huang, Li-Min; Lee, Ping-Ing] NTU Hosp, Dept Pediat, Taipei, Taiwan; [Wu, Ko-Wen] Natl Yang Ming Univ, Sch Life Sci, Inst Biomed Informat, Taipei 112, Taiwan; [Shen, Yea-Huei] Yuans Gen Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Yang, ChingLai; Compans, Richard] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Yang, ChingLai; Compans, Richard] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA USA; [Rouse, Barry T.] Univ Tennessee, Coll Vet Med, Dept Pathobiol, Knoxville, TN 37901 USA	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Yang Ming Chiao Tung University; Emory University; Emory University; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Kao, CL (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	chwanchuen@gmail.com	Yang, Chinglai/D-1409-2014; Compans, Richard W/I-4087-2013	Yang, Chinglai/0000-0002-9308-7760; Compans, Richard W/0000-0003-2360-335X; King, Chwan-Chuen/0000-0002-6078-2601; HUANG, LI-MIN/0000-0002-9291-260X; KAO, CHUAN-LIANG/0000-0002-1020-2605; CHANG, LUAN-YIN/0000-0003-2632-1956; LEE, PING-ING/0000-0002-7299-2825	Taiwan's National Science Council [98-2321-B-002-016]; National Institutes of Health (NIH) in the United States [2U19AI05726606, HHSN266200700006C]	Taiwan's National Science Council; National Institutes of Health (NIH) in the United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by three grants: NSC #98-2321-B-002-016 from Taiwan's National Science Council, and financial support from the National Institutes of Health in the United States (NIH grant #2U19AI05726606 and NIH grant #HHSN266200700006C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2004, J VIROL, V78, P9605, DOI 10.1128/JVI.78.18.9605-9611.2004; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P21; Ansart S, 2009, INFLUENZA OTHER RESP, V3, P99, DOI 10.1111/j.1750-2659.2009.00080.x; ARCHETTI I, 1950, J EXP MED, V92, P441, DOI 10.1084/jem.92.5.441; Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45; Barr IG, 2010, EURO SURVEILL, V15; Blackburne BP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000058; Boni MF, 2008, VACCINE, V26, pC8, DOI 10.1016/j.vaccine.2008.04.011; Boni MF, 2006, P ROY SOC B-BIOL SCI, V273, P1307, DOI 10.1098/rspb.2006.3466; Bradley KC, 2011, VIROLOGY, V413, P169, DOI 10.1016/j.virol.2011.01.027; Brookes SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009068; Chan MCW, 2010, AM J PATHOL, V176, P1828, DOI 10.2353/ajpath.2010.091087; Chan PKS, 2011, J CLIN VIROL, V50, P320, DOI 10.1016/j.jcv.2011.01.013; Chen HL, 2010, J INFECT DIS, V201, P1517, DOI 10.1086/652661; Cherry Joshua L, 2009, PLoS Curr, V1, pRRN1001; Chi CY, 2010, CLIN VACCINE IMMUNOL, V17, P1958, DOI 10.1128/CVI.00212-10; COLMAN PM, 1983, NATURE, V303, P41, DOI 10.1038/303041a0; Das SR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001211; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Wit E, 2010, J VIROL, V84, P1597, DOI 10.1128/JVI.01783-09; DRAKE JW, 1993, P NATL ACAD SCI USA, V90, P4171, DOI 10.1073/pnas.90.9.4171; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Ertek M, 2010, JPN J INFECT DIS, V63, P239; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ghedin E, 2011, J INFECT DIS, V203, P168, DOI 10.1093/infdis/jiq040; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Glinsky GV, 2010, CELL CYCLE, V9, P958, DOI 10.4161/cc.9.5.10913; Graham M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016087; Ho TS, 2010, PEDIATR NEONATOL, V51, P83, DOI 10.1016/S1875-9572(10)60016-2; Hoper D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019075; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hsueh PR, 2010, EMERG INFECT DIS, V16, P1309, DOI 10.3201/eid1608.100310; Huang JW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S41; Huang WT, 2010, EUROSURVEILLANCE, V15, P2; Hughes MT, 2001, J VIROL, V75, P3766, DOI 10.1128/JVI.75.8.3766-3770.2001; Igarashi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008553; Ikonen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013329; Jayaraman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017616; Kilander A, 2010, EURO SURVEILL, V15; Kobasa D, 2001, J VIROL, V75, P11773, DOI 10.1128/JVI.75.23.11773-11780.2001; Kuroda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010256; Langley WA, 2009, VIROLOGY, V394, P321, DOI 10.1016/j.virol.2009.08.031; Lee CW, 2004, J VIROL, V78, P8372, DOI [10.1128/JVI.78.15.8372-8381.2004, 10.1128/jvi.78.15.8372-8381.2004]; Lee SS, 2011, J INFECTION, V63, P274, DOI 10.1016/j.jinf.2011.03.011; Lee VJ, 2010, J INFECT DIS, V202, P1319, DOI 10.1086/656480; Li IW, 2010, CHEST, V137, P759, DOI 10.1378/chest.09-3072; Malato L, 2011, EURO SURVEILL, V16; Maurer-Stroh Sebastian, 2010, PLoS Curr, V2, pRRN1162; Mehle A, 2009, P NATL ACAD SCI USA, V106, P21312, DOI 10.1073/pnas.0911915106; Melidou A, 2010, VIRUS RES, V151, P192, DOI 10.1016/j.virusres.2010.05.005; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; Mitchell T, 2011, CLIN INFECT DIS, V52, pS138, DOI 10.1093/cid/ciq056; Morlighem JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018956; Muller V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000454; Nelson M., 2009, PLOS CURR, V1, DOI [DOI 10.1371/CURRENTS.RRN1126, 10.1371/currents.RRN1126]; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Nunes B, 2008, J MOL EVOL, V67, P427, DOI 10.1007/s00239-008-9154-9; ORTIN J, 1980, GENE, V11, P319, DOI 10.1016/0378-1119(80)90072-4; Ozawa M, 2011, J VIROL, V85, P4596, DOI 10.1128/JVI.00029-11; Pan CE, 2010, PLOS ONE, V5, pA31, DOI 10.1371/journal.pone.0009549; Poon LLM, 2011, J CLIN VIROL, V52, P146, DOI 10.1016/j.jcv.2011.06.022; Potter CW, 2001, J APPL MICROBIOL, V91, P572, DOI 10.1046/j.1365-2672.2001.01492.x; Puzelli S, 2010, EMERG INFECT DIS, V16, P863, DOI [10.3201/eid1605.091858, 10.3201/eid1605.091815]; Rabadan R, 2007, EVOL BIOINFORM, V3, P299; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Shih ACC, 2007, P NATL ACAD SCI USA, V104, P6283, DOI 10.1073/pnas.0701396104; Skountzou I, 2010, J IMMUNOL, V185, P1642, DOI 10.4049/jimmunol.1000091; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Steinhauer DA, 2002, ANNU REV GENET, V36, P305, DOI 10.1146/annurev.genet.36.052402.152757; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; To KKW, 2010, J MED VIROL, V82, P1, DOI 10.1002/jmv.21664; Tsai KN, 2011, MICROBES INFECT, V13, P479, DOI 10.1016/j.micinf.2011.01.013; van der Vries E, 2010, NEW ENGL J MED, V363, P1381, DOI 10.1056/NEJMc1003749; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wen TH, 2010, INT J INFECT DIS, V14, pE334, DOI 10.1016/j.ijid.2009.06.006; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; World Health Organization, 2009, PAND H1N1 2009 BRIEF; Xu LL, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-325; Yang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008905; Ye JQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001145; Zambon MC, 2001, REV MED VIROL, V11, P227, DOI 10.1002/rmv.319; Zepeda HM, 2010, J CLIN VIROL, V48, P36, DOI 10.1016/j.jcv.2010.02.008	85	26	26	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e31162	10.1371/journal.pone.0031162	http://dx.doi.org/10.1371/journal.pone.0031162			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328930	Green Submitted, Green Published, gold			2022-12-25	WOS:000302179300016
J	Perez, C; Martinez-Calle, N; Martin-Subero, JI; Segura, V; Delabesse, E; Fernandez-Mercado, M; Garate, L; Alvarez, S; Rifon, J; Varea, S; Boultwood, J; Wainscoat, JS; Cigudosa, JC; Calasanz, MJ; Cross, NCP; Prosper, F; Agirre, X				Perez, Cristina; Martinez-Calle, Nicolas; Ignacio Martin-Subero, Jose; Segura, Victor; Delabesse, Eric; Fernandez-Mercado, Marta; Garate, Leire; Alvarez, Sara; Rifon, Jose; Varea, Sara; Boultwood, Jacqueline; Wainscoat, James S.; Cruz Cigudosa, Juan; Jose Calasanz, Maria; Cross, Nicholas C. P.; Prosper, Felipe; Agirre, Xabier			TET2 Mutations Are Associated with Specific 5-Methylcytosine and 5-Hydroxymethylcytosine Profiles in Patients with Chronic Myelomonocytic Leukemia	PLOS ONE			English	Article							CHRONIC MYELOPROLIFERATIVE DISORDERS; WORLD-HEALTH-ORGANIZATION; ACUTE MYELOID-LEUKEMIA; CELL SELF-RENEWAL; DNA METHYLATION; MYELODYSPLASTIC SYNDROMES; MICROARRAY DATA; GENE; REVEALS; HYPERMETHYLATION	Chronic myelomonocytic leukemia (CMML) has recently been associated with a high incidence of diverse mutations in genes such as TET2 or EZH2 that are implicated in epigenetic mechanisms. We have performed genome-wide DNA methylation arrays and mutational analysis of TET2, IDH1, IDH2, EZH2 and JAK2 in a group of 24 patients with CMML. 249 genes were differentially methylated between CMML patients and controls. Using Ingenuity pathway analysis, we identified enrichment in a gene network centered around PLC, JNK and ERK suggesting that these pathways, whose deregulation has beenrecently described in CMML, are affected by epigenetic mechanisms. Mutations of TET2, JAK2 and EZH2 were found in 15 patients (65%), 4 patients (17%) and 1 patient (4%) respectively while no mutations in the IDH1 and IDH2 genes were identified. Interestingly, patients with wild type TET2 clustered separately from patients with TET2 mutations, showed a higher degree of hypermethylation and were associated with higher risk karyotypes. Our results demonstrate the presence of aberrant DNA methylation in CMML and identifies TET2 mutant CMML as a biologically distinct disease subtype with a different epigenetic profile.	[Perez, Cristina; Martinez-Calle, Nicolas; Garate, Leire; Prosper, Felipe; Agirre, Xabier] Univ Navarra, Lab Myeloproliferat Syndromes, Oncol Area, E-31080 Pamplona, Spain; [Ignacio Martin-Subero, Jose] Univ Barcelona, Dept Anat Pathol Pharmacol & Microbiol, Barcelona, Spain; [Segura, Victor] Univ Navarra, Dept Bioinformat, Fdn Appl Med Res, E-31080 Pamplona, Spain; [Delabesse, Eric] Univ Toulouse 3, CHU Toulouse, Hematol Lab, Hop Purpan,Inserm U1037, F-31062 Toulouse, France; [Fernandez-Mercado, Marta; Boultwood, Jacqueline; Wainscoat, James S.] John Radcliffe Hosp, LLR Mol Haematol Unit, NDCLS, Oxford OX3 9DU, England; [Alvarez, Sara; Cruz Cigudosa, Juan] CNIO, Mol Cytogenet Grp, Madrid, Spain; [Rifon, Jose; Varea, Sara; Prosper, Felipe] Univ Navarra, Hematol Serv, E-31080 Pamplona, Spain; [Rifon, Jose; Varea, Sara; Prosper, Felipe] Univ Navarra, Area Cell Therapy, Univ Navarra Clin, E-31080 Pamplona, Spain; [Jose Calasanz, Maria] Univ Navarra, Dept Genet, E-31080 Pamplona, Spain; [Cross, Nicholas C. P.] Wessex Reg Genet Lab, Salisbury, Wilts, England; [Cross, Nicholas C. P.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England	University of Navarra; University of Barcelona; University of Navarra; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Oxford; Centro Nacional de Investigaciones Oncologicas (CNIO); University of Navarra; University of Navarra; University of Navarra; University of Southampton	Perez, C (corresponding author), Univ Navarra, Lab Myeloproliferat Syndromes, Oncol Area, E-31080 Pamplona, Spain.	fprosper@unav.es; xaguirre@unav.es	DELABESSE, Eric/I-5221-2016; Agirre, Xabier/ABE-4110-2020; Segura, Victor/E-4531-2010; Calasanz, MJ/R-5813-2016; Cross, Nicholas/B-4817-2009; Martinez-Calle, Nicolas/ABE-4394-2020; Prosper, Felipe/H-6859-2017	DELABESSE, Eric/0000-0002-0928-0753; Segura, Victor/0000-0002-7740-6290; Calasanz, MJ/0000-0002-0374-3008; Cross, Nicholas/0000-0001-5481-2555; Martinez-Calle, Nicolas/0000-0002-5184-9464; Prosper, Felipe/0000-0001-6115-8790; Martin-Subero, Jose Ignacio/0000-0001-8809-5195; Fernandez-Mercado, Marta/0000-0003-3458-9231; Boultwood, Jacqueline/0000-0002-4330-2928	Ministerio de Ciencia e Innovacion; Instituto de Salud Carlos III (ISCIII) [PI10/01691, PI10/02983, PI08/0440, SAF2009-08663, RTICC RD06/0020]; Contrato Miguel Servet [CP07/00215]; European FEDER funds Interreg IVA (CITTIL); Leukemia and Lymphoma Research UK; Programa Tu Eliges; Tu Decides (CAN); Gobierno de Navarra; Departamento de Salud; UTE	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Contrato Miguel Servet; European FEDER funds Interreg IVA (CITTIL); Leukemia and Lymphoma Research UK(Leukemia and Lymphoma Society); Programa Tu Eliges; Tu Decides (CAN); Gobierno de Navarra; Departamento de Salud; UTE	This work have been supported in part by grants from Ministerio de Ciencia e Innovacion and Instituto de Salud Carlos III (ISCIII) PI10/01691, PI10/02983, PI08/0440, SAF2009-08663 and RTICC RD06/0020, Contrato Miguel Servet CP07/00215, European FEDER funds Interreg IVA (CITTIL), Leukemia and Lymphoma Research UK, Programa Tu Eliges, Tu Decides (CAN), Gobierno de Navarra, Departamento de Salud, Beca Ortiz de Landazuri 2009 (6/2009) and funds from the "UTE project CIMA''. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI 10.2217/EPI.09.14; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Costa R, 2011, CANCER; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Elliot MA, 2006, BEST PRACT RES CL HA, V19, P571, DOI 10.1016/j.beha.2005.07.012; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Gelsi-Boyer V, 2009, BRIT J HAEMATOL, V145, P788, DOI 10.1111/j.1365-2141.2009.07697.x; Gentleman RC, 2005, STAT BIOL HLTH; Grossmann V, 2011, LEUKEMIA, V25, P877, DOI 10.1038/leu.2011.10; Harris NL, 1999, J CLIN ONCOL, V17, P3835, DOI 10.1200/JCO.1999.17.12.3835; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jankowska AM, 2011, BLOOD           0809; Jiang Y, 2009, BLOOD, V113, P1315, DOI 10.1182/blood-2008-06-163246; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Kantarjian H, 2007, BLOOD, V109, P52, DOI 10.1182/blood-2006-05-021162; Kantarjian HM, 2010, BLOOD, V116, P3163, DOI 10.1182/blood-2010-03-274753; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Kohlmann A, 2010, J CLIN ONCOL, V28, P3858, DOI 10.1200/JCO.2009.27.1361; Kosmider O, 2009, BLOOD, V114, P3285, DOI 10.1182/blood-2009-04-215814; Lagadinou ED, 2008, LEUKEMIA, V22, P1899, DOI 10.1038/leu.2008.192; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Levine RL, 2005, BLOOD, V106, P3377, DOI 10.1182/blood-2005-05-1898; Li Z, 2011, BLOOD           0729; Lin P, 2006, AM J CLIN PATHOL, V126, P530, DOI 10.1309/JT5BE2L1FGG8P8Y6; Martin-Subero JI, 2009, BLOOD, V113, P2488, DOI 10.1182/blood-2008-04-152900; Milani L, 2010, BLOOD, V115, P1214, DOI 10.1182/blood-2009-04-214668; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Oki Y, 2008, BLOOD, V111, P2382, DOI 10.1182/blood-2007-07-103960; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Puissant A, 2010, CANCER RES, V70, P1042, DOI 10.1158/0008-5472.CAN-09-3537; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Shannon K, 2005, CANCER CELL, V7, P291, DOI 10.1016/j.ccr.2005.04.002; Smith AE, 2010, BLOOD, V116, P3923, DOI 10.1182/blood-2010-03-274704; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; STEPHENSON J, 1993, LEUKEMIA RES, V17, P291, DOI 10.1016/0145-2126(93)90014-C; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Such E, 2010, HAEMATOLOGICA, V96, P375; Tessema M, 2003, LEUKEMIA, V17, P910, DOI 10.1038/sj.leu.2402891; Thol F, 2010, HAEMATOL-HEMATOL J, V95, P1668, DOI 10.3324/haematol.2010.025494; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Vilas-Zornoza A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017012; Voso MT, 2009, CLIN CANCER RES, V15, P5002, DOI 10.1158/1078-0432.CCR-09-0494; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Xiao WB, 2010, BLOOD, V116, P6003, DOI 10.1182/blood-2010-05-283937; Xiao WB, 2009, CANCER CELL, V16, P161, DOI 10.1016/j.ccr.2009.05.018; Yang SH, 2008, CELL BIOL TOXICOL, V24, P291, DOI 10.1007/s10565-007-9038-6; Zhang HK, 2010, CELL RES, V20, P1390, DOI 10.1038/cr.2010.156	49	56	59	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2012	7	2							e31605	10.1371/journal.pone.0031605	http://dx.doi.org/10.1371/journal.pone.0031605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LV	22328940	Green Published, gold, Green Accepted			2022-12-25	WOS:000302179300026
J	Velez-Juarbe, J; Domning, DP; Pyenson, ND				Velez-Juarbe, Jorge; Domning, Daryl P.; Pyenson, Nicholas D.			Iterative Evolution of Sympatric Seacow (Dugongidae, Sirenia) Assemblages during the Past similar to 26 Million Years	PLOS ONE			English	Article							CETACEANS CENOZOIC DRIVERS; BODY-SIZE; ENVIRONMENTAL-CHANGE; ECOLOGICAL CHANGE; CARIBBEAN REGION; FOSSIL SIRENIA; WEST ATLANTIC; MIOCENE; COMMUNITY; MAMMALIA	Extant sirenians show allopatric distributions throughout most of their range. However, their fossil record shows evidence of multispecies communities throughout most of the past similar to 26 million years, in different oceanic basins. Morphological differences among co-occurring sirenian taxa suggest that resource partitioning played a role in structuring these communities. We examined body size and ecomorphological differences (e.g., rostral deflection and tusk morphology) among sirenian assemblages from the late Oligocene of Florida, early Miocene of India and early Pliocene of Mexico; each with three species of the family Dugongidae. Although overlapping in several ecomorphological traits, each assemblage showed at least one dominant trait in which coexisting species differed. Fossil sirenian occurrences occasionally are monotypic, but the assemblages analyzed herein show iterative evolution of multispecies communities, a phenomenon unparalleled in extant sirenian ecology. As primary consumers of seagrasses, these communities likely had a strong impact on past seagrass ecology and diversity, although the sparse fossil record of seagrasses limits direct comparisons. Nonetheless, our results provide robust support for previous suggestions that some sirenians in these extinct assemblages served as keystone species, controlling the dominance of climax seagrass species, permitting more taxonomically diverse seagrass beds (and sirenian communities) than many of those observed today.	[Velez-Juarbe, Jorge; Domning, Daryl P.] Howard Univ, Dept Anat, Lab Evolutionary Biol, Washington, DC 20059 USA; [Velez-Juarbe, Jorge; Domning, Daryl P.; Pyenson, Nicholas D.] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA; [Pyenson, Nicholas D.] Univ Washington, Burke Museum Nat Hist & Culture, Dept Mammal, Seattle, WA 98195 USA; [Pyenson, Nicholas D.] Univ Washington, Burke Museum Nat Hist & Culture, Dept Paleontol, Seattle, WA 98195 USA	Howard University; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Velez-Juarbe, J (corresponding author), Howard Univ, Dept Anat, Lab Evolutionary Biol, Washington, DC 20059 USA.	velezjuarbe@gmail.com		Pyenson, Nicholas/0000-0003-4678-5782	Washington-Baltimore-Hampton-Roads Louis Stokes Alliance for Minority Participation Bridge; National Museum of Natural History, Smithsonian Institution; Smithsonian Institution; National Science Foundation [0929117]	Washington-Baltimore-Hampton-Roads Louis Stokes Alliance for Minority Participation Bridge; National Museum of Natural History, Smithsonian Institution(Smithsonian InstitutionSmithsonian National Museum of Natural History); Smithsonian Institution(Smithsonian Institution); National Science Foundation(National Science Foundation (NSF))	JVJ was partially supported by the Washington-Baltimore-Hampton-Roads Louis Stokes Alliance for Minority Participation Bridge to the Doctorate Program at Howard University and a predoctoral fellowship from the National Museum of Natural History, Smithsonian Institution. NDP was also supported by funding from the Smithsonian Institution. Ongoing work by DPD and JVJ is supported by National Science Foundation Earth Sciences grant no. 0929117. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajpai S, 1997, J VERTEBR PALEONTOL, V17, P219, DOI 10.1080/02724634.1997.10010965; Bajpai S, 2010, NEUES JAHRB GEOL P-A, V258, P39, DOI 10.1127/0077-7749/2010/0082; Barnosky AD, 2004, P NATL ACAD SCI USA, V101, P9297, DOI 10.1073/pnas.0402592101; Barry JC, 2002, PALEOBIOLOGY, V28, P1, DOI 10.1666/0094-8373(2002)28[1:FAECIT]2.0.CO;2; Benzecry A, 2008, BOT J LINN SOC, V157, P19, DOI 10.1111/j.1095-8339.2007.00749.x; Calandra I, 2008, NATURWISSENSCHAFTEN, V95, P831, DOI 10.1007/s00114-008-0391-y; Clementz MT, 2006, J VERTEBR PALEONTOL, V26, P355, DOI 10.1671/0272-4634(2006)26[355:IRFEWA]2.0.CO;2; Clementz MT, 2009, GEOLOGY, V37, P307, DOI 10.1130/G25533A.1; Clyde WC, 1998, GEOLOGY, V26, P1011, DOI 10.1130/0091-7613(1998)026<1011:MCRTTL>2.3.CO;2; de Toledo PM., 1991, B MUSEU PARAENSE EMI, V1, P119; Diamond J.M., 1975, P342; Domning D.P., 1989, Journal of Vertebrate Paleontology, V9, P415; Domning D.P., 1989, Journal of Vertebrate Paleontology, V9, P429; Domning D.P., 1990, Journal of Vertebrate Paleontology, V10, P361; Domning DP, 2008, J VERTEBR PALEONTOL, V28, P479, DOI 10.1671/0272-4634(2008)28[479:FSOTWA]2.0.CO;2; Domning DP, 2007, ANAT REC, V290, P523, DOI 10.1002/ar.20540; Domning Daryl P., 1994, Contributions from the Museum of Paleontology University of Michigan, V29, P69; Domning Daryl P., 1994, Proceedings of the San Diego Society of Natural History, V29, P177; Domning DP, 1997, J VERTEBR PALEONTOL, V17, P397, DOI 10.1080/02724634.1997.10010984; Domning DP, 2001, PALAEOGEOGR PALAEOCL, V166, P27, DOI 10.1016/S0031-0182(00)00200-5; DOMNING DP, 1981, PALEOBIOLOGY, V7, P417, DOI 10.1017/S009483730002546X; Domning DP, 2001, NATURE, V413, P625, DOI 10.1038/35098072; DOMNING DP, 1982, J PALEONTOL, V56, P599; Domning DP., 1978, U CALIFORNIA PUBLICA, V118, P1; Edwards L. E, 2000, 00049B USGS; Eronen JT, 2010, INTEGR ZOOL, V5, P88, DOI 10.1111/j.1749-4877.2010.00192.x; Eva A.N., 1980, Palaeontology (Oxford), V23, P231; FORDYCE RE, 1977, PALAEOGEOGR PALAEOCL, V21, P265; FORDYCE RE, 1980, PALAEOGEOGR PALAEOCL, V31, P319, DOI 10.1016/0031-0182(80)90024-3; GINGERICH PD, 1992, U MICHIGAN PAPERS PA, V30, P1; Goloboff P, 2008, CLADISTICS, V24, P91; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.1890/0012-9658(2002)083[2091:SCOAMA]2.0.CO;2; Hamilton H, 2001, P ROY SOC B-BIOL SCI, V268, P549, DOI 10.1098/rspb.2000.1385; IVANY L C, 1990, Palaios, V5, P244, DOI 10.2307/3514943; Janis CM, 2002, PALAEOGEOGR PALAEOCL, V177, P183, DOI 10.1016/S0031-0182(01)00359-5; Jernvall J, 2004, AM NAT, V164, P614, DOI 10.1086/424967; Klumpp DW, 1989, BIOL SEAGRASSES, P394; LOSOS JB, 1994, ANNU REV ECOL SYST, V25, P467, DOI 10.1146/annurev.es.25.110194.002343; LUMBERT SH, 1984, AQUAT BOT, V20, P121, DOI 10.1016/0304-3770(84)90032-9; MacFadden BJ, 2004, OECOLOGIA, V140, P169, DOI 10.1007/s00442-004-1571-x; MacFadden BJ, 2004, PALEOBIOLOGY, V30, P297, DOI 10.1666/0094-8373(2004)030<0297:DHPAND>2.0.CO;2; MacFadden BJ, 2000, ANNU REV ECOL SYST, V31, P33, DOI 10.1146/annurev.ecolsys.31.1.33; Marx FG, 2010, SCIENCE, V327, P993, DOI 10.1126/science.1185581; Marx FG, 2009, P ROY SOC B-BIOL SCI, V276, P887, DOI 10.1098/rspb.2008.1473; McRoy C. P., 1980, HDB SEAGRASS BIOL EC, P297; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Morgan G.S., 1983, Plaster Jacket, P4; MORGAN ME, 1995, PALAEOGEOGR PALAEOCL, V115, P287, DOI 10.1016/0031-0182(94)00116-P; MURRAY RM, 1977, COMP BIOCHEM PHYS A, V56, P7, DOI 10.1016/0300-9629(77)90432-7; O'Dea A, 2007, P NATL ACAD SCI USA, V104, P5501, DOI 10.1073/pnas.0610947104; Parham JF, 2010, J PALEONTOL, V84, P231, DOI 10.1666/09-077R.1; Polly PD, 2011, P ROY SOC B-BIOL SCI, V278, P1131, DOI 10.1098/rspb.2010.2233; Pyenson ND, 2011, J MAMM EVOL, V18, P269, DOI 10.1007/s10914-011-9170-1; Pyenson ND, 2010, SCIENCE, V330, DOI 10.1126/science.1189866; Raia P, 2010, PALAIOS, V25, P327, DOI 10.2110/palo.2009.p09-154r; REINHART R H, 1976, Bulletin of the Florida State Museum Biological Sciences, V20, P187; Sarko DK, 2010, MAR MAMMAL SCI, V26, P937, DOI 10.1111/j.1748-7692.2010.00384.x; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Terborgh J., 2010, TROPHIC CASCADES PRE, P488; Thewissen JGM, 2009, ACTA PALAEONTOL POL, V54, P7, DOI 10.4202/app.2009.0102; Uhen Mark D., 2007, Palaeontologia Electronica, V10, P1; VANVALKENBURGH B, 1991, PALEOBIOLOGY, V17, P340, DOI 10.1017/S0094837300010691; Velez-Juarbe J, 2009, GEOL SOC AM ABSTR, V41, P634; Vianna JA, 2006, MOL ECOL, V15, P433, DOI 10.1111/j.1365-294X.2005.02771.x	64	60	62	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2012	7	2							e31294	10.1371/journal.pone.0031294	http://dx.doi.org/10.1371/journal.pone.0031294			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917LO	22319622	Green Published, gold, Green Submitted			2022-12-25	WOS:000302178400034
J	Bhavsar, PJ; Infante, E; Khwaja, A; Ridley, AJ				Bhavsar, P. J.; Infante, E.; Khwaja, A.; Ridley, A. J.			Analysis of Rho GTPase expression in T-ALL identifies RhoU as a target for Notch involved in T-ALL cell migration	ONCOGENE			English	Article						Rho GTPases; acute lymphoblastic leukaemia; Notch1; RhoU; cell migration; cytoskeleton	ACUTE LYMPHOBLASTIC-LEUKEMIA; FAMILY; CANCER; TUMORIGENESIS; INFILTRATION; CYTOSKELETON; INHIBITION; RESISTANCE; REGULATORS; MUTATIONS	NOTCH1 is frequently mutated in T-cell acute lymphoblastic leukaemia (T-ALL), and can stimulate T-ALL cell survival and proliferation. Here we explore the hypothesis that Notch1 also alters T-ALL cell migration. Rho GTPases are well known to regulate cell adhesion and migration. We have analysed the expression levels of Rho GTPases in primary T-ALL samples compared with normal T cells by quantitative PCR. We found that 5 of the 20 human Rho genes are highly and consistently upregulated in T-ALL, and 3 further Rho genes are expressed in T-ALL but not detectable in normal T cells. Of these, RHOU expression is highly correlated with the expression of the Notch1 target DELTEX-1. Inhibition of Notch1 signalling with a gamma-secretase inhibitor (GSI) or Notch1 RNA interference reduced RhoU expression in T-ALL cells, whereas constitutively active Notch1 increased RhoU expression. In addition, Notch1 or RhoU depletion, or GSI treatment, inhibits T-ALL cell adhesion, migration and chemotaxis. These results indicate that NOTCH1 mutation stimulates T-ALL cell migration through RhoU upregulation that could contribute to the leukaemia cell dissemination. Oncogene (2013) 32, 198-208; doi:10.1038/onc.2012.42; published online 20 February 2012	[Bhavsar, P. J.; Infante, E.; Ridley, A. J.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Infante, E.] Guys & St Thomas NHS, Biomed Res Ctr, NIHR, London, England; [Khwaja, A.] UCL, UCL Canc Inst, London, England	University of London; King's College London; University of London; King's College London; University of London; University College London	Ridley, AJ (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, New Hunts House,Guys Campus, London SE1 1UL, England.	anne.ridley@kcl.ac.uk		Infante, Elvira/0000-0002-9883-8391; Ridley, Anne/0000-0001-8186-5708	Leukaemia and Lymphoma Research UK; Cancer Research UK; King's College London British Heart Foundation Centre of Excellence; Department of Health via National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre; King's College London; King's College Hospital NHS Foundation Trust; Cancer Research UK [15961] Funding Source: researchfish	Leukaemia and Lymphoma Research UK; Cancer Research UK(Cancer Research UK); King's College London British Heart Foundation Centre of Excellence; Department of Health via National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); King's College London; King's College Hospital NHS Foundation Trust; Cancer Research UK(Cancer Research UK)	This work was supported by Leukaemia and Lymphoma Research UK, Cancer Research UK and King's College London British Heart Foundation Centre of Excellence. El was supported by the Department of Health via National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre Award to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. We are grateful to Sarah Heasman for scientific discussion and guidance; Ritu Garg and Katrina Soderquest for technical assistance; Katherine Lawler for advice on statistical analysis; and Matthew Arno and Estibaliz Aldecoa-otalora Astarloa for assistance and advice on qPCR.	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Aronheim A, 1998, CURR BIOL, V8, P1125, DOI 10.1016/S0960-9822(98)70468-3; Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Aspenstrom P, 2007, EXP CELL RES, V313, P3673, DOI 10.1016/j.yexcr.2007.07.022; Aster JC, 2011, J PATHOL, V223, P262, DOI 10.1002/path.2789; Berthold J, 2008, ACTA PHARMACOL SIN, V29, P285, DOI 10.1111/j.1745-7254.2008.00773.x; Berthold J, 2008, EXP CELL RES, V314, P3453, DOI 10.1016/j.yexcr.2008.09.005; Bhojwani D, 2009, CLIN LYMPHOMA MYELOM, V9, pS222, DOI 10.3816/CLM.2009.s.016; Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; Brazier H, 2009, INT J BIOCHEM CELL B, V41, P1391, DOI 10.1016/j.biocel.2008.12.007; Buonamici S, 2009, NATURE, V459, P1000, DOI 10.1038/nature08020; Chang FK, 2006, J MOL BIOL, V364, P302, DOI 10.1016/j.jmb.2006.09.026; Chuang YY, 2007, J CELL SCI, V120, P1927, DOI 10.1242/jcs.03456; Crazzolara R, 2001, BRIT J HAEMATOL, V115, P545, DOI 10.1046/j.1365-2141.2001.03164.x; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; del Pulgar TG, 2005, BIOESSAYS, V27, P602, DOI 10.1002/bies.20238; Ellenbroek SIJ, 2007, CLIN EXP METASTAS, V24, P657, DOI 10.1007/s10585-007-9119-1; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Ferrando Adolfo A, 2009, Hematology Am Soc Hematol Educ Program, P353, DOI 10.1182/asheducation-2009.1.353; Fort P, 2011, DEV BIOL, V350, P451, DOI 10.1016/j.ydbio.2010.12.011; Fueller Florian, 2008, Cell Commun Signal, V6, P6, DOI 10.1186/1478-811X-6-6; Graux C, 2006, LEUKEMIA, V20, P1496, DOI 10.1038/sj.leu.2404302; Hayday AC, 2007, NAT IMMUNOL, V8, P137, DOI 10.1038/ni1436; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Heasman SJ, 2010, J CELL BIOL, V190, P553, DOI 10.1083/jcb.201002067; Huang M, 2006, HISTOL HISTOPATHOL, V21, P213, DOI 10.14670/HH-21.213; Hubsman MW, 2007, BIOCHEM J, V404, P487, DOI 10.1042/BJ20061696; Infante E, 2011, J LEUKOCYTE BIOL, V89, P577, DOI 10.1189/jlb.0810441; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Ono Y, 1997, J BIOL CHEM, V272, P4576, DOI 10.1074/jbc.272.7.4576; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Palomero T, 2006, BLOOD, V108, P986, DOI 10.1182/blood-2005-08-3482; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Pieters R, 2008, PEDIATR CLIN N AM, V55, P1, DOI 10.1016/j.pcl.2007.11.002; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Riou P, 2010, BIOESSAYS, V32, P986, DOI 10.1002/bies.201000060; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Symons M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-213; Takesono A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008774; Tao WK, 2001, GENE DEV, V15, P1796, DOI 10.1101/gad.894301; Tybulewicz VLJ, 2009, NAT REV IMMUNOL, V9, P630, DOI 10.1038/nri2606; van Grotel M, 2008, LEUKEMIA, V22, P124, DOI 10.1038/sj.leu.2404957; Van Hennik PB, 2005, ANTIOXID REDOX SIGN, V7, P1440, DOI 10.1089/ars.2005.7.1440; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Vicente R, 2010, SEMIN IMMUNOL, V22, P270, DOI 10.1016/j.smim.2010.04.016; Wang H, 2010, CELL SIGNAL, V22, P1022, DOI 10.1016/j.cellsig.2010.02.005; Weerkamp F, 2006, LEUKEMIA, V20, P1197, DOI 10.1038/sj.leu.2404255; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wolfe MS, 2009, SEMIN CELL DEV BIOL, V20, P219, DOI 10.1016/j.semcdb.2008.12.011; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004	53	27	28	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 10	2013	32	2					198	208		10.1038/onc.2012.42	http://dx.doi.org/10.1038/onc.2012.42			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	078CK	22349824	Green Accepted			2022-12-25	WOS:000314075500008
J	Sullenger, B; Woodruff, R; Monroe, DM				Sullenger, Bruce; Woodruff, Rebecca; Monroe, Dougald M.			Potent Anticoagulant Aptamer Directed against Factor IXa Blocks Macromolecular Substrate Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAPID EXTRUSION PROCEDURE; CARDIOPULMONARY BYPASS; FACTOR-VIIA; FACTOR-X; BLOOD-COAGULATION; TISSUE FACTOR; FACTOR XIA; IN-VIVO; INHIBITION; EXOSITE	An aptamer targeting factor IXa has been evaluated in animal models and several clinical studies as a potential antithombotic therapy. We elucidate the molecular mechanism by which this aptamer acts as an anticoagulant. The aptamer binds tightly to factor IXa and prolongs the clotting time of human plasma. The aptamer completely blocks factor IXa activation of factor X regardless of the presence of factor VIIIa. However, the aptamer does not completely block small synthetic substrate cleavage, although it does slow the rate of cleavage. These data are consistent with the aptamer binding to the catalytic domain of factor IXa in such a way as to block an extended substrate-binding site. Therefore, unlike small molecule inhibitors, aptamers appear to be able to bind surfaces surrounding an active site and thereby sterically interfere with enzyme activity. Thus, aptamers may be useful agents to probe and block substrate-binding sites outside of the active site of an enzyme.	[Monroe, Dougald M.] Univ N Carolina, Div Hematol & Oncol, Sch Med, Dept Med, Chapel Hill, NC 27599 USA; [Sullenger, Bruce; Woodruff, Rebecca] Duke Univ, Med Ctr, Dept Surg, Duke Translat Res Inst, Durham, NC 27710 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University	Monroe, DM (corresponding author), Univ N Carolina, Div Hematol & Oncol, Sch Med, Dept Med, 310 Mary Ellen Jones Bldg, Chapel Hill, NC 27599 USA.	dmonroe@med.unc.edu		Monroe, Dougald/0000-0002-0493-2943	National Institutes of Health [HL065222]; Coagulation Research Trust from the University of North Carolina; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coagulation Research Trust from the University of North Carolina; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL065222. This work was also supported by the Coagulation Research Trust Fund from the University of North Carolina.	Aktimur A, 2003, J BIOL CHEM, V278, P7981, DOI 10.1074/jbc.M212748200; Bauer KA, 2002, SEMIN THROMB HEMOST, V28, P15, DOI 10.1055/s-2002-32313; BEGUIN S, 1991, THROMB HAEMOSTASIS, V66, P306; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; Chan MY, 2008, J THROMB HAEMOST, V6, P789, DOI 10.1111/j.1538-7836.2008.02932.x; Chan MY, 2008, CIRCULATION, V117, P2865, DOI 10.1161/CIRCULATIONAHA.107.745687; Chen SWW, 2002, THROMB HAEMOSTASIS, V88, P74; Cohen MG, 2010, CIRCULATION, V122, P614, DOI 10.1161/CIRCULATIONAHA.109.927756; Dyke CK, 2006, CIRCULATION, V114, P2490, DOI 10.1161/CIRCULATIONAHA.106.668434; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Gopinath SCB, 2006, THROMB HAEMOSTASIS, V95, P767, DOI 10.1160/TH06-01-0047; GRIFFITH MJ, 1985, J BIOL CHEM, V260, P2218; GRIFFITH MJ, 1985, J CLIN INVEST, V75, P4, DOI 10.1172/JCI111694; HAMAGUCHI N, 1993, BIOCHEMISTRY-US, V32, P6324, DOI 10.1021/bi00076a004; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; LOLLAR P, 1984, ARCH BIOCHEM BIOPHYS, V233, P438, DOI 10.1016/0003-9861(84)90465-X; Long SB, 2008, RNA, V14, P2504, DOI 10.1261/rna.1239308; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; MCCORD DM, 1990, J BIOL CHEM, V265, P10250; MCNEELY TB, 1985, BLOOD, V65, P1226; Millar JA, 2008, MED J AUSTRALIA, V189, P504, DOI 10.5694/j.1326-5377.2008.tb02145.x; Monteiro RQ, 2005, BIOCHEM J, V387, P871, DOI 10.1042/BJ20041738; Muller J, 2008, J THROMB HAEMOST, V6, P2105, DOI 10.1111/j.1538-7836.2008.03162.x; Nimjee SM, 2006, MOL THER, V14, P408, DOI 10.1016/j.ymthe.2006.04.006; Nimjee SM, 2009, RNA, V15, P2105, DOI 10.1261/rna.1240109; Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915; Ogawa T, 2005, J BIOL CHEM, V280, P23523, DOI 10.1074/jbc.M500894200; Oney S, 2007, OLIGONUCLEOTIDES, V17, P265, DOI 10.1089/oli.2007.0089; Perka C, 2011, THROMB J, V9, DOI 10.1186/1477-9560-9-17; Refino CJ, 1999, THROMB HAEMOSTASIS, V82, P1188; Roberge M, 2002, BIOCHEM J, V363, P387, DOI 10.1042/0264-6021:3630387; Roberge M, 2001, BIOCHEMISTRY-US, V40, P9522, DOI 10.1021/bi010592d; Rusconi CP, 2004, NAT BIOTECHNOL, V22, P1423, DOI 10.1038/nbt1023; Rusconi CP, 2002, NATURE, V419, P90, DOI 10.1038/nature00963; Spanier TB, 1998, J THORAC CARDIOV SUR, V116, P860, DOI 10.1016/S0022-5223(98)00437-1; Spanier TB, 1998, J THORAC CARDIOV SUR, V115, P1179, DOI 10.1016/S0022-5223(98)70419-2; SULLENGER BA, 1990, CELL, V63, P601, DOI 10.1016/0092-8674(90)90455-N; TELGT DSC, 1989, THROMB RES, V56, P603, DOI 10.1016/0049-3848(89)90268-5; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Yavari M, 2008, J THROMB THROMBOLYS, V26, P218, DOI 10.1007/s11239-008-0280-4; Zhang Y, 1998, BIOCHEMISTRY-US, V37, P10681, DOI 10.1021/bi973050y	43	25	25	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12779	12786		10.1074/jbc.M111.300772	http://dx.doi.org/10.1074/jbc.M111.300772			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22334679	Green Published, hybrid			2022-12-25	WOS:000302903700017
J	Liu, YC; Chen, ZJ; Burrows, SR; Purcell, AW; McCluskey, J; Rossjohn, J; Gras, S				Liu, Yu Chih; Chen, Zhenjun; Burrows, Scott R.; Purcell, Anthony W.; McCluskey, James; Rossjohn, Jamie; Gras, Stephanie			The Energetic Basis Underpinning T-cell Receptor Recognition of a Super-bulged Peptide Bound to a Major Histocompatibility Complex Class I Molecule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; BINDING; SPECIFICITY; IMPACT; LONG; BIAS	Although the major histocompatibility complex class I (MHC-I) molecules typically bind short peptide (p) fragments (8-10 amino acids in length), longer, "bulged" peptides are often be presented by MHC-I. Such bulged pMHC-I complexes represent challenges for T-cell receptor (TCR) ligation, although the general principles underscoring the interaction between TCRs and bulged pMHC-I complexes are unclear. To address this, we have explored the energetic basis of how an immunodominant TCR (termed SB27) binds to a 13-amino acid viral peptide (LPEPLPQGQLTAY) complexed to human leukocyte antigen (HLA) B*3508. Using the crystal structure of the SB27 TCR-HLA B*3508(LPEP) complex as a guide, we undertook a comprehensive alanine-scanning mutagenesis approach at the TCR-pMHC-I interface and examined the effect of the mutations by biophysical (affinity measurements) and cellular approaches (tetramer staining). Although the structural footprint on HLA B*3508 was small, the energetic footprint was even smaller in that only two HLA B*3508 residues were critical for the TCR interaction. Instead, the energetic basis of this TCR-pMHC-I interaction was attributed to peptide-mediated interactions in which the complementarity determining region 3 alpha and germline-encoded complementarity determining region 1 beta loops of the SB27 TCR played the principal role. Our findings highlight the peptide-centricity of TCR ligation toward a bulged pMHC-I complex.	[Liu, Yu Chih; Rossjohn, Jamie; Gras, Stephanie] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Chen, Zhenjun; McCluskey, James] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Purcell, Anthony W.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Purcell, Anthony W.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Burrows, Scott R.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Burrows, Scott R.] Australian Ctr Vaccine Dev, Brisbane, Qld 4006, Australia	Monash University; University of Melbourne; University of Melbourne; University of Melbourne; QIMR Berghofer Medical Research Institute		jamie.rossjohn@monash.edu; Stephanie.gras@monash.edu	McCluskey, James/A-1291-2007; Purcell, Anthony/AAH-1942-2019; gras, stephanie/C-8307-2013; Burrows, Scott/G-2050-2011; Rossjohn, Jamie/F-9032-2013	McCluskey, James/0000-0002-8597-815X; Purcell, Anthony/0000-0003-0532-8331; Burrows, Scott/0000-0002-1430-0472; Rossjohn, Jamie/0000-0002-2020-7522; gras, stephanie/0000-0001-7416-038X	Australian National Health and Medical Research Council (NHMRC); Australian Research Council; Monash University	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Monash University(Monash University)	This work was supported in part by the Australian National Health and Medical Research Council (NHMRC) and the Australian Research Council.; Supported by a Senior Fellowship from Monash University.	Adams JJ, 2011, IMMUNITY, V35, P681, DOI 10.1016/j.immuni.2011.09.013; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Bade-Doding C, 2011, HAEMATOL-HEMATOL J, V96, P110, DOI 10.3324/haematol.2010.030924; Baker BM, 2001, J EXP MED, V193, P551, DOI 10.1084/jem.193.5.551; Beddoe T, 2009, IMMUNITY, V30, P777, DOI 10.1016/j.immuni.2009.03.018; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Bulek AM, 2012, NAT IMMUNOL, V13, P283, DOI 10.1038/ni.2206; Burrows SR, 2010, P NATL ACAD SCI USA, V107, P10608, DOI 10.1073/pnas.1004926107; Burrows SR, 2006, TRENDS IMMUNOL, V27, P11, DOI 10.1016/j.it.2005.11.001; Day EB, 2011, P NATL ACAD SCI USA, V108, P9536, DOI 10.1073/pnas.1106851108; Ebert LM, 2009, CANCER RES, V69, P1046, DOI 10.1158/0008-5472.CAN-08-2926; Ely LK, 2006, P NATL ACAD SCI USA, V103, P6641, DOI 10.1073/pnas.0600743103; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Godfrey DI, 2008, IMMUNITY, V28, P304, DOI 10.1016/j.immuni.2008.02.004; Gras S, 2008, CURR OPIN IMMUNOL, V20, P119, DOI 10.1016/j.coi.2007.12.001; Gras S, 2012, J IMMUNOL, V188, P311, DOI 10.4049/jimmunol.1102686; Gras S, 2010, J EXP MED, V207, P1555, DOI 10.1084/jem.20100603; Gras S, 2009, IMMUNITY, V30, P193, DOI 10.1016/j.immuni.2008.11.011; Hickman HD, 2004, J IMMUNOL, V172, P2944, DOI 10.4049/jimmunol.172.5.2944; Ishizuka J, 2008, IMMUNITY, V28, P171, DOI 10.1016/j.immuni.2007.12.018; Jones LL, 2008, BIOCHEMISTRY-US, V47, P12398, DOI 10.1021/bi801349g; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Macdonald WA, 2009, IMMUNITY, V31, P897, DOI 10.1016/j.immuni.2009.09.025; Manning TC, 1998, IMMUNITY, V8, P413, DOI 10.1016/S1074-7613(00)80547-6; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miles JJ, 2005, J IMMUNOL, V175, P3826, DOI 10.4049/jimmunol.175.6.3826; Miles JJ, 2006, J IMMUNOL, V177, P6804, DOI 10.4049/jimmunol.177.10.6804; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Speir JA, 2001, IMMUNITY, V14, P81, DOI 10.1016/S1074-7613(01)00091-7; Stadinski BD, 2011, IMMUNITY, V35, P694, DOI 10.1016/j.immuni.2011.10.012; Theodossis A, 2010, P NATL ACAD SCI USA, V107, P5534, DOI 10.1073/pnas.1000032107; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Tynan FE, 2005, J BIOL CHEM, V280, P23900, DOI 10.1074/jbc.M503060200; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920	41	24	25	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12267	12276		10.1074/jbc.M112.344689	http://dx.doi.org/10.1074/jbc.M112.344689			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22343629	Green Published, hybrid			2022-12-25	WOS:000302782200067
J	Karman, J; Jiang, JL; Gumlaw, N; Zhao, HM; Campos-Rivera, J; Sancho, J; Zhang, JH; Jiang, CW; Cheng, SH; Zhu, YX				Karman, Jozsef; Jiang, Ji-Lei; Gumlaw, Nathan; Zhao, Hongmei; Campos-Rivera, Juanita; Sancho, Jose; Zhang, Jinhua; Jiang, Canwen; Cheng, Seng H.; Zhu, Yunxiang			Ligation of Cytotoxic T Lymphocyte Antigen-4 to T Cell Receptor Inhibits T Cell Activation and Directs Differentiation into Foxp3(+) Regulatory T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; IMMUNOLOGICAL SYNAPSE; PERIPHERAL HOMEOSTASIS; NEGATIVE REGULATOR; CTLA-4 SUPPRESSES; CUTTING EDGE; CD28; ENGAGEMENT; INDUCTION; TOLERANCE	Background: Cross-linking of TCR to CTLA-4 attenuates TCR signaling and inhibits T activation. Results: A novel bispecific fusion protein comprising CD80 mutant (CD80w88a) and LAG-3 was designed to promote TCR and CTLA-4 cross-linking via MHCII. Conclusion: TCR and CTLA-4 cross-linking resulted in T cell inhibition and Foxp3(+) regulatory T cell differentiation. Significance: This novel bispecific protein may represent a new class of therapeutics for immune modulation.	[Karman, Jozsef; Jiang, Ji-Lei; Gumlaw, Nathan; Zhao, Hongmei; Campos-Rivera, Juanita; Sancho, Jose; Zhang, Jinhua; Jiang, Canwen; Cheng, Seng H.; Zhu, Yunxiang] Genzyme Corp, Framingham, MA 01701 USA	Sanofi-Aventis; Genzyme Corporation	Zhu, YX (corresponding author), Genzyme Corp, 49 New York Ave, Framingham, MA 01701 USA.	yunxiang.zhu@genzyme.com	Cheng, Seng H/AAC-6564-2022					BAIXERAS E, 1992, J EXP MED, V176, P327, DOI 10.1084/jem.176.2.327; Baroja ML, 2002, J IMMUNOL, V168, P5070, DOI 10.4049/jimmunol.168.10.5070; Blair PJ, 1998, J IMMUNOL, V160, P12; Bluestone JA, 2006, IMMUNITY, V24, P233, DOI 10.1016/j.immuni.2006.03.001; Bour-Jordan H, 2009, IMMUNOL REV, V229, P41, DOI 10.1111/j.1600-065X.2009.00775.x; Chen WJ, 1998, J EXP MED, V188, P1849, DOI 10.1084/jem.188.10.1849; Chuang E, 2000, IMMUNITY, V13, P313, DOI 10.1016/S1074-7613(00)00031-5; Cools N, 2008, J CELL MOL MED, V12, P690, DOI 10.1111/j.1582-4934.2007.00084.x; Darlington PJ, 2002, J EXP MED, V195, P1337, DOI 10.1084/jem.20011868; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Eagar TN, 2002, EUR J IMMUNOL, V32, P972, DOI 10.1002/1521-4141(200204)32:4<972::AID-IMMU972>3.0.CO;2-M; Fife BT, 2008, IMMUNOL REV, V224, P166, DOI 10.1111/j.1600-065X.2008.00662.x; Fife BT, 2006, J CLIN INVEST, V116, P2252, DOI 10.1172/JCI27856; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Friedline RH, 2009, J EXP MED, V206, P421, DOI 10.1084/jem.20081811; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Griffin MD, 2000, J IMMUNOL, V164, P4433, DOI 10.4049/jimmunol.164.9.4433; Griffin MD, 2001, J IMMUNOL METHODS, V248, P77, DOI 10.1016/S0022-1759(00)00344-6; Guntermann C, 2002, J IMMUNOL, V168, P4420, DOI 10.4049/jimmunol.168.9.4420; Haribhai D, 2007, J IMMUNOL, V178, P2961, DOI 10.4049/jimmunol.178.5.2961; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Ise W, 2010, NAT IMMUNOL, V11, P129, DOI 10.1038/ni.1835; Jago CB, 2004, CLIN EXP IMMUNOL, V136, P463, DOI 10.1111/j.1365-2249.2004.02478.x; Jain N, 2010, P NATL ACAD SCI USA, V107, P1524, DOI 10.1073/pnas.0910341107; Karandikar NJ, 1996, J EXP MED, V184, P783, DOI 10.1084/jem.184.2.783; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Li RB, 2007, J IMMUNOL, V179, P5191, DOI 10.4049/jimmunol.179.8.5191; Linsley PS, 2009, IMMUNOL REV, V229, P307, DOI 10.1111/j.1600-065X.2009.00780.x; LINSLEY PS, 1994, IMMUNITY, V1, P793, DOI 10.1016/S1074-7613(94)80021-9; Paterson AM, 2010, NAT IMMUNOL, V11, P109, DOI 10.1038/ni0210-109; Pentcheva-Hoang T, 2004, IMMUNITY, V21, P401, DOI 10.1016/j.immuni.2004.06.017; Rao S, 2001, CLIN IMMUNOL, V101, P136, DOI 10.1006/clim.2001.5119; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Schmidt EM, 2009, J IMMUNOL, V182, P274, DOI 10.4049/jimmunol.182.1.274; Selvaraj RK, 2007, J IMMUNOL, V178, P7667, DOI 10.4049/jimmunol.178.12.7667; Tang QZ, 2004, EUR J IMMUNOL, V34, P2996, DOI 10.1002/eji.200425143; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; TRIEBEL F, 1990, J EXP MED, V171, P1393, DOI 10.1084/jem.171.5.1393; Turner MS, 2009, J IMMUNOL, V183, P4895, DOI 10.4049/jimmunol.0901459; Vasu C, 2004, J IMMUNOL, V173, P2866, DOI 10.4049/jimmunol.173.4.2866; Vasu C, 2003, INT IMMUNOL, V15, P167, DOI 10.1093/intimm/dxg017; Walunas TL, 1996, J EXP MED, V183, P2541, DOI 10.1084/jem.183.6.2541; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Walunas TL, 1998, J IMMUNOL, V160, P3855; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wu Y, 1997, J EXP MED, V185, P1327, DOI 10.1084/jem.185.7.1327	48	24	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11098	11107		10.1074/jbc.M111.283705	http://dx.doi.org/10.1074/jbc.M111.283705			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22337882	Green Published, hybrid			2022-12-25	WOS:000302780100038
J	Lemkau, LR; Comellas, G; Kloepper, KD; Woods, WS; George, JM; Rienstra, CM				Lemkau, Luisel R.; Comellas, Gemma; Kloepper, Kathryn D.; Woods, Wendy S.; George, Julia M.; Rienstra, Chad M.			Mutant Protein A30P alpha-Synuclein Adopts Wild-type Fibril Structure, Despite Slower Fibrillation Kinetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; FAMILIAL PARKINSONS-DISEASE; ANGLE-SPINNING NMR; POINT MUTATIONS A30P; HUMAN PRION PROTEIN; CHEMICAL-SHIFT; AMYLOID FIBRILS; SECONDARY STRUCTURE; MOLECULAR-CONFORMATION; RESONANCE ASSIGNMENTS	alpha-Synuclein (AS) is associated with both sporadic and familial forms of Parkinson disease (PD). In sporadic disease, wild-type AS fibrillates and accumulates as Lewy bodies within dopaminergic neurons of the substantia nigra. The accumulation of misfolded AS is associated with the death of these neurons, which underlies many of the clinical features of PD. In addition, a rare missense mutation in AS, A30P, is associated with highly penetrant, autosomal dominant PD, although the pathogenic mechanism is unclear. A30P AS fibrillates more slowly than the wild-type (WT) protein in vitro and has been reported to preferentially adopt a soluble, protofibrillar conformation. This has led to speculation that A30P forms aggregates that are distinct in structure compared with wild-type AS. Here, we perform a detailed comparison of the chemical shifts and secondary structures of these fibrillar species, based upon our recent characterization of full-length WT fibrils. We have assigned A30P AS fibril chemical shifts de novo and used them to determine its secondary structure empirically. Our results illustrate that although A30P forms fibrils more slowly than WT in vitro, the chemical shifts and secondary structure of the resultant fibrils are in high agreement, demonstrating a conserved beta-sheet core.	[Lemkau, Luisel R.; Kloepper, Kathryn D.; Rienstra, Chad M.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Comellas, Gemma; Rienstra, Chad M.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Woods, Wendy S.; George, Julia M.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Rienstra, Chad M.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Rienstra, CM (corresponding author), Univ Illinois, Dept Chem, 600 S Mathews Ave, Urbana, IL 61801 USA.	rienstra@scs.illinois.edu	George, Julia M/B-2169-2008	George, Julia M/0000-0001-6194-6914	National Institutes of Health [R01-GM073770]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073770] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM073770.	Baldus M, 1998, MOL PHYS, V95, P1197, DOI 10.1080/00268979809483251; Bockmann A, 2003, J BIOMOL NMR, V27, P323, DOI 10.1023/A:1025820611009; Castellani F, 2002, NATURE, V420, P98, DOI 10.1038/nature01070; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Cho MK, 2011, PROTEIN SCI, V20, P387, DOI 10.1002/pro.570; Choi W, 2004, FEBS LETT, V576, P363, DOI 10.1016/j.febslet.2004.09.038; Comellas G, 2011, J MOL BIOL, V411, P881, DOI 10.1016/j.jmb.2011.06.026; Comellas G, 2011, J MAGN RESON, V209, P131, DOI 10.1016/j.jmr.2010.12.011; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Darios F, 2010, EMBO REP, V11, P528, DOI 10.1038/embor.2010.66; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fredenburg RA, 2007, BIOCHEMISTRY-US, V46, P7107, DOI 10.1021/bi7000246; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; Galvin JE, 2001, ARCH NEUROL-CHICAGO, V58, P186, DOI 10.1001/archneur.58.2.186; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Goddard T. D., 2006, SPARKY 3 106; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; HEDIGER S, 1994, CHEM PHYS LETT, V223, P283, DOI 10.1016/0009-2614(94)00470-6; Helmus JJ, 2008, P NATL ACAD SCI USA, V105, P6284, DOI 10.1073/pnas.0711716105; Helmus JJ, 2010, J AM CHEM SOC, V132, P2393, DOI 10.1021/ja909827v; Huang L, 2008, BBA-BIOENERGETICS, V1777, P1098, DOI 10.1016/j.bbabio.2008.01.006; Igumenova TI, 2004, J AM CHEM SOC, V126, P5323, DOI 10.1021/ja030546w; Jaroniec CP, 2002, P NATL ACAD SCI USA, V99, P16748, DOI 10.1073/pnas.252625999; Kloepper KD, 2006, PROTEIN EXPRES PURIF, V48, P112, DOI 10.1016/j.pep.2006.02.009; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Li J, 2002, NEUROTOXICOLOGY, V23, P553, DOI 10.1016/S0161-813X(02)00066-9; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Li Y, 2008, PROTEIN SCI, V17, P199, DOI 10.1110/ps.073225008; Marulanda D, 2005, J PHYS CHEM B, V109, P18135, DOI 10.1021/jp052774d; Meuvis J, 2010, BIOCHEMISTRY-US, V49, P9345, DOI 10.1021/bi1010927; Morcombe CR, 2003, J MAGN RESON, V162, P479, DOI 10.1016/S1090-7807(03)00082-X; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Oldfield E, 2002, ANNU REV PHYS CHEM, V53, P349, DOI 10.1146/annurev.physchem.53.082201.124235; Pauli J, 2001, CHEMBIOCHEM, V2, P272, DOI 10.1002/1439-7633(20010401)2:4<272::AID-CBIC272>3.3.CO;2-U; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Pintacuda G, 2007, ANGEW CHEM INT EDIT, V46, P1079, DOI 10.1002/anie.200603093; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Schmidt HLF, 2007, J PHYS CHEM B, V111, P14362, DOI 10.1021/jp075531p; Scott DA, 2010, J NEUROSCI, V30, P8083, DOI 10.1523/JNEUROSCI.1091-10.2010; Seidel K, 2010, ANN NEUROL, V67, P684, DOI 10.1002/ana.21966; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Siemer AB, 2006, J AM CHEM SOC, V128, P13224, DOI 10.1021/ja063639x; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; van Raaij ME, 2006, BIOPHYS J, V91, pL96, DOI 10.1529/biophysj.106.090449; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Wishart DS, 1997, J BIOMOL NMR, V10, P329, DOI 10.1023/A:1018373822088; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; Wylie BJ, 2009, J AM CHEM SOC, V131, P985, DOI 10.1021/ja804041p; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zibaee S, 2007, J MOL BIOL, V374, P454, DOI 10.1016/j.jmb.2007.09.039	56	52	53	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11526	11532		10.1074/jbc.M111.306902	http://dx.doi.org/10.1074/jbc.M111.306902			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334684	hybrid, Green Published			2022-12-25	WOS:000302780100080
J	Huang, Y; Zhao, JX; Yan, X; Zhu, MJ; Long, NM; McCormick, RJ; Ford, SP; Nathanielsz, PW; Du, M				Huang, Yan; Zhao, Jun-Xing; Yan, Xu; Zhu, Mei-Jun; Long, Nathan M.; McCormick, Richard J.; Ford, Stephen P.; Nathanielsz, Peter W.; Du, Min			Maternal Obesity Enhances Collagen Accumulation and Cross-Linking in Skeletal Muscle of Ovine Offspring	PLOS ONE			English	Article							ADIPOSE-TISSUE; TGF-BETA; INSULIN-RESISTANCE; METABOLIC SYNDROME; LYSYL OXIDASE; MURINE MODEL; GROWTH; EXPRESSION; DIET; RAT	Maternal obesity (MO) has harmful effects on both fetal development and subsequent offspring health. We previously demonstrated that MO enhances collagen accumulation in fetal skeletal muscle, but its impact on mature offspring muscle collagen accumulation is unknown. Ewes were fed either a control diet (Con, fed 100% of NRC nutrient recommendations) or obesogenic diet (OB, fed 150% of NRC nutrient recommendations) from 60 days before conception to birth. All ewes received the Con diet during lactation. Male offspring were euthanized at 2.5 years (mean) and the left Longissimus dorsi (LD) muscle and semitendinosus (ST) muscle were sampled. Collagen concentration increased by 37.8 +/- 19.0% (P<0.05) in LD and 31.2616.0% (P<0.05) in ST muscle of OB compared to Con offspring muscle. Mature collagen cross-linking (pyridinoline concentration) was increased for 22.3 +/- 7.4% and 36.3 +/- 9.9% (P<0.05) in LD and ST muscle of OB group respectively. Expression of lysyl oxidase, lysyl hydroxylase-2b (LH2b) and prolyl 4-hydroxylase (P4HA) was higher in OB LD and ST muscle. In addition, the expression of metalloproteinases (MMPs) was lower but tissue inhibitor of metalloproteinases (TIMPs) was higher in OB offspring muscle, indicating reduced collagen remodeling. MO enhanced collagen content and cross-linking in offspring muscle, which might be partially due to reduced collagen remodeling. Our observation that the collagen content and cross-linking are enhanced in MO offspring muscle is significant, because fibrosis is known to impair muscle functions and is a hallmark of muscle aging.	[Huang, Yan; Zhao, Jun-Xing; Yan, Xu; Zhu, Mei-Jun; Long, Nathan M.; McCormick, Richard J.; Ford, Stephen P.; Du, Min] Univ Wyoming, Dept Anim Sci, Dev Biol Grp, Ctr Study Fetal Programming, Laramie, WY 82071 USA; [Nathanielsz, Peter W.] Univ Texas San Antonio, Hlth Sci Ctr, Ctr Pregnancy & Newborn Res, San Antonio, TX USA; [Du, Min] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA	University of Wyoming; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas Health San Antonio; Washington State University	Huang, Y (corresponding author), Univ Wyoming, Dept Anim Sci, Dev Biol Grp, Ctr Study Fetal Programming, Laramie, WY 82071 USA.	min.du@wsu.edu	Huang, Yan/C-8202-2014; Zhu, Mei-Jun/A-4248-2013; Du, Min/H-4311-2011; Yan, Xu/T-1427-2019	Huang, Yan/0000-0001-9464-6889; Du, Min/0000-0002-7232-072X; Yan, Xu/0000-0001-8547-4210; Nathanielsz, Peter/0000-0001-8410-6280	National Institutes of Health [HD057506, HD067449]; U.S. Department of Agriculture [2008-35206-18826]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067449] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD057506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Agriculture(United States Department of Agriculture (USDA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health Grants HD057506 and HD067449, as well as Research Initiative Grant 2008-35206-18826 from the U.S. Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony RV, 2003, REPRODUCTION, P183; Bayol SA, 2005, J PHYSIOL-LONDON, V567, P951, DOI 10.1113/jphysiol.2005.088989; Bayol SA, 2009, EUR J NUTR, V48, P62, DOI 10.1007/s00394-008-0760-5; Beggs ML, 2004, AGING CELL, V3, P353, DOI 10.1111/j.1474-9728.2004.00135.x; Bispham J, 2003, ENDOCRINOLOGY, V144, P3575, DOI 10.1210/en.2003-0320; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Chen YW, 2005, NEUROLOGY, V65, P826, DOI 10.1212/01.wnl.0000173836.09176.c4; Das UG, 1999, AM J PHYSIOL-REG I, V276, pR809, DOI 10.1152/ajpregu.1999.276.3.R809; Dziembowska M, 2007, BIOCHEM BIOPH RES CO, V354, P1101, DOI 10.1016/j.bbrc.2007.01.113; Edlund S, 2003, MOL BIOL CELL, V14, P529, DOI 10.1091/mbc.02-03-0037; EDWARDS DR, 1987, EMBO J, V6, P1899, DOI 10.1002/j.1460-2075.1987.tb02449.x; Eyre DR, 2005, TOP CURR CHEM, V247, P207, DOI 10.1007/b103828; EYRE DR, 1987, FEBS LETT, V220, P337, DOI 10.1016/0014-5793(87)80842-6; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; FASS, 2010, GUID CAR US AGR AN A; FOIDART M, 1981, ARCH NEUROL-CHICAGO, V38, P152, DOI 10.1001/archneur.1981.00510030046006; Furukawa F, 2003, HEPATOLOGY, V38, P879, DOI 10.1053/jhep.2003.50384; Greenwood PL, 2000, J ANIM SCI, V78, P50; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Hamid T, 2009, CIRCULATION, V119, P1386, DOI 10.1161/CIRCULATIONAHA.108.802918; HAY WW, 1984, AM J PHYSIOL, V246, pE237, DOI 10.1152/ajpendo.1984.246.3.E237; Huang Y, 2010, AM J PHYSIOL-ENDOC M, V299, pE968, DOI 10.1152/ajpendo.00434.2010; Huang Y, 2010, AM J PHYSIOL-ENDOC M, V298, pE1254, DOI 10.1152/ajpendo.00015.2010; Kamaraju SK, 2005, J BIOL CHEM, V280, P1024, DOI 10.1074/jbc.M403960200; Karunaratne JF, 2005, J ANAT, V207, P763, DOI 10.1111/j.1469-7580.2005.00494.x; Klotz S, 2005, CIRCULATION, V112, P364, DOI 10.1161/CIRCULATIONAHA.104.515106; Lahoute C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003910; Lee RC, 2001, CAN J APPL PHYSIOL, V26, P102, DOI 10.1139/h01-008; LEHTO M, 1985, RES EXP MED, V185, P95, DOI 10.1007/BF01854894; LIGHT N, 1985, MEAT SCI, V13, P137, DOI 10.1016/0309-1740(85)90054-3; Long NM, 2010, J ANIM SCI, V88, P3546, DOI 10.2527/jas.2010-3083; Martinez DA, 2003, DIABETES RES CLIN PR, V59, P1, DOI 10.1016/S0168-8227(02)00178-X; Mehan RS, 2011, CELLS TISSUES ORGANS; Miller TA, 2001, AM J PHYSIOL-REG I, V281, pR1710, DOI 10.1152/ajpregu.2001.281.5.R1710; Morgan J, 2010, MUSCLE NERVE    0825; Mu XD, 2010, AM J PATHOL, V177, P2399, DOI 10.2353/ajpath.2010.091121; Muhlhausler BS, 2007, ENDOCRINOLOGY, V148, P878, DOI 10.1210/en.2006-1115; MURPHY G, 1992, AM J RESP CELL MOL, V7, P120, DOI 10.1165/ajrcmb/7.2.120; Nathanielsz PW, 2006, ILAR J, V47, P73, DOI 10.1093/ilar.47.1.73; National Research Council (U.S.). Subcommittee on Sheep Nutrition, 1985, NUTR REQ SHEEP, pvii; Nissen PM, 2003, J ANIM SCI, V81, P3018; Oben JA, 2010, BIOCHEM BIOPH RES CO, V394, P24, DOI 10.1016/j.bbrc.2010.02.057; REISER K, 1992, FASEB J, V6, P2439, DOI 10.1096/fasebj.6.7.1348714; Reusens B, 2007, CURR DRUG TARGETS, V8, P935; Salvadori C, 2005, MUSCLE NERVE, V31, P192, DOI 10.1002/mus.20252; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Sebert SP, 2009, ENDOCRINOLOGY, V150, P634, DOI 10.1210/en.2008-0542; Smith-Mungo LI, 1998, MATRIX BIOL, V16, P387, DOI 10.1016/S0945-053X(98)90012-9; Tayebjee MH, 2003, J HYPERTENS, V21, P2211, DOI 10.1097/00004872-200312000-00002; Thandavarayan RA, 2009, AM J PHYSIOL-HEART C, V297, pH911, DOI 10.1152/ajpheart.00124.2009; Tong JF, 2009, AM J PHYSIOL-ENDOC M, V296, pE917, DOI 10.1152/ajpendo.90924.2008; Vohr BR, 2008, J MATERN-FETAL NEO M, V21, P149, DOI 10.1080/14767050801929430; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Wu NJ, 2003, J INVEST DERMATOL, V121, P926, DOI 10.1046/j.1523-1747.2003.12497.x; Yan X, 2011, BIOL REPROD IN PRESS; Yan X, 2011, BIOL REPROD, V85, P172, DOI 10.1095/biolreprod.110.089649; Yan X, 2011, INFLAMM BOWEL DIS, V17, P1513, DOI 10.1002/ibd.21539; Yan X, 2010, ENDOCRINOLOGY, V151, P380, DOI 10.1210/en.2009-0849; Yu QL, 2006, HYPERTENSION, V48, P98, DOI 10.1161/01.HYP.0000227247.27111.B2; Zhu MJ, 2008, J PHYSIOL-LONDON, V586, P2651, DOI 10.1113/jphysiol.2007.149633; Zibadi S, 2009, AM J PHYSIOL-HEART C, V297, pH976, DOI 10.1152/ajpheart.00398.2009; Zimmerman SD, 2001, AM J PHYSIOL-HEART C, V281, pH1816, DOI 10.1152/ajpheart.2001.281.4.H1816	63	28	32	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31691	10.1371/journal.pone.0031691	http://dx.doi.org/10.1371/journal.pone.0031691			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22348119	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000302737400041
J	Ettorre, M; Lorenzetto, E; Laperchia, C; Baiguera, C; Branca, C; Benarese, M; Spano, P; Pizzi, M; Buffelli, M				Ettorre, Michele; Lorenzetto, Erika; Laperchia, Claudia; Baiguera, Cristina; Branca, Caterina; Benarese, Manuela; Spano, PierFranco; Pizzi, Marina; Buffelli, Mario			Glutamatergic Neurons Induce Expression of Functional Glutamatergic Synapses in Primary Myotubes	PLOS ONE			English	Article							RAT SKELETAL-MUSCLE; CEREBELLAR GRANULE CELLS; NEUROMUSCULAR-JUNCTION; AMPA RECEPTORS; SYNAPTIC PLASTICITY; DISTINCT MECHANISMS; NEURITE OUTGROWTH; IN-VIVO; AGRIN; NEUROTRANSMITTER	Background: The functioning of the nervous system depends upon the specificity of its synaptic contacts. The mechanisms triggering the expression of the appropriate receptors on postsynaptic membrane and the role of the presynaptic partner in the differentiation of postsynaptic structures are little known. Methods and Findings: To address these questions we cocultured murine primary muscle cells with several glutamatergic neurons, either cortical, cerebellar or hippocampal. Immunofluorescence and electrophysiology analyses revealed that functional excitatory synaptic contacts were formed between glutamatergic neurons and muscle cells. Moreover, immunoprecipitation and immunofluorescence experiments showed that typical anchoring proteins of central excitatory synapses coimmunoprecipitate and colocalize with rapsyn, the acetylcholine receptor anchoring protein at the neuromuscular junction. Conclusions: These results support an important role of the presynaptic partner in the induction and differentiation of the postsynaptic structures.	[Ettorre, Michele; Lorenzetto, Erika; Laperchia, Claudia; Buffelli, Mario] Univ Verona, Dept Neurol Neuropsychol Morphol & Movement Sci, Sect Physiol & Psychol, I-37100 Verona, Italy; [Baiguera, Cristina; Branca, Caterina; Benarese, Manuela; Spano, PierFranco; Pizzi, Marina] Univ Brescia, Dept Biomed Sci & Biotechnol, Brescia, Italy; [Ettorre, Michele; Lorenzetto, Erika; Laperchia, Claudia; Baiguera, Cristina; Branca, Caterina; Benarese, Manuela; Spano, PierFranco; Pizzi, Marina; Buffelli, Mario] Natl Inst Neurosci, Rome, Italy; [Ettorre, Michele; Buffelli, Mario] Univ Verona, Ctr Biomed Comp, I-37100 Verona, Italy; [Spano, PierFranco; Pizzi, Marina] San Camillo Hosp, Ist Ricovero & Cura Carattere Sci, Venice, Italy	University of Verona; University of Brescia; University of Verona; IRCCS Ospedale San Camillo	Ettorre, M (corresponding author), Univ Verona, Dept Neurol Neuropsychol Morphol & Movement Sci, Sect Physiol & Psychol, I-37100 Verona, Italy.	Mario.buffelli@univr.it	Buffelli, Mario/C-6953-2018; Spano, Pier Franco A/E-7621-2010; SPANO, PIERFRANCO/J-9944-2016; Pizzi, Marina/K-2064-2016	Buffelli, Mario/0000-0002-3709-013X; SPANO, PIERFRANCO/0000-0002-9906-0964; Pizzi, Marina/0000-0002-4857-5204	University of Verona; Fondazione Cariverona	University of Verona; Fondazione Cariverona(Fondazione Cariverona)	This study was supported by University of Verona (http://www.univr.it) and Fondazione Cariverona (http://www.fondazionecariverona.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleakman D, 1996, NEUROPHARMACOLOGY, V35, P1689, DOI 10.1016/S0028-3908(96)00156-6; Borodinsky LN, 2007, P NATL ACAD SCI USA, V104, P335, DOI 10.1073/pnas.0607450104; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Bruneau EG, 2009, FASEB J, V23, P679, DOI 10.1096/fj.08-107946; Brunelli G, 2005, P NATL ACAD SCI USA, V102, P8752, DOI 10.1073/pnas.0500530102; Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Craig AM, 2006, TRENDS NEUROSCI, V29, P8, DOI 10.1016/j.tins.2005.11.002; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Escher P, 2005, SCIENCE, V308, P1920, DOI 10.1126/science.1108258; FIELDS RD, 1990, J NEUROSCI, V10, P2950; Francolini M, 2009, J NEUROPATH EXP NEUR, V68, P1103, DOI 10.1097/NEN.0b013e3181b7bfc8; Gallant EM, 1996, MUSCLE NERVE, V19, P450, DOI 10.1002/(SICI)1097-4598(199604)19:4<450::AID-MUS4>3.0.CO;2-B; GALLI C, 1995, J NEUROSCI, V15, P1172; Garner CC, 2006, CELL TISSUE RES, V326, P249, DOI 10.1007/s00441-006-0278-1; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; Herbst R, 2002, DEVELOPMENT, V129, P5449, DOI 10.1242/dev.00112; Hirai H, 2005, NAT NEUROSCI, V8, P1534, DOI 10.1038/nn1576; Jin CY, 2002, EUR J NEUROSCI, V15, P1125, DOI 10.1046/j.1460-9568.2002.01951.x; JO SA, 1995, NATURE, V373, P158, DOI 10.1038/373158a0; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Mays TA, 2009, MUSCLE NERVE, V39, P343, DOI 10.1002/mus.21099; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; OBATA K, 1977, BRAIN RES, V119, P141, DOI 10.1016/0006-8993(77)90096-8; Pinard A, 2003, EUR J NEUROSCI, V18, P3241, DOI 10.1111/j.1460-9568.2003.03028.x; Pizzi M, 2006, CURR OPIN NEUROBIOL, V16, P323, DOI 10.1016/j.conb.2006.05.013; Prakash YS, 1999, AM J PHYSIOL-CELL PH, V276, pC1038, DOI 10.1152/ajpcell.1999.276.5.C1038; Sandrock AW, 1997, SCIENCE, V276, P599, DOI 10.1126/science.276.5312.599; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Shen K, 2010, ANN REV NEUROSCI; So KL, 1996, FEBS LETT, V379, P63, DOI 10.1016/0014-5793(95)01486-1; Spitzer NC, 2008, PHILOS T R SOC B, V363, P1393, DOI 10.1098/rstb.2007.2257; Szabados T, 2001, BRAIN RES BULL, V55, P387, DOI 10.1016/S0361-9230(01)00516-0; Takayama C, 2004, DEV BRAIN RES, V150, P177, DOI 10.1016/j.devbrainres.2004.03.011; Trinidad JC, 2000, J NEUROSCI, V20, P8762; Tsui CC, 1996, J NEUROSCI, V16, P2463; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711; Yu XY, 2002, CELL MOL NEUROBIOL, V22, P197, DOI 10.1023/A:1019870022977; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006	51	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31451	10.1371/journal.pone.0031451	http://dx.doi.org/10.1371/journal.pone.0031451			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347480	Green Published, Green Submitted, gold			2022-12-25	WOS:000302730200023
J	Li, XS; Liu, ZB; Xu, X; Blair, CA; Sun, Z; Xie, J; Lilly, MB; Zi, XL				Li, Xuesen; Liu, Zhongbo; Xu, Xia; Blair, Christopher A.; Sun, Zheng; Xie, Jun; Lilly, Michael B.; Zi, Xiaolin			Kava Components Down-Regulate Expression of AR and AR Splice Variants and Reduce Growth in Patient-Derived Prostate Cancer Xenografts in Mice	PLOS ONE			English	Article							ANDROGEN RECEPTOR PROMOTER; TUMOR-GROWTH; FLAVOKAWAIN; CHALCONE; ANTIANDROGEN; RESISTANCE; MORTALITY; APOPTOSIS; THERAPY; CELLS	Men living in Fiji and drinking kava have low incidence of prostate cancer (PCa). However, the PCa incidence among Fijian men who had migrated to Australia, increased by 5.1-fold. We therefore examined the potential effects of kava root extracts and its active components (kavalactones and flavokawains) on PCa growth and androgen receptor (AR) expression. PCa cell lines (LNCaP, LAPC-4, 22Rv1, C4-2B, DU145 and PC-3) with different AR expression, and a transformed prostate myofibroblast cell line (WPMY-1), were treated with a commercial kava extract, kavalactones (kawain, 5'6'-dehydrokawain, yangonin, methysticin) and flavokawain B. Expression of AR and its target genes (PSA and TMPRSS2) was examined. Two novel patient-derived PCa xenograft models from high grade PCa specimens were established by implanting the specimens into nude mice and passing tumor pieces through subcutaneous injection in nude mice, and then treated with kava extract and flavokawain B to examine their effects on tumor growth, AR expression and serum PSA levels. The kava extract and flavokawain B effectively down-regulated the expression of both the full-length AR and AR splice variants. The kava extract and kavalactones accelerated AR protein degradation, while flavokawain B inhibited AR mRNA transcription via decreasing Sp1 expression and the binding of Sp1 to the AR promoter. The kava root extract and flavokawain B reduce tumor growth, AR expression in tumor tissues and levels of serum PSA in the patient-derived PCa xenograft models. These results suggest a potential usefulness of a safe kava product or its active components for prevention and treatment of advanced PCa by targeting AR.	[Li, Xuesen; Liu, Zhongbo; Xu, Xia; Blair, Christopher A.; Sun, Zheng; Zi, Xiaolin] Univ Calif Irvine, Dept Urol, Orange, CA 92668 USA; [Xie, Jun; Zi, Xiaolin] Univ Calif Irvine, Dept Pharmaceut Sci, Orange, CA 92668 USA; [Blair, Christopher A.; Zi, Xiaolin] Univ Calif Irvine, Dept Pharmacol, Orange, CA 92668 USA; [Lilly, Michael B.] Univ Calif Irvine, Dept Med, Orange, CA 92668 USA; [Lilly, Michael B.; Zi, Xiaolin] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Orange, CA 92668 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Li, XS (corresponding author), Univ Calif Irvine, Dept Urol, Orange, CA 92668 USA.	xzi@uci.edu	Liu, Zhongbo/U-3004-2017		National Institutes of Health [CA129793, CA122558]; American Institute for Cancer Research [41493]; NATIONAL CANCER INSTITUTE [R01CA122558, R21CA152804, P30CA062203, R21CA129793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Institute for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants CA129793 and CA122558 (http://www.cancer.gov/)and American Institute for Cancer Research grant 41493(http://www.aicr.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RJ, 2010, CANCER CELL, V17, P535, DOI 10.1016/j.ccr.2010.04.027; Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; FABER PW, 1993, J BIOL CHEM, V268, P9296; Foster WR, 2011, PROSTATE, V71, P480, DOI 10.1002/pros.21263; HAENSZEL W, 1968, JNCI-J NATL CANCER I, V40, P43; Henderson B E, 1985, Natl Cancer Inst Monogr, V69, P73; Hu R, 2011, PROSTATE, V71, P1656, DOI 10.1002/pros.21382; Jansen AAAJ, 1991, FOOD NUTR FIJI HIST; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Mostaghel EA, 2011, CLIN CANCER RES, V17, P5913, DOI 10.1158/1078-0432.CCR-11-0728; Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9; Sharifi N, 2010, ENDOCR-RELAT CANCER, V17, pR305, DOI 10.1677/ERC-10-0187; SINGH YN, 1992, J ETHNOPHARMACOL, V37, P13, DOI 10.1016/0378-8741(92)90003-A; Steiner G G, 2000, Hawaii Med J, V59, P420; Supramaniam Rajah, 2006, CANC NEW S WALES MIG, P33; Takane KK, 1996, MOL CELL ENDOCRINOL, V119, P83, DOI 10.1016/0303-7207(96)03800-2; Tang YX, 2010, INT J CANCER, V127, P1758, DOI 10.1002/ijc.25210; Tang YX, 2008, CANCER PREV RES, V1, P439, DOI 10.1158/1940-6207.CAPR-08-0165; Tang YX, 2009, MOL CANCER THER, V8, P458, DOI 10.1158/1535-7163.MCT-08-0885; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Wang LG, 2008, CANCER RES, V68, P2678, DOI 10.1158/0008-5472.CAN-07-6017; Wang YW, 2005, LAB INVEST, V85, P1392, DOI 10.1038/labinvest.3700335; Wang YZ, 2005, PROSTATE, V64, P149, DOI 10.1002/pros.20225; Webber MM, 1999, CARCINOGENESIS, V20, P1185, DOI 10.1093/carcin/20.7.1185; Yu S., 2011, PROSTATE; Zi XL, 2005, CANCER RES, V65, P3479, DOI 10.1158/0008-5472.CAN-04-3803	28	44	44	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31213	10.1371/journal.pone.0031213	http://dx.doi.org/10.1371/journal.pone.0031213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347450	Green Published, gold			2022-12-25	WOS:000302730200015
J	Rijken, MJ; Papageorghiou, AT; Thiptharakun, S; Kiricharoen, S; Dwell, SLM; Wiladphaingern, J; Pimanpanarak, M; Kennedy, SH; Nosten, F; McGready, R				Rijken, Marcus J.; Papageorghiou, Aris T.; Thiptharakun, Supan; Kiricharoen, Suporn; Dwell, Saw Lu Mu; Wiladphaingern, Jacher; Pimanpanarak, Mupawjay; Kennedy, Stephen H.; Nosten, Francois; McGready, Rose			Ultrasound Evidence of Early Fetal Growth Restriction after Maternal Malaria Infection	PLOS ONE			English	Article							THAI-BURMESE BORDER; LOW-BIRTH-WEIGHT; FALCIPARUM-MALARIA; PLASMODIUM-VIVAX; PREGNANCY; 1ST-TRIMESTER; VELOCITY; PATHOGENESIS; ENDEMICITY; REFUGEES	Background: Intermittent preventive treatment (IPT), the main strategy to prevent malaria and reduce anaemia and low birthweight, focuses on the second half of pregnancy. However, intrauterine growth restriction may occur earlier in pregnancy. The aim of this study was to measure the effects of malaria in the first half of pregnancy by comparing the fetal biparietal diameter (BPD) of infected and uninfected women whose pregnancies had been accurately dated by crown rump length (CRL) before 14 weeks of gestation. Methodology/Principal Findings: In 3,779 women living on the Thai-Myanmar border who delivered a normal singleton live born baby between 2001-10 and who had gestational age estimated by CRL measurement <14 weeks, the observed and expected BPD z-scores (<24 weeks) in pregnancies that were (n = 336) and were not (n = 3,443) complicated by malaria between the two scans were compared. The mean (standard deviation) fetal BPD z-scores in women with Plasmodium (P) falciparum and/or P. vivax malaria infections were significantly lower than in non-infected pregnancies; -0.57 (1.13) versus -0.10 (1.17), p<0.001. Even a single or an asymptomatic malaria episode resulted in a significantly lower z-score. Fetal female sex (p<0.001) and low body mass index (p = 0.01) were also independently associated with a smaller BPD in multivariate analysis. Conclusions/Significance: Despite early treatment in all positive women, one or more (a) symptomatic P. falciparum or P. vivax malaria infections in the first half of pregnancy result in a smaller than expected mid-trimester fetal head diameter. Strategies to prevent malaria in pregnancy should include early pregnancy.	[Rijken, Marcus J.; Thiptharakun, Supan; Kiricharoen, Suporn; Dwell, Saw Lu Mu; Wiladphaingern, Jacher; Pimanpanarak, Mupawjay; Nosten, Francois; McGready, Rose] Shoklo Malaria Res Unit, Mae Sot, Tak, Thailand; [Papageorghiou, Aris T.; Kennedy, Stephen H.] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Green Templeton Coll, Oxford, England; [Papageorghiou, Aris T.; Kennedy, Stephen H.] Univ Oxford, Oxford Maternal & Perinatal Hlth Inst, Green Templeton Coll, Oxford, England; [Nosten, Francois; McGready, Rose] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand; [Nosten, Francois; McGready, Rose] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England	Mahidol University; University of Oxford; University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford	Rijken, MJ (corresponding author), Shoklo Malaria Res Unit, Mae Sot, Tak, Thailand.	marcus@shoklo-unit.com	Nosten, Francois/AAC-5509-2019; McGready, Rose/A-3290-2014	Nosten, Francois/0000-0002-7951-0745; McGready, Rose/0000-0003-1621-3257; Papageorghiou, Aris T./0000-0001-8143-2232; Rijken, Marcus/0000-0003-0914-5508	Wellcome Trust of Great Britain; Oxford Partnership Comprehensive Biomedical Research Centre; Department of Health NIHR Biomedical Research Centres	Wellcome Trust of Great Britain(Wellcome Trust); Oxford Partnership Comprehensive Biomedical Research Centre; Department of Health NIHR Biomedical Research Centres(National Institute for Health Research (NIHR))	This research was a part of the Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme, supported by the Wellcome Trust of Great Britain (Major Overseas Programme-Thailand Unit Core Grant). A T Papageorghiou is supported by the Oxford Partnership Comprehensive Biomedical Research Centre with funding from the Department of Health NIHR Biomedical Research Centres funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BURMESE BORDER GUIDE; Arbeille P, 2003, PARASITOLOGY, V126, P513, DOI 10.1017/S0031182003003160; Bertino E, 1996, ARCH DIS CHILD-FETAL, V74, pF10, DOI 10.1136/fn.74.1.F10; Huynh BT, 2011, AM J TROP MED HYG, V85, P214, DOI 10.4269/ajtmh.2011.11-0103; Bottomley C, 2009, HUM REPROD, V24, P284, DOI 10.1093/humrep/den389; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Carrara VI, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-45; Carrara VI, 2006, PLOS MED, V3, P856, DOI 10.1371/journal.pmed.0030183; Carvalho BO, 2010, J INFECT DIS, V202, P638, DOI 10.1086/654815; Cottrell G, 2007, AM J TROP MED HYG, V76, P849, DOI 10.4269/ajtmh.2007.76.849; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Dorman EK, 2002, ULTRASOUND OBST GYN, V19, P165, DOI 10.1046/j.0960-7692.2001.00545.x; Harris RD, 2009, J ULTRAS MED, V28, P1067, DOI 10.7863/jum.2009.28.8.1067; Hofmeyr GJ, 2009, ULTRASOUND OBST GYN, V34, P367, DOI 10.1002/uog.7352; Lampl M, 2003, AM J HUM BIOL, V15, P667, DOI 10.1002/ajhb.10204; Lampl M, 2001, ANN HUM BIOL, V28, P403, DOI 10.1080/03014460010016662; Lampl M, 2007, AM J HUM BIOL, V19, P643, DOI 10.1002/ajhb.20707; Lampl M, 2009, AM J HUM BIOL, V21, P782, DOI 10.1002/ajhb.20880; Landis SH, 2009, EPIDEMIOL INFECT, V137, P294, DOI 10.1017/S0950268808000915; Leung TN, 2008, ULTRASOUND OBST GYN, V31, P321, DOI 10.1002/uog.5192; Liabsuetrakul T, 2011, J HEALTH POPUL NUTR, V29, P218, DOI 10.3329/jhpn.v29i3.7869; Luxemburger C, 2003, T ROY SOC TROP MED H, V97, P251, DOI 10.1016/S0035-9203(03)90134-9; McGready R, 2011, LANCET INFECT DIS; Milani S, 2005, PEDIATR RES, V57, P205, DOI 10.1203/01.PDR.0000148452.98518.D5; Mook-Kanamori DO, 2010, JAMA-J AM MED ASSOC, V303, P527, DOI 10.1001/jama.2010.78; Mukri F, 2008, BJOG-INT J OBSTET GY, V115, P1273, DOI 10.1111/j.1471-0528.2008.01833.x; Neilson JP, 2000, COCHRANE DB SYST REV; Nosten F, 2004, TRENDS PARASITOL, V20, P425, DOI 10.1016/j.pt.2004.06.007; NOSTEN F, 1991, T ROY SOC TROP MED H, V85, P424, DOI 10.1016/0035-9203(91)90205-D; Nosten F, 1999, LANCET, V354, P546, DOI 10.1016/S0140-6736(98)09247-2; Nosten F, 2007, LANCET INFECT DIS, V7, P118, DOI 10.1016/S1473-3099(07)70023-3; Pedersen NG, 2008, ULTRASOUND OBST GYN, V32, P147, DOI 10.1002/uog.6109; Pedersen NG, 2008, OBSTET GYNECOL, V112, P765, DOI 10.1097/AOG.0b013e318187d034; Poespoprodjo JR, 2008, CLIN INFECT DIS, V46, P1374, DOI 10.1086/586743; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Rijken MJ, 2011, BJOG-INT J OBSTET GY, V118, P671, DOI 10.1111/j.1471-0528.2010.02880.x; Rijken MJ, 2009, ULTRASOUND OBST GYN, V34, P395, DOI 10.1002/uog.7350; Rijken MJ, 2012, LANCET INFECT DIS, V12, P75, DOI 10.1016/S1473-3099(11)70315-2; Rijken MJ, 2011, THAI BURMES IN PRESS; ROBINSON HP, 1975, BRIT J OBSTET GYNAEC, V82, P702, DOI 10.1111/j.1471-0528.1975.tb00710.x; Rogerson SJ, 2007, AM J TROP MED HYG, V77, P14; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Salomon LJ, 2006, ULTRASOUND OBST GYN, V28, P193, DOI 10.1002/uog.2733; Salomon LJ, 2005, ULTRASOUND OBST GYN, V26, P750, DOI 10.1002/uog.2640; Smith GCS, 2004, SEMIN PERINATOL, V28, P41, DOI 10.1053/j.semperi.2003.10.012; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; TAHA TE, 1993, AM J EPIDEMIOL, V138, P318, DOI 10.1093/oxfordjournals.aje.a116861; Umbers AJ, 2011, TRENDS PARASITOL, V27, P168, DOI 10.1016/j.pt.2011.01.007; Villar J, 1982, Obstet Gynecol Surv, V37, P499, DOI 10.1097/00006254-198208000-00001; WHO, WHO STRAT FRAM MAL C; WHO, 2010, GUID TREATM MAL, V2nd	52	54	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2012	7	2							e31411	10.1371/journal.pone.0031411	http://dx.doi.org/10.1371/journal.pone.0031411			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZQ	22347473	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000302730200021
J	Jacobberger, JW; Avva, J; Sreenath, SN; Weis, MC; Stefan, T				Jacobberger, James W.; Avva, Jayant; Sreenath, Sree N.; Weis, Michael C.; Stefan, Tammy			Dynamic Epitope Expression from Static Cytometry Data: Principles and Reproducibility	PLOS ONE			English	Article							CELL-CYCLE; GENE-EXPRESSION; FLOW-CYTOMETRY; ANTIGEN LEVELS; QUANTIFICATION; PROTEIN; MITOSIS; LINES; B1	Background: An imprecise quantitative sense for the oscillating levels of proteins and their modifications, interactions, and translocations as a function of the cell cycle is fundamentally important for a cartoon/narrative understanding for how the cell cycle works. Mathematical modeling of the same cartoon/narrative models would be greatly enhanced by an open-ended methodology providing precise quantification of many proteins and their modifications, etc. Here we present methodology that fulfills these features. Methodology: Multiparametric flow cytometry was performed on Molt4 cells to measure cyclins A2 and B1, phospho-S10-histone H3, DNA content, and light scatter (cell size). The resulting 5 dimensional data were analyzed as a series of bivariate plots to isolate the data as segments of an N-dimensional "worm" through the data space. Sequential, unidirectional regions of the data were used to assemble expression profiles for each parameter as a function of cell frequency. Results: Analysis of synthesized data in which the true values where known validated the approach. Triplicate experiments demonstrated exceptional reproducibility. Comparison of three triplicate experiments stained by two methods (single cyclin or dual cyclin measurements with common DNA and phospho-histone H3 measurements) supported the feasibility of combining an unlimited number of epitopes through this methodology. The sequential degradations of cyclin A2 followed by cyclin B1 followed by de-phosphorylation of histone H3 were precisely mapped. Finally, a two phase expression rate during interphase for each cyclin was robustly identified. Conclusions: Very precise, correlated expression profiles for important cell cycle regulating and regulated proteins and their modifications can be produced, limited only by the number of available high-quality antibodies. These profiles can be assembled into large information libraries for calibration and validation of mathematical models.	[Jacobberger, James W.; Stefan, Tammy] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Avva, Jayant; Sreenath, Sree N.; Weis, Michael C.] Case Western Reserve Univ, Dept Elect Engn & Comp Sci, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Jacobberger, JW (corresponding author), Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.	jwj@case.edu	Jacobberger, James/P-9183-2014	Jacobberger, James/0000-0002-3092-5157	National Cancer Institute [R01CA73413, P30CA43703]; NATIONAL CANCER INSTITUTE [P30CA043703, R01CA073413] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants R01CA73413 (JWJ) and P30CA43703 (Case Comprehensive Cancer Center Core Facility Support) from the National Cancer Institute (http://www.cancer.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagwell CB, 2011, METHODS MOL BIOL, V699, P31, DOI 10.1007/978-1-61737-950-5_2; Darzynkiewicz Z, 2004, CYTOM PART A, V58A, P21, DOI 10.1002/cyto.a.20003; Darzynkiewicz Z, 1996, CYTOMETRY, V25, P1; FRIED J, 1976, COMPUT BIOMED RES, V9, P263, DOI 10.1016/0010-4809(76)90006-9; Frisa PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007064; Frisa PS, 2000, CYTOMETRY, V39, P79, DOI 10.1002/(SICI)1097-0320(20000101)39:1<79::AID-CYTO11>3.0.CO;2-3; Frisa PS, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-10; Gray JW, 1990, FLOW CYTOMETRY CELL; Jacobberger JW, 2008, CYTOM PART A, V73A, P5, DOI 10.1002/cyto.a.20501; Jacobberger JW, 2011, METHODS MOL BIOL, V699, P229, DOI 10.1007/978-1-61737-950-5_11; Jacobberger JW, 1999, CYTOMETRY, V35, P284, DOI 10.1002/(SICI)1097-0320(19990301)35:3<284::AID-CYTO12>3.0.CO;2-K; Laoukili J, 2008, MOL CELL BIOL, V28, P3076, DOI 10.1128/MCB.01710-07; MINOWADA J, 1972, J NATL CANCER I, V49, P891; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Sible JC, 2007, METHODS, V41, P238, DOI 10.1016/j.ymeth.2006.08.003; SLADEK TL, 1993, CYTOMETRY, V14, P23, DOI 10.1002/cyto.990140106; Soni DV, 2008, CELL CYCLE, V7, P1285, DOI 10.4161/cc.7.9.5711; Sramkoski RM, 1999, CYTOMETRY, V35, P274, DOI 10.1002/(SICI)1097-0320(19990301)35:3<274::AID-CYTO11>3.0.CO;2-O; Stefan T, 2011, METHOD CELL BIOL, V102, P341, DOI 10.1016/B978-0-12-374912-3.00014-6; Tomasoni D, 2003, EXP CELL RES, V288, P158, DOI 10.1016/S0014-4827(03)00207-6; WALKER PMB, 1954, J EXP BIOL, V31, P8; Watson JV, 1991, INTRO FLOW CYTOMETRY	23	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30870	10.1371/journal.pone.0030870	http://dx.doi.org/10.1371/journal.pone.0030870			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22347408	Green Submitted, Green Published, gold			2022-12-25	WOS:000302730100027
J	Bol, SM; Booiman, T; van Manen, D; Bunnik, EM; van Sighem, AI; Sieberer, M; Boeser-Nunnink, B; de Wolf, F; Schuitemaker, H; Portegies, P; Kootstra, NA; van 't Wout, AB				Bol, Sebastiaan M.; Booiman, Thijs; van Manen, Danielle; Bunnik, Evelien M.; van Sighem, Ard I.; Sieberer, Margit; Boeser-Nunnink, Brigitte; de Wolf, Frank; Schuitemaker, Hanneke; Portegies, Peter; Kootstra, Neeltje A.; van 't Wout, Angelique B.			Single Nucleotide Polymorphism in Gene Encoding Transcription Factor Prep1 Is Associated with HIV-1-Associated Dementia	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NECROSIS-FACTOR-ALPHA; AIDS DEMENTIA; TYPE-1 INFECTION; CLINICAL-COURSE; HIV-SUBTYPE; BRAIN; EXPRESSION; PROMOTER; GENOTYPE	Background: Infection with HIV-1 may result in severe cognitive and motor impairment, referred to as HIV-1-associated dementia (HAD). While its prevalence has dropped significantly in the era of combination antiretroviral therapy, milder neurocognitive disorders persist with a high prevalence. To identify additional therapeutic targets for treating HIV-associated neurocognitive disorders, several candidate gene polymorphisms have been evaluated, but few have been replicated across multiple studies. Methods: We here tested 7 candidate gene polymorphisms for association with HAD in a case-control study consisting of 86 HAD cases and 246 non-HAD AIDS patients as controls. Since infected monocytes and macrophages are thought to play an important role in the infection of the brain, 5 recently identified single nucleotide polymorphisms (SNPs) affecting HIV-1 replication in macrophages in vitro were also tested. Results: The CCR5 wt/Delta 32 genotype was only associated with HAD in individuals who developed AIDS prior to 1991, in agreement with the observed fading effect of this genotype on viral load set point. A significant difference in genotype distribution among all cases and controls irrespective of year of AIDS diagnosis was found only for a SNP in candidate gene PREP1 (p = 1.2x10(-5)). Prep1 has recently been identified as a transcription factor preferentially binding the -2,518 G allele in the promoter of the gene encoding MCP-1, a protein with a well established role in the etiology of HAD. Conclusion: These results support previous findings suggesting an important role for MCP-1 in the onset of HIV-1-associated neurocognitive disorders.	[Bol, Sebastiaan M.; Booiman, Thijs; van Manen, Danielle; Bunnik, Evelien M.; Sieberer, Margit; Boeser-Nunnink, Brigitte; Schuitemaker, Hanneke; Kootstra, Neeltje A.; van 't Wout, Angelique B.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Bol, Sebastiaan M.; Booiman, Thijs; van Manen, Danielle; Bunnik, Evelien M.; Sieberer, Margit; Boeser-Nunnink, Brigitte; Schuitemaker, Hanneke; Kootstra, Neeltje A.; van 't Wout, Angelique B.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [van Sighem, Ard I.; de Wolf, Frank] Univ Amsterdam, Acad Med Ctr, HIV Monitoring Fdn, NL-1105 AZ Amsterdam, Netherlands; [de Wolf, Frank] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Portegies, Peter] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; [Portegies, Peter] OLVG Hosp, Dept Neurol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Imperial College London; University of Amsterdam; Academic Medical Center Amsterdam	Bol, SM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Landsteiner Lab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	a.b.vantwout@amc.uva.nl		Kootstra, Neeltje A./0000-0001-9429-7754; Bunnik, Evelien/0000-0003-4003-3053; Bol, Sebastiaan/0000-0002-3843-6657	Center for Infectious Disease Control of the Netherlands National Institute for Public Health and the Environment; Landsteiner Foundation Blood Research [0526]; European Union [029167]	Center for Infectious Disease Control of the Netherlands National Institute for Public Health and the Environment; Landsteiner Foundation Blood Research; European Union(European Commission)	The Amsterdam Cohort Studies on HIV infection and AIDS, a collaboration between the Public Health Service of Amsterdam, the Academic Medical Center of the University of Amsterdam, the Sanquin Blood Supply Foundation, Jan van Goyen Medical Center, and the University Medical Center Utrecht, are part of the Netherlands HIV Monitoring Foundation and financially supported by the Center for Infectious Disease Control of the Netherlands National Institute for Public Health and the Environment.; Landsteiner Foundation Blood Research (registration number 0526) and the European Union (Marie Curie International Reintegration Grant 029167). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHIM CL, 1993, J CLIN INVEST, V91, P2769, DOI 10.1172/JCI116518; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Ashton Katie A, 2006, Hered Cancer Clin Pract, V4, P94, DOI 10.1186/1897-4287-4-2-94; Banisadr G, 2005, J COMP NEUROL, V489, P275, DOI 10.1002/cne.20598; Bhaskaran K, 2008, ANN NEUROL, V63, P213, DOI 10.1002/ana.21225; Birchler JA, 2003, PLANT CELL, V15, P2236, DOI 10.1105/tpc.151030; Boivin MJ, 2010, AIDS, V24, P1163, DOI 10.1097/QAD.0b013e3283389dcc; Bol SM, 2011, FUTURE VIROL, V6, P187, DOI 10.2217/FVL.10.93; Bol SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017190; Bol SM, 2009, VIROLOGY, V390, P205, DOI 10.1016/j.virol.2009.05.027; BUKRINSKY MI, 1995, J EXP MED, V181, P735, DOI 10.1084/jem.181.2.735; Chen Y, 2008, KIDNEY INT, V74, P115, DOI 10.1038/ki.2008.113; Cirulli ET, 2010, EUR J HUM GENET, V18, P815, DOI 10.1038/ejhg.2010.2; Comings DE, 2000, MOL GENET METAB, V71, P19, DOI 10.1006/mgme.2000.3015; Corder EH, 1998, NAT MED, V4, P1182, DOI 10.1038/2677; Diaz-Arrastia R, 2004, J NEUROVIROL, V10, P67, DOI 10.1080/13550280490270770; Dunlop O, 1997, ACTA NEUROL SCAND, V95, P315, DOI 10.1111/j.1600-0404.1997.tb00217.x; GELBARD HA, 1994, J VIROL, V68, P4628, DOI 10.1128/JVI.68.7.4628-4635.1994; GENIS P, 1992, J EXP MED, V176, P1703, DOI 10.1084/jem.176.6.1703; GLASS JD, 1995, ANN NEUROL, V38, P755, DOI 10.1002/ana.410380510; Gonzalez E, 2002, P NATL ACAD SCI USA, V99, P13795, DOI 10.1073/pnas.202357499; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; GRIFFIN DE, 1994, ANN NEUROL, V35, P592, DOI 10.1002/ana.410350513; Harezlak J, 2011, AIDS; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Husman AMD, 1997, ANN INTERN MED, V127, P882, DOI 10.7326/0003-4819-127-10-199711150-00004; JANSSEN RS, 1991, NEUROLOGY, V41, P778; Jiang ZG, 2001, J NEUROIMMUNOL, V117, P97, DOI 10.1016/S0165-5728(01)00315-0; Kaul M, 1999, P NATL ACAD SCI USA, V96, P8212, DOI 10.1073/pnas.96.14.8212; Kroeger KM, 1997, MOL IMMUNOL, V34, P391, DOI 10.1016/S0161-5890(97)00052-7; Leduc V, 2010, TRENDS MOL MED, V16, P469, DOI 10.1016/j.molmed.2010.07.008; Levine Andrew J, 2009, Neurobehav HIV Med, V1, P1; MAGNUSON DSK, 1995, ANN NEUROL, V37, P373, DOI 10.1002/ana.410370314; Mishra M, 2008, ANN NEUROL, V63, P366, DOI 10.1002/ana.21292; Monforte AD, 2004, ANN NEUROL, V55, P320, DOI 10.1002/ana.10827; NAVIA BA, 1986, ANN NEUROL, V19, P517, DOI 10.1002/ana.410190602; Patel CA, 2000, J VIROL, V74, P9717, DOI 10.1128/JVI.74.20.9717-9726.2000; PELUSO R, 1985, VIROLOGY, V147, P231, DOI 10.1016/0042-6822(85)90246-6; Pemberton LA, 2008, HIV MED, V9, P677, DOI 10.1111/j.1468-1293.2008.00614.x; PORTEGIES P, 1993, AIDS, V7, P669, DOI 10.1097/00002030-199305000-00010; PULLIAM L, 1993, AIDS RES HUM RETROV, V9, P439, DOI 10.1089/aid.1993.9.439; Quasney MW, 2001, ANN NEUROL, V50, P157, DOI 10.1002/ana.1284.abs; Rovin BH, 1999, BIOCHEM BIOPH RES CO, V259, P344, DOI 10.1006/bbrc.1999.0796; Sacktor N, 2009, CLIN INFECT DIS, V49, P780, DOI 10.1086/605284; Sato-Matsumura KC, 1998, J NEUROIMMUNOL, V91, P89, DOI 10.1016/S0165-5728(98)00161-1; Schmidtmayerova H, 1996, P NATL ACAD SCI USA, V93, P700, DOI 10.1073/pnas.93.2.700; Schouten J, 2010, AIDS; Seilhean D, 1997, ACTA NEUROPATHOL, V93, P508, DOI 10.1007/s004010050646; Shiramizu B, 2006, J INVEST MED, V54, P468, DOI 10.2310/6650.2006.06007; Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b; Singh KK, 2004, J NEUROIMMUNOL, V157, P185, DOI 10.1016/j.jneuroim.2004.08.027; Takahashi K, 1996, ANN NEUROL, V39, P705, DOI 10.1002/ana.410390606; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; VAGO L, 1993, J ACQ IMMUN DEF SYND, V6, P42; van Manen D, 2011, AIDS, V25, P2217, DOI 10.1097/QAD.0b013e32834bec9c; van Manen D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022208; van Rij RP, 1998, J INFECT DIS, V178, P1806, DOI 10.1086/314522; van Rij RP, 1999, J INFECT DIS, V180, P854, DOI 10.1086/314940; Vivithanaporn P, 2010, NEUROLOGY, V75, P1150, DOI 10.1212/WNL.0b013e3181f4d5bb; WILEY CA, 1986, P NATL ACAD SCI USA, V83, P7089, DOI 10.1073/pnas.83.18.7089; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; Wright EK, 2008, GENES IMMUN, V9, P419, DOI 10.1038/gene.2008.33; Zemunik T, 2009, CROAT MED J, V50, P23, DOI 10.3325/cmj.2009.50.23; Zivelin A, 1997, CLIN CHEM, V43, P1657	64	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e30990	10.1371/journal.pone.0030990	http://dx.doi.org/10.1371/journal.pone.0030990			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22347417	Green Published, Green Submitted, gold			2022-12-25	WOS:000302180600019
J	Cerqueira, FM; Brandizzi, LI; Cunha, FM; Laurindo, FRM; Kowaltowski, AJ				Cerqueira, Fernanda M.; Brandizzi, Laura I.; Cunha, Fernanda M.; Laurindo, Francisco R. M.; Kowaltowski, Alicia J.			Serum from Calorie-Restricted Rats Activates Vascular Cell eNOS through Enhanced Insulin Signaling Mediated by Adiponectin	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PROTEIN-KINASE-B; ENDOTHELIAL-CELLS; MITOCHONDRIAL BIOGENESIS; AKT; GLUCOSE; PHOSPHORYLATION; EXPRESSION; AGE; ADIPOCYTES	eNOS activation resulting in mitochondrial biogenesis is believed to play a central role in life span extension promoted by calorie restriction (CR). We investigated the mechanism of this activation by treating vascular cells with serum from CR rats and found increased Akt and eNOS phosphorylation, in addition to enhanced nitrite release. Inhibiting Akt phosphorylation or immunoprecipitating adiponectin (found in high quantities in CR serum) completely prevented the increment in nitrite release and eNOS activation. Overall, we demonstrate that adiponectin in the serum from CR animals increases NO center dot signaling by activating the insulin pathway. These results suggest this hormone may be a determinant regulator of the beneficial effects of CR.	[Cerqueira, Fernanda M.; Cunha, Fernanda M.; Kowaltowski, Alicia J.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Brandizzi, Laura I.; Laurindo, Francisco R. M.] Univ Sao Paulo, Fac Med, Inst Coracao, Sao Paulo, Brazil; [Cunha, Fernanda M.] Univ Sao Paulo, Escola Artes Ciencias & Humanidades, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Cerqueira, FM (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.	alicia@iq.usp.br	da Cunha, Fernanda M/G-3575-2012; Kowaltowski, Alicia J/H-8698-2012; Laurindo, Francisco R/J-6575-2015; cerqueira, fernanda/C-8326-2014; DA CUNHA, FERNANDA MARQUES/AAY-4000-2020	da Cunha, Fernanda M/0000-0002-1583-5380; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (Redoxoma); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento do Pessoal de Nivel Superior (CAPES); John Simon Guggenheim Memorial Foundation	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (Redoxoma); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento do Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); John Simon Guggenheim Memorial Foundation	This work is supported by grants from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (Redoxoma), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento do Pessoal de Nivel Superior (CAPES) and the John Simon Guggenheim Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barros MH, 2010, MECH AGEING DEV, V131, P494, DOI 10.1016/j.mad.2010.04.008; Baylis C, 1998, CURR OPIN NEPHROL HY, V7, P59, DOI 10.1097/00041552-199801000-00010; Benard G, 2006, AM J PHYSIOL-CELL PH, V291, pC1172, DOI 10.1152/ajpcell.00195.2006; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Cerqueira FM, 2011, FREE RADICAL BIO MED, V51, P1454, DOI 10.1016/j.freeradbiomed.2011.07.006; Cerqueira FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018433; Cerqueira FM, 2010, AGEING RES REV, V9, P424, DOI 10.1016/j.arr.2010.05.002; Chen H, 2003, J BIOL CHEM, V278, P45021, DOI 10.1074/jbc.M307878200; da Silva CCC, 2008, AGING CELL, V7, P552, DOI 10.1111/j.1474-9726.2008.00407.x; de Cabo R, 2003, EXP GERONTOL, V38, P631, DOI 10.1016/S0531-5565(03)00055-X; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Fisslthaler B, 2003, NITRIC OXIDE-BIOL CH, V8, P253, DOI 10.1016/S1089-8603(03)00042-9; Fukuzawa K, 2004, BIOCHEMISTRY-MOSCOW+, V69, P50, DOI 10.1023/B:BIRY.0000016351.77553.74; Gao F, 2002, CIRCULATION, V105, P1497, DOI 10.1161/01.CIR.0000012529.00367.0F; Gopalsamy A, 2007, J MED CHEM, V50, P5547, DOI 10.1021/jm070851i; Han SH, 2009, PROG CARDIOVASC DIS, V52, P126, DOI 10.1016/j.pcad.2009.06.004; Hartell NA, 2005, BIOCHEM PHARMACOL, V69, P781, DOI 10.1016/j.bcp.2004.11.022; Hayashi H, 2008, EXP GERONTOL, V43, P827, DOI 10.1016/j.exger.2008.05.011; Head E, 2009, EXP NEUROL, V220, P171, DOI 10.1016/j.expneurol.2009.08.014; Heilbronn LK, 2003, CURR PHARM DESIGN, V9, P1411, DOI 10.2174/1381612033454766; Hepple RT, 2006, REJUV RES, V9, P219, DOI 10.1089/rej.2006.9.219; Hepple RT, 2005, FASEB J, V19, P1320, DOI 10.1096/fj.04-3535fje; Koh EH, 2010, AM J PHYSIOL-ENDOC M, V298, pE846, DOI 10.1152/ajpendo.00008.2010; Le Gouill E, 2007, DIABETES, V56, P2690, DOI 10.2337/db06-1228; Leite PF, 2003, ARTERIOSCL THROM VAS, V23, P2197, DOI 10.1161/01.ATV.0000093980.46838.41; Lev-Ran A, 1998, MECH AGEING DEV, V102, P95, DOI 10.1016/S0047-6374(98)00027-X; Li B., 2011, J AGING RES; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lopez-Lluch G, 2008, EXP GERONTOL, V43, P813, DOI 10.1016/j.exger.2008.06.014; Mahoney LB, 2006, LIPIDS HLTH DIS, V18, P5; MASORO EJ, 1992, J GERONTOL, V47, pB202, DOI 10.1093/geronj/47.6.B202; McConell GK, 2010, J APPL PHYSIOL, V108, P589, DOI 10.1152/japplphysiol.00377.2009; Motoshima H, 2004, BIOCHEM BIOPH RES CO, V315, P264, DOI 10.1016/j.bbrc.2004.01.049; NECHAD M, 1983, EXP CELL RES, V149, P119, DOI 10.1016/0014-4827(83)90385-3; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Oberley TD, 2008, J HISTOCHEM CYTOCHEM, V56, P615, DOI 10.1369/jhc.2008.950873; Okado-Matsumoto A, 2000, ANTIOXID REDOX SIGN, V2, P631, DOI 10.1089/ars.2000.2.4-631; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; Picard Martin, 2010, Aging Cell, V9, P1032, DOI 10.1111/j.1474-9726.2010.00628.x; Reynolds JD, 1998, J PHARMACOL TOXICOL, V39, P125, DOI 10.1016/S1056-8719(98)00007-0; Ritchie SA, 2010, BIOCHEM J, V426, P85, DOI 10.1042/BJ20091580; Rogozina OP, 2011, CANCER PREV RES, V4, P568, DOI 10.1158/1940-6207.CAPR-10-0140; Roth GS, 2004, SCIENCE, V305, P1423, DOI 10.1126/science.1102541; Sobrevia L, 1996, J PHYSIOL-LONDON, V490, P775, DOI 10.1113/jphysiol.1996.sp021185; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Symons JD, 2009, CIRC RES, V104, P1085, DOI 10.1161/CIRCRESAHA.108.189316; Tahara EB, 2007, FASEB J, V21, P274, DOI 10.1096/fj.06-6686com; Takahashi S, 2003, J BIOL CHEM, V278, P30821, DOI 10.1074/jbc.M304471200; van Diepeningen AD, 2010, EXP GERONTOL, V45, P516, DOI 10.1016/j.exger.2010.01.002; Wenz T, 2009, IUBMB LIFE, V61, P1051, DOI 10.1002/iub.261; Xi W, 2005, BIOCHEM BIOPH RES CO, V332, P200, DOI 10.1016/j.bbrc.2005.04.111; Zeng GY, 1996, J CLIN INVEST, V98, P894, DOI 10.1172/JCI118871; Zhu M, 2007, EXP GERONTOL, V42, P733, DOI 10.1016/j.exger.2007.05.011	54	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2012	7	2							e31155	10.1371/journal.pone.0031155	http://dx.doi.org/10.1371/journal.pone.0031155			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UV	22319612	Green Published, gold, Green Submitted			2022-12-25	WOS:000301979000024
J	Qi, YF; Fu, XQ; Xiong, ZG; Zhang, HT; Hill, SM; Rowan, BG; Dong, Y				Qi, Yanfeng; Fu, Xueqi; Xiong, Zhenggang; Zhang, Haitao; Hill, Steven M.; Rowan, Brian G.; Dong, Yan			Methylseleninic Acid Enhances Paclitaxel Efficacy for the Treatment of Triple-Negative Breast Cancer	PLOS ONE			English	Article							HUMAN PROSTATE-CANCER; IN-VIVO; SELENIUM; APOPTOSIS; CELLS; PHOSPHORYLATION; DOXORUBICIN; SURVIVAL; MODEL	A major challenge in breast cancer therapy is the lack of an effective therapeutic option for a particularly aggressive subtype of breast cancer, triple-negative breast cancer. Here we provide the first preclinical evidence that a second-generation selenium compound, methylseleninic acid, significantly enhances the anticancer efficacy of paclitaxel in triple-negative breast cancer. Through combination-index value calculation, we demonstrated that methylseleninic acid synergistically enhanced the growth inhibitory effect of paclitaxel in triple-negative breast cancer cells. The synergism was attributable to more pronounced induction of caspase-mediated apoptosis, arrest of cell cycle progression at the G2/M checkpoint, and inhibition of cell proliferation. Treatment of SCID mice bearing MDA-MB-231 triple-negative breast cancer xenografts for four weeks with methylseleninic acid (4.5 mg/kg/day, orally) and paclitaxel (10 mg/kg/week, through intraperitoneal injection) resulted in a more pronounced inhibition of tumor growth compared with either agent alone. The attenuated tumor growth correlated with a decrease in tumor cell proliferation and an induction of apoptosis. The in vivo study also indicated the safety of using methylseleninic acid in the combination regime. Our findings thus provide strong justification for the further development of methylseleninic acid and paclitaxel combination therapy for the treatment of triple-negative breast cancer.	[Qi, Yanfeng; Hill, Steven M.; Rowan, Brian G.; Dong, Yan] Tulane Univ, Sch Med, Tulane Canc Ctr, Dept Biol Struct, New Orleans, LA 70112 USA; [Qi, Yanfeng; Hill, Steven M.; Rowan, Brian G.; Dong, Yan] Tulane Univ, Sch Med, Tulane Canc Ctr, Dept Cellular Biol, New Orleans, LA 70112 USA; [Zhang, Haitao; Dong, Yan] Jilin Univ, Coll Life Sci, Natl Engn Lab AIDS Vaccine, Changchun 130023, Jilin, Peoples R China; [Xiong, Zhenggang; Zhang, Haitao] Tulane Univ, Sch Med, Tulane Canc Ctr, Dept Pathol & Lab Med, New Orleans, LA 70112 USA	Tulane University; Tulane University; Jilin University; Tulane University	Qi, YF (corresponding author), Tulane Univ, Sch Med, Tulane Canc Ctr, Dept Biol Struct, 1430 Tulane Ave, New Orleans, LA 70112 USA.	ydong@tulane.edu	Qi, Yanfeng/G-5311-2013	Dong, Yan/0000-0003-1622-5354	National Cancer Institute [K01CA114252]; American Cancer Society [RSG-07-218-01-TBE]; Mary Kay Foundation [019-11]; Louisiana Cancer Research Consortium; Tulane Cancer Center; Department of Structural and Cellular Biology, Tulane University School of Medicine; NATIONAL CANCER INSTITUTE [K01CA114252] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Mary Kay Foundation; Louisiana Cancer Research Consortium; Tulane Cancer Center; Department of Structural and Cellular Biology, Tulane University School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute grant K01CA114252 (YD), American Cancer Society grant RSG-07-218-01-TBE (YD), Mary Kay Foundation grant 019-11 (YD), Louisiana Cancer Research Consortium Start-up Fund (YD and HZ), Tulane Cancer Center Developmental Fund (YD), and Departmental Seed Fund from the Department of Structural and Cellular Biology, Tulane University School of Medicine (YD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LS, 2011, J NUTR; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Bhalla KN, 2003, ONCOGENE, V22, P9075, DOI 10.1038/sj.onc.1207233; CHOU TC, 1977, J BIOL CHEM, V252, P6438; Cleator S, 2007, LANCET ONCOL, V8, P235, DOI 10.1016/S1470-2045(07)70074-8; Dong Y, 2003, CANCER RES, V63, P52; Fost C, 2011, ONCOL REP, V25, P1481, DOI 10.3892/or.2011.1188; Gluz O, 2009, ANN ONCOL, V20, P1913, DOI 10.1093/annonc/mdp492; Hu HB, 2005, CLIN CANCER RES, V11, P2379, DOI 10.1158/1078-0432.CCR-04-2084; Hu H, 2008, CLIN CANCER RES, V14, P1150, DOI 10.1158/1078-0432.CCR-07-4037; Ip C, 1998, J NUTR, V128, P1845, DOI 10.1093/jn/128.11.1845; Ip C, 2000, CANCER RES, V60, P2882; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang WQ, 2009, MOL CANCER THER, V8, P682, DOI 10.1158/1535-7163.MCT-08-0908; Kotsopoulos J, 2010, CANCER CAUSE CONTROL, V21, P679, DOI 10.1007/s10552-009-9495-8; Kreike B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1832; Li GX, 2008, CARCINOGENESIS, V29, P1005, DOI 10.1093/carcin/bgn007; Li HJ, 2004, JNCI-J NATL CANCER I, V96, P696, DOI 10.1093/jnci/djh125; Li S, 2007, ANTICANCER RES, V27, P3075; Li S, 2007, MOL CANCER THER, V6, P1031, DOI 10.1158/1535-7163.MCT-06-0643; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Liu SA, 2008, MOL CANCER RES, V6, P306, DOI 10.1158/1541-7786.MCR-07-0159; Liu SA, 2010, MOL CANCER THER, V9, P2016, DOI 10.1158/1535-7163.MCT-09-0924; Matsuyoshi S, 2006, BRIT J CANCER, V94, P532, DOI 10.1038/sj.bjc.6602955; Matsuyoshi S, 2006, PATHOBIOLOGY, V73, P205, DOI 10.1159/000096022; Morris GJ, 2007, CANCER-AM CANCER SOC, V110, P876, DOI 10.1002/cncr.22836; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ohta Y, 2009, CHEM RES TOXICOL, V22, P1795, DOI 10.1021/tx900202m; Prud'homme GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013831; Reid ME, 2004, J TRACE ELEM MED BIO, V18, P69, DOI 10.1016/j.jtemb.2004.03.004; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Suzana S, 2009, SINGAP MED J, V50, P265; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Vogt TM, 2007, AM J EPIDEMIOL, V166, P280, DOI 10.1093/aje/kwm075; Wang L, 2009, CANCER PREV RES, V2, P484, DOI 10.1158/1940-6207.CAPR-08-0173; Yamanaka K, 2011, INT J ONCOL, V39, P569, DOI 10.3892/ijo.2011.1077; Zeng Q, 2010, EUR J CANCER, V46, P1132, DOI 10.1016/j.ejca.2010.01.014	38	83	87	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31539	10.1371/journal.pone.0031539	http://dx.doi.org/10.1371/journal.pone.0031539			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22448277	Green Submitted, Green Published, gold			2022-12-25	WOS:000302737400031
J	Lin, HP; Jiang, SS; Chuu, CP				Lin, Hui-Ping; Jiang, Shih Sheng; Chuu, Chih-Pin			Caffeic Acid Phenethyl Ester Causes p21(Cip1) Induction, Akt Signaling Reduction, and Growth Inhibition in PC-3 Human Prostate Cancer Cells	PLOS ONE			English	Article							ANDROGEN RECEPTOR; IN-VITRO; DOWN-REGULATION; PROTEIN-KINASE; TRANSCRIPTION FACTOR; LUNG ADENOCARCINOMA; UP-REGULATION; KAPPA-B; APOPTOSIS; PHOSPHORYLATION	Caffeic acid phenethyl ester (CAPE) treatment suppressed proliferation, colony formation, and cell cycle progression in PC-3 human prostate cancer cells. CAPE decreased protein expression of cyclin D1, cyclin E, SKP2, c-Myc, Akt1, Akt2, Akt3, total Akt, mTOR, Bcl-2, Rb, as well as phosphorylation of Rb, ERK1/2, Akt, mTOR, GSK3 alpha, GSK3 beta, PDK1; but increased protein expression of KLF6 and p21(Cip1). Microarray analysis indicated that pathways involved in cellular movement, cell death, proliferation, and cell cycle were affected by CAPE. Co-treatment of CAPE with chemotherapeutic drugs vinblastine, paclitaxol, and estramustine indicated synergistic suppression effect. CAPE administration may serve as a potential adjuvant therapy for prostate cancer.	[Lin, Hui-Ping; Chuu, Chih-Pin] Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli, Taiwan; [Lin, Hui-Ping; Jiang, Shih Sheng; Chuu, Chih-Pin] Natl Hlth Res Inst, Translat Ctr Glandular Malignancies, Miaoli, Taiwan; [Jiang, Shih Sheng] Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli, Taiwan; [Chuu, Chih-Pin] China Med Univ, Grad Program Aging, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; China Medical University Taiwan	Lin, HP (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli, Taiwan.	cpchuu@nhri.org.tw	Chuu, Chih-Pin/N-6697-2019; Jiang, Shih Sheng/C-6187-2011; Jiang, Shih Sheng/J-9671-2019; Chuu, Chih-Pin/B-1086-2010	Jiang, Shih Sheng/0000-0003-1909-437X; Lin, Hua/0000-0001-5001-5567	National Health Research Institutes [CS-100-PP-12]; National Science Council, NSC in Taiwan [NSC 99-2320-B-400-015-MY3]; Department of Health [DOH100-TD-C-111-014]; Protein Chemistry Core Facility of Core Instrument Center in NHRI; Taiwan Bioinformatics Institute by NSC [NSC100-2319-B-400-001]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council, NSC in Taiwan(Ministry of Science and Technology, Taiwan); Department of Health; Protein Chemistry Core Facility of Core Instrument Center in NHRI; Taiwan Bioinformatics Institute by NSC	This work was supported by CS-100-PP-12 (National Health Research Institutes) and NSC 99-2320-B-400-015-MY3 (National Science Council, NSC) in Taiwan for CPC, as well as DOH100-TD-C-111-014 (Department of Health) for SSJ and CPC. We thank support from Protein Chemistry Core Facility of Core Instrument Center in NHRI and Taiwan Bioinformatics Institute Core Facility of the National Core Facility Program for Biotechnology by NSC (NSC100-2319-B-400-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Bektic J, 2005, PROSTATE, V64, P332, DOI 10.1002/pros.20243; BHIMANI RS, 1993, CANCER RES, V53, P4528; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Celli N, 2007, J AGR FOOD CHEM, V55, P3398, DOI 10.1021/jf063477o; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; Chen XM, 2001, J BIOL CHEM, V276, P30423, DOI 10.1074/jbc.M101194200; Chen YJ, 2001, J AGR FOOD CHEM, V49, P5615, DOI 10.1021/jf0107252; Chuu CP, 2007, J BIOMED SCI, V14, P543, DOI 10.1007/s11373-007-9160-8; Chuu CP, 2007, BIOCHEM BIOPH RES CO, V357, P341, DOI 10.1016/j.bbrc.2007.03.116; Chuu CP, 2011, CANCER SCI, V102, P2022, DOI 10.1111/j.1349-7006.2011.02043.x; Chuu CP, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-63; Chuu CP, 2010, ANTICANCER RES, V30, P3643; Chuu CP, 2009, CANCER LETT, V275, P86, DOI 10.1016/j.canlet.2008.10.001; Coffer PJ, 1998, BIOCHEM J, V335, P1; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Ding H, 2003, BIOCHEM BIOPH RES CO, V305, P950, DOI 10.1016/S0006-291X(03)00873-8; Duchene J, 2007, J IMMUNOL, V179, P4849, DOI 10.4049/jimmunol.179.7.4849; ELLEDGE SJ, 1994, CURR OPIN CELL BIOL, V6, P847, DOI 10.1016/0955-0674(94)90055-8; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gao H, 2005, J BIOL CHEM, V280, P10988, DOI 10.1074/jbc.M412720200; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Gilligan T, 2002, UROLOGY, V60, P94, DOI 10.1016/S0090-4295(02)01583-2; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; HARPER JW, 1993, CELL, V75, P805; He YJ, 2006, WORLD J GASTROENTERO, V12, P4981, DOI 10.3748/wjg.v12.i31.4981; Heliez C, 2003, ONCOGENE, V22, P3260, DOI 10.1038/sj.onc.1206409; Hellerstedt BA, 2002, CA-CANCER J CLIN, V52, P154, DOI 10.3322/canjclin.52.3.154; Ho HC, 2009, CELL MOL BIOL, V55, P1161, DOI 10.1170/132; Horiguchi-Yamada J, 2002, ANTICANCER RES, V22, P3827; Huggins C, 1941, ARCH SURG-CHICAGO, V43, P15; Ibrahim T, 2010, CANCER-AM CANCER SOC, V116, P1406, DOI 10.1002/cncr.24896; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jiang SS, 2010, CLIN CANCER RES, V16, P4363, DOI 10.1158/1078-0432.CCR-10-0138; Jin SQ, 2000, J BIOL CHEM, V275, P16602, DOI 10.1074/jbc.M000284200; Katsuki Y, 2008, BIOCHEM BIOPH RES CO, V368, P808, DOI 10.1016/j.bbrc.2008.02.010; Keller ET, 2001, CANCER METAST REV, V20, P333, DOI 10.1023/A:1015599831232; Kolomeichuk SN, 2008, MOL PHARMACOL, V73, P128, DOI 10.1124/mol.108.039750; Kreisberg JI, 2004, CANCER RES, V64, P5232, DOI 10.1158/0008-5472.CAN-04-0272; Kuo HC, 2006, CANCER LETT, V234, P199, DOI 10.1016/j.canlet.2005.03.046; Lebedeva I, 2000, CANCER RES, V60, P6052; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Liu QY, 1997, CLIN CANCER RES, V3, P2039; Liu RH, 2009, CANCER RES, V69, P2252, DOI 10.1158/0008-5472.CAN-08-3717; Majumder PK, 2005, ONCOGENE, V24, P7465, DOI 10.1038/sj.onc.1209096; Malhotra S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020293; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McEleny K, 2004, BJU INT, V94, P402, DOI 10.1111/j.1464-410X.2004.04936.x; Nakatani K, 1999, J BIOL CHEM, V274, P21528, DOI 10.1074/jbc.274.31.21528; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; PIENTA KJ, 1993, J UROLOGY, V149, P1622, DOI 10.1016/S0022-5347(17)36463-7; Pinto AC, 2011, PROSTATE, V71, P81, DOI 10.1002/pros.21224; Polin L, 1997, INVEST NEW DRUG, V15, P99, DOI 10.1023/A:1005856605726; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sasaki T, 2010, BIOCHEM BIOPH RES CO, V399, P79, DOI 10.1016/j.bbrc.2010.07.045; Schutyser E, 2000, J IMMUNOL, V165, P4470, DOI 10.4049/jimmunol.165.8.4470; Shankar S, 2005, PROSTATE, V62, P165, DOI 10.1002/pros.20126; Shigeoka Y, 2004, J CANCER RES CLIN, V130, P146, DOI 10.1007/s00432-003-0520-0; Wang LC, 2010, CLIN EXP IMMUNOL, V160, P223, DOI 10.1111/j.1365-2249.2009.04067.x; Watabe M, 2004, J BIOL CHEM, V279, P6017, DOI 10.1074/jbc.M306040200; Williams JF, 2000, PROSTATE, V44, P275, DOI 10.1002/1097-0045(20000901)44:4<275::AID-PROS3>3.0.CO;2-9; WOLPE SD, 1989, P NATL ACAD SCI USA, V86, P612, DOI 10.1073/pnas.86.2.612; Yagi A, 2003, J CELL BIOCHEM, V90, P1242, DOI 10.1002/jcb.10711; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Zhao HC, 2000, EXP CELL RES, V258, P92, DOI 10.1006/excr.2000.4906; Zhao H, 2010, CYTOM PART A, V77A, P999, DOI 10.1002/cyto.a.20983; Zimmers TA, 2008, J CANCER RES CLIN, V134, P753, DOI 10.1007/s00432-007-0336-4	70	308	321	6	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31286	10.1371/journal.pone.0031286	http://dx.doi.org/10.1371/journal.pone.0031286			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22506074	Green Submitted, Green Published, gold			2022-12-25	WOS:000302180600033
J	Wang, XM; Zhu, CF; Bao, WG; Zhao, K; Niu, JQ; Yu, XF; Zhang, WY				Wang, Xiaomei; Zhu, Chunfeng; Bao, Wanguo; Zhao, Ke; Niu, Junqi; Yu, Xiao-Fang; Zhang, Wenyan			Characterization of Full-Length Enterovirus 71 Strains from Severe and Mild Disease Patients in Northeastern China	PLOS ONE			English	Article							MOUTH-DISEASE; MOLECULAR EPIDEMIOLOGY; FOOT; HAND; TAIWAN; RECOMBINATION; INFECTION; EVOLUTION; OUTBREAK	Human enterovirus 71 (EV71)-associated hand, foot, and mouth disease (HFMD) has been a leading cause of childhood infection in China since 2008. Epidemic and molecular characteristics of HFMD have been examined in many areas of China, including the central and southern regions. However, clinical and genetic characterization of EV71 in the northeastern region of China is scarce. In this study, a series of analyses were performed on seven full-length EV71 sequences from HFMD patients who had either severe or mild disease. We have determined that these seven circulating EV71 viruses from Changchun, China are actually complex recombinant viruses involving multiple type A human enterovirus (HEV). Classified as EV71 subtype C4 (EV71 C4), these Changchun EV71 viruses contain genetic recombination events between the CA4, CA5, EV71B4 and EV71C1 strains. Most of the structural protein region (P1) of these viruses resembled that of the prototype EV71 C1 strains. The non-structural protein domains (P2 and P3) showed a high degree of similarity with CA4, CA5 and EV71 B4 in different regions. The 5'UTR had unclassified recombination, while partial 3D region of these viruses showed a high degree of similarity to CA16. Phylogenetic analysis of full-length or partial sequences of isolates from severe or mild disease patients in Changchun always formed a single cluster in various phylogenetic analyses of different genomic regions, suggesting that all seven strains originated from one single common ancestor. There was no correlation between viral genomic sequence and virulence. Thus, we found that circulating recombinant forms of EV71 are prevalent among HFMD patients in Northeastern China. The existence of a unique cluster of EV71 related viruses in Northeast China has important implications for vaccine development that would address the increasing prevalence of HFMD.	[Wang, Xiaomei; Zhu, Chunfeng; Zhao, Ke; Yu, Xiao-Fang; Zhang, Wenyan] Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun, Jilin Province, Peoples R China; [Wang, Xiaomei; Niu, Junqi] Jilin Univ, Hosp 1, Dept Hepatol, Changchun, Jilin Province, Peoples R China; [Bao, Wanguo] Jilin Univ, Hosp 1, Dept Infect Dis, Changchun, Jilin Province, Peoples R China	Jilin University; Jilin University; Jilin University	Wang, XM (corresponding author), Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun, Jilin Province, Peoples R China.	junqiniu@yahoo.com.cn; xfyu@jhsph.edu; zhangwenyan@jlu.edu.cn	Li, Yuan/GXV-1310-2022; Pausch, Hubert/U-5934-2019; Wang, Xugao/B-1111-2015; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; li, yong/HDN-3885-2022; Wang, Xiaohui/B-8126-2011; Li, Yang/GWM-7879-2022; Pausch, Hubert/B-7637-2018	Pausch, Hubert/0000-0002-0501-6760; Wang, Xugao/0000-0003-1207-8852; YIN, HANG/0000-0002-9762-4818; Wang, Xiaohui/0000-0002-3415-5612; wang, yizhen/0000-0002-3908-7102; Wang, Jing/0000-0002-2806-6517; Fiorini, Zeno/0000-0001-5218-2502; Comita, Liza/0000-0002-9169-1331; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629	Specialized Research Fund for the Doctoral Program of Higher Education; Jilin University [200903258]; Key Laboratory of Molecular Virology, Jilin Province, China [20102209]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Jilin University(Jilin University); Key Laboratory of Molecular Virology, Jilin Province, China; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported in part by funding from the Specialized Research Fund for the Doctoral Program of Higher Education and Jilin University (No200903258) to Wenyan Zhang, and a grant from the Key Laboratory of Molecular Virology, Jilin Province (20102209), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chan YF, 2004, EMERG INFECT DIS, V10, P1468; Chan YF, 2010, INFECT GENET EVOL, V10, P404, DOI 10.1016/j.meegid.2009.05.010; Chang GH, 2010, VIRUS RES, V151, P66, DOI 10.1016/j.virusres.2010.04.001; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; CHUMAKOV M, 1979, ARCH VIROL, V60, P329, DOI 10.1007/BF01317504; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Huang SC, 2008, VIRUS RES, V131, P250, DOI 10.1016/j.virusres.2007.10.002; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li RQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026237; Mao LX, 2010, J CLIN VIROL, V49, P100, DOI 10.1016/j.jcv.2010.07.009; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Shi XD, 2011, CENT EUR J MED, V6, P220, DOI 10.2478/s11536-010-0075-9; Shimizu H, 2004, PEDIATR INT, V46, P231, DOI 10.1046/j.1442-200x.2004.01868.x; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Yoke-Fun C, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-74; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu Z, 2007, BIOMED ENVIRON SCI, V20, P321	22	318	350	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e32405	10.1371/journal.pone.0050575	http://dx.doi.org/10.1371/journal.pone.0050575			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	23110176	Green Submitted, Green Published, gold			2022-12-25	WOS:000304523400005
J	Wang, XX; Huang, M; Wang, YZ				Wang, Xinxia; Huang, Ming; Wang, Yizhen			The Effect of Insulin, TNF alpha and DHA on the Proliferation, Differentiation and Lipolysis of Preadipocytes Isolated from Large Yellow Croaker (Pseudosciaena Crocea R.)	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TROUT ONCORHYNCHUS-MYKISS; FATTY-ACID SYNTHASE; INHIBITS ADIPOCYTE DIFFERENTIATION; ADIPOSE TRIGLYCERIDE LIPASE; ACTIVATED RECEPTORS ALPHA; SIGNAL-RELATED KINASE; LPL GENE-EXPRESSION; RAINBOW-TROUT; LIPOPROTEIN-LIPASE	Fish final product can be affected by excessive lipid accumulation. Therefore, it is important to develop strategies to control obesity in cultivated fish to strengthen the sustainability of the aquaculture industry. As in mammals, the development of adiposity in fish depends on hormonal, cytokine and dietary factors. In this study, we investigated the proliferation and differentiation of preadipocytes isolated from the large yellow croaker and examined the effects of critical factors such as insulin, TNF alpha and DHA on the proliferation, differentiation and lipolysis of adipocytes. Preadipocytes were isolated by collagenase digestion, after which their proliferation was evaluated. The differentiation process was optimized by assaying glycerol-3-phosphate dehydrogenase (GPDH) activity. Oil red O staining and electron microscopy were performed to visualize the accumulated triacylglycerol. Gene transcript levels were measured using SYBR green quantitative real-time PCR. Insulin promoted preadipocytes proliferation, stimulated cell differentiation and decreased lipolysis of mature adipocytes. TNF alpha and DHA inhibited cell proliferation and differentiation. While TNF alpha stimulated mature adipocyte lipolysis, DHA showed no lipolytic effect on adipocytes. The expressions of adipose triglyceride lipase (ATGL), fatty acid synthase (FAS), lipoprotein lipase (LPL) and peroxisome proliferator-activated receptor alpha, gamma (PPAR alpha, PPAR gamma) were quantified during preadipocytes differentiation and adipocytes lipolysis to partly explain the regulation mechanisms. In summary, the results of this study indicated that although preadipocytes proliferation and the differentiation process in large yellow croaker are similar to these processes in mammals, the effects of critical factors such as insulin, TNF alpha and DHA on fish adipocytes development are not exactly the same. Our findings fill in the gaps in the basic data regarding the effects of critical factors on adiposity development in fish and will facilitate the further study of molecular mechanism by which these factors act in fish and the application of this knowledge to eventually control obesity in cultured species.	[Wang, Xinxia; Huang, Ming; Wang, Yizhen] Zhejiang Univ, Inst Feed Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Wang, YZ (corresponding author), Zhejiang Univ, Inst Feed Sci, Hangzhou 310003, Zhejiang, Peoples R China.	yzwang@zju.edu.cn	Li, Yuan/GXV-1310-2022; Pausch, Hubert/U-5934-2019; Wang, Xugao/B-1111-2015; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; li, yong/HDN-3885-2022; Wang, Xiaohui/B-8126-2011; Li, Yang/GWM-7879-2022; Pausch, Hubert/B-7637-2018	Pausch, Hubert/0000-0002-0501-6760; Wang, Xugao/0000-0003-1207-8852; YIN, HANG/0000-0002-9762-4818; Wang, Xiaohui/0000-0002-3415-5612; wang, yizhen/0000-0002-3908-7102; Wang, Jing/0000-0002-2806-6517; Fiorini, Zeno/0000-0001-5218-2502; Comita, Liza/0000-0002-9169-1331; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629	NSFC (National Natural Science Foundation of China) [30901104]; China Postdoctoral Science Foundation [2009046138]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	NSFC (National Natural Science Foundation of China)(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by grants from the NSFC (National Natural Science Foundation of China, grant # 30901104), and the China Postdoctoral Science Foundation (grant # 2009046138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albalat A, 2007, COMP BIOCHEM PHYS B, V148, P151, DOI 10.1016/j.cbpb.2007.05.004; Albalat A, 2005, COMP BIOCHEM PHYS A, V142, P347, DOI 10.1016/j.cbpa.2005.08.006; Albalat A, 2005, AM J PHYSIOL-REG I, V289, pR259, DOI 10.1152/ajpregu.00574.2004; Albalat A, 2005, J ENDOCRINOL, V184, P527, DOI 10.1677/joe.1.05940; Albalat A, 2006, GEN COMP ENDOCR, V146, P226, DOI 10.1016/j.ygcen.2005.11.011; [Anonymous], 2011, CHIN FISH STAT YB; Awad AB, 2000, J NUTR BIOCHEM, V11, P153, DOI 10.1016/S0955-2863(99)00087-X; Boney CM, 2000, MOL ENDOCRINOL, V14, P805, DOI 10.1210/me.14.6.805; Boone C, 2000, REPROD NUTR DEV, V40, P325, DOI 10.1051/rnd:2000103; Bouraoui L, 2008, J ENDOCRINOL, V198, P459, DOI 10.1677/JOE-08-0264; Bouraoui L, 2012, COMP BIOCHEM PHYS A, V161, P83, DOI 10.1016/j.cbpa.2011.09.008; Bouraoui L, 2010, AM J PHYSIOL-REG I, V299, pR33, DOI 10.1152/ajpregu.00457.2009; Calviello G, 1999, LIPIDS, V34, P599, DOI 10.1007/s11745-999-0404-6; Capilla E, 2011, GEN COMP ENDOCR, V172, P107, DOI 10.1016/j.ygcen.2011.03.020; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Cersosimo E, 2012, AM J PHYSIOL-CELL PH, V302, pC652, DOI 10.1152/ajpcell.00022.2011; CHAJES V, 1995, BREAST CANCER RES TR, V34, P199, DOI 10.1007/BF00689711; Chamras H, 2002, J NUTR BIOCHEM, V13, P711, DOI 10.1016/S0955-2863(02)00230-9; CHEATHAM B, 1995, ENDOCR REV, V16, P117, DOI 10.1210/er.16.2.117; Choi SM, 2010, MOL CELL BIOL, V30, P5009, DOI 10.1128/MCB.00797-10; Claycombe KJ, 1998, AM J PHYSIOL-REG I, V274, pR1253, DOI 10.1152/ajpregu.1998.274.5.R1253; CORNELIUS P, 1990, J BIOL CHEM, V265, P20506; DANI C, 1990, J CELL BIOCHEM, V43, P103, DOI 10.1002/jcb.240430202; Degerman E, 1998, METHODS, V14, P43, DOI 10.1006/meth.1997.0564; Deiuliis JA, 2008, LIPIDS, V43, P215, DOI 10.1007/s11745-007-3146-1; DOERRLER W, 1994, CYTOKINE, V6, P478, DOI 10.1016/1043-4666(94)90074-4; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; FRANSEN L, 1986, CELL IMMUNOL, V100, P260, DOI 10.1016/0008-8749(86)90025-0; Garcia-Castillo J, 2004, CELL MOL LIFE SCI, V61, P1331, DOI 10.1007/s00018-004-4068-1; Gasic S, 1999, J BIOL CHEM, V274, P6770, DOI 10.1074/jbc.274.10.6770; Glosli H, 2005, BBA-MOL CELL BIOL L, V1734, P235, DOI 10.1016/j.bbalip.2005.02.011; Goldberg IJ, 1996, J LIPID RES, V37, P693; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Grohmann M, 2005, J LIPID RES, V46, P93, DOI 10.1194/jlr.M400295-JLR200; GRUNFELD C, 1988, J LIPID RES, V29, P1327; Hansen JO, 2008, AQUACULTURE, V284, P159, DOI 10.1016/j.aquaculture.2008.07.043; HARMON JS, 1992, GEN COMP ENDOCR, V87, P214, DOI 10.1016/0016-6480(92)90025-F; Hensler M, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-128; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Khan S, 2002, J LIPID RES, V43, P979; Kim HK, 2006, J NUTR, V136, P409, DOI 10.1093/jn/136.2.409; Kim HK, 2006, J NUTR, V136, P2965, DOI 10.1093/jn/136.12.2965; Kim JY, 2006, AM J PHYSIOL-ENDOC M, V291, pE115, DOI 10.1152/ajpendo.00317.2005; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Kralisch S, 2005, MOL CELL ENDOCRINOL, V240, P43, DOI 10.1016/j.mce.2005.06.002; Kras KM, 2000, OBES RES, V8, P186, DOI 10.1038/oby.2000.20; Li XF, 2012, FISH PHYSIOL BIOCHEM, V38, P529, DOI 10.1007/s10695-011-9533-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LopezSoriano J, 1997, MOL CELL ENDOCRINOL, V132, P93, DOI 10.1016/S0303-7207(97)00125-1; Madsen L, 2005, BBA-MOL BASIS DIS, V1740, P266, DOI 10.1016/j.bbadis.2005.03.001; Montserrat N, 2007, GEN COMP ENDOCR, V150, P462, DOI 10.1016/j.ygcen.2006.11.009; Morrison RF, 1999, J BIOL CHEM, V274, P17088, DOI 10.1074/jbc.274.24.17088; Niemela SM, 2007, J CRANIOFAC SURG, V18, P325, DOI 10.1097/scs.0b013e3180333b6a; Oku H, 2006, COMP BIOCHEM PHYS B, V144, P326, DOI 10.1016/j.cbpb.2006.03.008; Okuno M, 1997, J NUTR, V127, P1752, DOI 10.1093/jn/127.9.1752; PALOMBELLA VJ, 1989, J BIOL CHEM, V264, P18128; PAULAUSKIS JD, 1989, J BIOL CHEM, V264, P574; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Radenne A, 2008, AM J PHYSIOL-ENDOC M, V295, pE884, DOI 10.1152/ajpendo.90438.2008; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Ramsay TG, 2003, COMP BIOCHEM PHYS B, V136, P245, DOI 10.1016/S1096-4959(02)00261-0; Rieusset J, 1999, DIABETES, V48, P699, DOI 10.2337/diabetes.48.4.699; Ruan H, 2003, J BIOL CHEM, V278, P28181, DOI 10.1074/jbc.M303141200; Ruan H, 2002, DIABETES, V51, P3176, DOI 10.2337/diabetes.51.11.3176; Ryden M, 2007, J INTERN MED, V262, P431, DOI 10.1111/j.1365-2796.2007.01854.x; Sakaguchi Y, 2004, BLOOD, V104, P2728, DOI 10.1182/blood-2003-12-4452; Shalev A, 1996, ENDOCRINOLOGY, V137, P4499, DOI 10.1210/en.137.10.4499; SMITH RA, 1986, J BIOL CHEM, V261, P4871; Sottile V, 2001, ANAL BIOCHEM, V293, P124, DOI 10.1006/abio.2001.5121; Souza SC, 2003, J CELL BIOCHEM, V89, P1077, DOI 10.1002/jcb.10565; Sun C, 2011, MOL BIOL REP, V38, P731, DOI 10.1007/s11033-010-0160-9; Suryawan A, 1997, J ANIM SCI, V75, P105; Todorcevic M, 2008, BBA-MOL CELL BIOL L, V1781, P326, DOI 10.1016/j.bbalip.2008.04.014; van Harmelen V, 2004, METABOLISM, V53, P632, DOI 10.1016/j.metabol.2003.11.012; Vegusdal A, 2003, LIPIDS, V38, P289, DOI 10.1007/s11745-003-1063-3; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wang D, 1998, J BIOL CHEM, V273, P25420, DOI 10.1074/jbc.273.39.25420; Wang XX, 2012, AQUAC RES, V43, P281, DOI 10.1111/j.1365-2109.2011.02826.x; Xing H, 1997, ENDOCRINOLOGY, V138, P2776, DOI 10.1210/en.138.7.2776; Xu HY, 1999, J BIOL CHEM, V274, P26287, DOI 10.1074/jbc.274.37.26287; Yoon M, 2009, PHARMACOL RES, V60, P151, DOI 10.1016/j.phrs.2009.02.004; Zhang F, 2004, DRUG NEWS PERSPECT, V17, P661, DOI 10.1358/dnp.2004.17.10.873918; Zhang HH, 2002, DIABETES, V51, P2929, DOI 10.2337/diabetes.51.10.2929; Zhao ZY, 2008, J FOOD LIPIDS, V15, P534, DOI 10.1111/j.1745-4522.2008.00138.x; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	87	318	350	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48069	10.1371/journal.pone.0048069	http://dx.doi.org/10.1371/journal.pone.0048069			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110176	Green Submitted, gold, Green Published			2022-12-25	WOS:000310262500033
J	Wang, XG; Comita, LS; Hao, ZQ; Davies, SJ; Ye, J; Lin, F; Yuan, ZQ				Wang, Xugao; Comita, Liza S.; Hao, Zhanqing; Davies, Stuart J.; Ye, Ji; Lin, Fei; Yuan, Zuoqiang			Local-Scale Drivers of Tree Survival in a Temperate Forest	PLOS ONE			English	Article							TROPICAL TREE; DENSITY-DEPENDENCE; HABITAT ASSOCIATIONS; SHADE TOLERANCE; SPATIAL DISTRIBUTIONS; SIZE DISTRIBUTIONS; SOIL INTERACTIONS; INDIVIDUAL TREES; LONG-TERM; GROWTH	Tree survival plays a central role in forest ecosystems. Although many factors such as tree size, abiotic and biotic neighborhoods have been proposed as being important in explaining patterns of tree survival, their contributions are still subject to debate. We used generalized linear mixed models to examine the relative importance of tree size, local abiotic conditions and the density and identity of neighbors on tree survival in an old-growth temperate forest in northeastern China at three levels (community, guild and species). Tree size and both abiotic and biotic neighborhood variables influenced tree survival under current forest conditions, but their relative importance varied dramatically within and among the community, guild and species levels. Of the variables tested, tree size was typically the most important predictor of tree survival, followed by biotic and then abiotic variables. The effect of tree size on survival varied from strongly positive for small trees (1-20 cm dbh) and medium trees (20-40 cm dbh), to slightly negative for large trees (>40 cm dbh). Among the biotic factors, we found strong evidence for negative density and frequency dependence in this temperate forest, as indicated by negative effects of both total basal area of neighbors and the frequency of conspecific neighbors. Among the abiotic factors tested, soil nutrients tended to be more important in affecting tree survival than topographic variables. Abiotic factors generally influenced survival for species with relatively high abundance, for individuals in smaller size classes and for shade-tolerant species. Our study demonstrates that the relative importance of variables driving patterns of tree survival differs greatly among size classes, species guilds and abundance classes in temperate forest, which can further understanding of forest dynamics and offer important insights into forest management.	[Wang, Xugao; Hao, Zhanqing; Ye, Ji; Lin, Fei; Yuan, Zuoqiang] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Liaoning Provin, Peoples R China; [Comita, Liza S.] Ohio State Univ, Dept Ecol Evolut & Organismal Biol, Columbus, OH 43210 USA; [Comita, Liza S.] Smithsonian Trop Res Inst, Balboa Ancon, Panama; [Davies, Stuart J.] Harvard Univ, Ctr Trop Forest Sci, Boston, MA 02115 USA; [Davies, Stuart J.] Smithsonian Trop Res Inst, Boston, MA USA	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; University System of Ohio; Ohio State University; Smithsonian Institution; Smithsonian Tropical Research Institute; Harvard University; Smithsonian Institution; Smithsonian Tropical Research Institute	Wang, XG (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Liaoning Provin, Peoples R China.	hzq@iae.ac.cn	Li, Yuan/GXV-1310-2022; Pausch, Hubert/U-5934-2019; Wang, Xugao/B-1111-2015; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; li, yong/HDN-3885-2022; Wang, Xiaohui/B-8126-2011; Li, Yang/GWM-7879-2022; Pausch, Hubert/B-7637-2018	Pausch, Hubert/0000-0002-0501-6760; Wang, Xugao/0000-0003-1207-8852; YIN, HANG/0000-0002-9762-4818; Wang, Xiaohui/0000-0002-3415-5612; wang, yizhen/0000-0002-3908-7102; Wang, Jing/0000-0002-2806-6517; Fiorini, Zeno/0000-0001-5218-2502; Comita, Liza/0000-0002-9169-1331; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629	Chinese Academy of Sciences [KSCX2-EW-Z-5, KZCX2-YW-QN402]; National Natural Science Foundation of China [40971286, 31011120470, 31061160188]; Center for Tropical Forest Science of the Smithsonian Tropical Research Institute; HSBC Climate Partnership; National Center for Ecological Analysis and Synthesis; NSF [EF-0553768]; University of California, Santa Barbara; State of California; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Center for Tropical Forest Science of the Smithsonian Tropical Research Institute; HSBC Climate Partnership; National Center for Ecological Analysis and Synthesis; NSF(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This study was supported by the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-Z-5 and KZCX2-YW-QN402) and the National Natural Science Foundation of China (40971286, 31011120470 and 31061160188). XW acknowledges the support of a fellowship from the Center for Tropical Forest Science of the Smithsonian Tropical Research Institute and the HSBC Climate Partnership. LSC acknowledges the support of a fellowship from the National Center for Ecological Analysis and Synthesis, a center funded by NSF (Grant #EF-0553768), the University of California, Santa Barbara, and the State of California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D., 2009, LME4 LINEAR MIXED EF; Blundell AG, 2001, J ECOL, V89, P608, DOI 10.1046/j.0022-0477.2001.00581.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Canham CD, 2006, ECOL APPL, V16, P540, DOI 10.1890/1051-0761(2006)016[0540:NAOCTC]2.0.CO;2; Castagneri D, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2009111; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CLARK DA, 1992, ECOL MONOGR, V62, P315, DOI 10.2307/2937114; COLEY PD, 1980, NATURE, V284, P545, DOI 10.1038/284545a0; Comita LS, 2007, J ECOL, V95, P482, DOI 10.1111/j.1365-2745.2007.01229.x; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; Comita LS, 2009, J ECOL, V97, P1346, DOI 10.1111/j.1365-2745.2009.01551.x; Comita LS, 2009, ECOLOGY, V90, P2755, DOI 10.1890/08-1482.1; Comita LS, 2009, ECOLOGY, V90, P328, DOI 10.1890/08-0451.1; CONDIT R, 1994, ECOLOGY, V75, P671, DOI 10.2307/1941725; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; CONNELL J H, 1971, P298; Coomes DA, 2007, J ECOL, V95, P27, DOI 10.1111/j.1365-2745.2006.01179.x; Coomes DA, 2006, TRENDS ECOL EVOL, V21, P593, DOI 10.1016/j.tree.2006.09.002; Das A, 2008, ECOLOGY, V89, P1744, DOI 10.1890/07-0524.1; Davies SJ, 2001, ECOLOGY, V82, P920, DOI 10.1890/0012-9658(2001)082[0920:TMAGIS]2.0.CO;2; Ehrenfeld JG, 2005, ANNU REV ENV RESOUR, V30, P75, DOI 10.1146/annurev.energy.30.050504.144212; FILIP GM, 1982, PLANT DIS, V66, P240, DOI 10.1094/PD-66-240; Finzi AC, 1998, ECOL APPL, V8, P447, DOI 10.2307/2641084; Finzi AC, 1998, ECOL APPL, V8, P440, DOI 10.2307/2641083; FRANKLIN JF, 1987, BIOSCIENCE, V37, P550, DOI 10.2307/1310665; Gelman A, DATA ANAL USING REGR; [郝占庆 HAO ZhanQing], 2008, [植物生态学报, Acta Phytoecologica Sinica], V32, P238; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Harrell FE, 2001, REGRESSION MODELING; He FL, 2000, J ECOL, V88, P676, DOI 10.1046/j.1365-2745.2000.00482.x; HIBBS DE, 1983, ECOLOGY, V64, P1394, DOI 10.2307/1937493; HilleRisLambers J, 2002, NATURE, V417, P732, DOI 10.1038/nature00809; Hubbell SP, 2001, ECOL RES, V16, P859, DOI 10.1046/j.1440-1703.2001.00445.x; Imaji A, 2010, OECOLOGIA, V162, P273, DOI 10.1007/s00442-009-1453-3; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Keane RE, 2001, CLIMATIC CHANGE, V51, P509, DOI 10.1023/A:1012539409854; KENKEL NC, 1988, ECOLOGY, V69, P1017, DOI 10.2307/1941257; Kunstler G, 2009, J ECOL, V97, P685, DOI 10.1111/j.1365-2745.2009.01482.x; Lines ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013212; LOEHLE C, 1988, CAN J FOREST RES, V18, P209, DOI 10.1139/x88-032; Lorimer CG, 2001, J ECOL, V89, P960, DOI 10.1111/j.1365-2745.2001.00619.x; Lu R.Q, 1999, SOIL AGRO CHEM ANAL; Lutz JA, 2006, ECOL MONOGR, V76, P257, DOI 10.1890/0012-9615(2006)076[0257:TMDEFD]2.0.CO;2; Maloney PE, 2008, CAN J FOREST RES, V38, P3011, DOI 10.1139/X08-141; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; McCarthy-Neumann S, 2008, ECOLOGY, V89, P1883, DOI 10.1890/07-0211.1; McCarthy-Neumann S, 2010, J ECOL, V98, P408, DOI 10.1111/j.1365-2745.2009.01620.x; Mordecai EA, 2011, ECOL MONOGR, V81, P429, DOI 10.1890/10-2241.1; Muller-Landau HC, 2006, ECOL LETT, V9, P575, DOI 10.1111/j.1461-0248.2006.00904.x; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nakashizuka T, 2001, TRENDS ECOL EVOL, V16, P205, DOI 10.1016/S0169-5347(01)02117-6; NORBERG RA, 1988, AM NAT, V131, P220, DOI 10.1086/284787; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; Packer A, 2003, ECOLOGY, V84, P108, DOI 10.1890/0012-9658(2003)084[0108:SPAPSS]2.0.CO;2; Peters HA, 2003, ECOL LETT, V6, P757, DOI 10.1046/j.1461-0248.2003.00492.x; Queenborough SA, 2007, ECOLOGY, V88, P2248, DOI 10.1890/06-0737.1; Queenborough SA, 2009, P ROY SOC B-BIOL SCI, V276, P4197, DOI 10.1098/rspb.2009.0921; R Development Core Team, 2009, R FDN STAT COMP; Reinhart KO, 2009, ECOLOGY, V90, P2984, DOI 10.1890/08-1380.1; Runkle JR, 2000, ECOLOGY, V81, P554, DOI 10.1890/0012-9658(2000)081[0554:CTTIOG]2.0.CO;2; Russo SE, 2005, J ECOL, V93, P879, DOI 10.1111/j.1365-2745.2005.01030.x; Shibata M, 2010, ECOSCIENCE, V17, P137, DOI 10.2980/17-2-3163; Slik JW, 2001, OECOLOGIA, V141, P114; SOMERS RH, 1962, AM SOCIOL REV, V27, P799, DOI 10.2307/2090408; STERNER RW, 1986, J ECOL, V74, P621, DOI 10.2307/2260386; Uriarte M, 2004, ECOL MONOGR, V74, P591, DOI 10.1890/03-4031; Volkov I, 2005, NATURE, V438, P658, DOI 10.1038/nature04030; Wang LiWei, 2011, Biodiversity Science, V19, P260, DOI 10.3724/SP.J.1003.2011.11279; Wang XG, 2008, ACTA OECOL, V33, P345, DOI 10.1016/j.actao.2008.01.005; Wang XG, 2010, CAN J FOREST RES, V40, P1011, DOI 10.1139/X10-056; Wang XG, 2010, J ECOL, V98, P674, DOI 10.1111/j.1365-2745.2010.01644.x; Wang XG, 2009, OIKOS, V118, P25, DOI 10.1111/j.0030-1299.2008.16598.x; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U; WHITE J, 1970, J ECOL, V58, P467, DOI 10.2307/2258284; Woods KD, 2000, ECOLOGY, V81, P110, DOI 10.2307/177138; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Yao XH, 2001, CAN J FOREST RES, V31, P283, DOI 10.1139/cjfr-31-2-283; Zhang J, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2008086; Zhao DH, 2006, ECOL MODEL, V196, P90, DOI 10.1016/j.ecolmodel.2006.02.002; Zuur Alain F., 2009, P1	83	318	350	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e29469	10.1371/journal.pone.0029469	http://dx.doi.org/10.1371/journal.pone.0029469			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	23110176	gold, Green Submitted, Green Published			2022-12-25	WOS:000302733900002
J	Wang, XM; Yang, R; Feng, SF; Hou, XQ; Zhang, YQ; Li, Y; Ren, Y				Wang, Xumei; Yang, Rui; Feng, Shifang; Hou, Xiaoqi; Zhang, Yuqu; Li, Yan; Ren, Yi			Genetic Variation in Rheum palmatum and Rheum tanguticum (Polygonaceae), Two Medicinally and Endemic Species in China Using ISSR Markers	PLOS ONE			English	Article							CHLOROPLAST DNA; DIVERSITY; SEQUENCE; EVOLUTION; RHUBARB; DIFFERENTIATION; POPULATIONS; RADIATION; PLATEAU; NUMBER	Aims: Both Rheum palmatum and R. tanguticum are important but endangered medicinal plants endemic to China. In this study, we aimed to (i) investigate the level and pattern of genetic variability within/among populations of those species; (ii) evaluate genetic differentiation between both species and its relationships and ascertain whether both species are consistent with their current taxonomical treatment as separate species; and (iii) discuss the implications for the effective conservation of two species. Methods: Total 574 individuals from 30 populations of R. palmatum and R. tanguticum were collected, covering the entire distribution range of two species in China. The genetic variation within and among 30 populations was evaluated using inter-simple sequence repeat (ISSR) markers. Important Findings: Twelve selected ISSR primers generated a total of 175 fragments, 173 (98.86%) of which were polymorphic. The Nei's gene diversity (H) and Shannon's index (I) of both species were high at species level (H = 0.3107, I = 0.4677 for R. palmatum; H = 0.2848, I = 0.4333 for R. tanguticum). But for both species, the genetic diversity was low at population level, and average within-population diversity of R. palmatum was H = 0.1438, I = 0.2151, and that of R. tanguticum was H = 0.1415, I = 0.2126. The hierarchical AMOVA revealed high levels of among-population genetic differentiation in both species, in line with the gene differentiation coefficient and the limited among-population gene flow (R. palmatum: Phi(st) = 0.592, G(st) = 0.537, N-m = 0.432; R. tanguticum: Phi(st) = 0.567, G(st) = 0.497, N-m = 0.507). By contrast, only 6.52% of the total genetic variance was partitioned between R. palmatum and R. tanguticum. Bayesian analysis, UPGMA cluster analysis, and PCoA analysis all demonstrated the similar results. A significant isolation-by-distance pattern was revealed in R. palmatum (r = 0.547, P = 0.010), but not in R. tanguticum (r = 0.241, P = 0.100). Based on these results, effective conservation strategies were proposed for these two species. The small molecular variance between R. palmatum and R. tanguticum revealed that they had a common ancestor, and we considered that these two species might not be good species.	[Wang, Xumei; Yang, Rui; Li, Yan] Xi An Jiao Tong Univ, Coll Med, Xian 710049, Peoples R China; [Feng, Shifang; Hou, Xiaoqi; Zhang, Yuqu; Ren, Yi] Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China	Xi'an Jiaotong University; Shaanxi Normal University	Wang, XM (corresponding author), Xi An Jiao Tong Univ, Coll Med, Xian 710049, Peoples R China.	wangxumei@mail.xjtu.edu.cn	Li, Yuan/GXV-1310-2022; Pausch, Hubert/U-5934-2019; Wang, Xugao/B-1111-2015; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; li, yong/HDN-3885-2022; Wang, Xiaohui/B-8126-2011; Li, Yang/GWM-7879-2022; Pausch, Hubert/B-7637-2018	Pausch, Hubert/0000-0002-0501-6760; Wang, Xugao/0000-0003-1207-8852; YIN, HANG/0000-0002-9762-4818; Wang, Xiaohui/0000-0002-3415-5612; wang, yizhen/0000-0002-3908-7102; Wang, Jing/0000-0002-2806-6517; Fiorini, Zeno/0000-0001-5218-2502; Comita, Liza/0000-0002-9169-1331; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629	National Nature Science Foundation of China [81001602]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by National Nature Science Foundation of China (No. 81001602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amel SH, 2004, GENET RESOUR CROP EV, V51, P269, DOI 10.1023/B:GRES.0000024012.59828.6b; [Anonymous], 1984, GARTENFLORA, V23, P305; Bao BJ., 2003, FLORA CHINA, V5, P341; BARRETT SCH, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P3; Chen Da-Xia, 2008, Zhongguo Zhong Yao Za Zhi, V33, P2309; Chen FJ, 2009, BIOCHEM SYST ECOL, V37, P613, DOI 10.1016/j.bse.2009.08.004; Chennaoui-Kourda H, 2007, BIOCHEM SYST ECOL, V35, P682, DOI 10.1016/j.bse.2007.05.005; Chinese Pharmacopoeia Committee, 2010, PHARM PEOPL REP CHIN, P22; Dodd SC, 2002, AM J BOT, V89, P613, DOI 10.3732/ajb.89.4.613; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Esselman EJ, 1999, MOL ECOL, V8, P443, DOI 10.1046/j.1365-294X.1999.00585.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Freeland J. R., 2011, MOL ECOLOGY; Ge XJ, 2005, BIODIVERS CONSERV, V14, P849, DOI 10.1007/s10531-004-0655-6; Ge XJ, 1999, MOL ECOL, V8, P2061, DOI 10.1046/j.1365-294x.1999.00821.x; Goropashnaya AV, 2001, MOL ECOL, V10, P2807, DOI 10.1046/j.1365-294X.2001.t01-1-01410.x; Hamrick J. L., 1990, Plant population genetics, breeding, and genetic resources., P43; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; Hamrick J. L., 1996, P281; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hogbin PM, 1999, CONSERV BIOL, V13, P514, DOI 10.1046/j.1523-1739.1999.98182.x; Hu YP, 2010, BIOCHEM SYST ECOL, V38, P264, DOI 10.1016/j.bse.2010.01.006; KARRON JD, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P87; Knuth P, 1906, HDB FLOWER POLLINATI, V3; Lewontin R.C., 1972, EVOLUTIONARY BIOL, V14, P381, DOI DOI 10.1007/978-1-4684-9063-3_14; Li EX, 2008, MOL PHYLOGENET EVOL, V49, P702, DOI 10.1016/j.ympev.2008.09.012; Li JM, 2007, PLANT SCI, V172, P1048, DOI 10.1016/j.plantsci.2007.02.009; Li PQ, 2010, LIAONING J TRAD CHIN, V37, P136; Lu Jian-ying, 2008, Xibei Shifan Daxue Xuebao (Ziran Kexue Ban), V44, P66; MCDERMOTT JM, 1993, ANNU REV PHYTOPATHOL, V31, P353, DOI 10.1146/annurev.py.31.090193.002033; Miller MP, 1997, TOOLS POPULATION GEN; Moreira RG, 2010, CONSERV GENET, V11, P1247, DOI 10.1007/s10592-009-9953-6; Moreno S, 1998, EUPHYTICA, V101, P117, DOI 10.1023/A:1018379805873; MULLER J, 1981, BOT REV, V47, P1, DOI 10.1007/BF02860537; NEI M, 1974, GENETICS, V76, P379; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Rajesh PN, 2003, EUPHYTICA, V129, P15, DOI 10.1023/A:1021567821141; Reddy MP, 2002, EUPHYTICA, V128, P9, DOI 10.1023/A:1020691618797; Song ZQ, 2010, GENETICA, V138, P241, DOI 10.1007/s10709-009-9416-5; Sun YS, 2012, MOL PHYLOGENET EVOL, V63, P150, DOI 10.1016/j.ympev.2012.01.002; Suo FengMei, 2010, Zhongcaoyao = Chinese Traditional and Herbal Drugs, V41, P292; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang A. T., 2009, THESIS LANZHOU U; Wang AL, 2005, ANN BOT-LONDON, V96, P489, DOI 10.1093/aob/mci201; Wang XM, 2012, INT J MOL SCI, V13, P3900, DOI 10.3390/ijms13033900; Wang XM, 2010, J MED PLANTS RES, V4, P1865; Wang XM, 2010, J MED PLANTS RES, V4, P904; Wright S, 1931, GENETICS, V16, P0097; Wu JK, 1992, ACTA BOT BOREALI-OCC, V12, P309; Xia T, 2005, BIOCHEM GENET, V43, P87, DOI 10.1007/s10528-005-1502-5; Xiao Su-ping, 2007, Zhongguo Zhong Yao Za Zhi, V32, P195; Yang DY, 2004, BIOL PHARM BULL, V27, P375, DOI 10.1248/bpb.27.375; Yeh F.C., 1997, POPGENE VERSION 1 31	55	318	350	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51667	10.1371/journal.pone.0051667	http://dx.doi.org/10.1371/journal.pone.0051667			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23110176	gold, Green Published, Green Submitted			2022-12-25	WOS:000312483300022
J	Wang, XH; Fiorini, Z; Smith, C; Zhang, YN; Li, J; Watkins, LR; Yin, H				Wang, Xiaohui; Fiorini, Zeno; Smith, Christina; Zhang, Yingning; Li, Jing; Watkins, Linda R.; Yin, Hang			Repositioning Antimicrobial Agent Pentamidine as a Disruptor of the Lateral Interactions of Transmembrane Domain 5 of EBV Latent Membrane Protein 1	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; HUMAN CYCLIN A(2); ENDOTHELIAL-CELLS; P-GLYCOPROTEIN; EXPRESSION; BRAIN; ACTIVATION; RESISTANCE; STABILITY; APOPTOSIS	The lateral transmembrane protein-protein interactions (PPI) have been regarded as "undruggable" despite their importance in many essential biological processes. The homo-trimerization of transmembrane domain 5 (TMD-5) of latent membrane protein 1 (LMP-1) is critical for the constitutive oncogenic activation of the Epstein-Barr virus (EBV). Herein we repurpose the antimicrobial agent pentamidine as a regulator of LMP-1 TMD-5 lateral interactions. The results of ToxR assay, tryptophan fluorescence assay, courmarin fluorescence dequenching assay, and Bis-Tris sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) consistently show pentamidine disrupts LMP-1 TMD-5 lateral interactions. Furthermore, pentamidine inhibits LMP-1 signaling, inducing cellular apoptosis and suppressing cell proliferation in the EBV infected B cells. In contrast, EBV negative cells are less susceptible to pentamidine. This study provides a novel non-peptide small molecule agent for regulating LMP-1 TMD-5 lateral interactions.	[Li, Jing] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100730, Peoples R China; [Wang, Xiaohui; Fiorini, Zeno; Smith, Christina; Yin, Hang] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Wang, Xiaohui; Fiorini, Zeno; Smith, Christina; Yin, Hang] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Wang, Xiaohui; Zhang, Yingning; Watkins, Linda R.] Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; [Wang, Xiaohui; Zhang, Yingning; Watkins, Linda R.] Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Li, J (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100730, Peoples R China.	lijing6515@pumch.cn; hubert.yin@colorado.edu	Li, Yuan/GXV-1310-2022; Pausch, Hubert/U-5934-2019; Wang, Xugao/B-1111-2015; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; li, yong/HDN-3885-2022; Wang, Xiaohui/B-8126-2011; Li, Yang/GWM-7879-2022; Pausch, Hubert/B-7637-2018	Pausch, Hubert/0000-0002-0501-6760; Wang, Xugao/0000-0003-1207-8852; YIN, HANG/0000-0002-9762-4818; Wang, Xiaohui/0000-0002-3415-5612; wang, yizhen/0000-0002-3908-7102; Wang, Jing/0000-0002-2806-6517; Fiorini, Zeno/0000-0001-5218-2502; Comita, Liza/0000-0002-9169-1331; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629	National Institutes of Health [R21CA138373, DA024044]; Cancer League of Colorado; American Association of Cancer Research; Sidney Kimmel Foundation for Cancer Research [SKF-08-101]; Stand Up to Cancer Innovative Research Award [SU2C]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer League of Colorado; American Association of Cancer Research; Sidney Kimmel Foundation for Cancer Research; Stand Up to Cancer Innovative Research Award; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The authors thank the National Institutes of Health (R21CA138373, DA024044), Cancer League of Colorado for financial supports of this work. H.Y. is also grateful for the 2009 Elion Award from the American Association of Cancer Research, a Kimmel Scholar Award from the Sidney Kimmel Foundation for Cancer Research (SKF-08-101) and a Stand Up to Cancer (SU2C) Innovative Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEY MC, 1988, CANCER RES, V48, P589; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Beaulieu E, 1997, BIOCHEM J, V326, P539, DOI 10.1042/bj3260539; Bray PG, 2003, TRENDS PARASITOL, V19, P232, DOI 10.1016/S1471-4922(03)00069-2; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; Grigoriev MY, 2002, CELL CYCLE, V1, P337, DOI 10.4161/cc.1.5.152; Jenssen Havard, 2008, V494, P177, DOI 10.1007/978-1-59745-419-3_10; Joce C, 2011, JOVE-J VIS EXP, DOI 10.3791/2721; Joce C, 2011, BBA-BIOMEMBRANES, V1808, P2948, DOI 10.1016/j.bbamem.2011.07.008; KAVATHAS P, 1980, P NATL ACAD SCI-BIOL, V77, P4251, DOI 10.1073/pnas.77.7.4251; Kaykas A, 2001, EMBO J, V20, P2641, DOI 10.1093/emboj/20.11.2641; Long HM, 2011, CURR OPIN IMMUNOL, V23, P258, DOI 10.1016/j.coi.2010.12.014; Maeda E, 2009, JPN J RADIOL, V27, P4, DOI 10.1007/s11604-008-0291-2; Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x; Quintana FJ, 2007, BIOCHEMISTRY-US, V46, P2317, DOI 10.1021/bi061849g; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Sackett DL, 2009, NAT CHEM, V1, P596, DOI 10.1038/nchem.427; Sammond DW, 2011, BIOPOLYMERS, V95, P772, DOI 10.1002/bip.21672; Sheikh MS, 2003, CELL CYCLE, V2, P550, DOI 10.4161/cc.2.6.566; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Sun BH, 2000, WORLD J GASTROENTERO, V6, P356; Toussirot E, 2008, BEST PRACT RES CL RH, V22, P883, DOI 10.1016/j.berh.2008.09.007; Vereide D, 2009, SEMIN CANCER BIOL, V19, P389, DOI 10.1016/j.semcancer.2009.07.006; Verma S, 2006, BRAIN BEHAV IMMUN, V20, P449, DOI 10.1016/j.bbi.2005.10.005; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang XH, 2008, J PHYS CHEM B, V112, P8346, DOI 10.1021/jp712026m; Wang X, 2007, PROTEIN EXPRES PURIF, V56, P27, DOI 10.1016/j.pep.2007.05.011; Wang XH, 2012, BBA-BIOMEMBRANES, V1818, P2282, DOI 10.1016/j.bbamem.2012.05.013; Wang XH, 2012, P NATL ACAD SCI USA, V109, P6325, DOI 10.1073/pnas.1200130109; Wang XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006665; Wilson AJ, 2009, CHEM SOC REV, V38, P3289, DOI 10.1039/b807197g; Yin H, 2008, ANGEW CHEM INT EDIT, V47, P2744, DOI 10.1002/anie.200704780; Yin H, 2006, J BIOL CHEM, V281, P36732, DOI 10.1074/jbc.M605877200; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zhang BC, 2012, CELL, V148, P739, DOI 10.1016/j.cell.2011.12.031; Zhao TX, 2010, CURR PHARM DESIGN, V16, P1055, DOI 10.2174/138161210790963878	38	318	350	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47703	10.1371/journal.pone.0047703	http://dx.doi.org/10.1371/journal.pone.0047703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23110176	gold, Green Published, Green Submitted			2022-12-25	WOS:000310050200040
